Citrus Sinensis ID: 007020
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 621 | 2.2.26 [Sep-21-2011] | |||||||
| Q94AG2 | 625 | Somatic embryogenesis rec | yes | no | 0.988 | 0.982 | 0.907 | 0.0 | |
| Q9XIC7 | 628 | Somatic embryogenesis rec | no | no | 0.969 | 0.958 | 0.933 | 0.0 | |
| Q94F62 | 615 | BRASSINOSTEROID INSENSITI | no | no | 0.966 | 0.975 | 0.801 | 0.0 | |
| Q9SKG5 | 620 | Somatic embryogenesis rec | no | no | 0.945 | 0.946 | 0.762 | 0.0 | |
| Q8LPS5 | 601 | Somatic embryogenesis rec | no | no | 0.940 | 0.971 | 0.681 | 0.0 | |
| Q8RY65 | 635 | Protein NSP-INTERACTING K | no | no | 0.950 | 0.929 | 0.546 | 1e-176 | |
| C0LGT1 | 613 | Probable LRR receptor-lik | no | no | 0.972 | 0.985 | 0.552 | 1e-175 | |
| Q9LFS4 | 638 | Protein NSP-INTERACTING K | no | no | 0.956 | 0.931 | 0.527 | 1e-174 | |
| C0LGX1 | 607 | Probable LRR receptor-lik | no | no | 0.962 | 0.985 | 0.547 | 1e-171 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.979 | 0.962 | 0.526 | 1e-164 |
| >sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 1055 bits (2728), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 558/615 (90%), Positives = 589/615 (95%), Gaps = 1/615 (0%)
Query: 8 LCLILV-VHSSWLASANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNNDNS 66
L LIL+ HS WLASAN+EGDALH+LR L+DPNNVLQSWDPTLVNPCTWFHVTCNN+NS
Sbjct: 11 LSLILLPNHSLWLASANLEGDALHTLRVTLVDPNNVLQSWDPTLVNPCTWFHVTCNNENS 70
Query: 67 VIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFT 126
VIRVDLGNA LSG LV +LG+LKNLQYLELYSNNITGPIPS+LGNLT+LVSLDLYLNSF+
Sbjct: 71 VIRVDLGNAELSGHLVPELGVLKNLQYLELYSNNITGPIPSNLGNLTNLVSLDLYLNSFS 130
Query: 127 GPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLF 186
GPIP++LGKLSKLRFLRLNNNSL+G IPMSLTNI++LQVLDLSNNRLSG VPDNGSFSLF
Sbjct: 131 GPIPESLGKLSKLRFLRLNNNSLTGSIPMSLTNITTLQVLDLSNNRLSGSVPDNGSFSLF 190
Query: 187 TPISFANNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIAGGVAAGAAL 246
TPISFANNLDLCGPVT PCPGSPPFSPPPPFI PPP+S+P G TGAIAGGVAAGAAL
Sbjct: 191 TPISFANNLDLCGPVTSHPCPGSPPFSPPPPFIQPPPVSTPSGYGITGAIAGGVAAGAAL 250
Query: 247 LFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGR 306
LFAAPAIAFAWWRRRKP + FFDVPAEEDPEVHLGQLKRFSLRELQVA+D FSNKNILGR
Sbjct: 251 LFAAPAIAFAWWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGR 310
Query: 307 GGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 366
GGFGKVYKGRLADG+LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT
Sbjct: 311 GGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 370
Query: 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDV 426
ERLLVYPYMANGSVASCLRERPPSQ PLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDV
Sbjct: 371 ERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDV 430
Query: 427 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 486
KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG
Sbjct: 431 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 490
Query: 487 YGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQ 546
YGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ NY E E+EQ
Sbjct: 491 YGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQ 550
Query: 547 LIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELAPHPNSDWIV 606
+IQVALLCTQGSPM+RPKMSEVVRMLEGDGLAE+WDEWQKVE+LR+E++L+P+PNSDWI+
Sbjct: 551 VIQVALLCTQGSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEILREEIDLSPNPNSDWIL 610
Query: 607 DSTENLHAVELSGPR 621
DST NLHAVELSGPR
Sbjct: 611 DSTYNLHAVELSGPR 625
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9XIC7|SERK2_ARATH Somatic embryogenesis receptor kinase 2 OS=Arabidopsis thaliana GN=SERK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 1053 bits (2722), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 562/602 (93%), Positives = 585/602 (97%)
Query: 20 ASANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAALSG 79
AS+NMEGDALHSLR+NL+DPNNVLQSWDPTLVNPCTWFHVTCNN+NSVIRVDLGNA LSG
Sbjct: 27 ASSNMEGDALHSLRANLVDPNNVLQSWDPTLVNPCTWFHVTCNNENSVIRVDLGNADLSG 86
Query: 80 QLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKL 139
QLV QLG LKNLQYLELYSNNITGP+PSDLGNLT+LVSLDLYLNSFTGPIPD+LGKL KL
Sbjct: 87 QLVPQLGQLKNLQYLELYSNNITGPVPSDLGNLTNLVSLDLYLNSFTGPIPDSLGKLFKL 146
Query: 140 RFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCG 199
RFLRLNNNSL+GPIPMSLTNI +LQVLDLSNNRLSG VPDNGSFSLFTPISFANNLDLCG
Sbjct: 147 RFLRLNNNSLTGPIPMSLTNIMTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCG 206
Query: 200 PVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWR 259
PVT RPCPGSPPFSPPPPFIPPP + +PGG SATGAIAGGVAAGAALLFAAPA+AFAWWR
Sbjct: 207 PVTSRPCPGSPPFSPPPPFIPPPIVPTPGGYSATGAIAGGVAAGAALLFAAPALAFAWWR 266
Query: 260 RRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLAD 319
RRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLAD
Sbjct: 267 RRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLAD 326
Query: 320 GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 379
G+LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS
Sbjct: 327 GTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 386
Query: 380 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 439
VASCLRERPPSQLPL W R++IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA
Sbjct: 387 VASCLRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 446
Query: 440 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQR 499
VVGDFGLA+LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQR
Sbjct: 447 VVGDFGLARLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQR 506
Query: 500 AFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSP 559
AFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ+NY EAEVEQLIQVALLCTQ SP
Sbjct: 507 AFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQSSP 566
Query: 560 MDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSG 619
M+RPKMSEVVRMLEGDGLAE+WDEWQKVEVLRQEVEL+ HP SDWI+DST+NLHA+ELSG
Sbjct: 567 MERPKMSEVVRMLEGDGLAEKWDEWQKVEVLRQEVELSSHPTSDWILDSTDNLHAMELSG 626
Query: 620 PR 621
PR
Sbjct: 627 PR 628
|
Serine/threonine-kinase involved in brassinosteroid-dependent and -independent signaling pathways. Acts redundantly with SERK1 as a control point for sporophytic development controlling male gametophyte production. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 929 bits (2401), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 493/615 (80%), Positives = 523/615 (85%), Gaps = 15/615 (2%)
Query: 10 LILVVHSSWLASANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIR 69
LILV+ S N EGDAL +L+++L DPN VLQSWD TLV PCTWFHVTCN+DNSV R
Sbjct: 13 LILVLDLVLRVSGNAEGDALSALKNSLADPNKVLQSWDATLVTPCTWFHVTCNSDNSVTR 72
Query: 70 VDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPI 129
VDLGNA LSGQLV QLG L NLQYLELYSNNITG IP LGNLT LVSLDLYLN+ +GPI
Sbjct: 73 VDLGNANLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLTELVSLDLYLNNLSGPI 132
Query: 130 PDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPI 189
P TLG+L KLRFLRLNNNSLSG IP SLT + +LQVLDLSNN L+G +P NGSFSLFTPI
Sbjct: 133 PSTLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNNPLTGDIPVNGSFSLFTPI 192
Query: 190 SFANNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFA 249
SFAN +P + PPP I P P S G N TGAIAGGVAAGAALLFA
Sbjct: 193 SFAN------------TKLTPLPASPPPPISPTPPSPAGSNRITGAIAGGVAAGAALLFA 240
Query: 250 APAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGF 309
PAIA AWWRR+KPQ+ FFDVPAEEDPEVHLGQLKRFSLRELQVA+D+FSNKNILGRGGF
Sbjct: 241 VPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGF 300
Query: 310 GKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369
GKVYKGRLADG+LVAVKRLKEERT GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL
Sbjct: 301 GKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 360
Query: 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAA 429
LVYPYMANGSVASCLRERP SQ PLDWP R+RIALGSARGL+YLHDHCDPKIIHRDVKAA
Sbjct: 361 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA 420
Query: 430 NILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGI 489
NILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG+
Sbjct: 421 NILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV 480
Query: 490 MLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQ 549
MLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE LVD DLQ NY + EVEQLIQ
Sbjct: 481 MLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQ 540
Query: 550 VALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELAPH--PNSDWIV- 606
VALLCTQ SPM+RPKMSEVVRMLEGDGLAERW+EWQK E+ RQ+ H S WI+
Sbjct: 541 VALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNYPTHHPAVSGWIIG 600
Query: 607 DSTENLHAVELSGPR 621
DST + SGPR
Sbjct: 601 DSTSQIENEYPSGPR 615
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 875 bits (2260), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/607 (76%), Positives = 506/607 (83%), Gaps = 20/607 (3%)
Query: 21 SANMEGDALHSLRSNLI--DP-NNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAAL 77
+ N EGDAL L+++L DP NNVLQSWD TLV PCTWFHVTCN +N V RVDLGNA L
Sbjct: 28 AGNAEGDALTQLKNSLSSGDPANNVLQSWDATLVTPCTWFHVTCNPENKVTRVDLGNAKL 87
Query: 78 SGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLS 137
SG+LV +LG L NLQYLELYSNNITG IP +LG+L LVSLDLY NS +GPIP +LGKL
Sbjct: 88 SGKLVPELGQLLNLQYLELYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKLG 147
Query: 138 KLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDL 197
KLRFLRLNNNSLSG IPM+LT++ LQVLD+SNNRLSG +P NGSFSLFTPISFANN
Sbjct: 148 KLRFLRLNNNSLSGEIPMTLTSVQ-LQVLDISNNRLSGDIPVNGSFSLFTPISFANN--- 203
Query: 198 CGPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAW 257
+T P PPP P P G T AIAGGVAAGAALLFA PAIAFAW
Sbjct: 204 --SLTDLP--------EPPPTSTSPTPPPPSGGQMTAAIAGGVAAGAALLFAVPAIAFAW 253
Query: 258 WRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRL 317
W RRKPQ+ FFDVPAEEDPEVHLGQLKRF+LREL VATD+FSNKN+LGRGGFGKVYKGRL
Sbjct: 254 WLRRKPQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRL 313
Query: 318 ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 377
ADG+LVAVKRLKEERT GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN
Sbjct: 314 ADGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 373
Query: 378 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF 437
GSVASCLRERP LDWP RK IALGSARGL+YLHDHCD KIIHRDVKAANILLDEEF
Sbjct: 374 GSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEF 433
Query: 438 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG 497
EAVVGDFGLAKLM+Y D+HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG+MLLELITG
Sbjct: 434 EAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 493
Query: 498 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQG 557
Q+AFDLARLANDDD+MLLDWVK +LKEKKLE LVD +L+ YVE EVEQLIQ+ALLCTQ
Sbjct: 494 QKAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQS 553
Query: 558 SPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEV--ELAPHPNSDWIVDSTENLHAV 615
S M+RPKMSEVVRMLEGDGLAERW+EWQK E+ + + PH +DW++ + +L
Sbjct: 554 SAMERPKMSEVVRMLEGDGLAERWEEWQKEEMPIHDFNYQAYPHAGTDWLIPYSNSLIEN 613
Query: 616 EL-SGPR 621
+ SGPR
Sbjct: 614 DYPSGPR 620
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LPS5|SERK5_ARATH Somatic embryogenesis receptor kinase 5 OS=Arabidopsis thaliana GN=SERK5 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 778 bits (2009), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/618 (68%), Positives = 475/618 (76%), Gaps = 34/618 (5%)
Query: 10 LILVVHSSWLASANMEGDALHSLRSNLID---PNNVLQSWDPTLVNPCTWFHVTCNNDNS 66
LIL + + + DAL +LRS+L NN+LQSW+ T V PC+WFHVTCN +NS
Sbjct: 12 LILFLDFVSRVTGKTQVDALIALRSSLSSGDHTNNILQSWNATHVTPCSWFHVTCNTENS 71
Query: 67 VIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFT 126
V R+DLG+A LSG+LV QL L NLQYLEL++NNITG IP +LG+L LVSLDL+ N+ +
Sbjct: 72 VTRLDLGSANLSGELVPQLAQLPNLQYLELFNNNITGEIPEELGDLMELVSLDLFANNIS 131
Query: 127 GPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLF 186
GPIP +LGKL KLRFLRL NNSLSG IP SLT + L VLD+SNNRLSG +P NGSFS F
Sbjct: 132 GPIPSSLGKLGKLRFLRLYNNSLSGEIPRSLTALP-LDVLDISNNRLSGDIPVNGSFSQF 190
Query: 187 TPISFANNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIAGGVAAGAAL 246
T +SFANN P P SP + + AI GVAAGAAL
Sbjct: 191 TSMSFANN----------------------KLRPRPASPSPSPSGTSAAIVVGVAAGAAL 228
Query: 247 LFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGR 306
LFA RRK Q F DVPAEEDPEV+LGQ KRFSLREL VAT+ FS +N+LG+
Sbjct: 229 LFALAWWL-----RRKLQGHFLDVPAEEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGK 283
Query: 307 GGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 366
G FG +YKGRLAD +LVAVKRL EERT GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT
Sbjct: 284 GRFGILYKGRLADDTLVAVKRLNEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 343
Query: 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDV 426
ERLLVYPYMANGSVASCLRERP LDWP RK IALGSARGL+YLHDHCD KIIH DV
Sbjct: 344 ERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDV 403
Query: 427 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 486
KAANILLDEEFEAVVGDFGLAKLM+Y D+HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG
Sbjct: 404 KAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 463
Query: 487 YGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQ 546
YG+MLLELITGQ+AFDLARLANDDD+MLLDWVK +LKEKKLE LVD +L+ YVE EVEQ
Sbjct: 464 YGVMLLELITGQKAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQ 523
Query: 547 LIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEV--ELAPHPNSDW 604
LIQ+ALLCTQ S M+RPKMSEVVRMLEGDGLAERW+EWQK E+ + + PH +DW
Sbjct: 524 LIQMALLCTQSSAMERPKMSEVVRMLEGDGLAERWEEWQKEEMPIHDFNYQAYPHAGTDW 583
Query: 605 IVDSTENLHAVEL-SGPR 621
++ + +L + SGPR
Sbjct: 584 LIPYSNSLIENDYPSGPR 601
|
Serine/threonine-kinase of unknown function. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 619 bits (1596), Expect = e-176, Method: Compositional matrix adjust.
Identities = 332/607 (54%), Positives = 415/607 (68%), Gaps = 17/607 (2%)
Query: 22 ANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAALSGQL 81
N E AL ++S+L DP+ VL +WD T V+PC+W +TC+ D VIR++ + LSG L
Sbjct: 39 VNFEVVALIGIKSSLTDPHGVLMNWDDTAVDPCSWNMITCS-DGFVIRLEAPSQNLSGTL 97
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
S +G L NLQ + L +N ITG IP ++G L L +LDL N+FTG IP TL L++
Sbjct: 98 SSSIGNLTNLQTVLLQNNYITGNIPHEIGKLMKLKTLDLSTNNFTGQIPFTLSYSKNLQY 157
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPV 201
LR+NNNSL+G IP SL N++ L LDLS N LSG VP SL + N +C
Sbjct: 158 LRVNNNSLTGTIPSSLANMTQLTFLDLSYNNLSGPVPR----SLAKTFNVMGNSQICPTG 213
Query: 202 TGRPCPGSPPFSPPPPFIPPPPISSPGGNSATG-AIAGGVAAGAALLFAAPAIAFAWWRR 260
T + C G+ P SS GG A+ GV+ L WWRR
Sbjct: 214 TEKDCNGTQPKPMSITLNSSQNKSSDGGTKNRKIAVVFGVSLTCVCLLIIGFGFLLWWRR 273
Query: 261 R-KPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLAD 319
R Q FFD+ + E+ LG L+RF+ +ELQ AT +FS+KN++G+GGFG VYKG L D
Sbjct: 274 RHNKQVLFFDINEQNKEEMCLGNLRRFNFKELQSATSNFSSKNLVGKGGFGNVYKGCLHD 333
Query: 320 GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 379
GS++AVKRLK+ GGE+QFQTE+EMIS+AVHRNLLRL GFC T +ERLLVYPYM+NGS
Sbjct: 334 GSIIAVKRLKDINNGGGEVQFQTELEMISLAVHRNLLRLYGFCTTSSERLLVYPYMSNGS 393
Query: 380 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 439
VAS L+ +P LDW TRKRIALG+ RGL YLH+ CDPKIIHRDVKAANILLD+ FEA
Sbjct: 394 VASRLKAKPV----LDWGTRKRIALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYFEA 449
Query: 440 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQR 499
VVGDFGLAKL+D++++HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+GI+LLELITG R
Sbjct: 450 VVGDFGLAKLLDHEESHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLR 509
Query: 500 AFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSP 559
A + + AN +LDWVK L +EKKLE +VD DL++NY EVE+++QVALLCTQ P
Sbjct: 510 ALEFGKAANQRGA-ILDWVKKLQQEKKLEQIVDKDLKSNYDRIEVEEMVQVALLCTQYLP 568
Query: 560 MDRPKMSEVVRMLEGDGLAERWD-EWQKVEVLRQEVE----LAPHPNSDWIVDSTENLHA 614
+ RPKMSEVVRMLEGDGL E+W+ Q+ E R + + SD DS+ + A
Sbjct: 569 IHRPKMSEVVRMLEGDGLVEKWEASSQRAETNRSYSKPNEFSSSERYSDLTDDSSVLVQA 628
Query: 615 VELSGPR 621
+ELSGPR
Sbjct: 629 MELSGPR 635
|
Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT1|Y5129_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g10290 OS=Arabidopsis thaliana GN=At5g10290 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 614 bits (1583), Expect = e-175, Method: Compositional matrix adjust.
Identities = 345/625 (55%), Positives = 416/625 (66%), Gaps = 21/625 (3%)
Query: 1 MKTKVWALCLILVVHSSWLASANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVT 60
++ A L+ S + +GDAL +LR +L N L W+ VNPCTW V
Sbjct: 6 LQKMAMAFTLLFFACLCSFVSPDAQGDALFALRISLRALPNQLSDWNQNQVNPCTWSQVI 65
Query: 61 CNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDL 120
C++ N V + L + SG L S++G+L+NL+ L L N ITG IP D GNLTSL SLDL
Sbjct: 66 CDDKNFVTSLTLSDMNFSGTLSSRVGILENLKTLTLKGNGITGEIPEDFGNLTSLTSLDL 125
Query: 121 YLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN 180
N TG IP T+G L KL+FL L+ N L+G IP SLT + +L L L +N LSG +P
Sbjct: 126 EDNQLTGRIPSTIGNLKKLQFLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSGQIPQ- 184
Query: 181 GSFSLFTPISF---ANNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIA 237
SLF + +NNL+ CG GR P P + S TG IA
Sbjct: 185 ---SLFEIPKYNFTSNNLN-CG---GRQ---------PHPCVSAVAHSGDSSKPKTGIIA 228
Query: 238 GGVAAGAALLFAAPAIAFAWWRRR-KPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATD 296
G VA +LF F R + ++ F DV E D + GQLKRF+ RELQ+ATD
Sbjct: 229 GVVAGVTVVLFGILLFLFCKDRHKGYRRDVFVDVAGEVDRRIAFGQLKRFAWRELQLATD 288
Query: 297 SFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 356
+FS KN+LG+GGFGKVYKG L D + VAVKRL + +PGG+ FQ EVEMIS+AVHRNLL
Sbjct: 289 NFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 348
Query: 357 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 416
RL GFC T TERLLVYP+M N S+A LRE LDW TRKRIALG+ARG YLH+H
Sbjct: 349 RLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGDPVLDWETRKRIALGAARGFEYLHEH 408
Query: 417 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 476
C+PKIIHRDVKAAN+LLDE+FEAVVGDFGLAKL+D + T+VTT VRGT+GHIAPEYLSTG
Sbjct: 409 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTG 468
Query: 477 KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 536
KSSE+TDVFGYGIMLLEL+TGQRA D +RL +DDV+LLD VK L +EK+L +VD +L
Sbjct: 469 KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLGAIVDKNLD 528
Query: 537 NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVEL 596
Y++ EVE +IQVALLCTQGSP DRP MSEVVRMLEG+GLAERW+EWQ VEV R+
Sbjct: 529 GEYIKEEVEMMIQVALLCTQGSPEDRPVMSEVVRMLEGEGLAERWEEWQNVEVTRRHEFE 588
Query: 597 APHPNSDWIVDSTENLHAVELSGPR 621
DW DS N A+ELSG R
Sbjct: 589 RLQRRFDWGEDSMHNQDAIELSGGR 613
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 612 bits (1578), Expect = e-174, Method: Compositional matrix adjust.
Identities = 336/637 (52%), Positives = 436/637 (68%), Gaps = 43/637 (6%)
Query: 8 LCLILVVHSSWLA--SANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNNDN 65
LCL+ L+ N E AL ++++L DP+ VL +WD V+PC+W VTC+++N
Sbjct: 22 LCLLCSSVHGLLSPKGVNFEVQALMDIKASLHDPHGVLDNWDRDAVDPCSWTMVTCSSEN 81
Query: 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSF 125
VI + + LSG L + L NL+ + L +NNI G IP+++G LT L +LDL N F
Sbjct: 82 FVIGLGTPSQNLSGTLSPSITNLTNLRIVLLQNNNIKGKIPAEIGRLTRLETLDLSDNFF 141
Query: 126 TGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSL 185
G IP ++G L L++LRLNNNSLSG P+SL+N++ L LDLS N LSG VP
Sbjct: 142 HGEIPFSVGYLQSLQYLRLNNNSLSGVFPLSLSNMTQLAFLDLSYNNLSGPVPR------ 195
Query: 186 FTPISFANNLDLCGPVTGRP--CP-GSPPFSPPPPFIPPP--------PISSPGGNSATG 234
F +F+ + G P CP G+ P IP P+ + G +
Sbjct: 196 FAAKTFS--------IVGNPLICPTGTEPDCNGTTLIPMSMNLNQTGVPLYAGGSRNHKM 247
Query: 235 AIAGGVAAGA-ALLFAAPAIAFAWWRRRKPQEFFFDVP-AEEDPEVHLGQLKRFSLRELQ 292
AIA G + G +L+F A + F WWR+R Q FFDV EV LG L+RF RELQ
Sbjct: 248 AIAVGSSVGTVSLIFIAVGL-FLWWRQRHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQ 306
Query: 293 VATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH 352
+AT++FS+KN+LG+GG+G VYKG L D ++VAVKRLK+ GGE+QFQTEVEMIS+AVH
Sbjct: 307 IATNNFSSKNLLGKGGYGNVYKGILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVH 366
Query: 353 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 412
RNLLRL GFC+T TE+LLVYPYM+NGSVAS ++ +P LDW RKRIA+G+ARGL Y
Sbjct: 367 RNLLRLYGFCITQTEKLLVYPYMSNGSVASRMKAKPV----LDWSIRKRIAIGAARGLVY 422
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 472
LH+ CDPKIIHRDVKAANILLD+ EAVVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEY
Sbjct: 423 LHEQCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEY 482
Query: 473 LSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532
LSTG+SSEKTDVFG+GI+LLEL+TGQRAF+ + AN VM LDWVK + +EKKLE+LVD
Sbjct: 483 LSTGQSSEKTDVFGFGILLLELVTGQRAFEFGKAANQKGVM-LDWVKKIHQEKKLELLVD 541
Query: 533 PDL--QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVL 590
+L + +Y E E++++++VALLCTQ P RPKMSEVVRMLEGDGLAE+W+ Q+ + +
Sbjct: 542 KELLKKKSYDEIELDEMVRVALLCTQYLPGHRPKMSEVVRMLEGDGLAEKWEASQRSDSV 601
Query: 591 RQ------EVELAPHPNSDWIVDSTENLHAVELSGPR 621
+ E+ + SD DS+ + A+ELSGPR
Sbjct: 602 SKCSNRINELMSSSDRYSDLTDDSSLLVQAMELSGPR 638
|
Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGX1|Y5524_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g65240 OS=Arabidopsis thaliana GN=At5g65240 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 603 bits (1555), Expect = e-171, Method: Compositional matrix adjust.
Identities = 341/623 (54%), Positives = 414/623 (66%), Gaps = 25/623 (4%)
Query: 7 ALCLI--LVVHSSWLA-SANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNN 63
AL +I LV S W + S + +GDAL +LRS+L L W+ V+PCTW V C++
Sbjct: 2 ALLIITALVFSSLWSSVSPDAQGDALFALRSSLRASPEQLSDWNQNQVDPCTWSQVICDD 61
Query: 64 DNSVIRVDLGNAALS-GQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYL 122
V V L S G L S +G+L L+ L L N I G IP +GNL+SL SLDL
Sbjct: 62 KKHVTSVTLSYMNFSSGTLSSGIGILTTLKTLTLKGNGIMGGIPESIGNLSSLTSLDLED 121
Query: 123 NSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGS 182
N T IP TLG L L+FL L+ N+L+G IP SLT +S L + L +N LSG +P
Sbjct: 122 NHLTDRIPSTLGNLKNLQFLTLSRNNLNGSIPDSLTGLSKLINILLDSNNLSGEIPQ--- 178
Query: 183 FSLFTPISF---ANNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIAGG 239
SLF + ANNL CG +PC + S + TG IAG
Sbjct: 179 -SLFKIPKYNFTANNLS-CGGTFPQPC------------VTESSPSGDSSSRKTGIIAGV 224
Query: 240 VAAGAALLFAAPAIAFAWWRRR-KPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSF 298
V+ A +L F + + ++ F DV E D + GQL+RF+ RELQ+ATD F
Sbjct: 225 VSGIAVILLGFFFFFFCKDKHKGYKRDVFVDVAGEVDRRIAFGQLRRFAWRELQLATDEF 284
Query: 299 SNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL 358
S KN+LG+GGFGKVYKG L+DG+ VAVKRL + PGG+ FQ EVEMIS+AVHRNLLRL
Sbjct: 285 SEKNVLGQGGFGKVYKGLLSDGTKVAVKRLTDFERPGGDEAFQREVEMISVAVHRNLLRL 344
Query: 359 RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 418
GFC T TERLLVYP+M N SVA CLRE P LDW RK+IALG+ARGL YLH+HC+
Sbjct: 345 IGFCTTQTERLLVYPFMQNLSVAYCLREIKPGDPVLDWFRRKQIALGAARGLEYLHEHCN 404
Query: 419 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 478
PKIIHRDVKAAN+LLDE+FEAVVGDFGLAKL+D + T+VTT VRGT+GHIAPE +STGKS
Sbjct: 405 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPECISTGKS 464
Query: 479 SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNN 538
SEKTDVFGYGIMLLEL+TGQRA D +RL +DDV+LLD VK L +EK+LE +VD L +
Sbjct: 465 SEKTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLEDIVDKKLDED 524
Query: 539 YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELAP 598
Y++ EVE +IQVALLCTQ +P +RP MSEVVRMLEG+GLAERW+EWQ +EV RQE
Sbjct: 525 YIKEEVEMMIQVALLCTQAAPEERPAMSEVVRMLEGEGLAERWEEWQNLEVTRQEEFQRL 584
Query: 599 HPNSDWIVDSTENLHAVELSGPR 621
DW DS N A+ELSG R
Sbjct: 585 QRRFDWGEDSINNQDAIELSGGR 607
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 580 bits (1495), Expect = e-164, Method: Compositional matrix adjust.
Identities = 334/634 (52%), Positives = 425/634 (67%), Gaps = 26/634 (4%)
Query: 5 VWALCLILVVHSSWLASA-------NMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWF 57
VW L ++ V ++SA N E AL ++++ L DP VL++WD V+PC+W
Sbjct: 8 VWRLGFLVFVWFFDISSATLSPTGVNYEVTALVAVKNELNDPYKVLENWDVNSVDPCSWR 67
Query: 58 HVTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVS 117
V+C D V +DL + +LSG L ++G L LQ + L +N ITGPIP +G L L S
Sbjct: 68 MVSCT-DGYVSSLDLPSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIGRLEKLQS 126
Query: 118 LDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVV 177
LDL NSFTG IP +LG+L L +LRLNNNSL G P SL+ I L ++D+S N LSG +
Sbjct: 127 LDLSNNSFTGEIPASLGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSL 186
Query: 178 PDNGSFSLFTPISFANNLDLCGPVTGRPCPGSP-PFSPPPPFIPPPPISSPGGNSATGAI 236
P + + N +CGP C P P + P P S N A+
Sbjct: 187 PKVSARTF----KVIGNALICGPKAVSNCSAVPEPLTLPQD---GPDESGTRTNGHHVAL 239
Query: 237 AGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATD 296
A + AA + F WWR R+ ++ FFDV + DPEV LG LKR++ +EL+ AT+
Sbjct: 240 AFAASFSAAFFVFFTSGMFLWWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATN 299
Query: 297 SFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 356
F++KNILGRGG+G VYKG L DG+LVAVKRLK+ GGE+QFQTEVE IS+A+HRNLL
Sbjct: 300 HFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLL 359
Query: 357 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 416
RLRGFC + ER+LVYPYM NGSVAS L++ + LDW RK+IA+G+ARGL YLH+
Sbjct: 360 RLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQ 419
Query: 417 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 476
CDPKIIHRDVKAANILLDE+FEAVVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLSTG
Sbjct: 420 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 479
Query: 477 KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 536
+SSEKTDVFG+GI+LLELITGQ+A D R A+ VM LDWVK L +E KL+ L+D DL
Sbjct: 480 QSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVM-LDWVKKLHQEGKLKQLIDKDLN 538
Query: 537 NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVEL 596
+ + E+E+++QVALLCTQ +P RPKMSEV++MLEGDGLAERW+ Q Q L
Sbjct: 539 DKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMKMLEGDGLAERWEATQNGTGEHQPPPL 598
Query: 597 AP---------HPNSDWIVDSTENLHAVELSGPR 621
P SD+I +S+ + A+ELSGPR
Sbjct: 599 PPGMVSSSPRVRYYSDYIQESSLVVEAIELSGPR 632
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 621 | ||||||
| 227184173 | 621 | somatic embryogenesis receptor-like kina | 1.0 | 1.0 | 1.0 | 0.0 | |
| 50657183 | 621 | somatic embryogenesis receptor kinase 1 | 0.995 | 0.995 | 0.972 | 0.0 | |
| 152926154 | 624 | somatic embryogenesis receptor kinase [C | 1.0 | 0.995 | 0.955 | 0.0 | |
| 152926161 | 624 | somatic embryogenesis receptor kinase [C | 1.0 | 0.995 | 0.953 | 0.0 | |
| 406868969 | 626 | protein kinase [Prunus persica] | 1.0 | 0.992 | 0.950 | 0.0 | |
| 356576127 | 624 | PREDICTED: somatic embryogenesis recepto | 1.0 | 0.995 | 0.948 | 0.0 | |
| 306489670 | 626 | somatic embryogenesis receptor-like kina | 0.990 | 0.982 | 0.949 | 0.0 | |
| 399146057 | 632 | somatic embryogenesis receptor-like kina | 0.990 | 0.973 | 0.942 | 0.0 | |
| 449441179 | 627 | PREDICTED: somatic embryogenesis recepto | 0.998 | 0.988 | 0.947 | 0.0 | |
| 224135431 | 627 | predicted protein [Populus trichocarpa] | 0.993 | 0.984 | 0.956 | 0.0 |
| >gi|227184173|gb|ACP20180.1| somatic embryogenesis receptor-like kinase [Citrus sinensis] | Back alignment and taxonomy information |
|---|
Score = 1269 bits (3285), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 621/621 (100%), Positives = 621/621 (100%)
Query: 1 MKTKVWALCLILVVHSSWLASANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVT 60
MKTKVWALCLILVVHSSWLASANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVT
Sbjct: 1 MKTKVWALCLILVVHSSWLASANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVT 60
Query: 61 CNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDL 120
CNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDL
Sbjct: 61 CNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDL 120
Query: 121 YLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN 180
YLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN
Sbjct: 121 YLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN 180
Query: 181 GSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIAGGV 240
GSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIAGGV
Sbjct: 181 GSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIAGGV 240
Query: 241 AAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSN 300
AAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSN
Sbjct: 241 AAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSN 300
Query: 301 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG 360
KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG
Sbjct: 301 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG 360
Query: 361 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 420
FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK
Sbjct: 361 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 420
Query: 421 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 480
IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE
Sbjct: 421 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 480
Query: 481 KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 540
KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV
Sbjct: 481 KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 540
Query: 541 EAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELAPHP 600
EAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELAPHP
Sbjct: 541 EAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELAPHP 600
Query: 601 NSDWIVDSTENLHAVELSGPR 621
NSDWIVDSTENLHAVELSGPR
Sbjct: 601 NSDWIVDSTENLHAVELSGPR 621
|
Source: Citrus sinensis Species: Citrus sinensis Genus: Citrus Family: Rutaceae Order: Sapindales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|50657183|dbj|BAD32780.1| somatic embryogenesis receptor kinase 1 [Citrus unshiu] | Back alignment and taxonomy information |
|---|
Score = 1116 bits (2886), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 607/624 (97%), Positives = 609/624 (97%), Gaps = 6/624 (0%)
Query: 1 MKTKVWALCLILVVHSSWLASANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFH-V 59
MKTKVWALCLILVVHSSWLASANMEGDALHSLRSNLIDPNNVL SWDP PC H V
Sbjct: 1 MKTKVWALCLILVVHSSWLASANMEGDALHSLRSNLIDPNNVLHSWDPY---PCQSLHMV 57
Query: 60 TC--NNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVS 117
+C +NSVI VDL NAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVS
Sbjct: 58 SCYMQMNNSVILVDLENAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVS 117
Query: 118 LDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVV 177
LDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVV
Sbjct: 118 LDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVV 177
Query: 178 PDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIA 237
PDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIA
Sbjct: 178 PDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIA 237
Query: 238 GGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDS 297
GGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDS
Sbjct: 238 GGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDS 297
Query: 298 FSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357
FSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR
Sbjct: 298 FSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357
Query: 358 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 417
LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC
Sbjct: 358 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 417
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 477
DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK
Sbjct: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 477
Query: 478 SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537
SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN
Sbjct: 478 SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537
Query: 538 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELA 597
NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELA
Sbjct: 538 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELA 597
Query: 598 PHPNSDWIVDSTENLHAVELSGPR 621
PHPNSDWIVDSTENLHAVELSGPR
Sbjct: 598 PHPNSDWIVDSTENLHAVELSGPR 621
|
Source: Citrus unshiu Species: Citrus unshiu Genus: Citrus Family: Rutaceae Order: Sapindales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|152926154|gb|ABS32228.1| somatic embryogenesis receptor kinase [Carica papaya] gi|164522080|gb|ABY60779.1| somatic embryogenesis receptor kinase [Carica papaya] | Back alignment and taxonomy information |
|---|
Score = 1106 bits (2860), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 596/624 (95%), Positives = 608/624 (97%), Gaps = 3/624 (0%)
Query: 1 MKTKVWALCL---ILVVHSSWLASANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWF 57
M+ +V A L I ++H WL SANMEGDALHSLR+NL DPNNVLQSWDPTLVNPCTWF
Sbjct: 1 MEARVGAFSLALLIFLLHPLWLGSANMEGDALHSLRTNLNDPNNVLQSWDPTLVNPCTWF 60
Query: 58 HVTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVS 117
HVTCNNDNSVIRVDLGNAALSGQLV QLGLLKNLQYLELYSNNI+GPIPSDLGNLTSLVS
Sbjct: 61 HVTCNNDNSVIRVDLGNAALSGQLVPQLGLLKNLQYLELYSNNISGPIPSDLGNLTSLVS 120
Query: 118 LDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVV 177
LDLYLNSF+GPIPD+LGKLSKLRFLRLNNNSL+GPIPMSLTNISSLQVLDLSNN LSGVV
Sbjct: 121 LDLYLNSFSGPIPDSLGKLSKLRFLRLNNNSLTGPIPMSLTNISSLQVLDLSNNHLSGVV 180
Query: 178 PDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIA 237
PDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPF+PPPPISSPGGNSATGAIA
Sbjct: 181 PDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPFVPPPPISSPGGNSATGAIA 240
Query: 238 GGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDS 297
GGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDS
Sbjct: 241 GGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDS 300
Query: 298 FSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357
FSNKNILGRGGFGKVYKGRLADG+LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR
Sbjct: 301 FSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 360
Query: 358 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 417
LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQ PLDWPTRKRIALGSARGLSYLHDHC
Sbjct: 361 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHC 420
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 477
DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK
Sbjct: 421 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 480
Query: 478 SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537
SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ
Sbjct: 481 SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQK 540
Query: 538 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELA 597
NYV+AEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELA
Sbjct: 541 NYVDAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELA 600
Query: 598 PHPNSDWIVDSTENLHAVELSGPR 621
PHPNSDWIVDSTENLHAVELSGPR
Sbjct: 601 PHPNSDWIVDSTENLHAVELSGPR 624
|
Source: Carica papaya Species: Carica papaya Genus: Carica Family: Caricaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|152926161|gb|ABS32233.1| somatic embryogenesis receptor kinase [Carica papaya] gi|164522085|gb|ABY60783.1| somatic embryogenesis receptor kinase [Carica papaya] | Back alignment and taxonomy information |
|---|
Score = 1105 bits (2857), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 595/624 (95%), Positives = 608/624 (97%), Gaps = 3/624 (0%)
Query: 1 MKTKVWALCL---ILVVHSSWLASANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWF 57
M+ +V A L I ++H WL SANMEGDALHSLR+NL DPNNVLQSWDPTLVNPCTWF
Sbjct: 1 MEARVGAFSLAFLIFLLHPLWLGSANMEGDALHSLRTNLNDPNNVLQSWDPTLVNPCTWF 60
Query: 58 HVTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVS 117
HVTCNNDNSVIRVDLGNAALSGQLV QLGLLKNLQYLELYSNNI+GPIPSDLGNLTSLVS
Sbjct: 61 HVTCNNDNSVIRVDLGNAALSGQLVPQLGLLKNLQYLELYSNNISGPIPSDLGNLTSLVS 120
Query: 118 LDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVV 177
LDLYLNSF+GPIPD+LGKLSKLRFLRLNNNSL+GPIPMSLTNISSLQVLDLSNN LSGVV
Sbjct: 121 LDLYLNSFSGPIPDSLGKLSKLRFLRLNNNSLTGPIPMSLTNISSLQVLDLSNNHLSGVV 180
Query: 178 PDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIA 237
PDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPF+PPPPISSPGGNSATGAIA
Sbjct: 181 PDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPFVPPPPISSPGGNSATGAIA 240
Query: 238 GGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDS 297
GGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDS
Sbjct: 241 GGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDS 300
Query: 298 FSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357
FSNKNILGRGGFGKVYKGRLADG+LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR
Sbjct: 301 FSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 360
Query: 358 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 417
LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQ PLDWPTRKRIALGSARGLSYLHDHC
Sbjct: 361 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHC 420
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 477
DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK
Sbjct: 421 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 480
Query: 478 SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537
SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ
Sbjct: 481 SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQR 540
Query: 538 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELA 597
NY++AEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELA
Sbjct: 541 NYIDAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELA 600
Query: 598 PHPNSDWIVDSTENLHAVELSGPR 621
PHPNSDWIVDSTENLHAVELSGPR
Sbjct: 601 PHPNSDWIVDSTENLHAVELSGPR 624
|
Source: Carica papaya Species: Carica papaya Genus: Carica Family: Caricaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|406868969|gb|AFS64763.1| protein kinase [Prunus persica] | Back alignment and taxonomy information |
|---|
Score = 1101 bits (2848), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 595/626 (95%), Positives = 606/626 (96%), Gaps = 5/626 (0%)
Query: 1 MKTKVW-ALCL--ILVVHSSWLAS--ANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCT 55
M++KV +LCL ILV H W+ ANMEGDALHSLR+NL DPNNVLQSWDPTLVNPCT
Sbjct: 1 MESKVGNSLCLWLILVAHPLWMTMVLANMEGDALHSLRTNLEDPNNVLQSWDPTLVNPCT 60
Query: 56 WFHVTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSL 115
WFHVTCNN+NSVIRVDLGNA LSGQLV QLGLLKNLQYLELYSNNI+GPIPS+LGNLTSL
Sbjct: 61 WFHVTCNNENSVIRVDLGNALLSGQLVPQLGLLKNLQYLELYSNNISGPIPSELGNLTSL 120
Query: 116 VSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSG 175
VSLDLYLNSF G IPDTLGKLSKLRFLRLNNNSL GPIPMSLTNISSLQVLDLSNN LSG
Sbjct: 121 VSLDLYLNSFAGLIPDTLGKLSKLRFLRLNNNSLVGPIPMSLTNISSLQVLDLSNNHLSG 180
Query: 176 VVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGA 235
VPDNGSFSLFTPISFANNL+LCGPVTGRPCPGSPPFSPPPPF+PPPPIS+PGGNSATGA
Sbjct: 181 EVPDNGSFSLFTPISFANNLNLCGPVTGRPCPGSPPFSPPPPFVPPPPISTPGGNSATGA 240
Query: 236 IAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVAT 295
IAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVAT
Sbjct: 241 IAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVAT 300
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 355
DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL
Sbjct: 301 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 360
Query: 356 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 415
LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQ PLDWPTRKRIALGSARGLSYLHD
Sbjct: 361 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHD 420
Query: 416 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 475
HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST
Sbjct: 421 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 480
Query: 476 GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 535
GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL
Sbjct: 481 GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 540
Query: 536 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVE 595
QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVE
Sbjct: 541 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVE 600
Query: 596 LAPHPNSDWIVDSTENLHAVELSGPR 621
LAPHPNSDWIVDSTENLHAVELSGPR
Sbjct: 601 LAPHPNSDWIVDSTENLHAVELSGPR 626
|
Source: Prunus persica Species: Prunus persica Genus: Prunus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356576127|ref|XP_003556185.1| PREDICTED: somatic embryogenesis receptor kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1093 bits (2828), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 592/624 (94%), Positives = 603/624 (96%), Gaps = 3/624 (0%)
Query: 1 MKTKVWALCLI---LVVHSSWLASANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWF 57
M+ K AL I ++VH L SANMEGDALHSLR+NL DPNNVLQSWDPTLVNPCTWF
Sbjct: 1 MERKFMALGFIWWVVLVHPLCLISANMEGDALHSLRTNLQDPNNVLQSWDPTLVNPCTWF 60
Query: 58 HVTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVS 117
HVTCNNDNSVIRVDLGNAALSGQLV QLG LKNLQYLELYSNNITGPIPSDLGNLT+LVS
Sbjct: 61 HVTCNNDNSVIRVDLGNAALSGQLVPQLGQLKNLQYLELYSNNITGPIPSDLGNLTNLVS 120
Query: 118 LDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVV 177
LDLYLN FTGPIPD+LGKLSKLRFLRLNNNSLSGPIPMSLTNI++LQVLDLSNN LSGVV
Sbjct: 121 LDLYLNHFTGPIPDSLGKLSKLRFLRLNNNSLSGPIPMSLTNITALQVLDLSNNHLSGVV 180
Query: 178 PDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIA 237
PDNGSFSLFTPISFANNLDLCGPVTG PCPGSPPFSPPPPF+PPPPIS+PGGN ATGAIA
Sbjct: 181 PDNGSFSLFTPISFANNLDLCGPVTGHPCPGSPPFSPPPPFVPPPPISAPGGNGATGAIA 240
Query: 238 GGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDS 297
GGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDS
Sbjct: 241 GGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDS 300
Query: 298 FSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357
FSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR
Sbjct: 301 FSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 360
Query: 358 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 417
LRGFCMTPTERLLVYPYMANGSVASCLRERPP Q PLDWPTRKRIALGSARGLSYLHDHC
Sbjct: 361 LRGFCMTPTERLLVYPYMANGSVASCLRERPPHQEPLDWPTRKRIALGSARGLSYLHDHC 420
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 477
DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK
Sbjct: 421 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 480
Query: 478 SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537
SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN
Sbjct: 481 SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 540
Query: 538 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELA 597
NY+EAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELA
Sbjct: 541 NYIEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELA 600
Query: 598 PHPNSDWIVDSTENLHAVELSGPR 621
PHPNSDWIVDSTENLHAVELSGPR
Sbjct: 601 PHPNSDWIVDSTENLHAVELSGPR 624
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|306489670|gb|ADM94278.1| somatic embryogenesis receptor-like kinase [Rosa canina] | Back alignment and taxonomy information |
|---|
Score = 1093 bits (2827), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 588/619 (94%), Positives = 600/619 (96%), Gaps = 4/619 (0%)
Query: 7 ALC--LILVVHSSW--LASANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCN 62
+LC LILV H W + +NMEGDALHSLR+NL DPNNVLQSWDPTLVNPCTWFHVTCN
Sbjct: 8 SLCPLLILVAHPLWIIMVLSNMEGDALHSLRANLEDPNNVLQSWDPTLVNPCTWFHVTCN 67
Query: 63 NDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYL 122
N+NSVIRVDLGNAALSGQLV LGLLKNLQYLELYSNNITGPIPS+LGNLTSLVSLDLYL
Sbjct: 68 NENSVIRVDLGNAALSGQLVPSLGLLKNLQYLELYSNNITGPIPSELGNLTSLVSLDLYL 127
Query: 123 NSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGS 182
NSFTG IPDTLGKLSKLRFLRLNNNSL G IPMSLTNISSLQVLDLSNN LSG VPDNGS
Sbjct: 128 NSFTGQIPDTLGKLSKLRFLRLNNNSLVGAIPMSLTNISSLQVLDLSNNHLSGEVPDNGS 187
Query: 183 FSLFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIAGGVAA 242
FSLFTPISFANNL+LCGPVTGRPCPGSPPFSPPPPF+PPPPIS+PGGNSATGAIAGGVAA
Sbjct: 188 FSLFTPISFANNLNLCGPVTGRPCPGSPPFSPPPPFVPPPPISTPGGNSATGAIAGGVAA 247
Query: 243 GAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKN 302
GAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKN
Sbjct: 248 GAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKN 307
Query: 303 ILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 362
ILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC
Sbjct: 308 ILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 367
Query: 363 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 422
MTPTERLLVYPYMANGSVASCLRERPPSQ PLDWPTRKRIALGSARGLSYLHDHCDPKII
Sbjct: 368 MTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKII 427
Query: 423 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 482
HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT
Sbjct: 428 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 487
Query: 483 DVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEA 542
DVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ NYV+A
Sbjct: 488 DVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQRNYVDA 547
Query: 543 EVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELAPHPNS 602
EVEQLIQVALLCTQGSPM+RPKMSEVVRMLEGDGLAERWDEWQKV+VLRQEVELAPHPNS
Sbjct: 548 EVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWDEWQKVKVLRQEVELAPHPNS 607
Query: 603 DWIVDSTENLHAVELSGPR 621
DWIVDSTENLHAVELSGPR
Sbjct: 608 DWIVDSTENLHAVELSGPR 626
|
Source: Rosa canina Species: Rosa canina Genus: Rosa Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|399146057|gb|AFP25205.1| somatic embryogenesis receptor-like kinase [Malus hupehensis] | Back alignment and taxonomy information |
|---|
Score = 1093 bits (2826), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 587/623 (94%), Positives = 602/623 (96%), Gaps = 8/623 (1%)
Query: 7 ALCLILVVHSSWLAS--ANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNND 64
L ILV H W+ ANMEGDALH+LR+NL DPNNVLQSWDPTLVNPCTWFHVTCNN+
Sbjct: 10 CLWFILVAHPLWMTMVLANMEGDALHTLRTNLEDPNNVLQSWDPTLVNPCTWFHVTCNNE 69
Query: 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNS 124
NSVIRVDLGNAALSGQLV QLGLLKNLQYLELYSNN++GPIPS+LGNLTSLVSLDLYLNS
Sbjct: 70 NSVIRVDLGNAALSGQLVPQLGLLKNLQYLELYSNNMSGPIPSELGNLTSLVSLDLYLNS 129
Query: 125 FTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
F+G IP TLG+LSKLRFLRLNNNSL+GPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS
Sbjct: 130 FSGLIPGTLGRLSKLRFLRLNNNSLAGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 189
Query: 185 LFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPISSPG------GNSATGAIAG 238
LFTPISFANN+DLCGPVTGRPCPGSPPFSPPPPF+PPPPIS+PG GNSATGAIAG
Sbjct: 190 LFTPISFANNMDLCGPVTGRPCPGSPPFSPPPPFVPPPPISTPGIASLVGGNSATGAIAG 249
Query: 239 GVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSF 298
GVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSF
Sbjct: 250 GVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSF 309
Query: 299 SNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL 358
SNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL
Sbjct: 310 SNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL 369
Query: 359 RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 418
RGFCMTPTERLLVYPYMANGSVASCLRERPP+Q PLDWPTRKRIALGSARGLSYLHDHCD
Sbjct: 370 RGFCMTPTERLLVYPYMANGSVASCLRERPPNQPPLDWPTRKRIALGSARGLSYLHDHCD 429
Query: 419 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 478
PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS
Sbjct: 430 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 489
Query: 479 SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNN 538
SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ+N
Sbjct: 490 SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQSN 549
Query: 539 YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELAP 598
YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELAP
Sbjct: 550 YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELAP 609
Query: 599 HPNSDWIVDSTENLHAVELSGPR 621
HPNSDWIVDSTENLHAVELSGPR
Sbjct: 610 HPNSDWIVDSTENLHAVELSGPR 632
|
Source: Malus hupehensis Species: Malus hupehensis Genus: Malus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449441179|ref|XP_004138361.1| PREDICTED: somatic embryogenesis receptor kinase 1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1093 bits (2826), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 590/623 (94%), Positives = 604/623 (96%), Gaps = 3/623 (0%)
Query: 2 KTKVWAL---CLILVVHSSWLASANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFH 58
+ KV AL LIL+V WL SANMEGDALHSLR++L DPNNVLQSWDPTLVNPCTWFH
Sbjct: 5 QYKVLALGFVSLILLVRPLWLVSANMEGDALHSLRTSLQDPNNVLQSWDPTLVNPCTWFH 64
Query: 59 VTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSL 118
VTCNNDNSVIRVDLGNAALSG LV QLGLLKNLQYLELYSNNI+G IPSDLGNLTSLVSL
Sbjct: 65 VTCNNDNSVIRVDLGNAALSGTLVPQLGLLKNLQYLELYSNNISGVIPSDLGNLTSLVSL 124
Query: 119 DLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
DLYLN F+GPIPDTLGKLSKLRFLRLNNNSL+GPIPMSLTNISSLQVLDLSNN LSGVVP
Sbjct: 125 DLYLNRFSGPIPDTLGKLSKLRFLRLNNNSLAGPIPMSLTNISSLQVLDLSNNHLSGVVP 184
Query: 179 DNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIAG 238
DNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPF+PPPPISSPGGNSATGAIAG
Sbjct: 185 DNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPFVPPPPISSPGGNSATGAIAG 244
Query: 239 GVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSF 298
GVAAGAALLFAAPAIAFAWWRRRKPQE FFDVPAEEDPEVHLGQLKRFSLRELQVATDSF
Sbjct: 245 GVAAGAALLFAAPAIAFAWWRRRKPQEVFFDVPAEEDPEVHLGQLKRFSLRELQVATDSF 304
Query: 299 SNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL 358
SNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL
Sbjct: 305 SNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL 364
Query: 359 RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 418
RGFCMTPTERLLVYPYMANGSVASCLRERPPSQ PLDW TRKRIALGSARGLSYLHDHCD
Sbjct: 365 RGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWRTRKRIALGSARGLSYLHDHCD 424
Query: 419 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 478
PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS
Sbjct: 425 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 484
Query: 479 SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNN 538
SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNN
Sbjct: 485 SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNN 544
Query: 539 YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELAP 598
Y+E+EVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVE+LRQE++L+P
Sbjct: 545 YIESEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEILRQEIDLSP 604
Query: 599 HPNSDWIVDSTENLHAVELSGPR 621
HPNSDWIVDSTENLHAVELSGPR
Sbjct: 605 HPNSDWIVDSTENLHAVELSGPR 627
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224135431|ref|XP_002327216.1| predicted protein [Populus trichocarpa] gi|222835586|gb|EEE74021.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1088 bits (2814), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 590/617 (95%), Positives = 602/617 (97%)
Query: 5 VWALCLILVVHSSWLASANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNND 64
VW L L L++H WL NMEGDALHSLRSNL DPNNVLQSWDPTLVNPCTWFHVTCNND
Sbjct: 11 VWLLILALLLHPVWLVLGNMEGDALHSLRSNLNDPNNVLQSWDPTLVNPCTWFHVTCNND 70
Query: 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNS 124
NSVIRVDLGNAALSGQLV QLGLLKNLQYLELYSNNI+GPIP DLGNLT+LVSLDLYLNS
Sbjct: 71 NSVIRVDLGNAALSGQLVPQLGLLKNLQYLELYSNNISGPIPGDLGNLTTLVSLDLYLNS 130
Query: 125 FTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
FTGPIPDTLGKLSKLRFLRLNNNSL+GPIPMSLTNIS+LQVLDLSNNRLSGVVPDNGSFS
Sbjct: 131 FTGPIPDTLGKLSKLRFLRLNNNSLTGPIPMSLTNISALQVLDLSNNRLSGVVPDNGSFS 190
Query: 185 LFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIAGGVAAGA 244
LFTPISFANNLDLCGPVTG PCPGSPPFSPPPPF+PPPPISSPGG SATGAIAGGVAAGA
Sbjct: 191 LFTPISFANNLDLCGPVTGHPCPGSPPFSPPPPFVPPPPISSPGGYSATGAIAGGVAAGA 250
Query: 245 ALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNIL 304
ALLFAAPA+AFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATD+FSNKNIL
Sbjct: 251 ALLFAAPALAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDTFSNKNIL 310
Query: 305 GRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT 364
GRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT
Sbjct: 311 GRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT 370
Query: 365 PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHR 424
PTERLLVYPYMANGSVASCLRERPPSQ PLDWPTRK+IALGSARGLSYLHDHCDPKIIHR
Sbjct: 371 PTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKQIALGSARGLSYLHDHCDPKIIHR 430
Query: 425 DVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDV 484
DVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDV
Sbjct: 431 DVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDV 490
Query: 485 FGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEV 544
FGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN YVEAEV
Sbjct: 491 FGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNKYVEAEV 550
Query: 545 EQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELAPHPNSDW 604
EQLIQVALLCTQGSPM+RPKMS+VVRMLEGDGLAERWDEWQKVEVLRQEVELAPHPNSDW
Sbjct: 551 EQLIQVALLCTQGSPMERPKMSDVVRMLEGDGLAERWDEWQKVEVLRQEVELAPHPNSDW 610
Query: 605 IVDSTENLHAVELSGPR 621
IVDSTENLHAVELSGPR
Sbjct: 611 IVDSTENLHAVELSGPR 627
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 621 | ||||||
| TAIR|locus:2026097 | 628 | SERK2 "somatic embryogenesis r | 0.587 | 0.581 | 0.917 | 4.1e-263 | |
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.587 | 0.584 | 0.906 | 8.9e-259 | |
| TAIR|locus:2040461 | 620 | SERK4 "somatic embryogenesis r | 0.587 | 0.588 | 0.796 | 1.8e-209 | |
| TAIR|locus:2040471 | 601 | SERK5 "somatic embryogenesis r | 0.843 | 0.871 | 0.598 | 6.1e-158 | |
| TAIR|locus:2145407 | 613 | AT5G10290 [Arabidopsis thalian | 0.574 | 0.582 | 0.662 | 3.2e-149 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.980 | 0.963 | 0.484 | 9.9e-142 | |
| TAIR|locus:2146102 | 638 | NIK1 "NSP-interacting kinase 1 | 0.974 | 0.948 | 0.480 | 1.3e-139 | |
| TAIR|locus:2160644 | 614 | AT5G63710 [Arabidopsis thalian | 0.581 | 0.587 | 0.591 | 4.8e-129 | |
| TAIR|locus:2118811 | 648 | SARK "SENESCENCE-ASSOCIATED RE | 0.515 | 0.493 | 0.610 | 2.7e-128 | |
| TAIR|locus:2061466 | 634 | AT2G23950 [Arabidopsis thalian | 0.908 | 0.889 | 0.455 | 8.9e-125 |
| TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1754 (622.5 bits), Expect = 4.1e-263, Sum P(2) = 4.1e-263
Identities = 335/365 (91%), Positives = 346/365 (94%)
Query: 257 WWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR 316
WWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR
Sbjct: 264 WWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR 323
Query: 317 LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 376
LADG+LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA
Sbjct: 324 LADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 383
Query: 377 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 436
NGSVASCLRERPPSQLPL W R++IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE
Sbjct: 384 NGSVASCLRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 443
Query: 437 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
FEAVVGDFGLA+LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT
Sbjct: 444 FEAVVGDFGLARLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 503
Query: 497 GQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDPDLQNNYVEAEVEQLIQVALLCTQ 556
GQRAFDLARLANDDDVMLLDWV VDPDLQ+NY EAEVEQLIQVALLCTQ
Sbjct: 504 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQ 563
Query: 557 GSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVE 616
SPM+RPKMSEVVRMLEGDGLAE+WDEWQKVEVLRQEVEL+ HP SDWI+DST+NLHA+E
Sbjct: 564 SSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEVLRQEVELSSHPTSDWILDSTDNLHAME 623
Query: 617 LSGPR 621
LSGPR
Sbjct: 624 LSGPR 628
|
|
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1746 (619.7 bits), Expect = 8.9e-259, Sum P(2) = 8.9e-259
Identities = 331/365 (90%), Positives = 345/365 (94%)
Query: 257 WWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR 316
WWRRRKP + FFDVPAEEDPEVHLGQLKRFSLRELQVA+D FSNKNILGRGGFGKVYKGR
Sbjct: 261 WWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGR 320
Query: 317 LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 376
LADG+LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA
Sbjct: 321 LADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 380
Query: 377 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 436
NGSVASCLRERPPSQ PLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE
Sbjct: 381 NGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 440
Query: 437 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT
Sbjct: 441 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 500
Query: 497 GQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDPDLQNNYVEAEVEQLIQVALLCTQ 556
GQRAFDLARLANDDDVMLLDWV VDPDLQ NY E E+EQ+IQVALLCTQ
Sbjct: 501 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQ 560
Query: 557 GSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVE 616
GSPM+RPKMSEVVRMLEGDGLAE+WDEWQKVE+LR+E++L+P+PNSDWI+DST NLHAVE
Sbjct: 561 GSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEILREEIDLSPNPNSDWILDSTYNLHAVE 620
Query: 617 LSGPR 621
LSGPR
Sbjct: 621 LSGPR 625
|
|
| TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1519 (539.8 bits), Expect = 1.8e-209, Sum P(2) = 1.8e-209
Identities = 293/368 (79%), Positives = 318/368 (86%)
Query: 257 WWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR 316
WW RRKPQ+ FFDVPAEEDPEVHLGQLKRF+LREL VATD+FSNKN+LGRGGFGKVYKGR
Sbjct: 253 WWLRRKPQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGR 312
Query: 317 LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 376
LADG+LVAVKRLKEERT GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA
Sbjct: 313 LADGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 372
Query: 377 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 436
NGSVASCLRERP LDWP RK IALGSARGL+YLHDHCD KIIHRDVKAANILLDEE
Sbjct: 373 NGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEE 432
Query: 437 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
FEAVVGDFGLAKLM+Y D+HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG+MLLELIT
Sbjct: 433 FEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 492
Query: 497 GQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDPDLQNNYVEAEVEQLIQVALLCTQ 556
GQ+AFDLARLANDDD+MLLDWV VD +L+ YVE EVEQLIQ+ALLCTQ
Sbjct: 493 GQKAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQ 552
Query: 557 GSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEV--ELAPHPNSDWIVDSTENLHA 614
S M+RPKMSEVVRMLEGDGLAERW+EWQK E+ + + PH +DW++ + +L
Sbjct: 553 SSAMERPKMSEVVRMLEGDGLAERWEEWQKEEMPIHDFNYQAYPHAGTDWLIPYSNSLIE 612
Query: 615 VEL-SGPR 621
+ SGPR
Sbjct: 613 NDYPSGPR 620
|
|
| TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1539 (546.8 bits), Expect = 6.1e-158, P = 6.1e-158
Identities = 318/531 (59%), Positives = 362/531 (68%)
Query: 94 LELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGXXXXXXXXXXXXXXXXGPI 153
L+L S N++G + L L +L L+L+ N+ TG IP+ LG GPI
Sbjct: 75 LDLGSANLSGELVPQLAQLPNLQYLELFNNNITGEIPEELGDLMELVSLDLFANNISGPI 134
Query: 154 PMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCXXXXXXX 213
P SL + L+ L L NN LSG +P + + + +NN L G + P
Sbjct: 135 PSSLGKLGKLRFLRLYNNSLSGEIPRSLTALPLDVLDISNNR-LSGDI---PVNGSFSQF 190
Query: 214 XXXXXXXXXXXXXXXGNSXXXXXXXXXXXXXXXXXXXXXXXXXWWRRRKPQEFFFDVPAE 273
S WW RRK Q F DVPAE
Sbjct: 191 TSMSFANNKLRPRPASPSPSPSGTSAAIVVGVAAGAALLFALAWWLRRKLQGHFLDVPAE 250
Query: 274 EDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT 333
EDPEV+LGQ KRFSLREL VAT+ FS +N+LG+G FG +YKGRLAD +LVAVKRL EERT
Sbjct: 251 EDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLADDTLVAVKRLNEERT 310
Query: 334 PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLP 393
GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP
Sbjct: 311 KGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPA 370
Query: 394 LDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453
LDWP RK IALGSARGL+YLHDHCD KIIH DVKAANILLDEEFEAVVGDFGLAKLM+Y
Sbjct: 371 LDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEAVVGDFGLAKLMNYN 430
Query: 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 513
D+HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG+MLLELITGQ+AFDLARLANDDD+M
Sbjct: 431 DSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIM 490
Query: 514 LLDWVXXXXXXXXXXXXVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
LLDWV VD +L+ YVE EVEQLIQ+ALLCTQ S M+RPKMSEVVRMLE
Sbjct: 491 LLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRMLE 550
Query: 574 GDGLAERWDEWQKVEVLRQEV--ELAPHPNSDWIVDSTENLHAVEL-SGPR 621
GDGLAERW+EWQK E+ + + PH +DW++ + +L + SGPR
Sbjct: 551 GDGLAERWEEWQKEEMPIHDFNYQAYPHAGTDWLIPYSNSLIENDYPSGPR 601
|
|
| TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1187 (422.9 bits), Expect = 3.2e-149, Sum P(2) = 3.2e-149
Identities = 238/359 (66%), Positives = 275/359 (76%)
Query: 264 QEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLV 323
++ F DV E D + GQLKRF+ RELQ+ATD+FS KN+LG+GGFGKVYKG L D + V
Sbjct: 256 RDVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKV 315
Query: 324 AVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASC 383
AVKRL + +PGG+ FQ EVEMIS+AVHRNLLRL GFC T TERLLVYP+M N S+A
Sbjct: 316 AVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHR 375
Query: 384 LRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 443
LRE LDW TRKRIALG+ARG YLH+HC+PKIIHRDVKAAN+LLDE+FEAVVGD
Sbjct: 376 LREIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 435
Query: 444 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 503
FGLAKL+D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYGIMLLEL+TGQRA D
Sbjct: 436 FGLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDF 495
Query: 504 ARLANDDDVMLLDWVXXXXXXXXXXXXVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP 563
+RL +DDV+LLD V VD +L Y++ EVE +IQVALLCTQGSP DRP
Sbjct: 496 SRLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRP 555
Query: 564 KMSEVVRMLEGDGLAERWDEWQKVEVLRQ-EVELAPHPNSDWIVDSTENLHAVELSGPR 621
MSEVVRMLEG+GLAERW+EWQ VEV R+ E E DW DS N A+ELSG R
Sbjct: 556 VMSEVVRMLEGEGLAERWEEWQNVEVTRRHEFERLQR-RFDWGEDSMHNQDAIELSGGR 613
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1386 (493.0 bits), Expect = 9.9e-142, P = 9.9e-142
Identities = 307/633 (48%), Positives = 387/633 (61%)
Query: 5 VWAL-CLILV----VHSSWLA--SANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWF 57
VW L L+ V + S+ L+ N E AL ++++ L DP VL++WD V+PC+W
Sbjct: 8 VWRLGFLVFVWFFDISSATLSPTGVNYEVTALVAVKNELNDPYKVLENWDVNSVDPCSWR 67
Query: 58 HVTCNNDNSVIRVDLGNAAXXXXXXXXXXXXKNLQYLELYSNNITGPIPSDLGNLTSLVS 117
V+C D V +DL + + LQ + L +N ITGPIP +G L L S
Sbjct: 68 MVSCT-DGYVSSLDLPSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIGRLEKLQS 126
Query: 118 LDLYLNSFTGPIPDTLGXXXXXXXXXXXXXXXXGPIPMSLTNISSLQVLDLSNNRLSGVV 177
LDL NSFTG IP +LG G P SL+ I L ++D+S N LSG +
Sbjct: 127 LDLSNNSFTGEIPASLGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSL 186
Query: 178 PDNGSFSLFTPISFANNLDLCGPVTGRPCXXXXXXXXXXXXXXXXXXXXXXGNSXXXXXX 237
P S F I N +CGP C G+
Sbjct: 187 P-KVSARTFKVIG---NALICGPKAVSNCSAVPEPLTLPQDGPDESGTRTNGHHVALAFA 242
Query: 238 XXXXXXXXXXXXXXXXXXXWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDS 297
WWR R+ ++ FFDV + DPEV LG LKR++ +EL+ AT+
Sbjct: 243 ASFSAAFFVFFTSGMFL--WWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATNH 300
Query: 298 FSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357
F++KNILGRGG+G VYKG L DG+LVAVKRLK+ GGE+QFQTEVE IS+A+HRNLLR
Sbjct: 301 FNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLR 360
Query: 358 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 417
LRGFC + ER+LVYPYM NGSVAS L++ + LDW RK+IA+G+ARGL YLH+ C
Sbjct: 361 LRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQC 420
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 477
DPKIIHRDVKAANILLDE+FEAVVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLSTG+
Sbjct: 421 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ 480
Query: 478 SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDPDLQN 537
SSEKTDVFG+GI+LLELITGQ+A D R A+ VML DWV +D DL +
Sbjct: 481 SSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVML-DWVKKLHQEGKLKQLIDKDLND 539
Query: 538 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELA 597
+ E+E+++QVALLCTQ +P RPKMSEV++MLEGDGLAERW+ Q Q L
Sbjct: 540 KFDRVELEEIVQVALLCTQFNPSHRPKMSEVMKMLEGDGLAERWEATQNGTGEHQPPPLP 599
Query: 598 P-----HPN----SDWIVDSTENLHAVELSGPR 621
P P SD+I +S+ + A+ELSGPR
Sbjct: 600 PGMVSSSPRVRYYSDYIQESSLVVEAIELSGPR 632
|
|
| TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1366 (485.9 bits), Expect = 1.3e-139, P = 1.3e-139
Identities = 301/626 (48%), Positives = 387/626 (61%)
Query: 8 LCLILV-VHSSWLASA-NMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNNDN 65
LCL+ VH N E AL ++++L DP+ VL +WD V+PC+W VTC+++N
Sbjct: 22 LCLLCSSVHGLLSPKGVNFEVQALMDIKASLHDPHGVLDNWDRDAVDPCSWTMVTCSSEN 81
Query: 66 SVIRVDLGNAAXXXXXXXXXXXXKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSF 125
VI + + NL+ + L +NNI G IP+++G LT L +LDL N F
Sbjct: 82 FVIGLGTPSQNLSGTLSPSITNLTNLRIVLLQNNNIKGKIPAEIGRLTRLETLDLSDNFF 141
Query: 126 TGPIPDTLGXXXXXXXXXXXXXXXXGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSL 185
G IP ++G G P+SL+N++ L LDLS N LSG VP F+
Sbjct: 142 HGEIPFSVGYLQSLQYLRLNNNSLSGVFPLSLSNMTQLAFLDLSYNNLSGPVP---RFAA 198
Query: 186 FTPISFANNLDLCGPVTGRPCXXXXXXXXXXXXXXXXXXXXXXGN-SXXXXXXXXXXXXX 244
T S N +C T C G+ +
Sbjct: 199 KT-FSIVGNPLICPTGTEPDCNGTTLIPMSMNLNQTGVPLYAGGSRNHKMAIAVGSSVGT 257
Query: 245 XXXXXXXXXXXXWWRRRKPQEFFFDVP-AEEDPEVHLGQLKRFSLRELQVATDSFSNKNI 303
WWR+R Q FFDV EV LG L+RF RELQ+AT++FS+KN+
Sbjct: 258 VSLIFIAVGLFLWWRQRHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNL 317
Query: 304 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM 363
LG+GG+G VYKG L D ++VAVKRLK+ GGE+QFQTEVEMIS+AVHRNLLRL GFC+
Sbjct: 318 LGKGGYGNVYKGILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCI 377
Query: 364 TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIH 423
T TE+LLVYPYM+NGSVAS ++ +P LDW RKRIA+G+ARGL YLH+ CDPKIIH
Sbjct: 378 TQTEKLLVYPYMSNGSVASRMKAKPV----LDWSIRKRIAIGAARGLVYLHEQCDPKIIH 433
Query: 424 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTD 483
RDVKAANILLD+ EAVVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLSTG+SSEKTD
Sbjct: 434 RDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 493
Query: 484 VFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDPDL--QNNYVE 541
VFG+GI+LLEL+TGQRAF+ + AN VML DWV VD +L + +Y E
Sbjct: 494 VFGFGILLLELVTGQRAFEFGKAANQKGVML-DWVKKIHQEKKLELLVDKELLKKKSYDE 552
Query: 542 AEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQ------EVE 595
E++++++VALLCTQ P RPKMSEVVRMLEGDGLAE+W+ Q+ + + + E+
Sbjct: 553 IELDEMVRVALLCTQYLPGHRPKMSEVVRMLEGDGLAEKWEASQRSDSVSKCSNRINELM 612
Query: 596 LAPHPNSDWIVDSTENLHAVELSGPR 621
+ SD DS+ + A+ELSGPR
Sbjct: 613 SSSDRYSDLTDDSSLLVQAMELSGPR 638
|
|
| TAIR|locus:2160644 AT5G63710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1088 (388.1 bits), Expect = 4.8e-129, Sum P(2) = 4.8e-129
Identities = 216/365 (59%), Positives = 270/365 (73%)
Query: 260 RRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLAD 319
RR + FFDV E+D ++ GQLKRFSLRE+Q+ATDSF+ N++G+GGFGKVY+G L D
Sbjct: 251 RRTKYDIFFDVAGEDDRKISFGQLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPD 310
Query: 320 GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 379
+ VAVKRL + +PGGE FQ E+++IS+AVH+NLLRL GFC T +ER+LVYPYM N S
Sbjct: 311 KTKVAVKRLADYFSPGGEAAFQREIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLS 370
Query: 380 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 439
VA LR+ + LDWPTRKR+A GSA GL YLH+HC+PKIIHRD+KAANILLD FE
Sbjct: 371 VAYRLRDLKAGEEGLDWPTRKRVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEP 430
Query: 440 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQR 499
V+GDFGLAKL+D THVTT VRGT+GHIAPEYL TGKSSEKTDVFGYGI LLEL+TGQR
Sbjct: 431 VLGDFGLAKLVDTSLTHVTTQVRGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQR 490
Query: 500 AFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDPDLQNNYVEAEVEQLIQVALLCTQGSP 559
A D +RL +++++LLD + VD +L Y EVE ++QVALLCTQGSP
Sbjct: 491 AIDFSRLEEEENILLLDHIKKLLREQRLRDIVDSNL-TTYDSKEVETIVQVALLCTQGSP 549
Query: 560 MDRPKMSEVVRMLEGDG-LAERWDEWQKVEVLR-QEVELAPHPNSDWIVDSTE-NLHAVE 616
DRP MSEVV+ML+G G LAE+W EW+++E +R +E L P + W + T + ++
Sbjct: 550 EDRPAMSEVVKMLQGTGGLAEKWTEWEQLEEVRNKEALLLPTLPATWDEEETTVDQESIR 609
Query: 617 LSGPR 621
LS R
Sbjct: 610 LSTAR 614
|
|
| TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1002 (357.8 bits), Expect = 2.7e-128, Sum P(2) = 2.7e-128
Identities = 199/326 (61%), Positives = 247/326 (75%)
Query: 257 WWRRRKPQEFFFDVPAEEDPEVH-LGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKG 315
W+R+++ + ++ +++ + LG L+ F+ REL V TD FS+KNILG GGFG VY+G
Sbjct: 261 WYRKKQRRLLILNLNDKQEEGLQGLGNLRSFTFRELHVYTDGFSSKNILGAGGFGNVYRG 320
Query: 316 RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 375
+L DG++VAVKRLK+ G+ QF+ E+EMIS+AVH+NLLRL G+C T ERLLVYPYM
Sbjct: 321 KLGDGTMVAVKRLKDINGTSGDSQFRMELEMISLAVHKNLLRLIGYCATSGERLLVYPYM 380
Query: 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE 435
NGSVAS L+ +P LDW RKRIA+G+ARGL YLH+ CDPKIIHRDVKAANILLDE
Sbjct: 381 PNGSVASKLKSKPA----LDWNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANILLDE 436
Query: 436 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELI 495
FEAVVGDFGLAKL+++ D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+GI+LLELI
Sbjct: 437 CFEAVVGDFGLAKLLNHADSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 496
Query: 496 TGQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDPDLQNNYVEAEVEQLIQVALLCT 555
TG RA + + + ML +WV +D +L NY + EV +++QVALLCT
Sbjct: 497 TGLRALEFGKTVSQKGAML-EWVRKLHEEMKVEELLDRELGTNYDKIEVGEMLQVALLCT 555
Query: 556 QGSPMDRPKMSEVVRMLEGDGLAERW 581
Q P RPKMSEVV MLEGDGLAERW
Sbjct: 556 QYLPAHRPKMSEVVLMLEGDGLAERW 581
|
|
| TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1226 (436.6 bits), Expect = 8.9e-125, P = 8.9e-125
Identities = 265/582 (45%), Positives = 352/582 (60%)
Query: 4 KVWALCLILVVHSSWLASA---NMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVT 60
K++++ L+L + S+ N E +AL ++++ L DP+ V ++WD V+PC+W ++
Sbjct: 10 KIFSVLLLLCFFVTCSLSSEPRNPEVEALINIKNELHDPHGVFKNWDEFSVDPCSWTMIS 69
Query: 61 CNNDNSVIRVDLGNAAXXXXXXXXXXXXKNLQYLELYSNNITGPIPSDLGNLTSLVSLDL 120
C++DN VI + + + NL+ + L +NNI+G IP ++ +L L +LDL
Sbjct: 70 CSSDNLVIGLGAPSQSLSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICSLPKLQTLDL 129
Query: 121 YLNSFTGPIPDTLGXXXXXXXXXXXXXXXXGPIPMSLTNISSLQVLDLSNNRLSGVVPDN 180
N F+G IP ++ GP P SL+ I L LDLS N L G VP
Sbjct: 130 SNNRFSGEIPGSVNQLSNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLRGPVP-- 187
Query: 181 GSFSLFTPISFANNLDLCGPVTGRPCXXXXXXXXXXXXXXXXXXXXXXGNSXXXXXXXXX 240
F T + A N +C C G
Sbjct: 188 -KFPART-FNVAGNPLICKNSLPEICSGSISASPLSVSLRSSS-----GRRTNILAVALG 240
Query: 241 XXXXXXXXXXXXXXXXWWRRRKPQEFFFDVP-AEEDPEVHLGQLKRFSLRELQVATDSFS 299
W+R+++ + + +E+ + LG L+ F+ REL VATD FS
Sbjct: 241 VSLGFAVSVILSLGFIWYRKKQRRLTMLRISDKQEEGLLGLGNLRSFTFRELHVATDGFS 300
Query: 300 NKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 359
+K+ILG GGFG VY+G+ DG++VAVKRLK+ G QF+TE+EMIS+AVHRNLLRL
Sbjct: 301 SKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLLRLI 360
Query: 360 GFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 419
G+C + +ERLLVYPYM+NGSVAS L+ +P LDW TRK+IA+G+ARGL YLH+ CDP
Sbjct: 361 GYCASSSERLLVYPYMSNGSVASRLKAKPA----LDWNTRKKIAIGAARGLFYLHEQCDP 416
Query: 420 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 479
KIIHRDVKAANILLDE FEAVVGDFGLAKL++++D+HVTTAVRGT+GHIAPEYLSTG+SS
Sbjct: 417 KIIHRDVKAANILLDEYFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGHIAPEYLSTGQSS 476
Query: 480 EKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDPDLQNNY 539
EKTDVFG+GI+LLELITG RA + + + ML +WV VD +L Y
Sbjct: 477 EKTDVFGFGILLLELITGMRALEFGKSVSQKGAML-EWVRKLHKEMKVEELVDRELGTTY 535
Query: 540 VEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERW 581
EV +++QVALLCTQ P RPKMSEVV+MLEGDGLAERW
Sbjct: 536 DRIEVGEMLQVALLCTQFLPAHRPKMSEVVQMLEGDGLAERW 577
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q94AG2 | SERK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9073 | 0.9887 | 0.9824 | yes | no |
| Q9XIC7 | SERK2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9335 | 0.9694 | 0.9585 | no | no |
| Q94F62 | BAK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8016 | 0.9661 | 0.9756 | no | no |
| Q9SKG5 | SERK4_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7627 | 0.9452 | 0.9467 | no | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| gw1.XIX.2216.1 | hypothetical protein (618 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 621 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-48 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-46 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-26 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-25 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-12 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 1e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 9e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.001 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.001 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 0.001 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| TIGR03921 | 350 | TIGR03921, T7SS_mycosin, type VII secretion-associ | 0.002 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.003 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 1e-48
Identities = 85/280 (30%), Positives = 132/280 (47%), Gaps = 30/280 (10%)
Query: 299 SNKNILGRGGFGKVYKGRLADGS-----LVAVKRLKEERTPGGELQFQTEVEMISMAVHR 353
+ LG G FG+VYKG+L VAVK LKE+ + +F E ++ H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
N+++L G C +V YM G + S LR+ P L AL ARG+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYL 118
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 473
IHRD+ A N L+ E + DFGL++ + D + + I +APE L
Sbjct: 119 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL 175
Query: 474 STGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532
GK + K+DV+ +G++L E+ T G++ + ++N++ +L+++K +L
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYP--GMSNEE---VLEYLK---NGYRLPQ--- 224
Query: 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 572
P E+ L+ L C P DRP SE+V +L
Sbjct: 225 PP----NCPPELYDLM---LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 1e-48
Identities = 85/280 (30%), Positives = 132/280 (47%), Gaps = 29/280 (10%)
Query: 299 SNKNILGRGGFGKVYKGRLADGS-----LVAVKRLKEERTPGGELQFQTEVEMISMAVHR 353
+ LG G FG+VYKG L VAVK LKE+ + +F E ++ H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
N+++L G C ++V YM G + LR+ P +L AL ARG+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELS--LSDLLSFALQIARGMEYL 119
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 473
IHRD+ A N L+ E + DFGL++ + D + + I +APE L
Sbjct: 120 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL 176
Query: 474 STGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532
GK + K+DV+ +G++L E+ T G+ + ++N + +L+++K K +L
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYP--GMSNAE---VLEYLK---KGYRLPK--- 225
Query: 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 572
P E+ +L+ L C P DRP SE+V +L
Sbjct: 226 PP----NCPPELYKLM---LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 6e-48
Identities = 70/194 (36%), Positives = 99/194 (51%), Gaps = 10/194 (5%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 362
LG GGFG VY R G VA+K +K+E + + E+E++ H N+++L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 363 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 422
LV Y GS+ L+E L RI L GL YLH + II
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 423 HRDVKAANILLDE-EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STGKSSE 480
HRD+K NILLD + + DFGL+KL+ + + T + GT ++APE L G SE
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSE 173
Query: 481 KTDVFGYGIMLLEL 494
K+D++ G++L EL
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 8e-47
Identities = 74/199 (37%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVKRL-KEERTPGGELQFQTEVEMISMAVHRNLLRLRG 360
LG G FG VYK + G +VAVK L K + + E+ ++ H N++RL
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 361 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 420
LV Y G + L P L K+IAL RGL YLH +
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGP----LSEDEAKKIALQILRGLEYLHSN---G 118
Query: 421 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SS 479
IIHRD+K NILLDE + DFGLAK + + +TT V GT ++APE L G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 480 EKTDVFGYGIMLLELITGQ 498
K DV+ G++L EL+TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 1e-46
Identities = 89/285 (31%), Positives = 133/285 (46%), Gaps = 36/285 (12%)
Query: 302 NILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357
LG G FG+VYKG+L VAVK LKE+ + F E ++ H N++R
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 358 LRGFCMTPTERLLVYPYMANGSVASCLRE-RPPSQLP----LDWPTRKRIALGSARGLSY 412
L G C LV YM G + LR+ RP P L A+ A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI---A 469
L K +HRD+ A N L+ E+ + DFGL++ + D + G I A
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK--TGGKLPIRWMA 175
Query: 470 PEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528
PE L G + K+DV+ +G++L E+ T G + L+N++ +L++++ K +L
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY--PGLSNEE---VLEYLR---KGYRLP 227
Query: 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
P+ Y E+ +L+ C Q P DRP SE+V LE
Sbjct: 228 K---PE----YCPDELYELML---SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 2e-46
Identities = 141/527 (26%), Positives = 244/527 (46%), Gaps = 78/527 (14%)
Query: 69 RVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGP 128
+DL SG + +LG L L L+L N ++G IP +L + LVSLDL N +G
Sbjct: 479 NLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQ 538
Query: 129 IPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTP 188
IP + ++ L L L+ N LSG IP +L N+ SL +++S+N L G +P G+F
Sbjct: 539 IPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINA 598
Query: 189 ISFANNLDLCGPVTGRPCPGSPPF-----SPPPPFIPPPPISSPGGNSATGAIAGGVAAG 243
+ A N+DLCG G G PP +P F I+ G
Sbjct: 599 SAVAGNIDLCG---GDTTSGLPPCKRVRKTPSWWFY----ITC--------------TLG 637
Query: 244 AALLFAAPAIAFAWWRRRKPQEF-------------FFDVPAEEDPEVHLGQLKRFSLRE 290
A L+ A A F + R R E FFD K ++ +
Sbjct: 638 AFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKV----------SKSITIND 687
Query: 291 LQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERT-PGGELQFQTEVEMIS 348
+ S +N++ RG G YKG+ + +G VK + + + P E+ +++
Sbjct: 688 I---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQ--- 741
Query: 349 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR 408
H N+++L G C + L++ Y+ +++ LR L W R++IA+G A+
Sbjct: 742 ---HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAK 791
Query: 409 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 468
L +LH C P ++ ++ I++D + E + L L+ ++ ++
Sbjct: 792 ALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISS-----AYV 845
Query: 469 APEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528
APE T +EK+D++G+G++L+EL+TG+ D + +++W + + L+
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS---IVEWARYCYSDCHLD 902
Query: 529 MLVDPDLQNNYV--EAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
M +DP ++ + + E+ +++ +AL CT P RP ++V++ LE
Sbjct: 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 8e-46
Identities = 77/275 (28%), Positives = 120/275 (43%), Gaps = 25/275 (9%)
Query: 298 FSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 356
+ LG G FGKVY R G LVA+K +K+++ + E++++ H N++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 357 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 416
RL + LV Y G + L++R L D + L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR--LSEDE--ARFYLRQILSALEYLHSK 116
Query: 417 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 476
I+HRD+K NILLDE+ + DFGLA+ +D +TT V GT ++APE L
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFV-GTPEYMAPEVLLGK 171
Query: 477 KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 536
+ D++ G++L EL+TG+ F +D + L +K +
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFP----GDDQLLELF--------KKIGKPKPPFPPP 219
Query: 537 NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571
+ E + LI+ LL P R E ++
Sbjct: 220 EWDISPEAKDLIR-KLLVKD--PEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 2e-45
Identities = 82/278 (29%), Positives = 128/278 (46%), Gaps = 35/278 (12%)
Query: 304 LGRGGFGKVYKGRLADGS-----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL 358
LG G FG+VYKG L VAVK LKE + +F E ++ H N++RL
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 359 RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 418
G C +V YM G + LR+ L ++AL A+G+ YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 419 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI---APEYLST 475
+HRD+ A N L+ E + DFGL++ + D + G I APE L
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPESLKD 178
Query: 476 GKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534
GK + K+DV+ +G++L E+ T G++ + ++N++ +L+ ++ +L P+
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPY--PGMSNEE---VLELLE---DGYRLPR---PE 227
Query: 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 572
E+ +L+ L C P DRP SE+V L
Sbjct: 228 ----NCPDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 66/218 (30%), Positives = 109/218 (50%), Gaps = 14/218 (6%)
Query: 302 NILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGEL-QFQTEVEMISMAVHRNLLRLR 359
+LGRG FG VY D G L+AVK ++ EL + E+ ++S H N++R
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 360 GFCMTPTER-LLVY-PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 417
G + L ++ Y++ GS++S L++ L P ++ GL+YLH +
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK----LPEPVIRKYTRQILEGLAYLHSN- 120
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTAVRGTIGHIAPEYLSTG 476
I+HRD+K ANIL+D + + DFG AK + D + T +VRGT +APE +
Sbjct: 121 --GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 477 KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 514
+ D++ G ++E+ TG+ + + L N +
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPW--SELGNPMAALY 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 7e-31
Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 298 FSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 356
F +G+GGFG+VYK R G VA+K +K E E E++++ H N++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN-EIQILKKCKHPNIV 60
Query: 357 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 416
+ G + E +V + + GS+ L+ L + +GL YLH +
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN 117
Query: 417 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYLST 475
IIHRD+KAANILL + E + DFGL+ L D K + GT +APE ++
Sbjct: 118 ---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVING 171
Query: 476 GKSSEKTDVFGYGIMLLELITGQ 498
K D++ GI +EL G+
Sbjct: 172 KPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 80/287 (27%), Positives = 124/287 (43%), Gaps = 30/287 (10%)
Query: 302 NILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 356
LG G FGKV R G VAVK L F+ E+E++ H N++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 357 RLRGFCMTPTER--LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
+ +G C P R L+ Y+ +GS+ L+ ++ + +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKRLLLFSSQICKGMDYLG 126
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEY 472
+ IHRD+ A NIL++ E + DFGLAK++ + G I APE
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 473 LSTGKSSEKTDVFGYGIMLLELITGQRAFD------LARLANDDDVMLLDWVKGLLKEKK 526
L T K S +DV+ +G+ L EL T L + M++ + LLKE
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG- 242
Query: 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
E L P EV L++ LC + P DRP ++++ +++
Sbjct: 243 -ERLPRPP----SCPDEVYDLMK---LCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 120 bits (300), Expect = 2e-29
Identities = 76/285 (26%), Positives = 119/285 (41%), Gaps = 24/285 (8%)
Query: 297 SFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGEL--QFQTEVE-MISMAVHR 353
S+ LG G FG+VY R D LVA+K L ++ + +F E++ + S+
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
N+++L F LV Y+ GS+ L ++ + PL I L YL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 414 HDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHV-----TTAVRGTIGH 467
H IIHRD+K NILLD + + DFGLAKL+ + + GT G+
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 468 IAPEYL---STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 524
+APE L S +S +D++ GI L EL+TG F+ + ++ L ++
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 525 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 569
L + E + + P +R S +
Sbjct: 235 LA------SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 81/288 (28%), Positives = 133/288 (46%), Gaps = 50/288 (17%)
Query: 302 NILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357
++G G FG+V +GRL VA+K LK + L F TE ++ H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 358 LRGFCMTPTERLLVYPYMANGSVASCLRER----PPSQLPLDWPTRKRIALGSARGLSYL 413
L G +++ YM NGS+ LRE QL + G A G+ YL
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL-------VGMLRGIASGMKYL 122
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHI 468
+ +HRD+ A NIL++ V DFGL++ ++ + TT +R T
Sbjct: 123 SEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT---- 175
Query: 469 APEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAF-DLARLANDDDVMLLDWVKGLLKEKK 526
APE ++ K + +DV+ +GI++ E+++ G+R + D++ + DV+ K + +
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS----NQDVI-----KAVEDGYR 226
Query: 527 LEMLVD-PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
L +D P L Q+ L C Q +RP S++V L+
Sbjct: 227 LPPPMDCPSA-----------LYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 20/208 (9%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQF-QTEVEMISMAVHRNLLRLRGF 361
+G+G FGKVY R +DG L +K + E + EV+++ H N+++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 362 CMTPTERLLVYPYMANGSVASCLRERPPSQLP------LDWPTRKRIALGSARGLSYLHD 415
+ +V Y G ++ ++++ P LDW + + L L YLH
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--LCLA----LKYLHS 121
Query: 416 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 475
KI+HRD+K NI L +GDFG++K++ T V GT +++PE L
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE-LCQ 176
Query: 476 GKS-SEKTDVFGYGIMLLELITGQRAFD 502
K + K+D++ G +L EL T + F+
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHPFE 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 65/226 (28%), Positives = 113/226 (50%), Gaps = 23/226 (10%)
Query: 298 FSNKNILGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNL 355
+ +++GRG FG VYKG L G VA+K++ E+ L+ E++++ H N+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 356 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSA---RGLSY 412
++ G T ++ Y NGS+ +++ P L +A+ +GL+Y
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL-------VAVYVYQVLQGLAY 114
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 472
LH+ +IHRD+KAANIL ++ + DFG+A ++ + +V GT +APE
Sbjct: 115 LHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEV 170
Query: 473 LSTGKSSEKTDVFGYGIMLLELITGQRA-FDLA------RLANDDD 511
+ +S +D++ G ++EL+TG +DL R+ DD
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH 216
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 303 ILGRGGFGKVYKGR-LADGSL----VAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357
+LG G FG VYKG + +G VA+K L+EE +P + E +++ H +++R
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 358 LRGFCMTPTERLLVYPYMANGSVASCLRE---RPPSQLPLDWPTRKRIALGSARGLSYLH 414
L G C++ L+ M G + +R SQ L+W + A+G+SYL
Sbjct: 74 LLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYLE 126
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYL 473
+ +++HRD+ A N+L+ + DFGLAKL+D + + I +A E +
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 474 STGKSSEKTDVFGYGIMLLELIT-GQRAFD 502
+ K+DV+ YG+ + EL+T G + ++
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 64/199 (32%), Positives = 103/199 (51%), Gaps = 7/199 (3%)
Query: 298 FSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357
F+ + LG G FG+V++G + VA+K LK + + FQ EV+ + H++L+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ-DFQKEVQALKRLRHKHLIS 66
Query: 358 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 417
L C ++ M GS+ + LR P L + +A A G++YL +
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEEQ- 123
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 477
IHRD+ A NIL+ E+ V DFGLA+L+ +D ++++ + APE S G
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAASHGT 180
Query: 478 SSEKTDVFGYGIMLLELIT 496
S K+DV+ +GI+L E+ T
Sbjct: 181 FSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 67/200 (33%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 301 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG 360
+G+G FG V G G VAVK LK++ T F E +++ H NL++L G
Sbjct: 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ--AFLAEASVMTTLRHPNLVQLLG 67
Query: 361 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 420
+ +V YMA GS+ LR R + + L + AL G+ YL +
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLA--QQLGFALDVCEGMEYLEEK---N 122
Query: 421 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 480
+HRD+ A N+L+ E+ A V DFGLAK V+ T APE L K S
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFST 178
Query: 481 KTDVFGYGIMLLELITGQRA 500
K+DV+ +GI+L E+ + R
Sbjct: 179 KSDVWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 81/287 (28%), Positives = 132/287 (45%), Gaps = 41/287 (14%)
Query: 304 LGRGGFGKVYKGRLAD------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357
LG+G FG VY+G + VA+K + E + ++F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 358 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQL---PLDWPTRKRI---ALGSARGLS 411
L G T L+V MA G + S LR R P L PT ++ A A G++
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DY--KDTHVTTAVRGTIG 466
YL K +HRD+ A N ++ E+ +GDFG+ + + DY K VR
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 186
Query: 467 HIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 526
+APE L G + K+DV+ +G++L E+ T LA +GL E+
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT------LAEQP----------YQGLSNEEV 230
Query: 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
L+ ++D + E ++L+++ +C Q +P RP E+V L+
Sbjct: 231 LKFVIDGGHL-DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 92/285 (32%), Positives = 132/285 (46%), Gaps = 41/285 (14%)
Query: 302 NILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357
++G+G FG VY G L D AVK L QF E ++ H N+L
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 358 LRGFCMTPTE--RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRI---ALGSARGLSY 412
L G C+ P+E L+V PYM +G + + +R PT K + L A+G+ Y
Sbjct: 61 LLGICL-PSEGSPLVVLPYMKHGDLRNFIRS------ETHNPTVKDLIGFGLQVAKGMEY 113
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIA 469
L K +HRD+ A N +LDE F V DFGLA+ + +Y H T + + +A
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 470 PEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528
E L T K + K+DV+ +G++L EL+T G + DV D LL+ ++L
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY--------PDVDSFDITVYLLQGRRL- 221
Query: 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
LQ Y + L +V L C P RP SE+V +E
Sbjct: 222 ------LQPEYCP---DPLYEVMLSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-25
Identities = 64/170 (37%), Positives = 98/170 (57%), Gaps = 6/170 (3%)
Query: 10 LILVVHSSWLASANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIR 69
L ++ S L + +E L S +S++ DP L +W+ + + C W +TCNN + V+
Sbjct: 17 FFLFLNFSMLHAEELE--LLLSFKSSINDPLKYLSNWNSS-ADVCLWQGITCNNSSRVVS 73
Query: 70 VDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLT-SLVSLDLYLNSFTGP 128
+DL +SG++ S + L +Q + L +N ++GPIP D+ + SL L+L N+FTG
Sbjct: 74 IDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGS 133
Query: 129 IPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
IP G + L L L+NN LSG IP + + SSL+VLDL N L G +P
Sbjct: 134 IPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181
|
Length = 968 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 59/198 (29%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 304 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM 363
+G+G FG VYKG L + VAVK + P + +F E E++ H N+++L G C+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 364 TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIH 423
+V + GS+ + LR + ++L + +++L +A G+ YL IH
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLR-KKKNRLTVK--KLLQMSLDAAAGMEYLESKN---CIH 116
Query: 424 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT----IGHIAPEYLSTGKSS 479
RD+ A N L+ E + DFG+++ ++ + T G I APE L+ G+ +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 480 EKTDVFGYGIMLLELITG 497
++DV+ YGI+L E +
Sbjct: 174 SESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-24
Identities = 73/240 (30%), Positives = 104/240 (43%), Gaps = 48/240 (20%)
Query: 28 ALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIR-----VDLGNAALSGQLV 82
AL +L+S+L P + DP + W C D++ + + L N L G +
Sbjct: 376 ALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIP 435
Query: 83 SQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFL 142
+ + L++LQ + L N+I G IP LG++TSL LDL NSF G IP++LG+L+ LR L
Sbjct: 436 NDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRIL 495
Query: 143 RLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVT 202
LN NSLSG +P +L G + +F +N LCG
Sbjct: 496 NLNGNSLSGRVPAAL-----------------GGRLLHR-----ASFNFTDNAGLCGIPG 533
Query: 203 GRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRK 262
R C P +S A IA GV+ L WW+RR+
Sbjct: 534 LRAC--------------GPHLSV----GAKIGIAFGVSVAFLFLVICAMC---WWKRRQ 572
|
Length = 623 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-23
Identities = 52/108 (48%), Positives = 74/108 (68%)
Query: 72 LGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPD 131
L + L GQ+ +LG +K+L+++ L NN++G IP ++G LTSL LDL N+ TGPIP
Sbjct: 195 LASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPS 254
Query: 132 TLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179
+LG L L++L L N LSGPIP S+ ++ L LDLS+N LSG +P+
Sbjct: 255 SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE 302
|
Length = 968 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 70/279 (25%), Positives = 113/279 (40%), Gaps = 34/279 (12%)
Query: 296 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 354
+LG+G G VYK R G + A+K++ + Q E++ +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRER---PPSQLPLDWPTRKRIALGSARGLS 411
+++ G E +V YM GS+A L++ P L IA +GL
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVL-------AYIARQILKGLD 113
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 471
YLH IIHRD+K +N+L++ + E + DFG++K+++ T V GT+ +++PE
Sbjct: 114 YLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPE 170
Query: 472 YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531
+ S D++ G+ LLE G+ F L ++ +
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP---SFFEL-----------MQAIC 216
Query: 532 D---PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSE 567
D P L E I C Q P RP +E
Sbjct: 217 DGPPPSLPAEEFSPEFRDFIS---ACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-23
Identities = 53/115 (46%), Positives = 76/115 (66%)
Query: 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSF 125
S+ +DL L+G + S LG LKNLQYL LY N ++GPIP + +L L+SLDL NS
Sbjct: 237 SLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSL 296
Query: 126 TGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN 180
+G IP+ + +L L L L +N+ +G IP++LT++ LQVL L +N+ SG +P N
Sbjct: 297 SGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKN 351
|
Length = 968 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 3e-23
Identities = 83/276 (30%), Positives = 125/276 (45%), Gaps = 29/276 (10%)
Query: 301 KNILGRGGFGKVYKGRLADGSL-VAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 359
K+ LG G +G+VY+G SL VAVK LKE+ E F E ++ H NL++L
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 68
Query: 360 GFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 419
G C ++ +M G++ LRE ++ +A + + YL
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA--VVLLYMATQISSAMEYLEKK--- 123
Query: 420 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHIAPEYLSTGKS 478
IHRD+ A N L+ E V DFGL++LM DT+ A + I APE L+ K
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 479 SEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537
S K+DV+ +G++L E+ T G + L+ V LL EK M
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------VYELL-EKGYRM-------- 224
Query: 538 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
E ++ ++ C Q +P DRP +E+ + E
Sbjct: 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 5e-23
Identities = 77/290 (26%), Positives = 138/290 (47%), Gaps = 33/290 (11%)
Query: 292 QVATDSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGGELQFQTEVEMI 347
++ + + ++G G FG+V++G L VA+K LK T F +E ++
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 348 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSA 407
H N++RL G +++ YM NG++ LR+ R G A
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIA 117
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTI 465
G+ YL D +HRD+ A NIL++ E V DFGL++++ D + T+ T+ + I
Sbjct: 118 AGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174
Query: 466 GHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAF-DLARLANDDDVMLLDWVKGLLK 523
APE ++ K + +DV+ +GI++ E+++ G+R + D++ + +VM K +
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS----NHEVM-----KAIND 225
Query: 524 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
+L +D + V QL+ L C Q RP+ ++V +L+
Sbjct: 226 GFRLPAPMD-------CPSAVYQLM---LQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 7e-23
Identities = 67/197 (34%), Positives = 99/197 (50%), Gaps = 15/197 (7%)
Query: 304 LGRGGFGKVYKGRLADGSLVAVKRLKE-ERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 362
LG G FG+V+ G + VAVK LK +P LQ E +++ H L++L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQ---EAQIMKKLRHDKLVQLYAVC 70
Query: 363 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 422
+V YM+ GS+ L+ +L L P +A A G++YL I
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLESR---NYI 125
Query: 423 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAPEYLSTGKSS 479
HRD+ A NIL+ E + DFGLA+L+ +D TA G I APE + G+ +
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLI--EDDEY-TAREGAKFPIKWTAPEAANYGRFT 182
Query: 480 EKTDVFGYGIMLLELIT 496
K+DV+ +GI+L E++T
Sbjct: 183 IKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 8e-23
Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 30/226 (13%)
Query: 293 VATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEM 346
V D+ K LG G FGKV+ G D LVAVK LKE + F+ E E+
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL 61
Query: 347 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK------ 400
++ H N+++ G C ++V+ YM +G + LR P L P
Sbjct: 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 401 ----RIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 456
+IA+ A G+ YL +HRD+ N L+ + +GDFG++ +D +
Sbjct: 122 SQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMS-----RDVY 173
Query: 457 VTT--AVRGT----IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
T V G I + PE + K + ++DV+ +G++L E+ T
Sbjct: 174 TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 1e-22
Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRG 360
LG+G FGKV R G L A+K LK+++ TE ++S H +++L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 361 FCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIA-LGSARGLSYLHDHCD 418
+ E+L LV Y G + S L + + + R A + A L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEG--RFSEER-ARFYAAEIVLA--LEYLHSL-- 112
Query: 419 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 478
II+RD+K NILLD + + DFGLAK + T GT ++APE L
Sbjct: 113 -GIIYRDLKPENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAPEVLLGKGY 170
Query: 479 SEKTDVFGYGIMLLELITGQRAFD 502
+ D + G++L E++TG+ F
Sbjct: 171 GKAVDWWSLGVLLYEMLTGKPPFY 194
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-22
Identities = 78/285 (27%), Positives = 125/285 (43%), Gaps = 46/285 (16%)
Query: 298 FSNKNILGRGGFGKVYKG-RLADGSLVAVK---------RLKEERTPGGELQFQTEVEMI 347
F N +G+G FG V+K R AD + A+K R +EE E ++
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI--------DEARVL 53
Query: 348 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLD--WPTRKRIALG 405
+ ++R + + +V Y NG + L+ + LP D W R +
Sbjct: 54 AKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQ 109
Query: 406 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 465
GL++LH KI+HRD+K+ N+ LD +GD G+AKL+ T V GT
Sbjct: 110 ILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTP 165
Query: 466 GHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525
+++PE +EK+DV+ G++L E TG+ FD AN+ ++L ++G
Sbjct: 166 YYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD----ANNQGALILKIIRG----- 216
Query: 526 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
V P + Y +QL Q+ C RP +++R
Sbjct: 217 -----VFPPVSQMY----SQQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 2e-22
Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 26/216 (12%)
Query: 298 FSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNL 355
+ +G G +G+VYK R G LVA+K+++ E G + E++++ H N+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 356 LRLRGFCMTPTERL-----LVYPYMA---NGSVASCLRERPPSQLPLDWPTRKRIALGSA 407
+RL+ T + +V+ YM G L + P + K
Sbjct: 61 VRLKEIV---TSKGKGSIYMVFEYMDHDLTG-----LLDSPEVKFTE--SQIKCYMKQLL 110
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 467
GL YLH + I+HRD+K +NIL++ + + DFGLA+ +++ T T+ +
Sbjct: 111 EGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWY 167
Query: 468 IAPEYL--STGKSSEKTDVFGYGIMLLELITGQRAF 501
PE L +T + + D++ G +L EL G+ F
Sbjct: 168 RPPELLLGAT-RYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-22
Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 20/210 (9%)
Query: 303 ILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGG---ELQ------FQTEVEMISMAVH 352
++G+G +G+VY G ++AVK+++ T G Q ++E+E + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 353 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 412
N+++ GF T + Y+ GS+ SCLR + L + GL+Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFFTEQVLEGLAY 123
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTAVRGTIGHIAPE 471
LH I+HRD+KA N+L+D + + DFG++K D D +++G++ +APE
Sbjct: 124 LHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 472 YLSTGKS--SEKTDVFGYGIMLLELITGQR 499
+ + S K D++ G ++LE+ G+R
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 354
+ F LG G +G VYK G +VA+K + + E+ ++
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPY 59
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIAL---GSARGLS 411
+++ G T+ +V Y GSV+ ++ L T + IA + +GL
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT---NKTL---TEEEIAAILYQTLKGLE 113
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT-IG---H 467
YLH + K IHRD+KA NILL+EE +A + DFG++ + T A R T IG
Sbjct: 114 YLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD-----TMAKRNTVIGTPFW 165
Query: 468 IAPEYLSTGKSSEKTDVFGYGIMLLELITG 497
+APE + + K D++ GI +E+ G
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 5e-22
Identities = 86/289 (29%), Positives = 128/289 (44%), Gaps = 38/289 (13%)
Query: 304 LGRGGFGKVYKGR---LAD--GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL 358
LG+G FG V R L D G +VAVK+L+ T F+ E+E++ H N+++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 359 RGFCMTPTER--LLVYPYMANGSVASCL---RERPPSQLPLDWPTRKRIALGSARGLSYL 413
+G C + R LV Y+ GS+ L RER LD A +G+ YL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER------LDHRKLLLYASQICKGMEYL 124
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAPE 471
+ +HRD+ NIL++ E +GDFGL K++ D + V I APE
Sbjct: 125 GSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE 181
Query: 472 YLSTGKSSEKTDVFGYGIMLLELIT------GQRAFDLARLAND-DDVMLLDWVKGLLKE 524
L+ K S +DV+ +G++L EL T A + + ND M++ + LLK
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241
Query: 525 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
L P AE+ ++ C P RP SE+ +E
Sbjct: 242 NG--RLPAPP----GCPAEIYAIM---KECWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 7e-22
Identities = 80/276 (28%), Positives = 118/276 (42%), Gaps = 30/276 (10%)
Query: 304 LGRGGFGKVYKGR----LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 359
LG G FG V +G VAVK LK ++ F E ++ H NL+RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 360 GFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 419
G +T ++V GS+ LR+ + T A+ A G+ YL
Sbjct: 63 GVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLI--STLCDYAVQIANGMRYLESK--- 116
Query: 420 KIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGT-IGHIAPEYLSTGK 477
+ IHRD+ A NILL + + +GDFGL + L +D +V APE L T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 478 SSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 536
S +DV+ +G+ L E+ T G+ + A L+ + +D K+ E L P
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEPW--AGLSGSQILKKID--------KEGERLERP--- 223
Query: 537 NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 572
EA + + V L C +P DRP + + L
Sbjct: 224 ----EACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 8e-22
Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 23/214 (10%)
Query: 303 ILGRGGFGKVYKGRLAD------GSLVAVKRLKEERTPGGELQFQTEVEMISM-AVHRNL 355
LG G FG+V K S VAVK LK++ T +E+EM+ M H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 356 LRLRGFCMTPTERLLVYPYMANGSVASCLR-ERPPSQ---LPLDWPTRKRI--------A 403
+ L G C +V Y A+G++ LR RPP + P + + A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 404 LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVR 462
ARG+ +L K IHRD+ A N+L+ E+ + DFGLA+ + + D + TT R
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 463 GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
+ +APE L + ++DV+ +G++L E+ T
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 3e-21
Identities = 78/273 (28%), Positives = 128/273 (46%), Gaps = 29/273 (10%)
Query: 303 ILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 362
+LG+G FG+V+KG L D + VAVK KE+ +++F +E ++ H N+++L G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 363 MTPTERLLVYPYM---ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 419
T+R +Y M G S LR++ L + AL +A G++YL
Sbjct: 62 ---TQRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLESK--- 112
Query: 420 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 479
IHRD+ A N L+ E + DFG+++ D + + I APE L+ G+ S
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 480 EKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNY 539
++DV+ YGI+L E F L G+ ++ E V+ + +
Sbjct: 173 SESDVWSYGILLWE------TFSLGVCP----------YPGMTNQQAREQ-VEKGYRMSC 215
Query: 540 VEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 572
+ + + +V C P +RPK SE+ + L
Sbjct: 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 3e-21
Identities = 61/195 (31%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 304 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVHRNLLRLRGF 361
LG G FG+V++G + + VAVK LK PG F E +++ H L++L
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK----PGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 362 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 421
C +V M GS+ L+ L L P +A A G++YL
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKL--PQLIDMAAQVASGMAYLEAQ---NY 124
Query: 422 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 481
IHRD+ A N+L+ E V DFGLA+++ + I APE + S K
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 482 TDVFGYGIMLLELIT 496
+DV+ +GI+L E++T
Sbjct: 185 SDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 3e-21
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 304 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQ---FQTEVEMISMAVHRNLLRLRG 360
LG G FG+V+ G + VA+K LK+ G + F E ++ H L+RL
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQ-----GSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 361 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 420
+T ++ YM NGS+ L+ +L + +A A G++++
Sbjct: 69 -VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTI--NKLIDMAAQIAEGMAFIERK---N 122
Query: 421 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 480
IHRD++AANIL+ E + DFGLA+L++ + + I APE ++ G +
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 481 KTDVFGYGIMLLELITGQR 499
K+DV+ +GI+L E++T R
Sbjct: 183 KSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 4e-21
Identities = 49/107 (45%), Positives = 71/107 (66%)
Query: 72 LGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPD 131
LG LSG++ ++G L +L +L+L NN+TGPIPS LGNL +L L LY N +GPIP
Sbjct: 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP 278
Query: 132 TLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
++ L KL L L++NSLSG IP + + +L++L L +N +G +P
Sbjct: 279 SIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP 325
|
Length = 968 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 4e-21
Identities = 79/281 (28%), Positives = 124/281 (44%), Gaps = 37/281 (13%)
Query: 304 LGRGGFGKVYKG--RLADGSL--VAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 359
LG G FG V KG + G VAVK LK+E G+ +F E +++ H ++RL
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 360 GFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 419
G C +LV G + L++R + K +A A G++YL
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPV----SDLKELAHQVAMGMAYLESK--- 114
Query: 420 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTIGHIAPEYLSTGK 477
+HRD+ A N+LL +A + DFG+++ + + TTA R + APE ++ GK
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 478 SSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL- 535
S K+DV+ YG+ L E + G + + + + + +L+ E L P+
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPY--GEMKGAEVIAMLE---------SGERLPRPEEC 223
Query: 536 -QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575
Q Y + L C + P DRP SE+ D
Sbjct: 224 PQEIY---------SIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 302 NILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG 360
++G G VY L + VA+KR+ E+ + + EV+ +S H N+++
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 361 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 420
+ E LV PY++ GS+ ++ P LD + +GL YLH +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG-LDEAIIATVLKEVLKGLEYLHSN---G 122
Query: 421 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR----GTIGHIAPEYLSTG 476
IHRD+KA NILL E+ + DFG++ + T VR GT +APE +
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASL-ADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 477 KS-SEKTDVFGYGIMLLELITG 497
K D++ +GI +EL TG
Sbjct: 182 HGYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 71/276 (25%), Positives = 117/276 (42%), Gaps = 34/276 (12%)
Query: 303 ILGRGGFGK--VYKGRLADGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLR 359
+LG+G FG+ +Y+ R D SLV K + R + E+ ++S+ H N++
Sbjct: 7 VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 360 GFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 419
M L+ Y G++ + + + + SA +SY+H
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA--VSYIHKA--- 120
Query: 420 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 479
I+HRD+K NI L + +GDFG++K++ + + T V GT +++PE K +
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYN 179
Query: 480 EKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNY 539
K+D++ G +L EL+T +R FD N LV +Q NY
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLN---------------------LVVKIVQGNY 218
Query: 540 ---VEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 572
V +LI + Q P RP EV+
Sbjct: 219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 8e-21
Identities = 68/282 (24%), Positives = 123/282 (43%), Gaps = 30/282 (10%)
Query: 303 ILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 356
LGRG FG+V+ + +LV VK L++ + + +F+ E++M H+N++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 357 RLRGFCMTPTERLLVYPYMANGS-----VASCLRERPPSQLPLDWPTRKRIALGSARGLS 411
RL G C ++ Y G A+ ++ PL + + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 471
+L + + +HRD+ A N L+ + E V L+K + + + + +APE
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 472 YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531
+ S K+DV+ +G+++ E+ T Q L++++ V L+ KLE+ V
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT-QGELPFYGLSDEE-------VLNRLQAGKLELPV 240
Query: 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
E +L ++ C +P DRP SE+V L
Sbjct: 241 P--------EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 304 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM 363
LG G FG V+ G+ VA+K ++E E F E +++ H NL++L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 364 TPTERLLVYPYMANGSVASCLRERP---PSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 420
+V YMANG + + LRER ++ LD + + YL +
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLD------MCSDVCEAMEYLESNG--- 120
Query: 421 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 480
IHRD+ A N L+ E+ V DFGLA+ + + + + PE + S
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 481 KTDVFGYGIMLLELITG 497
K+DV+ +G+++ E+ +
Sbjct: 181 KSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 24/210 (11%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKR--LKEERTPGGELQFQTEVEMISMAVH 352
+ F+ +G+G FG+VYK +VA+K L+E ++Q E++ +S
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQ--QEIQFLSQCRS 58
Query: 353 RNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 411
+ + G +L ++ Y GS L+ LD I GL
Sbjct: 59 PYITKYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPGK-----LDETYIAFILREVLLGLE 112
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG----LAKLMDYKDTHVTTAVRGTIGH 467
YLH+ IHRD+KAANILL EE + + DFG L M ++T V GT
Sbjct: 113 YLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-----GTPFW 164
Query: 468 IAPEYLSTGKSSEKTDVFGYGIMLLELITG 497
+APE + EK D++ GI +EL G
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 72/219 (32%), Positives = 105/219 (47%), Gaps = 22/219 (10%)
Query: 292 QVATDSFSNKNILGRGGFGKVYKG----RLADGS--LVAVKRLKEERTPGGELQFQTEVE 345
+V DS + LG G FG+VY+G R D VAVK L E + E F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 346 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RP----PSQLPLDWPTRK 400
++S H+N++RL G R ++ MA G + S LRE RP PS L +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMK--DLL 119
Query: 401 RIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGLAKLMDYKDTHV 457
A A+G YL ++ IHRD+ A N LL + A + DFG+A+ + Y+ ++
Sbjct: 120 FCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI-YRASYY 175
Query: 458 TTAVRGT--IGHIAPEYLSTGKSSEKTDVFGYGIMLLEL 494
R I + PE G + KTDV+ +G++L E+
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 304 LGRGGFGKVYKGRLADGS------LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357
LG G FGKVYKG L + VA+K LKE P + +F+ E E++S H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 358 LRGFCMTPTERLLVYPYMANGSVASCLRERPPS------------QLPLDWPTRKRIALG 405
L G C +++ Y+A+G + L P + LD IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 406 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 464
A G+ YL H +HRD+ A N L+ E + DFGL++ + D + V +
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 465 IGHIAPEYLSTGKSSEKTDVFGYGIMLLEL 494
+ + PE + GK + ++D++ +G++L E+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 3e-20
Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 302 NILGRGGFGKVYKGRLADGSLVAVKR--LKEERTPGGELQF---QTEVEMISMAVHRNLL 356
+LG+G +G VY G G L+AVK+ L E ++ Q EV+++ H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 357 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 416
+ G C+ + ++ GS++S L P P+ K+I G++YLH++
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI----LDGVAYLHNN 121
Query: 417 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-----TAVRGTIGHIAPE 471
C ++HRD+K N++L + DFG A+ + + H T ++ GT +APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 472 YLSTGKSSEKTDVFGYGIMLLELITGQ 498
++ K+D++ G + E+ TG+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 4e-20
Identities = 66/198 (33%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 303 ILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 362
I+G G FG V +G G VAVK +K + T F E +++ H+NL+RL G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 363 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 422
+ +V M+ G++ + LR R + + + + +L A G+ YL K++
Sbjct: 69 LH-NGLYIVMELMSKGNLVNFLRTRGRALVSV--IQLLQFSLDVAEGMEYLESK---KLV 122
Query: 423 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 482
HRD+ A NIL+ E+ A V DFGLA++ + V+ T APE L K S K+
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKS 178
Query: 483 DVFGYGIMLLELITGQRA 500
DV+ YG++L E+ + RA
Sbjct: 179 DVWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-20
Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 32/220 (14%)
Query: 304 LGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357
+G+G FG+V++ R ++VAVK LKEE + + FQ E +++ H N+++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 358 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQ------------------LPLDWPTR 399
L G C L++ YMA G + LR R P LPL +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 400 KRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK---LMDYKDTH 456
IA A G++YL + K +HRD+ N L+ E + DFGL++ DY
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 457 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
A+ I + PE + + + ++DV+ YG++L E+ +
Sbjct: 190 ENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 6e-20
Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 16/196 (8%)
Query: 304 LGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 362
+GRG FG+V+ GRL AD + VAVK +E P + +F E ++ H N++RL G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 363 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 422
+V + G + LR P L ++ +A G+ YL I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPR---LKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 423 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI-----APEYLSTGK 477
HRD+ A N L+ E+ + DFG+++ ++ A G + I APE L+ G+
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 478 SSEKTDVFGYGIMLLE 493
S ++DV+ +GI+L E
Sbjct: 173 YSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 7e-20
Identities = 77/293 (26%), Positives = 125/293 (42%), Gaps = 59/293 (20%)
Query: 303 ILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL 358
++G G FG+V +GRL VA+K LK T F +E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 359 RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 418
G +++ +M NG++ S LR+ + R G A G+ YL +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSEM-- 125
Query: 419 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIG--HIAPEYLS 474
+HRD+ A NIL++ V DFGL++ + D D T+++ G I APE ++
Sbjct: 126 -NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 475 TGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533
K + +DV+ YGI++ E+++ G+R + W
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERPY---------------W---------------- 213
Query: 534 DLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 573
D+ N V +EQ L Q+ L C Q RPK ++V L+
Sbjct: 214 DMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 9e-20
Identities = 65/220 (29%), Positives = 106/220 (48%), Gaps = 17/220 (7%)
Query: 302 NILGRGGFGKVYKG-RLADGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLR 359
N +G G FGKVY L G L+AVK ++ + P + E++++ + H NL++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 360 GFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 419
G + + + Y + G++ L LD + L GL+YLH H
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRI----LDEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 420 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG---HIAPEYLSTG 476
I+HRD+K ANI LD +GDFG A + T + V+ G ++APE ++ G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 477 KSSEK---TDVFGYGIMLLELITGQRAFDLARLANDDDVM 513
K D++ G ++LE+ TG+R + + L N+ +M
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPW--SELDNEFQIM 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 72/278 (25%), Positives = 127/278 (45%), Gaps = 31/278 (11%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQ-----FQTEVEMISMAVHRNLL 356
LG G F Y+ R + G+L+AVK++ R E + + E+ +++ H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 357 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 416
R+ G + L +MA GSV+ L + + + RGLSYLH++
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAV----IINYTEQLLRGLSYLHEN 122
Query: 417 CDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEY 472
+IIHRDVK AN+L+D + + + DFG A + K T + GTI +APE
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 473 LSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532
L + DV+ G +++E+ T + ++ + +N + L+ + + +
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN--HLALIFKIASATTAPSIPEHLS 237
Query: 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
P L++ V L C + P DRP E+++
Sbjct: 238 PGLRD------------VTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 292 QVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGG-ELQ-FQTEVEMISM 349
++ +S LG G FG+V+ G + + VAVK LK PG +Q F E ++
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLK----PGTMSVQAFLEEANLMKT 57
Query: 350 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARG 409
H L+RL ++ YMA GS+ L+ ++ L P + A G
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEG 115
Query: 410 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 469
++Y+ IHRD++AAN+L+ E + DFGLA++++ + + I A
Sbjct: 116 MAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTA 172
Query: 470 PEYLSTGKSSEKTDVFGYGIMLLELIT 496
PE ++ G + K+DV+ +GI+L E++T
Sbjct: 173 PEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-19
Identities = 45/109 (41%), Positives = 66/109 (60%)
Query: 70 VDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPI 129
+DL N LSG++ + +G +L+ L+L N + G IP+ L NLTSL L L N G I
Sbjct: 145 LDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQI 204
Query: 130 PDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
P LG++ L+++ L N+LSG IP + ++SL LDL N L+G +P
Sbjct: 205 PRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253
|
Length = 968 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 77/289 (26%), Positives = 135/289 (46%), Gaps = 42/289 (14%)
Query: 303 ILGRGGFGKVYKGRLA--DGSL--VAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNLLR 357
ILG G FG V +G+L+ DGS VAVK +K + E++ F +E + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 358 LRGFCMTPTER------LLVYPYMANGSVASCLRERPPSQLPLDWPTRK--RIALGSARG 409
L G C + +++ P+M +G + S L LP P + + + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 410 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM----DYKDTHVTTAVRGTI 465
+ YL + IHRD+ A N +L E+ V DFGL+K + Y+ + + +
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA---KMPV 179
Query: 466 GHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKE 524
IA E L+ + K+DV+ +G+ + E+ T GQ + + N + + D+++ +
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY--PGVENHE---IYDYLRHGNRL 234
Query: 525 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
K+ E +D +L + C + P DRP +++ +LE
Sbjct: 235 KQPEDCLD-------------ELYDLMYSCWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 13/206 (6%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 354
D LG G G V K G ++AVK ++ E + Q E++++
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
++ G + + YM GS+ L+E Q + +IA+ +GL+YLH
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKE---VQGRIPERILGKIAVAVLKGLTYLH 117
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAPEY 472
+ KIIHRDVK +NIL++ + + DFG++ + T V GT ++APE
Sbjct: 118 E--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPER 170
Query: 473 LSTGKSSEKTDVFGYGIMLLELITGQ 498
+ S K+D++ G+ L+EL TG+
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 304 LGRGGFGKVYKG-RLADGSLVAVKRLK----EERTPGGELQFQTEVEMISMAVHRNLLRL 358
LG G FG VY+G L DG AVK + + Q + E+ ++S H N+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 359 RGFCMTPTERLLVY-PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 417
G + L ++ + GS+A L++ P+ ++I LG L YLHD
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLHDR- 121
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STG 476
+HRD+K ANIL+D + DFG+AK + + +G+ +APE + G
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIAQQG 177
Query: 477 KSSEKTDVFGYGIMLLELITGQ 498
D++ G +LE+ TG+
Sbjct: 178 GYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 72/278 (25%), Positives = 129/278 (46%), Gaps = 39/278 (14%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGEL-QFQTEVEMISMAVH---RNLLR 357
++GRG +G VY+G+ + G +VA+K + + TP ++ Q EV ++S N+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLD-TPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 358 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 417
G + ++ Y GSV + ++ P ++ + R+ + L Y+H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLV-----ALKYIHKV- 120
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 477
+IHRD+KAANIL+ + DFG+A L++ + +T V GT +APE ++ GK
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGK 177
Query: 478 SSE-KTDVFGYGIMLLELITGQRAF---DLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533
+ K D++ GI + E+ TG + D R M+L + K K P
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMML-----IPKSKP------P 220
Query: 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571
L++N + + + C P +R E+++
Sbjct: 221 RLEDNGYSKLLREFVA---ACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-19
Identities = 55/128 (42%), Positives = 76/128 (59%), Gaps = 5/128 (3%)
Query: 70 VDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPI 129
+DLG L G++ + L L +L++L L SN + G IP +LG + SL + L N+ +G I
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228
Query: 130 PDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPI 189
P +G L+ L L L N+L+GPIP SL N+ +LQ L L N+LSG +P FSL I
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIP-PSIFSLQKLI 287
Query: 190 SFANNLDL 197
S LDL
Sbjct: 288 S----LDL 291
|
Length = 968 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 65/211 (30%), Positives = 110/211 (52%), Gaps = 18/211 (8%)
Query: 303 ILGRGGFGKVYK-GRLADGSLVAVKRLK-EERTPGGELQFQTEVEMISMAVHRNLLRLRG 360
++GRG FG V+ R AD LV +K++ E+ T L Q E +++ + H N++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 361 FCMTPTERLLVYPYMANGSVASCLRERPPSQLP----LDWPTRKRIALGSARGLSYLHDH 416
+ ++V Y G++A +++R S L L + + +AL ++H
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL------HHVHTK 120
Query: 417 CDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 475
I+HRD+K NILLD+ V +GDFG++K++ K T V GT +I+PE
Sbjct: 121 ---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEG 175
Query: 476 GKSSEKTDVFGYGIMLLELITGQRAFDLARL 506
++K+D++ G +L EL + +RAF+ A L
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFEAANL 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 78/278 (28%), Positives = 131/278 (47%), Gaps = 31/278 (11%)
Query: 303 ILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL 358
++G G FG+V GRL VA+K LK T F +E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 359 RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 418
G ++V YM NGS+ + LR+ + R G A G+ YL D
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMKYLSDM-- 125
Query: 419 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAPEYLSTG 476
+HRD+ A NIL++ V DFGL++++ D + + T + I APE ++
Sbjct: 126 -GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 477 KSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 535
K + +DV+ YGI++ E+++ G+R + ++N D +K + + +L +D
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERPY--WEMSNQ------DVIKAIEEGYRLPAPMD--- 233
Query: 536 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
A + QL+ L C Q +RPK ++V +L+
Sbjct: 234 ----CPAALHQLM---LDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 65/210 (30%), Positives = 110/210 (52%), Gaps = 20/210 (9%)
Query: 303 ILGRGGFGKVYKG-RLADGSLV----AVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357
+LG G FG VYKG + +G V A+K L E P ++F E +++ H +L+R
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 358 LRGFCMTPTERLLVYPYMANGSVASCLRERPP---SQLPLDWPTRKRIALGSARGLSYLH 414
L G C++PT + LV M +G + + E SQL L+W + A+G+ YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 126
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYL 473
+ +++HRD+ A N+L+ + DFGLA+L++ + + I +A E +
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 474 STGKSSEKTDVFGYGIMLLELIT-GQRAFD 502
K + ++DV+ YG+ + EL+T G + +D
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 16/204 (7%)
Query: 304 LGRGGFGKVYKGRLAD-GSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRG 360
LG+GGFG+V ++ G + A K+L ++R GE E +++ R ++ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 361 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR---GLSYLHDHC 417
T + LV M G + + P R +A+ GL +LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP-----EARAIFYAAQIICGLEHLHQR- 114
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 477
+I++RD+K N+LLD+ + D GLA ++ K GT G++APE L
Sbjct: 115 --RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEV 170
Query: 478 SSEKTDVFGYGIMLLELITGQRAF 501
D F G L E+I G+ F
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 26/206 (12%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQF-QTEVEMISMAVHRNLLRLRGF 361
+G G +G VYK R +A G LVA+K +K E PG + + Q E+ M+ H N++ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 362 CMTPTERLLVYPYMANGSVAS--CLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 419
+ + +V Y GS+ + P S+L + + R+ + +GL+YLH+
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE-----TLKGLAYLHET--- 120
Query: 420 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT-IGH---IAPEYL-- 473
IHRD+K ANILL E+ + + DFG++ + T T A R + IG +APE
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQL----TA-TIAKRKSFIGTPYWMAPEVAAV 175
Query: 474 -STGKSSEKTDVFGYGIMLLELITGQ 498
G K D++ GI +EL Q
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 52/193 (26%), Positives = 91/193 (47%), Gaps = 8/193 (4%)
Query: 304 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM 363
+G G FG V+ G + VA+K ++E E F E +++ H L++L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 364 TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIH 423
+ LV+ +M +G ++ LR + T + L G++YL +IH
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 424 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTD 483
RD+ A N L+ E V DFG+ + + +T + + +PE S K S K+D
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 484 VFGYGIMLLELIT 496
V+ +G+++ E+ +
Sbjct: 184 VWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 33/225 (14%)
Query: 294 ATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVK--RLKEERTPGGELQFQTEVEMI-SM 349
T F ++G G +GKVYK R G LVA+K + E+ E + + E ++
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKEEYNILRKY 59
Query: 350 AVHRNLLRLRG--FCMTPT----ERLLVYPYMANGSVASCLR--ERPPSQLPLDWPTRKR 401
+ H N+ G P + LV GSV ++ + +L +W
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW----- 114
Query: 402 IAL---GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 458
IA + RGL+YLH++ K+IHRD+K NILL + E + DFG++ +D
Sbjct: 115 IAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN 171
Query: 459 TAVRGTIGHIAPEYLSTGKSSEKT-----DVFGYGIMLLELITGQ 498
T + GT +APE ++ + + + DV+ GI +EL G+
Sbjct: 172 TFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 78/284 (27%), Positives = 121/284 (42%), Gaps = 34/284 (11%)
Query: 304 LGRGGFGKVYKG---RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG 360
+G G FGKV G R + V VK L+ TP +L F EV+ H N+L+ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 361 FCMTPTERLLVYPYMANGSVASCLR-ERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 419
C+ LLV + G + + LR R +R+A A GL +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 420 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEY----- 472
IH D+ N L + +GD+GLA L Y + + T + +APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 473 --LSTGKSSEKTDVFGYGIMLLELIT-GQRAF-DLARLANDDDVMLLDWVKGLLKEKKLE 528
L ++K++++ G+ + EL T + + DL+ D+ V+ K +++E+ ++
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS----DEQVL-----KQVVREQDIK 229
Query: 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 572
L P L Y + E V C P RP EV +L
Sbjct: 230 -LPKPQLDLKYSDRWYE----VMQFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 71/219 (32%), Positives = 109/219 (49%), Gaps = 24/219 (10%)
Query: 302 NILGRGGFGKVYKGR----LADGS---LVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 354
N LG G FG+VY+G L GS VAVK L++ T + +F E ++S H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLR----ERPPSQLPLDWPTRKRIALGSARGL 410
+++L G C+ + ++ M G + S LR ER L L I L A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPL-LTLKELLDICLDVAKGC 119
Query: 411 SYLHDHCDPKIIHRDVKAANILLDEEFEAV-----VGDFGLAKLMDYKDTHVTTAVRGTI 465
YL IHRD+ A N L+ E+ +GDFGLA+ + YK + G +
Sbjct: 120 VYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI-YKSDYYRKEGEGLL 175
Query: 466 G--HIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAF 501
+APE L GK + ++DV+ +G+++ E++T GQ+ +
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 304 LGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357
LG G FGKV+ D LVAVK LKE + FQ E E++++ H++++R
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVR 71
Query: 358 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQL-----------PLDWPTRKRIALGS 406
G C L+V+ YM +G + LR P L IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 407 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTI 465
A G+ YL +HRD+ N L+ + +GDFG+++ + D + V I
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 466 GHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
+ PE + K + ++D++ +G++L E+ T
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 78/291 (26%), Positives = 135/291 (46%), Gaps = 45/291 (15%)
Query: 304 LGRGGFGKVYKGRLAD------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357
LG+G FG VY+G D + VAVK + E + ++F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 358 LRGFCMTPTERLLVYPYMANGSVASCLR------ERPPSQLPLDWPTRKRI---ALGSAR 408
L G L+V MA+G + S LR E P + P PT + + A A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP---PTLQEMIQMAAEIAD 130
Query: 409 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--TIG 466
G++YL+ K +HRD+ A N ++ +F +GDFG+ + + Y+ + +G +
Sbjct: 131 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVR 186
Query: 467 HIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 526
+APE L G + +D++ +G++L E+ + LA +GL E+
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------LAEQP-------YQGLSNEQV 230
Query: 527 LEMLVDPDL--QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575
L+ ++D Q + V L++ +C Q +P RP E+V +L+ D
Sbjct: 231 LKFVMDGGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-18
Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 303 ILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQ-----------FQTEVEMISMA 350
++G G FG VY G A G L+AVK+++ P E+ ++
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVE---LPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 351 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGL 410
H N+++ G + + Y+ GSVA+ L + L ++I +GL
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGL 119
Query: 411 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-----AVRGTI 465
+YLH+ IIHRD+K ANIL+D + + DFG++K ++ T +++G++
Sbjct: 120 NYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 466 GHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
+APE + + K D++ G +++E++TG+ F
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 9e-18
Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 303 ILGRGGFGKVYKGRLA-DGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357
+LG G FG VYKG DG VA+K L+E +P + E +++ + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 358 LRGFCMTPTERLLVYPYMANGSVASCLRE---RPPSQLPLDWPTRKRIALGSARGLSYLH 414
L G C+T T +L V M G + +RE R SQ L+W + A+G+SYL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLE 126
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYL 473
+ +++HRD+ A N+L+ + DFGLA+L+D +T + I +A E +
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 474 STGKSSEKTDVFGYGIMLLELIT-GQRAFD 502
+ + ++DV+ YG+ + EL+T G + +D
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 302 NILGRGGFGKVYK-GRLADGSLVAVKRLK-EERTPGGELQFQTEVEMISMAVHRNLLRLR 359
+G+G FG V K R +DG ++ K + T + Q +EV ++ H N++R
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 360 GFCMTPTERLLVYPYM---ANGSVAS----CLRERPPSQLPLDWPTRKRIALGSARGLSY 412
+ + + L Y M G +A C +ER + W RI L
Sbjct: 66 DRIIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILTQLLLALYE 120
Query: 413 LH--DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 470
H ++HRD+K ANI LD +GDFGLAK++ + + T V GT +++P
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSP 179
Query: 471 EYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
E L+ EK+D++ G ++ EL F
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPPF 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 14/211 (6%)
Query: 292 QVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG--GELQFQTEVEMISM 349
++ +S LG G FG+V+ G + VAVK LK PG F E +++
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLK----PGTMSPESFLEEAQIMKK 57
Query: 350 AVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR 408
H L++L + + E + +V YM+ GS+ L++ L L P +A A
Sbjct: 58 LRHDKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKL--PNLVDMAAQVAA 113
Query: 409 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 468
G++Y+ IHRD+++ANIL+ + + DFGLA+L++ + + I
Sbjct: 114 GMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT 170
Query: 469 APEYLSTGKSSEKTDVFGYGIMLLELITGQR 499
APE G+ + K+DV+ +GI+L EL+T R
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 66/198 (33%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 303 ILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 362
+G+G FG V G G+ VAVK +K + T F E +++ H NL++L G
Sbjct: 13 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 68
Query: 363 MTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 421
+ L +V YMA GS+ LR R S L D + +L + YL +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD--CLLKFSLDVCEAMEYLEAN---NF 123
Query: 422 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 481
+HRD+ A N+L+ E+ A V DFGL K V+ T APE L K S K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 179
Query: 482 TDVFGYGIMLLELITGQR 499
+DV+ +GI+L E+ + R
Sbjct: 180 SDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 65/216 (30%), Positives = 110/216 (50%), Gaps = 22/216 (10%)
Query: 298 FSNKNILGRGGFGKVYKGR-LADGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVH 352
F +LG G FG VYKG + +G VA+K L+E +P + E +++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 353 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE---RPPSQLPLDWPTRKRIALGSARG 409
++ RL G C+T T +L + M G + +RE SQ L+W + A+G
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121
Query: 410 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGH 467
++YL + +++HRD+ A N+L+ + DFGLAKL+ D K+ H + I
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG-KVPIKW 177
Query: 468 IAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFD 502
+A E + + ++DV+ YG+ + EL+T G + +D
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-17
Identities = 47/112 (41%), Positives = 68/112 (60%)
Query: 67 VIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFT 126
+I +DL + +LSG++ + L+NL+ L L+SNN TG IP L +L L L L+ N F+
Sbjct: 286 LISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFS 345
Query: 127 GPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
G IP LGK + L L L+ N+L+G IP L + +L L L +N L G +P
Sbjct: 346 GEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP 397
|
Length = 968 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 4e-17
Identities = 64/198 (32%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 304 LGRGGFGKVYKGRLADGSLVAVKRLKE-ERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 362
LG+G FG+V+ G + VA+K LK +P LQ E +++ H L++L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQL--YA 68
Query: 363 MTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 421
+ E + +V YM+ GS+ L+ L L P +A A G++Y+
Sbjct: 69 VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVERM---NY 123
Query: 422 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 481
+HRD++AANIL+ E V DFGLA+L++ + + I APE G+ + K
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 482 TDVFGYGIMLLELITGQR 499
+DV+ +GI+L EL T R
Sbjct: 184 SDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 66/210 (31%), Positives = 95/210 (45%), Gaps = 33/210 (15%)
Query: 304 LGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL 358
LG G FGKV G +VAVK LK E ++ E+ ++ H N+++
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 359 RGFCMTPTER--LLVYPYMANGSVASCLRERPP------SQLPLDWPTRKRIALGSARGL 410
+G C + L+ Y+ GS LR+ P +QL L A G+
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGS----LRDYLPKHKLNLAQLLL-------FAQQICEGM 120
Query: 411 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR----GTIG 466
+YLH IHRD+ A N+LLD + +GDFGLAK + + H VR +
Sbjct: 121 AYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV--PEGHEYYRVREDGDSPVF 175
Query: 467 HIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
A E L K S +DV+ +G+ L EL+T
Sbjct: 176 WYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 30/221 (13%)
Query: 303 ILGRGGFGKVYKGR------LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 356
LG G FGKV K A + VAVK LKE + +E ++ H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 357 RLRGFCMTPTERLLVYPYMANGSVASCLRER------------PPSQLPLDWPTRKRIAL 404
+L G C LL+ Y GS+ S LRE + LD P + + +
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 405 GS--------ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 456
G +RG+ YL + K++HRD+ A N+L+ E + + DFGL++ + +D++
Sbjct: 127 GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 457 VTTAV-RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
V + R + +A E L + ++DV+ +G++L E++T
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 304 LGRGGFGKVY--------KGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISM-AVHRN 354
LG G FG+V K + VAVK LK++ T +E+EM+ M H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLR-ERPPS--------QLPLDWPTRKRI--- 402
++ L G C ++ Y + G++ LR RPP +LP + T K +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 403 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAV 461
A ARG+ YL K IHRD+ A N+L+ E+ + DFGLA+ + D + TT
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 462 RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
R + +APE L + ++DV+ +G++L E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 73/239 (30%), Positives = 102/239 (42%), Gaps = 44/239 (18%)
Query: 264 QEFFFDVPAEEDPEVHLGQLKRFS-LRELQVATDSFSNKNILGRGGFGKVYKGR-LADGS 321
E F +DPE K F+ LRE+ G G FG VY R +
Sbjct: 5 AELFSK----DDPE------KLFTDLREI-------------GHGSFGAVYFARDVRTNE 41
Query: 322 LVAVKRLKEERTPGGELQFQ---TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 378
+VA+K++ E ++Q EV + H N + +G + LV Y G
Sbjct: 42 VVAIKKMSYSGKQSNE-KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-G 99
Query: 379 SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE 438
S + L + PL I G+ +GL+YLH H IHRD+KA NILL E
Sbjct: 100 SASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGT 153
Query: 439 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY---LSTGKSSEKTDVFGYGIMLLEL 494
+ DFG A L+ ++ V GT +APE + G+ K DV+ GI +EL
Sbjct: 154 VKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 76/284 (26%), Positives = 128/284 (45%), Gaps = 35/284 (12%)
Query: 304 LGRGGFGKVYKGRL-ADGSL--VAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNLLRLR 359
LG G FG V +G+L D S+ VAVK +K E++ F +E + H N++RL
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 360 GFCMTPTER------LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGS--ARGLS 411
G C+ E +++ P+M +G + S L P PT+ + + A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV-RGTIGHIAP 470
YL IHRD+ A N +L+E V DFGL+K + D + + + + IA
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 471 EYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529
E L+ + K+DV+ +G+ + E+ T GQ + ++ + D+++ + K+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPY-----PGVENSEIYDYLRQGNRLKQ--- 235
Query: 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
PD ++ L + C +P DRP + LE
Sbjct: 236 --PPDC--------LDGLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 7e-17
Identities = 69/267 (25%), Positives = 114/267 (42%), Gaps = 26/267 (9%)
Query: 304 LGRGGFGKVYK-GRLADGSLVAVKRLKEERTPGGE-LQFQTEVEMISMAVHRNLLRLRGF 361
LG+G +G VYK RL+D A+K + E E+ +++ H N++ +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 362 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 421
+ + +V Y G ++ + +R + + RI + RGL LH+ KI
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KI 124
Query: 422 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 481
+HRD+K+ANILL +GD G++K++ K T + GT ++APE S K
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQI-GTPHYMAPEVWKGRPYSYK 181
Query: 482 TDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVE 541
+D++ G +L E+ T F+ AR D L+ K P + Y
Sbjct: 182 SDIWSLGCLLYEMATFAPPFE-ARSMQD------------LRYKVQRGKYPP-IPPIY-- 225
Query: 542 AEVEQLIQVALLCTQGSPMDRPKMSEV 568
+ L Q P RP ++
Sbjct: 226 --SQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 9e-17
Identities = 47/121 (38%), Positives = 64/121 (52%), Gaps = 5/121 (4%)
Query: 77 LSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKL 136
+G++ L L LQ L+L+SN +G IP +LG +L LDL N+ TG IP+ L
Sbjct: 320 FTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS 379
Query: 137 SKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196
L L L +NSL G IP SL SL+ + L +N SG +P S FT + LD
Sbjct: 380 GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP-----SEFTKLPLVYFLD 434
Query: 197 L 197
+
Sbjct: 435 I 435
|
Length = 968 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 63/199 (31%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 304 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGEL--QFQTEVEMISMAVHRNLLRLRGF 361
LG+G FG+V+ G + VA+K LK PG + F E +++ H L+ L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK----PGTMMPEAFLQEAQIMKKLRHDKLVPL--Y 67
Query: 362 CMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 420
+ E + +V +M GS+ L+E L L P +A A G++Y+
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKL--PQLVDMAAQIADGMAYIERM---N 122
Query: 421 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 480
IHRD++AANIL+ + + DFGLA+L++ + + I APE G+ +
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 481 KTDVFGYGIMLLELITGQR 499
K+DV+ +GI+L EL+T R
Sbjct: 183 KSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 70/272 (25%), Positives = 123/272 (45%), Gaps = 29/272 (10%)
Query: 304 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGEL--QFQTEVEMISMAVHRNLLRLRGF 361
LG G FG+V+ + VAVK +K PG F E ++ H L++L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK----PGSMSVEAFLAEANVMKTLQHDKLVKLHA- 68
Query: 362 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 421
+T ++ +MA GS+ L+ S+ PL P + A G++++
Sbjct: 69 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NY 123
Query: 422 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 481
IHRD++AANIL+ + DFGLA++++ + + I APE ++ G + K
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183
Query: 482 TDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVE 541
+DV+ +GI+L+E++T R ++N + + L E+ M E
Sbjct: 184 SDVWSFGILLMEIVTYGRI-PYPGMSNPEVIRAL--------ERGYRM--------PRPE 226
Query: 542 AEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
E+L + + C + P +RP + +L+
Sbjct: 227 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (199), Expect = 1e-16
Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 298 FSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK----EERTPGGELQFQTEVEMISMAVH 352
+ LG G +G VYK R G +VA+K+++ EE P L+ E+ ++ H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR---EISLLKELKH 57
Query: 353 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 412
N+++L T + LV+ Y + L +RP PL K I RGL+Y
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPG---PLSPNLIKSIMYQLLRGLAY 113
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 472
H H +I+HRD+K NIL++ + + DFGLA+ T V T+ + APE
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEI 169
Query: 473 L------STGKSSEKTDVFGYGIMLLELITGQ 498
L ST D++ G + E+ITG+
Sbjct: 170 LLGSKHYSTA-----VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 67/271 (24%), Positives = 100/271 (36%), Gaps = 47/271 (17%)
Query: 298 FSNKNILGRGGFGKVYKGRLADGSLV-AVK--------RLKEERTPGGELQFQTEVEMIS 348
F ++G+G FGKV + D + A+K R E + E+
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN--- 58
Query: 349 MAVHRNLLRLR-GFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGS 406
H L+ L F E + LV + G LR ++ K
Sbjct: 59 ---HPFLVNLWYSFQ--DEENMYLVVDLLLGGD----LRYHLSQKVKFSEEQVKFWICEI 109
Query: 407 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 466
L YLH IIHRD+K NILLDE+ + DF +A +TT+ GT G
Sbjct: 110 VLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIAT--KVTPDTLTTSTSGTPG 164
Query: 467 HIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM------------- 513
++APE L S D + G+ E + G+R + D +
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPAT 224
Query: 514 ----LLDWVKGLLKEKKLEMLVDP--DLQNN 538
+D + LL+ + L D DL+N+
Sbjct: 225 WSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 304 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM 363
LG G FG V G+ VA+K +KE E +F E +++ H L++L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 364 TPTERLLVYPYMANGSVASCLRE---RP-PSQLPLDWPTRKRIALGSARGLSYLHDHCDP 419
+V YM+NG + + LRE R PSQL + G++YL
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-------LEMCKDVCEGMAYLESK--- 119
Query: 420 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAPEYLSTG 476
+ IHRD+ A N L+D++ V DFGL++ + D T++V G+ + PE L
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSV-GSKFPVRWSPPEVLLYS 176
Query: 477 KSSEKTDVFGYGIMLLELIT-GQRAFDL 503
K S K+DV+ +G+++ E+ + G+ ++
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 303 ILGRGGFGKVYKGRLAD-GSLVAVKRLKEER----TPGGELQFQTEVEMISMAVHRNLLR 357
+LG+G FG+VY D G +AVK++ + T + E++++ H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 358 LRGFCMTPTERLLVY-PYMANGSVASCLRERPPSQLPLDWPTRK--RIALGSARGLSYLH 414
G C+ E L ++ YM GSV L+ + TRK R L G+ YLH
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALT---ETVTRKYTRQIL---EGVEYLH 121
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPEY 472
+ I+HRD+K ANIL D +GDFG +K + + T +V GT ++PE
Sbjct: 122 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178
Query: 473 LSTGKSSEKTDVFGYGIMLLELIT 496
+S K DV+ G ++E++T
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 69/227 (30%), Positives = 110/227 (48%), Gaps = 25/227 (11%)
Query: 292 QVATDSFSNKNILGRGGFGKVY--------KGRLADGSLVAVKRLKEERTPGGELQFQTE 343
+V D LG G FG+V K + + VAVK LK + T +E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 344 VEMISM-AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR-ERPP--------SQLP 393
+EM+ M H+N++ L G C ++ Y + G++ LR RPP +Q+P
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 394 LDWPTRKRI---ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450
+ + K + A ARG+ YL K IHRD+ A N+L+ E+ + DFGLA+ +
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 451 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
+ D + TT R + +APE L + ++DV+ +G++L E+ T
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 71/281 (25%), Positives = 122/281 (43%), Gaps = 31/281 (11%)
Query: 302 NILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG 360
+ LG G G V K RL G + A+K + + P + Q E+E+ +++ G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 361 FCMTPTERLL--VYPYMANGSVASC---LRERPP--SQLPLDWPTRKRIALGSARGLSYL 413
+ + + Y GS+ S +++R + L +IA +GLSYL
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVLKGLSYL 121
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIAPEY 472
H KIIHRD+K +NILL + + + DFG++ +L++ T GT ++APE
Sbjct: 122 HSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYMAPER 174
Query: 473 LSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532
+ S +DV+ G+ LLE+ + F + ++ + ++ E+ +
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP---LGPIELLSYIVNMPNPELKDE 231
Query: 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
P + E E + I+ C + P RP MLE
Sbjct: 232 PGNGIKWSE-EFKDFIKQ---CLEKDPTRRPTPW---DMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 25/215 (11%)
Query: 304 LGRGGFGKVY--------KGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISM-AVHRN 354
LG G FG+V K + + VAVK LK++ T +E+EM+ M H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPP---------SQLPLDWPTRKRIALG 405
++ L G C ++ Y + G++ LR R P +++P + T K +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 406 S---ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAV 461
+ ARG+ YL K IHRD+ A N+L+ E + DFGLA+ ++ D + TT
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 462 RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
R + +APE L + ++DV+ +G+++ E+ T
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 298 FSNKNILGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 356
F+ +G+G FG+V+KG +VA+K + E Q E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 357 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 416
+ G + T+ ++ Y+ GS LR P + + ++ + +GL YLH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL-----KGLDYLHSE 120
Query: 417 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 476
K IHRD+KAAN+LL E+ + + DFG+A + T V GT +APE +
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 176
Query: 477 KSSEKTDVFGYGIMLLELITGQ 498
K D++ GI +EL G+
Sbjct: 177 AYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 10/205 (4%)
Query: 295 TDSFSNKNILGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 353
+ + N +G G G+VYK A G VA+K+++ + EL E+ ++ H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIIN-EILIMKDCKHP 75
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
N++ + E +V YM GS+ + + + ++ P + +GL YL
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYL 132
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 473
H +IHRD+K+ NILL ++ + DFG A + + + + V GT +APE +
Sbjct: 133 HSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVI 188
Query: 474 STGKSSEKTDVFGYGIMLLELITGQ 498
K D++ GIM +E+ G+
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 304 LGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL 358
LG FGK+YKG L LVA+K LK+ P +FQ E +++ H N++ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 359 RGFCMTPTERLLVYPYMANGSVASCLRERPPS-------------QLPLDWPTRKRIALG 405
G +++ Y+ G + L R P + LD IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 406 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 464
A G+ YL H +H+D+ A NIL+ E+ + D GL++ + D + V
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 465 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
I + PE + GK S +D++ +G++L E+ +
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKE-ERTPGGELQFQTEVEMISMAVHRNLLRLRGF 361
+G G +G VYK R G +VA+K++K + G E++++ H N+++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 362 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 421
+ LV+ +M + + +++R Q L K +GL++ H H I
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 422 IHRDVKAANILLDEEFEAVVGDFGLAKLMD-----YKDTHVTTAVRGTIGHIAPEYLSTG 476
+HRD+K N+L++ E + DFGLA+ Y VT R APE L
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYR------APELLLGD 173
Query: 477 KS-SEKTDVFGYGIMLLELITGQRAF 501
K S D++ G + EL++ + F
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 39/217 (17%)
Query: 303 ILGRGGFGKV----YKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMI----------S 348
+LGRG FGKV YK G L A+K LK+ G++ + EVE + +
Sbjct: 6 VLGRGHFGKVLLAEYKK---TGELYAIKALKK-----GDIIARDEVESLMCEKRIFETAN 57
Query: 349 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR 408
H L+ L T V Y A G + + D + R +A
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--------DVFSEPRAVFYAAC 109
Query: 409 ---GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGT 464
GL YLH++ KI++RD+K N+LLD E + DFGL K M + D T+ GT
Sbjct: 110 VVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGT 164
Query: 465 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
+APE L+ + D +G G+++ E++ G+ F
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 304 LGRGGFGKVY--------KGRLADGSLVAVKRLKEERTPGGELQFQTEVEMIS-MAVHRN 354
LG G FG+V K R VAVK LK+ T +E+E++ + H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLR-ERPP-----------SQLPLDWPTRKRI 402
++ L G C ++ Y A G++ LR RPP + L +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 403 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAV 461
A ARG+ YL + IHRD+ A N+L+ E+ + DFGLA+ + D + T+
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 462 RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
R + +APE L + ++DV+ +GI++ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGG-ELQFQTEVEMISMAVHRNLLRLRGF 361
+G G G V+K + G VA+K++ R GG Q E++ + H +++L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 362 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 421
+ +LV YM ++ LR+ PL K +G++Y+H + I
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHAN---GI 120
Query: 422 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STGKSSE 480
+HRD+K AN+L+ + + DFGLA+L ++ + + T + APE L K
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180
Query: 481 KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 515
D++ G + EL+ G F ++D+ L
Sbjct: 181 GVDLWAVGCIFAELLNGSPLF-----PGENDIEQL 210
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 62/224 (27%), Positives = 112/224 (50%), Gaps = 26/224 (11%)
Query: 303 ILGRGGFGKVYKG-RLADGSL----VAVKRLKEERTPGGELQFQTEVE-MISMAV--HRN 354
+LG G FG V+KG + +G VA+K + ++R+ G FQ + M++M H
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI-QDRS--GRQTFQEITDHMLAMGSLDHAY 70
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPS---QLPLDWPTRKRIALGSARGLS 411
++RL G C + +L V GS+ +R+ S Q L+W + A+G+
Sbjct: 71 IVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMY 123
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAP 470
YL +H ++HR++ A NILL + + DFG+A L+ D + + + I +A
Sbjct: 124 YLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL 180
Query: 471 EYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVM 513
E + G+ + ++DV+ YG+ + E+++ G + R D++
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 16/204 (7%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKE-ERTPGGELQFQTEVEMISMAVHRNLLRLRGF 361
+G G +G V K R A G +VA+K+ KE E + EV+++ H N++ L+
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 362 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 421
LV+ Y+ ++ L E P LP D + + ++Y H H I
Sbjct: 69 FRRKGRLYLVFEYVER-TLLELL-EASPGGLPPD--AVRSYIWQLLQAIAYCHSH---NI 121
Query: 422 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL----STGK 477
IHRD+K NIL+ E + DFG A+ + + T T + APE L + GK
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGK 181
Query: 478 SSEKTDVFGYGIMLLELITGQRAF 501
DV+ G ++ EL+ G+ F
Sbjct: 182 P---VDVWAIGCIMAELLDGEPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 60/192 (31%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 302 NILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV--------- 351
+G G +G VYK R L G VA+K++ R P E E I ++
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKV---RVPLSE-------EGIPLSTLREIALLKQ 54
Query: 352 -----HRNLLRLRGFCMTP-TER----LLVYPYMANGSVASCLRERPPSQLPLDWPTRKR 401
H N++RL C P T+R LV+ ++ + +A+ L + P LP + T K
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPE--TIKD 111
Query: 402 IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 461
+ RG+ +LH H I+HRD+K NIL+ + + + DFGLA++ Y T+V
Sbjct: 112 LMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI--YSFEMALTSV 166
Query: 462 RGTIGHIAPEYL 473
T+ + APE L
Sbjct: 167 VVTLWYRAPEVL 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 18/199 (9%)
Query: 304 LGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNLLRLRGF 361
LG G FGKVYK + + G A K ++ E EL+ F E++++S H N++ L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 362 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 421
+ ++ + G++ S + E + L P + + L++LH H K+
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSH---KV 124
Query: 422 IHRDVKAANILLDEEFEAVVGDFGL-AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 480
IHRD+KA NILL + + + DFG+ AK T GT +APE ++ +
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEVVACETFKD 182
Query: 481 -----KTDVFGYGIMLLEL 494
K D++ GI L+EL
Sbjct: 183 NPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 31/217 (14%)
Query: 301 KNILGRGGFGKVYKGRLADGSL---VAVKRLKEERTPGGELQFQTEVEMI-SMAVHRNLL 356
++++G G FG+V K R+ L A+KR+KE + F E+E++ + H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 357 RLRGFCMTPTERLLVYPYMANGSVASCLR-----ERPPS-----QLPLDWPTRKRIALGS 406
L G C L Y +G++ LR E P+ +++ + +
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 407 --ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 464
ARG+ YL + IHRD+ A NIL+ E + A + DFGL++ + V+ T
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKT 181
Query: 465 IGHI-----APEYLSTGKSSEKTDVFGYGIMLLELIT 496
+G + A E L+ + +DV+ YG++L E+++
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 298 FSNKNILGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 356
F+ +G+G FG+VYKG +VA+K + E Q E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 357 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 416
R G + T+ ++ Y+ GS L+ P + + R+ + +GL YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL-----KGLDYLHSE 120
Query: 417 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 476
+ IHRD+KAAN+LL E+ + + DFG+A + T V GT +APE +
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 176
Query: 477 KSSEKTDVFGYGIMLLELITGQ 498
K D++ GI +EL G+
Sbjct: 177 AYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 304 LGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL 358
LG G FGKV R G VAVK LK E + E+E++ H N+++
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 359 RGFCMTPTER--LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 416
+G C L+ ++ +GS+ L P ++ ++ + + A+ +G+ YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 417 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--VRGTIGHIAPEYLS 474
+ +HRD+ A N+L++ E + +GDFGL K ++ + T + + APE L
Sbjct: 129 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 475 TGKSSEKTDVFGYGIMLLELIT 496
K +DV+ +G+ L EL+T
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 1e-15
Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 40/228 (17%)
Query: 303 ILGRGGFGKVYKGRL-ADGSLVAVKRL------KEERTPGGELQFQTEVEMIS-MAVHRN 354
I+G G F V + A+K L KE++ + E E+++ + H
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVK----YVKIEKEVLTRLNGHPG 63
Query: 355 LLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
+++L + E L V Y NG + +R+ LD + A L YL
Sbjct: 64 IIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGS----LDEKCTRFYAAEILLALEYL 118
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-------------------YKD 454
H IIHRD+K NILLD++ + DFG AK++D K+
Sbjct: 119 HSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 502
+ GT +++PE L+ + + +D++ G ++ +++TG+ F
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 42/99 (42%), Positives = 57/99 (57%)
Query: 77 LSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKL 136
SG++ LG NL L+L +NN+TG IP L + +L L L+ NS G IP +LG
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGAC 403
Query: 137 SKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSG 175
LR +RL +NS SG +P T + + LD+SNN L G
Sbjct: 404 RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQG 442
|
Length = 968 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 2e-15
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 21/208 (10%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMIS-MAVHRNLLRLRG 360
++G G +G+VYKGR + G L A+K + + T E + + E+ M+ + HRN+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 361 FCMTPT------ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
+ + LV + GSV ++ + L +W I RGLS+LH
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLH 128
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 474
H K+IHRD+K N+LL E E + DFG++ +D T + GT +APE ++
Sbjct: 129 QH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIA 184
Query: 475 TGKSSE-----KTDVFGYGIMLLELITG 497
++ + K+D++ GI +E+ G
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 21/208 (10%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMIS-MAVHRNLLRLRG 360
++G G +G+VYKGR + G L A+K + + T E + + E+ M+ + HRN+ G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 361 FCMTPT------ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
+ + + LV + GSV ++ + L DW I RGL++LH
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLH 138
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 474
H K+IHRD+K N+LL E E + DFG++ +D T + GT +APE ++
Sbjct: 139 AH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIA 194
Query: 475 TGKSSEKT-----DVFGYGIMLLELITG 497
++ + T D++ GI +E+ G
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 73/293 (24%), Positives = 135/293 (46%), Gaps = 37/293 (12%)
Query: 292 QVATDSFSNKNILGRGGFGKVYKGRLADG-------SLVAVKRLKEERTPGGELQFQTEV 344
+VA + + LG+G FG VY+G +A G + VA+K + E + ++F E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60
Query: 345 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR------ERPPSQLPLDWPT 398
++ +++RL G L++ M G + S LR E P Q P
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 399 RKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 458
++A A G++YL+ + K +HRD+ A N ++ E+F +GDFG+ + + Y+ +
Sbjct: 121 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYR 176
Query: 459 TAVRG--TIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLD 516
+G + ++PE L G + +DV+ +G++L E+ T LA
Sbjct: 177 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQP------ 221
Query: 517 WVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 569
+G+ E+ L +++ L + + L ++ +C Q +P RP E++
Sbjct: 222 -YQGMSNEQVLRFVMEGGLLDKPDNCP-DMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 3e-15
Identities = 62/203 (30%), Positives = 93/203 (45%), Gaps = 12/203 (5%)
Query: 298 FSNKNILGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 356
F+ +G+G FG+V+KG +VA+K + E Q E+ ++S +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 357 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 416
+ G + T+ ++ Y+ GS L P PLD I +GL YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLE---PG--PLDETQIATILREILKGLDYLHSE 120
Query: 417 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYLST 475
K IHRD+KAAN+LL E E + DFG+A + DT + GT +APE +
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 476 GKSSEKTDVFGYGIMLLELITGQ 498
K D++ GI +EL G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 298 FSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQ---TEVEMISMAVHR 353
FS+ +G G FG VY R + + +VA+K++ E ++Q EV + H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHP 75
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
N ++ RG + LV Y GS + L + PL + G+ +GL+YL
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYL 131
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY- 472
H H +IHRDVKA NILL E +GDFG A +M + V GT +APE
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 473 --LSTGKSSEKTDVFGYGIMLLEL 494
+ G+ K DV+ GI +EL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 27/211 (12%)
Query: 303 ILGRGGFGKVYKGRLAD-GSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLR 359
I+GRGGFG+VY R AD G + A+K L ++R GE E M+S+ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI- 59
Query: 360 GFCMT-----PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR---GLS 411
CMT P + + M G + L + + K + + GL
Sbjct: 60 -VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVF-------SEKEMRFYATEIILGLE 111
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 471
++H+ +++RD+K ANILLDE + D GLA K H + GT G++APE
Sbjct: 112 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPE 165
Query: 472 YLSTGKSSEKT-DVFGYGIMLLELITGQRAF 501
L G + + + D F G ML +L+ G F
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 23/215 (10%)
Query: 301 KNILGRGGFGKVYKGR------LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 354
K LG G FGKV+ D LVAVK LK+ T FQ E E+++ H +
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEH 68
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL-DWPTRK-----------RI 402
+++ G C ++V+ YM +G + LR P + L D R+ I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 403 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAV 461
A A G+ YL +HRD+ N L+ +GDFG+++ + D + V
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 462 RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
I + PE + K + ++DV+ +G++L E+ T
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 68/209 (32%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 303 ILGRGGFGKVYKGRLAD-GSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLR 359
I+GRGGFG+VY R AD G + A+K L ++R GE E M+S+ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI- 59
Query: 360 GFCM-----TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRI-ALGSARGLSYL 413
CM TP + + M G + L SQ + R A GL ++
Sbjct: 60 -VCMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSEAEMRFYAAEIILGLEHM 113
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 473
H+ +++RD+K ANILLDE + D GLA K H + GT G++APE L
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 474 STGKSSEKT-DVFGYGIMLLELITGQRAF 501
G + + + D F G ML +L+ G F
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 37/275 (13%)
Query: 304 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM 363
LG G FG V+ G+ VA+K + E E F E +++ H L++L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 364 TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR----GLSYLHDHCDP 419
+V +M NG + + LR+R +L K + L + G+ YL +
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQ-GKL------SKDMLLSMCQDVCEGMEYLERN--- 119
Query: 420 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHIAPEYLSTGKS 478
IHRD+ A N L+ V DFG+ + + D + +++ + + PE + K
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSKY 178
Query: 479 SEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537
S K+DV+ +G+++ E+ T G+ F + +N + V ++ + L P L +
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMPF--EKKSNYEVVEMI---------SRGFRLYRPKLAS 227
Query: 538 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 572
V +V C P RP +E++R +
Sbjct: 228 MTV-------YEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 304 LGRGGFGKVYKGRLADG---SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG 360
+G G FGKV G + G + V VK L+ + +++F E + H NLL+ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 361 FCMTPTERLLVYPYMANGSVASCLRE-RPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 419
C T LLV + G + LR R + D T +R+A A GL +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 420 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--TIGHIAPEYLSTGK 477
IH D+ N LL + +GD+GL+ YK+ + T + + IAPE +
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHN-KYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 478 S-------SEKTDVFGYGIMLLEL 494
+++++V+ G+ + EL
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 57/204 (27%), Positives = 109/204 (53%), Gaps = 27/204 (13%)
Query: 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANIL 432
+M GS+ ++ P +P++ +IA+ GL+YL++ H +I+HRD+K +NIL
Sbjct: 84 FMDCGSLDRIYKKGGP--IPVE--ILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNIL 136
Query: 433 LDEEFEAVVGDFGLA-KLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIM 490
++ + + DFG++ +L++ DT V GT +++PE + GK + K+DV+ GI
Sbjct: 137 VNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERIQGGKYTVKSDVWSLGIS 191
Query: 491 LLELITGQRAFDLARLAND--DDVM-LLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQL 547
++EL G+ F + + +D DD M +LD ++ +++E P L ++ ++
Sbjct: 192 IIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP------PRLPSSDFPEDLRDF 245
Query: 548 IQVALLCTQGSPMDRPKMSEVVRM 571
+ LL P +RP ++ M
Sbjct: 246 VDACLLKD---PTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 32/218 (14%)
Query: 301 KNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 354
K LG G FGKV+ D LVAVK LK+ + F E E+++ H +
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEH 68
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL---DWPTR------KRIALG 405
+++ G C+ ++V+ YM +G + LR P + + + P IA
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 406 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 465
A G+ YL +HRD+ N L+ E +GDFG++ +D + T R
Sbjct: 129 IAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMS-----RDVYSTDYYR-VG 179
Query: 466 GH-------IAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
GH + PE + K + ++DV+ G++L E+ T
Sbjct: 180 GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 4e-14
Identities = 66/222 (29%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 303 ILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQ------FQTEVEMISMAVHRNL 355
+LG+G FGKV RL G L AVK LK++ LQ TE ++S+A +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVI----LQDDDVECTMTEKRILSLARNHPF 57
Query: 356 LRLRGFCMTPTERLLVYPYMANGS-----VASCLRERPPSQLPLDWPTRKRIALGSARGL 410
L C +RL NG + R D + A L
Sbjct: 58 LTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--------FDEARARFYAAEITSAL 109
Query: 411 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 470
+LHD II+RD+K N+LLD E + DFG+ K + T+ GT +IAP
Sbjct: 110 MFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAP 165
Query: 471 EYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDV 512
E L D + G++L E++ G F+ N+DD+
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE---AENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 65/221 (29%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 303 ILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG- 360
+LG+G FGKV L L AVK LK++ + Q + ++ + +L L G
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKD------VILQDD-DVECTMTEKRVLALAGK 54
Query: 361 -------FCMTPT-ERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 411
T +RL V Y+ G L D P + A GL
Sbjct: 55 HPFLTQLHSCFQTKDRLFFVMEYVNGGD----LMFHIQRSGRFDEPRARFYAAEIVLGLQ 110
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAP 470
+LH+ II+RD+K N+LLD E + DFG+ K + T T+ GT +IAP
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAP 165
Query: 471 EYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDD 511
E LS D + G++L E++ GQ F+ +D+D
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQSPFE----GDDED 202
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 298 FSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGG-ELQFQTEVEMISMAVHRNL 355
F N +G G +G VY+ R G +VA+K+++ + G + E+ ++ H N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 356 LRLRGFCMTPTERL----LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 411
+ L+ + + L LV Y +AS L P P K + L RGL
Sbjct: 69 VELKE--VVVGKHLDSIFLVMEYCEQ-DLASLLDNMPT---PFSESQVKCLMLQLLRGLQ 122
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 471
YLH++ IIHRD+K +N+LL ++ + DFGLA+ +T V T+ + APE
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPE 178
Query: 472 YL-STGKSSEKTDVFGYGIMLLELITGQ 498
L + D++ G +L EL+ +
Sbjct: 179 LLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 23/220 (10%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLK---EERTPGGELQFQTEVEMISMAVHRNLLRLR 359
LG G + VYKGR G +VA+K + EE TP ++ E+ ++ H N++RL
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKHENIVRLH 64
Query: 360 GFCMTPTERLLVYPYMANGSVASCLR---ERPPSQLPLDWPTRKRIALGSARGLSYLHDH 416
T + +LV+ YM L+ + + LD T K +G+++ H++
Sbjct: 65 DVIHTENKLMLVFEYMDKD-----LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 417 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 476
+++HRD+K N+L+++ E + DFGLA+ + V T+ + AP+ L
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGS 175
Query: 477 KS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 515
++ S D++ G ++ E+ITG+ F N++D +L
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLF---PGTNNEDQLLK 212
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-14
Identities = 50/134 (37%), Positives = 73/134 (54%), Gaps = 8/134 (5%)
Query: 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNS 124
N++ +DL L+G++ L NL L L+SN++ G IP LG SL + L NS
Sbjct: 356 NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNS 415
Query: 125 FTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSF 183
F+G +P KL + FL ++NN+L G I ++ SLQ+L L+ N+ G +PD+ GS
Sbjct: 416 FSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSK 475
Query: 184 SLFTPISFANNLDL 197
L NLDL
Sbjct: 476 RL-------ENLDL 482
|
Length = 968 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 53/200 (26%), Positives = 101/200 (50%), Gaps = 20/200 (10%)
Query: 304 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM 363
LG G FGKVYK + + ++A ++ + ++ + E+++++ H N+++L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 364 TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIH 423
++ + A G+V + + E + PL P + + + L+YLH++ KIIH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 424 RDVKAANILLDEEFEAVVGDFGLA----KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 479
RD+KA NIL + + + DFG++ + + +D+ + GT +APE + S
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSK 181
Query: 480 E-----KTDVFGYGIMLLEL 494
+ K DV+ GI L+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 303 ILGRGGFGKVYKGRLAD-GSLVAVKRLK---EERTPGGELQ-FQTEVEMISMAVHRNLLR 357
+LG+G FG+VY AD G +AVK+++ E E+ + E++++ +H +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 358 LRGFCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 415
G P ER L +M GS+ L+ S L ++ G+SYLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHS 124
Query: 416 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPEYL 473
+ I+HRD+K ANIL D +GDFG +K + T +V GT ++PE +
Sbjct: 125 N---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 474 STGKSSEKTDVFGYGIMLLELIT 496
S K D++ G ++E++T
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 65/233 (27%), Positives = 113/233 (48%), Gaps = 27/233 (11%)
Query: 304 LGRGGFGKVYKGR-LADGS-LVAVKRLK----EERTPGGELQFQTEVEMISMAVHRNLLR 357
+G G +GKV+K R L +G VA+KR++ EE P ++ + + H N++R
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 358 LRGFCMTP-----TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 412
L C T+ LV+ ++ + + + L + P +P + T K + RGL +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTE--TIKDMMFQLLRGLDF 125
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 472
LH H +++HRD+K NIL+ + + DFGLA++ ++ T+V T+ + APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEV 180
Query: 473 LSTGKSSEKTDVFGYGIMLLELITGQRAF----DLARLANDDDVMLL----DW 517
L + D++ G + E+ + F D+ +L DV+ L DW
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 1e-13
Identities = 69/224 (30%), Positives = 102/224 (45%), Gaps = 23/224 (10%)
Query: 281 GQLKRFSLRELQVATDS---FSNKNILGRGGFGKVYKGRLADGS-LVAVKRLKEERTPGG 336
G LK + EL D F++ +G G FG VY R + +VA+K++
Sbjct: 7 GSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN 66
Query: 337 ELQFQ---TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLP 393
E ++Q EV+ + H N + +G + LV Y GS + L + P
Sbjct: 67 E-KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVH---KKP 121
Query: 394 LDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453
L I G+ +GL+YLH H +IHRD+KA NILL E + + DFG A +
Sbjct: 122 LQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178
Query: 454 DTHVTTAVRGTIGHIAPEY---LSTGKSSEKTDVFGYGIMLLEL 494
++ V GT +APE + G+ K DV+ GI +EL
Sbjct: 179 NSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 303 ILGRGGFGKVYKGRL-----ADGSL-VAVKRLKEERTPGGELQFQTEVEMIS-MAVHRNL 355
LG G FGKV + +D + VAVK LK +E++++S + H N+
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 356 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL-H 414
+ L G C L++ Y G + + LR + S L L+ + A+G+++L
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLE--DLLSFSYQVAKGMAFLAS 159
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYL 473
+C IHRD+ A N+LL + DFGLA+ +M+ + V R + +APE +
Sbjct: 160 KNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215
Query: 474 STGKSSEKTDVFGYGIMLLELIT 496
+ ++DV+ YGI+L E+ +
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 16/203 (7%)
Query: 303 ILGRGGFGKVYKGRLAD-GSLVAVKRL----KEERTPGGELQFQTEVEMISMAVHRNLLR 357
+LGRG FG+VY AD G +AVK++ + T + E++++ H +++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 358 LRGFCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 415
G P E+ L YM GS+ L+ + L +R +G+SYLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHS 124
Query: 416 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD--YKDTHVTTAVRGTIGHIAPEYL 473
+ I+HRD+K ANIL D +GDFG +K + +V GT ++PE +
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 474 STGKSSEKTDVFGYGIMLLELIT 496
S K DV+ ++E++T
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 71/277 (25%), Positives = 128/277 (46%), Gaps = 39/277 (14%)
Query: 303 ILGRGGFGKVY--KGRLADGSLVAVKRLKEERTPGGELQF-QTEVEMISMAVHRNLLRLR 359
+G G FGK+Y K + +D +K + + P E + + EV +++ H N++
Sbjct: 7 KIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 360 GFCMTPTERLLVYPYMANGSVASCL-RER----PPSQLPLDWPTRKRIALGSARGLSYLH 414
+V Y G + + R+R Q+ L W + I+LG L ++H
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI-LSWFVQ--ISLG----LKHIH 118
Query: 415 DHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 473
D KI+HRD+K+ NI L + A +GDFG+A+ ++ T V GT +++PE
Sbjct: 119 DR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEIC 174
Query: 474 STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533
+ KTD++ G +L EL T + F+ N+ ++L +G + P
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFE----GNNLHQLVLKICQGYFAP------ISP 224
Query: 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
+ + + + + QL +V SP DRP ++ +++
Sbjct: 225 NFSRD-LRSLISQLFKV-------SPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 66/209 (31%), Positives = 95/209 (45%), Gaps = 23/209 (11%)
Query: 304 LGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEM-ISMAVH-RNLLRLRG 360
LG+GGFG+V ++ A G L A K+L ++R + VE I VH R ++ L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 361 FCMTPTERLLVYPYMANGS----VASCLRERPPSQLPLDWPTRKRIALGSAR---GLSYL 413
T T+ LV M G + + E P P R +A+ GL +L
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEP-------RACFYTAQIISGLEHL 113
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIAPEY 472
H +II+RD+K N+LLD + + D GLA +L D + T GT G +APE
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPEL 168
Query: 473 LSTGKSSEKTDVFGYGIMLLELITGQRAF 501
L + D F G+ L E+I + F
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 71/289 (24%), Positives = 128/289 (44%), Gaps = 34/289 (11%)
Query: 290 ELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQ-FQTEVEMI 347
E + D + +LG+G +G VY R L+ +A+K + E + +Q E+ +
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALH 59
Query: 348 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER--PPSQLPLDWPTRKRIALG 405
S HRN+++ G + + GS+++ LR + P L + T
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGP---LKDNEQTIIFYTKQ 116
Query: 406 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRG 463
GL YLHD+ +I+HRD+K N+L++ + VV DFG +K + + T G
Sbjct: 117 ILEGLKYLHDN---QIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINP-CTETFTG 171
Query: 464 TIGHIAPEYLSTGKS--SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGL 521
T+ ++APE + G D++ G ++E+ TG+ F L M + G+
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF--IELGEPQAAM---FKVGM 226
Query: 522 LKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
K + P++ + + AE + I L C + P R ++++
Sbjct: 227 FK-------IHPEIPES-LSAEAKNFI---LRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 4e-13
Identities = 49/181 (27%), Positives = 80/181 (44%), Gaps = 25/181 (13%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGG----------ELQFQTEVEMISMAVH 352
LG G + VYK R G +VA+K++K E++ E++ H
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK------H 61
Query: 353 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 412
N++ L + LV+ +M + ++++ P D K L + RGL Y
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPAD---IKSYMLMTLRGLEY 117
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 472
LH + I+HRD+K N+L+ + + DFGLA+ + +T V T + APE
Sbjct: 118 LHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPEL 173
Query: 473 L 473
L
Sbjct: 174 L 174
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQF-QTEVEMISMAVHRNLLRLRGF 361
+G G +G VYK R L G L AVK +K E PG + Q E+ M+ H N++ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 362 CMTPTERLLVYPYMANGSVASCLRERPP-SQLPLDWPTRKRIALGSARGLSYLHDHCDPK 420
++ + + Y GS+ P S+L + + R+ + +GL+YLH
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGK-- 127
Query: 421 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR----GTIGHIAPEYLSTG 476
+HRD+K ANILL + + + DFG+A + T A R GT +APE +
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAAKIT-----ATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 477 KS---SEKTDVFGYGIMLLELITGQRA-FDL 503
K+ ++ D++ GI +EL Q FDL
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 76/281 (27%), Positives = 113/281 (40%), Gaps = 51/281 (18%)
Query: 304 LGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQ---TEVEMISMAVHRNLLRLR 359
+G G FG VY + +VAVK++ E ++Q EV+ + H N + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 360 GFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 419
G + LV Y GS + L + PL I G+ +GL+YLH H
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 420 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY---LSTG 476
+IHRD+KA NILL E + + DFG A ++ V GT +APE + G
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEG 195
Query: 477 KSSEKTDVFGYGIMLLELITGQRAF-------DLARLANDDDVMLLDWVKGLLKEKKLEM 529
+ K DV+ GI +EL + L +A +D
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND------------------- 236
Query: 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
P LQ+N + C Q P +RP +E++R
Sbjct: 237 --SPTLQSNEWTDSFRGFVD---YCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 10/208 (4%)
Query: 296 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 354
DS+ LG G + VYKG+ +G LVA+K ++ + G E ++ H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
++ L T LV+ Y+ + + + + P P K RGLSY+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHP---ENVKLFLFQLLRGLSYIH 120
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-YL 473
I+HRD+K N+L+ + E + DFGLA+ +H + T+ + P+ L
Sbjct: 121 QR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSNEVVTLWYRPPDVLL 176
Query: 474 STGKSSEKTDVFGYGIMLLELITGQRAF 501
+ + S D++G G + +E+I G AF
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 32/225 (14%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKR----LKEERTPGGELQFQTEVEMISMA 350
D++ +G G +GKVYK R G LVA+K+ + EE P L+ + ++M+S +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 351 VHRNLLRLRGFCMTPTER-------LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIA 403
++ ++RL + E LV+ Y+ + PL T K
Sbjct: 61 IY--IVRL--LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 404 LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAK-----LMDYKDTHV 457
+G+++ H H ++HRD+K N+L+D++ + + D GL + + Y V
Sbjct: 117 YQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 458 TTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAF 501
T R APE L S D++ G + E+ Q F
Sbjct: 174 TLWYR------APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 51/159 (32%), Positives = 77/159 (48%), Gaps = 19/159 (11%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRL--KEERTPGGELQFQTEVEMISMAVHRNLLRL-- 358
LG G FG+VYK R + G +VA+K++ E+ G + E++++ H N++ L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLID 74
Query: 359 ------RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 412
+V PYM S L E P +L K L G++Y
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYMD--HDLSGLLENPSVKL--TESQIKCYMLQLLEGINY 130
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451
LH++ I+HRD+KAANIL+D + + DFGLA+ D
Sbjct: 131 LHEN---HILHRDIKAANILIDNQGILKIADFGLARPYD 166
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 29/215 (13%)
Query: 303 ILGRGGFGKVY----KGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL 358
+LG G +GKV+ G G L A+K LK+ +Q E + + L +
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI----VQKAKTAEH-TRTERQVLEAV 61
Query: 359 RG--FCM-------TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGS-AR 408
R F + T T+ L+ Y+ G + + L +R + R+ +
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE-----SEVRVYIAEIVL 116
Query: 409 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 468
L +LH II+RD+K NILLD E V+ DFGL+K ++ + GTI ++
Sbjct: 117 ALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 469 APEYLSTGKS--SEKTDVFGYGIMLLELITGQRAF 501
APE + G + D + G++ EL+TG F
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 7e-13
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLK------EERTPGGELQFQTEVEMISMAVHRNLL 356
LG G FG VY R G LVA+K++K EE E++ + + H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKS-----LRKLNEHPNIV 61
Query: 357 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 416
+L+ E V+ YM G++ +++R + I +GL+++H H
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSE--SVIRSIIYQILQGLAHIHKH 118
Query: 417 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL--S 474
HRD+K N+L+ + DFGLA+ + + + T V T + APE L S
Sbjct: 119 ---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYRAPEILLRS 173
Query: 475 TGKSSEKTDVFGYGIMLLELITGQ 498
T SS D++ G ++ EL T +
Sbjct: 174 TSYSS-PVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 8e-13
Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 18/219 (8%)
Query: 298 FSNKNILGRGGFGKVYKGRLA--DGSL--VAVKRLKEERTPGGEL-QFQTEVEMISMAVH 352
F+ +LG+G FG V + +L DGS VAVK LK + ++ +F E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 353 RNLLRLRGFCM--TPTERL----LVYPYMANGSVASCLRERPPSQLPLDWP--TRKRIAL 404
N+++L G + RL ++ P+M +G + + L + P P T R +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 405 GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAVRG 463
A G+ YL IHRD+ A N +L+E V DFGL+K + D + A +
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 464 TIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAF 501
+ +A E L+ + +DV+ +G+ + E++T GQ +
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 9e-13
Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLK----EERTPGGELQFQTEVEMISMAVHRNLLRL 358
+G G +G VYK R G VA+K ++ E+ P ++ ++ + H N++RL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 359 RGFCMT-----PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
C T T+ LV+ ++ + + + L + PP LP + T K + RGL +L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAE--TIKDLMRQFLRGLDFL 124
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 473
H +C I+HRD+K NIL+ + + DFGLA++ + T V T+ + APE L
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--MALTPVVVTLWYRAPEVL 179
Query: 474 STGKSSEKTDVFGYGIMLLEL 494
+ D++ G + E+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 15/93 (16%)
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-----MDYKDTHVTTAVR 462
GL YLH +IIHRDVK NI +++ + +GD G A+ +
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL-------GLA 217
Query: 463 GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELI 495
GT+ APE L+ K + K D++ GI+L E++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 73/300 (24%), Positives = 131/300 (43%), Gaps = 45/300 (15%)
Query: 291 LQVATDSFSNKNILGRGGFGKVYKGRLADGSL-----VAVKRLKEERTPGGELQFQTEVE 345
+ ++ D + ++L G FG+++ G L D V VK +K+ + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 346 MISMAVHRNLLRLRGFCMTPTERLLV-YPYMANGSVASCLRE--RPPSQLPLDWPTRKRI 402
++ H+N+L + C+ E V YPYM G++ L++ + P T++ +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 403 ALGS--ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK---LMDYK---D 454
+ A G+SYLH +IH+D+ A N ++DEE + + D L++ MDY D
Sbjct: 121 HMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVM 513
+ +A E L + S +DV+ +G++L EL+T GQ + ++
Sbjct: 178 NE-----NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY--------VEID 224
Query: 514 LLDWVKGLLKEKKLEMLVD-PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 572
+ L +L ++ PD +L V C P +RP S++V+ L
Sbjct: 225 PFEMAAYLKDGYRLAQPINCPD-----------ELFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 17/204 (8%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 362
+ +G +G+V+ + + G + A+K +K+ Q E ++ ++ ++ +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 363 MTPTER--LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 420
++ LV Y+ G +AS L L D R IA L YLH +
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENV--GSLDEDV-ARIYIA-EIVLALEYLHSN---G 113
Query: 421 IIHRDVKAANILLDEEFEAVVGDFGLAK-------LMDYKDTHVTTAVRGTIGHIAPEYL 473
IIHRD+K NIL+D + DFGL+K + D + GT +IAPE +
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 474 STGKSSEKTDVFGYGIMLLELITG 497
S+ D + G +L E + G
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 15/210 (7%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRL-KEERTPGGELQFQTEVEMISMAVH 352
T+ + + +G G FG V R G VA+K++ K TP + E++++ H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 353 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 412
N++ L ++P E + + + L RP L+ + RGL Y
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRP-----LEKQFIQYFLYQILRGLKY 123
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 472
+H ++HRD+K +NIL++E + + DFGLA++ +D +T V T + APE
Sbjct: 124 VHS---AGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMTGYV-STRYYRAPEI 176
Query: 473 LST-GKSSEKTDVFGYGIMLLELITGQRAF 501
+ T K + D++ G + E++ G+ F
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 38/216 (17%)
Query: 303 ILGRGGFGKVYKGRLADGS-LVAVKRLKEERTPGGELQFQTEVEMISMAV------HRNL 355
+LG+G FGKV L + A+K LK++ + E M+ V H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDD---DVECTMVERRVLALAWEHPFL 58
Query: 356 LRLRGFCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR----- 408
L FC T+ L V Y+ G + ++ R AR
Sbjct: 59 THL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSS------------GRFDEARARFYAAE 104
Query: 409 ---GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 465
GL +LH II+RD+K N+LLD++ + DFG+ K + +T GT
Sbjct: 105 IICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTP 160
Query: 466 GHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
+IAPE L K +E D + +G++L E++ GQ F
Sbjct: 161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 297 SFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVHR 353
+F +LG+GGFG+V ++ A G + A K+L+++R GE E +++ R
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR---GL 410
++ L T LV M G + + + R +A GL
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE-----EGRAVFYAAEICCGL 115
Query: 411 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 470
LH +I++RD+K NILLD+ + D GLA + + GT+G++AP
Sbjct: 116 EDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAP 170
Query: 471 EYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
E + + + D + G +L E+I GQ F
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 16/221 (7%)
Query: 288 LRELQVATDSFSNKNILGRGGFGKVYK-GRLADGSLVAVKRLKEERTPGGELQFQTEVEM 346
L L TD++ +G+G +GKVYK DGSL AVK L E++ + + +
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI-L 72
Query: 347 ISMAVHRNLLRLRGFC-----MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKR 401
S+ H N+++ G + + LV GSV ++ LD
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 402 IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 461
I G+ GL +LH++ +IIHRDVK NILL E + DFG++ + T+V
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189
Query: 462 RGTIGHIAPEYLSTGKSSE-----KTDVFGYGIMLLELITG 497
GT +APE ++ + + + DV+ GI +EL G
Sbjct: 190 -GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 64/280 (22%), Positives = 124/280 (44%), Gaps = 26/280 (9%)
Query: 297 SFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK--EERTPGGELQFQTEVEMISMAVHR 353
+F + +GRG F +VY+ L DG VA+K+++ + E++++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLR--ERPPSQLPLDWPTRKRIALGSARGLS 411
N+++ + E +V G ++ ++ ++ +P + + L SA L
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--LE 120
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 471
++H +++HRD+K AN+ + +GD GL + K T + V GT +++PE
Sbjct: 121 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 472 YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531
+ + K+D++ G +L E+ Q F D + L KK+E
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPF------YGDKMNLYSLC------KKIEQCD 224
Query: 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571
P L +++ E+ QL+ +C P RP ++ V +
Sbjct: 225 YPPLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 65/209 (31%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 303 ILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVE--MISMA-VHRNLLRL 358
+LG+G FGKV+ L A+K LK++ + T VE ++S+A H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 359 RGFCMTPTERLL--VYPYMANGS----VASCLRERPPSQLPLDWPTRKRIALGSARGLSY 412
+C T+ L V Y+ G + SC + D P A GL +
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK--------FDLPRATFYAAEIICGLQF 111
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 472
LH I++RD+K NILLD + + DFG+ K D T GT +IAPE
Sbjct: 112 LHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEI 167
Query: 473 LSTGKSSEKTDVFGYGIMLLELITGQRAF 501
L K + D + +G++L E++ GQ F
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 63/277 (22%), Positives = 116/277 (41%), Gaps = 22/277 (7%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK--EERTPGGELQFQTEVEMISMAV 351
+F + +G+G F VYK L DG +VA+K+++ E E++++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 352 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 411
H N+++ + E +V G ++ ++ + + T + + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 471
++H +I+HRD+K AN+ + +GD GL + K T + V GT +++PE
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 472 YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531
+ + K+D++ G +L E+ Q F D + L KK+E
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFY------GDKMNLYSLC------KKIEKCD 224
Query: 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 568
P L ++ E+ L+ C P RP +S V
Sbjct: 225 YPPLPADHYSEELRDLVSR---CINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 67/279 (24%), Positives = 127/279 (45%), Gaps = 43/279 (15%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQF-QTEVEMISMAVHRNLLRLR- 359
++G+G +G+V R DG +K+L E + + E +++S H N++ R
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 360 ----GFCMTPTERLLVYPYMANGSVASCLRERPPSQLP----LDWPTRKRIALGSARGLS 411
+ +V + G + L+E+ LP ++W + +AL
Sbjct: 67 SWEGEDGLL----YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL------Q 116
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 471
YLH+ I+HRD+K N+ L VGD G+A++++ + +T + GT +++PE
Sbjct: 117 YLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPE 172
Query: 472 YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531
S + K+DV+ G + E+ T + AF+ A D + ++ ++G L
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLKHAFN----AKDMNSLVYRIIEGKL--------- 219
Query: 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
P + +Y E+ +LI +L + P RP + ++R
Sbjct: 220 -PPMPKDY-SPELGELIA-TMLSKR--PEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 297 SFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK----EERTPGGELQFQTEVEMISMAV 351
+F +G G +G VYK R G +VA+K+++ E P ++ E+ ++
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELN 57
Query: 352 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 411
H N+++L T + LV+ ++ + + + P S +PL P K +GL+
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPL--PLIKSYLFQLLQGLA 114
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTHVTTAVRGTIG 466
+ H H +++HRD+K N+L++ E + DFGLA+ + Y VT R
Sbjct: 115 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR---- 167
Query: 467 HIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAF 501
APE L K S D++ G + E++T + F
Sbjct: 168 --APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 16/204 (7%)
Query: 304 LGRGGFGKVYKGRLAD-GSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRG 360
LG+GGFG+V ++ + G + A K+L ++R GE E E++ ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 361 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR---GLSYLHDHC 417
+ T LV M G + + L ++ R+ SA+ G+ +LH
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEME-----RVIHYSAQITCGILHLHSM- 114
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 477
I++RD+K N+LLD++ + D GLA ++ KD T GT G++APE L
Sbjct: 115 --DIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEP 170
Query: 478 SSEKTDVFGYGIMLLELITGQRAF 501
S D F G + E++ G+ F
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 69/270 (25%), Positives = 119/270 (44%), Gaps = 25/270 (9%)
Query: 301 KNILGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 359
+ ILG G G VYK L ++AVK + + T + Q +E+E++ ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 360 GFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 419
G + +M GS+ R+ P RIA+ +GL+YL
Sbjct: 66 GAFFVENRISICTEFMDGGSL-DVYRKIPE-------HVLGRIAVAVVKGLTYLWSL--- 114
Query: 420 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 479
KI+HRDVK +N+L++ + + DFG++ + ++ T V GT ++APE +S +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKTYV-GTNAYMAPERISGEQYG 171
Query: 480 EKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNY 539
+DV+ GI +EL G+ + N +M L + L+ +VD D
Sbjct: 172 IHSDVWSLGISFMELALGRFPY-PQIQKNQGSLMPL---------QLLQCIVDEDPPVLP 221
Query: 540 VEAEVEQLIQVALLCTQGSPMDRPKMSEVV 569
V E+ + C + P +RP ++
Sbjct: 222 VGQFSEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 303 ILGRGGFGKVY-KGRLADGSLVAVKRLKEERTPGGELQFQTEVE---MISMAVHRNLLRL 358
++G+G FGKV R +DGS AVK L+++ + Q E ++ H L+ L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 359 RGFCMTPTERLLVYPYMANGSVASCL-RERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 417
T + V Y+ G + L RER + P + A A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLE-----PRARFYAAEVASAIGYLHSL- 115
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTG 476
II+RD+K NILLD + V+ DFGL K ++ ++T T+ GT ++APE L
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171
Query: 477 KSSEKTDVFGYGIMLLELITGQRAF 501
D + G +L E++ G F
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 301 KNILGRGGFGKVYKGRLADGSL---VAVKRLKEERTPGGELQFQTEVEMI-SMAVHRNLL 356
++++G G FG+V + + L A+K LKE + F E+E++ + H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 357 RLRGFCMTPTERLLVYPYMANGSVASCLR-----ERPP-------SQLPLDWPTRKRIAL 404
L G C + Y G++ LR E P + L + A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 405 GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRG 463
A G+ YL + + IHRD+ A N+L+ E + + DFGL++ ++ +V T R
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRL 180
Query: 464 TIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
+ +A E L+ + K+DV+ +G++L E+++
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 20/200 (10%)
Query: 304 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM 363
LG G FGKVYK + + +A ++ E ++ + E+E+++ H +++L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 364 TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIH 423
+ ++ + G+V + + E L P + I L YLH KIIH
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVICRQMLEALQYLHSM---KIIH 133
Query: 424 RDVKAANILLDEEFEAVVGDFGLA----KLMDYKDTHVTTAVRGTIGHIAPEYL--STGK 477
RD+KA N+LL + + + DFG++ K + +D+ + GT +APE + T K
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCETMK 188
Query: 478 SSE---KTDVFGYGIMLLEL 494
+ K D++ GI L+E+
Sbjct: 189 DTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 16/211 (7%)
Query: 297 SFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHR 353
+F + +LG+GGFG+V ++ A G + A K+L+++R GE E +++ R
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR---GL 410
++ L T LV M G + + +R +A GL
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD-----EERAVFYAAEITCGL 115
Query: 411 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 470
LH +I++RD+K NILLD+ + D GLA ++ + GT+G++AP
Sbjct: 116 EDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAP 170
Query: 471 EYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
E + + + D +G G ++ E+I G+ F
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 51/189 (26%), Positives = 87/189 (46%), Gaps = 23/189 (12%)
Query: 322 LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 381
LVAVK L+ + + F EV+++S N+ RL G C ++ YM NG +
Sbjct: 48 LVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107
Query: 382 SCLRERPP-------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD 434
L++ + L + T +A A G+ YL +HRD+ N L+
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVG 164
Query: 435 EEFEAVVGDFGLAKLM---DYKDTHVTTAVRGT----IGHIAPEYLSTGKSSEKTDVFGY 487
+ + + DFG+++ + DY V+G I +A E + GK + K+DV+ +
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYYR------VQGRAPLPIRWMAWESVLLGKFTTKSDVWAF 218
Query: 488 GIMLLELIT 496
G+ L E++T
Sbjct: 219 GVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 8e-12
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 302 NILGRGGFGKVYKGRLADGSL---VAVKRLKEERTPGGELQFQTEVEMI-SMAVHRNLLR 357
+++G G FG+V K R+ L A+KR+KE + F E+E++ + H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 358 LRGFCMTPTERLLVYPYMANGSVASCLR-----ERPP-------SQLPLDWPTRKRIALG 405
L G C L Y +G++ LR E P + L A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 406 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGT 464
ARG+ YL + IHRD+ A NIL+ E + A + DFGL++ ++ +V T R
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174
Query: 465 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
+ +A E L+ + +DV+ YG++L E+++
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 304 LGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 362
LG G + V+KGR +LVA+K ++ E G EV ++ H N++ L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 363 MTPTERLLVYPYMANG---SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 419
T LV+ Y+ + + +C L + K RGLSY H
Sbjct: 73 HTERCLTLVFEYLDSDLKQYLDNC------GNL-MSMHNVKIFMFQLLRGLSYCHKR--- 122
Query: 420 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-YLSTGKS 478
KI+HRD+K N+L++E+ E + DFGLA+ + V T+ + P+ L + +
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEY 181
Query: 479 SEKTDVFGYGIMLLELITGQRAF 501
S D++G G +L E+ TG+ F
Sbjct: 182 STPIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 297 SFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVHR 353
+F +LG+GGFG+V ++ A G + A KRL+++R GE E +++ +
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR---GL 410
++ L T LV M G + + +R +A GL
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF-----EEERALFYAAEILCGL 115
Query: 411 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 470
LH ++RD+K NILLD+ + D GLA + + GT+G++AP
Sbjct: 116 EDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAP 170
Query: 471 EYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
E L+ + + D +G G ++ E+I GQ F
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 9e-12
Identities = 73/283 (25%), Positives = 126/283 (44%), Gaps = 33/283 (11%)
Query: 304 LGRGGFGKVYKGRLADGSLVA---VKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG 360
+G G FGKV + + VA VK LK + + +F + + + H N+L+ G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 361 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 420
C+ LLV+ Y G + S L + + +R+A A G++++H H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---N 119
Query: 421 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT------AVRGTIGHIAPEY-- 472
+H D+ N L + VGD+G+ YK+ ++ T +R + E+
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELVGEFHG 178
Query: 473 -LSTGKSSEKTDVFGYGIMLLELITGQRAFDLAR--LANDDDVMLLDWVKGLLKEKKLEM 529
L T + ++ ++V+ G+ L EL F+ A ++ D +L+ V +K+++++
Sbjct: 179 GLITAEQTKPSNVWALGVTLWEL------FENAAQPYSHLSDREVLNHV---IKDQQVK- 228
Query: 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 572
L P L+ Y E E L Q L SP R EV R+L
Sbjct: 229 LFKPQLELPYSERWYEVL-QFCWL----SPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 304 LGRGGFGKVYKGRLAD-GSLVAVKRLKE-ERTPGGELQFQTEVEMISMAVHRNLLRLRGF 361
+G G +G V+K R + G +VA+K+ E E P + E+ M+ H NL+ L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 362 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 421
+ LV+ Y + +V + L E+ P +P K+I + + +++ H H
Sbjct: 69 FRRKRKLHLVFEYCDH-TVLNEL-EKNPRGVPEH--LIKKIIWQTLQAVNFCHKH---NC 121
Query: 422 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 481
IHRDVK NIL+ ++ + + DFG A+++ T V T + APE L G +
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELL-VGDTQYG 179
Query: 482 T--DVFGYGIMLLELITGQ 498
DV+ G + EL+TGQ
Sbjct: 180 PPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 304 LGRGGFGKVYKGR--LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 361
LG G + VYKGR L D +LVA+K ++ E G EV ++ H N++ L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 362 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 421
T LV+ Y+ + + L + S ++ K RGL+Y H K+
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNS---INMHNVKLFLFQLLRGLNYCHRR---KV 125
Query: 422 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-YLSTGKSSE 480
+HRD+K N+L++E E + DFGLA+ + V T+ + P+ L + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184
Query: 481 KTDVFGYGIMLLELITGQRAF 501
+ D++G G + E+ TG+ F
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 50/199 (25%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 362
+G+G G V+ +A G VA+K++ ++ P EL E+ ++ + N++
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN-EILVMKELKNPNIVNFLDSF 85
Query: 363 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 422
+ E +V Y+A GS+ + E + + R+ + + L +LH + ++I
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-----QALEFLHAN---QVI 137
Query: 423 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 482
HRD+K+ N+LL + + DFG + + + +T V GT +APE ++ K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 483 DVFGYGIMLLELITGQRAF 501
D++ GIM +E++ G+ +
Sbjct: 197 DIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 57/188 (30%), Positives = 82/188 (43%), Gaps = 31/188 (16%)
Query: 323 VAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL-------RGFCMT-PTERLLVYPY 374
V VK + +TPG E++++ HR ++ L CM P + ++ Y
Sbjct: 122 VIVKAVTGGKTPG------REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTY 175
Query: 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD 434
+ +R LPL+ I L+YLH IIHRDVK NI LD
Sbjct: 176 V----------DRS-GPLPLE--QAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLD 219
Query: 435 EEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLE 493
E AV+GDFG A KL + DT GT+ +PE L+ KTD++ G++L E
Sbjct: 220 EPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE 279
Query: 494 LITGQRAF 501
+
Sbjct: 280 MSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 52/199 (26%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 304 LGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 362
+G+G G VY +A G VA+K++ ++ P EL E+ ++ + N++
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 85
Query: 363 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 422
+ E +V Y+A GS+ + E + + R+ + + L +LH + ++I
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHSN---QVI 137
Query: 423 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 482
HRD+K+ NILL + + DFG + + + +T V GT +APE ++ K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 483 DVFGYGIMLLELITGQRAF 501
D++ GIM +E++ G+ +
Sbjct: 197 DIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 16/211 (7%)
Query: 297 SFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVHR 353
+F + +LG+GGFG+V ++ A G + A K+L+++R GE E ++ R
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
++ L T LV M G + + +R +A L
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF-----DEQRAIFYAAELCCGL 115
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG---TIGHIAP 470
D +I++RD+K NILLD+ + D GLA + +T VRG T+G++AP
Sbjct: 116 EDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-----VRGRVGTVGYMAP 170
Query: 471 EYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
E ++ K + D +G G ++ E+I GQ F
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 303 ILGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN---LLRL 358
+LG+G FGKV R L A+K LK++ + T VE +A+ L +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 359 RGFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 417
C +RL V Y+ G + +++ + P I++G L +LH
Sbjct: 67 HS-CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG----LFFLHRR- 120
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 477
II+RD+K N++LD E + DFG+ K D T GT +IAPE ++
Sbjct: 121 --GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV-DGVTTRTFCGTPDYIAPEIIAYQP 177
Query: 478 SSEKTDVFGYGIMLLELITGQRAFD 502
+ D + YG++L E++ GQ FD
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 31/222 (13%)
Query: 301 KNILGRGGFGKVYKGRLADG----------------SLVAVKRLKEERTPGGELQFQTEV 344
K LG G FG+V+ A+G LVAVK L+ + T F E+
Sbjct: 10 KEKLGEGQFGEVHLCE-AEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 345 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP-PSQLPL--DWPTRKR 401
+++S + N++RL G C++ ++ YM NG + L +R S + P+
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 402 -----IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 456
+A+ A G+ YL +HRD+ N L+ + + DFG+++ + Y +
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL-YSGDY 184
Query: 457 VTTAVRGT--IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
R I +A E + GK + +DV+ +G+ L E+ T
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 62/229 (27%), Positives = 97/229 (42%), Gaps = 36/229 (15%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 354
+++ + LG G + VYKGR G LVA+K ++ E G E ++ H N
Sbjct: 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHAN 64
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDW------PTRKRIALGS-A 407
++ L T LV+ Y+ + Q +D R+ L
Sbjct: 65 IVTLHDIIHTKKTLTLVFEYL----------DTDLKQY-MDDCGGGLSMHNVRLFLFQLL 113
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-----YKDTHVTTAVR 462
RGL+Y H +++HRD+K N+L+ E E + DFGLA+ Y + VT R
Sbjct: 114 RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYR 170
Query: 463 GTIGHIAPEYL--STGKSSEKTDVFGYGIMLLELITGQRAFDLARLAND 509
P+ L ST S+ D++G G + E+ TG+ F + D
Sbjct: 171 ------PPDVLLGSTEYSTS-LDMWGVGCIFYEMATGRPLFPGSTDVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 52/223 (23%), Positives = 104/223 (46%), Gaps = 18/223 (8%)
Query: 301 KNILGRGGFGKVYKG---RLADGSL-VAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 356
+G G FG VY+G + + VAVK K +P +F E ++ H +++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 357 RLRGFCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
+L G ++ + P G + S L+ S LD + + + L+YL
Sbjct: 71 KLIGVITENPVWIVMELAPL---GELRSYLQVNKYS---LDLASLILYSYQLSTALAYLE 124
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 474
+ +HRD+ A N+L+ +GDFGL++ ++ + + + + I +APE ++
Sbjct: 125 SK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181
Query: 475 TGKSSEKTDVFGYGIMLLE-LITGQRAFDLARLANDDDVMLLD 516
+ + +DV+ +G+ + E L+ G + F + N+D + ++
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLGVKPF--QGVKNNDVIGRIE 222
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 303 ILGRGGFGKVYKGRLAD-GSLVAVKRLK-EERTPGGELQ---FQTEVEMISMAVHRNLLR 357
+LG+G FG+VY D G +A K+++ + +P + + E++++ H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 358 LRGFCMTPTERLLV--YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 415
G E+ L YM GSV L+ + L ++ G+SYLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHS 124
Query: 416 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPEYL 473
+ I+HRD+K ANIL D +GDFG +K + T +V GT ++PE +
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 474 STGKSSEKTDVFGYGIMLLELIT 496
S K DV+ G ++E++T
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 51/290 (17%)
Query: 304 LGRGGFGKVYKGRLADG--SLVAVKRL----------KEERTPGGELQFQTEVEMISMAV 351
LG G FG VYK R + +L+A+K + K ER +EV +I +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIG-DIVSEVTIIKEQL 66
Query: 352 -HRNLLRLRGFCMTPTERLLVYPYMANGS----VASCLRER----PPSQLPLDWPTRKRI 402
H N++R +RL + + G+ + L+E+ ++ W ++
Sbjct: 67 RHPNIVRYYK-TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI---WNIFVQM 122
Query: 403 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 462
L L YLH + +I+HRD+ NI+L E+ + + DFGLAK ++ +T+ V
Sbjct: 123 VLA----LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVV- 174
Query: 463 GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 522
GTI + PE + EK DV+ +G +L ++ T Q F ML L
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-------ML------SL 221
Query: 523 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 572
K +E + +P L +V +I C RP + +V M+
Sbjct: 222 ATKIVEAVYEP-LPEGMYSEDVTDVITS---CLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK-EERTPGGELQFQTEVEMISMAVHR 353
D + N + G +G VY+ R G +VA+K+LK E+ G + E+ ++ H
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64
Query: 354 NLLRLRGFCM--TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 411
N++ ++ + + +V Y+ + + S + L K + L G++
Sbjct: 65 NIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQ---SEVKCLMLQLLSGVA 120
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTHVTTAVRGTIG 466
+LHD+ I+HRD+K +N+LL+ + DFGLA+ L Y VT R
Sbjct: 121 HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR---- 173
Query: 467 HIAPE-YLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
APE L + S D++ G + EL+T + F
Sbjct: 174 --APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLF 207
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 304 LGRGGFGKVYKG--RLADGSL-VAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG 360
LG G FG V KG ++ + VA+K LK E + E E++ + ++R+ G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 361 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 420
C E L++ MA+G + ++ + + + G+ YL
Sbjct: 63 VC--EAEALMLVMEMASGGPLNKFLSGKKDEITVS--NVVELMHQVSMGMKYLEGK---N 115
Query: 421 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPEYLSTGKS 478
+HRD+ A N+LL + A + DFGL+K + D++ +A + + APE ++ K
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 479 SEKTDVFGYGIMLLELIT-GQRAF 501
S ++DV+ YGI + E + GQ+ +
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 66/219 (30%), Positives = 96/219 (43%), Gaps = 25/219 (11%)
Query: 303 ILGRGGFGKVYKGRLADGSLV-AVKRLKEERTPGGELQ------FQTEVEMISMAVHRNL 355
+LG+G FGKV L V A+K LK++ LQ TE ++++A
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI----LQDDDVDCTMTEKRILALAAKHPF 57
Query: 356 LRLRGFCMTPTERLL-VYPYMANGSVA-SCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
L C +RL V Y+ G + R R D P + A L +L
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK-----FDEPRSRFYAAEVTLALMFL 112
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 473
H H +I+RD+K NILLD E + DFG+ K TT GT +IAPE L
Sbjct: 113 HRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTFCGTPDYIAPEIL 168
Query: 474 STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDV 512
+ D + G+++ E++ GQ F+ N+DD+
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPPFE---ADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 53/196 (27%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 304 LGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 362
+G+G G VY +A G VA+K++ ++ P EL E+ ++ H N++
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKHPNIVNYLDSY 85
Query: 363 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 422
+ E +V Y+A GS+ + E + + R+ + + L +LH + ++I
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 137
Query: 423 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 482
HRD+K+ NILL + + DFG + + + +T V GT +APE ++ K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 483 DVFGYGIMLLELITGQ 498
D++ GIM +E++ G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 61/231 (26%), Positives = 108/231 (46%), Gaps = 12/231 (5%)
Query: 303 ILGRGGFGKVYKGRLADGSLV-AVKRLKEERTPGGEL--QFQTEVEMISMAV-HRNLLRL 358
++GRG + KV RL + A+K +K+E E QTE + A H L+ L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 359 RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 418
T + V Y+ G + ++ + +LP + + A L+YLH+
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLA--LNYLHER-- 115
Query: 419 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 478
II+RD+K N+LLD E + D+G+ K + T+ GT +IAPE L
Sbjct: 116 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 479 SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529
D + G+++ E++ G+ FD+ +++ D D++ ++ EK++ +
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 224
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 61/247 (24%), Positives = 100/247 (40%), Gaps = 44/247 (17%)
Query: 301 KNILGRGGFGKVY--------------------KGRLADGSLVAVKRLKEERTPGGELQF 340
K LG G FG+V+ KGR LVAVK L+ + F
Sbjct: 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGR---PLLVAVKILRPDANKNARNDF 66
Query: 341 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER------------- 387
EV+++S N++RL G C+ ++ YM NG + L
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 388 -PPSQLP-LDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 445
P LP + + + +AL A G+ YL +HRD+ N L+ E + DFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFG 183
Query: 446 LAKLMDYKDTHVTTAVRGT--IGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 503
+++ + Y + R I +A E + GK + +DV+ +G+ L E++ +
Sbjct: 184 MSRNL-YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
Query: 504 ARLANDD 510
L ++
Sbjct: 243 GELTDEQ 249
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 42/214 (19%)
Query: 306 RGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT 364
+G FG VY + + G A+K LK+ +MI+ N+ R M
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKS-------------DMIAKNQVTNVKAERAIMMI 52
Query: 365 PTE-----RL-----------LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR 408
E +L LV Y+ G AS ++ LP DW ++ IA
Sbjct: 53 QGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDW-AKQYIA-EVVL 108
Query: 409 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 468
G+ LH IIHRD+K N+L+D+ + DFGL++ V GT ++
Sbjct: 109 GVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-----GTPDYL 160
Query: 469 APEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 502
APE + + +D + G ++ E + G F
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVE---MISMAVHRNLLRL 358
++G+G FGKV + ADG AVK L+++ + Q E ++ H L+ L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 359 RGFCMTPTERLLVYPYMANGSVASCL-RERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 417
T + V Y+ G + L RER + P + A A L YLH
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPE-----PRARFYAAEIASALGYLHSL- 115
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTG 476
II+RD+K NILLD + V+ DFGL K +++ T T+ GT ++APE L
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQ 171
Query: 477 KSSEKTDVFGYGIMLLELITGQRAF 501
D + G +L E++ G F
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 303 ILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH-RNLLRLRG 360
+LG+G FGKV L G AVK LK++ + T VE +A+ N
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 361 FCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR---GLSYLHD 415
+C T+ L V ++ G + ++++ L R +A GL +LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL-------YRATFYAAEIVCGLQFLHS 114
Query: 416 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 475
II+RD+K N++LD + + DFG+ K + D +T GT +IAPE L
Sbjct: 115 K---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQG 170
Query: 476 GKSSEKTDVFGYGIMLLELITGQRAF 501
K + D + +G++L E++ GQ F
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 30/210 (14%)
Query: 304 LGRGGFGKVYKGR--LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 361
LG G + V+KGR L + +LVA+K ++ E G EV ++ H N++ L
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 362 CMTPTERLLVYPYMAN---------GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 412
T LV+ Y+ G++ S K RGL+Y
Sbjct: 73 VHTDKSLTLVFEYLDKDLKQYMDDCGNIMSM-------------HNVKIFLYQILRGLAY 119
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE- 471
H K++HRD+K N+L++E E + DFGLA+ + V T+ + P+
Sbjct: 120 CHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDV 175
Query: 472 YLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
L + + S + D++G G + E+ +G+ F
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 6e-11
Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 26/221 (11%)
Query: 320 GSLVAVKRLKEERTPGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLL-VYPYMA 376
G VA+K L+ + +F+ E + + H N++ L P L V+ Y+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 377 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL--- 433
+ LRE + L R+ L L+ H+ I+HRD+K NI++
Sbjct: 63 GRT----LREVLAADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQT 115
Query: 434 DEEFEAVVGDFGLAKLM-DYKDTHVTTAVR-----GTIGHIAPEYLSTGKSSEKTDVFGY 487
A V DFG+ L+ +D V T R GT + APE L + +D++ +
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 488 GIMLLELITGQRAFDLARLA-------NDDDVMLLDWVKGL 521
G++ LE +TGQR A +A + DV L W+ G
Sbjct: 176 GLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGH 216
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 64/223 (28%), Positives = 101/223 (45%), Gaps = 28/223 (12%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLAD-GSLVAVK--RLKEERTPGGELQFQTEVEMISMAVH 352
D F +G G +G+VYK R D G LVA+K RL E+ G + E++++ H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNH 65
Query: 353 RNLLRLRGFCMTPTERL----------LVYPYMAN---GSVASCLRERPPSQLPLDWPTR 399
RN++ L+ + L LV+ YM + G + S L +
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI------- 118
Query: 400 KRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 459
K GL+Y H +HRD+K +NILL+ + + + DFGLA+L + +++ T
Sbjct: 119 KSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 460 AVRGTIGHIAPE-YLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
T+ + PE L + DV+ G +L EL T + F
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIF 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 64/252 (25%), Positives = 116/252 (46%), Gaps = 45/252 (17%)
Query: 281 GQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRL-----KEERTP 334
GQ L +L+ + +G G G+VYK R G ++AVK++ KEE
Sbjct: 7 GQKYPADLNDLENLGE-------IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENK- 58
Query: 335 GGELQFQTEVEMISMAVHR--NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQL 392
+ +++++ + H +++ G+ +T ++ + M+ + L +R Q
Sbjct: 59 ----RILMDLDVVLKS-HDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKR--IQG 109
Query: 393 PLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLM 450
P+ ++ + + L YL + H +IHRDVK +NILLD + DFG++ +L+
Sbjct: 110 PIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166
Query: 451 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK----TDVFGYGIMLLELITGQRAFD---- 502
D K +A G ++APE + + K DV+ GI L+EL TGQ +
Sbjct: 167 DSK-AKTRSA--GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT 223
Query: 503 ----LARLANDD 510
L ++ ++
Sbjct: 224 EFEVLTKILQEE 235
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 9e-11
Identities = 53/154 (34%), Positives = 73/154 (47%), Gaps = 23/154 (14%)
Query: 421 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEYLSTGK 477
+IHRD+K+ANILL +GDFG +K+ Y T V GT ++APE
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKM--YAATVSDDVGRTFCGTPYYVAPEIWRRKP 221
Query: 478 SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537
S+K D+F G++L EL+T +R FD N ++VM K L DP +
Sbjct: 222 YSKKADMFSLGVLLYELLTLKRPFD---GENMEEVM----------HKTLAGRYDPLPPS 268
Query: 538 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571
E Q I ALL P RP S+++ M
Sbjct: 269 ISPEM---QEIVTALLS--SDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 298 FSNKNILGRGGFGKVYKGRLAD-GSLVAVKRL--KEERTPGGELQFQTEVEMISMAVHRN 354
+ N ++G G +G V K + + G +VA+K+ E+ ++ + E+ M+ H N
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHEN 61
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
L+ L LV+ ++ + +V L + P LD ++ RG+ + H
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCH 117
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-----DYKDTHVTTAVRGTIGHIA 469
H IIHRD+K NIL+ + + DFG A+ + Y D T R A
Sbjct: 118 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYR------A 168
Query: 470 PEYL-STGKSSEKTDVFGYGIMLLELITGQRAF 501
PE L K D++ G ++ E++TG+ F
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 84/347 (24%), Positives = 138/347 (39%), Gaps = 91/347 (26%)
Query: 303 ILGRGGFGKVYKG------RLADGSLVAVKRLKEERTPGGELQFQTEVE-MISMAVHRNL 355
+LG G FGKV + + + + VAVK LKE T +E++ +I + H N+
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73
Query: 356 LRLRGFCMTPTERLL-VYPYMANGSVASCL----------RERPPSQLPLDWPT------ 398
+ L G C P L+ + + G++++ L RE+ P Q
Sbjct: 74 VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133
Query: 399 RKRIALGS------------------------------------------ARGLSYLHDH 416
+RI G ARG+ +L
Sbjct: 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR 193
Query: 417 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT--AVRGTIGHIAPEYLS 474
K IHRD+ A NILL E + DFGLA+ + YKD + R + +APE +
Sbjct: 194 ---KCIHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGSARLPLKWMAPESIF 249
Query: 475 TGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533
+ ++DV+ +G++L E+ + G + ++ + L D + + P
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR----------MRAP 299
Query: 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAER 580
+ E+ +++ L C QG P +RP S +V +L GD L E
Sbjct: 300 E----NATPEIYRIM---LACWQGDPKERPTFSALVEIL-GDLLQEN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 16/185 (8%)
Query: 320 GSLVAVKRL---KEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 376
G VAVK++ K++R EL F EV ++ H N++ + + E +V ++
Sbjct: 44 GRQVAVKKMDLRKQQRR---ELLFN-EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99
Query: 377 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 436
G++ + + ++ + L + LS+LH +IHRD+K+ +ILL +
Sbjct: 100 GGALTDIV-----THTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSD 151
Query: 437 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
+ DFG + K+ ++ GT +APE +S + D++ GIM++E++
Sbjct: 152 GRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVD 210
Query: 497 GQRAF 501
G+ +
Sbjct: 211 GEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 52/199 (26%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 362
+G+G G VY +A G VA++++ ++ P EL E+ ++ + N++
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 86
Query: 363 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 422
+ E +V Y+A GS+ + E + + R+ + + L +LH + ++I
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 138
Query: 423 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 482
HRD+K+ NILL + + DFG + + + +T V GT +APE ++ K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 483 DVFGYGIMLLELITGQRAF 501
D++ GIM +E+I G+ +
Sbjct: 198 DIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 294 ATDSFSNKNILGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH 352
A S+ N LG G + VYKG +G LVA+K + + G E ++ H
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 353 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 412
N++ L T V+ YM + +A + + P P + + RGL+Y
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYN---VRLFMFQLLRGLAY 118
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 472
+H I+HRD+K N+L+ E + DFGLA+ ++ V T+ + P+
Sbjct: 119 IHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDV 174
Query: 473 L--STGKSSEKTDVFGYGIMLLELITGQRAF 501
L +T SS D++G G + +E++ GQ AF
Sbjct: 175 LLGATDYSSA-LDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 22/213 (10%)
Query: 303 ILGRGGFGKVYKGRLADG----SLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRN--- 354
+LG G +GKV+ R G L A+K L++ + T E + R
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR---GLS 411
L+ L T + L+ Y++ G + + L +R D + + S L
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR-------DNFSEDEVRFYSGEIILALE 119
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 471
+LH I++RD+K NILLD E V+ DFGL+K ++ T + GTI ++APE
Sbjct: 120 HLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176
Query: 472 YL-STGKSSEKTDVFGYGIMLLELITGQRAFDL 503
+ G + D + GI++ EL+TG F L
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 64/274 (23%), Positives = 125/274 (45%), Gaps = 36/274 (13%)
Query: 304 LGRGGFGK--VYKGRLADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNLLRLRG 360
+G G FGK + K + DG +K + + E + + EV ++S H N+++ +
Sbjct: 8 IGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 361 FCMTPTERLLVYPYMANGSVASCLRERPPSQLP----LDWPTRKRIALGSARGLSYLHDH 416
+V Y G + + + P LDW + I L L ++HD
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ--ICLA----LKHVHDR 120
Query: 417 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 476
KI+HRD+K+ NI L ++ +GDFG+A++++ T + GT +++PE
Sbjct: 121 ---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENR 176
Query: 477 KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 536
+ K+D++ G +L E+ T + AF+ + N ++L ++G P +
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN----LVLKIIRGSY----------PPVS 222
Query: 537 NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
++Y ++ L+ + +P DRP ++ ++
Sbjct: 223 SHY-SYDLRNLVSQLF---KRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 68/284 (23%), Positives = 122/284 (42%), Gaps = 43/284 (15%)
Query: 297 SFSNKNILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVH 352
S + ILG G FG++ +G L S VA+ L+ + F E + H
Sbjct: 6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDH 65
Query: 353 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP----PSQLPLDWPTRKRIALGSAR 408
N++RL G ++V YM+NG++ S LR+ QL + G A
Sbjct: 66 SNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL-MGMLP------GLAS 118
Query: 409 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--TIG 466
G+ YL + +H+ + A +L++ + + F +L + K + T + G +
Sbjct: 119 GMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVL 173
Query: 467 HIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAF-DLARLANDDDVMLLDWVKGLLKE 524
APE + S +DV+ +GI++ E+++ G+R + D++ DV+ K + E
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS----GQDVI-----KAV--E 222
Query: 525 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 568
+ + N L Q+ L C Q +RP+ S++
Sbjct: 223 DGFRLPAPRNCPN--------LLHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 28/228 (12%)
Query: 290 ELQVATDSFSNKNILGRGGFGKVYKGRL---ADG---SLVAVKRLKEERTPGGELQFQTE 343
E+ ++T F + LG FGKVYKG L A G VA+K LK++ +F+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 344 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPS------------Q 391
M S H N++ L G +++ Y ++ + L R P +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 392 LPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM- 450
L+ I A G+ +L H ++H+D+ N+L+ ++ + D GL + +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 451 --DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
DY + + I ++PE + GK S +D++ YG++L E+ +
Sbjct: 176 AADYYKLMGNSLL--PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 30/227 (13%)
Query: 296 DSFSNKNILGRGGFGKVY------------KGRLADGS-----LVAVKRLKEERTPGGEL 338
+ K LG G FG+V+ K D S LVAVK L+E+
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64
Query: 339 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL-RERPPSQLP---- 393
F E++++S N++RL C+T ++ YM NG + L R P
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 394 --LDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451
+ + T +A A G+ YL +HRD+ N L+ + + + DFG+++ +
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNL- 180
Query: 452 YKDTHVTTAVRGT--IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
Y + R I ++ E + GK + +DV+ +G+ L E++T
Sbjct: 181 YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQF-QTEVEMISMAVHRNLLRLRGF 361
+G G +G VYK R + G L A+K +K E PG + Q E+ M+ H N++ G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 362 CMTPTERLLVYPYMANGSVASCLRERPP-SQLPLDWPTRKRIALGSARGLSYLHDHCDPK 420
+ + + + GS+ P S+ + + +R+ + +GL YLH
Sbjct: 75 YLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGK-- 127
Query: 421 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR----GTIGHIAPEYLST- 475
+HRD+K ANILL + + DFG++ + T A R GT +APE +
Sbjct: 128 -MHRDIKGANILLTDNGHVKLADFGVSAQIT-----ATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 476 --GKSSEKTDVFGYGIMLLELITGQRA-FDL 503
G ++ D++ GI +EL Q FDL
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 54/211 (25%), Positives = 103/211 (48%), Gaps = 16/211 (7%)
Query: 292 QVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKE-ERTPGGELQFQTEVEMISMA 350
++ D F + LG G G V+K L+ ++L E P Q E++++
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 351 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE--RPPSQLPLDWPTRKRIALGSAR 408
++ G + E + +M GS+ L++ R P Q+ ++++ +
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI------LGKVSIAVIK 114
Query: 409 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGH 467
GL+YL + KI+HRDVK +NIL++ E + DFG++ +L+D + + GT +
Sbjct: 115 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSY 168
Query: 468 IAPEYLSTGKSSEKTDVFGYGIMLLELITGQ 498
++PE L S ++D++ G+ L+E+ G+
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 55/211 (26%), Positives = 103/211 (48%), Gaps = 16/211 (7%)
Query: 292 QVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKE-ERTPGGELQFQTEVEMISMA 350
++ D F + LG G G V K + L+ ++L E P Q E++++
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 351 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE--RPPSQLPLDWPTRKRIALGSAR 408
++ G + E + +M GS+ L+E R P ++ ++++ R
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEI------LGKVSIAVLR 114
Query: 409 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGH 467
GL+YL + +I+HRDVK +NIL++ E + DFG++ +L+D + + GT +
Sbjct: 115 GLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSY 168
Query: 468 IAPEYLSTGKSSEKTDVFGYGIMLLELITGQ 498
++PE L S ++D++ G+ L+EL G+
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 37/213 (17%)
Query: 304 LGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVEMISMAVH-RNLLRLRG- 360
+GRG FG V K G+++AVKR++ + + +++++ + +++ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 361 --------FCM----TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR 408
CM ++ Y Y L+ P ++ +IA+ + +
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEV-------LKSVIPEEI------LGKIAVATVK 118
Query: 409 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGH 467
L+YL + + KIIHRDVK +NILLD + DFG++ +L+ D+ T G +
Sbjct: 119 ALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCRPY 173
Query: 468 IAPEYLSTGKSSE---KTDVFGYGIMLLELITG 497
+APE + ++DV+ GI L E+ TG
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 303 ILGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG- 360
+LG+G FGKV R L A+K LK+ ++ Q + +M V + +L L G
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKK------DVVIQDDDVECTM-VEKRVLALSGK 59
Query: 361 --------FCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 411
C +RL V Y+ G + +++ + P IA+ GL
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI----GLF 115
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 471
+LH II+RD+K N++LD E + DFG+ K + D T GT +IAPE
Sbjct: 116 FLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAPE 171
Query: 472 YLSTGKSSEKTDVFGYGIMLLELITGQRAFD 502
++ + D + +G++L E++ GQ F+
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 3e-10
Identities = 55/231 (23%), Positives = 90/231 (38%), Gaps = 60/231 (25%)
Query: 298 FSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQT---------EVEMI 347
+ +G G +G V G VA+K++ F E++++
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNV------FDDLIDAKRILREIKLL 53
Query: 348 SMAVHRNLLRLRGFCMTPTERL------LVYPYMANGSVASCLRERPPSQLPLDWPTRKR 401
H N++ L + P +V M + ++ S PL T
Sbjct: 54 RHLRHENIIGLLDI-LRPPSPEDFNDVYIVTELMET-DLHKVIK----SPQPL---TDDH 104
Query: 402 I------ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455
I L RGL YLH +IHRD+K +NIL++ + + DFGLA+ +D +
Sbjct: 105 IQYFLYQIL---RGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158
Query: 456 H--------VTTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGIMLLELITG 497
VT R APE LS+ + ++ D++ G + EL+T
Sbjct: 159 EKGFLTEYVVTRWYR------APELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 69/292 (23%), Positives = 117/292 (40%), Gaps = 63/292 (21%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 362
LGRG +G V K R + G+++AVKR++ V S R L+ L
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIR------------ATVN--SQEQKRLLMDL-DIS 53
Query: 363 MTPTERLLVYPYMAN--------GSVASCLRERPPS-----------QLPLDWPTRKRIA 403
M R + PY G V C+ S L + +IA
Sbjct: 54 M----RSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIA 109
Query: 404 LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 463
+ + L YLH +IHRDVK +N+L++ + + DFG++ + D+ T G
Sbjct: 110 VSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTIDAG 165
Query: 464 TIGHIAPEYLSTGKSSE----KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 519
++APE ++ + + K+DV+ GI ++EL TG+ +D W
Sbjct: 166 CKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD-------------SWKT 212
Query: 520 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571
+ K++ P L E + + C + + +RP E+++
Sbjct: 213 PFQQLKQVVEEPSPQLPAEKFSPEFQDFVNK---CLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 39/156 (25%), Positives = 71/156 (45%), Gaps = 14/156 (8%)
Query: 305 GRGGFGKVYKGRLADGS---LVAVKRLKEERTPGGELQFQT--EVEMISMAVHRNLLRLR 359
GRG +G+VYK + +G A+K+ K ++ + E+ ++ H N++ L
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 360 GFCMTPTERL--LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 417
+ ++ L++ Y + R ++ + K + G+ YLH +
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW 128
Query: 418 DPKIIHRDVKAANILL--DEEFEAVV--GDFGLAKL 449
++HRD+K ANIL+ + VV GD GLA+L
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 64/207 (30%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGE--LQFQTEVEMISMAVHRNLLRLR 359
+LG+G FGKV R A G A+K LK+E + TE ++ H L L+
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 360 GFCMTPTERL-LVYPYMANGSVASCL-RERPPSQLPLDWPTRKRI---ALGSARGLSYLH 414
+ +RL V Y G + L RER S+ R R + SA L YLH
Sbjct: 62 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSE------DRARFYGAEIVSA--LGYLH 112
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 474
CD +++RD+K N++LD++ + DFGL K D GT ++APE L
Sbjct: 113 S-CD--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLE 168
Query: 475 TGKSSEKTDVFGYGIMLLELITGQRAF 501
D +G G+++ E++ G+ F
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 4e-10
Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 304 LGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQ--FQTEVEMISMAVHRNLLRL-R 359
LG GGFG+V ++ A+K +K+ Q +E E++ H +++L R
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 360 GFCMTPTERLLVY---PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 416
F ++ +Y Y G + + LR+R ++ R IA YLH+
Sbjct: 61 TF----KDKKYIYMLMEYCLGGELWTILRDR--GLFD-EYTARFYIA-CVVLAFEYLHNR 112
Query: 417 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYLST 475
II+RD+K N+LLD + DFG AK L + T T GT ++APE +
Sbjct: 113 ---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEIILN 166
Query: 476 GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 513
D + GI+L EL+TG+ F +D+D M
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGRPPFG----EDDEDPM 200
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 61/204 (29%), Positives = 89/204 (43%), Gaps = 15/204 (7%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGE--LQFQTEVEMISMAVHRNLLRLR 359
+LG+G FGKV R A G A+K LK+E + TE ++ H L L+
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 360 GFCMTPTERLLVYPYMANGSVASCL-RERPPSQLPLDWPTRKRIALGS-ARGLSYLHDHC 417
T V Y+ G + L RER S+ R R L YLH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSE------DRTRFYGAEIVSALDYLHSG- 114
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 477
KI++RD+K N++LD++ + DFGL K D GT ++APE L
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDND 171
Query: 478 SSEKTDVFGYGIMLLELITGQRAF 501
D +G G+++ E++ G+ F
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-10
Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 27/211 (12%)
Query: 304 LGRGGFGKVYKGRLAD-GSLVAVKRL--------KEERTPGGELQFQTEVEMISMAVHRN 354
+G+G FG+VY+ R D + A+K L KE GE + +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNI---LVRTLLDESPF 57
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRE--RPPSQLPLDWPTRKRIALGS-ARGLS 411
++ L+ T ++ LV YM+ G + L++ R R + + L
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED-------RAKFYIAELVLALE 110
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 471
+LH + I++RD+K NILLD + DFGL+K + D T GT ++APE
Sbjct: 111 HLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPE 166
Query: 472 YLSTGKSSEK-TDVFGYGIMLLELITGQRAF 501
L K K D + G+++ E+ G F
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 59/234 (25%), Positives = 89/234 (38%), Gaps = 48/234 (20%)
Query: 302 NILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGG-------------------ELQFQ 341
LG G +GKV K G +VA+K++K EL+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 342 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKR 401
E++ H N++ L + LV MA S L++ ++ L K
Sbjct: 75 NEIK------HENIMGLVDVYVEGDFINLVMDIMA-----SDLKKVVDRKIRLTESQVKC 123
Query: 402 IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK------LMDYKDT 455
I L GL+ LH +HRD+ ANI ++ + + DFGLA+ D
Sbjct: 124 ILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 456 HVTTAVRG-------TIGHIAPEYL-STGKSSEKTDVFGYGIMLLELITGQRAF 501
T R T+ + APE L K D++ G + EL+TG+ F
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF 234
|
Length = 335 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 70/299 (23%), Positives = 103/299 (34%), Gaps = 50/299 (16%)
Query: 303 ILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQF-QTEVEMISMAVHRNLLRLRGF 361
+ K + +LVAVK++ + +L+ Q E+ H N+L
Sbjct: 9 CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV-T 66
Query: 362 CMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIAL---GSARGLSYLH-DH 416
L +V P MA GS L+ P LP IA L Y+H
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----ELAIAFILKDVLNALDYIHSKG 121
Query: 417 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI------AP 470
IHR VKA++ILL + + V+ + M + +P
Sbjct: 122 F----IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 471 EYLSTGKS--SEKTDVFGYGIMLLELITGQRAF-DLARLANDDDVMLLDWVKGL---LKE 524
E L +EK+D++ GI EL G F D+ MLL+ V+G L +
Sbjct: 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM-----PATQMLLEKVRGTVPCLLD 232
Query: 525 KKLEMLVDPDLQNNYVEAEV----------------EQLIQVALLCTQGSPMDRPKMSE 567
K L + + + E E Q LC Q P RP S+
Sbjct: 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 63/232 (27%), Positives = 110/232 (47%), Gaps = 16/232 (6%)
Query: 303 ILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGEL--QFQTEVEMISMAVHRNLLRLR 359
++GRG + KV RL + + A+K +K+E E QTE + A L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 360 GFCMTPTERL-LVYPYMANGSVASCL-RERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 417
C T RL LV Y+ G + + R+R +LP + + A L++LH+
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQR---KLPEE--HARFYAAEICIALNFLHER- 115
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 477
II+RD+K N+LLD + + D+G+ K T+ GT +IAPE L +
Sbjct: 116 --GIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 478 SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529
D + G+++ E++ G+ FD+ + ++ D+ D++ ++ EK + +
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDI--ITDNPDMNTEDYLFQVILEKPIRI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 61/234 (26%), Positives = 111/234 (47%), Gaps = 18/234 (7%)
Query: 303 ILGRGGFGKVYKGRLADGSLV-AVKRLKEERTPGGEL--QFQTEVEMISMAV-HRNLLRL 358
++GRG + KV L + A+K +K+E E QTE + A H L+ L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 359 RGFCMTPTERLLVYPYMANGSVASCL-RERPPSQLPLDWPT--RKRIALGSARGLSYLHD 415
T + V +++ G + + R+R +LP + I+L L++LH+
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQR---KLPEEHARFYSAEISLA----LNFLHE 114
Query: 416 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 475
II+RD+K N+LLD E + D+G+ K + T+ GT +IAPE L
Sbjct: 115 R---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAPEILRG 170
Query: 476 GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529
D + G+++ E++ G+ FD+ ++++ D D++ ++ EK++ +
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRI 224
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 25/219 (11%)
Query: 297 SFSNKNILGRGGFGKVYKGRLADG----SLVAVKRLKE----ERTPGGELQFQTEVEMIS 348
+F +LG G +GKV+ R G L A+K LK+ ++ E +TE +++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTE-HTRTERQVLE 59
Query: 349 MAVHRN-LLRLRGFCMTPTERLLVYPYMANGSVASCL--RERPPSQLPLDWPTRKRIALG 405
L+ L T T+ L+ Y+ G + + L RER Q +I G
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ-------EVQIYSG 112
Query: 406 S-ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 464
L +LH II+RD+K NILLD V+ DFGL+K + + GT
Sbjct: 113 EIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169
Query: 465 IGHIAPEYLSTGKS--SEKTDVFGYGIMLLELITGQRAF 501
I ++AP+ + G + D + G+++ EL+TG F
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-09
Identities = 18/42 (42%), Positives = 28/42 (66%), Gaps = 1/42 (2%)
Query: 22 ANMEGDALHSLRSNL-IDPNNVLQSWDPTLVNPCTWFHVTCN 62
N + DAL + +S+L DP+ L SW+P+ +PC+W VTC+
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 298 FSNKNILGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 356
F+ +LG+G FGKV R L A+K LK++ + Q + +M V + +L
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKD------VIIQDDDVECTM-VEKRVL 54
Query: 357 RLRG---------FCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGS 406
L G C +RL V Y+ G + +++ + P IA+G
Sbjct: 55 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG- 113
Query: 407 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 466
L +LH II+RD+K N++LD E + DFG+ K + T GT
Sbjct: 114 ---LFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK-TTRTFCGTPD 166
Query: 467 HIAPE---YLSTGKSSEKTDVFGYGIMLLELITGQRAFD 502
+IAPE Y GKS D + +G++L E++ GQ FD
Sbjct: 167 YIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 45/162 (27%), Positives = 72/162 (44%), Gaps = 27/162 (16%)
Query: 302 NILGRGGFGKVYKGR-LADGSLVAVKR-LKEERTPGGELQFQTEVEMISMAVHRNLLRLR 359
+G+G FG+V+K R +VA+K+ L E G + E++++ + H N++ L
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 360 GFCMTPTERLLVYPYMANGSVAS-------C------LRERPPSQLPLDWPTRKRIALGS 406
C T N S C L + L K++
Sbjct: 78 EICRTK-------ATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL--SEIKKVMKML 128
Query: 407 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448
GL Y+H + KI+HRD+KAANIL+ ++ + DFGLA+
Sbjct: 129 LNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 49/221 (22%)
Query: 304 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEV------------------- 344
LG+G F K++KG ++ E GEL +TEV
Sbjct: 3 LGQGTFTKIFKG------------IRREVGDYGELH-KTEVLLKVLDKSHRNYSESFFEA 49
Query: 345 -EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIA 403
M+S H++L+ G C+ E ++V Y+ GS+ + L++ + + + W + +A
Sbjct: 50 ASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKN-KNLINISW--KLEVA 106
Query: 404 LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 463
A L +L D + H +V A N+LL E + G+ KL D ++ V
Sbjct: 107 KQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKL---SDPGISITVLP 160
Query: 464 T------IGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITG 497
I + PE + ++ S D + +G L E+ +G
Sbjct: 161 KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 65/228 (28%), Positives = 97/228 (42%), Gaps = 27/228 (11%)
Query: 287 SLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLV-AVKRL-KEERTPGGELQFQTEV 344
+ +L++ + F ++GRG FG+V R V A+K L K E + F E
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 345 EMISMAVHRN---LLRLRGFCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLDWPTR 399
I MA H N +++L ++ L V YM G + + + +P W R
Sbjct: 94 RDI-MA-HANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSN---YDIPEKW-AR 145
Query: 400 KRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD--THV 457
A L +H IHRDVK N+LLD+ + DFG MD +
Sbjct: 146 FYTA-EVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD-ANGMVRC 200
Query: 458 TTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGIMLLELITGQRAF 501
TAV GT +I+PE L + G + D + G+ L E++ G F
Sbjct: 201 DTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 62/223 (27%), Positives = 94/223 (42%), Gaps = 19/223 (8%)
Query: 288 LRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRL--KEERTPGGELQFQTEVE 345
+R+LQ+ + + ++GRG FG+V R V +L K E + F E
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 346 MISMAVHRNLLRLRGFCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLDWPTRKRIA 403
I MA + ++ FC ++ L V YM G + + + +P W K
Sbjct: 95 DI-MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN---YDVPEKWA--KFYT 148
Query: 404 LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVR 462
L +H +IHRDVK N+LLD+ + DFG MD TAV
Sbjct: 149 AEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV- 204
Query: 463 GTIGHIAPEYLST----GKSSEKTDVFGYGIMLLELITGQRAF 501
GT +I+PE L + G + D + G+ L E++ G F
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 52/224 (23%), Positives = 96/224 (42%), Gaps = 36/224 (16%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQ--FQTEVEMISMAVHRNLLRLR 359
++G+GG G+VY VA+K+++E+ + L+ F E ++ + +H ++ +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 360 GFCMTPTERLLVY---PYMANGSVASCLRE-RPPSQLPLDW------PTRKRIALGSARG 409
C ++ VY PY+ ++ S L+ L + I
Sbjct: 69 SIC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 410 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-----------------Y 452
+ Y+H ++HRD+K NILL E V+ D+G A Y
Sbjct: 126 IEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
+ + GT ++APE L +SE TD++ G++L +++T
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 302 NILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG 360
N +G G G VYK G L A+K + Q E+E++ H N+++
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 361 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 420
E ++ +M GS+ + L R+ ++ G++YLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEG---THIADEQFLADVARQILS-----GIAYLHRR---H 188
Query: 421 IIHRDVKAANILLDEEFEAVVGDFG----LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 476
I+HRD+K +N+L++ + DFG LA+ MD ++ V GTI +++PE ++T
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-----GTIAYMSPERINTD 243
Query: 477 KSSEK-----TDVFGYGIMLLELITGQRAFDLAR 505
+ D++ G+ +LE G+ F + R
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 303 ILGRGGFGKVY-KGRLADGSLVAVKRLKEERTPGGELQFQTEVE---MISMAVHRNLLRL 358
++G+G FGKV R DG AVK L+++ + Q E ++ H L+ L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 359 RGFCMTPTERL-LVYPYMANGSVASCL-RERPPSQLPLDWPTRKRIALGSARGLSYLHDH 416
+ TE+L V ++ G + L RER + P + A A L YLH
Sbjct: 62 H-YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPE-----PRARFYAAEIASALGYLHS- 114
Query: 417 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLST 475
I++RD+K NILLD + V+ DFGL K + DT TT GT ++APE +
Sbjct: 115 --INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIRK 170
Query: 476 GKSSEKTDVFGYGIMLLELITGQRAF 501
D + G +L E++ G F
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 3e-09
Identities = 63/239 (26%), Positives = 98/239 (41%), Gaps = 52/239 (21%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVE-------MI 347
D F LG G FG+V R G A+K L + ++ +VE ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKA-----KIVKLKQVEHVLNEKRIL 55
Query: 348 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSA 407
H L+ L G + LV Y+ G + S LR+ R A
Sbjct: 56 QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS------------GRFPEPVA 103
Query: 408 R--------GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 459
R L YLH D I++RD+K N+LLD + + DFG AK + + T
Sbjct: 104 RFYAAQVVLALEYLH-SLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TY 156
Query: 460 AVRGTIGHIAPEYLST---GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 515
+ GT ++APE + + GK+ D + GI++ E++ G F DD+ + +
Sbjct: 157 TLCGTPEYLAPEIILSKGYGKAV---DWWALGILIYEMLAGYPPFF------DDNPIQI 206
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 37/94 (39%), Positives = 57/94 (60%), Gaps = 3/94 (3%)
Query: 80 QLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKL 139
L S L L NL+ L+L N+++ +P L NL++L +LDL N + +P + LS L
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSAL 211
Query: 140 RFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRL 173
L L+NNS+ + SL+N+ +L L+LSNN+L
Sbjct: 212 EELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL 244
|
Length = 394 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 48/208 (23%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 303 ILGRGGFGK--VYKGRLADGSLVAVKRLKEERTPGGELQFQT---EVEMISMAVHRNLLR 357
++G G FG+ + + +D +KE R P + E +++ H N++
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYA----MKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA 62
Query: 358 LRGFCMTPTERLLVYPYMANGSVASCLRERP----PSQLPLDWPTRKRIALGSARGLSYL 413
+ +V Y G + ++ + P L W + + LG + ++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ--MCLG----VQHI 116
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 473
H+ +++HRD+K+ NI L + + +GDFG A+L+ + T V GT ++ PE
Sbjct: 117 HEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIW 172
Query: 474 STGKSSEKTDVFGYGIMLLELITGQRAF 501
+ K+D++ G +L EL T + F
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 303 ILGRGGFGKVY---KGRLAD-GSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLR 357
+LG+G FGKV+ K D G L A+K LK+ ++ + E ++++ H +++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 358 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 417
L T + L+ ++ G + + R ++ K A L +LH
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFT----RLSKEVMFTEEDVKFYLAELALALDHLHSL- 117
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAK--LMDYKDTHVTTAVRGTIGHIAPEYLST 475
II+RD+K NILLDEE + DFGL+K + K + + GT+ ++APE ++
Sbjct: 118 --GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVNR 172
Query: 476 GKSSEKTDVFGYGIMLLELITGQRAF 501
++ D + +G+++ E++TG F
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 21/153 (13%)
Query: 304 LGRGGFGKVYKGRLAD-GSLVAVKRLK----EERTPGGELQFQTEVEMISMAVHRNLLRL 358
+G G +G V+K + + +VA+KR++ +E P L+ E+ ++ H+N++RL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELKHKNIVRL 64
Query: 359 RGFCMTPTERLLVYPYMANG---SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 415
+ + LV+ Y SC + +D K +GL++ H
Sbjct: 65 YDVLHSDKKLTLVFEYCDQDLKKYFDSCNGD-------IDPEIVKSFMFQLLKGLAFCHS 117
Query: 416 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448
H ++HRD+K N+L+++ E + DFGLA+
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 3/91 (3%)
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 467
R + YLH++ +IIHRD+KA NI ++ + +GDFG A + + GTI
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249
Query: 468 IAPEYLSTGKSSEKTDVFGYGIMLLELITGQ 498
APE L+ D++ GI+L E+ T
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 48/218 (22%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVK--------RLKEERTPGGELQFQTEVEMISMAVHRN 354
+G G FG+V+ R A+K RLK+E+ E ++ H
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQ------HVHNEKRVLKEVSHPF 62
Query: 355 LLRLRGFCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR---- 408
++RL F +R L + Y+ G + S LR R + +
Sbjct: 63 IIRL--FWTEHDQRFLYMLMEYVPGGELFSYLR------------NSGRFSNSTGLFYAS 108
Query: 409 ----GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRG 463
L YLH +I++RD+K NILLD+E + DFG AK L D T + G
Sbjct: 109 EIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCG 160
Query: 464 TIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
T ++APE + + ++ D + GI++ E++ G F
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 25/220 (11%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGE--LQFQTEVEMISMAVH 352
F K+++GRG FG+V R A G + A+K +K+ E F+ E +++S++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 353 RNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLD----WPTRKRIALGSA 407
+ +L+ + + L LV Y G + S L R Q D + +A+ S
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLL-NRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 467
+ Y +HRD+K N+L+D + DFG A + + GT +
Sbjct: 119 HQMGY---------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169
Query: 468 IAPEYLSTGKSSEKT------DVFGYGIMLLELITGQRAF 501
IAPE L+T K D + G++ E+I G+ F
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-09
Identities = 47/179 (26%), Positives = 86/179 (48%), Gaps = 10/179 (5%)
Query: 320 GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 379
G VAVK++ + EL F EV ++ H N++ + + E +V ++ G+
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 380 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 439
+ + + ++ + L R LSYLH+ +IHRD+K+ +ILL +
Sbjct: 106 LTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRI 157
Query: 440 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQ 498
+ DFG + K+ ++ GT +APE +S + D++ GIM++E+I G+
Sbjct: 158 KLSDFGFCAQVS-KEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 59/273 (21%), Positives = 118/273 (43%), Gaps = 26/273 (9%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLK--EERTPGGELQFQTEVEMISMAVHRNLLRLRG 360
+GRG F +VY+ L D VA+K+++ E E++++ H N+++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 361 FCMTPTERLLVYPYMANGSVASCLR--ERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 418
+ E +V G ++ ++ ++ +P + + L SA + ++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA--VEHMHSR-- 125
Query: 419 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 478
+++HRD+K AN+ + +GD GL + K T + V GT +++PE +
Sbjct: 126 -RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGY 183
Query: 479 SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNN 538
+ K+D++ G +L E+ Q F D + L +K+E P L
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPF------YGDKMNLFSLC------QKIEQCDYPPLPTE 231
Query: 539 YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571
+ ++ +L+ +C P RP + V ++
Sbjct: 232 HYSEKLRELVS---MCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLR 359
++G+G FGKV R A+ AVK L+++ E +E ++ V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 360 GFCMTPTERL-LVYPYMANGSVASCL-RERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 417
F ++L V Y+ G + L RER + P + A A L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLE-----PRARFYAAEIASALGYLHSL- 115
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 477
I++RD+K NILLD + V+ DFGL K + + T+ GT ++APE L
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 478 SSEKTDVFGYGIMLLELITGQRAF 501
D + G +L E++ G F
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 11/196 (5%)
Query: 304 LGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 362
+G G G V R G VAVK + + EL F EV ++ H+N++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN-EVVIMRDYQHQNVVEMYKSY 87
Query: 363 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 422
+ E ++ ++ G++ + SQ L+ + + L YLH +I
Sbjct: 88 LVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLHSQ---GVI 139
Query: 423 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 482
HRD+K+ +ILL + + DFG + KD ++ GT +APE +S +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 483 DVFGYGIMLLELITGQ 498
D++ GIM++E++ G+
Sbjct: 199 DIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 49/196 (25%), Positives = 92/196 (46%), Gaps = 11/196 (5%)
Query: 304 LGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 362
+G G G V + + G LVAVK++ + EL F EV ++ H N++ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSY 86
Query: 363 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 422
+ E +V ++ G++ + + ++ + L + LS LH +I
Sbjct: 87 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLKALSVLHAQ---GVI 138
Query: 423 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 482
HRD+K+ +ILL + + DFG + K+ ++ GT +APE +S +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 483 DVFGYGIMLLELITGQ 498
D++ GIM++E++ G+
Sbjct: 198 DIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 9e-09
Identities = 38/127 (29%), Positives = 70/127 (55%), Gaps = 15/127 (11%)
Query: 374 YMANGSVASCLRE--RPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANI 431
+M GS+ L++ R P + +I++ RGL+YL + KI+HRDVK +NI
Sbjct: 80 HMDGGSLDQVLKKAGRIPENI------LGKISIAVLRGLTYLRE--KHKIMHRDVKPSNI 131
Query: 432 LLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIM 490
L++ E + DFG++ +L+D + + GT +++PE L + ++D++ G+
Sbjct: 132 LVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLS 187
Query: 491 LLELITG 497
L+E+ G
Sbjct: 188 LVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT----HVTTAVRG 463
RGL Y+H +IHRD+K +N+L++E+ E +GDFG+A+ + T +T V
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV-A 173
Query: 464 TIGHIAPE-YLSTGKSSEKTDVFGYGIMLLELI 495
T + APE LS + + D++ G + E++
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 10/116 (8%)
Query: 85 LGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144
L L NL L+L S N +P ++ L++L LDL NS + +L L L L L
Sbjct: 182 LSNLSNLNNLDL-SGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLEL 239
Query: 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGP 200
+NN L +P S+ N+S+L+ LDLSNN++S S S ++ LDL G
Sbjct: 240 SNNKLE-DLPESIGNLSNLETLDLSNNQIS-------SISSLGSLTNLRELDLSGN 287
|
Length = 394 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGE--LQFQTEVEMISMAVHRNLLRLR 359
+LG+G FGKV + A G A+K LK+E + TE ++ + H L L+
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 360 GFCMTPTERLLVYPYMANGSVASCL-RERPPSQLPLDWPTRKRIALGS-ARGLSYLHDHC 417
T V Y G + L RER S+ R R L YLH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSE------DRARFYGAEIVSALDYLH--S 113
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 477
+ +++RD+K N++LD++ + DFGL K KD GT ++APE L
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDND 172
Query: 478 SSEKTDVFGYGIMLLELITGQRAF 501
D +G G+++ E++ G+ F
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 46/219 (21%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLK----EERTPGGELQFQTEVEMISMAVHRNLLRL 358
+G G +G VYK R G +VA+K+++ +E P ++ E+ ++ H N++RL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR---EISLLKELNHPNIVRL 63
Query: 359 RGFCMTPTERLLVY--------PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGL 410
+ + LV+ YM + P LD P K +G+
Sbjct: 64 LDVVHSENKLYLVFEFLDLDLKKYM----------DSSPLT-GLDPPLIKSYLYQLLQGI 112
Query: 411 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTH--VTTAVRG 463
+Y H H +++HRD+K N+L+D E + DFGLA+ + Y TH VT R
Sbjct: 113 AYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY--THEVVTLWYR- 166
Query: 464 TIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAF 501
APE L + S D++ G + E++ + F
Sbjct: 167 -----APEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLF 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 46/182 (25%), Positives = 84/182 (46%), Gaps = 22/182 (12%)
Query: 326 KRLKEERTPGGE---LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV--------YPY 374
+RL +R G +Q + E+ + H N+L++ + ++ Y +
Sbjct: 193 ERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSF 252
Query: 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD 434
M + + ++RP L TR I + Y+HD K+IHRD+K NI L+
Sbjct: 253 MYDEAFD--WKDRP-----LLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301
Query: 435 EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLEL 494
+ + V+GDFG A + + GT+ +PE L+ E TD++ G++LL++
Sbjct: 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361
Query: 495 IT 496
++
Sbjct: 362 LS 363
|
Length = 501 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 38/122 (31%), Positives = 62/122 (50%), Gaps = 7/122 (5%)
Query: 377 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL-HDHCDPKIIHRDVKAANILLDE 435
S + + S PLD R + A+G+ +L +C IHRDV A N+LL +
Sbjct: 193 QSSDSKDEEDTEDSW-PLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTD 247
Query: 436 EFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLEL 494
A + DFGLA+ +M+ + V R + +APE + + ++DV+ YGI+L E+
Sbjct: 248 GRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
Query: 495 IT 496
+
Sbjct: 308 FS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLK----EERTPGGELQFQTEVEMISMAVHRNLLRL 358
+G G +G VYKGR G +VA+K+++ EE P ++ E+ ++ H N++ L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR---EISLLKELQHPNIVCL 64
Query: 359 RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLP----LDWPTRKRIALGSARGLSYLH 414
+ M + L++ ++ S ++ LP +D K +G+ + H
Sbjct: 65 QDVLMQESRLYLIFEFL------SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL- 473
+++HRD+K N+L+D + + DFGLA+ V T T+ + APE L
Sbjct: 119 SR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-VRVYTHEVVTLWYRAPEVLL 174
Query: 474 STGKSSEKTDVFGYGIMLLELITGQRAF 501
+ + S D++ G + E+ T + F
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 40/136 (29%), Positives = 66/136 (48%), Gaps = 8/136 (5%)
Query: 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKA 428
LL+ Y + G + +++R LP + L +H ++HRD+K+
Sbjct: 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKS 197
Query: 429 ANILLDEEFEAVVGDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEYLSTGKSSEKTDVF 485
ANI L +GDFG +K Y D+ V ++ GT ++APE + S+K D++
Sbjct: 198 ANIFLMPTGIIKLGDFGFSK--QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMW 255
Query: 486 GYGIMLLELITGQRAF 501
G++L EL+T R F
Sbjct: 256 SLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 16/211 (7%)
Query: 304 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM 363
+GRG +G VYK + DG LK+ G + E+ ++ H N++ L+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 364 TPTER--LLVYPYMANG--SVASCLRERPPSQLPLDWPTR--KRIALGSARGLSYLHDHC 417
+ ++R L++ Y + + R ++ P+ P K + G+ YLH +
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 418 DPKIIHRDVKAANILL----DEEFEAVVGDFGLAKLMD--YKDTHVTTAVRGTIGHIAPE 471
++HRD+K ANIL+ E + D G A+L + K V T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 472 YLSTGKSSEKT-DVFGYGIMLLELITGQRAF 501
L + K D++ G + EL+T + F
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 14/205 (6%)
Query: 304 LGRGGFGKVYKGRLADGSLVAVKRLKE-ERTPGGEL------QFQTEVEMISMAVHRNLL 356
LG+G FG VY + D VA +RLK + P GEL Q E +++S H ++
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 357 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 416
+ + ++ Y + L E + L + G+ Y+H
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125
Query: 417 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 476
+I+HRD+KA NI L +GDFG+++L+ + T GT +++PE L
Sbjct: 126 ---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEALKHQ 180
Query: 477 KSSEKTDVFGYGIMLLELITGQRAF 501
K+D++ G +L E+ AF
Sbjct: 181 GYDSKSDIWSLGCILYEMCCLAHAF 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 304 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQT---EVEMISMAVHRNLLRLRG 360
LG+G +G VYK + +KE R E +F E++++ AV ++ G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMA--MKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 361 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 420
+ YM GS+ ++ + +RI +GL +L + +
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEG-IPEDVLRRITYAVVKGLKFLKE--EHN 123
Query: 421 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG---HIAPEYLSTGK 477
IIHRDVK N+L++ + + DFG++ + V + + IG ++APE + +G
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL------VASLAKTNIGCQSYMAPERIKSGG 177
Query: 478 SSE------KTDVFGYGIMLLELITG 497
++ ++DV+ G+ +LE+ G
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 42/225 (18%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQT---------EVE 345
D + N + +G G +G+V G VA+K+L P FQ+ E+
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSR---P-----FQSAIHAKRTYRELR 66
Query: 346 MISMAVHRNLLRLRGFCMTPTERL-------LVYPYMANGSVASCLRERPPSQLPLDWPT 398
++ H N++ L TP L LV M + + ++ + S
Sbjct: 67 LLKHMDHENVIGLLD-VFTPASSLEDFQDVYLVTHLMG-ADLNNIVKCQKLSD-----DH 119
Query: 399 RKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HV 457
+ + RGL Y+H IIHRD+K +NI ++E+ E + DFGLA+ D + T +V
Sbjct: 120 IQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV 176
Query: 458 TTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
T + APE L+ ++ D++ G ++ EL+TG+ F
Sbjct: 177 ATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 55/215 (25%), Positives = 88/215 (40%), Gaps = 30/215 (13%)
Query: 298 FSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 356
F LG G FG+V + G A+K LK+ E+ +V+ ++ +++L
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKR-----EILKMKQVQHVAQ--EKSIL 72
Query: 357 R----------LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGS 406
+ F + ++ G + + LR+ + P D K
Sbjct: 73 MELSHPFIVNMMCSF-QDENRVYFLLEFVVGGELFTHLRK--AGRFPND--VAKFYHAEL 127
Query: 407 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 466
YLH D II+RD+K N+LLD + V DFG AK K T + GT
Sbjct: 128 VLAFEYLHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRTFTLCGTPE 180
Query: 467 HIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
++APE + + + D + G++L E I G F
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 45/129 (34%), Positives = 66/129 (51%), Gaps = 8/129 (6%)
Query: 74 NAALSGQLVSQL----GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPI 129
N LSG +S L LL L+ L+L +N+I + S L NL +L L+L N +
Sbjct: 190 NLDLSGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DL 247
Query: 130 PDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPI 189
P+++G LS L L L+NN +S SL ++++L+ LDLS N LS +P L +
Sbjct: 248 PESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLEL 305
Query: 190 SFANNLDLC 198
L L
Sbjct: 306 LLNLLLTLK 314
|
Length = 394 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 304 LGRGGFGKVYKGRLADGSLV-AVKRLKEERTPGGELQFQTEVEMISMAVHRN--LLRLRG 360
+G+G FGKV + R D + A+K +++ T E +A ++ L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 361 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR-GLSYLHDHCDP 419
+P + LV ++ G + L+ L +R R L LH
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDL-----SRARFYTAELLCALENLHKF--- 112
Query: 420 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 479
+I+RD+K NILLD + + DFGL KL + KD T GT ++APE L +
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLAPELLLGHGYT 171
Query: 480 EKTDVFGYGIMLLELITG 497
+ D + G++L E++TG
Sbjct: 172 KAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 67/236 (28%), Positives = 103/236 (43%), Gaps = 33/236 (13%)
Query: 304 LGRG--GFGKVYKGR-LADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNLLRLR 359
+GRG VY R G+LV V+ E L+ Q EV + H N++
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65
Query: 360 GFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 419
T + ++ P+MA GS S L+ P + I G+ RGL+YLH +
Sbjct: 66 TVFTTGSWLWVISPFMAYGSANSLLKTYFPEGM--SEALIGNILFGALRGLNYLHQN--- 120
Query: 420 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-----------YKDTHVTTAVRGTIGHI 468
IHR++KA++IL+ + +V GL+ L Y +T+V + +
Sbjct: 121 GYIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV---LPWL 175
Query: 469 APEYLSTGKS--SEKTDVFGYGIMLLELITGQRAF-DLARLANDDDVMLLDWVKGL 521
+PE L + K+D++ GI EL TG+ F D+ R MLL +KG
Sbjct: 176 SPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ-----MLLQKLKGP 226
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 8e-08
Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 304 LGRGGFGKVYKG---RLADGSLVAVKRLK-EERTPGGELQFQTEVEMISMAVHRNLLRLR 359
LG G FG V KG VAVK LK + P + + E ++ + ++R+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 360 GFCMTPTERLLVYPYMAN-GSVASCLRERPPSQLPLDWPTRKRI---ALGSARGLSYLHD 415
G C E ++ +A G + L++ T K I + G+ YL +
Sbjct: 63 GIC--EAESWMLVMELAELGPLNKFLQKNKHV-------TEKNITELVHQVSMGMKYLEE 113
Query: 416 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEYL 473
+HRD+ A N+LL + A + DFGL+K + + + G + APE +
Sbjct: 114 T---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170
Query: 474 STGKSSEKTDVFGYGIMLLELIT-GQRAF 501
+ K S K+DV+ +G+++ E + GQ+ +
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 8e-08
Identities = 41/167 (24%), Positives = 72/167 (43%), Gaps = 18/167 (10%)
Query: 349 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR 408
M + N ++L T +L+ Y+ +G + L+ + L K+I
Sbjct: 65 MKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK----KEGKLSEAEVKKIIRQLVE 120
Query: 409 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGH 467
L+ LH H IIH D+K N+L D + + + D+GL K++ + GT+ +
Sbjct: 121 ALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDY 172
Query: 468 IAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 514
+PE + D + G++ EL+TG+ F D+D L
Sbjct: 173 FSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK-----EDEDEEL 214
|
Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 9e-08
Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 25/203 (12%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLK------EERTPGGELQFQTEVEMISMAVHRNLL 356
+G G F +V K + G A+K +K E+ E+Q + ++ H N+L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQ-----ALRRLSPHPNIL 61
Query: 357 RLRGFCM-TPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
RL T RL LV+ M + ++ ++ R + PL K + L ++H
Sbjct: 62 RLIEVLFDRKTGRLALVFELM-DMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-YL 473
+ I HRD+K NIL+ ++ + DFG + + K + T T + APE L
Sbjct: 118 RN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY--TEYISTRWYRAPECLL 171
Query: 474 STGKSSEKTDVFGYGIMLLELIT 496
+ G K D++ G + E+++
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 9e-08
Identities = 51/176 (28%), Positives = 83/176 (47%), Gaps = 25/176 (14%)
Query: 407 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--VRGT 464
ARG+ +L K IHRD+ A NILL E + DFGLA+ + YKD R
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGDARLP 238
Query: 465 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 523
+ +APE + + ++DV+ +G++L E+ + G + ++ + L + +
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR---- 294
Query: 524 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAE 579
+ P+ Y E+ ++ L C +P DRP SE+V +L GD L E
Sbjct: 295 ------MRAPE----YATPEIYSIM---LDCWHNNPEDRPTFSELVEIL-GDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 46/147 (31%), Positives = 67/147 (45%), Gaps = 10/147 (6%)
Query: 306 RGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN--LLRLRGFC 362
RG FGKVY GR + L AVK +K+ + Q + E ++A+ ++ ++ L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 363 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 422
+ LV Y+ G V S L D + A L YLH H II
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGY----FDEEMAVKYISEVALALDYLHRH---GII 126
Query: 423 HRDVKAANILLDEEFEAVVGDFGLAKL 449
HRD+K N+L+ E + DFGL+K+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 57/205 (27%), Positives = 87/205 (42%), Gaps = 22/205 (10%)
Query: 304 LGRGGFGKVYKGRL-ADGSLVAVKRLKEERT------PGGE--LQFQTEVEMISMAVHRN 354
LG+G F +YKG L L V +E L F ++S H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
L++L G C+ E ++V Y+ G + L R + + L W + +A A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD--YKDTHVTTAVR-GTIGHIAPE 471
D K++H +V NIL+ G KL D T ++ R I IAPE
Sbjct: 119 DK---KLVHGNVCGKNILVARY-GLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAPE 174
Query: 472 YLSTGKSS--EKTDVFGYGIMLLEL 494
+ G++S D + +G LLE+
Sbjct: 175 CIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 16/214 (7%)
Query: 295 TDSFSNKNILGRGGFGKVYK-GRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 353
+D++ +G+G +GKV+K +GS AVK L E++ + + + +++ H
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI-LKALSDHP 75
Query: 354 NLLRLRGF-----CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR 408
N+++ G + LV GSV ++ ++ P I +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135
Query: 409 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 468
GL +LH + K IHRDVK NILL E + DFG++ + T+V GT +
Sbjct: 136 GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWM 191
Query: 469 APEYLSTGKS-----SEKTDVFGYGIMLLELITG 497
APE ++ + + DV+ GI +EL G
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 16/211 (7%)
Query: 304 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM 363
+GRG +G VYK + DG LK+ G + E+ ++ H N++ L+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 364 TPTER--LLVYPYMANG--SVASCLRERPPSQLPLDWP--TRKRIALGSARGLSYLHDHC 417
+ +R L++ Y + + R ++ P+ P K + G+ YLH +
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 418 DPKIIHRDVKAANILL----DEEFEAVVGDFGLAKLMD--YKDTHVTTAVRGTIGHIAPE 471
++HRD+K ANIL+ E + D G A+L + K V T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 472 YLSTGKSSEKT-DVFGYGIMLLELITGQRAF 501
L + K D++ G + EL+T + F
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGE--LQFQTEVEMISMAVHRNLLRLR 359
+LG+G FGKV R A G A+K L++E + TE ++ H L L+
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 360 GFCMTPTERLLVYPYMANGSVASCL-RERPPSQLPLDWPTRKRIALGS-ARGLSYLHDHC 417
T V Y G + L RER ++ R R L YLH
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTE------ERARFYGAEIVSALEYLHSR- 114
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 477
+++RD+K N++LD++ + DFGL K D GT ++APE L
Sbjct: 115 --DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 478 SSEKTDVFGYGIMLLELITGQRAF 501
D +G G+++ E++ G+ F
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 52/219 (23%), Positives = 99/219 (45%), Gaps = 19/219 (8%)
Query: 289 RELQVATDSFSNKNILGRGGFGKVYKGRLADGSL--VAVKRLKEERTPGGEL--QFQTEV 344
R+ ++ + F+ LG G FG+V + VA+KR ++ + + +E
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 345 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR--ERPPSQLPLDWPTRKRI 402
++++ H + L G + LV ++ G + LR +R P+ + + + +
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL 142
Query: 403 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 462
+ L+ I++RD+K N+LLD++ + DFG AK++D + T +
Sbjct: 143 IFEYLQSLN---------IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLC 189
Query: 463 GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
GT +IAPE L + D + GI + E++ G F
Sbjct: 190 GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 33/217 (15%)
Query: 301 KNILGRGGFGKVYKGRLADGS----LVAVKRLKEE---RTPGGELQFQTEVEMISMAVHR 353
+LG+GG+GKV++ R G+ + A+K LK+ R + E ++ H
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR----- 408
++ L T + L+ Y++ G + L R+ I +
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLE-------------REGIFMEDTACFYLS 107
Query: 409 ----GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 464
L +LH II+RD+K NILLD + + DFGL K ++ T VT GT
Sbjct: 108 EISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGT 163
Query: 465 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
I ++APE L + D + G ++ +++TG F
Sbjct: 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 22/218 (10%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRL--KEERTPGGELQ-FQTEVEMISMAVH 352
+ F ++GRG FG+V +L + V ++ K E E F+ E +++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 353 RNLLRLRGFCMTPTERLLVYPYMANGSVASCL---RERPPSQLPLDWPTRKRIALGSARG 409
+ + L LV Y G + + L +R P + + IA+ S
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 410 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG-LAKLMDYKDTHVTTAVRGTIGHI 468
L Y +HRD+K NIL+D + DFG KLM+ + AV GT +I
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYI 170
Query: 469 APEYLST-----GKSSEKTDVFGYGIMLLELITGQRAF 501
+PE L GK + D + G+ + E++ G+ F
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 40/139 (28%), Positives = 73/139 (52%), Gaps = 13/139 (9%)
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 466
RGL Y+H ++HRD+K AN+ ++ E+ +GDFGLA+++D +H G +
Sbjct: 125 RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 467 --HIAPE-YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM--LLDWVKGL 521
+ +P LS ++ D++ G + E++TG+ F A++ + M +L+ V +
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA---GAHELEQMQLILESVPVV 238
Query: 522 LKEKKLEML-VDPDLQNNY 539
+E + E+L V P N
Sbjct: 239 REEDRNELLNVIPSFVRND 257
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTI 465
+GL Y+H IIHRD+K N+ ++E+ E + DFGLA+ D + T VT R
Sbjct: 129 KGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYR--- 182
Query: 466 GHIAPEY-LSTGKSSEKTDVFGYGIMLLELITGQRAF 501
APE L+ ++ D++ G ++ E++TG+ F
Sbjct: 183 ---APEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF 216
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 8/95 (8%)
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 467
RGL Y+H IIHRD+K +N+ ++E+ E + DFGLA+ + D +T V T +
Sbjct: 131 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 183
Query: 468 IAPE-YLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
APE L+ ++ D++ G ++ EL+TG+ F
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 67/245 (27%), Positives = 98/245 (40%), Gaps = 52/245 (21%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRL-KEERTPGGEL-QFQTEVEMISMAVH 352
F +LG+G G+V+ RL G L A+K L K+E ++ + TE E+++ H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 353 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR---- 408
L L T T LV Y G + L+ +P L + AR
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEE----------VARFYAA 110
Query: 409 ----GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR-- 462
L YLH I++RD+K NILL E ++ DF L+K D + V+ A+R
Sbjct: 111 EVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167
Query: 463 --------------------------GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
GT +IAPE +S D + GI+L E++
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY 227
Query: 497 GQRAF 501
G F
Sbjct: 228 GTTPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 467
RGL Y+H ++HRD+K +N+LL+ + + DFGLA+ K +T V T +
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 468 IAPEYLSTGKSSEKT---DVFGYGIMLLELITGQRAF 501
APE L SE T DV+ G + EL+ + F
Sbjct: 175 RAPELLLN--CSEYTTAIDVWSVGCIFAELLGRKPLF 209
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 24/169 (14%)
Query: 407 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--VRGT 464
A+G+ +L K IHRD+ A NILL E + DFGLA+ + YKD R
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGDARLP 244
Query: 465 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 523
+ +APE + + ++DV+ +G++L E+ + G + ++ D++ +
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--DEEF--------CRR 294
Query: 524 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 572
K+ + PD Y E + Q L C G P RP SE+V L
Sbjct: 295 LKEGTRMRAPD----YTTPE---MYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 467
RGL YLH I+HRD+K N+L++ + DFGLA++ + ++ T T +
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 468 IAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAF 501
APE L + + D++ G + EL+ + F
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 288 LRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRL--KEERTPGGELQFQTEVE 345
+R+L++ + + ++GRG FG+V R V +L K E + F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 346 MISMAVHRNLLRLRGFCMTPTERLL--VYPYMANGSVASCLRERP-PSQLPLDWPTRKRI 402
I MA + ++ F +R L V YM G + + + P + + +
Sbjct: 95 DI-MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL 153
Query: 403 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV--TTA 460
AL + + + IHRDVK N+LLD+ + DFG M+ K+ V TA
Sbjct: 154 ALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTA 203
Query: 461 VRGTIGHIAPEYLST----GKSSEKTDVFGYGIMLLELITGQRAF 501
V GT +I+PE L + G + D + G+ L E++ G F
Sbjct: 204 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLK----EERTPGGELQFQTEVEMISMAVHRNLLRL 358
+G G +G VYK R +A+K+++ +E P ++ E+ ++ H N++RL
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR---EISLLKEMQHGNIVRL 66
Query: 359 RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 418
+ + LV+ Y+ + + + P + K RG++Y H H
Sbjct: 67 QDVVHSEKRLYLVFEYL-DLDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH-- 121
Query: 419 PKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 477
+++HRD+K N+L+D A+ + DFGLA+ T V T+ + APE L +
Sbjct: 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSR 179
Query: 478 S-SEKTDVFGYGIMLLELITGQRAF 501
S D++ G + E++ + F
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQKPLF 204
|
Length = 294 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 59/231 (25%), Positives = 93/231 (40%), Gaps = 48/231 (20%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKE-ERTPGGELQFQTEVEMISMAV--- 351
D F ++GRG FG+V AV ++K ER ++ + EM+ A
Sbjct: 1 DDFEIIKVIGRGAFGEV-----------AVVKMKHTERIYA--MKILNKWEMLKRAETAC 47
Query: 352 ---HRNLLRLRGFCMTPTER----------LLVYPYMANGSVASCL---RERPPSQLPLD 395
RN+L + G C T LV Y G + + L +R P +
Sbjct: 48 FREERNVL-VNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF 106
Query: 396 WPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455
+ +A+ S L Y +HRD+K N+LLD + DFG M+ T
Sbjct: 107 YIAEMVLAIHSIHQLHY---------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157
Query: 456 HVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGIMLLELITGQRAF 501
++ GT +I+PE L GK + D + G+ + E++ G+ F
Sbjct: 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 13/210 (6%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLK--EERTPGGELQFQTEVEMISMAVH 352
+ F ++G G +G V K R + +VA+K+ K EE E + E++M+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQ 59
Query: 353 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 412
N++ L+ + LV+ Y+ ++ L E P P + + + +
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPP---EKVRSYIYQLIKAIHW 115
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPE 471
H + I+HRD+K N+L+ + DFG A+ L + + + T V T + +PE
Sbjct: 116 CHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPE 171
Query: 472 YLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
L + D++ G +L EL GQ F
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 4e-06
Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 10/100 (10%)
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK----LMDYKDTHVTTAVRG 463
+ L Y+H +IHRD+K +NILL+ + + DFGLA+ L + + V T
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 464 TIGHIAPEYL--STGKSSEKTDVFGYGIMLLELITGQRAF 501
T + APE L ST + ++ D++ G +L E++ G+ F
Sbjct: 175 TRWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 8/95 (8%)
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 467
RGL Y+H IIHRD+K +N+ ++E+ E + DFGLA+ D + T T +
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWY 181
Query: 468 IAPE-YLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
APE L+ ++ D++ G ++ EL+ G+ F
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 6e-06
Identities = 22/60 (36%), Positives = 31/60 (51%)
Query: 114 SLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRL 173
+L SLDL N T L L+ L L+ N+L+ P + + + SL+ LDLS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 43/217 (19%)
Query: 304 LGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEV---------EMISMAVHR 353
+G G +G V G VA+K+L FQ+E+ ++ H
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRP--------FQSEIFAKRAYRELTLLKHMQHE 74
Query: 354 NLLRLRG-FCMTPTER-----LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSA 407
N++ L F + LV PYM + P S+ + + + +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQML----- 127
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTI 465
GL Y+H IIHRD+K N+ ++E+ E + DFGLA+ D + T VT R
Sbjct: 128 CGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYR--- 181
Query: 466 GHIAPEY-LSTGKSSEKTDVFGYGIMLLELITGQRAF 501
APE L+ ++ D++ G ++ E++TG+ F
Sbjct: 182 ---APEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLF 215
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 41/170 (24%), Positives = 75/170 (44%), Gaps = 24/170 (14%)
Query: 407 ARGLSYL-HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGT 464
A+G+S+L +C IHRD+ A NILL + DFGLA+ + +V R
Sbjct: 224 AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 465 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 523
+ +APE + + ++DV+ YGI+L E+ + G + G+
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY-----------------PGMPV 322
Query: 524 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ K ++ + E ++ + C P+ RP ++V+++E
Sbjct: 323 DSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 22/218 (10%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRL-KEERTPGGELQ-FQTEVEMISMAVH 352
D F ++GRG FG+V ++ + G + A+K L K E E F+ E +++
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 353 RNLLRLRGFCMTPTERL-LVYPYMANGSVASCLR---ERPPSQLPLDWPTRKRIALGSAR 408
R + L + L LV Y G + + L +R P + + +A+ S
Sbjct: 61 RWITNLH-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH 119
Query: 409 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 468
L Y +HRD+K N+LLD+ + DFG + T + GT +I
Sbjct: 120 QLGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYI 170
Query: 469 APEYL-----STGKSSEKTDVFGYGIMLLELITGQRAF 501
+PE L G+ + D + G+ + E++ G+ F
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 58/275 (21%), Positives = 113/275 (41%), Gaps = 46/275 (16%)
Query: 312 VYKGRLADGSLVAVKRLKEERTPGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369
+YKG + V ++ K+ L + E++ + N+L++ GF + + L
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 370 ----LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRD 425
L+ Y G LRE + L + T+ +A+ +GL L+ + +++
Sbjct: 95 PRLSLILEYCTRGY----LREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKN 148
Query: 426 VKAANILLDEEFEAVVGDFGLAKLMD---YKDTHVTTAV---RGTIGHIAPEYLSTGKSS 479
+ + + L+ E ++ + GL K++ +K+ V V + I EY
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPPFKN--VNFMVYFSYKMLNDIFSEYT------ 200
Query: 480 EKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD-PDLQNN 538
K D++ G++L E+ TG+ F+ N + D + + K L++ +D P
Sbjct: 201 IKDDIYSLGVVLWEIFTGKIPFE-----NLTTKEIYDLI--INKNNSLKLPLDCPLEIKC 253
Query: 539 YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
VEA CT + RP + E++ L
Sbjct: 254 IVEA-----------CTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 9e-06
Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH---VTTAVRGT 464
RGL Y+H ++HRD+K +N+LL+ + + DFGLA++ D + H +T V T
Sbjct: 117 RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV-AT 172
Query: 465 IGHIAPEYLSTGKSSEKT-DVFGYGIMLLELITGQRAF 501
+ APE + K K D++ G +L E+++ + F
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 67 VIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFT 126
++ +DL + LSGQ+ + + L L+L N ++G IP +LGN+ SLV +++ N
Sbjct: 525 LVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLH 584
Query: 127 GPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISS 162
G +P T FL +N ++++G I + + +S
Sbjct: 585 GSLPSTGA------FLAINASAVAGNIDLCGGDTTS 614
|
Length = 968 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 49/153 (32%), Positives = 70/153 (45%), Gaps = 23/153 (15%)
Query: 361 FCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 418
FC T+R L V Y+ G A+ L+ LP+D R A + L YLH++
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCATLLKNIGA--LPVDM-ARMYFA-ETVLALEYLHNY-- 120
Query: 419 PKIIHRDVKAANILLDEEFEAVVGDFGLAK--LMDY----------KDTH--VTTAVRGT 464
I+HRD+K N+L+ + DFGL+K LM KDT + V GT
Sbjct: 121 -GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGT 179
Query: 465 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG 497
+IAPE + + D + GI+L E + G
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 17/164 (10%)
Query: 338 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWP 397
L F ++S H +L + G C+ +E ++V ++ +G + CLR + ++P+ W
Sbjct: 61 LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLR-KEKGRVPVAWK 119
Query: 398 TRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457
L SA LSYL D ++H +V A NILL + + G + + D V
Sbjct: 120 ITVAQQLASA--LSYLEDK---NLVHGNVCAKNILLARLG---LAE-GTSPFIKLSDPGV 170
Query: 458 TTAVRG------TIGHIAPEYLSTGKS-SEKTDVFGYGIMLLEL 494
+ I IAPE + G S S D + +G LLE+
Sbjct: 171 SFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 2e-05
Identities = 23/61 (37%), Positives = 32/61 (52%), Gaps = 2/61 (3%)
Query: 90 NLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNS 148
NL+ L+L +N +T IP L +L LDL N+ T P+ L LR L L+ N+
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 149 L 149
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT---TAVRGT 464
R L Y+H + HRD+K NIL + + + + DFGLA++ + DT T T
Sbjct: 114 RALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTPTAIFWTDYVAT 169
Query: 465 IGHIAPEYLST--GKSSEKTDVFGYGIMLLELITGQRAF 501
+ APE + K + D++ G + E++TG+ F
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 58/239 (24%), Positives = 95/239 (39%), Gaps = 51/239 (21%)
Query: 304 LGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQ--------TEVEMISMAVHRN 354
+G+GG+G+V+ + D G +VA+KR+K+ L F+ TE ++++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKK------SLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR------ 408
L++L L Y+ G + L ++ AR
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN------------NLGVLSEDHARFYMAEM 110
Query: 409 --GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--VRGT 464
+ LH+ IHRD+K N L+D + DFGL+K + VT A V G+
Sbjct: 111 FEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGI------VTYANSVVGS 161
Query: 465 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM--LLDWVKGL 521
++APE L D + G ML E + G F + ++ L W + L
Sbjct: 162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS---GSTPNETWENLKYWKETL 217
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 59/247 (23%), Positives = 92/247 (37%), Gaps = 58/247 (23%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVH 352
D F ++GRG FG+V+ R G + A+K L++ + E ++++ A
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 353 RNLLRLRGFC-MTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRI-----ALG 405
+++L + E L LV YM G + + L + P + R I AL
Sbjct: 61 PWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEET-ARFYIAELVLALD 115
Query: 406 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR--- 462
S L + IHRD+K NIL+D + + DFGL K
Sbjct: 116 SVHKLGF---------IHRDIKPDNILIDADGHIKLADFGLCK--KMNKAKDREYYLNDS 164
Query: 463 ---------------------------GTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLEL 494
GT +IAPE L G + D + G++L E+
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL-RGTPYGLECDWWSLGVILYEM 223
Query: 495 ITGQRAF 501
+ G F
Sbjct: 224 LYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 3e-04
Identities = 15/42 (35%), Positives = 25/42 (59%)
Query: 138 KLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179
L+ L L+NN L+ + + +L+VLDLS N L+ + P+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPE 42
|
Length = 60 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD----YKDTHVTTAVRG 463
GL Y+H ++HRD+K N+L++ + E + DFGLA+ +T V
Sbjct: 116 CGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-A 171
Query: 464 TIGHIAPE-YLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
T + APE LS ++ DV+ G +L EL+ + F
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 39/98 (39%), Positives = 53/98 (54%), Gaps = 4/98 (4%)
Query: 78 SGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKL- 136
S L L L L+L N + I S+L LT+L SLDL N+ T IP +G L
Sbjct: 82 SLDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLK 139
Query: 137 SKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
S L+ L L++N + +P L N+ +L+ LDLS N LS
Sbjct: 140 SNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS 176
|
Length = 394 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 10/94 (10%)
Query: 407 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT-- 464
ARG+ +L +HRD+ A N+LL + + DFGLA+ + + +V+ +G+
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS---KGSTF 300
Query: 465 --IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
+ +APE + + +DV+ YGI+L E+ +
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 304 LGRGGFGKVYK------GRLADGSLVAVKRLKEERTPGGELQFQTEVE-MISMAVHRNLL 356
LGRG FGKV + + A VAVK LKE T TE++ +I + H N++
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 357 RLRGFCMTPTERLLV-YPYMANGSVASCLR 385
L G C P L+V Y G++++ LR
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLR 104
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 9e-04
Identities = 28/102 (27%), Positives = 46/102 (45%), Gaps = 4/102 (3%)
Query: 393 PLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD- 451
PL +A + Y+H IIHRD+K N+L++ + +GDFG A
Sbjct: 256 PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312
Query: 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLE 493
T + GT+ APE L+ + D++ G+++ E
Sbjct: 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 5/93 (5%)
Query: 409 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 468
G+ +LH IIHRD+K +NI++ + + DFGLA+ + T T +
Sbjct: 135 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--CTNFMMTPYVVTRYYR 189
Query: 469 APEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
APE + E D++ G ++ EL+ G F
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGSVIF 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 36.7 bits (86), Expect = 0.001
Identities = 14/37 (37%), Positives = 25/37 (67%), Gaps = 2/37 (5%)
Query: 138 KLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
L L L+NN ++ +P L+N+ +L+ LDLS N+++
Sbjct: 2 NLETLDLSNNQITD-LP-PLSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 32/93 (34%), Positives = 54/93 (58%), Gaps = 10/93 (10%)
Query: 87 LLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L + L+YL +Y N+I +P+ L + + L++ NS T +P+TL L+ L
Sbjct: 281 LPEELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGE 334
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179
N+L+ +P SL LQVLD+S N+++ V+P+
Sbjct: 335 NALTS-LPASLP--PELQVLDVSKNQIT-VLPE 363
|
Length = 754 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 27/209 (12%)
Query: 304 LGRGGFGKVYKGRLAD---------GSLVAVKRLKEERTPGGE---LQFQTEVEMISMAV 351
LGRG ++Y G L +K + + P L F M+
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 352 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 411
H++++ L G C+ E ++V ++ G + + + L P + ++A A LS
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD---VLTTPWKFKVAKQLASALS 119
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG-LAKLMDYKDTHVTTAVRGT----IG 466
YL D ++H +V NILL E + G+ G KL D +T R I
Sbjct: 120 YLEDK---DLVHGNVCTKNILLAR--EGIDGECGPFIKLSD-PGIPITVLSRQECVERIP 173
Query: 467 HIAPEYLSTGKS-SEKTDVFGYGIMLLEL 494
IAPE + K+ S D + +G L E+
Sbjct: 174 WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|234398 TIGR03921, T7SS_mycosin, type VII secretion-associated serine protease mycosin | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 23/66 (34%), Positives = 30/66 (45%), Gaps = 4/66 (6%)
Query: 199 GPVTGRPCPGSPPFSPP--PPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFA 256
P GRP +P + P P PPPP +P G A G+AA A ++ A A
Sbjct: 287 PPEDGRPLRPAPAPARPVAAPAPPPPPDDTPRGRVA--LWGAGLAALAVVVGLAAAAVRR 344
Query: 257 WWRRRK 262
RRR+
Sbjct: 345 RGRRRR 350
|
Members of this family are subtilisin-related serine proteases, found strictly in the Actinobacteria and associated with type VII secretion operons. The designation mycosin is used for members from Mycobacterium [Protein fate, Protein and peptide secretion and trafficking, Protein fate, Protein modification and repair]. Length = 350 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 31/100 (31%), Positives = 47/100 (47%), Gaps = 19/100 (19%)
Query: 409 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK------LM-DYKDTHVTTAV 461
G+ +LH IIHRD+K +NI++ + + DFGLA+ +M Y VT
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYY 183
Query: 462 RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
R APE + E D++ G ++ E+I G F
Sbjct: 184 R------APEVILGMGYKENVDIWSVGCIMGEMIRGTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 621 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.51 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.41 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.39 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.37 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.34 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.31 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.31 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.29 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.26 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.25 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.24 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.24 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.2 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.2 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.18 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.14 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.13 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.08 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.02 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.02 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.99 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.97 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.96 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.95 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.94 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.93 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.92 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.92 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.85 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.8 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.79 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.79 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.78 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.77 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.76 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.76 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.74 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.72 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.7 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.69 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.69 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.63 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.62 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.6 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.54 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.48 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.47 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.45 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.44 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.43 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.41 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 98.39 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.36 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.36 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.31 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-60 Score=556.85 Aligned_cols=468 Identities=29% Similarity=0.518 Sum_probs=309.4
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 145 (621)
+|+.|+|++|++++.+|..|..+++|++|+|++|++++.+|..|.++++|++|+|++|.+++.+|..|..+++|+.|+|+
T Consensus 476 ~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 555 (968)
T PLN00113 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLS 555 (968)
T ss_pred cceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECC
Confidence 45556666666655555555566666666666666665566566666666666666666665566666666666666666
Q ss_pred ccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcccCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 007020 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPIS 225 (621)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~~~~~~c~~~~~~~p~~~~~~~pp~s 225 (621)
+|++++.+|..+.++++|+.|++++|++.+..|..+.+..+....+.+|+.+||..... . .++..
T Consensus 556 ~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~------------~---~~~c~ 620 (968)
T PLN00113 556 QNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTS------------G---LPPCK 620 (968)
T ss_pred CCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCcccc------------C---CCCCc
Confidence 66666556666666666666666666666555555445555555555666555432100 0 00000
Q ss_pred CCCCCCCcceeeeeehhhhHHHhhhhHHHHHhhhcCCCCcccccCCCCCCccccc-----CcccccCHHHHHHHhcCCCc
Q 007020 226 SPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHL-----GQLKRFSLRELQVATDSFSN 300 (621)
Q Consensus 226 ~~~~~~~~~~i~~~v~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 300 (621)
.. .......+++++++++++++++++++++++|+++..+.. .... ++..... .....+.. ......|..
T Consensus 621 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 694 (968)
T PLN00113 621 RV-RKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELK-RVEN-EDGTWELQFFDSKVSKSITI---NDILSSLKE 694 (968)
T ss_pred cc-cccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhccccc-cccc-ccccccccccccccchhhhH---HHHHhhCCc
Confidence 00 011112222223333333333333334444443322110 0100 0000000 00111222 223356778
Q ss_pred CceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCc
Q 007020 301 KNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 379 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 379 (621)
.+.||+|+||.||+|+. .++..||||.++..... ...|++.+++++|||||+++|++.+++..++||||+++|+
T Consensus 695 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~ 769 (968)
T PLN00113 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN 769 (968)
T ss_pred ccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCc
Confidence 88999999999999986 47899999998643321 2356888999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeeee
Q 007020 380 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 459 (621)
Q Consensus 380 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 459 (621)
|.++++. ++|..+..|+.|+++||+|||+.+.++|+||||||+||+++.++..++. ||.+...... .
T Consensus 770 L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~ 836 (968)
T PLN00113 770 LSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----T 836 (968)
T ss_pred HHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----C
Confidence 9999963 7899999999999999999997666699999999999999999888775 6655432211 1
Q ss_pred cccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccC--
Q 007020 460 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN-- 537 (621)
Q Consensus 460 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-- 537 (621)
...++..|+|||++.+..++.++|||||||++|||+||+.||+... .......+|++............|+.+..
T Consensus 837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF---GVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc---CCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 2357899999999999999999999999999999999999996332 23345667777655555555566665533
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 538 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 538 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
....++..++.+++.+||+.+|++||+|+||+++|+..
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 23445667889999999999999999999999999874
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-54 Score=442.47 Aligned_cols=289 Identities=53% Similarity=0.898 Sum_probs=254.1
Q ss_pred cccccCHHHHHHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeee
Q 007020 282 QLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 361 (621)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 361 (621)
..+.|++.++..++++|...+.||+|+||.||+|...+|..||||++....... ..+|..|++++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 567899999999999999999999999999999999988999999887655433 5569999999999999999999999
Q ss_pred eecCC-ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEE
Q 007020 362 CMTPT-ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV 440 (621)
Q Consensus 362 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 440 (621)
|.+.+ +.+||||||++|+|.++++..... +++|..+.+||.++|+||+|||+.+.|.||||||||+|||+|+++++|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99998 599999999999999999986543 689999999999999999999999988999999999999999999999
Q ss_pred EcccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH
Q 007020 441 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 520 (621)
Q Consensus 441 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 520 (621)
|+|||+|+..............||.+|+|||++..+..+.|+|||||||+|.|++||+.+.+.... .....+.+|+..
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~--~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP--RGELSLVEWAKP 295 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC--cccccHHHHHHH
Confidence 999999976543112111111799999999999999999999999999999999999998875441 223348899999
Q ss_pred HhhhcccccccCcccc-CcccH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 521 LLKEKKLEMLVDPDLQ-NNYVE-AEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 521 ~~~~~~~~~~~d~~~~-~~~~~-~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
.+....+.+++|+.+. ..+.. ++..++..++..|++.+|.+||+|.||+++|+..
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 9999899999999987 55554 6888999999999999999999999999999553
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-49 Score=379.77 Aligned_cols=251 Identities=26% Similarity=0.436 Sum_probs=212.0
Q ss_pred CcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCC-ceEEEEeccC
Q 007020 299 SNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLLVYPYMA 376 (621)
Q Consensus 299 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~ 376 (621)
+..+.||+|..|+||++.++ +++.+|+|.+.....+....++.+|+++++..+||+||++||.|..+. ...++||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 33578999999999999986 789999999977777777889999999999999999999999999998 5999999999
Q ss_pred CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCC
Q 007020 377 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455 (621)
Q Consensus 377 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 455 (621)
+|||.+++...+. +++...-+|+.+|++||.|||+ . +||||||||+|||++..|+|||+|||.+..+...
T Consensus 162 gGSLd~~~k~~g~----i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 162 GGSLDDILKRVGR----IPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred CCCHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 9999999986532 8899999999999999999996 5 9999999999999999999999999999876543
Q ss_pred eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccc
Q 007020 456 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 535 (621)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 535 (621)
.....+||..|||||.+.+..|+.++||||||+.++|+.+|+.||.... .......+.+..+..+. -|.+
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~---~~~~~~~~Ll~~Iv~~p------pP~l 302 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN---PPYLDIFELLCAIVDEP------PPRL 302 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC---CCCCCHHHHHHHHhcCC------CCCC
Confidence 5566789999999999999999999999999999999999999997541 11222333333332211 1222
Q ss_pred cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 536 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 536 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
... .++.++..++..|+++||.+||++.|++++
T Consensus 303 P~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 303 PEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred Ccc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 221 356789999999999999999999999763
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=395.92 Aligned_cols=256 Identities=32% Similarity=0.510 Sum_probs=208.5
Q ss_pred CCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCC-ceEEEEec
Q 007020 297 SFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLLVYPY 374 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 374 (621)
.+...+.||+|+||+||+|.+.....||||++..... ......|.+|+.++.+++|||||+++|+|.++. ..++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 3334456999999999999997444499999976542 223568999999999999999999999999887 79999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEecCCCCCCeeeCCCC-cEEEcccccceeccc
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK-IIHRDVKAANILLDEEF-EAVVGDFGLAKLMDY 452 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlk~~Nill~~~~-~~kl~DfGla~~~~~ 452 (621)
+++|+|.++++.. ....+++..+..++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++....
T Consensus 122 ~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred CCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 9999999999874 233499999999999999999999999 7 99999999999999997 999999999987654
Q ss_pred CCCeeeecccccccccchhhhc--cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLS--TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
.. ...+...||+.|||||++. ...++.|+||||||+++|||+||+.||..... .+.+......
T Consensus 197 ~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------~~~~~~v~~~------ 261 (362)
T KOG0192|consen 197 SK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------VQVASAVVVG------ 261 (362)
T ss_pred cc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhc------
Confidence 32 2333467999999999999 56899999999999999999999999962221 1222222111
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
......+..+...+..++..||+.||+.||++.+++..|+..
T Consensus 262 ---~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 262 ---GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred ---CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 111112223557899999999999999999999999999864
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=391.36 Aligned_cols=261 Identities=30% Similarity=0.472 Sum_probs=218.7
Q ss_pred HHHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 291 LQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 291 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
+++..+.+...+.||+|.||.||.|.+.....||+|.++.... ...+|.+|+++|++++|+|||+++|+|..++..+|
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m--~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM--SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc--ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 3444445555678999999999999998777999999986532 34578899999999999999999999999889999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
|||||+.|+|.++|+... +..+...+.+.++.|||+||+||+++ ++|||||.++|||++++..+||+|||+|+..
T Consensus 279 VtE~m~~GsLl~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EEEecccCcHHHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccccc
Confidence 999999999999999733 23478889999999999999999999 9999999999999999999999999999965
Q ss_pred ccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
............-...|.|||.+..+.++.|||||||||+||||+| |+.||. .+...+.++.+.++..+..
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~--------~msn~ev~~~le~GyRlp~ 425 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP--------GMSNEEVLELLERGYRLPR 425 (468)
T ss_pred CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC--------CCCHHHHHHHHhccCcCCC
Confidence 5444444444556779999999999999999999999999999999 888874 2334455555444443332
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 576 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 576 (621)
+..++..++++|..||+.+|++|||++.+...|++..
T Consensus 426 ----------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 426 ----------PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred ----------CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 4456789999999999999999999999999988753
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=385.79 Aligned_cols=248 Identities=28% Similarity=0.470 Sum_probs=210.6
Q ss_pred cCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
..|...+.||+|||+.||+++. .+|+.||+|++.+.. .+.....+.+|+++.+.++|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5788999999999999999997 789999999997643 3455667999999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
|+|++|+|..+++.+. ++++.+++.++.||+.||.|||++ +|+|||||..|++++++.+|||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Krrk----~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK----PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999998543 499999999999999999999999 999999999999999999999999999998764
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
. .......+||+.|+|||++....++..+||||+|||+|-|+.|++||+... ++...+.-+..+..-
T Consensus 171 ~-~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------------vkety~~Ik~~~Y~~ 237 (592)
T KOG0575|consen 171 D-GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------------VKETYNKIKLNEYSM 237 (592)
T ss_pred c-ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------------HHHHHHHHHhcCccc
Confidence 3 334556789999999999999999999999999999999999999997322 111111111111111
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
+........++|..+++.+|.+|||+++|+.
T Consensus 238 -------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 238 -------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -------ccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1223356778899999999999999999975
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=371.92 Aligned_cols=254 Identities=25% Similarity=0.382 Sum_probs=207.9
Q ss_pred HhcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCch------hHHHHHHHHHHHHhccCCceeeeeeeeecCC
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPG------GELQFQTEVEMISMAVHRNLLRLRGFCMTPT 366 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 366 (621)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||++++..... ....+++|+++|++++|||||+++++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 356778889999999999999985 479999999997654322 2234679999999999999999999999999
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC---CcEEEcc
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGD 443 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~D 443 (621)
..|+||||++||+|.+.+-.+.. +.+...+.+++|++.|+.|||++ ||+||||||+|||++.+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999987654 67778899999999999999999 99999999999999866 7899999
Q ss_pred cccceecccCCCeeeecccccccccchhhhccCCC---CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH
Q 007020 444 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS---SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 520 (621)
Q Consensus 444 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 520 (621)
||+|+..+ ........+||+.|.|||++.+..+ ..++|+||+||+||-+++|.+||.... .++.+.+.+.
T Consensus 323 FGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~----~~~sl~eQI~- 395 (475)
T KOG0615|consen 323 FGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY----TDPSLKEQIL- 395 (475)
T ss_pred cchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc----CCccHHHHHh-
Confidence 99999865 4556777899999999999977653 348899999999999999999996322 2221222111
Q ss_pred HhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 521 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 521 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
++. ..+ ....+.+...+..+++.+|+..||++|||+.|+++
T Consensus 396 --~G~---y~f----~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 --KGR---YAF----GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred --cCc---ccc----cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 110 001 12234566788999999999999999999999976
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=364.36 Aligned_cols=199 Identities=28% Similarity=0.456 Sum_probs=180.5
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.+|...+.||+|+||+||+|+++ ++..||||.+.... .....+.+..|+++|+.++|||||++++++..++..|+|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 56778888999999999999976 68999999997665 44455668899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC------CcEEEcccccc
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE------FEAVVGDFGLA 447 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~------~~~kl~DfGla 447 (621)
||.||+|.+||+.++. +++.+++.++.|+|.||++||++ +||||||||+|||++.. -.+||+|||+|
T Consensus 90 yC~gGDLs~yi~~~~~----l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGR----LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999998753 89999999999999999999999 99999999999999865 46899999999
Q ss_pred eecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCccc
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 503 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~ 503 (621)
+.+.. .......+|++-|||||++..++|+.|+|+||+|+|+|++++|+.||+.
T Consensus 163 R~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 163 RFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 98763 3445667899999999999999999999999999999999999999973
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=356.17 Aligned_cols=244 Identities=28% Similarity=0.356 Sum_probs=205.8
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCch--hHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
.++|+..++||+|+||+||.++.+ +++.||+|++++..... .......|..++..++||+||+++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467889999999999999999854 68999999998765333 356789999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
+||+.||.|...|++... +++..++-++..|+.||.|||++ +||||||||+|||+|.+|+++|+|||+++..-
T Consensus 104 ld~~~GGeLf~hL~~eg~----F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR----FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHhcCC----cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999986543 99999999999999999999999 99999999999999999999999999998532
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
.....+...+||+.|||||++.+..++..+|.||+|+++|||++|.+||... ...++++.+.+.... .
T Consensus 177 -~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~--------~~~~~~~~I~~~k~~---~ 244 (357)
T KOG0598|consen 177 -KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE--------DVKKMYDKILKGKLP---L 244 (357)
T ss_pred -cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc--------cHHHHHHHHhcCcCC---C
Confidence 2334456689999999999999999999999999999999999999999632 234555555544310 0
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCC
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK 564 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt 564 (621)
...+ ...+..+++...+..||++|-.
T Consensus 245 ----~p~~---ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 245 ----PPGY---LSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred ----CCcc---CCHHHHHHHHHHhccCHHHhcC
Confidence 1111 1256677788888999999963
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=351.12 Aligned_cols=260 Identities=23% Similarity=0.347 Sum_probs=208.6
Q ss_pred CCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeee-eeecCCc-eEEEE
Q 007020 297 SFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRG-FCMTPTE-RLLVY 372 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv~ 372 (621)
+|.+.++||+|+||+||++.. .+|..||.|.++-... .....+...|+.+|+.++|||||++++ .+.++.+ +++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 455568899999999999984 5899999999974443 334557899999999999999999998 4555555 79999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP-KIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||..|+|...++.......-+++.++++++.|++.||.++|++... -|+||||||.||+++.+|.|||+|||+++++.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999999987665666699999999999999999999994221 38899999999999999999999999999887
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
... ....+.+||+.||+||.+...+|+.||||||+||++|||+.-.+||... .+.+.-+.+-+ ..
T Consensus 180 s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--------n~~~L~~KI~q-gd----- 244 (375)
T KOG0591|consen 180 SKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--------NLLSLCKKIEQ-GD----- 244 (375)
T ss_pred chh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--------cHHHHHHHHHc-CC-----
Confidence 543 3455678999999999999999999999999999999999999999632 12222222111 11
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
-+.+. ....+.++..++..|+..||+.||+.-.+++.+..
T Consensus 245 ~~~~p---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 245 YPPLP---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCCCc---HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11111 24456889999999999999999986555554444
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=391.77 Aligned_cols=262 Identities=28% Similarity=0.473 Sum_probs=217.9
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecC
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 365 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 365 (621)
++...+....+.||+|.||+||+|+.. +...||||.+++........+|++|+++++.++|||||+|+|+|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 344455566788999999999999843 35689999999888777888999999999999999999999999999
Q ss_pred CceEEEEeccCCCchhhhhccCCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC
Q 007020 366 TERLLVYPYMANGSVASCLRERPPS----------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE 435 (621)
Q Consensus 366 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 435 (621)
+..++|+|||..|+|.++|..+... ..+++..+.+.||.|||.||+||-++ .+|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 9999999999999999999764321 23488899999999999999999999 9999999999999999
Q ss_pred CCcEEEcccccceecccCCCeeee-cccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcch
Q 007020 436 EFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVM 513 (621)
Q Consensus 436 ~~~~kl~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~ 513 (621)
+..|||+|||+++.....+.+... ...-.++|||||.+..+++|.+||||||||+|||+++ |+.||....
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS-------- 710 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS-------- 710 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc--------
Confidence 999999999999876554443332 2334679999999999999999999999999999999 999985211
Q ss_pred HHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 514 LLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
..+.+. .++.+ ++ -.-+++++.++++||..||+..|.+||+++||-..|+.
T Consensus 711 n~EVIe-~i~~g--------~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 711 NQEVIE-CIRAG--------QL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred hHHHHH-HHHcC--------Cc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 112222 22222 22 12355678999999999999999999999999999976
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=336.73 Aligned_cols=262 Identities=23% Similarity=0.316 Sum_probs=204.7
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
+.|+...++|+|+||+||+++++ +|+.||||++.+... +...+-.++|+++++.++|+|+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45777788999999999999976 699999999976654 3334457899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
||+. ++.+-+..... .++...+++++.|+++|+.|+|++ ++|||||||+|||++.+|.+||||||+|+.+..
T Consensus 82 ~~dh-TvL~eLe~~p~---G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPN---GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecch-HHHHHHHhccC---CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 9998 55555555432 278889999999999999999999 999999999999999999999999999998874
Q ss_pred CCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhh--------
Q 007020 454 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE-------- 524 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-------- 524 (621)
.....+..+.|..|+|||.+.+ .+|...+||||.||++.||++|.+.|... .+.+..-.++..+..
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~-----SDiDQLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR-----SDIDQLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc-----chHHHHHHHHHHHcccCHHHHHH
Confidence 3445566778999999999988 67999999999999999999999988522 222222222211110
Q ss_pred ----cccccccCccc-----cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 525 ----KKLEMLVDPDL-----QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 525 ----~~~~~~~d~~~-----~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.....+.-|.. ...-.+....-+++++..|++.||++|++-++++.
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 00111111111 11111223456889999999999999999999874
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=365.02 Aligned_cols=267 Identities=29% Similarity=0.465 Sum_probs=215.4
Q ss_pred CHHHHHHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecC
Q 007020 287 SLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 365 (621)
Q Consensus 287 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 365 (621)
+.++|++..+.+.+.+.||+|+||+||+|+|.. .||||+++... .+...+.|+.|+.++++-+|.||+-+.|||..+
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 457888888899999999999999999999852 49999998665 344556799999999999999999999999988
Q ss_pred CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccc
Q 007020 366 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 445 (621)
Q Consensus 366 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 445 (621)
.. .+|+.||+|-+|+.+++.... .|+..+.+.||.||++|+.|||.+ +|||||||..||++.++++|||+|||
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~et---kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQET---KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred ce-eeeehhccCchhhhhccchhh---hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccc
Confidence 77 999999999999999997653 389999999999999999999999 99999999999999999999999999
Q ss_pred cceeccc-CCCeeeecccccccccchhhhccC---CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHH
Q 007020 446 LAKLMDY-KDTHVTTAVRGTIGHIAPEYLSTG---KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGL 521 (621)
Q Consensus 446 la~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 521 (621)
++..... ..........|...|||||++..+ +|++.+||||||+++|||+||..||. . +..++.+...-++.
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i---~~~dqIifmVGrG~ 609 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-I---QNRDQIIFMVGRGY 609 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-C---CChhheEEEecccc
Confidence 9975432 112222334488899999999644 68999999999999999999999996 1 11121211111111
Q ss_pred hhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007020 522 LKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 576 (621)
Q Consensus 522 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 576 (621)
. ..|... ....+.+++.+|+..||..++++||.+.+|+..|++.-
T Consensus 610 l-------~pd~s~---~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 610 L-------MPDLSK---IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred c-------Cccchh---hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 0 011111 12345678999999999999999999999999888743
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=373.55 Aligned_cols=255 Identities=29% Similarity=0.463 Sum_probs=218.2
Q ss_pred CCCcCceeeeccCceEEEEEcC----CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
...+.++||.|.||.||+|+++ ....||||.++....+.++.+|+.|..+|.+++||||++|.|+.......++|.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 4456789999999999999875 245799999999988888999999999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
|||++|+|+.+|+.+... |.+.+...++.+||.||+||-+. ++|||||..+|||++.+..+|++|||+++.+.+
T Consensus 710 EyMENGsLDsFLR~~DGq---ftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQ---FTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhCCcHHHHHhhcCCc---eEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 999999999999987643 88889999999999999999999 999999999999999999999999999998865
Q ss_pred CCCeeeecccc--cccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 453 KDTHVTTAVRG--TIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 453 ~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
......+...| ..+|.|||.+..++++.+|||||||++|||.++ |.+||- ++.-.+.++.+.++..
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW--------dmSNQdVIkaIe~gyR--- 852 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW--------DMSNQDVIKAIEQGYR--- 852 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc--------ccchHHHHHHHHhccC---
Confidence 44333333333 468999999999999999999999999999888 999973 1222344444333222
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
-..+.+++..|++||+.||++|-.+||++.+|+..|...
T Consensus 853 -------LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 853 -------LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred -------CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 223567889999999999999999999999999999774
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=340.14 Aligned_cols=263 Identities=25% Similarity=0.374 Sum_probs=211.6
Q ss_pred HhcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
..+.|++.+.||.|..++||+|+. +.+..||||++.-++.......+++|+..++.++||||++.+..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 356788999999999999999985 4689999999987776666788999999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
.||.+||+.+.+......+ +++..+..|..++++||.|||++ |.||||||+.||||+.+|.|||+|||....+..
T Consensus 104 pfMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999998865544 89999999999999999999999 999999999999999999999999998765543
Q ss_pred CCCee---eecccccccccchhhhcc--CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 453 KDTHV---TTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 453 ~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
..... ....+||+.|||||++.. ..|+.|+||||||++..||.+|..||..-. .+ +..-..+++...
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p-------Pm-kvLl~tLqn~pp 250 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP-------PM-KVLLLTLQNDPP 250 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC-------hH-HHHHHHhcCCCC
Confidence 33221 145679999999999643 468999999999999999999999996211 01 111111221111
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
... -..+..+........+.+++..|+++||++|||++++++
T Consensus 251 ~~~-t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 251 TLL-TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred Ccc-cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000 111111222334468999999999999999999999984
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=354.07 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=206.5
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCch--hHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG--GELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 369 (621)
...+|..++.||+|+|++|++|+.. +++.||||++.+..... ....+..|-++|.++ .||.|++|+.-|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3467888999999999999999854 78999999986543222 223477888899988 7999999999999999999
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+|+||+++|+|.++|++.+. |++..++.++.+|+.||+|||++ |||||||||+|||+|++|++||+|||.|+.
T Consensus 151 FvLe~A~nGdll~~i~K~Gs----fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGS----FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEecCCCcHHHHHHHhCc----chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence 99999999999999998754 99999999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCe----------e--eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHH
Q 007020 450 MDYKDTH----------V--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDW 517 (621)
Q Consensus 450 ~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~ 517 (621)
+...... . ...++||..|.+||++..+..++.+|+|+||||+|+|+.|++||.... .....+
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N-----eyliFq- 297 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN-----EYLIFQ- 297 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc-----HHHHHH-
Confidence 7643221 1 145789999999999999999999999999999999999999996322 111111
Q ss_pred HHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 518 VKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 518 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
++++- .-.+++..+..+.+|+...+..||.+|+|..+|-++
T Consensus 298 -----------kI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 298 -----------KIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -----------HHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11111 111222333677888889999999999999777653
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=352.75 Aligned_cols=264 Identities=23% Similarity=0.306 Sum_probs=209.0
Q ss_pred HhcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-CCceeeeeeeeecCC-ceEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPT-ERLL 370 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l 370 (621)
..++|...+.||.|.||.||+|+. .+|..||||+++.....-++..-.+|++.|++++ ||||+++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 456888899999999999999985 4789999999987654444445679999999999 999999999999888 9999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
|||||+. +|+++++.+ ...|++..++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+..
T Consensus 88 VfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 9999987 999999987 34599999999999999999999999 9999999999999998889999999999976
Q ss_pred ccCCCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcc---
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK--- 526 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 526 (621)
.... ..+..+.|..|+|||++.. +.|+.+.||||+|||++|+.+-++.|..... .+-.--+..++....
T Consensus 161 ~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE-----~Dqi~KIc~VLGtP~~~~ 233 (538)
T KOG0661|consen 161 RSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE-----IDQIYKICEVLGTPDKDS 233 (538)
T ss_pred ccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH-----HHHHHHHHHHhCCCcccc
Confidence 5433 4566779999999999854 5689999999999999999999988853221 111111111111100
Q ss_pred ------ccccc---Cccc----cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 527 ------LEMLV---DPDL----QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 527 ------~~~~~---d~~~----~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
+...+ -|.. ..........+..+++..|+++||.+|||+.|.+++
T Consensus 234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 234 WPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred chhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00001 1111 111223356789999999999999999999999764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=346.45 Aligned_cols=255 Identities=27% Similarity=0.441 Sum_probs=203.8
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCC--ceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 372 (621)
.++...+.||+|+||+||++... +|...|||.+....... ...+.+|+.++++++|||||+.+|...... ..++.|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 45667789999999999999975 48999999987653332 556899999999999999999999855554 589999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-CCcEEEcccccceecc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMD 451 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfGla~~~~ 451 (621)
||+++|+|.+++...+. .+++..+..++.||++||+|||++ |||||||||+|||++. ++.+||+|||++....
T Consensus 96 Ey~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999999999997653 389999999999999999999999 9999999999999999 7999999999998765
Q ss_pred c--CCCeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 452 Y--KDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 452 ~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
. ..........||+.|||||++..+ ....++||||+||++.||+||+.||... .....++-.......
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~~~-- 240 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGREDS-- 240 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhccCC--
Confidence 3 222234457799999999999854 3346999999999999999999999631 111122222221111
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 573 (621)
-| ..+...+.+..+++..|+..+|++||||++++...-
T Consensus 241 ---~P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 241 ---LP----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ---CC----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 11 223334567889999999999999999999987653
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=361.35 Aligned_cols=263 Identities=27% Similarity=0.459 Sum_probs=206.2
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEc------CCCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeeec
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 364 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 364 (621)
++..++|.+.+.||+|+||.||+|.+ .+++.||||+++..........+.+|+.++..+ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 45667899999999999999999963 235689999997655444556789999999999 89999999998876
Q ss_pred CC-ceEEEEeccCCCchhhhhccCCCC-----------------------------------------------------
Q 007020 365 PT-ERLLVYPYMANGSVASCLRERPPS----------------------------------------------------- 390 (621)
Q Consensus 365 ~~-~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------- 390 (621)
.+ ..+++|||+++|+|.+++......
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 54 578999999999999998753210
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCe-eeeccccc
Q 007020 391 -----QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 464 (621)
Q Consensus 391 -----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt 464 (621)
..++++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++........ ......++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 12478889999999999999999999 9999999999999999999999999999865332221 12233466
Q ss_pred ccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHH
Q 007020 465 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAE 543 (621)
Q Consensus 465 ~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 543 (621)
..|+|||++.+..++.++|||||||++|||++ |..||..... .. .+......... ... ....
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~----~~---~~~~~~~~~~~------~~~----~~~~ 302 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI----NE---EFCQRLKDGTR------MRA----PENA 302 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc----cH---HHHHHHhcCCC------CCC----CCCC
Confidence 78999999999899999999999999999997 9999963221 11 11111111110 000 1123
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 544 VEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 544 ~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
...+.+++..||+.||++|||+.+|++.|++
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 3578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=354.58 Aligned_cols=249 Identities=27% Similarity=0.470 Sum_probs=207.2
Q ss_pred HHHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 291 LQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 291 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
|++..+.....+-||+|+.|.||+|++. ++.||||+++..+ ..+|+-|++++|+||+.|.|+|.....+++
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCI 189 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCI 189 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEE
Confidence 4444455555678999999999999995 7889999886433 367888999999999999999999999999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
|||||..|-|...|+.... +.......+..+||.||.|||.+ .|||||||+-||||+.+..|||+|||-++.+
T Consensus 190 iMEfCa~GqL~~VLka~~~----itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKAGRP----ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred eeeccccccHHHHHhccCc----cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhh
Confidence 9999999999999987543 67778889999999999999999 9999999999999999999999999999876
Q ss_pred ccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
... .....++||+.|||||++.+.+.++|+||||||||||||+||..||..-+ . ...+.+ +
T Consensus 263 ~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd----s----sAIIwG---------V 323 (904)
T KOG4721|consen 263 SDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD----S----SAIIWG---------V 323 (904)
T ss_pred hhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc----h----heeEEe---------c
Confidence 544 34456789999999999999999999999999999999999999995211 0 011111 1
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
=...+.-..+..++..+.-+++.||+..|..||++++++..|+-
T Consensus 324 GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 324 GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 11122223355677889999999999999999999999999865
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=343.73 Aligned_cols=264 Identities=23% Similarity=0.350 Sum_probs=205.7
Q ss_pred hcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecC--CceEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLL 370 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 370 (621)
.+.|+..++||+|.||.||+|+. .+|+.||+|+++.+.. +....-..+||.+|++++||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35677778899999999999985 4799999999986653 33344578999999999999999999998876 68999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
|+|||+. +|.-++... ...|++.+++.++.|++.||+|+|++ +|+|||||.+|||||.+|.+||+|||+|+++
T Consensus 196 VFeYMdh-DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 9999998 888888753 34599999999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCc--------chHHHHHHHH
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDD--------VMLLDWVKGL 521 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~--------~~~~~~~~~~ 521 (621)
........+..+-|..|.|||.+.|. .|+.++|+||.||||.||++|++.|.......+.. ..-..|-...
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 87776667777789999999999876 58999999999999999999999986322110000 0000111000
Q ss_pred hhhcccccccCccccCccc-------HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 522 LKEKKLEMLVDPDLQNNYV-------EAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 522 ~~~~~~~~~~d~~~~~~~~-------~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
+.. ...+.+ ...+. .......++++..++..||.+|.|+.++++
T Consensus 349 LP~---~~~~kp--~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPH---ATIFKP--QQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCc---ccccCC--CCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 000 000111 11111 112345678888999999999999998864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=339.64 Aligned_cols=266 Identities=29% Similarity=0.408 Sum_probs=200.5
Q ss_pred CCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHh--ccCCceeeeeeeeecCC----ceEE
Q 007020 297 SFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISM--AVHRNLLRLRGFCMTPT----ERLL 370 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~l 370 (621)
...+.++||+|+||.||+|.+. ++.||||++.. ...+.|+.|-++++. +.|+||++++++-.... +.+|
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3344578999999999999985 69999999963 446678888888774 57999999999866554 8899
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEecCCCCCCeeeCCCCcEEEccc
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH------CDPKIIHRDVKAANILLDEEFEAVVGDF 444 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~------~~~~ivH~Dlk~~Nill~~~~~~kl~Df 444 (621)
|+||.+.|+|.++|..+- ++|....+|+..+++||+|||+. ++|+|+|||||++|||+.+|++..|+||
T Consensus 286 Vt~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EeeeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 999999999999998754 89999999999999999999964 5889999999999999999999999999
Q ss_pred ccceecccCC-CeeeecccccccccchhhhccCCC------CCcccchhHHHHHHHHHhCCCCccc--------ccccCC
Q 007020 445 GLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKS------SEKTDVFGYGIMLLELITGQRAFDL--------ARLAND 509 (621)
Q Consensus 445 Gla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~------~~~~DvwSlGvil~elltg~~pf~~--------~~~~~~ 509 (621)
|+|..+.... .......+||.+|||||++.+... -.+.||||+|.|||||+++...++. +....-
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9999876432 223344679999999999977532 2468999999999999997755432 111111
Q ss_pred CcchHHHHHHHHhhhcccccccCccccCcccH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007020 510 DDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVE-AEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 576 (621)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~-~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 576 (621)
......+-++..+-.++ .+|.+...... ..+..+.+.+..||..||+.|.|+.=|-+++.+..
T Consensus 441 G~hPt~e~mq~~VV~kK----~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKK----QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred cCCCCHHHHHHHHHhhc----cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 11111122222221111 22222111100 23467888999999999999999998888876643
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=381.55 Aligned_cols=262 Identities=30% Similarity=0.482 Sum_probs=215.9
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC--CCc----EEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCc
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA--DGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 367 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 367 (621)
..+..+..+.||+|.||.||.|... .|. .||||.+++........+|.+|..+|+.++|||||+++|++.+...
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 3556667788999999999999864 233 4999999988888888899999999999999999999999999999
Q ss_pred eEEEEeccCCCchhhhhccCCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPS---QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 444 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 444 (621)
.++++|||++|+|..+|++.... ...+...+.+.++.|||+|+.||+++ ++|||||..+|+|++....|||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999985222 33488899999999999999999999 9999999999999999999999999
Q ss_pred ccceecccCCCeeeecc-cccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHh
Q 007020 445 GLAKLMDYKDTHVTTAV-RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 522 (621)
Q Consensus 445 Gla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 522 (621)
|+|+.....+.+..... .-..+|||||.+..+.++.|+|||||||++||++| |..||..-. . .+.+....
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~-----n---~~v~~~~~ 918 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS-----N---FEVLLDVL 918 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc-----h---HHHHHHHH
Confidence 99995544433333322 24579999999999999999999999999999999 889985211 1 12222222
Q ss_pred hhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007020 523 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 576 (621)
Q Consensus 523 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 576 (621)
+...+. .+..++..++++|..||+.+|++||++..|++.++.+.
T Consensus 919 ~ggRL~----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 919 EGGRLD----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred hCCccC----------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 222111 24556789999999999999999999999999877753
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=350.21 Aligned_cols=250 Identities=23% Similarity=0.355 Sum_probs=206.8
Q ss_pred hcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
...|...++||+|+.|.||.|.. .+++.||||++.....+ .++-+..|+.+|+..+|+|||++++.|...+++|+|||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 34677778999999999999974 47889999999765432 34457899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
||+||+|.+.+.... +++.++..|..++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+...
T Consensus 351 ym~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred ecCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 999999999987653 88999999999999999999999 9999999999999999999999999999877654
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 533 (621)
.. .....+||+.|||||++....|.+|+||||||++++||+.|.+||-... .+... .-+-... .|
T Consensus 423 ~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~-------PlrAl-yLIa~ng------~P 487 (550)
T KOG0578|consen 423 QS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN-------PLRAL-YLIATNG------TP 487 (550)
T ss_pred cC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC-------hHHHH-HHHhhcC------CC
Confidence 43 4455679999999999999999999999999999999999999994211 11110 1110111 11
Q ss_pred cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 534 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.+. .....+..+.+++.+|+..|+++||++.|+|+
T Consensus 488 ~lk--~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 488 KLK--NPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CcC--CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 111 13334578899999999999999999999975
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=314.42 Aligned_cols=263 Identities=24% Similarity=0.338 Sum_probs=206.8
Q ss_pred cCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCch-hHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 296 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
++|...++||+|.||.||+|++ .+|+.||||.++.....+ -.....+|++.++.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677788999999999999985 479999999998664333 23467899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
||+. +|...++.. ...++...++.++.++++|++|||++ .|+||||||.|+|++.+|.+||+|||+|+.+...
T Consensus 82 fm~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9987 999999874 34588899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc--
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML-- 530 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 530 (621)
....... +-|..|+|||.+.|. .|+..+||||.|||+.||+-|.+-|.. +.+.+....+-+.+.....+..
T Consensus 155 ~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG-----~sDidQL~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 155 NRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG-----DSDIDQLSKIFRALGTPTPDQWPE 228 (318)
T ss_pred Ccccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC-----CchHHHHHHHHHHcCCCCcccCcc
Confidence 5444333 578999999999876 489999999999999999999876642 1221111222221111111111
Q ss_pred ----cC-------c-cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 531 ----VD-------P-DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 531 ----~d-------~-~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.| | ...............+++..++..||.+|.++.|.+++
T Consensus 229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 10 0 00111223445677999999999999999999999763
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=346.63 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=212.1
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+... +.+...+.+|+++++.++|||||.++++|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 56788889999999999999865 688999999866543 3455679999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+.| +|..++..... +++..+..|+.++..||.|||++ +|+|||+||.|||++.++++|++|||+|+.+..
T Consensus 82 ~a~g-~L~~il~~d~~----lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK----LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9988 99999987554 89999999999999999999999 999999999999999999999999999998764
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 533 (621)
.....+...||+-|||||...++.|+..+|+||+|||+||+++|++||... .+.+.++.+.... .
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--------si~~Lv~~I~~d~-------v 217 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--------SITQLVKSILKDP-------V 217 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH--------HHHHHHHHHhcCC-------C
Confidence 455667788999999999999999999999999999999999999999522 2334444433221 1
Q ss_pred cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 534 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. .+......+.+++...+.+||..|.+-.+++.
T Consensus 218 ~----~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 K----PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred C----CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1 12355578899999999999999999988864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=319.37 Aligned_cols=237 Identities=24% Similarity=0.341 Sum_probs=197.9
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc--hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|+..+.||.|+||+|.+++.+ +|..||+|++.+...- .+.+....|..+|+.+.||+++++.+.+.+....++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 45677789999999999999865 6899999999765432 23446788999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||++||.|.+++++.+. ++++.++-+|.+|+.||+|||++ +|++|||||+|||+|.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999998654 99999999999999999999999 999999999999999999999999999997653
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
. +...+||+.|+|||+++...+..++|.|||||++|||+.|.+||..... .+....+..
T Consensus 197 r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY~KI~~--------- 255 (355)
T KOG0616|consen 197 R----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIYEKILE--------- 255 (355)
T ss_pred c----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHHHHHHh---------
Confidence 2 5667899999999999999999999999999999999999999963221 111122211
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCC
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDR 562 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~R 562 (621)
.++ .++......+.+++...++.|-.+|
T Consensus 256 ~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 256 GKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred Ccc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 111 1122233567777888888888888
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=346.92 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=205.3
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc----hhHHHHHHHHHHHHhcc-CCceeeeeeeeecCC
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP----GGELQFQTEVEMISMAV-HRNLLRLRGFCMTPT 366 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 366 (621)
.....|...+.||+|+||+|+.|.+. ++..||+|++...... .....+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34568889999999999999999754 6899999977654211 23446778999999999 999999999999999
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC-CcEEEcccc
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFG 445 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfG 445 (621)
..++||||+.||+|.+++.+.+. +.+..+..++.|++.|++|||++ ||+||||||+|||++.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~----l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGR----LKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCC----CChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999999998433 78899999999999999999999 99999999999999999 999999999
Q ss_pred cceecccCCCeeeecccccccccchhhhccCC-CC-CcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh
Q 007020 446 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SS-EKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 523 (621)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 523 (621)
++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... .. ...+.+.+
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-----~~---~l~~ki~~ 237 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-----VP---NLYRKIRK 237 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-----HH---HHHHHHhc
Confidence 999764 3334556678999999999999877 74 88999999999999999999997421 11 11111110
Q ss_pred hcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 007020 524 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 569 (621)
Q Consensus 524 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl 569 (621)
. ...-|... . ..++..++.+|+..+|.+|+++.+|+
T Consensus 238 -~---~~~~p~~~----~--S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 238 -G---EFKIPSYL----L--SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred -C---CccCCCCc----C--CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0 01111111 0 47889999999999999999999997
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=342.91 Aligned_cols=251 Identities=27% Similarity=0.368 Sum_probs=211.7
Q ss_pred hcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
...|+..+.||+|.||.||+|.. .+++.||+|++.-+........+++|+.++..++++||.++||.+..+..++++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 34577778999999999999985 47899999999988877778889999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
||.||++.+.+..... +++..+..|+.+++.|+.|||++ +.+|||||+.|||+..+|.+|++|||.+..+...
T Consensus 92 y~~gGsv~~lL~~~~~----~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGNI----LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HhcCcchhhhhccCCC----CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech
Confidence 9999999999986542 47778888999999999999999 9999999999999999999999999999877644
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 533 (621)
... ...++||+.|||||++....|+.|+||||||++.+||.+|.+|+.....- +- .-.+.+-..|
T Consensus 165 ~~r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-----------rv---lflIpk~~PP 229 (467)
T KOG0201|consen 165 VKR-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-----------RV---LFLIPKSAPP 229 (467)
T ss_pred hhc-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-----------eE---EEeccCCCCC
Confidence 333 36778999999999999889999999999999999999999999522110 00 0011111223
Q ss_pred cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 534 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.+.+ .+...+.+++..|+.++|+.||++.++++.
T Consensus 230 ~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 RLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 3333 445779999999999999999999999853
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=339.69 Aligned_cols=268 Identities=20% Similarity=0.275 Sum_probs=207.0
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCce
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 368 (621)
....++|+..+.||+|+||.||+|+-+ +|..||+|++++... ..+...++.|..+|....+|+||+++..|++.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 345678999999999999999999854 799999999987542 33455688999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
||||||++||++..+|..... +++..++.++.+++.|++.||+. |+|||||||+|+|||..|++||+||||+.
T Consensus 217 YLiMEylPGGD~mTLL~~~~~----L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDT----LTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHHHhcCc----CchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccc
Confidence 999999999999999987653 89999999999999999999999 99999999999999999999999999985
Q ss_pred eccc----------------------CCCe------------------------eeecccccccccchhhhccCCCCCcc
Q 007020 449 LMDY----------------------KDTH------------------------VTTAVRGTIGHIAPEYLSTGKSSEKT 482 (621)
Q Consensus 449 ~~~~----------------------~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~ 482 (621)
-+.. .+.. ...+.+||+.|||||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 3210 0000 01224699999999999999999999
Q ss_pred cchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCC
Q 007020 483 DVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDR 562 (621)
Q Consensus 483 DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~R 562 (621)
|.||+|||+|||+.|.+||..... ...|- .+..-... +.-| .......+..++|.+|+. ||++|
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp-------~~T~r-kI~nwr~~--l~fP-----~~~~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETP-------QETYR-KIVNWRET--LKFP-----EEVDLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCH-------HHHHH-HHHHHhhh--ccCC-----CcCcccHHHHHHHHHHhc-CHHHh
Confidence 999999999999999999963322 11221 11111100 1111 111223677888889998 99999
Q ss_pred CCHHHHHHHHhcC-CCcc-chhh
Q 007020 563 PKMSEVVRMLEGD-GLAE-RWDE 583 (621)
Q Consensus 563 Pt~~~vl~~L~~~-~~~~-~~~~ 583 (621)
-...-+- .+... .+.. .|+.
T Consensus 434 LG~~G~~-EIK~HPfF~~v~W~~ 455 (550)
T KOG0605|consen 434 LGSKGAE-EIKKHPFFKGVDWDH 455 (550)
T ss_pred cCcccHH-HHhcCCccccCCcch
Confidence 9743333 33333 3332 5554
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=338.24 Aligned_cols=269 Identities=23% Similarity=0.364 Sum_probs=219.9
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
+.+.+....+++||+|.||.|.++....+.+||||+++.......+.+|.+|+++|.+++|||||+++|+|..++..+++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 44566777789999999999999999878999999999988888888999999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
+|||++|+|..++..+.... .+.....+|+.||+.||+||.+. ++|||||.++|+|+++++++||+|||+++-+.
T Consensus 614 ~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence 99999999999998864322 45566778999999999999999 99999999999999999999999999999665
Q ss_pred cCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh--CCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 452 YKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT--GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 452 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
..+.+ .....+-..+|||||.+..++++.++|||+||+++||+++ ...||..... ....+-...+.+.....
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-----e~vven~~~~~~~~~~~ 763 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-----EQVVENAGEFFRDQGRQ 763 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-----HHHHHhhhhhcCCCCcc
Confidence 54443 3334556789999999999999999999999999999876 7778852211 11112122222211111
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 576 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 576 (621)
. .-..+.-++.+++++|..||..|.++||+++++...|.+..
T Consensus 764 ~------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 764 V------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred e------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 1 11123456688999999999999999999999999987743
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=340.84 Aligned_cols=266 Identities=23% Similarity=0.387 Sum_probs=205.9
Q ss_pred hcCCCcCceeeeccCceEEEEEcCC-----------------CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceee
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLAD-----------------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 357 (621)
.++|...+.||+|+||.||+|.+.+ +..||+|.++.........++.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4578888999999999999997532 34699999976655555667999999999999999999
Q ss_pred eeeeeecCCceEEEEeccCCCchhhhhccCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 007020 358 LRGFCMTPTERLLVYPYMANGSVASCLRERPP---------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 422 (621)
Q Consensus 358 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iv 422 (621)
+++++.+.+..++||||+++|+|.+++..... ....+++..+..++.||+.||+|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999999865321 112478889999999999999999999 999
Q ss_pred ecCCCCCCeeeCCCCcEEEcccccceecccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh--CCC
Q 007020 423 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT--GQR 499 (621)
Q Consensus 423 H~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~ 499 (621)
||||||+|||++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865433221 2223346788999999988889999999999999999997 556
Q ss_pred CcccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 500 AFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 500 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
||.... .......+....+........ .....++..+.+++..||+.+|++|||+.+|.+.|++
T Consensus 241 p~~~~~-----~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELT-----DEQVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCC-----HHHHHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 775221 111222222222111110000 0011234678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=354.07 Aligned_cols=264 Identities=27% Similarity=0.432 Sum_probs=208.0
Q ss_pred HHHHhcCCCcCceeeeccCceEEEEEc------CCCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeee
Q 007020 291 LQVATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCM 363 (621)
Q Consensus 291 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 363 (621)
+....++|+..+.||+|+||+||+|.+ .++..||||+++..........+.+|+.++..+ +||||+++++++.
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 445566788899999999999999963 246689999997655445556788999999999 8999999999999
Q ss_pred cCCceEEEEeccCCCchhhhhccCCC------------------------------------------------------
Q 007020 364 TPTERLLVYPYMANGSVASCLRERPP------------------------------------------------------ 389 (621)
Q Consensus 364 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 389 (621)
..+..++||||+++|+|.++++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 99999999999999999999865321
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 390 -----------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 390 -----------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
....+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 112478889999999999999999999 999999999999999999999999999986543
Q ss_pred CCCee-eecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 453 KDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 453 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
..... .....++..|+|||++.+..++.++|||||||++|||++ |..||.... ......+++... .. .
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~----~~~~~~~~~~~~---~~---~ 336 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP----VDSKFYKMIKEG---YR---M 336 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC----chHHHHHHHHhC---cc---C
Confidence 32211 122335668999999999999999999999999999998 888985321 111112221111 00 0
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
..+ .....++.+++..||+.||++||++.+|++.|+.
T Consensus 337 ~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 337 LSP-------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCC-------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 011 1123578899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=352.70 Aligned_cols=267 Identities=29% Similarity=0.427 Sum_probs=214.9
Q ss_pred cCHHHHHHHhcCCCcCceeeeccCceEEEEEcCC--C--cE-EEEEEecc--cCCchhHHHHHHHHHHHHhccCCceeee
Q 007020 286 FSLRELQVATDSFSNKNILGRGGFGKVYKGRLAD--G--SL-VAVKRLKE--ERTPGGELQFQTEVEMISMAVHRNLLRL 358 (621)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--~--~~-vavK~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l 358 (621)
+..+.|+...++....++||+|+||.||+|.+.. + .. ||||..+. ........+|.+|.++++.++|||||++
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~ 226 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF 226 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 3445577777888888999999999999998642 2 23 89999885 3445667789999999999999999999
Q ss_pred eeeeecCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc
Q 007020 359 RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE 438 (621)
Q Consensus 359 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 438 (621)
+|++......++|||+|.||+|.++|++... .++..+...++.+.|.||+|||++ +++||||..+|+|++.++.
T Consensus 227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~ 300 (474)
T KOG0194|consen 227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGV 300 (474)
T ss_pred EEEEcCCCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCe
Confidence 9999999999999999999999999998654 388999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecccCCCeeee--cccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHH
Q 007020 439 AVVGDFGLAKLMDYKDTHVTT--AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLL 515 (621)
Q Consensus 439 ~kl~DfGla~~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~ 515 (621)
+||+|||+++... ..... ...-..+|+|||.+....++.++|||||||++||+++ |..||.... .....
T Consensus 301 vKISDFGLs~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~-----~~~v~ 372 (474)
T KOG0194|consen 301 VKISDFGLSRAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK-----NYEVK 372 (474)
T ss_pred EEeCccccccCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC-----HHHHH
Confidence 9999999987543 11111 1234679999999999999999999999999999999 888985322 11122
Q ss_pred HHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCCc
Q 007020 516 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLA 578 (621)
Q Consensus 516 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~ 578 (621)
+++. ... ..-..+...+..+..++..||..+|++||+|.++.+.|+.....
T Consensus 373 ~kI~---~~~---------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 373 AKIV---KNG---------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred HHHH---hcC---------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 2221 111 11111223457788889999999999999999999999885433
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=347.13 Aligned_cols=246 Identities=26% Similarity=0.382 Sum_probs=203.4
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhcc-CCceeeeeeeeecCCc
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTE 367 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 367 (621)
....++|...++||+|+||+|+++..+ +++.||||.+++... .+..+..+.|..++.... ||.++.++..|+..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 445678999999999999999999876 688999999988753 344567888888887765 9999999999999999
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
+|+||||+.||++....+.. .+++..+.-++..|+.||+|||++ +|||||||.+|||+|.+|++||+|||++
T Consensus 444 l~fvmey~~Ggdm~~~~~~~-----~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTD-----VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEEecCCCcEEEEEecc-----cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccc
Confidence 99999999999955554432 399999999999999999999999 9999999999999999999999999999
Q ss_pred eecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
+..- .....+..++||+.|||||++.+..|+..+|.|||||+||||+.|..||...+ ++.. ...++.
T Consensus 516 Ke~m-~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd----Eee~----FdsI~~---- 582 (694)
T KOG0694|consen 516 KEGM-GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD----EEEV----FDSIVN---- 582 (694)
T ss_pred cccC-CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC----HHHH----HHHHhc----
Confidence 8643 23336677899999999999999999999999999999999999999996222 1111 111111
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCH
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 565 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 565 (621)
.|+ .|+.-.+.+.+.++...+.++|++|.-+
T Consensus 583 ---d~~----~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 ---DEV----RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---CCC----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 111 1233445788999999999999999976
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=335.12 Aligned_cols=245 Identities=16% Similarity=0.264 Sum_probs=197.1
Q ss_pred ceeeeccCceEEEEEcCCCcEEEEEEecccCCch--hHHHHHHHHHHHHhccCCceeeeeeeeec----CCceEEEEecc
Q 007020 302 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERLLVYPYM 375 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 375 (621)
..||+|++|.||+|.+ +|+.||||.++...... ....+.+|+.++++++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 68999999997653222 13568899999999999999999999876 34678999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCC
Q 007020 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 455 (621)
++|+|.+++.... .+++.....++.+++.||.|||+.. +++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999998643 3788999999999999999999742 78899999999999999999999999998654321
Q ss_pred eeeecccccccccchhhhcc--CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCc
Q 007020 456 HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533 (621)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 533 (621)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+.......... .+
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~--------~~~~~~~i~~~~~-----~~ 241 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT--------TKEIYDLIINKNN-----SL 241 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhcCC-----CC
Confidence 22358899999999976 678999999999999999999999996321 1122222211110 01
Q ss_pred cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 534 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
. .+......+.+++..||+.||++|||++++++.|+.
T Consensus 242 ~----~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 242 K----LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred C----CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 1 111234678999999999999999999999999876
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=343.48 Aligned_cols=247 Identities=23% Similarity=0.336 Sum_probs=206.8
Q ss_pred CCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 297 SFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
-|.+++.||+|+-|.|-+|++ .+|+.+|||++.+.. .......+.+|+-+|+.+.||||+++++++.+..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 466788999999999999986 489999999997652 23345568999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++|.|++++-.++. +.+.++.+++.||+.|+.|+|.. +|+||||||+|+|++..+.+||+|||+|..-.
T Consensus 93 yv~gGELFdylv~kG~----l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-- 163 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGP----LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV-- 163 (786)
T ss_pred ecCCchhHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence 9999999999987654 88999999999999999999999 99999999999999999999999999998632
Q ss_pred CCeeeecccccccccchhhhccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
........+|++.|.|||++.|..| ..++||||.|||||.|+||+.||+... +........ .+..
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN--------ir~LLlKV~-~G~f----- 229 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN--------IRVLLLKVQ-RGVF----- 229 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc--------HHHHHHHHH-cCcc-----
Confidence 3445566789999999999999987 689999999999999999999997211 111111111 1111
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
+.+...+.+..+++..|+..||++|.|++||+++
T Consensus 230 -----~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 -----EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -----cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1122334678899999999999999999999875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=332.16 Aligned_cols=256 Identities=24% Similarity=0.344 Sum_probs=205.4
Q ss_pred hcCCCcCceeeeccCceEEEEEcC----CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
.++|++.+.||+|+||.||+|.+. .+..||+|.++..........+.+|+.++..++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 456888899999999999999753 4668999999876555555678999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+|++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999987643 2388999999999999999999999 9999999999999999999999999987653
Q ss_pred ccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
............++..|+|||.+.+..++.++|||||||++||+++ |..||.... ..+.+....+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~--------~~~~~~~~~~~~~--- 226 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS--------GQDVIKAVEDGFR--- 226 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC--------HHHHHHHHHCCCC---
Confidence 2222111222335678999999999999999999999999999775 999995221 1111222111100
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
. ......+..+.+++..||+.+|++||++++|++.|+.
T Consensus 227 ~-------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 L-------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred C-------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 0 0122334678899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=351.03 Aligned_cols=265 Identities=26% Similarity=0.441 Sum_probs=207.6
Q ss_pred HHHHHhcCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeee
Q 007020 290 ELQVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFC 362 (621)
Q Consensus 290 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 362 (621)
.+....++|...+.||+|+||.||+|... ++..||+|+++..........+.+|+.+++.+ +|+||+++++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 34556678999999999999999998742 34579999997665555556788999999999 899999999999
Q ss_pred ecCCceEEEEeccCCCchhhhhccCCC-----------------------------------------------------
Q 007020 363 MTPTERLLVYPYMANGSVASCLRERPP----------------------------------------------------- 389 (621)
Q Consensus 363 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------- 389 (621)
...+..++||||+++|+|.++++....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 999999999999999999999864211
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCe
Q 007020 390 -------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 456 (621)
Q Consensus 390 -------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 456 (621)
...++++..+.+++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 112478889999999999999999999 9999999999999999999999999999865432221
Q ss_pred -eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 457 -VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 457 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ...... ...... ....+.
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~----~~~~~~----~~~~~~--~~~~~~ 338 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV----NSKFYK----MVKRGY--QMSRPD 338 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc----cHHHHH----HHHccc--CccCCC
Confidence 1222335678999999998899999999999999999997 9999963211 111111 111100 000111
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
..+..+.+++..||+.||++||++.+|++.|++
T Consensus 339 -------~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 339 -------FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred -------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 123678899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=335.48 Aligned_cols=200 Identities=26% Similarity=0.378 Sum_probs=176.7
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.++|+..+.||+|+||.||++... ++..||+|.++..........+.+|+++++.++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468899999999999999999875 6889999998765544555679999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999997643 3788899999999999999999862 6999999999999999999999999998765322
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCccc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 503 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~ 503 (621)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 22334689999999999998999999999999999999999999963
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=328.07 Aligned_cols=256 Identities=25% Similarity=0.332 Sum_probs=199.9
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc-------------hhHHHHHHHHHHHHhccCCceeee
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-------------GGELQFQTEVEMISMAVHRNLLRL 358 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l 358 (621)
..-++|++.+.||+|.||.|-+|+.. +++.||||++.+.... ...+...+|+.++++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999865 7999999999653211 112468899999999999999999
Q ss_pred eeeeecC--CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC
Q 007020 359 RGFCMTP--TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 436 (621)
Q Consensus 359 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~ 436 (621)
+++..++ +.+|||+|||..|.+...=.. ...+++.++++++.++..||+|||.+ |||||||||+|+|++++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d----~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPD----KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCC----cccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence 9998775 678999999999887543222 22288999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceecccCC----CeeeecccccccccchhhhccCC----CCCcccchhHHHHHHHHHhCCCCcccccccC
Q 007020 437 FEAVVGDFGLAKLMDYKD----THVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGIMLLELITGQRAFDLARLAN 508 (621)
Q Consensus 437 ~~~kl~DfGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~pf~~~~~~~ 508 (621)
|+|||+|||.+....... .......+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||-...
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~--- 323 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF--- 323 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch---
Confidence 999999999998763221 11222357999999999997743 3678899999999999999999995211
Q ss_pred CCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007020 509 DDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 572 (621)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L 572 (621)
..+.... ++...+.-....+....+.++++.++.+||+.|.+..+|....
T Consensus 324 -----~~~l~~K---------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 324 -----ELELFDK---------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred -----HHHHHHH---------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1111111 2222221112234557889999999999999999999997765
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=324.34 Aligned_cols=248 Identities=21% Similarity=0.362 Sum_probs=209.7
Q ss_pred cCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchh--HHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
.+|++.+.||+|.||+|-+|.. ..|+.||||.+++....+. .-.+.+|+++|+.++||||+.++++|...+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4677778899999999999985 6899999999988775443 336899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||..+|.|++|+.++.. +++.++..++.||..|+.|+|.+ +++|||||.+|||+|.++++||+|||++..+.
T Consensus 133 EYaS~GeLYDYiSer~~----LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~- 204 (668)
T KOG0611|consen 133 EYASGGELYDYISERGS----LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA- 204 (668)
T ss_pred EecCCccHHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc-
Confidence 99999999999998764 89999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCeeeecccccccccchhhhccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
+......++|++-|.+||++.+.+| .+.+|-||+||+||-|+.|..||+.- +....++++.++. ..
T Consensus 205 -~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~--------Dhk~lvrQIs~Ga----Yr 271 (668)
T KOG0611|consen 205 -DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR--------DHKRLVRQISRGA----YR 271 (668)
T ss_pred -cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc--------hHHHHHHHhhccc----cc
Confidence 3345567889999999999999988 68999999999999999999999732 2223333332211 11
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 572 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L 572 (621)
.| +.+....-+|++|+..+|++|.|+.+|...-
T Consensus 272 EP--------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 272 EP--------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred CC--------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 11 1124556788899999999999999998754
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=315.32 Aligned_cols=261 Identities=25% Similarity=0.304 Sum_probs=198.5
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCch-hHHHHHHHHHHHHhccCCceeeeeeeeec--CCceEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLV 371 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 371 (621)
+.|+..+.|++|+||.||+|+++ +++.||+|+++-..... -...-.+|+.++.+.+|||||.+..+... -+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 34566788999999999999975 68999999997654222 22346799999999999999999998764 3679999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
||||+. +|..++.... .++...+++.++.|+++|++|||.+ .|+|||||++|+|++..|.+||+|||+|+.++
T Consensus 156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999998 9999998765 3488999999999999999999999 99999999999999999999999999999887
Q ss_pred cCCCeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
... ...+..+-|..|+|||.+.+. .|+.+.||||+|||+.||+++++.|...... +..+-+-..+. ...+.+
T Consensus 229 sp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~-----dQl~~If~llG-tPte~i 301 (419)
T KOG0663|consen 229 SPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI-----DQLDKIFKLLG-TPSEAI 301 (419)
T ss_pred CCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH-----HHHHHHHHHhC-CCcccc
Confidence 543 334556679999999999876 4899999999999999999999988532211 11111111000 000000
Q ss_pred -------------cCc-----cccCcccHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 531 -------------VDP-----DLQNNYVEA-EVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 531 -------------~d~-----~~~~~~~~~-~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.-+ .+...+... ....-++++...+..||.+|-|++|.++
T Consensus 302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 000 000111111 2245677888899999999999998854
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=330.12 Aligned_cols=252 Identities=26% Similarity=0.356 Sum_probs=199.7
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.|+..+.||+|+||+||+|... +|+.||+|.+..... ......+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3667789999999999999864 789999999865432 2233457889999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 9999999988765322 2488999999999999999999999 9999999999999999999999999999865322
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 533 (621)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||....... .... +.......
T Consensus 156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~----~~~~-~~~~~~~~-------- 220 (285)
T cd05631 156 E--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV----KREE-VDRRVKED-------- 220 (285)
T ss_pred C--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch----hHHH-HHHHhhcc--------
Confidence 1 2234568999999999999999999999999999999999999996332110 0001 11111100
Q ss_pred cccCcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007020 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-----MSEVVR 570 (621)
Q Consensus 534 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-----~~~vl~ 570 (621)
...+.......+.+++..||+.||++||+ ++++++
T Consensus 221 --~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 --QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred --cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 01112223467889999999999999997 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=305.16 Aligned_cols=251 Identities=25% Similarity=0.361 Sum_probs=208.2
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
.-++|++++.||+|.||.||.|+.+ ++-.||+|++.+... .....++.+|+++-+.++||||++++++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3467889999999999999999865 678999999865542 2234578999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
++||.++|+++..+...... .+++.....++.|+|.||.|+|.+ +|+||||||+|+|++..+..||+|||.+..-
T Consensus 100 ilEya~~gel~k~L~~~~~~--~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMK--RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHhcccc--cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999864332 388889999999999999999999 9999999999999999999999999998753
Q ss_pred ccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
. .......+||..|.+||+..+..++..+|+|++|++.||++.|.+||.... .+ +-.+.+.+ .++
T Consensus 175 p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~----~~----etYkrI~k----~~~ 239 (281)
T KOG0580|consen 175 P---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS----HS----ETYKRIRK----VDL 239 (281)
T ss_pred C---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh----hH----HHHHHHHH----ccc
Confidence 3 334556789999999999999999999999999999999999999996322 11 11111111 112
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.+| ........+++..|+.++|.+|.+..|++..
T Consensus 240 ~~p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 KFP-------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred cCC-------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 222 2233678899999999999999999999863
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=304.36 Aligned_cols=265 Identities=25% Similarity=0.323 Sum_probs=211.8
Q ss_pred HHHhcCCCcCceeeeccCceEEEEE-cCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCC----
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT---- 366 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 366 (621)
.+..++|.+.+.||+|||+-||.++ ..+++.||+|++.-.. .......++|++..++++|||+++++++...+.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 3456789999999999999999998 4578999999997655 445667899999999999999999999875443
Q ss_pred -ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccc
Q 007020 367 -ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 445 (621)
Q Consensus 367 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 445 (621)
..|++++|+..|||.+.+.....++..+++.+.+.|+.+|++||++||+. .|+++||||||.|||+++++.+++.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence 48999999999999999998777776799999999999999999999998 3459999999999999999999999999
Q ss_pred cceecccCCCe--------eeecccccccccchhhhcc---CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchH
Q 007020 446 LAKLMDYKDTH--------VTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 514 (621)
Q Consensus 446 la~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~ 514 (621)
.++........ ......-|..|+|||.+.- ...++++|||||||+||+|+.|..||+......
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G------ 248 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG------ 248 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC------
Confidence 98764321111 1112337889999999853 456899999999999999999999997433211
Q ss_pred HHHHHHHhhhcccc-cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 515 LDWVKGLLKEKKLE-MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 515 ~~~~~~~~~~~~~~-~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
+.+. .+..+.+........++.+.+++.+|++.||.+||++.+++..++.
T Consensus 249 ----------gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 249 ----------GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred ----------CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 1111 1112222111122256889999999999999999999999998865
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=327.97 Aligned_cols=250 Identities=30% Similarity=0.514 Sum_probs=196.3
Q ss_pred cCceeeeccCceEEEEEcC-----CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 300 NKNILGRGGFGKVYKGRLA-----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 300 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
..+.||.|.||.||+|.+. .+..|+||.++..........+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3468999999999999875 36789999997655555577899999999999999999999999988889999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++|+|.+++.... ...+++..+..|+.||++||+|||++ +++|+||+++||++++++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 99999999999862 23489999999999999999999999 99999999999999999999999999998763222
Q ss_pred C-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 455 T-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 455 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
. ...........|+|||.+.+..++.++||||||+++|||++ |+.||... ...++.....+.....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--------~~~~~~~~~~~~~~~~---- 225 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--------DNEEIIEKLKQGQRLP---- 225 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--------CHHHHHHHHHTTEETT----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccccccccce----
Confidence 2 22233447789999999999889999999999999999999 77887421 1223333332222111
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 572 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L 572 (621)
........+.+++..||+.+|++||++.++++.|
T Consensus 226 ------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112236788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=336.61 Aligned_cols=268 Identities=28% Similarity=0.403 Sum_probs=223.5
Q ss_pred HHHHHHhcCCCcCceeeeccCceEEEEEcCC-CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCc
Q 007020 289 RELQVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 367 (621)
Q Consensus 289 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 367 (621)
++|+....+....++||-|.||.||.|.|+. .-.||||.++++.. ...+|..|..+|+.++|||+|+++|+|..+..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM--eveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch--hHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 6778888888899999999999999999874 56799999987654 35679999999999999999999999999999
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
+|+|+|||.+|+|.+|+++..... +..-..+.++.||+.||+||..+ ++|||||..+|+|+.++..||++|||++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~e--v~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSE--VPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhh--cchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence 999999999999999999876543 55567789999999999999999 9999999999999999999999999999
Q ss_pred eecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcc
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (621)
+++............-.+.|.|||.+....++.|+|||+|||+|||+.| |..||.. .++.+.. +++
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG--------idlSqVY-~LL---- 479 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG--------IDLSQVY-GLL---- 479 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC--------ccHHHHH-HHH----
Confidence 9987655444444456789999999999999999999999999999999 8888842 2222222 221
Q ss_pred cccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCCccch
Q 007020 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERW 581 (621)
Q Consensus 527 ~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~~~ 581 (621)
...++-..++.|+.+++++|+.||+++|.+||+++|+-+.+|...-....
T Consensus 480 -----EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSi 529 (1157)
T KOG4278|consen 480 -----EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSI 529 (1157)
T ss_pred -----hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccc
Confidence 12222222456778999999999999999999999999988875444433
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=323.26 Aligned_cols=251 Identities=25% Similarity=0.430 Sum_probs=203.0
Q ss_pred cCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEecc
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 375 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 375 (621)
++|+..+.||+|+||.||++.+.++..+|+|.++.... ...++..|+.+++.++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc--cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 45777889999999999999988888999998864432 2456889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCC
Q 007020 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 455 (621)
++|+|.++++.... .+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||.++.......
T Consensus 82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 99999999875432 378899999999999999999999 999999999999999999999999999876543222
Q ss_pred eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 456 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+.+....+... ...+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--------~~~~~~~i~~~~~---~~~~~ 224 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--------NYEVVEMISRGFR---LYRPK 224 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHCCCC---CCCCC
Confidence 22222335678999999988889999999999999999999 899985221 1122222222111 11111
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 572 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L 572 (621)
. ....+.+++.+||+.+|++||+++++++.|
T Consensus 225 ~-------~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 L-------ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred C-------CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1 235789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=327.64 Aligned_cols=256 Identities=25% Similarity=0.442 Sum_probs=206.8
Q ss_pred HhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
..++|++.++||+|+||.||+|...++..||+|.+.... .....+.+|+.+++.++|+||+++++++...+..+++||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 456788899999999999999998888899999986432 234578999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 82 YMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred cCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999999997643 22478889999999999999999999 9999999999999999999999999999876533
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
.........++..|+|||.+.+..++.++||||||+++|+|++ |+.||.... ......++. .....
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-----~~~~~~~~~---~~~~~----- 223 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS-----NSDVMSALQ---RGYRM----- 223 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC-----HHHHHHHHH---cCCCC-----
Confidence 2222223346678999999988889999999999999999998 999995211 111111111 11000
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
+. .......+.+++.+|+..+|++||+++++.+.|+.
T Consensus 224 ~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 PR-----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CC-----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 10 11223578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=325.97 Aligned_cols=257 Identities=27% Similarity=0.399 Sum_probs=207.1
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
+..++|+..+.||+|+||.||+|...+++.||+|.++.... ...++.+|+.++++++|+||+++++++...+..+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 44567888999999999999999987788999999875432 3456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++++|.+++.... ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 81 ELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred ecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999999997654 23488999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
...........+..|+|||++.+..++.++||||||+++|||++ |+.||.... .... .........
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~---~~~~~~~~~----- 222 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT-----NAEV---LQQVDQGYR----- 222 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-----HHHH---HHHHHcCCC-----
Confidence 22211122223457999999998889999999999999999999 999985221 1111 111111100
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
..........+.+++.+|++.+|++||++.++++.|++
T Consensus 223 -----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 -----MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -----CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 00112234678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=328.49 Aligned_cols=258 Identities=27% Similarity=0.486 Sum_probs=206.9
Q ss_pred cCCCcCceeeeccCceEEEEEcCC------CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLAD------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
++|+..+.||+|+||.||+|.... ...||+|.++..........+.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467788999999999999998532 25799999876655555667899999999999999999999999989999
Q ss_pred EEEeccCCCchhhhhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC
Q 007020 370 LVYPYMANGSVASCLRERPPS------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF 437 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 437 (621)
++|||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999998764221 13478889999999999999999999 999999999999999999
Q ss_pred cEEEcccccceecccCCC-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHH
Q 007020 438 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLL 515 (621)
Q Consensus 438 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~ 515 (621)
.+||+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--------~ 233 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--------Q 233 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence 999999999986533221 12233346788999999988889999999999999999998 9999853211 1
Q ss_pred HHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 516 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 516 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
+.... +..... .......+.++.+++.+||+.+|.+||++.+|++.|+.
T Consensus 234 ~~~~~-i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 EVIEM-IRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHH-HHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111 111111 11123345789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=344.43 Aligned_cols=265 Identities=23% Similarity=0.355 Sum_probs=208.6
Q ss_pred HHHHHhcCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-CCceeeeeeee
Q 007020 290 ELQVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFC 362 (621)
Q Consensus 290 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 362 (621)
.+....++|.+.+.||+|+||.||+|.+. .+..||||+++..........+.+|+++++++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 34556778999999999999999999752 234799999976555555567999999999996 99999999999
Q ss_pred ecCCceEEEEeccCCCchhhhhccCCC-----------------------------------------------------
Q 007020 363 MTPTERLLVYPYMANGSVASCLRERPP----------------------------------------------------- 389 (621)
Q Consensus 363 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------- 389 (621)
.+....++||||+++|+|.++++....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 999999999999999999998865321
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 007020 390 ---------------------------------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAAN 430 (621)
Q Consensus 390 ---------------------------------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 430 (621)
....+++..+..++.|+++||+|||+. +|+||||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHh
Confidence 012377888899999999999999999 99999999999
Q ss_pred eeeCCCCcEEEcccccceecccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccC
Q 007020 431 ILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLAN 508 (621)
Q Consensus 431 ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~ 508 (621)
||++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~-- 345 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV-- 345 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch--
Confidence 99999999999999999865432221 1223346788999999998889999999999999999997 9999853211
Q ss_pred CCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 509 DDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
+..... ...... .. .........+.+++..||+.+|++||++.+|.++|+.
T Consensus 346 --~~~~~~----~~~~~~-----~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 346 --DSTFYN----KIKSGY-----RM----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred --hHHHHH----HHhcCC-----CC----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 001111 111110 00 0112234678999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=336.08 Aligned_cols=268 Identities=24% Similarity=0.402 Sum_probs=223.2
Q ss_pred CHHHHHHHhcCCCcCceeeeccCceEEEEEcCC---C--cEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeee
Q 007020 287 SLRELQVATDSFSNKNILGRGGFGKVYKGRLAD---G--SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 361 (621)
Q Consensus 287 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 361 (621)
+..+.++..+.....++||+|.||.||+|.+.+ | -.||||.-+.+..++..+.|..|..+++.++||||++++|+
T Consensus 380 ~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv 459 (974)
T KOG4257|consen 380 TVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGV 459 (974)
T ss_pred CCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeee
Confidence 334555666667778899999999999998642 3 35999999988888888899999999999999999999999
Q ss_pred eecCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEE
Q 007020 362 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV 441 (621)
Q Consensus 362 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 441 (621)
|.+ ...|+|||.++.|.|..|++.+... ++......++.||+.||+|||+. .+|||||..+|||+.....||+
T Consensus 460 ~~e-~P~WivmEL~~~GELr~yLq~nk~s---L~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKL 532 (974)
T KOG4257|consen 460 CVE-QPMWIVMELAPLGELREYLQQNKDS---LPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKL 532 (974)
T ss_pred eec-cceeEEEecccchhHHHHHHhcccc---chHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeee
Confidence 865 4689999999999999999976543 88889999999999999999999 9999999999999999999999
Q ss_pred cccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHH
Q 007020 442 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKG 520 (621)
Q Consensus 442 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 520 (621)
+|||+++.+.+...+......-...|||||.+.-.+++.++|||-|||.+||++. |..||..-. .
T Consensus 533 aDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk--------------N 598 (974)
T KOG4257|consen 533 ADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK--------------N 598 (974)
T ss_pred cccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc--------------c
Confidence 9999999987766655555556778999999999999999999999999999998 999995211 1
Q ss_pred HhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCCcc
Q 007020 521 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAE 579 (621)
Q Consensus 521 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~ 579 (621)
.+.+..+ ...-+-..++.|+..++.++.+||..+|.+||++.++...|.++-..+
T Consensus 599 ---sDVI~~i-EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 599 ---SDVIGHI-ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred ---cceEEEe-cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 1111111 111122345677889999999999999999999999999998865544
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=339.34 Aligned_cols=264 Identities=29% Similarity=0.445 Sum_probs=205.9
Q ss_pred HHHHhcCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeee
Q 007020 291 LQVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCM 363 (621)
Q Consensus 291 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 363 (621)
|+++.++|++.+.||+|+||.||+|... +++.||+|+++..........+..|+.++.++ +|+||+++++++.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 4556678999999999999999999632 35789999997654444455678899999999 7999999999886
Q ss_pred cC-CceEEEEeccCCCchhhhhccCCCC----------------------------------------------------
Q 007020 364 TP-TERLLVYPYMANGSVASCLRERPPS---------------------------------------------------- 390 (621)
Q Consensus 364 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------- 390 (621)
.. ...+++|||+++|+|.+++......
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 54 5678999999999999998643210
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee-eeccccc
Q 007020 391 -----QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGT 464 (621)
Q Consensus 391 -----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt 464 (621)
..++++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++..+....... .....++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 12578999999999999999999999 99999999999999999999999999998754332221 2233466
Q ss_pred ccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHH
Q 007020 465 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAE 543 (621)
Q Consensus 465 ~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 543 (621)
..|+|||++.+..++.++|||||||++|||++ |..||..... ...+. . ........ .. ....
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~----~~~~~---~-~~~~~~~~--~~-------~~~~ 301 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI----DEEFC---R-RLKEGTRM--RA-------PEYA 301 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc----cHHHH---H-HHhccCCC--CC-------CccC
Confidence 78999999999999999999999999999998 9999953211 11111 1 11111100 00 1122
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 544 VEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 544 ~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
..++.+++..||+.+|++||++.+|+++|+.
T Consensus 302 ~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 302 TPEIYSIMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 3678999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=320.29 Aligned_cols=267 Identities=24% Similarity=0.352 Sum_probs=204.2
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHH--hccCCceeeeeeeeecC----C
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMIS--MAVHRNLLRLRGFCMTP----T 366 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~----~ 366 (621)
....+..+.+.||+|.||.||+|.|. |+.||||++.. .++..+.+|.+++. .++|+||+.+++.-..+ .
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc-CCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 34567778899999999999999996 88999999963 23456777777766 57999999999885544 4
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEecCCCCCCeeeCCCCcEEE
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD-----HCDPKIIHRDVKAANILLDEEFEAVV 441 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-----~~~~~ivH~Dlk~~Nill~~~~~~kl 441 (621)
++|||++|.+.|||+|||.... ++....++++..+|.||+|||. +++|.|.|||||++|||+.+++...|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~t-----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRNT-----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEEeeecccCCcHHHHHhhcc-----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 6799999999999999998743 8889999999999999999994 57999999999999999999999999
Q ss_pred cccccceecccCCCe---eeecccccccccchhhhccCCC------CCcccchhHHHHHHHHHhCC----------CCcc
Q 007020 442 GDFGLAKLMDYKDTH---VTTAVRGTIGHIAPEYLSTGKS------SEKTDVFGYGIMLLELITGQ----------RAFD 502 (621)
Q Consensus 442 ~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~------~~~~DvwSlGvil~elltg~----------~pf~ 502 (621)
+|+|+|......... .....+||.+|||||++...-. -..+||||||.|+||+.... .||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 999999877654322 2334579999999999965421 24689999999999998633 4553
Q ss_pred cccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007020 503 LARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 576 (621)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 576 (621)
.-- ..+... +-++..+-..++...++..+. ..+.+..+.++|+.||..+|..|-|+-.+-+.|.+..
T Consensus 438 d~V---p~DPs~-eeMrkVVCv~~~RP~ipnrW~---s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 438 DVV---PSDPSF-EEMRKVVCVQKLRPNIPNRWK---SDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred cCC---CCCCCH-HHHhcceeecccCCCCCcccc---cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 211 111111 222333322333322222222 3456788999999999999999999999988887643
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=328.78 Aligned_cols=268 Identities=19% Similarity=0.251 Sum_probs=201.5
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
++|++.+.||+|+||+||+|+.. +++.||+|+++.... ......+.+|+.+++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999975 688999999875432 2334568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|++++++..+.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99998776554332 2388899999999999999999999 9999999999999999999999999999876433
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCC-------cchHHHHHHHHhhhcc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD-------DVMLLDWVKGLLKEKK 526 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-------~~~~~~~~~~~~~~~~ 526 (621)
.........|+..|+|||++.+..++.++|||||||++|||++|+.||......... +.....+.+.......
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 333333456899999999999888999999999999999999999999632110000 0000000000000000
Q ss_pred cccccCcccc------CcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 527 LEMLVDPDLQ------NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 527 ~~~~~d~~~~------~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
......+... ..........+.+++..|++.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000001000 0011123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=329.06 Aligned_cols=262 Identities=24% Similarity=0.401 Sum_probs=206.1
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecC
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 365 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 365 (621)
.+..++|+..+.||+|+||.||+|.+. .+..||+|.++.........++.+|+.+++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 346678999999999999999998743 35679999986554444556788999999999999999999999999
Q ss_pred CceEEEEeccCCCchhhhhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcE
Q 007020 366 TERLLVYPYMANGSVASCLRERPPS------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 439 (621)
Q Consensus 366 ~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 439 (621)
...++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence 9999999999999999998753221 22467888999999999999999999 99999999999999999999
Q ss_pred EEcccccceecccCCCee-eecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHH
Q 007020 440 VVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDW 517 (621)
Q Consensus 440 kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~ 517 (621)
+|+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.... ..+.
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~--------~~~~ 230 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS--------NEQV 230 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHH
Confidence 999999987654322211 112235778999999998889999999999999999999 788885221 1111
Q ss_pred HHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 518 VKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 518 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.+...... ... ........+.+++.+|++.+|++|||+.++++.|++
T Consensus 231 ~~~~~~~~-~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 231 LRFVMEGG-LLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHHHcCC-cCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111111 100 011223578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=329.33 Aligned_cols=262 Identities=24% Similarity=0.341 Sum_probs=199.3
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
++|...+.||+|+||+||+|... +++.||+|.++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888899999999999999865 68899999987554444445678999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++ +|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNCGN---LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 985 89988865432 378889999999999999999999 99999999999999999999999999997654322
Q ss_pred Ceeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh-----------
Q 007020 455 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL----------- 522 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----------- 522 (621)
. ......++..|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+ ..+....
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~----~~~-~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK----EEL-HLIFRLLGTPTEETWPGI 231 (288)
T ss_pred c-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHH-HHHHHHhCCCChHHhhcc
Confidence 2 2233458899999999865 45789999999999999999999999632211 000 1010000
Q ss_pred -hhcccccccCccccCcc----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 523 -KEKKLEMLVDPDLQNNY----VEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 523 -~~~~~~~~~d~~~~~~~----~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..........+...... ......+..+++..|++.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000111111110000 0112356789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=350.43 Aligned_cols=261 Identities=21% Similarity=0.287 Sum_probs=211.2
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcCCC-cEEEEEEecccCCchhHHHHHHHHHHHHhcc-CCceeeeeee-eec-----
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLADG-SLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGF-CMT----- 364 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~----- 364 (621)
+..-++++.+.|.+|||+.||.|....+ ..||+|++... .+.....+.+|+++|+.+. |+|||.+++. ...
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 3345667789999999999999997655 99999998765 5566677999999999998 9999999993 221
Q ss_pred -CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcc
Q 007020 365 -PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 443 (621)
Q Consensus 365 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 443 (621)
..+.+|.||||.||.|-|++..+...+ |.+.++++|+.|+++|+++||.. +|+|||||||-+||||+.++..||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 246789999999999999999765544 89999999999999999999997 77899999999999999999999999
Q ss_pred cccceecccCC-Cee-------eecccccccccchhhh---ccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcc
Q 007020 444 FGLAKLMDYKD-THV-------TTAVRGTIGHIAPEYL---STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDV 512 (621)
Q Consensus 444 fGla~~~~~~~-~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~ 512 (621)
||.|.-..... ... ......|+.|+|||++ .+...++|+|||||||+||-|+....||+...
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------- 262 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------- 262 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-------
Confidence 99987432221 110 0112378999999987 46678999999999999999999999997331
Q ss_pred hHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCCc
Q 007020 513 MLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLA 578 (621)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~ 578 (621)
.-.+++.++.-...+.+...+.+||..||+.+|++||++.+|+..+-...-.
T Consensus 263 --------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 263 --------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred --------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 1123444443333456778999999999999999999999999988765333
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=330.79 Aligned_cols=245 Identities=23% Similarity=0.265 Sum_probs=199.5
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|+..+.||+|+||.||+|... +++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999875 689999999864321 223456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999997643 378889999999999999999999 999999999999999999999999999986542
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
. .....|++.|+|||++.+..++.++|||||||++|||++|+.||.... ............ .
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~~-~----- 215 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN--------PFGIYEKILAGK-L----- 215 (291)
T ss_pred C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-c-----
Confidence 2 223458999999999998889999999999999999999999996321 111222221111 0
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-----MSEVVR 570 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-----~~~vl~ 570 (621)
.+ .......+.+++..|++.||.+||+ ++++++
T Consensus 216 -~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 216 -EF----PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred -CC----CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 11 1112356889999999999999995 777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=335.03 Aligned_cols=252 Identities=25% Similarity=0.397 Sum_probs=213.6
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCc-eEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE-RLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 372 (621)
++|...+.+|+|+||.++..+++ +++.|++|.+.... ....+....+|+.++++++|||||.+++.+.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888899999999999999876 67899999997655 33344568899999999999999999999999988 89999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
+|++||++.+.|.+.. +.-++++.+..++.|++.|+.|||++ .|+|||||+.||+++.++.|||+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998765 44599999999999999999999998 999999999999999999999999999998876
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
.. .....+.||+.||+||++.+.+|..|+|||||||++|||++-+++|...+ +...+..+.+. ...
T Consensus 159 ~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~--------m~~Li~ki~~~-----~~~ 224 (426)
T KOG0589|consen 159 ED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN--------MSELILKINRG-----LYS 224 (426)
T ss_pred ch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc--------hHHHHHHHhhc-----cCC
Confidence 54 24455679999999999999999999999999999999999999996332 22222222221 122
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
..+.....++..++..|++.+|+.||++.+++.+
T Consensus 225 -----Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 -----PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -----CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2233455789999999999999999999999876
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=338.06 Aligned_cols=248 Identities=22% Similarity=0.349 Sum_probs=194.2
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
++|+..+.||+|+||+||+|.+. +++.||||++...........+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34556688999999999999865 68999999997655445566789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++|+|.+... ..+..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 154 ~~~~~L~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGTHI--------ADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCccccccc--------CCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 99999865321 45677889999999999999999 99999999999999999999999999998654321
Q ss_pred Ceeeecccccccccchhhhcc-----CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 455 THVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||..... ......+.......
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~---- 292 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-----GDWASLMCAICMSQ---- 292 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----ccHHHHHHHHhccC----
Confidence 12233469999999998743 2345689999999999999999999962211 11111111111000
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.+. .......++.+++..||+.||++||++.|+++
T Consensus 293 --~~~----~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 293 --PPE----APATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred --CCC----CCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011 11123467899999999999999999999976
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=329.57 Aligned_cols=249 Identities=22% Similarity=0.292 Sum_probs=199.0
Q ss_pred eeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCch
Q 007020 304 LGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 380 (621)
Q Consensus 304 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 380 (621)
||+|+||+||+|... +++.||+|.++... .......+..|+.++..++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999875 58899999986532 223345678899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeeeec
Q 007020 381 ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 460 (621)
Q Consensus 381 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 460 (621)
.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQREG----RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 99997643 388899999999999999999999 99999999999999999999999999997543222 22334
Q ss_pred ccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCccc
Q 007020 461 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 540 (621)
Q Consensus 461 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 540 (621)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... ..+ +
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--------~~~~~~~~~~~~-------~~~----~ 213 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--------VNEMYRKILQEP-------LRF----P 213 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcCC-------CCC----C
Confidence 569999999999999999999999999999999999999996321 112222222110 011 1
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCCcc
Q 007020 541 EAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAE 579 (621)
Q Consensus 541 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~ 579 (621)
......+.+++..|++.||++||++..+.+.|....+..
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence 122357889999999999999997655555566655544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=324.78 Aligned_cols=256 Identities=29% Similarity=0.398 Sum_probs=205.3
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
..+|...+.||+|+||.||+|... .++.||+|.+.... .....+.+|+++++.++|+||+++++++..++..+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 455777889999999999999865 58899999986432 234568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++++|.+++..... ..+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 83 FMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred eCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999999876432 2378899999999999999999999 9999999999999999999999999999876533
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
.........++..|+|||.+.+..++.++||||||+++|||++ |..||.... ..+........ ..
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--------~~~~~~~~~~~------~~ 223 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVYELLEKG------YR 223 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHCC------CC
Confidence 2222222234668999999998899999999999999999998 999985221 11221111111 00
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
+. .....+..+.+++.+|++.+|++||++.+++++|+..
T Consensus 224 ~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 ME----RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CC----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11 1122346789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=334.08 Aligned_cols=245 Identities=22% Similarity=0.285 Sum_probs=198.8
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|+..+.||+|+||.||+|+.. +++.||+|.++... .......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888899999999999999875 68899999986532 1223456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999997643 378889999999999999999999 999999999999999999999999999986543
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ .. .-
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~i~~~-~~---~~ 234 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT--------PFRIYEKILAG-RL---KF 234 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC--------HHHHHHHHhcC-Cc---CC
Confidence 22 23468999999999999999999999999999999999999995221 11111221111 10 00
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-----MSEVVR 570 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-----~~~vl~ 570 (621)
+. .....+.+++..||+.||.+||+ +++++.
T Consensus 235 p~-------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 235 PN-------WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CC-------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11 12256789999999999999997 566543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=333.35 Aligned_cols=242 Identities=23% Similarity=0.284 Sum_probs=195.2
Q ss_pred ceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCC
Q 007020 302 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 378 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 378 (621)
+.||+|+||.||++... +|+.||+|+++... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 78999999997543 2233446788999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeee
Q 007020 379 SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 458 (621)
Q Consensus 379 sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 458 (621)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~ 152 (323)
T cd05571 81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATM 152 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcc
Confidence 9999987643 388999999999999999999999 9999999999999999999999999998753221 1223
Q ss_pred ecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCc
Q 007020 459 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNN 538 (621)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 538 (621)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........... +..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~~~~~~~~~-------~~~~--- 214 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILME-------EIRF--- 214 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC--------HHHHHHHHHcC-------CCCC---
Confidence 34569999999999999999999999999999999999999995221 11111111110 1111
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007020 539 YVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 570 (621)
Q Consensus 539 ~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~ 570 (621)
+......+.+++..|++.||++|| ++.++++
T Consensus 215 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 -PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 112236788999999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.40 Aligned_cols=254 Identities=21% Similarity=0.249 Sum_probs=202.8
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|++.+.||+|+||.||+|... +++.||+|+++.... ......+..|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888899999999999999975 588999999975432 223456888999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999997543 378899999999999999999999 999999999999999999999999999975432
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... .+.......... ....
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~--~~~~ 219 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--------NETWENLKYWKE--TLQR 219 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH--------HHHHHHHHhccc--cccC
Confidence 22345699999999999999999999999999999999999999963211 111111111000 0011
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
+.... ........+.+++..|+..+|++||+++++++.
T Consensus 220 ~~~~~-~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 PVYDD-PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCc-cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 11100 001234678899999999999999999999764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=332.77 Aligned_cols=201 Identities=25% Similarity=0.379 Sum_probs=176.5
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
..++|+..+.||+|+||.||++.+. ++..+|+|.++..........+.+|+++++.++|+||+++++++.+++..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3578999999999999999999876 688899999876554455567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++.... .+++..+..++.+++.||.|||+.. +|+||||||+|||++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999997643 3788899999999999999999742 799999999999999999999999999875432
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCccc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 503 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~ 503 (621)
. ......|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2 12234589999999999988899999999999999999999999963
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=322.29 Aligned_cols=256 Identities=29% Similarity=0.467 Sum_probs=206.8
Q ss_pred hcCCCcCceeeeccCceEEEEEcC----CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
.++|+..+.||+|+||+||+|.+. +...||||.++..........+.+|+.+++.++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 356888899999999999999864 2457999998766555556678999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
+|||+++++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999976432 488999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCC-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 451 DYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 451 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
..... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.... . .+...........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-----~---~~~~~~~~~~~~~- 227 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS-----N---QDVIKAVEDGYRL- 227 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC-----H---HHHHHHHHcCCCC-
Confidence 52222 22222335678999999998889999999999999999998 999985211 1 1111111111000
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
+ .....+..+.+++..|++.+|++||++++|++.|+.
T Consensus 228 ----~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 228 ----P-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred ----C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0 011234678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=325.74 Aligned_cols=259 Identities=26% Similarity=0.459 Sum_probs=206.8
Q ss_pred hcCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCce
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 368 (621)
.++|.+.+.||+|+||.||+|... +++.||+|.++..........+.+|+++++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 356777889999999999999863 34789999997665544567899999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhccCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc
Q 007020 369 LLVYPYMANGSVASCLRERPP----------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE 438 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~----------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 438 (621)
+++|||+++|+|.+++..... ....+++..+..++.|++.|++|||++ +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 999999999999999976431 223478889999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecccCCC-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHH
Q 007020 439 AVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLD 516 (621)
Q Consensus 439 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~ 516 (621)
+||+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||.... . .+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~-----~---~~ 232 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS-----N---EE 232 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC-----H---HH
Confidence 99999999976432221 11223345778999999999999999999999999999998 999985221 1 11
Q ss_pred HHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 517 WVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 517 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.+..... .... .........+.+++..||+.+|++||++.||++.|+.
T Consensus 233 ~~~~~~~-~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 233 VIECITQ-GRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHHc-CCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1121111 1100 0111234678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=327.42 Aligned_cols=261 Identities=25% Similarity=0.377 Sum_probs=197.7
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.++|...+.||+|+||+||+|... +++.||+|.++..........+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367889999999999999999975 6889999999755443444567889999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|++ ++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 57888776542 2378889999999999999999999 9999999999999999999999999999754322
Q ss_pred CCeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh---hccc--
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK---EKKL-- 527 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~-- 527 (621)
. .......|+..|+|||++.+. .++.++||||+||++|||++|+.||..... ..+.+..... ....
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~ 228 (303)
T cd07869 157 S-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD-------IQDQLERIFLVLGTPNEDT 228 (303)
T ss_pred C-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc-------HHHHHHHHHHHhCCCChhh
Confidence 2 122334588999999998654 578899999999999999999999963211 1111111100 0000
Q ss_pred ----cc--ccCcc-c---cCcccH------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 528 ----EM--LVDPD-L---QNNYVE------AEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 528 ----~~--~~d~~-~---~~~~~~------~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.. ..++. . ...... .....+.+++..|++.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 229 WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00 00000 0 000000 01245778999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=321.10 Aligned_cols=252 Identities=25% Similarity=0.415 Sum_probs=202.3
Q ss_pred cCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEecc
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 375 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 375 (621)
++|...+.||+|+||+||+|.+.++..||+|.++.... ....+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 45777889999999999999987777799999875432 2456889999999999999999999999888999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCC
Q 007020 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 455 (621)
.+|+|.+++..... .+++..++.++.||+.||+|||+. +++|+||||+||+++.++.+||+|||.++.......
T Consensus 82 ~~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 99999999976432 388999999999999999999999 999999999999999999999999999886543322
Q ss_pred eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 456 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .+........... ..+
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~---~~~- 223 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--------SETVEKVSQGLRL---YRP- 223 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHHhcCCCC---CCC-
Confidence 22222335678999999988889999999999999999999 9999852211 1111111111100 001
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 573 (621)
......+.+++..||+.+|++||++.+|++.|+
T Consensus 224 ------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 ------HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112367899999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=331.52 Aligned_cols=258 Identities=25% Similarity=0.422 Sum_probs=203.3
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCc----EEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
..+|+..+.||+|+||+||+|.+. ++. .||+|.++.........++..|+.+++.++||||++++|++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 356888999999999999999853 333 48999987655455566788999999999999999999998764 578
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+++||+++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 99999999999999986432 378889999999999999999999 999999999999999999999999999987
Q ss_pred cccCCCee-eecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 450 MDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 450 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
........ .....++..|+|||.+.+..++.++||||||+++|||++ |+.||+... ..++.. ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~--------~~~~~~-~~~~~~- 228 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--------ASEISS-ILEKGE- 228 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--------HHHHHH-HHhCCC-
Confidence 65332221 122234678999999999999999999999999999998 999985211 111111 111110
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCC
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGL 577 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 577 (621)
.... ...+...+.+++..||+.+|++||++.+++..+.....
T Consensus 229 -~~~~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 229 -RLPQ-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred -CCCC-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 0000 11223578899999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=331.39 Aligned_cols=246 Identities=24% Similarity=0.332 Sum_probs=194.3
Q ss_pred ceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceEEEEeccCC
Q 007020 302 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPYMAN 377 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 377 (621)
+.||+|+||.||+|... +++.||+|+++.... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999865 688999999975432 22344578899999888 699999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee
Q 007020 378 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457 (621)
Q Consensus 378 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 457 (621)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~ 152 (329)
T cd05588 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT 152 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence 99999886543 389999999999999999999999 9999999999999999999999999998742211 122
Q ss_pred eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccC
Q 007020 458 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537 (621)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 537 (621)
.....||..|+|||++.+..++.++|||||||++|||++|+.||+.............++........... +.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~p- 225 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------IP- 225 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------CC-
Confidence 33456999999999999999999999999999999999999999743322222222223333322221111 11
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCCCH
Q 007020 538 NYVEAEVEQLIQVALLCTQGSPMDRPKM 565 (621)
Q Consensus 538 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 565 (621)
......+.+++..|++.||.+||++
T Consensus 226 ---~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 226 ---RSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred ---CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1123568899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=318.96 Aligned_cols=261 Identities=20% Similarity=0.325 Sum_probs=209.0
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|++.+.||+|+||.||+|+.. +++.||||.++... .......+.+|+++++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888999999999999999864 68999999876432 2334456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++.........+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998865433334478889999999999999999999 999999999999999999999999999887543
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
... ......|+..|+|||.+.+...+.++||||||+++|||++|+.||.... ....++...... ...
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~------~~~~~~~~~~~~------~~~ 225 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLFSLCQKIEQ------CDY 225 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc------ccHHHHHHHHhc------CCC
Confidence 221 1223458889999999988888999999999999999999999985221 111222222111 011
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
+.. ........+.+++.+||+.+|++||++.+|++.+++.
T Consensus 226 ~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 226 PPL---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCC---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111 1123346789999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=320.24 Aligned_cols=256 Identities=27% Similarity=0.441 Sum_probs=204.8
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
+..++|++.+.||+|+||.||+|...++..||+|.++.... ....+.+|+.++++++|+|++++++++. ....+++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT 79 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence 34567888899999999999999988888899999875433 2456899999999999999999999875 45689999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++++|.++++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 80 EYMSKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 99999999999976432 2378999999999999999999999 999999999999999999999999999987644
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
..........++..|+|||.+.+..++.++||||||+++|+|++ |..||.... . .+...........
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-----~---~~~~~~~~~~~~~---- 222 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-----N---REVLEQVERGYRM---- 222 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-----H---HHHHHHHHcCCCC----
Confidence 32222222335678999999988889999999999999999999 889985211 1 1111111111000
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.........+.+++.+|+..+|++|||++++.+.|++
T Consensus 223 ------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 ------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=333.56 Aligned_cols=252 Identities=27% Similarity=0.339 Sum_probs=197.6
Q ss_pred CCCcCceeeeccCceEEEEEc----CCCcEEEEEEecccC---CchhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCce
Q 007020 297 SFSNKNILGRGGFGKVYKGRL----ADGSLVAVKRLKEER---TPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 368 (621)
+|++.+.||+|+||+||+++. .+++.||+|+++... .......+..|+.++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999874 358899999986532 122234578899999999 499999999999999999
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999987643 388899999999999999999999 99999999999999999999999999998
Q ss_pred ecccCCCeeeecccccccccchhhhccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 449 LMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
..............||..|+|||++.+.. ++.++|||||||++|||++|+.||....... ...........
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~~~~~~~~~~~---- 225 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN----TQSEVSRRILK---- 225 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC----CHHHHHHHHhc----
Confidence 65443333344556999999999998654 7889999999999999999999996322111 11111111111
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 570 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~ 570 (621)
.++... ......+.+++..|++.||++|| +++++++
T Consensus 226 ---~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 ---CDPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ---CCCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 111111 12235678999999999999999 5556654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=336.55 Aligned_cols=261 Identities=20% Similarity=0.226 Sum_probs=197.2
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
..+|++.+.||+|+||.||+|... +++.||+|.... ..+.+|+++++.++||||+++++++......++|+|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 467999999999999999999864 688999997532 246789999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
++. ++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 164 ~~~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 164 RYK-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred cCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 996 58888886543 378899999999999999999999 9999999999999999999999999999754332
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCC---CcchHHHHHHHHhhh------
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLAND---DDVMLLDWVKGLLKE------ 524 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~---~~~~~~~~~~~~~~~------ 524 (621)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||-....... ....+...+......
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 22233445699999999999998999999999999999999999988642211110 000011100000000
Q ss_pred ---cccc---------cccCccccC--cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 525 ---KKLE---------MLVDPDLQN--NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 525 ---~~~~---------~~~d~~~~~--~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.... ....+.... .........+.+++..|++.||++|||++|+++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 000000000 001123467889999999999999999999975
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=330.56 Aligned_cols=246 Identities=25% Similarity=0.338 Sum_probs=193.1
Q ss_pred ceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceEEEEeccCC
Q 007020 302 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPYMAN 377 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 377 (621)
+.||+|+||+||+|... +++.||+|+++... .......+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 67899999997643 222344577888888766 799999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee
Q 007020 378 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457 (621)
Q Consensus 378 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 457 (621)
|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~ 152 (329)
T cd05618 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 152 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence 99998886543 388999999999999999999999 99999999999999999999999999987532211 12
Q ss_pred eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccC
Q 007020 458 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537 (621)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 537 (621)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...............++......... .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~-- 224 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI-- 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CC--
Confidence 2345689999999999999999999999999999999999999963222222222222333322221111 11
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCCCH
Q 007020 538 NYVEAEVEQLIQVALLCTQGSPMDRPKM 565 (621)
Q Consensus 538 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 565 (621)
+......+.+++..|++.||++||++
T Consensus 225 --p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 --PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred --CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11223578899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=323.28 Aligned_cols=257 Identities=28% Similarity=0.426 Sum_probs=208.2
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
....+|+..+.||+|+||.||+|...+++.+|+|.+.... .....++..|+.+++.++|+||+++++++...+..++||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 3456788889999999999999998889999999987543 223456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 82 ELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred eecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999999986432 3478999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.... .. +..........
T Consensus 157 ~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-----~~---~~~~~~~~~~~----- 222 (261)
T cd05148 157 DVY-LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-----NH---EVYDQITAGYR----- 222 (261)
T ss_pred ccc-cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-----HH---HHHHHHHhCCc-----
Confidence 221 1223346778999999988889999999999999999998 899995321 11 11111111100
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
..........+.+++.+|++.+|++|||++++++.|+.
T Consensus 223 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 -----MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 01112234678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=332.75 Aligned_cols=253 Identities=21% Similarity=0.277 Sum_probs=201.3
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|.+.+.||+|+||+||++... +|+.||+|+++.... ......+..|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888899999999999999865 689999999975432 223456888999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999997652 2388999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCeeeecccccccccchhhhc------cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLS------TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (621)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||.... .............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--------~~~~~~~i~~~~~ 226 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT--------SAKTYNNIMNFQR 226 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC--------HHHHHHHHHcCCC
Confidence 4333334456999999999986 4567889999999999999999999996321 1122222221111
Q ss_pred cccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 527 ~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.... +. .......+.+++..|++ +|.+||++.++++
T Consensus 227 ~~~~--~~-----~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 FLKF--PE-----DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ccCC--CC-----CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1110 10 01123567888899997 9999999998864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=339.34 Aligned_cols=265 Identities=21% Similarity=0.326 Sum_probs=208.2
Q ss_pred HHHHHhcCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-CCceeeeeeee
Q 007020 290 ELQVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFC 362 (621)
Q Consensus 290 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 362 (621)
++++..++|.+.+.||+|+||.||+|++. .++.||+|+++..........+.+|+.++.++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 35666778888999999999999999853 346899999976544444557889999999997 99999999999
Q ss_pred ecCCceEEEEeccCCCchhhhhccCCC-----------------------------------------------------
Q 007020 363 MTPTERLLVYPYMANGSVASCLRERPP----------------------------------------------------- 389 (621)
Q Consensus 363 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------- 389 (621)
......++||||+++|+|.++++....
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999999975321
Q ss_pred -----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 007020 390 -----------------------------------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKA 428 (621)
Q Consensus 390 -----------------------------------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~ 428 (621)
....+++..+..++.|++.||+|||+. +|+||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCc
Confidence 112367788899999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEcccccceecccCCC-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccc
Q 007020 429 ANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARL 506 (621)
Q Consensus 429 ~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~ 506 (621)
+|||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999986532221 11222346788999999998889999999999999999998 8889852210
Q ss_pred cCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 507 ANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.+.......... .+ ..+......+.+++..||..+|++||++++|++.|+.
T Consensus 348 --------~~~~~~~~~~~~-----~~----~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 348 --------NEQFYNAIKRGY-----RM----AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred --------hHHHHHHHHcCC-----CC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 011111111110 00 0111223678999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=323.96 Aligned_cols=266 Identities=25% Similarity=0.371 Sum_probs=201.1
Q ss_pred CcCceeeeccCceEEEEEc-----CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecC--CceEEE
Q 007020 299 SNKNILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLV 371 (621)
Q Consensus 299 ~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 371 (621)
...+.||+|+||+||++.+ .+++.||+|.++..........+.+|+++++.++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7788999999999988652 357889999997654444556788999999999999999999987654 457899
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++....
T Consensus 87 ~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 87 MEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred ecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999753 289999999999999999999999 99999999999999999999999999998654
Q ss_pred cCCCe--eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 452 YKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 452 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
..... ......++..|+|||.+.+..++.++||||||+++|||++|..||........ ....+..+.........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE---EMIGPKQGQMTVVRLIE 235 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh---hhhcccccccchhhhhh
Confidence 32211 11222356679999999888899999999999999999999999853221100 00000000000000111
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
..+...........+..+.+++..||+.+|++|||+++|++.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 1111111111223346899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=335.85 Aligned_cols=256 Identities=22% Similarity=0.287 Sum_probs=201.6
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
...++|+..+.||+|+||+||+++.. +++.||+|.+.... .......+..|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 44568889999999999999999865 68899999986432 1223345788999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 999999999999998753 277888999999999999999999 999999999999999999999999999987
Q ss_pred cccCCCeeeecccccccccchhhhccC----CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 450 MDYKDTHVTTAVRGTIGHIAPEYLSTG----KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
.............||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...........
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~ 263 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMDHK 263 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------HHHHHHHHcCC
Confidence 643332233345699999999998654 378899999999999999999999963211 11111211111
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 007020 526 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMD--RPKMSEVVRM 571 (621)
Q Consensus 526 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~--RPt~~~vl~~ 571 (621)
. ....+. .......+.+++..|++.+|++ ||+++++++.
T Consensus 264 ~--~~~~~~-----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 264 N--SLTFPD-----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred C--cCCCCC-----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 000111 1112367888999999999988 9999998654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=327.12 Aligned_cols=264 Identities=30% Similarity=0.449 Sum_probs=208.7
Q ss_pred HHHHhcCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeee
Q 007020 291 LQVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCM 363 (621)
Q Consensus 291 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 363 (621)
+++..++|+..+.||+|+||.||++... ....+|+|.++..........+.+|++++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 4556678888999999999999999853 23689999987655545556788999999999 7999999999999
Q ss_pred cCCceEEEEeccCCCchhhhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 007020 364 TPTERLLVYPYMANGSVASCLRERP------------PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANI 431 (621)
Q Consensus 364 ~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Ni 431 (621)
.+...+++|||+++|+|.++++... .....+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 9999999999999999999987532 1233588999999999999999999999 999999999999
Q ss_pred eeCCCCcEEEcccccceecccCCCee-eecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCC
Q 007020 432 LLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLAND 509 (621)
Q Consensus 432 ll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~ 509 (621)
+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---- 239 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---- 239 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC----
Confidence 99999999999999998654322211 122235678999999988899999999999999999998 999985211
Q ss_pred CcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 510 DDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
..+.... ..... ...........+.+++.+|++.+|++|||+.++++.|+..
T Consensus 240 ----~~~~~~~-~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 240 ----VEELFKL-LKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ----HHHHHHH-HHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1111111 11110 0011122346788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=317.74 Aligned_cols=248 Identities=27% Similarity=0.419 Sum_probs=197.2
Q ss_pred ceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCch
Q 007020 302 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 380 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 380 (621)
+.||+|+||.||+|... +++.||+|.+...........+.+|+++++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999875 68899999987555445566799999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeee-e
Q 007020 381 ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-T 459 (621)
Q Consensus 381 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~-~ 459 (621)
.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........... .
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 99987532 2378999999999999999999999 999999999999999999999999999875432211111 1
Q ss_pred cccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCc
Q 007020 460 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNN 538 (621)
Q Consensus 460 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 538 (621)
....+..|+|||.+.++.++.++||||||+++|||++ |..||..... .. ........ ....
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--------~~-~~~~~~~~---------~~~~ 216 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--------QQ-TREAIEQG---------VRLP 216 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--------HH-HHHHHHcC---------CCCC
Confidence 1123457999999998889999999999999999998 8888852211 01 11111100 0001
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007020 539 YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573 (621)
Q Consensus 539 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 573 (621)
.....+..+.+++.+|++.+|++||++.+|.++|+
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 11223467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=319.60 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=204.0
Q ss_pred HhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
..++|++.+.||+|+||.||+|.+.++..||+|.++.... ....+.+|+++++.++|+||+++++++. ....++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 80 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence 3467889999999999999999987777899999875332 2356889999999999999999999874 456899999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 81 YMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred cCCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 999999999997642 22378899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
.........++..|+|||+..+..++.++||||||+++|||++ |..||.... . .+.........
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~-----~---~~~~~~~~~~~------- 220 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----N---REVLDQVERGY------- 220 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----h---HHHHHHHhcCC-------
Confidence 3322233446778999999988889999999999999999999 888885221 0 01111111100
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
...........+.+++..|++.+|++||++.++++.|++
T Consensus 221 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 221 ---RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred ---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 001122344678999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=333.33 Aligned_cols=259 Identities=21% Similarity=0.282 Sum_probs=200.8
Q ss_pred HHHHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCC
Q 007020 290 ELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 366 (621)
Q Consensus 290 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 366 (621)
++....++|+..+.||+|+||.||++... +++.||+|.+.... .......+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34455678999999999999999999875 58899999986432 1223445788999999999999999999999999
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccc
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 446 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 446 (621)
..++||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccc
Confidence 999999999999999999753 278889999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCeeeecccccccccchhhhccCC----CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh
Q 007020 447 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 522 (621)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 522 (621)
+...............||+.|+|||++.+.. ++.++||||+||++|||++|+.||.... .........
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~--------~~~~~~~i~ 260 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS--------LVGTYSKIM 260 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC--------HHHHHHHHH
Confidence 9876543333334556999999999997643 6789999999999999999999996321 111112211
Q ss_pred hhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 007020 523 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMD--RPKMSEVVRM 571 (621)
Q Consensus 523 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~--RPt~~~vl~~ 571 (621)
........ + ........+.+++..|+..++.+ |+++.++++.
T Consensus 261 ~~~~~~~~--p-----~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 261 DHKNSLNF--P-----EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred hCCcccCC--C-----CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11110000 0 01122356777888888755543 8899988764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=304.65 Aligned_cols=253 Identities=21% Similarity=0.302 Sum_probs=206.2
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
..+.|++.+.||+|.|+.||++.+. +|+.+|+|++.... .....+.+.+|+.+-+.++|||||++.+.+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3567888899999999999999754 79999999986543 233556789999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---CCcEEEcccccce
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFGLAK 448 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfGla~ 448 (621)
+|+|.||+|..-|-.+ ..+++..+-..+.||+++|.|+|.+ +|||||+||+|+++-. ..-+|++|||+|.
T Consensus 89 Fe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 9999999998766543 2378888899999999999999999 9999999999999943 3469999999999
Q ss_pred ecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 449 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
.++ +.......+||++|||||++...+++..+|||+.|||||-|+.|.+||... +....+ +++... .
T Consensus 162 ~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~----~~~rly----e~I~~g-~-- 228 (355)
T KOG0033|consen 162 EVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE----DQHRLY----EQIKAG-A-- 228 (355)
T ss_pred EeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc----cHHHHH----HHHhcc-c--
Confidence 877 555667788999999999999999999999999999999999999999521 121111 221111 0
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. +....++....++..+++++|+..||.+|.|+.|.+.
T Consensus 229 --y--d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 229 --Y--DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred --c--CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1 1122234444577888999999999999999998864
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=323.34 Aligned_cols=258 Identities=26% Similarity=0.451 Sum_probs=203.9
Q ss_pred cCCCcCceeeeccCceEEEEEc-----CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
++|+..+.||+|+||+||+|.. .++..||+|.++..........+.+|+.+++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4677788999999999999974 25678999999765544445678999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC
Q 007020 371 VYPYMANGSVASCLRERPP-------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF 437 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 437 (621)
+|||+++|+|.+++..... ....+++..+..++.|++.||+|||++ +++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999864321 122478889999999999999999999 999999999999999999
Q ss_pred cEEEcccccceecccCCC-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHH
Q 007020 438 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLL 515 (621)
Q Consensus 438 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~ 515 (621)
.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||.... . .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~-----~---~ 233 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-----N---Q 233 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-----H---H
Confidence 999999999986543221 12223345678999999988889999999999999999998 999985211 1 1
Q ss_pred HHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 516 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 516 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
..... ....... .........+.+++..|++.+|++||++.+|.++|+.
T Consensus 234 ~~~~~-~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 EVIEM-VRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHH-HHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111 1111110 0111233678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=318.33 Aligned_cols=257 Identities=27% Similarity=0.451 Sum_probs=206.3
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
++..++|.+.++||+|+||.||+|...+++.||+|.+..... ...++.+|+.++++++|+||+++++++. .+..+++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 345678889999999999999999988899999999875432 3457889999999999999999999864 5678999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 79 TEYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 99999999999987643 23488899999999999999999999 99999999999999999999999999998655
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
...........++..|+|||++.+..++.++||||||+++|||++ |+.||.... . .+.+........
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~---~~~~~~~~~~~~---- 221 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT-----N---PEVIQNLERGYR---- 221 (260)
T ss_pred CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC-----h---HHHHHHHHcCCC----
Confidence 322222223346778999999988889999999999999999999 999996221 1 111111111100
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
... .......+.+++.+|++.+|++||++++++..|+.
T Consensus 222 --~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 --MPR----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 001 11223579999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=330.51 Aligned_cols=247 Identities=22% Similarity=0.259 Sum_probs=198.9
Q ss_pred HhcCCCcCceeeeccCceEEEEEcCC--CcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLAD--GSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
..++|...+.||+|+||.||+|.+.. +..||+|.+.... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34578888999999999999998543 3689999986432 2233456889999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 108 lv~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 9999999999999997643 388899999999999999999999 999999999999999999999999999986
Q ss_pred cccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 450 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... . ........... .
T Consensus 181 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~---~~~~~~i~~~~-~-- 245 (340)
T PTZ00426 181 VDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE-----P---LLIYQKILEGI-I-- 245 (340)
T ss_pred cCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC-----H---HHHHHHHhcCC-C--
Confidence 5432 223469999999999998889999999999999999999999996221 0 01111111110 0
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 570 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~ 570 (621)
.. +......+.+++..|++.+|++|+ +++++++
T Consensus 246 ----~~----p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 246 ----YF----PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred ----CC----CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 00 111225678899999999999995 7888764
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=311.47 Aligned_cols=266 Identities=24% Similarity=0.306 Sum_probs=202.5
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCc-eeeeeeeeecCC------
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRN-LLRLRGFCMTPT------ 366 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------ 366 (621)
..|...++||+|+||+||+|+.. +|+.||+|.++.... +.......+|+.+++.++|+| ||++++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 44566678999999999999864 789999999986654 223334679999999999999 999999998877
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccc
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 446 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 446 (621)
..++|+||++. +|..++.........++...++.++.||++||+|||++ +|+||||||+|||++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 78899999987 99999988664323366689999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 447 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
|+........ .+..++|..|.|||++.+. .|+...||||+|||++||++++..|..... ......+-..+...
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-----~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-----IDQLFRIFRLLGTP 240 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-----HHHHHHHHHHcCCC
Confidence 9976543332 4455689999999999887 689999999999999999999998863221 11111111111110
Q ss_pred c------cccccCcc-----cc--CcccHHH---HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 526 K------LEMLVDPD-----LQ--NNYVEAE---VEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 526 ~------~~~~~d~~-----~~--~~~~~~~---~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
. ...+.+-+ .. ....... .....+++..|++.+|.+|.|++..+++
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0 00000100 00 0011111 1368899999999999999999999875
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=315.69 Aligned_cols=248 Identities=29% Similarity=0.436 Sum_probs=199.5
Q ss_pred ceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCchh
Q 007020 302 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 381 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 381 (621)
++||+|+||.||+|...+++.||+|.++..........+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988889999999876654444557889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeeeecc
Q 007020 382 SCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 461 (621)
Q Consensus 382 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 461 (621)
+++..... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKKKD---ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 99875432 378999999999999999999999 999999999999999999999999999875433222111222
Q ss_pred cccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCccc
Q 007020 462 RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 540 (621)
Q Consensus 462 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 540 (621)
.++..|+|||++.+..++.++||||||+++|++++ |..||..... ........... ... ..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~--------~~~~~~~~~~~------~~~----~~ 216 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN--------QQAREQVEKGY------RMS----CP 216 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHHcCC------CCC----CC
Confidence 34668999999998889999999999999999998 9999852211 11111111110 001 11
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007020 541 EAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573 (621)
Q Consensus 541 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 573 (621)
......+.+++.+|++.+|++||++.++++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 123467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=318.61 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=200.8
Q ss_pred cCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEecc
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 375 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 375 (621)
.+|+..+.||+|+||.||++.+.++..+|+|.+..... ....+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 35777889999999999999987778899999864332 2346888999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCC
Q 007020 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 455 (621)
++++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 82 ANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 99999999976432 488999999999999999999999 999999999999999999999999999986543222
Q ss_pred eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 456 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||+.... . +........ ....
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~---~~~~~~~~~------~~~~ 221 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-----S---EVVESVSAG------YRLY 221 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH-----H---HHHHHHHcC------CcCC
Confidence 11122224457999999998899999999999999999999 8999863211 0 111111110 0111
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 572 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L 572 (621)
. ....+..+.+++..||..+|++|||+.++++.|
T Consensus 222 ~----~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 R----PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred C----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0 112346799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=324.92 Aligned_cols=262 Identities=25% Similarity=0.367 Sum_probs=194.0
Q ss_pred cCCCcCceeeeccCceEEEEEcC--CCcEEEEEEecccCCc-hhHHHHHHHHHHHHhc---cCCceeeeeeeee-----c
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA--DGSLVAVKRLKEERTP-GGELQFQTEVEMISMA---VHRNLLRLRGFCM-----T 364 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~ 364 (621)
++|+..+.||+|+||+||+|... +++.||+|.++..... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 4688999998754322 2233566777776655 6999999999875 2
Q ss_pred CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccc
Q 007020 365 PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 444 (621)
Q Consensus 365 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 444 (621)
....++||||++ ++|.+++...... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999997 5899988764322 378899999999999999999999 9999999999999999999999999
Q ss_pred ccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhh
Q 007020 445 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 524 (621)
Q Consensus 445 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 524 (621)
|+++..... .......|+..|+|||.+.+..++.++|||||||++|||++|++||..... ......+......
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~-----~~~~~~i~~~~~~ 227 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-----VDQLGKILDVIGL 227 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH-----HHHHHHHHHHhCC
Confidence 999865433 223345589999999999888899999999999999999999999963221 1111111110000
Q ss_pred ----ccc------ccccCcccc---CcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 525 ----KKL------EMLVDPDLQ---NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 525 ----~~~------~~~~d~~~~---~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
... .....+... ..........+.+++.+|++.||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 000000000 0001122356789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=327.53 Aligned_cols=243 Identities=25% Similarity=0.294 Sum_probs=195.8
Q ss_pred ceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCC
Q 007020 302 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 378 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 378 (621)
+.||+|+||.||++... +|+.||+|+++.... ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 689999999975432 233456788999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeee
Q 007020 379 SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 458 (621)
Q Consensus 379 sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 458 (621)
+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~ 152 (328)
T cd05593 81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATM 152 (328)
T ss_pred CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccc
Confidence 9998887543 388999999999999999999999 9999999999999999999999999998753221 1222
Q ss_pred ecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCc
Q 007020 459 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNN 538 (621)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 538 (621)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ +..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~--------~~~~~~~~~~~-------~~~~--- 214 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILME-------DIKF--- 214 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC--------HHHHHHHhccC-------CccC---
Confidence 34569999999999998899999999999999999999999995321 11111111110 1111
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 007020 539 YVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVRM 571 (621)
Q Consensus 539 ~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~~ 571 (621)
+......+.+++..|++.||++|| ++.++++.
T Consensus 215 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 -PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 112235788999999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=328.08 Aligned_cols=242 Identities=23% Similarity=0.287 Sum_probs=194.1
Q ss_pred ceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCC
Q 007020 302 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 378 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 378 (621)
+.||+|+||.||++... +|+.||+|.++... .......+..|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999864 68999999997543 2233446778999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeee
Q 007020 379 SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 458 (621)
Q Consensus 379 sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 458 (621)
+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~ 152 (323)
T cd05595 81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATM 152 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcc
Confidence 9998887543 388999999999999999999999 9999999999999999999999999998753221 1222
Q ss_pred ecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCc
Q 007020 459 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNN 538 (621)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 538 (621)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......... +..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~~~~~-------~~~~--- 214 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILME-------EIRF--- 214 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcC-------CCCC---
Confidence 345699999999999988999999999999999999999999953211 0111111110 0011
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007020 539 YVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 570 (621)
Q Consensus 539 ~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~ 570 (621)
+......+.+++..|++.||++|| ++.++++
T Consensus 215 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 -PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred -CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 112236788999999999999998 7777764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=333.12 Aligned_cols=253 Identities=20% Similarity=0.277 Sum_probs=194.6
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.|...+.||+|+||+||+|... +++.||+|+++... .......+..|+++++.++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999864 68899999997543 22334568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999987643 378889999999999999999999 9999999999999999999999999997643110
Q ss_pred CC----------------------------------------------eeeecccccccccchhhhccCCCCCcccchhH
Q 007020 454 DT----------------------------------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 487 (621)
Q Consensus 454 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl 487 (621)
.. .......||..|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00123469999999999998889999999999
Q ss_pred HHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHh--ccCCCCCCCCCH
Q 007020 488 GIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALL--CTQGSPMDRPKM 565 (621)
Q Consensus 488 Gvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~--c~~~~P~~RPt~ 565 (621)
||++|||++|+.||...... ............ ..-+. ......++.+++.. |+..+|..||++
T Consensus 235 G~il~elltG~~Pf~~~~~~--------~~~~~i~~~~~~--~~~~~-----~~~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPT--------ETQLKVINWENT--LHIPP-----QVKLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHH--------HHHHHHHccccc--cCCCC-----CCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 99999999999999632210 001111110000 00000 00112456666665 666677779999
Q ss_pred HHHHHH
Q 007020 566 SEVVRM 571 (621)
Q Consensus 566 ~~vl~~ 571 (621)
++++..
T Consensus 300 ~~~l~h 305 (381)
T cd05626 300 DDIKAH 305 (381)
T ss_pred HHHhcC
Confidence 999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=333.50 Aligned_cols=252 Identities=20% Similarity=0.292 Sum_probs=197.2
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|+..+.||+|+||+||+|+.. +|+.||||+++... .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999875 68999999997532 1223445788999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999997643 388999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCe-------------------------------------eeecccccccccchhhhccCCCCCcccchhHHHHHHHHH
Q 007020 453 KDTH-------------------------------------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELI 495 (621)
Q Consensus 453 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell 495 (621)
.... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011245999999999999989999999999999999999
Q ss_pred hCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 007020 496 TGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK---MSEVVR 570 (621)
Q Consensus 496 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt---~~~vl~ 570 (621)
+|..||..... .+.......... ....+. .......+.+++..|+. +|.+|++ ++++++
T Consensus 234 ~G~~Pf~~~~~--------~~~~~~i~~~~~--~~~~~~-----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNP--------QETYRKIINWKE--TLQFPD-----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCH--------HHHHHHHHcCCC--ccCCCC-----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99999963211 111111111110 000010 00123567788888886 8999998 777754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=321.31 Aligned_cols=259 Identities=28% Similarity=0.393 Sum_probs=204.3
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCc
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 367 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 367 (621)
..++|.+.+.||+|+||.||+|.+. .+..||+|.+...........+..|+.+++.++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4567888999999999999999874 3568999988765555555678999999999999999999999999999
Q ss_pred eEEEEeccCCCchhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC---cEEE
Q 007020 368 RLLVYPYMANGSVASCLRERPP---SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF---EAVV 441 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl 441 (621)
.++||||+++|+|.+++..... ....+++..+..++.||+.||+|||+. +++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999876432 123488999999999999999999999 999999999999998654 5999
Q ss_pred cccccceecccCCCee-eecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHH
Q 007020 442 GDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVK 519 (621)
Q Consensus 442 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 519 (621)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||..... .+.+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--------~~~~~ 232 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--------QEVME 232 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHH
Confidence 9999998653222111 112223568999999998899999999999999999997 9999963211 11111
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007020 520 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573 (621)
Q Consensus 520 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 573 (621)
........ ......+..+.+++..|++.+|++||++.+|++.|+
T Consensus 233 ~~~~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 FVTGGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHcCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111110 111223467889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=313.69 Aligned_cols=261 Identities=22% Similarity=0.345 Sum_probs=210.8
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|+..+.||+|+||.||+|... +|+.||+|.++... .......+.+|++++++++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999976 78999999886432 2333567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++.........+++..+..++.++++||.|||+. +|+||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999876444445588999999999999999999999 999999999999999999999999999886543
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
.... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ....+....... .. ..
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~-~~----~~ 226 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIEK-CD----YP 226 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC------ccHHHHHhhhhc-CC----CC
Confidence 3221 223458889999999998889999999999999999999999985321 112222221111 00 00
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
+ . ........+.+++..||..+|++||++.+|+++|++.
T Consensus 227 ~-~---~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 227 P-L---PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred C-C---ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 0 0 0113346788999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=337.84 Aligned_cols=253 Identities=25% Similarity=0.315 Sum_probs=202.7
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|.+.+.||+|+||+||+|... +|+.||+|+++.... ......+..|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888899999999999999875 689999999975431 233456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRKD----VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 9999999999998652 388899999999999999999999 999999999999999999999999999986543
Q ss_pred CC----------------------------CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccc
Q 007020 453 KD----------------------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLA 504 (621)
Q Consensus 453 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~ 504 (621)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11223345999999999999999999999999999999999999999632
Q ss_pred cccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 007020 505 RLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-MSEVVRM 571 (621)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-~~~vl~~ 571 (621)
.. ........... .....+.. ......+.+++..|+. +|.+||+ ++++++.
T Consensus 234 ~~--------~~~~~~i~~~~--~~~~~p~~-----~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TL--------QETYNKIINWK--ESLRFPPD-----PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CH--------HHHHHHHhccC--CcccCCCC-----CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 21 11111111100 00111110 0124678889999997 9999999 9999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=322.33 Aligned_cols=248 Identities=24% Similarity=0.310 Sum_probs=195.1
Q ss_pred eeeccCceEEEEEcC-CCcEEEEEEecccCCc--hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCch
Q 007020 304 LGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 380 (621)
Q Consensus 304 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 380 (621)
||+|+||+||++... +++.||+|.+...... .....+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999865 6889999998654322 2234577899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeeeec
Q 007020 381 ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 460 (621)
Q Consensus 381 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 460 (621)
.+++.........+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988865433344589999999999999999999999 999999999999999999999999999986543322 2233
Q ss_pred ccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCccc
Q 007020 461 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 540 (621)
Q Consensus 461 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 540 (621)
..||+.|+|||++.+..++.++||||||+++|||++|+.||....... .......... .... ...
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~----~~~~~~~~~~---------~~~~--~~~ 221 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV----ENKELKQRIL---------NDSV--TYP 221 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch----hHHHHHHhhc---------ccCC--CCc
Confidence 468999999999999999999999999999999999999996322110 0111111111 0000 111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007020 541 EAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 570 (621)
Q Consensus 541 ~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~ 570 (621)
...+..+.+++..|++.||++|| +++++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 22346788999999999999999 5666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=314.10 Aligned_cols=258 Identities=24% Similarity=0.351 Sum_probs=194.7
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCC-----ceEE
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-----ERLL 370 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 370 (621)
+|...+++|.|+||.||+|... +++.||||+.-.+..- -.+|+++|+.+.|||||++.-+|.... ...+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 5667789999999999999864 5789999987544321 247899999999999999998886432 3358
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC-CcEEEccccccee
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKL 449 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfGla~~ 449 (621)
|||||+. +|.++++........++.-.++-+..||.+||+|||+. +|+||||||+|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999998 99999986433344578888999999999999999998 99999999999999976 8999999999998
Q ss_pred cccCCCeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc---
Q 007020 450 MDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK--- 525 (621)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 525 (621)
+...... .+..-|..|+|||.+.+. .|+.+.||||.|||+.||+-|++.|..... ...+...+ .++.-.
T Consensus 176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~----~dQL~eIi-k~lG~Pt~e 248 (364)
T KOG0658|consen 176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS----VDQLVEII-KVLGTPTRE 248 (364)
T ss_pred eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH----HHHHHHHH-HHhCCCCHH
Confidence 7654433 233467889999999876 589999999999999999999999953221 11111111 111110
Q ss_pred ccc-------cccCccccCc-----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 526 KLE-------MLVDPDLQNN-----YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 526 ~~~-------~~~d~~~~~~-----~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.+. ....+.+... +......+..+++.+++..+|.+|.++.|++.
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 010 1111222111 22334578899999999999999999998875
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=330.96 Aligned_cols=262 Identities=21% Similarity=0.291 Sum_probs=203.0
Q ss_pred HHHHHHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeec
Q 007020 288 LRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMT 364 (621)
Q Consensus 288 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 364 (621)
+.++....++|++.+.||+|+||.||++... +++.||+|++.... .......+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4456667789999999999999999999875 68899999986432 12233457889999999999999999999999
Q ss_pred CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccc
Q 007020 365 PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 444 (621)
Q Consensus 365 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 444 (621)
+...++||||+++|+|.+++.... +++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 999999999999999999987532 77888999999999999999999 9999999999999999999999999
Q ss_pred ccceecccCCCeeeecccccccccchhhhccCC----CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH
Q 007020 445 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 520 (621)
Q Consensus 445 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 520 (621)
|++...............||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ......
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~ 258 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSK 258 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--------HHHHHH
Confidence 999876543333334556999999999997543 78899999999999999999999963221 111122
Q ss_pred HhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHH
Q 007020 521 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMD--RPKMSEVVRML 572 (621)
Q Consensus 521 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~--RPt~~~vl~~L 572 (621)
+..........+ .......+.+++..|+..++.+ ||+++++++..
T Consensus 259 i~~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 259 IMNHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HHcCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 211111111111 1122356778888999844433 77888887654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=325.14 Aligned_cols=261 Identities=25% Similarity=0.400 Sum_probs=206.9
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEc------CCCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeeec
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 364 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 364 (621)
....++|...+.||+|+||.||++.. ..+..||+|.++..........+.+|+.+++++ +|+||+++++++..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 44556788999999999999999974 135579999987655444556789999999999 79999999999999
Q ss_pred CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccc
Q 007020 365 PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 444 (621)
Q Consensus 365 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 444 (621)
.+..+++|||+++|+|.++++.... ..+++.++..++.|++.||+|||++ +|+|+||||+||+++.++.++++||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCC
Confidence 9999999999999999999975432 2278999999999999999999999 9999999999999999999999999
Q ss_pred ccceecccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHh
Q 007020 445 GLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 522 (621)
Q Consensus 445 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 522 (621)
|++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .......+.
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~----~~~~~~~~~--- 258 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV----DSKFYKLIK--- 258 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc----hHHHHHHHH---
Confidence 999865433221 1222345778999999998889999999999999999998 9999853211 111111111
Q ss_pred hhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 523 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 523 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.. ............+.+++..|++.+|++||++.+|++.|+.
T Consensus 259 -~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 259 -EG---------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred -cC---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 00 0000011123578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=321.02 Aligned_cols=265 Identities=23% Similarity=0.381 Sum_probs=203.5
Q ss_pred hcCCCcCceeeeccCceEEEEEcCC---------------CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeee
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLAD---------------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 359 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 359 (621)
.++|++.+.||+|+||.||++.... ...||+|.++..........+.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4578888999999999999987532 2358999997665555566799999999999999999999
Q ss_pred eeeecCCceEEEEeccCCCchhhhhccCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 007020 360 GFCMTPTERLLVYPYMANGSVASCLRERPP--------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANI 431 (621)
Q Consensus 360 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Ni 431 (621)
+++...+..++||||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999865321 112368889999999999999999999 999999999999
Q ss_pred eeCCCCcEEEcccccceecccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh--CCCCcccccccC
Q 007020 432 LLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT--GQRAFDLARLAN 508 (621)
Q Consensus 432 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~pf~~~~~~~ 508 (621)
+++.++.+||+|||++......... ......++..|+|||.+.++.++.++||||||+++|+|++ |..||.....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-- 238 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-- 238 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--
Confidence 9999999999999999765332211 1222335678999999998889999999999999999998 6667752211
Q ss_pred CCcchHHHHHHHHhhhccc-ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 509 DDDVMLLDWVKGLLKEKKL-EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
. ...+.+......... ..... ....+..+.+++.+||+.+|++||++++|++.|++
T Consensus 239 --~-~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 --E-QVIENTGEFFRNQGRQIYLSQ-------TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred --H-HHHHHHHHhhhhccccccCCC-------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1 111111111111000 00001 11123679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=330.43 Aligned_cols=200 Identities=21% Similarity=0.337 Sum_probs=173.5
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|+..+.||+|+||+||+|... +++.||+|+++.... ......+..|+.++..++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999865 688999999975321 223346788999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999997643 388999999999999999999999 999999999999999999999999999875432
Q ss_pred CCC----------------------------------eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCC
Q 007020 453 KDT----------------------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQ 498 (621)
Q Consensus 453 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~ 498 (621)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012346999999999999999999999999999999999999
Q ss_pred CCcc
Q 007020 499 RAFD 502 (621)
Q Consensus 499 ~pf~ 502 (621)
.||.
T Consensus 234 ~Pf~ 237 (363)
T cd05628 234 PPFC 237 (363)
T ss_pred CCCC
Confidence 9996
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=322.04 Aligned_cols=261 Identities=28% Similarity=0.438 Sum_probs=206.9
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCC
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 366 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 366 (621)
+..++|.+.+.||+|+||.||+|... .+..||+|.+...........+.+|+.+++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 34567888899999999999999854 246899999875554455567889999999999999999999999999
Q ss_pred ceEEEEeccCCCchhhhhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEE
Q 007020 367 ERLLVYPYMANGSVASCLRERPPS------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV 440 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 440 (621)
..++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence 999999999999999998754321 22478889999999999999999999 999999999999999999999
Q ss_pred EcccccceecccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHH
Q 007020 441 VGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWV 518 (621)
Q Consensus 441 l~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~ 518 (621)
|+|||+++........ ......++..|+|||.+.+..++.++||||||+++||+++ |..||.... .....+++
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-----~~~~~~~~ 234 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-----NEEVLKFV 234 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-----HHHHHHHH
Confidence 9999998765433221 1223346789999999988889999999999999999998 999985211 11111111
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 519 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 519 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
. .... ... +......+.+++..||+.+|++|||+.++++.|++
T Consensus 235 ~----~~~~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 I----DGGH-----LDL----PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred h----cCCC-----CCC----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1 1110 011 11124678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=320.96 Aligned_cols=263 Identities=25% Similarity=0.420 Sum_probs=206.6
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecC
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 365 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 365 (621)
++..++|++.+.||+|+||.||+|..+ .+..||+|.++..........+.+|+.+++.++|+||+++++++.+.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 456788999999999999999999643 24589999987554444455688899999999999999999999999
Q ss_pred CceEEEEeccCCCchhhhhccCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcE
Q 007020 366 TERLLVYPYMANGSVASCLRERPP------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 439 (621)
Q Consensus 366 ~~~~lv~e~~~~gsL~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 439 (621)
+..++||||+++|+|.+++..... ......+..+..++.|++.||.|||++ +|+||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 999999999999999999975321 123356778899999999999999999 99999999999999999999
Q ss_pred EEcccccceecccCCCee-eecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHH
Q 007020 440 VVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDW 517 (621)
Q Consensus 440 kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~ 517 (621)
+|+|||+++......... .....++..|+|||.+.++.++.++|||||||++|||++ |..||.... ..++
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~--------~~~~ 230 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--------NEQV 230 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHH
Confidence 999999988653322111 112235678999999998889999999999999999999 788885211 1122
Q ss_pred HHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 518 VKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 518 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
........... ........+.+++..|++.+|++|||+.++++.|++.
T Consensus 231 ~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 231 LKFVMDGGYLD----------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHHHcCCCCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 22211111100 0112236799999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=329.69 Aligned_cols=262 Identities=20% Similarity=0.348 Sum_probs=194.7
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecC-----CceE
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TERL 369 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 369 (621)
+|++.+.||+|+||.||+|... +|+.||||.++... .......+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999864 68999999987432 223345688999999999999999999987543 2479
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+||||+. ++|.+++.... .+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999996 58988887543 388999999999999999999999 999999999999999999999999999975
Q ss_pred cccCCC--eeeecccccccccchhhhcc--CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh---
Q 007020 450 MDYKDT--HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL--- 522 (621)
Q Consensus 450 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--- 522 (621)
...... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||..... ....+.+....
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~-----~~~~~~~~~~~~~~ 227 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-----VHQLDLITDLLGTP 227 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHHHHhCCC
Confidence 432211 12234568999999999876 5788999999999999999999999953221 00011110000
Q ss_pred --------hhcccccc---cCccccCcc---cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 523 --------KEKKLEML---VDPDLQNNY---VEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 523 --------~~~~~~~~---~d~~~~~~~---~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
........ +........ .......+.+++..|++.+|++|||++++++.
T Consensus 228 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000 000000000 01123567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=344.32 Aligned_cols=258 Identities=24% Similarity=0.321 Sum_probs=206.3
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecCC----
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT---- 366 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 366 (621)
...++|.+.+.||+|+||+||+|+.. +|+.||||++.... .......+.+|+..+..++|+||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34578999999999999999999854 78999999986543 2344556889999999999999999988765432
Q ss_pred ----ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEc
Q 007020 367 ----ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 442 (621)
Q Consensus 367 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 442 (621)
..++||||+++|+|.+++.........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 35799999999999999986554445689999999999999999999999 99999999999999999999999
Q ss_pred ccccceecccCC-CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHH
Q 007020 443 DFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGL 521 (621)
Q Consensus 443 DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 521 (621)
|||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....+...
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~--------~~~~~~~~ 257 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN--------MEEVMHKT 257 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHH
Confidence 999998754322 122334569999999999999999999999999999999999999996321 12222222
Q ss_pred hhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 522 LKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 522 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.... .++ .+......+.+++..||+.+|++||++.++++.
T Consensus 258 ~~~~-----~~~-----~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LAGR-----YDP-----LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hcCC-----CCC-----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 2111 111 112234678899999999999999999999764
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=321.40 Aligned_cols=258 Identities=28% Similarity=0.412 Sum_probs=203.7
Q ss_pred CCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
+|++.+.||+|+||.||+|... ....+|+|.+..........++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3677889999999999999752 2357999988765544455678999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 007020 371 VYPYMANGSVASCLRERPP--------------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAAN 430 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 430 (621)
++||+.+|+|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999999864321 123478899999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEcccccceecccCCCee-eecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccC
Q 007020 431 ILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLAN 508 (621)
Q Consensus 431 ill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~ 508 (621)
|++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--- 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--- 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence 999999999999999998653322211 122335678999999988889999999999999999999 999985221
Q ss_pred CCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 509 DDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
...+.+++.. . .... ........+.+++..|++.+|++||+++++++.|++.
T Consensus 235 --~~~~~~~~~~----~-----~~~~----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 235 --PERLFNLLKT----G-----YRME----RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred --HHHHHHHHhC----C-----CCCC----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 1111111111 0 0000 1112236788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=320.29 Aligned_cols=257 Identities=23% Similarity=0.355 Sum_probs=203.1
Q ss_pred CCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
+|.+.+.||+|+||.||+|... .++.||+|+++..........+..|+.++..++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4566788999999999999853 3578999999765544445678899999999999999999999999999999
Q ss_pred EEeccCCCchhhhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc
Q 007020 371 VYPYMANGSVASCLRERP------------PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE 438 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 438 (621)
++||+.+++|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999985321 1123478888999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecccCCC-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHH
Q 007020 439 AVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLD 516 (621)
Q Consensus 439 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~ 516 (621)
+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.... ..+
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~ 234 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--------NQD 234 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC--------HHH
Confidence 99999999886543221 12223346779999999988889999999999999999998 888885211 112
Q ss_pred HHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 517 WVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 517 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
+........ .. ......+..+.+++..||+.+|++||++++|++.|+.
T Consensus 235 ~~~~i~~~~-~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIRNRQ-VL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHcCC-cC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 222222111 10 1112334678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=316.06 Aligned_cols=255 Identities=28% Similarity=0.426 Sum_probs=203.0
Q ss_pred HhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
..++|.+.+.||+|+||.||+|....+..+|+|.+..... ....+.+|+.+++.++|+|++++++++. .+..+++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE 80 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence 3466888899999999999999987777899998765332 3456889999999999999999999875 456899999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++|+|.++++... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 81 FMGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 999999999997643 22478899999999999999999999 9999999999999999999999999999865433
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
.........++..|+|||...+..++.++||||||+++|||++ |..||.... ......++ .....
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~~---~~~~~------ 221 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV-----NREVLEQV---ERGYR------ 221 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHH---HcCCC------
Confidence 2222223346778999999988889999999999999999999 899985221 11111111 11100
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
. ......+..+.+++.+||+.+|++||++++|++.|++
T Consensus 222 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 M----PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred C----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0 0112234678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=326.42 Aligned_cols=242 Identities=26% Similarity=0.331 Sum_probs=194.1
Q ss_pred ceeeeccCceEEEEEc----CCCcEEEEEEecccC---CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 302 NILGRGGFGKVYKGRL----ADGSLVAVKRLKEER---TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
+.||+|+||.||+++. .+++.||+|+++... .......+..|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999974 357899999987532 122334578899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++|+|.+++.... .+.+..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 99999999987643 277888999999999999999999 99999999999999999999999999987543222
Q ss_pred CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+....... ..
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~--------~~~~~~~~~~~~-------~~ 218 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN--------RKKTIDKILKGK-------LN 218 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCC-------CC
Confidence 22233569999999999998889999999999999999999999996321 112222222111 01
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 570 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~ 570 (621)
+ +......+.+++..|++.+|++|| ++.++++
T Consensus 219 ~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 219 L----PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred C----CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1 111235788999999999999999 7887765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=320.95 Aligned_cols=262 Identities=26% Similarity=0.399 Sum_probs=209.2
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcCC-----CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeec-CC
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLAD-----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PT 366 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 366 (621)
+..++|...+.||+|+||.||+|.+.+ +..|++|+++..........+.+|+.+++.++|+||+++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 345788889999999999999998765 788999998766555556678999999999999999999998766 46
Q ss_pred ceEEEEeccCCCchhhhhccCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEc
Q 007020 367 ERLLVYPYMANGSVASCLRERPPS----QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 442 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 442 (621)
..++++||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999998764322 14588999999999999999999999 99999999999999999999999
Q ss_pred ccccceecccCCCee-eecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHH
Q 007020 443 DFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKG 520 (621)
Q Consensus 443 DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 520 (621)
|||+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||.... ......++..
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~ 234 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID-----PFEMAAYLKD 234 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC-----HHHHHHHHHc
Confidence 999998654333221 122346778999999988889999999999999999999 999996321 1112222111
Q ss_pred HhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 521 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 521 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
..... .....+..+.+++.+||+.+|++|||+.++++.|++.
T Consensus 235 ---~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 235 ---GYRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred ---CCCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11100 0112235788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=319.69 Aligned_cols=266 Identities=24% Similarity=0.402 Sum_probs=207.5
Q ss_pred hcCCCcCceeeeccCceEEEEEcCC-----------------CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceee
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLAD-----------------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 357 (621)
.++|++.+.||+|+||.||+|.... +..||+|.+...........+.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678889999999999999987542 24689999887665556678999999999999999999
Q ss_pred eeeeeecCCceEEEEeccCCCchhhhhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 007020 358 LRGFCMTPTERLLVYPYMANGSVASCLRERPP-------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAAN 430 (621)
Q Consensus 358 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 430 (621)
+++++..++..+++|||+++++|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999876431 112489999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEcccccceecccCCC-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh--CCCCccccccc
Q 007020 431 ILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT--GQRAFDLARLA 507 (621)
Q Consensus 431 ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~pf~~~~~~ 507 (621)
|+++.++.++|+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999986543322 12233446788999999988889999999999999999998 677775221
Q ss_pred CCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 508 NDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.....+.+....+........ ......+.++.+++..|++.+|++|||+.+|++.|++
T Consensus 239 ---~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 ---DQQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ---hHHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111112111111111101000 0111233679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=314.65 Aligned_cols=247 Identities=24% Similarity=0.353 Sum_probs=195.9
Q ss_pred eeeccCceEEEEEcC---CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCch
Q 007020 304 LGRGGFGKVYKGRLA---DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 380 (621)
Q Consensus 304 lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 380 (621)
||+|+||.||+|.+. .+..||+|++...........+.+|+.++++++|+||+++++++. .+..++||||+++|+|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999753 355799999876554444567999999999999999999999875 4578999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeeee-
Q 007020 381 ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT- 459 (621)
Q Consensus 381 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~- 459 (621)
.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++............
T Consensus 82 ~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 82 NKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99987532 2388999999999999999999999 9999999999999999999999999999865433222111
Q ss_pred -cccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccC
Q 007020 460 -AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537 (621)
Q Consensus 460 -~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 537 (621)
...++..|+|||.+.+..++.++||||||+++||+++ |..||.... ..++......... +
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~~------~---- 217 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK--------GPEVMSFIEQGKR------L---- 217 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC--------HHHHHHHHHCCCC------C----
Confidence 1223578999999988889999999999999999996 999995221 1122211111111 0
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 538 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 538 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
.....+..++.+++..||..+|++||++.+|.+.|+..
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11122346888999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=341.60 Aligned_cols=252 Identities=21% Similarity=0.287 Sum_probs=202.9
Q ss_pred CCCcCceeeeccCceEEEEEcC-C-CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-D-GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
.|.+.+.||+|+||.||+|... + ++.||+|.+.... ......+..|+.+++.++||||+++++++...+..++||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 4888899999999999999754 3 6788888764432 33345678899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++|+|.+++........++++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999998876443445688999999999999999999999 99999999999999999999999999998764332
Q ss_pred C-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCc
Q 007020 455 T-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533 (621)
Q Consensus 455 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 533 (621)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+....... .++
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~--------~~~~~~~~~~~~-----~~~ 290 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS--------QREIMQQVLYGK-----YDP 290 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-----CCC
Confidence 2 12334569999999999999999999999999999999999999995321 112222221111 000
Q ss_pred cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 534 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
........+.+++..|++.+|++||++++++.
T Consensus 291 -----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 -----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -----CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11122357889999999999999999999875
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=319.75 Aligned_cols=254 Identities=24% Similarity=0.395 Sum_probs=198.3
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCc----EEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
++|...+.||+|+||+||+|.+. +++ .|++|.+..........++..|+..++.+.||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46777889999999999999864 344 478888754433334456788888999999999999999875 456789
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
++||+++|+|.+++..... .+++..+..++.||+.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999976432 388999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 451 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 451 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .....+++ ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----~~~~~~~~----~~~~-- 228 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR-----PHEVPDLL----EKGE-- 228 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH----HCCC--
Confidence 433221 2233447788999999998899999999999999999998 999985221 11111211 1111
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
....+.. +...+.+++..||..+|++|||+.++++.|+.
T Consensus 229 ~~~~~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 229 RLAQPQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred cCCCCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 1111111 22567889999999999999999999998866
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=298.81 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=204.3
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc----h---hHHHHHHHHHHHHhcc-CCceeeeeeeeec
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP----G---GELQFQTEVEMISMAV-HRNLLRLRGFCMT 364 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 364 (621)
.-+.|...+.||+|..++|-++.++ +|+.+|+|++...... . -.+.-.+|+.+++++. ||+|+.+.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456788899999999999999765 6889999998643321 1 1234567999999875 9999999999999
Q ss_pred CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccc
Q 007020 365 PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 444 (621)
Q Consensus 365 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 444 (621)
+...++|+|.|+.|.|+|++... ..++++...+|+.|+.+|++|||.. .||||||||+|||++++.++||+||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 99999999999999999999864 3489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecccCCCeeeecccccccccchhhhccC------CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHH
Q 007020 445 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG------KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 518 (621)
Q Consensus 445 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 518 (621)
|+|+.+.. .......+||++|+|||.+... .|+..+|+||+|||+|-|+.|.+||-.-. .+.+.
T Consensus 168 GFa~~l~~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-----QmlML--- 237 (411)
T KOG0599|consen 168 GFACQLEP--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-----QMLML--- 237 (411)
T ss_pred ceeeccCC--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-----HHHHH---
Confidence 99997654 3345678899999999998643 57889999999999999999999994111 11111
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 519 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 519 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.++-.++ . .+....+.+......+++.+|++.||.+|-|++|.++
T Consensus 238 -R~ImeGk-y-----qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 238 -RMIMEGK-Y-----QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred -HHHHhcc-c-----ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1111111 1 1123335566678899999999999999999999975
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=317.82 Aligned_cols=266 Identities=23% Similarity=0.398 Sum_probs=204.3
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-----------------CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceee
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-----------------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 357 (621)
.++|++.+.||+|+||.||++... ++..||+|.++.........++.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 457889999999999999998532 244699999976555555668999999999999999999
Q ss_pred eeeeeecCCceEEEEeccCCCchhhhhccCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 007020 358 LRGFCMTPTERLLVYPYMANGSVASCLRERPPS-------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAAN 430 (621)
Q Consensus 358 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 430 (621)
+++++...+..+++|||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999998764321 12477889999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEcccccceecccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh--CCCCccccccc
Q 007020 431 ILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT--GQRAFDLARLA 507 (621)
Q Consensus 431 ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~pf~~~~~~ 507 (621)
|+++.++.++|+|||++..+...... ......++..|+|||...++.++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD- 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-
Confidence 99999999999999999765332211 1122334678999999888889999999999999999998 7788852211
Q ss_pred CCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 508 NDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
......+........ .....+. ...+...+.+++..||+.||++||++.+|++.|++
T Consensus 240 ----~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 ----EQVIENTGEFFRDQG-RQVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ----HHHHHHHHHHHhhcc-ccccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 001111111111100 0001111 11233678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=332.51 Aligned_cols=253 Identities=18% Similarity=0.243 Sum_probs=194.9
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|.+.+.||+|+||+||++... +++.||||.+.... .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888899999999999999864 78999999986432 1223456888999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999987643 378889999999999999999999 999999999999999999999999999864321
Q ss_pred CCCe----------------------------------------------eeecccccccccchhhhccCCCCCcccchh
Q 007020 453 KDTH----------------------------------------------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 486 (621)
Q Consensus 453 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS 486 (621)
.... ......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 001245999999999999989999999999
Q ss_pred HHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCC---C
Q 007020 487 YGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDR---P 563 (621)
Q Consensus 487 lGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~R---P 563 (621)
|||++|||++|..||..... .+.......... .+.-+. .......+.+++..|+. +|.+| +
T Consensus 234 lGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~~--~~~~p~-----~~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENS--------HETYRKIINWRE--TLYFPD-----DIHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred cchhhhhhhcCCCCCCCCCH--------HHHHHHHHccCC--ccCCCC-----CCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 99999999999999953211 111111111100 011011 01123567788888987 66665 5
Q ss_pred CHHHHHHH
Q 007020 564 KMSEVVRM 571 (621)
Q Consensus 564 t~~~vl~~ 571 (621)
++.++++.
T Consensus 298 ~~~~~l~h 305 (377)
T cd05629 298 GAHEIKSH 305 (377)
T ss_pred CHHHHhcC
Confidence 88887653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=318.31 Aligned_cols=252 Identities=26% Similarity=0.338 Sum_probs=199.5
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.|+..++||+|+||+||++... +++.||+|.+..... ......+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3777889999999999999864 689999999865432 2223457789999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999988865322 2488999999999999999999999 9999999999999999999999999999865422
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 533 (621)
. ......|+..|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~-------- 220 (285)
T cd05605 156 E--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE-----KVKREEVERRVKED-------- 220 (285)
T ss_pred C--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch-----hhHHHHHHHHhhhc--------
Confidence 2 12234589999999999988899999999999999999999999963211 01111111111100
Q ss_pred cccCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007020 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 570 (621)
Q Consensus 534 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~ 570 (621)
...+.......+.+++..||+.||++|| +++++++
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 221 --QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred --ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 0111223346788999999999999999 7777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=321.61 Aligned_cols=262 Identities=27% Similarity=0.427 Sum_probs=207.6
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEc--------CCCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeee
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRL--------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFC 362 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 362 (621)
.+..++|.+.+.||+|+||.||+|.. .++..||+|.++..........+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 34567788889999999999999963 134579999987554444556789999999999 799999999999
Q ss_pred ecCCceEEEEeccCCCchhhhhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 007020 363 MTPTERLLVYPYMANGSVASCLRERPPS------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAAN 430 (621)
Q Consensus 363 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 430 (621)
......+++|||+++|+|.+++...... ...+++..+..++.||+.||+|||++ +|+||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence 9999999999999999999999764321 22478889999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEcccccceecccCCCee-eecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccC
Q 007020 431 ILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLAN 508 (621)
Q Consensus 431 ill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~ 508 (621)
|+++.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~---- 243 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI---- 243 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC----
Confidence 999999999999999998764332221 222335678999999988889999999999999999998 78888421
Q ss_pred CCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 509 DDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
...++.......... . ........+.+++..||+.+|++||++.+|++.|+.
T Consensus 244 ----~~~~~~~~~~~~~~~---~-------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~ 295 (304)
T cd05101 244 ----PVEELFKLLKEGHRM---D-------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295 (304)
T ss_pred ----CHHHHHHHHHcCCcC---C-------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 122222222111110 0 111234678899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=321.84 Aligned_cols=239 Identities=25% Similarity=0.346 Sum_probs=188.6
Q ss_pred ceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHh-ccCCceeeeeeeeecCCceEEEEeccCC
Q 007020 302 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTERLLVYPYMAN 377 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 377 (621)
+.||+|+||+||+|... +++.||+|.++.... ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999865 578999999975431 2223345566666654 4799999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee
Q 007020 378 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457 (621)
Q Consensus 378 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 457 (621)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 99999987643 388899999999999999999999 99999999999999999999999999997643222 22
Q ss_pred eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccC
Q 007020 458 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537 (621)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 537 (621)
.....||..|+|||++.+..++.++|||||||++|||++|+.||..... .+........ .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~-------~~~~-- 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--------DELFDSILND-------RPHF-- 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC-------CCCC--
Confidence 3345699999999999998899999999999999999999999963211 1111111110 0111
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 007020 538 NYVEAEVEQLIQVALLCTQGSPMDRPKMSE 567 (621)
Q Consensus 538 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~ 567 (621)
+......+.+++..||+.+|++||++.+
T Consensus 216 --~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 216 --PRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred --CCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 1112356788999999999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=324.35 Aligned_cols=253 Identities=24% Similarity=0.335 Sum_probs=212.7
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCch--hHHHHHHHHHHHHhcc-CCceeeeeeeeecCCceE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG--GELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 369 (621)
..+.|++.+.||+|.||.||+++.+ +|+.+|+|.+.+..... ....+.+|+.+|+++. |||||.+++++.+.+..+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3467888899999999999999976 49999999997665433 3467899999999998 999999999999999999
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC----CcEEEcccc
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE----FEAVVGDFG 445 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~----~~~kl~DfG 445 (621)
+|||++.||.|.+.+... .+++..+..++.|++.+++|||+. ||+||||||+|+|+... +.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999876 289999999999999999999999 99999999999999643 579999999
Q ss_pred cceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 446 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
++..... .......+||+.|+|||++....++..+||||+||++|.|++|.+||...... .... .+.+.
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~----~~~~----~i~~~- 253 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF----EIFL----AILRG- 253 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh----HHHH----HHHcC-
Confidence 9998765 45566778999999999999999999999999999999999999999633211 1111 11111
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 526 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 526 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
+..+.............+++..|+..||.+|+|+.++++.
T Consensus 254 ------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 254 ------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1123334455556788899999999999999999999884
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=313.84 Aligned_cols=246 Identities=24% Similarity=0.373 Sum_probs=195.6
Q ss_pred eeeeccCceEEEEEc---CCCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCC
Q 007020 303 ILGRGGFGKVYKGRL---ADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 378 (621)
Q Consensus 303 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 378 (621)
.||+|+||.||+|.+ .+++.||+|+++.... .....++..|+.+++.+.|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 3578899999865432 234557899999999999999999999875 45678999999999
Q ss_pred chhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeee
Q 007020 379 SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 458 (621)
Q Consensus 379 sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 458 (621)
+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999997543 388899999999999999999999 999999999999999999999999999987654332211
Q ss_pred --ecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccCccc
Q 007020 459 --TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 535 (621)
Q Consensus 459 --~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 535 (621)
....++..|+|||.+....++.++||||||+++|||++ |+.||.... . ..+......... +..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~---~~~~~~i~~~~~------~~~ 219 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK-----G---NEVTQMIESGER------MEC 219 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-----H---HHHHHHHHCCCC------CCC
Confidence 12234578999999988888999999999999999998 999996321 1 122222111110 011
Q ss_pred cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 536 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 536 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
+...+.++.+++..||+.||++||++.+|++.|++
T Consensus 220 ----~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 ----PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ----CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11234678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=321.20 Aligned_cols=257 Identities=23% Similarity=0.386 Sum_probs=200.9
Q ss_pred cCCCcCceeeeccCceEEEEEcCC-C--cEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLAD-G--SLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 371 (621)
++|+..+.||+|+||.||+|...+ + ..+++|.++..........+.+|+.++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 568888999999999999998653 3 347888887544444556789999999998 799999999999999999999
Q ss_pred EeccCCCchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcE
Q 007020 372 YPYMANGSVASCLRERPP------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 439 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 439 (621)
+||+++|+|.++++.... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999975321 112478899999999999999999999 99999999999999999999
Q ss_pred EEcccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHH
Q 007020 440 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWV 518 (621)
Q Consensus 440 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~ 518 (621)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||.... ..+..
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~--------~~~~~ 228 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT--------CAELY 228 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------HHHHH
Confidence 99999998642211 11111123557999999998889999999999999999998 999995221 11122
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 519 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 519 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
...... ..... .......+.+++..|++.+|.+||+++++++.|+..
T Consensus 229 ~~~~~~------~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 229 EKLPQG------YRMEK----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred HHHhcC------CCCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 211111 00111 112336788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=323.30 Aligned_cols=239 Identities=28% Similarity=0.393 Sum_probs=191.0
Q ss_pred ceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceEEEEeccCC
Q 007020 302 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPYMAN 377 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 377 (621)
+.||+|+||+||+|+.. +++.||+|+++... .......+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 58899999987542 223344567788888766 699999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee
Q 007020 378 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457 (621)
Q Consensus 378 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 457 (621)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 99999887643 388899999999999999999999 99999999999999999999999999987543222 22
Q ss_pred eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccC
Q 007020 458 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537 (621)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 537 (621)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--------~~~~~~~i~~~~----~~~~---- 216 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN--------EDDLFEAILNDE----VVYP---- 216 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHhcCC----CCCC----
Confidence 334569999999999998889999999999999999999999996321 112222222111 1111
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 007020 538 NYVEAEVEQLIQVALLCTQGSPMDRPKMSE 567 (621)
Q Consensus 538 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~ 567 (621)
......+.+++..|++.||++||++.+
T Consensus 217 ---~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 217 ---TWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred ---CCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 112357889999999999999999833
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=325.97 Aligned_cols=243 Identities=23% Similarity=0.281 Sum_probs=194.2
Q ss_pred ceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCC
Q 007020 302 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 378 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 378 (621)
+.||+|+||+||++... +|+.||+|.++.... ......+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 689999999975432 223446778999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee
Q 007020 379 SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457 (621)
Q Consensus 379 sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 457 (621)
+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (325)
T cd05594 81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT 152 (325)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cc
Confidence 9999887543 38899999999999999999997 6 89999999999999999999999999987533221 12
Q ss_pred eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccC
Q 007020 458 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537 (621)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 537 (621)
.....||..|+|||++.+..++.++|||||||++|||++|+.||.... ........... ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~--------~~~~~~~i~~~-------~~~~-- 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILME-------EIRF-- 215 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC--------HHHHHHHHhcC-------CCCC--
Confidence 233469999999999999899999999999999999999999995221 11111111110 0011
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 007020 538 NYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVRM 571 (621)
Q Consensus 538 ~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~~ 571 (621)
+......+.+++..|++.||++|+ ++.++++.
T Consensus 216 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 --PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred --CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 111235788999999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=318.24 Aligned_cols=257 Identities=26% Similarity=0.414 Sum_probs=203.4
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCc----EEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
.++|+..+.||+|+||+||+|.+. +|+ .||+|.++..........+.+|+.++..++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 456788899999999999999853 444 4899998766555556678899999999999999999999875 4578
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+++||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKD---RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 99999999999999976432 388899999999999999999999 999999999999999999999999999987
Q ss_pred cccCCCee-eecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 450 MDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 450 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
........ .....++..|+|||...+..++.++||||||+++|||++ |..||+... ......++.. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~~~~----~~~ 229 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-----AREIPDLLEK----GER 229 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHHC----CCc
Confidence 65332221 122235678999999998889999999999999999998 999985321 1112222211 100
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 576 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 576 (621)
. .........+.+++..||+.||++||++.++++.|+...
T Consensus 230 ~---------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 230 L---------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred C---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 0 001123367889999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=320.00 Aligned_cols=259 Identities=25% Similarity=0.425 Sum_probs=204.4
Q ss_pred hcCCCcCceeeeccCceEEEEEc------CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCce
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 368 (621)
.++|.+.+.||+|+||+||++.. .++..||+|.+.... ......+.+|++++++++|+||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 35678889999999999999974 234569999886543 33455789999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhccCCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcE
Q 007020 369 LLVYPYMANGSVASCLRERPP---------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 439 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~---------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 439 (621)
++||||+++++|.+++..... ....+++..+..++.|++.||+|||++ +++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 999999999999999875431 223489999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHH
Q 007020 440 VVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDW 517 (621)
Q Consensus 440 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~ 517 (621)
||+|||++......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||..... .+.
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--------~~~ 231 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEV 231 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHH
Confidence 99999999765332211 1122335778999999998889999999999999999998 9999853221 111
Q ss_pred HHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 518 VKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 518 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
....... .... .. ......+.+++..||+.+|.+|||+.++++.|+..
T Consensus 232 ~~~i~~~-~~~~-----~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 232 IECITQG-RVLQ-----RP----RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred HHHHHcC-CcCC-----CC----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1111111 1000 01 11235789999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=323.04 Aligned_cols=245 Identities=26% Similarity=0.342 Sum_probs=192.4
Q ss_pred CCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHH---HhccCCceeeeeeeeecCCceEEE
Q 007020 298 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMI---SMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 298 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
|.+.+.||+|+||.||+|... +++.||||+++... .......+..|+.++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999865 68999999997542 122234566666654 566799999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++|+|..+++.. .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999999888643 389999999999999999999999 99999999999999999999999999987532
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
.. ........|++.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+.........
T Consensus 153 ~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~--------~~~~~~~i~~~~------ 217 (324)
T cd05589 153 GF-GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD--------EEEVFDSIVNDE------ 217 (324)
T ss_pred CC-CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC------
Confidence 21 122334569999999999999899999999999999999999999996321 112222221111
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-----MSEVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-----~~~vl~ 570 (621)
... +......+.+++..|++.||.+||+ +.++++
T Consensus 218 -~~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 -VRY----PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -CCC----CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 011 1122366789999999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=323.12 Aligned_cols=242 Identities=26% Similarity=0.366 Sum_probs=192.6
Q ss_pred ceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceEEEEeccCC
Q 007020 302 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPYMAN 377 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 377 (621)
+.||+|+||.||+|+.. +++.||+|+++... .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999865 57899999987542 123344577788888765 799999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee
Q 007020 378 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457 (621)
Q Consensus 378 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 457 (621)
|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 99999887543 388899999999999999999999 99999999999999999999999999987543222 22
Q ss_pred eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccC
Q 007020 458 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537 (621)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 537 (621)
.....||..|+|||++.+..++.++|||||||++|||++|+.||.... ............ ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~--------~~~~~~~i~~~~----~~~p---- 216 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN--------EDDLFESILHDD----VLYP---- 216 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCC----CCCC----
Confidence 334568999999999999899999999999999999999999996321 112222222111 0111
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCC-------CHHHHHH
Q 007020 538 NYVEAEVEQLIQVALLCTQGSPMDRP-------KMSEVVR 570 (621)
Q Consensus 538 ~~~~~~~~~l~~l~~~c~~~~P~~RP-------t~~~vl~ 570 (621)
......+.+++..|++.||++|| ++.++++
T Consensus 217 ---~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 217 ---VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred ---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 11235788999999999999999 6666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=318.09 Aligned_cols=260 Identities=27% Similarity=0.464 Sum_probs=205.9
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCc
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 367 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 367 (621)
..++|+..+.||+|+||.||+|... ++..||+|.+..........++.+|+.+++.++||||+++++++..++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467888899999999999999853 4678999998766555556679999999999999999999999999999
Q ss_pred eEEEEeccCCCchhhhhccCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 007020 368 RLLVYPYMANGSVASCLRERPP------------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAA 429 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~------------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 429 (621)
.+++|||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 9999999999999999975321 123478889999999999999999999 9999999999
Q ss_pred CeeeCCCCcEEEcccccceecccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCccccccc
Q 007020 430 NILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLA 507 (621)
Q Consensus 430 Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~ 507 (621)
||+++.++.++|+|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~-- 237 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA-- 237 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC--
Confidence 999999999999999998754322211 1122234667999999998899999999999999999998 888884211
Q ss_pred CCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 508 NDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
..++........ ... ........+.+++.+|++.+|++|||+.|+++.|+.
T Consensus 238 ------~~~~~~~~~~~~-~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 ------HEEVIYYVRDGN-VLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------HHHHHHHHhcCC-CCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 112222221111 100 011223678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=322.71 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=200.7
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCc--EEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGS--LVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 371 (621)
++|++.+.||+|+||.||+|.+. ++. .+|+|.++..........+.+|++++.++ +|+||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 56788899999999999999864 444 46888776544444556788999999999 899999999999999999999
Q ss_pred EeccCCCchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcE
Q 007020 372 YPYMANGSVASCLRERPP------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 439 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 439 (621)
|||+++|+|.++++.... ....+++..++.++.|++.||+|||++ +++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 999999999999975431 123478999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHH
Q 007020 440 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWV 518 (621)
Q Consensus 440 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~ 518 (621)
||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||..... .+..
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~ 233 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELY 233 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh--------HHHH
Confidence 999999986422111 1111224567999999988889999999999999999998 9999952211 1111
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 519 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 519 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
...... .... ........+.+++..|++.+|++||+++++++.|++.
T Consensus 234 ~~~~~~------~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 234 EKLPQG------YRLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHHhcC------CcCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111110 0000 0111235688999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=315.94 Aligned_cols=256 Identities=27% Similarity=0.471 Sum_probs=204.8
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CC---cEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DG---SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
.++|+..+.||+|+||.||+|... ++ ..+|+|.++..........+..|+++++.++|+||+++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 356778899999999999999864 23 37999998765445556678999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
||||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999987643 2378899999999999999999999 9999999999999999999999999999866
Q ss_pred ccCCCeeee--cccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 451 DYKDTHVTT--AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 451 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
......... ....+..|+|||++.+..++.++||||||+++|||++ |+.||.... ..++..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~--------~~~~~~~i~~~~~~ 229 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS--------NHEVMKAINDGFRL 229 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC--------HHHHHHHHhcCCCC
Confidence 433222111 1223457999999988889999999999999999998 999995221 11222222111100
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
+ ........+.+++..||+.+|++||++.+|++.|++
T Consensus 230 -----~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 230 -----P-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred -----C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1 111234678999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=329.32 Aligned_cols=264 Identities=28% Similarity=0.443 Sum_probs=203.1
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEc------CCCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeeec
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 364 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 364 (621)
....++|.+.+.||+|+||+||+|.+ .+++.||||+++..........+.+|+.++.++ +|+||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 34567899999999999999999973 357889999997655444455788999999999 68999999998865
Q ss_pred C-CceEEEEeccCCCchhhhhccCCCC-----------------------------------------------------
Q 007020 365 P-TERLLVYPYMANGSVASCLRERPPS----------------------------------------------------- 390 (621)
Q Consensus 365 ~-~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------- 390 (621)
. ...+++|||+++|+|.++++.....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 4 4678999999999999998653210
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCe-eee
Q 007020 391 ----------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTT 459 (621)
Q Consensus 391 ----------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~ 459 (621)
...+++..+..++.||++||+|||++ +|+||||||+||++++++.+||+|||++......... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 12367888899999999999999999 9999999999999999999999999999765322211 112
Q ss_pred cccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCc
Q 007020 460 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNN 538 (621)
Q Consensus 460 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 538 (621)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .. ..... ...... ...+.
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~---~~~~~-~~~~~~--~~~~~---- 305 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----DE---EFCRR-LKEGTR--MRAPD---- 305 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc----cH---HHHHH-HhccCC--CCCCC----
Confidence 2335678999999988889999999999999999997 9999853211 00 11111 111110 00011
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 539 YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 539 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
.....+.+++..||+.+|++||++.+|++.|+..
T Consensus 306 ---~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 306 ---YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred ---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1125688999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=324.43 Aligned_cols=262 Identities=29% Similarity=0.420 Sum_probs=205.8
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcC--------CCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeee
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLA--------DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFC 362 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 362 (621)
++..++|.+.+.||+|+||.||++... ++..||+|.++..........+..|++++..+ +|+||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 334567899999999999999999742 23579999997654444455788899999999 799999999999
Q ss_pred ecCCceEEEEeccCCCchhhhhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 007020 363 MTPTERLLVYPYMANGSVASCLRERPPS------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAAN 430 (621)
Q Consensus 363 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 430 (621)
...+..++||||+++|+|.+++...... ...+++.+++.++.|++.||+|||+. +++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence 9999999999999999999999764321 12488899999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEcccccceecccCCCee-eecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccC
Q 007020 431 ILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLAN 508 (621)
Q Consensus 431 ill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~ 508 (621)
|+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~--- 247 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--- 247 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC---
Confidence 999999999999999987654221111 111224568999999998889999999999999999998 888885211
Q ss_pred CCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 509 DDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
..+....... ... ..........+.+++..|++.+|++||++.+|++.|+.
T Consensus 248 -----~~~~~~~~~~-~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 248 -----VEELFKLLKE-GHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred -----HHHHHHHHHc-CCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 1122221111 110 01112234678899999999999999999999999977
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=315.11 Aligned_cols=257 Identities=28% Similarity=0.458 Sum_probs=207.0
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
+..++|.+.+.||+|+||.||+|...+++.||||.+..... ...++.+|+.+++.++|+||+++++++......+++|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 45678899999999999999999988888999999875432 3457889999999999999999999999889999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++++|.+++..... ..+++..+..++.+++.|++|||++ +++|+||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 81 EYMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999999976432 2488999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
..........++..|+|||.+.+..++.++||||||+++|+|++ |+.||.... .. ........... ..
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-----~~---~~~~~~~~~~~---~~ 224 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT-----NR---EVLEQVERGYR---MP 224 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-----HH---HHHHHHHcCCC---CC
Confidence 22111222234568999999998889999999999999999999 999985211 11 11111111100 00
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
. ....+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 225 ~-------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 R-------PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred C-------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0 11123678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.54 Aligned_cols=241 Identities=25% Similarity=0.353 Sum_probs=190.3
Q ss_pred ceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHh-ccCCceeeeeeeeecCCceEEEEeccCC
Q 007020 302 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTERLLVYPYMAN 377 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 377 (621)
+.||+|+||+||+|... +++.||+|.++.... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 578999999975421 2233446667777765 5899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee
Q 007020 378 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457 (621)
Q Consensus 378 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 457 (621)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05619 81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence 99999987643 378899999999999999999999 99999999999999999999999999987532221 12
Q ss_pred eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccC
Q 007020 458 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537 (621)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 537 (621)
.....||..|+|||++.+..++.++|||||||++|||++|+.||.... ..+..+..... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~~~~i~~~-------~~~~-- 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD--------EEELFQSIRMD-------NPCY-- 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhC-------CCCC--
Confidence 334568999999999999899999999999999999999999996321 11111111110 0111
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 007020 538 NYVEAEVEQLIQVALLCTQGSPMDRPKMS-EVV 569 (621)
Q Consensus 538 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~-~vl 569 (621)
+......+.+++..|++.+|++||++. ++.
T Consensus 216 --~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 216 --PRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred --CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 111235678899999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=315.39 Aligned_cols=260 Identities=22% Similarity=0.349 Sum_probs=207.9
Q ss_pred cCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|++.+.||+|+||.||++.. .+++.||||.+.... ......++.+|+.+++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677888999999999999985 478999999886432 2233457889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999875433344589999999999999999999999 999999999999999999999999999886543
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.... .....+.+.... ...
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~------~~~ 225 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIEQ------CDY 225 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc------chHHHHhhhhhc------CCC
Confidence 322 1223458899999999988889999999999999999999999985221 111122111111 111
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
+... .......+.+++..||+.+|++|||+.+|++.+++
T Consensus 226 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 226 PPLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CCCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 1111 12234678899999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=313.75 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=201.4
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc----hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
++|...+.||+|++|.||+|... +++.||+|.++..... .....+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999864 6899999998654321 123468889999999999999999999999999999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
++||+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||+|+||++++++.++|+|||++...
T Consensus 82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999987643 278889999999999999999999 9999999999999999999999999999765
Q ss_pred ccCCCeee--ecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 451 DYKDTHVT--TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 451 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
........ ....|+..|+|||.+.+..++.++||||||+++|||++|+.||..... . .-+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~-~~~~~~~~~~--- 223 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-------M-AAIFKIATQP--- 223 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-------H-HHHHHHhccC---
Confidence 43221111 234578899999999998899999999999999999999999952210 0 0011111100
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
............+.+++..||..+|++|||+.++++.
T Consensus 224 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 ------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0111122234678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=313.53 Aligned_cols=257 Identities=24% Similarity=0.442 Sum_probs=205.8
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
++..++|.+.+.||+|+||.||++...++..+|+|.++... .....+.+|+++++.++|+||+++++++.. ...+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence 44567889999999999999999998777889999886432 234578899999999999999999999887 778999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||.+....
T Consensus 79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 79 TEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred EEeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 99999999999997643 23478889999999999999999999 99999999999999999999999999998654
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
...........++..|+|||++.+..++.++||||||+++|++++ |+.||.... ......++.. ....
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-----~~~~~~~~~~---~~~~--- 222 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-----NPEVIRALER---GYRM--- 222 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHhC---CCCC---
Confidence 332222223345678999999988889999999999999999999 999985221 1111111111 0000
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
+ ........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 --~-----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 --P-----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --C-----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 111233678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=319.00 Aligned_cols=258 Identities=26% Similarity=0.431 Sum_probs=204.2
Q ss_pred cCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
.+|.+.+.||+|+||.||+|... ++..+++|.+.... ......+.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 45777889999999999999742 35679999886433 333456889999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC
Q 007020 370 LVYPYMANGSVASCLRERPP------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF 437 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 437 (621)
+||||+++++|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 99999999999999976432 112378999999999999999999999 999999999999999999
Q ss_pred cEEEcccccceecccCCC-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHH
Q 007020 438 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLL 515 (621)
Q Consensus 438 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~ 515 (621)
.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||..... .
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~ 232 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--------T 232 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------H
Confidence 999999999976543221 11223346788999999998899999999999999999999 9999853211 1
Q ss_pred HHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 516 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 516 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
..+..... ..... .....+..+.+++.+||+.+|++||++.+|+++|++.
T Consensus 233 ~~~~~~~~-~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 233 EVIECITQ-GRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HHHHHHhC-CCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 11111111 11100 0112346788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=314.03 Aligned_cols=255 Identities=28% Similarity=0.449 Sum_probs=203.9
Q ss_pred cCCCcCceeeeccCceEEEEEcC----CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
.+|...+.||+|+||.||+|... .+..||+|.++..........+..|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56778899999999999999853 23479999987655455566789999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++++|.+++..... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.++++|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 999999999999976432 378899999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCeeeec--ccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 452 YKDTHVTTA--VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 452 ~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
......... ..++..|+|||.+.+..++.++||||||+++||+++ |..||..... ..... ...+....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-----~~~~~---~~~~~~~~- 228 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-----QDVIK---AIEEGYRL- 228 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH-----HHHHH---HHhCCCcC-
Confidence 433222211 223568999999998889999999999999999887 9999852211 11111 11111000
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
+ .....+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 229 ----~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 229 ----P-----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred ----C-----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0 011234678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=332.05 Aligned_cols=252 Identities=21% Similarity=0.268 Sum_probs=193.9
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.|++.+.||+|+||.||+|+.. +++.||+|.+..... ......+.+|++++..++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999864 689999999864321 2234467899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|..+...
T Consensus 82 ~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 999999999997643 378888999999999999999999 9999999999999999999999999997532110
Q ss_pred C------------------------------------------CeeeecccccccccchhhhccCCCCCcccchhHHHHH
Q 007020 454 D------------------------------------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIML 491 (621)
Q Consensus 454 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil 491 (621)
. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001234699999999999999999999999999999
Q ss_pred HHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCC---CHHHH
Q 007020 492 LELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP---KMSEV 568 (621)
Q Consensus 492 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP---t~~~v 568 (621)
|||++|+.||..... ............. ...+. .......+.+++..|+ .+|++|+ ++.++
T Consensus 235 yell~G~~Pf~~~~~--------~~~~~~i~~~~~~--~~~~~-----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 235 YEMLVGQPPFLADTP--------AETQLKVINWETT--LHIPS-----QAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred eehhhCCCCCCCCCH--------HHHHHHHhccCcc--ccCCC-----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 999999999963221 1111111110000 00010 0112245666666665 4999999 78887
Q ss_pred HHH
Q 007020 569 VRM 571 (621)
Q Consensus 569 l~~ 571 (621)
++.
T Consensus 299 l~h 301 (376)
T cd05598 299 KAH 301 (376)
T ss_pred hCC
Confidence 654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=314.16 Aligned_cols=251 Identities=25% Similarity=0.303 Sum_probs=196.3
Q ss_pred eeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCch
Q 007020 304 LGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 380 (621)
Q Consensus 304 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 380 (621)
||+|+||+||++... +|+.||+|.+..... ......+..|+++++.++||||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 689999999864322 22233456799999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeeeec
Q 007020 381 ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 460 (621)
Q Consensus 381 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 460 (621)
.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 988865432 2378889999999999999999999 99999999999999999999999999998654322 2233
Q ss_pred ccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCccc
Q 007020 461 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 540 (621)
Q Consensus 461 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 540 (621)
..|+..|+|||++.+..++.++||||+||++|||++|+.||..... .....+......... ... . .
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~-----~~~--~---~ 219 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE----KVAKEELKRRTLEDE-----VKF--E---H 219 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc----hhhHHHHHHHhhccc-----ccc--c---c
Confidence 4689999999999988899999999999999999999999963211 111112222211110 000 0 0
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 541 EAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 541 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
.....++.+++..|++.||++||+++|+++.+...
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h 254 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKH 254 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcC
Confidence 11235688999999999999999998877655443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=323.76 Aligned_cols=242 Identities=24% Similarity=0.332 Sum_probs=192.9
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccC-CceeeeeeeeecCCceEEEE
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 372 (621)
+|+..+.||+|+||.||+|... +++.||+|+++... .......+..|..++..+.| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999865 57899999987542 22334567888999988876 56888999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999987643 378899999999999999999999 999999999999999999999999999875322
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
... ......||..|+|||++.+..++.++||||+||++|||++|+.||..... .+........ .
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~-------~ 217 (324)
T cd05587 154 GGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQSIMEH-------N 217 (324)
T ss_pred CCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC-------C
Confidence 222 23345699999999999999999999999999999999999999963211 1111111110 0
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCH
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 565 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 565 (621)
... +......+.+++..|+..+|.+|++.
T Consensus 218 ~~~----~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 VSY----PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCC----CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 111 11223578899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=311.94 Aligned_cols=251 Identities=18% Similarity=0.283 Sum_probs=203.5
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEecc
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 375 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 375 (621)
+|+..+.||+|+||.||++... +++.||+|.++..........+..|+.+++.++|+||+++++++.+.+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999865 688999999876554555667889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCC
Q 007020 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 455 (621)
++|+|.+++..... ..+++..+..++.|++.||.|||++ +|+|+||||+||++++++.++++|||++........
T Consensus 81 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999998875332 2378889999999999999999999 999999999999999999999999999986543222
Q ss_pred eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccc
Q 007020 456 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 535 (621)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 535 (621)
......|+..|+|||++.+..++.++||||||+++|+|++|..||.... .......... .....
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~~~------ 219 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS--------WKNLILKVCQ-GSYKP------ 219 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC--------HHHHHHHHhc-CCCCC------
Confidence 2233458899999999998889999999999999999999999996321 1111111111 11110
Q ss_pred cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 536 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 536 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
........+.+++.+||+.+|++||++.+++..
T Consensus 220 ---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 ---LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111223568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=311.16 Aligned_cols=263 Identities=23% Similarity=0.259 Sum_probs=206.0
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc--hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
.++|++.+.||+|.-|+||+++.. ++..+|+|++.+.... ....+.+.|-++|+.++||.+..+|+.++.+...+++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 345666788999999999999976 4689999999765432 2334678899999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
||||+||+|..+.+++..+ .+++..++-++..|+-||+|||-. |||+|||||+||||.++|++.|+||.++....
T Consensus 156 meyCpGGdL~~LrqkQp~~--~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGK--RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EecCCCccHHHHHhhCCCC--ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 9999999999999887644 388999999999999999999999 99999999999999999999999999864431
Q ss_pred c---------------------------------CCC----------------------eeeecccccccccchhhhccC
Q 007020 452 Y---------------------------------KDT----------------------HVTTAVRGTIGHIAPEYLSTG 476 (621)
Q Consensus 452 ~---------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~ 476 (621)
. ... ..+.+++||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 000 112345699999999999999
Q ss_pred CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccC
Q 007020 477 KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQ 556 (621)
Q Consensus 477 ~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~ 556 (621)
..+.++|.|+|||++|||+.|+.||.... ....+.. ++-..+.-....+.+..+.++|+..+.
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~----~~~Tl~N-------------Iv~~~l~Fp~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSN----NKETLRN-------------IVGQPLKFPEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCC----chhhHHH-------------HhcCCCcCCCCCcchhHHHHHHHHHhc
Confidence 99999999999999999999999996322 1111211 221111111122445778899999999
Q ss_pred CCCCCCCCHHHHHHHHhcCCCcc
Q 007020 557 GSPMDRPKMSEVVRMLEGDGLAE 579 (621)
Q Consensus 557 ~~P~~RPt~~~vl~~L~~~~~~~ 579 (621)
+||.+|-....=...+++..+-+
T Consensus 374 KdP~kRlg~~rGA~eIK~HpFF~ 396 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKRHPFFE 396 (459)
T ss_pred cChhhhhccccchHHhhcCcccc
Confidence 99999998444344444444443
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=314.24 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=199.6
Q ss_pred cCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
++|+..+.||+|+||.||+|.. .+++.||+|.+...........+..|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577788999999999999985 478899999987654444556789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++++|..+. .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 9999987552 267888999999999999999999 9999999999999999999999999999765322
Q ss_pred CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||.......... ....+........ .+.
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~------~~~ 219 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCIVDED------PPV 219 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHHHHhccC------CCC
Confidence 1223468999999999998889999999999999999999999996432111111 1111111111110 111
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.. ......++.+++..|++.+|++||+++++++.
T Consensus 220 ~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 LP---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11 11123568899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=322.41 Aligned_cols=263 Identities=28% Similarity=0.433 Sum_probs=205.8
Q ss_pred HHHHhcCCCcCceeeeccCceEEEEEcC--------CCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeee
Q 007020 291 LQVATDSFSNKNILGRGGFGKVYKGRLA--------DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGF 361 (621)
Q Consensus 291 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 361 (621)
+....++|.+.+.||+|+||.||++... .+..||+|.++..........+..|+.+++.+ +||||++++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 3445578888999999999999999742 24579999987655455556788999999999 69999999999
Q ss_pred eecCCceEEEEeccCCCchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 007020 362 CMTPTERLLVYPYMANGSVASCLRERPP------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAA 429 (621)
Q Consensus 362 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 429 (621)
+......+++|||+++|+|.+++..... ....+++..+..++.|++.||+|||++ +++||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~ 163 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAAR 163 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccce
Confidence 9998999999999999999999976421 123488899999999999999999999 9999999999
Q ss_pred CeeeCCCCcEEEcccccceecccCCCee-eecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCccccccc
Q 007020 430 NILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLA 507 (621)
Q Consensus 430 Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~ 507 (621)
||+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-- 241 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP-- 241 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC--
Confidence 9999999999999999998654322111 111224567999999998889999999999999999999 888885211
Q ss_pred CCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 508 NDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
..+...... .... . . .......++.+++.+|++.+|++||++.++++.|+.
T Consensus 242 ------~~~~~~~~~-~~~~---~--~----~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 292 (314)
T cd05099 242 ------VEELFKLLR-EGHR---M--D----KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292 (314)
T ss_pred ------HHHHHHHHH-cCCC---C--C----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 111111111 1110 0 0 111223578899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=330.26 Aligned_cols=199 Identities=25% Similarity=0.344 Sum_probs=171.0
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.|+..+.||+|+||+||+|... +++.||+|.+..... ......+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999864 688999999865321 2334568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999987643 378889999999999999999999 9999999999999999999999999997532110
Q ss_pred C----------------------------------------------CeeeecccccccccchhhhccCCCCCcccchhH
Q 007020 454 D----------------------------------------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 487 (621)
Q Consensus 454 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl 487 (621)
. ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000123468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCcc
Q 007020 488 GIMLLELITGQRAFD 502 (621)
Q Consensus 488 Gvil~elltg~~pf~ 502 (621)
||++|||++|+.||.
T Consensus 235 Gvil~elltG~~Pf~ 249 (382)
T cd05625 235 GVILYEMLVGQPPFL 249 (382)
T ss_pred hHHHHHHHhCCCCCC
Confidence 999999999999996
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=314.11 Aligned_cols=255 Identities=27% Similarity=0.399 Sum_probs=196.5
Q ss_pred CcCceeeeccCceEEEEEcCC-Cc--EEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecC------Cce
Q 007020 299 SNKNILGRGGFGKVYKGRLAD-GS--LVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TER 368 (621)
Q Consensus 299 ~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 368 (621)
.+.+.||+|+||.||+|.+.+ +. .||+|.++... .......+..|+.+++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456889999999999998754 32 69999987543 233455788999999999999999999987432 246
Q ss_pred EEEEeccCCCchhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccc
Q 007020 369 LLVYPYMANGSVASCLRERP--PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 446 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 446 (621)
+++|||+++|+|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998874321 2233488999999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCeee-ecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhh
Q 007020 447 AKLMDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKE 524 (621)
Q Consensus 447 a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 524 (621)
++.......... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.... . .+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~---~~~~~~~~~~ 230 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE-----N---SEIYDYLRQG 230 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC-----H---HHHHHHHHcC
Confidence 987643322111 22235678999999998889999999999999999999 888985211 1 1111111111
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 525 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 525 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.... ........+.+++..||+.+|++|||+.+|++.|++
T Consensus 231 ~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NRLK----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1100 011223568899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=313.97 Aligned_cols=263 Identities=25% Similarity=0.388 Sum_probs=203.9
Q ss_pred cCCCcCceeeeccCceEEEEEc-----CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecC--Cce
Q 007020 296 DSFSNKNILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 368 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 368 (621)
..|...+.||+|+||.||++.+ .++..||+|.++..........+.+|+.+++.+.|+||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467788999999999999973 357889999987655455556799999999999999999999998775 567
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 89999999999999986542 2378999999999999999999999 99999999999999999999999999998
Q ss_pred ecccCCCe--eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCccccccc-------CCCcchHHHHHH
Q 007020 449 LMDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLA-------NDDDVMLLDWVK 519 (621)
Q Consensus 449 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~-------~~~~~~~~~~~~ 519 (621)
........ ......++..|+|||++.+..++.++||||||+++|||++++.|+...... .........++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 66433221 122344677899999998888999999999999999999987765321100 001111111221
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 520 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 520 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
....... .......+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 238 ~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 238 VLEEGKR----------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HHHcCcc----------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 1111100 00111234689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=306.28 Aligned_cols=266 Identities=21% Similarity=0.297 Sum_probs=199.1
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEeccc-CCchhHHHHHHHHHHHHhccCCceeeeeeeeec-----CCc
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEE-RTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT-----PTE 367 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~ 367 (621)
...|...+.||+|+||.|+.|..+ +|+.||||.+... .......+..+|+++++.++|+||+.+++.+.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 445666788999999999999865 7899999998633 233445568899999999999999999998865 357
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
.|+|+|+|+. +|...++.... ++...+..+++|+++||.|+|+. +|+||||||+|+|++.+..+||+|||+|
T Consensus 101 vYiV~elMet-DL~~iik~~~~----L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 101 VYLVFELMET-DLHQIIKSQQD----LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eEEehhHHhh-HHHHHHHcCcc----ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence 7999999965 99999986542 88889999999999999999999 9999999999999999999999999999
Q ss_pred eecccC-CCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCC----------CcchHH
Q 007020 448 KLMDYK-DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLAND----------DDVMLL 515 (621)
Q Consensus 448 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~----------~~~~~~ 515 (621)
+..... .....+..+.|..|.|||++.. ..|+.+.||||.|||+.||++|++.|...+..++ .+....
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 987532 1223355678999999998854 5789999999999999999999999953221110 000000
Q ss_pred HHH-----HHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 516 DWV-----KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 516 ~~~-----~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
..+ +..++.-.. ..+.-.....+......++++.+|+..||.+|+|++|.++.
T Consensus 253 ~~i~s~~ar~yi~slp~---~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQ---IPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHhccHHHHHHHHhCCC---CCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111 011110000 00000000111233567899999999999999999999763
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=327.42 Aligned_cols=250 Identities=26% Similarity=0.392 Sum_probs=204.9
Q ss_pred CCCcCceeeeccCceEEEEEcC--CCc--EEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA--DGS--LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
...+.++||+|.||.|++|.|. +|+ .||||.++.........+|.+|+.+|.+++|+|++++||+..+ ....+||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3345578999999999999986 344 5999999877655567789999999999999999999999887 6788999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
|.++.|||.+.|++. ....|-......++.|||.||.||.++ ++|||||..+|+|+-....|||+|||+.+.++.
T Consensus 190 ELaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999982 233477788899999999999999999 999999999999999999999999999998876
Q ss_pred CCCeeee--cccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 453 KDTHVTT--AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 453 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
.+..... ...-.+.|+|||.+....++.++|||+|||++|||+| |..||-... -.+.++.
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--------g~qIL~~--------- 327 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--------GIQILKN--------- 327 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC--------HHHHHHh---------
Confidence 5544322 2234568999999999999999999999999999999 888884211 1122221
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
+|....-..+..++++++++++.||..+|++|||+..|.+
T Consensus 328 -iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 328 -IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred -ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 2222222224567799999999999999999999999974
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=328.34 Aligned_cols=248 Identities=25% Similarity=0.322 Sum_probs=196.5
Q ss_pred ceeeeccCceEEEEEc----CCCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccC
Q 007020 302 NILGRGGFGKVYKGRL----ADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 376 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 376 (621)
+.||+|+||.||+++. .+|+.||+|+++.... ......+..|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3688999999975432 2233457789999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCe
Q 007020 377 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 456 (621)
Q Consensus 377 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 456 (621)
+|+|.+++.... .+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||++....... .
T Consensus 82 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~ 153 (318)
T cd05582 82 GGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K 153 (318)
T ss_pred CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence 999999987543 388999999999999999999999 99999999999999999999999999987654321 2
Q ss_pred eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcccc
Q 007020 457 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 536 (621)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 536 (621)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||.... ..+......... . ..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~--------~~~~~~~i~~~~-~------~~- 217 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD--------RKETMTMILKAK-L------GM- 217 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC--------HHHHHHHHHcCC-C------CC-
Confidence 2334569999999999998889999999999999999999999996321 111111111110 0 01
Q ss_pred CcccHHHHHHHHHHHHhccCCCCCCCCCHHH--HHHHHhcCC
Q 007020 537 NNYVEAEVEQLIQVALLCTQGSPMDRPKMSE--VVRMLEGDG 576 (621)
Q Consensus 537 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~--vl~~L~~~~ 576 (621)
+......+.+++..|++.||++||++.+ +.+.++...
T Consensus 218 ---p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~ 256 (318)
T cd05582 218 ---PQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPF 256 (318)
T ss_pred ---CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCC
Confidence 1122357889999999999999999766 444444433
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=310.44 Aligned_cols=257 Identities=27% Similarity=0.421 Sum_probs=200.8
Q ss_pred CCcCceeeeccCceEEEEEcCC----CcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCc-----
Q 007020 298 FSNKNILGRGGFGKVYKGRLAD----GSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE----- 367 (621)
Q Consensus 298 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 367 (621)
|.+.+.||+|+||.||+|.... +..||+|+++.... ......+.+|++.++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999998642 46799999875432 2334578999999999999999999998866544
Q ss_pred -eEEEEeccCCCchhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccc
Q 007020 368 -RLLVYPYMANGSVASCLRERP--PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 444 (621)
Q Consensus 368 -~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 444 (621)
.+++|||+++|+|..++.... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 699999999999999985532 1223588899999999999999999999 9999999999999999999999999
Q ss_pred ccceecccCCCee-eecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHh
Q 007020 445 GLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 522 (621)
Q Consensus 445 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 522 (621)
|+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.... .. +......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~-----~~---~~~~~~~ 229 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-----NH---EIYDYLR 229 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----HH---HHHHHHH
Confidence 9998764332221 112235678999999988889999999999999999999 888885211 11 2222211
Q ss_pred hhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 523 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 523 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
.... .. ........+.+++.+||+.||++||++.++++.|++.
T Consensus 230 ~~~~------~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 HGNR------LK----QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCC------CC----CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 01 1122346789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=310.71 Aligned_cols=248 Identities=29% Similarity=0.470 Sum_probs=198.3
Q ss_pred ceeeeccCceEEEEEcCC----CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCC
Q 007020 302 NILGRGGFGKVYKGRLAD----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 377 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 377 (621)
+.||+|+||.||+|.+.. +..||+|.+..........++..|+.+++.+.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997532 36899999986655445667899999999999999999999875 4568999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee
Q 007020 378 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457 (621)
Q Consensus 378 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 457 (621)
|+|.+++.... .+++..+..++.|++.||+|||.. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999998654 388999999999999999999999 99999999999999999999999999998765433222
Q ss_pred eec--ccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 458 TTA--VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 458 ~~~--~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
... ..++..|+|||.+.+..++.++||||||+++|||++ |..||+... ......++. .... ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~-----~~~~~~~~~---~~~~---~~--- 218 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-----GAEVIAMLE---SGER---LP--- 218 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC-----HHHHHHHHH---cCCc---CC---
Confidence 111 123567999999998889999999999999999998 999996321 111222221 1111 01
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
........+.+++.+|+..+|++||++.+|++.|++.
T Consensus 219 ----~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 ----RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred ----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1112236788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=311.95 Aligned_cols=254 Identities=27% Similarity=0.398 Sum_probs=193.1
Q ss_pred eeeeccCceEEEEEcC---CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCc
Q 007020 303 ILGRGGFGKVYKGRLA---DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 379 (621)
Q Consensus 303 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 379 (621)
.||+|+||.||+|... ++..+|+|.++..........+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 5899999999999754 3467999998766544455678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee-
Q 007020 380 VASCLRERPP-SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV- 457 (621)
Q Consensus 380 L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~- 457 (621)
|.+++..... .....++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999975432 223467778889999999999999999 99999999999999999999999999987543222211
Q ss_pred eecccccccccchhhhccC-------CCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 458 TTAVRGTIGHIAPEYLSTG-------KSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||..... .....+ ... .....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-----~~~~~~---~~~-~~~~~ 229 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD-----EQVLTY---TVR-EQQLK 229 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh-----HHHHHH---Hhh-cccCC
Confidence 1233477889999998643 35789999999999999996 9999953211 111111 111 11111
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 573 (621)
..++..... ....+.+++..|| .+|++|||+++|++.|+
T Consensus 230 ~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 222222211 2245778889999 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=320.90 Aligned_cols=242 Identities=24% Similarity=0.343 Sum_probs=192.4
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceEEEE
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 372 (621)
+|...+.||+|+||+||+|... +++.||+|.++.... ......+..|..++... +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4777899999999999999865 578999999875432 22233466777777766 5899999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999987643 278899999999999999999999 999999999999999999999999999975432
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .. ..........
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-----~~---~~~~~i~~~~------- 217 (323)
T cd05616 154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----ED---ELFQSIMEHN------- 217 (323)
T ss_pred CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC-----HH---HHHHHHHhCC-------
Confidence 22 22334569999999999999999999999999999999999999996321 11 1111111110
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCH
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 565 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 565 (621)
.. ++.....++.+++..|++.+|++|++.
T Consensus 218 ~~----~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 VA----YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CC----CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 00 111233678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=319.19 Aligned_cols=241 Identities=24% Similarity=0.338 Sum_probs=190.3
Q ss_pred ceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHh-ccCCceeeeeeeeecCCceEEEEeccCC
Q 007020 302 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTERLLVYPYMAN 377 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 377 (621)
+.||+|+||.||+|... +|+.||+|.++.... ......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999875 688999999975431 2233456677777765 4899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee
Q 007020 378 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457 (621)
Q Consensus 378 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 457 (621)
|+|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 99999987643 378889999999999999999999 99999999999999999999999999987532222 22
Q ss_pred eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccC
Q 007020 458 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537 (621)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 537 (621)
.....||..|+|||++.+..++.++|||||||++|||++|+.||..... .+........ .+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--------~~~~~~~~~~-------~~~~~~ 217 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--------DELFESIRVD-------TPHYPR 217 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC-------CCCCCC
Confidence 3345699999999999999999999999999999999999999963211 1111111110 111111
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 007020 538 NYVEAEVEQLIQVALLCTQGSPMDRPKMS-EVV 569 (621)
Q Consensus 538 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~-~vl 569 (621)
....++.+++..|++.||++||++. ++.
T Consensus 218 ----~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 ----WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ----CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1235788999999999999999984 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=321.97 Aligned_cols=267 Identities=27% Similarity=0.412 Sum_probs=209.3
Q ss_pred HHHHhcCCCcCceeeeccCceEEEEEcC--------CCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeee
Q 007020 291 LQVATDSFSNKNILGRGGFGKVYKGRLA--------DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGF 361 (621)
Q Consensus 291 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 361 (621)
+++...+|.+.+.||+|+||.||+|... .+..||+|.++.........++.+|+++++++ +|+||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 4455567889999999999999999742 12369999887655445566789999999999 79999999999
Q ss_pred eecCCceEEEEeccCCCchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 007020 362 CMTPTERLLVYPYMANGSVASCLRERPP------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAA 429 (621)
Q Consensus 362 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 429 (621)
+...+..+++|||+++|+|.+++..... ....+++..+..++.|++.||+|||++ +|+||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence 9999999999999999999999876421 123478889999999999999999999 9999999999
Q ss_pred CeeeCCCCcEEEcccccceecccCCCee-eecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCccccccc
Q 007020 430 NILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLA 507 (621)
Q Consensus 430 Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~ 507 (621)
||+++.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--- 240 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--- 240 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC---
Confidence 9999999999999999998654322111 112224567999999999889999999999999999998 88888521
Q ss_pred CCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCCc
Q 007020 508 NDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLA 578 (621)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~ 578 (621)
...++.......... .........+.+++..||+.+|++||++.++++.|+.....
T Consensus 241 -----~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 241 -----PVEELFKLLKEGHRM----------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred -----CHHHHHHHHHcCCCC----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 122222222111110 01112336788999999999999999999999999876433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=311.41 Aligned_cols=250 Identities=30% Similarity=0.454 Sum_probs=203.9
Q ss_pred hcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
.++|+..+.||+|+||.||+|... |+.||+|.++.... ...++.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 467888899999999999999875 78999999975543 456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||.++......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 999999999976542 2388999999999999999999999 99999999999999999999999999998653221
Q ss_pred CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccCc
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 533 (621)
. ...++..|+|||.+.+..++.++||||||+++|||++ |..||.... ..+.... ..... ..
T Consensus 157 ~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~-~~~~~-----~~ 218 (256)
T cd05039 157 D----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPH-VEKGY-----RM 218 (256)
T ss_pred c----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHH-HhcCC-----CC
Confidence 1 2235678999999988889999999999999999997 999985221 1111111 11110 00
Q ss_pred cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 534 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
. .....+..+.+++.+|+..+|++||++.+++++|+.
T Consensus 219 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 E----APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred C----CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0 111224678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=312.57 Aligned_cols=250 Identities=26% Similarity=0.438 Sum_probs=195.5
Q ss_pred ceeeeccCceEEEEEcCC-Cc--EEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceEEEEeccCC
Q 007020 302 NILGRGGFGKVYKGRLAD-GS--LVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPYMAN 377 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 377 (621)
+.||+|+||.||+|...+ +. .+|+|.++..........+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998753 43 47888887554445556788999999999 799999999999999999999999999
Q ss_pred CchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccc
Q 007020 378 GSVASCLRERPP------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 445 (621)
Q Consensus 378 gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 445 (621)
|+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999975431 122478899999999999999999999 99999999999999999999999999
Q ss_pred cceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhh
Q 007020 446 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKE 524 (621)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 524 (621)
++....... .......+..|+|||++.+..++.++||||||+++|||++ |..||.... ..+........
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~--------~~~~~~~~~~~ 227 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAELYEKLPQG 227 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC--------HHHHHHHHhCC
Confidence 986322111 1111223567999999988889999999999999999997 999995221 11111111111
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 525 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 525 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
... . ........+.+++..||+.+|.+||++.++++.|+.
T Consensus 228 ~~~------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 228 YRL------E----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred CCC------C----CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 000 0 111223578899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=320.69 Aligned_cols=241 Identities=25% Similarity=0.314 Sum_probs=189.6
Q ss_pred ceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHH-HHHhccCCceeeeeeeeecCCceEEEEeccCC
Q 007020 302 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 377 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 377 (621)
+.||+|+||+||+|... +|+.||+|++..... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999875 689999999865321 122334555554 46789999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee
Q 007020 378 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457 (621)
Q Consensus 378 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 457 (621)
|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (323)
T cd05575 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKT 152 (323)
T ss_pred CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCc
Confidence 99999987643 378889999999999999999999 9999999999999999999999999998753222 122
Q ss_pred eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccC
Q 007020 458 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537 (621)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 537 (621)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... ..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~-------~~~~~ 217 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------TAEMYDNILNKP-------LRLKP 217 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC--------HHHHHHHHHcCC-------CCCCC
Confidence 334568999999999999899999999999999999999999995321 112222222110 01111
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 007020 538 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 569 (621)
Q Consensus 538 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl 569 (621)
.....+.+++..|++.||.+||++.+.+
T Consensus 218 ----~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (323)
T cd05575 218 ----NISVSARHLLEGLLQKDRTKRLGAKDDF 245 (323)
T ss_pred ----CCCHHHHHHHHHHhhcCHHhCCCCCCCH
Confidence 1236788999999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=319.48 Aligned_cols=244 Identities=25% Similarity=0.321 Sum_probs=192.0
Q ss_pred ceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceEEEEeccCC
Q 007020 302 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPYMAN 377 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 377 (621)
+.||+|+||+||+|... +++.||+|+++.... ......+..|+.++.++ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 678999999976432 22344578899988887 699999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee
Q 007020 378 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457 (621)
Q Consensus 378 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 457 (621)
|+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 99999887543 389999999999999999999999 99999999999999999999999999987532211 22
Q ss_pred eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccC
Q 007020 458 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537 (621)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 537 (621)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||+...... .....+++.......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~------~-- 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP--DMNTEDYLFQVILEKPIR------I-- 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCc--ccccHHHHHHHHHhCCCC------C--
Confidence 334569999999999999999999999999999999999999996322111 111122222222211110 1
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCCCH
Q 007020 538 NYVEAEVEQLIQVALLCTQGSPMDRPKM 565 (621)
Q Consensus 538 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 565 (621)
+......+.+++..|++.||++|+++
T Consensus 223 --p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 --PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 11123567899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=319.23 Aligned_cols=242 Identities=27% Similarity=0.366 Sum_probs=193.4
Q ss_pred ceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceEEEEeccCC
Q 007020 302 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPYMAN 377 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 377 (621)
+.||+|+||+||+|... +++.||+|+++... .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 57899999997543 122344567888888877 699999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee
Q 007020 378 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457 (621)
Q Consensus 378 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 457 (621)
|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (318)
T cd05570 81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT 152 (318)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence 99999887643 388999999999999999999999 99999999999999999999999999987532221 22
Q ss_pred eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccC
Q 007020 458 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537 (621)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 537 (621)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||.... ............ ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~--------~~~~~~~i~~~~-------~~--- 214 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD--------EDELFQSILEDE-------VR--- 214 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC--------HHHHHHHHHcCC-------CC---
Confidence 233468999999999999999999999999999999999999996321 111112111110 00
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 007020 538 NYVEAEVEQLIQVALLCTQGSPMDRPKM-----SEVVR 570 (621)
Q Consensus 538 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~-----~~vl~ 570 (621)
++......+.+++..||+.||++||++ .++++
T Consensus 215 -~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 215 -YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 111223678899999999999999999 77754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=328.25 Aligned_cols=262 Identities=23% Similarity=0.306 Sum_probs=196.9
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCC-----ceE
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-----ERL 369 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 369 (621)
+|+..+.||+|+||+||++... +|+.||+|.+..... ......+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999864 789999999865422 233456889999999999999999999998776 789
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+||||+.+ +|.+.+.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~~-~l~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQS-DLHKIIVSPQ----PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeecccc-CHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 99999974 7888776432 388999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCCeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccc-
Q 007020 450 MDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL- 527 (621)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 527 (621)
.............++..|+|||.+.+. .++.++|||||||++|||++|+.||...... ...+.+.........
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~g~~~~~ 227 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-----QQLDLITDLLGTPSLE 227 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHHHcCCCCHH
Confidence 544333333344588999999999875 4789999999999999999999999632211 000000000000000
Q ss_pred ----------cccc-CccccC------cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 528 ----------EMLV-DPDLQN------NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 528 ----------~~~~-d~~~~~------~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
..+. .+.... .........+.+++..|++.||++|||+.++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000 000000 0011124578899999999999999999999764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=313.55 Aligned_cols=254 Identities=27% Similarity=0.460 Sum_probs=202.0
Q ss_pred CCCcCceeeeccCceEEEEEcCC-C---cEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 297 SFSNKNILGRGGFGKVYKGRLAD-G---SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
.|.+.+.||+|+||.||+|.... + ..||+|.++.........+|..|+.+++.++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778899999999999998642 3 3699999876555555668999999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++..... .+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999876432 378999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCee--eeccc--ccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 453 KDTHV--TTAVR--GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 453 ~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
..... ..... .+..|+|||.+.+..++.++||||||+++|||++ |..||.... .....+++. .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~-----~~~~~~~i~---~~~~~ 230 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----NQDVINAIE---QDYRL 230 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC-----HHHHHHHHH---cCCcC
Confidence 22211 11111 2457999999998899999999999999999887 999985221 111222221 11000
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
....+.+..+.+++..||+.+|++||++++|+..|+.
T Consensus 231 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 231 ----------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0112234678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=314.42 Aligned_cols=248 Identities=23% Similarity=0.327 Sum_probs=210.7
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCch-hHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.-|.+.+.||+|.|+.|-+|++- +|..||||++.+.+... ....+.+|+..|+.++|||||++|++......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45777889999999999999854 79999999997765433 44578899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee-CCCCcEEEcccccceeccc
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL-DEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill-~~~~~~kl~DfGla~~~~~ 452 (621)
.-++|+|++||.+.... +.+..+.+++.||..|+.|+|+. .+|||||||+||.+ .+-|-|||.|||++..+..
T Consensus 98 LGD~GDl~DyImKHe~G---l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEG---LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhhhcc---ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999886543 88999999999999999999999 89999999999876 5668999999999986543
Q ss_pred CCCeeeecccccccccchhhhccCCCC-CcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
.......+|+..|.|||++.+..|+ +++||||+|||||-|++|+.||+.+.. .+.+..++
T Consensus 172 --G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND-----------------SETLTmIm 232 (864)
T KOG4717|consen 172 --GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND-----------------SETLTMIM 232 (864)
T ss_pred --cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc-----------------hhhhhhhh
Confidence 3344566799999999999998885 789999999999999999999974432 22344456
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
|-+.. .+.....++.++|..|+..||.+|.+.++|+.
T Consensus 233 DCKYt--vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 233 DCKYT--VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccccc--CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 65443 24556788999999999999999999999874
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=319.68 Aligned_cols=263 Identities=23% Similarity=0.347 Sum_probs=198.5
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
++|...+.||+|+||+||+|... +++.||+|.++..........+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888899999999999999865 67889999987654444445678899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++ +|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDCGN---IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 986 88888765432 378889999999999999999999 99999999999999999999999999997654322
Q ss_pred Ceeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHH-----------HHh
Q 007020 455 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK-----------GLL 522 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~-----------~~~ 522 (621)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ......+ ...
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED----ELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCHHHHhhhc
Confidence 2 2223457899999999865 457899999999999999999999996322110 0000000 000
Q ss_pred hhcccccccCccccC----cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 523 KEKKLEMLVDPDLQN----NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 523 ~~~~~~~~~d~~~~~----~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..........+.... .........+.+++.+|++.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000000000 001122356789999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=308.46 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=203.5
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
+|+..+.||+|++|.||+|... +++.|++|.+.... .......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3677789999999999999865 68999999986432 334556788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999998642 23488899999999999999999999 99999999999999999999999999998765432
Q ss_pred CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.... . ...+...... .. +.
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~---~~~~~~~~~~-~~-----~~ 220 (256)
T cd08529 156 N-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-----Q---GALILKIIRG-VF-----PP 220 (256)
T ss_pred c-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-----H---HHHHHHHHcC-CC-----CC
Confidence 2 2233458899999999999889999999999999999999999996322 1 1111111110 00 11
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
........+.+++.+||+.+|++||++.++++.
T Consensus 221 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 ----VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ----CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111234678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=319.96 Aligned_cols=201 Identities=23% Similarity=0.345 Sum_probs=172.4
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|++.+.||+|+||+||+++.. +++.||+|++.... .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999865 68999999986422 1223445888999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999975322 378889999999999999999999 999999999999999999999999999976544
Q ss_pred CCCeeeecccccccccchhhhcc-----CCCCCcccchhHHHHHHHHHhCCCCcc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGIMLLELITGQRAFD 502 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~ 502 (621)
..........||+.|+|||++.. ..++.++|||||||++|||++|+.||.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 33322333459999999999863 456889999999999999999999995
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=335.05 Aligned_cols=262 Identities=22% Similarity=0.293 Sum_probs=191.9
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecC-------
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------- 365 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 365 (621)
..++|...+.||+|+||+||+|... +++.||||.+.... ....+|+.+++.++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 3567999999999999999999864 68899999885432 1245799999999999999999886432
Q ss_pred -CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-cEEEcc
Q 007020 366 -TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGD 443 (621)
Q Consensus 366 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~D 443 (621)
...++||||+++ +|.+++.........+++..++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 235689999986 77777764333344588999999999999999999999 999999999999998664 799999
Q ss_pred cccceecccCCCeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh
Q 007020 444 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 522 (621)
Q Consensus 444 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 522 (621)
||+|+.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||...... ..+...+....
T Consensus 215 FGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~----~~~~~i~~~~~ 288 (440)
T PTZ00036 215 FGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV----DQLVRIIQVLG 288 (440)
T ss_pred cccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhC
Confidence 99998654322 22234589999999998764 6899999999999999999999999632110 11111111000
Q ss_pred h--hc-------ccccccCc-----cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 523 K--EK-------KLEMLVDP-----DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 523 ~--~~-------~~~~~~d~-----~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. .. ....+.-+ .+...++...+.++.+++..||+.||.+|||+.|+++
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0 00 00000000 0111111123467889999999999999999999874
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=311.84 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=202.2
Q ss_pred hcCCCcCceeeeccCceEEEEEc------CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCce
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 368 (621)
..+|...+.||+|+||.||++.. .++..+|+|.+.... ......+.+|+++++.++|+||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 35677788999999999999963 246689999886443 44456799999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhccCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC
Q 007020 369 LLVYPYMANGSVASCLRERPPS-----------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF 437 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 437 (621)
+++|||+++|+|.+++...... ...+++..+..++.|++.|++|||+. +++||||||+||++++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCC
Confidence 9999999999999998764321 12478899999999999999999999 999999999999999999
Q ss_pred cEEEcccccceecccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHH
Q 007020 438 EAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLL 515 (621)
Q Consensus 438 ~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~ 515 (621)
.+||+|||++......... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||..... .
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~ 231 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--------T 231 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--------H
Confidence 9999999999765432211 1122235678999999998899999999999999999998 9999852211 1
Q ss_pred HHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007020 516 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573 (621)
Q Consensus 516 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 573 (621)
+.+......... .. ....+..+.+++..||+.||++||++.+|++.|+
T Consensus 232 ~~~~~~~~~~~~---~~-------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 232 EAIECITQGREL---ER-------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHHHcCccC---CC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111111111110 00 1122356889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=307.21 Aligned_cols=249 Identities=27% Similarity=0.433 Sum_probs=199.3
Q ss_pred ceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCchh
Q 007020 302 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 381 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 381 (621)
++||+|+||.||++...+++.||+|.++..........+.+|+++++.++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36999999999999987799999999876654445667999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeee-ec
Q 007020 382 SCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TA 460 (621)
Q Consensus 382 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~-~~ 460 (621)
+++..... .+++..+..++.+++.||+|||++ +++||||||+||+++.++.+||+|||++........... ..
T Consensus 81 ~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 99876432 378889999999999999999999 999999999999999999999999999976542211111 11
Q ss_pred ccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCcc
Q 007020 461 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNY 539 (621)
Q Consensus 461 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 539 (621)
..++..|+|||.+.++.++.++||||||+++|||++ |..||..... ....+.+. ... .. ..
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-----~~~~~~~~---~~~---~~-------~~ 216 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-----QQTRERIE---SGY---RM-------PA 216 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-----HHHHHHHh---cCC---CC-------CC
Confidence 224567999999988889999999999999999999 8888852211 11111111 000 00 01
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 540 VEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 540 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
....+..+.+++..|+..+|++||++.+|++.|+.
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 12234678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=312.53 Aligned_cols=264 Identities=27% Similarity=0.406 Sum_probs=199.6
Q ss_pred cCCCcCceeeeccCceEEEEEc-----CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeec--CCce
Q 007020 296 DSFSNKNILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTER 368 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 368 (621)
.+|+..+.||+|+||+||++.. .+++.||+|.++... ......+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 4677889999999999999974 257899999986543 3445578999999999999999999998754 3467
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence 89999999999999997542 2378999999999999999999999 99999999999999999999999999998
Q ss_pred ecccCCCeee--ecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCccccccc------C-CCcchHHHHHH
Q 007020 449 LMDYKDTHVT--TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLA------N-DDDVMLLDWVK 519 (621)
Q Consensus 449 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~------~-~~~~~~~~~~~ 519 (621)
.......... ....++..|+|||.+.+..++.++||||||+++|||++|..|+...... . ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 7643322211 1122445699999998888999999999999999999988775321100 0 00000000000
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 520 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 520 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
..... .............+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 237 ~~~~~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKN---------NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhc---------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 10100 000001112346799999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=310.51 Aligned_cols=255 Identities=24% Similarity=0.334 Sum_probs=199.5
Q ss_pred hcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.++|+..+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.++..++||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 45788899999999999999986 468899999986443 2234467889999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++++|.++++... ++++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 87 YCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 999999999987543 378899999999999999999999 9999999999999999999999999999865422
Q ss_pred CCeeeecccccccccchhhhc---cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
.. ......|+..|+|||.+. ...++.++|||||||++|||++|+.||........ .... .....
T Consensus 160 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-----------~~~~-~~~~~ 226 (267)
T cd06646 160 IA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-----------LFLM-SKSNF 226 (267)
T ss_pred cc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-----------heee-ecCCC
Confidence 11 122345888999999884 34467899999999999999999999852211000 0000 00000
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 572 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L 572 (621)
..+.... .......+.+++..||+.+|++||+++++++.|
T Consensus 227 ~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 QPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1111110 112346788999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=309.13 Aligned_cols=249 Identities=31% Similarity=0.437 Sum_probs=199.5
Q ss_pred ceeeeccCceEEEEEcCC--C--cEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCC
Q 007020 302 NILGRGGFGKVYKGRLAD--G--SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 377 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 377 (621)
+.||+|++|.||+|.+.+ + ..||+|.+...........+.+|+.++++++|+||+++++++.. ...+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998643 3 36999999776544556679999999999999999999999988 889999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCe-
Q 007020 378 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH- 456 (621)
Q Consensus 378 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~- 456 (621)
|+|.+++..... ..+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999987542 3489999999999999999999999 9999999999999999999999999999876442221
Q ss_pred -eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 457 -VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 457 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+..+...... ....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~~~~~~~~~~--~~~~--- 221 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS--------GSQILKKIDKEG--ERLE--- 221 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHhcC--CcCC---
Confidence 1112347789999999998899999999999999999999 999995221 111122211100 0000
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 573 (621)
.....+..+.+++..|++.+|++||++.++++.|.
T Consensus 222 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 ----RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ----CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11123467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=310.54 Aligned_cols=257 Identities=22% Similarity=0.349 Sum_probs=203.1
Q ss_pred hcCCCcCceeeeccCceEEEEEcCC----CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLAD----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
.++|...+.||+|+||.||+|.+.+ ...||+|.............+.+|+.+++.++|+||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4567788999999999999998643 246999988765545556679999999999999999999998865 56789
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
||||+++|+|.+++..... .+++..+..++.+++.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 9999999999999976432 378999999999999999999999 9999999999999999999999999999866
Q ss_pred ccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
............++..|+|||.+.+..++.++||||||+++||+++ |..||..... .....++. .....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~~~~~~~~---~~~~~-- 227 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-----NDVIGRIE---NGERL-- 227 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHH---cCCcC--
Confidence 4432222222334568999999988889999999999999999996 9999963221 11111111 11110
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 576 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 576 (621)
. ........+.+++.+|+..+|++|||+.+++..|++..
T Consensus 228 -~-------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 228 -P-------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred -C-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 11123367889999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.76 Aligned_cols=246 Identities=24% Similarity=0.305 Sum_probs=191.2
Q ss_pred ceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHH-HHHhccCCceeeeeeeeecCCceEEEEeccCC
Q 007020 302 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 377 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 377 (621)
+.||+|+||+||+|... +++.||+|++..... ......+..|.. +++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 578899999865321 122233444444 56788999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee
Q 007020 378 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457 (621)
Q Consensus 378 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 457 (621)
|+|.+++.... .+.+..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~ 152 (325)
T cd05602 81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT 152 (325)
T ss_pred CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence 99999987643 277888899999999999999999 99999999999999999999999999987533221 22
Q ss_pred eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccC
Q 007020 458 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537 (621)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 537 (621)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ ... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~-~~~--~~----- 216 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYDNILNK-PLQ--LK----- 216 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC--------HHHHHHHHHhC-CcC--CC-----
Confidence 334569999999999999999999999999999999999999995221 11222222111 000 11
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 538 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 538 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
......+.+++..|++.+|.+||++.+.+..+.+
T Consensus 217 ---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 217 ---PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred ---CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 1223578899999999999999998865544444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=316.18 Aligned_cols=259 Identities=24% Similarity=0.346 Sum_probs=201.5
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
++|+..+.||+|+||.||++... ++..||+|.++.........++.+|+++++.++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888899999999999999865 68889999987654444455788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++++|.+++.... .+++..+..++.|+++||.|||+.. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 99999999997643 3788899999999999999999732 8999999999999999999999999998754322
Q ss_pred CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcc--------
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK-------- 526 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------- 526 (621)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ....+.........
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-----ELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh-----hHHHhhcCccccccccCCcccc
Confidence 123346889999999998888999999999999999999999998532210 01111100000000
Q ss_pred ----------------cccc---cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 527 ----------------LEML---VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 527 ----------------~~~~---~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
...+ ..+.... ......+.+++.+|++.+|++||++.+|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPS---GAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcC---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0000000 0123568899999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=308.90 Aligned_cols=249 Identities=29% Similarity=0.410 Sum_probs=200.1
Q ss_pred hcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeee-cCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM-TPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e 373 (621)
.++|...+.||+|+||.||++... |..||+|.++... ....+..|+.++++++|+|++++++++. ..+..+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 457888899999999999999875 7889999986432 3456889999999999999999999764 4567899999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++|+|.+++..... ..+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 81 YMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred CCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 9999999999976432 2378899999999999999999999 9999999999999999999999999998754322
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
. ....++..|+|||++.+..++.++||||||+++|||++ |+.||.... ..+..........
T Consensus 156 ~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~------ 217 (256)
T cd05082 156 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRVEKGYK------ 217 (256)
T ss_pred C----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHhcCCC------
Confidence 1 22335668999999998889999999999999999998 999985221 1222222111100
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
+. .....+..+.+++.+|++.+|++|||+.++++.|++
T Consensus 218 ~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 218 MD----APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 01 111234678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=324.99 Aligned_cols=260 Identities=19% Similarity=0.279 Sum_probs=197.4
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|+..+.||+|+||+||++... +++.||+|+++... .......+..|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36788899999999999999865 68999999996432 1223456788999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999997643 388899999999999999999999 999999999999999999999999999875432
Q ss_pred CCC----------------------------------eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCC
Q 007020 453 KDT----------------------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQ 498 (621)
Q Consensus 453 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~ 498 (621)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 0012346999999999999999999999999999999999999
Q ss_pred CCcccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCCc
Q 007020 499 RAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLA 578 (621)
Q Consensus 499 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~ 578 (621)
.||..... .............. ...+.. .....+.+++..|+ .+|.+|++...+-+.++...+.
T Consensus 234 ~Pf~~~~~--------~~~~~~i~~~~~~~-~~p~~~------~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~ 297 (360)
T cd05627 234 PPFCSETP--------QETYRKVMNWKETL-VFPPEV------PISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFE 297 (360)
T ss_pred CCCCCCCH--------HHHHHHHHcCCCce-ecCCCC------CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCC
Confidence 99963211 11111111110000 011110 11245666776665 4999999754444445554444
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=318.59 Aligned_cols=246 Identities=24% Similarity=0.322 Sum_probs=191.9
Q ss_pred ceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHH-HHHhccCCceeeeeeeeecCCceEEEEeccCC
Q 007020 302 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 377 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 377 (621)
+.||+|+||+||+|... +|+.||+|++..... ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999864 689999999865421 222334555555 46778999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee
Q 007020 378 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457 (621)
Q Consensus 378 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 457 (621)
|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~ 152 (325)
T cd05604 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDT 152 (325)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCC
Confidence 99998887543 388999999999999999999999 9999999999999999999999999998753221 112
Q ss_pred eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccC
Q 007020 458 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537 (621)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 537 (621)
.....||..|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... ....+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~~~~~~~~~---~~~~~---- 217 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD--------VAEMYDNILHKP---LVLRP---- 217 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC--------HHHHHHHHHcCC---ccCCC----
Confidence 234569999999999999999999999999999999999999995321 111122221110 00111
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 538 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 538 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.....+.+++..|++.+|.+||++++.++.+..
T Consensus 218 ----~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05604 218 ----GASLTAWSILEELLEKDRQRRLGAKEDFLEIQE 250 (325)
T ss_pred ----CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhc
Confidence 123567889999999999999998755544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=312.24 Aligned_cols=258 Identities=26% Similarity=0.419 Sum_probs=204.0
Q ss_pred cCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
++|+..+.||+|+||+||+|+.+ +.+.|++|.+...........+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888899999999999999853 346799998865443334567899999999999999999999999989999
Q ss_pred EEEeccCCCchhhhhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccc
Q 007020 370 LVYPYMANGSVASCLRERPPS-----QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 444 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 444 (621)
+||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999765421 12489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhh
Q 007020 445 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 523 (621)
Q Consensus 445 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 523 (621)
|++...............++..|+|||.+.+...+.++||||||+++|+|++ |..||.... . .+.+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~-----~---~~~~~~~~~ 233 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS-----D---EEVLNRLQA 233 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----h---HHHHHHHHc
Confidence 9987543222222333446778999999988888999999999999999999 788885211 0 111111111
Q ss_pred hcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007020 524 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573 (621)
Q Consensus 524 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 573 (621)
..... . ........+.+++.+|++.+|++||++.++++.|.
T Consensus 234 -~~~~~-~-------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 -GKLEL-P-------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -CCcCC-C-------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11110 0 01122367899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=305.63 Aligned_cols=251 Identities=33% Similarity=0.506 Sum_probs=204.0
Q ss_pred ceeeeccCceEEEEEcCC----CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCC
Q 007020 302 NILGRGGFGKVYKGRLAD----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 377 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 377 (621)
+.||+|+||.||+|.... +..||+|.++..........+.+|++.+..++|+||+++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998753 7889999998765544567889999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 378 GSVASCLRERPPS-----QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 378 gsL~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
++|.+++...... ...+++..+..++.|+++||+|||++ +++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875211 24589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 453 KDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 453 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
... .......++..|+|||.+....++.++||||+|+++|||++ |..||.... ..+......... ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~---~~ 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--------NEEVLEYLRKGY---RL 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCC---CC
Confidence 321 12233457889999999988889999999999999999999 699996331 112222211110 00
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 573 (621)
.........+.+++..|++.+|++||++.++++.|+
T Consensus 227 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 -------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111222468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=306.30 Aligned_cols=251 Identities=25% Similarity=0.447 Sum_probs=202.0
Q ss_pred cCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEecc
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 375 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 375 (621)
.+|+..+.||+|+||.||++.+.++..+|+|.++.... ...++..|+++++.++||||+++++++......+++|||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 45777889999999999999987788999999865432 2456889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCC
Q 007020 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 455 (621)
++++|.+++..... .+++..+..++.+++.|++|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 99999999875432 378899999999999999999999 999999999999999999999999999886543222
Q ss_pred eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 456 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
.......++.+|+|||.+.++.++.++||||||+++|||++ |..||.... ....+...... .....+.
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~---~~~~~~~ 224 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS--------NSEVVETINAG---FRLYKPR 224 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHHHHhCC---CCCCCCC
Confidence 22222335678999999998889999999999999999998 999985221 11222221111 1111122
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 572 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L 572 (621)
. ....+.+++.+||+.+|++||++.+++++|
T Consensus 225 ~-------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 L-------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred C-------CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1 236789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=306.03 Aligned_cols=254 Identities=24% Similarity=0.396 Sum_probs=191.7
Q ss_pred eeeeccCceEEEEEcCCC---cEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCc
Q 007020 303 ILGRGGFGKVYKGRLADG---SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 379 (621)
Q Consensus 303 ~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 379 (621)
.||+|+||+||+|...++ ..+++|.++..........+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975433 34667776655444455679999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC-Ceee
Q 007020 380 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVT 458 (621)
Q Consensus 380 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~-~~~~ 458 (621)
|.++++.........++..+..++.||++||+|||+. +++||||||+|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999986543333466778889999999999999999 99999999999999999999999999986422111 1112
Q ss_pred ecccccccccchhhhcc-------CCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 459 TAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 459 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
....++..|+|||++.. ..++.++||||||+++|||++ |..||.... ..+.+....... ....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--------~~~~~~~~~~~~-~~~~ 229 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS--------DREVLNHVIKDQ-QVKL 229 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHhhc-cccc
Confidence 23457889999998753 235789999999999999997 566774211 112222222221 1223
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 573 (621)
.++.....+ ...+.+++..|| .+|++||++++|++.|.
T Consensus 230 ~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 344433222 256778888999 57999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=306.44 Aligned_cols=250 Identities=32% Similarity=0.459 Sum_probs=192.5
Q ss_pred ceeeeccCceEEEEEcC----CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeee-cCCceEEEEeccC
Q 007020 302 NILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM-TPTERLLVYPYMA 376 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~ 376 (621)
+.||+|+||.||+|.+. ++..||+|.+...........+.+|+.+++.++||||+++++++. .++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 245799999865444444567889999999999999999999875 4556799999999
Q ss_pred CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCe
Q 007020 377 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 456 (621)
Q Consensus 377 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 456 (621)
+|+|.+++..... ..++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 9999999976432 256778889999999999999999 9999999999999999999999999999755332111
Q ss_pred ---eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhC-CCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 457 ---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG-QRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 457 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
......++..|+|||.+.+..++.++||||||+++|||++| .+||... . ..+..........
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-----~---~~~~~~~~~~~~~------ 220 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----D---SFDITVYLLQGRR------ 220 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-----C---HHHHHHHHhcCCC------
Confidence 11123457789999999888899999999999999999995 5556421 1 1122222211110
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
+.. ....+..+.+++..||+.+|++||++.+|++.|++.
T Consensus 221 ~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 221 LLQ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CCC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 000 111235788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=312.34 Aligned_cols=260 Identities=23% Similarity=0.392 Sum_probs=206.3
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.++|+..+.||+|+||+||++... +|+.||+|++...........+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356777789999999999999865 6889999998765545556678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++++|.+++.... ++++..+..++.+++.||.|||+.. +++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999987643 3889999999999999999999732 8999999999999999999999999998754322
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCC---cchHHHHHHHHhhhcccccc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD---DVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 530 (621)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||+......+. .....+++.......
T Consensus 158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 229 (284)
T cd06620 158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----- 229 (284)
T ss_pred ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence 122346899999999998888999999999999999999999999743321111 111122222222111
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 572 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L 572 (621)
.+.+. .......+.+++..|++.||++|||+.|++++.
T Consensus 230 -~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 -PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11111 112346788999999999999999999998863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=344.32 Aligned_cols=260 Identities=22% Similarity=0.311 Sum_probs=201.9
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|++.++||+|+||.||+|... +|+.||+|+++.... +....++.+|+++++.++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47888999999999999999865 589999999975432 233457899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccc
Q 007020 373 PYMANGSVASCLRERPP-------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 445 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~-------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 445 (621)
||++||+|.+++..... .....++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 112356778899999999999999999 99999999999999999999999999
Q ss_pred cceecccCCC-----------------eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccC
Q 007020 446 LAKLMDYKDT-----------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLAN 508 (621)
Q Consensus 446 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~ 508 (621)
+++....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~- 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR- 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence 9986521110 0112246999999999999999999999999999999999999999632110
Q ss_pred CCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHhc
Q 007020 509 DDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-KMSEVVRMLEG 574 (621)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-t~~~vl~~L~~ 574 (621)
..... ....++.... ...+.+..+.+++.+|++.||++|| +++++.+.|+.
T Consensus 238 -------ki~~~-------~~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 238 -------KISYR-------DVILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred -------hhhhh-------hhccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00000 0011110000 0112345688999999999999996 56667776655
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=313.29 Aligned_cols=250 Identities=22% Similarity=0.350 Sum_probs=201.2
Q ss_pred hcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
..+|+..+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+.+++.+.|+||+++++.+......++|||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 35788889999999999999985 46889999998754433 34568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 98 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred ccCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 99999999998653 278889999999999999999999 9999999999999999999999999998765432
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 533 (621)
.. ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||..... ...+.. ..... . +
T Consensus 170 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~-------~~~~~~-~~~~~-~-----~ 234 (296)
T cd06654 170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYL-IATNG-T-----P 234 (296)
T ss_pred cc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-------HHhHHH-HhcCC-C-----C
Confidence 21 12234588999999999988889999999999999999999999963221 111111 11000 0 0
Q ss_pred cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 534 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.. .........+.+++.+||..+|++||++.++++
T Consensus 235 ~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 235 EL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CC--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 00 011223367889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=316.14 Aligned_cols=249 Identities=24% Similarity=0.307 Sum_probs=191.6
Q ss_pred ceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHH-HHHhccCCceeeeeeeeecCCceEEEEeccCC
Q 007020 302 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 377 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 377 (621)
+.||+|+||+||+|+.. +++.||+|++..... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 688999999865321 122334555554 57889999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee
Q 007020 378 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457 (621)
Q Consensus 378 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 457 (621)
|+|...+.... .+.+..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (321)
T cd05603 81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EET 152 (321)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCc
Confidence 99998886532 378888999999999999999999 9999999999999999999999999998753222 122
Q ss_pred eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccC
Q 007020 458 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537 (621)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 537 (621)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~-~------~~-- 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------VSQMYDNILHKP-L------QL-- 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--------HHHHHHHHhcCC-C------CC--
Confidence 334568999999999998889999999999999999999999995321 112222221110 0 01
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCCCHH-HHHHHHhcCCC
Q 007020 538 NYVEAEVEQLIQVALLCTQGSPMDRPKMS-EVVRMLEGDGL 577 (621)
Q Consensus 538 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~-~vl~~L~~~~~ 577 (621)
+......+.+++..|++.+|.+||++. ++.+.++...+
T Consensus 216 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~ 254 (321)
T cd05603 216 --PGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFF 254 (321)
T ss_pred --CCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCc
Confidence 112235788999999999999999864 33444444333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=309.43 Aligned_cols=249 Identities=25% Similarity=0.368 Sum_probs=203.9
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
..|+..+.||.|+||.||+|... +++.||+|.+...........+.+|+.+++.+.|+||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35667788999999999999865 58899999987655455566789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++|+|.+++... ++++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 9999999998753 278889999999999999999999 99999999999999999999999999997654332
Q ss_pred CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
. ......++..|+|||++.+...+.++|+||||+++|||++|+.||...... ...... ...
T Consensus 156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~~~----------~~~ 216 (277)
T cd06640 156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--------RVLFLI----------PKN 216 (277)
T ss_pred c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--------hHhhhh----------hcC
Confidence 2 223345788999999998888999999999999999999999999632110 111100 001
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
............+.+++..||+.+|++||++.++++.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1112233456788999999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=322.16 Aligned_cols=198 Identities=24% Similarity=0.292 Sum_probs=167.4
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCC-----
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----- 366 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 366 (621)
..++|+..+.||+|+||.||++... +|+.||+|.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999864 689999999865432 233456789999999999999999999986543
Q ss_pred -ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccc
Q 007020 367 -ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 445 (621)
Q Consensus 367 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 445 (621)
..++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 46999999976 56666543 277888999999999999999999 99999999999999999999999999
Q ss_pred cceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCccc
Q 007020 446 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 503 (621)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~ 503 (621)
+++..... .......||..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 169 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 169 LARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred CccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 99754321 222334689999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=308.59 Aligned_cols=253 Identities=29% Similarity=0.437 Sum_probs=199.3
Q ss_pred CCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHH-HHHHHHHHHHhccCCceeeeeeeeecCCceEEEEecc
Q 007020 298 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGEL-QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 375 (621)
Q Consensus 298 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~-~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 375 (621)
|+..+.||+|+||+||+++.. +++.||+|.+.......... ...+|+.+++.++|+||+++++++.+....+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999976 56789999997665333222 3456999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCC
Q 007020 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 455 (621)
++++|.+++.... .+++..+..++.|+++||+|||+. +|+|+||||+||++++++.++|+|||.+.... ...
T Consensus 81 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQKNK----PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENN 152 (260)
T ss_dssp TTEBHHHHHHHHS----SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STT
T ss_pred ccccccccccccc----cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccc
Confidence 9999999998322 389999999999999999999999 99999999999999999999999999998642 223
Q ss_pred eeeecccccccccchhhhc-cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 456 HVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
.......++..|+|||++. +...+.++||||+|+++|+|++|..||.... .......+...........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~-----~~~~~~~~~~~~~~~~~~~----- 222 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN-----SDDQLEIIEKILKRPLPSS----- 222 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS-----HHHHHHHHHHHHHTHHHHH-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc-----chhhhhhhhhccccccccc-----
Confidence 3444566899999999998 7888999999999999999999999996331 0111111111111000000
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
... .......+.+++..|++.||++||++.++++
T Consensus 223 ~~~--~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 223 SQQ--SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TTS--HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccc--cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0011278999999999999999999999976
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=310.72 Aligned_cols=252 Identities=29% Similarity=0.478 Sum_probs=198.2
Q ss_pred ceeeeccCceEEEEEcCC-------CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 302 NILGRGGFGKVYKGRLAD-------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
+.||+|+||.||+|+..+ ++.||+|.+...........+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 3579999987654445566789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-----cEEEccccc
Q 007020 375 MANGSVASCLRERPP---SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF-----EAVVGDFGL 446 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-----~~kl~DfGl 446 (621)
+++|+|.+++..... ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975322 123478899999999999999999999 999999999999999877 899999999
Q ss_pred ceecccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhh
Q 007020 447 AKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKE 524 (621)
Q Consensus 447 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 524 (621)
+......... ......++..|+|||++.+..++.++||||||+++|||++ |+.||.... .......+. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~-----~~~~~~~~~---~~ 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN-----NQEVLQHVT---AG 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC-----HHHHHHHHh---cC
Confidence 8755332211 1122335678999999999999999999999999999998 999985221 111111111 10
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 525 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 525 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
... ......+..+.+++.+||..+|++||++++|++.|++
T Consensus 230 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 GRL----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred Ccc----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 000 1112234678899999999999999999999998864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=318.28 Aligned_cols=256 Identities=20% Similarity=0.268 Sum_probs=195.2
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|.+.+.||+|+||+||+++.. +++.||+|++.+.. .......+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888899999999999999865 57889999986432 1222345788999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999976322 378889999999999999999999 999999999999999999999999999976543
Q ss_pred CCCeeeecccccccccchhhhc-----cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~ 226 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHKER 226 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC--------HHHHHHHHhCCCcc
Confidence 3333333456999999999986 3457889999999999999999999996321 11222222211100
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCC--CCCCHHHHHHH
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPM--DRPKMSEVVRM 571 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~--~RPt~~~vl~~ 571 (621)
..-+. ........+.+++..|+..+++ .|++++++++.
T Consensus 227 --~~~p~----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 --FQFPA----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --ccCCC----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00011 0112235677777787755443 36788888654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=312.96 Aligned_cols=251 Identities=26% Similarity=0.349 Sum_probs=197.9
Q ss_pred CCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc--hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 298 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 298 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
|+..+.||+|+||.||++... +++.||+|.+...... .....+..|+.+++.++|+||+.+++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667788999999999999865 6889999998654322 2234577899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++|+|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999998865432 2388899999999999999999999 99999999999999999999999999987643222
Q ss_pred CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||...... ....-........ ..
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~-----~~~~~~~~~~~~~------~~- 222 (285)
T cd05630 157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK-----IKREEVERLVKEV------QE- 222 (285)
T ss_pred --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc-----chHHHHHhhhhhh------hh-
Confidence 122346899999999999989999999999999999999999999632110 0001011111000 00
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPK-----MSEVVR 570 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-----~~~vl~ 570 (621)
.+.......+.+++..||+.||++||| ++++++
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 ---EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ---hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 011122356889999999999999999 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=319.79 Aligned_cols=255 Identities=20% Similarity=0.271 Sum_probs=195.3
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|.+.+.||+|+||+||+++.. +++.||+|.+.... .......+..|..++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999865 67899999986432 1223345788999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999976322 378889999999999999999999 999999999999999999999999999987654
Q ss_pred CCCeeeecccccccccchhhhcc-----CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
..........||+.|+|||++.+ +.++.++|||||||++|||++|+.||.... ..+...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~ 226 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHEER 226 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC--------HHHHHHHHHcCCCc
Confidence 33333334569999999999875 457889999999999999999999996321 11111111111100
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMD--RPKMSEVVR 570 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~--RPt~~~vl~ 570 (621)
.. . +. ........+.+++.+|+..++++ |++++++++
T Consensus 227 ~~-~-p~----~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 227 FQ-F-PS----HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred cc-C-CC----ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 00 0 11 01122356778888888765543 457777754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=325.82 Aligned_cols=262 Identities=19% Similarity=0.237 Sum_probs=195.2
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
...|.+.+.||+|+||.||+|.+. .++.||||.... ..+.+|++++++++|+|||++++++......++|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 346888999999999999999875 578899996421 235689999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
++. ++|.+++..... .+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 241 ~~~-~~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 241 KYR-SDLYTYLGARLR---PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred ccC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 995 688888865322 489999999999999999999999 9999999999999999999999999999875432
Q ss_pred CCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc--cc
Q 007020 454 DTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE--ML 530 (621)
Q Consensus 454 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 530 (621)
... ......||..|+|||++.+..++.++|||||||++|||++|..|+-.............+ +...++..... ..
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~-l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQ-ILRIIRQAQVHVDEF 392 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHH-HHHHHHhhccccccC
Confidence 221 223456999999999999999999999999999999999988664321111111111111 11111110000 00
Q ss_pred -------------------cCccccCcccH---HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 531 -------------------VDPDLQNNYVE---AEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 531 -------------------~d~~~~~~~~~---~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
..+......+. .....+.+++..|++.||.+|||+.|+++.
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000000000 112367889999999999999999999873
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=311.18 Aligned_cols=252 Identities=26% Similarity=0.396 Sum_probs=196.7
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeeecC------
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP------ 365 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------ 365 (621)
+.+.|+..+.||+|+||.||+|... +++.||+|.+.... .....+..|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 4567888899999999999999865 68899999986543 3345688899999988 699999999998653
Q ss_pred CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccc
Q 007020 366 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 445 (621)
Q Consensus 366 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 445 (621)
...+++|||+++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+|+||||+||++++++.++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 45789999999999999987643 22488999999999999999999999 99999999999999999999999999
Q ss_pred cceecccCCCeeeecccccccccchhhhc-----cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH
Q 007020 446 LAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 520 (621)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 520 (621)
++........ ......|+..|+|||++. ...++.++|||||||++|||++|+.||..... ......
T Consensus 157 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-------~~~~~~- 227 (272)
T cd06637 157 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRALFL- 227 (272)
T ss_pred Cceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-------HHHHHH-
Confidence 9986543221 223345899999999986 33578899999999999999999999952211 111110
Q ss_pred HhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 521 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 521 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..... .+... .......+.+++.+||..+|.+|||+.++++
T Consensus 228 -~~~~~-----~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 228 -IPRNP-----APRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -HhcCC-----CCCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00000 11111 1122357889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=308.09 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=190.4
Q ss_pred eeeeccCceEEEEEcC---CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCc
Q 007020 303 ILGRGGFGKVYKGRLA---DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 379 (621)
Q Consensus 303 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 379 (621)
.||+|+||+||+|... ....+|+|.+...........+.+|+..++.++|+||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 5899999999999753 2457888887655444445678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCe-e
Q 007020 380 VASCLRERPPS-QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-V 457 (621)
Q Consensus 380 L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-~ 457 (621)
|.+++...... ....++.....++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999764321 22256778899999999999999999 9999999999999999999999999998754322111 1
Q ss_pred eecccccccccchhhhcc-------CCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 458 TTAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||..... . +......... ...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~---~~~~~~~~~~-~~~ 229 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-----E---QVLKQVVREQ-DIK 229 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH-----H---HHHHHHhhcc-Ccc
Confidence 122345678999999753 346789999999999999999 7888852210 0 1111111111 111
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 573 (621)
..++... ......+.+++..|| .||++||++++|++.|.
T Consensus 230 ~~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1222221 123356777888898 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=312.69 Aligned_cols=248 Identities=26% Similarity=0.377 Sum_probs=200.4
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEecc
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 375 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 375 (621)
.|+..+.||+|+||.||+|... +++.||+|.+...........+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3555678999999999999864 578999999875554455567899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCC
Q 007020 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 455 (621)
++++|.+++... .+++..+..++.|+++|+.|||++ +++|+||+|+||++++++.++++|||++........
T Consensus 85 ~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999999988643 378899999999999999999999 999999999999999999999999999976543221
Q ss_pred eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccc
Q 007020 456 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 535 (621)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 535 (621)
......|+..|+|||++.+..++.++||||||+++|||++|+.||...... .+...... ...+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~~~~~------~~~~~- 220 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM--------RVLFLIPK------NSPPT- 220 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh--------hHHhhhhc------CCCCC-
Confidence 122345788999999999888999999999999999999999998522110 01110000 00111
Q ss_pred cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 536 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 536 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
........+.+++..|++.+|++||++.++++.
T Consensus 221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 ---LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 112234678899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=315.44 Aligned_cols=262 Identities=23% Similarity=0.352 Sum_probs=198.8
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
++|...+.||+|+||.||+|... +++.||+|.++..........+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888899999999999999865 68899999987554444445678899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
++ ++|.+++..... .+++..+..++.|+++||+|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDCGN---SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 98 489888875432 378889999999999999999999 99999999999999999999999999997643322
Q ss_pred CeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh-----------
Q 007020 455 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL----------- 522 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----------- 522 (621)
. ......++..|+|||.+.+. .++.++|||||||++|||++|+.||...... .....+....
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 159 K-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE-----EQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred C-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHcCCCChhhchhh
Confidence 1 12233478899999998654 4788999999999999999999999632211 0011111100
Q ss_pred -hhcccccccCccccCc----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 523 -KEKKLEMLVDPDLQNN----YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 523 -~~~~~~~~~d~~~~~~----~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..........+..... ........+.+++..|++.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000000111000 01112356789999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=318.82 Aligned_cols=243 Identities=24% Similarity=0.338 Sum_probs=192.5
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhcc-CCceeeeeeeeecCCceEEEE
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 372 (621)
+|+..+.||+|+||+||+|... +|+.||+|+++... .......+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999865 68899999987542 1223345777888888775 577888999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999987643 388999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
.. .......||..|+|||++.+..++.++|||||||++|||++|+.||..... ........... .
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~~-~----- 218 (323)
T cd05615 154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELFQSIMEHN-V----- 218 (323)
T ss_pred CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC-C-----
Confidence 21 223345689999999999988899999999999999999999999963211 11122221111 0
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHH
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMS 566 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ 566 (621)
. ++......+.+++..|++.+|.+|++..
T Consensus 219 -~----~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 219 -S----YPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -C----CCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 1 1112235778899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=308.88 Aligned_cols=251 Identities=26% Similarity=0.338 Sum_probs=196.6
Q ss_pred CCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc--hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 298 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 298 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
|+..+.||+|+||+||+|... +++.||+|.+...... .....+.+|+++++.++|+||+++.+++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999864 6889999998654322 2234577899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999988865432 2489999999999999999999999 99999999999999999999999999997653221
Q ss_pred CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
......|+..|+|||.+.+..++.++|+||||+++|||++|+.||..... ......+...... . . ..
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~----~~~~~~~~~~~~~-~--~----~~ 223 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE----KVKREEVDRRVLE-T--E----EV 223 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhhhc-c--c----cc
Confidence 12334689999999999988899999999999999999999999963211 0001111111100 0 0 01
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPK-----MSEVVR 570 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-----~~~vl~ 570 (621)
+.......+.+++..|++.+|++||+ +++++.
T Consensus 224 ----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 224 ----YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ----cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 11222356789999999999999999 555544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=309.43 Aligned_cols=249 Identities=27% Similarity=0.403 Sum_probs=203.5
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
++|+..+.||.|+||.||+|... +++.||+|.+...........+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778889999999999999865 68899999987654444556788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++++|.+++... ++++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998764 488999999999999999999999 99999999999999999999999999998765432
Q ss_pred CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ......... . ..+.
T Consensus 153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--------~~~~~~~~~-~-----~~~~ 217 (274)
T cd06609 153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--------MRVLFLIPK-N-----NPPS 217 (274)
T ss_pred c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--------HHHHHHhhh-c-----CCCC
Confidence 1 22334588899999999988899999999999999999999999963221 011111111 1 1111
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.... .....+.+++..|+..+|++|||++++++
T Consensus 218 ~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 218 LEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred Cccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1111 03357889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=310.89 Aligned_cols=264 Identities=26% Similarity=0.393 Sum_probs=205.1
Q ss_pred cCCCcCceeeeccCceEEEEEcC-----CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeec--CCce
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTER 368 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 368 (621)
+.|...+.||+|+||.||+|.+. +++.||||.++..........+.+|+++++.+.|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45667789999999999999853 3688999999765543345679999999999999999999999877 5678
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
+++|||+++++|.+++..... .+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 999999999999999976542 388999999999999999999999 99999999999999999999999999998
Q ss_pred ecccCCCee--eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCC------c-chHHHHHH
Q 007020 449 LMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD------D-VMLLDWVK 519 (621)
Q Consensus 449 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~------~-~~~~~~~~ 519 (621)
......... .....++..|+|||.+.+..++.++||||||+++|||++|..||......... + .....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 765322211 11223556799999998888999999999999999999999998633211100 0 00111111
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 520 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 520 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
. .... ........+..++.+++.+|++.+|++||++.+|+++|+.+
T Consensus 238 ~-~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 L-LKEG---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred H-HHcC---------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1 1100 00011122336789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=308.86 Aligned_cols=262 Identities=24% Similarity=0.317 Sum_probs=203.4
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecC--CceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 372 (621)
++|...+.||.|++|.||++... +++.||+|.+..........++.+|+++++.++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35777889999999999999974 68899999987654444566789999999999999999999988654 4689999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998765333344578889999999999999999999 999999999999999999999999999875432
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||+..............++.. ... ..+.+
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~-~~~~~ 230 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---MPN-PELKD 230 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc---CCc-hhhcc
Confidence 21 123447889999999998899999999999999999999999997443211111222222221 111 01110
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. .. ........+.+++.+||+.+|++|||+.|+++
T Consensus 231 ~-~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 231 E-PG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred C-CC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0 00 00123467889999999999999999999977
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=307.81 Aligned_cols=257 Identities=25% Similarity=0.351 Sum_probs=201.4
Q ss_pred CCCcCceeeeccCceEEEEEcCC--CcEEEEEEecccC---------CchhHHHHHHHHHHHHh-ccCCceeeeeeeeec
Q 007020 297 SFSNKNILGRGGFGKVYKGRLAD--GSLVAVKRLKEER---------TPGGELQFQTEVEMISM-AVHRNLLRLRGFCMT 364 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 364 (621)
.|+..+.||+|+||.||+|.... ++.+|+|.+.... ......++..|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37778899999999999999754 6889999885322 12223456778887764 789999999999999
Q ss_pred CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccc
Q 007020 365 PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 444 (621)
Q Consensus 365 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 444 (621)
.+..+++|||+++++|.+++.........+++..++.++.|++.||.|||+.. +++|+||+|+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988653333445888999999999999999999631 8999999999999999999999999
Q ss_pred ccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhh
Q 007020 445 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 524 (621)
Q Consensus 445 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 524 (621)
|.+....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.... ..........
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~--------~~~~~~~~~~- 227 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN--------MLSLATKIVE- 227 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC--------HHHHHHHHhh-
Confidence 9998754432 2334558899999999998889999999999999999999999995321 1111111111
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 525 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 525 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.... +.. .......+.+++.+||+.||++||++.|+..++++
T Consensus 228 ~~~~----~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 228 AVYE----PLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ccCC----cCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 1111 100 11123678899999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=312.88 Aligned_cols=262 Identities=26% Similarity=0.314 Sum_probs=192.5
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCch-hHHHHHHHHHHHHhc---cCCceeeeeeeeec-----CC
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMA---VHRNLLRLRGFCMT-----PT 366 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 366 (621)
+|+..+.||+|+||+||+|... +++.||+|.++...... ....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999865 68899999987543222 223456677776655 69999999998764 24
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccc
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 446 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 446 (621)
..+++|||+++ +|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 57899999985 88888876432 2378999999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh--h
Q 007020 447 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--E 524 (621)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~ 524 (621)
+....... ......|+..|+|||++.+..++.++||||+||++|||++|++||..... ...+.+....... .
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~----~~~~~~~~~~~~~~~~ 228 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE----ADQLGKIFDLIGLPPE 228 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH----HHHHHHHHHHhCCCCh
Confidence 98654221 22334588999999999988899999999999999999999999953211 0111111110000 0
Q ss_pred ccc-------ccccCccc---cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 525 KKL-------EMLVDPDL---QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 525 ~~~-------~~~~d~~~---~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
... .....+.. ......+....+.+++..|++.||++|||+.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 00000000 00011123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=304.70 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=202.6
Q ss_pred hcCCCcCceeeeccCceEEEEEcCC-CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.++|+..+.||+|+||.||+|...+ ++.|++|.++... ...++.+|+++++.++|+||+++++++.+....++++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 3678888999999999999999764 7899999986442 25679999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 79 ~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 79 YCGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred cCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 999999999987533 2489999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 533 (621)
.. ......++..|+|||++.+..++.++||||||+++|+|++|+.||....... . +... .. ...+
T Consensus 153 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-------~-~~~~-~~-----~~~~ 217 (256)
T cd06612 153 MA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-------A-IFMI-PN-----KPPP 217 (256)
T ss_pred cc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-------h-hhhh-cc-----CCCC
Confidence 22 2233447889999999998889999999999999999999999996322110 0 0000 00 0000
Q ss_pred cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 534 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.. .........+.+++..|++.+|++|||+.+|++
T Consensus 218 ~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 TL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 01 011223367889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=307.06 Aligned_cols=251 Identities=24% Similarity=0.419 Sum_probs=199.8
Q ss_pred CCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCC-----chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 297 SFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT-----PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
+|...+.||+|+||+||+|...+++.+|+|.++.... ......+.+|+++++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677889999999999999988899999999864321 12234688999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++++|.+++.... ++++..+..++.|++.||+|||+. +|+|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999999997643 378889999999999999999999 99999999999999999999999999987643
Q ss_pred cCC-----CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcc
Q 007020 452 YKD-----THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 452 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (621)
... ........|+..|+|||++.+..++.++||||||+++|+|++|+.||..... .... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~-~~~~~~~- 224 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-------LAAM-FYIGAHR- 224 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-------HHHH-HHhhhcc-
Confidence 211 1112234588999999999988899999999999999999999999963210 0010 0000000
Q ss_pred cccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 527 ~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
...+.... .....+.+++.+|++.+|++||++.++++
T Consensus 225 ---~~~~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 ---GLMPRLPD----SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCCCCCCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01111111 22367889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=341.50 Aligned_cols=260 Identities=20% Similarity=0.318 Sum_probs=200.6
Q ss_pred HHHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeec--CC
Q 007020 291 LQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PT 366 (621)
Q Consensus 291 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~ 366 (621)
.+...++|.+.+.||+|+||+||+|... ++..||+|.+.... .......+..|+.++..++|||||++++++.. ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3445578999999999999999999865 57789999986543 23345578999999999999999999998854 35
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCCCeeeCC-------
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD----PKIIHRDVKAANILLDE------- 435 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~----~~ivH~Dlk~~Nill~~------- 435 (621)
..++||||+++|+|.++|.........+++..++.|+.||+.||+|||+... .+||||||||+|||++.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 6899999999999999997643333458999999999999999999998521 25999999999999964
Q ss_pred ----------CCcEEEcccccceecccCCCeeeecccccccccchhhhcc--CCCCCcccchhHHHHHHHHHhCCCCccc
Q 007020 436 ----------EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGIMLLELITGQRAFDL 503 (621)
Q Consensus 436 ----------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~ 503 (621)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||+|||++|+.||..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 3358999999998654321 2234469999999999864 4578999999999999999999999963
Q ss_pred ccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 504 ARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.. ...+.+...... +.+. .......+.+++..||+.+|.+||++.|++.
T Consensus 246 ~~-------~~~qli~~lk~~--------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 AN-------NFSQLISELKRG--------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CC-------cHHHHHHHHhcC--------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 21 111222221111 1110 0112367889999999999999999999984
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=315.23 Aligned_cols=256 Identities=26% Similarity=0.448 Sum_probs=200.6
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCc----EEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
.++|+..+.||+|+||.||+|.+. +|. .||+|.+...........+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356777889999999999999863 343 57999887655444455788999999999999999999998754 467
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+++||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 99999999999999876432 378889999999999999999999 999999999999999999999999999986
Q ss_pred cccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 450 MDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 450 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .....+++. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-----~~~~~~~~~----~~~- 228 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-----TREIPDLLE----KGE- 228 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHH----CCC-
Confidence 5432221 1122335678999999998889999999999999999998 899985211 111122211 110
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
.... ...+...+.+++..||..+|++||+++++++.|+..
T Consensus 229 -~~~~-------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 229 -RLPQ-------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred -CCCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0000 111235788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=309.61 Aligned_cols=262 Identities=23% Similarity=0.309 Sum_probs=201.3
Q ss_pred HHHHHHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeee--
Q 007020 288 LRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCM-- 363 (621)
Q Consensus 288 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-- 363 (621)
++.+..+.++|+..+.||+|+||.||++... +++.||+|.+.... ....++..|+.+++.+ +|+||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 3445567889999999999999999999864 68899999875432 2234678899999998 6999999999874
Q ss_pred ---cCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEE
Q 007020 364 ---TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV 440 (621)
Q Consensus 364 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 440 (621)
.++..++||||+++++|.+++.........+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence 34568999999999999998865332334588889999999999999999999 999999999999999999999
Q ss_pred EcccccceecccCCCeeeecccccccccchhhhcc-----CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHH
Q 007020 441 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 515 (621)
Q Consensus 441 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~ 515 (621)
|+|||++........ ......|+..|+|||++.. ..++.++|||||||++|||++|+.||...... .
T Consensus 165 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-------~ 236 (286)
T cd06638 165 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-------R 236 (286)
T ss_pred EccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-------H
Confidence 999999986543221 2233458999999999853 44788999999999999999999998632110 0
Q ss_pred HHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 516 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 516 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.. ...... ......++. .....+.+++..||+.+|++||++.+|++.
T Consensus 237 ~~-~~~~~~-~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 237 AL-FKIPRN-PPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred HH-hhcccc-CCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 11 000000 000111111 123568899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=306.34 Aligned_cols=256 Identities=26% Similarity=0.451 Sum_probs=203.7
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCc----EEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
..+|...+.||+|+||+||+|.+. +|+ .||+|.+...........+.+|+.+++.++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 356778899999999999999864 232 6899988766555555678899999999999999999999887 7889
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 99999999999999976432 388999999999999999999998 999999999999999999999999999987
Q ss_pred cccCCCeee-ecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 450 MDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 450 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
......... ....++..|+|||.+....++.++|+||||+++||+++ |+.||+... ..++.........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~~- 229 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP--------AVEIPDLLEKGER- 229 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHHHhCCCC-
Confidence 653322211 11224568999999988889999999999999999999 999996321 1122221111110
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
...+ ..+...+.+++..||..+|.+||++.++++.|++.
T Consensus 230 --~~~~-------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 230 --LPQP-------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred --CCCC-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111 11225688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=303.07 Aligned_cols=240 Identities=25% Similarity=0.376 Sum_probs=186.3
Q ss_pred ceeeeccCceEEEEEcCC-------------CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCce
Q 007020 302 NILGRGGFGKVYKGRLAD-------------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 368 (621)
+.||+|+||.||+|+..+ ...|++|.+.... ......+..|+.+++.++||||+++++++..+...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 358999999999998532 2358889875432 23344688899999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc-------EEE
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE-------AVV 441 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~-------~kl 441 (621)
+++|||+++|+|..++.... ..+++..+..++.||++||+|||++ +|+||||||+|||++.++. +++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 99999999999999887532 2388899999999999999999999 9999999999999987664 899
Q ss_pred cccccceecccCCCeeeecccccccccchhhhc-cCCCCCcccchhHHHHHHHHH-hCCCCcccccccCCCcchHHHHHH
Q 007020 442 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGIMLLELI-TGQRAFDLARLANDDDVMLLDWVK 519 (621)
Q Consensus 442 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell-tg~~pf~~~~~~~~~~~~~~~~~~ 519 (621)
+|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||...... +. .
T Consensus 154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--------~~-~ 219 (262)
T cd05077 154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA--------EK-E 219 (262)
T ss_pred CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh--------HH-H
Confidence 999998754321 2234788999999886 456889999999999999998 588887522110 00 0
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007020 520 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573 (621)
Q Consensus 520 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 573 (621)
..... . .... ......+.+++..||+.||++||++.+|++.|+
T Consensus 220 ~~~~~-~-~~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 220 RFYEG-Q-CMLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHHhc-C-ccCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00000 0 0000 111356889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=323.26 Aligned_cols=262 Identities=22% Similarity=0.278 Sum_probs=197.7
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC---CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA---DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
...+|.+.+.||+|+||.||++... .++.||+|.+.... ...+|+++++.++||||+++++++......++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 3467999999999999999999743 46789999876432 34689999999999999999999999999999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
+||++. ++|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.++|+|||+++..
T Consensus 164 v~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EehhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999996 5888888433 2389999999999999999999999 9999999999999999999999999999765
Q ss_pred ccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc-
Q 007020 451 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE- 528 (621)
Q Consensus 451 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~- 528 (621)
...... ......||..|+|||++.+..++.++|||||||++|||++|+.||....... ....+...++. .......
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~~-~~~~~~~~ 313 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIRC-MQVHPLEF 313 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHHH-hccCcccc
Confidence 433221 2234569999999999999999999999999999999999999996433221 11111111111 0000000
Q ss_pred ----------------cccCcccc-Ccc--cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 529 ----------------MLVDPDLQ-NNY--VEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 529 ----------------~~~d~~~~-~~~--~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
....+... ... .......+.+++..|+..||++||++.+++..
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 000 00113467789999999999999999999874
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=319.47 Aligned_cols=266 Identities=20% Similarity=0.240 Sum_probs=196.1
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecC------
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------ 365 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 365 (621)
..++|...+.||+|+||.||++... .++.||||.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999864 688999999875432 23345678899999999999999999988643
Q ss_pred CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccc
Q 007020 366 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 445 (621)
Q Consensus 366 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 445 (621)
...++||||+++ ++.+.+.. .+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 346999999976 66666643 278889999999999999999999 99999999999999999999999999
Q ss_pred cceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcc-------hHHHH-
Q 007020 446 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDV-------MLLDW- 517 (621)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~-------~~~~~- 517 (621)
+++..... .......||..|+|||++.+..++.++|||||||++|+|++|+.||........... ....+
T Consensus 165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99864322 222344689999999999998999999999999999999999999963221000000 00000
Q ss_pred ------HHHHhhhc-ccccccCccc-----c---CcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 518 ------VKGLLKEK-KLEMLVDPDL-----Q---NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 518 ------~~~~~~~~-~~~~~~d~~~-----~---~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
+....... .......+.. . ..........+.+++..|++.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000 0000000000 0 00011123567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.34 Aligned_cols=198 Identities=23% Similarity=0.309 Sum_probs=164.6
Q ss_pred cCceeeec--cCceEEEEEcC-CCcEEEEEEecccCCc-hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEecc
Q 007020 300 NKNILGRG--GFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 375 (621)
Q Consensus 300 ~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 375 (621)
+.++||+| +||+||++... +|+.||+|+++..... .....+..|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35679999 67899999864 7899999999765432 33446788999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCC
Q 007020 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 455 (621)
++|+|.+++...... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.++++|||.+........
T Consensus 82 ~~~~l~~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFMD--GMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999999754322 378899999999999999999999 999999999999999999999999986543321111
Q ss_pred e------eeecccccccccchhhhcc--CCCCCcccchhHHHHHHHHHhCCCCcc
Q 007020 456 H------VTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGIMLLELITGQRAFD 502 (621)
Q Consensus 456 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~ 502 (621)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 211 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 0 0112346778999999976 458899999999999999999999996
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=302.36 Aligned_cols=251 Identities=25% Similarity=0.379 Sum_probs=204.2
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
+|+..+.||.|+||.||.++.. +++.+++|.+.... ......++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4778899999999999999854 68899999986543 344456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997653 23478899999999999999999999 99999999999999999999999999998764433
Q ss_pred CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
. ......|+..|+|||.+.+...+.++||||||+++|||++|..||.... ..+.+....... .. +
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~~~-~~----~- 220 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN--------PLNLVVKIVQGN-YT----P- 220 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcCC-CC----C-
Confidence 2 2234458999999999988888999999999999999999999996321 112222221111 00 0
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
........+.+++..||+.+|++||++.++++.
T Consensus 221 ----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 ----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ----CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 012234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=307.60 Aligned_cols=254 Identities=21% Similarity=0.361 Sum_probs=200.3
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
++|++.+.||+|+||.||++... +++.||+|.++..........+.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35778899999999999999875 78999999987654444456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++++|..++..... ...+++..+..++.|++.||.|||+.+ +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVA-TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 999999998876421 224899999999999999999999632 8999999999999999999999999998754322
Q ss_pred CeeeecccccccccchhhhccCC------CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGK------SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
......++..|+|||.+.+.. ++.++|||||||++|+|++|+.||..... ......+......
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~---- 225 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-----ANIFAQLSAIVDG---- 225 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-----hhHHHHHHHHhhc----
Confidence 122335788999999986543 47899999999999999999999963211 0011111111110
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..+. ........+.+++.+|++.+|++||++++++.
T Consensus 226 --~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 226 --DPPT----LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred --CCCC----CCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 0111 12224467889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=302.23 Aligned_cols=252 Identities=32% Similarity=0.506 Sum_probs=202.4
Q ss_pred CCcCceeeeccCceEEEEEcCC-----CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 298 FSNKNILGRGGFGKVYKGRLAD-----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 298 ~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
+++.+.||.|+||.||++...+ +..||+|.++..........+..|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3466889999999999998753 48899999976654445678999999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++++|.+++...... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhhc--cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 999999999999764321 178999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
..........++..|+|||.+.+..++.++||||+|+++|+|++ |..||... . ..+........... .
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-----~---~~~~~~~~~~~~~~---~ 224 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-----S---NEEVLEYLKKGYRL---P 224 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----C---HHHHHHHHhcCCCC---C
Confidence 32222222337789999999988889999999999999999998 78888531 1 11222221111110 0
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 572 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L 572 (621)
........+.+++..|+..+|++|||+.++++.|
T Consensus 225 -------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 -------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0111346788999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=317.73 Aligned_cols=198 Identities=26% Similarity=0.365 Sum_probs=171.8
Q ss_pred HHhcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-C-----CceeeeeeeeecC
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-H-----RNLLRLRGFCMTP 365 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~ 365 (621)
...-+|++.+.||+|+||.|-+|.. .+++.||||+++... ....+-+.|+.+|..++ | -|+|+++++|.-.
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 3344889999999999999999985 479999999998653 33456678999999887 4 4899999999999
Q ss_pred CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC--CcEEEcc
Q 007020 366 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE--FEAVVGD 443 (621)
Q Consensus 366 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~D 443 (621)
++.|+|+|.+.. +|+++++.+...+ ++...++.++.||+.||.+||+. +|||+||||+|||+.+- ..+||+|
T Consensus 261 ~HlciVfELL~~-NLYellK~n~f~G--lsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVID 334 (586)
T KOG0667|consen 261 NHLCIVFELLST-NLYELLKNNKFRG--LSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVID 334 (586)
T ss_pred cceeeeehhhhh-hHHHHHHhcCCCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEe
Confidence 999999999976 9999999876555 88899999999999999999999 99999999999999653 3799999
Q ss_pred cccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcc
Q 007020 444 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 502 (621)
Q Consensus 444 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~ 502 (621)
||.++..... .. ....+..|+|||++.|.+|+.+.||||||||++||++|.+.|.
T Consensus 335 FGSSc~~~q~---vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 335 FGSSCFESQR---VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred cccccccCCc---ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 9999975432 22 4456789999999999999999999999999999999988884
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.46 Aligned_cols=193 Identities=25% Similarity=0.388 Sum_probs=164.8
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
.....|.+.+.||+|+||.||+|... +++.||+|...... ...|+.+++.++|+||+++++++......++|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 44567999999999999999999875 57789999754322 34689999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+. ++|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 136 ~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEccC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 99996 58888886532 2489999999999999999999999 99999999999999999999999999997533
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf 501 (621)
.. .......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 209 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VA--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cC--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 22 1223355899999999999999999999999999999999865544
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=304.63 Aligned_cols=257 Identities=24% Similarity=0.360 Sum_probs=198.5
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
+.+++.+.....||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++|+||+++++++..++..++
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 445566666678999999999999854 57889999886543 3345578999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-CCcEEEccccccee
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKL 449 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfGla~~ 449 (621)
++||+++++|.+++..... ....++..+..++.||+.||+|||+. +|+||||||+||+++. ++.++|+|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999999976421 11127788899999999999999999 9999999999999976 67999999999876
Q ss_pred cccCCCeeeecccccccccchhhhccCC--CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 450 MDYKDTHVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
...... ......|+..|+|||++.+.. ++.++||||||+++|+|++|+.||..... .....+......
T Consensus 159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~-----~~~~~~~~~~~~---- 228 (268)
T cd06624 159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE-----PQAAMFKVGMFK---- 228 (268)
T ss_pred cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC-----hhhhHhhhhhhc----
Confidence 543222 222335889999999986643 78899999999999999999999953211 001111110000
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..+. ........+.+++.+||+.+|++|||+.+++.
T Consensus 229 ---~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 ---IHPE----IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ---cCCC----CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0111 12223467889999999999999999999976
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=308.47 Aligned_cols=254 Identities=23% Similarity=0.369 Sum_probs=195.9
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHH-HHhccCCceeeeeeeeecCCceEEEEe
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEM-ISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
++|+..+.||+|+||.||++... +|+.||+|+++.........++..|+.. ++..+||||+++++++..+...+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36788899999999999999875 6899999998765443444456666665 666789999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|++ |+|.+++.........+++..+..++.|++.||+|||+++ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 5888887664333456899999999999999999999853 7999999999999999999999999998865322
Q ss_pred CCeeeecccccccccchhhhcc----CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
.......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..... .. +.+......
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~-~~~~~~~~~----- 223 (283)
T cd06617 158 --VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT------PF-QQLKQVVEE----- 223 (283)
T ss_pred --cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc------CH-HHHHHHHhc-----
Confidence 11222458889999998865 3468899999999999999999999952110 01 111111110
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..+.... ...+..+.+++..|+..+|++||++.++++
T Consensus 224 -~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 -PSPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -CCCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111110 112367889999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=309.06 Aligned_cols=250 Identities=21% Similarity=0.325 Sum_probs=201.3
Q ss_pred hcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
..+|+..+.||+|+||.||+|.. .+++.||+|.+..... .....+..|+.+++.++|+||+++++++...+..++|||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 36788899999999999999985 4789999999865443 234568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++++|.+++.+. .+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 97 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 97 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred ccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 99999999998653 278889999999999999999999 9999999999999999999999999998765433
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 533 (621)
... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||......... ...... ..+
T Consensus 169 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~--------~~~~~~------~~~ 233 (297)
T cd06656 169 QSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--------YLIATN------GTP 233 (297)
T ss_pred ccC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe--------eeeccC------CCC
Confidence 221 22345888999999999888999999999999999999999999633211000 000000 000
Q ss_pred cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 534 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.. .........+.+++..||+.+|++||+++++++
T Consensus 234 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 234 EL--QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 011223356788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=310.53 Aligned_cols=196 Identities=24% Similarity=0.380 Sum_probs=160.1
Q ss_pred CceeeeccCceEEEEEcC---CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeec--CCceEEEEecc
Q 007020 301 KNILGRGGFGKVYKGRLA---DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPYM 375 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~ 375 (621)
.++||+|+||+||+|... +++.||+|.+..... ...+.+|+.+++.++||||+++++++.. +...+++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 357999999999999854 467899999865432 3356789999999999999999998854 45678999998
Q ss_pred CCCchhhhhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee----CCCCcEEEccccc
Q 007020 376 ANGSVASCLRERP-----PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGL 446 (621)
Q Consensus 376 ~~gsL~~~l~~~~-----~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~DfGl 446 (621)
.+ +|.+++.... .....+++..+..++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 75 8887765321 1223488899999999999999999999 99999999999999 4567899999999
Q ss_pred ceecccCCC--eeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCccc
Q 007020 447 AKLMDYKDT--HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDL 503 (621)
Q Consensus 447 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~ 503 (621)
++....... .......||+.|+|||++.+. .++.++||||+||++|||++|++||..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 987643221 122345689999999999774 578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=309.29 Aligned_cols=264 Identities=22% Similarity=0.302 Sum_probs=196.8
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
+|+..+.||+|++|.||+|+.. +++.||+|.++.... ......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777889999999999999865 689999999865432 22345678899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
++ ++|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 98 588888865432 23488999999999999999999999 99999999999999999999999999997654322
Q ss_pred CeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh-----------
Q 007020 455 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL----------- 522 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----------- 522 (621)
.......++..|+|||.+.+. .++.++||||||+++|+|+||+.||....... ..........
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID----QLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHHhCCCChhhhhcch
Confidence 122233478899999988654 46889999999999999999999996321100 0000000000
Q ss_pred hhcccccccCc---cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 523 KEKKLEMLVDP---DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 523 ~~~~~~~~~d~---~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.........+. ............++.+++.+|++.||++|||+.+|+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 0000001112356789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=325.98 Aligned_cols=251 Identities=27% Similarity=0.434 Sum_probs=206.8
Q ss_pred CcCceeeeccCceEEEEEc-CCC----cEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 299 SNKNILGRGGFGKVYKGRL-ADG----SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 299 ~~~~~lG~G~~g~Vy~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
...++||+|+||+||+|.| ..| -+||+|++..........++..|..+|.+++|||+++++|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3457899999999999985 233 4699999988877777889999999999999999999999998776 889999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
||+.|+|.++++.... .+..+..+.+..|||+||.|||.+ ++|||||..+|||+.+-..+||.|||+|+.+...
T Consensus 778 ~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999998544 377789999999999999999999 9999999999999999999999999999987654
Q ss_pred CCee-eecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 454 DTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 454 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
.... .....-.+.|||-|.+....++.++|||||||++||++| |..|++.-.. +-+...++..
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~---------~eI~dlle~g------ 916 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA---------EEIPDLLEKG------ 916 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH---------HHhhHHHhcc------
Confidence 4332 223334568999999999999999999999999999999 9999862211 1112221111
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.+-.-++.+..+++.++.+||..|+..||+++++...+.+
T Consensus 917 ---eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 917 ---ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred ---ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 1111244566899999999999999999999999987765
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=304.03 Aligned_cols=249 Identities=24% Similarity=0.415 Sum_probs=198.6
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCch--------hHHHHHHHHHHHHhccCCceeeeeeeeecCCc
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG--------GELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 367 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 367 (621)
+|.....||+|+||.||+|... +++.||+|.+....... ....+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999864 57899999886543211 12457889999999999999999999999999
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
.+++|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 999999999999999997643 378889999999999999999999 9999999999999999999999999998
Q ss_pred eecccCCCe-----eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh
Q 007020 448 KLMDYKDTH-----VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 522 (621)
Q Consensus 448 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 522 (621)
+........ ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... . +-+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~-~~~~~~~ 225 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-------L-QAIFKIG 225 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-------H-HHHHHHh
Confidence 866422111 11223478899999999988889999999999999999999999963210 0 1111100
Q ss_pred hhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 523 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 523 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
....+.. .......+.+++..||+.+|++||++.++++
T Consensus 226 ------~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 ------ENASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ------ccCCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0111111 1223467889999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=302.44 Aligned_cols=257 Identities=27% Similarity=0.414 Sum_probs=205.5
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
++|+..+.||.|+||+||+|... ++..+|+|++...........+.+|++.++.++|+||+++++.+..++..+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999864 67899999987655444566799999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++++|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999976432 12488999999999999999999999 99999999999999999999999999987665433
Q ss_pred Ce---eeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 455 TH---VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 455 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
.. ......|+..|+|||++... ..+.++|+||||+++|+|++|+.||...... ....+. ...
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----~~~~~~----~~~------ 222 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM----KVLMLT----LQN------ 222 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh----hhHHHH----hcC------
Confidence 22 22334588999999999877 7899999999999999999999999632111 111111 111
Q ss_pred cCccccCc-ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 531 VDPDLQNN-YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 531 ~d~~~~~~-~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..+..... ........+.+++..|++.+|++||++.+|++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 223 DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 01111110 01233467889999999999999999999976
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=304.84 Aligned_cols=253 Identities=26% Similarity=0.383 Sum_probs=204.7
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEecc
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 375 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 375 (621)
+|+..+.||+|+||.||++... +++.||+|.+..........++.+|+++++.++||||+++++++...+..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677789999999999999876 689999999977655555667899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
++++|.+++.... ..+++..+..++.|++.||+|||+ . +++|+||||+||++++++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 82 DGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred CCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 9999999998643 348889999999999999999999 7 99999999999999999999999999987553221
Q ss_pred CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
.. ...++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ....+.++...... .+.
T Consensus 156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~------~~~ 223 (265)
T cd06605 156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP---DGIFELLQYIVNEP------PPR 223 (265)
T ss_pred hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc---ccHHHHHHHHhcCC------CCC
Confidence 11 1558889999999999899999999999999999999999996332111 11222222222111 011
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
... ......+.+++..||..+|++|||+.+++.
T Consensus 224 ~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 224 LPS---GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCh---hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 111 113467889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=304.40 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=198.3
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.+.|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++|+||+++++++..+...++|||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 467888899999999999999875 58899999986542 3445578899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++++|..++.+... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 90 FCPGGAVDAIMLELDR---GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred cCCCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 9999999888765322 388999999999999999999999 9999999999999999999999999998754322
Q ss_pred CCeeeecccccccccchhhhc-----cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
. .......++..|+|||++. ...++.++|||||||++|||++|..||..... .+.+.......
T Consensus 164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~--- 231 (292)
T cd06644 164 L-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSE--- 231 (292)
T ss_pred c-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--------HHHHHHHhcCC---
Confidence 1 1123345888999999985 33467899999999999999999999853210 11111111110
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.+... .......++.+++..||+.+|++||++.++++
T Consensus 232 ---~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 232 ---PPTLS--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ---CccCC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 01000 01122357889999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=304.47 Aligned_cols=239 Identities=25% Similarity=0.364 Sum_probs=184.6
Q ss_pred eeeeccCceEEEEEcC-------------------------CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceee
Q 007020 303 ILGRGGFGKVYKGRLA-------------------------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357 (621)
Q Consensus 303 ~lG~G~~g~Vy~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 357 (621)
+||+|+||.||+|... ....||+|++.... ......+.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 5999999999999742 12358899886433 233446788899999999999999
Q ss_pred eeeeeecCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC
Q 007020 358 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF 437 (621)
Q Consensus 358 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 437 (621)
+++++.+....++||||+++|+|..++..... .+++..+..++.||++||+|||++ +|+||||||+||+++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG---RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence 99999999999999999999999999865322 378889999999999999999999 999999999999997643
Q ss_pred -------cEEEcccccceecccCCCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHH-hCCCCcccccccC
Q 007020 438 -------EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELI-TGQRAFDLARLAN 508 (621)
Q Consensus 438 -------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell-tg~~pf~~~~~~~ 508 (621)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.....
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-- 227 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP-- 227 (274)
T ss_pred cccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh--
Confidence 3899999988643221 12347888999998865 45789999999999999995 69999853211
Q ss_pred CCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007020 509 DDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573 (621)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 573 (621)
.....+... . ..... .....+.+++..||+.+|++||++.+|++.|.
T Consensus 228 ---~~~~~~~~~----~-------~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 228 ---SEKERFYEK----K-------HRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HHHHHHHHh----c-------cCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 011111110 0 00111 11246889999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=302.12 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=193.6
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC----chhHHHHHHHHHHHHhccCCceeeeeeeeec--CCce
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT----PGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTER 368 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 368 (621)
.+|+..+.||+|+||.||+|... +++.||+|.+..... ......+.+|+.+++.++|+||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888899999999999999864 688999998864321 1233468889999999999999999998865 3567
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
++++||+++++|.+++.... .+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 89999999999999997643 278889999999999999999999 99999999999999999999999999987
Q ss_pred ecccCC--CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcc
Q 007020 449 LMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 449 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (621)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.||.... ....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~--------~~~~~~~~~~--- 223 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE--------AMAAIFKIAT--- 223 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc--------hHHHHHHHhc---
Confidence 653211 111223458889999999998889999999999999999999999996221 0111111110
Q ss_pred cccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 527 ~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
....+.. .......+..++ .||..+|++||+++||++
T Consensus 224 --~~~~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 224 --QPTNPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --CCCCCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0011111 112234555565 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=301.02 Aligned_cols=250 Identities=23% Similarity=0.355 Sum_probs=200.0
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeec-CCceEEEEe
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLVYP 373 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 373 (621)
.|++.+.||+|++|.||++... +++.||+|.+..... ......+..|++++++++|+|++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999865 578999999865432 3344568899999999999999999998764 446789999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++++|.+++.... ...+++.++..++.+++.|++|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999997642 22478999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 533 (621)
.. ......++..|+|||++.+..++.++||||||+++|+|++|+.||+... ...+....... .. +
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--------~~~~~~~~~~~-~~-----~ 220 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--------MNSLVYRIIEG-KL-----P 220 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhc-CC-----C
Confidence 22 2233458899999999999889999999999999999999999996221 11222221111 11 1
Q ss_pred cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 534 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. ........+.+++..|++.+|++||++.++++
T Consensus 221 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 P----MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred C----CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1 11233467889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=302.44 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=197.3
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 46677788999999999999864 68899999986543 22334578899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 88 CGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 99999999987543 388999999999999999999999 99999999999999999999999999987654322
Q ss_pred Ceeeecccccccccchhhhc---cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 455 THVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
.......|+..|+|||++. ...++.++|||||||++|+|++|+.||...... ..+...... . ..
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~--------~~~~~~~~~-~---~~ 227 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM--------RALFLMTKS-N---FQ 227 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch--------hhHHhhhcc-C---CC
Confidence 1223345899999999974 445788999999999999999999998422110 000000000 0 00
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.+.... .......+.+++..|++.+|++||++++|++
T Consensus 228 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 228 PPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 111100 0012356889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=302.01 Aligned_cols=247 Identities=29% Similarity=0.451 Sum_probs=197.8
Q ss_pred cCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEecc
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 375 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 375 (621)
++|++.+.||+|+||.||++.. +++.||+|.++... ....+.+|+.+++.++||||+++++++... ..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 5678889999999999999976 57889999986432 345688999999999999999999998654 579999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCC
Q 007020 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 455 (621)
++|+|.+++..... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 81 SKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred CCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 99999999976432 2378889999999999999999999 9999999999999999999999999998754321
Q ss_pred eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 456 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
......+..|+|||.+.+..++.++||||||+++|||++ |+.||.... ...+......... .+
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~~----~~-- 217 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS--------LKEVKECVEKGYR----ME-- 217 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC--------HHHHHHHHhCCCC----CC--
Confidence 112234568999999988889999999999999999998 999985321 1112111111100 01
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.....+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 218 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 ----PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ----CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 011234678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.27 Aligned_cols=259 Identities=25% Similarity=0.390 Sum_probs=200.5
Q ss_pred CHHHHHHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeeec
Q 007020 287 SLRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 364 (621)
Q Consensus 287 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 364 (621)
++.++..+.+.|+..+.||+|+||.||+|... +++.||+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 45556667788999999999999999999864 68899999985432 3345678899998888 69999999999853
Q ss_pred ------CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc
Q 007020 365 ------PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE 438 (621)
Q Consensus 365 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 438 (621)
.+..+++|||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 4577999999999999999876432 2377888999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecccCCCeeeecccccccccchhhhc-----cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcch
Q 007020 439 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 513 (621)
Q Consensus 439 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~ 513 (621)
++|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||.......
T Consensus 160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~----- 233 (282)
T cd06636 160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR----- 233 (282)
T ss_pred EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh-----
Confidence 99999999875532211 123345889999999985 3457889999999999999999999995321100
Q ss_pred HHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 514 LLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. +....+ ...+... .......+.+++..||+.||.+||++.|+++
T Consensus 234 --~-~~~~~~------~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 234 --A-LFLIPR------NPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --h-hhhHhh------CCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 000000 0011111 1123467899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=301.00 Aligned_cols=254 Identities=25% Similarity=0.349 Sum_probs=202.4
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.++|+..+.||+|+||.||+|... +++.+|+|.+..... .....+.+|+++++.++||||+++++++.+....+++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 367888899999999999999864 578899999875432 245678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 81 YCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred CCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 999999999987642 2388999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCeeeecccccccccchhhhccC---CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTG---KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
. .......++..|+|||.+.+. .++.++||||||+++|||++|+.||...... .. +... .... .
T Consensus 155 ~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~-------~~-~~~~-~~~~---~ 221 (262)
T cd06613 155 I-AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM-------RA-LFLI-SKSN---F 221 (262)
T ss_pred h-hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH-------HH-HHHH-Hhcc---C
Confidence 1 122334588899999999776 7889999999999999999999999532110 00 0000 0000 0
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..+... ........+.+++.+||..+|.+|||+.+|+.
T Consensus 222 ~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 222 PPPKLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CCcccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 011111 12234567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=304.04 Aligned_cols=253 Identities=26% Similarity=0.372 Sum_probs=200.1
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.++|++.+.||.|+||.||++... ++..||+|.+... .......+..|+++++.++|+||+++++++..+...++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 456888899999999999999875 6889999998644 23445578899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++++|.+++.... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 83 FCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred ccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 999999999987643 2388999999999999999999999 9999999999999999999999999998764332
Q ss_pred CCeeeecccccccccchhhhcc-----CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
.. ......++..|+|||.+.. ..++.++||||||+++|||++|+.||..... .+.+.......
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~--- 224 (280)
T cd06611 157 LQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP--------MRVLLKILKSE--- 224 (280)
T ss_pred cc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH--------HHHHHHHhcCC---
Confidence 21 2233458999999999853 3467799999999999999999999963211 11111111110
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.+.+. ........+.+++..||+.+|++||++.++++.
T Consensus 225 ---~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 225 ---PPTLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CCCcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 01110 011223578899999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=308.90 Aligned_cols=249 Identities=20% Similarity=0.320 Sum_probs=200.8
Q ss_pred cCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
.+|+..+.||.|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 4688889999999999999985 4789999999865432 3345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++++|.+++... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 98 LAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred cCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 9999999988653 278999999999999999999999 99999999999999999999999999987654332
Q ss_pred CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
. ......++..|+|||.+.+..++.++|||||||++|+|++|+.||..... . ......... ......
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-------~-~~~~~~~~~-~~~~~~--- 236 (296)
T cd06655 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------L-RALYLIATN-GTPELQ--- 236 (296)
T ss_pred c-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------H-HHHHHHHhc-CCcccC---
Confidence 2 12234588899999999988899999999999999999999999963221 0 111111100 000000
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
........+.+++.+||..+|++||++.+++.
T Consensus 237 ----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 237 ----NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ----CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 11223357888999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=316.64 Aligned_cols=197 Identities=23% Similarity=0.290 Sum_probs=167.4
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecC------C
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------T 366 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 366 (621)
.++|...+.||+|+||.||++... .++.||||++..... ......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 568999999999999999999864 688999999875432 23345678899999999999999999987543 3
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccc
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 446 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 446 (621)
..++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 56999999976 67776643 277889999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCccc
Q 007020 447 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 503 (621)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~ 503 (621)
++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 173 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 173 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred ccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 9865322 122334689999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=317.52 Aligned_cols=241 Identities=25% Similarity=0.413 Sum_probs=196.3
Q ss_pred CceeeeccCceEEEEEcC-CCcEEEEEEe---cccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCc--eEEEEec
Q 007020 301 KNILGRGGFGKVYKGRLA-DGSLVAVKRL---KEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE--RLLVYPY 374 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~---~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~ 374 (621)
..+||+|+|-+||+|.+. +|..||--.+ .....+....+|..|+.+|+.++|+||++++.++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 467999999999999875 5777774333 233455556789999999999999999999999987765 6799999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC-CcEEEcccccceecccC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfGla~~~~~~ 453 (621)
+..|+|..|+.+... ++.+.++.++.||++||.|||++ .|+|+|||||-+||+|+.+ |.|||+|.|+|..+...
T Consensus 125 ~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999988654 78889999999999999999998 7899999999999999865 89999999999976533
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhh---cccccc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE---KKLEML 530 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 530 (621)
....+.||+.|||||++. ..|...+||||||+.++||+|+..||..... -.+..+....+ ..+.++
T Consensus 200 ---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-------~AQIYKKV~SGiKP~sl~kV 268 (632)
T KOG0584|consen 200 ---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-------PAQIYKKVTSGIKPAALSKV 268 (632)
T ss_pred ---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-------HHHHHHHHHcCCCHHHhhcc
Confidence 233477999999999997 7889999999999999999999999963321 22333333222 222222
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
-| .++.++|..|+.. .++|||+.|++.
T Consensus 269 ~d------------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 269 KD------------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred CC------------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 33 4688899999999 999999999964
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=303.77 Aligned_cols=263 Identities=24% Similarity=0.300 Sum_probs=199.0
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
++|+..+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.+++.++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999876 689999999865432 2234467899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++++|..++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999988888765432 388999999999999999999999 9999999999999999999999999999876443
Q ss_pred CCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh---h------
Q 007020 454 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL---K------ 523 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~------ 523 (621)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ........... .
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV----DQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCChHHhhhc
Confidence 22 2223447889999999876 45788999999999999999999999632210 00111110000 0
Q ss_pred -h-cccccccCccccC-----cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 524 -E-KKLEMLVDPDLQN-----NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 524 -~-~~~~~~~d~~~~~-----~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. ........+.... .........+.+++..||+.+|++||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 0000000010000 001122467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=318.61 Aligned_cols=246 Identities=25% Similarity=0.391 Sum_probs=198.4
Q ss_pred eeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCchh
Q 007020 303 ILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 381 (621)
Q Consensus 303 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 381 (621)
+||+|.||+||-|++. +...+|||-+.... .....-+..|+.+.+.++|.|||+++|.+.+.+.+-+.||-++||||.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 6999999999999976 45679999886543 333445889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC-CCCcEEEcccccceecccCCCeeeec
Q 007020 382 SCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDTHVTTA 460 (621)
Q Consensus 382 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~ 460 (621)
++++.... ...=.+.+.-.+..||++||.|||++ .|||||||-+|||++ ..|.+||+|||-++.+.. ....+..
T Consensus 661 sLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTET 735 (1226)
T ss_pred HHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCccccc
Confidence 99987543 22237778889999999999999999 999999999999995 678999999999887653 2334556
Q ss_pred ccccccccchhhhccC--CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCc
Q 007020 461 VRGTIGHIAPEYLSTG--KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNN 538 (621)
Q Consensus 461 ~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 538 (621)
+.||..|||||++..+ .|..++|||||||++.||.||++||-.-..+. . .+.+-+ +. +..++
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq------A----AMFkVG-my-----KvHP~ 799 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ------A----AMFKVG-MY-----KVHPP 799 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh------H----hhhhhc-ce-----ecCCC
Confidence 6799999999999766 47899999999999999999999995221110 0 001100 00 12334
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 539 YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 539 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.+++...+...++++|+..||.+||++.++++
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 56677788999999999999999999999964
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=310.43 Aligned_cols=255 Identities=24% Similarity=0.358 Sum_probs=202.8
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccC-CchhHHHHHHHHHHHHhcc-CCceeeeeeeeecCCceE
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEER-TPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 369 (621)
.+....|++.+.||+||.+.||++...+.+.||+|++.... .......|..|+..|.+++ |.+|+++++|-..++.+|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 34566788899999999999999999888889998875443 4445567999999999996 999999999999999999
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+||||=+. +|...|++..... .+| .++.+..|++.|+.++|+. ||||.||||.|+|+-+ |.+||+|||+|..
T Consensus 437 mvmE~Gd~-DL~kiL~k~~~~~--~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~a 508 (677)
T KOG0596|consen 437 MVMECGDI-DLNKILKKKKSID--PDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANA 508 (677)
T ss_pred EEeecccc-cHHHHHHhccCCC--chH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcc
Confidence 99997654 9999998865432 334 8899999999999999999 9999999999999976 4899999999998
Q ss_pred cccCCCe-eeecccccccccchhhhccC-----------CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHH
Q 007020 450 MDYKDTH-VTTAVRGTIGHIAPEYLSTG-----------KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDW 517 (621)
Q Consensus 450 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~ 517 (621)
....... .....+||+.||+||.+... ..++++||||+|||||+|+.|+.||..-. -.|
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---------n~~ 579 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---------NQI 579 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---------HHH
Confidence 7655433 44567799999999998533 24689999999999999999999995110 011
Q ss_pred HHHHhhhcccccccCccccCcccHHH-HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 518 VKGLLKEKKLEMLVDPDLQNNYVEAE-VEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 518 ~~~~~~~~~~~~~~d~~~~~~~~~~~-~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.++..+.||...-+|+.-. ..+++++|+.|+..||.+||++.++++
T Consensus 580 -------aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 -------AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -------HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 2334455553322221111 123999999999999999999999976
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=302.58 Aligned_cols=253 Identities=24% Similarity=0.337 Sum_probs=202.5
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeec--CCceEEEE
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVY 372 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 372 (621)
+|+..+.||.|+||.||++... +++.||+|.++... ......++..|+++++.++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4777889999999999999854 68899999987543 33345568899999999999999999998764 35678999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH-----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH-----~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
||+++++|.+++........++++..++.++.|++.||+||| +. +++|+||||+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999765433445899999999999999999999 66 9999999999999999999999999999
Q ss_pred eecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
......... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ...+...... ..
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~-~~- 226 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--------QLQLASKIKE-GK- 226 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--------HHHHHHHHhc-CC-
Confidence 876543321 233458999999999998889999999999999999999999996322 1112111111 11
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.+ .........+.+++..|++.+|++||++.+|++.
T Consensus 227 ----~~----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 ----FR----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----CC----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11 1122334678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=328.03 Aligned_cols=200 Identities=22% Similarity=0.325 Sum_probs=163.3
Q ss_pred HHHHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccC------Cceeeeeeee
Q 007020 290 ELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH------RNLLRLRGFC 362 (621)
Q Consensus 290 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~ 362 (621)
++....++|.+.+.||+|+||+||+|... +++.||||+++... .....+..|+.+++.++| .+++++++++
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 34456788999999999999999999864 57889999986432 223345567777666654 5689999988
Q ss_pred ecC-CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeeCCCC---
Q 007020 363 MTP-TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILLDEEF--- 437 (621)
Q Consensus 363 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~--- 437 (621)
... .+.++|||++ +++|.+++.... .+++..+..|+.||+.||+|||+ . +||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence 765 5678999988 668888887543 38899999999999999999997 5 899999999999998765
Q ss_pred -------------cEEEcccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCccc
Q 007020 438 -------------EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 503 (621)
Q Consensus 438 -------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~ 503 (621)
.+||+|||.+.... .......||..|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 49999999886422 123345699999999999999999999999999999999999999963
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=299.99 Aligned_cols=238 Identities=25% Similarity=0.390 Sum_probs=188.8
Q ss_pred ceeeeccCceEEEEEcCCCc-----------EEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 302 NILGRGGFGKVYKGRLADGS-----------LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
+.||+|+||.||+|.+.+.. .|++|.+...... ...+.+|+.+++.++|+||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 46999999999999876432 5788877544322 5678899999999999999999999988 77899
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-------cEEEcc
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF-------EAVVGD 443 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-------~~kl~D 443 (621)
||||+++|+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|
T Consensus 78 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 9999999999999986542 488899999999999999999999 999999999999999887 799999
Q ss_pred cccceecccCCCeeeecccccccccchhhhccC--CCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHH
Q 007020 444 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKG 520 (621)
Q Consensus 444 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 520 (621)
||++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||...... .+...
T Consensus 152 fg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--------~~~~~ 218 (259)
T cd05037 152 PGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--------EKERF 218 (259)
T ss_pred CCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--------hHHHH
Confidence 999986543 2223467789999999876 68899999999999999999 57777532110 11111
Q ss_pred HhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007020 521 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573 (621)
Q Consensus 521 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 573 (621)
.... .....+ ....+.+++..||..+|++||++.+|++.|+
T Consensus 219 ~~~~---~~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 YQDQ---HRLPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HhcC---CCCCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1100 000000 0167889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=316.02 Aligned_cols=237 Identities=23% Similarity=0.274 Sum_probs=182.7
Q ss_pred eeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhc---cCCceeeeeeeeecCCceEEEEeccCC
Q 007020 304 LGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMA---VHRNLLRLRGFCMTPTERLLVYPYMAN 377 (621)
Q Consensus 304 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 377 (621)
||+|+||+||+|+.. +++.||+|++..... ......+..|..++... .||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999865 689999999864321 12223455566666554 699999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee
Q 007020 378 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457 (621)
Q Consensus 378 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 457 (621)
|+|.+++.... .+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 99999887543 388899999999999999999999 99999999999999999999999999987533222 22
Q ss_pred eecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcccc
Q 007020 458 TTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 536 (621)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 536 (621)
.....||..|+|||++.+. .++.++|||||||++|||++|+.||.... ..+........ .. .+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~--------~~~~~~~i~~~-~~------~~~ 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED--------TQQMYRNIAFG-KV------RFP 217 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC--------HHHHHHHHHcC-CC------CCC
Confidence 3345699999999998765 47899999999999999999999995321 11111111111 00 111
Q ss_pred CcccHHHHHHHHHHHHhccCCCCCCCCCHH
Q 007020 537 NNYVEAEVEQLIQVALLCTQGSPMDRPKMS 566 (621)
Q Consensus 537 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ 566 (621)
.. .....+.+++..|++.||.+||++.
T Consensus 218 ~~---~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 218 KN---VLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred Cc---cCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 10 1235678899999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=298.03 Aligned_cols=245 Identities=24% Similarity=0.389 Sum_probs=204.7
Q ss_pred CCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccC
Q 007020 298 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 376 (621)
Q Consensus 298 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 376 (621)
|.+..+||+|+||.||+|.++ +|+.+|+|.+... ....++.+|+.++.+...+++|++||.+.....+|+|||||.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 445678999999999999875 7999999998643 346678999999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCe
Q 007020 377 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 456 (621)
Q Consensus 377 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 456 (621)
.|+..+.++.+.. ++.+.++..++.+.++||+|||.. .-+|||||..|||++-+|.+|++|||.|..+... -.
T Consensus 112 AGSiSDI~R~R~K---~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MA 184 (502)
T KOG0574|consen 112 AGSISDIMRARRK---PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MA 184 (502)
T ss_pred CCcHHHHHHHhcC---CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh-HH
Confidence 9999999987543 599999999999999999999998 7899999999999999999999999999765432 12
Q ss_pred eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc---cCc
Q 007020 457 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML---VDP 533 (621)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~d~ 533 (621)
....+.||+.|||||+++.-.|..++||||+|+...||..|++||..-.. .+.+..+ ..|
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP-----------------MRAIFMIPT~PPP 247 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP-----------------MRAIFMIPTKPPP 247 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc-----------------cceeEeccCCCCC
Confidence 23456699999999999999999999999999999999999999952110 0011111 112
Q ss_pred cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 534 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.+. .++..+.++-++++.|+-+.|++|-|+.++++.
T Consensus 248 TF~--KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 248 TFK--KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCC--ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 222 255667889999999999999999999888764
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=303.15 Aligned_cols=248 Identities=25% Similarity=0.426 Sum_probs=200.1
Q ss_pred CCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhcc---CCceeeeeeeeecCCceEEEE
Q 007020 297 SFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV---HRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 372 (621)
.|+..+.||+|+||.||+|.+ .+++.||+|.++.........++.+|+.+++.++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 466778899999999999986 4789999999876544555567889999999886 999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++++|.+++... ++++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999998653 388999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
... ......|+..|+|||.+.++ .++.++||||||+++|+|++|..||..... ..++... ....
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--------~~~~~~~------~~~~ 218 (277)
T cd06917 154 NSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA--------FRAMMLI------PKSK 218 (277)
T ss_pred Ccc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh--------hhhhhcc------ccCC
Confidence 332 22334588999999998754 468899999999999999999999963221 1111110 0001
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.+.+... .....+.+++..||+.+|++||++.++++
T Consensus 219 ~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 219 PPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1111111 13467889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=299.98 Aligned_cols=248 Identities=26% Similarity=0.399 Sum_probs=199.8
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC----chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT----PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
+|+..+.||+|+||+||+|... +++.|++|.+..... ......+.+|+.+++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999876 789999999864331 22345688999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
+||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999997643 378889999999999999999999 99999999999999999999999999988654
Q ss_pred cCCCeeeecccccccccchhhhccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
... ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||.... ..+............
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~-- 221 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--------GVAAVFKIGRSKELP-- 221 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--------HHHHHHHHHhcccCC--
Confidence 332 223455889999999997766 8899999999999999999999996321 011111111101111
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. ........+.+++.+||+.+|++||++.++++
T Consensus 222 ---~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 ---P----IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---C----cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1 11122367888999999999999999999976
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=301.57 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=195.4
Q ss_pred CCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccC
Q 007020 298 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 376 (621)
Q Consensus 298 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 376 (621)
|++.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+++++.++|+||+++++++..++..++||||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 556688999999999999875 57788999885432 3345568899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCe
Q 007020 377 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 456 (621)
Q Consensus 377 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 456 (621)
+|+|..++.... .++++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++....... .
T Consensus 86 ~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~ 158 (282)
T cd06643 86 GGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 158 (282)
T ss_pred CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-c
Confidence 999998876532 2488999999999999999999999 99999999999999999999999999987643221 1
Q ss_pred eeecccccccccchhhhc-----cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 457 VTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
......++..|+|||++. +..++.++|||||||++|||++|+.||..... .+.+......... ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~~~~-~~~ 229 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSEPP-TLA 229 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--------HHHHHHHhhcCCC-CCC
Confidence 223345899999999984 34567899999999999999999999853210 1111111111110 011
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. .......+.+++..||+.+|++||++.++++
T Consensus 230 ~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 230 Q-------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred C-------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 1122357889999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=298.20 Aligned_cols=250 Identities=21% Similarity=0.349 Sum_probs=202.3
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
+|+..+.||+|+||.||++... +|+.||+|.+.... ......++.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999864 68899999986543 233445788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++++|.+++..... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999999876432 2378889999999999999999999 99999999999999999999999999998654322
Q ss_pred CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
. ......|+..|+|||++.+...+.++||||||+++|+|++|+.||.... ..+.+........ +.
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~~~~------~~ 220 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN--------MKNLVLKIIRGSY------PP 220 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC--------HHHHHHHHhcCCC------CC
Confidence 1 1223458889999999998889999999999999999999999996321 1122222211110 00
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
........+.+++..|++.+|++||++.+|++
T Consensus 221 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 ----VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ----CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11223467899999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=312.46 Aligned_cols=260 Identities=22% Similarity=0.270 Sum_probs=193.1
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc-hhHHHHHHHHHHHHhccCCceeeeeeeeecC------
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP------ 365 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 365 (621)
..++|...+.||+|+||+||+|... +++.||||.+...... .....+.+|+.+++.++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3578999999999999999999864 6889999998654322 2334577899999999999999999987543
Q ss_pred CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccc
Q 007020 366 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 445 (621)
Q Consensus 366 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 445 (621)
...++++|++ +++|.+++... .+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 4568999988 67998887643 288999999999999999999999 99999999999999999999999999
Q ss_pred cceecccCCCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh-
Q 007020 446 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK- 523 (621)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~- 523 (621)
+++..... .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||...... ..+..+......
T Consensus 164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~ 235 (343)
T cd07878 164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI----DQLKRIMEVVGTP 235 (343)
T ss_pred cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHhCCC
Confidence 99865432 223458999999999876 46789999999999999999999999532110 011111100000
Q ss_pred ---------hcccccccC--ccccCc----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 524 ---------EKKLEMLVD--PDLQNN----YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 524 ---------~~~~~~~~d--~~~~~~----~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
......... +..... ........+.+++..|++.||++|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 000000 00011235779999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=310.92 Aligned_cols=253 Identities=26% Similarity=0.317 Sum_probs=199.6
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc--hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|+..+.||+|+||+||+|... +++.||+|.+...... .....+..|+++++.++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999875 5899999999765433 24456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+.+++|.+++.... ...+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999987543 23488899999999999999999999 999999999999999999999999999875432
Q ss_pred CCCe----------------------------eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccc
Q 007020 453 KDTH----------------------------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLA 504 (621)
Q Consensus 453 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~ 504 (621)
.... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2110 111235788999999999888999999999999999999999999632
Q ss_pred cccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCC----HHHHHH
Q 007020 505 RLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK----MSEVVR 570 (621)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt----~~~vl~ 570 (621)
.. . ..+. ... +..............+.+++..|+..+|++||+ +++++.
T Consensus 236 ~~----~---~~~~-~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NR----D---ETFS-NIL---------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ch----H---HHHH-HHh---------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 21 1 0111 111 100000001113478999999999999999999 555544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=303.06 Aligned_cols=248 Identities=27% Similarity=0.406 Sum_probs=201.1
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEecc
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 375 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 375 (621)
-|+..+.||+|+||.||+|... +++.||+|.+...........+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667788999999999999864 688999999865544445567889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCC
Q 007020 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 455 (621)
++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999998643 378999999999999999999999 999999999999999999999999999876543221
Q ss_pred eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccc
Q 007020 456 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 535 (621)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 535 (621)
......++..|+|||.+.+...+.++|||||||++|+|++|..||.... ...+...... .. .+.+
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~-~~-----~~~~ 221 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH--------PMKVLFLIPK-NN-----PPTL 221 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc--------hHHHHHHHhc-CC-----CCCC
Confidence 1223457889999999988888999999999999999999999995211 0111111111 00 0111
Q ss_pred cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 536 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 536 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.......+.+++..|++.+|++||++.++++.
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 ----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11234678899999999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=301.77 Aligned_cols=255 Identities=24% Similarity=0.405 Sum_probs=197.8
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc---------hhHHHHHHHHHHHHhccCCceeeeeeeeecCC
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP---------GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 366 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 366 (621)
+|...+.||+|+||.||+|... +|+.||+|.++..... .....+..|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999854 6889999988532211 11235788999999999999999999999999
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccc
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 446 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 446 (621)
..++||||+++|+|.++++... .+++..+..++.|++.||.|||++ +++||||+|+||+++.++.++++|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 9999999999999999997652 388889999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCC-eeeecccccccccchhhhccCC--CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh
Q 007020 447 AKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 523 (621)
Q Consensus 447 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 523 (621)
+........ .......|+..|+|||.+.... ++.++||||||+++|++++|..||..... .... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~-~~~~~ 226 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-------IAAM-FKLGN 226 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-------HHHH-HHhhc
Confidence 976432211 1123345889999999987654 78999999999999999999999952210 1111 11110
Q ss_pred hcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 524 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 524 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
. ... +.............+.+++..|+..+|++||++++|++.
T Consensus 227 ~-~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 227 K-RSA----PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred c-ccC----CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0 001 111111112234688899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.91 Aligned_cols=261 Identities=20% Similarity=0.268 Sum_probs=204.5
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|+..+.||+|+||.||++... +++.||+|.+..... ......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36788899999999999999865 578999999875432 223446789999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999999997643 378889999999999999999999 999999999999999999999999999864211
Q ss_pred CCC--------------eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHH
Q 007020 453 KDT--------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 518 (621)
Q Consensus 453 ~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 518 (621)
... .......++..|+|||.+.+..++.++||||||+++|||++|..||.... ..++.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~--------~~~~~ 225 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--------PEELF 225 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHH
Confidence 000 01112347889999999988889999999999999999999999995211 11222
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCCcc
Q 007020 519 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAE 579 (621)
Q Consensus 519 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~ 579 (621)
....... ...+.... .....+.+++..|++.+|++||++.++.+.|+...+..
T Consensus 226 ~~~~~~~----~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 226 GQVISDD----IEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred HHHHhcc----cCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 2211111 11111111 22356889999999999999999888888888765543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=306.62 Aligned_cols=261 Identities=26% Similarity=0.338 Sum_probs=200.9
Q ss_pred HHHHHHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeeecC
Q 007020 288 LRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP 365 (621)
Q Consensus 288 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 365 (621)
+.++..+.++|...+.||+|+||.||++... +++.||+|.+.... .....+.+|+.++.++ +|||++++++++...
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 3444556788999999999999999999864 68899999986432 2234677899999888 799999999998654
Q ss_pred -----CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEE
Q 007020 366 -----TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV 440 (621)
Q Consensus 366 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 440 (621)
+..++||||+++|+|.++++........+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence 357999999999999998875333334588999999999999999999999 999999999999999999999
Q ss_pred EcccccceecccCCCeeeecccccccccchhhhccCC-----CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHH
Q 007020 441 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-----SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 515 (621)
Q Consensus 441 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~ 515 (621)
|+|||++........ ......|+..|+|||.+.... ++.++|||||||++|||++|+.||..... ....
T Consensus 169 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~----~~~~- 242 (291)
T cd06639 169 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP----VKTL- 242 (291)
T ss_pred Eeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH----HHHH-
Confidence 999999876543221 122345889999999986543 57899999999999999999999952210 0011
Q ss_pred HHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 516 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 516 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
....+ .....+.+ .......+.+++..|++.+|++||++.++++
T Consensus 243 ---~~~~~-~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 243 ---FKIPR-NPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ---HHHhc-CCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11110 11111111 1123356889999999999999999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=299.26 Aligned_cols=250 Identities=23% Similarity=0.332 Sum_probs=194.7
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC----chhHHHHHHHHHHHHhccCCceeeeeeeeecC--Cce
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT----PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 368 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 368 (621)
++|+..+.||+|+||.||+|... +++.||+|.+..... ......+.+|+.+++.++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999999999999864 589999998853321 12234688899999999999999999988764 457
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
+++|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 89999999999999987543 277888999999999999999999 99999999999999999999999999987
Q ss_pred ecccCCC--eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcc
Q 007020 449 LMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 449 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (621)
....... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.... ..... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-------~~~~~-~~~~~~-- 224 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-------AMAAI-FKIATQ-- 224 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc-------hHHHH-HHHhcC--
Confidence 6432111 11223458889999999988889999999999999999999999995211 01111 111100
Q ss_pred cccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 527 ~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
...+. .+......+.+++..|+. +|++||++++|++
T Consensus 225 ---~~~~~----~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 225 ---PTNPV----LPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ---CCCCC----CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 01111 122334567788888885 8999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=305.69 Aligned_cols=262 Identities=22% Similarity=0.298 Sum_probs=195.2
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
+|+..+.||+|+||.||+|... +|+.||+|.++.... ......+.+|+.+++.++|+||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999875 689999999865432 22234577899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++ +|.+++.... ..+++..++.++.||++||.|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CDQ-DLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 975 7888776532 2389999999999999999999999 99999999999999999999999999998654322
Q ss_pred CeeeecccccccccchhhhccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc------cc
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK------KL 527 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~ 527 (621)
. ......++..|+|||.+.+.. ++.++|||||||++|+|++|..||...... ....+.+....... ..
T Consensus 154 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 154 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV----DDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred C-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH----HHHHHHHHHHhCCCChHHhHHh
Confidence 2 122345788999999987654 689999999999999999999986422110 00001110000000 00
Q ss_pred ccccC----cccc-----CcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 528 EMLVD----PDLQ-----NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 528 ~~~~d----~~~~-----~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
....+ +... .+........+.+++..|++.||.+|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 0000 0111123467789999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=305.40 Aligned_cols=263 Identities=24% Similarity=0.365 Sum_probs=196.0
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
++|+..+.||+|++|.||+|... +++.||+|.+...........+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999875 68899999987544333334577899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+.+ +|.+++..... .+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 985 89998876432 478899999999999999999999 99999999999999999999999999987543221
Q ss_pred Ceeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhh---cc----
Q 007020 455 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE---KK---- 526 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~---- 526 (621)
. ......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||....... .....+...... ..
T Consensus 158 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE----DQLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred c-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH----HHHHHHHHhcCCCChhhhhhh
Confidence 1 1122346789999999875 457899999999999999999999995322100 000000000000 00
Q ss_pred -----ccc----ccCccccCcccHH--HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 527 -----LEM----LVDPDLQNNYVEA--EVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 527 -----~~~----~~d~~~~~~~~~~--~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
... ...+......... ....+.+++..|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 0000000000000 1256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=299.84 Aligned_cols=252 Identities=27% Similarity=0.438 Sum_probs=201.0
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc-hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
+|...+.||+|+||.||+|... +++.||+|.++..... .....+..|+++++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999864 6889999998765432 3556789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++++|.+++.... .+++..+..++.+++.||+|||+. +|+|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999987643 277889999999999999999999 99999999999999999999999999998765433
Q ss_pred Ceee---ecccccccccchhhhccCC---CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 455 THVT---TAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 455 ~~~~---~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
.... ....++..|+|||++.+.. .+.++||||||+++|++++|+.||.... ... ....... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~----~~~---~~~~~~~-~~--- 222 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD----NEF---QIMFHVG-AG--- 222 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc----chH---HHHHHHh-cC---
Confidence 2221 1345788999999998766 7899999999999999999999996321 110 1111000 00
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..+.+.. .......+.+++..|++.+|++||++.+++.
T Consensus 223 --~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 --HKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred --CCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111111 1112466789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=306.11 Aligned_cols=257 Identities=23% Similarity=0.343 Sum_probs=194.6
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-CCceeeeeeeeecCCceEEEEec
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
+|...+.||+|+||.||++... +++.||+|.+...........+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4445678999999999999865 689999999876554455667889999999986 99999999999999999999999
Q ss_pred cCCCchhhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 375 MANGSVASCLRER-PPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 375 ~~~gsL~~~l~~~-~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
+.. ++.++.... ......+++..+..++.+++.||+|||+.. +++||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 875 555443211 011234889999999999999999999742 8999999999999999999999999999754322
Q ss_pred CCeeeecccccccccchhhhccC---CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTG---KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
. ......|+..|+|||++.+. .++.++|||||||++|||++|+.||.... ....-+......
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~------ 226 (288)
T cd06616 162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVKG------ 226 (288)
T ss_pred C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcCC------
Confidence 1 11223588899999999776 68899999999999999999999996321 011111111110
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
..+.+...........+.+++..|++.+|++|||+++|++.
T Consensus 227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11112111112345678999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=308.35 Aligned_cols=195 Identities=24% Similarity=0.389 Sum_probs=159.2
Q ss_pred ceeeeccCceEEEEEcC---CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeec--CCceEEEEeccC
Q 007020 302 NILGRGGFGKVYKGRLA---DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPYMA 376 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 376 (621)
.+||+|+||+||+|+.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++.. +...++||||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 57999999999999864 457899999865432 3357789999999999999999998854 467799999987
Q ss_pred CCchhhhhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee----CCCCcEEEcccccc
Q 007020 377 NGSVASCLRERP-----PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLA 447 (621)
Q Consensus 377 ~gsL~~~l~~~~-----~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~DfGla 447 (621)
+ +|.+++.... .....+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 7777765321 1223478889999999999999999999 99999999999999 56678999999999
Q ss_pred eecccCCCe--eeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCccc
Q 007020 448 KLMDYKDTH--VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDL 503 (621)
Q Consensus 448 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~ 503 (621)
+........ ......||..|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 876433221 22334589999999998764 578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=304.74 Aligned_cols=240 Identities=23% Similarity=0.352 Sum_probs=186.6
Q ss_pred ceeeeccCceEEEEEcCC--------CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 302 NILGRGGFGKVYKGRLAD--------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
+.||+|+||.||+|.... ...||+|.+.... ......+..|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 369999999999997532 2348888875432 2334568889999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc--------EEEcccc
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE--------AVVGDFG 445 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~--------~kl~DfG 445 (621)
|+++|+|.++++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++. ++++|||
T Consensus 80 ~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 80 YVKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cCCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence 9999999999986532 478899999999999999999999 9999999999999987765 6999999
Q ss_pred cceecccCCCeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCC-CCcccccccCCCcchHHHHHHHHhh
Q 007020 446 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQ-RAFDLARLANDDDVMLLDWVKGLLK 523 (621)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~ 523 (621)
++..... .....++..|+|||++.+. .++.++||||||+++|||++|. .||..... ..... ...
T Consensus 154 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--------~~~~~-~~~ 219 (258)
T cd05078 154 ISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--------QKKLQ-FYE 219 (258)
T ss_pred cccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--------HHHHH-HHH
Confidence 8865432 1224578899999999864 5789999999999999999985 55532110 00000 000
Q ss_pred hcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007020 524 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573 (621)
Q Consensus 524 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 573 (621)
. ...+ +.....++.+++..||+.+|++|||++++++.|+
T Consensus 220 ~-------~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 D-------RHQL----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c-------cccC----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0011 1112257889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=305.53 Aligned_cols=263 Identities=24% Similarity=0.368 Sum_probs=198.8
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc-hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
++|+..+.||+|+||.||+|.+. +++.||+|.+...... .....+.+|+++++.++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999975 5899999998654322 234568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++++|..+..... .+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999999888765432 288999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHH----------HHh
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK----------GLL 522 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~----------~~~ 522 (621)
. .......++..|+|||++.+. .++.++||||||+++|||++|++||...... ....+... ...
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 154 G-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI----DQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred c-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH----HHHHHHHHHhCCCchhhHHHh
Confidence 2 222334578899999998754 4678999999999999999999998532210 00000000 000
Q ss_pred hhcc-cccccCccccC-----cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 523 KEKK-LEMLVDPDLQN-----NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 523 ~~~~-~~~~~d~~~~~-----~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.... ......+.... .........+.+++..||+.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000 00000011000 001123467899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=301.82 Aligned_cols=255 Identities=27% Similarity=0.374 Sum_probs=199.9
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeeecCC-----
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPT----- 366 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~----- 366 (621)
++++|++.+.||+|+||.||+|... +++.|++|.+.... ....++.+|+.+++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4678999999999999999999975 57899999986543 2345789999999998 6999999999987644
Q ss_pred -ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccc
Q 007020 367 -ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 445 (621)
Q Consensus 367 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 445 (621)
..++||||+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 47999999999999999876442334588999999999999999999999 99999999999999999999999999
Q ss_pred cceecccCCCeeeecccccccccchhhhccC-----CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH
Q 007020 446 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 520 (621)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 520 (621)
++....... .......|+..|+|||++... .++.++||||||+++|+|++|+.||.... ..... ..
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~----~~ 229 (275)
T cd06608 159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH----PMRAL----FK 229 (275)
T ss_pred cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc----hHHHH----HH
Confidence 987654322 222334588999999988542 46788999999999999999999995221 00011 11
Q ss_pred HhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 521 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 521 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.... ..+... ........+.+++.+|+..||++|||+.++++
T Consensus 230 ~~~~------~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPRN------PPPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhcc------CCCCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1110 011111 11224467889999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=298.83 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=197.8
Q ss_pred CCcCceeeeccCceEEEEEcC----CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCC------
Q 007020 298 FSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 366 (621)
Q Consensus 298 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 366 (621)
|.+.+.||+|+||.||+|.+. +++.||||+++.... .....++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556788999999999999753 468899999875442 334557889999999999999999999876532
Q ss_pred ceEEEEeccCCCchhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccc
Q 007020 367 ERLLVYPYMANGSVASCLRERP--PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 444 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 444 (621)
..++++||+.+|+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2378899999999998875322 1223478889999999999999999999 9999999999999999999999999
Q ss_pred ccceecccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHh
Q 007020 445 GLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 522 (621)
Q Consensus 445 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 522 (621)
|+++........ ......++..|++||.+.+..++.++||||||+++|||++ |+.||.... ......++.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~-----~~~~~~~~~--- 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-----NSEIYNYLI--- 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC-----HHHHHHHHH---
Confidence 999865432211 1122335678999999988889999999999999999999 888885221 111111111
Q ss_pred hhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 523 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 523 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
...... . .......+.+++.+|++.+|++||++.++++.|++.
T Consensus 230 ~~~~~~------~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 KGNRLK------Q----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCcCC------C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111100 0 112336899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=302.68 Aligned_cols=263 Identities=23% Similarity=0.325 Sum_probs=201.5
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
+|++.+.||+|+||.||+|... +|+.||+|.+..... ......+.+|+.+++.++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778889999999999999864 689999999876543 33345789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+ +++|.+++.... .++++..+..++.||++||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999987643 3489999999999999999999999 99999999999999999999999999998765433
Q ss_pred CeeeecccccccccchhhhccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc--------
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK-------- 525 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 525 (621)
........|+..|+|||.+.+.. ++.++||||+|+++|||++|.+||.... ......++.......
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN-----DIEQLAIVFRTLGTPNEETWPGL 228 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC-----HHHHHHHHHHHcCCCChHHHhhc
Confidence 22233445889999999986544 6899999999999999999988875221 111111111110000
Q ss_pred ----ccccccCcccc----CcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 526 ----KLEMLVDPDLQ----NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 526 ----~~~~~~d~~~~----~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
....+..+... .....+....+.+++..|++.+|++||+++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 00111234788999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=288.39 Aligned_cols=282 Identities=24% Similarity=0.319 Sum_probs=216.9
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
..++|...++||+|.||+|-+++-+ +|+.||+|++++... .+....-..|-.++...+||.+..+...|+..+.+++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3467777899999999999999865 799999999987653 2334456788999999999999999999999999999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
||||..||.|+-++.... .+++...+-+...|..||.|||++ +||+||||.+|.|+|++|++||+|||+++.-
T Consensus 246 VMeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence 999999999998887643 388889999999999999999999 9999999999999999999999999999752
Q ss_pred ccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
.........++||+.|+|||++....|..++|.|.+||++|||++|+.||...+ ..-+...+ ...
T Consensus 319 -I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d-----h~kLFeLI-------l~e-- 383 (516)
T KOG0690|consen 319 -IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD-----HEKLFELI-------LME-- 383 (516)
T ss_pred -ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc-----hhHHHHHH-------Hhh--
Confidence 234455677899999999999999999999999999999999999999996211 11111111 011
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCC--CHHHHHHHHhcCCCcc-chhhhhHhHhhhhccccCCCCCCCcccC
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP--KMSEVVRMLEGDGLAE-RWDEWQKVEVLRQEVELAPHPNSDWIVD 607 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP--t~~~vl~~L~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (621)
|-++ +.....+...++...+.+||.+|. ..+++.+..+...++. +|.. +.+.++.-|+.|.-....+
T Consensus 384 -d~kF----Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~-----~~~Kki~PPfKPqVtSetD 453 (516)
T KOG0690|consen 384 -DLKF----PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA-----TYRKKIEPPFKPQVTSETD 453 (516)
T ss_pred -hccC----CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH-----HHHhccCCCCCCCcccccc
Confidence 1111 122224566677778889999998 3455555555554443 4443 3455555566654433333
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=306.60 Aligned_cols=263 Identities=22% Similarity=0.335 Sum_probs=201.3
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
++|+..+.||+|+||.||+|... +++.||+|.++.... ......+.+|+++++.++|+||+++++++..++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999875 588999999875432 3334578999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|++++.+..+..... .+++..+..++.||+.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEASPG----GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999877776654422 378899999999999999999999 9999999999999999999999999999876544
Q ss_pred CCeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh---------
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--------- 523 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--------- 523 (621)
.........++..|+|||++.+. .++.++||||||+++|+|++|+.||..... ............
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD-----IDQLYLIQKCLGPLPPSHQEL 228 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCCHHHhhh
Confidence 33233345678899999999888 789999999999999999999999963211 000000000000
Q ss_pred ---hcccc--cccCccc----cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 524 ---EKKLE--MLVDPDL----QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 524 ---~~~~~--~~~d~~~----~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..... ...+... ...+......++.+++..||..+|++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 0000000 00011122577999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=312.08 Aligned_cols=245 Identities=29% Similarity=0.411 Sum_probs=197.6
Q ss_pred CCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCch--hHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 298 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 298 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
|+..+.||.|+||.||.|++. +.+.||||.+.-..... .-.++.+|+..+..++|||++.+.|+|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 444567999999999999864 78899999986543322 234689999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
|-| |-.|++.-.. .++.+.++..|..+.+.||+|||+. +.||||||..|||+++.|.||++|||.|....+
T Consensus 108 ClG-SAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 108 CLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred Hhc-cHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 976 7777776532 2488889999999999999999999 999999999999999999999999999987654
Q ss_pred Ceeeecccccccccchhhhc---cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 455 THVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
..+++||+.|||||++. .+.|+-|+||||+|++..||...++|+-. -+. +.-...+....
T Consensus 179 ---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn-----MNA---------MSALYHIAQNe 241 (948)
T KOG0577|consen 179 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-----MNA---------MSALYHIAQNE 241 (948)
T ss_pred ---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC-----chH---------HHHHHHHHhcC
Confidence 34567999999999985 46789999999999999999999999621 111 11111122223
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.|.++. .+.+..+.+++..|+++-|.+|||.+++++.
T Consensus 242 sPtLqs---~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 242 SPTLQS---NEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCCC---chhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 344443 3455678889999999999999999998753
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=295.46 Aligned_cols=252 Identities=25% Similarity=0.404 Sum_probs=205.9
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEecc
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 375 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 375 (621)
+|+..+.||+|++|.||+|... +++.|++|++...........+..|+..+..++|+||+++++++...+..+++|||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 5778899999999999999876 589999999876554445667999999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
++++|.+++... .++++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 82 DGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 999999999764 238899999999999999999999 8 99999999999999999999999999998765333
Q ss_pred CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ....+.+...... ..+.
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~------~~~~ 222 (264)
T cd06623 155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAICDG------PPPS 222 (264)
T ss_pred Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHhcC------CCCC
Confidence 22 1234578899999999988899999999999999999999999964321 0111112221111 0111
Q ss_pred ccCcccHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 535 LQNNYVEA-EVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 535 ~~~~~~~~-~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
. ... ....+.+++..|++.+|++||++.++++.
T Consensus 223 ~----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 L----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred C----CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1 111 34689999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=300.83 Aligned_cols=251 Identities=25% Similarity=0.328 Sum_probs=202.1
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
+..+.|+.-++||+|+||.||-+... +|+.||.|.+.+.+. ...+.....|-.++.+++.+.||.+-.+|.+.+.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 44567888899999999999999754 799999998865432 223445678999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+|+..|.||+|.-+|.+.+. ..+++..+.-++.+|+.||++||+. +||+||+||+|||+|+.|+++|+|.|+|..
T Consensus 262 lVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred EEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEe
Confidence 99999999999988887654 3499999999999999999999999 999999999999999999999999999997
Q ss_pred cccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 450 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
+.... .....+||.+|||||++++..|+...|.||+||++|||+.|+.||..-..... .+-+....
T Consensus 337 i~~g~--~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-----~eEvdrr~------- 402 (591)
T KOG0986|consen 337 IPEGK--PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-----REEVDRRT------- 402 (591)
T ss_pred cCCCC--ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-----HHHHHHHH-------
Confidence 65433 33444799999999999999999999999999999999999999952211000 00011111
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCH
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 565 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 565 (621)
+.| ...++...+.+..++....+++||++|..-
T Consensus 403 ~~~---~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 403 LED---PEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hcc---hhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 111 122344455677788888889999999844
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=302.05 Aligned_cols=265 Identities=24% Similarity=0.303 Sum_probs=195.5
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
+++|...+.||+|+||.||+|... +++.||+|.+...........+.+|+.+++.++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 467888999999999999999864 6889999998765444444567889999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+. +++.+++.... ..+.+..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 996 57777765432 1367788899999999999999999 9999999999999999999999999998754322
Q ss_pred CCeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHH-----------HH
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK-----------GL 521 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~-----------~~ 521 (621)
.. ......++..|+|||.+.+. .++.++||||||+++|||++|+.||+..... ...+.+... ..
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 157 SQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV---FEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred CC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH---HHHHHHHHHHcCCCChhhhhhh
Confidence 21 12233478899999998764 4788999999999999999999999632210 000000000 00
Q ss_pred hhhccc-ccccCccccCcc-----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 522 LKEKKL-EMLVDPDLQNNY-----VEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 522 ~~~~~~-~~~~d~~~~~~~-----~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
...... ............ .......+.+++..|+..||.+|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000 000000000000 0011356788999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=294.64 Aligned_cols=249 Identities=28% Similarity=0.428 Sum_probs=200.2
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
+|+..+.||+|+||.||++... +++.+|+|.+.... .......+..|+++++.++|+||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999864 68899999986543 233455788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC-CcEEEcccccceecccC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfGla~~~~~~ 453 (621)
+++++|.+++.... ...+++..+..++.++++||+|||++ +++|+||||+||+++.+ +.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997643 23478899999999999999999999 99999999999999855 46899999999876432
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 533 (621)
. ......++..|+|||.+.+...+.++||||||+++|+|++|+.||+.... ...+....... ...+
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--------~~~~~~~~~~~-~~~~--- 221 (256)
T cd08220 156 S--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL--------PALVLKIMSGT-FAPI--- 221 (256)
T ss_pred c--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch--------HHHHHHHHhcC-CCCC---
Confidence 2 12234588899999999988889999999999999999999999963221 11111111110 0011
Q ss_pred cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 534 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.......+.+++..||+.+|++|||+.++++
T Consensus 222 ------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 ------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ------CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1123467889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=297.43 Aligned_cols=253 Identities=28% Similarity=0.413 Sum_probs=199.9
Q ss_pred CCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCc-----hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 297 SFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTP-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
+|+..+.||+|+||.||++.. .+++.||+|.++..... .....+..|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467788999999999999985 46899999998644321 124568899999999999999999999999999999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-cEEEccccccee
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKL 449 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~~ 449 (621)
||||+++++|.+++.... ++++..+..++.|++.||+|||++ +++|+||||+||+++.++ .+||+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999987643 378899999999999999999999 999999999999998775 599999999876
Q ss_pred cccCCC---eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcc
Q 007020 450 MDYKDT---HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 450 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (621)
...... .......|+..|+|||.+.+..++.++||||+|+++|+|++|..||...... .....+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~-- 226 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-----NHLALIFKIASA-- 226 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-----chHHHHHHHhcc--
Confidence 543211 1122345788999999998888899999999999999999999999632211 111111111000
Q ss_pred cccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 527 ~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.. ...........+.+++..|+..+|++||++.++++
T Consensus 227 ---~~----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 ---TT----APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---CC----CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00 11122234467889999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=301.60 Aligned_cols=248 Identities=22% Similarity=0.327 Sum_probs=195.9
Q ss_pred CCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccC
Q 007020 298 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 376 (621)
Q Consensus 298 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 376 (621)
|.....||+|+||.||++... ++..||||.+.... ......+.+|+.+++.++|+||+++++.+...+..++||||++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 333466999999999999864 68899999986433 3344568899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCe
Q 007020 377 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 456 (621)
Q Consensus 377 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 456 (621)
+++|.+++... .+++..+..++.||+.||+|||++ +|+||||||+||++++++.++|+|||++........
T Consensus 103 ~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~- 173 (292)
T cd06658 103 GGALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP- 173 (292)
T ss_pred CCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence 99999988542 278899999999999999999999 999999999999999999999999999875432221
Q ss_pred eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcccc
Q 007020 457 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 536 (621)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 536 (621)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... .+.+.... ....+...
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~------~~~~~~~~ 239 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--------LQAMRRIR------DNLPPRVK 239 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH------hcCCCccc
Confidence 12234588999999999888899999999999999999999999952211 01111110 01111111
Q ss_pred CcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 537 NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 537 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
. .......+.+++..|+..+|.+|||++++++.
T Consensus 240 ~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 D--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred c--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1 11123567889999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=301.72 Aligned_cols=250 Identities=20% Similarity=0.313 Sum_probs=200.7
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
++|...+.||+|+||.||++... +++.||+|.+.... ......+..|+.+++.++||||+++++++...+..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 67888899999999999999854 67899999986433 23345688899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++++|.+++.+.. +++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~~-----l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhhcC-----CCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 99999999987532 77889999999999999999999 99999999999999999999999999987654332
Q ss_pred CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
. ......|+..|+|||.+.+..++.++||||||+++|++++|+.||........ +..... .+.
T Consensus 170 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--------~~~~~~--------~~~ 232 (293)
T cd06647 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--------LYLIAT--------NGT 232 (293)
T ss_pred c-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--------eeehhc--------CCC
Confidence 2 22234588899999999888889999999999999999999999963321100 000000 000
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
............+.+++..||..+|++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001112233568899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=298.92 Aligned_cols=245 Identities=24% Similarity=0.312 Sum_probs=198.8
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|+..+.||+|+||.||++... +++.||+|.++.... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788899999999999999865 689999999865432 233456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999987653 388899999999999999999999 999999999999999999999999999986543
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
. .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||..... .+........ .
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~-~------ 214 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKILEG-K------ 214 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcC-C------
Confidence 3 2334588999999999888889999999999999999999999963220 0111111110 0
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 570 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~ 570 (621)
..+ +......+.+++..||..+|.+|+ +++++++
T Consensus 215 ~~~----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 215 VRF----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ccC----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 011 111236788999999999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=301.32 Aligned_cols=248 Identities=28% Similarity=0.403 Sum_probs=195.6
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
.+.|...+.||+|+||+||+|... +++.||+|.+..... ......+.+|+++++.++||||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888899999999999999865 689999999864332 23335688999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+.+ ++.+++.... ..+++..+..++.|++.||.|||+. +|+||||+|+||++++++.++|+|||++....
T Consensus 94 ~e~~~g-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCLG-SASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhCC-CHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 999974 7777765432 2388999999999999999999999 99999999999999999999999999987654
Q ss_pred cCCCeeeecccccccccchhhhc---cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
.. ....++..|+|||++. ...++.++||||||+++|||++|+.||..... ..........
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~--------~~~~~~~~~~---- 229 (307)
T cd06607 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQN---- 229 (307)
T ss_pred CC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH--------HHHHHHHhcC----
Confidence 22 2235788999999874 35578899999999999999999999852211 0111111000
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
..+... .......+.+++..||+.+|++||++.+|+..
T Consensus 230 --~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 230 --DSPTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --CCCCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 001111 12244678999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=327.07 Aligned_cols=265 Identities=27% Similarity=0.422 Sum_probs=215.4
Q ss_pred HHHHHhcCCCcCceeeeccCceEEEEEcC----C----CcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeee
Q 007020 290 ELQVATDSFSNKNILGRGGFGKVYKGRLA----D----GSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRG 360 (621)
Q Consensus 290 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~ 360 (621)
.+++..++..+.+.||+|.||.|++|... . ...||||.++......+...+..|+++++.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 56777777777889999999999999732 1 4579999999888777788899999999987 5999999999
Q ss_pred eeecCCceEEEEeccCCCchhhhhccCC---CCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 007020 361 FCMTPTERLLVYPYMANGSVASCLRERP---PSQ---------LPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKA 428 (621)
Q Consensus 361 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~ 428 (621)
+|......++|+||+..|+|.++++... .-. ..+...+...++.|||.|++||++. ++|||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999998765 000 2378889999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEcccccceecccCCCeeeecccc--cccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCccccc
Q 007020 429 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--TIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLAR 505 (621)
Q Consensus 429 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~ 505 (621)
+|||++++..+||+|||+|+............-.| ...|||||.+....++.++|||||||+|||++| |..||..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~-- 524 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG-- 524 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC--
Confidence 99999999999999999999655444444333333 346999999999999999999999999999999 8888842
Q ss_pred ccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 506 LANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
-.....+.++++. +..+ ..+..+..+++++|+.||+.+|++||++.++.+.++.
T Consensus 525 --~~~~~~l~~~l~~---G~r~----------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 525 --IPPTEELLEFLKE---GNRM----------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred --CCcHHHHHHHHhc---CCCC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 0001112222221 1111 1133445789999999999999999999999999988
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=300.70 Aligned_cols=245 Identities=21% Similarity=0.304 Sum_probs=194.8
Q ss_pred CceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCc
Q 007020 301 KNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 379 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 379 (621)
...||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++||||+++++++...+..+++|||+++++
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 346999999999999864 689999999865432 334568899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeeee
Q 007020 380 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 459 (621)
Q Consensus 380 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 459 (621)
|.+++... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....... ....
T Consensus 105 L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~ 175 (297)
T cd06659 105 LTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK 175 (297)
T ss_pred HHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cccc
Confidence 99987542 278899999999999999999999 99999999999999999999999999987543222 1223
Q ss_pred cccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCcc
Q 007020 460 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNY 539 (621)
Q Consensus 460 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 539 (621)
...|+..|+|||++.+..++.++||||||+++|||++|+.||..... . ..+..... .... ... .
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~---~~~~~~~~-~~~~-----~~~--~ 239 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP-----V---QAMKRLRD-SPPP-----KLK--N 239 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----H---HHHHHHhc-cCCC-----Ccc--c
Confidence 34588999999999988899999999999999999999999952211 0 11111110 0000 000 0
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 540 VEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 540 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.......+.+++..|++.+|++||+++++++.
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11123568899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=312.94 Aligned_cols=201 Identities=29% Similarity=0.422 Sum_probs=175.0
Q ss_pred CcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecC------CceEEE
Q 007020 299 SNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TERLLV 371 (621)
Q Consensus 299 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv 371 (621)
...+.||+|+||.||+|++ .+|+.||||.++........+...+|++++++++|+|||+++++-.+. ....+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 3456799999999999995 479999999999877777778899999999999999999999985543 356899
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC--CCC--cEEEcccccc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD--EEF--EAVVGDFGLA 447 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~~~--~~kl~DfGla 447 (621)
||||.+|||...+++- .+...+++.+.+.+..+++.||.|||++ +||||||||.||++- ++| .-||+|||.|
T Consensus 96 mEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999863 3445599999999999999999999999 999999999999983 334 4799999999
Q ss_pred eecccCCCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCccccc
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLAR 505 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~ 505 (621)
+.++... ...+.+||..|++||++.. +.|+..+|.|||||++|+.+||..||....
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 9876443 6677889999999999985 788999999999999999999999996433
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=299.82 Aligned_cols=262 Identities=22% Similarity=0.279 Sum_probs=197.4
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc----hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
+|...+.||+|+||.||+|... +|+.||+|.++..... .....+..|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677889999999999999865 6899999999755432 2234567899999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+ +|+|.+++.... ..+++..+..++.||++||+|||++ +|+|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 889999997643 2489999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh--------
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL-------- 522 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-------- 522 (621)
.... ......++..|+|||.+.+ ..++.++|||||||++|||++|.+||...... ..+........
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 154 SPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI----DQLGKIFEALGTPTEENWP 228 (298)
T ss_pred CCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH----HHHHHHHHHcCCCchhhhh
Confidence 4322 1222346788999999865 45688999999999999999998877522110 00000000000
Q ss_pred hhcccccccCcccc-----CcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 523 KEKKLEMLVDPDLQ-----NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 523 ~~~~~~~~~d~~~~-----~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.............. ..........+.+++..||+.+|++|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000000000000 0011223467889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=298.95 Aligned_cols=264 Identities=23% Similarity=0.325 Sum_probs=199.2
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEecc
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 375 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 375 (621)
+|+..+.||.|++|.||+|+.. +|+.||+|.++..........+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999975 688999999976554444556778999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCC
Q 007020 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 455 (621)
++ +|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 88888865432 23489999999999999999999999 999999999999999999999999999976543221
Q ss_pred eeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH-----------Hhh
Q 007020 456 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG-----------LLK 523 (621)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~-----------~~~ 523 (621)
......++..|++||.+.+. .++.++||||||+++|+|++|+.||...... ......... ...
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE----DQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHHHhCCCChhhHHHHhc
Confidence 12233478899999998664 4688999999999999999999999633211 000000000 000
Q ss_pred hcccccccCc---cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 524 EKKLEMLVDP---DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 524 ~~~~~~~~d~---~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.......... .............+.+++..|++.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000000 0000111123467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=298.10 Aligned_cols=252 Identities=24% Similarity=0.392 Sum_probs=203.0
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
..+.|+..+.||+|+||.||+|.+. +++.|++|.+..... ....+..|+++++.++|+||+++++++...+..++++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 4566788889999999999999976 688999999875443 4557889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9999999999998754 2489999999999999999999998 999999999999999999999999998875443
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||..... . ........ .......+
T Consensus 169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~-------~-~~~~~~~~-~~~~~~~~ 238 (286)
T cd06614 169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP-------L-RALFLITT-KGIPPLKN 238 (286)
T ss_pred chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-------H-HHHHHHHh-cCCCCCcc
Confidence 221 12233478899999999888899999999999999999999999852111 0 11111110 01111010
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.......+.+++..|++.+|.+||++.+++.
T Consensus 239 -------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 -------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -------hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1113467889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=299.50 Aligned_cols=262 Identities=23% Similarity=0.323 Sum_probs=196.1
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
+|+..+.||+|++|.||+|+.. +|+.||||.++.... ......+..|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778889999999999999865 689999999865432 22334688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+. ++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 589888875432 2488999999999999999999999 99999999999999999999999999987654322
Q ss_pred CeeeecccccccccchhhhccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc--------
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK-------- 525 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 525 (621)
. ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||..... .....+.+.......
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE----IDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHHhCCCChhhhhhhh
Confidence 1 122334688999999887654 58899999999999999999999953211 011111111000000
Q ss_pred -------ccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 526 -------KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 526 -------~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.......... ..........+.+++..|++.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 230 SLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 0001112356788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=311.96 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=196.5
Q ss_pred cCceeeeccCceEEEEEcCCC-cEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCC
Q 007020 300 NKNILGRGGFGKVYKGRLADG-SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 378 (621)
Q Consensus 300 ~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 378 (621)
++..||.|+||.||+|..++. -..|.|++.. ........+.-|+++|+...||+||++++.|.-++.+|++.|||.||
T Consensus 36 IiGELGDGAFGKVyKA~nket~~lAAaKvIet-kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG 114 (1187)
T KOG0579|consen 36 IIGELGDGAFGKVYKAVNKETKLLAAAKVIET-KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG 114 (1187)
T ss_pred HHhhhcCccchhhhhhhcccchhhhhhhhhcc-cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence 345699999999999997754 4455676643 34555668999999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeee
Q 007020 379 SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 458 (621)
Q Consensus 379 sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 458 (621)
-....+-..+ .++.+.++..+.+|++.||.|||++ .|||||||..|||++-+|.++|+|||.+.... ......
T Consensus 115 AVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qkR 187 (1187)
T KOG0579|consen 115 AVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQKR 187 (1187)
T ss_pred hHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch-hHHhhh
Confidence 9998877643 3488999999999999999999999 99999999999999999999999999875432 223344
Q ss_pred ecccccccccchhhhc-----cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCc
Q 007020 459 TAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533 (621)
Q Consensus 459 ~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 533 (621)
..+.||+.|||||+.. ..+|+.++||||||++|.||..+.+|-..-. . ++-+++ +.+--.|
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-------p----MRVllK---iaKSePP 253 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-------P----MRVLLK---IAKSEPP 253 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-------h----HHHHHH---HhhcCCC
Confidence 5677999999999874 4578999999999999999999999864111 0 111111 1111112
Q ss_pred cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 534 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.+.. +......+.+++..|+.++|..||+++++++.
T Consensus 254 TLlq--PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 254 TLLQ--PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cccC--cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 2221 33455788999999999999999999999754
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=298.21 Aligned_cols=267 Identities=23% Similarity=0.308 Sum_probs=197.2
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc-hhHHHHHHHHHHHHhccCCceeeeeeeeecC--CceEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLV 371 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 371 (621)
++|+..+.||+|+||.||+|... +++.+|+|.++..... .....+.+|+.++..++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46788899999999999999976 5889999998754322 2233567899999999999999999998877 889999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++ +|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999985 99988876432 489999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCeeeecccccccccchhhhccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCc--------chHHHHHH--H
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDD--------VMLLDWVK--G 520 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~--------~~~~~~~~--~ 520 (621)
.... ......++..|+|||.+.+.. .+.++||||||+++|+|++|..||.......... .....|-. .
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 158 SPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred CCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 4322 122334788999999987654 5889999999999999999999996321100000 00000000 0
Q ss_pred Hhhh--cccccccCccccCcccHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 521 LLKE--KKLEMLVDPDLQNNYVEA-EVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 521 ~~~~--~~~~~~~d~~~~~~~~~~-~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.... ..........+...+... ....+.+++..|++.+|++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000 000000000111111111 2466889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=294.57 Aligned_cols=248 Identities=23% Similarity=0.305 Sum_probs=201.3
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
+|+..+.||.|+||.||+|... +++.||+|.+..... ......+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999875 689999999875432 2345678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+.+++|.+++... .++++..+..++.|+++||.|||++ +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999999764 2488999999999999999999999 9999999999999999999999999998865433
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 533 (621)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... ...++...... .
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~--~------ 217 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------IRDQIRAKQET--A------ 217 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc------HHHHHHHHhcc--c------
Confidence 2 223345888999999998888999999999999999999999999633211 11222211111 0
Q ss_pred cccCcccHHHHHHHHHHHHhccCCCCCCCCCH--HHHH
Q 007020 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM--SEVV 569 (621)
Q Consensus 534 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~--~~vl 569 (621)
....+......+.+++.+||+.+|.+||++ +|++
T Consensus 218 --~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 --DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 011112234788899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=275.72 Aligned_cols=248 Identities=24% Similarity=0.393 Sum_probs=195.4
Q ss_pred CceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-CCceeeeeeeeecCCceEEEEeccCCC
Q 007020 301 KNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYMANG 378 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 378 (621)
...||.|+-|+|+++++. +|...|||.++......+..++...+.++..-+ .|.||+-+|||..+...++.||.|..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 356999999999999875 589999999988776666677888888776654 89999999999999999999999865
Q ss_pred chhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeee
Q 007020 379 SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 458 (621)
Q Consensus 379 sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 458 (621)
-+..++.... .++++..+-++...+.+||.||.+++ +|+|||+||+|||+|+.|.+|++|||++-++-.. ...
T Consensus 176 C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--kAh 248 (391)
T KOG0983|consen 176 CAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--KAH 248 (391)
T ss_pred HHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc--ccc
Confidence 4555555432 23888888899999999999999987 9999999999999999999999999999776432 333
Q ss_pred ecccccccccchhhhcc---CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccc
Q 007020 459 TAVRGTIGHIAPEYLST---GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 535 (621)
Q Consensus 459 ~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 535 (621)
+...|.+.|||||.+.- ..|+.++||||||+.++||.||..||.... .+. +.+..++++.. |.+
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~----tdF---e~ltkvln~eP------P~L 315 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK----TDF---EVLTKVLNEEP------PLL 315 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC----ccH---HHHHHHHhcCC------CCC
Confidence 44569999999999854 357889999999999999999999996322 111 22222222111 222
Q ss_pred cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 536 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 536 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
... ...+..+.+++..|+++|+.+||.+.++++.
T Consensus 316 ~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 316 PGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred Ccc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 221 1145789999999999999999999999763
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=294.46 Aligned_cols=243 Identities=24% Similarity=0.315 Sum_probs=195.5
Q ss_pred eeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCch
Q 007020 304 LGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 380 (621)
Q Consensus 304 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 380 (621)
||.|+||.||+++.. +++.||+|.+..... ......+.+|+.+++.++|+||+++++++.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 589999999875432 23445789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeeeec
Q 007020 381 ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 460 (621)
Q Consensus 381 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 460 (621)
.+++.... .+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 99997643 278889999999999999999999 99999999999999999999999999998765432 2223
Q ss_pred ccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCccc
Q 007020 461 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 540 (621)
Q Consensus 461 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 540 (621)
..++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ...+......... ....++
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~---------~~~~~~ 216 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE------DPMEIYNDILKGN---------GKLEFP 216 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC------CHHHHHHHHhccC---------CCCCCC
Confidence 4588899999999888889999999999999999999999963321 0112222211100 011111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007020 541 EAEVEQLIQVALLCTQGSPMDRPK-----MSEVVR 570 (621)
Q Consensus 541 ~~~~~~l~~l~~~c~~~~P~~RPt-----~~~vl~ 570 (621)
......+.+++..||+.+|++||+ ++|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 122468999999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=292.89 Aligned_cols=250 Identities=22% Similarity=0.344 Sum_probs=200.7
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
+|+..+.||+|+||.||++... +|..||+|.+..... ......+.+|+.+++.++|+||+++++.+......++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999875 588999999865422 23345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-cEEEcccccceecccC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYK 453 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~~~~~~ 453 (621)
+++++|.+++..... ..+++..+..++.|+++||+|||+. +++|+||||+||++++++ .+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999876432 2478999999999999999999999 999999999999999885 4699999999866433
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 533 (621)
.. ......|+..|+|||++.+..++.++||||||+++|||++|..||.... ..+++....... ..+
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~-----~~~ 221 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--------LHQLVLKICQGY-----FAP 221 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHhccc-----CCC
Confidence 22 2223458899999999988889999999999999999999999985321 122332222111 111
Q ss_pred cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 534 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. .......+.+++.+|+..+|++|||+.++++
T Consensus 222 -~----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 -I----SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -C----CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0 1122357889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=293.80 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=203.6
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
+|++.+.||+|+||.||++... +++.+|+|.+.... .......+..|+++++.++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4777889999999999999754 68899999987543 233455678899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++++|.+++.........+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999876433334588999999999999999999999 9999999999999999999999999999876543
Q ss_pred CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||..... ....... ....
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~-~~~~-------- 217 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--------QDLRYKV-QRGK-------- 217 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHH-hcCC--------
Confidence 22234588899999999988899999999999999999999999963221 1111111 1111
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
...........+.+++..|++.+|++||++.++++.
T Consensus 218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 218 -YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111122345679999999999999999999999763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=324.06 Aligned_cols=210 Identities=25% Similarity=0.365 Sum_probs=188.3
Q ss_pred CHHHHHHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeee
Q 007020 287 SLRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCM 363 (621)
Q Consensus 287 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 363 (621)
.+.+++...++|.+.++||+|+||.|..++++ +++.||+|++++.. .......|..|..+|...+.+.|+.++..|+
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 35677888899999999999999999999976 68999999997632 1233456999999999999999999999999
Q ss_pred cCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcc
Q 007020 364 TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 443 (621)
Q Consensus 364 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 443 (621)
++.++|+|||||+||+|..++.+.. ++++..++.++..|.-||.-||+. |+|||||||+|||+|..|++||+|
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeecc
Confidence 9999999999999999999998764 388899999999999999999999 999999999999999999999999
Q ss_pred cccceecccCCCeeeecccccccccchhhhcc-----CCCCCcccchhHHHHHHHHHhCCCCccc
Q 007020 444 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGIMLLELITGQRAFDL 503 (621)
Q Consensus 444 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~ 503 (621)
||.+-.++..+.-.....+|||-|++||++.. +.|++.+|.||+||++|||+.|..||..
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 99998887666666777889999999999953 4688999999999999999999999963
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.84 Aligned_cols=263 Identities=20% Similarity=0.313 Sum_probs=196.0
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecC-----Cce
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TER 368 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 368 (621)
.++|++.+.||+|+||.||+|... +|+.||+|.+...........+.+|+.+++.++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999854 68999999986543334455688899999999999999999987544 357
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
++++||+.+ +|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 999999975 888777643 388999999999999999999999 99999999999999999999999999998
Q ss_pred ecccCCCe--eeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 449 LMDYKDTH--VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 449 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
........ ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... .....+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-----~~~~~~~~~~~~~ 229 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-----HQLNLILGVLGTP 229 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHcCCC
Confidence 65432211 1123458899999998755 46789999999999999999999999532210 0111111111000
Q ss_pred ---ccccccCcc-----------ccC---cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 526 ---KLEMLVDPD-----------LQN---NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 526 ---~~~~~~d~~-----------~~~---~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
....+.+.. ... .........+.+++..||+.+|++|||+.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 000 0011224668899999999999999999999775
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=292.90 Aligned_cols=247 Identities=22% Similarity=0.336 Sum_probs=197.3
Q ss_pred CCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccC
Q 007020 298 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 376 (621)
Q Consensus 298 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 376 (621)
|...+.||+|++|.||++... +++.|++|.+.... ......+.+|+.+++.++|+||+++++++...+..++++||++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 444578999999999999864 68899999886432 2334568899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCe
Q 007020 377 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 456 (621)
Q Consensus 377 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 456 (621)
+++|.+++... .+++..+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||.+........
T Consensus 100 ~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 100 GGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred CCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence 99999998762 278889999999999999999999 999999999999999999999999998875433221
Q ss_pred eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcccc
Q 007020 457 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 536 (621)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 536 (621)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||.... ....+...... . .+...
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~--------~~~~~~~~~~~-~-----~~~~~ 236 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP--------PLQAMKRIRDN-L-----PPKLK 236 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC--------HHHHHHHHHhc-C-----CCCCc
Confidence 2233458899999999988889999999999999999999999985321 11222221111 1 01111
Q ss_pred CcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 537 NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 537 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. .......+.+++..||+.+|++||++.++++
T Consensus 237 ~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 N--LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred c--cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0 1112367899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=295.74 Aligned_cols=258 Identities=21% Similarity=0.261 Sum_probs=193.2
Q ss_pred CCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-CCceeeeeeeeecC--CceEEEEe
Q 007020 298 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTP--TERLLVYP 373 (621)
Q Consensus 298 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 373 (621)
|+..+.||+|+||.||+|... +++.||+|.++............+|+.++.++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566788999999999999864 688999999876543333334567888888885 99999999999887 88999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++ +|.+.+.... ..+++..+..++.|++.||+|||+. +++||||||+||+++. +.+||+|||++......
T Consensus 81 ~~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMDM-NLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCCc-cHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 9975 8888876533 2389999999999999999999999 9999999999999999 99999999999865432
Q ss_pred CCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh----------
Q 007020 454 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL---------- 522 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---------- 522 (621)
.. .....++..|+|||.+.. ..++.++|||||||++|||++|+.||..... .....+.....
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE-----LDQIAKIHDVLGTPDAEVLKK 225 (282)
T ss_pred CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH-----HHHHHHHHHHcCCCCHHHHHh
Confidence 22 122447889999997754 4568899999999999999999999953221 11111111111
Q ss_pred -hhcccccccCccccC----cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 523 -KEKKLEMLVDPDLQN----NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 523 -~~~~~~~~~d~~~~~----~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..........+.... ......+..+.+++..|++.+|++||+++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000110000 011233578999999999999999999999976
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=297.74 Aligned_cols=261 Identities=16% Similarity=0.210 Sum_probs=184.4
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcCC----CcEEEEEEecccCCchhHH----------HHHHHHHHHHhccCCceeee
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLAD----GSLVAVKRLKEERTPGGEL----------QFQTEVEMISMAVHRNLLRL 358 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~----------~~~~E~~~l~~l~h~niv~l 358 (621)
+..++|.+.+.||+|+||+||+|...+ +..+|+|...........+ ....+...+..+.|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 345689999999999999999998654 3456777543222111000 11223334556789999999
Q ss_pred eeeeecCC----ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC
Q 007020 359 RGFCMTPT----ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD 434 (621)
Q Consensus 359 ~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~ 434 (621)
++.+.... ..++++|++.. ++.+.+.... ..++..+..++.|++.||+|||+. +|+||||||+|||++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~ 160 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD 160 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence 98765443 34678887754 6666655432 256778899999999999999999 999999999999999
Q ss_pred CCCcEEEcccccceecccCCCe------eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccC
Q 007020 435 EEFEAVVGDFGLAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLAN 508 (621)
Q Consensus 435 ~~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~ 508 (621)
.++.++|+|||+|+.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 9999999999999876432211 1123459999999999999999999999999999999999999996331110
Q ss_pred C-CcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007020 509 D-DDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573 (621)
Q Consensus 509 ~-~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 573 (621)
. ......+++.... .+... .......+.+++..|++.+|++||++.++++.|+
T Consensus 241 ~~~~~~~~~~~~~~~---------~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 241 NLIHAAKCDFIKRLH---------EGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHhHHHHHHHhh---------hhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0 0000011111111 11111 1122467889999999999999999999998763
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=290.99 Aligned_cols=252 Identities=24% Similarity=0.375 Sum_probs=205.8
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
+|...+.||+|+||.||++... +++.||+|.+..... ......+..|+++++.++|+|++++.+.+...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999975 688999999875443 24456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++++|.+++.........+++..+..++.++++||.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999987543334589999999999999999999999 99999999999999999999999999998765432
Q ss_pred CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
.......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||+... ..+........ ... .
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~~-~~~-----~ 222 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--------LLELALKILKG-QYP-----P 222 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc--------HHHHHHHHhcC-CCC-----C
Confidence 22333468899999999988889999999999999999999999996322 11222221111 111 1
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
+ .......+.+++..|+..+|++||++.++++
T Consensus 223 ~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 I----PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1 1123367889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=285.56 Aligned_cols=249 Identities=27% Similarity=0.431 Sum_probs=202.5
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEecc
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 375 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 375 (621)
.|+..+.||+|++|.||++... +++.|++|++..... .....+.+|+++++.++|+|++++++++......++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 3677889999999999999975 688999999876543 34567899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCC
Q 007020 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 455 (621)
++++|.+++.... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 80 SGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999987653 2489999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccc
Q 007020 456 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 535 (621)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 535 (621)
.....++..|+|||.+.+...+.++||||||+++|+|++|+.||..... ......... ........+
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~~~~~~~-- 220 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP--------MKALFKIAT-NGPPGLRNP-- 220 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch--------HHHHHHHHh-cCCCCcCcc--
Confidence 2344588999999999888889999999999999999999999963210 011111111 111111111
Q ss_pred cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 536 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 536 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
......+.+++..|++.||++|||+.++++
T Consensus 221 -----~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 -----EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -----cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111367899999999999999999999976
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=321.43 Aligned_cols=274 Identities=19% Similarity=0.252 Sum_probs=188.8
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcC--CCcEEEEEE--------------eccc--CCchhHHHHHHHHHHHHhccCCc
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLA--DGSLVAVKR--------------LKEE--RTPGGELQFQTEVEMISMAVHRN 354 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~--------------~~~~--~~~~~~~~~~~E~~~l~~l~h~n 354 (621)
...++|.+.+.||+|+||+||++..+ .+..+++|. +.+. ........+.+|+.+++.++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34578999999999999999998653 222222221 1100 11223446889999999999999
Q ss_pred eeeeeeeeecCCceEEEEeccCCCchhhhhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee
Q 007020 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPS-QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL 433 (621)
Q Consensus 355 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill 433 (621)
|+++++++...+..++++|++.+ +|.+++...... ........+..++.||+.||+|||++ +||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 99999999999999999999865 777776543211 11133566788999999999999999 99999999999999
Q ss_pred CCCCcEEEcccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcch
Q 007020 434 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 513 (621)
Q Consensus 434 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~ 513 (621)
+.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++...... .....
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~-~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG-KPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC-CHHHH
Confidence 99999999999999876544333334456999999999999999999999999999999999987543211110 11111
Q ss_pred HHHHHHHHhh-hcc-------cccccCc-cc--cCcccH------HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 514 LLDWVKGLLK-EKK-------LEMLVDP-DL--QNNYVE------AEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 514 ~~~~~~~~~~-~~~-------~~~~~d~-~~--~~~~~~------~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
+.+.+..... ... +...++. .. ...... .....+.+++.+|++.||.+|||+.|++..
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111110000 000 0000000 00 000000 012356778899999999999999999863
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=299.14 Aligned_cols=248 Identities=27% Similarity=0.399 Sum_probs=194.7
Q ss_pred CCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 298 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 298 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
|...+.||+|+||.||+++.. ++..||+|.+..... ......+..|+++++.++|+|++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 556788999999999999864 688999999864322 23345688899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+.+ +|.+.+.... .++++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~g-~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 975 7777775432 2388999999999999999999999 9999999999999999999999999998754322
Q ss_pred Ceeeecccccccccchhhhc---cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 455 THVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||.... .. ...........
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~----~~----~~~~~~~~~~~----- 241 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AM----SALYHIAQNES----- 241 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc----HH----HHHHHHHhccC-----
Confidence 2335888999999974 4567899999999999999999999985211 10 11111111100
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
+.. ........+.+++.+|++.+|.+||++.++++.+.-
T Consensus 242 -~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 242 -PTL---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred -CCC---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 000 111233568899999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=326.02 Aligned_cols=252 Identities=26% Similarity=0.387 Sum_probs=192.3
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeee---------
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM--------- 363 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--------- 363 (621)
-..+|+..++||+||||.||+++.+ ||+.||||+|...........+.+|+..+++++|||||+++..+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 4467788899999999999999977 899999999987654455567899999999999999999865321
Q ss_pred -----------------------------------------------c----------------------C---------
Q 007020 364 -----------------------------------------------T----------------------P--------- 365 (621)
Q Consensus 364 -----------------------------------------------~----------------------~--------- 365 (621)
. .
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0 0
Q ss_pred --------------------------------CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 007020 366 --------------------------------TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413 (621)
Q Consensus 366 --------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~L 413 (621)
..+|+-||||+..++.++++.+.... .....++++.+|++||.|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHH
Confidence 12378899999988888887654321 3568899999999999999
Q ss_pred HhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc-----------------cCCCeeeecccccccccchhhhccC
Q 007020 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-----------------YKDTHVTTAVRGTIGHIAPEYLSTG 476 (621)
Q Consensus 414 H~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~ 476 (621)
|++ |||||||||.||+++++..|||+|||+|+... .......+..+||.-|+|||++.+.
T Consensus 714 H~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 999 99999999999999999999999999998721 0111133456799999999999765
Q ss_pred C---CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccC--cccHHHHHHHHHHH
Q 007020 477 K---SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN--NYVEAEVEQLIQVA 551 (621)
Q Consensus 477 ~---~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~~l~~l~ 551 (621)
. |+.|+||||+|||++||+. ||.... .+ ...+..+-++.+.. .+.......=.+++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM-------------ER---a~iL~~LR~g~iP~~~~f~~~~~~~e~slI 851 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSM-------------ER---ASILTNLRKGSIPEPADFFDPEHPEEASLI 851 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchH-------------HH---HHHHHhcccCCCCCCcccccccchHHHHHH
Confidence 4 8999999999999999985 575221 11 11111122222221 22333445566889
Q ss_pred HhccCCCCCCCCCHHHHHH
Q 007020 552 LLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 552 ~~c~~~~P~~RPt~~~vl~ 570 (621)
.+++++||.+|||+.|++.
T Consensus 852 ~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 852 RWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHhcCCCccCCCHHHHhh
Confidence 9999999999999999965
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=296.24 Aligned_cols=262 Identities=23% Similarity=0.288 Sum_probs=194.8
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc-hhHHHHHHHHHHHHhcc-CCceeeeeeeeecCCc-----
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTE----- 367 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 367 (621)
++|+..+.||+|+||.||+|... +++.||+|.++..... .....+.+|+.+++.+. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999865 6899999998654322 22346788999999995 6999999999877665
Q ss_pred eEEEEeccCCCchhhhhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-CCcEEEcccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPS-QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFG 445 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfG 445 (621)
.+++|||+++ +|.+++...... ...+++..+..++.||++||+|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 888888654322 34589999999999999999999999 9999999999999998 8899999999
Q ss_pred cceecccCCCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhh
Q 007020 446 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 524 (621)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 524 (621)
++........ ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||..... . .....+...
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-------~-~~~~~~~~~ 227 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE-------L-QQLLHIFKL 227 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-------H-HHHHHHHHH
Confidence 9886533211 1222346888999998865 4578999999999999999999999953211 1 111111000
Q ss_pred -c-ccccc-------c----CccccC----cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 525 -K-KLEML-------V----DPDLQN----NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 525 -~-~~~~~-------~----d~~~~~----~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. ..... . .+.... .........+.+++..|++.+|.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 228 LGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 00000 0 000000 001123467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=299.78 Aligned_cols=270 Identities=22% Similarity=0.300 Sum_probs=195.9
Q ss_pred CCCcCceeeeccCceEEEEEcC---CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecC--CceE
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA---DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERL 369 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 369 (621)
+|...+.||+|+||.||+|... +++.||+|.+.... .......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4677889999999999999865 47899999987632 122234577899999999999999999999988 7899
Q ss_pred EEEeccCCCchhhhhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC----CCcEEEccc
Q 007020 370 LVYPYMANGSVASCLRERPPS-QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE----EFEAVVGDF 444 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~----~~~~kl~Df 444 (621)
+||||+++ +|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 676666543222 23588899999999999999999999 9999999999999999 899999999
Q ss_pred ccceecccCCC--eeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcc-----hHHH
Q 007020 445 GLAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDV-----MLLD 516 (621)
Q Consensus 445 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~-----~~~~ 516 (621)
|++........ .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||........... .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543322 112234578899999988764 578999999999999999999999964332210000 0111
Q ss_pred HHHHHh-----------hhccccc----ccCccccCcccH-------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 517 WVKGLL-----------KEKKLEM----LVDPDLQNNYVE-------AEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 517 ~~~~~~-----------~~~~~~~----~~d~~~~~~~~~-------~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.+..+. ....... ............ .....+.+++..|++.||++|||+.+++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111000 0000000 000000000000 22356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=296.90 Aligned_cols=261 Identities=25% Similarity=0.312 Sum_probs=204.0
Q ss_pred CCCcCceeeeccCceEEEEEc----CCCcEEEEEEecccCC---chhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCce
Q 007020 297 SFSNKNILGRGGFGKVYKGRL----ADGSLVAVKRLKEERT---PGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 368 (621)
+|+..+.||+|+||.||++.. .+++.||||.++.... ......+..|+.++.++ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 366778999999999999874 3578899999875321 22334678899999999 599999999999999999
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
++||||+++|+|.+++.... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 99999999999999987532 378889999999999999999999 99999999999999999999999999988
Q ss_pred ecccCCCeeeecccccccccchhhhccCC--CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcc
Q 007020 449 LMDYKDTHVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (621)
..............|+..|+|||.+.+.. .+.++||||||+++|||++|..||..... ......+.+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~----~~~~~~~~~~~~~~-- 227 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE----QNSQSEISRRILKS-- 227 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc----cchHHHHHHHHHcc--
Confidence 65443332233445889999999987665 68899999999999999999999953211 11111222221111
Q ss_pred cccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCCcc
Q 007020 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAE 579 (621)
Q Consensus 527 ~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~ 579 (621)
.+.. .......+.+++.+|++.+|++|||+.++.+.|+...+..
T Consensus 228 -----~~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~ 271 (288)
T cd05583 228 -----KPPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271 (288)
T ss_pred -----CCCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccccc
Confidence 1111 1122356889999999999999999999999888866543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=291.62 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=195.9
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC----CchhHHHHHHHHHHHHhccCCceeeeeeeeecC--Cce
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER----TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 368 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 368 (621)
.+|.+.+.||+|+||.||+|... +++.||+|.+.... .......+.+|+++++.++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888899999999999999864 68999999875321 223345788999999999999999999998764 457
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
++++||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 89999999999999987543 278889999999999999999999 99999999999999999999999999998
Q ss_pred ecccCC--CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcc
Q 007020 449 LMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 449 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (621)
...... ........++..|+|||.+.+...+.++|||||||++|+|++|+.||.... .... +.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~-~~~~~~~~- 225 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE-------AMAA-IFKIATQP- 225 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC-------HHHH-HHHHHcCC-
Confidence 653211 111223458899999999988888999999999999999999999995221 0111 11111000
Q ss_pred cccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 527 ~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..+ ..+......+.+++..|++ +|.+||++.+++.
T Consensus 226 ----~~~----~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 ----TKP----MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ----CCC----CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 011 1122334678899999999 5799999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=295.51 Aligned_cols=261 Identities=23% Similarity=0.334 Sum_probs=197.3
Q ss_pred CCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecC--CceEEEEe
Q 007020 298 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVYP 373 (621)
Q Consensus 298 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 373 (621)
|+..+.||+|+||.||+|... +++.||+|.+.... .......+.+|+++++.++|+|++++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566788999999999999876 58899999997653 223345688899999999999999999999888 88999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++ +|.+++.... ..+++..+..++.||++||+|||+. +++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9985 8888886542 2488999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcc------
Q 007020 454 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK------ 526 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------ 526 (621)
.........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .....+........
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-----EQLEKIFELCGSPTDENWPG 228 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCchhhccc
Confidence 3222333457888999998765 35789999999999999999999999632210 00011111000000
Q ss_pred ccc-----------ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 527 LEM-----------LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 527 ~~~-----------~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
... .....+.......+...+.+++..|++.+|++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 00000000000112567899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=295.66 Aligned_cols=243 Identities=28% Similarity=0.344 Sum_probs=186.5
Q ss_pred eeeeccCceEEEEEcC-CCcEEEEEEecccCCc--hhHHHHHHHHHHHH---hccCCceeeeeeeeecCCceEEEEeccC
Q 007020 303 ILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMIS---MAVHRNLLRLRGFCMTPTERLLVYPYMA 376 (621)
Q Consensus 303 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~ 376 (621)
.||+|+||.||++... +++.||+|.+...... .....+..|..++. ..+|+||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 6889999998654322 22223444444433 3479999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCe
Q 007020 377 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 456 (621)
Q Consensus 377 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 456 (621)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 999999987543 389999999999999999999999 99999999999999999999999999987543322
Q ss_pred eeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccc
Q 007020 457 VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 535 (621)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 535 (621)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|..||....... . ..+..... ..+..+
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~-~~~~~~~~------~~~~~~ 218 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----K-HEIDRMTL------TVNVEL 218 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-----H-HHHHHHhh------cCCcCC
Confidence 123458999999999864 557899999999999999999999996322111 1 11111100 011111
Q ss_pred cCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 007020 536 QNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVRM 571 (621)
Q Consensus 536 ~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~~ 571 (621)
+.....++.+++..|++.||++|| ++++++++
T Consensus 219 ----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 ----PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ----ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 222346788999999999999999 58888664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=297.00 Aligned_cols=267 Identities=24% Similarity=0.346 Sum_probs=198.5
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCC---
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--- 366 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 366 (621)
+...++|++.+.||+|+||.||+|... +|+.||+|.++.... ......+.+|+++++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 345678999999999999999999975 588999999875432 223346788999999999999999999987654
Q ss_pred -------ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcE
Q 007020 367 -------ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 439 (621)
Q Consensus 367 -------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 439 (621)
..++|+||+++ ++.+.+.... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence 78999999987 6777766532 2489999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecccCCCeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHH
Q 007020 440 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 518 (621)
Q Consensus 440 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 518 (621)
||+|||++...............++..|+|||.+.+. .++.++|||||||++|||++|++||..... ......+
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-----~~~~~~~ 230 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-----LAQLELI 230 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHH
Confidence 9999999987654332222233467889999988654 468899999999999999999999963221 1111111
Q ss_pred HHHhhhcccc---cc--------cCcccc-----CcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 519 KGLLKEKKLE---ML--------VDPDLQ-----NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 519 ~~~~~~~~~~---~~--------~d~~~~-----~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.......... .+ .+.... .......+..+.+++..||+.+|++||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111000000 00 000000 0001112467899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=304.02 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=206.2
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc-hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
...|.+.+.||+|.|++|.+|++. ++..||+|.+.+.... .....+.+|++++..++|||||+++.+...+..+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 356778899999999999999865 6899999999776543 33455889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+.+|.+++++.+.+. ..+..+..++.|+.+|++|||++ .|||||||.+|||++.+..+||+|||++.++..
T Consensus 135 eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999988654 55588999999999999999999 999999999999999999999999999998763
Q ss_pred CCCeeeecccccccccchhhhccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
.......+|++.|.|||++.+..+ .+++|+||+|+++|-|+.|..||+......-. .+ ++
T Consensus 208 --~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-------------~r----vl 268 (596)
T KOG0586|consen 208 --GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-------------PR----VL 268 (596)
T ss_pred --cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-------------ch----he
Confidence 344566789999999999998876 68999999999999999999999743322111 01 11
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
..+++- +.-...++.++++.++-.+|.+|++.+++.+.
T Consensus 269 ~gk~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 269 RGKYRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eeeecc--cceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 111111 11123567788889999999999999999763
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=286.31 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=195.0
Q ss_pred CceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHH-hccCCceeeeeeeeecCCceEEEEeccCCC
Q 007020 301 KNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMIS-MAVHRNLLRLRGFCMTPTERLLVYPYMANG 378 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 378 (621)
...||.|+||+|++-.++ .|+..|||+++......+..++..|.+... .-+.||||+++|++..+...|+.||.|+-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~- 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI- 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence 356999999999999875 799999999998877677778889988754 55799999999999999999999999976
Q ss_pred chhhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee
Q 007020 379 SVASCLRERP-PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457 (621)
Q Consensus 379 sL~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 457 (621)
||..+-..-. -....+++...-.|..-...||.||.... .|||||+||+|||++..|.+||||||.+-.+-. +..
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--SiA 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--SIA 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH--HHH
Confidence 6655432210 01223777788888888999999999875 899999999999999999999999999865432 223
Q ss_pred eecccccccccchhhhcc--CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccc
Q 007020 458 TTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 535 (621)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 535 (621)
.+.-+|...|||||.+.. ..|+.+|||||+|++|||+.||+.|+.... +..+.+.....+....-..
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-------svfeql~~Vv~gdpp~l~~---- 292 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-------SVFEQLCQVVIGDPPILLF---- 292 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-------HHHHHHHHHHcCCCCeecC----
Confidence 344468999999999854 358899999999999999999999986211 1222233333222211111
Q ss_pred cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 536 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 536 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.....+....+.+++..|+.+|-..||.+.++.++
T Consensus 293 -~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 -DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11123456789999999999999999999998763
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=301.38 Aligned_cols=265 Identities=20% Similarity=0.246 Sum_probs=196.8
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecC------
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------ 365 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 365 (621)
..++|+..+.||+|+||.||+|... +|+.||+|.+.... .......+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999864 78999999986432 223344677899999999999999999988644
Q ss_pred CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccc
Q 007020 366 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 445 (621)
Q Consensus 366 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 445 (621)
...++||||+.+ +|.+.+... ++...+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 356999999975 888877542 77889999999999999999999 99999999999999999999999999
Q ss_pred cceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCC-------CcchHHHHH
Q 007020 446 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLAND-------DDVMLLDWV 518 (621)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~-------~~~~~~~~~ 518 (621)
+++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||........ ......++.
T Consensus 164 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 164 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred cceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 998654322 12334578899999999999999999999999999999999999963221000 000000010
Q ss_pred HH-------Hhhhcc------cccccCccc----cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 519 KG-------LLKEKK------LEMLVDPDL----QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 519 ~~-------~~~~~~------~~~~~d~~~----~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.. ...... ......... ...........+.+++.+|++.||++|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 000000 000000000 00001123456889999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=293.50 Aligned_cols=242 Identities=24% Similarity=0.302 Sum_probs=189.6
Q ss_pred eeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCch
Q 007020 304 LGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 380 (621)
Q Consensus 304 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 380 (621)
||+|+||+||++... +|+.||+|.+..... ......+..|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999854 689999999865321 22344567899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeeeec
Q 007020 381 ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 460 (621)
Q Consensus 381 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 460 (621)
.+++..... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||.+..... ......
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKG 153 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCcccc
Confidence 999876542 2488999999999999999999999 999999999999999999999999999876543 112233
Q ss_pred ccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCccc
Q 007020 461 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 540 (621)
Q Consensus 461 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 540 (621)
..++..|+|||++.+..++.++||||||+++|+|++|+.||........ ....... .. . .... ..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~-~~----~--~~~~----~~ 218 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE----KEELKRR-TL----E--MAVE----YP 218 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc----HHHHHhc-cc----c--cccc----CC
Confidence 4578899999999888899999999999999999999999963321110 1011110 00 0 0001 11
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHH
Q 007020 541 EAEVEQLIQVALLCTQGSPMDRPKMSE 567 (621)
Q Consensus 541 ~~~~~~l~~l~~~c~~~~P~~RPt~~~ 567 (621)
......+.+++..||+.+|++||++++
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCc
Confidence 122467889999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=298.30 Aligned_cols=260 Identities=25% Similarity=0.352 Sum_probs=191.8
Q ss_pred ceeeec--cCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCC
Q 007020 302 NILGRG--GFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 377 (621)
Q Consensus 302 ~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 377 (621)
..||+| +||+||++.+. +|+.||+|++..... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346766 89999999874 789999999875442 23345788999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee
Q 007020 378 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457 (621)
Q Consensus 378 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 457 (621)
|+|.+++...... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+..........
T Consensus 84 ~~l~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYFPE--GMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 9999998865322 378889999999999999999999 99999999999999999999999998654322111100
Q ss_pred ------eecccccccccchhhhccC--CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH---------
Q 007020 458 ------TTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG--------- 520 (621)
Q Consensus 458 ------~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~--------- 520 (621)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||...... .........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT----QMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH----HHHHHHhcCCCCCCcccc
Confidence 0112246679999999764 4689999999999999999999999632110 000000000
Q ss_pred -----------------------HhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 521 -----------------------LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 521 -----------------------~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
...........+..+...........+.+++..||+.||++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000000011111112223345678899999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=295.47 Aligned_cols=262 Identities=23% Similarity=0.316 Sum_probs=196.0
Q ss_pred CCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc-hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEecc
Q 007020 298 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 375 (621)
Q Consensus 298 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 375 (621)
|+..+.||+|++|.||+|... +|+.||+|++...... .....+.+|+++++.++|+|++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999864 7999999998754322 22346788999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCC
Q 007020 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 455 (621)
+ ++|.+++..... ..+++..+..++.|+++||+|||++ +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 589999876542 2488999999999999999999999 999999999999999999999999999976543221
Q ss_pred eeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc---------
Q 007020 456 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK--------- 525 (621)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------- 525 (621)
......++..|+|||++.+. .++.++||||||+++|+|++|+.||...... ..+.+.++......
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI----DQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCChHHhhhhhh
Confidence 11223468899999988664 4688999999999999999999999532110 01111111000000
Q ss_pred --cccccc---CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 526 --KLEMLV---DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 526 --~~~~~~---d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
...... ...............+.+++.+|++.+|++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000 000000011122357889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=286.98 Aligned_cols=251 Identities=27% Similarity=0.403 Sum_probs=204.0
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecC--CceEEEE
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVY 372 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 372 (621)
+|...+.||+|++|.||+|... +++.|++|.+..... ......+.+|++++++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3677789999999999999976 689999999865542 23456789999999999999999999999888 8899999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++++|.+++.... .+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999998654 489999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 453 KDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 453 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
.... ......++..|+|||.+.+...+.++||||||+++|+|++|..||.... . ....+....
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~--~~~~~~~~~--------- 217 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----N--PMAALYKIG--------- 217 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----c--hHHHHHhcc---------
Confidence 4321 1233458899999999988889999999999999999999999996332 0 111111111
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
........+......+.+++.+|++.+|++||++.++++
T Consensus 218 ~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 218 SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 001111122223578999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=288.55 Aligned_cols=247 Identities=20% Similarity=0.249 Sum_probs=190.6
Q ss_pred ceeeeccCceEEEEEcC-CCcEEEEEEecccCCc--hhHHHHHHHHHH-HHhccCCceeeeeeeeecCCceEEEEeccCC
Q 007020 302 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEM-ISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 377 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 377 (621)
+.||+|+||.||+|... +|+.||+|.++..... .....+..|..+ ....+|+|++++++++...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999864 6889999998654321 122234455444 3455899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee
Q 007020 378 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457 (621)
Q Consensus 378 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 457 (621)
++|.+++.... ++++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++.....
T Consensus 82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 99999997643 378889999999999999999999 999999999999999999999999999875432
Q ss_pred eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccC
Q 007020 458 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537 (621)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 537 (621)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||..... .......... ... ...
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~-~~~------~~~ 214 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--------DAVFDNILSR-RIN------WPE 214 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhc-ccC------CCC
Confidence 2234588899999999888889999999999999999999999963211 1111111111 000 011
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 538 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 538 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
.........+.+++..|++.+|++||++.++.+.|...
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~ 252 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP 252 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcCh
Confidence 11112346789999999999999999887776666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=287.36 Aligned_cols=246 Identities=21% Similarity=0.278 Sum_probs=190.4
Q ss_pred HHHhcCCCcCcee--eeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCc
Q 007020 292 QVATDSFSNKNIL--GRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTE 367 (621)
Q Consensus 292 ~~~~~~~~~~~~l--G~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 367 (621)
....+.|+..+.+ |+|+||.||++... ++..+|+|.+....... .|+.....+ +|+||+++++.+...+.
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 3344566666666 99999999999864 68889999986532211 122222222 69999999999999999
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-cEEEccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGL 446 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGl 446 (621)
.++||||+++|+|.+++.... .+++..+..++.|+++||+|||+. +++||||||+||+++.++ .++|+|||+
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 999999999999999997653 489999999999999999999999 999999999999999998 999999999
Q ss_pred ceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcc
Q 007020 447 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (621)
+....... ...++..|+|||++.+..++.++||||||+++|||++|+.||..... ......++.....
T Consensus 157 ~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~---- 224 (267)
T PHA03390 157 CKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED---EELDLESLLKRQQ---- 224 (267)
T ss_pred ceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc---chhhHHHHHHhhc----
Confidence 87654321 23588999999999988899999999999999999999999963221 1112222222110
Q ss_pred cccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 007020 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-MSEVVR 570 (621)
Q Consensus 527 ~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-~~~vl~ 570 (621)
... .........+.+++..|++.+|.+||+ ++++++
T Consensus 225 -~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 -KKL-------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -ccC-------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 000 011123467899999999999999996 688874
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=293.43 Aligned_cols=250 Identities=24% Similarity=0.320 Sum_probs=198.4
Q ss_pred eeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCch
Q 007020 304 LGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 380 (621)
Q Consensus 304 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 380 (621)
||+|+||.||++... +|+.||+|.+..... ......+.+|++++++++|+||+++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999865432 23445688999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCC-----
Q 007020 381 ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT----- 455 (621)
Q Consensus 381 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~----- 455 (621)
.+++.... .+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99997643 388999999999999999999999 999999999999999999999999999875433211
Q ss_pred --eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCc
Q 007020 456 --HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533 (621)
Q Consensus 456 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 533 (621)
.......++..|+|||.......+.++||||||+++|++++|+.||..... ......... ... ..+
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~---~~~ 221 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP--------EEIFQNILN-GKI---EWP 221 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhc-CCc---CCC
Confidence 122334578899999999888889999999999999999999999963221 111111111 000 000
Q ss_pred cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCC
Q 007020 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGL 577 (621)
Q Consensus 534 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 577 (621)
. .......+.+++..|++.+|++|||+..+.+.|+...+
T Consensus 222 ~-----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~ 260 (265)
T cd05579 222 E-----DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260 (265)
T ss_pred c-----cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccc
Confidence 0 00124678899999999999999999777777766443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=293.57 Aligned_cols=255 Identities=23% Similarity=0.399 Sum_probs=195.1
Q ss_pred HhcCCCcCceeeeccCceEEEEEcCC-CcEEEEEEecccCCchhHHHHHHHHHHHHhcc-CCceeeeeeeeecCCceEEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 371 (621)
..++|+..+.||+|+||.||+|.+.+ ++.||||.++..........+..|+.++.... |+||+++++++.++...+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34677888999999999999999764 89999999976544444556677777666665 99999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+.+ ++.+++..... .+++..+..++.|++.||+|||+.. +|+||||+|+||++++++.+||+|||++....
T Consensus 93 ~e~~~~-~l~~l~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 93 MELMST-CLDKLLKRIQG---PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eeccCc-CHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 999864 77776655322 4889999999999999999999732 89999999999999999999999999987654
Q ss_pred cCCCeeeecccccccccchhhhccCC----CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
.... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||..... . .+......... .
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~---~~~~~~~~~~~-~ 236 (296)
T cd06618 167 DSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT----E---FEVLTKILQEE-P 236 (296)
T ss_pred CCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh----H---HHHHHHHhcCC-C
Confidence 3221 12234788999999987654 78899999999999999999999953211 0 11111111111 0
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
..... ......++.+++.+||+.+|++||++.++++.
T Consensus 237 ~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 PSLPP-------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000 01123678999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=295.16 Aligned_cols=260 Identities=25% Similarity=0.324 Sum_probs=190.2
Q ss_pred ceeeeccCceEEEEEcCCCcEEEEEEeccc-CCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCch
Q 007020 302 NILGRGGFGKVYKGRLADGSLVAVKRLKEE-RTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 380 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 380 (621)
+.+|.|+++.||++.. +++.||||+++.. ........+.+|+++++.++|+||+++++++.+.+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3345555555555555 6899999999765 2344556799999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCC-----
Q 007020 381 ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT----- 455 (621)
Q Consensus 381 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~----- 455 (621)
.+++...... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 87 ~~~l~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 87 EDLLKTHFPE--GLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999864322 378889999999999999999999 999999999999999999999999998875532211
Q ss_pred -eeeecccccccccchhhhccC--CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh----hc---
Q 007020 456 -HVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK----EK--- 525 (621)
Q Consensus 456 -~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~----~~--- 525 (621)
.......++..|+|||++.+. .++.++|||||||++|||++|+.||...... ....+.+.+... ..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT----QMLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccCccccccCchh
Confidence 111233477889999998763 5788999999999999999999999632111 001010000000 00
Q ss_pred ----cccc----ccCcc----ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 526 ----KLEM----LVDPD----LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 526 ----~~~~----~~d~~----~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.... ..++. ...........++.+++..||+.+|++|||++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 00000 0111122334678899999999999999999999763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=289.84 Aligned_cols=260 Identities=22% Similarity=0.288 Sum_probs=198.9
Q ss_pred CCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc-hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEecc
Q 007020 298 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 375 (621)
Q Consensus 298 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 375 (621)
|...+.||+|++|.||+|... +++.+++|.++..... .....+..|+.+++.++|+||+++++++..++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 556788999999999999875 6889999998754432 34457888999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCC
Q 007020 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 455 (621)
++ +|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 86 8888877643 2488999999999999999999999 99999999999999999999999999998765433
Q ss_pred eeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhh---ccccccc
Q 007020 456 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE---KKLEMLV 531 (621)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 531 (621)
.......++..|+|||.+.+. ..+.++||||||+++|+|++|+.||...... .....+...... .......
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-----DQLFKIFRTLGTPDPEVWPKFT 227 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHcCCCchHhcccch
Confidence 122234578899999999877 6889999999999999999999999532210 000000000000 0000000
Q ss_pred C---------cc----ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 532 D---------PD----LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 532 d---------~~----~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
+ +. ...........++.+++..||+.||.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 00 001112234578999999999999999999999976
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=292.73 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=195.9
Q ss_pred CCCcCceeeeccCceEEEEEc----CCCcEEEEEEecccCC---chhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCce
Q 007020 297 SFSNKNILGRGGFGKVYKGRL----ADGSLVAVKRLKEERT---PGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 368 (621)
+|++.+.||+|+||.||++.. .+|+.||+|+++.... ......+..|+.++..+ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 367788999999999999985 3688999999875321 22345678899999999 599999999999999999
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
++||||+++++|.+++.... ++++..+..++.|+++||.|||+. +++||||+|+||+++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999987643 378889999999999999999999 99999999999999999999999999998
Q ss_pred ecccCCCeeeecccccccccchhhhccC--CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcc
Q 007020 449 LMDYKDTHVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (621)
..............|+..|+|||.+.+. .++.++||||||+++|+|++|..||..... ......+........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~----~~~~~~~~~~~~~~~- 228 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE----KNSQAEISRRILKSE- 228 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc----cccHHHHHHHhhccC-
Confidence 7544332233345588999999998753 467899999999999999999999963211 111122222211110
Q ss_pred cccccCccccCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007020 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 570 (621)
Q Consensus 527 ~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~ 570 (621)
+. +.......+.+++..|++.+|++|| ++++++.
T Consensus 229 ------~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 ------PP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ------CC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 11 1112336788999999999999997 5666643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=292.36 Aligned_cols=262 Identities=22% Similarity=0.317 Sum_probs=194.2
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
++|+..+.||+|++|+||+|... +|+.||+|.++.... ......+.+|+++++.++|+||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999875 688999999865432 2234568889999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-CCcEEEcccccceeccc
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfGla~~~~~ 452 (621)
|+++ +|.+++..... ..+++..+..++.||+.||+|||++ +++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLDL-DLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred cccc-cHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 9964 78887765432 2367888899999999999999999 9999999999999985 56799999999976543
Q ss_pred CCCeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
... ......++..|+|||.+.+. .++.++||||||+++|+|+||+.||...... ........ ... .......
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~----~~~~~~~~-~~~-~~~~~~~ 228 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI----DELFKIFR-ILG-TPNEETW 228 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHH-HhC-CCChhhc
Confidence 211 12233578899999998764 5788999999999999999999999532110 00000000 000 0000000
Q ss_pred ------------CccccC----cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 532 ------------DPDLQN----NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 532 ------------d~~~~~----~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.+.... .........+.+++..|++.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 001122356889999999999999999999986
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=294.46 Aligned_cols=263 Identities=26% Similarity=0.364 Sum_probs=194.8
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc-hhHHHHHHHHHHHHhccCCceeeeeeeeecC--CceEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLL 370 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 370 (621)
.++|+..+.||+|+||.||+|... +|+.||+|.++..... .....+.+|+.+++.++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467888999999999999999865 6899999998754322 2233467899999999999999999998755 56799
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
||||+.+ +|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999975 8888876532 2488999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcc---
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK--- 526 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 526 (621)
...... .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||..... .....-+........
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~-----~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07845 159 GLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE-----IEQLDLIIQLLGTPNESI 232 (309)
T ss_pred CCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhcCCCChhh
Confidence 533211 222335788999999875 4578999999999999999999999963211 111111111000000
Q ss_pred ---------cccccCccccCcc----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 527 ---------LEMLVDPDLQNNY----VEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 527 ---------~~~~~d~~~~~~~----~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
......+...... .......+.+++..|++.||++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000000 0112466788999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=290.19 Aligned_cols=243 Identities=22% Similarity=0.347 Sum_probs=193.9
Q ss_pred ceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCch
Q 007020 302 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 380 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 380 (621)
..||+|+||.||++... +++.||+|.+.... ......+.+|+.+++.++|+||+++++++...+..+++|||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 56999999999999864 68999999885432 33455688999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeeeec
Q 007020 381 ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 460 (621)
Q Consensus 381 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 460 (621)
.+++... .+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++........ ....
T Consensus 105 ~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~ 175 (292)
T cd06657 105 TDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 175 (292)
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence 9987543 278889999999999999999999 999999999999999999999999999876543221 2233
Q ss_pred ccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCccc
Q 007020 461 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 540 (621)
Q Consensus 461 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 540 (621)
..|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... .+.+...... ..+.+.. .
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--------~~~~~~~~~~------~~~~~~~--~ 239 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRDN------LPPKLKN--L 239 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhh------CCcccCC--c
Confidence 4588999999999888889999999999999999999999852211 1111111100 0111100 1
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 541 EAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 541 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
......+.+++..|++.+|.+||++.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 112356788999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=294.41 Aligned_cols=248 Identities=30% Similarity=0.420 Sum_probs=193.7
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.|+..+.||+|+||.||+|... +++.+|+|.+.... ......++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 4666678999999999999865 67889999986432 22334467889999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+. |++.+.+.... .++++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 997 58887775432 2378899999999999999999999 9999999999999999999999999998765432
Q ss_pred CCeeeecccccccccchhhhc---cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
....++..|+|||.+. ...++.++|||||||++|+|++|+.||..... ...........
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~----- 230 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNE----- 230 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH--------HHHHHHHhhcC-----
Confidence 2235788999999985 34578899999999999999999999852110 01111111110
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 573 (621)
.+... .......+.+++.+||+.+|++||++.+++..-.
T Consensus 231 -~~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 231 -SPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred -CCCcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 01111 1123467889999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.71 Aligned_cols=264 Identities=20% Similarity=0.317 Sum_probs=196.9
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeec----CCce
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTER 368 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 368 (621)
.++|+..+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888999999999999999865 689999999875432 2334567789999999999999999998753 3467
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
++||||+. |+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999996 58988886543 288999999999999999999999 99999999999999999999999999997
Q ss_pred ecccCCCe---eeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhh
Q 007020 449 LMDYKDTH---VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 524 (621)
Q Consensus 449 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 524 (621)
........ ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .....+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-----~~~~~~~~~~g~ 230 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-----HQLKLILSVLGS 230 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-----HHHHHHHHHhCC
Confidence 65432211 1223468899999999865 45789999999999999999999999532210 000110000000
Q ss_pred -----------cccccc---cCcccc---CcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 525 -----------KKLEML---VDPDLQ---NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 525 -----------~~~~~~---~d~~~~---~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
..+... ...... ..........+.+++..|++.+|++||++++++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000 000000 00112235779999999999999999999998763
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=289.64 Aligned_cols=261 Identities=25% Similarity=0.354 Sum_probs=194.7
Q ss_pred CCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc-hhHHHHHHHHHHHHhc---cCCceeeeeeeeecCCc-----
Q 007020 298 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMA---VHRNLLRLRGFCMTPTE----- 367 (621)
Q Consensus 298 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 367 (621)
|+..+.||+|+||.||+|+.. +++.||+|.++..... .....+.+|+.++.++ .|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566788999999999999976 4899999999754332 2234566787776655 59999999999988776
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
.+++|||+.+ +|.+++..... ..+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999985 89888876432 2488999999999999999999999 9999999999999999999999999999
Q ss_pred eecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
........ .....++..|+|||++.+..++.++||||||+++|||++|..||..... ......+..........
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 228 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE----ADQLDKIFDVIGLPSEE 228 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh----HHHHHHHHHHcCCCChH
Confidence 87643321 1223478899999999988899999999999999999999999863221 11111111111000000
Q ss_pred c---------cccCcccc---CcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 528 E---------MLVDPDLQ---NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 528 ~---------~~~d~~~~---~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. ........ .....+....+.+++..||+.||++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 00000000 1111233467789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=281.81 Aligned_cols=248 Identities=26% Similarity=0.456 Sum_probs=201.5
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc-hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
+|+..+.||+|++|.||++... +++.||+|.+...... .....+.+|++++++++|+|++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777899999999999999865 6789999998765432 3455789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKFG----PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999999987652 389999999999999999999999 99999999999999999999999999998765433
Q ss_pred CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
.. .....++..|+|||...+...+.++||||+|+++|+|++|..||.... ....... ... . ..+.
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-------~~~~~~~-~~~-~-----~~~~ 218 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN-------PMAALFR-IVQ-D-----DHPP 218 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHH-Hhc-c-----CCCC
Confidence 22 233458889999999988888999999999999999999999996321 0111111 110 0 0011
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. .......+.+++..|+..+|++||++.+++.
T Consensus 219 ~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 L----PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred C----CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1 1122367889999999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=288.60 Aligned_cols=265 Identities=25% Similarity=0.355 Sum_probs=197.1
Q ss_pred CCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-CCceeeeeeeeecCCceEEEEecc
Q 007020 298 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYM 375 (621)
Q Consensus 298 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 375 (621)
|...+.||+|+||+||+|... +++.||+|.+.............+|+..+.+++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566788999999999999975 578899999876543333444567899999999 999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCC
Q 007020 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 455 (621)
+|+|.+++.... ...+++..+..++.|++.+|.|||++ +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 779999887654 22479999999999999999999999 999999999999999999999999999986543222
Q ss_pred eeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCC--------CcchHHHHHHHHhhhcc
Q 007020 456 HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLAND--------DDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~--------~~~~~~~~~~~~~~~~~ 526 (621)
.....++..|+|||++.+ ..++.++|+||||+++|||++|+.||........ .......|.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 223457889999998854 4578999999999999999999999953211000 00000112111111111
Q ss_pred cccccCcccc---CcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 527 LEMLVDPDLQ---NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 527 ~~~~~d~~~~---~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.......... ..........+.+++..||+.+|++|||++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 1111100000 0001111367889999999999999999999976
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=286.21 Aligned_cols=251 Identities=25% Similarity=0.353 Sum_probs=196.6
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC----CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER----TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
+|.+.+.||+|+||.||++... .+..+++|.++... ......++..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778899999999999999865 34556666665322 223344577899999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||||+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999876433344589999999999999999999999 9999999999999976 569999999987654
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
... .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.... ........... .
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--------~~~~~~~~~~~------~ 221 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--------FLSVVLRIVEG------P 221 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHcC------C
Confidence 322 22233458889999999988888999999999999999999999985211 11221111110 1
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.+.. .......+.+++.+|++.+|++||++.++++
T Consensus 222 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 TPSL----PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCC----cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1111 2234467889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=292.71 Aligned_cols=264 Identities=23% Similarity=0.330 Sum_probs=192.9
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCC------
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 366 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 366 (621)
-++|+..+.||+|+||.||+|... +++.||||.+..... ......+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 356888999999999999999865 689999999865432 222335678999999999999999999987654
Q ss_pred --ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccc
Q 007020 367 --ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 444 (621)
Q Consensus 367 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 444 (621)
..++||||+.+ +|.+++.... ..+++.++..++.|++.||+|||++ +++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 34999999975 7888776542 2388999999999999999999999 9999999999999999999999999
Q ss_pred ccceecccCCCe---eeecccccccccchhhhccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH
Q 007020 445 GLAKLMDYKDTH---VTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 520 (621)
Q Consensus 445 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 520 (621)
|++......... ......++..|+|||.+.+.. ++.++||||||+++|||++|..||..... ......+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~-----~~~~~~~~~ 238 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE-----QHQLTLISQ 238 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHH
Confidence 999865432221 112334788899999886654 68899999999999999999999863221 011111111
Q ss_pred Hhh---hccc---------ccccCccccCcccH------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 521 LLK---EKKL---------EMLVDPDLQNNYVE------AEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 521 ~~~---~~~~---------~~~~d~~~~~~~~~------~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
... .... .....+.-...... .....+.+++..|+..+|++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 100 0000 00000000000000 01245678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=289.18 Aligned_cols=242 Identities=28% Similarity=0.353 Sum_probs=185.9
Q ss_pred eeeeccCceEEEEEcC-CCcEEEEEEecccCCc--hhHHHHHHHHH---HHHhccCCceeeeeeeeecCCceEEEEeccC
Q 007020 303 ILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVE---MISMAVHRNLLRLRGFCMTPTERLLVYPYMA 376 (621)
Q Consensus 303 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 376 (621)
.||+|+||.||+|... +++.||+|.+...... .....+..|.. .++...||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 5889999998654322 11222334433 3445679999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCe
Q 007020 377 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 456 (621)
Q Consensus 377 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 456 (621)
+|+|.+++.... .+++..++.++.|+++||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 999999886532 389999999999999999999999 99999999999999999999999999987543222
Q ss_pred eeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccc
Q 007020 457 VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 535 (621)
Q Consensus 457 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 535 (621)
.....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||........ ... ..... ..+..+
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-----~~~-~~~~~------~~~~~~ 218 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEI-DRMTL------TMAVEL 218 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-----HHH-HHHhh------ccCCCC
Confidence 1234589999999999754 578999999999999999999999964321111 010 00000 011111
Q ss_pred cCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007020 536 QNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 570 (621)
Q Consensus 536 ~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~ 570 (621)
.. .....+.+++..|+..+|.+|| ++.++++
T Consensus 219 ~~----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 PD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CC----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 11 1246788999999999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=274.49 Aligned_cols=252 Identities=22% Similarity=0.258 Sum_probs=197.5
Q ss_pred hcCCCcC-ceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeeec----CCc
Q 007020 295 TDSFSNK-NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMT----PTE 367 (621)
Q Consensus 295 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 367 (621)
+++|++. ++||-|-.|.|..+..+ +++.+|+|++.... ..++|+++.-.. .|||||.++++|.. ...
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP------KARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH------HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 4556543 58999999999999865 78999999986432 245788875544 59999999998764 356
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---CCcEEEccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDF 444 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Df 444 (621)
+++|||.|+||.|++.+++++. ..+.+.++..|+.||+.|+.|||+. +|.||||||+|+|.+. +..+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence 7899999999999999998764 3489999999999999999999999 9999999999999964 457999999
Q ss_pred ccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhh
Q 007020 445 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 524 (621)
Q Consensus 445 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 524 (621)
|+|+.... .......+-|+.|.|||++...+|+...|+||+||++|-|++|.+||..... ..+..=++..++.
T Consensus 209 GFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-----~aispgMk~rI~~ 281 (400)
T KOG0604|consen 209 GFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----LAISPGMKRRIRT 281 (400)
T ss_pred ccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-----ccCChhHHhHhhc
Confidence 99986442 2334456689999999999988999999999999999999999999963221 1111111222221
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 525 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 525 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.. . .+....+...++...++++..+..+|.+|.|+.+++.
T Consensus 282 gq-y-----~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 282 GQ-Y-----EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred cC-c-----cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 11 1 1223345566778889999999999999999999975
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=272.47 Aligned_cols=256 Identities=21% Similarity=0.292 Sum_probs=193.4
Q ss_pred ceeeeccCceEEEEE-cCCCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-CCceeeeeeeeecCCceEEEEeccCCCc
Q 007020 302 NILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYMANGS 379 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 379 (621)
++||+|+|+.|-.+. ..+|..||||++.+. ....+.++.+|++++...+ |+||+.++++|.++..+|||||-|.||.
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 679999999999987 568999999999766 3455667889999998875 9999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC---cEEEcccccceecccCC--
Q 007020 380 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAKLMDYKD-- 454 (621)
Q Consensus 380 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~DfGla~~~~~~~-- 454 (621)
|...|+++.. +++.++.++..+|+.||.|||.+ ||.|||+||+|||-.... -+||+||.++.-.....
T Consensus 163 lLshI~~~~~----F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 163 LLSHIQKRKH----FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred HHHHHHHhhh----ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 9999987654 99999999999999999999999 999999999999997554 48999998875432111
Q ss_pred ----Ceeeecccccccccchhhhc-----cCCCCCcccchhHHHHHHHHHhCCCCcccc---cccCCCcchHHHHHHHHh
Q 007020 455 ----THVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLA---RLANDDDVMLLDWVKGLL 522 (621)
Q Consensus 455 ----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~---~~~~~~~~~~~~~~~~~~ 522 (621)
.......+|+..|||||+.. ...|+.+.|.||+|||+|-|++|.+||... +-..+.+..-..-
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~C----- 310 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVC----- 310 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHH-----
Confidence 11223456999999999873 345789999999999999999999999621 1111111111000
Q ss_pred hhcccccccCcc--ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 523 KEKKLEMLVDPD--LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 523 ~~~~~~~~~d~~--~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
++.-.+.+-+.. +....+...+.+..+++...+..++.+|.++.+++.
T Consensus 311 Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 311 QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 000111111111 111223334455666777777899999999998886
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=296.41 Aligned_cols=262 Identities=21% Similarity=0.311 Sum_probs=196.0
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecC-----Cc
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TE 367 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 367 (621)
.++|...+.||+|+||+||+|... +++.||||.++... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357888899999999999999864 68999999986532 222344677899999999999999999987644 34
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
.++++||+. ++|.+++.... .+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 58888886543 388999999999999999999999 9999999999999999999999999999
Q ss_pred eecccCCCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh---
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--- 523 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--- 523 (621)
....... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...... .....+.....
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~ 229 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-----HQLKLITELLGSPS 229 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-----HHHHHHHHHhCCCC
Confidence 8654332 22233457889999998865 46889999999999999999999999632110 00000000000
Q ss_pred --------hcc-------cccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 524 --------EKK-------LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 524 --------~~~-------~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
... .....++... ........++.+++.+|++.+|++|||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 230 EEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000 0000000000 0011234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=328.49 Aligned_cols=251 Identities=28% Similarity=0.381 Sum_probs=199.5
Q ss_pred CCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCc-hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 297 SFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
++.....||.|.||.||.|.. .+|...|+|-++..... .....+.+|+.++..++|||+|+++|+-...+..++.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 455677899999999999985 57999999988654322 2334688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
|++|+|.+.+..... .++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|.......
T Consensus 1316 C~~GsLa~ll~~gri----~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRI----EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred hccCcHHHHHHhcch----hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 999999999986543 56667778899999999999999 99999999999999999999999999998775443
Q ss_pred Ce---eeecccccccccchhhhccCC---CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 455 TH---VTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 455 ~~---~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
.. ......||+.|||||++.+.. ...++||||+|||+.||+||++||..-+ + .|.-...
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d--n-------e~aIMy~------ 1453 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD--N-------EWAIMYH------ 1453 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc--c-------hhHHHhH------
Confidence 22 223456999999999997654 4678999999999999999999996221 1 2221110
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
+--.-.++.+.....+-.+++..|+..||++|.++.|+++.
T Consensus 1454 --V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1454 --VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 00011222344455677889999999999999998887653
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=275.35 Aligned_cols=272 Identities=22% Similarity=0.313 Sum_probs=199.5
Q ss_pred hcCCCcCceeeeccCceEEEEEcCC-----CcEEEEEEecccCCchh-HHHHHHHHHHHHhccCCceeeeeeeeec-CCc
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLAD-----GSLVAVKRLKEERTPGG-ELQFQTEVEMISMAVHRNLLRLRGFCMT-PTE 367 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 367 (621)
...|+....||+|.||.||+|..++ .+.||+|.++..+.... ....-+|+.+++.++||||+.+..++.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3568888999999999999996432 34799999987643222 2346789999999999999999999887 788
Q ss_pred eEEEEeccCCCchhhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC----CcEEEc
Q 007020 368 RLLVYPYMANGSVASCLRERP-PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE----FEAVVG 442 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~----~~~kl~ 442 (621)
.++++||.+. +|...|+-.. .....++...++.|+.||+.|+.|||++ =|+||||||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 8999999998 8888886532 2234588889999999999999999999 79999999999999887 899999
Q ss_pred ccccceecccCCCe--eeecccccccccchhhhccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCc-chHHHHH
Q 007020 443 DFGLAKLMDYKDTH--VTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDD-VMLLDWV 518 (621)
Q Consensus 443 DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~~ 518 (621)
|||+|+.+...-.. ....++-|..|.|||.+.+.. |+++.||||.|||+.||+|-++.|.......... ....+.+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99999987654322 334566899999999998865 7999999999999999999998886443322221 1222222
Q ss_pred HHHhhh---cccccccC----ccc-------cCcccHH------------HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 519 KGLLKE---KKLEMLVD----PDL-------QNNYVEA------------EVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 519 ~~~~~~---~~~~~~~d----~~~-------~~~~~~~------------~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.++.+- ..-+...+ |+. ...+... ....-++++..++..||.+|.|+++.++
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 222211 00000000 000 0000000 0123678889999999999999988754
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=291.19 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=201.0
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhcc-CCceeeeeeeeecCCceEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 371 (621)
++|...+.||+|+||.||+|... +++.||+|++.... .......+..|.+++.+++ |+||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999865 78999999986532 2233456888999999998 99999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999998653 389999999999999999999999 99999999999999999999999999988654
Q ss_pred cCCC-------------------eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcc
Q 007020 452 YKDT-------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDV 512 (621)
Q Consensus 452 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~ 512 (621)
.... .......++..|+|||...+...+.++||||||++++++++|..||.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------ 227 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------ 227 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH------
Confidence 3321 122234578899999999888889999999999999999999999963320
Q ss_pred hHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCH----HHHHH
Q 007020 513 MLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM----SEVVR 570 (621)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~----~~vl~ 570 (621)
......... ... .........+.+++..|++.+|++||++ +++++
T Consensus 228 --~~~~~~~~~---~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 228 --YLTFQKILK---LEY--------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --HHHHHHHHh---cCC--------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 011111110 000 1111224678899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=294.60 Aligned_cols=261 Identities=21% Similarity=0.302 Sum_probs=198.9
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCC-----ceE
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-----ERL 369 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 369 (621)
+|.+.+.||+|+||.||+|... +++.||+|.+..... ......+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999975 589999999875432 334457889999999999999999999988775 789
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
++|||+++ +|.+++.... ++++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~~-~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchhh-hHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 99999985 8988887543 489999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCC--eeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhh--
Q 007020 450 MDYKDT--HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE-- 524 (621)
Q Consensus 450 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 524 (621)
...... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...... .....+......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~~~~ 227 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI-----DQLNLIVEVLGTPS 227 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH-----HHHHHHHHhcCCCC
Confidence 654321 122334578899999999887 7899999999999999999999999532210 000000000000
Q ss_pred ---------cccccccC---ccc---cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 525 ---------KKLEMLVD---PDL---QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 525 ---------~~~~~~~d---~~~---~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
........ ... ...........+.+++..||+.+|++||++++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 00000000 000 00001113467889999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=295.04 Aligned_cols=267 Identities=23% Similarity=0.313 Sum_probs=196.7
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeec-CCce
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTER 368 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 368 (621)
...+++|+..+.||+|+||.||+|... +++.||+|.+.... .......+..|++++..++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999855 78999999886432 22344567889999999999999999998865 4678
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
++++||+. ++|.+++... ++++..+..++.|+++||+|||+. +|+||||+|+||++++++.++|+|||++.
T Consensus 86 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELLG-TDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehhc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 99999984 5898887643 277788889999999999999999 99999999999999999999999999987
Q ss_pred ecccCCCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCC-------CcchHHHHHHH
Q 007020 449 LMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLAND-------DDVMLLDWVKG 520 (621)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~-------~~~~~~~~~~~ 520 (621)
..... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ .+....+|...
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54321 122347889999998766 5688999999999999999999999953221000 00000111111
Q ss_pred HhhhcccccccCccccCcc-----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 521 LLKEKKLEMLVDPDLQNNY-----VEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 521 ~~~~~~~~~~~d~~~~~~~-----~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
............-...... .......+.+++..|++.+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111110000000000000 01123678899999999999999999998653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=291.16 Aligned_cols=245 Identities=29% Similarity=0.424 Sum_probs=191.7
Q ss_pred CCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 298 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 298 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
|...+.||+|+||+||+|+.. +++.||+|.+..... ......+..|+++++.++|+|++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999864 688999999864432 22334688899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+. |++.+++.... .++++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 96 47777776432 2488999999999999999999999 999999999999999999999999999864322
Q ss_pred Ceeeecccccccccchhhhc---cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 455 THVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
.....|+..|+|||++. ...++.++||||||+++|+|++|..||.... . ...+.......
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~-----~---~~~~~~~~~~~------ 236 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----A---MSALYHIAQND------ 236 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----h---HHHHHHHHhcC------
Confidence 12345888999999984 3567889999999999999999999985321 1 11111111111
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.+... .......+.+++..|++.+|.+||++.+++..
T Consensus 237 ~~~~~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 237 SPTLQ---SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111 11123568889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=295.52 Aligned_cols=267 Identities=21% Similarity=0.306 Sum_probs=195.5
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhc-cCCceeeeeeeeecC--CceE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP--TERL 369 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~ 369 (621)
.++|+..+.||+|+||.||+|... +++.||+|.+.... .......+.+|+.+++.+ +|+||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 467888899999999999999865 68899999885432 223344577899999999 999999999998654 3679
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+||||+++ +|..++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 86 lv~e~~~~-~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 86 LVFEYMET-DLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEeccccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999985 999888753 378889999999999999999999 999999999999999999999999999986
Q ss_pred cccCCC----eeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCC-----------Ccch
Q 007020 450 MDYKDT----HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLAND-----------DDVM 513 (621)
Q Consensus 450 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~-----------~~~~ 513 (621)
...... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 543322 12233458899999998765 4578899999999999999999999953211000 0000
Q ss_pred HHHHHHHHhhhcccccccCccc--cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 514 LLDWVKGLLKEKKLEMLVDPDL--QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~d~~~--~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
...+ ........+........ ...........+.+++..||+.+|++|||+.++++.
T Consensus 237 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESI-KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHH-HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000 00000000000000000 000111134678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=277.30 Aligned_cols=266 Identities=24% Similarity=0.330 Sum_probs=215.7
Q ss_pred HHHHHHHhcCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeee
Q 007020 288 LRELQVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 361 (621)
Q Consensus 288 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 361 (621)
.+++.+...+++...++.+|.||.||+|.|. +.+.|-||.++....+-+...+..|.-++..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4567777888999999999999999999654 3456888998877777677778899999999999999999999
Q ss_pred eecC-CceEEEEeccCCCchhhhhccCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC
Q 007020 362 CMTP-TERLLVYPYMANGSVASCLRERP----PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 436 (621)
Q Consensus 362 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~ 436 (621)
+.++ +..+++|.++.-|+|..++.... .....+...+...++.|++.|++|||+. +|||.||..+|++|++.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 8654 67799999999999999998321 2233467778899999999999999999 99999999999999999
Q ss_pred CcEEEcccccceecccCCCeee-ecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchH
Q 007020 437 FEAVVGDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVML 514 (621)
Q Consensus 437 ~~~kl~DfGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~ 514 (621)
.++||+|-.+++.+...+.+.. ........||+||.+....++.++|||||||+||||+| |+.|+..-++. .+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf-----Em 507 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF-----EM 507 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH-----HH
Confidence 9999999999997765554432 33446789999999999999999999999999999999 99998522211 11
Q ss_pred HHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 515 LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 515 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
..+ ..++..+ ..+-+++.+++.+|.-||..+|++||+++|++.-|.+
T Consensus 508 ~~y---lkdGyRl----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 508 EHY---LKDGYRL----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHH---Hhcccee----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 111 1111111 1244677899999999999999999999999998876
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=291.62 Aligned_cols=264 Identities=24% Similarity=0.316 Sum_probs=192.1
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc-hhHHHHHHHHHHHHhccCCceeeeeeeeecCC------
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 366 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 366 (621)
.++|++.+.||+|+||.||+|... +++.||+|.+...... .....+.+|+++++.++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468889999999999999999865 6889999998654322 22345678999999999999999999875433
Q ss_pred --ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccc
Q 007020 367 --ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 444 (621)
Q Consensus 367 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 444 (621)
..++|+||+.+ ++...+.... ..+++..+..++.|+++||+|||+. +|+|+||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 46999999976 6776665432 2489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecccCCCe----------eeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcch
Q 007020 445 GLAKLMDYKDTH----------VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 513 (621)
Q Consensus 445 Gla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~ 513 (621)
|++......... ......++..|+|||.+.+. .++.++||||||+++|||++|++||...... .
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-----~ 234 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-----D 234 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-----H
Confidence 999765432211 11233468889999988654 4789999999999999999999999532211 0
Q ss_pred HHHHHHHHhhh---------ccccc----ccCccccCc---ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 514 LLDWVKGLLKE---------KKLEM----LVDPDLQNN---YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 514 ~~~~~~~~~~~---------~~~~~----~~d~~~~~~---~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
...-+...... ..+.. ......... ........+.+++..|++.+|++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000000 00000 000000000 00112256889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=285.80 Aligned_cols=260 Identities=27% Similarity=0.359 Sum_probs=197.3
Q ss_pred CCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEecc
Q 007020 298 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 375 (621)
Q Consensus 298 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 375 (621)
|+..+.||+|+||.||+|+.. +++.||+|.+.... .......+..|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456678999999999999976 58999999987654 2223456788999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCC
Q 007020 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 455 (621)
++ +|.+++.... ..+++..+..++.|++.||+|||+. +|+||||+|+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 DM-DLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred Cc-CHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 84 8999998653 2388999999999999999999999 999999999999999999999999999986543322
Q ss_pred eeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc---------
Q 007020 456 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK--------- 525 (621)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------- 525 (621)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||..... ......+.......
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE-----IDQLFKIFQILGTPTEESWPGVT 227 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHHHhCCCcHHHHHhhc
Confidence 12223467789999998776 788999999999999999999999953221 11111111100000
Q ss_pred cc--ccccCccccC----cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 526 KL--EMLVDPDLQN----NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 526 ~~--~~~~d~~~~~----~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.. ....-+.... .........+.+++..|+..+|++||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00 0000000000 001112467999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=292.78 Aligned_cols=261 Identities=24% Similarity=0.306 Sum_probs=193.3
Q ss_pred cCCC-cCceeeeccCceEEEEEcC-CCcEEEEEEecccCCch-------------hHHHHHHHHHHHHhccCCceeeeee
Q 007020 296 DSFS-NKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-------------GELQFQTEVEMISMAVHRNLLRLRG 360 (621)
Q Consensus 296 ~~~~-~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~niv~l~~ 360 (621)
++|. +.+.||+|+||+||+|... +++.||||.++...... ....+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 3467999999999999865 68999999986543221 0124678999999999999999999
Q ss_pred eeecCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEE
Q 007020 361 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV 440 (621)
Q Consensus 361 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 440 (621)
++...+..+++|||+. |+|.+++.... .+++.....++.|++.||+|||+. +|+|+||+|+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999997 58998886532 378899999999999999999999 999999999999999999999
Q ss_pred EcccccceecccCC-------------CeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccc
Q 007020 441 VGDFGLAKLMDYKD-------------THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARL 506 (621)
Q Consensus 441 l~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~ 506 (621)
|+|||++....... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999998654111 1111223467889999998764 368899999999999999999999963221
Q ss_pred cCCCcchHHHHHHHHhhhcccc---------------cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 507 ANDDDVMLLDWVKGLLKEKKLE---------------MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~---------------~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
......+.......... ....+... .........+.+++..|++.+|++||++++++.
T Consensus 240 -----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 -----IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred -----HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11111111111000000 00000000 001122467889999999999999999999976
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=291.14 Aligned_cols=266 Identities=21% Similarity=0.241 Sum_probs=196.4
Q ss_pred HHHHHHHhcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecC
Q 007020 288 LRELQVATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 365 (621)
Q Consensus 288 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 365 (621)
..++....++|...+.||+|+||.||+|.. .+++.||+|++..... ......+.+|+.++++++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 455666789999999999999999999985 4789999999865432 22344678899999999999999999987543
Q ss_pred ------CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcE
Q 007020 366 ------TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 439 (621)
Q Consensus 366 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 439 (621)
...+++++++ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 3467788876 67998887643 288899999999999999999999 99999999999999999999
Q ss_pred EEcccccceecccCCCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHH
Q 007020 440 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 518 (621)
Q Consensus 440 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 518 (621)
||+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...+...+
T Consensus 160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~----~~~~~~~~ 231 (345)
T cd07877 160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH----IDQLKLIL 231 (345)
T ss_pred EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Confidence 99999998754321 223457889999999876 4678899999999999999999999952211 01111110
Q ss_pred HHHhh--hccc---------------ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 519 KGLLK--EKKL---------------EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 519 ~~~~~--~~~~---------------~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
..... .... ......... .........+.+++..|++.||.+||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000 0000 000000000 0000123568899999999999999999988753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=294.63 Aligned_cols=262 Identities=22% Similarity=0.306 Sum_probs=190.4
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecC--------
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-------- 365 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 365 (621)
..+|...+.||.|+||.||+|... +|+.||+|.+..... .....+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 367888999999999999999864 688999999865443 3445688999999999999999999876543
Q ss_pred ------CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC-CCCc
Q 007020 366 ------TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD-EEFE 438 (621)
Q Consensus 366 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~ 438 (621)
...++||||+++ +|.+++... .+++..++.++.||++||+|||+. +|+||||||+||+++ +++.
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 83 GSLTELNSVYIVQEYMET-DLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred ccccccceEEEEeecccc-cHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCce
Confidence 357899999974 888887643 278899999999999999999999 999999999999997 4567
Q ss_pred EEEcccccceecccCCCe--eeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHH
Q 007020 439 AVVGDFGLAKLMDYKDTH--VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 515 (621)
Q Consensus 439 ~kl~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~ 515 (621)
+|++|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ...
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~----~~~ 229 (342)
T cd07854 154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE----QMQ 229 (342)
T ss_pred EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHH
Confidence 899999999865432111 1122347889999998754 457889999999999999999999996322100 000
Q ss_pred HHHHHH-----------hhhc--ccc-cccCccc-cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 516 DWVKGL-----------LKEK--KLE-MLVDPDL-QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 516 ~~~~~~-----------~~~~--~~~-~~~d~~~-~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
...... .... ... ....+.. ..........++.+++..|++.||++|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000 0000 000 0000000 00001122356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=282.64 Aligned_cols=245 Identities=24% Similarity=0.346 Sum_probs=197.6
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchh--HHHHHHHHHHHHhc-cCCceeeeeeeeecCCce
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGG--ELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 368 (621)
+...+|....+||+|+||+|.+|..+ +.+.||||++++....+. .+--+.|-++|+.. +-|.++.++..|+..+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 34457888899999999999999865 577899999987653222 22245566677655 468999999999999999
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
|+||||+.||+|.-.|++.+. +.++.+.-+|..||-||-+||++ ||++||||..|||++.+|++||+|||+++
T Consensus 426 yFVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccc
Confidence 999999999999999887654 78889999999999999999999 99999999999999999999999999998
Q ss_pred ecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 449 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
.-- -+...+...+||+.|+|||++..++|+..+|.|||||+||||+.|++||+..+ ++.....
T Consensus 499 Eni-~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD----E~elF~a------------ 561 (683)
T KOG0696|consen 499 ENI-FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED----EDELFQA------------ 561 (683)
T ss_pred ccc-cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHH------------
Confidence 532 23445667889999999999999999999999999999999999999997332 2222211
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCC
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK 564 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt 564 (621)
+.+.. -.++...+.+...+...-+.+.|.+|..
T Consensus 562 -I~ehn--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 562 -IMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -HHHcc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 11111 1233444577788888888999999973
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=289.34 Aligned_cols=263 Identities=22% Similarity=0.307 Sum_probs=193.9
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCC-----
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----- 366 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 366 (621)
..++|+..+.||+|+||.||+|... +++.||||.+..... ......+..|+.+++.++|+||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999854 789999999864332 223446789999999999999999999987553
Q ss_pred -ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccc
Q 007020 367 -ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 445 (621)
Q Consensus 367 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 445 (621)
..++||||+ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999998 67998887642 388999999999999999999999 99999999999999999999999999
Q ss_pred cceecccCCCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCC-------CcchHHHH
Q 007020 446 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLAND-------DDVMLLDW 517 (621)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~-------~~~~~~~~ 517 (621)
++...... .....++..|+|||.+.+ ..++.++|+||||+++|++++|+.||........ .......|
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 99764322 223357889999999876 4578899999999999999999999963211000 00000011
Q ss_pred HHHHhhhcccccccC--cccc----CcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 518 VKGLLKEKKLEMLVD--PDLQ----NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 518 ~~~~~~~~~~~~~~d--~~~~----~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
........ ...... +... ..........+.+++..|++.||++|||+.+++.
T Consensus 240 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 240 VQKLQSED-AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHhhcchh-HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11000000 000000 0000 0011122356889999999999999999999874
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=291.17 Aligned_cols=259 Identities=22% Similarity=0.327 Sum_probs=190.5
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecC------C
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------T 366 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 366 (621)
.++|...+.||+|+||.||+|... +|+.||+|.++.... ......+.+|+.+++.++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468888999999999999999864 689999999865332 22334678999999999999999999998654 3
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccc
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 446 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 446 (621)
..++|+||+.. +|..++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMGH------PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 45899999975 77665431 278899999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH-----
Q 007020 447 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG----- 520 (621)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~----- 520 (621)
++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+...+..
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~ 235 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL----DQLTQILKVTGVPG 235 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcCCCC
Confidence 8754322 123357889999999876 45788999999999999999999999632110 000000000
Q ss_pred -----HhhhcccccccC--cccc-Ccc---cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 521 -----LLKEKKLEMLVD--PDLQ-NNY---VEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 521 -----~~~~~~~~~~~d--~~~~-~~~---~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
............ +... ... .......+.+++..|++.||++||++++++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000000 0000 000 01123567899999999999999999999753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=287.30 Aligned_cols=245 Identities=23% Similarity=0.325 Sum_probs=197.7
Q ss_pred CceeeeccCceEEEEEcC-CCcEEEEEEecccCCc-hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCC
Q 007020 301 KNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 378 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 378 (621)
.++||+|.||+||-|+++ +|+.||||++.+.+-+ ..+.+++.|+.++..++||.||.+.-.|+.++..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 368999999999999865 7999999999776533 4456899999999999999999999999999999999999976
Q ss_pred chhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC---CcEEEcccccceecccCCC
Q 007020 379 SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLAKLMDYKDT 455 (621)
Q Consensus 379 sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DfGla~~~~~~~~ 455 (621)
++.+.|-..... .+++...+.++.||+.||.|||.+ +|||+||||+|||+... -.+||+|||+|++.+. .
T Consensus 648 DMLEMILSsEkg--RL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--k 720 (888)
T KOG4236|consen 648 DMLEMILSSEKG--RLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--K 720 (888)
T ss_pred hHHHHHHHhhcc--cchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch--h
Confidence 666665443322 388888999999999999999999 99999999999999654 4799999999998764 3
Q ss_pred eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccc
Q 007020 456 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 535 (621)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 535 (621)
.....++||+.|+|||++..+.|...-|+||.|||+|--++|..||+.... +.+.++.. .++-
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-------IndQIQNA-------aFMy--- 783 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-------INDQIQNA-------AFMY--- 783 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-------hhHHhhcc-------cccc---
Confidence 445678899999999999999999999999999999999999999973322 22222111 1111
Q ss_pred cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 536 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 536 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
....+.+.....+++|...++..=.+|-+.+.-+.
T Consensus 784 Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 784 PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 22234555667788888888888888888876554
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=290.55 Aligned_cols=256 Identities=23% Similarity=0.312 Sum_probs=194.1
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCc----
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE---- 367 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 367 (621)
..++|+..+.||+|+||.||+|... +++.||+|.+.... .......+.+|+.+++.++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567889999999999999999875 57899999986532 22233457789999999999999999998766554
Q ss_pred --eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccc
Q 007020 368 --RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 445 (621)
Q Consensus 368 --~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 445 (621)
.++|+||+ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 56999988752 389999999999999999999999 99999999999999999999999999
Q ss_pred cceecccCCCeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhh
Q 007020 446 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 524 (621)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 524 (621)
++...... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||..... .+.+......
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--------~~~~~~i~~~ 231 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH--------IDQLKRIMNL 231 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHh
Confidence 99865432 2234578899999998653 578899999999999999999999953211 0111111000
Q ss_pred c--------------ccccccC---ccccCcc---cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 525 K--------------KLEMLVD---PDLQNNY---VEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 525 ~--------------~~~~~~d---~~~~~~~---~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. .....+. ......+ .......+.+++..|++.+|++|||+.+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 232 VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred cCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0 0000000 0000000 0112467899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=288.38 Aligned_cols=265 Identities=20% Similarity=0.245 Sum_probs=189.4
Q ss_pred CCCcCceeeeccCceEEEEEcC-C--CcEEEEEEecccCC-chhHHHHHHHHHHHHhc-cCCceeeeeeeeec----CCc
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-D--GSLVAVKRLKEERT-PGGELQFQTEVEMISMA-VHRNLLRLRGFCMT----PTE 367 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 367 (621)
+|+..+.||+|+||.||++... . +..||+|.+..... ......+.+|+.+++++ .|+||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999865 3 77899999865322 22344678899999988 59999999987532 245
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
.++++||+. ++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 688889886 58988886533 388999999999999999999999 9999999999999999999999999999
Q ss_pred eecccCCCe---eeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCC-------cchHHH
Q 007020 448 KLMDYKDTH---VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD-------DVMLLD 516 (621)
Q Consensus 448 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-------~~~~~~ 516 (621)
......... ......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||......... +....+
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 865432211 1223458999999998765 46789999999999999999999999632210000 000000
Q ss_pred HHHHHhhhc------ccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 517 WVKGLLKEK------KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 517 ~~~~~~~~~------~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
+........ .........+ ..........+.+++.+|++.+|++|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPF-ESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcch-HhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 0000000000 0000112357889999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=273.18 Aligned_cols=237 Identities=28% Similarity=0.324 Sum_probs=192.4
Q ss_pred eeeccCceEEEEEcC-CCcEEEEEEecccCCc--hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCch
Q 007020 304 LGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 380 (621)
Q Consensus 304 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 380 (621)
||+|+||.||++... +++.||+|.++..... .....+..|+++++.++|+||+++++.+..++..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999875 5899999998765432 2455788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeeeec
Q 007020 381 ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 460 (621)
Q Consensus 381 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 460 (621)
.+++.... .+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 99997653 378999999999999999999998 99999999999999999999999999998754332 12334
Q ss_pred ccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCccc
Q 007020 461 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 540 (621)
Q Consensus 461 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 540 (621)
..++..|+|||...+...+.++|+||||+++|++++|..||..... .+....... .. ... +
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~----~~---~~~----~ 213 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILK----DP---LRF----P 213 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhc----CC---CCC----C
Confidence 4588899999999888889999999999999999999999963221 111122111 00 011 1
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHH
Q 007020 541 EAEVEQLIQVALLCTQGSPMDRPKMSE 567 (621)
Q Consensus 541 ~~~~~~l~~l~~~c~~~~P~~RPt~~~ 567 (621)
......+.+++..|+..||++||++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 111367889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=308.86 Aligned_cols=146 Identities=32% Similarity=0.428 Sum_probs=130.6
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|.+.+.||+|+||+||+|.+. +++.||||+++.... ......+..|+.++..++|+||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888899999999999999876 689999999975432 223456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
||+.+++|.+++.... .+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997643 278889999999999999999999 99999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=254.52 Aligned_cols=212 Identities=24% Similarity=0.359 Sum_probs=177.9
Q ss_pred cCHHHHHHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHH-hccCCceeeeeeeee
Q 007020 286 FSLRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMIS-MAVHRNLLRLRGFCM 363 (621)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~ 363 (621)
+..+.+++..+.......||+|++|.|-+.++. +|+..|+|+++.........+..+|+.+.. ....|.+|.++|...
T Consensus 36 I~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 36 IGDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred EecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 334446667777777788999999999888754 799999999987776666777888998854 457999999999999
Q ss_pred cCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcc
Q 007020 364 TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 443 (621)
Q Consensus 364 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 443 (621)
.....++.||.|.. ||..+-.+--..+..+++...-+|+..+..||.|||++. .++|||+||+|||++.+|+||+||
T Consensus 116 regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCD 192 (282)
T KOG0984|consen 116 REGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICD 192 (282)
T ss_pred ccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcc
Confidence 99999999999987 888877664445556888899999999999999999986 899999999999999999999999
Q ss_pred cccceecccCCCeeeecccccccccchhhhcc----CCCCCcccchhHHHHHHHHHhCCCCcc
Q 007020 444 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGIMLLELITGQRAFD 502 (621)
Q Consensus 444 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltg~~pf~ 502 (621)
||.+-.+.++ -..+.-.|...|||||.+.. ..|+.|+||||+|+.+.||.+++.||+
T Consensus 193 FGIsG~L~dS--iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 193 FGISGYLVDS--IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred cccceeehhh--hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 9998765432 12222458889999998853 368899999999999999999999996
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=272.11 Aligned_cols=219 Identities=20% Similarity=0.176 Sum_probs=174.8
Q ss_pred ccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCchhhhhc
Q 007020 307 GGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR 385 (621)
Q Consensus 307 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 385 (621)
|.||.||++... +++.||+|.++... .+..|...+....||||+++++++...+..+++|||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 889999999865 68999999986542 23344555555679999999999999999999999999999999987
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeeeecccccc
Q 007020 386 ERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 465 (621)
Q Consensus 386 ~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~ 465 (621)
... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++++|||.+...... .....++.
T Consensus 78 ~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~ 146 (237)
T cd05576 78 KFL----NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVEN 146 (237)
T ss_pred Hhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCc
Confidence 643 288999999999999999999999 9999999999999999999999999987654322 12234567
Q ss_pred cccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHH
Q 007020 466 GHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVE 545 (621)
Q Consensus 466 ~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 545 (621)
.|+|||.+.+..++.++||||+|+++|||++|+.||........ ....... +.....
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-------------------~~~~~~~----~~~~~~ 203 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-------------------THTTLNI----PEWVSE 203 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-------------------cccccCC----cccCCH
Confidence 89999999888889999999999999999999988752110000 0000001 111235
Q ss_pred HHHHHHHhccCCCCCCCCCH
Q 007020 546 QLIQVALLCTQGSPMDRPKM 565 (621)
Q Consensus 546 ~l~~l~~~c~~~~P~~RPt~ 565 (621)
.+.+++..|++.||++||++
T Consensus 204 ~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 204 EARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHHHccCCHHHhcCC
Confidence 78899999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=245.67 Aligned_cols=198 Identities=25% Similarity=0.400 Sum_probs=169.3
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCch-hHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
.|...++||+|.||+||+|+.. +++.||+|+++-..... ......+|+-+++.+.|.|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4556678999999999999865 68899999998654332 334578999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
|.. +|..+....... ++...++.++.|+++||.++|++ ++.|||+||.|.||+.+|+.|++|||+|+.++..-
T Consensus 83 cdq-dlkkyfdslng~---~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGD---LDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHhcCCc---CCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 987 888887765432 88899999999999999999999 99999999999999999999999999999877543
Q ss_pred CeeeecccccccccchhhhccCC-CCCcccchhHHHHHHHHHh-CCCCcc
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELIT-GQRAFD 502 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt-g~~pf~ 502 (621)
.. ....+-|..|.+|.++.+.. |+...|+||.|||+.|+.. |++.|.
T Consensus 156 rc-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 156 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred Ee-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 33 33345789999999998876 7889999999999999998 555553
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=289.42 Aligned_cols=239 Identities=22% Similarity=0.331 Sum_probs=191.9
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceEEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 372 (621)
+++|.....+|.|+|+.|-.+... +++..+||++.+... +-.+|+.++... +||||+++.+.+.+..+.|+||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 567778888999999999999864 688999999976522 234677665544 6999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee-CCCCcEEEcccccceecc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL-DEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill-~~~~~~kl~DfGla~~~~ 451 (621)
|.+.+|-+.+.+..... ....+..|+.+|+.|+.|||++ |||||||||+|||+ ++.++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~~~-----~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE-----FCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhcch-----hHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999999888876542 2267778999999999999999 99999999999999 688999999999998765
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
.. ....+-|..|.|||++....+++++|+||||++||+|++|+.||...... .+ +...+.
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~e-i~~~i~-------- 527 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IE-IHTRIQ-------- 527 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HH-HHHhhc--------
Confidence 43 22334688999999999999999999999999999999999999733211 11 111111
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.+ .+....+....+++..|++.||.+||++.++..
T Consensus 528 ~~----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 528 MP----KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred CC----ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 11 112334467788999999999999999999965
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=282.89 Aligned_cols=204 Identities=24% Similarity=0.345 Sum_probs=173.7
Q ss_pred hcCCCcCceeeeccCceEEEEE-cCCCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
..-|..++.||-|+||.|.++. ..+...||.|.+++.. .......++.|.++|...+.+.||+||..|++++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3456678889999999999996 4457789999997643 223445688999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||++||++..+|...+- |.+..++.++..+..|+++.|.. |+|||||||+|||||.+|++||+||||+.-+.
T Consensus 708 MdYIPGGDmMSLLIrmgI----FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGI----FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHHHHhcc----CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccce
Confidence 999999999999887543 88888999999999999999999 99999999999999999999999999986432
Q ss_pred c---------CCC--------------------------------eeeecccccccccchhhhccCCCCCcccchhHHHH
Q 007020 452 Y---------KDT--------------------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIM 490 (621)
Q Consensus 452 ~---------~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvi 490 (621)
- .+. ......+||..|+|||++....++..+|.||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 0 000 00123469999999999999999999999999999
Q ss_pred HHHHHhCCCCccccc
Q 007020 491 LLELITGQRAFDLAR 505 (621)
Q Consensus 491 l~elltg~~pf~~~~ 505 (621)
||||+.|+.||-...
T Consensus 861 l~em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADT 875 (1034)
T ss_pred HHHHhhCCCCccCCC
Confidence 999999999996443
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=290.21 Aligned_cols=259 Identities=26% Similarity=0.387 Sum_probs=206.5
Q ss_pred HHHHHHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeee--
Q 007020 288 LRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCM-- 363 (621)
Q Consensus 288 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-- 363 (621)
++.+...++.|++.+.||.|.+|.||+++.. +++.+|+|++..... ...++..|.++++.. .|||++.++|++.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d--~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED--EEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc--ccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3344456778889999999999999999854 789999999865443 344577788888776 5999999999985
Q ss_pred ---cCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEE
Q 007020 364 ---TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV 440 (621)
Q Consensus 364 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 440 (621)
.++++|||||||.+||..|+++... +..+.|..+..|+..++.|+.+||.+ .++|||||-.|||++.++.||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEE
Confidence 3588999999999999999998765 44589999999999999999999999 999999999999999999999
Q ss_pred EcccccceecccCCCeeeecccccccccchhhhccC-----CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHH
Q 007020 441 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 515 (621)
Q Consensus 441 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~ 515 (621)
+.|||.+..++. .........||+.|||||++... .|+.++|+||+|++..||.-|.+|+-....
T Consensus 164 LvDFGvSaQlds-T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP--------- 233 (953)
T KOG0587|consen 164 LVDFGVSAQLDS-TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP--------- 233 (953)
T ss_pred Eeeeeeeeeeec-ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch---------
Confidence 999999887653 23344556699999999999644 357789999999999999999999841110
Q ss_pred HHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 516 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 516 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
++.+. .+.....|.+. -+.....++.++|..|+.+|-++||++.++++
T Consensus 234 --mraLF---~IpRNPPPkLk--rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 234 --MRALF---LIPRNPPPKLK--RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --hhhhc---cCCCCCCcccc--chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 01111 11111223332 24566789999999999999999999988864
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-33 Score=274.17 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=196.8
Q ss_pred HHhcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccC--C----chhHHHHHHHHHHHHhccCCceeeeeeeee-c
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEER--T----PGGELQFQTEVEMISMAVHRNLLRLRGFCM-T 364 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~ 364 (621)
...++|-+..+||+|||+.||+|.+ ...+.||||+-...+ . ........+|..+.+.++||.||++|+++. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3456777889999999999999985 467889999854322 1 122334678999999999999999999986 5
Q ss_pred CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---CCcEEE
Q 007020 365 PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---EFEAVV 441 (621)
Q Consensus 365 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl 441 (621)
.+.++-|+|||+|.+|.-|+..... +++.++..|+.||..||.||.+. +|+|||-||||.|||+-+ -|.+||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhkl----mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKL----MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhh----hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 5678899999999999999987653 89999999999999999999997 778999999999999954 478999
Q ss_pred cccccceecccCCC------eeeecccccccccchhhhccC----CCCCcccchhHHHHHHHHHhCCCCcccccccCCCc
Q 007020 442 GDFGLAKLMDYKDT------HVTTAVRGTIGHIAPEYLSTG----KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDD 511 (621)
Q Consensus 442 ~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~ 511 (621)
+|||+++.++.... ..+....||..|++||.+.-+ ..+.|+||||.|||+|+.+.|+.||......
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ---- 690 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ---- 690 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH----
Confidence 99999998865322 234456799999999988533 4688999999999999999999999632211
Q ss_pred chHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 007020 512 VMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 569 (621)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl 569 (621)
..++....+-....-.+. .-+....+...+|++|++.--++|....++.
T Consensus 691 -------QdILqeNTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 691 -------QDILQENTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -------HHHHhhhchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111222222111111111 1112235677889999999999998777664
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=295.27 Aligned_cols=264 Identities=20% Similarity=0.214 Sum_probs=172.3
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-C----CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeee------e
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-D----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF------C 362 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~ 362 (621)
..++|...+.||+|+||.||+|.+. + +..||+|++..... ...+..| .+....+.+++.+... .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 5678999999999999999999875 4 68999998764321 1111111 1112222222222211 2
Q ss_pred ecCCceEEEEeccCCCchhhhhccCCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 007020 363 MTPTERLLVYPYMANGSVASCLRERPPS----------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDV 426 (621)
Q Consensus 363 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 426 (621)
......++||||+.+++|.+++...... ........+..++.|++.||+|||+. +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 4556789999999999999998754210 00112334668999999999999999 9999999
Q ss_pred CCCCeeeCC-CCcEEEcccccceecccCCCeeeecccccccccchhhhccCC----------------------CCCccc
Q 007020 427 KAANILLDE-EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK----------------------SSEKTD 483 (621)
Q Consensus 427 k~~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----------------------~~~~~D 483 (621)
||+|||++. ++.+||+|||+|+.+............+++.|+|||.+.... ++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 579999999999866544334445567899999999764322 334669
Q ss_pred chhHHHHHHHHHhCCCCcccccc-----cCCCcchHHHHHHHHhhhcccccccCccccC--cccHHHHHHHHHHHHhccC
Q 007020 484 VFGYGIMLLELITGQRAFDLARL-----ANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN--NYVEAEVEQLIQVALLCTQ 556 (621)
Q Consensus 484 vwSlGvil~elltg~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~~l~~l~~~c~~ 556 (621)
||||||++|||+++..+++.... ....+.....|....... ..+.... ...........+++..|++
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHcc
Confidence 99999999999998776542110 001111222332211100 0000000 0000011345589999999
Q ss_pred CCCCCCCCHHHHHHH
Q 007020 557 GSPMDRPKMSEVVRM 571 (621)
Q Consensus 557 ~~P~~RPt~~~vl~~ 571 (621)
.||++|||++++++.
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999864
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=267.38 Aligned_cols=261 Identities=22% Similarity=0.267 Sum_probs=198.6
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccC--C----ceeeeeeeeecC
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH--R----NLLRLRGFCMTP 365 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~~~~ 365 (621)
..+++|.+...+|+|.||.|-.+.+. .+..||||+++.. ......-+-|++++.++.+ | -+|.+.++|.-.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 34789999999999999999999754 5789999998753 3344456789999998842 2 378888899999
Q ss_pred CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC----------
Q 007020 366 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---------- 435 (621)
Q Consensus 366 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---------- 435 (621)
++.++|+|.+ |-|+++++..+.. .+++...+..|+.|++++++|||+. +++|.||||+|||+.+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccC
Confidence 9999999988 4499999988653 4588889999999999999999999 9999999999999941
Q ss_pred ----------CCcEEEcccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCccccc
Q 007020 436 ----------EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLAR 505 (621)
Q Consensus 436 ----------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~ 505 (621)
+..+|++|||.|++-... ....+.|..|.|||++.+-.++.++||||+||||+|+.||...|+..+
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 345899999999864332 245668999999999999999999999999999999999999996322
Q ss_pred ccCCCcchHHHHHHHHhhh-----------------cccc-----------cccC-ccc---cCcccHHHHHHHHHHHHh
Q 007020 506 LANDDDVMLLDWVKGLLKE-----------------KKLE-----------MLVD-PDL---QNNYVEAEVEQLIQVALL 553 (621)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~-----------------~~~~-----------~~~d-~~~---~~~~~~~~~~~l~~l~~~ 553 (621)
+. .....++.++.. +.++ ...+ +.. .-.....+..+|++++..
T Consensus 314 ----n~-EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 314 ----NL-EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred ----cH-HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 11 111222211110 0000 0000 000 001123445779999999
Q ss_pred ccCCCCCCCCCHHHHHH
Q 007020 554 CTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 554 c~~~~P~~RPt~~~vl~ 570 (621)
|+..||.+|+|+.|++.
T Consensus 389 mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 389 MLEFDPARRITLREALS 405 (415)
T ss_pred HHccCccccccHHHHhc
Confidence 99999999999999976
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=259.15 Aligned_cols=253 Identities=24% Similarity=0.339 Sum_probs=200.7
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCch--hHHHHHHHHHHHHhc-cCCceeeeeeeeecCCc
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG--GELQFQTEVEMISMA-VHRNLLRLRGFCMTPTE 367 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 367 (621)
.+...+|.+..+||+|+|++|..+++. +.+.||+|++++.-... ...-.+.|-.+.... +||.+|.++.+|+.+..
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 344568889999999999999999865 68899999998764322 233466777776654 69999999999999999
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
+++|.||++||+|.-.++... .++++.+..+...|+-||.|||+. ||++||||..|||++..|++|++|+|++
T Consensus 326 lffvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmc 398 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMC 398 (593)
T ss_pred EEEEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchh
Confidence 999999999999987776543 389999999999999999999999 9999999999999999999999999999
Q ss_pred eecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
+.- ......+..++||+.|+|||++.+..|...+|.|++||+++||+.|+.||+.-...+ .++...+++-..+-++.+
T Consensus 399 ke~-l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n-~d~ntedylfqvilekqi 476 (593)
T KOG0695|consen 399 KEG-LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDN-PDMNTEDYLFQVILEKQI 476 (593)
T ss_pred hcC-CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCC-cccchhHHHHHHHhhhcc
Confidence 853 234445677889999999999999999999999999999999999999998544322 223333444333322222
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCC
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP 563 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP 563 (621)
.- +...+.+...+++.-+.+||.+|.
T Consensus 477 ri----------prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 RI----------PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cc----------cceeehhhHHHHHHhhcCCcHHhc
Confidence 11 112224555677788899999986
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-33 Score=256.84 Aligned_cols=263 Identities=24% Similarity=0.376 Sum_probs=191.1
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecc-cCCchhHHHHHHHHHHHHhccCCceeeeeeeeecC--------
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKE-ERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-------- 365 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 365 (621)
..|+...+||+|.||.||+|+.+ +|+.||+|++-- .........-.+|++++..+.|+|++.+++.|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34556678999999999999875 578889986532 22233334567899999999999999999988532
Q ss_pred CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccc
Q 007020 366 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 445 (621)
Q Consensus 366 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 445 (621)
..+++||++|+. +|..++.+.. ..++..++.+++.++..||.|+|.. .|+|||+|+.|+||+.+|.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 347999999998 8888887643 2388899999999999999999999 99999999999999999999999999
Q ss_pred cceecccCCCe---eeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHH
Q 007020 446 LAKLMDYKDTH---VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGL 521 (621)
Q Consensus 446 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 521 (621)
+|+.+...... ..+..+-|..|++||.+.+. .++++.|||..|||+.||+||.+-++... .......+...
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt-----eqqql~~Is~L 244 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT-----EQQQLHLISQL 244 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh-----HHHHHHHHHHH
Confidence 99876543221 23344568999999998875 58999999999999999999998875211 11111222211
Q ss_pred hhhcc-----------ccccc--Cc--cccCcccHHHH------HHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 522 LKEKK-----------LEMLV--DP--DLQNNYVEAEV------EQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 522 ~~~~~-----------~~~~~--d~--~~~~~~~~~~~------~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..... +.+.+ .| +-+.....+.. ....+++..++..||.+|+++++++.
T Consensus 245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 11000 00000 00 00000011112 25667888899999999999999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=289.62 Aligned_cols=247 Identities=27% Similarity=0.348 Sum_probs=187.1
Q ss_pred CCCcCceeeeccCce-EEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceEEEEec
Q 007020 297 SFSNKNILGRGGFGK-VYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
-|...+++|.|+.|+ ||+|.+ +|+.||||++-... ..-.++|+..+..- .|||||++++.-.++...|+..|.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 345567899999986 899999 48999999985332 33467899998876 499999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---C--CcEEEccccccee
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---E--FEAVVGDFGLAKL 449 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~--~~~kl~DfGla~~ 449 (621)
|.. +|.+++...........-...+.+..|++.||++||+. +||||||||.||||+. + ..++|+|||+++.
T Consensus 585 C~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 585 CAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred hhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 976 99999987411111111135678899999999999998 9999999999999976 2 4799999999998
Q ss_pred cccCCCee--eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhC-CCCcccccccCCCcchHHHHHHHHhhhcc
Q 007020 450 MDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG-QRAFDLARLANDDDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 450 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (621)
+....... .....||.+|+|||++....-+.++||||+||++|+.++| ++||...-... ..++...
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~----------~NIl~~~- 729 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ----------ANILTGN- 729 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh----------hhhhcCc-
Confidence 87654433 3355699999999999998888899999999999999995 99996221100 0111110
Q ss_pred cccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 527 ~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..+. .+.. ..++ ...++|..|++.+|..||++.+|+.
T Consensus 730 -~~L~--~L~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 730 -YTLV--HLEP--LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -ccee--eecc--CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0000 0000 1111 6778999999999999999999973
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=256.93 Aligned_cols=239 Identities=29% Similarity=0.381 Sum_probs=192.7
Q ss_pred cCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCchhhhhcc
Q 007020 308 GFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 386 (621)
Q Consensus 308 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 386 (621)
+||.||+|... +|+.+|+|++...........+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999987654433256899999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeeeeccccccc
Q 007020 387 RPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 466 (621)
Q Consensus 387 ~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~ 466 (621)
... +++..+..++.++++++.|||+. +++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~~~----~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 RGR----LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred ccC----CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 432 78899999999999999999999 99999999999999999999999999998765432 2334458889
Q ss_pred ccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHH
Q 007020 467 HIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQ 546 (621)
Q Consensus 467 y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 546 (621)
|++||.+.+...+.++||||||+++|+|++|..||.... ......++.. . ..... ..........
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~----~~~~~~~~~~---~-~~~~~-------~~~~~~~~~~ 216 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD----QLLELFKKIG---K-PKPPF-------PPPEWKISPE 216 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHh---c-cCCCC-------ccccccCCHH
Confidence 999999988888999999999999999999999996321 1111111111 1 00000 0000003367
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHH
Q 007020 547 LIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 547 l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
+.+++.+|+..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=280.57 Aligned_cols=263 Identities=22% Similarity=0.248 Sum_probs=180.9
Q ss_pred HhcCCCcCceeeeccCceEEEEEc-----------------CCCcEEEEEEecccCCchhHH--------------HHHH
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRL-----------------ADGSLVAVKRLKEERTPGGEL--------------QFQT 342 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~~ 342 (621)
..++|.+.++||+|+||+||+|.. ..++.||||+++.... .... ....
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~-~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ-GVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch-hhHHHHHhhhhhhhcccchhHH
Confidence 467899999999999999999963 2356899999864321 1111 2334
Q ss_pred HHHHHHhccCCce-----eeeeeeeec--------CCceEEEEeccCCCchhhhhccCCC--------------------
Q 007020 343 EVEMISMAVHRNL-----LRLRGFCMT--------PTERLLVYPYMANGSVASCLRERPP-------------------- 389 (621)
Q Consensus 343 E~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~-------------------- 389 (621)
|+.++.+++|.++ ++++++|.. ....++||||+++|+|.++++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6677777766654 677777653 3568999999999999999875321
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeeeecccccccccc
Q 007020 390 SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 469 (621)
Q Consensus 390 ~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~a 469 (621)
....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...............+++.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 011356788999999999999999999 99999999999999999999999999997654322211222235789999
Q ss_pred hhhhccCCC----------------------CCcccchhHHHHHHHHHhCCC-CcccccccC----CCcchHHHHHHHHh
Q 007020 470 PEYLSTGKS----------------------SEKTDVFGYGIMLLELITGQR-AFDLARLAN----DDDVMLLDWVKGLL 522 (621)
Q Consensus 470 PE~~~~~~~----------------------~~~~DvwSlGvil~elltg~~-pf~~~~~~~----~~~~~~~~~~~~~~ 522 (621)
||.+..... ..+.||||+||++|+|++|.. ||....... ..+.....|...
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~-- 456 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY-- 456 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--
Confidence 998854321 234799999999999999875 664211111 111122222211
Q ss_pred hhcccccccCccccCcccHHHHHHHHHHHHhccCCCC---CCCCCHHHHHH
Q 007020 523 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSP---MDRPKMSEVVR 570 (621)
Q Consensus 523 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P---~~RPt~~~vl~ 570 (621)
.... .+-. ..........+++..++..+| .+|+|++|+++
T Consensus 457 ~~~~----~~~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 457 KGQK----YDFS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cccC----CCcc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0000 0100 112223567788888888765 68999999976
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-33 Score=275.92 Aligned_cols=243 Identities=23% Similarity=0.290 Sum_probs=197.1
Q ss_pred cCCCcCceeeeccCceEEEEEcCCCc-EEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLADGS-LVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
.++.....||-|+||.|-+....+.. .+|+|++++... ..+...+..|-.+|...+.|.||++|.-|.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34445567999999999998865433 489999976543 334456788999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
|-|-||.|...+++++. |+..+++-++.-+.+|++|||++ +||+|||||+|.+++.+|-+||.|||+|+....
T Consensus 500 EaClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999998765 89999999999999999999999 999999999999999999999999999998764
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
. ..+-.++||+.|.|||++.+...+.++|.||+|+++|||++|.+||...+.- ..+ ..+++ .++.+.
T Consensus 573 g--~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm----ktY----n~ILk--Gid~i~- 639 (732)
T KOG0614|consen 573 G--RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM----KTY----NLILK--GIDKIE- 639 (732)
T ss_pred C--CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH----HHH----HHHHh--hhhhhh-
Confidence 4 3455678999999999999999999999999999999999999999733211 111 11111 111111
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCC
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK 564 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt 564 (621)
++....+...++++..+..+|.+|..
T Consensus 640 ------~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 640 ------FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ------cccccchhHHHHHHHHHhcCcHhhhc
Confidence 12223356677888888899999985
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=248.35 Aligned_cols=266 Identities=23% Similarity=0.271 Sum_probs=193.3
Q ss_pred CceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecC-----CceEEEEe
Q 007020 301 KNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TERLLVYP 373 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e 373 (621)
.+.||.|+||.||...+. +|+.||.|++..... -...+.+-+|++++..++|.|++..++..+-. .+.|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 467999999999999865 799999998864321 22345688999999999999999998887644 35688889
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
.|.. +|...|-. ..+++...++-+.+||++||.|||+. +|.||||||.|.|++.+..+||+|||+|+.....
T Consensus 138 LmQS-DLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 138 LMQS-DLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHh-hhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence 8876 77776653 33477888999999999999999999 9999999999999999999999999999987666
Q ss_pred CCeeeecccccccccchhhhccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCc-------chHHHHHHHHhhhc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDD-------VMLLDWVKGLLKEK 525 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-------~~~~~~~~~~~~~~ 525 (621)
+....+..+-|..|.|||++.+.. |+.+.||||.|||+.|++..+..|+.......-+ ....+-++..-++.
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 555556666789999999998864 7999999999999999999998886332211100 00011111111111
Q ss_pred ccccc----cCccccCcc----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 526 KLEML----VDPDLQNNY----VEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 526 ~~~~~----~d~~~~~~~----~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
+...+ -.|++..-| ......+-..+...++..||++|.+.++.+..+-.
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 11100 011111100 11122345567778889999999999988876544
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=251.75 Aligned_cols=133 Identities=22% Similarity=0.320 Sum_probs=112.3
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-----C---Cceeeeeeeee--
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-----H---RNLLRLRGFCM-- 363 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~-- 363 (621)
..+|.+.++||.|.|++||+|.+. +.+.||+|+.+.. ....+.-..||++|+.++ | ..||+|++.|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 478999999999999999999865 5788999998753 233445678999998875 2 46999999986
Q ss_pred --cCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC
Q 007020 364 --TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD 434 (621)
Q Consensus 364 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~ 434 (621)
.+.+.++|+|++ |.+|..+|......+ ++...+++|+.||+.||.|||..| ||||.||||+|||+.
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrG--lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRG--LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCC--CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 356889999998 559999998866555 677899999999999999999999 999999999999993
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=260.92 Aligned_cols=197 Identities=24% Similarity=0.347 Sum_probs=168.7
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchh-------HHHHHHHHHHHHhcc---CCceeeeeeeeec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGG-------ELQFQTEVEMISMAV---HRNLLRLRGFCMT 364 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 364 (621)
.+|+..+.+|+|+||.|+.|.++ +...|+||.+.+.+.-.. .-.+-.|+.+|+.++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35788899999999999999986 467899999976542111 112456999999997 9999999999999
Q ss_pred CCceEEEEeccC-CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcc
Q 007020 365 PTERLLVYPYMA-NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 443 (621)
Q Consensus 365 ~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 443 (621)
++..|++||-.. +-+|+++|..+.. +++.+++.|+.||+.|+++||++ +|||||||-+||.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~----m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPR----MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCc----cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 999999999654 4589999987654 89999999999999999999999 999999999999999999999999
Q ss_pred cccceecccCCCeeeecccccccccchhhhccCCC-CCcccchhHHHHHHHHHhCCCCcc
Q 007020 444 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFD 502 (621)
Q Consensus 444 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~ 502 (621)
||.|..... .....++||..|.|||++.+..| ...-|||++|++||-++....||.
T Consensus 714 fgsaa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999876443 33455679999999999998877 667899999999999999888874
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=234.00 Aligned_cols=211 Identities=35% Similarity=0.522 Sum_probs=183.6
Q ss_pred eeeccCceEEEEEcCC-CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCchhh
Q 007020 304 LGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS 382 (621)
Q Consensus 304 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 382 (621)
||+|.+|.||++...+ ++.+++|++...........+.+|+..++.+.|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999998765443234678999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-CCcEEEcccccceecccCCCeeeecc
Q 007020 383 CLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMDYKDTHVTTAV 461 (621)
Q Consensus 383 ~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~ 461 (621)
++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 987642 2378899999999999999999999 9999999999999999 89999999999987654321 12334
Q ss_pred cccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCccc
Q 007020 462 RGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 540 (621)
Q Consensus 462 ~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 540 (621)
.+...|++||..... ..+.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 478899999999877 778999999999999998
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 541 EAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 541 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 357788999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=233.24 Aligned_cols=255 Identities=20% Similarity=0.315 Sum_probs=191.1
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHH-HhccCCceeeeeee-eecCCceEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMI-SMAVHRNLLRLRGF-CMTPTERLLV 371 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~-~~~~~~~~lv 371 (621)
.+.|.+.+.+|+|.||.+-++.++ +.+.+++|.+..... ..++|.+|...- ..-.|.||+.-|+. |+..+..+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 467888899999999999999986 567899999875543 355788888763 33469999988764 6677888899
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC--CCCcEEEccccccee
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD--EEFEAVVGDFGLAKL 449 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~DfGla~~ 449 (621)
+||++.|+|.+-+...+ +.+...++++.|+++|+.|||++ .+||||||.+||||- +..++|++|||+.+.
T Consensus 101 qE~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eccCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccc
Confidence 99999999999887643 77888999999999999999999 999999999999993 345899999999875
Q ss_pred cccCCCeeeecccccccccchhhhccC-----CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhh
Q 007020 450 MDYKDTHVTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 524 (621)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 524 (621)
.+. .......+..|.+||..... ...+.+|||.||+++|.++||+.||+.+. ..+..+..|..-..+.
T Consensus 173 ~g~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~---~~d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 173 VGT----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS---IMDKPYWEWEQWLKRK 245 (378)
T ss_pred cCc----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh---ccCchHHHHHHHhccc
Confidence 432 12223356689999987543 24678999999999999999999998433 2334455554432221
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 525 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 525 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
. . .-|+....+ ...+.++.+.-+..+|++|-...++.++...
T Consensus 246 ~--~--~~P~~F~~f----s~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 246 N--P--ALPKKFNPF----SEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred C--c--cCchhhccc----CHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 1 1 112222222 3567777888889999999777777665544
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=229.12 Aligned_cols=255 Identities=20% Similarity=0.287 Sum_probs=191.5
Q ss_pred hcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-CCceeeeeeeeecCC--ceEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPT--ERLL 370 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~l 370 (621)
.++|++.+++|+|.|+.||.|.. .+.+.++||+++.. ..+.+.+|++++..+. ||||+++++...++. ...|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 46788889999999999999984 46889999999743 3557899999999998 999999999998764 4579
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC-CcEEEccccccee
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKL 449 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfGla~~ 449 (621)
++||+.+.+...+-.. ++...+..++.+++.||.|+|++ ||+|||+||.|++||.. ..++|+|+|+|.+
T Consensus 113 iFE~v~n~Dfk~ly~t-------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYPT-------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred HhhhhccccHHHHhhh-------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhh
Confidence 9999999777665443 66678899999999999999999 99999999999999864 5799999999998
Q ss_pred cccCCCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHH--------H
Q 007020 450 MDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK--------G 520 (621)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~--------~ 520 (621)
+..... ....+.+..|.-||.+.. +.++..-|+|||||++..|+..+.||-.+....+ .+.+.++ .
T Consensus 183 YHp~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D---QLVkIakVLGt~el~~ 257 (338)
T KOG0668|consen 183 YHPGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD---QLVKIAKVLGTDELYA 257 (338)
T ss_pred cCCCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH---HHHHHHHHhChHHHHH
Confidence 764433 233345677889999865 4578899999999999999999999954332222 1222211 1
Q ss_pred HhhhcccccccCccccC---ccc----H---------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 521 LLKEKKLEMLVDPDLQN---NYV----E---------AEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 521 ~~~~~~~~~~~d~~~~~---~~~----~---------~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.+....+ -+||.+.. ... . -...+.++++...+..|.++|+|++|.+.
T Consensus 258 Yl~KY~i--~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 258 YLNKYQI--DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHcc--CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1111111 12332211 000 0 01256778888889999999999999865
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-29 Score=235.59 Aligned_cols=256 Identities=22% Similarity=0.237 Sum_probs=191.4
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecC------Cc
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TE 367 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 367 (621)
.+|...+.+|.|.- .|..|.+. .++.||+|.+..... .....+..+|...+..+.|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666778888888 56666543 688999998754322 12234567899999999999999999998643 45
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
.|+|||||.. +|...+... ++-.++..|..|++.|++|||+. +|+||||||+||++..+..+||.|||+|
T Consensus 96 ~y~v~e~m~~-nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILME------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhhhh-HHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 6999999976 898888732 67789999999999999999999 9999999999999999999999999999
Q ss_pred eecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
+.-+. ....+..+.|..|.|||++.+..+.+.+||||+||++.||++|+..|... ..+.+|.+-....+..
T Consensus 166 r~e~~--~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~-------d~idQ~~ki~~~lgtp 236 (369)
T KOG0665|consen 166 RTEDT--DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK-------DHIDQWNKIIEQLGTP 236 (369)
T ss_pred cccCc--ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc-------hHHHHHHHHHHHhcCC
Confidence 86432 23556667899999999999999999999999999999999999988521 1223333221111111
Q ss_pred cc----------------------------ccCccccCc--ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 528 EM----------------------------LVDPDLQNN--YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 528 ~~----------------------------~~d~~~~~~--~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.. +.|..+... ...-......+++.+|+..+|++|-+++++++.
T Consensus 237 d~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 237 DPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred CHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 011111100 011123456788899999999999999999763
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-29 Score=255.07 Aligned_cols=251 Identities=26% Similarity=0.368 Sum_probs=198.0
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.++|+....+|+|.||.||||++. +++..|+|+++-... ....-+++|+-+++..+|+||+.++|.+...+..|++||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 467888899999999999999965 689999999986643 334457889999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
||.+|+|.+.-+... ++++.++..+....++|++|||++ +=+|||||-.|||+++.|.+|++|||.+-.+..
T Consensus 93 ycgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita- 164 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA- 164 (829)
T ss_pred ecCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh-
Confidence 999999999877544 488889999999999999999999 889999999999999999999999998765432
Q ss_pred CCeeeecccccccccchhhh---ccCCCCCcccchhHHHHHHHHHhCCCCc-ccccccCCCcchHHHHHHHHhhhccccc
Q 007020 454 DTHVTTAVRGTIGHIAPEYL---STGKSSEKTDVFGYGIMLLELITGQRAF-DLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
.......+.||+.|||||+. ..+.|..++|||+.|+...|+-.-++|- +... + +-.. +.. +.
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--------m-r~l~-LmT----kS 230 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--------M-RALF-LMT----KS 230 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch--------H-HHHH-Hhh----cc
Confidence 22234556799999999987 4567889999999999999998777663 2100 0 0000 000 01
Q ss_pred ccCc-cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 530 LVDP-DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 530 ~~d~-~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..+| .+.+ .......+.++++.|+.++|.+||+++.+++
T Consensus 231 ~~qpp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 231 GFQPPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1111 1111 1223467889999999999999999988876
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=231.37 Aligned_cols=199 Identities=33% Similarity=0.502 Sum_probs=171.4
Q ss_pred CCcCceeeeccCceEEEEEcCC-CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccC
Q 007020 298 FSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 376 (621)
Q Consensus 298 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 376 (621)
|...+.||+|++|.||++...+ ++.+|+|.+...........+.+|++.++.++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999764 889999998765433245678899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCe
Q 007020 377 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 456 (621)
Q Consensus 377 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 456 (621)
+++|.+++...... +++.....++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGGK---LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhcccC---CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 99999998864321 67889999999999999999999 9999999999999999999999999999876543211
Q ss_pred eeecccccccccchhhh-ccCCCCCcccchhHHHHHHHHHhCCCCcc
Q 007020 457 VTTAVRGTIGHIAPEYL-STGKSSEKTDVFGYGIMLLELITGQRAFD 502 (621)
Q Consensus 457 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg~~pf~ 502 (621)
......++..|++||.+ ....++.++|||+||+++++|++|+.||+
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 22334578889999998 66677889999999999999999999995
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=244.98 Aligned_cols=207 Identities=22% Similarity=0.241 Sum_probs=174.3
Q ss_pred cCHHHHHHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhcc------CCceeee
Q 007020 286 FSLRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV------HRNLLRL 358 (621)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l 358 (621)
|.+.-.++...+|.+....|+|-|++|.+|... .|+.||||+|+... .....=+.|+++|++++ --|.+++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE--~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE--VMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch--HHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 344556777889999999999999999999865 47899999998653 22334568999999986 3578999
Q ss_pred eeeeecCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-
Q 007020 359 RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF- 437 (621)
Q Consensus 359 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~- 437 (621)
+..|...+++|||+|-+.- +|.+++.+.+. ...+....+..++.|+.-||..|... +|+|.||||.|||+++..
T Consensus 500 ~r~F~hknHLClVFE~Lsl-NLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPLSL-NLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHhhhcceeEEEehhhhc-hHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcc
Confidence 9999999999999998865 99999988654 34588889999999999999999998 999999999999998764
Q ss_pred cEEEcccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcc
Q 007020 438 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 502 (621)
Q Consensus 438 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~ 502 (621)
.+||||||.|....... .+.+.-+..|.|||++.|..|+...|+||+||.||||.||+..|.
T Consensus 575 iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp 636 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP 636 (752)
T ss_pred eeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence 68999999998755432 222334567999999999999999999999999999999999885
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=235.50 Aligned_cols=199 Identities=26% Similarity=0.423 Sum_probs=166.6
Q ss_pred HHHHhcCCCcCceeeeccCceEEEEEcC----CCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-CCceeeeeeeeecC
Q 007020 291 LQVATDSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTP 365 (621)
Q Consensus 291 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 365 (621)
.....+.|...++||+|.|++||++... ..+.||+|.+.....+. .+..|++++..+. +.||+++.+++...
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~---ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS---RILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch---HHHHHHHHHHHhccchhhhcchhhhccC
Confidence 3445677889999999999999999753 46789999997655443 5789999999885 89999999999999
Q ss_pred CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-CCcEEEccc
Q 007020 366 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDF 444 (621)
Q Consensus 366 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Df 444 (621)
++..+|+||++..+..++... ++...+..++..++.||+++|.+ |||||||||+|+|.+. .+.-.|.||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEec
Confidence 999999999999999998876 66789999999999999999999 9999999999999985 467899999
Q ss_pred ccceecccCC---------------------------------C----------eeeecccccccccchhhhccCC-CCC
Q 007020 445 GLAKLMDYKD---------------------------------T----------HVTTAVRGTIGHIAPEYLSTGK-SSE 480 (621)
Q Consensus 445 Gla~~~~~~~---------------------------------~----------~~~~~~~gt~~y~aPE~~~~~~-~~~ 480 (621)
|+|....... . .......||++|.|||++...+ .++
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 9997321000 0 0011235999999999997654 588
Q ss_pred cccchhHHHHHHHHHhCCCCcc
Q 007020 481 KTDVFGYGIMLLELITGQRAFD 502 (621)
Q Consensus 481 ~~DvwSlGvil~elltg~~pf~ 502 (621)
++||||.|||+.-++++..||-
T Consensus 258 aiDiws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred ccceeeccceeehhhccccccc
Confidence 9999999999999999999994
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=266.40 Aligned_cols=194 Identities=14% Similarity=0.138 Sum_probs=138.0
Q ss_pred ccC-Cceeeeeeee-------ecCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 007020 350 AVH-RNLLRLRGFC-------MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 421 (621)
Q Consensus 350 l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i 421 (621)
+.| .||+++++++ .....+++++||+. ++|.+++.... ..+++.+++.++.||++||+|||++ +|
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 445 5777888877 23345678889874 59999997532 2488999999999999999999999 99
Q ss_pred EecCCCCCCeeeCC-------------------CCcEEEcccccceecccCCC---------------eeeecccccccc
Q 007020 422 IHRDVKAANILLDE-------------------EFEAVVGDFGLAKLMDYKDT---------------HVTTAVRGTIGH 467 (621)
Q Consensus 422 vH~Dlk~~Nill~~-------------------~~~~kl~DfGla~~~~~~~~---------------~~~~~~~gt~~y 467 (621)
+||||||+|||++. ++.+|++|||+++....... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566667776654211000 001113478889
Q ss_pred cchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHH
Q 007020 468 IAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQL 547 (621)
Q Consensus 468 ~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l 547 (621)
||||++.+..++.++|||||||+||||++|..|+.... ..+.... . ....+.. .......
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----------~~~~~~~-~----~~~~~~~-----~~~~~~~ 241 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----------RTMSSLR-H----RVLPPQI-----LLNWPKE 241 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----------HHHHHHH-H----hhcChhh-----hhcCHHH
Confidence 99999999999999999999999999999988874211 1111110 0 0111111 1112345
Q ss_pred HHHHHhccCCCCCCCCCHHHHHH
Q 007020 548 IQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 548 ~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..++..||+.+|.+||++.|+++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhh
Confidence 67888999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=207.42 Aligned_cols=166 Identities=22% Similarity=0.265 Sum_probs=125.3
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee
Q 007020 378 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457 (621)
Q Consensus 378 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 457 (621)
|+|.++++... .++++..+..++.||+.||+|||+. + ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 68999997642 2489999999999999999999999 5 999999999999999 99998754322
Q ss_pred eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccC
Q 007020 458 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537 (621)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 537 (621)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+..+....... ++...
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~---~~~~~~~~~~~~~~~-------~~~~~- 129 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE---LSAILEILLNGMPAD-------DPRDR- 129 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch---hcHHHHHHHHHhccC-------Ccccc-
Confidence 2489999999999999999999999999999999999999953211 111122221111110 00000
Q ss_pred cccHHHHH--HHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 538 NYVEAEVE--QLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 538 ~~~~~~~~--~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
........ .+.+++..|+..+|++||++.++++.+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 01112222 68999999999999999999999998755
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-26 Score=209.76 Aligned_cols=247 Identities=23% Similarity=0.380 Sum_probs=186.3
Q ss_pred CceeeeccCceEEEEEcCCCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCc
Q 007020 301 KNILGRGGFGKVYKGRLADGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 379 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 379 (621)
..+|.+...|..|+|+|+ |..+++|+++... +....++|..|.-.++.+.||||+.++|.|..+....++..||+.||
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 346889999999999996 5667778776432 34445679999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeeee
Q 007020 380 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 459 (621)
Q Consensus 380 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 459 (621)
|+..+++.. ....+..++.+++.+|++|++|||+.. |-|.---|.+..|++|++.+++|+ .+-+++ +....
T Consensus 274 lynvlhe~t--~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris-mad~kf-----sfqe~ 344 (448)
T KOG0195|consen 274 LYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS-MADTKF-----SFQEV 344 (448)
T ss_pred HHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee-ccccee-----eeecc
Confidence 999999753 455788899999999999999999973 334445689999999999988875 111111 00111
Q ss_pred cccccccccchhhhccCCCC---CcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcccc
Q 007020 460 AVRGTIGHIAPEYLSTGKSS---EKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 536 (621)
Q Consensus 460 ~~~gt~~y~aPE~~~~~~~~---~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 536 (621)
...-.+.||+||.++..+.+ .++|+|||++++||+.|...||..-..-+ .+ ++ +.-..+.
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme-cg------mk----------ialeglr 407 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME-CG------MK----------IALEGLR 407 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh-hh------hh----------hhhcccc
Confidence 12246789999999877643 57899999999999999999996221110 00 00 1111222
Q ss_pred CcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 537 NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 537 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
...++.....+.++|.-|+..||.+||.++.|+-.||.
T Consensus 408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 22333445678889999999999999999999988875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=220.27 Aligned_cols=176 Identities=22% Similarity=0.242 Sum_probs=134.9
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcC--CCcEEEEEEecccC----CchhHHHHHHHHHHHHhccCCceee-eeeeeec
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLA--DGSLVAVKRLKEER----TPGGELQFQTEVEMISMAVHRNLLR-LRGFCMT 364 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~ 364 (621)
....+.|.+.+.||+|+||+||+|.+. +++.||||++.... .......+.+|+++++.++|+|++. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 345678999999999999999999864 57788999875331 1223556899999999999999985 4442
Q ss_pred CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCeeeCCCCcEEEcc
Q 007020 365 PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDV-KAANILLDEEFEAVVGD 443 (621)
Q Consensus 365 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-k~~Nill~~~~~~kl~D 443 (621)
+..++||||++|++|... .. .. ...++.++++||+|||+. ||+|||| ||+|||++.++.+||+|
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Cc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEE
Confidence 457999999999999732 11 11 146788999999999999 9999999 99999999999999999
Q ss_pred cccceecccCCCee-------eecccccccccchhhhccCC------CCCcccch
Q 007020 444 FGLAKLMDYKDTHV-------TTAVRGTIGHIAPEYLSTGK------SSEKTDVF 485 (621)
Q Consensus 444 fGla~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~------~~~~~Dvw 485 (621)
||+|+.+....... .....++..|+|||.+.... .+..+|-|
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 99999765432111 13456888999999986443 23346666
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-23 Score=198.51 Aligned_cols=258 Identities=16% Similarity=0.208 Sum_probs=194.5
Q ss_pred cCCCcCceeeeccCceEEEEE-cCCCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-CCceeeeeeeeecCCceEEEEe
Q 007020 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 373 (621)
-.|.++++||+|+||.++.|+ .-+++.||||.-... ....++..|...++.+. .++|...+.|...+-+..||+|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc---CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 468889999999999999998 347999999975322 22346888999988885 6899999999888999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-----cEEEcccccce
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF-----EAVVGDFGLAK 448 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-----~~kl~DfGla~ 448 (621)
.+ |-||.|+..-.+. .|+..++..||.|++.-++|+|++ .+|.|||||+|+||...+ .+.|+|||+|+
T Consensus 105 LL-GPSLEDLFD~CgR---~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGR---RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hh-CcCHHHHHHHhcC---cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 87 6699998876543 389999999999999999999999 999999999999997543 58999999999
Q ss_pred ecccCCCe------eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh
Q 007020 449 LMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 522 (621)
Q Consensus 449 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 522 (621)
.+.+.... ...+..||.+||+--...+...+.+.|+-|+|-++.+++.|..||+.-...... + ...
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK-----~---kYe 249 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK-----E---KYE 249 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH-----H---HHH
Confidence 87654332 234456999999999999999999999999999999999999999743322211 1 111
Q ss_pred hhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 523 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 523 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
+....+..... .......+.++..-+...-..+-++-|..+-+...+.+
T Consensus 250 KIGe~Kr~T~i---~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~d 298 (449)
T KOG1165|consen 250 KIGETKRSTPI---EVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDD 298 (449)
T ss_pred HhccccccCCH---HHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 11111111111 11122234455555555557888999988777665544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-23 Score=211.71 Aligned_cols=258 Identities=20% Similarity=0.249 Sum_probs=190.8
Q ss_pred CCCcCceeeeccCceEEEEEcCCC--cEEEEEEecccCCchhHHHHHHHHHHHHhccC----Cceeeeeeee-ecCCceE
Q 007020 297 SFSNKNILGRGGFGKVYKGRLADG--SLVAVKRLKEERTPGGELQFQTEVEMISMAVH----RNLLRLRGFC-MTPTERL 369 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~ 369 (621)
+|.+.+.||+|+||.||.+..... ..+|+|........... .+..|..++..+.. +++..+++.. ..+...+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 789999999999999999996543 47999987654333222 67788888888763 6888898888 4777889
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC-----CcEEEccc
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE-----FEAVVGDF 444 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-----~~~kl~Df 444 (621)
+||+.+ |.+|.++..... ...++..++..|+.|++.+|++||+. |++||||||.|+++... ..+.+.||
T Consensus 98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 999977 669999886654 23488999999999999999999999 99999999999999865 46999999
Q ss_pred ccceecc--cCCCe----e---eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHH
Q 007020 445 GLAKLMD--YKDTH----V---TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 515 (621)
Q Consensus 445 Gla~~~~--~~~~~----~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~ 515 (621)
|+++... ..... . .....||..|.++....+...+.+.|+||++.++.|++.|..||........ .
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~----~- 246 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL----K- 246 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch----H-
Confidence 9998332 11111 1 1234599999999999999999999999999999999999999953321111 1
Q ss_pred HHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 516 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 516 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
.-+.... ....... ........+.++...+-..+..++|....+...+++.
T Consensus 247 ~~~~~~~----~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 247 SKFEKDP----RKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHHHHh----hhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 1111111 1111110 1111224555555556668999999999999887663
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.2e-24 Score=193.69 Aligned_cols=258 Identities=18% Similarity=0.217 Sum_probs=197.5
Q ss_pred HhcCCCcCceeeeccCceEEEEE-cCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccC-CceeeeeeeeecCCceEEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv 371 (621)
....|.+.++||+|+||.+|.|. ..+|..||||+-..... ..++..|..+++.++| ..|..+..|..+.....+|
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~---hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK---HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC---CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 34689999999999999999998 45799999998654332 3367889999998874 6788888888889999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC---CcEEEcccccce
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLAK 448 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DfGla~ 448 (621)
||.+ |.||.+++.-.... ++..+++-++.|++.-++|+|.+ ++|||||||+|+|..-+ ..+.++|||+|+
T Consensus 90 MdLL-GPsLEdLfnfC~R~---ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSRR---FTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eecc-CccHHHHHHHHhhh---hhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 9987 66999988765432 88899999999999999999999 89999999999999643 468999999998
Q ss_pred ecccCCCe------eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh
Q 007020 449 LMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 522 (621)
Q Consensus 449 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 522 (621)
.+.+.... ......||.+|.+--...+...+.+.|+-|+|.+|.++-.|..||+.-.....
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk------------- 229 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK------------- 229 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH-------------
Confidence 77543221 12345699999998888777888999999999999999999999973322111
Q ss_pred hhcccccccCcccc---CcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 523 KEKKLEMLVDPDLQ---NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 523 ~~~~~~~~~d~~~~---~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
..+.+.+...+.. ...+...+.++.-.+..|-..--++-|....+-+.++-.
T Consensus 230 -~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 230 -KQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred -HHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 1111111111111 112223356788888899999999999987777666543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-21 Score=200.30 Aligned_cols=262 Identities=28% Similarity=0.363 Sum_probs=198.2
Q ss_pred CCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCch--hHHHHHHHHHHHHhccCC-ceeeeeeeeecCCceEEEEec
Q 007020 298 FSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVHR-NLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 298 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 374 (621)
|...+.||.|+||.||++... ..+++|.+....... ....+.+|+.+++.+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999986 789999997665444 366799999999999988 799999999777778999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-cEEEcccccceecccC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYK 453 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~~~~~~ 453 (621)
+.++++.+++...... ..+.......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||.+......
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777654321 2478889999999999999999999 999999999999999988 7999999999865543
Q ss_pred CCe-----eeecccccccccchhhhcc---CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 454 DTH-----VTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 454 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
... ......|+..|+|||.+.+ ...+...|+||+|++++++++|..||...... .......+.+.. .
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~----~ 230 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTLKIILE----L 230 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHHHHHHh----c
Confidence 322 2355679999999999987 57889999999999999999999997533211 000111111111 1
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 526 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 526 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
... .................+.+++..|+..+|..|.+..+....
T Consensus 231 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 231 PTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 100 000000000001223567788889999999999999887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-23 Score=227.35 Aligned_cols=254 Identities=20% Similarity=0.246 Sum_probs=187.3
Q ss_pred CcCceeeeccCceEEEEEcC-CCcEEEEEEec----ccCCchh-HHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 299 SNKNILGRGGFGKVYKGRLA-DGSLVAVKRLK----EERTPGG-ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 299 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
...+++|.|++|.|+..... ..+.++.|.++ ....... ...+..|+.+-..+.|+|++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999988877643 33444444433 1111111 112566777778899999998888877776666669
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
|||++ +|+.++.... .+...++..++.|++.|++|||+. ||.|||+|++|++++.+|.+||+|||.+..+..
T Consensus 401 E~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 9999998752 266778999999999999999999 999999999999999999999999999987654
Q ss_pred CCC---eeeecccccccccchhhhccCCCCC-cccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 453 KDT---HVTTAVRGTIGHIAPEYLSTGKSSE-KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 453 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
... .......|+..|+|||++.+..|.+ ..||||.|+++..|.+|+.||..+....+.- .. .....
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------~~---~~~~~ 542 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------KT---NNYSD 542 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------hh---hcccc
Confidence 333 4556678999999999999988864 5899999999999999999997554332211 00 00000
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..-...-........+.....++..+++.+|.+|-|+++|++
T Consensus 543 ~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 543 QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 001111111223344567788999999999999999999976
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=183.20 Aligned_cols=140 Identities=16% Similarity=0.189 Sum_probs=108.3
Q ss_pred CceeeeccCceEEEEEcCCCcEEEEEEecccCCch-h------------------------HHHHHHHHHHHHhccCCce
Q 007020 301 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG-G------------------------ELQFQTEVEMISMAVHRNL 355 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~------------------------~~~~~~E~~~l~~l~h~ni 355 (621)
...||+|+||.||+|...+|+.||||+++...... . ......|++.+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999998889999999997643211 1 0122458999999988776
Q ss_pred eeeeeeeecCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCCeeeC
Q 007020 356 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL-HDHCDPKIIHRDVKAANILLD 434 (621)
Q Consensus 356 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlk~~Nill~ 434 (621)
.....+.. ...++||||++++++....... .+++...+..++.|++.+|.|+ |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 44333322 2348999999998776543222 2378889999999999999999 688 999999999999998
Q ss_pred CCCcEEEcccccceec
Q 007020 435 EEFEAVVGDFGLAKLM 450 (621)
Q Consensus 435 ~~~~~kl~DfGla~~~ 450 (621)
++.++|+|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=229.32 Aligned_cols=170 Identities=37% Similarity=0.639 Sum_probs=119.0
Q ss_pred cchhHHHHHHHHHhCCCCCCCCCCCCCCCCCCccceeeEEcCCCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCC
Q 007020 22 ANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNI 101 (621)
Q Consensus 22 ~~~~~~~l~~~~~~~~~~~~~l~~w~~~~~~~c~w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 101 (621)
...|..||++||+++.+|.+.+.+|+.. .+||.|.||+|++.++|+.|+|++|++++.++..|..+++|++|+|++|++
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~-~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~ 105 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSS-ADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQL 105 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCC-CCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCcc
Confidence 4478889999999999898889999754 689999999999888999999999999999999999999999999999999
Q ss_pred CCCCccccc-CCCccceeeeccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCC
Q 007020 102 TGPIPSDLG-NLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN 180 (621)
Q Consensus 102 ~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~ 180 (621)
++.+|..+. ++++|++|+|++|++++.+|. ..+++|++|+|++|.+++.+|..+.++++|++|+|++|.+.+..|..
T Consensus 106 ~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 183 (968)
T PLN00113 106 SGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183 (968)
T ss_pred CCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChh
Confidence 887776654 777777777777776654443 23444444444444444444444444444444444444444333322
Q ss_pred -CCCCCcccccccCC
Q 007020 181 -GSFSLFTPISFANN 194 (621)
Q Consensus 181 -~~~~~l~~l~l~~N 194 (621)
..+++|+.|++++|
T Consensus 184 ~~~l~~L~~L~L~~n 198 (968)
T PLN00113 184 LTNLTSLEFLTLASN 198 (968)
T ss_pred hhhCcCCCeeeccCC
Confidence 33444444444444
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-21 Score=183.76 Aligned_cols=174 Identities=10% Similarity=0.091 Sum_probs=135.0
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhH--HH------HHHHHHHHHhccCCceeeeeeeeec
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGE--LQ------FQTEVEMISMAVHRNLLRLRGFCMT 364 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--~~------~~~E~~~l~~l~h~niv~l~~~~~~ 364 (621)
....+|...+++|.|+||.||++.. ++..+|+|.++........ .. +.+|+..+.++.|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 5678999999999999999999766 5778999999765433221 12 5789999999999999999988653
Q ss_pred C--------CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC
Q 007020 365 P--------TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 436 (621)
Q Consensus 365 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~ 436 (621)
. ...+++|||++|.+|.++.. ++. ....+++.++..+|+. |++|||+||+||+++.+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence 3 35789999999999988732 222 3456999999999999 99999999999999998
Q ss_pred CcEEEcccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh
Q 007020 437 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496 (621)
Q Consensus 437 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt 496 (621)
+ ++|+|||........... ..+.....+..++|+||||+.+..+..
T Consensus 172 g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred C-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 8 999999987644211100 113344456678999999999876643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=212.41 Aligned_cols=257 Identities=24% Similarity=0.269 Sum_probs=190.3
Q ss_pred CCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHH---HHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 297 SFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGEL---QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
+|...+.||++.|=+|.+|++.+|. |+||++-+....-... +...|++ ...++|||.+.+.-....+.-.|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4556778999999999999998777 8999986554332233 3344444 566789999998888777777788889
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec--c
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--D 451 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~--~ 451 (621)
|..+ +|+|.+..+.- +...+.+-|+.|++.||..+|.. ||+|||||.+||||+.=.=+.|+||..-+-. .
T Consensus 102 yvkh-nLyDRlSTRPF----L~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPF----LVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhhccchH----HHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9877 99999987653 67778889999999999999999 9999999999999998878999999865422 2
Q ss_pred cCCC----eeeecccccccccchhhhccC----------C-CCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHH
Q 007020 452 YKDT----HVTTAVRGTIGHIAPEYLSTG----------K-SSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLL 515 (621)
Q Consensus 452 ~~~~----~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~ 515 (621)
..+. ...........|+|||.+... . .+++.||||+||+++||++ |++||...+.-
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~-------- 245 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLL-------- 245 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHH--------
Confidence 2111 122233355689999987542 1 4678999999999999999 78999744321
Q ss_pred HHHHH--HhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCCccchhh
Q 007020 516 DWVKG--LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDE 583 (621)
Q Consensus 516 ~~~~~--~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~~~~~ 583 (621)
.+-.+ ...+..++++.| ..+.++++.|++.||++|-++++.++.-++..+.+=|..
T Consensus 246 aYr~~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~yFy~ 303 (1431)
T KOG1240|consen 246 AYRSGNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPEYFYS 303 (1431)
T ss_pred hHhccCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhhccccHHHHHH
Confidence 11110 001111222222 357789999999999999999999999999888776544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.4e-22 Score=205.18 Aligned_cols=257 Identities=24% Similarity=0.272 Sum_probs=196.2
Q ss_pred eeeccCceEEEEE----cCCCcEEEEEEecccCCchh-HHHHHHHHHHHHhcc-CCceeeeeeeeecCCceEEEEeccCC
Q 007020 304 LGRGGFGKVYKGR----LADGSLVAVKRLKEERTPGG-ELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYMAN 377 (621)
Q Consensus 304 lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 377 (621)
+|+|.||.|+++. ...|..||.|.+++...... ......|..++...+ ||.+|++...++.+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999999764 33578899999876542221 224566788888887 99999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee
Q 007020 378 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457 (621)
Q Consensus 378 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 457 (621)
|.|...+.+... +++.....+...++-+++++|+. +|+|||+|++||+++.+|++++.|||+.+..-.....
T Consensus 82 g~lft~l~~~~~----f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 82 GDLFTRLSKEVM----FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred chhhhccccCCc----hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999988876443 77788888899999999999999 9999999999999999999999999999865432221
Q ss_pred eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccC
Q 007020 458 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537 (621)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 537 (621)
+||..|||||++. .....+|.||||++++||+||..||.. +-++.+++. ..
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~-----------~~ 204 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKA-----------EL 204 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhh-----------cc
Confidence 7999999999998 567889999999999999999999962 122222221 11
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCCCH--HHHHHHHhcCCCcc-chhhhhHhHhhhhccccCCCCCC
Q 007020 538 NYVEAEVEQLIQVALLCTQGSPMDRPKM--SEVVRMLEGDGLAE-RWDEWQKVEVLRQEVELAPHPNS 602 (621)
Q Consensus 538 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~--~~vl~~L~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 602 (621)
..+.+......+++..+...+|.+|--. ..+.+..+...... .|. +...+++..++.|.-
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~-----~l~~r~~~~~fkp~~ 267 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN-----ELEARSRPPPFKPGS 267 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh-----hHhhcCCCCCCCCcc
Confidence 2244555677778888889999999866 45555555544433 333 234455555555543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=208.59 Aligned_cols=159 Identities=39% Similarity=0.647 Sum_probs=128.3
Q ss_pred ccchhHHHHHHHHHhCCCCCCCCCCCCCCCCCCc-----cceeeEEcCC-----CcEEEEEcCCCCccccCcccccCCCC
Q 007020 21 SANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPC-----TWFHVTCNND-----NSVIRVDLGNAALSGQLVSQLGLLKN 90 (621)
Q Consensus 21 ~~~~~~~~l~~~~~~~~~~~~~l~~w~~~~~~~c-----~w~gv~c~~~-----~~l~~L~L~~n~l~~~~~~~~~~l~~ 90 (621)
....|..||+.+|..+.++.. .+|.+ ++| .|.||.|... ..++.|+|++|+|+|.+|..+..|++
T Consensus 369 t~~~~~~aL~~~k~~~~~~~~--~~W~g---~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~ 443 (623)
T PLN03150 369 TLLEEVSALQTLKSSLGLPLR--FGWNG---DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRH 443 (623)
T ss_pred cCchHHHHHHHHHHhcCCccc--CCCCC---CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCC
Confidence 455788899999999876642 48964 345 7999999532 24889999999999999999999999
Q ss_pred CcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeecc
Q 007020 91 LQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSN 170 (621)
Q Consensus 91 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 170 (621)
|+.|+|++|+|+|.+|..++++++|+.|+|++|+|+|.+|+.+++|++|+.|+|++|+++|.+|..+..+
T Consensus 444 L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~---------- 513 (623)
T PLN03150 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR---------- 513 (623)
T ss_pred CCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhc----------
Confidence 9999999999999999889999999999999999998899889999999999999999988888766432
Q ss_pred CcCcccCCCCCCCCCcccccccCCcccCCCCCCCCC
Q 007020 171 NRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPC 206 (621)
Q Consensus 171 N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~~~~~~c 206 (621)
+.++..+++.+|+.+|+.+....|
T Consensus 514 ------------~~~~~~l~~~~N~~lc~~p~l~~C 537 (623)
T PLN03150 514 ------------LLHRASFNFTDNAGLCGIPGLRAC 537 (623)
T ss_pred ------------cccCceEEecCCccccCCCCCCCC
Confidence 123456778888889986544444
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.3e-21 Score=196.98 Aligned_cols=216 Identities=24% Similarity=0.400 Sum_probs=165.8
Q ss_pred HhccCCceeeeeeeeecCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EecCC
Q 007020 348 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI-IHRDV 426 (621)
Q Consensus 348 ~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i-vH~Dl 426 (621)
+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+... ...+++.....++.+|+.||+|||.. .| .|+.+
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 4678999999999999999999999999999999999873 34589999999999999999999998 55 89999
Q ss_pred CCCCeeeCCCCcEEEcccccceecccC-CCeeeecccccccccchhhhccCC-------CCCcccchhHHHHHHHHHhCC
Q 007020 427 KAANILLDEEFEAVVGDFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGK-------SSEKTDVFGYGIMLLELITGQ 498 (621)
Q Consensus 427 k~~Nill~~~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwSlGvil~elltg~ 498 (621)
++.|++++....+|++|||+....... .........-..-|.|||.+.... .+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998765321 111111122445699999997641 367799999999999999999
Q ss_pred CCcccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCC
Q 007020 499 RAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGL 577 (621)
Q Consensus 499 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 577 (621)
.||+......+.+ .+..+++. .-.....|.+.... +....+..++..||..+|++||++++|-..++....
T Consensus 156 ~~~~~~~~~~~~~-eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 156 GPFDLRNLVEDPD-EIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred CccccccccCChH-HHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9998654433321 12222222 12222334333211 334579999999999999999999999988877654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=175.72 Aligned_cols=140 Identities=18% Similarity=0.228 Sum_probs=110.8
Q ss_pred CceeeeccCceEEEEEcCCCcEEEEEEecccCCch-h------------------------HHHHHHHHHHHHhccCCce
Q 007020 301 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG-G------------------------ELQFQTEVEMISMAVHRNL 355 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~------------------------~~~~~~E~~~l~~l~h~ni 355 (621)
...||+|+||+||+|...+|+.||||+++...... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999998789999999987643110 0 1124578899999999987
Q ss_pred eeeeeeeecCCceEEEEeccCCCchhhh-hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeee
Q 007020 356 LRLRGFCMTPTERLLVYPYMANGSVASC-LRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILL 433 (621)
Q Consensus 356 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill 433 (621)
.....+... ..++||||++++++... +.. ..++......++.|++.++.++|+ . ||+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 555444333 34899999998865443 332 136778899999999999999999 8 99999999999999
Q ss_pred CCCCcEEEcccccceecc
Q 007020 434 DEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 434 ~~~~~~kl~DfGla~~~~ 451 (621)
+ ++.++|+|||++....
T Consensus 152 ~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 152 H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred E-CCCEEEEEcccceecC
Confidence 9 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-20 Score=170.96 Aligned_cols=184 Identities=18% Similarity=0.091 Sum_probs=138.9
Q ss_pred cCceeeeccCceEEEEEcCCCcEEEEEEecccCC---chhHHHHHHHHHHHHhcc-CCceeeeeeeeecCCceEEEEecc
Q 007020 300 NKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT---PGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYM 375 (621)
Q Consensus 300 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 375 (621)
....|++|+||+||.+.. .+.+++.+.+..... ......+.+|+++++++. |+++.+++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 456799999999998876 578888777765433 112235789999999995 5889999886 4579999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCeeeCCCCcEEEcccccceecccCC
Q 007020 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDV-KAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-k~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
.|.+|...+.. ....++.|++++|+++|++ ||+|||| ||+|||++.++.++|+|||+|.......
T Consensus 81 ~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99998754321 1135778999999999999 9999999 7999999999999999999998654322
Q ss_pred Ce----e--------eecccccccccchhhhccC-CCC-CcccchhHHHHHHHHHhCCCCcc
Q 007020 455 TH----V--------TTAVRGTIGHIAPEYLSTG-KSS-EKTDVFGYGIMLLELITGQRAFD 502 (621)
Q Consensus 455 ~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwSlGvil~elltg~~pf~ 502 (621)
.. . ..-...++.|++|+...-. ..+ ...+.++-|.-+|.++|+..++-
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 10 0 0112267788888765332 223 56788999999999999998763
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.1e-20 Score=204.26 Aligned_cols=252 Identities=20% Similarity=0.243 Sum_probs=184.8
Q ss_pred HHHHHHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhcc---CCceeeeeeeeec
Q 007020 288 LRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV---HRNLLRLRGFCMT 364 (621)
Q Consensus 288 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 364 (621)
..+.++..+.|.+.+.||+|+||+||+|...+|+.||+|+=+.... .+|--=.+++.+++ -+-|..+...+.-
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~----WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP----WEFYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc----eeeeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 3456677888999999999999999999988899999998654332 12211122333333 3456666666667
Q ss_pred CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-------CC
Q 007020 365 PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE-------EF 437 (621)
Q Consensus 365 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-------~~ 437 (621)
.+.-+||+||.+.|||.++++... .++|..++.++.|+++.+++||.. +|||+||||+|+||.. ..
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~----~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNK----VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred CCcceeeeeccccccHHHhhccCC----CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCccc
Confidence 788899999999999999998433 389999999999999999999999 9999999999999953 34
Q ss_pred cEEEcccccceeccc-CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHH
Q 007020 438 EAVVGDFGLAKLMDY-KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLD 516 (621)
Q Consensus 438 ~~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~ 516 (621)
-++|+|||.+..+.- .+.......++|-.+-.+|+..|..+++++|.|.++.+++-|+.|+.-
T Consensus 839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~---------------- 902 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM---------------- 902 (974)
T ss_pred ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH----------------
Confidence 589999999875542 334466677899999999999999999999999999999999999742
Q ss_pred HHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 517 WVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 517 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
+ .. ......++..+......+...+++.+++ ..|=..=|...++...+++
T Consensus 903 --q--~~-~g~~~~~~~~~~Ry~~~~~W~~~F~~lL---N~~~~~~p~l~~lr~~~~~ 952 (974)
T KOG1166|consen 903 --E--VK-NGSSWMVKTNFPRYWKRDMWNKFFDLLL---NPDCDTLPNLQELRTELEE 952 (974)
T ss_pred --H--hc-CCcceeccccchhhhhHHHHHHHHHHHh---CcCcccchhHHHHHHHHHH
Confidence 1 00 0111122222222233344455665555 3555555677777777766
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.9e-20 Score=178.95 Aligned_cols=196 Identities=21% Similarity=0.289 Sum_probs=138.0
Q ss_pred cCCceeeeeeeeec---------------------------CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHH
Q 007020 351 VHRNLLRLRGFCMT---------------------------PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIA 403 (621)
Q Consensus 351 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~ 403 (621)
+|||||++.++|.+ +...|+||.-++. +|..++..+. .+.....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----CchHHHHHHH
Confidence 59999999988753 2345899988876 9999987654 4556788899
Q ss_pred HHHHHHHHHHHhCCCCCeEecCCCCCCeeeC--CCC--cEEEcccccceecccCC-----Ceeeecccccccccchhhhc
Q 007020 404 LGSARGLSYLHDHCDPKIIHRDVKAANILLD--EEF--EAVVGDFGLAKLMDYKD-----THVTTAVRGTIGHIAPEYLS 474 (621)
Q Consensus 404 ~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~~~--~~kl~DfGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~ 474 (621)
.|+++|+.|||++ ||.|||+|++|||+. +|+ .+.|+|||.+-.-.... ....-...|...-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 999999999999994 333 47899999875422211 11112234788899999986
Q ss_pred cCCC------CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHH
Q 007020 475 TGKS------SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLI 548 (621)
Q Consensus 475 ~~~~------~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~ 548 (621)
..+- -.|+|.|+.|.+.||+++...||..- ..+. +......+--- ...++.++..+.
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r-----Gem~--------L~~r~Yqe~qL----Palp~~vpp~~r 487 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR-----GEML--------LDTRTYQESQL----PALPSRVPPVAR 487 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCccccc-----chhe--------echhhhhhhhC----CCCcccCChHHH
Confidence 5431 35899999999999999999999631 0000 11111111111 122334456778
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHH
Q 007020 549 QVALLCTQGSPMDRPKMSEVVRML 572 (621)
Q Consensus 549 ~l~~~c~~~~P~~RPt~~~vl~~L 572 (621)
+++...++.||.+|++..-....|
T Consensus 488 qlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 488 QLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHHhcCCccccCCccHHHhHH
Confidence 888999999999999875544443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=176.10 Aligned_cols=233 Identities=23% Similarity=0.297 Sum_probs=146.9
Q ss_pred CcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccC----------Cceeeeeeee---
Q 007020 299 SNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVH----------RNLLRLRGFC--- 362 (621)
Q Consensus 299 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~--- 362 (621)
...+.||.|+++.||.+++. +|+.+|||++..... ....+++++|.-....+.+ -.++-.++..
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 34578999999999999975 589999999854432 2234566666655444322 1122112211
Q ss_pred ------ecC---C-----ceEEEEeccCCCchhhhhcc---CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 007020 363 ------MTP---T-----ERLLVYPYMANGSVASCLRE---RPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRD 425 (621)
Q Consensus 363 ------~~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 425 (621)
... . ..+++|+-+.+ +|.+++.. .......+....+..+..|+.+.+++||+. |+||+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence 111 1 23677887754 88877542 222111233445567778999999999999 999999
Q ss_pred CCCCCeeeCCCCcEEEcccccceecccCCCeeeecccccccccchhhhccC--------CCCCcccchhHHHHHHHHHhC
Q 007020 426 VKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG--------KSSEKTDVFGYGIMLLELITG 497 (621)
Q Consensus 426 lk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DvwSlGvil~elltg 497 (621)
|||+|++++.+|.++|+||+.....+.. ......+..|.+||..... .++.+.|.|++|+++|.|.+|
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999999999999999988754321 1113356789999987442 368889999999999999999
Q ss_pred CCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCC
Q 007020 498 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDR 562 (621)
Q Consensus 498 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~R 562 (621)
..||+.......... .+. .+.+.++.+..++..+++.+|++|
T Consensus 247 ~lPf~~~~~~~~~~~---------------------~f~--~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW---------------------DFS--RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG---------------------GGT--TSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc---------------------cch--hcCCcCHHHHHHHHHHccCCcccC
Confidence 999985443322211 111 122556788899999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=165.01 Aligned_cols=136 Identities=19% Similarity=0.217 Sum_probs=104.8
Q ss_pred CcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhc-----cCCceeeeeeeeecCC---ceE-
Q 007020 299 SNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-----VHRNLLRLRGFCMTPT---ERL- 369 (621)
Q Consensus 299 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~- 369 (621)
...+.||+|+||.||. +++....+||++.... ......+.+|+.+++.+ .||||++++|++.++. ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 4457899999999996 4433334799886543 22455789999999999 5799999999998864 333
Q ss_pred EEEec--cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCCeeeCC----CCcEEEc
Q 007020 370 LVYPY--MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGL-SYLHDHCDPKIIHRDVKAANILLDE----EFEAVVG 442 (621)
Q Consensus 370 lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~Dlk~~Nill~~----~~~~kl~ 442 (621)
+|+|| +.+|+|.+++.+.. +++. ..++.+++.++ +|||++ +|+||||||+|||++. ++.++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~-----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR-----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHccc-----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 55799999996531 4444 35677888777 999999 9999999999999974 3479999
Q ss_pred ccccc
Q 007020 443 DFGLA 447 (621)
Q Consensus 443 DfGla 447 (621)
||+.+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.9e-18 Score=164.76 Aligned_cols=143 Identities=14% Similarity=0.111 Sum_probs=111.0
Q ss_pred CCCcCceeeeccCceEEEEE--cCCCcEEEEEEecccCCch-----------------------hHHHHHHHHHHHHhcc
Q 007020 297 SFSNKNILGRGGFGKVYKGR--LADGSLVAVKRLKEERTPG-----------------------GELQFQTEVEMISMAV 351 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~ 351 (621)
-|.+.+.||+|+||.||+|. ..+|+.||+|+++...... ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46778899999999999998 5689999999987542110 1123568999999987
Q ss_pred CCc--eeeeeeeeecCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEecCCCC
Q 007020 352 HRN--LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK-IIHRDVKA 428 (621)
Q Consensus 352 h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlk~ 428 (621)
+.. +.+++++ ...++||||+++++|........ .........++.|++.++++||+. + |+||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 533 3344433 23589999999988876643221 255566789999999999999999 8 99999999
Q ss_pred CCeeeCCCCcEEEcccccceecc
Q 007020 429 ANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 429 ~Nill~~~~~~kl~DfGla~~~~ 451 (621)
+||+++ ++.++|+|||.+...+
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 7899999999987543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-17 Score=157.91 Aligned_cols=146 Identities=21% Similarity=0.144 Sum_probs=113.0
Q ss_pred HHHHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCc---------------------hhHHHHHHHHHHHH
Q 007020 290 ELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP---------------------GGELQFQTEVEMIS 348 (621)
Q Consensus 290 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~E~~~l~ 348 (621)
++......|...+.||+|+||.||++...+|+.||||+++..... ........|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 344444457888999999999999999888999999987643210 01123567888888
Q ss_pred hccCCc--eeeeeeeeecCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 007020 349 MAVHRN--LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDV 426 (621)
Q Consensus 349 ~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 426 (621)
.+.|++ +...++ ....+++|||+++++|...... .....++.+++.++.++|+. +|+||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl 151 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDL 151 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence 888774 444443 2456899999999998765431 24567889999999999998 9999999
Q ss_pred CCCCeeeCCCCcEEEcccccceeccc
Q 007020 427 KAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 427 k~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+||++++++.++|+|||.+.....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.4e-18 Score=177.20 Aligned_cols=175 Identities=23% Similarity=0.329 Sum_probs=129.9
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccc
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 446 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 446 (621)
..++.|++|..++|.++|..+.. ....++...+.++.|++.|++| + +.+|+|+||.||++..+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 56899999999999999975432 2336778899999999999999 6 899999999999999999999999999
Q ss_pred ceecccCC-----CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHH
Q 007020 447 AKLMDYKD-----THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGL 521 (621)
Q Consensus 447 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 521 (621)
........ ....+...||..||+||.+.+..|+.|+||||||+||+|++. +|+...
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~---------------- 463 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQF---------------- 463 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHH----------------
Confidence 98765443 223344569999999999999999999999999999999987 232111
Q ss_pred hhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 007020 522 LKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 568 (621)
Q Consensus 522 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~v 568 (621)
.+......+-|..+...+..+. .+=+.++.+++...|.+||++.++
T Consensus 464 er~~t~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 464 ERIATLTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HHHHhhhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence 1111222222222221111111 233467788999999999955444
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.7e-17 Score=158.49 Aligned_cols=135 Identities=20% Similarity=0.304 Sum_probs=113.8
Q ss_pred ceeeeccCceEEEEEcCCCcEEEEEEecccCCch-------hHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 302 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG-------GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
+.||+|++|.||+|.+ .|..|++|......... ....+.+|+.++..+.|++|.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5699999999999987 67789999865432211 123577899999999999988888777777888999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
++|++|.+++.... . .+..++.+++.+|.++|+. +++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986421 2 7889999999999999999 999999999999999 78899999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.5e-17 Score=157.13 Aligned_cols=131 Identities=19% Similarity=0.309 Sum_probs=107.4
Q ss_pred eeeeccCceEEEEEcCCCcEEEEEEecccCCch-------hHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEecc
Q 007020 303 ILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG-------GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 375 (621)
Q Consensus 303 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 375 (621)
.||+|+||.||+|.+ +|..|++|......... ...++.+|++++..+.|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999996 57889999865432111 1245778999999999887666666666677789999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+|++|.+++.... ..++.+++.+|.+||+. +++|||++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----------DELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-----------HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875421 07899999999999999 999999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.1e-17 Score=177.00 Aligned_cols=138 Identities=18% Similarity=0.281 Sum_probs=112.0
Q ss_pred hcCCCcCceeeeccCceEEEEEcCCCcEEEEEEe-cccCC-c-----hhHHHHHHHHHHHHhccCCceeeeeeeeecCCc
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRL-KEERT-P-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 367 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~~~-~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 367 (621)
...|...+.||+|+||+||+|.+... .+++|+. .+... . .....+.+|++++..++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34556678999999999999987544 3444432 22111 1 123458899999999999999988888877788
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
.++||||+++++|.+++. ....++.+++++|.|||+. +++||||||+|||+ .++.++|+|||++
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 899999999999998875 3467899999999999999 99999999999999 6778999999999
Q ss_pred ee
Q 007020 448 KL 449 (621)
Q Consensus 448 ~~ 449 (621)
+.
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 75
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.7e-17 Score=178.12 Aligned_cols=238 Identities=23% Similarity=0.320 Sum_probs=153.4
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
.+|..++.|..|+||.||..+++ +.+.+|+|+ ++... +.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l------ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL------ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccch------hhhc--cccccCCccee------------------
Confidence 56778899999999999999886 467788854 32211 0000 11122222222
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
|+=.+.+...+. ++ .+++.+++|||+. +|+|||+||+|.+|+.-|++|++|||+.+......
T Consensus 136 ---gDc~tllk~~g~----lP--------vdmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGP----LP--------VDMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ---chhhhhcccCCC----Cc--------chhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 344444443222 21 1227889999999 99999999999999999999999999886532111
Q ss_pred --------------CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH
Q 007020 455 --------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 520 (621)
Q Consensus 455 --------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 520 (621)
......++||+.|+|||++..+.|...+|.|++|+|+||++-|+.||..... ...+.+.+..
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp----eelfg~visd 273 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP----EELFGQVISD 273 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH----HHHHhhhhhh
Confidence 1122345799999999999999999999999999999999999999963321 1112222221
Q ss_pred HhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCCcc-chhhhhHhHhhhhccccCCC
Q 007020 521 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAE-RWDEWQKVEVLRQEVELAPH 599 (621)
Q Consensus 521 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 599 (621)
.+ .-++ .......+...++...++.+|..|--...-++.-++..+.. .|. ...||+.++-++
T Consensus 274 ~i--------~wpE----~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~-----~llRqkaefvpq 336 (1205)
T KOG0606|consen 274 DI--------EWPE----EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK-----SLLRQKAEFVPQ 336 (1205)
T ss_pred hc--------cccc----cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc-----hhhhhhcccccc
Confidence 11 0011 11222356777788888999999986655555444433322 332 344666666444
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.2e-18 Score=146.46 Aligned_cols=133 Identities=26% Similarity=0.426 Sum_probs=121.9
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+++.|.||+|+|+ .+|+.+..|.+|+.|+|++|+|+ .+|..+++|++|+.|+++-|++. .+|..|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 467899999999999 78999999999999999999999 88889999999999999999999 8999999999999999
Q ss_pred ccccccC-CCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcccCC
Q 007020 144 LNNNSLS-GPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCG 199 (621)
Q Consensus 144 l~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~ 199 (621)
|++|++. ..+|..|..+..|+.|+|+.|.+.-+|++.+.+++|+.|.+..|..+.-
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll~l 165 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLLSL 165 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchhhC
Confidence 9999997 4679999999999999999999999999999999999999999976554
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-15 Score=143.84 Aligned_cols=137 Identities=20% Similarity=0.213 Sum_probs=98.2
Q ss_pred CceeeeccCceEEEEEcCCCcEEEEEEecccCCchh-HHH----------------------HHHHHHHHHhccCCc--e
Q 007020 301 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGG-ELQ----------------------FQTEVEMISMAVHRN--L 355 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~----------------------~~~E~~~l~~l~h~n--i 355 (621)
.+.||+|+||+||+|...+|+.||||+++....... ... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999988899999999875432111 111 134555555554432 3
Q ss_pred eeeeeeeecCCceEEEEeccCCCchhhh-hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeee
Q 007020 356 LRLRGFCMTPTERLLVYPYMANGSVASC-LRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILL 433 (621)
Q Consensus 356 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill 433 (621)
.+.++. ...++||||++++++... +.... .. .....++.+++.++.++|+ . +|+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 334433 346899999999654321 21111 11 4678899999999999999 7 99999999999999
Q ss_pred CCCCcEEEcccccceecc
Q 007020 434 DEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 434 ~~~~~~kl~DfGla~~~~ 451 (621)
+ ++.++++|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.1e-15 Score=135.51 Aligned_cols=134 Identities=17% Similarity=0.135 Sum_probs=113.6
Q ss_pred CceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccC--CceeeeeeeeecCCceEEEEeccCCC
Q 007020 301 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH--RNLLRLRGFCMTPTERLLVYPYMANG 378 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 378 (621)
.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..++| .++.+++++....+..+++|||++++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 4679999999999999854 7899999865432 4568899999999986 58999999888888899999999998
Q ss_pred chhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 379 SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 379 sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
.+..+ +......++.++++++++||.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77654 3356678899999999999996444799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.6e-16 Score=173.49 Aligned_cols=255 Identities=22% Similarity=0.278 Sum_probs=190.3
Q ss_pred cCCCcCceeeeccCceEEEEEcC--CCcEEEEEEecccC-CchhHHHHHHHHHHHHhcc-CCceeeeeeeeecCCceEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA--DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 371 (621)
..|...+.||+|+|+.|-..... ....+|+|.+.... ..........|..+-..+. |.|++++++.....+..++.
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45666677999999999888753 34557777665442 2333344566777777776 99999999999999999999
Q ss_pred EeccCCCchhhhhc-cCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCCeeeCCCC-cEEEcccccce
Q 007020 372 YPYMANGSVASCLR-ERPPSQLPLDWPTRKRIALGSARGLSYLH-DHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAK 448 (621)
Q Consensus 372 ~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~ 448 (621)
++|..+|++.+.+. ... ...+......+..|+..++.|+| .. ++.|||+||+|.+++..+ ..+++|||+|.
T Consensus 100 ~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 99999999999883 321 12455677888999999999999 77 999999999999999999 99999999998
Q ss_pred eccc--CCCeeeecccc-cccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhh
Q 007020 449 LMDY--KDTHVTTAVRG-TIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 524 (621)
Q Consensus 449 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 524 (621)
.+.. ..........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++.+.... .....|+....
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~---~~~~~~~~~~~-- 248 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD---GRYSSWKSNKG-- 248 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc---ccceeeccccc--
Confidence 8765 23334445568 9999999999884 45788999999999999999999998554333 22223322210
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 525 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 525 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
...............++...++..+|..|.+.+++..
T Consensus 249 ---------~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 ---------RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ---------ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0000111222345677778888899999999888754
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1e-14 Score=142.39 Aligned_cols=136 Identities=18% Similarity=0.199 Sum_probs=105.1
Q ss_pred Cceee-eccCceEEEEEcCCCcEEEEEEecccCC------------chhHHHHHHHHHHHHhccCCce--eeeeeeeecC
Q 007020 301 KNILG-RGGFGKVYKGRLADGSLVAVKRLKEERT------------PGGELQFQTEVEMISMAVHRNL--LRLRGFCMTP 365 (621)
Q Consensus 301 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 365 (621)
...|| .|+.|+||++... +..++||++..... ......+.+|+.++..+.|++| .+.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35688 8999999999875 77899998853210 1223457889999999998875 6677664432
Q ss_pred C----ceEEEEeccCC-CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEE
Q 007020 366 T----ERLLVYPYMAN-GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV 440 (621)
Q Consensus 366 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 440 (621)
. ..++||||+++ .+|.+++.... ++.. .+.+++.++.+||+. ||+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~-----l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAP-----LSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCC-----CCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 22599999997 68988876421 3332 367899999999999 999999999999999988999
Q ss_pred Eccccccee
Q 007020 441 VGDFGLAKL 449 (621)
Q Consensus 441 l~DfGla~~ 449 (621)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999999875
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=7.7e-16 Score=134.24 Aligned_cols=130 Identities=22% Similarity=0.396 Sum_probs=122.9
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCC-CCCcccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTG-PIPDTLGKLSKLRFL 142 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L 142 (621)
..+|+.|+|++|+|. .+|..++.|++|+.|+++-|++. +.|..|+.++.|+.|||++|++.. .+|+.|..|+.|+.|
T Consensus 55 l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlral 132 (264)
T KOG0617|consen 55 LKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRAL 132 (264)
T ss_pred hhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHH
Confidence 357999999999999 78999999999999999999999 999999999999999999999974 479999999999999
Q ss_pred cccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 143 RLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 143 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
+|+.|.+. .+|..++++++|+.|.+..|.+-..|...+.+..|+.|.+.+|..
T Consensus 133 yl~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 133 YLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred HhcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhccccee
Confidence 99999999 899999999999999999999999999999999999999999975
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.1e-13 Score=144.63 Aligned_cols=142 Identities=23% Similarity=0.256 Sum_probs=99.9
Q ss_pred CceeeeccCceEEEEEcCCCcEEEEEEecccCCchh---------------------------------------HHHHH
Q 007020 301 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGG---------------------------------------ELQFQ 341 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------------------------------~~~~~ 341 (621)
.+.||.|++|.||+|+..+|+.||||+.+......- +.+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999865421110 01234
Q ss_pred HHHHHHHhcc----CCceeeeeeee-ecCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 007020 342 TEVEMISMAV----HRNLLRLRGFC-MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR-GLSYLHD 415 (621)
Q Consensus 342 ~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~-~L~~LH~ 415 (621)
.|...+.++. |.+-+.+-.++ ......++||||++|++|.++...... + . ....++..++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~--~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-G--L---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-C--C---CHHHHHHHHHHHHHHHHHh
Confidence 4555444442 22223322222 223457999999999999987653211 1 2 23456666666 4788898
Q ss_pred CCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 416 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 416 ~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
. |++|+|+||.||+++.++.++++|||++..++
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 99999999999999999999999999998765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.1e-14 Score=149.18 Aligned_cols=130 Identities=25% Similarity=0.233 Sum_probs=71.6
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 145 (621)
+++.|+|+.|+++..-...+.+|+.|+.|+||+|.|..+-++.+.-.++|++|+|++|+|+...++.|..|..|+.|+|+
T Consensus 270 kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs 349 (873)
T KOG4194|consen 270 KMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLS 349 (873)
T ss_pred ccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhccc
Confidence 45556666666655555555566666666666666665555555555666666666666664445555555555555555
Q ss_pred ccccCCCCCCCccCCccccEEeeccCcCcccCCCC----CCCCCcccccccCCc
Q 007020 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN----GSFSLFTPISFANNL 195 (621)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~----~~~~~l~~l~l~~N~ 195 (621)
+|.|...-...|..+++|+.|||++|.|+..+.+. .++++|+.|.|.||+
T Consensus 350 ~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNq 403 (873)
T KOG4194|consen 350 HNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQ 403 (873)
T ss_pred ccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCce
Confidence 55555444444555555555555555555444432 234455555555554
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.2e-13 Score=130.98 Aligned_cols=206 Identities=19% Similarity=0.274 Sum_probs=143.1
Q ss_pred HHHHHhccCCceeeeeeeeecC-----CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 007020 344 VEMISMAVHRNLLRLRGFCMTP-----TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 418 (621)
Q Consensus 344 ~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~ 418 (621)
+..+-.+.|.|||+++.|+.+. ....++.|||..|++..+|++....+..+....-.++..||+.||.|||+. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 4445567799999999998654 356899999999999999998776666788888899999999999999996 7
Q ss_pred CCeEecCCCCCCeeeCCCCcEEEcccccceecc---cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHH
Q 007020 419 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD---YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELI 495 (621)
Q Consensus 419 ~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell 495 (621)
|.|+|+++..+-|++..+|-+||.----..... ...........+-++|.|||.-.....+.++|||+||+-..||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 889999999999999999988875221111000 00011111223678999999877777788999999999999998
Q ss_pred hCCCCcccccccCCCcchH-HHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007020 496 TGQRAFDLARLANDDDVML-LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 572 (621)
Q Consensus 496 tg~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L 572 (621)
-+..--. +...... ..-+. ..+..+-++ .=..++..|++..|..||+|++++...
T Consensus 277 ilEiq~t-----nseS~~~~ee~ia-----~~i~~len~------------lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 277 ILEIQST-----NSESKVEVEENIA-----NVIIGLENG------------LQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HheeccC-----CCcceeehhhhhh-----hheeeccCc------------cccCcCcccccCCCCCCcchhhhhcCc
Confidence 8764211 0000000 00000 000000111 112456689999999999999987654
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.6e-14 Score=146.24 Aligned_cols=129 Identities=25% Similarity=0.396 Sum_probs=91.3
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCC-------------------
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFT------------------- 126 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~------------------- 126 (621)
++..|+||+|+|..+.-+.|.+|+.|-+||||+|++. .+|+.+..|..|++|+|++|.+.
T Consensus 127 n~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms 205 (1255)
T KOG0444|consen 127 NSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMS 205 (1255)
T ss_pred CcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcc
Confidence 4556666666666544455666777777777777777 56666777777777777777653
Q ss_pred ------CCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 127 ------GPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 127 ------~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
..+|.++..|.+|..+|||.|.+. .+|..+-++++|+.|+||+|+|+..........+|++|++|+|..
T Consensus 206 ~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQL 280 (1255)
T KOG0444|consen 206 NTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQL 280 (1255)
T ss_pred cccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchh
Confidence 345667777788888888888887 778888888888888888888877655555556666666666654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.37 E-value=5.5e-13 Score=142.95 Aligned_cols=146 Identities=22% Similarity=0.243 Sum_probs=93.0
Q ss_pred hcCCCcCceeeeccCceEEEEEcCC-CcEEEEEEecccCCch---------------------------------hHH--
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPG---------------------------------GEL-- 338 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~---------------------------------~~~-- 338 (621)
-..|+. +.||+|++|.||+|+.++ |+.||||+.+....+. ...
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 789999999999999877 9999999997542110 011
Q ss_pred ----HHHHHHHHHHhcc----CCceeeeeeeeec-CCceEEEEeccCCCchhhhh--ccCCCCCCCCCHHHHHHHHHHHH
Q 007020 339 ----QFQTEVEMISMAV----HRNLLRLRGFCMT-PTERLLVYPYMANGSVASCL--RERPPSQLPLDWPTRKRIALGSA 407 (621)
Q Consensus 339 ----~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~~~~~i~~~i~ 407 (621)
++.+|...+.+++ +.+.+.+=.++.+ ....++||||++|+.+.++- ...+ .+. ..++...+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-----~d~---~~la~~~v 269 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-----TDM---KLLAERGV 269 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-----CCH---HHHHHHHH
Confidence 1333443333332 3333333233322 34568999999999998742 2211 111 12222222
Q ss_pred H-HHHHHHhCCCCCeEecCCCCCCeeeCCCC----cEEEcccccceeccc
Q 007020 408 R-GLSYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDFGLAKLMDY 452 (621)
Q Consensus 408 ~-~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfGla~~~~~ 452 (621)
+ -+..++.. |++|+|+||.||+++.++ .++++|||++..++.
T Consensus 270 ~~~~~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 270 EVFFTQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 1 12334456 999999999999999888 999999999987653
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.34 E-value=6.1e-14 Score=137.89 Aligned_cols=115 Identities=30% Similarity=0.474 Sum_probs=104.4
Q ss_pred cCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccccccccCCCCCCCccC
Q 007020 80 QLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTN 159 (621)
Q Consensus 80 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 159 (621)
.+|..+..+++|+.|+|++|-+. .+|..++.+..|+.||||+|+|. .+|..+-.+..|+.+-.++|++....|..+.+
T Consensus 426 fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~n 503 (565)
T KOG0472|consen 426 FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKN 503 (565)
T ss_pred cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhh
Confidence 45667788899999999999998 88999999999999999999998 88988888888888888889999776777999
Q ss_pred CccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 160 ISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 160 l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
+.+|.+|||.+|.|..+||..+.+.+|+.|.+.|||+
T Consensus 504 m~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpf 540 (565)
T KOG0472|consen 504 MRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPF 540 (565)
T ss_pred hhhcceeccCCCchhhCChhhccccceeEEEecCCcc
Confidence 9999999999999999999999999999999999986
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.8e-12 Score=135.42 Aligned_cols=248 Identities=21% Similarity=0.193 Sum_probs=180.0
Q ss_pred CCCcCceeee--ccCceEEEEEc---CCCcEEEEEEecccCC-chhHHHHHHHHHHHHhcc-CCceeeeeeeeecCCceE
Q 007020 297 SFSNKNILGR--GGFGKVYKGRL---ADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 297 ~~~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 369 (621)
.|...+.+|. |.+|.||.+.. .++..+|+|.-+.... +.....=.+|+...+.++ |+|.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4455677999 99999999986 3688899998433221 122223346676666665 999999999999999999
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCCCeeeCCC-CcEEEccc
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR----GLSYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDF 444 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Df 444 (621)
+-+|++. .+|.++.+.... .++....+.+..+..+ |+.++|+. .++|-|+||.||+...+ ...+++||
T Consensus 195 iqtE~~~-~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeecccc-chhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 9999886 588888776432 1566677888888888 99999999 99999999999999999 88999999
Q ss_pred ccceecccCCCe----eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH
Q 007020 445 GLAKLMDYKDTH----VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 520 (621)
Q Consensus 445 Gla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 520 (621)
|+...+....-. ......|...|++||..++ -++..+|+||+|.++.+..++..++...... .|..
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--------~W~~- 337 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS--------SWSQ- 337 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC--------Cccc-
Confidence 999877654311 1223357889999998754 5678899999999999999988776432110 1211
Q ss_pred HhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 521 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 521 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
+.... ++.++......++...+..+++.+|-.|++.+.+..
T Consensus 338 ------~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 ------LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ------ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00011 122222233345666888999999999999877654
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.34 E-value=8.2e-14 Score=143.65 Aligned_cols=134 Identities=28% Similarity=0.370 Sum_probs=105.7
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCC-CCCccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTG-PIPDTLGKLSKLRFLR 143 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~ 143 (621)
.+|+.|+||+|+|+ .+.-..+...+|++|+||.|+++ .+|.++..|++|+.|++.+|+++- -+|+.+++|.+|+.+.
T Consensus 245 ~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~ 322 (1255)
T KOG0444|consen 245 RNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFH 322 (1255)
T ss_pred hhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHH
Confidence 35667777777776 44445555667777777777777 778888888888888888887662 2677888888888888
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcccCCCC
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPV 201 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~~ 201 (621)
.++|++. ..|..++.|.+|+.|.|++|++...|..+.-++.|+.|++..||.+-.+|
T Consensus 323 aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 323 AANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred hhccccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCccCCC
Confidence 8888888 78888999999999999999999888888888899999999998876654
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.5e-12 Score=132.12 Aligned_cols=129 Identities=26% Similarity=0.276 Sum_probs=92.6
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 145 (621)
..+.|||++|.|+...+..|.++++|+.++|.+|.++ .+|.......+|+.|+|.+|.|+..-.+.+..++.|+.||||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 4567999999999888888889999998888888888 777555555568888888888876656667777777777777
Q ss_pred ccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCc
Q 007020 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNL 195 (621)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~ 195 (621)
.|.|+.+.-.+|..-.+|++|+|++|+|+.+-... .++.+|..|.|+.|.
T Consensus 158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNr 208 (873)
T KOG4194|consen 158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNR 208 (873)
T ss_pred hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCc
Confidence 77777444445555566666776666666655543 455566666666664
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=5.3e-12 Score=116.98 Aligned_cols=131 Identities=20% Similarity=0.186 Sum_probs=97.0
Q ss_pred CceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCcee-eeeeeeecCCceEEEEeccCCCc
Q 007020 301 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL-RLRGFCMTPTERLLVYPYMANGS 379 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gs 379 (621)
.+.|+.|.++.||++... ++.|++|....... ....+..|+.+++.+.+.+++ +++.+. ....++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 356899999999999875 77899998754432 123567899998888765544 444443 334689999999988
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 380 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC--DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 380 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+.+. . . ....++.+++++|+.||+.. ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 78 l~~~--~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTE--D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc--c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 7643 0 1 11345678999999999982 12359999999999999 66899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.31 E-value=6.1e-14 Score=137.88 Aligned_cols=125 Identities=27% Similarity=0.353 Sum_probs=86.9
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccc-cccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLG-KLSKLRFLRL 144 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l 144 (621)
+|+.||..+|-++ .+|+.++.|.+|..|+|..|+|. .+| .|.++..|++|+++.|+|. .+|.... ++++|..|||
T Consensus 184 ~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDL 259 (565)
T KOG0472|consen 184 RLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDL 259 (565)
T ss_pred HHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeec
Confidence 5566666666665 56666777777777777777776 555 6677777777777777776 5555433 6777777777
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
..|+++ +.|..+.-+.+|++||+++|.|++.++..+++ +|+.|.+.|||.
T Consensus 260 RdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPl 309 (565)
T KOG0472|consen 260 RDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPL 309 (565)
T ss_pred cccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCch
Confidence 777777 66777777777777777777777777777776 777777777763
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.1e-13 Score=133.95 Aligned_cols=137 Identities=26% Similarity=0.354 Sum_probs=124.2
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeecc-ccCCCCCCcccccccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYL-NSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~l 144 (621)
..+.|+|..|+|+.+.+.+|..+.+|+.||||+|+|+.+-|++|.+|.+|..|-+-+ |+|+...-+.|.+|.+|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 678999999999988889999999999999999999999999999999998886655 9999666678999999999999
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcccCCCCC
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDLCGPVT 202 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~~~~~~ 202 (621)
.-|++.-.....|..+++|..|.+-.|.+..+.... ..+..++++.++.|++.|.+.+
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL 206 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNL 206 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccccccc
Confidence 999999777889999999999999999999887744 7788999999999998887643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.1e-10 Score=123.29 Aligned_cols=231 Identities=18% Similarity=0.178 Sum_probs=153.9
Q ss_pred CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCchhhhhccCCCCCCCCCHH
Q 007020 318 ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWP 397 (621)
Q Consensus 318 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~ 397 (621)
.++.+|.|...+.... .......+.++.++.++||||++++..+......|+|+|-+. -|..++.+. ...
T Consensus 35 ~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~~ 104 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GKE 104 (690)
T ss_pred ccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HHH
Confidence 3677888888765433 333456778889999999999999999999999999999875 466666653 234
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeeeecccccccccchhhhccCC
Q 007020 398 TRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 477 (621)
Q Consensus 398 ~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 477 (621)
...-.+.||+.||.|||..| +++|++|.-.-|+++..|+.||++|-++........ ......--..|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 66777899999999999776 899999999999999999999999998865432221 111111222466666543222
Q ss_pred CCCcccchhHHHHHHHHHhCCCCcccccccCCCcc---hHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhc
Q 007020 478 SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDV---MLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLC 554 (621)
Q Consensus 478 ~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c 554 (621)
-..|.|-||++++|++.|..+- .......+. ........ ++..... .... ..+++..|
T Consensus 182 --~s~D~~~Lg~li~el~ng~~~~--~~~~~~~~~ipk~~~~~~~k--------~~~~~~~------~r~n-~~~~~~~~ 242 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNGSLLT--KTDLSNTGKIPKALIELYCK--------KLGATEL------KRPN-KLRFILEC 242 (690)
T ss_pred --cchhhhhHHHHHHHHhCcccCc--chhhhccCccchhHHHHHHH--------Hhccccc------cccc-hhhHHHHH
Confidence 2369999999999999993221 111000000 00000000 0000000 0012 55677777
Q ss_pred cCCCCCCCCCHHHHHHHHhcCCCccc
Q 007020 555 TQGSPMDRPKMSEVVRMLEGDGLAER 580 (621)
Q Consensus 555 ~~~~P~~RPt~~~vl~~L~~~~~~~~ 580 (621)
.....-.|=.+-+++..|++..+.+.
T Consensus 243 ~~~~gff~n~fvd~~~fLeel~lks~ 268 (690)
T KOG1243|consen 243 RLLGGFFRNDFVDTLLFLEELRLKSV 268 (690)
T ss_pred HhccccccchHHHHHHHHHhcccCcH
Confidence 77777888888888888888766653
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.6e-13 Score=144.49 Aligned_cols=130 Identities=31% Similarity=0.385 Sum_probs=117.1
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
..|+.|.|.+|.|+...-+.|.++.+|+.|+|++|+|.......+.++..|+.|+||+|+++ .+|+.+.++..|++|..
T Consensus 359 ~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a 437 (1081)
T KOG0618|consen 359 AALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA 437 (1081)
T ss_pred HHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence 36889999999999998899999999999999999999666677899999999999999999 89999999999999999
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCccc
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDL 197 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~ 197 (621)
.+|+|. .+| .+..++.|+.+|++.|+|+...-.. ...++|++|+|+||.++
T Consensus 438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred cCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 999999 778 8899999999999999998764433 33389999999999963
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.6e-12 Score=118.82 Aligned_cols=121 Identities=27% Similarity=0.330 Sum_probs=45.9
Q ss_pred cEEEEEcCCCCccccCccccc-CCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccc-cccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLG-LLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTL-GKLSKLRFLR 143 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~ 143 (621)
+++.|+|++|+|+. + +.++ .+.+|+.|+|++|.|+.. . .+..|+.|+.|+|++|+|+ .+.+.+ ..+++|+.|+
T Consensus 20 ~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred cccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 57788888888883 3 2454 578888888888888843 3 5788888888888888888 444444 4688888888
Q ss_pred ccccccCCCC-CCCccCCccccEEeeccCcCcccCCC----CCCCCCcccccc
Q 007020 144 LNNNSLSGPI-PMSLTNISSLQVLDLSNNRLSGVVPD----NGSFSLFTPISF 191 (621)
Q Consensus 144 l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~~~l~~l~l 191 (621)
|++|+|...- -..+..+++|+.|+|.+|+++....- ...+++|+.||.
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 8888887421 13456788888888888888754221 134666766654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.3e-10 Score=108.49 Aligned_cols=137 Identities=13% Similarity=0.122 Sum_probs=98.5
Q ss_pred ceeeeccCceEEEEEcCC-------CcEEEEEEecccCC---------------------chhHHHHH----HHHHHHHh
Q 007020 302 NILGRGGFGKVYKGRLAD-------GSLVAVKRLKEERT---------------------PGGELQFQ----TEVEMISM 349 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~---------------------~~~~~~~~----~E~~~l~~ 349 (621)
..||.|.=+.||.|...+ +..+|||+.+.... ......+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 47999998863210 11122233 78888888
Q ss_pred ccC--CceeeeeeeeecCCceEEEEeccCCCchhh-hhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecC
Q 007020 350 AVH--RNLLRLRGFCMTPTERLLVYPYMANGSVAS-CLRERPPSQLPLDWPTRKRIALGSARGLSYL-HDHCDPKIIHRD 425 (621)
Q Consensus 350 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~D 425 (621)
+.. -++..++++ ...++||||+.++.+.. .+.+. .++......+..+++.+|..| |.. ++||+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 763 455555554 56789999998754422 22221 144456677889999999999 788 999999
Q ss_pred CCCCCeeeCCCCcEEEcccccceecc
Q 007020 426 VKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 426 lk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|++.||++++ +.+.|+|||.+....
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeCC
Confidence 9999999974 679999999887544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=9.6e-13 Score=129.41 Aligned_cols=92 Identities=22% Similarity=0.243 Sum_probs=64.0
Q ss_pred cCCCccceeeeccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCccc
Q 007020 110 GNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTP 188 (621)
Q Consensus 110 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~ 188 (621)
..|++|+.|+|++|+|+.+-+++|.++..|+.|.|..|+|...-...|.++..|+.|+|.+|+|+.+.+.. ..+.+|.+
T Consensus 271 ~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~ 350 (498)
T KOG4237|consen 271 KKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLST 350 (498)
T ss_pred hhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeee
Confidence 34555555555555555555555555666666666666655444456777888888899999998887766 66778888
Q ss_pred ccccCCcccCCCC
Q 007020 189 ISFANNLDLCGPV 201 (621)
Q Consensus 189 l~l~~N~~~~~~~ 201 (621)
|++-.||+.|.+.
T Consensus 351 l~l~~Np~~CnC~ 363 (498)
T KOG4237|consen 351 LNLLSNPFNCNCR 363 (498)
T ss_pred eehccCcccCccc
Confidence 9999999988764
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.1e-12 Score=124.39 Aligned_cols=126 Identities=25% Similarity=0.309 Sum_probs=109.6
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
..|+.||||+|.|+ .+.++..-++.++.|+||+|.|+. +- ++..|++|+.||||+|.++ .+.+.-.+|-+++.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-VQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEeccccceee-eh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 36889999999999 788888899999999999999994 33 4899999999999999999 66777778999999999
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCC--CCCCCCCcccccccCCcc
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP--DNGSFSLFTPISFANNLD 196 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~~l~~l~l~~N~~ 196 (621)
+.|.|... ..+..+-+|..||+++|+|..... .+++++.|+.+.|.+||.
T Consensus 360 a~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl 411 (490)
T KOG1259|consen 360 AQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPL 411 (490)
T ss_pred hhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCc
Confidence 99999832 467788899999999999987644 448899999999999984
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.7e-10 Score=111.80 Aligned_cols=143 Identities=19% Similarity=0.219 Sum_probs=110.3
Q ss_pred ceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccC--CceeeeeeeeecC---CceEEEEeccC
Q 007020 302 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH--RNLLRLRGFCMTP---TERLLVYPYMA 376 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~e~~~ 376 (621)
+.|+.|.++.||++...+|+.+++|.............+..|.++++.+.+ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 568999999999998876789999997654322234468899999998875 3456677776553 25689999999
Q ss_pred CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 007020 377 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC--------------------------------------- 417 (621)
Q Consensus 377 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------- 417 (621)
|.++.+.+.. ..++......++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9988876542 12666778888889999999888521
Q ss_pred --------------CCCeEecCCCCCCeeeCC--CCcEEEccccccee
Q 007020 418 --------------DPKIIHRDVKAANILLDE--EFEAVVGDFGLAKL 449 (621)
Q Consensus 418 --------------~~~ivH~Dlk~~Nill~~--~~~~kl~DfGla~~ 449 (621)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.9e-11 Score=127.80 Aligned_cols=248 Identities=20% Similarity=0.194 Sum_probs=173.3
Q ss_pred HHhcCCCcCceeeeccCceEEEEEc--CCCcEEEEEEecccCCchhHH-HHHHHHHHHHhc-cCCceeeeeeeeecCCce
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRL--ADGSLVAVKRLKEERTPGGEL-QFQTEVEMISMA-VHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~-~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 368 (621)
....+|..+..||.|.|+.|+.... .++..|++|.+.........+ .-..|+.+...+ .|.++++....+....+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 4456788899999999999998763 368899999886654332222 224556555544 589999988888777888
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC-CcEEEcccccc
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLA 447 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfGla 447 (621)
++-.||+.++++...+.- ...++...++.+..|++.++.++|+. .++|+|+||+||++..+ +.-+++|||.+
T Consensus 342 ~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence 899999999988776622 22377788899999999999999999 99999999999999886 78899999998
Q ss_pred eecccCCCeeeeccccccccc--chhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 448 KLMDYKDTHVTTAVRGTIGHI--APEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
..+... .....+..++. +++......+..+.|+||||.-+.+..+|...-.... +|..
T Consensus 415 t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----------~~~~------ 474 (524)
T KOG0601|consen 415 TRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----------QSLT------ 474 (524)
T ss_pred ccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc----------ccee------
Confidence 642211 11112334444 4555555667899999999999999999874321100 1100
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007020 526 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573 (621)
Q Consensus 526 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 573 (621)
+..-.-+... .....+..+...+...++..||.+.++..+.+
T Consensus 475 -i~~~~~p~~~-----~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 475 -IRSGDTPNLP-----GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred -eecccccCCC-----chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 0000001111 11245666677777899999999988766543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.18 E-value=5.6e-12 Score=115.18 Aligned_cols=119 Identities=34% Similarity=0.410 Sum_probs=41.7
Q ss_pred EcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCccccc-CCCccceeeeccccCCCCCCccccccccccccccccccc
Q 007020 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLG-NLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSL 149 (621)
Q Consensus 71 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 149 (621)
.|+.+.|. .. +.+.+..++++|+|++|+|+. +. .++ .+.+|+.|||++|.|+. ++ .+..+++|+.|+|++|+|
T Consensus 3 ~lt~~~i~-~~-~~~~n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I 76 (175)
T PF14580_consen 3 RLTANMIE-QI-AQYNNPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRI 76 (175)
T ss_dssp -------------------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS--
T ss_pred cccccccc-cc-ccccccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCC
Confidence 34555555 22 234556689999999999994 43 566 68999999999999994 44 588999999999999999
Q ss_pred CCCCCCCc-cCCccccEEeeccCcCcccCCCC--CCCCCcccccccCCcc
Q 007020 150 SGPIPMSL-TNISSLQVLDLSNNRLSGVVPDN--GSFSLFTPISFANNLD 196 (621)
Q Consensus 150 ~~~~p~~~-~~l~~L~~L~l~~N~l~~~~~~~--~~~~~l~~l~l~~N~~ 196 (621)
+. +...+ ..+++|+.|++++|+|.....-. ..+++|+.|++.+||.
T Consensus 77 ~~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv 125 (175)
T PF14580_consen 77 SS-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPV 125 (175)
T ss_dssp -S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GG
T ss_pred Cc-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcc
Confidence 94 44444 46899999999999998765432 6789999999999985
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.14 E-value=8.8e-10 Score=112.86 Aligned_cols=242 Identities=17% Similarity=0.209 Sum_probs=164.4
Q ss_pred cCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeee----cCCceEEEEeccCC-Cchh
Q 007020 308 GFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM----TPTERLLVYPYMAN-GSVA 381 (621)
Q Consensus 308 ~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~ 381 (621)
...+.|++.. .+|..|++|+++..+....- .-..-+++++++.|.|||++.+++. .+..+++||+|+++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n-k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN-KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc-cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 3457899975 48999999999544322111 1234578899999999999999886 34567999999996 5777
Q ss_pred hhhccCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 382 SCLRERP-----------PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 382 ~~l~~~~-----------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
++-.... ..+...++...+.++.|+..||.++|+. |+.-+-|.+++||++.+.+++|+..|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 7643321 1233477889999999999999999999 9999999999999999999999988887665
Q ss_pred ccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
..... |.+.+ ..+-|.=.||.+++.|.||..--. ..+... ...++.
T Consensus 444 ~~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~------~~d~~~---------~s~~~~- 489 (655)
T KOG3741|consen 444 QEDPT---------------EPLES---QQQNDLRDLGLLLLALATGTENSN------RTDSTQ---------SSHLTR- 489 (655)
T ss_pred cCCCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccccc------cccchH---------HHHHHH-
Confidence 43320 11111 235788899999999999964210 000000 000111
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCCccchhhhhHhHhhhhcccc
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVEL 596 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~~~~~~~~~~~~~~~~~~ 596 (621)
.......++.+++.......+++ -++.+++.++-+..+..--..+.+.+.++.+++.
T Consensus 490 --------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~vmes~q~~~d~mE~~Ls~ 546 (655)
T KOG3741|consen 490 --------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTVMESVQLKTDVMETELSR 546 (655)
T ss_pred --------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHH
Confidence 11233456666777666777776 7888888887765555444444455555555443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.8e-10 Score=100.23 Aligned_cols=132 Identities=20% Similarity=0.311 Sum_probs=99.5
Q ss_pred ceeeeccCceEEEEEcCCCcEEEEEE-ecccCCchh------HHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 302 NILGRGGFGKVYKGRLADGSLVAVKR-LKEERTPGG------ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
..+++|+=+.+|.+.+. |..+++|. +++...... .....+|..++.++.--.|--..=+..+++...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999775 44456664 333222111 22456788888888755555555566688888999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
++|..|.+.+... ...++..+-.-+.-||.. ||||+||.++||+++.+. +.++|||++.+
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888764 135667777788899999 999999999999998875 99999999874
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=8.8e-11 Score=130.50 Aligned_cols=90 Identities=41% Similarity=0.650 Sum_probs=86.5
Q ss_pred CCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeec
Q 007020 90 NLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLS 169 (621)
Q Consensus 90 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 169 (621)
.++.|+|++|.++|.+|..+.+|++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|++.+|..+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcCcccCCC
Q 007020 170 NNRLSGVVPD 179 (621)
Q Consensus 170 ~N~l~~~~~~ 179 (621)
+|++++..|.
T Consensus 499 ~N~l~g~iP~ 508 (623)
T PLN03150 499 GNSLSGRVPA 508 (623)
T ss_pred CCcccccCCh
Confidence 9999988774
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.8e-11 Score=131.10 Aligned_cols=250 Identities=18% Similarity=0.192 Sum_probs=166.4
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
...+.+.+.+-+-+|.++.++.+.-. .|...+.|....... .........+-.++-..++|.+++...-+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 44566777778899999999988643 354455554432211 001112223333333345677776655555567789
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
|+++|..+++|...++.... .+..........+.++++|||+. .+.|+|++|.|.++..++..+++|||....
T Consensus 881 L~~~~~~~~~~~Skl~~~~~----~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGC----LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred hhhHHhccCCchhhhhcCCC----cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccc
Confidence 99999999999999987552 45555666777888999999998 799999999999999999999999984332
Q ss_pred ccc------C------------------CC------eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCC
Q 007020 450 MDY------K------------------DT------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQR 499 (621)
Q Consensus 450 ~~~------~------------------~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~ 499 (621)
.+. . .. .......||+.|.+||...+......+|.|++|++++|.++|.+
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 210 0 00 01223458999999999999999999999999999999999999
Q ss_pred CcccccccCCCcchHHHHHHHHhhhcccccccCcccc-CcccHHHHHHHHHHHHhccCCCCCCCCCHH
Q 007020 500 AFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ-NNYVEAEVEQLIQVALLCTQGSPMDRPKMS 566 (621)
Q Consensus 500 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ 566 (621)
||+..... +..+.+.+ .... .....+......+++..-+..+|.+|-.+.
T Consensus 1034 p~na~tpq--------~~f~ni~~---------~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQ--------QIFENILN---------RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCcchh--------hhhhcccc---------CCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99743321 11111111 1110 011122234455566666678888888776
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.1e-09 Score=95.04 Aligned_cols=144 Identities=17% Similarity=0.289 Sum_probs=105.2
Q ss_pred cCceeeeccCceEEEEEcCCCcEEEEEE-ecccC-Cch-----hHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 300 NKNILGRGGFGKVYKGRLADGSLVAVKR-LKEER-TPG-----GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 300 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~-~~~~~-~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
...++-+|+-+.|+++.+. |+...||. +.+.. .+. ...+..+|...+.++.--.|.-..=++.+.....++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 3467899999999999985 77766664 33222 111 2335678999988887555555555667777888999
Q ss_pred eccCC-CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC---cEEEcccccce
Q 007020 373 PYMAN-GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAK 448 (621)
Q Consensus 373 e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~DfGla~ 448 (621)
||++| .++.+++...-... ........++..|-+.+.-||.. +|+|+||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99987 47888877643221 22223367888999999999999 999999999999996554 46899999976
Q ss_pred e
Q 007020 449 L 449 (621)
Q Consensus 449 ~ 449 (621)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 3
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=3e-10 Score=126.33 Aligned_cols=35 Identities=20% Similarity=0.129 Sum_probs=22.4
Q ss_pred cccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 162 SLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 162 ~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
+|+.|++++|+|+.+|.....+++|+.|+|++|+.
T Consensus 423 ~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~L 457 (788)
T PRK15387 423 GLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPL 457 (788)
T ss_pred hhhhhhhccCcccccChHHhhccCCCeEECCCCCC
Confidence 45556666666665555556667777777777764
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.4e-11 Score=123.05 Aligned_cols=127 Identities=30% Similarity=0.411 Sum_probs=103.3
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
+.|+.|||+.|+++ .+|..++.|+ |+.|-+++|+++ .+|..++.+..|..||.+.|+|. .+|..++.+.+|+.|.+
T Consensus 121 ~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~v 196 (722)
T KOG0532|consen 121 EALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNV 196 (722)
T ss_pred hHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHH
Confidence 46778888888888 6677766654 788888888888 77888888888888888888888 67888888888888888
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCccc
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDL 197 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~ 197 (621)
..|++. .+|..+.. -.|..||+++|+|+.+|..+..|..|+.|-|.+||.-
T Consensus 197 rRn~l~-~lp~El~~-LpLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 197 RRNHLE-DLPEELCS-LPLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred hhhhhh-hCCHHHhC-CceeeeecccCceeecchhhhhhhhheeeeeccCCCC
Confidence 888888 56777764 3588899999999988888888899999999999853
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.8e-10 Score=86.60 Aligned_cols=58 Identities=43% Similarity=0.581 Sum_probs=23.1
Q ss_pred cceeeeccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccCc
Q 007020 115 LVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNR 172 (621)
Q Consensus 115 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 172 (621)
|++|+|++|+|+...++.|.++++|+.|+|++|+|+...|..|.++++|+.|++++|+
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 3344444444442222333444444444444444443333344444444444444443
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.1e-10 Score=85.30 Aligned_cols=61 Identities=41% Similarity=0.615 Sum_probs=55.5
Q ss_pred CCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccccccccc
Q 007020 89 KNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSL 149 (621)
Q Consensus 89 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 149 (621)
++|++|+|++|+|+...+..|.++++|++|+|++|+|+...|+.|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5789999999999977778999999999999999999977788899999999999999986
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=6.7e-09 Score=96.63 Aligned_cols=127 Identities=22% Similarity=0.234 Sum_probs=83.3
Q ss_pred eEEEEEcCCCcEEEEEEecccCC------------c--------h-----hHHHHHHHHHHHHhccCC--ceeeeeeeee
Q 007020 311 KVYKGRLADGSLVAVKRLKEERT------------P--------G-----GELQFQTEVEMISMAVHR--NLLRLRGFCM 363 (621)
Q Consensus 311 ~Vy~~~~~~~~~vavK~~~~~~~------------~--------~-----~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 363 (621)
.||.|...+|..+|||+.+.... . . .....++|.+.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 48999988899999998864210 0 0 112357799999998755 45556554
Q ss_pred cCCceEEEEeccC--CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEecCCCCCCeeeCCCCcEE
Q 007020 364 TPTERLLVYPYMA--NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY-LHDHCDPKIIHRDVKAANILLDEEFEAV 440 (621)
Q Consensus 364 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~-LH~~~~~~ivH~Dlk~~Nill~~~~~~k 440 (621)
....+||||++ |..+..+... . ++......++.+++..+.. +|.. ||+|+||.+.||+++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~-~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDV-D-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHC-G-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccchhhHHhc-c-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 24579999999 5455443322 1 1123566778888886666 4677 99999999999999988 899
Q ss_pred Ecccccceecc
Q 007020 441 VGDFGLAKLMD 451 (621)
Q Consensus 441 l~DfGla~~~~ 451 (621)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=5.5e-11 Score=128.80 Aligned_cols=130 Identities=25% Similarity=0.266 Sum_probs=110.4
Q ss_pred CcEEEEEcCCCCccccCccccc--------------------------CCCCCcEEEeeeCCCCCCCcccccCCCcccee
Q 007020 65 NSVIRVDLGNAALSGQLVSQLG--------------------------LLKNLQYLELYSNNITGPIPSDLGNLTSLVSL 118 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~--------------------------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 118 (621)
++|+.|||..|+|.. +|+.+- .+..|+.|+|.+|.|+...-+.|.++.+|+.|
T Consensus 310 ~sL~tLdL~~N~L~~-lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVL 388 (1081)
T KOG0618|consen 310 KSLRTLDLQSNNLPS-LPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVL 388 (1081)
T ss_pred ceeeeeeehhccccc-cchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeee
Confidence 478999999999984 443221 13457888999999998777789999999999
Q ss_pred eeccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCccc
Q 007020 119 DLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDL 197 (621)
Q Consensus 119 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~ 197 (621)
+|++|+|.......+.++..|+.|+||+|+|+ .+|..+.+++.|++|...+|+|...| ....++.|+.+|++.|..-
T Consensus 389 hLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fP-e~~~l~qL~~lDlS~N~L~ 465 (1081)
T KOG0618|consen 389 HLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFP-ELAQLPQLKVLDLSCNNLS 465 (1081)
T ss_pred eecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeech-hhhhcCcceEEecccchhh
Confidence 99999999444445889999999999999999 78899999999999999999999887 7788999999999999753
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.1e-09 Score=122.47 Aligned_cols=116 Identities=28% Similarity=0.385 Sum_probs=68.5
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 145 (621)
+++.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|+|+
T Consensus 200 ~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls 270 (754)
T PRK15370 200 QITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLF 270 (754)
T ss_pred CCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECc
Confidence 5667777777777 3444433 46777777777776 4454443 35667777777766 5555443 466777777
Q ss_pred ccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCc
Q 007020 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNL 195 (621)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~ 195 (621)
+|+|+ .+|..+. ++|+.|+|++|+|++++.... ++|+.|++++|.
T Consensus 271 ~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~ 315 (754)
T PRK15370 271 HNKIS-CLPENLP--EELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNS 315 (754)
T ss_pred CCccC-ccccccC--CCCcEEECCCCccccCcccch--hhHHHHHhcCCc
Confidence 77776 4555443 466777777777766544321 245555555554
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.3e-08 Score=100.41 Aligned_cols=142 Identities=15% Similarity=0.094 Sum_probs=99.6
Q ss_pred ceeeeccCceEEEEEcCCCcEEEEEEecccCCch----------hHHHHHHHHHHHHhccCCc--eeeeeeeeec-----
Q 007020 302 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG----------GELQFQTEVEMISMAVHRN--LLRLRGFCMT----- 364 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~----- 364 (621)
+.+-......|.+..+ +|+.|.||......... ....+.+|...+.++...+ ...++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3344444445777766 57889999774332111 1113678888888775333 3344455432
Q ss_pred CCceEEEEeccCCC-chhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-------C
Q 007020 365 PTERLLVYPYMANG-SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE-------E 436 (621)
Q Consensus 365 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-------~ 436 (621)
....++|+|++++. +|.+++..... .+.+......++.+++..+.-||.. ||+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23568999999986 89888864321 1245567789999999999999999 9999999999999975 4
Q ss_pred CcEEEccccccee
Q 007020 437 FEAVVGDFGLAKL 449 (621)
Q Consensus 437 ~~~kl~DfGla~~ 449 (621)
+.+.++||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6899999998853
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.3e-09 Score=122.04 Aligned_cols=100 Identities=29% Similarity=0.512 Sum_probs=57.4
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+|+.|+|++|+|+ .+|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|
T Consensus 220 ~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~L 290 (754)
T PRK15370 220 GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSV 290 (754)
T ss_pred cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEEC
Confidence 46788888888887 3454443 35677777777766 4555443 35666666666666 4555442 35666666
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCccc
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGV 176 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 176 (621)
++|+|++ +|..+. ++|+.|++++|+++.+
T Consensus 291 s~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~L 319 (754)
T PRK15370 291 YDNSIRT-LPAHLP--SGITHLNVQSNSLTAL 319 (754)
T ss_pred CCCcccc-Ccccch--hhHHHHHhcCCccccC
Confidence 6666663 343321 2444445555555443
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.8e-07 Score=91.56 Aligned_cols=262 Identities=16% Similarity=0.183 Sum_probs=155.9
Q ss_pred cCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHH-hccCCceeeeeee----e--ecC-CceEEE
Q 007020 300 NKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMIS-MAVHRNLLRLRGF----C--MTP-TERLLV 371 (621)
Q Consensus 300 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~----~--~~~-~~~~lv 371 (621)
....||+|+-+.+|-.---.+ -+.|+....-.. ... +.+..|. .-.||-+-.=+.+ . -+. ...-++
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa-~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPA-AQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchhhc--hhheeecCCCch-HHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 456799999999996532111 244666543221 111 1222232 2345543321111 1 111 224577
Q ss_pred EeccCCCc-hhhhhcc--CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 372 YPYMANGS-VASCLRE--RPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 372 ~e~~~~gs-L~~~l~~--~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
|..+.+.. ...+..- +...-...+|...++++..++.+.+.||.. |.+-+|+.++|+|+++++.|.+.|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 77776641 1122211 122233489999999999999999999999 99999999999999999999998765433
Q ss_pred ecccCCCeeeecccccccccchhhhc-----cCCCCCcccchhHHHHHHHHHhC-CCCcccccccCCCcchHH-HHHHHH
Q 007020 449 LMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITG-QRAFDLARLANDDDVMLL-DWVKGL 521 (621)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg-~~pf~~~~~~~~~~~~~~-~~~~~~ 521 (621)
.. .........+|...|.+||.-. +...+...|-|.+||++++++.| ++||..-....+....+. +...+.
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 32 2334455567999999999754 33457789999999999999996 999974333333322222 111111
Q ss_pred hh-h--cccccccCccccCcccHHHHHHHHHHHHhccCCC--CCCCCCHHHHHHHHhc
Q 007020 522 LK-E--KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGS--PMDRPKMSEVVRMLEG 574 (621)
Q Consensus 522 ~~-~--~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~--P~~RPt~~~vl~~L~~ 574 (621)
.- . ........|. .....-....+..+...|+... +.-|||++..+..|..
T Consensus 244 f~ya~~~~~g~~p~P~--~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 244 FAYASDQRRGLKPPPR--SIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred eeechhccCCCCCCCC--CCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 00 0 0000000110 0011222355666777887644 5689999999888765
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.80 E-value=8.7e-09 Score=123.02 Aligned_cols=128 Identities=26% Similarity=0.321 Sum_probs=99.3
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+|+.|+|++|...+.+|..++++++|+.|+|++|...+.+|..+ ++++|+.|+|++|.....+|.. .++|+.|+|
T Consensus 778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L 853 (1153)
T PLN03210 778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNL 853 (1153)
T ss_pred ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeEC
Confidence 368888888887777788888888888888888865444677665 7888888888887654455543 367888889
Q ss_pred cccccCCCCCCCccCCccccEEeecc-CcCcccCCCCCCCCCcccccccCCccc
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSN-NRLSGVVPDNGSFSLFTPISFANNLDL 197 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~~~l~~l~l~~N~~~ 197 (621)
++|.|+ .+|..+..+++|+.|+|++ |++.+++.....+++|+.+++++++.+
T Consensus 854 s~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~~L 906 (1153)
T PLN03210 854 SRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCGAL 906 (1153)
T ss_pred CCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCccc
Confidence 998888 6788888888999999887 678877777777888888888776543
|
syringae 6; Provisional |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.9e-08 Score=93.94 Aligned_cols=135 Identities=22% Similarity=0.187 Sum_probs=97.7
Q ss_pred CcCceeeeccCceEEEEEcCCCcEEEEEEecccCC---------------------chhHHHHHHHHHHHHhccCC--ce
Q 007020 299 SNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT---------------------PGGELQFQTEVEMISMAVHR--NL 355 (621)
Q Consensus 299 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------------------~~~~~~~~~E~~~l~~l~h~--ni 355 (621)
.+++.||-|.=+.||.|..+.|.++|||.=+...+ .-.+...++|.++|.++.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 35678999999999999999999999996542211 01122356788888887643 45
Q ss_pred eeeeeeeecCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC
Q 007020 356 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE 435 (621)
Q Consensus 356 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 435 (621)
.+.+++ +...+||||++|--|...- ++-.....++..|++-+..+-.. ||||+|+++-||++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 555544 6778999999996665432 12223445556666666655566 9999999999999999
Q ss_pred CCcEEEccccccee
Q 007020 436 EFEAVVGDFGLAKL 449 (621)
Q Consensus 436 ~~~~kl~DfGla~~ 449 (621)
+|.+.++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999987754
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.79 E-value=5.7e-10 Score=114.69 Aligned_cols=132 Identities=27% Similarity=0.325 Sum_probs=101.8
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCC---CcEEEeeeCCCCC----CCcccccCC-CccceeeeccccCCCC----CCc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKN---LQYLELYSNNITG----PIPSDLGNL-TSLVSLDLYLNSFTGP----IPD 131 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~ 131 (621)
..+|+.|+|++|.+.+..+..+..+.+ |++|+|++|++++ .+...+..+ ++|+.|+|++|.+++. ++.
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 568999999999998767777766666 9999999999983 333456677 8999999999999843 334
Q ss_pred ccccccccccccccccccCCC----CCCCccCCccccEEeeccCcCcccCC-----CCCCCCCcccccccCCc
Q 007020 132 TLGKLSKLRFLRLNNNSLSGP----IPMSLTNISSLQVLDLSNNRLSGVVP-----DNGSFSLFTPISFANNL 195 (621)
Q Consensus 132 ~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~-----~~~~~~~l~~l~l~~N~ 195 (621)
.+..+++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++... ....+++|+.|++++|+
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~ 232 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNN 232 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCc
Confidence 566778899999999999842 23345566799999999999875432 22457889999999986
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.3e-10 Score=98.08 Aligned_cols=132 Identities=23% Similarity=0.307 Sum_probs=99.2
Q ss_pred EcCCCcEEEEEcCCCCccccCccc---ccCCCCCcEEEeeeCCCCCCCccccc-CCCccceeeeccccCCCCCCcccccc
Q 007020 61 CNNDNSVIRVDLGNAALSGQLVSQ---LGLLKNLQYLELYSNNITGPIPSDLG-NLTSLVSLDLYLNSFTGPIPDTLGKL 136 (621)
Q Consensus 61 c~~~~~l~~L~L~~n~l~~~~~~~---~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l 136 (621)
|.+...+-.|||+++.|- .+++. +.....|+..+|++|.+. ..|+.|. .++.++.|+|++|.|+ .+|..+..+
T Consensus 23 cedakE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam 99 (177)
T KOG4579|consen 23 CEDAKELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAM 99 (177)
T ss_pred hHHHHHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhh
Confidence 555556677888888877 45554 444566777799999999 4455554 4568999999999999 788889999
Q ss_pred cccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 137 SKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 137 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
+.|+.|++++|.|. ..|..+..|.+|..|+..+|.+..++.+...-+......+.+||+
T Consensus 100 ~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~dl~~s~~~al~~lgnepl 158 (177)
T KOG4579|consen 100 PALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVDLFYSSLPALIKLGNEPL 158 (177)
T ss_pred HHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccccCcHHHhccccHHHHHhcCCcc
Confidence 99999999999998 678888889999999999999988777643223334445555554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.1e-08 Score=113.98 Aligned_cols=97 Identities=27% Similarity=0.405 Sum_probs=54.7
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 145 (621)
+|+.|+|++|+|+. +|. .+++|++|+|++|+|+ .+|.. .++|+.|+|++|.|+ .+|..+ ++|+.|+|+
T Consensus 223 ~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~Ls 290 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLT-HLPALP---SGLCKLWIF 290 (788)
T ss_pred CCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCc---ccccceeeccCCchh-hhhhch---hhcCEEECc
Confidence 45666666666663 332 1356666666666666 33432 245666666666665 344322 445566666
Q ss_pred ccccCCCCCCCccCCccccEEeeccCcCcccCC
Q 007020 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178 (621)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 178 (621)
+|+|+ .+|.. +++|+.|+|++|+|++++.
T Consensus 291 ~N~Lt-~LP~~---p~~L~~LdLS~N~L~~Lp~ 319 (788)
T PRK15387 291 GNQLT-SLPVL---PPGLQELSVSDNQLASLPA 319 (788)
T ss_pred CCccc-ccccc---ccccceeECCCCccccCCC
Confidence 66666 34432 3567777777777766543
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.1e-09 Score=104.22 Aligned_cols=110 Identities=25% Similarity=0.251 Sum_probs=94.3
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
..++.|+||+|+|.. +. .+..|++|+.||||+|.++ .+-++-..|-+.+.|.|+.|.|... +.+.+|-+|..||+
T Consensus 307 Pkir~L~lS~N~i~~-v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~L--SGL~KLYSLvnLDl 381 (490)
T KOG1259|consen 307 PKLRRLILSQNRIRT-VQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIETL--SGLRKLYSLVNLDL 381 (490)
T ss_pred cceeEEeccccceee-eh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHhhh--hhhHhhhhheeccc
Confidence 579999999999983 33 3899999999999999999 6666778899999999999999843 56888999999999
Q ss_pred cccccCCCC-CCCccCCccccEEeeccCcCcccCCC
Q 007020 145 NNNSLSGPI-PMSLTNISSLQVLDLSNNRLSGVVPD 179 (621)
Q Consensus 145 ~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~~~ 179 (621)
++|+|.... -..++++|.|+.|.|.+|.|++++.-
T Consensus 382 ~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vdY 417 (490)
T KOG1259|consen 382 SSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVDY 417 (490)
T ss_pred cccchhhHHHhcccccccHHHHHhhcCCCccccchH
Confidence 999998322 34788999999999999999988763
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.76 E-value=7.1e-10 Score=114.30 Aligned_cols=123 Identities=32% Similarity=0.473 Sum_probs=108.3
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 145 (621)
-|+.|-+++|+++ .+|+.++.+..|..||.+.|.|. .+|..+++|.+|+.|.+..|++. .+|..+..| .|..||+|
T Consensus 144 pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfS 219 (722)
T KOG0532|consen 144 PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFS 219 (722)
T ss_pred cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecc
Confidence 3888999999999 78999999999999999999999 88889999999999999999999 677777744 68899999
Q ss_pred ccccCCCCCCCccCCccccEEeeccCcCcccCCCC---CCCCCcccccccC
Q 007020 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN---GSFSLFTPISFAN 193 (621)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~---~~~~~l~~l~l~~ 193 (621)
.|+++ .+|-.|.+|..|++|-|.+|.+...|..+ +...-+++|+..-
T Consensus 220 cNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPAqIC~kGkVHIFKyL~~qA 269 (722)
T KOG0532|consen 220 CNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPAQICEKGKVHIFKYLSTQA 269 (722)
T ss_pred cCcee-ecchhhhhhhhheeeeeccCCCCCChHHHHhccceeeeeeecchh
Confidence 99999 89999999999999999999999877765 4445566666543
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.4e-10 Score=122.23 Aligned_cols=128 Identities=30% Similarity=0.344 Sum_probs=106.4
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcc-cccccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDT-LGKLSKLRFLRL 144 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~l 144 (621)
.|...+.+.|.|+ ....++.-++.|+.|||++|+++.. ..+..|++|+.|||++|.++ .+|.. ...+. |..|.|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 6778889999998 6788888999999999999999955 38899999999999999999 55542 33444 999999
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCCCC--CCCCCcccccccCCcccCCC
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN--GSFSLFTPISFANNLDLCGP 200 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~~l~~l~l~~N~~~~~~ 200 (621)
+||.++.. ..+.+|.+|+.|||++|-|.+...-. +.+..|..|.|.|||.-|.+
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 99999843 45778999999999999998765543 67788999999999987765
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.9e-08 Score=118.53 Aligned_cols=126 Identities=20% Similarity=0.228 Sum_probs=78.3
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 145 (621)
+|+.|++.+|.++ .+|..| .+.+|+.|+|++|+|. .++..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|+
T Consensus 590 ~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~ 665 (1153)
T PLN03210 590 KLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLS 665 (1153)
T ss_pred ccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEec
Confidence 4556666666555 445555 3566777777777766 5566666677777777776654335553 6667777777777
Q ss_pred ccccCCCCCCCccCCccccEEeeccCc-CcccCCCCCCCCCcccccccCCcc
Q 007020 146 NNSLSGPIPMSLTNISSLQVLDLSNNR-LSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
+|.....+|..+.++++|+.|++++|. +..++. ...+++|+.|+|++|..
T Consensus 666 ~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~-~i~l~sL~~L~Lsgc~~ 716 (1153)
T PLN03210 666 DCSSLVELPSSIQYLNKLEDLDMSRCENLEILPT-GINLKSLYRLNLSGCSR 716 (1153)
T ss_pred CCCCccccchhhhccCCCCEEeCCCCCCcCccCC-cCCCCCCCEEeCCCCCC
Confidence 765555667777777777777777643 443333 23566677777766543
|
syringae 6; Provisional |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=6e-09 Score=110.78 Aligned_cols=172 Identities=17% Similarity=0.264 Sum_probs=113.7
Q ss_pred HHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee--------eecccccccccchhhhcc
Q 007020 404 LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV--------TTAVRGTIGHIAPEYLST 475 (621)
Q Consensus 404 ~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~ 475 (621)
.+++.|+.|+|... ++||++|.|++|.++..+..||+.|+++.......... ..-......|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 45558999999875 99999999999999999999999999876433211111 111124567999999999
Q ss_pred CCCCCcccchhHHHHHHHHH-hCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhc
Q 007020 476 GKSSEKTDVFGYGIMLLELI-TGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLC 554 (621)
Q Consensus 476 ~~~~~~~DvwSlGvil~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c 554 (621)
...+.++|+||+|+++|.+. .|+.-+.... .......... .+..-...+..+.+.++.+-+...
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~-----~~~~~~~~~~----------~~~~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANG-----GLLSYSFSRN----------LLNAGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccC-----Ccchhhhhhc----------ccccccccccccCcHHHHHHHHHH
Confidence 88899999999999999999 4555443211 0111111111 111111122334456778888888
Q ss_pred cCCCCCCCCCHHHHH----------HHHhcCCCccchhhhhHhHhhhh
Q 007020 555 TQGSPMDRPKMSEVV----------RMLEGDGLAERWDEWQKVEVLRQ 592 (621)
Q Consensus 555 ~~~~P~~RPt~~~vl----------~~L~~~~~~~~~~~~~~~~~~~~ 592 (621)
+..++..||++.++. ..|+..+-..++++.++....+.
T Consensus 249 l~~~~~~rp~~~~l~~~~ff~D~~~~aLrfLD~l~~kdn~qKs~Flk~ 296 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLSIPFFSDPGLKALRFLDDLPQKDNSQKSSFLKG 296 (700)
T ss_pred hcCCcccCcchhhhhcccccCCchhhhhhhcccccccCcHHHHHHHHH
Confidence 999999999877764 34444444444666666666554
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.69 E-value=6.2e-09 Score=110.40 Aligned_cols=126 Identities=34% Similarity=0.553 Sum_probs=57.9
Q ss_pred cEEEEEcCCCCccccCcccccCCC-CCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLK-NLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.++.|++.+|.++ .+++....+. +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|.....+++|+.|++
T Consensus 117 ~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l 193 (394)
T COG4886 117 NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193 (394)
T ss_pred ceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence 3445555555554 3444444442 5555555555554 33334455555555555555555 33433334455555555
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCc
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNL 195 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~ 195 (621)
++|+++ .+|.....+..|++|.+++|++...+.....+.++..+.+.+|+
T Consensus 194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~ 243 (394)
T COG4886 194 SGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNK 243 (394)
T ss_pred cCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCce
Confidence 555554 33333333333555555555433333333444444444444443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.69 E-value=5.1e-09 Score=111.03 Aligned_cols=127 Identities=34% Similarity=0.467 Sum_probs=106.2
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 145 (621)
+|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|.....++.|+.|++++|+++ .+|.....+..|+.|+++
T Consensus 141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~ 217 (394)
T COG4886 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217 (394)
T ss_pred hcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhc
Confidence 7999999999999 66788999999999999999999 66766668999999999999999 778776677779999999
Q ss_pred ccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
+|.+. ..+..+.++.++..|.+.+|++...+.....++++++|++++|..
T Consensus 218 ~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i 267 (394)
T COG4886 218 NNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQI 267 (394)
T ss_pred CCcce-ecchhhhhcccccccccCCceeeeccchhccccccceeccccccc
Confidence 99655 456677788888888888888877655566777788888888864
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.2e-09 Score=110.25 Aligned_cols=133 Identities=23% Similarity=0.188 Sum_probs=98.4
Q ss_pred CCcEEEEEcCCCCccc------cCcccccCCCCCcEEEeeeCCCCCCCcccccCCCc---cceeeeccccCCC----CCC
Q 007020 64 DNSVIRVDLGNAALSG------QLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTS---LVSLDLYLNSFTG----PIP 130 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~------~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p 130 (621)
..+++.|+++++.+.+ .++..+..+++|+.|+|++|.+.+..+..+..+.+ |+.|+|++|++++ .+.
T Consensus 50 ~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~ 129 (319)
T cd00116 50 QPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLA 129 (319)
T ss_pred CCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHH
Confidence 3458889998888772 34456777889999999999998766666766666 9999999999873 223
Q ss_pred cccccc-cccccccccccccCCC----CCCCccCCccccEEeeccCcCcccC-----CCCCCCCCcccccccCCcc
Q 007020 131 DTLGKL-SKLRFLRLNNNSLSGP----IPMSLTNISSLQVLDLSNNRLSGVV-----PDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 131 ~~~~~l-~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~-----~~~~~~~~l~~l~l~~N~~ 196 (621)
..+..+ ++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++.. .....+++|+.|++++|..
T Consensus 130 ~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i 205 (319)
T cd00116 130 KGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGL 205 (319)
T ss_pred HHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCcc
Confidence 345566 8899999999998842 3335666778999999999988421 1123456899999998853
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.62 E-value=3.5e-08 Score=67.94 Aligned_cols=40 Identities=43% Similarity=0.967 Sum_probs=30.7
Q ss_pred chhHHHHHHHHHhCC-CCCCCCCCCCCCC-CCCccceeeEEc
Q 007020 23 NMEGDALHSLRSNLI-DPNNVLQSWDPTL-VNPCTWFHVTCN 62 (621)
Q Consensus 23 ~~~~~~l~~~~~~~~-~~~~~l~~w~~~~-~~~c~w~gv~c~ 62 (621)
+.|.+||++||.++. +|.+.+.+|+.+. .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 468899999999998 5778999998764 799999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.7e-07 Score=88.16 Aligned_cols=105 Identities=18% Similarity=0.190 Sum_probs=81.9
Q ss_pred HHHHHHHHHHHhccC--CceeeeeeeeecC----CceEEEEeccCCC-chhhhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 007020 338 LQFQTEVEMISMAVH--RNLLRLRGFCMTP----TERLLVYPYMANG-SVASCLRERPPSQLPLDWPTRKRIALGSARGL 410 (621)
Q Consensus 338 ~~~~~E~~~l~~l~h--~niv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L 410 (621)
....+|...+..+.. -...+.+++.... ...++|+|++++. +|.+++..... .+......++.++++.+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHH
Confidence 356778887777653 3344555665442 2448999999984 79998876332 44557789999999999
Q ss_pred HHHHhCCCCCeEecCCCCCCeeeCCCC---cEEEccccccee
Q 007020 411 SYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAKL 449 (621)
Q Consensus 411 ~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~DfGla~~ 449 (621)
+-||.. ||+|+|+++.|||++.+. .+.++||+.++.
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999 999999999999999887 899999998775
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.9e-07 Score=98.55 Aligned_cols=142 Identities=20% Similarity=0.243 Sum_probs=91.6
Q ss_pred ceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHH---------------------------------------HHHH
Q 007020 302 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGEL---------------------------------------QFQT 342 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------------------------------------~~~~ 342 (621)
+.|+.++-|.||+|++++|+.||||+.+....+.-.. ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6799999999999999999999999986432111100 1223
Q ss_pred HHHHHHhcc-----CCceeeeeeeeecCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHH-HHHHHhC
Q 007020 343 EVEMISMAV-----HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARG-LSYLHDH 416 (621)
Q Consensus 343 E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~-L~~LH~~ 416 (621)
|...+.+++ .+++.=..=|..-.....++|||++|-.+.+....... + .+ ...++..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~-g--~d---~k~ia~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA-G--ID---RKELAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc-C--CC---HHHHHHHHHHHHHHHHHhc
Confidence 333333332 22222111122224567899999999888887432211 1 44 33444444432 3333345
Q ss_pred CCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 417 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 417 ~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
|+.|.|.+|.||+++.+|.+.+.|||+...++.
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999876653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.7e-06 Score=81.01 Aligned_cols=140 Identities=21% Similarity=0.126 Sum_probs=102.0
Q ss_pred eeeccCceEEEEEcCCCcEEEEEEecccC-----CchhHHHHHHHHHHHHhccCC--ceeeeeeeeec----CCceEEEE
Q 007020 304 LGRGGFGKVYKGRLADGSLVAVKRLKEER-----TPGGELQFQTEVEMISMAVHR--NLLRLRGFCMT----PTERLLVY 372 (621)
Q Consensus 304 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~----~~~~~lv~ 372 (621)
-|+||-+-|++-... |+.|-+|+-.... .+.....|.+|+..+..+... .+.++..+... ...-+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 477888889998774 5578888764211 144566799999999888632 24444422111 13457999
Q ss_pred eccCC-CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc--EEEccccccee
Q 007020 373 PYMAN-GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAKL 449 (621)
Q Consensus 373 e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~DfGla~~ 449 (621)
|-+++ -+|.+++.+.... +.+......++.+++..+.-||+. |+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~--~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVS--PYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcC--CcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 4888887654322 256667789999999999999999 9999999999999986666 99999987653
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.2e-08 Score=84.89 Aligned_cols=111 Identities=22% Similarity=0.290 Sum_probs=89.2
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+|+..+|++|.+....+..-..++.++.|+|++|.|+ .+|..+..++.|+.|++++|.|. ..|..+..|.+|-.||.
T Consensus 53 ~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 53 YELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS 130 (177)
T ss_pred ceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence 47999999999999544444455679999999999999 78889999999999999999999 78888888999999999
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCC
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 178 (621)
.+|.+. .+|..+..-.++-..++.++.+.+--+
T Consensus 131 ~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 131 PENARA-EIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred CCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence 999998 666554333334445567777765443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.45 E-value=4.2e-08 Score=98.49 Aligned_cols=133 Identities=23% Similarity=0.217 Sum_probs=65.4
Q ss_pred CCCcEEEEEcCCCCccccCccc-ccCCCCCcEEEeeeCCCCC-CCcccccCCCccceeeeccccCCCCCCcccccccccc
Q 007020 63 NDNSVIRVDLGNAALSGQLVSQ-LGLLKNLQYLELYSNNITG-PIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLR 140 (621)
Q Consensus 63 ~~~~l~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 140 (621)
...+|+.|+|+.|++....... -..++.|+.|.|+.+.|+. .+-..+..+|+|+.|+|..|.....-.....-+..|+
T Consensus 170 qLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~ 249 (505)
T KOG3207|consen 170 QLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQ 249 (505)
T ss_pred hcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHh
Confidence 3445555555555444211111 1133445555555555441 1112233455566666666642222223344456666
Q ss_pred cccccccccCCCCC--CCccCCccccEEeeccCcCcccCC-CC------CCCCCcccccccCCcc
Q 007020 141 FLRLNNNSLSGPIP--MSLTNISSLQVLDLSNNRLSGVVP-DN------GSFSLFTPISFANNLD 196 (621)
Q Consensus 141 ~L~l~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~~-~~------~~~~~l~~l~l~~N~~ 196 (621)
.|||++|++.. .+ .....++.|+.|+++.+.|..+-. +. ..+++|++|+++.|+.
T Consensus 250 ~LdLs~N~li~-~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I 313 (505)
T KOG3207|consen 250 ELDLSNNNLID-FDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNI 313 (505)
T ss_pred hccccCCcccc-cccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCcc
Confidence 66666666652 23 334566666666666666655421 11 3466677777766654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.44 E-value=3e-06 Score=82.06 Aligned_cols=139 Identities=12% Similarity=0.118 Sum_probs=85.0
Q ss_pred ceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCc--eeeeeeeeecCCceEEEEeccCCCc
Q 007020 302 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN--LLRLRGFCMTPTERLLVYPYMANGS 379 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs 379 (621)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 46899999999984 24567888876433 2335688999988876433 3566777777777789999999963
Q ss_pred -hhhh---------------------hccCCCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHhC-CCCCeEec
Q 007020 380 -VASC---------------------LRERPPSQLPLDWPTRK-RIAL----------GSAR-GLSYLHDH-CDPKIIHR 424 (621)
Q Consensus 380 -L~~~---------------------l~~~~~~~~~~~~~~~~-~i~~----------~i~~-~L~~LH~~-~~~~ivH~ 424 (621)
+... +|........+ .... .+.. .+.+ ..++|... ..+.++|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l--~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTF--QSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcH--HHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 2111 12111111111 1100 0000 0011 12222211 13467899
Q ss_pred CCCCCCeeeCCCCcEEEccccccee
Q 007020 425 DVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 425 Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
|+.|.||++++++ +.++||+.+..
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcCc
Confidence 9999999999988 99999998763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.43 E-value=6.5e-08 Score=97.21 Aligned_cols=141 Identities=19% Similarity=0.132 Sum_probs=105.7
Q ss_pred cceeeEEcCCCcEEEEEcCCCCcccc-CcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCC--c
Q 007020 55 TWFHVTCNNDNSVIRVDLGNAALSGQ-LVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP--D 131 (621)
Q Consensus 55 ~w~gv~c~~~~~l~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--~ 131 (621)
-|..++-....+++.|.|+.|+|+.. +...+..+++|+.|+|..|....+.......+..|+.|||++|++.. .+ .
T Consensus 187 ~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~ 265 (505)
T KOG3207|consen 187 FISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGY 265 (505)
T ss_pred CccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-ccccc
Confidence 34444444567899999999999843 33456678999999999996443555566778899999999999884 44 4
Q ss_pred ccccccccccccccccccCCC-CCCC-----ccCCccccEEeeccCcCcccCCC--CCCCCCcccccccCCcc
Q 007020 132 TLGKLSKLRFLRLNNNSLSGP-IPMS-----LTNISSLQVLDLSNNRLSGVVPD--NGSFSLFTPISFANNLD 196 (621)
Q Consensus 132 ~~~~l~~L~~L~l~~N~l~~~-~p~~-----~~~l~~L~~L~l~~N~l~~~~~~--~~~~~~l~~l~l~~N~~ 196 (621)
..+.++.|+.|+++.+.+.+. +|+. ...+++|++|+++.|+|.....- ...+++|+.|.+..|+.
T Consensus 266 ~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~l 338 (505)
T KOG3207|consen 266 KVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYL 338 (505)
T ss_pred ccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccc
Confidence 578899999999999999843 2333 35789999999999999755442 25567777777777653
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=5.5e-08 Score=103.53 Aligned_cols=127 Identities=29% Similarity=0.405 Sum_probs=92.7
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
..+..++|..|.|. .+-..+..+++|+.|+|.+|+|.++ ...+..+++|++|+|++|.|+.. ..+..++.|+.|++
T Consensus 72 ~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l 147 (414)
T KOG0531|consen 72 TSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNL 147 (414)
T ss_pred HhHHhhccchhhhh-hhhcccccccceeeeeccccchhhc-ccchhhhhcchheeccccccccc--cchhhccchhhhee
Confidence 35566667777777 3445577788888888888888843 33377788888888888888854 34667777888888
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCCC-CCCCCCcccccccCCccc
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD-NGSFSLFTPISFANNLDL 197 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~ 197 (621)
++|.|+.. ..+..+.+|+.+++++|++..+... ...+.+++.+.+.+|...
T Consensus 148 ~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 148 SGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIR 199 (414)
T ss_pred ccCcchhc--cCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchh
Confidence 88888732 3455678888888888888877663 356677888888888653
|
|
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.8e-07 Score=83.57 Aligned_cols=122 Identities=24% Similarity=0.238 Sum_probs=84.8
Q ss_pred EEEEcCCCCccccCccccc-CCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccccc
Q 007020 68 IRVDLGNAALSGQLVSQLG-LLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146 (621)
Q Consensus 68 ~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 146 (621)
..++|.+.++.. +.. ++ -+.+...+||++|.|... ..|..++.|.+|.|++|+|+.+-|.--.-+++|..|.|.+
T Consensus 22 ~e~~LR~lkip~-ien-lg~~~d~~d~iDLtdNdl~~l--~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~Ltn 97 (233)
T KOG1644|consen 22 RELDLRGLKIPV-IEN-LGATLDQFDAIDLTDNDLRKL--DNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTN 97 (233)
T ss_pred cccccccccccc-hhh-ccccccccceecccccchhhc--ccCCCccccceEEecCCcceeeccchhhhccccceEEecC
Confidence 346666665542 211 22 245677888888888733 3688888888999999998866665555677888889999
Q ss_pred cccCCCC-CCCccCCccccEEeeccCcCcccCCC----CCCCCCcccccccC
Q 007020 147 NSLSGPI-PMSLTNISSLQVLDLSNNRLSGVVPD----NGSFSLFTPISFAN 193 (621)
Q Consensus 147 N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~~~l~~l~l~~ 193 (621)
|.|.... -..+..||+|++|.+-+|+++...-- ...+++|+.||+++
T Consensus 98 Nsi~~l~dl~pLa~~p~L~~Ltll~Npv~~k~~YR~yvl~klp~l~~LDF~k 149 (233)
T KOG1644|consen 98 NSIQELGDLDPLASCPKLEYLTLLGNPVEHKKNYRLYVLYKLPSLRTLDFQK 149 (233)
T ss_pred cchhhhhhcchhccCCccceeeecCCchhcccCceeEEEEecCcceEeehhh
Confidence 8887321 23466788999999999988765432 25678888888865
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.36 E-value=5e-06 Score=78.17 Aligned_cols=138 Identities=14% Similarity=0.130 Sum_probs=91.9
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHH---------HHHHHHHHhccCC---ceeeeee
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQF---------QTEVEMISMAVHR---NLLRLRG 360 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~---------~~E~~~l~~l~h~---niv~l~~ 360 (621)
+...+|...+++-......|.+-.. +|+.+++|..+..... ..+.| .+.+....++... .++.++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 4567788888888777777777766 5789999988754322 22222 2333333344322 2222222
Q ss_pred eee-----cCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC
Q 007020 361 FCM-----TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE 435 (621)
Q Consensus 361 ~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 435 (621)
+.. -....+++|||++|..|.+... ++. .++..+.+++.-||+. |++|+|..|.|+++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEEC
Confidence 222 2244578999999988776532 221 2456677889999999 9999999999999996
Q ss_pred CCcEEEcccccce
Q 007020 436 EFEAVVGDFGLAK 448 (621)
Q Consensus 436 ~~~~kl~DfGla~ 448 (621)
++ ++++||+..+
T Consensus 171 ~~-i~iID~~~k~ 182 (229)
T PF06176_consen 171 NG-IRIIDTQGKR 182 (229)
T ss_pred Cc-EEEEECcccc
Confidence 65 9999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.36 E-value=7.6e-06 Score=77.75 Aligned_cols=153 Identities=20% Similarity=0.252 Sum_probs=98.1
Q ss_pred CHHHHHHHhcCCCcCcee---eeccCceEEEEEcCCCcEEEEEEecccCCchh------------------HHH-----H
Q 007020 287 SLRELQVATDSFSNKNIL---GRGGFGKVYKGRLADGSLVAVKRLKEERTPGG------------------ELQ-----F 340 (621)
Q Consensus 287 ~~~~~~~~~~~~~~~~~l---G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------~~~-----~ 340 (621)
++..+....++..+.... .+|.-+.||+|...++..+|||+++....... ..+ .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 444555555555555554 45666679999988899999999874321110 000 2
Q ss_pred HHHHHHHHhcc--CCceeeeeeeeecCCceEEEEeccCCCc-hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 007020 341 QTEVEMISMAV--HRNLLRLRGFCMTPTERLLVYPYMANGS-VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 417 (621)
Q Consensus 341 ~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~ 417 (621)
.+|+.-|.++. +-.+.+.+++ ....|||||+.... -.-.|.. .++...+...+..++++.+.-|-..+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 34555555553 2233333443 34579999997641 1111221 11333357777888888888887733
Q ss_pred CCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 418 ~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
++||+||+.-|||+. ++.+.|+|||-|....
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 999999999999999 7799999999887544
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.5e-07 Score=100.07 Aligned_cols=126 Identities=28% Similarity=0.280 Sum_probs=98.8
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+++.|+|.+|+|.. +...+..+++|++|+|++|.|+.+. .+..++.|+.|++++|.|+.. ..+..+++|+.++
T Consensus 94 ~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~ 168 (414)
T KOG0531|consen 94 LKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLD 168 (414)
T ss_pred ccceeeeeccccchhh-cccchhhhhcchheecccccccccc--chhhccchhhheeccCcchhc--cCCccchhhhccc
Confidence 3689999999999994 4444888999999999999999664 478888899999999999943 4567799999999
Q ss_pred ccccccCCCCCCC-ccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 144 LNNNSLSGPIPMS-LTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 144 l~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
+++|++...-+ . ...+.+|+.+++.+|.+..+.. ...+..+..+++..|..
T Consensus 169 l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~~i~~-~~~~~~l~~~~l~~n~i 220 (414)
T KOG0531|consen 169 LSYNRIVDIEN-DELSELISLEELDLGGNSIREIEG-LDLLKKLVLLSLLDNKI 220 (414)
T ss_pred CCcchhhhhhh-hhhhhccchHHHhccCCchhcccc-hHHHHHHHHhhcccccc
Confidence 99999995433 2 5788999999999999885432 22333444456666654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 621 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-174 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-170 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-44 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-44 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-36 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-34 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-22 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-22 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-22 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-22 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-22 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-21 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-21 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-21 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-12 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-12 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 8e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 9e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-09 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 7e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 621 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 0.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-154 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-138 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-79 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-62 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 4e-61 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 3e-59 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-58 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-57 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-55 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-55 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-54 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-54 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-54 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-52 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-51 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-44 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-51 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 9e-51 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-49 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-45 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-37 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-36 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-36 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 5e-36 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 5e-36 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 9e-35 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-34 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-32 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-30 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-25 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-22 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-40 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 1e-38 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 9e-38 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-37 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-37 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-37 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 3e-37 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 3e-37 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 4e-37 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 7e-37 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 8e-37 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-36 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-36 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-36 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 7e-36 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-35 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 5e-35 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 5e-35 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 5e-35 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 6e-35 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 8e-35 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 9e-35 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-34 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-34 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-34 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-34 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-34 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 3e-34 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 5e-34 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 7e-34 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 7e-34 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-33 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-33 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-33 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-33 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-33 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-33 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-33 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-33 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-33 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-33 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-33 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 3e-33 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 3e-33 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 4e-33 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-33 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 7e-33 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 7e-33 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-32 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-32 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 2e-32 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-32 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-32 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-32 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-32 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-32 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 5e-32 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 6e-32 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 6e-32 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 9e-32 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 1e-31 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-31 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 3e-31 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 6e-31 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-30 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 5e-30 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 8e-30 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 8e-30 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-29 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-29 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-29 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-29 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 4e-29 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 8e-29 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 9e-29 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-28 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 4e-28 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 4e-28 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 9e-28 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-27 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-27 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 4e-27 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 5e-27 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 6e-27 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 6e-27 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 8e-27 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-25 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-24 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-23 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 5e-22 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-21 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-19 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-18 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 9e-17 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-13 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 9e-27 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-26 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-26 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-26 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-25 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-25 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-25 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-25 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 9e-25 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-24 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-23 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-22 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-20 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 6e-20 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-15 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-14 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-26 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 5e-26 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 6e-26 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 6e-26 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-24 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 8e-24 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-23 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-22 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-22 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-22 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-22 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-21 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 6e-21 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 9e-21 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-07 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 6e-26 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-25 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-25 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-25 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-25 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 3e-25 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-24 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-24 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-24 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-24 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-21 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-20 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 7e-20 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-19 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 6e-18 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-17 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-12 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-07 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 3e-23 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 7e-23 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-22 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-22 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-22 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-22 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-22 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-21 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-21 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-19 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-19 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-19 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-19 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-18 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-18 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-17 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-17 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 5e-14 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-12 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 5e-22 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 7e-22 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 9e-22 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-21 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-21 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-21 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-21 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-21 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-21 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-21 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-21 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-20 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-19 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 9e-18 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-14 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 6e-13 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-12 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 8e-12 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 7e-21 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-20 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-20 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-20 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 4e-20 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 6e-20 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 6e-20 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-19 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 8e-19 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-18 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 5e-18 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 6e-18 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-15 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 7e-20 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 7e-20 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 8e-20 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 9e-07 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-19 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-19 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-19 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-19 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-19 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-17 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-15 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-04 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-19 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-19 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 5e-19 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 6e-19 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 7e-19 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-06 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 7e-19 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-18 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 6e-18 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 9e-18 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 7e-17 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 7e-17 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-16 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-14 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 8e-19 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-18 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 3e-18 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 3e-18 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 4e-18 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 4e-18 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 5e-18 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 3e-17 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 6e-17 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 7e-16 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 6e-14 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-08 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 5e-04 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 5e-18 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 5e-18 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 6e-18 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 6e-18 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 8e-18 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 8e-18 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 9e-18 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-17 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-17 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-17 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-16 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 7e-16 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-14 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-11 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-10 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-07 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-17 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-17 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-17 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 6e-17 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-15 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 9e-15 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-14 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 5e-14 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 9e-12 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-06 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-17 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-17 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-17 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-17 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-17 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-17 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 4e-17 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 5e-16 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-15 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 4e-14 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 9e-14 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-12 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 6e-12 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 9e-07 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 7e-05 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-17 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-17 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-17 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 3e-17 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 3e-17 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 3e-17 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 3e-17 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-17 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-14 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-14 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-13 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-13 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-10 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 4e-17 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-17 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 4e-17 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 5e-17 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 6e-17 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 6e-17 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-16 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-16 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 6e-16 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-15 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 4e-15 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-12 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-16 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-16 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-15 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-13 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-13 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 8e-13 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 7e-12 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 8e-12 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-11 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-10 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-07 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-04 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-16 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 3e-15 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-13 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-13 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 3e-13 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 9e-13 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 5e-12 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-16 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-16 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 3e-16 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 3e-16 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-16 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 5e-14 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 9e-14 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-13 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 4e-12 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 8e-12 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-11 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-10 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-10 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 7e-07 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 4e-16 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 4e-16 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 5e-16 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-13 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-13 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-13 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 6e-12 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 5e-11 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 5e-11 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-10 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-10 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-06 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 6e-16 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 8e-16 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-13 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 7e-13 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-12 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-12 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 9e-12 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 5e-11 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 8e-16 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-15 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-15 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-15 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-15 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-15 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-13 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-13 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-12 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-11 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-09 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 7e-07 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 4e-15 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 4e-15 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 4e-15 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 6e-15 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-13 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-13 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 6e-12 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 4e-07 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 9e-15 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-14 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-13 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-12 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-11 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-06 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 9e-15 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 9e-15 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-14 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-11 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 6e-09 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 9e-07 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-14 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-14 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-14 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-14 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-14 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 4e-14 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 5e-14 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 9e-14 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-13 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-12 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-14 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-14 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 3e-14 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-13 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 5e-12 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 7e-09 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 3e-14 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-14 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-13 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 5e-12 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-11 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-09 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-09 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-08 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-06 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-05 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 5e-14 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 6e-13 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-12 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-12 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-12 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-11 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-10 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 7e-10 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-09 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 5e-14 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-13 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 4e-13 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-11 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 4e-06 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 6e-14 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-12 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 6e-12 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 4e-10 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-09 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 4e-06 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-04 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 7e-14 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-11 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 4e-11 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 4e-11 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-09 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 5e-05 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 7e-14 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 9e-14 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 9e-14 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-13 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 8e-13 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-12 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 7e-12 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 7e-12 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-11 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 5e-11 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-10 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 5e-10 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 8e-10 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-09 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 6e-08 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 9e-13 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-11 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-11 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 5e-10 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-12 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 5e-12 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 5e-12 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-11 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-10 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 4e-10 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 9e-08 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 4e-07 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 2e-12 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-12 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 4e-11 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 4e-11 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 7e-10 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 3e-07 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 4e-12 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 4e-10 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-08 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 5e-12 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-10 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 7e-09 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 9e-12 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-11 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 5e-10 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 5e-10 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-08 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-08 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-06 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-11 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-11 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-10 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-10 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-09 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-05 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-11 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-10 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-10 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-10 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-10 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-10 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-09 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-11 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 6e-11 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-10 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 8e-06 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 3e-06 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-11 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-11 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-09 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-05 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 5e-11 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-10 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-09 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 3e-09 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 6e-11 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-10 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-10 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-10 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-05 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 3e-10 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 4e-10 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 1e-09 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-09 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-08 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 6e-10 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-06 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 1e-09 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-09 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 4e-09 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 4e-09 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-06 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 6e-09 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 6e-09 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-08 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-07 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-08 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-06 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-06 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-05 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 8e-05 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-04 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 3e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-04 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 4e-08 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-06 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 3e-04 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 4e-08 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 4e-08 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-07 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-07 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-07 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-07 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 3e-07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 3e-07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 7e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-04 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 6e-07 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 7e-07 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 2e-06 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-06 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-06 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-06 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 6e-06 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 4e-05 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-04 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 2e-06 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 5e-05 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 2e-04 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 5e-06 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 2e-05 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 4e-05 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 4e-04 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 6e-06 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 9e-06 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 1e-04 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-05 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 2e-05 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 3e-05 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 4e-05 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 5e-05 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 6e-04 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 7e-05 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 1e-04 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 2e-04 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 4e-04 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 4e-04 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 5e-04 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 8e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 635 bits (1640), Expect = 0.0
Identities = 304/326 (93%), Positives = 314/326 (96%)
Query: 267 FFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVK 326
FFDVPAEEDPEVHLGQLKRFSLRELQVA+D+FSNKNILGRGGFGKVYKGRLADG+LVAVK
Sbjct: 1 FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60
Query: 327 RLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 386
RLKEERT GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE
Sbjct: 61 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 387 RPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 446
RP SQ PLDWP R+RIALGSARGL+YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 447 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARL 506
AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG+MLLELITGQRAFDLARL
Sbjct: 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 507 ANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMS 566
ANDDDVMLLDWVKGLLKEKKLE LVD DLQ NY + EVEQLIQVALLCTQ SPM+RPKMS
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 567 EVVRMLEGDGLAERWDEWQKVEVLRQ 592
EVVRMLEGDGLAERW+EWQK E+ RQ
Sbjct: 301 EVVRMLEGDGLAERWEEWQKEEMFRQ 326
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 445 bits (1146), Expect = e-154
Identities = 109/314 (34%), Positives = 171/314 (54%), Gaps = 22/314 (7%)
Query: 273 EEDPEVHLGQLKRFSLRELQVATDSFSNK------NILGRGGFGKVYKGRLADGSLVAVK 326
+ EV + FS EL+ T++F + N +G GGFG VYKG + + + VAVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 327 RLKEERTPG---GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASC 383
+L + QF E+++++ H NL+ L GF + LVY YM NGS+
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 384 LRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 443
L PL W R +IA G+A G+++LH++ IHRD+K+ANILLDE F A + D
Sbjct: 121 LSCL-DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 444 FGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 502
FGLA+ + + T +T+ + GT ++APE L G+ + K+D++ +G++LLE+ITG A D
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 503 LARLANDDDVMLLDWVKGLLKEKK-LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMD 561
R + +LLD + + E+K +E +D + N+ VE + VA C
Sbjct: 236 EHR----EPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNK 290
Query: 562 RPKMSEVVRMLEGD 575
RP + +V ++L+
Sbjct: 291 RPDIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 404 bits (1040), Expect = e-138
Identities = 114/306 (37%), Positives = 171/306 (55%), Gaps = 7/306 (2%)
Query: 271 PAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKE 330
A + + R L +L+ AT++F +K ++G G FGKVYKG L DG+ VA+KR
Sbjct: 14 DALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP 73
Query: 331 ERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPS 390
E + G +F+TE+E +S H +L+ L GFC E +L+Y YM NG++ L
Sbjct: 74 ESSQG-IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP 132
Query: 391 QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450
+ + W R I +G+ARGL YLH IIHRDVK+ NILLDE F + DFG++K
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 451 DYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLAND 509
D TH++T V+GT+G+I PEY G+ +EK+DV+ +G++L E++ + A +
Sbjct: 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL--PR 247
Query: 510 DDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 569
+ V L +W +LE +VDP+L + + + A+ C S DRP M +V+
Sbjct: 248 EMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307
Query: 570 RMLEGD 575
LE
Sbjct: 308 WKLEYA 313
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 253 bits (647), Expect = 2e-79
Identities = 72/312 (23%), Positives = 117/312 (37%), Gaps = 35/312 (11%)
Query: 286 FSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVE 345
L + + RG FG V+K +L VAVK + Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD--KQSWQNEYEVY 70
Query: 346 MISMAVHRNLLRLRGFCMTP----TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKR 401
+ H N+L+ G + L+ + GS++ L+ + W
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELCH 125
Query: 402 IALGSARGLSYLHDH-------CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YK 453
IA ARGL+YLH+ P I HRD+K+ N+LL A + DFGLA + K
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 454 DTHVTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGIMLLELITGQRAFDLARLAN 508
T GT ++APE L + + D++ G++L EL + A D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD---GPV 242
Query: 509 DDDVMLLDWVKGL------LKEKKLEMLVDPDLQNNYVEAEV-EQLIQVALLCTQGSPMD 561
D+ ++ + G ++E + P L++ + + L + C
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 562 RPKMSEVVRMLE 573
R V +
Sbjct: 303 RLSAGCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 1e-62
Identities = 72/322 (22%), Positives = 118/322 (36%), Gaps = 44/322 (13%)
Query: 286 FSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVE 345
+ E + D+ ++GRG +G VYKG L D VAVK F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINEKN 57
Query: 346 MISMAV--HRNLLRLRGFCMTP-----TERLLVYPYMANGSVASCLRERPPSQLPLDWPT 398
+ + + H N+ R E LLV Y NGS+ L DW +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVS 112
Query: 399 RKRIALGSARGLSYLH------DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452
R+A RGL+YLH DH P I HRD+ + N+L+ + V+ DFGL+ +
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 453 -------KDTHVTTAVRGTIGHIAPEYL-------STGKSSEKTDVFGYGIMLLELITGQ 498
++ + + GTI ++APE L + ++ D++ G++ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 499 RAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD-----PDLQNNYVEAEV--EQLIQVA 551
+ + V + +++LV P + E + L +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 552 LLCTQGSPMDRPKMSEVVRMLE 573
C R +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMA 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 4e-61
Identities = 76/274 (27%), Positives = 134/274 (48%), Gaps = 22/274 (8%)
Query: 301 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNLLRLR 359
K +G G FG V++ GS VAVK L E+ + F EV ++ H N++
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 360 GFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 419
G P +V Y++ GS+ L + ++ LD R +A A+G++YLH + +P
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLH-NRNP 158
Query: 420 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 479
I+HR++K+ N+L+D+++ V DFGL++L + + GT +APE L S+
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 480 EKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNY 539
EK+DV+ +G++L EL T Q+ + ++ V + + K ++ N
Sbjct: 218 EKSDVYSFGVILWELATLQQPW--------GNLNPAQVVAAVGFKCKR-----LEIPRN- 263
Query: 540 VEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ +V +I+ C P RP + ++ +L
Sbjct: 264 LNPQVAAIIE---GCWTNEPWKRPSFATIMDLLR 294
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 3e-59
Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 36/283 (12%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 355
+ ++GRG FG V K + VA+K+++ E F E+ +S H N+
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE---RKAFIVELRQLSRVNHPNI 63
Query: 356 LRLRGFCMTP----TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 411
++L G C+ P E Y GS+ + L P L ++G++
Sbjct: 64 VKLYGACLNPVCLVME------YAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVA 116
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 470
YLH +IHRD+K N+LL + + DFG A + T +G+ +AP
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAP 172
Query: 471 EYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530
E SEK DVF +GI+L E+IT ++ FD + + + + +
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFD------EIGGPAFRIMWAVHNGTRPPL- 225
Query: 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ +E L+ C P RP M E+V+++
Sbjct: 226 --IK----NLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMT 259
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-58
Identities = 75/291 (25%), Positives = 132/291 (45%), Gaps = 47/291 (16%)
Query: 301 KNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGEL------QFQTEVEMISMAVHR 353
+ +G+GGFG V+KGR + D S+VA+K L + G +FQ EV ++S H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 354 NLLRLRGFCMTP----TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARG 409
N+++L G P E ++ G + L ++ P+ W + R+ L A G
Sbjct: 84 NIVKLYGLMHNPPRMVME------FVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALG 134
Query: 410 LSYLHDHCDPKIIHRDVKAANILLDEEFEAV-----VGDFGLAKLMDYKDTHVTTAVRGT 464
+ Y+ + +P I+HRD+++ NI L E V DFGL++ H + + G
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----VHSVSGLLGN 189
Query: 465 IGHIAPEYLST--GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 522
+APE + +EK D + + ++L ++TG+ FD + + ++ +
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------EYSYGKIKFINMIR 243
Query: 523 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
+E P + + + +I+ LC G P RP S +V+ L
Sbjct: 244 EEGLR-----PTIPED-CPPRLRNVIE---LCWSGDPKKRPHFSYIVKELS 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-57
Identities = 76/284 (26%), Positives = 123/284 (43%), Gaps = 37/284 (13%)
Query: 301 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGEL---QFQTEVEMISMAVHRNLLR 357
+ I+G GGFGKVY+ G VAVK + + + E ++ +M H N++
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 358 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 417
LRG C+ LV + G + L + + A+ ARG++YLHD
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMNYLHDEA 125
Query: 418 DPKIIHRDVKAANILLDEEFEAV--------VGDFGLAKLMDYKDTHVTTAVRGTIGHIA 469
IIHRD+K++NIL+ ++ E + DFGLA+ T +A G +A
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAA-GAYAWMA 182
Query: 470 PEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529
PE + S+ +DV+ YG++L EL+TG+ F + L G+ KL +
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPF--------RGIDGLAVAYGVA-MNKLAL 233
Query: 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ +L++ C P RP + ++ L
Sbjct: 234 PIPST-----CPEPFAKLME---DCWNPDPHSRPSFTNILDQLT 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-55
Identities = 72/287 (25%), Positives = 109/287 (37%), Gaps = 37/287 (12%)
Query: 301 KNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 359
+LG+G FG+ K G ++ +K L + F EV+++ H N+L+
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 360 GFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 419
G + Y+ G++ ++ W R A A G++YLH
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSM--- 127
Query: 420 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-------------YKDTHVTTAVRGTIG 466
IIHRD+ + N L+ E VV DFGLA+LM D V G
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 467 HIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 526
+APE ++ EK DVF +GI+L E+I A D D + GL
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--------DPDYLPRTMDFGLNVRGF 239
Query: 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
L+ P+ + + C P RP ++ LE
Sbjct: 240 LDRYCPPNCP--------PSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-54
Identities = 77/302 (25%), Positives = 129/302 (42%), Gaps = 37/302 (12%)
Query: 282 QLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEER-TPGGELQF 340
R + + ++ + +G G FG VYKG+ VAVK L TP F
Sbjct: 10 HGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAF 67
Query: 341 QTEVEMISMAVHRNLLRLRGFCMTP-----TERLLVYPYMANGSVASCLRERPPSQLPLD 395
+ EV ++ H N+L G+ P T+ + S+ L +
Sbjct: 68 KNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQ------WCEGSSLYHHLHASETK---FE 118
Query: 396 WPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KD 454
IA +ARG+ YLH IIHRD+K+ NI L E+ +GDFGLA
Sbjct: 119 MKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175
Query: 455 THVTTAVRGTIGHIAPE---YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDD 511
+H + G+I +APE + S ++DV+ +GI+L EL+TGQ + + + N D
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY--SNINNRDQ 233
Query: 512 VMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571
++ + G + +++N +++L+ C + +RP ++
Sbjct: 234 II---EMVG----RGSLSPDLSKVRSN-CPKRMKRLMA---ECLKKKRDERPSFPRILAE 282
Query: 572 LE 573
+E
Sbjct: 283 IE 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-54
Identities = 59/279 (21%), Positives = 111/279 (39%), Gaps = 33/279 (11%)
Query: 301 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNLLRLR 359
L G+++KGR G+ + VK LK + + F E + + H N+L +
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 360 GFCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 417
G C +P + +M GS+ + L E +D + AL ARG+++LH
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLH-TL 130
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 477
+P I + + ++++DE+ A + + + +APE L
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKP 184
Query: 478 S---SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534
D++ + ++L EL+T + F D+ ++ + E P
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPF--------ADLSNMEIGMKVALEGLR-----PT 231
Query: 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ + V +L++ +C P RPK +V +LE
Sbjct: 232 IPPG-ISPHVSKLMK---ICMNEDPAKRPKFDMIVPILE 266
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 4e-54
Identities = 70/305 (22%), Positives = 124/305 (40%), Gaps = 44/305 (14%)
Query: 285 RFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQ-FQTE 343
L+E + + ++G+G FG+VY GR G VA++ + ER +L+ F+ E
Sbjct: 22 SIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKRE 79
Query: 344 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIA 403
V H N++ G CM+P ++ ++ S +R+ LD ++IA
Sbjct: 80 VMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIA 136
Query: 404 LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD----YKDTHVTT 459
+G+ YLH I+H+D+K+ N+ D + V+ DFGL + +
Sbjct: 137 QEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLR 192
Query: 460 AVRGTIGHIAPEYLSTGKS---------SEKTDVFGYGIMLLELITGQRAFDLARLANDD 510
G + H+APE + S+ +DVF G + EL + F
Sbjct: 193 IQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK------TQ 246
Query: 511 DVMLLDWV--KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 568
+ W G+ P+L + E+ ++ C +RP +++
Sbjct: 247 PAEAIIWQMGTGMK----------PNLSQIGMGKEISDILL---FCWAFEQEERPTFTKL 293
Query: 569 VRMLE 573
+ MLE
Sbjct: 294 MDMLE 298
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-51
Identities = 61/179 (34%), Positives = 91/179 (50%), Gaps = 10/179 (5%)
Query: 25 EGDALHSLRSNLIDPNNVLQSWDPTL-VNPCTWFHVTCNNDNSVIRV---DLGNAALSGQ 80
+ AL ++ +L +P L SW PT TW V C+ D RV DL L
Sbjct: 7 DKQALLQIKKDLGNPTT-LSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 81 LV--SQLGLLKNLQYLELYS-NNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLS 137
S L L L +L + NN+ GPIP + LT L L + + +G IPD L ++
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 138 KLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSF-SLFTPISFANN 194
L L + N+LSG +P S++++ +L + NR+SG +PD+ GSF LFT ++ + N
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-44
Identities = 37/129 (28%), Positives = 59/129 (45%), Gaps = 2/129 (1%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP 130
+ L+G++ L NL +++L N + G G+ + + L NS +
Sbjct: 180 TISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
Query: 131 DTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPIS 190
+G L L L NN + G +P LT + L L++S N L G +P G+ F +
Sbjct: 239 K-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSA 297
Query: 191 FANNLDLCG 199
+ANN LCG
Sbjct: 298 YANNKCLCG 306
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-51
Identities = 64/298 (21%), Positives = 120/298 (40%), Gaps = 39/298 (13%)
Query: 302 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV--HRNLLRLR 359
+G+G +G+V++G G VAVK E + E E+ + + H N+L
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFI 68
Query: 360 GFCMT----PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH- 414
MT T+ L+ Y GS+ L+ LD + RI L A GL++LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHI 123
Query: 415 ----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV---TTAVRGTIGH 467
P I HRD+K+ NIL+ + + + D GLA + + GT +
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 468 IAPE------YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLA---RLANDDDVML---L 515
+APE + S ++ D++ +G++L E+ + + + D V
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 516 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ ++ ++ + + ++ + +L++ C +P R + + L
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 9e-51
Identities = 66/298 (22%), Positives = 116/298 (38%), Gaps = 39/298 (13%)
Query: 302 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV--HRNLLRLR 359
+G+G +G+V+ G+ G VAVK E + E E+ + H N+L
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFI 97
Query: 360 GFCMTP----TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH- 414
+ T+ L+ Y NGS+ L+ LD + ++A S GL +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHT 152
Query: 415 ----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV---TTAVRGTIGH 467
P I HRD+K+ NIL+ + + D GLA V GT +
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 468 IAPE------YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLA---RLANDDDV---MLL 515
+ PE + +S D++ +G++L E+ + + +L D V
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 516 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ ++ ++ KKL ++ ++ +L+ C +P R V + L
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE---CWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-49
Identities = 66/298 (22%), Positives = 120/298 (40%), Gaps = 39/298 (13%)
Query: 302 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV--HRNLLRLR 359
+G+G FG+V++G+ G VAVK E + E E+ + H N+L
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFI 102
Query: 360 GFCM----TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH- 414
T T+ LV Y +GS+ L + ++AL +A GL++LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHM 157
Query: 415 ----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT---TAVRGTIGH 467
P I HRD+K+ NIL+ + + D GLA D + GT +
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 468 IAPEYL------STGKSSEKTDVFGYGIMLLELITGQRAFDLA---RLANDDDV---MLL 515
+APE L +S ++ D++ G++ E+ + +L D V +
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 516 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ ++ ++ E+KL + Q+ + ++++ C + R + + L
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLS 332
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 4e-45
Identities = 48/154 (31%), Positives = 78/154 (50%)
Query: 62 NNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLY 121
N ++ ++ + G ++ +L++ N ++G IP ++G++ L L+L
Sbjct: 605 NRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLG 664
Query: 122 LNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNG 181
N +G IPD +G L L L L++N L G IP +++ ++ L +DLSNN LSG +P+ G
Sbjct: 665 HNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMG 724
Query: 182 SFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPP 215
F F P F NN LCG R P +
Sbjct: 725 QFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAH 758
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 3e-37
Identities = 44/115 (38%), Positives = 64/115 (55%)
Query: 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNS 124
N++ + L N +G++ L L L L N ++G IPS LG+L+ L L L+LN
Sbjct: 394 NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNM 453
Query: 125 FTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179
G IP L + L L L+ N L+G IP L+N ++L + LSNNRL+G +P
Sbjct: 454 LEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 508
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-36
Identities = 45/109 (41%), Positives = 63/109 (57%)
Query: 70 VDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPI 129
+ L L G++ +L +K L+ L L N++TG IPS L N T+L + L N TG I
Sbjct: 447 LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI 506
Query: 130 PDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
P +G+L L L+L+NNS SG IP L + SL LDL+ N +G +P
Sbjct: 507 PKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-36
Identities = 49/121 (40%), Positives = 65/121 (53%), Gaps = 2/121 (1%)
Query: 62 NNDNSVIRVDLGNAALSGQLVSQLG--LLKNLQYLELYSNNITGPIPSDLGNLTSLVSLD 119
N S++ +DL + SG ++ L LQ L L +N TG IP L N + LVSL
Sbjct: 365 NLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLH 424
Query: 120 LYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179
L N +G IP +LG LSKLR L+L N L G IP L + +L+ L L N L+G +P
Sbjct: 425 LSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484
Query: 180 N 180
Sbjct: 485 G 485
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-36
Identities = 44/130 (33%), Positives = 67/130 (51%), Gaps = 1/130 (0%)
Query: 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSF 125
++ + L LSG + S LG L L+ L+L+ N + G IP +L + +L +L L N
Sbjct: 419 ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478
Query: 126 TGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFS 184
TG IP L + L ++ L+NN L+G IP + + +L +L LSNN SG +P G
Sbjct: 479 TGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCR 538
Query: 185 LFTPISFANN 194
+ N
Sbjct: 539 SLIWLDLNTN 548
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-36
Identities = 57/236 (24%), Positives = 87/236 (36%), Gaps = 59/236 (25%)
Query: 14 VHSSWLASANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNNDN-------- 65
+S S E L S + L D N +L W NPCT+ VTC +D
Sbjct: 2 FQASPSQSLYREIHQLISFKDVLPDKN-LLPDWSSN-KNPCTFDGVTCRDDKVTSIDLSS 59
Query: 66 -----------------------------------------SVIRVDLGNAALSGQL--V 82
S+ +DL +LSG + +
Sbjct: 60 KPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTL 119
Query: 83 SQLGLLKNLQYLELYSNNITGPIP-SDLGNLTSLVSLDLYLNSFTGPIPDTL---GKLSK 138
+ LG L++L + SN + P S L SL LDL NS +G +
Sbjct: 120 TSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGE 179
Query: 139 LRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANN 194
L+ L ++ N +SG + +S +L+ LD+S+N S +P G S + + N
Sbjct: 180 LKHLAISGNKISGDVDVS--RCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGN 233
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-35
Identities = 36/136 (26%), Positives = 68/136 (50%), Gaps = 7/136 (5%)
Query: 61 CNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDL 120
+ + + + +SG + + NL++L++ SNN + IP LG+ ++L LD+
Sbjct: 174 SDGCGELKHLAISGNKISGDV--DVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDI 230
Query: 121 YLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN 180
N +G + ++L+ L +++N GPIP + SLQ L L+ N+ +G +PD
Sbjct: 231 SGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDF 288
Query: 181 --GSFSLFTPISFANN 194
G+ T + + N
Sbjct: 289 LSGACDTLTGLDLSGN 304
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-34
Identities = 46/130 (35%), Positives = 66/130 (50%), Gaps = 6/130 (4%)
Query: 71 DLGNAALSGQL-VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPI 129
L +G++ G L L+L N+ G +P G+ + L SL L N+F+G +
Sbjct: 275 SLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGEL 334
Query: 130 P-DTLGKLSKLRFLRLNNNSLSGPIPMSLTNIS-SLQVLDLSNNRLSGVVPDNGSFSLFT 187
P DTL K+ L+ L L+ N SG +P SLTN+S SL LDLS+N SG + N +
Sbjct: 335 PMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKN 394
Query: 188 PISFANNLDL 197
+ L L
Sbjct: 395 TLQE---LYL 401
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-32
Identities = 44/139 (31%), Positives = 68/139 (48%), Gaps = 5/139 (3%)
Query: 61 CNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSD-LGNLTSLVSLD 119
+++ +DL G + G L+ L L SNN +G +P D L + L LD
Sbjct: 290 SGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLD 349
Query: 120 LYLNSFTGPIPDTLGKLS-KLRFLRLNNNSLSGPIPMSLTNI--SSLQVLDLSNNRLSGV 176
L N F+G +P++L LS L L L++N+ SGPI +L ++LQ L L NN +G
Sbjct: 350 LSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK 409
Query: 177 VPDN-GSFSLFTPISFANN 194
+P + S + + N
Sbjct: 410 IPPTLSNCSELVSLHLSFN 428
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-30
Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 5/134 (3%)
Query: 63 NDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYL 122
++ + L L+G++ S L NL ++ L +N +TG IP +G L +L L L
Sbjct: 464 YVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSN 523
Query: 123 NSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-G 181
NSF+G IP LG L +L LN N +G IP ++ S ++ N ++G
Sbjct: 524 NSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIK 579
Query: 182 SFSLFTPISFANNL 195
+ + A NL
Sbjct: 580 NDGMKKECHGAGNL 593
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 3e-25
Identities = 22/127 (17%), Positives = 45/127 (35%), Gaps = 7/127 (5%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP 130
L N + SG + ++LG ++L +L+L +N G IP+ + S + N G
Sbjct: 520 KLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRY 575
Query: 131 DTLGKLSKLRFLRL--NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFT 187
+ + N G L +S+ ++++ G +
Sbjct: 576 VYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMM 635
Query: 188 PISFANN 194
+ + N
Sbjct: 636 FLDMSYN 642
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 26/116 (22%), Positives = 43/116 (37%), Gaps = 6/116 (5%)
Query: 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLN-- 123
S+I +DL +G + + + + +N I G + N N
Sbjct: 539 SLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLL 594
Query: 124 SFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179
F G + L +LS + + G + N S+ LD+S N LSG +P
Sbjct: 595 EFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPK 650
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 70/299 (23%), Positives = 116/299 (38%), Gaps = 63/299 (21%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSL-VAVKRLKEERTPGGELQFQTEVEMISMAVHRN 354
+ +GRG FG+V+ GRL + VAVK +E P + +F E ++ H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
++RL G C +V + G + LR L T ++ +A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLE 230
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA------VRGTIGHI 468
IHRD+ A N L+ E+ + DFG+++ + + V+ T
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE-ADGVYAASGGLRQVPVKWT---- 282
Query: 469 APEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527
APE L+ G+ S ++DV+ +GI+L E + G +
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASPY-------------------------- 316
Query: 528 EMLVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 573
P+L N VE+ + ++ C P RP S + + L+
Sbjct: 317 -----PNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 83/294 (28%), Positives = 120/294 (40%), Gaps = 59/294 (20%)
Query: 302 NILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357
++GRG FG VY G L D AVK L G QF TE ++ H N+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 358 LRGFCMTPTE-RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 416
L G C+ L+V PYM +G + + +R + L A+G+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKYLASK 147
Query: 417 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAPEYL 473
K +HRD+ A N +LDE+F V DFGLA+ M +Y H T + + +A E L
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 474 STGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532
T K + K+DV+ +G++L EL+T G +
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPY------------------------------- 233
Query: 533 PDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 573
PD+ + + Q L +V L C RP SE+V +
Sbjct: 234 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 9e-38
Identities = 68/291 (23%), Positives = 114/291 (39%), Gaps = 36/291 (12%)
Query: 301 KNILGRGGFGKVYKGRLA-----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 355
LG G FGKV R G VAVK LK E + E+E++ H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 356 LRLRGFCMTPTER--LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
++ +G C L+ ++ +GS+ L + ++ + + A+ +G+ YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYL 142
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAP 470
+ +HRD+ A N+L++ E + +GDFGL K + D T + AP
Sbjct: 143 GSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDRDSPVFWYAP 198
Query: 471 EYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529
E L K +DV+ +G+ L EL+T L M+ + + +
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK---MIGPTHGQMTVTRLVNT 255
Query: 530 LVDPDLQNNYV-------EAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
L+ EV QL+ C + P +R ++ E
Sbjct: 256 -----LKEGKRLPCPPNCPDEVYQLM---RKCWEFQPSNRTSFQNLIEGFE 298
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 70/304 (23%), Positives = 120/304 (39%), Gaps = 69/304 (22%)
Query: 301 KNILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNL 355
ILG G FG V +G L VAVK +K + + E++ F +E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 356 LRLRGFC-----MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK--RIALGSAR 408
+RL G C + +++ P+M G + + L P P + + + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 409 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 468
G+ YL + +HRD+ A N +L ++ V DFGL+K + D + +G I +
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKM 211
Query: 469 -----APEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 522
A E L+ + K+DV+ +G+ + E+ T G +
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY--------------------- 250
Query: 523 KEKKLEMLVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVV 569
P +QN+ + + L ++ C + P+DRP S +
Sbjct: 251 ----------PGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLR 300
Query: 570 RMLE 573
LE
Sbjct: 301 LQLE 304
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 67/325 (20%), Positives = 121/325 (37%), Gaps = 77/325 (23%)
Query: 274 EDP-EVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSL-----VAVKR 327
E P + L LK F +LG G FG VYKG VA+K
Sbjct: 2 EAPNQALLRILKE----------TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE 51
Query: 328 LKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 387
L+E +P + E +++ + ++ RL G C+T T L+ M G + +RE
Sbjct: 52 LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH 110
Query: 388 PPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447
+ + + A+G++YL D +++HRD+ A N+L+ + DFGLA
Sbjct: 111 KDN---IGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 448 KLMDYKDTHVTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAF 501
KL+ ++ ++ A E + + ++DV+ YG+ + EL+T G + +
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220
Query: 502 DLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQ-------------LI 548
+ + + + +E+ +
Sbjct: 221 -------------------------------DGIPASEISSILEKGERLPQPPICTIDVY 249
Query: 549 QVALLCTQGSPMDRPKMSEVVRMLE 573
+ C RPK E++
Sbjct: 250 MIMRKCWMIDADSRPKFRELIIEFS 274
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGEL-QFQTEVEMISMAVHRNLLRLRG 360
+GRG F VYKG VA L++ + E +F+ E EM+ H N++R
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 361 FCMTPTE---RLLVYP-YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 416
+ + +++ M +G++ + L+ + + +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTR 148
Query: 417 CDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 475
P IIHRD+K NI + +V +GD GLA L AV GT +APE
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 204
Query: 476 GKSSEKTDVFGYGIMLLELITGQ 498
E DV+ +G+ +LE+ T +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-37
Identities = 81/424 (19%), Positives = 135/424 (31%), Gaps = 75/424 (17%)
Query: 179 DNGSFSLFTPISFAN--------NLDLCGPVT--GRPCPGSPPFSPPPPFIPPPPISSPG 228
G + + F L G + CP S + P P
Sbjct: 217 KAGKYCIPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPST 276
Query: 229 GNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSL 288
I + G I R P + DPE +LK L
Sbjct: 277 LTHPQRRIDTLNSDG--YTPEPARITSPDKPRPMPMDTSVFESPFSDPE----ELKDKKL 330
Query: 289 RELQVATDSFSNKNILGRGGFGKVYKGRLADGS---LVAVKRLKEERTPGGELQFQTEVE 345
+ + LG G FG V +G VA+K LK+ + E +
Sbjct: 331 FLKR--DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 388
Query: 346 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALG 405
++ + ++RL G C +LV G + L + + +
Sbjct: 389 IMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQ 444
Query: 406 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT- 464
+ G+ YL + +HR++ A N+LL A + DFGL+K + D++ T G
Sbjct: 445 VSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 501
Query: 465 -IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 522
+ APE ++ K S ++DV+ YG+ + E ++ GQ+ +
Sbjct: 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY--------------------- 540
Query: 523 KEKKLEMLVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVV 569
++ V A +EQ L + C DRP V
Sbjct: 541 ----------KKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVE 590
Query: 570 RMLE 573
+ +
Sbjct: 591 QRMR 594
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-37
Identities = 82/295 (27%), Positives = 121/295 (41%), Gaps = 61/295 (20%)
Query: 302 NILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357
++GRG FG VY G L D AVK L G QF TE ++ H N+L
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 358 LRGFCMTPTE--RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 415
L G C +E L+V PYM +G + + +R + L A+G+ +L
Sbjct: 155 LLGIC-LRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKFLAS 210
Query: 416 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAPEY 472
K +HRD+ A N +LDE+F V DFGLA+ M ++ H T + + +A E
Sbjct: 211 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 473 LSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531
L T K + K+DV+ +G++L EL+T G +
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPPY------------------------------ 297
Query: 532 DPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 573
PD+ + + Q L +V L C RP SE+V +
Sbjct: 298 -PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-37
Identities = 63/296 (21%), Positives = 112/296 (37%), Gaps = 46/296 (15%)
Query: 301 KNILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 355
LG+G FG V R G +VAVK+L+ T F+ E+E++ H N+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNI 73
Query: 356 LRLRGFCMTPTER--LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
++ +G C + R L+ Y+ GS+ L++ +D + +G+ YL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL 130
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAP 470
+ IHRD+ NIL++ E +GDFGL K++ D I AP
Sbjct: 131 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESPIFWYAP 186
Query: 471 EYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530
E L+ K S +DV+ +G++L EL T + +
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEK---------------SKSPPAEFMRMIGND 231
Query: 531 VDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ ++ ++ + + C + RP ++ ++
Sbjct: 232 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-37
Identities = 72/296 (24%), Positives = 110/296 (37%), Gaps = 61/296 (20%)
Query: 301 KNILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 356
++G+G FG VY G D + A+K L F E ++ H N+L
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 357 RLRGFCMTPTE--RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
L G P E ++ PYM +G + +R + L ARG+ YL
Sbjct: 86 ALIGIM-LPPEGLPHVLLPYMCHGDLLQFIRSPQRN---PTVKDLISFGLQVARGMEYLA 141
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAPE 471
+ K +HRD+ A N +LDE F V DFGLA+ + +Y R + A E
Sbjct: 142 EQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198
Query: 472 YLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530
L T + + K+DV+ +G++L EL+T G +
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPY----------------------------- 229
Query: 531 VDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ + + Q L QV C + P RP +V +E
Sbjct: 230 --RHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-37
Identities = 83/290 (28%), Positives = 130/290 (44%), Gaps = 35/290 (12%)
Query: 301 KNILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 355
+ LG+G FG V R G+LVAVK+L+ P + FQ E++++ +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFI 86
Query: 356 LRLRGFCMTPTER--LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
++ RG P + LV Y+ +G + L+ LD + +G+ YL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYL 143
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTIGHIAPE 471
+ +HRD+ A NIL++ E + DFGLAKL+ + V + I APE
Sbjct: 144 GSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 200
Query: 472 YLSTGKSSEKTDVFGYGIMLLELIT-GQR-----AFDLARLANDDDVMLLDWVKGLLKE- 524
LS S ++DV+ +G++L EL T + A L + + DV L + LL+E
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260
Query: 525 KKLEMLVD-PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
++L P EV +L+ LC SP DRP S + L+
Sbjct: 261 QRLPAPPACPA--------EVHELM---KLCWAPSPQDRPSFSALGPQLD 299
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 63/296 (21%), Positives = 111/296 (37%), Gaps = 46/296 (15%)
Query: 301 KNILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 355
LG+G FG V R G +VAVK+L+ T F+ E+E++ H N+
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNI 104
Query: 356 LRLRGFCMTPTER--LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
++ +G C + R L+ Y+ GS+ L++ +D + +G+ YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL 161
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAP 470
+ IHRD+ NIL++ E +GDFGL K++ D I AP
Sbjct: 162 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFWYAP 217
Query: 471 EYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530
E L+ K S +DV+ +G++L EL T +
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ------------- 264
Query: 531 VDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ ++ ++ + + C + RP ++ ++
Sbjct: 265 --GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 70/291 (24%), Positives = 113/291 (38%), Gaps = 38/291 (13%)
Query: 301 KNILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 355
LG G FGKV G +VAVK LK + P ++ E++++ H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 356 LRLRGFCMTPTER--LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
++ +G C LV Y+ GS+ L + A G++YL
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYL 150
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAP 470
H IHRD+ A N+LLD + +GDFGLAK + + + AP
Sbjct: 151 HAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAP 206
Query: 471 EYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDV-----MLLDWVKGLLKE 524
E L K +DV+ +G+ L EL+T + + M + + LL+
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266
Query: 525 -KKLEMLVD-PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
++L P EV L+ C + RP ++ +L+
Sbjct: 267 GERLPRPDKCPA--------EVYHLM---KNCWETEASFRPTFENLIPILK 306
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 62/305 (20%), Positives = 110/305 (36%), Gaps = 70/305 (22%)
Query: 301 KNILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNL 355
+LG+G FG V + +L VAVK LK + +++ F E + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 356 LRLRGFC------MTPTERLLVYPYMANGSVASCLRERPPSQLP--LDWPTRKRIALGSA 407
+L G +++ P+M +G + + L + P L T R + A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VR 462
G+ YL IHRD+ A N +L E+ V DFGL++ + D + V+
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 463 GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGL 521
A E L+ + +DV+ +G+ + E++T GQ +
Sbjct: 205 WL----ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY-------------------- 240
Query: 522 LKEKKLEMLVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEV 568
++N + + + + C P RP + +
Sbjct: 241 -----------AGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCL 289
Query: 569 VRMLE 573
LE
Sbjct: 290 RMELE 294
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-36
Identities = 74/292 (25%), Positives = 119/292 (40%), Gaps = 53/292 (18%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 355
+S + LG+G FG+V+ G + VA+K LK F E +++ H L
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKL 241
Query: 356 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 415
++L + +V YM+ GS+ L+ L L P +A A G++Y+
Sbjct: 242 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYVER 298
Query: 416 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 475
+HRD++AANIL+ E V DFGLA+L++ + + I APE
Sbjct: 299 M---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 355
Query: 476 GKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534
G+ + K+DV+ +GI+L EL T G+ + P
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGRVPY-------------------------------PG 384
Query: 535 LQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ N V +VE+ L + C + P +RP + LE
Sbjct: 385 MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 62/292 (21%), Positives = 106/292 (36%), Gaps = 57/292 (19%)
Query: 301 KNILGRGGFGKVYKGRLADGS---LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 357
LG G FG V +G VA+K LK+ + E +++ + ++R
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 358 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 417
L G C +LV G + L + + + + G+ YL +
Sbjct: 75 LIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK- 129
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEYLST 475
+HRD+ A N+LL A + DFGL+K + D++ T G + APE ++
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 476 GKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534
K S ++DV+ YG+ + E ++ GQ+ +
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPY-------------------------------KK 216
Query: 535 LQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 573
++ V A +EQ L + C DRP V + +
Sbjct: 217 MKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-35
Identities = 61/307 (19%), Positives = 114/307 (37%), Gaps = 64/307 (20%)
Query: 289 RELQVATDSFSNKNILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQFQTEV 344
R+ ++ + +G G FG V++G VA+K K + +F E
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 345 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIAL 404
+ H ++++L G ++ G + S L+ R S LD + A
Sbjct: 443 LTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFS---LDLASLILYAY 498
Query: 405 GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD----YKDTHVTTA 460
+ L+YL + +HRD+ A N+L+ +GDFGL++ M+ YK +
Sbjct: 499 QLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 461 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVK 519
++ APE ++ + + +DV+ +G+ + E++ G + F
Sbjct: 556 IKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKPF------------------ 593
Query: 520 GLLKEKKLEMLVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMS 566
++NN V +E L + C P RP+ +
Sbjct: 594 -------------QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFT 640
Query: 567 EVVRMLE 573
E+ L
Sbjct: 641 ELKAQLS 647
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 71/296 (23%), Positives = 125/296 (42%), Gaps = 53/296 (17%)
Query: 301 KNILGRGGFGKVYKGRLADGS------LVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 354
LG+G FG VY+G VA+K + E + ++F E ++ +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRER------PPSQLPLDWPTRKRIALGSAR 408
++RL G L++ M G + S LR P P ++A A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 409 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 468
G++YL+ + K +HRD+ A N ++ E+F +GDFG+ + + D + +G G +
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLL 202
Query: 469 -----APEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLAR-----LANDDDVMLLDWV 518
+PE L G + +DV+ +G++L E+ T LA L+N+ V
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQGLSNEQ-------V 249
Query: 519 KGLLKE-KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ E L+ PD + +L+ +C Q +P RP E++ ++
Sbjct: 250 LRFVMEGGLLDK---PD----NCPDMLFELM---RMCWQYNPKMRPSFLEIISSIK 295
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-35
Identities = 61/306 (19%), Positives = 115/306 (37%), Gaps = 56/306 (18%)
Query: 286 FSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQFQ 341
S R+ ++ + +G G FG V++G VA+K K + +F
Sbjct: 5 SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 64
Query: 342 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKR 401
E + H ++++L G ++ G + S L+ R S LD +
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS---LDLASLIL 120
Query: 402 IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 461
A + L+YL + +HRD+ A N+L+ +GDFGL++ M+ + +
Sbjct: 121 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177
Query: 462 RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKG 520
+ I +APE ++ + + +DV+ +G+ + E++ G + F
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF------------------- 218
Query: 521 LLKEKKLEMLVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSE 567
++NN V +E L + C P RP+ +E
Sbjct: 219 ------------QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE 266
Query: 568 VVRMLE 573
+ L
Sbjct: 267 LKAQLS 272
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 22/215 (10%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGS-----LVAVKRLKEERTPGGELQFQTEVEMISMA 350
F +LG G FG VYKG VA+K L+E +P + E +++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 351 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGL 410
+ ++ RL G C+T T L+ M G + +RE + + + A+G+
Sbjct: 75 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGM 130
Query: 411 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTI 465
+YL D +++HRD+ A N+L+ + DFGLAKL+ ++ ++
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM- 186
Query: 466 GHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQR 499
A E + + ++DV+ YG+ + EL+T G +
Sbjct: 187 ---ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-35
Identities = 62/301 (20%), Positives = 119/301 (39%), Gaps = 66/301 (21%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSL----VAVKRLKEERTPGGELQFQTEVEMISMAV 351
+ ILG G FG+VY+G + VAVK K++ T + +F +E ++
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 352 HRNLLRLRGFCMT-PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGL 410
H ++++L G PT ++ G + L S L T +L + +
Sbjct: 72 HPHIVKLIGIIEEEPT--WIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAM 126
Query: 411 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA----VRGTIG 466
+YL +HRD+ NIL+ +GDFGL++ ++ +D + + ++
Sbjct: 127 AYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM-- 181
Query: 467 HIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEK 525
+PE ++ + + +DV+ + + + E+++ G++ F
Sbjct: 182 --SPESINFRRFTTASDVWMFAVCMWEILSFGKQPF------------------------ 215
Query: 526 KLEMLVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRML 572
L+N V +E+ L + C P DRP+ +E+V L
Sbjct: 216 -------FWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 268
Query: 573 E 573
Sbjct: 269 S 269
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-35
Identities = 77/321 (23%), Positives = 129/321 (40%), Gaps = 45/321 (14%)
Query: 272 AEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGS------LVAV 325
+P +V + + LG G FG+VY+G+++ VAV
Sbjct: 6 HHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAV 65
Query: 326 KRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR 385
K L E + EL F E +IS H+N++R G + R ++ MA G + S LR
Sbjct: 66 KTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR 125
Query: 386 ERPPSQLPLDWPTRKR---IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV- 441
E P +A A G YL ++ IHRD+ A N LL V
Sbjct: 126 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 182
Query: 442 --GDFGLAKLMDYKDTHVTTAVRGTIGHI-----APEYLSTGKSSEKTDVFGYGIMLLEL 494
GDFG+A+ + + +G + PE G + KTD + +G++L E+
Sbjct: 183 KIGDFGMARDIYRASYY----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238
Query: 495 IT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD-PDLQNNYVEAEVEQLIQVAL 552
+ G + +N + +L++V +++ + P V +++
Sbjct: 239 FSLGYMPY--PSKSNQE---VLEFVT---SGGRMDPPKNCPG--------PVYRIM---T 279
Query: 553 LCTQGSPMDRPKMSEVVRMLE 573
C Q P DRP + ++ +E
Sbjct: 280 QCWQHQPEDRPNFAIILERIE 300
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 65/297 (21%), Positives = 117/297 (39%), Gaps = 63/297 (21%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 355
+ +G G FG V+ G + VA+K ++E E F E E++ H L
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKL 65
Query: 356 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 415
++L G C+ LV +M +G ++ LR + T + L G++YL +
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEE 122
Query: 416 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIAP 470
+IHRD+ A N L+ E V DFG+ + + D + ++ V+ +P
Sbjct: 123 A---CVIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWA----SP 174
Query: 471 EYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529
E S + S K+DV+ +G+++ E+ + G+ +
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY---------------------------- 206
Query: 530 LVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ N+ V ++ + Q+ C + P DRP S ++R L
Sbjct: 207 ---ENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 62/293 (21%), Positives = 119/293 (40%), Gaps = 54/293 (18%)
Query: 298 FSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 356
F ++G GGFG+V+K + DG +KR+K + + EV+ ++ H N++
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIV 67
Query: 357 RLRGFCMTPTERLLVYP----------------YMANGSVASCLRERPPSQLPLDWPTRK 400
G + G++ + +R +L
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV--LAL 125
Query: 401 RIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 460
+ +G+ Y+H K+I+RD+K +NI L + + +GDFGL + +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK 182
Query: 461 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQR-AFDLARLANDDDVMLLDWVK 519
GT+ +++PE +S+ ++ D++ G++L EL+ AF+ ++ D
Sbjct: 183 --GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD---------- 230
Query: 520 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 572
L++ + + D + L+Q P DRP SE++R L
Sbjct: 231 --LRDGIISDIFDKKEKT---------LLQ---KLLSKKPEDRPNTSEILRTL 269
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 25/230 (10%)
Query: 281 GQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSL-----VAVKRLKEERTPG 335
G +K R + +LG G FG V+KG V +K ++++
Sbjct: 1 GAMKVL-ARIFKE--TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ 57
Query: 336 GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLD 395
+ I H +++RL G C + LV Y+ GS+ +R+ + L
Sbjct: 58 SFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGA---LG 113
Query: 396 WPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455
+ A+G+ YL +H ++HR++ A N+LL + V DFG+A L+ D
Sbjct: 114 PQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170
Query: 456 HVTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQR 499
+ + ++ A E + GK + ++DV+ YG+ + EL+T G
Sbjct: 171 QLLYSEAKTPIKWM----ALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-34
Identities = 75/294 (25%), Positives = 120/294 (40%), Gaps = 57/294 (19%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 355
+S + LG+G FG+V+ G + VA+K LK F E +++ H L
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKL 324
Query: 356 LRLRGFCMTPTER--LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
++L +E +V YM+ GS+ L+ L L P +A A G++Y+
Sbjct: 325 VQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYV 379
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 473
+HRD++AANIL+ E V DFGLA+L++ + + I APE
Sbjct: 380 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 436
Query: 474 STGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532
G+ + K+DV+ +GI+L EL T G+ +
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVPY------------------------------- 465
Query: 533 PDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 573
P + N V +VE+ L + C + P +RP + LE
Sbjct: 466 PGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 67/297 (22%), Positives = 115/297 (38%), Gaps = 63/297 (21%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 355
+ + LG G FG V G+ VAVK +KE E +F E + + H L
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKL 65
Query: 356 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 415
++ G C +V Y++NG + + LR L+ + G+++L
Sbjct: 66 VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFLES 122
Query: 416 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIAP 470
H + IHRD+ A N L+D + V DFG+ + + D +V++ V+ + AP
Sbjct: 123 H---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWS----AP 174
Query: 471 EYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529
E K S K+DV+ +GI++ E+ + G+ +
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY---------------------------- 206
Query: 530 LVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 573
N+ V +V Q + Q+ C P RP +++ +E
Sbjct: 207 ---DLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 60/323 (18%), Positives = 114/323 (35%), Gaps = 68/323 (21%)
Query: 270 VPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLK 329
+ ++ P ++ + LG G FG V G+ VA+K +K
Sbjct: 3 LGSKNAP-----STAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK 57
Query: 330 EERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPP 389
E E +F E +++ H L++L G C ++ YMANG + + LRE
Sbjct: 58 EGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH 115
Query: 390 SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449
+ + YL + +HRD+ A N L++++ V DFGL++
Sbjct: 116 R---FQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169
Query: 450 MDYKDTHVTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDL 503
+ D + ++ VR + PE L K S K+D++ +G+++ E+ + G+ +
Sbjct: 170 V-LDDEYTSSVGSKFPVRWS----PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY-- 222
Query: 504 ARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQ-------------LIQV 550
N+ + Q + +
Sbjct: 223 -----------------------------ERFTNSETAEHIAQGLRLYRPHLASEKVYTI 253
Query: 551 ALLCTQGSPMDRPKMSEVVRMLE 573
C +RP ++ +
Sbjct: 254 MYSCWHEKADERPTFKILLSNIL 276
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 58/279 (20%), Positives = 119/279 (42%), Gaps = 22/279 (7%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK-EERTPGGELQF-QTEVEMISMAVH 352
+F + +GRG F +VY+ L DG VA+K+++ + E++++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 353 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 412
N+++ + E +V G ++ ++ + + T + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 472
+H +++HRD+K AN+ + +GD GL + K T + V GT +++PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 473 LSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532
+ + K+D++ G +L E+ Q F + ++ L +K +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLY-------SLCKKIEQCDYP 256
Query: 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571
P ++Y E+ QL+ +C P RP ++ V +
Sbjct: 257 PLPSDHY-SEELRQLVN---MCINPDPEKRPDVTYVYDV 291
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 69/307 (22%), Positives = 133/307 (43%), Gaps = 37/307 (12%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQF-QTEVEMISMAVHR 353
+ + +G G FGK + DG +K + R E + + EV +++ H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLP----LDWPTRKRIALGSARG 409
N+++ R +V Y G + + + LDW + I L
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ--ICLA---- 137
Query: 410 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 469
L ++HD KI+HRD+K+ NI L ++ +GDFG+A++++ + GT +++
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLS 193
Query: 470 PEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529
PE + K+D++ G +L EL T + AF+ + L +LK
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFE------AGSMKNL-----VLKIISGSF 242
Query: 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEV 589
P + +Y ++ L+ + +P DRP ++ + LE +A+R +++ ++
Sbjct: 243 ---PPVSLHY-SYDLRSLVS---QLFKRNPRDRPSVNSI---LEKGFIAKRIEKFLSPQL 292
Query: 590 LRQEVEL 596
+ +E L
Sbjct: 293 IAEEFCL 299
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 31/217 (14%)
Query: 301 KNILGRGGFGKVYKGRLADGSL---VAVKRLKEERTPGGELQFQTEVE-MISMAVHRNLL 356
++++G G FG+V K R+ L A+KR+KE + F E+E + + H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 357 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK------------RIAL 404
L G C L Y +G++ LR+ + + A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 405 GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 464
ARG+ YL + IHRD+ A NIL+ E + A + DFGL++ + V+ T
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKT 199
Query: 465 IGHI-----APEYLSTGKSSEKTDVFGYGIMLLELIT 496
+G + A E L+ + +DV+ YG++L E+++
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-33
Identities = 74/280 (26%), Positives = 121/280 (43%), Gaps = 27/280 (9%)
Query: 296 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 354
+ K+ LG G +G+VY+G VAVK LKE+ +F E ++ H N
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 277
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
L++L G C ++ +M G++ LRE ++ +A + + YL
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA--VVLLYMATQISSAMEYLE 335
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 474
IHR++ A N L+ E V DFGL++LM + I APE L+
Sbjct: 336 KK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 392
Query: 475 TGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533
K S K+DV+ +G++L E+ T G + + LL+ K E+ P
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMSPYP--GIDLSQVYELLE--KDYRMER-------P 441
Query: 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ E++ ++ C Q +P DRP +E+ + E
Sbjct: 442 EGC-------PEKVYELMRACWQWNPSDRPSFAEIHQAFE 474
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 79/332 (23%), Positives = 131/332 (39%), Gaps = 69/332 (20%)
Query: 265 EFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGS--- 321
+F+ + E+P + R RE++ + I+G G G+V GRL
Sbjct: 24 QFYAEPHTYEEPG----RAGRSFTREIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRD 77
Query: 322 -LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 380
VA+K LK T F +E ++ H N++RL G ++V YM NGS+
Sbjct: 78 VPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL 137
Query: 381 ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV 440
+ LR + G G+ YL D +HRD+ A N+L+D
Sbjct: 138 DTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCK 191
Query: 441 VGDFGLAKLMDYKDTHVTTAVRGTIGHI-----APEYLSTGKSSEKTDVFGYGIMLLELI 495
V DFGL++++ D G G I APE ++ S +DV+ +G+++ E++
Sbjct: 192 VSDFGLSRVL-EDDPDAAYTTTG--GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248
Query: 496 T-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQ-------- 546
G+R + ++ N V + VE+
Sbjct: 249 AYGERPY-------------------------------WNMTNRDVISSVEEGYRLPAPM 277
Query: 547 -----LIQVALLCTQGSPMDRPKMSEVVRMLE 573
L Q+ L C RP+ S++V +L+
Sbjct: 278 GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 75/293 (25%), Positives = 112/293 (38%), Gaps = 59/293 (20%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 355
+G+G FG V G G+ VAVK +K + T F E +++ H NL
Sbjct: 21 KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATA---QAFLAEASVMTQLRHSNL 76
Query: 356 LRLRGFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
++L G + L +V YMA GS+ LR R S L + +L + YL
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG--DCLLKFSLDVCEAMEYLE 134
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 474
+ +HRD+ A N+L+ E+ A V DFGL K V+ T APE L
Sbjct: 135 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALR 187
Query: 475 TGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533
K S K+DV+ +GI+L E+ + G+ + P
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPY-------------------------------P 216
Query: 534 DLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ V VE+ + +V C RP ++ LE
Sbjct: 217 RIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 269
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 71/305 (23%), Positives = 118/305 (38%), Gaps = 62/305 (20%)
Query: 301 KNILGRGGFGKVYKGRLAD--------GSLVAVKRLKEERTPGGELQFQTEVE-MISMAV 351
LG G FG+V VAVK LK++ T +E+E M +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 352 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK----------- 400
H+N++ L G C ++ Y + G++ LR R P + + +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 401 -RIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 459
ARG+ YL K IHRD+ A N+L+ E + DFGLA+ ++ D + T
Sbjct: 206 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 460 A-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLAR-----LAND 509
V+ APE L + ++DV+ +G+++ E+ T L + +
Sbjct: 263 TNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE 312
Query: 510 DDVMLLDWVK-GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 568
+ L +K G +K P E+ ++ C P RP ++
Sbjct: 313 E---LFKLLKEGHRMDK-------PA----NCTNELYMMM---RDCWHAVPSQRPTFKQL 355
Query: 569 VRMLE 573
V L+
Sbjct: 356 VEDLD 360
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 81/320 (25%), Positives = 133/320 (41%), Gaps = 63/320 (19%)
Query: 274 EDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGS----LVAVKRLK 329
EDP + + + ++ + S ++G G FG+V GRL S VA+K LK
Sbjct: 29 EDPTQTVHEFAK------ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 330 EERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPP 389
T F E ++ H N++RL G ++V YM NGS+ S LR+
Sbjct: 83 VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA 142
Query: 390 SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449
+ G A G+ YL D +HRD+ A NIL++ V DFGL ++
Sbjct: 143 Q---FTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV 196
Query: 450 M--DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARL 506
+ D + + T + I +PE ++ K + +DV+ YGI+L E+++ G+R +
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY----- 251
Query: 507 ANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQ-------------LIQVALL 553
++ N V V++ L Q+ L
Sbjct: 252 --------------------------WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD 285
Query: 554 CTQGSPMDRPKMSEVVRMLE 573
C Q +RPK ++V +L+
Sbjct: 286 CWQKDRNNRPKFEQIVSILD 305
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-33
Identities = 75/293 (25%), Positives = 111/293 (37%), Gaps = 59/293 (20%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 355
+G+G FG V G G+ VAVK +K + T F E +++ H NL
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNL 248
Query: 356 LRLRGFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
++L G + L +V YMA GS+ LR R S L + +L + YL
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG--DCLLKFSLDVCEAMEYLE 306
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 474
+ +HRD+ A N+L+ E+ A V DFGL K V+ T APE L
Sbjct: 307 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALR 359
Query: 475 TGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533
K S K+DV+ +GI+L E+ + G+ + P
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPY-------------------------------P 388
Query: 534 DLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ V VE+ + V C RP ++ LE
Sbjct: 389 RIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLE 441
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 75/292 (25%), Positives = 123/292 (42%), Gaps = 45/292 (15%)
Query: 301 KNILGRGGFGKVYKGRLADGS------LVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 354
LG G FG+VY+G+++ VAVK L E + EL F E +IS H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKR---IALGSARGLS 411
++R G + R ++ MA G + S LRE P +A A G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVV---GDFGLAKLMDYKDTHVTTAVRGTIGHI 468
YL ++ IHRD+ A N LL V GDFG+A+ + + +G +
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY----RKGGCAML 248
Query: 469 -----APEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 522
PE G + KTD + +G++L E+ + G + +N + +L++V
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY--PSKSNQE---VLEFVT--- 300
Query: 523 KEKKLEMLVD-PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
+++ + P V +++ C Q P DRP + ++ +E
Sbjct: 301 SGGRMDPPKNCPG--------PVYRIM---TQCWQHQPEDRPNFAIILERIE 341
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 73/299 (24%), Positives = 125/299 (41%), Gaps = 67/299 (22%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 355
++ LG G FG+V+ G + VAVK LK+ F E ++ H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRL 70
Query: 356 LRLRGFCMTPTER--LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
+RL T+ ++ YM NGS+ L+ +L + +A A G++++
Sbjct: 71 VRLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTI--NKLLDMAAQIAEGMAFI 125
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHI 468
+ IHRD++AANIL+ + + DFGLA+L+ + + ++ T
Sbjct: 126 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWT---- 177
Query: 469 APEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527
APE ++ G + K+DV+ +GI+L E++T G+ +
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-------------------------- 211
Query: 528 EMLVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 573
P + N V +E+ L Q+ LC + P DRP + +LE
Sbjct: 212 -----PGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 62/291 (21%), Positives = 111/291 (38%), Gaps = 59/291 (20%)
Query: 303 ILGRGGFGKVYKGRLADGSL---VAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRL 358
LG G FG V KG + VAVK LK E P + + E ++ + ++R+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 359 RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 418
G C + +LV G + L++ + + + G+ YL +
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNKYLQQN--RHVKD--KNIIELVHQVSMGMKYLEES-- 136
Query: 419 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEYLSTG 476
+HRD+ A N+LL + A + DFGL+K + + + G + APE ++
Sbjct: 137 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 477 KSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 535
K S K+DV+ +G+++ E + GQ+ + +
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKPY-------------------------------RGM 224
Query: 536 QNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ + V A +E+ + + LC +RP + V L
Sbjct: 225 KGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 71/305 (23%), Positives = 118/305 (38%), Gaps = 62/305 (20%)
Query: 301 KNILGRGGFGKVYKGRLAD--------GSLVAVKRLKEERTPGGELQFQTEVE-MISMAV 351
LG G FG+V VAVK LK++ T +E+E M +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 352 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK----------- 400
H+N++ L G C ++ Y + G++ LR R P + + +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 401 -RIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 459
ARG+ YL K IHRD+ A N+L+ E + DFGLA+ ++ D + T
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 460 A-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLAR-----LAND 509
V+ APE L + ++DV+ +G+++ E+ T L + +
Sbjct: 217 TNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE 266
Query: 510 DDVMLLDWVK-GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 568
+ L +K G +K P E+ ++ C P RP ++
Sbjct: 267 E---LFKLLKEGHRMDK-------PA----NCTNELYMMM---RDCWHAVPSQRPTFKQL 309
Query: 569 VRMLE 573
V L+
Sbjct: 310 VEDLD 314
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 78/298 (26%), Positives = 124/298 (41%), Gaps = 63/298 (21%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSL-VAVKRLKEERTPGGELQFQTEVEMISMAVHRN 354
+ K+ LG G +G+VY+G SL VAVK LKE+ E F E ++ H N
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 70
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
L++L G C ++ +M G++ LRE ++ +A + + YL
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA--VVLLYMATQISSAMEYLE 128
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIA 469
IHRD+ A N L+ E V DFGL++LM DT+ A ++ T A
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWT----A 180
Query: 470 PEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528
PE L+ K S K+DV+ +G++L E+ T G +
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY--------------------------- 213
Query: 529 MLVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 573
P + + V +E+ + ++ C Q +P DRP +E+ + E
Sbjct: 214 ----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-33
Identities = 67/292 (22%), Positives = 120/292 (41%), Gaps = 53/292 (18%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 355
+S + LG G FG+V+ + VAVK +K F E ++ H L
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKL 245
Query: 356 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 415
++L T ++ +MA GS+ L+ S+ PL P + A G++++
Sbjct: 246 VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQ 302
Query: 416 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 475
IHRD++AANIL+ + DFGLA++++ + + I APE ++
Sbjct: 303 R---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 359
Query: 476 GKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534
G + K+DV+ +GI+L+E++T G+ + P
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGRIPY-------------------------------PG 388
Query: 535 LQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ N V +E+ L + + C + P +RP + +L+
Sbjct: 389 MSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 440
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 51/219 (23%), Positives = 91/219 (41%), Gaps = 30/219 (13%)
Query: 301 KNILGRGGFGKVYKGRLADGS------LVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 354
LG FGKVYKG L + VA+K LK++ +F+ E + + H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK------------RI 402
++ L G +++ Y ++G + L R P + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 403 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-- 460
A G+ YL H ++H+D+ N+L+ ++ + D GL + + D +
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 461 ---VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
+R APE + GK S +D++ YG++L E+ +
Sbjct: 191 LLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 73/302 (24%), Positives = 127/302 (42%), Gaps = 60/302 (19%)
Query: 301 KNILGRGGFGKVYKGRLADGS------LVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 354
K LG G FGKV+ + S LVAVK LK+ T FQ E E+++ H +
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEH 78
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPPSQLPLDWPTRKR-----------I 402
+++ G C ++V+ YM +G + LR P + + +D R+ I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 403 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-- 460
A A G+ YL +HRD+ N L+ +GDFG+++ + D +
Sbjct: 139 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 461 ---VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLAR-----LANDDDV 512
+R PE + K + ++DV+ +G++L E+ T + L+N +
Sbjct: 196 MLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFT------YGKQPWFQLSNTE-- 243
Query: 513 MLLDWVKGLLKEKKLEMLVD-PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571
+++ + + + LE P EV ++ L C Q P R + E+ ++
Sbjct: 244 -VIECIT---QGRVLERPRVCPK--------EVYDVM---LGCWQREPQQRLNIKEIYKI 288
Query: 572 LE 573
L
Sbjct: 289 LH 290
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 71/306 (23%), Positives = 118/306 (38%), Gaps = 46/306 (15%)
Query: 289 RELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRL----KEERTPGGELQFQTE 343
+ + + LG GGF V L DG A+KR+ +++R + Q E
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE-----EAQRE 76
Query: 344 VEMISMAVHRNLLRLRGFCMTPTER----LLVYPYMANGSVASCLRERPPSQLPLDWPTR 399
+M + H N+LRL +C+ L+ P+ G++ + + L
Sbjct: 77 ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI 136
Query: 400 KRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 459
+ LG RGL +H HRD+K NILL +E + V+ D G
Sbjct: 137 LWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ 193
Query: 460 AVR--------GTIGHIAPEYLSTGKS----SEKTDVFGYGIMLLELITGQRAFDLARLA 507
A+ TI + APE L + +S E+TDV+ G +L ++ G+ +D+
Sbjct: 194 ALTLQDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252
Query: 508 NDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSE 567
D + L P Q+ + + QL+ + P RP +
Sbjct: 253 GD-----------SVALAVQNQLSIP--QSPRHSSALWQLLNSMM---TVDPHQRPHIPL 296
Query: 568 VVRMLE 573
++ LE
Sbjct: 297 LLSQLE 302
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 76/303 (25%), Positives = 129/303 (42%), Gaps = 66/303 (21%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGS-----LVAVKRLKEERTPGGELQFQTEVEMISMA 350
+ + ++G G FG+VYKG L S VA+K LK T + F E ++
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 351 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGL 410
H N++RL G +++ YM NG++ LRE+ + G A G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGM 160
Query: 411 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTA-----VRGT 464
YL + +HRD+ A NIL++ V DFGL++++ D + TT+ +R T
Sbjct: 161 KYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 217
Query: 465 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 523
APE +S K + +DV+ +GI++ E++T G+R +
Sbjct: 218 ----APEAISYRKFTSASDVWSFGIVMWEVMTYGERPY---------------------- 251
Query: 524 EKKLEMLVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVR 570
+L N+ V + + Q+ + C Q RPK +++V
Sbjct: 252 ---------WELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 302
Query: 571 MLE 573
+L+
Sbjct: 303 ILD 305
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-33
Identities = 73/305 (23%), Positives = 119/305 (39%), Gaps = 62/305 (20%)
Query: 301 KNILGRGGFGKVYKGRLAD--------GSLVAVKRLKEERTPGGELQFQTEVE-MISMAV 351
LG G FG+V + VAVK LK + T +E+E M +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 352 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKR---------- 401
H+N++ L G C ++ Y + G++ L+ R P L +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 402 --IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 459
A ARG+ YL K IHRD+ A N+L+ E+ + DFGLA+ + + D + T
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 460 A-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLAR-----LAND 509
V+ APE L + ++DV+ +G++L E+ T L + +
Sbjct: 251 TNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE 300
Query: 510 DDVMLLDWVK-GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 568
+ L +K G +K P E+ ++ C P RP ++
Sbjct: 301 E---LFKLLKEGHRMDK-------PS----NCTNELYMMM---RDCWHAVPSQRPTFKQL 343
Query: 569 VRMLE 573
V L+
Sbjct: 344 VEDLD 348
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 75/304 (24%), Positives = 124/304 (40%), Gaps = 60/304 (19%)
Query: 301 KNILGRGGFGKVYKGRLAD------GSLVAVKRLKEERTPGGELQFQTEVE-MISMAVHR 353
LGRG FG+V + VAVK LKE T +E++ +I + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 354 NLLRLRGFCMTPTE-RLLVYPYMANGSVASCLRERPPSQLPLDWPTRK------------ 400
N++ L G C P +++ + G++++ LR + +P
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 401 RIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 460
+ A+G+ +L K IHRD+ A NILL E+ + DFGLA+ + +V
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 461 -----VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLAR-----LANDD 510
++ APE + + ++DV+ +G++L E+ + L + D+
Sbjct: 209 DARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDE 258
Query: 511 DVMLLDWVKGLLKE-KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 569
+ LKE ++ PD Y E+ Q + L C G P RP SE+V
Sbjct: 259 EFC------RRLKEGTRMRA---PD----YTTPEMYQTM---LDCWHGEPSQRPTFSELV 302
Query: 570 RMLE 573
L
Sbjct: 303 EHLG 306
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 55/218 (25%), Positives = 88/218 (40%), Gaps = 29/218 (13%)
Query: 301 KNILGRGGFGKVYKGRLAD------GSLVAVKRLKEERTPGGELQFQTEVE-MISMAVHR 353
LG G FGKV + VAVK LK + +E++ M + H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK----------RIA 403
N++ L G C L++ Y G + + LR + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 404 LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--- 460
A+G+++L IHRDV A N+LL A +GDFGLA+ + ++
Sbjct: 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 461 --VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
V+ APE + + ++DV+ YGI+L E+ +
Sbjct: 228 LPVKWM----APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 51/201 (25%), Positives = 97/201 (48%), Gaps = 10/201 (4%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 361
+LG+G +G VY GR L++ +A+K + E + + E+ + H+N+++ G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIVQYLGS 87
Query: 362 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 421
+ + GS+++ LR + L + T GL YLHD+ +I
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QI 143
Query: 422 IHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-- 478
+HRD+K N+L++ + + DFG +K + + T GT+ ++APE + G
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGY 202
Query: 479 SEKTDVFGYGIMLLELITGQR 499
+ D++ G ++E+ TG+
Sbjct: 203 GKAADIWSLGCTIIEMATGKP 223
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 67/213 (31%), Positives = 88/213 (41%), Gaps = 16/213 (7%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSL----VAVKRLKEERTPGGELQ--FQTEVEMISM 349
LG G FG V +G S VAVK LK + E F EV +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 350 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARG 409
HRNL+RL G +TP +V GS+ LR+ T R A+ A G
Sbjct: 78 LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEG 133
Query: 410 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGH 467
+ YL + IHRD+ A N+LL +GDFGL + + D H
Sbjct: 134 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 468 IAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQR 499
APE L T S +D + +G+ L E+ T GQ
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 75/297 (25%), Positives = 128/297 (43%), Gaps = 51/297 (17%)
Query: 301 KNILGRGGFGKVYKGRLADGS------LVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 354
K LG G FGKV+ + LVAVK LKE + FQ E E+++M H++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQH 104
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPPSQLPLDWPTRKR----------IA 403
++R G C L+V+ YM +G + LR P ++L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 404 LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DY--KDTHVT 458
A G+ YL +HRD+ N L+ + +GDFG+++ + DY
Sbjct: 165 SQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 459 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDW 517
+R PE + K + ++DV+ +G++L E+ T G++ + +L+N + +D
Sbjct: 222 LPIRWM----PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW--YQLSNTE---AIDC 272
Query: 518 VKGLLKEKKLEMLVD-PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ + ++LE P EV ++ C Q P R + +V L+
Sbjct: 273 IT---QGRELERPRACPP--------EVYAIM---RGCWQREPQQRHSIKDVHARLQ 315
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 66/330 (20%), Positives = 106/330 (32%), Gaps = 43/330 (13%)
Query: 248 FAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRG 307
+ F + +P+ F A E + R Q SF + LG G
Sbjct: 13 LGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQ----SFQRLSRLGHG 68
Query: 308 GFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV---HRNLLRLRGFCM 363
+G+V+K R DG L AVKR + + E+ S H +RL
Sbjct: 69 SYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA-RKLAEVGSHEKVGQHPCCVRLEQAWE 127
Query: 364 TPTERLLVYPYM--ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 421
+Y S+ L + L++LH +
Sbjct: 128 EGGI---LYLQTELCGPSLQQHCEAWGA---SLPEAQVWGYLRDTLLALAHLHSQ---GL 178
Query: 422 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 481
+H DVK ANI L +GDFGL + G ++APE L G
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDFGLLVELG--TAGAGEVQEGDPRYMAPELLQ-GSYGTA 235
Query: 482 TDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVE 541
DVF G+ +LE+ W + L++ L P+
Sbjct: 236 ADVFSLGLTILEVACNMELPHGGE----------GWQQ--LRQGYL----PPEFTAGL-S 278
Query: 542 AEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571
+E+ ++ + + P R ++ +
Sbjct: 279 SELRSVLV---MMLEPDPKLRATAEALLAL 305
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 58/274 (21%), Positives = 107/274 (39%), Gaps = 26/274 (9%)
Query: 232 ATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLREL 291
+G+++ G A A L + A +R P+ E++ V L + + E
Sbjct: 1 GSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPE-------TEDNEGVLLTEKLKPVDYEY 53
Query: 292 QVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMA 350
+ +++ +GRG FG+V++ + G AVK+++ E E+ +
Sbjct: 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVACAGL 107
Query: 351 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGL 410
++ L G + + GS+ +++ L + GL
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC----LPEDRALYYLGQALEGL 163
Query: 411 SYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTA----VRGTI 465
YLH +I+H DVKA N+LL + + DFG A + + + GT
Sbjct: 164 EYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220
Query: 466 GHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQR 499
H+APE + K D++ M+L ++ G
Sbjct: 221 THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 55/302 (18%), Positives = 102/302 (33%), Gaps = 72/302 (23%)
Query: 301 KNILGRGGFGKVYKGRLADGSL--------VAVKRLKEERTPGGELQFQTEVEMISMAVH 352
LG+G F K++KG + V +K L + F M+S H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSH 71
Query: 353 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 412
++L+ G C+ E +LV ++ GS+ + L++ ++ + +A A + +
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAAAMHF 128
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAV--------VGDFGLAKLMDYKDTHVTTAVRGT 464
L ++ +IH +V A NILL E + + D G++ + + +
Sbjct: 129 LEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQERIPWV 184
Query: 465 IGHIAPEYLSTGKS-SEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 522
PE + K+ + TD + +G L E+ + G +
Sbjct: 185 ----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL--------------------- 219
Query: 523 KEKKLEMLVDPDLQNNYVEAEVEQ-----------LIQVALLCTQGSPMDRPKMSEVVRM 571
L + E L + C P RP ++R
Sbjct: 220 ----------SALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269
Query: 572 LE 573
L
Sbjct: 270 LN 271
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 63/299 (21%), Positives = 106/299 (35%), Gaps = 48/299 (16%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 354
F LGRGGFG V++ + D A+KR++ + EV+ ++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 355 LLRLRGFCMTPTERLLVYP------------YMANGSVASCLRERPPSQLPLDWPTRKRI 402
++R + + P ++ + R + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHI 123
Query: 403 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 462
L A + +LH ++HRD+K +NI + VGDFGL MD + T
Sbjct: 124 FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 463 -----------GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDD 511
GT +++PE + S K D+F G++L EL+ F
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ------- 230
Query: 512 VMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
M ++ K P L E ++Q SPM+RP+ ++
Sbjct: 231 -MERVRTLTDVRNLKF-----PPLFTQKYPCEY-VMVQ---DMLSPSPMERPEAINIIE 279
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 38/227 (16%)
Query: 301 KNILGRGGFGKVYKGRLADG------SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 354
LG G FGKV K + VAVK LKE +P +E ++ H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGS-------- 406
+++L G C LL+ Y GS+ LRE R +
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 407 ------------ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454
++G+ YL + K++HRD+ A NIL+ E + + DFGL++ + +D
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 455 THVTTAVRGTIGHI-----APEYLSTGKSSEKTDVFGYGIMLLELIT 496
++ V+ + G I A E L + ++DV+ +G++L E++T
Sbjct: 205 SY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 6e-32
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 7/213 (3%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQF-QTEVEMISMAVHR 353
+ + +G G +G+ K R +DG ++ K L E Q +EV ++ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 354 NLLRLRGFCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 411
N++R + T L V Y G +AS + + + LD R+ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 412 YLHDHCDP--KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 469
H D ++HRD+K AN+ LD + +GDFGLA+++++ + T V GT +++
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 470 PEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 502
PE ++ +EK+D++ G +L EL F
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 217
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-32
Identities = 56/222 (25%), Positives = 85/222 (38%), Gaps = 33/222 (14%)
Query: 301 KNILGRGGFGKVYKGRLAD------GSLVAVKRLKEERTPGGELQFQTEVE-MISMAVHR 353
LG G FGKV + VAVK LK +E++ + + H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPPSQLPLDWPTRKR----------- 401
N++ L G C L++ Y G + + LR R P
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 402 --IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 459
+ A+G+++L IHRD+ A NILL + DFGLA+ + +V
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 460 A-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
V+ APE + + ++DV+ YGI L EL +
Sbjct: 205 GNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 48/235 (20%), Positives = 85/235 (36%), Gaps = 23/235 (9%)
Query: 279 HLGQLKRFSLRELQVATDSFSNKNILGRG--GFGKVYKGR-LADGSLVAVKRLKEERTPG 335
H+ L + + ++G+G V R G V V+R+ E
Sbjct: 8 HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67
Query: 336 GELQF-QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL 394
+ F Q E+ + + H N++ R + E +V +MA GS + +
Sbjct: 68 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE 127
Query: 395 DWPTRKRIAL---GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451
IA G + L Y+H +HR VKA++IL+ + + + M
Sbjct: 128 LA-----IAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179
Query: 452 ---YKDTHVTTAVRGTIGHI---APEYLSTGKS--SEKTDVFGYGIMLLELITGQ 498
+ V + ++ + +PE L K+D++ GI EL G
Sbjct: 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 71/270 (26%), Positives = 110/270 (40%), Gaps = 29/270 (10%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRL-KEE-RTPGGELQFQTEVEMISMAVHRNLLRLRG 360
LG+G F VY+ + G VA+K + K+ G + Q EV++ H ++L L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 361 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 420
+ LV NG + L+ R P + G+ YLH H
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVK---PFSENEARHFMHQIITGMLYLHSH---G 132
Query: 421 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 480
I+HRD+ +N+LL + DFGLA + T GT +I+PE +
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRSAHGL 191
Query: 481 KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 540
++DV+ G M L+ G+ FD D V L K + + P ++
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPFD------TDTVKNT-----LNKVVLADYEM-PS----FL 235
Query: 541 EAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
E + LI LL + +P DR +S V+
Sbjct: 236 SIEAKDLIH-QLL--RRNPADRLSLSSVLD 262
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 71/309 (22%), Positives = 125/309 (40%), Gaps = 65/309 (21%)
Query: 301 KNILGRGGFGKVYKGRLADG------SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 354
+G G FG+V++ R ++VAVK LKEE + + FQ E +++ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPPSQLPLDWPTRK------------- 400
+++L G C L++ YMA G + LR P + L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 401 ------RIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454
IA A G++YL + K +HRD+ N L+ E + DFGL++ + D
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 455 THVTTAVRGTIGHI-----APEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLAR---- 505
+ I PE + + + ++DV+ YG++L E+ +
Sbjct: 229 YY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS------YGLQPYY 278
Query: 506 -LANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK 564
+A+++ ++ +V+ L P+ E+ L+ LC P DRP
Sbjct: 279 GMAHEE---VIYYVR---DGNILAC---PE----NCPLELYNLM---RLCWSKLPADRPS 322
Query: 565 MSEVVRMLE 573
+ R+L+
Sbjct: 323 FCSIHRILQ 331
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 68/310 (21%), Positives = 111/310 (35%), Gaps = 66/310 (21%)
Query: 301 KNILGRGGFGKVYKGRLADGS------LVAVKRLKEERTPGGELQFQTEVE-MISMAVHR 353
+LG G FGKV S VAVK LKE+ +E++ M + H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGS------- 406
N++ L G C L++ Y G + + LR + + + L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 407 ------------ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454
A+G+ +L +HRD+ A N+L+ + DFGLA+ +
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 455 THVTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLAR---- 505
+V V+ APE L G + K+DV+ YGI+L E+ + L
Sbjct: 227 NYVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFS------LGVNPYP 276
Query: 506 -LANDDDVMLLDWVKGLLKE-KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP 563
+ D + L++ K++ P Y E+ ++ C RP
Sbjct: 277 GIPVDANFY------KLIQNGFKMDQ---PF----YATEEIYIIM---QSCWAFDSRKRP 320
Query: 564 KMSEVVRMLE 573
+ L
Sbjct: 321 SFPNLTSFLG 330
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 56/213 (26%), Positives = 88/213 (41%), Gaps = 13/213 (6%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 354
D + + ++G G V VA+KR+ E+ + E++ +S H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWP-TRKRIAL---GSARGL 410
++ + E LV ++ GSV ++ IA GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 411 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT-IGH-- 467
YLH + IHRDVKA NILL E+ + DFG++ + VR T +G
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 468 -IAPEYLSTGKS-SEKTDVFGYGIMLLELITGQ 498
+APE + + K D++ +GI +EL TG
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 67/270 (24%), Positives = 112/270 (41%), Gaps = 30/270 (11%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRG 360
LG+GGF K ++ + A K + + P + E+ + H++++ G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 361 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 420
F +V S+ + R L P + G YLH + +
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLGCQYLHRN---R 135
Query: 421 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 480
+IHRD+K N+ L+E+ E +GDFGLA ++Y GT +IAPE LS S
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHSF 194
Query: 481 KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 540
+ DV+ G ++ L+ G+ F+ + L+ KK E + P ++
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFE------TSCLKET-----YLRIKKNEYSI-PK----HI 238
Query: 541 EAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
LIQ +L Q P RP ++E++
Sbjct: 239 NPVAASLIQ-KML--QTDPTARPTINELLN 265
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 62/307 (20%), Positives = 122/307 (39%), Gaps = 54/307 (17%)
Query: 284 KRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRL-KEERTPGGELQFQT 342
+ + + V +S +G GG KV++ + A+K + EE ++
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN 75
Query: 343 EVEMISMAVHRNL--LRLRGFCMTPTERLLVYPYM--ANGSVASCLRERPPSQLPLDWPT 398
E+ ++ + +RL + +T +Y M N + S L+++ +D
Sbjct: 76 EIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKK----SIDPWE 128
Query: 399 RKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTH 456
RK + +H H I+H D+K AN L+ + ++ DFG+A M T
Sbjct: 129 RKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTS 182
Query: 457 VT-TAVRGTIGHIAPEYL-----------STGKSSEKTDVFGYGIMLLELITGQRAFDLA 504
V + GT+ ++ PE + S K S K+DV+ G +L + G+ F
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-- 240
Query: 505 RLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNY---VEAEVEQLIQVALLCTQGSPMD 561
+ + KL ++DP+ + + E +++ +++ C + P
Sbjct: 241 ---QIINQI-----------SKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQ 283
Query: 562 RPKMSEV 568
R + E+
Sbjct: 284 RISIPEL 290
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-30
Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 10/205 (4%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 353
+ F+ +G+G FG+V+KG +VA+K + E Q E+ ++S
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
+ + G + T+ ++ Y+ GS L P LD I +GL YL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYL 135
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 473
H K IHRD+KAAN+LL E E + DFG+A + T V GT +APE +
Sbjct: 136 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVI 191
Query: 474 STGKSSEKTDVFGYGIMLLELITGQ 498
K D++ GI +EL G+
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGE 216
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 35/301 (11%), Positives = 74/301 (24%), Gaps = 50/301 (16%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVK--RLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 359
L G V+ R + A+K + E + + + + + R
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 360 GFC--------------------------MTPTERLLVYPYMA--NGSVASCLRERPPSQ 391
LL+ P + + S L +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 392 LPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451
+ R + L ++H N+ + + ++GD
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 452 YKDTHVTTAVRGTIGHIAPEYLSTGKS--SEKTDVFGYGIMLLELITGQRAFDLARLAND 509
K A + + E+L+ + + + + G+ + + F L
Sbjct: 243 -KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 510 DDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 569
W + L+ + L + V+ LI L R E +
Sbjct: 302 G-----SWKRPSLRVPGTDSLAFGSCTP--LPDFVKTLIG-RFLNFD--RRRRLLPLEAM 351
Query: 570 R 570
Sbjct: 352 E 352
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 57/300 (19%), Positives = 96/300 (32%), Gaps = 54/300 (18%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-- 351
T F +G G FG V+K DG + A+KR K+ + Q E+ + AV
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ-NALREVYAHAVLG 68
Query: 352 -HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGL 410
H +++R L+ Y GS+A + E K + L RGL
Sbjct: 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 411 SYLHDHCDPKIIHRDVKAANILLDEEFEAVV-------------------GDFGLAKLMD 451
Y+H ++H D+K +NI + GD G +
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 452 YKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDD 510
G +A E L + K D+F + ++ + N D
Sbjct: 186 SPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR-----NGD 235
Query: 511 DVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
+ +G L P + ++ ++ + P RP +V+
Sbjct: 236 QWHEI--RQGRL----------PRIPQVL----SQEFTELLKVMIHPDPERRPSAMALVK 279
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 67/270 (24%), Positives = 112/270 (41%), Gaps = 30/270 (11%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRG 360
LG+GGF K ++ + A K + + P + E+ + H++++ G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 361 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 420
F +V S+ + R L P + G YLH + +
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLGCQYLHRN---R 161
Query: 421 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 480
+IHRD+K N+ L+E+ E +GDFGLA ++Y GT +IAPE LS S
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHSF 220
Query: 481 KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 540
+ DV+ G ++ L+ G+ F+ + L+ KK E + P ++
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFE------TSCLKET-----YLRIKKNEYSI-PK----HI 264
Query: 541 EAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
LIQ +L Q P RP ++E++
Sbjct: 265 NPVAASLIQ-KML--QTDPTARPTINELLN 291
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 60/289 (20%), Positives = 116/289 (40%), Gaps = 54/289 (18%)
Query: 302 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNL--LRL 358
+G GG KV++ + A+K + E L ++ E+ ++ + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 359 RGFCMTPTERLLVYPYM--ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 416
+ +T +Y M N + S L+++ +D RK + +H H
Sbjct: 75 YDYEITDQY---IYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 417 CDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYL 473
I+H D+K AN L+ + ++ DFG+A M T V + GT+ ++ PE +
Sbjct: 128 ---GIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 474 -----------STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 522
S K S K+DV+ G +L + G+ F + +
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQI--------- 227
Query: 523 KEKKLEMLVDPDLQNNY---VEAEVEQLIQVALLCTQGSPMDRPKMSEV 568
KL ++DP+ + + E +++ +++ C + P R + E+
Sbjct: 228 --SKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPEL 271
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 66/234 (28%), Positives = 109/234 (46%), Gaps = 27/234 (11%)
Query: 281 GQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQ 339
L L L+ F ++G G +G+VYKGR + G L A+K + E++
Sbjct: 9 RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK 68
Query: 340 FQTEVEMIS-MAVHRNLLR-----LRGFCMTPTERL-LVYPYMANGSVASCLRERPPSQL 392
E+ M+ + HRN+ ++ ++L LV + GSV ++ + L
Sbjct: 69 --QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL 126
Query: 393 PLDWPTRKRIAL---GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449
+W IA RGLS+LH H K+IHRD+K N+LL E E + DFG++
Sbjct: 127 KEEW-----IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178
Query: 450 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE-----KTDVFGYGIMLLELITGQ 498
+D T + GT +APE ++ ++ + K+D++ GI +E+ G
Sbjct: 179 LDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 70/303 (23%), Positives = 119/303 (39%), Gaps = 55/303 (18%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 353
F +LG+G FG+V K R D A+K+++ T +EV +++ H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQ 62
Query: 354 NLLRLRGFCMTPTERLLVYP-------------YMANGSVASCLRERPPSQLPLDWPTRK 400
++R + + Y NG++ + L
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYW 119
Query: 401 RIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-------- 452
R+ LSY+H IIHRD+K NI +DE +GDFGLAK +
Sbjct: 120 RLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 453 ------KDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGIMLLELITGQRAFDLAR 505
++T+A+ GT ++A E L TG +EK D++ GI+ E+I
Sbjct: 177 SQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FST--- 230
Query: 506 LANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 565
+ +L L+ +E PD +N ++ +++I+ L+ P RP
Sbjct: 231 -GMERVNILKK-----LRSVSIEF--PPDFDDNKMK-VEKKIIR-LLIDH--DPNKRPGA 278
Query: 566 SEV 568
+
Sbjct: 279 RTL 281
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 58/289 (20%), Positives = 114/289 (39%), Gaps = 54/289 (18%)
Query: 302 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNL--LRL 358
+G GG KV++ + A+K + E L ++ E+ ++ + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 359 RGFCMTPTERLLVYPYM--ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 416
+ +T +Y M N + S L+++ +D RK + +H H
Sbjct: 122 YDYEITDQY---IYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 417 CDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYL 473
I+H D+K AN L+ + ++ DFG+A M T V + G + ++ PE +
Sbjct: 175 ---GIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 474 S-----------TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 522
K S K+DV+ G +L + G+ F + +
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQI--------- 274
Query: 523 KEKKLEMLVDPDLQNNY---VEAEVEQLIQVALLCTQGSPMDRPKMSEV 568
KL ++DP+ + + E +++ +++ C + P R + E+
Sbjct: 275 --SKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPEL 318
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 42/254 (16%), Positives = 83/254 (32%), Gaps = 24/254 (9%)
Query: 268 FDVPAEEDPEVHLGQLKRFSL-RELQVATDSFSNKNILGRGGFGKVYKGR------LADG 320
V + + +L E Q+ + ++LG G F +VY+ +
Sbjct: 36 KPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNK 95
Query: 321 SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 380
+K K P +E + ++ ++ + +LV + G++
Sbjct: 96 QKFVLKVQKPA-NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL 154
Query: 381 ASCLRE-RPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 439
+ + + + + A+ + +HD +IIH D+K N +L F
Sbjct: 155 LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLE 211
Query: 440 VVG-----------DFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 487
D G + M + + TA T G E LS + + D FG
Sbjct: 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGV 271
Query: 488 GIMLLELITGQRAF 501
+ ++ G
Sbjct: 272 AATVYCMLFGTYMK 285
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 71/232 (30%), Positives = 100/232 (43%), Gaps = 21/232 (9%)
Query: 276 PEVHLGQLKRFSLRELQVATD---SFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEE 331
G LK + EL D FS+ +G G FG VY R + + +VA+K++
Sbjct: 31 AGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS 90
Query: 332 RTPGGE--LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPP 389
E EV + H N ++ RG + LV Y GS + L
Sbjct: 91 GKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK 149
Query: 390 SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449
PL + G+ +GL+YLH H +IHRDVKA NILL E +GDFG A +
Sbjct: 150 ---PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI 203
Query: 450 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE---KTDVFGYGIMLLELITGQ 498
M ++ V GT +APE + + K DV+ GI +EL +
Sbjct: 204 MAPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 70/270 (25%), Positives = 110/270 (40%), Gaps = 32/270 (11%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRG 360
LG+G FG VY R ++A+K L + + G E Q + EVE+ S H N+LRL G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 361 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 420
+ T L+ Y G+V L++ D A LSY H +
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHSK---R 129
Query: 421 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 480
+IHRD+K N+LL E + DFG + GT+ ++ PE + E
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC--GTLDYLPPEMIEGRMHDE 186
Query: 481 KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 540
K D++ G++ E + G+ F+ + + ++E +V
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFE------ANTYQET-----YKRISRVEFTFPD-----FV 230
Query: 541 EAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
LI LL + +P RP + EV+
Sbjct: 231 TEGARDLIS-RLL--KHNPSQRPMLREVLE 257
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-28
Identities = 65/290 (22%), Positives = 110/290 (37%), Gaps = 41/290 (14%)
Query: 292 QVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVE-MISMA 350
V SF K++LG G G + + D VAVKR+ E EV+ +
Sbjct: 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESD 75
Query: 351 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGL 410
H N++R + + A ++ + ++ + L L+ + + GL
Sbjct: 76 EHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGL 131
Query: 411 SYLHDHCDPKIIHRDVKAANILLDEEFE-----AVVGDFGLAKLMD---YKDTHVTTAVR 462
++LH I+HRD+K NIL+ A++ DFGL K + + + +
Sbjct: 132 AHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP- 187
Query: 463 GTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWV 518
GT G IAPE LS + D+F G + +I+ G F + +
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG------KSLQRQANIL 241
Query: 519 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 568
G L+ L + + +LI+ ++ P RP V
Sbjct: 242 LG---ACSLDCLHPEK----HEDVIARELIE-KMIAMD--PQKRPSAKHV 281
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 53/214 (24%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 353
+ + LG G FGKVYK + G+L A K ++ + E + E+E+++ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHP 76
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
+++L G + ++ + G+V + + E L P + + L++L
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFL 133
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFG----LAKLMDYKDTHVTTAVRGTIGHIA 469
H +IIHRD+KA N+L+ E + + DFG K + +D+ + GT +A
Sbjct: 134 HSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMA 185
Query: 470 PEYLSTGKSSE-----KTDVFGYGIMLLELITGQ 498
PE + + K D++ GI L+E+ +
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 57/300 (19%), Positives = 101/300 (33%), Gaps = 53/300 (17%)
Query: 304 LGRGGFGKVYKGRLADGSLVAVKRLK----------------EERTPGGELQFQTEVEMI 347
L +G F K+ D A+K+ + + F+ E+++I
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 348 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSA 407
+ + L G E ++Y YM N S+ LD I +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV----LDKNYTCFIPIQVI 153
Query: 408 R--------GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 459
+ SY+H+ + I HRDVK +NIL+D+ + DFG ++ M D +
Sbjct: 154 KCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYM--VDKKIKG 209
Query: 460 AVRGTIGHIAPEYLSTGK--SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL-- 515
+ GT + PE+ S + K D++ GI L + F ++ L
Sbjct: 210 SR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS-----LKISLVELFN 263
Query: 516 -------DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 568
++ NN++ E ++ L P +R +
Sbjct: 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLK-LFLRKN--PAERITSEDA 320
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 11/205 (5%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 353
++ +G+G G VY +A G VA++++ ++ P EL E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
N++ + E +V Y+A GS+ + E +D + + L +L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFL 132
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 473
H + ++IHRD+K+ NILL + + DFG + + + +T V GT +APE +
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 188
Query: 474 STGKSSEKTDVFGYGIMLLELITGQ 498
+ K D++ GIM +E+I G+
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 47/205 (22%), Positives = 88/205 (42%), Gaps = 11/205 (5%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 353
+ +G G G V R G VAVK + + EL EV ++ H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-LFNEVVIMRDYQHF 102
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
N++ + + E ++ ++ G++ + + L+ + + L+YL
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR-----LNEEQIATVCEAVLQALAYL 157
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 473
H +IHRD+K+ +ILL + + DFG + + V GT +APE +
Sbjct: 158 HAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVI 213
Query: 474 STGKSSEKTDVFGYGIMLLELITGQ 498
S + + D++ GIM++E++ G+
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 6e-27
Identities = 69/288 (23%), Positives = 124/288 (43%), Gaps = 31/288 (10%)
Query: 301 KNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 359
K LG GGFG V + G VA+K+ ++E +P ++ E++++ H N++ R
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 360 GFCMTPTE------RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
+ LL Y G + L + + L + + + L YL
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDISSALRYL 137
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAV---VGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 470
H++ +IIHRD+K NI+L + + + D G AK +D + T V GT+ ++AP
Sbjct: 138 HEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV-GTLQYLAP 192
Query: 471 EYLSTGKSSEKTDVFGYGIMLLELITGQRAFD----------LARLANDDDVMLLDWVKG 520
E L K + D + +G + E ITG R F R +++ +++ D + G
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252
Query: 521 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 568
+K +L P+ + + ++E+ +Q L R +
Sbjct: 253 AVKFSS--VLPTPNHLSGILAGKLERWLQCML---MWHQRQRGTDPQN 295
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-27
Identities = 38/305 (12%), Positives = 80/305 (26%), Gaps = 63/305 (20%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVK------------------------RLKEERTPGG- 336
+LG+ + G V L+ +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 337 --ELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVYPYMA--NGSVASCLRERPPS 390
L+F +++ + ++R+R R +YP M + L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 391 QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450
L R ++ L R L+ LH + ++H ++ +I+LD+ + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 451 DYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLAR 505
A L + D + G+ + +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD-- 319
Query: 506 LANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 565
D + +W+ K + V L++ L + DR
Sbjct: 320 ---DAALGGSEWIFRSCKN---------------IPQPVRALLEGFL---RYPKEDRLLP 358
Query: 566 SEVVR 570
+ +
Sbjct: 359 LQAME 363
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-27
Identities = 25/123 (20%), Positives = 43/123 (34%), Gaps = 1/123 (0%)
Query: 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNS 124
S +DL L LQ L+L I +L+ L +L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 125 FTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
LS L+ L +L+ + ++ +L+ L++++N + FS
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE-YFS 146
Query: 185 LFT 187
T
Sbjct: 147 NLT 149
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 20/94 (21%), Positives = 31/94 (32%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145
L + + L+L N + + L LDL LS L L L
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179
N + + + +SSLQ L L+ +
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 25/110 (22%), Positives = 41/110 (37%), Gaps = 1/110 (0%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSFTGPI 129
D+ + L +L+ L++ N+ D L +L LDL
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486
Query: 130 PDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179
P LS L+ L +++N+ ++SLQVLD S N +
Sbjct: 487 PTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 536
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 23/107 (21%), Positives = 44/107 (41%), Gaps = 2/107 (1%)
Query: 71 DLGNAALSGQLVSQ-LGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPI 129
+ + + L+NL +L+L + P+ +L+SL L++ N+F
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 510
Query: 130 PDTLGKLSKLRFLRLNNNSLSGPIPMSLTNI-SSLQVLDLSNNRLSG 175
L+ L+ L + N + L + SSL L+L+ N +
Sbjct: 511 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-22
Identities = 32/132 (24%), Positives = 46/132 (34%), Gaps = 10/132 (7%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITG-PIPSDLGNLTSLVSLDLYLNSFTGPI 129
L+ +G LK L+ L + N I +P NLT+L LDL N
Sbjct: 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 165
Query: 130 PDTLGKLSKLRF----LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSL 185
L L ++ L L+ N ++ P + I L L L NN S V
Sbjct: 166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKT----C 220
Query: 186 FTPISFANNLDL 197
++ L
Sbjct: 221 IQGLAGLEVHRL 232
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-21
Identities = 25/122 (20%), Positives = 44/122 (36%), Gaps = 6/122 (4%)
Query: 77 LSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP-DTLGK 135
G +L+YL+L N + + S+ L L LD ++
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419
Query: 136 LSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNL 195
L L +L +++ +SSL+VL ++ N + +FT + L
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD----IFTELRNLTFL 475
Query: 196 DL 197
DL
Sbjct: 476 DL 477
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 30/126 (23%), Positives = 47/126 (37%), Gaps = 10/126 (7%)
Query: 78 SGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSL----VSLDLYLNSFTGPIPDTL 133
S +L L NL++L+L SN I +DL L + +SLDL LN P
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 134 GKLSKLRFLRLNNNSLSGPIP-MSLTNISSLQVLDLSNNRLSG----VVPDNGSFSLFTP 188
++ L L L NN S + + ++ L+V L D +
Sbjct: 198 KEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 189 ISFANN 194
++
Sbjct: 257 LTIEEF 262
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-18
Identities = 28/113 (24%), Positives = 36/113 (31%), Gaps = 3/113 (2%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP 130
DL L + L +LQ L + NN L SL LD LN
Sbjct: 476 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 535
Query: 131 DTLGKL-SKLRFLRLNNNSLSGPIPMS--LTNISSLQVLDLSNNRLSGVVPDN 180
L S L FL L N + L I + L + R+ P +
Sbjct: 536 QELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD 588
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 9e-17
Identities = 30/177 (16%), Positives = 47/177 (26%), Gaps = 30/177 (16%)
Query: 29 LHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAALSGQLVSQLGLL 88
+H L L+ +D + + + ++ L
Sbjct: 229 VHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY-------LDYYLDDIIDLFNCL 281
Query: 89 KNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFT-------------------GPI 129
N+ L S I L+L F G
Sbjct: 282 TNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN 339
Query: 130 PDTLGKLSKLRFLRLNNNSLS--GPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
+ L L FL L+ N LS G S +SL+ LDLS N + + +
Sbjct: 340 AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLE 396
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-13
Identities = 23/137 (16%), Positives = 47/137 (34%), Gaps = 10/137 (7%)
Query: 70 VDLGNAALSGQLVSQLGLLKNLQY----LELYSNNITGPIPSDLGNLTSLVSLDLYLNSF 125
+DL + + + L +L + L+L N + P + L L L N
Sbjct: 154 LDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFD 212
Query: 126 TGPIP-DTLGKLSKLRFLRLNNNSLSGPIPM---SLTNISSLQVLDLSNNRLSGV-VPDN 180
+ + + L+ L RL + + + L L + RL+ + +
Sbjct: 213 SLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLD 272
Query: 181 GSFSLFTPISFANNLDL 197
LF ++ ++ L
Sbjct: 273 DIIDLFNCLTNVSSFSL 289
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 19/215 (8%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRG 360
LG+G FG VY R + ++A+K L + + G E Q + E+E+ S H N+LR+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 361 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 420
+ L+ + G + L++ D A L Y H+ K
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGR----FDEQRSATFMEELADALHYCHER---K 134
Query: 421 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 480
+IHRD+K N+L+ + E + DFG + T GT+ ++ PE + E
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TMC--GTLDYLPPEMIEGKTHDE 191
Query: 481 KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 515
K D++ G++ E + G FD
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFD------SPSHTET 220
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 11/205 (5%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 353
+ F LG G +G VYK G +VA+K++ E + E+ ++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ---EIIKEISIMQQCDSP 84
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
++++ G T+ +V Y GSV+ +R R L I + +GL YL
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK---TLTEDEIATILQSTLKGLEYL 141
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 473
H + IHRD+KA NILL+ E A + DFG+A + T + GT +APE +
Sbjct: 142 HFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVI 197
Query: 474 STGKSSEKTDVFGYGIMLLELITGQ 498
+ D++ GI +E+ G+
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 39/311 (12%), Positives = 84/311 (27%), Gaps = 74/311 (23%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVK------------------------RLKEERTPG-- 335
+LG+ + G V L+ +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 336 -GELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLVYPYMA--NGSVASCLRERPPS 390
L+F +++ + ++R+R R +YP M + L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 391 QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450
L R ++ L R L+ LH + ++H ++ +I+LD+ + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 451 DYKDTHVTTAVRGTIGHIAPEYLST-----------GKSSEKTDVFGYGIMLLELITGQR 499
+ + G PE + + D + G+++ +
Sbjct: 257 GARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 500 AFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSP 559
D + +W+ K + V L++ L
Sbjct: 312 PIT-----KDAALGGSEWIFRSCKN---------------IPQPVRALLE-GFLRYP--K 348
Query: 560 MDRPKMSEVVR 570
DR + +
Sbjct: 349 EDRLLPLQAME 359
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 22/117 (18%), Positives = 46/117 (39%), Gaps = 9/117 (7%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFT---- 126
+ A + LK+L +E+Y+ +P+ L L + +++ N
Sbjct: 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQ 290
Query: 127 ----GPIPDTLGKLSKLRFLRLNNNSL-SGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
K++ + + N+L + P+ SL + L +L+ N+L G +P
Sbjct: 291 LKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-25
Identities = 30/177 (16%), Positives = 53/177 (29%), Gaps = 18/177 (10%)
Query: 17 SWLASANMEGDALHSLRSNLIDPN--------NVLQSWDPTLVNPCTWFH---VTCNNDN 65
S A + AL + L N +W+ W V+ N++
Sbjct: 23 SRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-KELDMWGAQPGVSLNSNG 81
Query: 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGP----IPSDLGNLTSLVSLDLY 121
V + L SG++ +G L L+ L L S+ P + S
Sbjct: 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141
Query: 122 LNSFTGPIPDTLGKL--SKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGV 176
+ D + S L +N++ I S + +N ++ V
Sbjct: 142 RMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFV 198
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-25
Identities = 17/144 (11%), Positives = 38/144 (26%), Gaps = 20/144 (13%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGP-- 128
+ + + + + SNNIT + + LT L + + F
Sbjct: 165 CINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENI 223
Query: 129 -----------------IPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNN 171
L L + + N +P L + +Q+++++ N
Sbjct: 224 CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN 283
Query: 172 RLSGVVPDNGSFSLFTPISFANNL 195
R + +
Sbjct: 284 RGISGEQLKDDWQALADAPVGEKI 307
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-25
Identities = 27/119 (22%), Positives = 46/119 (38%), Gaps = 3/119 (2%)
Query: 78 SGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLS 137
+ + + L +K L LE N + G +P+ G+ L SL+L N T + G
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTE 377
Query: 138 KLRFLRLNNNSLSG-PIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNL 195
++ L +N L P ++S + +D S N + V L N+
Sbjct: 378 QVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGS-VDGKNFDPLDPTPFKGINV 435
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 22/110 (20%), Positives = 45/110 (40%), Gaps = 2/110 (1%)
Query: 77 LSGQLVSQLGLLKNLQYLELYSNNI-TGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGK 135
Q ++ + + +Q + + NN+ T P+ + L + L L+ N G +P G
Sbjct: 293 DDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGS 351
Query: 136 LSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSL 185
KL L L N ++ ++ L ++N+L + + S+
Sbjct: 352 EIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSV 401
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-25
Identities = 24/127 (18%), Positives = 37/127 (29%), Gaps = 8/127 (6%)
Query: 79 GQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTG-------PIPD 131
L N+ + L +N I+ + L S++L N T +
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENE 482
Query: 132 TLGKLSKLRFLRLNNNSLSG-PIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPIS 190
L + L N L+ T + L +DLS N S + S
Sbjct: 483 NFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFG 542
Query: 191 FANNLDL 197
N D
Sbjct: 543 IRNQRDA 549
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 23/135 (17%), Positives = 48/135 (35%), Gaps = 9/135 (6%)
Query: 69 RVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITG-PIPSDLGNLTSLVSLDLYLNSFTG 127
++L ++ + G + ++ L N + P D +++ + ++D N
Sbjct: 357 SLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGS 416
Query: 128 -------PIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN 180
P+ T K + + L+NN +S + S L ++L N L+ +P N
Sbjct: 417 VDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IPKN 475
Query: 181 GSFSLFTPISFANNL 195
L
Sbjct: 476 SLKDENENFKNTYLL 490
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 18/115 (15%), Positives = 38/115 (33%), Gaps = 15/115 (13%)
Query: 84 QLGLLKNLQYLELYSNNITG-------PIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKL 136
+ + ++ N I P+ ++ S++L N + +
Sbjct: 397 DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTG 456
Query: 137 SKLRFLRLNNNSLSG-------PIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
S L + L N L+ + N L +DL N+L+ + D+ +
Sbjct: 457 SPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRAT 510
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 30/129 (23%), Positives = 45/129 (34%), Gaps = 17/129 (13%)
Query: 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITG-------PIPSDLGNLTSLVSL 118
+V ++L N +S L + L N +T + N L S+
Sbjct: 434 NVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSI 493
Query: 119 DLYLNSFTGPIPDTL--GKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSN------ 170
DL N T + D L L + L+ NS S P N S+L+ + N
Sbjct: 494 DLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQG 551
Query: 171 NRLSGVVPD 179
NR P+
Sbjct: 552 NRTLREWPE 560
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-20
Identities = 18/102 (17%), Positives = 39/102 (38%), Gaps = 10/102 (9%)
Query: 84 QLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSL------DLYLNSFTGPIPDTLGKLS 137
+ L L ++L N+ + P+ N ++L D N P+ +
Sbjct: 508 RATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCP 566
Query: 138 KLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179
L L++ +N + + +T ++ VLD+ +N +
Sbjct: 567 SLTQLQIGSNDIRK-VNEKIT--PNISVLDIKDNPNISIDLS 605
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-20
Identities = 20/172 (11%), Positives = 41/172 (23%), Gaps = 6/172 (3%)
Query: 20 ASANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAALSG 79
+ + S + I L+ L + +
Sbjct: 12 LTDDAIVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGA 71
Query: 80 QLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGP----IPDTLGK 135
Q L + L L +G +P +G LT L L L + P +
Sbjct: 72 QPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISA 131
Query: 136 LSKLRFLRLNNNSLSGPIPMSLT--NISSLQVLDLSNNRLSGVVPDNGSFSL 185
+ + S L ++++ + + +L
Sbjct: 132 NMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL 183
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 14/110 (12%), Positives = 30/110 (27%), Gaps = 10/110 (9%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLEL------YSNNITGPIPSDLGNLTSLVSLDLYLNS 124
DL + S +Q L+ + N P + SL L + N
Sbjct: 519 DLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577
Query: 125 FTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
+ + + + L + +N + + L ++
Sbjct: 578 IRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-14
Identities = 15/86 (17%), Positives = 30/86 (34%), Gaps = 4/86 (4%)
Query: 109 LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGP----IPMSLTNISSLQ 164
L + + L L +G +PD +G+L++L L L ++ P ++ S +
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 165 VLDLSNNRLSGVVPDNGSFSLFTPIS 190
D F+ +
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLI 162
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 46/238 (19%), Positives = 89/238 (37%), Gaps = 21/238 (8%)
Query: 292 QVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMA 350
+ + +ILG+G V++GR G L A+K E E++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 351 VHRNLLRLRGFCMTPTERL--LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR 408
H+N+++L T R L+ + GS+ + L E + L +
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVG 123
Query: 409 GLSYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 464
G+++L ++ I+HR++K NI+ D + + DFG A+ ++ D + GT
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GT 178
Query: 465 IGHIAPEYLSTGKS--------SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 514
++ P+ D++ G+ TG F + ++
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 53/213 (24%), Positives = 103/213 (48%), Gaps = 14/213 (6%)
Query: 289 RELQVATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMI 347
+ ++ D F + LG G G V+K G ++A K + E P Q E++++
Sbjct: 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85
Query: 348 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSA 407
++ G + E + +M GS+ L++ + ++++
Sbjct: 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVI 141
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYK-DTHVTTAVRGTI 465
+GL+YL + KI+HRDVK +NIL++ E + DFG++ +L+D ++ V GT
Sbjct: 142 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTR 194
Query: 466 GHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQ 498
+++PE L S ++D++ G+ L+E+ G+
Sbjct: 195 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 53/237 (22%), Positives = 94/237 (39%), Gaps = 26/237 (10%)
Query: 289 RELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVE-M 346
+ +++ + +L GGF VY+ + + G A+KRL EV M
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS-NEEEKNRAIIQEVCFM 79
Query: 347 ISMAVHRNLLRLRGFCMTPTER-------LLVYPYMANGSVASCLRERPPSQLPLDWPTR 399
++ H N+++ E L+ + G + L++ S+ PL T
Sbjct: 80 KKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKME-SRGPLSCDTV 138
Query: 400 KRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 459
+I + R + ++H P IIHRD+K N+LL + + DFG A + + + +
Sbjct: 139 LKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 197
Query: 460 A-----------VRGTIGHIAPEYLSTGKS---SEKTDVFGYGIMLLELITGQRAFD 502
A T + PE + + EK D++ G +L L Q F+
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-26
Identities = 32/129 (24%), Positives = 50/129 (38%), Gaps = 3/129 (2%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP 130
D+G +S L L+ L L N ++ T+L L L NS
Sbjct: 55 DVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN 114
Query: 131 DTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPIS 190
+ K L L L++N LS + + +LQ L LSNN++ + + +F S
Sbjct: 115 NPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE--ELDIFANSS 172
Query: 191 FANNLDLCG 199
L+L
Sbjct: 173 L-KKLELSS 180
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-24
Identities = 26/115 (22%), Positives = 42/115 (36%)
Query: 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNS 124
++ ++L + L + L L++ N I+ P L L L+L N
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84
Query: 125 FTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179
+ T + L L L +NS+ +L LDLS+N LS
Sbjct: 85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLG 139
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-24
Identities = 23/94 (24%), Positives = 41/94 (43%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145
L N+ L L N + ++ + L SLD+ N+ + P+ KL L+ L L
Sbjct: 22 DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQ 81
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179
+N LS + ++L L L +N + + +
Sbjct: 82 HNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNN 115
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 27/128 (21%), Positives = 50/128 (39%), Gaps = 6/128 (4%)
Query: 71 DLGNAALSGQLVSQLGL---LKNLQYLELYSNNITGPIPSDLGNL--TSLVSLDLYLNSF 125
L N L L +L L +++ L L ++ ++ + L T+L LDL N+
Sbjct: 201 FLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNL 260
Query: 126 TGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSL 185
D+ L +L + L N++ SL + +++ L+L + + S
Sbjct: 261 NVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA-SLPK 319
Query: 186 FTPISFAN 193
SF
Sbjct: 320 IDDFSFQW 327
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 34/119 (28%), Positives = 52/119 (43%), Gaps = 5/119 (4%)
Query: 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLG--NLTSLVSLDLYLN 123
++I +DL + LS + L+NLQ L L +N I +L +SL L+L N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 124 SFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLT---NISSLQVLDLSNNRLSGVVPD 179
P + +L L LNN L + L +S++ L LSN++LS
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 30/117 (25%), Positives = 48/117 (41%), Gaps = 8/117 (6%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNIT--------GPIPSDLGNLTSLVSLDLYL 122
DL N ++ L L+ L+ L+L NN+ G L L+ L L+L
Sbjct: 486 DLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLES 545
Query: 123 NSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179
N F + L +L+ + L N+L+ N SL+ L+L N ++ V
Sbjct: 546 NGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKK 602
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 30/131 (22%), Positives = 47/131 (35%), Gaps = 9/131 (6%)
Query: 63 NDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLY- 121
++ +DL L+ L L+Y L NNI L L ++ L+L
Sbjct: 246 KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305
Query: 122 --------LNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRL 173
L S + L L L + +N + G T + +L+ L LSN+
Sbjct: 306 SFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT 365
Query: 174 SGVVPDNGSFS 184
S N +F
Sbjct: 366 SLRTLTNETFV 376
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-22
Identities = 27/128 (21%), Positives = 49/128 (38%), Gaps = 3/128 (2%)
Query: 71 DLGNAALSGQL-VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTG-- 127
DLG + +L + L+N+ + L N + + SL L L +
Sbjct: 411 DLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVD 470
Query: 128 PIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFT 187
P L L L L+NN+++ L + L++LDL +N L+ +
Sbjct: 471 SSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIY 530
Query: 188 PISFANNL 195
+ ++L
Sbjct: 531 FLKGLSHL 538
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-21
Identities = 27/133 (20%), Positives = 40/133 (30%), Gaps = 1/133 (0%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP 130
L A G + L L +L L L SN +L L +DL LN+
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577
Query: 131 DTLGKLSKLRFLRLNNNSLSGPIPMSL-TNISSLQVLDLSNNRLSGVVPDNGSFSLFTPI 189
L+ L L N ++ +L LD+ N F +
Sbjct: 578 SVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINE 637
Query: 190 SFANNLDLCGPVT 202
+ N +L
Sbjct: 638 THTNIPELSSHYL 650
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-21
Identities = 30/127 (23%), Positives = 49/127 (38%), Gaps = 5/127 (3%)
Query: 62 NNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLY 121
N S + + A+L LK L++L + N+I G + L +L L L
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS 361
Query: 122 LN--SFTGPIPDTLGKL--SKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVV 177
+ S +T L S L L L N +S + + + L+VLDL N + +
Sbjct: 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL 421
Query: 178 PDNGSFS 184
+
Sbjct: 422 T-GQEWR 427
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-21
Identities = 29/105 (27%), Positives = 44/105 (41%), Gaps = 7/105 (6%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLG---KLSKLRFLRL 144
+L+ LEL SN I P + L L L + + L + +R L L
Sbjct: 170 NSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSL 229
Query: 145 NNNSLSGPIPMSLTN--ISSLQVLDLSNNRLSGVVPDNGSFSLFT 187
+N+ LS + ++L +LDLS N L+ V D SF+
Sbjct: 230 SNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND--SFAWLP 272
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 23/110 (20%), Positives = 37/110 (33%), Gaps = 6/110 (5%)
Query: 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLG-NLTSLVSLDLYLNS 124
+ +DLG L+ S +L+ L L N IT G +L LD+ N
Sbjct: 561 ELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNP 620
Query: 125 FTGPIPDTLGKLSKLRFLRLNNNSLSGPI----PMSLTNISSLQVLDLSN 170
F ++ + N LS P +++ D S+
Sbjct: 621 FDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGF-PVRLFDTSS 669
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 57/216 (26%), Positives = 86/216 (39%), Gaps = 38/216 (17%)
Query: 304 LGRGGFGKVYKGRLADGSL---VAVKRLKEE--RTPGGELQFQTEVEMISMAVHRNLLRL 358
LG GG VY D L VA+K + +F+ EV S H+N++
Sbjct: 19 LGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS- 75
Query: 359 RGFCMTPTERLLVY--------PYMA----NGSVASCLRERPPSQLPLDWPTRKRIALGS 406
+ Y+ G L E S PL T
Sbjct: 76 ------------MIDVDEEDDCYYLVMEYIEGPT---LSEYIESHGPLSVDTAINFTNQI 120
Query: 407 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 466
G+ + HD +I+HRD+K NIL+D + DFG+AK + T V GT+
Sbjct: 121 LDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ 177
Query: 467 HIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 502
+ +PE + E TD++ GI+L E++ G+ F+
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 53/228 (23%), Positives = 98/228 (42%), Gaps = 18/228 (7%)
Query: 281 GQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQ 339
G+LK + + + +GRG +G V K G ++AVKR++ + Q
Sbjct: 7 GKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQ 66
Query: 340 FQTEVEMI-SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPT 398
+++++ + +++ G + + M+ +
Sbjct: 67 LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI 126
Query: 399 RKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL-AKLMDYKDTHV 457
+I L + + L++L + + KIIHRD+K +NILLD + DFG+ +L+D
Sbjct: 127 LGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD------ 178
Query: 458 TTAVRGTIG---HIAPEYLSTGKS----SEKTDVFGYGIMLLELITGQ 498
+ A G ++APE + S ++DV+ GI L EL TG+
Sbjct: 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 46/238 (19%), Positives = 89/238 (37%), Gaps = 21/238 (8%)
Query: 292 QVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMA 350
+ + +ILG+G V++GR G L A+K E E++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 351 VHRNLLRLRGFCMTPTERL--LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR 408
H+N+++L T R L+ + GS+ + L E P + L +
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVG 123
Query: 409 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAV----VGDFGLAKLMDYKDTHVTTAVRGT 464
G+++L ++ I+HR++K NI+ + + DFG A+ ++ D + GT
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GT 178
Query: 465 IGHIAPEYLSTGKS--------SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 514
++ P+ D++ G+ TG F + ++
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 65/302 (21%), Positives = 115/302 (38%), Gaps = 52/302 (17%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVE-MISMAVHRN 354
+ ++ ILG G G V G VAVKR+ + E++ + H N
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD----IALMEIKLLTESDDHPN 70
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTR---KRIALGSARGLS 411
++R T + N ++ + + S L + A G++
Sbjct: 71 VIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 412 YLHDHCDPKIIHRDVKAANILLD-------------EEFEAVVGDFGLAKLMD----YKD 454
+LH KIIHRD+K NIL+ E ++ DFGL K +D
Sbjct: 130 HLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 455 THVTTAVRGTIGHIAPEYLS-------TGKSSEKTDVFGYGIMLLELIT-GQRAFDLARL 506
T++ GT G APE L + + D+F G + +++ G+ F +
Sbjct: 187 TNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG-DKY 244
Query: 507 ANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMS 566
+ + +++ +G+ +++ L D + AE LI ++ P+ RP
Sbjct: 245 SRESNII-----RGIFSLDEMKCLHDRS-----LIAEATDLIS-QMIDHD--PLKRPTAM 291
Query: 567 EV 568
+V
Sbjct: 292 KV 293
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 43/205 (20%), Positives = 75/205 (36%), Gaps = 21/205 (10%)
Query: 304 LGRGGFGKVYKGR--LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 361
+ GG G +Y +G V +K L + E + ++ VH +++++ F
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 362 CMTPTERLLVYPYMA----NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 417
Y+ G L+ +LP+ L LSYLH
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQS---LKRSKGQKLPVAEAIA--YLLEILPALSYLHSI- 201
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 477
+++ D+K NI+L EE + + D G ++ + GT G APE +
Sbjct: 202 --GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-----SFGYLYGTPGFQAPE-IVRTG 252
Query: 478 SSEKTDVFGYGIMLLELITGQRAFD 502
+ TD++ G L L +
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPTRN 277
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 50/232 (21%), Positives = 97/232 (41%), Gaps = 15/232 (6%)
Query: 291 LQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISM 349
++V D LGRG +G V K R + G ++AVKR++ + + +++ ISM
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD-ISM 60
Query: 350 AV--HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSA 407
+ G + + M + S+ ++ + +IA+
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 467
+ L +LH +IHRDVK +N+L++ + + DFG++ + D G +
Sbjct: 120 KALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPY 175
Query: 468 IAPEYLSTGKS----SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 515
+APE ++ + S K+D++ GI ++EL + F +
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQ 225
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 50/206 (24%), Positives = 82/206 (39%), Gaps = 18/206 (8%)
Query: 304 LGRGGFGKVYKGRLADGSL---VAVKRLKEERTPGGELQ--FQTEVEMISMAVHRNLLRL 358
+GRGG G VY+ D VA+K + E + + Q E +++ +
Sbjct: 42 VGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 359 RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 418
F + + + +A+ LR + P L P I L H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGP----LAPPRAVAIVRQIGSALDAAHAA-- 153
Query: 419 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT--AVRGTIGHIAPEYLSTG 476
HRDVK NIL+ + A + DFG+A D +T GT+ ++APE S
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSES 210
Query: 477 KSSEKTDVFGYGIMLLELITGQRAFD 502
++ + D++ +L E +TG +
Sbjct: 211 HATYRADIYALTCVLYECLTGSPPYQ 236
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 304 LGRGGFGKVYKGRLADGSL---VAVKRLKEE--RTPGGELQFQTEVEMISMAVHRNLLRL 358
LG GG +V+ R D VAVK L+ + R P L+F+ E + + H ++ +
Sbjct: 20 LGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 359 --RGFCMTPTERLLVYPYMA----NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 412
G TP L PY+ +G LR+ ++ P+ + + + L++
Sbjct: 78 YDTGEAETPAGPL---PYIVMEYVDGVT---LRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT--AVRGTIGHIAP 470
H + IIHRDVK ANI++ V DFG+A+ + VT AV GT +++P
Sbjct: 132 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 471 EYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 502
E ++DV+ G +L E++TG+ F
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-24
Identities = 25/116 (21%), Positives = 44/116 (37%), Gaps = 10/116 (8%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGP-- 128
+ A LK+L +ELY+ +P L +L L SL++ N
Sbjct: 473 NSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQ 532
Query: 129 -------IPDTLGKLSKLRFLRLNNNSLSG-PIPMSLTNISSLQVLDLSNNRLSGV 176
+ D K++ + N+L P SL + L +LD +N++ +
Sbjct: 533 LKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHL 588
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 1e-21
Identities = 21/130 (16%), Positives = 36/130 (27%), Gaps = 29/130 (22%)
Query: 83 SQLGLLKNLQYLELYSNNITGP-------------------IPSDLGNLTSLVSLDLYLN 123
+ L LQ + ++ T NL L ++LY
Sbjct: 442 KAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501
Query: 124 SFTGPIPDTLGKLSKLRFLRLNNNSLSGP---------IPMSLTNISSLQVLDLSNNRLS 174
+PD L L +L+ L + N + +Q+ + N L
Sbjct: 502 PNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561
Query: 175 GVVPDNGSFS 184
P + S
Sbjct: 562 E-FPASASLQ 570
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 1e-20
Identities = 26/132 (19%), Positives = 47/132 (35%), Gaps = 10/132 (7%)
Query: 55 TWFHVTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITG-PIPSDLGNLT 113
++ CN S ++ +L +Q + NN+ P + L +
Sbjct: 518 QSLNIACNRGISAAQLKAD----WTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMV 573
Query: 114 SLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSL-TNISSLQVLDLSNNR 172
L LD N + G KL L+L+ N + IP ++ L S+N+
Sbjct: 574 KLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNK 630
Query: 173 LSGVVPDNGSFS 184
L +P+ +
Sbjct: 631 LKY-IPNIFNAK 641
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 7e-20
Identities = 20/139 (14%), Positives = 45/139 (32%), Gaps = 16/139 (11%)
Query: 60 TCNNDNSVIRVDLGNAALSGQLVSQLGL--LKNLQYLELYSNNITG-----PIPSDLGNL 112
C + V + + L + + + + ++ N I D
Sbjct: 614 FCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKG 672
Query: 113 TSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLS-------GPIPMSLTNISSLQV 165
+ ++ L N + S + + L+NN ++ P + N L
Sbjct: 673 INASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTT 732
Query: 166 LDLSNNRLSGVVPDNGSFS 184
+DL N+L+ + D+ +
Sbjct: 733 IDLRFNKLTS-LSDDFRAT 750
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 3e-19
Identities = 26/132 (19%), Positives = 49/132 (37%), Gaps = 12/132 (9%)
Query: 79 GQLVSQLGLLKNLQYLELYSNNITGPIPSDL--GNLTSLVSLDLYLNSFTGPIPDTLGKL 136
L ++L N +T + D L L ++D+ N F+ P
Sbjct: 718 KPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNS 775
Query: 137 SKLRFLRL------NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPIS 190
S+L+ + N + P +T SL L + +N + V + + L+ +
Sbjct: 776 SQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKLTPQLYI-LD 833
Query: 191 FANNLDLCGPVT 202
A+N ++ VT
Sbjct: 834 IADNPNISIDVT 845
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 6e-18
Identities = 29/186 (15%), Positives = 50/186 (26%), Gaps = 21/186 (11%)
Query: 14 VHSSWLASANMEGDALHSLRSNLIDPNNVLQSWDP-TLVNPCTWFHVTCNNDNSVIRVDL 72
+ A + AL ++ L N S ++ W N + +
Sbjct: 259 IQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW-----NFNKEL----- 308
Query: 73 GNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDT 132
Q L + L L G +P +G LT L L +S T
Sbjct: 309 --DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLF 366
Query: 133 LGKLSKLRFLRLNNNSLSGPI-PMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISF 191
+ + + M L L + DL + ++ PI
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN-------RNPEMKPIKK 419
Query: 192 ANNLDL 197
+ + L
Sbjct: 420 DSRISL 425
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 2e-17
Identities = 26/181 (14%), Positives = 53/181 (29%), Gaps = 35/181 (19%)
Query: 31 SLRSNLIDPNNVLQSWDPTLVNPCTWFH---VTCNNDNSVIRVDLGNAALSGQLVSQLGL 87
S I+ +W+ W V +N+ V + L G++ +G
Sbjct: 287 RYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQ 345
Query: 88 LKNLQYLELYSNNITGPIPSD-------------------------LGNLTSLVSLDLYL 122
L L+ L +++ T L L DL
Sbjct: 346 LTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQ 405
Query: 123 NSFT-----GPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVV 177
++ PI K + N ++ I ++ ++ LQ++ +N+ +
Sbjct: 406 DAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDN 464
Query: 178 P 178
Sbjct: 465 I 465
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 19/111 (17%), Positives = 36/111 (32%), Gaps = 12/111 (10%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLEL------YSNNITGPIPSDLGNLTSLVSLDLYLNS 124
D+ S +Q L+ + N I P+ + SL+ L + N
Sbjct: 759 DVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSND 817
Query: 125 FTGPIPDTLGKLSKLRFLRLNNNSL-SGPIPMSLTNISS-LQVLDLSNNRL 173
+ + L +L L + +N S + I + + VL +
Sbjct: 818 IRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 13/87 (14%), Positives = 26/87 (29%), Gaps = 5/87 (5%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFT-GPI 129
D + Q + + +L L++ SN+I + L L LD+ N +
Sbjct: 788 DAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDV 844
Query: 130 PDTLGKLSK-LRFLRLNNNSLSGPIPM 155
+ + L +
Sbjct: 845 TSVCPYIEAGMYVLLYDKTQDIRGCDA 871
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-23
Identities = 70/282 (24%), Positives = 113/282 (40%), Gaps = 31/282 (10%)
Query: 260 RRKPQEFFFDVPAEEDPEVHLGQLKRF----SLRELQVATDSFSNKNILGRGGFGKVYKG 315
R E+ P + + RF L V ++F +LG+GGFG+V
Sbjct: 146 TRLTHEYLSVAPFADYLD--SIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCAC 203
Query: 316 RLAD-GSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372
++ G + A K+L+++R GE E +++ R ++ L T LV
Sbjct: 204 QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263
Query: 373 PYMANGSVASCLRERPPSQLPLDWPTRKR-----IALGSARGLSYLHDHCDPKIIHRDVK 427
M G + + + P R I GL LH +I++RD+K
Sbjct: 264 TLMNGGDLKFHIYHMGQAGFPEA---RAVFYAAEICC----GLEDLHRE---RIVYRDLK 313
Query: 428 AANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 487
NILLD+ + D GLA + T GT+G++APE + + + D +
Sbjct: 314 PENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWAL 371
Query: 488 GIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529
G +L E+I GQ F + + V+ L+KE E
Sbjct: 372 GCLLYEMIAGQSPFQ-----QRKKKIKREEVERLVKEVPEEY 408
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-23
Identities = 73/258 (28%), Positives = 111/258 (43%), Gaps = 28/258 (10%)
Query: 268 FDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVK 326
F E D Q K L + + FS I+GRGGFG+VY R AD G + A+K
Sbjct: 162 FQKFIESDKFTRFCQWKNVELNI-HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220
Query: 327 RLKEER--TPGGELQFQTE---VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 381
L ++R GE E + ++S ++ + TP + + M G +
Sbjct: 221 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 280
Query: 382 SCLRERPPSQLPLDWPTRKR-----IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 436
L + R I L GL ++H+ +++RD+K ANILLDE
Sbjct: 281 YHLSQHGVFSEA-----DMRFYAAEIIL----GLEHMHNR---FVVYRDLKPANILLDEH 328
Query: 437 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT-DVFGYGIMLLELI 495
+ D GLA K H +V GT G++APE L G + + + D F G ML +L+
Sbjct: 329 GHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
Query: 496 TGQRAFDLARLANDDDVM 513
G F + + ++
Sbjct: 386 RGHSPFRQHKTKDKHEID 403
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 64/288 (22%), Positives = 107/288 (37%), Gaps = 64/288 (22%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVK-----RLKEERTPGGELQFQTEVEMISM----AVHR 353
LG+GGFG V+ G L D VA+K R+ + EV ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK-RIALGSAR---- 408
++RL + T +LV L D+ T K + G +R
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQ-----------DL-FDYITEKGPLGEGPSRCFFG 146
Query: 409 ----GLSYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRG 463
+ + H ++HRD+K NIL+D + DFG L+ D T G
Sbjct: 147 QVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFD-G 200
Query: 464 TIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 522
T + PE++S + + V+ GI+L +++ G F+ D +++ + L
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE-----RDQEIL-----EAEL 250
Query: 523 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
+V + LI+ L P RP + E++
Sbjct: 251 HFPA------------HVSPDCCALIR-RCLAP--KPSSRPSLEEILL 283
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 51/219 (23%), Positives = 96/219 (43%), Gaps = 15/219 (6%)
Query: 287 SLRELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVE 345
+ Q + N +G G G+V+K R G ++AVK+++ + +++
Sbjct: 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD 75
Query: 346 -MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIAL 404
++ +++ G +T T+ + M + R + P + ++ +
Sbjct: 76 VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP----IPERILGKMTV 131
Query: 405 GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 464
+ L YL + +IHRDVK +NILLDE + + DFG++ + D G
Sbjct: 132 AIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSAGC 187
Query: 465 IGHIAPEYLSTGKSSE-----KTDVFGYGIMLLELITGQ 498
++APE + ++ + DV+ GI L+EL TGQ
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 61/221 (27%), Positives = 93/221 (42%), Gaps = 21/221 (9%)
Query: 292 QVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEER--TPGGELQFQTEVEMIS 348
+ D F + +LGRGGFG+V+ ++ G L A K+L ++R G E ++++
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 349 MAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKR-----I 402
R ++ L + L LV M G + + P R I
Sbjct: 241 KVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP-RAIFYTAQI 298
Query: 403 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAV 461
GL +LH II+RD+K N+LLD++ + D GLA L + T
Sbjct: 299 VS----GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGY 349
Query: 462 RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 502
GT G +APE L + D F G+ L E+I + F
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-22
Identities = 30/163 (18%), Positives = 57/163 (34%), Gaps = 11/163 (6%)
Query: 23 NMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAALSGQLV 82
++ + SL + + C + SV ++L
Sbjct: 221 GLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC---------EMSVESINLQKHYFFNISS 271
Query: 83 SQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFL 142
+ LQ L+L + +++ +PS L L++L L L N F + L L
Sbjct: 272 NTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHL 330
Query: 143 RLNNNSLSGPIPM-SLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
+ N+ + L N+ +L+ LDLS++ + N
Sbjct: 331 SIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-22
Identities = 23/120 (19%), Positives = 38/120 (31%), Gaps = 3/120 (2%)
Query: 60 TCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLD 119
C + N L+ + L + + LE N + + L +L LD
Sbjct: 7 KCIEKEVNKTYNCENLGLNE--IPG-TLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLD 63
Query: 120 LYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179
L DT +L L L N L +L+ +L+ L +S +
Sbjct: 64 LTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFI 123
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-21
Identities = 28/132 (21%), Positives = 45/132 (34%), Gaps = 3/132 (2%)
Query: 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNS 124
NS ++ L + L NL +L+L I + L +L L N
Sbjct: 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92
Query: 125 FTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD--NGS 182
L L+ L +S + L N +L+ L L +N +S + +
Sbjct: 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPT 152
Query: 183 FSLFTPISFANN 194
L + F NN
Sbjct: 153 EKLKV-LDFQNN 163
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-21
Identities = 23/110 (20%), Positives = 36/110 (32%), Gaps = 5/110 (4%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
L L L +N + + L +L L + L L L L +N
Sbjct: 80 QHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSN 139
Query: 148 SLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDL 197
+S L+VLD NN + + + + + A NL L
Sbjct: 140 HISSIKLPKGFPTEKLKVLDFQNNAIHYLSKE-----DMSSLQQATNLSL 184
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-19
Identities = 23/109 (21%), Positives = 44/109 (40%), Gaps = 2/109 (1%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
K L++L I+ L N +L SL L N + KL+ L NN
Sbjct: 104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163
Query: 148 SLSGPIPMSLTNISSLQV--LDLSNNRLSGVVPDNGSFSLFTPISFANN 194
++ ++++ L+L+ N ++G+ P ++F ++F
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGT 212
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-19
Identities = 25/100 (25%), Positives = 42/100 (42%), Gaps = 3/100 (3%)
Query: 83 SQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPI---PDTLGKLSKL 139
S L L+ L L + + L +L L+L N F ++L L +L
Sbjct: 419 SPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRL 478
Query: 140 RFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179
L L+ LS + T++ + +DLS+NRL+ +
Sbjct: 479 EILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIE 518
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-19
Identities = 24/124 (19%), Positives = 36/124 (29%), Gaps = 10/124 (8%)
Query: 63 NDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYL 122
+ + + D N L L +LQ L L N L LDL
Sbjct: 358 SHDDIETSDCCNLQLRN--------LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409
Query: 123 NSFTGPIPDT-LGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD-N 180
+ L L+ L L+++ L + +LQ L+L N
Sbjct: 410 TRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT 469
Query: 181 GSFS 184
S
Sbjct: 470 NSLQ 473
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-19
Identities = 23/113 (20%), Positives = 34/113 (30%), Gaps = 4/113 (3%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITG-PIPSDLGNLTSLVSLDLYLNSFTGPI 129
+L L+ L+L + S NL L L+L +
Sbjct: 382 NLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISS 441
Query: 130 PDTLGKLSKLRFLRLNNNSLSGPI---PMSLTNISSLQVLDLSNNRLSGVVPD 179
L L+ L L N SL + L++L LS LS +
Sbjct: 442 EQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQH 494
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-18
Identities = 28/130 (21%), Positives = 43/130 (33%), Gaps = 7/130 (5%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSFT--G 127
L +L +L + N + + L NL +L LDL +
Sbjct: 307 VLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSD 366
Query: 128 PIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFT 187
L LS L+ L L+ N + L++LDL+ RL S F
Sbjct: 367 CCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ----SPFQ 422
Query: 188 PISFANNLDL 197
+ L+L
Sbjct: 423 NLHLLKVLNL 432
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-18
Identities = 23/99 (23%), Positives = 41/99 (41%), Gaps = 1/99 (1%)
Query: 77 LSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKL 136
+ Q + L L L+ L L +++ +L + +DL N T + L L
Sbjct: 464 GNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHL 523
Query: 137 SKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSG 175
+ L L +N +S +P L +S + ++L N L
Sbjct: 524 KGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 25/129 (19%), Positives = 42/129 (32%), Gaps = 3/129 (2%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP 130
+S L K L+ L L SN+I+ L LD N+
Sbjct: 111 FFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK 170
Query: 131 DTLGKLSKLR--FLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTP 188
+ + L + L LN N ++G I + + Q L+ + V+ S
Sbjct: 171 EDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQS 229
Query: 189 ISFANNLDL 197
+ D+
Sbjct: 230 LWLGTFEDM 238
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-17
Identities = 23/112 (20%), Positives = 46/112 (41%), Gaps = 4/112 (3%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPI---PSDLGNLTSLVSLDLYLNSFTG 127
+L ++ L L LQ+L L N+ + L L L L L +
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490
Query: 128 PIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179
L + + L++N L+ +L+++ + L+L++N +S ++P
Sbjct: 491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPS 541
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-14
Identities = 24/135 (17%), Positives = 47/135 (34%), Gaps = 6/135 (4%)
Query: 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNS- 124
++ + LG+ +S + + + L+ L+ +N I D+ +L +L L LN
Sbjct: 130 TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN 189
Query: 125 FTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTN--ISSLQVLDLSNNRLSGVVPDNGS 182
I + + L I L N I SL + + +
Sbjct: 190 DIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDI--SPAV 247
Query: 183 FSLFTPISFANNLDL 197
F +S +++L
Sbjct: 248 FEGLCEMSV-ESINL 261
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 23/138 (16%), Positives = 41/138 (29%), Gaps = 12/138 (8%)
Query: 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELY--SNNITGPIPSDLGNLTSLVSLDLYLN 123
+ +D N A+ + L+ L L N+I G I + SL+
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGT 212
Query: 124 SFTGPIPDTLG--KLSKLRFLRLNNNSLSGPIPMSLTNIS--SLQVLDLSNNRLSGVVPD 179
I L + L + P + S++ ++L + + +
Sbjct: 213 QNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272
Query: 180 NGSFSLFTPISFANNLDL 197
F S LDL
Sbjct: 273 -----TFHCFSGLQELDL 285
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-22
Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 15/212 (7%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVH 352
++ + LG G +G+V R A+K +++ EV ++ + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 353 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 412
N+++L F LV G L + ++ + I G++Y
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGE----LFDEIIHRMKFNEVDAAVIIKQVLSGVTY 151
Query: 413 LHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 469
LH H I+HRD+K N+LL +++ + DFGL+ + +++ GT +IA
Sbjct: 152 LHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV--FENQKKMKERLGTAYYIA 206
Query: 470 PEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
PE L K EK DV+ G++L L+ G F
Sbjct: 207 PEVLR-KKYDEKCDVWSIGVILFILLAGYPPF 237
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 7e-22
Identities = 65/303 (21%), Positives = 101/303 (33%), Gaps = 64/303 (21%)
Query: 204 RPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKP 263
R P S N A A + +
Sbjct: 27 RHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDA-----------------QPKGT 69
Query: 264 QEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR-LADGSL 322
+ +F ED K F + K+++GRG V + A G
Sbjct: 70 ENLYFQSMGPEDELPDWAAAKEF--------YQKYDPKDVIGRGVSSVVRRCVHRATGHE 121
Query: 323 VAVK-------RLKEERTPGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPY 374
AVK RL E+ + E + +A H +++ L + + LV+
Sbjct: 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDL 181
Query: 375 MANGSVASCLRERPPSQLPLDWPTRK-----RIALGSAR----GLSYLHDHCDPKIIHRD 425
M G +L D+ T K + R +S+LH + I+HRD
Sbjct: 182 MRKG------------EL-FDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRD 225
Query: 426 VKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVF 485
+K NILLD+ + + DFG + + + + GT G++APE L K S
Sbjct: 226 LKPENILLDDNMQIRLSDFGFSCHL--EPGEKLRELCGTPGYLAPEIL---KCSMDETHP 280
Query: 486 GYG 488
GYG
Sbjct: 281 GYG 283
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 9e-22
Identities = 65/286 (22%), Positives = 114/286 (39%), Gaps = 62/286 (21%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVK-----RLKEERTPGGELQFQTEVEMISMAVHR--NL 355
LG GGFG VY G ++D VA+K R+ + + EV ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 356 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK-RIALGSAR------ 408
+RL + P +L+ P Q D+ T + + AR
Sbjct: 111 IRLLDWFERPDSFVLILERPE------------PVQDLFDFITERGALQEELARSFFWQV 158
Query: 409 --GLSYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTI 465
+ + H+ ++HRD+K NIL+D + + DFG L+ KDT T GT
Sbjct: 159 LEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFD-GTR 212
Query: 466 GHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 524
+ PE++ + V+ GI+L +++ G F+ +D++++ +G +
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEII-----RGQVFF 262
Query: 525 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
++ V +E + LI+ L P DRP E+
Sbjct: 263 RQ------------RVSSECQHLIR-WCLAL--RPSDRPTFEEIQN 293
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 54/229 (23%), Positives = 91/229 (39%), Gaps = 37/229 (16%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVK---RLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 359
LG G +GKV + AVK + K R P GE + E++++ H+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 360 G--FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR--------G 409
+ + +V Y G ++E LD KR + A G
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCG-----MQEM------LDSVPEKRFPVCQAHGYFCQLIDG 121
Query: 410 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHI 468
L YLH I+H+D+K N+LL + G+A+ + + +G+
Sbjct: 122 LEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178
Query: 469 APEYLSTGK--SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 515
PE + S K D++ G+ L + TG F+ D++ L
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE------GDNIYKL 221
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-21
Identities = 24/120 (20%), Positives = 41/120 (34%), Gaps = 1/120 (0%)
Query: 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNS 124
+S +DL L LQ+L+L I L L +L L N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 125 FTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
P + L+ L L L+ + + +L+ L++++N + FS
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFS 150
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-21
Identities = 18/94 (19%), Positives = 33/94 (35%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145
+ + + ++L N + N + L LDL L L L L
Sbjct: 29 DIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILT 88
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179
N + P S + ++SL+ L +L+ +
Sbjct: 89 GNPIQSFSPGSFSGLTSLENLVAVETKLASLESF 122
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 5e-21
Identities = 20/102 (19%), Positives = 36/102 (35%)
Query: 73 GNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDT 132
GN+ L + NL +L+L + L L L++ N+
Sbjct: 457 GNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSH 516
Query: 133 LGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
+L L L + N + + SL +L+NN ++
Sbjct: 517 YNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-20
Identities = 26/128 (20%), Positives = 44/128 (34%), Gaps = 6/128 (4%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSFTGPI 129
D+ L +L L++ N+ S+ N T+L LDL
Sbjct: 430 DISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQIS 489
Query: 130 PDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPI 189
L +L+ L +++N+L + SL LD S NR+ +
Sbjct: 490 WGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETS--KGILQHFPKSL 547
Query: 190 SFANNLDL 197
+F +L
Sbjct: 548 AF---FNL 552
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 23/107 (21%), Positives = 40/107 (37%), Gaps = 4/107 (3%)
Query: 83 SQLGLLKNLQYLELYSNNITGPIP-SDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
+ L+ LQ+L+ + + S +L L+ LD+ + L+ L
Sbjct: 393 ANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNT 452
Query: 142 LRLNNNSLSGPIP-MSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFT 187
L++ NS N ++L LDLS +L + G F
Sbjct: 453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQI--SWGVFDTLH 497
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 9e-18
Identities = 17/94 (18%), Positives = 34/94 (36%), Gaps = 2/94 (2%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP-DTLGKLSKLRFLRLNN 146
+L++L+L N + ++ L L LD ++ L KL +L ++
Sbjct: 375 TNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISY 433
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN 180
+ ++SL L ++ N N
Sbjct: 434 TNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 29/124 (23%), Positives = 44/124 (35%), Gaps = 11/124 (8%)
Query: 83 SQLGLLKNLQYLELYSNNITGPIPSDLGNLT----SLVSLDLYLNSFTGPIPDTLGKLSK 138
+ L NL +++L N I +DL L +SLD+ LN I D + K
Sbjct: 147 AYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIK 205
Query: 139 LRFLRLNNNSLSGPIP-MSLTNISSLQVLDLSNNRLSGV----VPDNGSFSLFTPISFAN 193
L L L N S I L N++ L V L + + ++ +
Sbjct: 206 LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTI-D 264
Query: 194 NLDL 197
L
Sbjct: 265 EFRL 268
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 6e-13
Identities = 18/105 (17%), Positives = 31/105 (29%), Gaps = 9/105 (8%)
Query: 90 NLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSFTG------PIPDTLGKLSKLRF- 141
L L L N + I L NL L L L F P + L +
Sbjct: 205 KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID 264
Query: 142 -LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSL 185
RL + + ++++ + L+ + + F
Sbjct: 265 EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKW 309
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-12
Identities = 22/80 (27%), Positives = 27/80 (33%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP 130
DL L L LQ L + NN+ S L SL +LD N
Sbjct: 479 DLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKG 538
Query: 131 DTLGKLSKLRFLRLNNNSLS 150
L F L NNS++
Sbjct: 539 ILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 8e-12
Identities = 32/178 (17%), Positives = 57/178 (32%), Gaps = 31/178 (17%)
Query: 20 ASANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAALSG 79
N+ G +H L L+ ++P+++ +
Sbjct: 224 CLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHC 283
Query: 80 QLVSQLGLLKNLQYLELYSNNITGPIPS---------DL----------GNLTSLVSLDL 120
L N+ + L +I + +L L SL L
Sbjct: 284 --------LANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTL 335
Query: 121 YLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNI--SSLQVLDLSNNRLSGV 176
+N + I L L +L L+ N+LS S +++ +SL+ LDLS N +
Sbjct: 336 TMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM 391
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 7e-21
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 16/214 (7%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGE--LQFQTEVEMISMAV 351
+D + + +LG+G FG+V + G AVK + + + EV+++
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 352 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 411
H N+++L F LV G L + S+ RI G++
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQVLSGIT 140
Query: 412 YLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 468
Y+H + KI+HRD+K N+LL ++ + DFGL+ ++ + GT +I
Sbjct: 141 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKMKDKIGTAYYI 195
Query: 469 APEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 502
APE L G EK DV+ G++L L++G F+
Sbjct: 196 APEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN 228
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 56/230 (24%), Positives = 93/230 (40%), Gaps = 33/230 (14%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 362
LG G +G+V VAVK + +R + E+ + M H N+++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 363 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR--------GLSYLH 414
+ L Y + G + + + A+ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPD------------IGMPEPDAQRFFHQLMAGVVYLH 122
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY--KDTHVTTAVRGTIGHIAPEY 472
I HRD+K N+LLDE + DFGLA + Y ++ + GT+ ++APE
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178
Query: 473 LSTGK--SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 520
L + +E DV+ GI+L ++ G+ +D +D DW +
Sbjct: 179 LK-RREFHAEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKEK 224
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 70/315 (22%), Positives = 119/315 (37%), Gaps = 62/315 (19%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRL-KEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 361
+G+G F KV R + G VA+K + K + P + EV ++ + H N+++L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 362 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR--------GLSYL 413
T L+ Y + G V L R+ AR + Y
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAH------------GRMKEKEARSKFRQIVSAVQYC 130
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 473
H I+HRD+KA N+LLD + + DFG + + G + APE
Sbjct: 131 HQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-VGGKLDAFC-GAPPYAAPELF 185
Query: 474 STGKSSE--KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531
GK + + DV+ G++L L++G FD ++ L+E+ L
Sbjct: 186 Q-GKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLK-------ELRERVLRGKY 231
Query: 532 D-PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVL 590
P Y+ + E L++ L +P+ R + ++++ D W
Sbjct: 232 RIPF----YMSTDCENLLKRFL---VLNPIKRGTLEQIMK-----------DRWINAGHE 273
Query: 591 RQEVELAPHPNSDWI 605
E++ P D
Sbjct: 274 EDELKPFVEPELDIS 288
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 51/213 (23%), Positives = 79/213 (37%), Gaps = 40/213 (18%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVK--------RLKEERTPGGELQFQTEVE 345
+++ K ILGRG V + AVK E EV+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 346 -MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK---- 400
+ ++ H N+++L+ T T LV+ M G +L D+ T K
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG------------EL-FDYLTEKVTLS 122
Query: 401 -RIALGSAR----GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455
+ R + LH I+HRD+K NILLD++ + DFG + +
Sbjct: 123 EKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPG 177
Query: 456 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG 488
V GT ++APE + + GYG
Sbjct: 178 EKLREVCGTPSYLAPEIIECSMNDNHP---GYG 207
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 61/251 (24%), Positives = 98/251 (39%), Gaps = 62/251 (24%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVK-------------------------RLKEERTPGGE 337
+G+G +G V D + A+K + G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 338 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLD 395
Q E+ ++ H N+++L P E L V+ + G V ++
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-------------ME 127
Query: 396 WPTRKRIALGSAR--------GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447
PT K ++ AR G+ YLH KIIHRD+K +N+L+ E+ + DFG++
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 448 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGIMLLELITGQRAFDLA 504
D ++ V GT +APE LS + S + DV+ G+ L + GQ F
Sbjct: 185 NEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM-- 241
Query: 505 RLANDDDVMLL 515
D+ +M L
Sbjct: 242 ----DERIMCL 248
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 6e-20
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 15/212 (7%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVH 352
+ ++ +LG+G FG+V K + AVK + + + EVE++ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 353 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 412
N+++L + +V G L + + RI G++Y
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 413 LHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 469
+H H I+HRD+K NILL +++ + + DFGL+ ++ GT +IA
Sbjct: 137 MHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTAYYIA 191
Query: 470 PEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
PE L G EK DV+ G++L L++G F
Sbjct: 192 PEVLR-GTYDEKCDVWSAGVILYILLSGTPPF 222
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 6e-20
Identities = 28/97 (28%), Positives = 47/97 (48%), Gaps = 5/97 (5%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
+S L L NL+ L L +NI+ P L NLT + SL+L N L ++ L +
Sbjct: 103 ISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNY 159
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
L + + + P + N++ L L L+ N++ + P
Sbjct: 160 LTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP 194
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 28/104 (26%), Positives = 49/104 (47%), Gaps = 6/104 (5%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP 130
++G +S ++ + L L+ L + SN I+ S L NL+ L SL L N
Sbjct: 249 EIGTNQISD--INAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDM 304
Query: 131 DTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
+ +G L+ L L L+ N ++ P L ++S + D +N +
Sbjct: 305 EVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 8e-19
Identities = 26/99 (26%), Positives = 44/99 (44%), Gaps = 6/99 (6%)
Query: 80 QLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKL 139
+S L + L YL + + + P + NLT L SL L N P L L+ L
Sbjct: 146 SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSL 201
Query: 140 RFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
+ N ++ P + N++ L L + NN+++ + P
Sbjct: 202 HYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 31/108 (28%), Positives = 53/108 (49%), Gaps = 6/108 (5%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP 130
+GN ++ +S L L L +LE+ +N I+ + + +LT L L++ N +
Sbjct: 227 KIGNNKITD--LSPLANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDISV 282
Query: 131 DTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
L LS+L L LNNN L + +++L L LS N ++ + P
Sbjct: 283 --LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 5e-18
Identities = 31/113 (27%), Positives = 50/113 (44%), Gaps = 6/113 (5%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
+ + L NL+YL L N IT P L NL L +L + N T L L+ LR
Sbjct: 59 IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRE 114
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANN 194
L LN +++S P L N++ + L+L N + + + ++ +
Sbjct: 115 LYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTES 165
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 6e-18
Identities = 27/109 (24%), Positives = 51/109 (46%), Gaps = 8/109 (7%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP 130
++ ++ + + L L++ +N IT P L NL+ L L++ N +
Sbjct: 205 TAYVNQITD--ITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI-- 258
Query: 131 DTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179
+ + L+KL+ L + +N +S L N+S L L L+NN+L +
Sbjct: 259 NAVKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDME 305
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 19/97 (19%), Positives = 37/97 (38%), Gaps = 6/97 (6%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
+ L L ++T + L S+ L + I + L+ L +
Sbjct: 15 IFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS-IQG-IEYLTNLEY 70
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
L LN N ++ P L+N+ L L + N+++ +
Sbjct: 71 LNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISA 105
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 7e-20
Identities = 62/224 (27%), Positives = 93/224 (41%), Gaps = 33/224 (14%)
Query: 294 ATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQF-QT---EV---E 345
AT + +G G +G VYK R G VA+K ++ GG + EV
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 346 MISMAVHRNLLRLRGFCMTPTERL-----LVYPYMANGSVASCLRERPPSQLPLDWPTRK 400
+ H N++RL C T LV+ ++ + + L + PP LP T K
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA--ETIK 123
Query: 401 RIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL----MDYKDTH 456
+ RGL +LH + I+HRD+K NIL+ + DFGLA++ M T
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TP 178
Query: 457 --VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQ 498
VT R APE L + D++ G + E+ +
Sbjct: 179 VVVTLWYR------APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 56/230 (24%), Positives = 93/230 (40%), Gaps = 33/230 (14%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 362
LG G +G+V VAVK + +R + E+ + M H N+++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 363 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR--------GLSYLH 414
+ L Y + G + + + A+ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPD------------IGMPEPDAQRFFHQLMAGVVYLH 122
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY--KDTHVTTAVRGTIGHIAPEY 472
I HRD+K N+LLDE + DFGLA + Y ++ + GT+ ++APE
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178
Query: 473 LSTGK--SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 520
L + +E DV+ GI+L ++ G+ +D +D DW +
Sbjct: 179 LK-RREFHAEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKEK 224
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 8e-20
Identities = 40/175 (22%), Positives = 68/175 (38%), Gaps = 36/175 (20%)
Query: 409 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR------ 462
+ +LH ++HRD+K +NI + VGDFGL MD + T
Sbjct: 176 AVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232
Query: 463 -----GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG-QRAFDLARLANDDDVMLLD 516
GT +++PE + S K D+F G++L EL+ + R+ D
Sbjct: 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITD------- 285
Query: 517 WVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571
++ K P L E ++Q SP +RP+ ++++
Sbjct: 286 -----VRNLKF-----PLLFTQKYPQEH-MMVQ---DMLSPSPTERPEATDIIEN 326
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 15/63 (23%), Positives = 29/63 (46%), Gaps = 1/63 (1%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 361
+GRGGFG V++ + D A+KR++ + EV+ ++ H ++R
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 362 CMT 364
+
Sbjct: 73 WLE 75
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 54/257 (21%), Positives = 84/257 (32%), Gaps = 53/257 (20%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVK----RLKEERTPGGELQFQTEVEMISM 349
+ K +G+G +G V ++ A+K + P + +TEV ++
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 350 AVHRNLLRLRGFCMTPTERLLVYPYMANG-------------SVASCLRERPPSQLPLDW 396
H N+ RL LV G + + P
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 397 PTRKRIALGSAR-----------------------GLSYLHDHCDPKIIHRDVKAANILL 433
+ I L YLH+ I HRD+K N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLF 201
Query: 434 --DEEFEAVVGDFGLAKLMDYKDTH----VTTAVRGTIGHIAPEYLSTG--KSSEKTDVF 485
++ FE + DFGL+K + +TT GT +APE L+T K D +
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 486 GYGIMLLELITGQRAFD 502
G++L L+ G F
Sbjct: 261 SAGVLLHLLLMGAVPFP 277
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 52/225 (23%), Positives = 88/225 (39%), Gaps = 27/225 (12%)
Query: 295 TDSFSNKNI---------LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEV 344
+ + I LG G FG V+ + G +K + ++R+ Q + E+
Sbjct: 12 ENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEI 71
Query: 345 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIAL 404
E++ H N++++ +V G L ER S +
Sbjct: 72 EVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGE----LLERIVSAQARGKALSEGYVA 127
Query: 405 GSAR----GLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHV 457
+ L+Y H ++H+D+K NIL + DFGLA+L D H
Sbjct: 128 ELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHS 183
Query: 458 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 502
T A GT ++APE + K D++ G+++ L+TG F
Sbjct: 184 TNAA-GTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFT 226
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 26/223 (11%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK------------EERTPGGELQFQ 341
+S+ LG G +G+V + S A+K +K + +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 342 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKR 401
E+ ++ H N+++L LV + G L E+ ++ D
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LFEQIINRHKFDECDAAN 150
Query: 402 IALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVT 458
I G+ YLH H I+HRD+K NILL + + DFGL+ + +
Sbjct: 151 IMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSF--FSKDYKL 205
Query: 459 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
GT +IAPE L K +EK DV+ G+++ L+ G F
Sbjct: 206 RDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPPF 247
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 58/265 (21%), Positives = 106/265 (40%), Gaps = 50/265 (18%)
Query: 253 IAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKV 312
IA + + + F F +D V+ L+ D + LG G G+V
Sbjct: 106 IALSL---SRNKVFVFFDLTVDDQSVYPKALR-----------DEYIMSKTLGSGACGEV 151
Query: 313 YKGR-LADGSLVAVK-------RLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT 364
VA++ + R L +TE+E++ H +++++ F
Sbjct: 152 KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211
Query: 365 PTERLLVYPYMANGS-----VAS-CLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 418
+ +V M G V + L+E T K + YLH++
Sbjct: 212 E-DYYIVLELMEGGELFDKVVGNKRLKEA----------TCKLYFYQMLLAVQYLHEN-- 258
Query: 419 PKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 475
IIHRD+K N+LL +E+ + DFG +K++ +T + + GT ++APE L +
Sbjct: 259 -GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVS 315
Query: 476 GKS---SEKTDVFGYGIMLLELITG 497
+ + D + G++L ++G
Sbjct: 316 VGTAGYNRAVDCWSLGVILFICLSG 340
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-19
Identities = 21/97 (21%), Positives = 41/97 (42%), Gaps = 1/97 (1%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
+ + L NL+ L + ++T +L LTSL LD+ ++ I + L K+
Sbjct: 81 YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNS 140
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
+ L+ N I L + L+ L++ + +
Sbjct: 141 IDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG 176
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 19/108 (17%), Positives = 41/108 (37%), Gaps = 3/108 (2%)
Query: 69 RVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGP 128
R+ + ++ + L L +L L++ + I + + L + S+DL N
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151
Query: 129 IPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGV 176
I L L +L+ L + + + + + L L + + G
Sbjct: 152 I-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-15
Identities = 22/115 (19%), Positives = 52/115 (45%), Gaps = 7/115 (6%)
Query: 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSF 125
+ + LG ++ + +Q+ +L Y+ L + N+T + + + ++ L +
Sbjct: 24 AYLNGLLGQSSTANITEAQM---NSLTYITLANINVTD-L-TGIEYAHNIKDLTINNIHA 78
Query: 126 TGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN 180
T P + LS L LR+ ++ +L+ ++SL +LD+S++ +
Sbjct: 79 TNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 14/71 (19%), Positives = 32/71 (45%), Gaps = 11/71 (15%)
Query: 111 NLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNIS---SLQVLD 167
+ ++ L +S T I T +++ L ++ L N +++ LT I +++ L
Sbjct: 21 TFKAYLNGLLGQSS-TANI--TEAQMNSLTYITLANINVT-----DLTGIEYAHNIKDLT 72
Query: 168 LSNNRLSGVVP 178
++N + P
Sbjct: 73 INNIHATNYNP 83
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 51/224 (22%), Positives = 97/224 (43%), Gaps = 16/224 (7%)
Query: 287 SLRELQVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRL-KEERTPGGELQ-FQTE 343
++++++ + F ++GRG FG+V +L + + A+K L K E E F+ E
Sbjct: 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 344 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIA 403
+++ + + L LV Y G + + L + +LP + R +A
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLS-KFEDRLPEEM-ARFYLA 182
Query: 404 -LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 462
+ A + +H +HRD+K NIL+D + DFG + T ++
Sbjct: 183 EMVIA--IDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV 237
Query: 463 GTIGHIAPEYLSTGKSSEKT-----DVFGYGIMLLELITGQRAF 501
GT +I+PE L + + D + G+ + E++ G+ F
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 56/227 (24%), Positives = 97/227 (42%), Gaps = 20/227 (8%)
Query: 287 SLRELQVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRL-KEERTPGGEL-QFQTE 343
L+E+++ D F ++GRG F +V ++ G + A+K + K + GE+ F+ E
Sbjct: 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREE 111
Query: 344 VEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRI 402
+++ R + +L F L LV Y G + + L + ++P + R +
Sbjct: 112 RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAEM-ARFYL 168
Query: 403 A-LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 461
A + A + +H +HRD+K NILLD + DFG + T +
Sbjct: 169 AEIVMA--IDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA 223
Query: 462 RGTIGHIAPEYLSTGKSSEKTDVFG-------YGIMLLELITGQRAF 501
GT +++PE L T +G G+ E+ GQ F
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 58/250 (23%), Positives = 88/250 (35%), Gaps = 47/250 (18%)
Query: 271 PAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLK 329
AE P Q + + + + F ILG G F V R A A+K L+
Sbjct: 5 AAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE 64
Query: 330 ---------EERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 380
E +++S H ++L + Y NG +
Sbjct: 65 KRHIIKENKVPYV-------TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL 117
Query: 381 ASCLRERPPSQLPLDWPTRKRIALGSAR--------GLSYLHDHCDPKIIHRDVKAANIL 432
+R+ R L YLH IIHRD+K NIL
Sbjct: 118 LKYIRKI------------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENIL 162
Query: 433 LDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYG 488
L+E+ + DFG AK L + GT +++PE L+ KSS D++ G
Sbjct: 163 LNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS---DLWALG 219
Query: 489 IMLLELITGQ 498
++ +L+ G
Sbjct: 220 CIIYQLVAGL 229
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 21/210 (10%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEER-------TPGGELQFQTEVEMISMAVHRNL 355
LG G FG V+ V VK +K+E+ + E+ ++S H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 356 LRLRGFCMTPTERLLVYPYMANGS-VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
+++ LV +G + + + P LD P I + YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR----LDEPLASYIFRQLVSAVGYLR 147
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 474
IIHRD+K NI++ E+F + DFG A ++ + T GTI + APE L
Sbjct: 148 LK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE-RGKLFYTFC-GTIEYCAPEVLM 202
Query: 475 TGKSSE--KTDVFGYGIMLLELITGQRAFD 502
G + +++ G+ L L+ + F
Sbjct: 203 -GNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 90.3 bits (223), Expect = 7e-19
Identities = 61/387 (15%), Positives = 119/387 (30%), Gaps = 93/387 (24%)
Query: 261 RKPQEFF-FDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNIL--GRGGFGKVYKGRL 317
Q F ++V + +L++ +L EL+ KN+L G G GK
Sbjct: 121 NDNQVFAKYNVSRLQ----PYLKLRQ-ALLELR------PAKNVLIDGVLGSGK------ 163
Query: 318 ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL-----LVY 372
+ VA+ + + + ++ +++ C +P L L+Y
Sbjct: 164 ---TWVALDVCLSYKV---QCKMDFKIFWLNL----------KNCNSPETVLEMLQKLLY 207
Query: 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANIL 432
N + S L + + + R L + + ++ +V+ A
Sbjct: 208 QIDPNWTSRSDHSSNIK--LRIHS-IQAEL-----RRLLKSKPYENCLLVLLNVQNAKAW 259
Query: 433 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG-TIGHIAPEYLSTGKSSEKTDVFGYGIML 491
F + L+ + VT + T HI+ ++ S + ++ L
Sbjct: 260 --NAF-----NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK------SL 306
Query: 492 LELITGQRAFDLARLAND--------------DDVMLLDWVKGLLKEKK-------LEML 530
L R DL R D + D K + +K L +L
Sbjct: 307 LLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVL 366
Query: 531 VDPDLQNNYVEAEV---EQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKV 587
+ + + V I LL + + + VV L L E+ + +
Sbjct: 367 EPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI 426
Query: 588 EVLRQEVELAPHPNSDWIVDSTENLHA 614
+ +EL ++ LH
Sbjct: 427 SIPSIYLELKVKLENE------YALHR 447
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 3e-06
Identities = 78/518 (15%), Positives = 139/518 (26%), Gaps = 163/518 (31%)
Query: 27 DALHSLRSNLIDPNNVLQ-------SWDPTLVNP-CTWFHVTCNNDNSVIRVDLGNAALS 78
AL LR N ++ +W + C + V C D + ++L N
Sbjct: 142 QALLELRPA---KNVLIDGVLGSGKTW---VALDVCLSYKVQCKMDFKIFWLNLKNCN-- 193
Query: 79 GQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP--DTLGKL 136
S +L+ LQ L I N TS +S + +L
Sbjct: 194 ----SPETVLEMLQKL---LYQID-------PNWTSRSD-----HSSNIKLRIHSIQAEL 234
Query: 137 SKLRFLRLNNNSLSGPIPMSLTNISSLQVLD--------------------LSNNRLSGV 176
+L + N L + L N+ + + + LS + +
Sbjct: 235 RRLLKSKPYENCL-----LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHI 289
Query: 177 VPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAI 236
D+ S + TP L P N +I
Sbjct: 290 SLDHHSMT-LTP---DEVKSLLLKYLDCRPQDLPR-------------EVLTTNPRRLSI 332
Query: 237 AGGVAAGAALLFAAPAIAFAW--WRR------RKPQEFFFDV--PAE------------E 274
+ A W W+ E +V PAE
Sbjct: 333 IA------ESIRDGLAT---WDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPP 383
Query: 275 D---PEVHLGQL-KRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKE 330
P + L + ++ V + SLV K+ KE
Sbjct: 384 SAHIPTILLSLIWFDVIKSDVMVVVNKLHKY-------------------SLVE-KQPKE 423
Query: 331 ERT--PGGELQFQTEVEMISMAVHRNLLR----LRGFC----MTPTERLLVYPY----MA 376
P L+ + ++E A+HR+++ + F + P Y + +
Sbjct: 424 STISIPSIYLELKVKLE-NEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLK 482
Query: 377 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGL--SYLHDHCDPKIIHRDVKAANILLD 434
N + L + +K +A S L+ K ++ N D
Sbjct: 483 NIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLK-FYKPYICDN---D 538
Query: 435 EEFEAVVGDFGLAKLMDYKDTHVTTAVRG---TIGHIA 469
++E +V ++D+ + + IA
Sbjct: 539 PKYERLVNA-----ILDFLPKIEENLICSKYTDLLRIA 571
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 7e-19
Identities = 31/114 (27%), Positives = 51/114 (44%), Gaps = 8/114 (7%)
Query: 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNS 124
+ V + + + + L NL + +N +T P L NLT LV + + N
Sbjct: 46 DQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 101
Query: 125 FTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
P L L+ L L L NN ++ P L N+++L L+LS+N +S +
Sbjct: 102 IADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA 151
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 35/108 (32%), Positives = 47/108 (43%), Gaps = 8/108 (7%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP 130
L L + L L NL L+L +N I+ P L LT L L L N + P
Sbjct: 227 SLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 282
Query: 131 DTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
L L+ L L LN N L P ++N+ +L L L N +S + P
Sbjct: 283 --LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-18
Identities = 36/124 (29%), Positives = 60/124 (48%), Gaps = 9/124 (7%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP 130
DL N +S ++ L L L L+L +N I+ P L LT+L +L+L N P
Sbjct: 249 DLANNQISN--LAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP 304
Query: 131 DTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPIS 190
+ L L +L L N++S P +++++ LQ L NN++S V ++ +S
Sbjct: 305 --ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSLANLTNINW-LS 359
Query: 191 FANN 194
+N
Sbjct: 360 AGHN 363
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 9e-18
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 85 LGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144
L L L+ L++ SN ++ S L LT+L SL N + P LG L+ L L L
Sbjct: 173 LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSL 228
Query: 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
N N L L ++++L LDL+NN++S + P
Sbjct: 229 NGNQLKDIGT--LASLTNLTDLDLANNQISNLAP 260
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 7e-17
Identities = 35/115 (30%), Positives = 53/115 (46%), Gaps = 9/115 (7%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP 130
L N ++ + L L NL LEL SN I+ L LTSL L N T P
Sbjct: 118 TLFNNQITD--IDPLKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFG-NQVTDLKP 172
Query: 131 DTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSL 185
L L+ L L +++N +S L +++L+ L +NN++S + P +L
Sbjct: 173 --LANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISDITPLGILTNL 223
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 7e-17
Identities = 31/101 (30%), Positives = 48/101 (47%), Gaps = 8/101 (7%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP 130
+ N L+ ++ L L L + + +N I P L NLT+L L L+ N T P
Sbjct: 74 NFSNNQLTD--ITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP 129
Query: 131 DTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNN 171
L L+ L L L++N++S L+ ++SLQ L N
Sbjct: 130 --LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFGNQ 166
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 19/97 (19%), Positives = 39/97 (40%), Gaps = 6/97 (6%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
+ L L N+T + +L + +L D + L+ L
Sbjct: 17 IFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQ 72
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
+ +NN L+ P L N++ L + ++NN+++ + P
Sbjct: 73 INFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 26/113 (23%), Positives = 45/113 (39%), Gaps = 4/113 (3%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
VS L L N+ +L N I+ P L NLT + L L ++T + +S
Sbjct: 346 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNT 403
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANN 194
++ +L P ++++ S D++ N S + +FS I
Sbjct: 404 VKNVTGALIAPA--TISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTT 454
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 8e-19
Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 17/223 (7%)
Query: 287 SLRELQVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRL-KEERTPGGELQ-FQTE 343
+R+L++ + + ++GRG FG+V R + A+K L K E + F E
Sbjct: 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119
Query: 344 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIA 403
++++ A +++L +V YM G + + + +P W R A
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKW-ARFYTA 175
Query: 404 -LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 462
+ A L +H IHRDVK N+LLD+ + DFG M+ +
Sbjct: 176 EVVLA--LDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 463 GTIGHIAPEYLSTGKSSEK----TDVFGYGIMLLELITGQRAF 501
GT +I+PE L + D + G+ L E++ G F
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 53/244 (21%), Positives = 99/244 (40%), Gaps = 47/244 (19%)
Query: 292 QVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEER---------TPGGELQFQ 341
V D F +G+G FGKV + D + A+K + +++
Sbjct: 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNV-------F 63
Query: 342 TEVEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRK 400
E++++ H L+ L + E + +V + G + L++
Sbjct: 64 KELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQN------------V 110
Query: 401 RIALGSAR--------GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452
+ + L YL + +IIHRD+K NILLDE + DF +A ++
Sbjct: 111 HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167
Query: 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKT---DVFGYGIMLLELITGQRAFDLARLAND 509
+ T A GT ++APE S+ K + + D + G+ EL+ G+R + + +
Sbjct: 168 ETQITTMA--GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS 225
Query: 510 DDVM 513
+++
Sbjct: 226 KEIV 229
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 49/228 (21%), Positives = 87/228 (38%), Gaps = 49/228 (21%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVK-----RLKEERTPGGELQFQTEVEMIS 348
D + LG G F V K R + G A K + + R + + EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 349 MAVHRNLLRLRGFCMTPTERLLVYPYMANG---------------SVASCLRERPPSQLP 393
+H N++ L T+ +L+ ++ G S ++ Q+
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-----QI- 124
Query: 394 LDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKL 449
G++YLH KI H D+K NI+L + + + DFGLA
Sbjct: 125 -------------LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 450 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG 497
+D + GT +APE ++ + D++ G++ L++G
Sbjct: 169 --IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 51/211 (24%), Positives = 88/211 (41%), Gaps = 21/211 (9%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHR 353
+ + N ++G G +G V K R G +VA+K+ E + E++++ H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
NL+ L C LV+ ++ + ++ L P LD+ ++ G+ +
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFC 140
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---TH--VTTAVRGTIGHI 468
H H IIHRD+K NIL+ + + DFG A+ + T R
Sbjct: 141 HSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR------ 191
Query: 469 APEYLSTGKS-SEKTDVFGYGIMLLELITGQ 498
APE L + DV+ G ++ E+ G+
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 49/228 (21%), Positives = 87/228 (38%), Gaps = 49/228 (21%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVK-----RLKEERTPGGELQFQTEVEMIS 348
D + LG G F V K R + G A K + + R + + EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 349 MAVHRNLLRLRGFCMTPTERLLVYPYMANG---------------SVASCLRERPPSQLP 393
+H N++ L T+ +L+ ++ G S ++ Q+
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-----QI- 124
Query: 394 LDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKL 449
G++YLH KI H D+K NI+L + + + DFGLA
Sbjct: 125 -------------LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 450 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG 497
+D + GT +APE ++ + D++ G++ L++G
Sbjct: 169 --IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 33/222 (14%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVH 352
+ ++ +LG+G FG+V K + AVK + + + EVE++ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 353 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK-----RIALGSA 407
N+++L + +V G +L D ++ A
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGG------------EL-FDEIIKRKRFSEHDAARII 127
Query: 408 R----GLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTA 460
+ G++Y+H H I+HRD+K NILL +++ + + DFGL+ ++T +
Sbjct: 128 KQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDR 183
Query: 461 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 502
+ GT +IAPE L G EK DV+ G++L L++G F
Sbjct: 184 I-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFY 223
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 23/110 (20%), Positives = 48/110 (43%), Gaps = 2/110 (1%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP 130
L + L + + L+NL+ L++ ++ ++ + + +L L LDL + P
Sbjct: 189 RLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYP 246
Query: 131 DTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN 180
G + L+ L L + S +P+ + ++ L+ LDL +P
Sbjct: 247 PIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSL 296
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 16/96 (16%), Positives = 35/96 (36%), Gaps = 2/96 (2%)
Query: 80 QLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLY-LNSFTGPIPDTLGKLSK 138
L + L L+ L+L P G L L L ++ +P + +L++
Sbjct: 220 ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQ 278
Query: 139 LRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
L L L +P + + + ++ + + +
Sbjct: 279 LEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 6e-17
Identities = 24/98 (24%), Positives = 39/98 (39%), Gaps = 3/98 (3%)
Query: 78 SGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLS 137
S + L NLQ L L I +P+ + NL +L SL + + + + + L
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSA-LGPAIHHLP 229
Query: 138 KLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSN-NRLS 174
KL L L + P + L+ L L + + L
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL 267
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 23/101 (22%), Positives = 42/101 (41%), Gaps = 11/101 (10%)
Query: 83 SQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGK------- 135
+ L+ L L N + +P+ + +L L L + +P+ L
Sbjct: 121 DTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179
Query: 136 --LSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
L L+ LRL + +P S+ N+ +L+ L + N+ LS
Sbjct: 180 QGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS 219
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 6e-14
Identities = 19/97 (19%), Positives = 35/97 (36%), Gaps = 5/97 (5%)
Query: 80 QLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTS--LVSLDLYLNSFTGPIPDTLGKLS 137
+ N Q + L + T V+L+L PD +LS
Sbjct: 47 HSAWRQANSNNPQIETRTGRALKA-TADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLS 104
Query: 138 KLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
L+ + ++ L +P ++ + L+ L L+ N L
Sbjct: 105 HLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR 140
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 9/89 (10%), Positives = 19/89 (21%), Gaps = 7/89 (7%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
+ L + P L + D + +
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGR 66
Query: 148 SLSGPIPMSLTNISS--LQVLDLSNNRLS 174
+L L + + L+L + L
Sbjct: 67 ALKA-TADLLEDATQPGRVALELRSVPLP 94
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 8/66 (12%), Positives = 19/66 (28%), Gaps = 4/66 (6%)
Query: 109 LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDL 168
+ + +L ++ P D L + + N N ++ Q+
Sbjct: 8 HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETR 63
Query: 169 SNNRLS 174
+ L
Sbjct: 64 TGRALK 69
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 5e-18
Identities = 48/228 (21%), Positives = 82/228 (35%), Gaps = 49/228 (21%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVK-----RLKEERTPGGELQFQTEVEMIS 348
D + LG G F V K R G A K RL R + + EV ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 349 MAVHRNLLRLRGFCMTPTERLLVYPYMANG---------------SVASCLRERPPSQLP 393
H N++ L T+ +L+ ++ G L+ Q+
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK-----QI- 117
Query: 394 LDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKL 449
G+ YLH +I H D+K NI+L + + + DFG+A
Sbjct: 118 -------------LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161
Query: 450 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG 497
++ GT +APE ++ + D++ G++ L++G
Sbjct: 162 IE-AGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 5e-18
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLK----EERTPGGELQFQTEVEMISMAV 351
+ + +G G +G VYK + + G +VA+KR++ +E P ++ E+ ++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR---EISLLKELH 77
Query: 352 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 411
H N++ L + LV+ +M + L E L K RG++
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKT---GLQDSQIKIYLYQLLRGVA 133
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---TH--VTTAVRGTIG 466
+ H H +I+HRD+K N+L++ + + DFGLA+ TH VT R
Sbjct: 134 HCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR---- 186
Query: 467 HIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQ 498
AP+ L K S D++ G + E+ITG+
Sbjct: 187 --APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 6e-18
Identities = 50/228 (21%), Positives = 92/228 (40%), Gaps = 30/228 (13%)
Query: 284 KRFSLRELQVATDSFSNK----NILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGEL 338
K++ + ++V S + LG G FG V++ A G + K + P +
Sbjct: 35 KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT-PYPLDKY 93
Query: 339 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG-------SVASCLRERPPSQ 391
+ E+ +++ H L+ L E +L+ +++ G + + E
Sbjct: 94 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN 153
Query: 392 LPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKL 449
R A GL ++H+H I+H D+K NI+ + + + V DFGLA
Sbjct: 154 Y-------MRQACE---GLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK 200
Query: 450 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG 497
++ D V T APE + TD++ G++ L++G
Sbjct: 201 LN-PDEIVKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 57/226 (25%), Positives = 87/226 (38%), Gaps = 41/226 (18%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 362
+G G FG R LVAVK + ER + Q E+ H N++R +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 363 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK-RIALGSAR--------GLSYL 413
+TPT ++ Y + G + + R + AR G+SY
Sbjct: 86 LTPTHLAIIMEYASGGEL-------------YERICNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAV--VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 471
H +I HRD+K N LLD + DFG +K + + V GT +IAPE
Sbjct: 133 HSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTV-GTPAYIAPE 187
Query: 472 YLSTGK--SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 515
L + + DV+ G+ L ++ G F+ D +
Sbjct: 188 VLL-RQEYDGKIADVWSCGVTLYVMLVGAYPFE------DPEEPRD 226
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 8e-18
Identities = 40/208 (19%), Positives = 78/208 (37%), Gaps = 25/208 (12%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVH 352
T+ + LG+G F V + + G A + ++ + Q + E + + H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 353 RNLLRLRGFCMTPTERLLVYPYMANG------SVASCLRERPPSQLPLDWPTRKRIALGS 406
N++RL L++ + G E S + L
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-------IQQILE- 121
Query: 407 ARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 463
+ + H ++HR++K N+LL + + DFGLA ++ + G
Sbjct: 122 --AVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-G 175
Query: 464 TIGHIAPEYLSTGKSSEKTDVFGYGIML 491
T G+++PE L + D++ G++L
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 8e-18
Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 33/225 (14%)
Query: 289 RELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKR-LKEERTPGGELQFQTEVEMI 347
+ + +++N ++G G FG V++ +L + VA+K+ L+++R ELQ V+
Sbjct: 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVK-- 90
Query: 348 SMAVHRNLLRLRGFCMTPTERL------LVYPYMANGSVASCLRERPPSQLPLDWPTRKR 401
H N++ L+ F + ++ LV Y+ +V R + + K
Sbjct: 91 ----HPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKL 145
Query: 402 IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTA 460
R L+Y+H I HRD+K N+LLD + + DFG AK + A
Sbjct: 146 YMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK--------ILIA 194
Query: 461 VRGTIGHI------APEYLSTGKS-SEKTDVFGYGIMLLELITGQ 498
+ +I APE + + + D++ G ++ EL+ GQ
Sbjct: 195 GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 9e-18
Identities = 49/207 (23%), Positives = 95/207 (45%), Gaps = 27/207 (13%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 353
+F +LG G F +V+ + G L A+K +K+ + + E+ ++ H
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK-SPAFRDSSLENEIAVLKKIKHE 66
Query: 354 NLLRLRGFCMTPTERLLVYPYMANG------SVASCLRERPPSQLPLDWPTRKRIALGSA 407
N++ L + T LV ++ G E+ S + +++
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV------IQQVL---- 116
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 464
+ YLH++ I+HRD+K N+L +E + ++ DFGL+K+ ++ ++TA GT
Sbjct: 117 SAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTAC-GT 170
Query: 465 IGHIAPEYLSTGKSSEKTDVFGYGIML 491
G++APE L+ S+ D + G++
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 50/243 (20%), Positives = 82/243 (33%), Gaps = 38/243 (15%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVK----RLKEERTPGGELQFQTEVEMISM 349
D + ++G+G F V + G AVK + E + M
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 350 AVHRNLLRLRGFCMTPTERLLVYPYM----------ANGSVASCLRERPPSQLPLDWPTR 399
H +++ L + +V+ +M E S
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY------M 136
Query: 400 KRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTH 456
++I L Y HD+ IIHRDVK +LL + +G FG+A +
Sbjct: 137 RQIL----EALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV 189
Query: 457 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLD 516
V GT +APE + + DV+G G++L L++G F L +
Sbjct: 190 AGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY------GTKERLFE 242
Query: 517 WVK 519
+
Sbjct: 243 GII 245
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 25/123 (20%), Positives = 43/123 (34%), Gaps = 1/123 (0%)
Query: 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNS 124
S +DL L LQ L+L I +L+ L +L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 125 FTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
LS L+ L +L+ + ++ +L+ L++++N + FS
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFS 146
Query: 185 LFT 187
T
Sbjct: 147 NLT 149
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 34/106 (32%), Positives = 51/106 (48%), Gaps = 3/106 (2%)
Query: 83 SQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPI-PDTLGKLSKLRF 141
S L+NL YL++ + L+SL L + NSF PD +L L F
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFT 187
L L+ L P + ++SSLQVL++++N+L V +G F T
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSV--PDGIFDRLT 518
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-16
Identities = 22/88 (25%), Positives = 34/88 (38%), Gaps = 1/88 (1%)
Query: 88 LKNLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L +L+ L++ N+ D L +L LDL P LS L+ L + +
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMAS 503
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNNRLS 174
N L ++SLQ + L N
Sbjct: 504 NQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 7e-16
Identities = 20/101 (19%), Positives = 37/101 (36%), Gaps = 3/101 (2%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTG-PIPDTLGKLSKLRFLRLNN 146
+L+YL+L N + + S+ L L LD ++ L L +L +++
Sbjct: 372 TTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFT 187
+SSL+VL ++ N F+
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFL-PDIFTELR 470
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 25/99 (25%), Positives = 42/99 (42%), Gaps = 6/99 (6%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLN--SFTGPIPDTLGKLSKLRFLRLN 145
LK+L+ L SN +L SL LDL N SF G + + L++L L+
Sbjct: 324 LKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
N + + + + L+ LD ++ L + + F
Sbjct: 382 FNGVIT-MSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFL 418
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 31/139 (22%), Positives = 54/139 (38%), Gaps = 11/139 (7%)
Query: 66 SVIRVDLGNAAL-SGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSL----VSLDL 120
++ +++ + + S +L L NL++L+L SN I +DL L + +SLDL
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 121 YLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIP-MSLTNISSLQVLDLSNNRLSG---- 175
LN I K +L L L NN S + + ++ L+V L
Sbjct: 185 SLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243
Query: 176 VVPDNGSFSLFTPISFANN 194
D + ++
Sbjct: 244 EKFDKSALEGLCNLTIEEF 262
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 28/157 (17%), Positives = 45/157 (28%), Gaps = 16/157 (10%)
Query: 29 LHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAALSGQLVSQLGLL 88
+H L L+ +D + + + ++ L
Sbjct: 229 VHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY-------LDYYLDDIIDLFNCL 281
Query: 89 KNLQYLELYSNNITG-PIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
N+ L S I S L ++ F KL L+ L +N
Sbjct: 282 TNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT------LKLKSLKRLTFTSN 335
Query: 148 SLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
S ++ SL+ LDLS N LS + S
Sbjct: 336 KGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 22/172 (12%), Positives = 57/172 (33%), Gaps = 14/172 (8%)
Query: 23 NMEGDALHSLRSNLIDPNNVLQSWDPTLV---NPCTWFHVTCNNDNSVIRVDLGNAALSG 79
++ + + S+ + + + + +L NP + + + ++ L N S
Sbjct: 155 DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSL 214
Query: 80 QLVSQ-LGLLKNLQYLELY------SNNITGPIPSDLGNLTSLVSLDLYLNS---FTGPI 129
++ + L L+ L N+ S L L +L + L + I
Sbjct: 215 NVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDI 274
Query: 130 PDTLGKLSKLRFLRLNNNSLSGPIPMS-LTNISSLQVLDLSNNRLSGVVPDN 180
D L+ + L + ++ S L++++ + + +
Sbjct: 275 IDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKS 326
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK---EERTPGGELQFQTEVEMISMAV 351
+++ + LG G + VYKG+ +LVA+K ++ EE P ++ EV ++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLK 58
Query: 352 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 411
H N++ L T LV+ Y+ + + L + ++ K RGL+
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCG---NIINMHNVKLFLFQLLRGLA 114
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTH--VTTAVRGT 464
Y H K++HRD+K N+L++E E + DFGLA+ Y + VT R
Sbjct: 115 YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVTLWYR-- 167
Query: 465 IGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQ 498
P+ L S + D++G G + E+ TG+
Sbjct: 168 ----PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 1e-17
Identities = 49/245 (20%), Positives = 91/245 (37%), Gaps = 30/245 (12%)
Query: 271 PAEEDPEVHLGQLKRFSLRELQVATDSFSNK----NILGRGGFGKVYKGR-LADGSLVAV 325
+ K++ + +++ D + LG G FG V++ A G+ A
Sbjct: 128 VSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAA 187
Query: 326 KRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG------- 378
K + E + E++ +S+ H L+ L E +++Y +M+ G
Sbjct: 188 KFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA 246
Query: 379 SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE 438
+ + E + R GL ++H++ +H D+K NI+ +
Sbjct: 247 DEHNKMSEDEAVEY-------MRQVCK---GLCHMHEN---NYVHLDLKPENIMFTTKRS 293
Query: 439 AVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 496
+ DFGL +D V GT APE TD++ G++ L++
Sbjct: 294 NELKLIDFGLTAHLD-PKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 351
Query: 497 GQRAF 501
G F
Sbjct: 352 GLSPF 356
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 35/120 (29%), Positives = 51/120 (42%), Gaps = 7/120 (5%)
Query: 63 NDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYL 122
N N + +++L L S N++ L+L N ++ +DL T L L+L
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 123 NSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGS 182
N D L LS LR L LNNN + L S++ L +NN +S V G
Sbjct: 68 NVLYE-TLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQ 120
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 20/90 (22%), Positives = 33/90 (36%), Gaps = 4/90 (4%)
Query: 85 LGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144
L++L L N I + + L +LDL N + + + ++ L
Sbjct: 165 AASSDTLEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISL 221
Query: 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
NN L I +L +L+ DL N
Sbjct: 222 RNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 20/104 (19%), Positives = 41/104 (39%), Gaps = 4/104 (3%)
Query: 77 LSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKL 136
L+ V +L + +++ L +NNI+ + ++ L N T G
Sbjct: 87 LNNNYVQELLVGPSIETLHAANNNISR-VSCS--RGQGKKNIYLANNKITMLRDLDEGCR 143
Query: 137 SKLRFLRLNNNSLSG-PIPMSLTNISSLQVLDLSNNRLSGVVPD 179
S++++L L N + + +L+ L+L N + V
Sbjct: 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQ 187
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 9e-15
Identities = 21/91 (23%), Positives = 39/91 (42%), Gaps = 4/91 (4%)
Query: 85 LGLLKNLQYLELYSNNITG-PIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143
G +QYL+L N I + +L L+L N + + +KL+ L
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV-FAKLKTLD 197
Query: 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
L++N L+ + + + + + L NN+L
Sbjct: 198 LSSNKLAF-MGPEFQSAAGVTWISLRNNKLV 227
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 22/106 (20%), Positives = 42/106 (39%), Gaps = 10/106 (9%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP 130
+L + L L L L+ L+L +N + +L S+ +L N+ + +
Sbjct: 64 NLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-VS 115
Query: 131 DTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGV 176
+ + + L NN ++ + S +Q LDL N + V
Sbjct: 116 --CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV 159
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 16/125 (12%), Positives = 34/125 (27%), Gaps = 5/125 (4%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP 130
+L + V + L+ L+L SN + + + + + + L N I
Sbjct: 175 NLQYNFIYD--VKGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IE 230
Query: 131 DTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPIS 190
L L L N + +V ++ + + N +
Sbjct: 231 KALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLG 289
Query: 191 FANNL 195
Sbjct: 290 HYGAY 294
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 9e-12
Identities = 15/72 (20%), Positives = 26/72 (36%)
Query: 105 IPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQ 164
I N + +S + ++ L L+ N LS L + L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 165 VLDLSNNRLSGV 176
+L+LS+N L
Sbjct: 62 LLNLSSNVLYET 73
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 10/51 (19%), Positives = 24/51 (47%)
Query: 129 IPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179
I + ++ + ++ ++SL + + +++ LDLS N LS +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAA 52
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 48/231 (20%), Positives = 88/231 (38%), Gaps = 31/231 (13%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-H 352
TD + K +G G + + A AVK + + + E+E++ H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-----RDPTEEIEILLRYGQH 75
Query: 353 RNLLRLRGFCMTPTERLLVYPYMANGS-----VA-SCLRERPPSQLPLDWPTRKRIALGS 406
N++ L+ +V M G + ER S + +
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV-----LFT---ITK 127
Query: 407 ARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKLMDYKDTHVTTAVR 462
+ YLH ++HRD+K +NIL E++ + DFG AK + ++ + T
Sbjct: 128 T--VEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC- 181
Query: 463 GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 513
T +APE L D++ G++L ++TG F ++++
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL 232
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 47/208 (22%), Positives = 84/208 (40%), Gaps = 26/208 (12%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVH 352
+D++ K LG+G F V + G A K + ++ + Q + E + H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 353 RNLLRLRGFCMTPTERLLVYPYMANG------SVASCLRERPPSQLPLDWPTRKRIALGS 406
N++RL + LV+ + G E S ++I
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC------IQQIL--- 115
Query: 407 ARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 463
++Y H + I+HR++K N+LL + + DFGLA + D+ G
Sbjct: 116 -ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAG 169
Query: 464 TIGHIAPEYLSTGKSSEKTDVFGYGIML 491
T G+++PE L S+ D++ G++L
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 58/294 (19%), Positives = 107/294 (36%), Gaps = 35/294 (11%)
Query: 215 PPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE 274
+ + + G + + + ++ D+PA
Sbjct: 15 GTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPV----KSKRTSALAVDIPAPP 70
Query: 275 DPEVH-LGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEER 332
P H + K+ ++ + S ILG G FG+V+K A G +A K +K
Sbjct: 71 APFDHRIVTAKQGAVNSFY----TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG 126
Query: 333 TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG-------SVASCLR 385
E + + E+ +++ H NL++L + + +LV Y+ G + L
Sbjct: 127 MKDKE-EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLT 185
Query: 386 ERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GD 443
E + G+ ++H I+H D+K NIL + D
Sbjct: 186 ELDTILF-------MKQICE---GIRHMHQM---YILHLDLKPENILCVNRDAKQIKIID 232
Query: 444 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG 497
FGLA+ + GT +APE ++ S TD++ G++ L++G
Sbjct: 233 FGLARRYK-PREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRG 360
LG G FGKV G G VAVK L ++ + + + E++ + + H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 361 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR--------GLSY 412
TPT+ +V Y++ G + + + R+ AR + Y
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKH------------GRVEEMEARRLFQQILSAVDY 126
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 472
H H ++HRD+K N+LLD A + DFGL+ +M + T+ G+ + APE
Sbjct: 127 CHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTSC-GSPNYAAPEV 181
Query: 473 LSTGK--SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 515
+S G+ + + D++ G++L L+ G FD D+ V L
Sbjct: 182 IS-GRLYAGPEVDIWSCGVILYALLCGTLPFD------DEHVPTL 219
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 49/219 (22%), Positives = 89/219 (40%), Gaps = 31/219 (14%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK----EERTPGGELQFQTEVEMISMA 350
+ +G G +G V+K + +VA+KR++ +E P L+ E+ ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKEL 58
Query: 351 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGL 410
H+N++RL + + LV+ + + + LD K +GL
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGL 114
Query: 411 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTH--VTTAVRG 463
+ H ++HRD+K N+L++ E + +FGLA+ + Y + VT R
Sbjct: 115 GFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYR- 168
Query: 464 TIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAF 501
P+ L K S D++ G + EL R
Sbjct: 169 -----PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 32/112 (28%), Positives = 49/112 (43%), Gaps = 7/112 (6%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP 130
+ +++L L S N++ L+L N ++ +DL T L L+L N +
Sbjct: 16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD 75
Query: 131 DTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGS 182
L LS LR L LNNN + L S++ L +NN +S V G
Sbjct: 76 --LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQ 120
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 4e-17
Identities = 20/89 (22%), Positives = 41/89 (46%), Gaps = 2/89 (2%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145
+ ++ +++ + S + ++ LDL N + L +KL L L+
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
+N L + L ++S+L+ LDL+NN +
Sbjct: 67 SNVLYETLD--LESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 5e-16
Identities = 20/90 (22%), Positives = 33/90 (36%), Gaps = 4/90 (4%)
Query: 85 LGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144
L++L L N I + + L +LDL N + + + ++ L
Sbjct: 165 AASSDTLEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISL 221
Query: 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
NN L I +L +L+ DL N
Sbjct: 222 RNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 20/104 (19%), Positives = 41/104 (39%), Gaps = 4/104 (3%)
Query: 77 LSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKL 136
L+ V +L + +++ L +NNI+ + ++ L N T G
Sbjct: 87 LNNNYVQELLVGPSIETLHAANNNISR-VSC--SRGQGKKNIYLANNKITMLRDLDEGCR 143
Query: 137 SKLRFLRLNNNSLSG-PIPMSLTNISSLQVLDLSNNRLSGVVPD 179
S++++L L N + + +L+ L+L N + V
Sbjct: 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQ 187
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 20/95 (21%), Positives = 38/95 (40%), Gaps = 8/95 (8%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
L L L+ L+L +N + +L S+ +L N+ + + + +
Sbjct: 73 TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-VS--CSRGQGKKN 124
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGV 176
+ L NN ++ + S +Q LDL N + V
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV 159
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 9e-14
Identities = 21/91 (23%), Positives = 39/91 (42%), Gaps = 4/91 (4%)
Query: 85 LGLLKNLQYLELYSNNITG-PIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143
G +QYL+L N I + +L L+L N + + +KL+ L
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV-FAKLKTLD 197
Query: 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
L++N L+ + + + + + L NN+L
Sbjct: 198 LSSNKLAF-MGPEFQSAAGVTWISLRNNKLV 227
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 16/113 (14%), Positives = 33/113 (29%), Gaps = 5/113 (4%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP 130
+L + V + L+ L+L SN + + + + + + L N I
Sbjct: 175 NLQYNFIYD--VKGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IE 230
Query: 131 DTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSF 183
L L L N + +V ++ + + N
Sbjct: 231 KALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEE 282
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 15/72 (20%), Positives = 26/72 (36%)
Query: 105 IPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQ 164
I N + +S + ++ L L+ N LS L + L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 165 VLDLSNNRLSGV 176
+L+LS+N L
Sbjct: 62 LLNLSSNVLYET 73
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 10/51 (19%), Positives = 24/51 (47%)
Query: 129 IPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179
I + ++ + ++ ++SL + + +++ LDLS N LS +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAA 52
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 7e-05
Identities = 15/131 (11%), Positives = 29/131 (22%), Gaps = 4/131 (3%)
Query: 61 CNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELY-SNNITGPIPSDLGNLTSLVSLD 119
C L +L LK ++ L + T + + N +D
Sbjct: 283 CTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREID 342
Query: 120 LYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVL---DLSNNRLSGV 176
+ I + L +L + + L + L
Sbjct: 343 ALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHA 402
Query: 177 VPDNGSFSLFT 187
+ L
Sbjct: 403 TEEQSPLQLLR 413
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 49/223 (21%), Positives = 88/223 (39%), Gaps = 26/223 (11%)
Query: 280 LGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGEL 338
+G+ F + +D++ K LG+G F V + G A K + ++ +
Sbjct: 13 MGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF 72
Query: 339 Q-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG------SVASCLRERPPSQ 391
Q + E + H N++RL + LV+ + G E S
Sbjct: 73 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH 132
Query: 392 LPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 448
+ L ++Y H + I+HR++K N+LL + + DFGLA
Sbjct: 133 C-------IQQILE---SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179
Query: 449 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIML 491
+ D+ GT G+++PE L S+ D++ G++L
Sbjct: 180 EV--NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 29/219 (13%)
Query: 294 ATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK---EERTPGGELQFQTEVEMISM 349
++ F LG G + VYKG G VA+K +K EE TP ++ E+ ++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR---EISLMKE 59
Query: 350 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLP--LDWPTRKRIALGSA 407
H N++RL T + LV+ +M + + + R P L+ K
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-----DYKDTH--VTTA 460
+GL++ H++ KI+HRD+K N+L+++ + +GDFGLA+ + + VT
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLW 173
Query: 461 VRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQ 498
R AP+ L ++ S D++ G +L E+ITG+
Sbjct: 174 YR------APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 45/212 (21%), Positives = 83/212 (39%), Gaps = 27/212 (12%)
Query: 301 KNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 359
+N +GRG +G+V A K++ + + +F+ E+E++ H N++RL
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD-RFKQEIEIMKSLDHPNIIRLY 72
Query: 360 GFCMTPTERLLVYPYMANG------SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
T+ LV G RE +++ + ++ ++Y
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-----MKDVLS-----AVAYC 122
Query: 414 HDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 470
H + HRD+K N L + + DFGLA + GT +++P
Sbjct: 123 HKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--PGKMMRTKVGTPYYVSP 177
Query: 471 EYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 502
+ L G + D + G+M+ L+ G F
Sbjct: 178 QVLE-GLYGPECDEWSAGVMMYVLLCGYPPFS 208
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 3e-17
Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLK----EERTPGGELQFQTEVEMISMAV 351
+ + +G G +G VYK + G A+K+++ +E P ++ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR---EISILKELK 58
Query: 352 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 411
H N+++L T +LV+ ++ + + L L+ T K L G++
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIA 114
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTH--VTTAVRGT 464
Y HD +++HRD+K N+L++ E E + DFGLA+ + Y TH VT R
Sbjct: 115 YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYR-- 167
Query: 465 IGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQ 498
AP+ L K S D++ G + E++ G
Sbjct: 168 ----APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 57/226 (25%), Positives = 94/226 (41%), Gaps = 43/226 (19%)
Query: 296 DSFSNKNILGRGGFGKVYKGR--LADGSLVAVKRLKEERTPGG-------E---LQFQTE 343
+ +G G +GKV+K R G VA+KR++ + G E L+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR---- 66
Query: 344 VEMISMAVHRNLLRLRGFCMTPTERL-----LVYPYMANGSVASCLRERPPSQLPLDWPT 398
+ H N++RL C LV+ ++ + + + L + P +P T
Sbjct: 67 --HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT--ET 121
Query: 399 RKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL----MDYKD 454
K + RGL +LH H +++HRD+K NIL+ + + DFGLA++ M
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-- 176
Query: 455 TH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQ 498
T VT R APE L + D++ G + E+ +
Sbjct: 177 TSVVVTLWYR------APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 52/219 (23%), Positives = 95/219 (43%), Gaps = 26/219 (11%)
Query: 295 TDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKR-LKEERTPGGELQFQTEVEMISMAVH 352
D F + + G+G FG V G+ G VA+K+ +++ R ELQ ++ +++ H
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---IMQDLAVLHH 78
Query: 353 RNLLRLRGFCMTPTER-------LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALG 405
N+++L+ + T ER +V Y+ ++ C R Q+ K
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 406 SARGLSYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTAV--- 461
R + LH + HRD+K N+L++E + DFG AK + + +V
Sbjct: 138 LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY 196
Query: 462 -RGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQ 498
R APE + + + D++ G + E++ G+
Sbjct: 197 YR------APELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 4e-17
Identities = 30/126 (23%), Positives = 44/126 (34%), Gaps = 7/126 (5%)
Query: 60 TCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLD 119
+C+ D + L+ V Q+ L + L L N I S L L L+
Sbjct: 1 SCSFDGRI--AFYRFCNLTQ--VPQV--LNTTERLLLSFNYIRTVTASSFPFLEQLQLLE 54
Query: 120 LYLNSFTGPI-PDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
L I + L LR L L ++ + P + + L L L LS V
Sbjct: 55 LGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVL 114
Query: 179 DNGSFS 184
+G F
Sbjct: 115 KDGYFR 120
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 1e-14
Identities = 35/161 (21%), Positives = 63/161 (39%), Gaps = 8/161 (4%)
Query: 32 LRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAALSG-QLVSQLGLLKN 90
LR N + + + S P + + + + L L ++ L + +
Sbjct: 369 LRDNALTTIHFIPSI-PDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPH 427
Query: 91 LQYLELYSNNITG-PIPSDLGNLTSLVSLDLYLNSFTGPI-----PDTLGKLSKLRFLRL 144
LQ L L N + SL L L N D LS L+ L L
Sbjct: 428 LQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYL 487
Query: 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSL 185
N+N L+ P +++++L+ L L++NRL+ + ++ +L
Sbjct: 488 NHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANL 528
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 1e-14
Identities = 27/110 (24%), Positives = 44/110 (40%)
Query: 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNS 124
+SV +DL + + LK+L+ L L N I L +L L+L N
Sbjct: 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNL 325
Query: 125 FTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
L K+ ++ L N ++ + + LQ LDL +N L+
Sbjct: 326 LGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 1e-13
Identities = 29/193 (15%), Positives = 56/193 (29%), Gaps = 10/193 (5%)
Query: 10 LILVVHSSWLASANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVT-CNNDNSVI 68
L V W N L + N N + + ++
Sbjct: 186 LYSRVSVDWGKCMNPF--RNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243
Query: 69 RVDLGNAALSGQLVSQLGLLK--NLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFT 126
G + + L ++++L+L + L L L+L N
Sbjct: 244 GAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN 303
Query: 127 GPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLF 186
+ L L+ L L+ N L + + + +DL N ++ + + +F
Sbjct: 304 KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAII--QDQTFKFL 361
Query: 187 TPISFANNLDLCG 199
+ LDL
Sbjct: 362 EKL---QTLDLRD 371
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 31/123 (25%), Positives = 43/123 (34%), Gaps = 11/123 (8%)
Query: 88 LKNLQYLELYSNNITG-PIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLS--KLRFLRL 144
LK L L+L N I + G L SL S+D N L L L F L
Sbjct: 122 LKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSL 181
Query: 145 NNNSLSGPIPMSLTNIS------SLQVLDLSNNRLSGVVPDN--GSFSLFTPISFANNLD 196
NSL + + L++LD+S N + + N + S S
Sbjct: 182 AANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHH 241
Query: 197 LCG 199
+ G
Sbjct: 242 IMG 244
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 47/233 (20%), Positives = 71/233 (30%), Gaps = 24/233 (10%)
Query: 32 LRSNLID--PNNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAALSGQLVSQLGLLK 89
L N + S +P+L + N +L G L
Sbjct: 433 LNQNRFSSCSGDQTPSENPSL----EQLFLGENMLQLAWETELCWDVFEG--------LS 480
Query: 90 NLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSL 149
+LQ L L N + P +LT+L L L N T + L + L L ++ N L
Sbjct: 481 HLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQL 538
Query: 150 SGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGS 209
P P + L VLD+++N+ S F N+ + GP C
Sbjct: 539 LAPNPDVFVS---LSVLDITHNKFICEC----ELSTFINWLNHTNVTIAGPPADIYCVYP 591
Query: 210 PPFSPPPPF-IPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRR 261
FS F + + V LF + +R
Sbjct: 592 DSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGF 644
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 52/216 (24%), Positives = 84/216 (38%), Gaps = 31/216 (14%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHR 353
+ + +G G +G V+K R G +VA+K+ E P + E+ M+ H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
NL+ L LV+ Y + +V L + K I + + +++
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFC 118
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV-----RGTIGHI 468
H H IHRDVK NIL+ + + DFG A+L+ + V R
Sbjct: 119 HKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR------ 169
Query: 469 APEYL------STGKSSEKTDVFGYGIMLLELITGQ 498
+PE L DV+ G + EL++G
Sbjct: 170 SPELLVGDTQYGPP-----VDVWAIGCVFAELLSGV 200
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 52/213 (24%), Positives = 84/213 (39%), Gaps = 29/213 (13%)
Query: 301 KNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVE-MISMAVHRNLLRL 358
LG G F K AVK + + E Q E+ + H N+++L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKL 71
Query: 359 RGFCMTPTERLLVYPYMANGS-----VA-SCLRERPPSQLPLDWPTRKRIALGSARGLSY 412
LV + G E S + RK L SA +S+
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-----MRK---LVSA--VSH 121
Query: 413 LHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 469
+HD ++HRD+K N+L ++ E + DFG A+L + + T T+ + A
Sbjct: 122 MHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAA 177
Query: 470 PEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 502
PE L+ E D++ G++L +++GQ F
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 51/228 (22%), Positives = 82/228 (35%), Gaps = 49/228 (21%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVK-----RLKEERTPGGELQFQTEVEMIS 348
D + LG G F V K R + G A K R K R + EV ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 349 MAVHRNLLRLRGFCMTPTERLLVYPYMANG---------------SVASCLRERPPSQLP 393
H N++ L T+ +L+ +A G L+ Q+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-----QI- 123
Query: 394 LDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKL 449
G+ YLH +I H D+K NI+L + + + DFGLA
Sbjct: 124 -------------LNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 450 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG 497
+D GT +APE ++ + D++ G++ L++G
Sbjct: 168 ID-FGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-17
Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 295 TDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKR-LKEERTPGGELQFQTEVEMISMAVH 352
S+++ ++G G FG VY+ +L D G LVA+K+ L+++R ELQ +++ H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------H 106
Query: 353 RNLLRLRGFCMTPTERL------LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGS 406
N++RLR F + E+ LV Y+ +V R ++ L K
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 407 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAV---- 461
R L+Y+H I HRD+K N+LLD + + + DFG AK + + + +
Sbjct: 166 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRY 221
Query: 462 -RGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQ 498
R APE + + DV+ G +L EL+ GQ
Sbjct: 222 YR------APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 48/217 (22%), Positives = 88/217 (40%), Gaps = 36/217 (16%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVK-------RLKEERTPGGELQFQTEVEM 346
D + LG G G+V VA+K + R L +TE+E+
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 347 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANG------SVASCLRERPPSQLPLDWPTRK 400
+ H +++++ F + +V M G L+E +
Sbjct: 69 LKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQ 122
Query: 401 RIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHV 457
+ + YLH++ IIHRD+K N+LL +E+ + DFG +K++ +T +
Sbjct: 123 MLL-----AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL 172
Query: 458 TTAVRGTIGHIAPEYLSTGKS---SEKTDVFGYGIML 491
+ GT ++APE L + + + D + G++L
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 6e-17
Identities = 59/229 (25%), Positives = 95/229 (41%), Gaps = 45/229 (19%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQF-QT---EVEMISMA 350
+ +G+G FG+V+K R G VA+K++ E G F T E++++ +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLL 73
Query: 351 VHRNLLRLRGFCMTPTERL--------LVYPYMAN---GSVASCLRERPPSQLPLDWPTR 399
H N++ L C T LV+ + + G L + L
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG-----LLSNVLVKFTL--SEI 126
Query: 400 KRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD----- 454
KR+ GL Y+H + KI+HRD+KAAN+L+ + + DFGLA+
Sbjct: 127 KRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 455 --TH--VTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQ 498
T+ VT R PE L + D++G G ++ E+ T
Sbjct: 184 RYTNRVVTLWYR------PPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 51/264 (19%), Positives = 94/264 (35%), Gaps = 68/264 (25%)
Query: 301 KNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVE-MISMAVHR 353
LGRG FG+V + A VAVK LKE T +E++ +I + H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 354 NLLRLRGFCMTPTERLLV-YPYMANGSVASCLRERPPSQLPLDWP--------------- 397
N++ L G C P L+V + G++++ LR + +P
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146
Query: 398 --------------TRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---------- 433
+ + LS + + P+ +++D L+
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206
Query: 434 --------------------DEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEY 472
E+ + DFGLA+ + +V R + +APE
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266
Query: 473 LSTGKSSEKTDVFGYGIMLLELIT 496
+ + ++DV+ +G++L E+ +
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 24/101 (23%), Positives = 41/101 (40%), Gaps = 4/101 (3%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLN--SFTGPIPDTLGKLSKLRFLR 143
G+ + LEL SN + LT L L L N SF G + + L++L
Sbjct: 25 GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84
Query: 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
L+ N + + + + L+ LD ++ L + + F
Sbjct: 85 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFL 123
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 21/119 (17%), Positives = 42/119 (35%), Gaps = 10/119 (8%)
Query: 63 NDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYL 122
+ N + + + G +L+YL+L N + + S+ L L LD
Sbjct: 60 SSNGLSFKGCCSQSDFG--------TTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQH 110
Query: 123 NSFTG-PIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN 180
++ L L +L +++ +SSL+VL ++ N +
Sbjct: 111 SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 169
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 30/99 (30%), Positives = 48/99 (48%), Gaps = 5/99 (5%)
Query: 88 LKNLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSF-TGPIPDTLGKLSKLRFLRLN 145
L+NL YL++ + + L+SL L + NSF +PD +L L FL L+
Sbjct: 125 LRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
L P + ++SSLQVL++S+N + D +
Sbjct: 184 QCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL--DTFPYK 220
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 24/90 (26%), Positives = 38/90 (42%), Gaps = 1/90 (1%)
Query: 88 LKNLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L +L+ L++ N+ D L +L LDL P LS L+ L +++
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 208
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNNRLSGV 176
N+ ++SLQVLD S N +
Sbjct: 209 NNFFSLDTFPYKCLNSLQVLDYSLNHIMTS 238
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 26/103 (25%), Positives = 45/103 (43%), Gaps = 1/103 (0%)
Query: 73 GNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDT 132
GN+ L L+NL +L+L + P+ +L+SL L++ N+F
Sbjct: 159 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 218
Query: 133 LGKLSKLRFLRLNNNSLSGPIPMSLTNI-SSLQVLDLSNNRLS 174
L+ L+ L + N + L + SSL L+L+ N +
Sbjct: 219 YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 14/159 (8%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK---EERTPGGELQFQT--EVEMISM 349
+ + LG G F VYK R +VA+K++K G + E++++
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDG-INRTALREIKLLQE 68
Query: 350 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARG 409
H N++ L + LV+ +M + +++ L L K L + +G
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNS---LVLTPSHIKAYMLMTLQG 124
Query: 410 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448
L YLH H I+HRD+K N+LLDE + DFGLAK
Sbjct: 125 LEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 27/99 (27%), Positives = 38/99 (38%), Gaps = 1/99 (1%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145
GL ++ L+L N IT DL +L L L + D L L L L+
Sbjct: 23 GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
+N LS +SSL+ L+L N + F
Sbjct: 83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFP 120
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 5e-15
Identities = 23/111 (20%), Positives = 42/111 (37%), Gaps = 3/111 (2%)
Query: 88 LKNLQYLELYSNNITGPIP-SDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L NLQ L + + I D LTSL L++ S +L + + L L+
Sbjct: 122 LTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHL 181
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDL 197
+ + + + +SS++ L+L + L+ + S L
Sbjct: 182 SESAFLLEIFADILSSVRYLELRDTNLARF--QFSPLPVDEVSSPMKKLAF 230
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 29/111 (26%), Positives = 44/111 (39%), Gaps = 5/111 (4%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
NLQ L L S+ I +L SL LDL N + G LS L++L L N
Sbjct: 49 CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGN 108
Query: 148 SLSG-PIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDL 197
+ N+++LQ L + N + F ++ N L++
Sbjct: 109 PYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRI----DFAGLTSLNELEI 155
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 23/92 (25%), Positives = 40/92 (43%), Gaps = 6/92 (6%)
Query: 88 LKNLQYLELYSNNIT---GPIPSDLGNLTSLVSLDLYLNSFT--GPIPDTLGKLSKLRFL 142
LK+L++L+L N + + G SL +L L N + L L L L
Sbjct: 333 LKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSL 392
Query: 143 RLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
++ N+ P+P S ++ L+LS+ +
Sbjct: 393 DISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 8e-13
Identities = 19/160 (11%), Positives = 48/160 (30%), Gaps = 6/160 (3%)
Query: 29 LHSLRSNLIDPNNVLQSWD-PTLVNPCTWFHVTCNNDNSVIRVDLGNAALSGQLVSQLGL 87
+ R +++ + + + + N + + + + +L ++
Sbjct: 227 KLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSEL-GKVET 285
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
+ ++ L + + + + L + + + + L L FL L+ N
Sbjct: 286 V-TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSEN 344
Query: 148 SLS---GPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
+ SLQ L LS N L +
Sbjct: 345 LMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILL 384
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 22/122 (18%), Positives = 45/122 (36%), Gaps = 9/122 (7%)
Query: 52 NPCTWFHVTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGN 111
N +C + ++L + + V + + + L+ L++ +NN+
Sbjct: 397 NTFHPMPDSCQWPEKMRFLNLSSTGIR---VVKTCIPQTLEVLDVSNNNLDS-FSL---F 449
Query: 112 LTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNN 171
L L L + N +PD L ++++ N L ++SLQ + L N
Sbjct: 450 LPRLQELYISRNKLKT-LPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
Query: 172 RL 173
Sbjct: 508 PW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 8e-12
Identities = 26/109 (23%), Positives = 41/109 (37%), Gaps = 20/109 (18%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDL---YLNSFTGPIPDTLGKL-------- 136
LKNL L++ N P+P + L+L + IP TL L
Sbjct: 386 LKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLD 444
Query: 137 ------SKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179
+L+ L ++ N L +P + L V+ +S N+L V
Sbjct: 445 SFSLFLPRLQELYISRNKLKT-LP-DASLFPVLLVMKISRNQLKSVPDG 491
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 20/112 (17%), Positives = 42/112 (37%), Gaps = 2/112 (1%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
L +L LE+ + ++ L ++ + L L+L+ + LS +R+L L +
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206
Query: 148 SLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD--NGSFSLFTPISFANNLDL 197
+L+ L + R S + + N L I + ++
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEF 258
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 22/169 (13%), Positives = 54/169 (31%), Gaps = 7/169 (4%)
Query: 27 DALHSLRSNLIDPNNV--LQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAALSGQLVSQ 84
D L S+R + N+ Q + + + + + + +
Sbjct: 193 DILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILE 252
Query: 85 LGLLK----NLQYLELYSNNITGPIPSDLG-NLTSLVSLDLYLNSFTGPIPDTLGKLSKL 139
L ++ L L ++ + + + ++ L + + L K+
Sbjct: 253 LSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKV 312
Query: 140 RFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTP 188
+ + + N+ + ++ SL+ LDLS N + N + P
Sbjct: 313 KRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWP 361
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 14/121 (11%), Positives = 40/121 (33%), Gaps = 8/121 (6%)
Query: 85 LGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144
L ++++ +L L+ + + L+S+ L+L + L ++
Sbjct: 168 LKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK 227
Query: 145 NNNSLS-------GPIPMSLTNISSLQVLDLSNNRLSGVVP-DNGSFSLFTPISFANNLD 196
S + L I L ++ + L+G+ + + + + +
Sbjct: 228 LAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVT 287
Query: 197 L 197
+
Sbjct: 288 I 288
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 22/169 (13%), Positives = 48/169 (28%), Gaps = 47/169 (27%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITG--------------------------- 103
L + + L +L +++YLEL N+
Sbjct: 178 TLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTD 237
Query: 104 -------PIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR--------LNNNS 148
+ + L+ + D LN P +S+L + +
Sbjct: 238 ESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFY 297
Query: 149 LSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDL 197
L + + + ++ + + N+++ V + F LDL
Sbjct: 298 LFYDLSTVYSLLEKVKRITVENSKVFLV--PCSFSQHLKSLEF---LDL 341
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 33/110 (30%), Positives = 47/110 (42%), Gaps = 3/110 (2%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145
GL +L L L N IT + L L +L L L NS + +L LR L LN
Sbjct: 189 GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 248
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNL 195
NN L +P L + +QV+ L NN +S + + F + +
Sbjct: 249 NNKLVK-VPGGLADHKYIQVVYLHNNNISAI--GSNDFCPPGYNTKKASY 295
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 37/114 (32%), Positives = 49/114 (42%), Gaps = 11/114 (9%)
Query: 63 NDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYL 122
N + + N A G +K L Y+ + NIT IP L SL L L
Sbjct: 153 GTNPLKSSGIENGAFQG--------MKKLSYIRIADTNITT-IPQGL--PPSLTELHLDG 201
Query: 123 NSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGV 176
N T +L L+ L L L+ NS+S SL N L+ L L+NN+L V
Sbjct: 202 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV 255
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 18/99 (18%), Positives = 38/99 (38%), Gaps = 7/99 (7%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
L L+ L L N + +P + +L L ++ N T L+++ + L N
Sbjct: 99 LVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN 155
Query: 148 SL-SGPIP-MSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
L S I + + L + +++ ++ + G
Sbjct: 156 PLKSSGIENGAFQGMKKLSYIRIADTNITTI--PQGLPP 192
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 25/103 (24%), Positives = 39/103 (37%), Gaps = 7/103 (6%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
L NL L L N+I+ L N L L L N +P L ++ + L+NN
Sbjct: 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNN 273
Query: 148 SLSG------PIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
++S P T +S + L +N + +F
Sbjct: 274 NISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 28/99 (28%), Positives = 42/99 (42%), Gaps = 5/99 (5%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145
L + L+L +N IT D NL +L +L L N + P L KL L L+
Sbjct: 49 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
N L +P + +LQ L + N ++ V F+
Sbjct: 109 KNQLKE-LPEKM--PKTLQELRVHENEITKV--RKSVFN 142
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 26/97 (26%), Positives = 43/97 (44%), Gaps = 3/97 (3%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
LKNL L L +N I+ P L L L L N +P+ + L+ LR++ N
Sbjct: 75 LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHEN 131
Query: 148 SLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
++ ++ + V++L N L +NG+F
Sbjct: 132 EITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 16/93 (17%), Positives = 34/93 (36%), Gaps = 9/93 (9%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTG------PIPDTLGKLSKLRF 141
+L+ L L +N + +P L + + + L+ N+ + P K +
Sbjct: 239 TPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSG 297
Query: 142 LRLNNNSLS-GPIPMSL-TNISSLQVLDLSNNR 172
+ L +N + I S + + L N +
Sbjct: 298 VSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 38/225 (16%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQT--EVEMISMAVHRNLLRLRG 360
LG G FGKV VA+K + + ++ + E+ + + H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 361 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR--------GLSY 412
TPT+ ++V Y A G + + E+ KR+ R + Y
Sbjct: 77 VITTPTDIVMVIEY-AGGELFDYIVEK------------KRMTEDEGRRFFQQIICAIEY 123
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 472
H H KI+HRD+K N+LLD+ + DFGL+ +M + T+ G+ + APE
Sbjct: 124 CHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTSC-GSPNYAAPEV 178
Query: 473 LSTGKSSE--KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 515
++ GK + DV+ GI+L ++ G+ FD D+ + L
Sbjct: 179 IN-GKLYAGPEVDVWSCGIVLYVMLVGRLPFD------DEFIPNL 216
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 56/246 (22%), Positives = 93/246 (37%), Gaps = 39/246 (15%)
Query: 276 PEVHLGQLKRFSLRELQVAT--DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK--- 329
E S+ AT D + LG G +G+VYK VA+KR++
Sbjct: 12 LEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH 71
Query: 330 -EERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 388
EE PG ++ EV ++ HRN++ L+ L++ Y N + + + P
Sbjct: 72 EEEGVPGTAIR---EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP 127
Query: 389 PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVG-----D 443
+ K G+++ H + +HRD+K N+LL + D
Sbjct: 128 D----VSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGD 180
Query: 444 FGLAKLM-----DYKDTH--VTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELI 495
FGLA+ + TH +T R PE L + S D++ + E++
Sbjct: 181 FGLARAFGIPIRQF--THEIITLWYR------PPEILLGSRHYSTSVDIWSIACIWAEML 232
Query: 496 TGQRAF 501
F
Sbjct: 233 MKTPLF 238
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 3e-16
Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRG 360
LG G FGKV G+ G VAVK L ++ + + + E++ + + H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 361 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR--------GLSY 412
TP++ +V Y++ G + + + R+ +R G+ Y
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKN------------GRLDEKESRRLFQQILSGVDY 131
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 472
H H ++HRD+K N+LLD A + DFGL+ +M + T+ G+ + APE
Sbjct: 132 CHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTSC-GSPNYAAPEV 186
Query: 473 LSTGKSSE--KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 515
+S G+ + D++ G++L L+ G FD DD V L
Sbjct: 187 IS-GRLYAGPEVDIWSSGVILYALLCGTLPFD------DDHVPTL 224
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 29/100 (29%), Positives = 44/100 (44%), Gaps = 5/100 (5%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145
+ L L+L NN+T L N LV +DL N + K+ +L L ++
Sbjct: 223 PVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 280
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSL 185
NN L + + I +L+VLDLS+N L V +
Sbjct: 281 NNRLVA-LNLYGQPIPTLKVLDLSHNHLLHV--ERNQPQF 317
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 27/129 (20%), Positives = 41/129 (31%), Gaps = 5/129 (3%)
Query: 69 RVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGP 128
V N+ + + L + ++ L L I ++ L + N+
Sbjct: 49 IVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYL 108
Query: 129 IPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTP 188
P + L L L N LS N L L +SNN L + D F
Sbjct: 109 PPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDD-----TFQA 163
Query: 189 ISFANNLDL 197
+ NL L
Sbjct: 164 TTSLQNLQL 172
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 17/113 (15%), Positives = 40/113 (35%), Gaps = 4/113 (3%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
+ L L ++L N + + + L L + N + + L+
Sbjct: 241 TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKV 299
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANN 194
L L++N L + + L+ L L +N + + + ++ ++N
Sbjct: 300 LDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTL--KLSTHHTLKNLTLSHN 349
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 19/87 (21%), Positives = 39/87 (44%), Gaps = 5/87 (5%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
++ L+ L + +N + + + +L LDL N + + +L L L++N
Sbjct: 271 MQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHN 328
Query: 148 SLSGPIPMSLTNISSLQVLDLSNNRLS 174
S+ + L+ +L+ L LS+N
Sbjct: 329 SIV---TLKLSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 24/98 (24%), Positives = 40/98 (40%), Gaps = 5/98 (5%)
Query: 77 LSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKL 136
+S L+S L + ++ L+ N+I + + L L L N+ T L
Sbjct: 193 VSYNLLSTLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNLTDT--AWLLNY 247
Query: 137 SKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
L + L+ N L + + L+ L +SNNRL
Sbjct: 248 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 26/99 (26%), Positives = 42/99 (42%), Gaps = 11/99 (11%)
Query: 88 LKNLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L L + +NN+ I D TSL +L L N T + L + L ++
Sbjct: 140 TPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLTH-VD--LSLIPSLFHANVSY 195
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSL 185
N LS +L +++ LD S+N ++ VV + L
Sbjct: 196 NLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNVEL 228
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 23/101 (22%), Positives = 40/101 (39%), Gaps = 12/101 (11%)
Query: 84 QLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143
L L+ +L + + N ++ L ++ LD NS + + +L L+
Sbjct: 181 DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPV--NVELTILK 232
Query: 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
L +N+L+ L N L +DLS N L + F
Sbjct: 233 LQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKI--MYHPFV 269
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 21/87 (24%), Positives = 39/87 (44%), Gaps = 11/87 (12%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
+LQ L+L SN +T + L + SL ++ N + TL + L ++N
Sbjct: 164 TTSLQNLQLSSNRLTH-VD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHN 215
Query: 148 SLSGPIPMSLTNISSLQVLDLSNNRLS 174
S++ + + L +L L +N L+
Sbjct: 216 SINV-VRGPVN--VELTILKLQHNNLT 239
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 11/102 (10%), Positives = 32/102 (31%), Gaps = 4/102 (3%)
Query: 85 LGLLKNLQYLELYSNNITGPIPSDL--GNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFL 142
L + + +++ + T + L + + ++ L ++ L
Sbjct: 15 SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELL 74
Query: 143 RLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
LN+ + + ++Q L + N + + F
Sbjct: 75 NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYL--PPHVFQ 114
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 10/80 (12%), Positives = 33/80 (41%), Gaps = 2/80 (2%)
Query: 105 IPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQ 164
I S+L + + + + L+ + + N+++ L + ++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 165 VLDLSNNRLSGVVPDNGSFS 184
+L+L++ ++ + D +F+
Sbjct: 73 LLNLNDLQIEEI--DTYAFA 90
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 52/222 (23%), Positives = 80/222 (36%), Gaps = 46/222 (20%)
Query: 294 ATDSFS---------NKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTE 343
+TDSFS +++LG G +V L AVK ++++ + E
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS-RVFRE 60
Query: 344 VE-MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS------CLRERPPSQLPLDW 396
VE + HRN+L L F LV+ M GS+ S E S +
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV---- 116
Query: 397 PTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYK 453
+ + SA L +LH+ I HRD+K NIL ++ + DF L +
Sbjct: 117 -VQD---VASA--LDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 454 DTHV-------TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG 488
T G+ ++APE + Y
Sbjct: 168 GDCSPISTPELLTPC-GSAEYMAPEVVEAFSEEAS----IYD 204
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 50/208 (24%), Positives = 84/208 (40%), Gaps = 29/208 (13%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRL-KEERTPGGELQFQTEVE-MISMAVHRNLLRLRG 360
LGRG F V + + G A K L K R + E+ + ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 361 FCMTPTERLLVYPYMANG--------SVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 412
+E +L+ Y A G +A + E +L + L G+ Y
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL-------IKQILE---GVYY 146
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAV---VGDFGLAKLMDYKDTHVTTAVRGTIGHIA 469
LH + I+H D+K NILL + + DFG+++ + + + GT ++A
Sbjct: 147 LHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREIM-GTPEYLA 201
Query: 470 PEYLSTGKSSEKTDVFGYGIMLLELITG 497
PE L+ + TD++ GI+ L+T
Sbjct: 202 PEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 5e-16
Identities = 29/100 (29%), Positives = 44/100 (44%), Gaps = 5/100 (5%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145
+ L L+L NN+T L N LV +DL N + K+ +L L ++
Sbjct: 229 PVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 286
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSL 185
NN L + + I +L+VLDLS+N L V +
Sbjct: 287 NNRLVA-LNLYGQPIPTLKVLDLSHNHLLHV--ERNQPQF 323
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 17/113 (15%), Positives = 40/113 (35%), Gaps = 4/113 (3%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
+ L L ++L N + + + L L + N + + L+
Sbjct: 247 TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKV 305
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANN 194
L L++N L + + L+ L L +N + + + ++ ++N
Sbjct: 306 LDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTL--KLSTHHTLKNLTLSHN 355
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 2e-13
Identities = 28/133 (21%), Positives = 43/133 (32%), Gaps = 5/133 (3%)
Query: 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNS 124
N+ V N+ + + L + ++ L L I ++ L + N+
Sbjct: 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA 110
Query: 125 FTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
P + L L L N LS N L L +SNN L + D
Sbjct: 111 IRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDD----- 165
Query: 185 LFTPISFANNLDL 197
F + NL L
Sbjct: 166 TFQATTSLQNLQL 178
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 3e-13
Identities = 19/87 (21%), Positives = 39/87 (44%), Gaps = 5/87 (5%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
++ L+ L + +N + + + +L LDL N + + +L L L++N
Sbjct: 277 MQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHN 334
Query: 148 SLSGPIPMSLTNISSLQVLDLSNNRLS 174
S+ + L+ +L+ L LS+N
Sbjct: 335 SIV---TLKLSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 6e-12
Identities = 24/98 (24%), Positives = 40/98 (40%), Gaps = 5/98 (5%)
Query: 77 LSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKL 136
+S L+S L + ++ L+ N+I + + L L L N+ T L
Sbjct: 199 VSYNLLSTLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNLTDT--AWLLNY 253
Query: 137 SKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
L + L+ N L + + L+ L +SNNRL
Sbjct: 254 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 24/93 (25%), Positives = 39/93 (41%), Gaps = 10/93 (10%)
Query: 88 LKNLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L L + +NN+ I D TSL +L L N T + L + L ++
Sbjct: 146 TPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLTH-VD--LSLIPSLFHANVSY 201
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179
N LS +L +++ LD S+N ++ V
Sbjct: 202 NLLS-----TLAIPIAVEELDASHNSINVVRGP 229
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 23/101 (22%), Positives = 39/101 (38%), Gaps = 12/101 (11%)
Query: 84 QLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143
L L+ +L + + N ++ L ++ LD NS + +L L+
Sbjct: 187 DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRG--PVNVELTILK 238
Query: 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
L +N+L+ L N L +DLS N L + F
Sbjct: 239 LQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKI--MYHPFV 275
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 21/87 (24%), Positives = 39/87 (44%), Gaps = 11/87 (12%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
+LQ L+L SN +T + L + SL ++ N + TL + L ++N
Sbjct: 170 TTSLQNLQLSSNRLTH-VD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHN 221
Query: 148 SLSGPIPMSLTNISSLQVLDLSNNRLS 174
S++ + + L +L L +N L+
Sbjct: 222 SINV-VRGPVN--VELTILKLQHNNLT 245
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 11/97 (11%), Positives = 32/97 (32%), Gaps = 2/97 (2%)
Query: 85 LGLLKNLQYLELYSNNITGPIPSDL--GNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFL 142
L + + +++ + T + L + + ++ L ++ L
Sbjct: 21 SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELL 80
Query: 143 RLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179
LN+ + + ++Q L + N + + P
Sbjct: 81 NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH 117
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 10/80 (12%), Positives = 33/80 (41%), Gaps = 2/80 (2%)
Query: 105 IPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQ 164
I S+L + + + + L+ + + N+++ L + ++
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78
Query: 165 VLDLSNNRLSGVVPDNGSFS 184
+L+L++ ++ + D +F+
Sbjct: 79 LLNLNDLQIEEI--DTYAFA 96
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 50/214 (23%), Positives = 92/214 (42%), Gaps = 28/214 (13%)
Query: 304 LGRGGFGKVYKGR---LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG 360
+GRG +G VYK + D A+K+++ + E+ ++ H N++ L+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR---EIALLRELKHPNVISLQK 85
Query: 361 FCMTPTERL--LVYPYMAN------GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 412
++ +R L++ Y + + + P QLP K + G+ Y
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR--GMVKSLLYQILDGIHY 143
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAV----VGDFGLAKLMDY---KDTHVTTAVRGTI 465
LH + ++HRD+K ANIL+ E + D G A+L + + V T
Sbjct: 144 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 199
Query: 466 GHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQ 498
+ APE L + ++ D++ G + EL+T +
Sbjct: 200 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 31/110 (28%), Positives = 41/110 (37%), Gaps = 3/110 (2%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145
L + L L L N I DL + L L L N +L L LR L L+
Sbjct: 190 DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLD 249
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNL 195
NN LS +P L ++ LQV+ L N ++ V F
Sbjct: 250 NNKLSR-VPAGLPDLKLLQVVYLHTNNITKV--GVNDFCPVGFGVKRAYY 296
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 30/87 (34%), Positives = 42/87 (48%), Gaps = 3/87 (3%)
Query: 90 NLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSL 149
L YL + +TG IP DL +L L L N + L + SKL L L +N +
Sbjct: 173 KLNYLRISEAKLTG-IPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQI 229
Query: 150 SGPIPMSLTNISSLQVLDLSNNRLSGV 176
SL+ + +L+ L L NN+LS V
Sbjct: 230 RMIENGSLSFLPTLRELHLDNNKLSRV 256
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 29/99 (29%), Positives = 44/99 (44%), Gaps = 5/99 (5%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145
+ + L+L +N+I+ D L L +L L N + L KL+ L ++
Sbjct: 51 EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
N L IP +L SSL L + +NR+ V G FS
Sbjct: 111 KNHLVE-IPPNL--PSSLVELRIHDNRIRKV--PKGVFS 144
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 23/98 (23%), Positives = 41/98 (41%), Gaps = 5/98 (5%)
Query: 88 LKNLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L++L L L +N I+ I L L L + N IP L S L LR+++
Sbjct: 77 LQHLYALVLVNNKISK-IHEKAFSPLRKLQKLYISKNHLVE-IPPNL--PSSLVELRIHD 132
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
N + + + ++ +++ N L + G+F
Sbjct: 133 NRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 25/119 (21%), Positives = 40/119 (33%), Gaps = 16/119 (13%)
Query: 88 LKNLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L L L N I I + L L +L L L N + +P L L L+ + L+
Sbjct: 216 YSKLYRLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHT 273
Query: 147 NSLSGPIP-------MSLTNISSLQVLDLSNNRLSGVVPDNGSF----SLFTPISFANN 194
N+++ + + + L NN + +F I F N
Sbjct: 274 NNITK-VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLA-IQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 22/93 (23%), Positives = 39/93 (41%), Gaps = 4/93 (4%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
L+ LQ L + N++ IP +L +SLV L ++ N L + + + N
Sbjct: 101 LRKLQKLYISKNHLVE-IPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGN 157
Query: 148 SL-SGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179
L + + L L +S +L+G+ D
Sbjct: 158 PLENSGFEPGAFDGLKLNYLRISEAKLTGIPKD 190
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 18/94 (19%), Positives = 37/94 (39%), Gaps = 11/94 (11%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDT-------LGKLSKLR 140
L L+ L L +N ++ +P+ L +L L + L+ N+ T + K +
Sbjct: 240 LPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNITK-VGVNDFCPVGFGVKRAYYN 297
Query: 141 FLRLNNNSLSGPI--PMSLTNISSLQVLDLSNNR 172
+ L NN + P + ++ + N +
Sbjct: 298 GISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 8e-16
Identities = 41/226 (18%), Positives = 84/226 (37%), Gaps = 45/226 (19%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 353
+ + LGRG FG V++ + K +K ++ + E+ ++++A HR
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHR 61
Query: 354 NLLRLRGFCMTPTERLLVYPYMANG----------------SVASCLRERPPSQLPLDWP 397
N+L L + E ++++ +++ + S + Q+
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH-----QV----- 111
Query: 398 TRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDT 455
L +LH H I H D++ NI+ + + +FG A+ +
Sbjct: 112 ---------CEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGD 158
Query: 456 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
+ + APE S TD++ G ++ L++G F
Sbjct: 159 NFRLLF-TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF 203
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 56/241 (23%), Positives = 90/241 (37%), Gaps = 56/241 (23%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLK---------EERTPGGELQFQTEVE 345
D F LG G FG+V + + G+ A+K L E T E
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-------LNEKR 93
Query: 346 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALG 405
++ L++L + +V Y+A G + S LR R +
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI------------GRFSEP 141
Query: 406 SAR--------GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457
AR YLH +I+RD+K N+L+D++ V DFG AK +
Sbjct: 142 HARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGR 194
Query: 458 TTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 514
T + GT +APE + + K+ D + G+++ E+ G F D +
Sbjct: 195 TWTLCGTPEALAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPPFF------ADQPIQ 245
Query: 515 L 515
+
Sbjct: 246 I 246
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 2e-15
Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 44/240 (18%)
Query: 292 QVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVEMISMA 350
++ F+ +LG+G FGKV L AVK LK++ + +VE
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKD-----VVIQDDDVE--CTM 389
Query: 351 VHRNLLRLRG---------FCMTPTERL-LVYPYMANGSVASCL-RERPPSQLPLDWPTR 399
V + +L L G C +RL V Y+ G + + + +
Sbjct: 390 VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG---RFKEP---H 443
Query: 400 KR-----IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYK 453
IA+G L +L II+RD+K N++LD E + DFG+ K +
Sbjct: 444 AVFYAAEIAIG----LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496
Query: 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 513
T T GT +IAPE ++ + D + +G++L E++ GQ F+ D+D +
Sbjct: 497 VT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE----GEDEDEL 550
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 68/256 (26%), Positives = 107/256 (41%), Gaps = 36/256 (14%)
Query: 269 DVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKR 327
D E+ EV L + K +V + F +LG+G FGKV + G A+K
Sbjct: 127 DNSGAEEMEVSLAKPKH------RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI 180
Query: 328 LKEERTPGGELQFQTEVE--MISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCL 384
LK+E + T E ++ + H L L+ + +RL V Y G + L
Sbjct: 181 LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHL 239
Query: 385 -RERPPSQLPLDWPTRKR-----IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE 438
RER D R R I L YLH + +++RD+K N++LD++
Sbjct: 240 SRER---VFSED---RARFYGAEIVSA----LDYLHSEKN--VVYRDLKLENLMLDKDGH 287
Query: 439 AVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG 497
+ DFGL K + T GT ++APE L D +G G+++ E++ G
Sbjct: 288 IKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345
Query: 498 QRAFDLARLANDDDVM 513
+ F D + +
Sbjct: 346 RLPFY----NQDHEKL 357
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 47/236 (19%), Positives = 86/236 (36%), Gaps = 46/236 (19%)
Query: 279 HLGQLKRFSLRELQVATDSFSN-----KNILGRGGFGKVYKGR-LADGSLVAVKRL-KEE 331
H + + + ++ K +LG G GKV + G A+K L
Sbjct: 7 HHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP 66
Query: 332 RTPGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTER----LLVYPYMANGS------- 379
+ + EV+ + +++ + L++ M G
Sbjct: 67 K-------ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQE 119
Query: 380 -VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DE 435
ER +++ R +G+A + +LH H I HRDVK N+L ++
Sbjct: 120 RGDQAFTEREAAEI-----MRD---IGTA--IQFLHSH---NIAHRDVKPENLLYTSKEK 166
Query: 436 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIML 491
+ + DFG AK + T T ++APE L K + D++ G+++
Sbjct: 167 DAVLKLTDFGFAKETT--QNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 7/110 (6%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
L NL+YL L NI +P +L L L L++ N F P + LS L+ L + N+
Sbjct: 195 LFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNS 252
Query: 148 SLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDL 197
+S + ++SL L+L++N LS + D LFTP+ + L L
Sbjct: 253 QVSLIERNAFDGLASLVELNLAHNNLSSLPHD-----LFTPLRYLVELHL 297
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 27/99 (27%), Positives = 41/99 (41%), Gaps = 2/99 (2%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145
G+ N +YL L NNI +L L L L NS L+ L L L
Sbjct: 72 GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
+N L+ + +S L+ L L NN + + + +F+
Sbjct: 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESI--PSYAFN 168
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 22/91 (24%), Positives = 35/91 (38%), Gaps = 3/91 (3%)
Query: 88 LKNLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL-N 145
L +L LEL+ N +T IPS L+ L L L N ++ L L L
Sbjct: 122 LASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGE 180
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGV 176
L + + +L+ L+L + +
Sbjct: 181 LKKLEYISEGAFEGLFNLKYLNLGMCNIKDM 211
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 23/90 (25%), Positives = 37/90 (41%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
+ L L L+ LE+ N+ P L+SL L + + + + L+ L
Sbjct: 211 MPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVE 270
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNN 171
L L +N+LS T + L L L +N
Sbjct: 271 LNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 30/98 (30%), Positives = 43/98 (43%), Gaps = 3/98 (3%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
L +L+ L+L N+I L SL +L+L+ N T LSKLR L L NN
Sbjct: 98 LHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNN 157
Query: 148 SLSGPIPMSLTNISSLQVLDLS-NNRLSGVVPDNGSFS 184
+ + + SL LDL +L + G+F
Sbjct: 158 PIESIPSYAFNRVPSLMRLDLGELKKLEYI--SEGAFE 193
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 20/95 (21%), Positives = 40/95 (42%), Gaps = 5/95 (5%)
Query: 90 NLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSL 149
+ ++ +P + ++ L+L N+ DT L L L+L NS+
Sbjct: 55 QFSKVVCTRRGLSE-VPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 150 SGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
+ ++SL L+L +N L+ + +G+F
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLTVI--PSGAFE 144
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 16/62 (25%), Positives = 29/62 (46%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
L +L+ L + ++ ++ + L SLV L+L N+ + D L L L L++N
Sbjct: 241 LSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
Query: 148 SL 149
Sbjct: 301 PW 302
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 42/214 (19%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAV----KRLKEERTPGGELQFQTEVEMISM 349
+D F ++ LGRG VY+ + A+ K + ++ +TE+ ++
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI-------VRTEIGVLLR 104
Query: 350 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK-----RIAL 404
H N+++L+ TPTE LV + G + D K R A
Sbjct: 105 LSHPNIIKLKEIFETPTEISLVLELVTGGEL-------------FDRIVEKGYYSERDAA 151
Query: 405 GSAR----GLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHV 457
+ + ++YLH++ I+HRD+K N+L + + DFGL+K+++++
Sbjct: 152 DAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208
Query: 458 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIML 491
T GT G+ APE L + D++ GI+
Sbjct: 209 TVC--GTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 70/266 (26%), Positives = 108/266 (40%), Gaps = 34/266 (12%)
Query: 261 RKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRL-AD 319
+PQE P Q+ F ++G+G FGKV R A+
Sbjct: 3 SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAE 62
Query: 320 GSLVAVKRLKEERTPGGELQFQTEVE---MISMAVHRNLLRLRGFCMTPTERL-LVYPYM 375
AVK L+++ + + E ++ H L+ L F ++L V Y+
Sbjct: 63 EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYI 121
Query: 376 ANGSVASCL-RERPPSQLPLDWPTRKR-----IALGSARGLSYLHDHCDPKIIHRDVKAA 429
G + L RER R R IA L YLH I++RD+K
Sbjct: 122 NGGELFYHLQRER---CFLEP---RARFYAAEIASA----LGYLHSL---NIVYRDLKPE 168
Query: 430 NILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT-DVFGY 487
NILLD + V+ DFGL K +++ T T+ GT ++APE L + ++T D +
Sbjct: 169 NILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLAPEVL-HKQPYDRTVDWWCL 225
Query: 488 GIMLLELITGQRAFDLARLANDDDVM 513
G +L E++ G F + + M
Sbjct: 226 GAVLYEMLYGLPPFY----SRNTAEM 247
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 66/275 (24%), Positives = 112/275 (40%), Gaps = 40/275 (14%)
Query: 261 RKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKN------------ILGRGG 308
+D+P E+ + + T + ++GRG
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGS 64
Query: 309 FGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVE---MISMAVHRNLLRLRGFCMT 364
+ KV RL + A++ +K+E E + E + H L+ L C
Sbjct: 65 YAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQ 123
Query: 365 PTERL-LVYPYMANGSVASCL-RERPPSQLPLDWPTRKR-----IALGSARGLSYLHDHC 417
RL V Y+ G + + R+R +LP + R I+L L+YLH+
Sbjct: 124 TESRLFFVIEYVNGGDLMFHMQRQR---KLPEE---HARFYSAEISLA----LNYLHER- 172
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTG 476
II+RD+K N+LLD E + D+G+ K + DT T+ GT +IAPE L
Sbjct: 173 --GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGE 228
Query: 477 KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDD 511
D + G+++ E++ G+ FD+ +++ D
Sbjct: 229 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 29/111 (26%), Positives = 44/111 (39%), Gaps = 7/111 (6%)
Query: 88 LKNLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L LQYL L N + +P D +L +L L L+ N + L L L L+
Sbjct: 128 LAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDL 197
N ++ P + ++ L L L N LS + + P+ L L
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLSALPTE-----ALAPLRALQYLRL 232
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 24/98 (24%), Positives = 39/98 (39%), Gaps = 3/98 (3%)
Query: 88 LKNLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L L+ L+L N + L L +L L P L+ L++L L +
Sbjct: 79 LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQD 138
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
N+L + ++ +L L L NR+S V +F
Sbjct: 139 NALQALPDDTFRDLGNLTHLFLHGNRISSVPE--RAFR 174
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 24/126 (19%), Positives = 41/126 (32%), Gaps = 7/126 (5%)
Query: 60 TCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLD 119
C N+ + L V G+ Q + L+ N I+ + +L L
Sbjct: 7 VCYNEPK-VTTSCPQQGLQA--VPV-GIPAASQRIFLHGNRISHVPAASFRACRNLTILW 62
Query: 120 LYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIP-MSLTNISSLQVLDLSNNRLSGVVP 178
L+ N L+ L L L++N+ + + + L L L L +
Sbjct: 63 LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQEL-- 120
Query: 179 DNGSFS 184
G F
Sbjct: 121 GPGLFR 126
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 27/84 (32%), Positives = 38/84 (45%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
L NL +L L+ N I+ L SL L L+ N P L +L L L N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 148 SLSGPIPMSLTNISSLQVLDLSNN 171
+LS +L + +LQ L L++N
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 18/63 (28%), Positives = 32/63 (50%), Gaps = 2/63 (3%)
Query: 88 LKNLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L +L L L+ N + + +L L++L L+ N+ + + L L L++LRLN+
Sbjct: 176 LHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLND 234
Query: 147 NSL 149
N
Sbjct: 235 NPW 237
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 9e-15
Identities = 32/110 (29%), Positives = 51/110 (46%), Gaps = 7/110 (6%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
L NL+YL L N+ IP +L L L LDL N + P + L L+ L + +
Sbjct: 184 LSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS 241
Query: 148 SLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDL 197
+ + N+ SL ++L++N L+ + D LFTP+ + L
Sbjct: 242 QIQVIERNAFDNLQSLVEINLAHNNLTLLPHD-----LFTPLHHLERIHL 286
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 29/124 (23%), Positives = 47/124 (37%), Gaps = 5/124 (4%)
Query: 61 CNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDL 120
C+ N +V L V G+ N + L L+ N I + +L L L L
Sbjct: 39 CSCSNQFSKVICVRKNLRE--VPD-GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQL 95
Query: 121 YLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN 180
N L+ L L L +N L+ + +S L+ L L NN + + +
Sbjct: 96 SRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESI--PS 153
Query: 181 GSFS 184
+F+
Sbjct: 154 YAFN 157
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 26/91 (28%), Positives = 39/91 (42%), Gaps = 3/91 (3%)
Query: 88 LKNLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL-N 145
L NL LEL+ N +T IP+ L+ L L L N ++ LR L L
Sbjct: 111 LANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGE 169
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGV 176
LS + +S+L+ L+L+ L +
Sbjct: 170 LKRLSYISEGAFEGLSNLRYLNLAMCNLREI 200
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 35/138 (25%), Positives = 55/138 (39%), Gaps = 13/138 (9%)
Query: 58 HVTCNN----------DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPS 107
V C + ++L + V+ L++L+ L+L N+I
Sbjct: 47 KVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIG 106
Query: 108 DLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLD 167
L +L +L+L+ N T LSKL+ L L NN + + I SL+ LD
Sbjct: 107 AFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLD 166
Query: 168 LS-NNRLSGVVPDNGSFS 184
L RLS + G+F
Sbjct: 167 LGELKRLSYI--SEGAFE 182
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 18/84 (21%), Positives = 33/84 (39%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
L L L+L N+++ P L L L + + + L L + L +N
Sbjct: 206 LIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHN 265
Query: 148 SLSGPIPMSLTNISSLQVLDLSNN 171
+L+ T + L+ + L +N
Sbjct: 266 NLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 18/62 (29%), Positives = 28/62 (45%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
L +LQ L + + I + NL SLV ++L N+ T D L L + L++N
Sbjct: 230 LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
Query: 148 SL 149
Sbjct: 290 PW 291
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 9e-15
Identities = 67/245 (27%), Positives = 99/245 (40%), Gaps = 56/245 (22%)
Query: 292 QVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLK---------EERTPGGELQFQ 341
+ + F LG G FG+V+ R G A+K LK E T
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-------N 54
Query: 342 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKR 401
E M+S+ H ++R+ G + ++ Y+ G + S LR+ +R
Sbjct: 55 DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS------------QR 102
Query: 402 IALGSAR--------GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453
A+ L YLH II+RD+K NILLD+ + DFG AK
Sbjct: 103 FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAK----Y 155
Query: 454 DTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD 510
VT + GT +IAPE +ST KS D + +GI++ E++ G F D
Sbjct: 156 VPDVTYTLCGTPDYIAPEVVSTKPYNKS---IDWWSFGILIYEMLAGYTPFY------DS 206
Query: 511 DVMLL 515
+ M
Sbjct: 207 NTMKT 211
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 9e-15
Identities = 62/241 (25%), Positives = 98/241 (40%), Gaps = 47/241 (19%)
Query: 292 QVATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKE---------ERTPGGELQFQ 341
+V + F +LG+G FGKV R A G A+K L++ T
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-------V 53
Query: 342 TEVEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCL-RERPPSQLPLDWPTR 399
TE ++ H L L+ + +RL V Y G + L RER + R
Sbjct: 54 TESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEE---R 106
Query: 400 KR-----IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYK 453
R I L YLH +++RD+K N++LD++ + DFGL K +
Sbjct: 107 ARFYGAEIVSA----LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159
Query: 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKT-DVFGYGIMLLELITGQRAFDLARLANDDDV 512
T GT ++APE L + D +G G+++ E++ G+ F D +
Sbjct: 160 AT--MKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFY----NQDHER 212
Query: 513 M 513
+
Sbjct: 213 L 213
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 29/111 (26%), Positives = 42/111 (37%), Gaps = 4/111 (3%)
Query: 88 LKNLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L NL L L N++ I S+ + +L LDL N L L L L N
Sbjct: 63 LTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYN 121
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDL 197
N + + +++ LQ L LS N++S + LDL
Sbjct: 122 NHIVVVDRNAFEDMAQLQKLYLSQNQISRFPV--ELIKDGNKLPKLMLLDL 170
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 27/101 (26%), Positives = 46/101 (45%), Gaps = 5/101 (4%)
Query: 86 GLLKNLQYLELYSNNITGPIPSD--LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143
L L+L NN++ + ++ LT+L SL L N + + LR+L
Sbjct: 36 SLPSYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLD 94
Query: 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
L++N L +++ +L+VL L NN + V D +F
Sbjct: 95 LSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVV--DRNAFE 133
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 6e-09
Identities = 25/92 (27%), Positives = 39/92 (42%), Gaps = 7/92 (7%)
Query: 88 LKNLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSFTGPIPDT---LGKLSKLRFLR 143
L+ L+ L LY+N+I + + ++ L L L N + + KL KL L
Sbjct: 111 LQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLD 169
Query: 144 LNNNSLSGPIPMSLTNISSLQV--LDLSNNRL 173
L++N L L + + L L NN L
Sbjct: 170 LSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 23/96 (23%), Positives = 40/96 (41%), Gaps = 6/96 (6%)
Query: 90 NLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDT-LGKLSKLRFLRLNNNS 148
L + +P L + LDL N+ + + +L+ L L L++N
Sbjct: 19 ASNILSCSKQQLPN-VPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH 75
Query: 149 LSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
L+ + + +L+ LDLS+N L + D FS
Sbjct: 76 LNFISSEAFVPVPNLRYLDLSSNHLHTL--DEFLFS 109
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 60/234 (25%), Positives = 96/234 (41%), Gaps = 32/234 (13%)
Query: 292 QVATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVE-MISM 349
++ + F +LG+G FGKV+ A+K LK++ + T VE +
Sbjct: 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 72
Query: 350 AVHRN--LLRLRGFCMTPTERL-LVYPYMANGSVASCL-RERPPSQLPLDWPTRKR---- 401
+ L + E L V Y+ G + + + L R
Sbjct: 73 LAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLS---RATFYAA 125
Query: 402 -IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTT 459
I LG L +LH I++RD+K NILLD++ + DFG+ K M T
Sbjct: 126 EIILG----LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TN 176
Query: 460 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 513
GT +IAPE L K + D + +G++L E++ GQ F D++ +
Sbjct: 177 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH----GQDEEEL 226
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 44/240 (18%)
Query: 292 QVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVEMISMA 350
++ F+ +LG+G FGKV L AVK LK++ + +VE
Sbjct: 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKD-----VVIQDDDVE--CTM 68
Query: 351 VHRNLLRLRG---------FCMTPTERL-LVYPYMANGSVASCL-RERPPSQLPLDWPTR 399
V + +L L G C +RL V Y+ G + + + +
Sbjct: 69 VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG---RFKEP---H 122
Query: 400 KR-----IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYK 453
IA+G L +L II+RD+K N++LD E + DFG+ K +
Sbjct: 123 AVFYAAEIAIG----LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175
Query: 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 513
T T GT +IAPE ++ + D + +G++L E++ GQ F+ D+D +
Sbjct: 176 VT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE----GEDEDEL 229
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 65/233 (27%), Positives = 107/233 (45%), Gaps = 30/233 (12%)
Query: 292 QVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVE---MI 347
+ F ++GRG + KV RL + A+K +K+E E + E
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 64
Query: 348 SMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCL-RERPPSQLPLDWPTRKR---- 401
+ H L+ L C RL V Y+ G + + R+R +LP + R
Sbjct: 65 QASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEE---HARFYSA 117
Query: 402 -IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTT 459
I+L L+YLH+ II+RD+K N+LLD E + D+G+ K + DT T+
Sbjct: 118 EISLA----LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TS 168
Query: 460 AVRGTIGHIAPEYLSTGKSSEKT-DVFGYGIMLLELITGQRAFDLARLANDDD 511
GT +IAPE L G+ + D + G+++ E++ G+ FD+ +++ D
Sbjct: 169 TFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 28/144 (19%), Positives = 54/144 (37%), Gaps = 16/144 (11%)
Query: 54 CTW--FHVTCNN----------DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNI 101
C+ V C+ +DLG + + +L+ LEL N +
Sbjct: 9 CSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV 68
Query: 102 TGPIPSD-LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNI 160
+ + NL +L +L L N LS L L ++ N + + ++
Sbjct: 69 SA-VEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDL 127
Query: 161 SSLQVLDLSNNRLSGVVPDNGSFS 184
+L+ L++ +N L + + +FS
Sbjct: 128 YNLKSLEVGDNDLVYI--SHRAFS 149
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 25/98 (25%), Positives = 42/98 (42%), Gaps = 4/98 (4%)
Query: 88 LKNLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L NL+ L L SN + IP L++L LD+ N + L L+ L + +
Sbjct: 79 LFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGD 137
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
N L + + ++SL+ L L L+ + + S
Sbjct: 138 NDLVYISHRAFSGLNSLEQLTLEKCNLTSI--PTEALS 173
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 26/109 (23%), Positives = 50/109 (45%), Gaps = 7/109 (6%)
Query: 90 NLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNS 148
NL L + N+T +P + +L L L+L N + L +L +L+ ++L
Sbjct: 225 NLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQ 283
Query: 149 LSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDL 197
L+ P + ++ L+VL++S N+L+ + +F + L L
Sbjct: 284 LAVVEPYAFRGLNYLRVLNVSGNQLTTLEES-----VFHSVGNLETLIL 327
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 18/97 (18%), Positives = 36/97 (37%), Gaps = 2/97 (2%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
L L L L NI L L L++ + + L L + +
Sbjct: 175 LHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHC 234
Query: 148 SLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
+L+ +++ ++ L+ L+LS N +S + +
Sbjct: 235 NLTAVPYLAVRHLVYLRFLNLSYNPISTI--EGSMLH 269
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 9e-14
Identities = 23/111 (20%), Positives = 48/111 (43%), Gaps = 7/111 (6%)
Query: 88 LKNLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L +L+ L L N+T IP++ L +L L+ L L + + +L +L+ L +++
Sbjct: 151 LNSLEQLTLEKCNLTS-IPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDL 197
+ + +L L +++ L+ VP + + L+L
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYL----AVRHLVYLRFLNL 255
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 23/97 (23%), Positives = 39/97 (40%), Gaps = 2/97 (2%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
L L+ LE+ + + +L SL + + T + L LRFL L+ N
Sbjct: 199 LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYN 258
Query: 148 SLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
+S L + LQ + L +L+ V + +F
Sbjct: 259 PISTIEGSMLHELLRLQEIQLVGGQLAVV--EPYAFR 293
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 30/146 (20%), Positives = 54/146 (36%), Gaps = 11/146 (7%)
Query: 29 LHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAALSGQLVSQLGLL 88
L+ L+ I L + P + ++ + ++ V A+ L
Sbjct: 199 LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITH-CNLTAVPYL--AVRH--------L 247
Query: 89 KNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNS 148
L++L L N I+ S L L L + L P L+ LR L ++ N
Sbjct: 248 VYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQ 307
Query: 149 LSGPIPMSLTNISSLQVLDLSNNRLS 174
L+ ++ +L+ L L +N L+
Sbjct: 308 LTTLEESVFHSVGNLETLILDSNPLA 333
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 64/262 (24%), Positives = 107/262 (40%), Gaps = 31/262 (11%)
Query: 269 DVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVY---KGRLAD-GSLVA 324
D + H + + +V ++F +LG G +GKV+ K D G L A
Sbjct: 27 DGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYA 86
Query: 325 VKRLKEER-TPGGELQFQTEVE-MISMAVHRN--LLRLRGFCMTPTERL-LVYPYMANGS 379
+K LK+ + T E + + ++ L+ L + +L L+ Y+ G
Sbjct: 87 MKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGE 145
Query: 380 VASCL-RERPPSQLPLDWPTRKR-----IALGSARGLSYLHDHCDPKIIHRDVKAANILL 433
+ + L + + + I L L +LH II+RD+K NILL
Sbjct: 146 LFTHLSQRE---RFTEH---EVQIYVGEIVLA----LEHLHKL---GIIYRDIKLENILL 192
Query: 434 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDV--FGYGIML 491
D V+ DFGL+K +T GTI ++AP+ + G S V + G+++
Sbjct: 193 DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLM 252
Query: 492 LELITGQRAFDLARLANDDDVM 513
EL+TG F + N +
Sbjct: 253 YELLTGASPFTVDGEKNSQAEI 274
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 60/242 (24%), Positives = 107/242 (44%), Gaps = 47/242 (19%)
Query: 292 QVATDSFSNKNILGRGGFGKVY---KGRLAD-GSLVAVKRLK--------EERTPGGELQ 339
+ F +LG+G FGKV+ K +D L A+K LK RT
Sbjct: 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT------ 73
Query: 340 FQTEVEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCL-RERPPSQLPLDWP 397
+ E +++ H +++L + +L L+ ++ G + + L +E +
Sbjct: 74 -KMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEE-- 126
Query: 398 TRKR-----IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MD 451
+ +AL L +LH II+RD+K NILLDEE + DFGL+K +D
Sbjct: 127 -DVKFYLAELALA----LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178
Query: 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDD 511
++ + GT+ ++APE ++ ++ D + +G+++ E++TG F D
Sbjct: 179 HEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ----GKDRK 232
Query: 512 VM 513
Sbjct: 233 ET 234
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 28/132 (21%), Positives = 43/132 (32%), Gaps = 12/132 (9%)
Query: 65 NSVIRVDLGNAALSGQLVS----QLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDL 120
+ ++L N + + + Q L L+ L + + + +L +LDL
Sbjct: 121 PDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDL 180
Query: 121 YLNSFTGPIPDT----LGKLSKLRFLRLNNN---SLSGPIPMSLTNISSLQVLDLSNNRL 173
N G K L+ L L N + SG LQ LDLS+N L
Sbjct: 181 SDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSL 240
Query: 174 SGVVPDNGSFSL 185
S
Sbjct: 241 RD-AAGAPSCDW 251
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 27/96 (28%), Positives = 35/96 (36%), Gaps = 7/96 (7%)
Query: 85 LGLLKNLQYLELYSNNIT---GPIPSDLGNLTSLVSLDLYLNSFTG-PIPDTLGKLSKLR 140
LQ L L + + G + L LDL NS + S+L
Sbjct: 197 PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLN 256
Query: 141 FLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGV 176
L L+ L +P L + L VLDLS NRL
Sbjct: 257 SLNLSFTGLKQ-VPKGLP--AKLSVLDLSYNRLDRN 289
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 26/107 (24%), Positives = 37/107 (34%), Gaps = 8/107 (7%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITG-PIPSDLGNLTSLVSLDLYLNSFTGPI 129
+ G SG + LQ L+L N++ + L SL+L +
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-V 268
Query: 130 PDTLGKLSKLRFLRLNNNSLSG-PIPMSLTNISSLQVLDLSNNRLSG 175
P L +KL L L+ N L P P L + L L N
Sbjct: 269 PKGL--PAKLSVLDLSYNRLDRNPSPDELPQ---VGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 25/137 (18%), Positives = 43/137 (31%), Gaps = 6/137 (4%)
Query: 60 TCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIP-SDLGNLTSLVSL 118
+CN + L V G ++L+YL + +D+ SL L
Sbjct: 14 SCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRL 73
Query: 119 DLYLNSFTGPIPDTLGKL---SKLRFLRLNNNSLSGPIPMSLTNI--SSLQVLDLSNNRL 173
+ I ++ S L+ L L N ++G P L L +L+L N
Sbjct: 74 TVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW 133
Query: 174 SGVVPDNGSFSLFTPIS 190
+ +
Sbjct: 134 ATRDAWLAELQQWLKPG 150
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 65/241 (26%), Positives = 102/241 (42%), Gaps = 46/241 (19%)
Query: 292 QVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVEMISMA 350
++ D+F +LG+G FGKV R+ + G L AVK LK++ + +VE
Sbjct: 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKD-----VILQDDDVE--CTM 71
Query: 351 VHRNLLRLRG---------FCMTPTERL-LVYPYMANGSVASCL-RERPPSQLPLDWPTR 399
+ +L L C +RL V ++ G + + + R + R
Sbjct: 72 TEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR---RFDEA---R 125
Query: 400 KR-----IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYK 453
R I L +LHD II+RD+K N+LLD E + DFG+ K +
Sbjct: 126 ARFYAAEIISA----LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178
Query: 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKT-DVFGYGIMLLELITGQRAFDLARLANDDDV 512
T T GT +IAPE L D + G++L E++ G F+ A ++D
Sbjct: 179 VT--TATFCGTPDYIAPEIL-QEMLYGPAVDWWAMGVLLYEMLCGHAPFE----AENEDD 231
Query: 513 M 513
+
Sbjct: 232 L 232
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 24/99 (24%), Positives = 39/99 (39%), Gaps = 4/99 (4%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145
L + L + N I+ SD+ +L+ L L + N +L +L L+
Sbjct: 18 DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLS 77
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
+N L +S +L+ LDLS N +P F
Sbjct: 78 HNKLVK---ISCHPTVNLKHLDLSFNAFD-ALPICKEFG 112
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 27/101 (26%), Positives = 52/101 (51%), Gaps = 6/101 (5%)
Query: 88 LKNLQYLELYSNNITGPIPSDL-GNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
+K+LQ L++ N+++ SL+SL++ N T I L +++ L L++
Sbjct: 373 MKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHS 430
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFT 187
N + IP + + +LQ L++++N+L V +G F T
Sbjct: 431 NKIKS-IPKQVVKLEALQELNVASNQLKSV--PDGIFDRLT 468
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 21/101 (20%), Positives = 45/101 (44%), Gaps = 3/101 (2%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFT--GPIPDTLGKLSKLRFLRLN 145
+ +L+ +N +T + + G+LT L +L L +N I + ++ L+ L ++
Sbjct: 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDIS 382
Query: 146 NNSL-SGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSL 185
NS+ + SL L++S+N L+ + +
Sbjct: 383 QNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRI 423
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 26/109 (23%), Positives = 43/109 (39%), Gaps = 5/109 (4%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTG-PIPDTLGKLSKLRFLRLNN 146
+ L+YL+L N + I +L LDL N+F PI G +S+L+FL L+
Sbjct: 68 NQELEYLDLSHNKLVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLST 124
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNL 195
L + + +++ +VL + D F S
Sbjct: 125 THLEKSSVLPIAHLNISKVLLVLGETYG-EKEDPEGLQDFNTESLHIVF 172
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 30/175 (17%), Positives = 58/175 (33%), Gaps = 10/175 (5%)
Query: 23 NMEGDALHSLRSNLIDPNNVLQSWDPTLVN-PCTWFHVT----CNNDNSVIRVDLGNAAL 77
+E + S L + + TL N TW +V + N L
Sbjct: 200 VLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKL 259
Query: 78 SGQLVSQLG-----LLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDT 132
GQL + LK L ++ S+ P +++ + ++
Sbjct: 260 QGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLC 319
Query: 133 LGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFT 187
K+S L +NN L+ + + +++ L+ L L N+L + +
Sbjct: 320 PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMK 374
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 25/84 (29%), Positives = 37/84 (44%), Gaps = 3/84 (3%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
K+L L + SN +T I L + LDL+ N IP + KL L+ L + +N
Sbjct: 398 TKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASN 454
Query: 148 SLSGPIPMSLTNISSLQVLDLSNN 171
L ++SLQ + L N
Sbjct: 455 QLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 22/110 (20%), Positives = 40/110 (36%), Gaps = 6/110 (5%)
Query: 88 LKNLQYLELYSNNITG-PIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLR-FLRLN 145
NL++L+L N PI + GN++ L L L + L+ + L L
Sbjct: 89 TVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLG 148
Query: 146 NNSLSGPIPMSLTNI--SSLQVLDLSNNRLSGVVPDNGSFSLFTPISFAN 193
P L + SL ++ +N ++ + S + +N
Sbjct: 149 ETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFIL--DVSVKTVANLELSN 196
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 18/64 (28%), Positives = 32/64 (50%), Gaps = 3/64 (4%)
Query: 87 LLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPD-TLGKLSKLRFLRLN 145
L ++ L+L+SN I IP + L +L L++ N +PD +L+ L+ + L+
Sbjct: 419 LPPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLH 476
Query: 146 NNSL 149
N
Sbjct: 477 TNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 13/103 (12%), Positives = 36/103 (34%), Gaps = 2/103 (1%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
+ L++L L + ++ + +L L + ++ L L+
Sbjct: 114 MSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESLHIV 171
Query: 148 SLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPIS 190
+ + ++S V +L + + V+ DN + ++
Sbjct: 172 FPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA 214
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 23/139 (16%), Positives = 43/139 (30%), Gaps = 21/139 (15%)
Query: 61 CNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDL 120
+ +D+ + L L+ + IT DL LV L L
Sbjct: 282 AEGCRKIKELDVTH-------------NTQLYLLDCQAAGIT---ELDLSQNPKLVYLYL 325
Query: 121 YLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN 180
T + + +KL+ L N + S+ I +L + + + +
Sbjct: 326 NNTELTE-LD--VSHNTKLKSLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQTITMPKET 380
Query: 181 GSFSLFTPISFANNLDLCG 199
+ + T + LD G
Sbjct: 381 LTNNSLTIAVSPDLLDQFG 399
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 27/116 (23%), Positives = 52/116 (44%), Gaps = 11/116 (9%)
Query: 59 VTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSL 118
++ ++ +D N++++ ++ + L L L SNNIT DL T+L L
Sbjct: 36 ISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNITTL---DLSQNTNLTYL 90
Query: 119 DLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
N T + + L+KL +L + N L+ + ++ L L+ + N L+
Sbjct: 91 ACDSNKLTN-LD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT 140
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 25/110 (22%), Positives = 44/110 (40%), Gaps = 11/110 (10%)
Query: 85 LGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144
+ L L+ N IT D+ L L+ N+ T + L + +L FL
Sbjct: 166 VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITK-LD--LNQNIQLTFLDC 219
Query: 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANN 194
++N L+ + +T ++ L D S N L+ + D + S T +
Sbjct: 220 SSNKLTE---IDVTPLTQLTYFDCSVNPLTEL--DVSTLSKLTTLHCIQT 264
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 20/90 (22%), Positives = 36/90 (40%), Gaps = 8/90 (8%)
Query: 85 LGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144
+ L L+ + N + D+ T L +LD N T + + L L
Sbjct: 144 VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNC 198
Query: 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
+ N+++ + L L LD S+N+L+
Sbjct: 199 DTNNITK---LDLNQNIQLTFLDCSSNKLT 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 21/119 (17%), Positives = 40/119 (33%), Gaps = 6/119 (5%)
Query: 77 LSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKL 136
+ ++ L N Q + + D+ + T L LD T + L +
Sbjct: 261 CIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQN 317
Query: 137 SKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNL 195
KL +L LNN L+ + +++ + L+ L N + +L
Sbjct: 318 PKLVYLYLNNTELTE---LDVSHNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEAEGQT 373
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 21/90 (23%), Positives = 37/90 (41%), Gaps = 8/90 (8%)
Query: 85 LGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144
+ L L YL +N +T D+ L L+ N+ T I + ++L L
Sbjct: 102 VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDC 155
Query: 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
+ N + +T + L LD S N+++
Sbjct: 156 HLNKKITKLD--VTPQTQLTTLDCSFNKIT 183
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 19/106 (17%), Positives = 34/106 (32%), Gaps = 19/106 (17%)
Query: 85 LGLLKNLQYLELYSNNITGPIPSDLGNLTSL-------VSLD---------LYLNSFTGP 128
+ L L Y + N +T S L LT+L + +D
Sbjct: 229 VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKI 288
Query: 129 IPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
+ ++L L ++ + L+ L L L+N L+
Sbjct: 289 KELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT 331
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 24/110 (21%), Positives = 39/110 (35%), Gaps = 27/110 (24%)
Query: 85 LGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144
L L +L+ SN +T D+ LT L D +N T + + LSKL L
Sbjct: 208 LNQNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHC 261
Query: 145 NNNSLSGPIPMS--------------------LTNISSLQVLDLSNNRLS 174
L I ++ +T+ + L +LD ++
Sbjct: 262 IQTDLLE-IDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT 310
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 18/86 (20%), Positives = 37/86 (43%), Gaps = 5/86 (5%)
Query: 89 KNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNS 148
N + + L +L SLD + +S T + + KL+ L L +N+
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MTG-IEKLTGLTKLICTSNN 75
Query: 149 LSGPIPMSLTNISSLQVLDLSNNRLS 174
++ + L+ ++L L +N+L+
Sbjct: 76 ITT-LD--LSQNTNLTYLACDSNKLT 98
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 26/113 (23%), Positives = 51/113 (45%), Gaps = 8/113 (7%)
Query: 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSF 125
+ I++ G + ++ L + L + +T I + L +L+ L+L N
Sbjct: 20 NAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQI 75
Query: 126 TGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
T P L L+K+ L L+ N L + + S++ LDL++ +++ V P
Sbjct: 76 TDLAP--LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTP 124
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 6/97 (6%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
+ + L NL LEL N IT + L NLT + L+L N + L ++
Sbjct: 56 IEGVQYLNNLIGLELKDNQITD--LAPLKNLTKITELELSGNPLKNVSA--IAGLQSIKT 111
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
L L + ++ P L +S+LQVL L N+++ + P
Sbjct: 112 LDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP 146
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 32/128 (25%), Positives = 54/128 (42%), Gaps = 18/128 (14%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
+S L L NLQYL + + ++ + + L NL+ L +L N + I L L L
Sbjct: 144 ISPLAGLTNLQYLSIGNAQVSD-L-TPLANLSKLTTLKADDNKISD-ISP-LASLPNLIE 199
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP------------DNGSFSLFTPI 189
+ L NN +S P L N S+L ++ L+N ++ S + P
Sbjct: 200 VHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPA 257
Query: 190 SFANNLDL 197
+ ++N
Sbjct: 258 TISDNGTY 265
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 21/93 (22%), Positives = 39/93 (41%), Gaps = 6/93 (6%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
+ L N + +N+T + +L + +L + T I + L+ L
Sbjct: 12 IFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IEG-VQYLNNLIG 67
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
L L +N ++ P L N++ + L+LS N L
Sbjct: 68 LELKDNQITDLAP--LKNLTKITELELSGNPLK 98
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 23/113 (20%), Positives = 47/113 (41%), Gaps = 6/113 (5%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
+S L L NL + L +N I+ P L N ++L + L + T L
Sbjct: 188 ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNV 245
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANN 194
++ + + P ++++ + +L+ N S +N S++ ++F N
Sbjct: 246 VKGPSGAPIAPA--TISDNGTYASPNLTWNLTSF--INNVSYTFNQSVTFKNT 294
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 25/112 (22%), Positives = 48/112 (42%), Gaps = 5/112 (4%)
Query: 88 LKNLQYLELYSNNITGPIPSDL-GNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L++LQ+L++ I ++ L+SL+ L L N F L+ L L L
Sbjct: 53 LQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQ 112
Query: 147 NSL-SGPIPM-SLTNISSLQVLDLSNNRLSGVVPDNGSFSL--FTPISFANN 194
+L + ++SL++L L +N + + P + ++ F + N
Sbjct: 113 CNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN 164
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 23/95 (24%), Positives = 40/95 (42%), Gaps = 1/95 (1%)
Query: 90 NLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP-DTLGKLSKLRFLRLNNNS 148
++ Y++L N+I + L L L + + I +T LS L L+L+ N
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 149 LSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSF 183
+ +++L+VL L+ L G V F
Sbjct: 91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFF 125
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 32/114 (28%), Positives = 44/114 (38%), Gaps = 8/114 (7%)
Query: 88 LKNLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
+L+ L L N I I + LT L+ L+L N L KL L L+
Sbjct: 298 FTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSY 356
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPIS----FANNLD 196
N + S + +L+ L L N+L VPD G F T + N D
Sbjct: 357 NHIRALGDQSFLGLPNLKELALDTNQLK-SVPD-GIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 23/96 (23%), Positives = 38/96 (39%), Gaps = 4/96 (4%)
Query: 90 NLQYLELYSNNITGPIPSDL-GNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNS 148
++ +L + I + + + T L L L N + L+ L L L+ N
Sbjct: 276 GVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNF 334
Query: 149 LSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
L N+ L+VLDLS N + + + SF
Sbjct: 335 LGSIDSRMFENLDKLEVLDLSYNHIRAL--GDQSFL 368
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 30/141 (21%), Positives = 41/141 (29%), Gaps = 13/141 (9%)
Query: 88 LKNLQYLELYSNNITGPIPSDL-GNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL-- 144
L +L+ L L NNI P+ N+ LDL N + L F L
Sbjct: 128 LTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRL 187
Query: 145 --------NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196
N L + +S+ LDLS N + F + +L
Sbjct: 188 SSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMA--KRFFDAIAGTKIQSLI 245
Query: 197 LCGPVTGRPCPGSPPFSPPPP 217
L G F P
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDN 266
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 16/63 (25%), Positives = 28/63 (44%), Gaps = 1/63 (1%)
Query: 113 TSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPM-SLTNISSLQVLDLSNN 171
+ +DL LNS + +L L+FL++ + I + +SSL +L L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 172 RLS 174
+
Sbjct: 90 QFL 92
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 23/126 (18%), Positives = 45/126 (35%), Gaps = 18/126 (14%)
Query: 77 LSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP---DTL 133
G+ + L L ++ + + TS+ +LDL N F +
Sbjct: 177 FQGKHFTLLRLSSI-TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDA 235
Query: 134 GKLSKLRFLRLNN----------NSLSGPIPMSLTNI--SSLQVLDLSNNRLSGVVPDNG 181
+K++ L L+N + P + + S ++ DLS +++ +
Sbjct: 236 IAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFAL--LKS 293
Query: 182 SFSLFT 187
FS FT
Sbjct: 294 VFSHFT 299
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 31/100 (31%), Positives = 45/100 (45%), Gaps = 3/100 (3%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145
GL + ++ L+L +N IT SDL +L +L L N D+ L L L L+
Sbjct: 49 GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLS 108
Query: 146 NNSLSGPIPMSL-TNISSLQVLDLSNNRLSGVVPDNGSFS 184
N LS + S +SSL L+L N + + FS
Sbjct: 109 YNYLSN-LSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFS 146
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 18/115 (15%), Positives = 44/115 (38%), Gaps = 8/115 (6%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
L L+ LE+ ++++ P L ++ ++ L L++ + + S + L L +
Sbjct: 173 LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDT 232
Query: 148 SLSGPIPMSLTNIS--------SLQVLDLSNNRLSGVVPDNGSFSLFTPISFANN 194
L L+ + + + +++ L V+ S + F+ N
Sbjct: 233 DLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRN 287
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 21/121 (17%), Positives = 41/121 (33%), Gaps = 4/121 (3%)
Query: 83 SQLGLLKNLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
S L LQ L + + + I LT L L++ + P +L + +
Sbjct: 143 SLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSH 202
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGV---VPDNGSFSLFTPISFANNLDLC 198
L L+ + + + SS++ L+L + L G + N+ +
Sbjct: 203 LILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKIT 262
Query: 199 G 199
Sbjct: 263 D 263
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 20/97 (20%), Positives = 41/97 (42%), Gaps = 9/97 (9%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLY--------LNSFTGPIPDTLGKLSKL 139
++N+ +L L+ + + +S+ L+L + + ++L K
Sbjct: 197 IQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTF 256
Query: 140 RFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGV 176
R +++ + SL + L IS L L+ S N+L V
Sbjct: 257 RNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSV 292
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 17/93 (18%), Positives = 36/93 (38%), Gaps = 11/93 (11%)
Query: 88 LKNLQYLELYSNNITGP----IPSD----LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKL 139
+++ LEL ++ + + L + ++ + S + L ++S L
Sbjct: 221 TSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGL 279
Query: 140 RFLRLNNNSLSGPIPMS-LTNISSLQVLDLSNN 171
L + N L +P ++SLQ + L N
Sbjct: 280 LELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 13/75 (17%), Positives = 31/75 (41%), Gaps = 3/75 (4%)
Query: 76 ALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPD-TLG 134
LS + L + +++ ++ + L ++ L+ L+ N +PD
Sbjct: 241 ELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFD 298
Query: 135 KLSKLRFLRLNNNSL 149
+L+ L+ + L+ N
Sbjct: 299 RLTSLQKIWLHTNPW 313
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 54/255 (21%), Positives = 91/255 (35%), Gaps = 45/255 (17%)
Query: 260 RRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSN-----KNILGRGGFGKVYK 314
+ P PA+ P + LQ+ ++ + +LG G GKV +
Sbjct: 21 PQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQ 80
Query: 315 GR-LADGSLVAVKRL-KEERTPGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTER--- 368
A+K L + + EVE + +++R+
Sbjct: 81 IFNKRTQEKFALKMLQDCPK-------ARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133
Query: 369 -LLVYPYMANGS--------VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 419
L+V + G ER S++ + +G A + YLH
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEI-----MKS---IGEA--IQYLHSI--- 180
Query: 420 KIIHRDVKAANILL-DEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 476
I HRDVK N+L + A++ DFG AK +TT T ++APE L
Sbjct: 181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPC-YTPYYVAPEVLGPE 238
Query: 477 KSSEKTDVFGYGIML 491
K + D++ G+++
Sbjct: 239 KYDKSCDMWSLGVIM 253
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 9e-14
Identities = 56/243 (23%), Positives = 97/243 (39%), Gaps = 47/243 (19%)
Query: 292 QVATDSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGGELQFQTEVEMI 347
++ + F +LG+GG+GKV++ R G + A+K LK+ ++ +
Sbjct: 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMI----VRNAKDTA-- 66
Query: 348 SMAVHRNLL---------RLRGFCMTPTERL-LVYPYMANGSVASCL-RERPPSQLPLDW 396
RN+L L + +L L+ Y++ G + L RE D
Sbjct: 67 HTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREG---IFMED- 121
Query: 397 PTRKR-----IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-M 450
I++ L +LH II+RD+K NI+L+ + + DFGL K +
Sbjct: 122 --TACFYLAEISMA----LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172
Query: 451 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD 510
T GTI ++APE L + D + G ++ +++TG F +
Sbjct: 173 HDGTV--THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT----GENR 226
Query: 511 DVM 513
Sbjct: 227 KKT 229
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 9e-14
Identities = 29/276 (10%), Positives = 74/276 (26%), Gaps = 59/276 (21%)
Query: 304 LGRGGFGKVYKGRLADGSL---VAVKRLKEE--RTPGGELQFQTEVEMISMAVHRNLLRL 358
G + ++ D +L VA+ + + + + +S + R+
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 359 RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK-RIALGSARGLSYLHDHC 417
T L+V ++ GS+ P P R A H
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTSPS-------PVGAIRAMQSLAAAADAAHRA- 148
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 477
+ + + + + + V+ +
Sbjct: 149 --GVALSIDHPSRVRVSIDGDVVLAYPA--------------------------TMPD-- 178
Query: 478 SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537
++ + D+ G G L L+ + L + ++P +
Sbjct: 179 ANPQDDIRGIGASLYALLVNRWPLP----EAGVRSGLAPAERDT-----AGQPIEPADID 229
Query: 538 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ ++ + ++ QG R S ++ +++
Sbjct: 230 RDIPFQISAVAARSV---QGDGGIRSA-STLLNLMQ 261
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.1 bits (173), Expect = 2e-13
Identities = 33/223 (14%), Positives = 58/223 (26%), Gaps = 45/223 (20%)
Query: 281 GQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVK--RLKEERTPGGEL 338
Q + T+ +G G FG+V++ AD + VA+K ++ G
Sbjct: 6 SQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSH 63
Query: 339 Q-----FQTEVEM---------ISMAVHRNLLRLRGFCM----TPTERLLVYPYMA--NG 378
Q E+ + + L P L + + G
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 379 SVASCLRERPPSQLPL-------------------DWPTRKRIALGSARGLSYLHDHCDP 419
S QL + T K I L+
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL-- 181
Query: 420 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 462
+ HRD+ N+LL + + K + ++
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 8e-13
Identities = 24/113 (21%), Positives = 46/113 (40%), Gaps = 21/113 (18%)
Query: 87 LLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP---------------D 131
L +L+ L N++T +P +L SL+ + L + + P
Sbjct: 89 LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLP 147
Query: 132 TLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
L S L+ + ++NNSL +P + L+ + NN+L +P+ +
Sbjct: 148 ELQNSSFLKIIDVDNNSLKK-LPDLPPS---LEFIAAGNNQLE-ELPELQNLP 195
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 26/89 (29%), Positives = 40/89 (44%), Gaps = 8/89 (8%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145
L L+YL + +N + +P +L N + L +D+ NS +PD L F+
Sbjct: 128 DLPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLPPSL---EFIAAG 181
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
NN L +P L N+ L + NN L
Sbjct: 182 NNQLEE-LP-ELQNLPFLTAIYADNNSLK 208
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 7e-12
Identities = 24/107 (22%), Positives = 42/107 (39%), Gaps = 20/107 (18%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
+ +L L L + +N + +P +L +L D YL +P+ L+ L
Sbjct: 230 LPELQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYLTD----LPELPQSLTFLDV 284
Query: 142 LRLNNNSLSGPIPMSLT--------------NISSLQVLDLSNNRLS 174
+ LS +P +L SL+ L++SNN+L
Sbjct: 285 SENIFSGLS-ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 7e-12
Identities = 22/89 (24%), Positives = 36/89 (40%), Gaps = 8/89 (8%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145
L +L+++ +N + +L NL L ++ NS +PD L +
Sbjct: 170 DLPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKK-LPDLPLSLESIV---AG 223
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
NN L +P L N+ L + NN L
Sbjct: 224 NNILEE-LP-ELQNLPFLTTIYADNNLLK 250
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 22/100 (22%), Positives = 36/100 (36%), Gaps = 18/100 (18%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLS---------- 137
LQ +S+N+T +P + N+ S + + P G+
Sbjct: 10 NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 138 ---KLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
+ L LNN LS +P + L+ L S N L+
Sbjct: 69 LDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT 104
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 19/95 (20%), Positives = 38/95 (40%), Gaps = 10/95 (10%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
+ +L L L + +N++ +P +L S+ N L L L
Sbjct: 188 LPELQNLPFLTAIYADNNSLKK-LPDLPLSLE---SIVAGNNILE--ELPELQNLPFLTT 241
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGV 176
+ +NN L +P + L+ L++ +N L+ +
Sbjct: 242 IYADNNLLKT-LPDLPPS---LEALNVRDNYLTDL 272
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 24/109 (22%), Positives = 40/109 (36%), Gaps = 20/109 (18%)
Query: 80 QLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKL--- 136
L + L +L+ L + N +T +P +LT L + + + +P L L
Sbjct: 248 LLKTLPDLPPSLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLS-ELPPNLYYLNAS 305
Query: 137 -----------SKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
L L ++NN L +P L+ L S N L+
Sbjct: 306 SNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA 350
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 21/110 (19%), Positives = 39/110 (35%), Gaps = 23/110 (20%)
Query: 80 QLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKL 139
++ S L +L+ L + +N + +P+ L L N +P+ L
Sbjct: 308 EIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHLAE-VPELPQ---NL 359
Query: 140 RFLRLNNNSLSG--PIPMSLTN-------------ISSLQVLDLSNNRLS 174
+ L + N L IP S+ + +L+ L + N L
Sbjct: 360 KQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 18/112 (16%), Positives = 36/112 (32%), Gaps = 18/112 (16%)
Query: 80 QLVSQLGLLKNLQYLELYSNNITGPIPSDLGNL-------------TSLVSLDLYLNSFT 126
++ + +K+ + P G L+L +
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 127 GPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
+P+ L L + NSL+ +P ++ SL V + + LS + P
Sbjct: 85 -SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP 131
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 16/104 (15%), Positives = 32/104 (30%), Gaps = 21/104 (20%)
Query: 87 LLKNLQYLELYSNNITGPIPSDLGNLT----------------SLVSLDLYLNSFTGPIP 130
L +NL+ L + N + P ++ +L L + N P
Sbjct: 355 LPQNLKQLHVEYNPLRE-FPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLRE-FP 412
Query: 131 DTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
D + LR +N+ + P + L+ ++
Sbjct: 413 DIPESVEDLR---MNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 20/107 (18%), Positives = 37/107 (34%), Gaps = 23/107 (21%)
Query: 87 LLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L L+ L N++ +P NL L + N PD + LR +N+
Sbjct: 335 LPPRLERLIASFNHLAE-VPELPQNLKQL---HVEYNPLRE-FPDIPESVEDLR---MNS 386
Query: 147 NSLSGP-IPMSLT--------------NISSLQVLDLSNNRLSGVVP 178
+ P +P +L S++ L +++ R+
Sbjct: 387 HLAEVPELPQNLKQLHVETNPLREFPDIPESVEDLRMNSERVVDPYE 433
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 9e-13
Identities = 30/115 (26%), Positives = 48/115 (41%), Gaps = 6/115 (5%)
Query: 60 TCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLD 119
+ S + V+ L+ + L K+ L L N + + L T L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLTA--LPP-DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 120 LYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
L T + G L L L L++N L +P+ + +L VLD+S NRL+
Sbjct: 62 LDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT 113
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 30/100 (30%), Positives = 40/100 (40%), Gaps = 6/100 (6%)
Query: 88 LKNLQYLELYSNNITGPIPSDL-GNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L L L++ N +T +P L L L L N P L KL L L N
Sbjct: 99 LPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN 157
Query: 147 NSLSGPIPMSL-TNISSLQVLDLSNNRLSGVVPDNGSFSL 185
N+L+ +P L + +L L L N L +P G F
Sbjct: 158 NNLTE-LPAGLLNGLENLDTLLLQENSLYT-IPK-GFFGS 194
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 28/87 (32%), Positives = 38/87 (43%), Gaps = 1/87 (1%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
L L L+L N + +P L +L LD+ N T L L +L+ L L N
Sbjct: 76 LPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134
Query: 148 SLSGPIPMSLTNISSLQVLDLSNNRLS 174
L P LT L+ L L+NN L+
Sbjct: 135 ELKTLPPGLLTPTPKLEKLSLANNNLT 161
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 26/85 (30%), Positives = 29/85 (34%), Gaps = 3/85 (3%)
Query: 88 LKNLQYLELYSNNITGPIPSDL-GNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L LQ L L N + +P L L L L N+ T L L L L L
Sbjct: 123 LGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNN 171
NSL IP L L N
Sbjct: 182 NSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 69.8 bits (170), Expect = 1e-12
Identities = 34/93 (36%), Positives = 46/93 (49%), Gaps = 6/93 (6%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
+S L LK L+ L L N I+ + L +L L SL L N T L +L+KL
Sbjct: 102 LSSLKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKITDITV--LSRLTKLDT 157
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
L L +N +S I L ++ LQ L LS N +S
Sbjct: 158 LSLEDNQISD-IV-PLAGLTKLQNLYLSKNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 67.8 bits (165), Expect = 5e-12
Identities = 38/122 (31%), Positives = 58/122 (47%), Gaps = 12/122 (9%)
Query: 59 VTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSL 118
VT N NS+ ++ N+ + V + L N+ L L N +T I L NL +L L
Sbjct: 37 VTQNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNGNKLTD-I-KPLTNLKNLGWL 92
Query: 119 DLYLNSFTGPIPD--TLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGV 176
L N I D +L L KL+ L L +N +S I L ++ L+ L L NN+++ +
Sbjct: 93 FLDEN----KIKDLSSLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKITDI 146
Query: 177 VP 178
Sbjct: 147 TV 148
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 67.8 bits (165), Expect = 5e-12
Identities = 23/108 (21%), Positives = 47/108 (43%), Gaps = 8/108 (7%)
Query: 67 VIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFT 126
I+ +L +++ L ++ + +++I + + L ++ L L N T
Sbjct: 23 TIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVTKLFLNGNKLT 78
Query: 127 GPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
I L L L +L L+ N + + SL ++ L+ L L +N +S
Sbjct: 79 D-IKP-LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGIS 122
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 66.7 bits (162), Expect = 1e-11
Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 6/97 (6%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
+ L LKNL +L L N I + S L +L L SL L N + I L L +L
Sbjct: 80 IKPLTNLKNLGWLFLDENKIKD-L-SSLKDLKKLKSLSLEHNGISD-ING-LVHLPQLES 135
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
L L NN ++ L+ ++ L L L +N++S +VP
Sbjct: 136 LYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVP 170
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 29/93 (31%), Positives = 44/93 (47%), Gaps = 6/93 (6%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
++ L L L+ L L +N IT + L LT L +L L N + I L L+KL+
Sbjct: 124 INGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQN 179
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
L L+ N +S L + +L VL+L +
Sbjct: 180 LYLSKNHISDLRA--LAGLKNLDVLELFSQECL 210
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 4e-10
Identities = 20/100 (20%), Positives = 35/100 (35%), Gaps = 12/100 (12%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLN---SFTGPIPDTLGKLSK 138
+ L ++T + L S+ + + S G + L
Sbjct: 14 IFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG-----IQYLPN 66
Query: 139 LRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
+ L LN N L+ I LTN+ +L L L N++ +
Sbjct: 67 VTKLFLNGNKLTD-IK-PLTNLKNLGWLFLDENKIKDLSS 104
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 18/107 (16%), Positives = 37/107 (34%), Gaps = 13/107 (12%)
Query: 91 LQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLS 150
+ S I P + +L S T + +L+ + + NN+ +
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 151 GPIPMSLTNIS---SLQVLDLSNNRLSGVVPDNGSFSLFTPISFANN 194
S+ I ++ L L+ N+L+ + P +L + N
Sbjct: 57 -----SVQGIQYLPNVTKLFLNGNKLTDIKPLTNLKNL-GWLFLDEN 97
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 18/90 (20%), Positives = 34/90 (37%), Gaps = 4/90 (4%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
+ L L LQ L L N+I+ L L +L L+L+ + L
Sbjct: 168 IVPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNT 225
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNN 171
++ + SL P +S + + ++ +
Sbjct: 226 VKNTDGSLVTPEIIS--DDGDYEKPNVKWH 253
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 43/256 (16%), Positives = 90/256 (35%), Gaps = 60/256 (23%)
Query: 291 LQVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQT-EVEMIS 348
L+ ++ +S LG G FG V + + G A+K++ ++ +++ E++++
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMK 55
Query: 349 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTR--------- 399
+ H N+++L + T + P + + +
Sbjct: 56 VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 400 ---------KRIALGSA-------------------RGLSYLHDHCDPKIIHRDVKAANI 431
++ R + ++H I HRD+K N+
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNL 172
Query: 432 LLDEEFEAV-VGDFGLAKLMDYKDTHVTTAV----RGTIGHIAPEYLSTGKS-SEKTDVF 485
L++ + + + DFG AK + + V R APE + + D++
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR------APELMLGATEYTPSIDLW 226
Query: 486 GYGIMLLELITGQRAF 501
G + ELI G+ F
Sbjct: 227 SIGCVFGELILGKPLF 242
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 34/93 (36%), Positives = 46/93 (49%), Gaps = 6/93 (6%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
+S L LK L+ L L N I+ + L +L L SL L N T L +L+KL
Sbjct: 105 LSSLKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDT 160
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
L L +N +S I L ++ LQ L LS N +S
Sbjct: 161 LSLEDNQISD-IV-PLAGLTKLQNLYLSKNHIS 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 22/108 (20%), Positives = 45/108 (41%), Gaps = 8/108 (7%)
Query: 67 VIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFT 126
I+ +L +++ L ++ + +++I + + L ++ L L N T
Sbjct: 26 TIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVTKLFLNGNKLT 81
Query: 127 GPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
I L L L +L L+ N + L ++ L+ L L +N +S
Sbjct: 82 D-IKP-LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 30/95 (31%), Positives = 45/95 (47%), Gaps = 10/95 (10%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPD--TLGKLSKL 139
V + L N+ L L N +T I L NL +L L L N + D +L L KL
Sbjct: 61 VQGIQYLPNVTKLFLNGNKLTD-I-KPLANLKNLGWLFLDEN----KVKDLSSLKDLKKL 114
Query: 140 RFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
+ L L +N +S L ++ L+ L L NN+++
Sbjct: 115 KSLSLEHNGISDING--LVHLPQLESLYLGNNKIT 147
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 17/97 (17%), Positives = 33/97 (34%), Gaps = 6/97 (6%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
+ L ++T + L S+ + + + + L +
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQG-IQYLPNVTK 72
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
L LN N L+ P L N+ +L L L N++ +
Sbjct: 73 LFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSS 107
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 21/113 (18%), Positives = 41/113 (36%), Gaps = 6/113 (5%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
+ L L LQ L L N+I+ L L +L L+L+ + L
Sbjct: 171 IVPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNT 228
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANN 194
++ + SL P +S + + ++ + + SF + P++
Sbjct: 229 VKNTDGSLVTPEIIS--DDGDYEKPNVKWHLPEFT--NEVSFIFYQPVTIGKA 277
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 22/103 (21%), Positives = 44/103 (42%), Gaps = 5/103 (4%)
Query: 86 GLLKNLQYLELYSNNITGPIPSD-LGNLTSLVSLDLYLNSFTGPIP-DTLGKLSKLRFLR 143
L + Q L+L ++ IPS NL ++ + + ++ + + LSK+ +
Sbjct: 28 SLPPSTQTLKLIETHLRT-IPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIE 86
Query: 144 L-NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSL 185
+ N +L+ P +L + L+ L + N L + PD
Sbjct: 87 IRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYS 128
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 19/96 (19%), Positives = 40/96 (41%), Gaps = 3/96 (3%)
Query: 88 LKNLQYLELYSNNITGPIPSDL-GNLTSLVSLDLYLNSFTGPIP-DTLGKLSKLRFLRLN 145
L N+ + + + + S NL+ + +++ I D L +L L+FL +
Sbjct: 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIF 113
Query: 146 NNSLSG-PIPMSLTNISSLQVLDLSNNRLSGVVPDN 180
N L P + + +L++++N +P N
Sbjct: 114 NTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 26/111 (23%), Positives = 43/111 (38%), Gaps = 20/111 (18%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSD-LGNLTS-LVSLDLYLNSFTGPIPDTLGKLSKL 139
++++ LE+ N IP + L + ++L LY N FT + +KL
Sbjct: 123 LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKL 181
Query: 140 RFLRLNNNSLSGPIPMSLTNI---------SSLQVLDLSNNRLSGVVPDNG 181
+ LN N LT I S +LD+S ++ +P G
Sbjct: 182 DAVYLNKNKY-------LTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG 224
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 24/116 (20%), Positives = 39/116 (33%), Gaps = 7/116 (6%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP-DTLGKLSKLRFLRL 144
L +N L + L +++ N I D L KL +R+
Sbjct: 27 DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86
Query: 145 -NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCG 199
N+L P + N+ +LQ L +SN + +PD LD+
Sbjct: 87 EKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDV----HKIHSLQKVLLDIQD 137
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 18/95 (18%), Positives = 40/95 (42%), Gaps = 2/95 (2%)
Query: 88 LKNLQYLELYSNNITGPIPSD-LGNLTSLVSLDL-YLNSFTGPIPDTLGKLSKLRFLRLN 145
+L+ +E+ N++ I +D NL L + + N+ P+ L L++L ++
Sbjct: 53 FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLIS 112
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN 180
N + + + +LD+ +N + N
Sbjct: 113 NTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERN 147
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 20/88 (22%), Positives = 29/88 (32%), Gaps = 2/88 (2%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDL-YLNSFTGPIPDTLGKLSKLRFLRL 144
GL L L N I I + N T L L+L N+ D S L +
Sbjct: 151 GLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 209
Query: 145 NNNSLSGPIPMSLTNISSLQVLDLSNNR 172
+ + L N+ L+ N +
Sbjct: 210 SRTRIHSLPSYGLENLKKLRARSTYNLK 237
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 47/229 (20%), Positives = 89/229 (38%), Gaps = 37/229 (16%)
Query: 295 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQ-FQT---------EV 344
++ + + G +G V G ++G VA+KR+ + G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 345 EMISMAVHRNLLRLRGFCMTPTERL------LVYPYMANGSVASCLRERPPSQLPLDWPT 398
+++ H N+L LR E LV M +A + ++ ++ +
Sbjct: 81 RLLNHFHHPNILGLRD-IFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQ---RIVISPQH 135
Query: 399 RKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 458
+ GL LH+ ++HRD+ NILL + + + DF LA+ D + T
Sbjct: 136 IQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDT-ADANKT 191
Query: 459 TAV-----RGTIGHIAPEY-LSTGKSSEKTDVFGYGIMLLELITGQRAF 501
V R APE + ++ D++ G ++ E+ + F
Sbjct: 192 HYVTHRWYR------APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 26/99 (26%), Positives = 40/99 (40%), Gaps = 4/99 (4%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145
L + L L N+I+ D+ L+ L L L N L +L ++
Sbjct: 49 DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVS 108
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
+N L +S ++SL+ LDLS N V+P F
Sbjct: 109 HNRLQN---ISCCPMASLRHLDLSFNDFD-VLPVCKEFG 143
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 27/111 (24%), Positives = 48/111 (43%), Gaps = 7/111 (6%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTG-PIPDTLGKLSKLRFLRLNN 146
++L+YL++ N + I + SL LDL N F P+ G L+KL FL L+
Sbjct: 99 NQDLEYLDVSHNRLQN-ISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSA 155
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDL 197
+ L ++ L + + + +S + + SL P + +L
Sbjct: 156 AKFRQ---LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVF 203
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 22/119 (18%), Positives = 36/119 (30%), Gaps = 5/119 (4%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP 130
L + + + +L N T + L L +L L N
Sbjct: 335 MLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN-FF 393
Query: 131 DTLGKLSKLRFLRLNNNSL----SGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSL 185
+ L + SL S + S+ VL+LS+N L+G V +
Sbjct: 394 KVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKV 452
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 24/87 (27%), Positives = 40/87 (45%), Gaps = 5/87 (5%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145
+++ L L SN +TG + L + LDL+ N IP + L L+ L +
Sbjct: 425 AWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVA 481
Query: 146 NNSLSGPIPM-SLTNISSLQVLDLSNN 171
+N L +P ++SLQ + L +N
Sbjct: 482 SNQLKS-VPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 30/106 (28%), Positives = 51/106 (48%), Gaps = 9/106 (8%)
Query: 86 GLLKNLQYLELYSNNIT----GPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
+ KN+ LE ++ S++ L+L N TG + L K++
Sbjct: 397 LMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKV 454
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFT 187
L L+NN + IP +T++ +LQ L++++N+L VPD G F T
Sbjct: 455 LDLHNNRIMS-IPKDVTHLQALQELNVASNQLK-SVPD-GVFDRLT 497
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 14/130 (10%), Positives = 33/130 (25%)
Query: 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNS 124
++ + + + LK+L + + + + L ++
Sbjct: 281 LNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD 340
Query: 125 FTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
S FL N + + + + LQ L L N L
Sbjct: 341 TPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTK 400
Query: 185 LFTPISFANN 194
+ + +
Sbjct: 401 NMSSLETLDV 410
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 28/120 (23%), Positives = 48/120 (40%), Gaps = 7/120 (5%)
Query: 80 QLVS-QLGLLKNLQYLELYSNNITG-PIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLS 137
+L + + +L++L+L N+ P+ + GNLT L L L F + L
Sbjct: 111 RLQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLH 170
Query: 138 -KLRFLRLNNNSLSGPIPMSLT--NISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANN 194
L L + + G SL N + L ++ N+ S V N S + + +N
Sbjct: 171 LSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFS--VQVNMSVNALGHLQLSNI 228
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 30/177 (16%), Positives = 50/177 (28%), Gaps = 8/177 (4%)
Query: 60 TCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPS-DLGNLTSLVSL 118
+ + + G + L +NL L + + + DL L L +L
Sbjct: 6 CPHGSSGLRCTRDGALDS----LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL 61
Query: 119 DLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNN--RLSGV 176
+ + PD +L L L+ N+L + SLQ L LS N S
Sbjct: 62 TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLHCSCA 120
Query: 177 VPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSAT 233
+ + C + P + P S G+
Sbjct: 121 LRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVL 177
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 24/103 (23%), Positives = 45/103 (43%), Gaps = 9/103 (8%)
Query: 88 LKNLQYLELYSNNITGPIPSDL-GNLTSLVSLDLYLNSFTG-PIPDTLGKLSKLRFLRLN 145
L +LQ L N+ + + G+L +L L++ N +P+ L+ L L L+
Sbjct: 99 LSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157
Query: 146 NNSLSGPIPMSLTNISSLQV----LDLSNNRLSGVVPDNGSFS 184
+N + L + + + LDLS N ++ + G+F
Sbjct: 158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI--QPGAFK 198
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 20/89 (22%), Positives = 30/89 (33%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145
L + + L+L N + + L LDL LS L L L
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
N + + + +SSLQ L L+
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLA 113
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 27/94 (28%), Positives = 38/94 (40%), Gaps = 6/94 (6%)
Query: 88 LKNLQYLELYSNNITG-PIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF----L 142
LK L+ L + N I +P NLT+L LDL N L L ++ L
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 143 RLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGV 176
L+ N ++ I L+ L L N+L V
Sbjct: 183 DLSLNPMNF-IQPGAFKEIRLKELALDTNQLKSV 215
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 28/88 (31%), Positives = 42/88 (47%), Gaps = 5/88 (5%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSL----VSLDLYLNSFTGPIPDTLGKLSKLRFLR 143
L NL++L+L SN I +DL L + +SLDL LN P ++ +L+ L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELA 206
Query: 144 LNNNSLSGPIPMSLTNISSLQVLDLSNN 171
L+ N L ++SLQ + L N
Sbjct: 207 LDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 20/81 (24%), Positives = 33/81 (40%), Gaps = 6/81 (7%)
Query: 105 IPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSL-TNISSL 163
IP +L S +LDL N + +L+ L L+ + I ++S L
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHL 78
Query: 164 QVLDLSNNRLSGVVPDNGSFS 184
L L+ N + + G+FS
Sbjct: 79 STLILTGNPIQSLAL--GAFS 97
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 20/100 (20%), Positives = 37/100 (37%), Gaps = 14/100 (14%)
Query: 77 LSGQLVSQL--GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLG 134
+ ++ L L ++ L + NN+T +P+ L +L++ N T +P
Sbjct: 47 VGESGLTTLPDCLPAHITTLVIPDNNLTS-LPALPPELR---TLEVSGNQLTS-LPVLPP 101
Query: 135 KLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
L +L L S L L + N+L+
Sbjct: 102 GLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLT 134
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 24/88 (27%), Positives = 38/88 (43%), Gaps = 12/88 (13%)
Query: 87 LLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L L L ++ N +T +P L L + N +P +L KL N
Sbjct: 119 LPSGLCKLWIFGNQLTS-LPVLPPGLQEL---SVSDNQLAS-LPALPSELCKLW---AYN 170
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNNRLS 174
N L+ +PM + LQ L +S+N+L+
Sbjct: 171 NQLTS-LPMLPSG---LQELSVSDNQLA 194
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 29/121 (23%), Positives = 44/121 (36%), Gaps = 7/121 (5%)
Query: 87 LLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L L+ L + N +T +P L SL +Y N T +P++L LS + L
Sbjct: 239 LPSELKELMVSGNRLTS-LPMLPSGLLSL---SVYRNQLTR-LPESLIHLSSETTVNLEG 293
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPC 206
N LS +L I+S S + + + + A L G P
Sbjct: 294 NPLSERTLQALREITSAP--GYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPA 351
Query: 207 P 207
P
Sbjct: 352 P 352
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 27/105 (25%), Positives = 41/105 (39%), Gaps = 23/105 (21%)
Query: 87 LLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKL---------- 136
L L L Y+N +T +P+ L L+ L S +P +L
Sbjct: 199 LPSELYKLWAYNNRLT-SLPALPSGLKELIVSGNRLTS----LPVLPSELKELMVSGNRL 253
Query: 137 -------SKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
S L L + N L+ +P SL ++SS ++L N LS
Sbjct: 254 TSLPMLPSGLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 26/95 (27%), Positives = 35/95 (36%), Gaps = 12/95 (12%)
Query: 80 QLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKL 139
QL S L L L Y+N +T +P L L + N +P +L KL
Sbjct: 152 QLASLPALPSELCKLWAYNNQLTS-LPMLPSGLQEL---SVSDNQLAS-LPTLPSELYKL 206
Query: 140 RFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
SL S L+ L +S NRL+
Sbjct: 207 WAYNNRLTSLPA-------LPSGLKELIVSGNRLT 234
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 24/95 (25%), Positives = 36/95 (37%), Gaps = 12/95 (12%)
Query: 80 QLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKL 139
L S L L+ LE+ N +T +P L L L S L
Sbjct: 72 NLTSLPALPPELRTLEVSGNQLTS-LPVLPPGLLELSIFSNPLTHLP-------ALPSGL 123
Query: 140 RFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
L + N L+ +P+ LQ L +S+N+L+
Sbjct: 124 CKLWIFGNQLTS-LPVLPPG---LQELSVSDNQLA 154
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 18/94 (19%), Positives = 36/94 (38%), Gaps = 9/94 (9%)
Query: 87 LLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L L + + +T +P L + +L + N+ T +P +L R L ++
Sbjct: 38 LNNGNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLTS-LPALPPEL---RTLEVSG 90
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN 180
N L+ +P+ + L + L +P
Sbjct: 91 NQLTS-LPVLPPGLLELSIFSNPLTHLP-ALPSG 122
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 18/93 (19%), Positives = 39/93 (41%), Gaps = 6/93 (6%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
V L N L ++T + L+ + + + ++ + + L+
Sbjct: 12 VFPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAG--MQFFTNLKE 67
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
L L++N +S P L +++ L+ L ++ NRL
Sbjct: 68 LHLSHNQISDLSP--LKDLTKLEELSVNRNRLK 98
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 6e-11
Identities = 28/115 (24%), Positives = 40/115 (34%), Gaps = 12/115 (10%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNL--TSLVSLDLYLNSFTGPIPDTLGKLSKL 139
+S L L L+ L + N + +L + L L L N L L L
Sbjct: 78 LSPLKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNELRDTDS--LIHLKNL 130
Query: 140 RFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANN 194
L + NN L I L +S L+VLDL N ++ + I
Sbjct: 131 EILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNTGGLTRLKKV-NWIDLTGQ 182
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 29/117 (24%), Positives = 46/117 (39%), Gaps = 17/117 (14%)
Query: 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSF 125
+ ++ +LG +++ + L +Q ++NI + + T+L L L N
Sbjct: 20 NAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKELHLSHNQ- 74
Query: 126 TGPIPD--TLGKLSKLRFLRLNNNSLSGPIPMSLTNIS--SLQVLDLSNNRLSGVVP 178
I D L L+KL L +N N L +L I L L L NN L
Sbjct: 75 ---ISDLSPLKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNELRDTDS 123
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 8e-06
Identities = 18/95 (18%), Positives = 30/95 (31%), Gaps = 4/95 (4%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
+ LG L L+ L+L+ N IT L L + +DL +L
Sbjct: 143 IVMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNT 200
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGV 176
++ + P +S N S +
Sbjct: 201 VKDPDGRWISPYYIS--NGGSYVDGCVLWELPVYT 233
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 28/124 (22%), Positives = 48/124 (38%), Gaps = 22/124 (17%)
Query: 89 KNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNS 148
+++ L L ++T + L L + LDL N +P L L L L+ ++N+
Sbjct: 441 ADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNA 497
Query: 149 LSGPIPMSLTNIS---SLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNL---DLCG-PV 201
L ++ ++ LQ L L NNRL + P+ L +L G +
Sbjct: 498 LE-----NVDGVANLPRLQELLLCNNRLQ-------QSAAIQPLVSCPRLVLLNLQGNSL 545
Query: 202 TGRP 205
Sbjct: 546 CQEE 549
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 3e-06
Identities = 25/141 (17%), Positives = 46/141 (32%), Gaps = 8/141 (5%)
Query: 35 NLIDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAALSGQLVSQLGL-LKNLQY 93
+ ++ LQ +P W +T + L + + Y
Sbjct: 366 SELESCKELQELEPE----NKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAY 421
Query: 94 LELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPI 153
L+ + + L L T + L +L + L L++N L +
Sbjct: 422 LDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-L 478
Query: 154 PMSLTNISSLQVLDLSNNRLS 174
P +L + L+VL S+N L
Sbjct: 479 PPALAALRCLEVLQASDNALE 499
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 25/84 (29%), Positives = 35/84 (41%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
L++L L LY N IT S L SL L L N D L L L L +N
Sbjct: 79 LRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDN 138
Query: 148 SLSGPIPMSLTNISSLQVLDLSNN 171
L + + + ++Q + L+ N
Sbjct: 139 KLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 30/104 (28%), Positives = 48/104 (46%), Gaps = 4/104 (3%)
Query: 88 LKNLQYLELYSNNITGPIPSDL-GNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
K L+ ++L +N I+ + D L SL SL LY N T L L+ L LN
Sbjct: 55 YKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNA 113
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPIS 190
N ++ + ++ +L +L L +N+L + G+FS I
Sbjct: 114 NKINCLRVDAFQDLHNLNLLSLYDNKLQTI--AKGTFSPLRAIQ 155
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 22/95 (23%), Positives = 36/95 (37%), Gaps = 2/95 (2%)
Query: 90 NLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSL 149
+ + L N I P L +DL N + PD L L L L N +
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92
Query: 150 SGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
+ + SLQ+L L+ N+++ + +F
Sbjct: 93 TELPKSLFEGLFSLQLLLLNANKINCL--RVDAFQ 125
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 19/70 (27%), Positives = 33/70 (47%), Gaps = 2/70 (2%)
Query: 105 IPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQ 164
IP++L ++ + L N+ P KLR + L+NN +S P + + SL
Sbjct: 26 IPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLN 83
Query: 165 VLDLSNNRLS 174
L L N+++
Sbjct: 84 SLVLYGNKIT 93
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 18/114 (15%), Positives = 39/114 (34%), Gaps = 6/114 (5%)
Query: 87 LLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYL----NSFTGPIPDTLGKLSKLRFL 142
L ++L+ L++ +N + +P+ +++ N T IP+ + L +
Sbjct: 178 LPESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTI 235
Query: 143 RLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196
L +N LS I SL+ ++ S + +
Sbjct: 236 ILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFP 289
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 26/146 (17%), Positives = 51/146 (34%), Gaps = 10/146 (6%)
Query: 80 QLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKL 139
QL L +L+ L + +N +T +P +L +L D+ N +P +
Sbjct: 151 QLTMLPELPTSLEVLSVRNNQLTF-LPELPESLEAL---DVSTNLLES-LPAVPVRNHHS 205
Query: 140 R----FLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNL 195
F R N ++ IP ++ ++ + L +N LS + ++ S P +
Sbjct: 206 EETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRI 264
Query: 196 DLCGPVTGRPCPGSPPFSPPPPFIPP 221
+ P + P
Sbjct: 265 YFSMSDGQQNTLHRPLADAVTAWFPE 290
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 25/127 (19%), Positives = 48/127 (37%), Gaps = 31/127 (24%)
Query: 71 DLGNAALSG----QLVSQL--GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNS 124
AL G + VS L L+ L+L N++ +P +L + L++ N+
Sbjct: 35 KWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNA 91
Query: 125 FTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTN-----------------ISSLQVLD 167
+P+ L +L +N LS +P + + L+ ++
Sbjct: 92 LI-SLPELPASL---EYLDACDNRLST-LPELPASLKHLDVDNNQLTMLPELPALLEYIN 146
Query: 168 LSNNRLS 174
NN+L+
Sbjct: 147 ADNNQLT 153
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 23/116 (19%), Positives = 41/116 (35%), Gaps = 11/116 (9%)
Query: 61 CNNDNSVIRVDLGN--AALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSL 118
NN+ S+ + N + S + N + L + L
Sbjct: 7 INNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSEL 64
Query: 119 DLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
L + + +PD L ++ L + N+L +P + L+ LD +NRLS
Sbjct: 65 QLNRLNLSS-LPDNLPP--QITVLEITQNALI-SLPELPAS---LEYLDACDNRLS 113
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 50/224 (22%), Positives = 86/224 (38%), Gaps = 38/224 (16%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQT---------EV 344
+ N +G G G V VA+K+L FQ E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR--------PFQNQTHAKRAYREL 75
Query: 345 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPYMANGSVASCLRERPPSQLPLDWP 397
++ H+N++ L TP + L +V M + ++ ++ LD
Sbjct: 76 VLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELM-DANLCQVIQM------ELDHE 127
Query: 398 TRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457
+ G+ +LH IIHRD+K +NI++ + + DFGLA+ + +
Sbjct: 128 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFM 182
Query: 458 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
T T + APE + E D++ G ++ E+I G F
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 47/234 (20%), Positives = 90/234 (38%), Gaps = 57/234 (24%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISM-----------A 350
LG G F V+ + + + + VA+K ++ ++ + E++++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 351 VHRNLLRLRGF-----------CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTR 399
++L+L M E L ++ + +++ +PL
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMV-FEVL-------GENLLALIKKYEHRGIPL--IYV 133
Query: 400 KRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE------FEAVVGDFGLAKLMDYK 453
K+I+ GL Y+H C IIH D+K N+L++ + + D G A +
Sbjct: 134 KQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWY 188
Query: 454 DTHVTTAV-----RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 502
D H T ++ R +PE L D++ ++ ELITG F+
Sbjct: 189 DEHYTNSIQTREYR------SPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 22/97 (22%), Positives = 41/97 (42%), Gaps = 2/97 (2%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
L L+ + +N IT + + + L N L L+ L L +N
Sbjct: 56 LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSN 115
Query: 148 SLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS 184
++ S +SS+++L L +N+++ V P G+F
Sbjct: 116 RITCVGNDSFIGLSSVRLLSLYDNQITTVAP--GAFD 150
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-10
Identities = 23/84 (27%), Positives = 35/84 (41%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
+ + L SN + L SL +L L N T D+ LS +R L L +N
Sbjct: 80 ASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDN 139
Query: 148 SLSGPIPMSLTNISSLQVLDLSNN 171
++ P + + SL L+L N
Sbjct: 140 QITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 20/80 (25%), Positives = 32/80 (40%), Gaps = 5/80 (6%)
Query: 105 IPSDLGNLTSLVSLDLYLNSFTG-PIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSL 163
IP + L L N FT KL +LR + +NN ++ + S +
Sbjct: 26 IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83
Query: 164 QVLDLSNNRLSGVVPDNGSF 183
+ L++NRL V + F
Sbjct: 84 NEILLTSNRLENV--QHKMF 101
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 54/227 (23%), Positives = 93/227 (40%), Gaps = 45/227 (19%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQT---------EV 344
++ + +G G +G V G VA+K+L FQ+ E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--------PFQSEIFAKRAYREL 74
Query: 345 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPYMANGSVASCLRERPPSQLPLDWP 397
++ H N++ L TP L LV P+M + +
Sbjct: 75 LLLKHMQHENVIGLLD-VFTPASSLRNFYDFYLVMPFM-QTDLQKIMGL------KFSEE 126
Query: 398 TRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH- 456
+ + +GL Y+H ++HRD+K N+ ++E+ E + DFGLA+ D + T
Sbjct: 127 KIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY 183
Query: 457 -VTTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
VT R APE LS ++ D++ G ++ E++TG+ F
Sbjct: 184 VVTRWYR------APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 30/94 (31%), Positives = 42/94 (44%), Gaps = 10/94 (10%)
Query: 88 LKNLQYLELYSNNITGPIPSDL-GNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
LKNL+ L + N + +P + L +L L L N P L+KL +L L
Sbjct: 84 LKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGY 142
Query: 147 NSLSGPIPM----SLTNISSLQVLDLSNNRLSGV 176
N L +P LT+ L+ L L NN+L V
Sbjct: 143 NELQS-LPKGVFDKLTS---LKELRLYNNQLKRV 172
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 21/86 (24%), Positives = 35/86 (40%), Gaps = 2/86 (2%)
Query: 90 NLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSL 149
+ + L+L SN ++ LT L L L N +L L L + +N L
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKL 97
Query: 150 SGPIPMSL-TNISSLQVLDLSNNRLS 174
+P+ + + +L L L N+L
Sbjct: 98 QA-LPIGVFDQLVNLAELRLDRNQLK 122
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 27/85 (31%), Positives = 40/85 (47%), Gaps = 2/85 (2%)
Query: 88 LKNLQYLELYSNNITGPIPSDL-GNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L L YL L N + +P + LTSL L LY N KL++L+ L+L+N
Sbjct: 132 LTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDN 190
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNN 171
N L + ++ L++L L N
Sbjct: 191 NQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 30/91 (32%), Positives = 43/91 (47%), Gaps = 4/91 (4%)
Query: 88 LKNLQYLELYSNNITGPIPSDL-GNLTSLVSLDLYLNSFTGPIPDTL-GKLSKLRFLRLN 145
L NL L L N + +P + +LT L L L N +P + KL+ L+ LRL
Sbjct: 108 LVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLY 165
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGV 176
NN L + ++ L+ L L NN+L V
Sbjct: 166 NNQLKRVPEGAFDKLTELKTLKLDNNQLKRV 196
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 37/165 (22%), Positives = 58/165 (35%), Gaps = 36/165 (21%)
Query: 301 KNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVE-MISMAVHRNLLRL 358
+LG G GKV + A+K L++ + + EVE + +++R+
Sbjct: 23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRI 76
Query: 359 RGFCMTPTER----LLVYPYMANG--------SVASCLRERPPSQLPLDWPTRKRIALGS 406
L+V + G ER S++ + +G
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI-----MKS---IGE 128
Query: 407 ARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 448
A + YLH I HRDVK N+L + DFG AK
Sbjct: 129 A--IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 28/95 (29%), Positives = 46/95 (48%), Gaps = 11/95 (11%)
Query: 83 SQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFL 142
+ L LK ++L L +NNI I S L + +L L L N I + L L
Sbjct: 42 ATLSTLKACKHLALSTNNIEK-I-SSLSGMENLRILSLGRNLIKK-IENLDAVADTLEEL 98
Query: 143 RLNNNSLSGPIPMSLTNIS---SLQVLDLSNNRLS 174
++ N ++ SL+ I +L+VL +SNN+++
Sbjct: 99 WISYNQIA-----SLSGIEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 20/89 (22%), Positives = 36/89 (40%), Gaps = 6/89 (6%)
Query: 88 LKNLQYLELY--SNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145
+ +EL+ I + + L L + L L N+ I +L + LR L L
Sbjct: 22 ATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLG 78
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
N + I +L+ L +S N+++
Sbjct: 79 RNLIKK-IENLDAVADTLEELWISYNQIA 106
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 28/104 (26%), Positives = 46/104 (44%), Gaps = 10/104 (9%)
Query: 85 LGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLN---SFTGPIPDTLGKLSKLRF 141
L ++NL+ L L N I I + +L L + N S +G + KL LR
Sbjct: 66 LSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASLSG-----IEKLVNLRV 119
Query: 142 LRLNNNSLSGPIPMS-LTNISSLQVLDLSNNRLSGVVPDNGSFS 184
L ++NN ++ + L + L+ L L+ N L +N + S
Sbjct: 120 LYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATS 163
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 51/225 (22%), Positives = 85/225 (37%), Gaps = 40/225 (17%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQT---------EV 344
+ N +G G G V VA+K+L FQ E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR--------PFQNQTHAKRAYREL 112
Query: 345 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPYMANGSVASCLRERPPSQLPLDWP 397
++ H+N++ L TP + L LV M + L + +L
Sbjct: 113 VLMKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMD-----ANLCQVIQMEL---DH 163
Query: 398 TRKRIALGSA-RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 456
R L G+ +LH IIHRD+K +NI++ + + DFGLA+ +
Sbjct: 164 ERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSF 218
Query: 457 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
+ T T + APE + E D++ G ++ E++ + F
Sbjct: 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 45/223 (20%), Positives = 86/223 (38%), Gaps = 42/223 (18%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK---EERTPGGELQFQTEVEMI-SM 349
D + LGRG + +V++ + + V VK LK +++ + E++++ ++
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI-------KREIKILENL 87
Query: 350 AVHRNLLRLRGFCMTPTER--LLVYPYMANGSVASCLRERPPS-------QLPLDWPTRK 400
N++ L P R LV+ ++ N + ++
Sbjct: 88 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEI-------- 139
Query: 401 RIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTT 459
+ L Y H I+HRDVK N+++D E + + D+GLA+ +
Sbjct: 140 ------LKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NV 189
Query: 460 AVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAF 501
V + PE L + D++ G ML +I + F
Sbjct: 190 RV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 44/227 (19%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQT---------EV 344
+ + +G G +G V G+ VA+K+L FQ+ E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--------PFQSELFAKRAYREL 75
Query: 345 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPYMANGSVASCLRERPPSQLPLDWP 397
++ H N++ L TP E L LV P+M + L + + L
Sbjct: 76 RLLKHMRHENVIGLLD-VFTPDETLDDFTDFYLVMPFMG-----TDLGKLMKHE-KLGED 128
Query: 398 TRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH- 456
+ + +GL Y+H IIHRD+K N+ ++E+ E + DFGLA+ D + T
Sbjct: 129 RIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY 185
Query: 457 -VTTAVRGTIGHIAPEY-LSTGKSSEKTDVFGYGIMLLELITGQRAF 501
VT R APE L+ + ++ D++ G ++ E+ITG+ F
Sbjct: 186 VVTRWYR------APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 4e-09
Identities = 29/96 (30%), Positives = 44/96 (45%), Gaps = 11/96 (11%)
Query: 92 QYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSG 151
L L N T +P +L N L +DL N + + +++L L L+ N L
Sbjct: 34 TELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC 92
Query: 152 PIP----MSLTNISSLQVLDLSNNRLSGVVPDNGSF 183
IP L + L++L L N +S VVP+ G+F
Sbjct: 93 -IPPRTFDGLKS---LRLLSLHGNDIS-VVPE-GAF 122
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 25/85 (29%), Positives = 41/85 (48%), Gaps = 2/85 (2%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
K+L ++L +N I+ N+T L++L L N P T L LR L L+ N
Sbjct: 53 YKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGN 112
Query: 148 SLSGPIPM-SLTNISSLQVLDLSNN 171
+S +P + ++S+L L + N
Sbjct: 113 DISV-VPEGAFNDLSALSHLAIGAN 136
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 38/195 (19%), Positives = 64/195 (32%), Gaps = 35/195 (17%)
Query: 304 LGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEVEMI-------------SM 349
+G GGFG +Y A +K E G L + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 350 AVHRNLLRLRGFCMTPTE----RLLVYPYMANG-SVASCLRERPPSQLPLDWPTRKRIAL 404
+ + G +T + R +V + G + + T ++ +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNG--TFKKS--TVLQLGI 158
Query: 405 GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKD--THVTTA 460
L Y+H++ +H D+KAAN+LL + V D+GL+ Y H
Sbjct: 159 RMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYR--YCPNGNHKQYQ 213
Query: 461 VRGTIGHI-APEYLS 474
GH E+ S
Sbjct: 214 ENPRKGHNGTIEFTS 228
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 58/227 (25%), Positives = 95/227 (41%), Gaps = 44/227 (19%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQT---------EV 344
+ + N + +G G +G V G VAVK+L FQ+ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--------PFQSIIHAKRTYREL 79
Query: 345 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPYMANGSVASCLRERPPSQLPLDWP 397
++ H N++ L TP L LV M + + ++ Q L
Sbjct: 80 RLLKHMKHENVIGLLD-VFTPARSLEEFNDVYLVTHLM-GADLNNIVK----CQ-KLTDD 132
Query: 398 TRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-- 455
+ + RGL Y+H IIHRD+K +N+ ++E+ E + DFGLA+ + T
Sbjct: 133 HVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189
Query: 456 HVTTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
T R APE L+ ++ D++ G ++ EL+TG+ F
Sbjct: 190 VATRWYR------APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 24/85 (28%), Positives = 33/85 (38%), Gaps = 6/85 (7%)
Query: 92 QYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN---S 148
+ L+L S + + LT L L+L N L++L L L NN S
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 149 LSGPIPMSLTNISSLQVLDLSNNRL 173
L + LT L L L N+L
Sbjct: 98 LPLGVFDHLTQ---LDKLYLGGNQL 119
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 42/118 (35%), Positives = 52/118 (44%), Gaps = 16/118 (13%)
Query: 88 LKNLQYLELYSNNITGPIPSDL-GNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L L L L +N + +P + +LT L L L N +L+KL+ LRLN
Sbjct: 82 LTELGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNT 140
Query: 147 NSLSGPIPM----SLTNISSLQVLDLSNNRLSGVVPDNGSF----SLFTPISFANNLD 196
N L IP LTN LQ L LS N+L VP G+F L T F N D
Sbjct: 141 NQLQS-IPAGAFDKLTN---LQTLSLSTNQLQS-VPH-GAFDRLGKLQTITLFGNQFD 192
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 32/118 (27%), Positives = 49/118 (41%), Gaps = 14/118 (11%)
Query: 71 DLGNAALSGQLVSQLG-LLKNLQYLELYSNNIT----GPIPSDLGNLTSLVSLDLYLNSF 125
D+ LS ++L LL+ Q + L +T I S L +L L+L N
Sbjct: 9 DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNEL 68
Query: 126 TGP----IPDTLGKLS-KLRFLRLNNNSLS----GPIPMSLTNISSLQVLDLSNNRLS 174
+ L S K++ L L N L+ G + +L + +LQ L LS+N L
Sbjct: 69 GDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 126
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 29/127 (22%), Positives = 49/127 (38%), Gaps = 18/127 (14%)
Query: 66 SVIRVDLGNAALSGQLVSQLG-LLKN----LQYLELYSNNIT----GPIPSDLGNLTSLV 116
++ ++L + L V + L+ +Q L L + +T G + S L L +L
Sbjct: 57 ALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQ 116
Query: 117 SLDLYLNSFTGPIPDTLGKL-----SKLRFLRLNNNSLS----GPIPMSLTNISSLQVLD 167
L L N L + +L L+L SLS P+ L + L
Sbjct: 117 ELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELT 176
Query: 168 LSNNRLS 174
+SNN ++
Sbjct: 177 VSNNDIN 183
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 24/129 (18%), Positives = 48/129 (37%), Gaps = 19/129 (14%)
Query: 65 NSVIRV-DLGNAALSGQLVSQL--GLLKN---LQYLELYSNNIT----GPIPSDLGNLTS 114
++ L + L + L GLL L+ L+L +++ P+ S L
Sbjct: 112 LPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPD 171
Query: 115 LVSLDLYLNSFTGP----IPDTLGK-LSKLRFLRLNNNSLS----GPIPMSLTNISSLQV 165
L + N + L +L L+L + ++ + + + +SL+
Sbjct: 172 FKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRE 231
Query: 166 LDLSNNRLS 174
L L +N+L
Sbjct: 232 LALGSNKLG 240
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 27/127 (21%), Positives = 44/127 (34%), Gaps = 21/127 (16%)
Query: 90 NLQYLELYSNNIT----GPIPSDLGNLTSLVSLDLYLNSFTGP-----IPDTLGKLSKLR 140
L+ L+L S +T + + + SL L L N P L S+LR
Sbjct: 200 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLR 259
Query: 141 FLRLNNNSLSGP----IPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFAN--- 193
L + ++ + L SL+ L L+ N L D G+ L +
Sbjct: 260 TLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG----DEGARLLCETLLEPGCQL 315
Query: 194 -NLDLCG 199
+L +
Sbjct: 316 ESLWVKS 322
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 27/99 (27%), Positives = 39/99 (39%), Gaps = 13/99 (13%)
Query: 89 KNLQYLELYSNNITG----PIPSDLGNLTSLVSLDLYLNSFTGP----IPDTLGK-LSKL 139
L+ L + S + T S L L+ L + N + LG+ S L
Sbjct: 313 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVL 372
Query: 140 RFLRLNNNSLS----GPIPMSLTNISSLQVLDLSNNRLS 174
R L L + +S + +L SL+ LDLSNN L
Sbjct: 373 RVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 18/96 (18%), Positives = 29/96 (30%), Gaps = 10/96 (10%)
Query: 89 KNLQYLELYSNNITGP-IPSDLGNLTSLVSLDLYLNSFT----GPIPDTLGKLSKLRFLR 143
++Q L++ ++ L L + L T I L L L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 144 LNNNSLSGPIPMSLTNI-----SSLQVLDLSNNRLS 174
L +N L + +Q L L N L+
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 98
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-08
Identities = 21/92 (22%), Positives = 34/92 (36%), Gaps = 3/92 (3%)
Query: 83 SQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFL 142
+Q + L+L I I + L ++D N + D L +L+ L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTL 69
Query: 143 RLNNNSLSGPIPMSLTNISSLQVLDLSNNRLS 174
+NNN + + L L L+NN L
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 20/86 (23%), Positives = 29/86 (33%), Gaps = 3/86 (3%)
Query: 87 LLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L ++ N I + L L +L + N L L L L N
Sbjct: 40 TLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTN 97
Query: 147 NSLSGPIPMS-LTNISSLQVLDLSNN 171
NSL + L ++ SL L + N
Sbjct: 98 NSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 15/86 (17%), Positives = 29/86 (33%), Gaps = 11/86 (12%)
Query: 94 LELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPI 153
++L + I N LDL I + L + + ++N +
Sbjct: 2 VKLTAELIEQ-AAQ-YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--- 55
Query: 154 PMSLTNISS---LQVLDLSNNRLSGV 176
L L+ L ++NNR+ +
Sbjct: 56 --KLDGFPLLRRLKTLLVNNNRICRI 79
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 34/118 (28%), Positives = 53/118 (44%), Gaps = 16/118 (13%)
Query: 62 NNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLG---NLTSLVSL 118
N NS+ ++ N+ + + V + L N++YL L N + D+ LT+L L
Sbjct: 38 NELNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNKLH-----DISALKELTNLTYL 90
Query: 119 DLYLNSFTGPIPDTLGKLSKLRFLRLNNN---SLSGPIPMSLTNISSLQVLDLSNNRL 173
L N KL+ L+ L L N SL + LTN L L+L++N+L
Sbjct: 91 ILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTN---LTYLNLAHNQL 145
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 32/100 (32%), Positives = 41/100 (41%), Gaps = 10/100 (10%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
L NL+ L L N + LT+L L+L N KL+ L L L+ N
Sbjct: 108 LTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYN 167
Query: 148 SLSGPIPM----SLTNISSLQVLDLSNNRLSGVVPDNGSF 183
L +P LT L+ L L N+L VPD G F
Sbjct: 168 QLQS-LPEGVFDKLTQ---LKDLRLYQNQLKS-VPD-GVF 201
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 30/88 (34%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLG---KLSKLRFLRL 144
L NL YL L N + LT+L LDL N +P+ G KL++L+ LRL
Sbjct: 132 LTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS-LPE--GVFDKLTQLKDLRL 188
Query: 145 NNNSLSGPIPM-SLTNISSLQVLDLSNN 171
N L +P ++SLQ + L +N
Sbjct: 189 YQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 30/103 (29%), Positives = 52/103 (50%), Gaps = 18/103 (17%)
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--------VTT 459
RGL Y+H ++HRD+K +N+LL+ + + DFGLA++ D H T
Sbjct: 139 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 460 AVRGTIGHIAPEY-LSTGKSSEKTDVFGYGIMLLELITGQRAF 501
R APE L++ ++ D++ G +L E+++ + F
Sbjct: 196 WYR------APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 34/212 (16%), Positives = 72/212 (33%), Gaps = 51/212 (24%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQT---------EV 344
D + ++++G G +G V + + +VA+K++ F+ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV--------FEDLIDCKRILREI 103
Query: 345 EMISMAVHRNLLRLRGFCMTPTERL-----LVYPYMANGSVASCLRERPPSQLPLDWPTR 399
+++ H +++++ + +V R
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA---------------DSDFKKLFR 148
Query: 400 KRIALGSA----------RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449
+ L G+ Y+H I+HRD+K AN L++++ V DFGLA+
Sbjct: 149 TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART 205
Query: 450 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 481
+DY + + + K
Sbjct: 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLK 237
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-07
Identities = 22/88 (25%), Positives = 40/88 (45%), Gaps = 3/88 (3%)
Query: 88 LKNLQYLELYSNNIT-GPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
+++ L L ++ G + L L T I + L KL+KL+ L L++
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IAN-LPKLNKLKKLELSD 73
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNNRLS 174
N +SG + + +L L+LS N++
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-07
Identities = 22/94 (23%), Positives = 34/94 (36%), Gaps = 12/94 (12%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGP-IPDTLGKLSKLR 140
++ L L L+ LEL N ++G + +L L+L N + L KL L+
Sbjct: 57 IANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLK 116
Query: 141 FLRLNNNSLSGPI-------PMSLTNISSLQVLD 167
L L N + + L LD
Sbjct: 117 SLDLFNC----EVTNLNDYRENVFKLLPQLTYLD 146
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 39/197 (19%), Positives = 67/197 (34%), Gaps = 37/197 (18%)
Query: 288 LRELQVATDSFSNK----NILGRGGFGKVYKGR---------LADGSLVAVKRLKEERTP 334
L V TD + + R G +Y+ ++K ++
Sbjct: 30 LPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRL 89
Query: 335 GGELQF-QTEVEMISMAVHRNLLRLRGFCMTPT----------ERLLVYPYMANG-SVAS 382
E F Q + + + + L + PT R LV P + G S+ S
Sbjct: 90 FNEQNFFQRAAKPLQVNKWKKLYSTPLLAI-PTCMGFGVHQDKYRFLVLPSL--GRSLQS 146
Query: 383 CLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV- 441
L P L + ++A L +LH++ +H +V A NI +D E ++ V
Sbjct: 147 ALDVSPKHVLSE--RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVT 201
Query: 442 -GDFGLAKLMDYKDTHV 457
+G A Y +
Sbjct: 202 LAGYGFAFR--YCPSGK 216
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 15/105 (14%)
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 467
R + LH +IHRD+K +N+L++ + V DFGLA+++D + + G
Sbjct: 123 RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIID-ESAADNSEPTGQQSG 178
Query: 468 I----------APEY-LSTGKSSEKTDVFGYGIMLLELITGQRAF 501
+ APE L++ K S DV+ G +L EL + F
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 19/104 (18%)
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDTH--------VT 458
RGL Y+H ++HRD+K AN+ ++ E +GDFGLA++MD +H VT
Sbjct: 131 RGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 459 TAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
R +P LS ++ D++ G + E++TG+ F
Sbjct: 188 KWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 45/220 (20%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR------NL 355
++G+G FG+V K VA+K ++ E Q E+ ++ + N+
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 356 LRL------RG-FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR 408
+ + R CMT E L + ++ +++ L P ++ A +
Sbjct: 162 IHMLENFTFRNHICMT-FELL-------SMNLYELIKKNKFQGFSL--PLVRKFAHSILQ 211
Query: 409 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAV--VGDFGLAKLMDYKDTHVTTAV----- 461
L LH + +IIH D+K NILL ++ + V DFG + Y+ V T +
Sbjct: 212 CLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC---YEHQRVYTYIQSRFY 265
Query: 462 RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
R APE + + D++ G +L EL+TG
Sbjct: 266 R------APEVILGARYGMPIDMWSLGCILAELLTGYPLL 299
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.9 bits (123), Expect = 3e-07
Identities = 21/159 (13%), Positives = 54/159 (33%), Gaps = 21/159 (13%)
Query: 34 SNLIDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAALSGQLVSQLG--LLKNL 91
S ++D +L + + + ++ +++ + L +V + L NL
Sbjct: 165 SPVLDAMPLLNNLK---IKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221
Query: 92 QYLELY---SNNITGPIPSDL------GNLTSLVSLDLYLNSFTGPIPDTLGK---LSKL 139
+ L LY + + +L L + + + + L +L
Sbjct: 222 EKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQL 281
Query: 140 RFLRLNNNSLSG----PIPMSLTNISSLQVLDLSNNRLS 174
+ ++ L+ + + I L+ +++ N LS
Sbjct: 282 ETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 47.6 bits (112), Expect = 7e-06
Identities = 30/178 (16%), Positives = 62/178 (34%), Gaps = 23/178 (12%)
Query: 8 LCLILVVHSSWLASANMEGDALHSLRSNLIDPNN-----VLQSWDPTLVNPCTWFHVTCN 62
L + + ++ L+ L SL + +L S P L + V
Sbjct: 174 LNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGV--E 231
Query: 63 NDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGN---LTSLVSLD 119
+ +++ S NL++L + + L L ++D
Sbjct: 232 DYGFDGDMNVFRPLFSK------DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMD 285
Query: 120 LYLNSFTG----PIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQV-LDLSNNR 172
+ T + D + K+ L+F+ + N LS + L SL + +D+S+++
Sbjct: 286 ISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQ--KSLPMKIDVSDSQ 341
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 4e-07
Identities = 24/87 (27%), Positives = 39/87 (44%), Gaps = 4/87 (4%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
++ L L+ +N G I +L L L + + L KL KL+ L L+ N
Sbjct: 26 VREL-VLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLIS-VSN-LPKLPKLKKLELSEN 81
Query: 148 SLSGPIPMSLTNISSLQVLDLSNNRLS 174
+ G + M + +L L+LS N+L
Sbjct: 82 RIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 26/99 (26%), Positives = 35/99 (35%), Gaps = 12/99 (12%)
Query: 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGP-IPDTLGKLSKLR 140
VS L L L+ LEL N I G + L +L L+L N + L KL L+
Sbjct: 64 VSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLK 123
Query: 141 FLRLNNNSLSGPI-------PMSLTNISSLQVLDLSNNR 172
L L N + + L LD +
Sbjct: 124 SLDLFNC----EVTNLNDYRESVFKLLPQLTYLDGYDRE 158
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 19/72 (26%), Positives = 29/72 (40%), Gaps = 9/72 (12%)
Query: 111 NLTSLVSLDLYLNSFT-GPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNIS---SLQVL 166
++ L L G I + L FL L N L S++N+ L+ L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-----SVSNLPKLPKLKKL 76
Query: 167 DLSNNRLSGVVP 178
+LS NR+ G +
Sbjct: 77 ELSENRIFGGLD 88
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 25/115 (21%), Positives = 48/115 (41%), Gaps = 25/115 (21%)
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 467
G +++H+ IIHRD+K AN LL+++ V DFGLA+ ++ +
Sbjct: 140 LGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 468 I---------------------APEYLSTGKS-SEKTDVFGYGIMLLELITGQRA 500
APE + ++ ++ D++ G + EL+ ++
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 7e-07
Identities = 28/97 (28%), Positives = 40/97 (41%), Gaps = 11/97 (11%)
Query: 92 QYLELYSNNITG-PIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLS 150
L L N + G L LV L+L N TG P+ S ++ L+L N +
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 151 GPIPM----SLTNISSLQVLDLSNNRLSGVVPDNGSF 183
I L L+ L+L +N++S V GSF
Sbjct: 92 E-ISNKMFLGLHQ---LKTLNLYDNQISC-VMP-GSF 122
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 25/85 (29%), Positives = 41/85 (48%), Gaps = 2/85 (2%)
Query: 88 LKNLQYLELYSNNITGPIPSDL-GNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L +L LEL N +TG I + + + L L N L +L+ L L +
Sbjct: 53 LPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYD 111
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNN 171
N +S +P S +++SL L+L++N
Sbjct: 112 NQISCVMPGSFEHLNSLTSLNLASN 136
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 51/241 (21%), Positives = 89/241 (36%), Gaps = 43/241 (17%)
Query: 292 QVATDSFSNK----NILGRGGFGKVYKGRLADGSLVAVKR---LKEERTPGGELQFQTEV 344
++ TD + +G+GGFG +Y + V +K E + G L + +
Sbjct: 27 EIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKF 86
Query: 345 -------EMISMAVHRNLLRLRGFC----------MTPTERLLVYPYMANGSVASCLRER 387
E I + L+ G + R ++ GS + E
Sbjct: 87 YQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEA 144
Query: 388 PPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFG 445
+ T +++L L Y+H+H +H D+KA+N+LL+ + V D+G
Sbjct: 145 NAKRFSR--KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYG 199
Query: 446 LAKLMDYKD--THVTTAVRGTIGHI-APEYLST----GKS-SEKTDVFGYGIMLLELITG 497
LA Y H A H E+ S G + S + D+ G +++ +TG
Sbjct: 200 LAY--RYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTG 257
Query: 498 Q 498
Sbjct: 258 H 258
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 27/112 (24%), Positives = 46/112 (41%), Gaps = 24/112 (21%)
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 467
+ + YLH ++HRD+K +NILL+ E V DFGL++ +
Sbjct: 120 KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 468 I--------------------APEY-LSTGKSSEKTDVFGYGIMLLELITGQ 498
APE L + K ++ D++ G +L E++ G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 23/84 (27%), Positives = 35/84 (41%), Gaps = 1/84 (1%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
L L L+L +N +T + L L L + N T +P + +L+ L L L+ N
Sbjct: 87 LTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQN 145
Query: 148 SLSGPIPMSLTNISSLQVLDLSNN 171
L + +SSL L N
Sbjct: 146 QLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 27/90 (30%), Positives = 42/90 (46%), Gaps = 3/90 (3%)
Query: 88 LKNLQYLELYSNNITGPIPSDL-GNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L NL+ L L SN + +P + +LT L LDL N T +L L+ L +
Sbjct: 63 LINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCC 121
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNNRLSGV 176
N L+ +P + ++ L L L N+L +
Sbjct: 122 NKLTE-LPRGIERLTHLTHLALDQNQLKSI 150
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 24/86 (27%), Positives = 35/86 (40%), Gaps = 8/86 (9%)
Query: 92 QYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSG 151
Q L L+ N IT P +L +L L L N L++L L L N L+
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 152 PIPM----SLTNISSLQVLDLSNNRL 173
+P L + L+ L + N+L
Sbjct: 103 -LPSAVFDRLVH---LKELFMCCNKL 124
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 24/73 (32%), Positives = 34/73 (46%), Gaps = 8/73 (10%)
Query: 105 IPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN---SLSGPIPMSLTNIS 161
+P+ G T+ L L+ N T P L L+ L L +N +L + SLT
Sbjct: 34 VPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQ-- 89
Query: 162 SLQVLDLSNNRLS 174
L VLDL N+L+
Sbjct: 90 -LTVLDLGTNQLT 101
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 36/119 (30%), Positives = 47/119 (39%), Gaps = 10/119 (8%)
Query: 69 RVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGP 128
+DL +L L +L L L N + LTSL L+L N
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSL 91
Query: 129 IPDTLGKLSKLRFLRLNNNSLSGPIPM----SLTNISSLQVLDLSNNRLSGVVPDNGSF 183
KL++L+ L LN N L +P LT L+ L L N+L VPD G F
Sbjct: 92 PNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQ---LKDLRLYQNQLKS-VPD-GVF 144
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 26/86 (30%), Positives = 37/86 (43%), Gaps = 8/86 (9%)
Query: 92 QYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSG 151
YL+L +N++ LTSL L L N KL+ L +L L+ N L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 152 PIPM----SLTNISSLQVLDLSNNRL 173
+P LT L+ L L+ N+L
Sbjct: 91 -LPNGVFDKLTQ---LKELALNTNQL 112
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 29/88 (32%), Positives = 41/88 (46%), Gaps = 8/88 (9%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLG---KLSKLRFLRL 144
L +L YL L +N + LT L L L N +PD G KL++L+ LRL
Sbjct: 75 LTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQS-LPD--GVFDKLTQLKDLRL 131
Query: 145 NNNSLSGPIPM-SLTNISSLQVLDLSNN 171
N L +P ++SLQ + L +N
Sbjct: 132 YQNQLKS-VPDGVFDRLTSLQYIWLHDN 158
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 24/114 (21%), Positives = 44/114 (38%), Gaps = 20/114 (17%)
Query: 80 QLVSQLGLLKNLQYLELYSNNITGP----IPSDLGNLTSLVSLDLYLNSFTGPIPDT--- 132
+ + L +++ + L N I + ++ + L + FTG + D
Sbjct: 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI-FTGRVKDEIPE 81
Query: 133 --------LGKLSKLRFLRLNNNSLSG----PIPMSLTNISSLQVLDLSNNRLS 174
L K KL +RL++N+ P+ L+ + L+ L L NN L
Sbjct: 82 ALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG 135
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 31/143 (21%), Positives = 50/143 (34%), Gaps = 33/143 (23%)
Query: 63 NDNSVIRVDLGNAALSGQ----LVSQLGLLKNLQYLELYSNNITGPIPSD---------- 108
D+SV + L + + L + K+L+ E S+ TG + +
Sbjct: 30 EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF-SDIFTGRVKDEIPEALRLLLQ 88
Query: 109 -LGNLTSLVSLDLYLNSFTG----PIPDTLGKLSKLRFLRLNNNSLS------------- 150
L L ++ L N+F P+ D L K + L L L+NN L
Sbjct: 89 ALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQE 148
Query: 151 GPIPMSLTNISSLQVLDLSNNRL 173
+ N L+ + NRL
Sbjct: 149 LAVNKKAKNAPPLRSIICGRNRL 171
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 25/119 (21%), Positives = 43/119 (36%), Gaps = 15/119 (12%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGP----IPSDLGNLTSLVSLDLYLNSFT 126
+ + L+ L + L+ L+L N T + L + +L L L +
Sbjct: 198 GIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
Query: 127 GP----IPDTLGKLS--KLRFLRLNNNSLSGP----IPMSL-TNISSLQVLDLSNNRLS 174
+ D KL L+ LRL N + + + + L L+L+ NR S
Sbjct: 258 ARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 21/133 (15%), Positives = 33/133 (24%), Gaps = 21/133 (15%)
Query: 63 NDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITG----PIPSDLGNLTSLVSL 118
+D RV L+ L L + L N P+ L T L L
Sbjct: 68 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 127
Query: 119 DLYLNSFT-------------GPIPDTLGKLSKLRFLRLNNNSLSGP----IPMSLTNIS 161
L+ N + LR + N L + +
Sbjct: 128 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 187
Query: 162 SLQVLDLSNNRLS 174
L + + N +
Sbjct: 188 LLHTVKMVQNGIR 200
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 38/184 (20%), Positives = 58/184 (31%), Gaps = 62/184 (33%)
Query: 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAA 429
+V+ + + + + + LPL P K+I +GL YLH C +IIH D+K
Sbjct: 122 MVFEVLGH-HLLKWIIKSNYQGLPL--PCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPE 176
Query: 430 NILL-------------------------------------------------DEEFEAV 440
NILL E+ +
Sbjct: 177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVK 236
Query: 441 VGDFGLAKLMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQ 498
+ D G A + T T R + E L + D++ M EL TG
Sbjct: 237 IADLGNACWVHKHFTEDIQTRQYR------SLEVLIGSGYNTPADIWSTACMAFELATGD 290
Query: 499 RAFD 502
F+
Sbjct: 291 YLFE 294
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 9e-06
Identities = 32/96 (33%), Positives = 38/96 (39%), Gaps = 10/96 (10%)
Query: 92 QYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSG 151
LEL SN + LT L L L N KL+KL L L+ N L
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQS 90
Query: 152 PIPM----SLTNISSLQVLDLSNNRLSGVVPDNGSF 183
+P LT L+ L L N+L VPD G F
Sbjct: 91 -LPNGVFDKLTQ---LKELALDTNQLKS-VPD-GIF 120
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 26/86 (30%), Positives = 38/86 (44%), Gaps = 4/86 (4%)
Query: 88 LKNLQYLELYSNNITGPIPSDL-GNLTSLVSLDLYLNSFTGPIPD-TLGKLSKLRFLRLN 145
L L L L N I +P + LT L L L+ N +P+ KL++L+ L L+
Sbjct: 51 LTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHENKLQS-LPNGVFDKLTQLKELALD 108
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNN 171
N L ++SLQ + L N
Sbjct: 109 TNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 46/223 (20%), Positives = 83/223 (37%), Gaps = 47/223 (21%)
Query: 302 NILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISM------AVHRN 354
+++G+G FG+V K + VA+K +K Q Q EV ++ + +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIK--NKKAFLNQAQIEVRLLELMNKHDTEMKYY 117
Query: 355 LLRLRGF-------CMTPTERLLVYPYMANGSVASCLRE--RPPSQLPLDWPTRKRIALG 405
++ L+ C+ E L + L + R + + ++ A
Sbjct: 118 IVHLKRHFMFRNHLCLV-FEML-----------SYNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 406 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV--VGDFGLAKLMDYKDTHVTTAV-- 461
L +L + IIH D+K NILL + + DFG + + +
Sbjct: 166 MCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC---QLGQRIYQYIQS 221
Query: 462 ---RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
R +PE L D++ G +L+E+ TG+ F
Sbjct: 222 RFYR------SPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 32/158 (20%), Positives = 57/158 (36%), Gaps = 19/158 (12%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH-RNLLRLRGF 361
+G G FG +++G L + VA+K E Q + E + + + F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 362 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 421
+LV + G L + + + T A + +H+ +
Sbjct: 75 GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSV--KTVAMAAKQMLARVQSIHEKS---L 127
Query: 422 IHRDVKAANILLDEEFEA-----VVGDFGLAKLMDYKD 454
++RD+K N L+ V DFG+ K Y+D
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK--FYRD 163
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 40/175 (22%), Positives = 60/175 (34%), Gaps = 20/175 (11%)
Query: 287 SLRELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVE 345
S+ L V +F +G G FG++ G+ L VA+K E Q E
Sbjct: 1 SMGVLMVG-PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAPQLHLEYR 56
Query: 346 MISMAVH-RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIAL 404
+ ++ F +V + G L + L T IA+
Sbjct: 57 FYKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSL--KTVLMIAI 112
Query: 405 GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVG-----DFGLAKLMDYKD 454
+ Y+H +I+RDVK N L+ DF LAK +Y D
Sbjct: 113 QLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK--EYID 162
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 40/156 (25%), Positives = 59/156 (37%), Gaps = 17/156 (10%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMIS-MAVHRNLLRLRGF 361
+G G FG +Y G +A G VA+K E Q E ++ M + +R
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 362 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 421
++V + G L + L T +A + Y+H
Sbjct: 74 GAEGDYNVMVMELL--GPSLEDLFNFCSRKFSL--KTVLLLADQMISRIEYIHSKN---F 126
Query: 422 IHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKD 454
IHRDVK N L+ + + DFGLAK Y+D
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAK--KYRD 160
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 18/102 (17%), Positives = 40/102 (39%), Gaps = 16/102 (15%)
Query: 89 KNLQYLELYSNNITGPIPSDLG-----NLTSLVSLDLYLNSFTGP----IPDTLGKLSKL 139
++ L+L +N + ++L +VSL+L LN GP + L L
Sbjct: 196 ASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHL 255
Query: 140 RFLRLNNNSLSGP-------IPMSLTNISSLQVLDLSNNRLS 174
+ + L+ + + + + NI + ++D + +
Sbjct: 256 QTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 25/101 (24%), Positives = 38/101 (37%), Gaps = 15/101 (14%)
Query: 89 KNLQYLELYSNNITGPIPSDLG-----NLTSLVSLDLYLNSFTGPIPDTLGKL-----SK 138
+ L+L NN+ +L S+ SL+L NS D L ++ +
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81
Query: 139 LRFLRLNNNSLSGPIPMSLTNI-----SSLQVLDLSNNRLS 174
+ L L+ N LS L ++ VLDL N S
Sbjct: 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS 122
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 7e-05
Identities = 33/87 (37%), Positives = 40/87 (45%), Gaps = 2/87 (2%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145
G+ Q L LY N IT P LT L LDL N T KL++L L LN
Sbjct: 27 GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86
Query: 146 NNSLSGPIPM-SLTNISSLQVLDLSNN 171
+N L IP + N+ SL + L NN
Sbjct: 87 DNQLKS-IPRGAFDNLKSLTHIWLLNN 112
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 38/158 (24%), Positives = 62/158 (39%), Gaps = 17/158 (10%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMIS-MAVHRNLLRLRGF 361
+G G FG++Y G + VA+K E Q E ++ + + +R F
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 362 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 421
+ +LV + G L +L L T +A + ++H
Sbjct: 72 GVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKS---F 124
Query: 422 IHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTH 456
+HRD+K N L+ + + DFGLAK Y+DT
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKK--YRDTS 160
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 29/87 (33%), Positives = 40/87 (45%), Gaps = 2/87 (2%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145
G+ + Q L L +N IT P +L +L L N T KL++L L LN
Sbjct: 30 GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLN 89
Query: 146 NNSLSGPIPM-SLTNISSLQVLDLSNN 171
+N L IP + N+ SL + L NN
Sbjct: 90 DNHLKS-IPRGAFDNLKSLTHIYLYNN 115
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 43/244 (17%), Positives = 78/244 (31%), Gaps = 77/244 (31%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISM-----AVHRNLL 356
+G G FG+V + + + AVK ++ + E +++ + N++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVR--NIKKYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 357 RLRGF-------CMTPTERLLVYPYMANGSVASCLRE--RPPSQLPLDWPTRKRIALGSA 407
+ G C+ E L L E + K +
Sbjct: 100 KYHGKFMYYDHMCLI-FEPL-----------GPSLYEIITRNNYNGFHIEDIKLYCIEIL 147
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-----------------KLM 450
+ L+YL + H D+K NILLD+ + KL+
Sbjct: 148 KALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 451 D-----YKDTHVTTAV-----RGTIGHIAPE------YLSTGKSSEKTDVFGYGIMLLEL 494
D +K + + + R APE + +D++ +G +L EL
Sbjct: 205 DFGCATFKSDYHGSIINTRQYR------APEVILNLGW------DVSSDMWSFGCVLAEL 252
Query: 495 ITGQ 498
TG
Sbjct: 253 YTGS 256
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 25/133 (18%), Positives = 49/133 (36%), Gaps = 19/133 (14%)
Query: 62 NNDNSVIRVDLGNA-ALSGQLVSQL--GLLKN--LQYLELYSNNITGPIPSDLGNL---- 112
NND + V+L N + + L N ++ + P+ L +
Sbjct: 33 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVN 92
Query: 113 TSLVSLDLYLNSFTGP----IPDTLGKLSKLRFLRLNNNS--LSGPIPMSLTNI----SS 162
+L SL++ N +G + + L + L LR++N S L + M + N+ ++
Sbjct: 93 NTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTT 152
Query: 163 LQVLDLSNNRLSG 175
L +
Sbjct: 153 LLKFGYHFTQQGP 165
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 20/97 (20%), Positives = 34/97 (35%), Gaps = 12/97 (12%)
Query: 90 NLQYLELYSNNITGP----IPSDLGNLTSLVSLDLYLNSFTGP----IPDTLGKLSKLRF 141
+ L L +N +T + L TS+ L L + L + +L+
Sbjct: 156 QITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQE 215
Query: 142 LRLNNNSLSGP----IPMSLTNISSLQVLDLSNNRLS 174
L + N + + SL++L L N LS
Sbjct: 216 LNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS 252
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 42/234 (17%), Positives = 75/234 (32%), Gaps = 61/234 (26%)
Query: 303 ILGRGGFGKVYKG--RLADGSLVAVKRLKEERTPGGELQFQTEVEMISM------AVHRN 354
LG G FGKV + S VA+K ++ + E+ ++
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIR--NVGKYREAARLEINVLKKIKEKDKENKFL 83
Query: 355 LLRLRGF-------CMTPTERLLVYPYMANGSVASCLRE--RPPSQLPLDWPTRKRIALG 405
+ + + C+ E L E + + P P + +A
Sbjct: 84 CVLMSDWFNFHGHMCIA-FELL-----------GKNTFEFLKENNFQPYPLPHVRHMAYQ 131
Query: 406 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-----------KLMD--- 451
L +LH++ ++ H D+K NIL + + + ++ D
Sbjct: 132 LCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 452 --YKDTHVTTAV-----RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQ 498
+ H TT V R PE + ++ DV+ G +L E G
Sbjct: 189 ATFDHEHHTTIVATRHYR------PPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 621 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.88 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.86 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.85 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.85 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.85 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.79 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.79 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.78 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.78 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.76 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.76 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.76 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.76 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.75 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.75 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.74 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.72 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.72 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.71 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.71 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.7 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.7 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.69 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.68 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.68 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.68 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.68 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.68 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.67 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.67 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.66 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.66 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.65 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.65 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.65 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.65 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.65 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.65 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.65 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.65 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.64 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.63 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.63 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.63 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.63 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.63 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.63 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.63 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.63 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.63 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.62 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.62 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.62 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.61 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.61 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.6 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.6 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.6 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.59 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.59 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.59 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.58 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.58 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.58 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.58 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.57 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.57 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.57 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.57 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.57 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.57 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.57 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.56 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.56 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.56 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.56 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.56 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.56 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.55 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.54 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.54 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.54 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.54 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.53 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.53 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.53 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.52 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.52 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.52 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.52 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.51 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.5 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.5 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.5 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.49 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.49 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.49 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.49 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.49 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.47 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.46 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.46 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.46 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.45 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.44 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.44 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.44 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.41 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.4 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.4 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.39 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.37 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.37 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.37 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.35 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.34 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.31 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.3 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.25 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.25 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.24 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.24 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.24 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.23 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.22 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.21 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.17 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.16 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.13 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.02 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.01 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.92 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.91 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.9 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.87 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.77 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.71 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.64 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.63 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.57 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.56 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.51 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.49 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.47 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.42 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.34 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.33 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.28 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.25 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.22 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.22 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.19 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.18 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.03 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.02 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.96 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.82 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.75 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.75 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.72 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.7 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.41 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.38 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.37 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.33 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.26 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.2 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.2 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.19 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.18 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.15 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.14 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.13 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.11 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.09 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.06 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.89 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.87 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.83 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.59 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.2 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 95.85 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.64 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 95.32 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.1 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.58 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.87 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 88.41 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 86.4 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.46 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.19 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 80.13 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-55 Score=440.94 Aligned_cols=258 Identities=24% Similarity=0.387 Sum_probs=211.7
Q ss_pred cCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
+++...+.||+|+||+||+|.+. +++.||||+++.........+|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34556788999999999999862 467899999987665556678999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC
Q 007020 370 LVYPYMANGSVASCLRERPPS------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF 437 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 437 (621)
+|||||++|+|.++|...... ...++|..+..|+.|||+||+|||++ +||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 999999999999999754321 23589999999999999999999999 999999999999999999
Q ss_pred cEEEcccccceecccCCC-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHH
Q 007020 438 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLL 515 (621)
Q Consensus 438 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~ 515 (621)
.+||+|||+|+.....+. .......||+.|||||++.++.++.++|||||||++|||+| |..||.... ..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~--------~~ 254 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--------NQ 254 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC--------HH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--------HH
Confidence 999999999987654332 23345679999999999999999999999999999999999 899995221 11
Q ss_pred HHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 516 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 516 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
+.+..+...... ..+..++..+.+++..||+.||++||||+||++.|+.
T Consensus 255 ~~~~~i~~~~~~----------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 255 DVVEMIRNRQVL----------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HHHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHcCCCC----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 222222221111 1122345779999999999999999999999999986
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-55 Score=438.45 Aligned_cols=258 Identities=25% Similarity=0.417 Sum_probs=211.0
Q ss_pred hcCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCce
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 368 (621)
.++|.+.+.||+|+||+||+|++. ++..||||+++.. ......+|.+|++++++++|||||+++|+|.+++..
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 356778899999999999999863 4778999999754 345567899999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcE
Q 007020 369 LLVYPYMANGSVASCLRERP---------PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 439 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 439 (621)
++|||||++|+|.++++... .....++|..+..|+.||++||+|||++ +||||||||+|||+++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence 99999999999999997642 2234599999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecccCCCee-eecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHH
Q 007020 440 VVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDW 517 (621)
Q Consensus 440 kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~ 517 (621)
||+|||+|+......... .....||+.|||||++.+..++.++|||||||++|||+| |+.||.... ..+.
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~--------~~~~ 239 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--------NNEV 239 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------HHHH
Confidence 999999998765433322 233569999999999999999999999999999999999 899996321 1122
Q ss_pred HHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 518 VKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 518 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
+......... ..+..++.++.+++..||+.||++|||+++|++.|++
T Consensus 240 ~~~i~~~~~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 240 IECITQGRVL----------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp HHHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHcCCCC----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 2222222111 1122334678999999999999999999999999876
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-54 Score=438.99 Aligned_cols=257 Identities=28% Similarity=0.451 Sum_probs=204.5
Q ss_pred cCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
++|.+.+.||+|+||+||+|++. +++.||||+++.. ......+|.+|++++++++|||||+++|+|.+++..+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45677789999999999999853 4788999999754 3455678999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc
Q 007020 370 LVYPYMANGSVASCLRERPP-----------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE 438 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 438 (621)
+|||||++|+|.++++.... ...+++|.++..|+.||++||+|||++ +||||||||+|||+++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 99999999999999986432 123589999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecccCCC-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHH
Q 007020 439 AVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLD 516 (621)
Q Consensus 439 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~ 516 (621)
+||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||.... ..+
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~--------~~~ 268 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS--------NTE 268 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC--------HHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC--------HHH
Confidence 99999999987644332 23345679999999999999999999999999999999999 899996221 112
Q ss_pred HHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 517 WVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 517 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.+..+...... . .+..++.++.+++..||+.||++||||+||+++|+.
T Consensus 269 ~~~~i~~g~~~------~----~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 316 (329)
T 4aoj_A 269 AIDCITQGREL------E----RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 316 (329)
T ss_dssp HHHHHHHTCCC------C----CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHH
T ss_pred HHHHHHcCCCC------C----CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 22222222111 1 122334678999999999999999999999999976
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-54 Score=434.33 Aligned_cols=262 Identities=27% Similarity=0.437 Sum_probs=205.1
Q ss_pred HHHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 291 LQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 291 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
|++..+++.+.+.||+|+||+||+|++.+ .||||+++... .......|.+|+.++++++|||||+++|++.+ +..+
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 44556788889999999999999999753 59999997544 33445679999999999999999999998864 5689
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+|||||++|+|.++++... .++++..+..|+.|||+||+|||++ +||||||||+|||+++++.+||+|||+|+.
T Consensus 108 iVmEy~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATV 181 (307)
T ss_dssp EEEECCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred EEEEcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCcee
Confidence 9999999999999997643 2489999999999999999999999 999999999999999999999999999987
Q ss_pred cccCC-Ceeeecccccccccchhhhcc---CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 450 MDYKD-THVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 450 ~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
..... ........||+.|||||++.+ ..++.++|||||||++|||+||+.||.... . ...+.......
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~-----~---~~~~~~~~~~~ 253 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN-----N---RDQIIFMVGRG 253 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----C---HHHHHHHHHTT
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC-----h---HHHHHHHHhcC
Confidence 65322 233445679999999999964 358999999999999999999999996221 1 11111111111
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 526 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 526 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
...|.+. ....+++..+.+++..||+.||++||||.||++.|+.
T Consensus 254 ----~~~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 254 ----YASPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp ----CCCCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred ----CCCCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1111111 1122345678999999999999999999999998865
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=432.43 Aligned_cols=325 Identities=93% Similarity=1.412 Sum_probs=274.9
Q ss_pred ccCCCCCCcccccCcccccCHHHHHHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHH
Q 007020 268 FDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMI 347 (621)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l 347 (621)
++.+.++++....+..+.++..+++...++|+..+.||+|+||+||+|...+|+.||||+++..........+.+|++++
T Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l 81 (326)
T 3uim_A 2 FDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMI 81 (326)
T ss_dssp -------------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGG
T ss_pred CCCCcccCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHH
Confidence 34566778888888999999999999999999999999999999999998889999999997665444444789999999
Q ss_pred HhccCCceeeeeeeeecCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 007020 348 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVK 427 (621)
Q Consensus 348 ~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 427 (621)
+.++||||+++++++.+++..++||||+++|+|.+++........++++..+..++.|++.||+|||+.+.++|+|||||
T Consensus 82 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlk 161 (326)
T 3uim_A 82 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVK 161 (326)
T ss_dssp GTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCS
T ss_pred HhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCc
Confidence 99999999999999999999999999999999999999876666679999999999999999999999877789999999
Q ss_pred CCCeeeCCCCcEEEcccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCccccccc
Q 007020 428 AANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLA 507 (621)
Q Consensus 428 ~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~ 507 (621)
|+|||++.++.+||+|||+++..............||+.|+|||++.+..++.++||||||+++|+|++|+.||+.....
T Consensus 162 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 241 (326)
T 3uim_A 162 AANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241 (326)
T ss_dssp GGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHT
T ss_pred hhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccc
Confidence 99999999999999999999987665555566667999999999999989999999999999999999999999877666
Q ss_pred CCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCCccchhhhhHh
Q 007020 508 NDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKV 587 (621)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~~~~~~~~~ 587 (621)
........+|+...........+.+.........+....+.+++..||+.||++|||+++|+++|++..+.+.|.+|+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 321 (326)
T 3uim_A 242 NDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKE 321 (326)
T ss_dssp TTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC-----
T ss_pred cccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhhhhhHH
Confidence 77777888999988888888888888888888889999999999999999999999999999999999999999998887
Q ss_pred Hhhhh
Q 007020 588 EVLRQ 592 (621)
Q Consensus 588 ~~~~~ 592 (621)
+..+|
T Consensus 322 ~~~~q 326 (326)
T 3uim_A 322 EMFRQ 326 (326)
T ss_dssp -----
T ss_pred HhhcC
Confidence 77664
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=433.93 Aligned_cols=251 Identities=22% Similarity=0.350 Sum_probs=203.5
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
++|++.+.||+|+||+||+|++. +|+.||||+++.... ......+.+|+.++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 67999999999999999999864 799999999976543 3445679999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
||+||+|.++|.... ...+++..++.|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999997643 23478899999999999999999999 9999999999999999999999999999875432
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 533 (621)
.......+||+.|||||++.+..|+.++|||||||++|||+||+.||.... ..+.+..+..... +
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~~~~------~ 243 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS--------MKNLVLKIISGSF------P 243 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHTCC------C
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHcCCC------C
Confidence 122344679999999999999999999999999999999999999996321 2223333322211 1
Q ss_pred cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 534 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.. ....+.++.+++..||+.||++|||++|+++
T Consensus 244 ~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 PV----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 1122367889999999999999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=426.80 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=206.4
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
+.|+..+.||+|+||+||+|++. +|+.||||++..... .....+.+|+.+++.++|||||++++++.+++..|+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 46888899999999999999875 799999999975432 2344688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
|++|+|.+++... .+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+....
T Consensus 153 ~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 153 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 9999999999763 289999999999999999999999 99999999999999999999999999998765432
Q ss_pred CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ..+.+..+... ..+.
T Consensus 225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~~------~~~~ 289 (346)
T 4fih_A 225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--------PLKAMKMIRDN------LPPR 289 (346)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHS------SCCC
T ss_pred -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHcC------CCCC
Confidence 23455679999999999999999999999999999999999999995221 11112221111 1111
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
+. .....+..+.+++..||+.||++|||++|+++
T Consensus 290 ~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 290 LK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CS--CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 11223467889999999999999999999865
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=437.69 Aligned_cols=269 Identities=26% Similarity=0.390 Sum_probs=220.0
Q ss_pred cCHHHHHHHhcCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhccC-Cceeee
Q 007020 286 FSLRELQVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH-RNLLRL 358 (621)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l 358 (621)
+..++|++..++|++.+.||+|+||+||+|.+. .++.||||+++..........|.+|++++.++.| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 456788899999999999999999999999853 2468999999877666667789999999999965 899999
Q ss_pred eeeeecC-CceEEEEeccCCCchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 007020 359 RGFCMTP-TERLLVYPYMANGSVASCLRERPP------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRD 425 (621)
Q Consensus 359 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 425 (621)
+|+|.++ +..++|||||++|+|.++|+.... ....+++..+..++.|||+||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9998765 568999999999999999976422 123489999999999999999999999 999999
Q ss_pred CCCCCeeeCCCCcEEEcccccceecccCCC-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCccc
Q 007020 426 VKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDL 503 (621)
Q Consensus 426 lk~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~ 503 (621)
|||+|||+++++.+||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987654433 33445679999999999999999999999999999999998 9999963
Q ss_pred ccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 504 ARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.. ....+ ...+.... .+.. +..++.++.+++..||+.||++|||++||+++|+.
T Consensus 291 ~~----~~~~~----~~~i~~g~-----~~~~----p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 291 VK----IDEEF----CRRLKEGT-----RMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp CC----CSHHH----HHHHHHTC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC----HHHHH----HHHHHcCC-----CCCC----CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 21 11111 12221111 1111 12234678999999999999999999999999876
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-52 Score=422.52 Aligned_cols=250 Identities=22% Similarity=0.245 Sum_probs=202.9
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
+.|...++||+|+||+||+|++. +|+.||||+++.... ..+|+.+++.++|||||++++++.+++..|+||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45777889999999999999965 699999999975432 24799999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-cEEEcccccceecccC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYK 453 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~~~~~~ 453 (621)
|+||+|.++++... .+++..+..++.||+.||+|||++ +||||||||+|||++.++ .+||+|||+|+.+...
T Consensus 132 ~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 99999999998653 389999999999999999999999 999999999999999987 6999999999976543
Q ss_pred CCe----eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 454 DTH----VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 454 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
... .....+||+.|||||++.+..++.++|||||||++|||+||+.||.... ........ .......
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~----~~~~~~~i----~~~~~~~- 275 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF----RGPLCLKI----ASEPPPI- 275 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC----CSCCHHHH----HHSCCGG-
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC----HHHHHHHH----HcCCCCc-
Confidence 221 2234579999999999999999999999999999999999999996322 11112111 1111000
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
. ..+...+..+.+++..||+.||++|||+.|+++.|..
T Consensus 276 ---~----~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 276 ---R----EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp ---G----GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---h----hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 0 1122234678899999999999999999999998754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=420.86 Aligned_cols=267 Identities=22% Similarity=0.327 Sum_probs=202.7
Q ss_pred cCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCC----ceEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERLLV 371 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv 371 (621)
++|.+.+.||+|+||+||+|++ +|+.||||+++... .....+..|+..+.+++|||||+++|++.+++ ..++|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 4577788999999999999998 58999999986432 12223445666667889999999999998654 57999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCCeeeCCCCcEEEccccc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH-----CDPKIIHRDVKAANILLDEEFEAVVGDFGL 446 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 446 (621)
||||++|+|.++++... ++|..+.+++.|+++||+|||++ ..++||||||||+|||++.++++||+|||+
T Consensus 80 ~Ey~~~gsL~~~l~~~~-----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCCcHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 99999999999998643 89999999999999999999986 255899999999999999999999999999
Q ss_pred ceecccCCCee---eecccccccccchhhhccC------CCCCcccchhHHHHHHHHHhCCCCcccccccCC-------C
Q 007020 447 AKLMDYKDTHV---TTAVRGTIGHIAPEYLSTG------KSSEKTDVFGYGIMLLELITGQRAFDLARLAND-------D 510 (621)
Q Consensus 447 a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~-------~ 510 (621)
|+......... .....||+.|||||++.+. .++.++|||||||++|||+||..||........ .
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 98876543322 2345799999999999765 357799999999999999999988753221110 1
Q ss_pred cchHHHHHHHHhhhcccccccCccccCcc-cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 511 DVMLLDWVKGLLKEKKLEMLVDPDLQNNY-VEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~-~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
...... +..... ....+|.+.... ..+....+.+++.+||+.||++||||.||++.|++.
T Consensus 235 ~~~~~~-~~~~~~----~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 235 DPSVEE-MRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp SCCHHH-HHHHHT----TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchHHH-HHHHHh----cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 111112 222111 112233332221 234567899999999999999999999999999763
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=412.70 Aligned_cols=245 Identities=24% Similarity=0.379 Sum_probs=196.3
Q ss_pred CcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeec----CCceEEEE
Q 007020 299 SNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERLLVY 372 (621)
Q Consensus 299 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 372 (621)
...+.||+|+||+||+|.+. +++.||+|.+.... .......|.+|++++++++|||||++++++.+ +...++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45567999999999999865 68999999997544 33445679999999999999999999999865 34579999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeeCC-CCcEEEccccccee
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK--IIHRDVKAANILLDE-EFEAVVGDFGLAKL 449 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~~-~~~~kl~DfGla~~ 449 (621)
|||++|+|.+++.... .+++..+..++.||+.||+|||++ + ||||||||+|||++. ++.+||+|||+|+.
T Consensus 109 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 9999999999998643 389999999999999999999998 6 999999999999984 78999999999985
Q ss_pred cccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 450 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
... ......+||+.|||||++.+ .++.++|||||||++|||+||+.||.... ..............
T Consensus 182 ~~~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~-------~~~~~~~~i~~~~~--- 247 (290)
T 3fpq_A 182 KRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQIYRRVTSGVK--- 247 (290)
T ss_dssp CCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHHHHHHHTTTCC---
T ss_pred CCC---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC-------cHHHHHHHHHcCCC---
Confidence 432 23445679999999999865 69999999999999999999999995211 11122222111110
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.+.. ....+.++.+++..||+.||++|||++|+++
T Consensus 248 --~~~~----~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 248 --PASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --CGGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111 1112256889999999999999999999976
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=420.42 Aligned_cols=248 Identities=22% Similarity=0.296 Sum_probs=207.6
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|++.+.||+|+||+||+|+.. +|+.||||++.+.. .......+.+|+++++.++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46889999999999999999864 79999999997542 1233457899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||++||+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999998653 389999999999999999999999 999999999999999999999999999998754
Q ss_pred CC-CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 453 KD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 453 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
.. .......+||+.|||||++.+..++.++||||+||++|||++|+.||.... ..+....+....
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~~~------ 250 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EGLIFAKIIKLE------ 250 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTC------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCC------
Confidence 33 334556789999999999999999999999999999999999999996321 112222222211
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 569 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl 569 (621)
..+.. ..+.++.+++..|++.||++|||++|++
T Consensus 251 -~~~p~----~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 251 -YDFPE----KFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -CCCCT----TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -CCCCc----ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11111 1235688999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=428.22 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=206.8
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
+.|+..+.||+|+||+||+|++. +|+.||||++..... .....+.+|+.+++.++|||||++++++.+++..|+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 56899999999999999999975 699999999975442 3345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
|+||+|.+++.... +++..+..|+.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~~~-----l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHhccC-----CCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 99999999997642 89999999999999999999999 99999999999999999999999999998765432
Q ss_pred CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ..+.+..+... ..+.
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~~------~~~~ 366 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--------PLKAMKMIRDN------LPPR 366 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHS------CCCC
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHcC------CCCC
Confidence 23455679999999999999999999999999999999999999995221 11212222111 1111
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
+. ........+.+++..||+.||++|||++|+++
T Consensus 367 ~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 367 LK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred Cc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 01122367889999999999999999999865
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=405.58 Aligned_cols=246 Identities=22% Similarity=0.355 Sum_probs=191.2
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|++.+.||+|+||+||+|... +|+.||||++++... ......+.+|+.+++.++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999865 799999999975532 233457899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+ +|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 679999998754 389999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCeeeecccccccccchhhhccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
. .......||+.|||||++.+..+ +.++||||+||++|||+||+.||.... .....+...... .
T Consensus 165 ~--~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--------~~~~~~~i~~~~-~---- 229 (275)
T 3hyh_A 165 G--NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--------IPVLFKNISNGV-Y---- 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTC-C----
T ss_pred C--CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcCC-C----
Confidence 2 23345679999999999998876 579999999999999999999996321 122222222211 0
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.+. ...+.++.+++..|++.||++|||++|+++
T Consensus 230 --~~p----~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 --TLP----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp --CCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --CCC----CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111 112357889999999999999999999976
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=412.75 Aligned_cols=243 Identities=24% Similarity=0.327 Sum_probs=194.0
Q ss_pred cCCCcCceeeeccCceEEEEEcC----CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
++|++.+.||+|+||+||+|+.. +++.||||+++.... ......+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999752 478999999975432 2233468899999999999999999999999999999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
|||||+||+|.+++.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999998653 389999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
.... ......+||+.|||||++.+..++.++||||+||++|||+||+.||.... ..+.+..+.+.. .
T Consensus 177 ~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~~~-~--- 243 (304)
T 3ubd_A 177 IDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD--------RKETMTMILKAK-L--- 243 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-C---
T ss_pred cCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC--------HHHHHHHHHcCC-C---
Confidence 4322 23345679999999999999999999999999999999999999996321 112222222211 0
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCH
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 565 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 565 (621)
.. +...+.++.+++..||+.||++|||+
T Consensus 244 ---~~----p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 ---GM----PQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ---CC----CTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ---CC----CCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 11 11223678899999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=407.95 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=191.1
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCC--------
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-------- 366 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 366 (621)
++|+..+.||+|+||+||+|++. +|+.||||+++..........+.+|+++++.++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35888999999999999999865 789999999986665556678999999999999999999999987544
Q ss_pred ----ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEc
Q 007020 367 ----ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 442 (621)
Q Consensus 367 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 442 (621)
..|+|||||++|+|.+++...... ...++..++.++.||++||+|||++ +||||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTI-EERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSG-GGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCC-ChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 368999999999999999865421 1255667889999999999999999 99999999999999999999999
Q ss_pred ccccceecccCCCe-----------eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCc
Q 007020 443 DFGLAKLMDYKDTH-----------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDD 511 (621)
Q Consensus 443 DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~ 511 (621)
|||+|+.+...... .....+||+.|||||++.+..++.++|||||||++|||++ ||....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------ 231 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------ 231 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH------
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc------
Confidence 99999876543221 1234569999999999999999999999999999999996 774211
Q ss_pred chHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 512 VMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.....+... . .... ..........+.+++..||+.||++|||+.|+++
T Consensus 232 -~~~~~~~~~-~--------~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 -ERVRTLTDV-R--------NLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -HHHHHHHHH-H--------TTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHH-h--------cCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011111111 0 1011 1112333456678999999999999999999976
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=396.73 Aligned_cols=263 Identities=20% Similarity=0.297 Sum_probs=200.0
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeec------CC
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMT------PT 366 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 366 (621)
.++|++.+.||+|+||+||+|.+. +|+.||||+++.... ......+.+|+++++.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 357999999999999999999864 799999999976543 3345578899999999999999999998754 36
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccc
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 446 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 446 (621)
..|+|||||+ |+|.+++.... ++++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence 7899999996 68999997643 399999999999999999999999 999999999999999999999999999
Q ss_pred ceecccCC---CeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh
Q 007020 447 AKLMDYKD---THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 522 (621)
Q Consensus 447 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 522 (621)
|+.+.... .......+||+.|||||++.+. .++.++||||+|||+|||++|++||.... .......+....
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~-----~~~~l~~I~~~~ 279 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN-----YVHQLQLIMMVL 279 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS-----HHHHHHHHHHHH
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHhc
Confidence 98764321 2234456799999999998875 46999999999999999999999996321 111111111111
Q ss_pred hhccccc--------------ccCccccC---cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 523 KEKKLEM--------------LVDPDLQN---NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 523 ~~~~~~~--------------~~d~~~~~---~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
....... ...+.... ........++.+++..||..||++|||++|+++
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000 00000000 000112356889999999999999999999865
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=389.37 Aligned_cols=196 Identities=23% Similarity=0.412 Sum_probs=169.3
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC----CCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCce
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 368 (621)
..+.|++.+.||+|+||+||+|+.+ +++.||+|.+.... ...++.+|+++++.+ +|||||++++++.+.++.
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 4578999999999999999999742 47889999986543 244678999999988 699999999999999999
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC-CcEEEcccccc
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLA 447 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfGla 447 (621)
++||||+++|+|.+++.. +++.+++.++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|
T Consensus 96 ~lvmE~~~g~~L~~~~~~-------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILNS-------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEECCCCCCHHHHHTT-------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeCCCcccHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 999999999999999852 88999999999999999999999 99999999999999876 79999999999
Q ss_pred eecccCCC---------------------------eeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCC
Q 007020 448 KLMDYKDT---------------------------HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQR 499 (621)
Q Consensus 448 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~ 499 (621)
+....... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 86542211 112345699999999999876 48999999999999999999999
Q ss_pred Ccc
Q 007020 500 AFD 502 (621)
Q Consensus 500 pf~ 502 (621)
||.
T Consensus 246 Pf~ 248 (361)
T 4f9c_A 246 PFY 248 (361)
T ss_dssp SSS
T ss_pred CCC
Confidence 995
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=381.46 Aligned_cols=279 Identities=40% Similarity=0.680 Sum_probs=238.9
Q ss_pred HHHHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 290 ELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 290 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
++....++|...+.||+|+||+||+|.+.+|+.||||++.... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 3444678999999999999999999998889999999986543 344567899999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+||||+++|+|.+++.........+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 99999999999999987654455689999999999999999999999 999999999999999999999999999986
Q ss_pred cccCC-CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 450 MDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 450 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||...... .......|.........+.
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR--EMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS--SCCCHHHHTHHHHTTTCCC
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH--HHHHHHHHhhhccccccHH
Confidence 54322 22233445899999999999999999999999999999999999999743322 2234556666656666677
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
...++........+....+.+++..||+.||++|||+.+|++.|+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 312 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 7777777777778888999999999999999999999999999986
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=403.40 Aligned_cols=251 Identities=19% Similarity=0.274 Sum_probs=206.8
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
++|++.+.||+|+||+||+|... +|+.||+|+++... ......+.+|+.+|+.++|||||++++++.+++..++||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 67999999999999999999865 79999999997543 34456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC--CcEEEcccccceeccc
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE--FEAVVGDFGLAKLMDY 452 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~DfGla~~~~~ 452 (621)
|+||+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 236 ~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 99999999997542 2389999999999999999999999 99999999999999854 8999999999998754
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
. ......+||+.|||||++.+..++.++||||+||++|||++|+.||.... ..+....+....
T Consensus 310 ~--~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~--------~~~~~~~i~~~~------- 372 (573)
T 3uto_A 310 K--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNVKSCD------- 372 (573)
T ss_dssp T--SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTTC-------
T ss_pred C--CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHhCC-------
Confidence 3 23345679999999999999999999999999999999999999996221 112222221111
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..+...........+.+++..||+.||++|||+.|+++
T Consensus 373 ~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 373 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111111223367889999999999999999999976
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=399.98 Aligned_cols=249 Identities=27% Similarity=0.333 Sum_probs=198.0
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHH---HHHHHHhccCCceeeeeeeeecCCce
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQT---EVEMISMAVHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~ 368 (621)
-++|++.++||+|+||+||+|+.. +|+.||||++++... ......+.. ++.+++.++|||||++++++.+++..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999865 699999999965321 111222333 45666778899999999999999999
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
|+||||++||+|.++|.... .+++..++.++.||+.||+|||++ +||||||||+|||++.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999998653 389999999999999999999999 99999999999999999999999999998
Q ss_pred ecccCCCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 449 LMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
.+... .....+||+.|||||++.+ ..|+.++||||+||++|||++|++||....... .....+..... .
T Consensus 341 ~~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-----~~~i~~~i~~~-~- 410 (689)
T 3v5w_A 341 DFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTLTM-A- 410 (689)
T ss_dssp ECSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-----HHHHHHHHHHC-C-
T ss_pred ecCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHhhcCC-C-
Confidence 76533 2345679999999999974 579999999999999999999999996332111 11111111111 1
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHH
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-----MSEVV 569 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-----~~~vl 569 (621)
... +...+.++.+++..|++.||.+|++ ++||+
T Consensus 411 -----~~~----p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 411 -----VEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp -----CCC----CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred -----CCC----CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 111 1122367889999999999999998 56664
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=354.40 Aligned_cols=250 Identities=21% Similarity=0.323 Sum_probs=206.1
Q ss_pred hcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.++|+..+.||+|+||+||+|.. .+++.||||.+..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 46899999999999999999985 4789999999875443 234568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++|+|.+++.... +++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 98 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 98 YLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CCTTCBHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCCHHHHHhhcC-----CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 999999999998642 88999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 533 (621)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ............ .....
T Consensus 170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~~~~~~~-~~~~~- 238 (297)
T 3fxz_A 170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLIATNGT-PELQN- 238 (297)
T ss_dssp TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHHCS-CCCSC-
T ss_pred cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCC-CCCCC-
Confidence 32 23445699999999999999999999999999999999999999953211 111111111111 01111
Q ss_pred cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 534 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.......+.+++..||+.||++|||++|+++
T Consensus 239 ------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 ------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp ------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1223367889999999999999999999976
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=372.92 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=211.4
Q ss_pred HhcCCCcCceeeeccCceEEEEEc--------CCCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeeec
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRL--------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 364 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 364 (621)
..++|.+.+.||+|+||+||+|.+ .++..||||+++..........+.+|+.+++.+ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 357888999999999999999974 245679999998765555566799999999999 89999999999999
Q ss_pred CCceEEEEeccCCCchhhhhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCee
Q 007020 365 PTERLLVYPYMANGSVASCLRERPPS------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANIL 432 (621)
Q Consensus 365 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nil 432 (621)
.+..++||||+++|+|.+++...... ...+++..+..++.||+.||+|||++ +|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEE
Confidence 99999999999999999999875421 22478999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccceecccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCC
Q 007020 433 LDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDD 510 (621)
Q Consensus 433 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~ 510 (621)
++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~----- 310 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----- 310 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC-----
Confidence 999999999999999876543221 2233457889999999999999999999999999999999 999996321
Q ss_pred cchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 511 DVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.......+ .... .+. .+......+.+++..||+.||++||++.|+++.|+.
T Consensus 311 ~~~~~~~~---~~~~------~~~----~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 361 (370)
T 2psq_A 311 VEELFKLL---KEGH------RMD----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361 (370)
T ss_dssp GGGHHHHH---HTTC------CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHH---hcCC------CCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11111111 1111 011 112234678999999999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=353.11 Aligned_cols=283 Identities=37% Similarity=0.612 Sum_probs=228.6
Q ss_pred cccccCHHHHHHHhcCCCcC------ceeeeccCceEEEEEcCCCcEEEEEEecccC---CchhHHHHHHHHHHHHhccC
Q 007020 282 QLKRFSLRELQVATDSFSNK------NILGRGGFGKVYKGRLADGSLVAVKRLKEER---TPGGELQFQTEVEMISMAVH 352 (621)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h 352 (621)
....++..++..+++.|... +.||+|+||+||+|.. +++.||||.+.... .......+.+|+.+++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 35678899999999998877 8999999999999998 58899999986543 23345678999999999999
Q ss_pred CceeeeeeeeecCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCee
Q 007020 353 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANIL 432 (621)
Q Consensus 353 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nil 432 (621)
|||+++++++.+.+..++||||+++|+|.+++..... ..++++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence 9999999999999999999999999999999875332 23489999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccceecccCCC-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCc
Q 007020 433 LDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDD 511 (621)
Q Consensus 433 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~ 511 (621)
++.++.+||+|||++........ .......||+.|+|||.+.+ .++.++||||||+++|+|++|..||......
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---- 240 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP---- 240 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS----
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch----
Confidence 99999999999999987654322 22334569999999998865 5789999999999999999999999743322
Q ss_pred chHHHHHHHHhhh-cccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 512 VMLLDWVKGLLKE-KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 512 ~~~~~~~~~~~~~-~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
.....+....... ..+...+++.+ ..........+.+++..||+.+|.+|||+++|++.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 241 QLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp SBTTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1222333322221 12233334333 233556778899999999999999999999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=366.61 Aligned_cols=264 Identities=28% Similarity=0.424 Sum_probs=203.6
Q ss_pred HHHHHHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCC
Q 007020 288 LRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 366 (621)
Q Consensus 288 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 366 (621)
..++++..++|++.+.||+|+||+||+|+. +|+.||||++..... ......+.+|++++++++||||+++++++.+..
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 334455677899999999999999999987 588999999876543 333457899999999999999999999999999
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeeCCCCcEEEccc
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDF 444 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~Df 444 (621)
..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCC
Confidence 99999999999999999986432 12378899999999999999999999 8 999999999999999999999999
Q ss_pred ccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhh
Q 007020 445 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 524 (621)
Q Consensus 445 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 524 (621)
|+++..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..+........
T Consensus 184 g~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~--------~~~~~~~~~~~ 254 (309)
T 3p86_A 184 GLSRLKAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN--------PAQVVAAVGFK 254 (309)
T ss_dssp C------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC--------HHHHHHHHHHS
T ss_pred CCCcccccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhc
Confidence 999864432 122334569999999999999999999999999999999999999996321 11111111110
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 525 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 525 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.. .... .......+.+++..||+.||++|||++++++.|+.
T Consensus 255 ~~-----~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~ 295 (309)
T 3p86_A 255 CK-----RLEI----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRP 295 (309)
T ss_dssp CC-----CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC-----CCCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 00 0111 11223678899999999999999999999999976
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=356.63 Aligned_cols=257 Identities=26% Similarity=0.400 Sum_probs=208.8
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.++|...+.||+|+||+||+|.+. +++.||+|.+... .......+.+|+++++.++||||+++++++.+++..++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 467888899999999999999875 6899999988543 34556679999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++|+|.+++..... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CCTTCBHHHHHHHCCT---TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 9999999999987432 389999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCee-------------eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCC-cchHHHHHH
Q 007020 454 DTHV-------------TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD-DVMLLDWVK 519 (621)
Q Consensus 454 ~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~ 519 (621)
.... .....||+.|+|||++.+..++.++||||||+++|||++|..||......... ......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 2211 11456999999999999999999999999999999999999998633221111 111111111
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 520 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 520 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
. .. ....+..+.+++..||+.||++|||++++++.|+..
T Consensus 242 ~-------------~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 242 R-------------YC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp H-------------TC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c-------------cC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 00 111225688999999999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=365.54 Aligned_cols=257 Identities=27% Similarity=0.418 Sum_probs=208.9
Q ss_pred hcCCCcCceeeeccCceEEEEEcC----CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
.++|.+.+.||+|+||+||+|.+. .+..||||+++..........+.+|+.+++.++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467888899999999999999874 3456999999876666667789999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 128 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999975432 389999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCCe--eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 451 DYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 451 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.... ..+...........
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--------~~~~~~~~~~~~~~ 273 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT--------NRDVISSVEEGYRL 273 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC--------HHHHHHHHHTTCCC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC--------HHHHHHHHHcCCCC
Confidence 543222 2223346778999999999999999999999999999999 999995221 11222222111110
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
.........+.+++..||+.||++|||+.+|++.|+..
T Consensus 274 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 274 ----------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11122346789999999999999999999999999873
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=367.40 Aligned_cols=272 Identities=23% Similarity=0.321 Sum_probs=209.8
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc--hhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 369 (621)
..++|++.+.||+|+||+||+|+.. +++.||+|++++.... .....+..|..++..+ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3467889999999999999999865 6889999999765322 2233578899998876 8999999999999999999
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 130 lV~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 9999999999999998643 389999999999999999999999 999999999999999999999999999985
Q ss_pred cccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 450 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
... .........||+.|+|||++.+..++.++|||||||++|||++|+.||..............+++.........
T Consensus 203 ~~~-~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-- 279 (396)
T 4dc2_A 203 GLR-PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-- 279 (396)
T ss_dssp CCC-TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--
T ss_pred ccc-CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--
Confidence 322 22234556799999999999999999999999999999999999999964322211111111222222211111
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHH---HHHHHHhcCCCcc-chhh
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMS---EVVRMLEGDGLAE-RWDE 583 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~---~vl~~L~~~~~~~-~~~~ 583 (621)
.+ +......+.+++..||+.||++||++. .+.+.++...+.. .|+.
T Consensus 280 ----~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~ 329 (396)
T 4dc2_A 280 ----RI----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM 329 (396)
T ss_dssp ----CC----CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHH
T ss_pred ----CC----CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHH
Confidence 11 112236788999999999999999962 4455556665553 4443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=372.75 Aligned_cols=270 Identities=27% Similarity=0.404 Sum_probs=217.3
Q ss_pred ccCHHHHHHHhcCCCcCceeeeccCceEEEEEc------CCCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceee
Q 007020 285 RFSLRELQVATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLR 357 (621)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 357 (621)
.+....+++..++|.+.+.||+|+||.||+|.+ .+++.||||+++..........+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 345677888899999999999999999999972 356899999998766556667899999999999 7999999
Q ss_pred eeeeeecCCc-eEEEEeccCCCchhhhhccCCCC----------------------------------------------
Q 007020 358 LRGFCMTPTE-RLLVYPYMANGSVASCLRERPPS---------------------------------------------- 390 (621)
Q Consensus 358 l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------- 390 (621)
+++++.+.+. .++||||+++|+|.+++......
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999887654 89999999999999999875421
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 391 ----------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 391 ----------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 11288899999999999999999999 99999999999999999999999999998654332
Q ss_pred C-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 455 T-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 455 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
. .......||..|+|||++.+..++.++||||||+++|||++ |..||..... .... ..........
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~----~~~~~~~~~~---- 315 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----DEEF----CRRLKEGTRM---- 315 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC----SHHH----HHHHHHTCCC----
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch----hHHH----HHHHHcCCCC----
Confidence 2 23344568999999999999999999999999999999998 9999963221 1111 1111111110
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.. .......+.+++..||+.||++|||+.+|+++|+.
T Consensus 316 -~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 316 -RA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp -CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 11 11123578899999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=370.82 Aligned_cols=258 Identities=29% Similarity=0.430 Sum_probs=200.1
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC----CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
..++|.+.+.||+|+||+||+|++. ++..||||.++..........+.+|+.+++.++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3468899999999999999999864 577899999987655566678999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+||||+++|+|.++++... ..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 9999999999999998643 2489999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCCee--eecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcc
Q 007020 450 MDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 450 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (621)
........ .....++..|+|||++.+..++.++||||||+++|||++ |+.||.... ..+..........
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~--------~~~~~~~i~~~~~ 268 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS--------NQDVIKAVDEGYR 268 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC--------HHHHHHHHHTTEE
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCC
Confidence 65432221 122235778999999999999999999999999999998 999995221 1122222111111
Q ss_pred cccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 527 ~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
.......+..+.+++..||+.||++||++.+|++.|+..
T Consensus 269 ----------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 269 ----------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ----------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 001112346789999999999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=377.68 Aligned_cols=260 Identities=27% Similarity=0.415 Sum_probs=210.4
Q ss_pred HHHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 291 LQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 291 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
+.+..++|.+.+.||+|+||+||+|.+. +++.||||.++..........+.+|+.+++.++||||+++++++...+..+
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 3445678889999999999999999976 789999999986654455567899999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 189 lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~ 262 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSRE 262 (377)
T ss_dssp EEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence 9999999999999997642 2388999999999999999999999 999999999999999999999999999986
Q ss_pred cccCCCeee-ecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 450 MDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 450 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
......... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.... .....+++ .....
T Consensus 263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~-----~~~~~~~~---~~~~~- 333 (377)
T 3cbl_A 263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS-----NQQTREFV---EKGGR- 333 (377)
T ss_dssp CTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC-----HHHHHHHH---HTTCC-
T ss_pred cCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHH---HcCCC-
Confidence 432211111 11235778999999999899999999999999999998 999995321 11111111 11110
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.. .+..++..+.+++..||+.||++|||+++|++.|++
T Consensus 334 --~~-------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 371 (377)
T 3cbl_A 334 --LP-------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371 (377)
T ss_dssp --CC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CC-------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 01 111233678899999999999999999999999976
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=351.12 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=212.7
Q ss_pred HhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
..++|+..+.||+|+||+||+|.+.++..||+|+++.... ...++.+|++++..++||||+++++++.+....++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 4578889999999999999999998888999999975432 34568999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 84 YISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred ccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 999999999997642 2388999999999999999999999 9999999999999999999999999999876554
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
.........+|..|+|||.+.+..++.++||||||+++|+|++ |+.||+... ............ ....
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~---~~~~ 226 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT--------NSEVVLKVSQGH---RLYR 226 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHHHHHHTTC---CCCC
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC--------hHHHHHHHHcCC---CCCC
Confidence 4444444557788999999999889999999999999999999 999996322 111111111111 1111
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 576 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 576 (621)
+.. ....+.+++..||+.+|++|||+.++++.|+...
T Consensus 227 ~~~-------~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 227 PHL-------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp CTT-------SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CCc-------ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111 1257889999999999999999999999998853
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=357.61 Aligned_cols=248 Identities=23% Similarity=0.358 Sum_probs=205.4
Q ss_pred hcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++.... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45788999999999999999987 579999999997654 3344557889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999997643 288999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCeeeecccccccccchhhhccCCCC-CcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
.. ......||+.|+|||++.+..+. .++||||+||++|+|++|+.||+... ..+......... .
T Consensus 167 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~-~---- 231 (328)
T 3fe3_A 167 GG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN--------LKELRERVLRGK-Y---- 231 (328)
T ss_dssp SC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-C----
T ss_pred CC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-C----
Confidence 22 23455699999999999888765 79999999999999999999996321 122222222211 0
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.. +......+.+++..|++.||.+|||++|+++
T Consensus 232 --~~----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 232 --RI----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp --CC----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred --CC----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 1112357889999999999999999999965
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=350.47 Aligned_cols=255 Identities=25% Similarity=0.433 Sum_probs=210.0
Q ss_pred HhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
..++|+..+.||+|+||+||+|.+.+++.||+|+++.... ...++.+|++++++++||||+++++++.+....++|||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc--CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 3467888999999999999999988889999999975432 34578999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++|+|.+++..... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CCTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCcHHHHHHhcCc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999976432 489999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
.........++..|+|||.+.+..++.++||||+|+++|+|++ |+.||.... ..+......... ....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~--------~~~~~~~~~~~~---~~~~ 228 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDISTGF---RLYK 228 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTC---CCCC
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHHHhcCc---cCCC
Confidence 2222333457788999999999999999999999999999999 999996321 112222221110 1111
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
+. .....+.+++..||+.||++||+++++++.|++
T Consensus 229 ~~-------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 229 PR-------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp CT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC-------cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 11 123678899999999999999999999999976
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=354.58 Aligned_cols=263 Identities=23% Similarity=0.320 Sum_probs=206.8
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
.++|++.+.||+|+||.||+|... +++.||+|.+..... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 567899999999999999999864 689999999865432 33345789999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++|+|.+++.... ++++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999998653 389999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
...........||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ............
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~~~~~~----- 229 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA--------VSIAIKHIQDSV----- 229 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH--------HHHHHHHHSSCC-----
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhhccC-----
Confidence 4433344456699999999999999999999999999999999999999963211 111111111100
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHhcCCCc
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-KMSEVVRMLEGDGLA 578 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-t~~~vl~~L~~~~~~ 578 (621)
+..........+..+.+++..|++.||++|| +++++.+.|+.....
T Consensus 230 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 230 -PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp -CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred -CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 0000011122346788999999999999999 999999999875433
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=354.43 Aligned_cols=275 Identities=18% Similarity=0.214 Sum_probs=216.7
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCC--ceEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLV 371 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 371 (621)
.++|.+.+.||+|+||+||+|... +++.||||+++..........+.+|+++++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467889999999999999999875 589999999976554445667889999999999999999999987665 77999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee----CCCCcEEEcccccc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLA 447 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~DfGla 447 (621)
|||+++|+|.+++..... ...+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999986432 22389999999999999999999999 99999999999999 78888999999999
Q ss_pred eecccCCCeeeecccccccccchhhhc--------cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHH
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLS--------TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 519 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 519 (621)
+...... ......||..|+|||++. +..++.++|||||||++|||++|+.||......... .+.+.
T Consensus 164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~----~~~~~ 237 (319)
T 4euu_A 164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN----KEVMY 237 (319)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC----HHHHH
T ss_pred eecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh----HHHHH
Confidence 8765432 223456999999999986 467899999999999999999999999643222222 22222
Q ss_pred HHhhhcccc---cc---c--------CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCCcc
Q 007020 520 GLLKEKKLE---ML---V--------DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAE 579 (621)
Q Consensus 520 ~~~~~~~~~---~~---~--------d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~ 579 (621)
......... .+ . +..............+.+++..|++.||++|||++|+++...+.....
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~ 311 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRG 311 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC--
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcC
Confidence 222221110 00 0 001112334667788999999999999999999999999988765543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=368.09 Aligned_cols=262 Identities=28% Similarity=0.420 Sum_probs=213.9
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcC--------CCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeee
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLA--------DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCM 363 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 363 (621)
+..++|.+.+.||+|+||+||+|.+. .+..||||+++.........++.+|+++++.+ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34578889999999999999999842 34679999998776666667899999999999 8999999999999
Q ss_pred cCCceEEEEeccCCCchhhhhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 007020 364 TPTERLLVYPYMANGSVASCLRERPPS------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANI 431 (621)
Q Consensus 364 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Ni 431 (621)
.++..++||||+++|+|.+++...... ...+++..++.++.||+.||+|||+. +|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence 999999999999999999999875421 23489999999999999999999999 999999999999
Q ss_pred eeCCCCcEEEcccccceecccCCC-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCC
Q 007020 432 LLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLAND 509 (621)
Q Consensus 432 ll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~ 509 (621)
|++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~---- 298 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---- 298 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC----
Confidence 999999999999999986643322 22333457889999999999999999999999999999999 999995221
Q ss_pred CcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 510 DDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
..+........... .. .......+.+++..||+.||++|||+++|++.|+..
T Consensus 299 ----~~~~~~~~~~~~~~------~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 299 ----VEELFKLLKEGHRM------DK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp ----HHHHHHHHHTTCCC------CC----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHHHcCCCC------CC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11222222111111 11 112236789999999999999999999999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=356.83 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=202.7
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.++|++.+.||+|+||+||+|... +++.||||++...........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 367889999999999999999865 7899999999765544445678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 86 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999997643 389999999999999999999999 9999999999999999999999999999876433
Q ss_pred CC-eeeecccccccccchhhhccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 454 DT-HVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 454 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
.. .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... .......|... . ...
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~----~---~~~ 228 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD---SCQEYSDWKEK----K---TYL 228 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT---TSHHHHHHHTT----C---TTS
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch---HHHHHHHHhcc----c---ccC
Confidence 22 22334569999999999987775 7789999999999999999999963221 11112222111 0 000
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.+ .......+.+++..|++.||++|||++|+++
T Consensus 229 ~~------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 229 NP------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp TT------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred Cc------cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00 1122357789999999999999999999965
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=365.47 Aligned_cols=268 Identities=24% Similarity=0.365 Sum_probs=212.5
Q ss_pred HHHHHhcCCCcCceeeeccCceEEEEEc------CCCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeee
Q 007020 290 ELQVATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFC 362 (621)
Q Consensus 290 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 362 (621)
++++..++|...+.||+|+||+||+|.+ .++..||||+++..........+.+|+.++..+ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4566778999999999999999999985 246689999997655455566799999999999 899999999999
Q ss_pred ecCCceEEEEeccCCCchhhhhccCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 007020 363 MTPTERLLVYPYMANGSVASCLRERPPS-------------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIH 423 (621)
Q Consensus 363 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 423 (621)
...+..++||||+++|+|.+++...... ...+++..+..++.||+.||+|||++ +|+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 9999999999999999999999865321 12378999999999999999999999 9999
Q ss_pred cCCCCCCeeeCCCCcEEEcccccceecccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCc
Q 007020 424 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAF 501 (621)
Q Consensus 424 ~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf 501 (621)
|||||+||+++.++.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||+| |..||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999999876543332 3334557889999999999999999999999999999998 99999
Q ss_pred ccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCC
Q 007020 502 DLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGL 577 (621)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 577 (621)
.... ........+. ... .... .......+.+++..||+.||.+|||+.+|++.|+....
T Consensus 276 ~~~~----~~~~~~~~~~----~~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 276 PGIP----VDANFYKLIQ----NGF-----KMDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp TTCC----CSHHHHHHHH----TTC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ccCC----cHHHHHHHHh----cCC-----CCCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 6322 1111111111 110 0111 11223678999999999999999999999999987533
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=362.28 Aligned_cols=266 Identities=26% Similarity=0.431 Sum_probs=215.3
Q ss_pred HHHHHhcCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeee
Q 007020 290 ELQVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM 363 (621)
Q Consensus 290 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 363 (621)
.+....++|.+.+.||+|+||.||+|.+. +++.||||+++..........+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34456788999999999999999999864 348899999987665556678999999999999999999999999
Q ss_pred cCCceEEEEeccCCCchhhhhccCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 007020 364 TPTERLLVYPYMANGSVASCLRERPPS--------------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIH 423 (621)
Q Consensus 364 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 423 (621)
+.+..++||||+++|+|.+++...... ...+++..++.++.||++||+|||++ +|+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 999999999999999999999874321 14589999999999999999999999 9999
Q ss_pred cCCCCCCeeeCCCCcEEEcccccceecccCCC-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCc
Q 007020 424 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAF 501 (621)
Q Consensus 424 ~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf 501 (621)
|||||+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999986543221 22334458899999999999999999999999999999999 99999
Q ss_pred ccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007020 502 DLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 576 (621)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 576 (621)
.... ..+........ ... .. .......+.+++..||+.||++||++.++++.|++..
T Consensus 278 ~~~~--------~~~~~~~~~~~-~~~-----~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 278 YGMA--------HEEVIYYVRDG-NIL-----AC----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp TTSC--------HHHHHHHHHTT-CCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCC--------hHHHHHHHhCC-CcC-----CC----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 5221 11222222111 111 11 1122367899999999999999999999999998853
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=350.41 Aligned_cols=260 Identities=21% Similarity=0.305 Sum_probs=209.7
Q ss_pred ccCHHHHHHHhcC----------CCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCC
Q 007020 285 RFSLRELQVATDS----------FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 353 (621)
Q Consensus 285 ~~~~~~~~~~~~~----------~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ 353 (621)
.++.+++..+.+. |...+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++.++||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCCT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCC
Confidence 4566666665543 566678999999999999876 79999999987544 33455788999999999999
Q ss_pred ceeeeeeeeecCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee
Q 007020 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL 433 (621)
Q Consensus 354 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill 433 (621)
||+++++++...+..++||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence 9999999999999999999999999999998753 389999999999999999999999 99999999999999
Q ss_pred CCCCcEEEcccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcch
Q 007020 434 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 513 (621)
Q Consensus 434 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~ 513 (621)
+.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~-------- 245 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS-------- 245 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------
T ss_pred CCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------
Confidence 9999999999999987653322 2344569999999999999999999999999999999999999996321
Q ss_pred HHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 514 LLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..+.+...... ..+.... .......+.+++..||+.||++|||++++++
T Consensus 246 ~~~~~~~~~~~------~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 246 PVQAMKRLRDS------PPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHHHHHHHS------SCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHhcC------CCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111211111 1111111 1122357889999999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=382.89 Aligned_cols=265 Identities=26% Similarity=0.384 Sum_probs=215.7
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
++..++|.+.+.||+|+||.||+|.+. ++..||||.++.... ....|.+|+.++++++||||+++++++......++
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 344567888899999999999999976 488999999976432 35679999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
||||+++|+|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 294 v~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp EEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceec
Confidence 9999999999999986432 2388999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
............++..|+|||++.+..++.++|||||||++|||++ |..||.... .....+.+.. ..
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~-----~~~~~~~~~~---~~---- 436 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK---DY---- 436 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GGGHHHHHHT---TC----
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHc---CC----
Confidence 5433223333446789999999999999999999999999999999 999996322 1111121111 10
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCCccch
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERW 581 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~~~ 581 (621)
....+..++..+.+++..||+.||++|||+.+|++.|+........
T Consensus 437 ------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~~~ 482 (495)
T 1opk_A 437 ------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 482 (495)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSSCH
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcccc
Confidence 0011122346789999999999999999999999999987655443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=358.36 Aligned_cols=252 Identities=21% Similarity=0.288 Sum_probs=205.7
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCch-----hHHHHHHHHHHHHhccCCceeeeeeeeecCCce
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-----GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 368 (621)
.+.|.+.+.||+|+||+||+|... +|+.||+|+++...... ....+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467889999999999999999875 68999999997654321 246789999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC----cEEEccc
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 444 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Df 444 (621)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999997643 389999999999999999999999 999999999999998877 7999999
Q ss_pred ccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhh
Q 007020 445 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 524 (621)
Q Consensus 445 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 524 (621)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+....+...
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~--------~~~~~~~i~~~ 233 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANITAV 233 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTT
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhc
Confidence 9998765322 2344569999999999999899999999999999999999999995321 11222222111
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 525 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 525 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. .-.++. ........+.+++..|+..||++|||+.|+++
T Consensus 234 ~---~~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 S---YDFDEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp C---CCCCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred C---CCCCch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 001111 11122367889999999999999999999865
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=351.79 Aligned_cols=261 Identities=25% Similarity=0.383 Sum_probs=202.6
Q ss_pred HhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHh--ccCCceeeeeeeeec----CCc
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISM--AVHRNLLRLRGFCMT----PTE 367 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~ 367 (621)
..++|++.+.||+|+||+||+|++ +++.||||++... ....+..|.+++.. ++||||+++++++.. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 357899999999999999999998 6899999998643 34456667777665 789999999998654 345
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCeeeCCCCcE
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH--------DHCDPKIIHRDVKAANILLDEEFEA 439 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlk~~Nill~~~~~~ 439 (621)
.++||||+++|+|.++++.. .+++..+..++.|++.||+||| +. +|+||||||+|||++.++.+
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred eEEehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence 79999999999999999643 3899999999999999999999 77 99999999999999999999
Q ss_pred EEcccccceecccCCCee---eecccccccccchhhhccC------CCCCcccchhHHHHHHHHHhC----------CCC
Q 007020 440 VVGDFGLAKLMDYKDTHV---TTAVRGTIGHIAPEYLSTG------KSSEKTDVFGYGIMLLELITG----------QRA 500 (621)
Q Consensus 440 kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg----------~~p 500 (621)
||+|||+++......... .....||+.|+|||++.+. .++.++||||||+++|||++| +.|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 999999998765443332 2234699999999999876 345789999999999999999 777
Q ss_pred cccccccCCCcchHHHHHHHHhhhcccccccCcccc-CcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 501 FDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ-NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 501 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
|........ .... +........ ..+... ..........+.+++..||+.||++|||+.+|++.|+++
T Consensus 233 f~~~~~~~~---~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 233 FYDVVPNDP---SFED-MRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTTSCSSC---CHHH-HHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCCCCc---chhh-hhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 753222111 1111 111111111 111111 112335668899999999999999999999999999863
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=359.74 Aligned_cols=264 Identities=27% Similarity=0.410 Sum_probs=214.1
Q ss_pred HHHHhcCCCcCceeeeccCceEEEEEc------CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeec
Q 007020 291 LQVATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT 364 (621)
Q Consensus 291 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 364 (621)
++...++|.+.+.||+|+||.||+|.. .+++.||||+++..........+.+|+.+++.++||||+++++++.+
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 344567889999999999999999975 24588999999876655666789999999999999999999999999
Q ss_pred CCceEEEEeccCCCchhhhhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 007020 365 PTERLLVYPYMANGSVASCLRERPP--------------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHR 424 (621)
Q Consensus 365 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 424 (621)
.+..++||||+++|+|.+++..... ....+++..+..++.||++||+|||++ +|+||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~ 174 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHR 174 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccc
Confidence 9999999999999999999987543 122478899999999999999999999 99999
Q ss_pred CCCCCCeeeCCCCcEEEcccccceecccCCCee-eecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcc
Q 007020 425 DVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFD 502 (621)
Q Consensus 425 Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~ 502 (621)
||||+||+++.++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998765433222 223447889999999999889999999999999999999 999996
Q ss_pred cccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 503 LARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
.... ......+. ... .... .......+.+++..||+.||++||++.++++.|+..
T Consensus 255 ~~~~-----~~~~~~~~----~~~-----~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 255 GIPP-----ERLFNLLK----TGH-----RMER----PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp TCCG-----GGHHHHHH----TTC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCH-----HHHHHHhh----cCC-----cCCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 3221 11111111 111 0111 112336789999999999999999999999999763
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=358.06 Aligned_cols=269 Identities=27% Similarity=0.340 Sum_probs=207.2
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCC----ce
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ER 368 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~ 368 (621)
+..++|++.+.||+|+||+||+|++. ++.||||+++... .....+..|+.+++.++||||+++++++.... ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 34578899999999999999999985 7999999986432 33445667888899999999999999998754 36
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCCeEecCCCCCCeeeCCCCcEEE
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH-------CDPKIIHRDVKAANILLDEEFEAVV 441 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-------~~~~ivH~Dlk~~Nill~~~~~~kl 441 (621)
++||||+++|+|.+++.... +++..+..++.|+++||+|||+. ++++|+||||||+|||++.++.+||
T Consensus 98 ~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKANV-----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEecCCCCCHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 99999999999999997643 89999999999999999999986 2347999999999999999999999
Q ss_pred cccccceecccCCCe-eeecccccccccchhhhccC-----CCCCcccchhHHHHHHHHHhCCCCcccccccCCC-----
Q 007020 442 GDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGIMLLELITGQRAFDLARLANDD----- 510 (621)
Q Consensus 442 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~----- 510 (621)
+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.........
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 999999876543322 23335699999999999863 3456889999999999999999999643221111
Q ss_pred ---cchHHHHHHHHhhhcccccccCccccCc-ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 511 ---DVMLLDWVKGLLKEKKLEMLVDPDLQNN-YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 511 ---~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
......+...... .. ..+.+... ........+.+++..||+.||++|||+++|++.|+.
T Consensus 253 ~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVH-KK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp HCSSCCHHHHHHHHTT-SC----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hccCCchhhhhhhhhc-cc----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 0111122111111 11 11111111 112345679999999999999999999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=365.59 Aligned_cols=261 Identities=21% Similarity=0.298 Sum_probs=209.4
Q ss_pred HHHHHHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeec
Q 007020 288 LRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMT 364 (621)
Q Consensus 288 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 364 (621)
+.+++...++|...+.||+|+||+||+|+.. +++.||+|++++... ......+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455566789999999999999999999875 689999999865221 1122347899999999999999999999999
Q ss_pred CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccc
Q 007020 365 PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 444 (621)
Q Consensus 365 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 444 (621)
....++||||+++|+|.+++.... +++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~~-----~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 999999999999999999997642 88999999999999999999999 9999999999999999999999999
Q ss_pred ccceecccCCCeeeecccccccccchhhhccCC----CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH
Q 007020 445 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 520 (621)
Q Consensus 445 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 520 (621)
|+++..............||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... .......
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~ 284 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSK 284 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHH
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC--------hhhHHHH
Confidence 999876654444445677999999999998765 7889999999999999999999996321 1122222
Q ss_pred HhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 007020 521 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMD--RPKMSEVVRM 571 (621)
Q Consensus 521 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~--RPt~~~vl~~ 571 (621)
+......... +. .......+.+++..|++.+|.+ ||+++||++.
T Consensus 285 i~~~~~~~~~--p~-----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 285 IMNHKNSLTF--PD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHTHHHHCCC--CT-----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred HHhccccccC--CC-----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 2221110011 10 0012367889999999999988 9999998764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=354.31 Aligned_cols=258 Identities=21% Similarity=0.332 Sum_probs=198.6
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcCC----CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCc
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLAD----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 367 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 367 (621)
++..++|++.+.||+|+||+||+|.+.. +..||+|.++..........+.+|+.+++.++||||+++++++. ++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 3445788899999999999999998642 45799999876655556677999999999999999999999974 567
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred cEEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccc
Confidence 899999999999999998643 2489999999999999999999999 9999999999999999999999999999
Q ss_pred eecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcc
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (621)
+..............+++.|+|||++.+..++.++||||||+++|||++ |..||..... ...... ......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~-----~~~~~~---i~~~~~ 235 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVIGR---IENGER 235 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHH---HHTTCC
T ss_pred cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH-----HHHHHH---HHcCCC
Confidence 8765443333334457889999999999999999999999999999997 9999963221 111111 111110
Q ss_pred cccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 527 ~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.. .....+..+.+++..||+.||++|||+.++++.|+.
T Consensus 236 ------~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 236 ------LP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp ------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 00 111233678899999999999999999999999987
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=364.83 Aligned_cols=260 Identities=27% Similarity=0.404 Sum_probs=210.6
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCc
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 367 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 367 (621)
..++|.+.+.||+|+||+||+|.+. +++.||||+++..........+.+|+.+++.++||||+++++++.+...
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3467888999999999999999843 4678999999876666666789999999999999999999999999999
Q ss_pred eEEEEeccCCCchhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC---cEEE
Q 007020 368 RLLVYPYMANGSVASCLRERPP---SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF---EAVV 441 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl 441 (621)
.++||||+++|+|.+++..... ....+++..++.++.||++||+|||++ +|+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEE
Confidence 9999999999999999986432 223589999999999999999999999 999999999999999555 5999
Q ss_pred cccccceecccCC-CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHH
Q 007020 442 GDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVK 519 (621)
Q Consensus 442 ~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 519 (621)
+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |..||.... ..+...
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~--------~~~~~~ 297 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------NQEVLE 297 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHH
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHH
Confidence 9999998653222 122334558899999999999999999999999999999998 999996321 112222
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 520 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 520 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
........ .. .......+.+++..||+.||++||++.+|++.|+.
T Consensus 298 ~i~~~~~~------~~----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 298 FVTSGGRM------DP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp HHHTTCCC------CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHcCCCC------CC----CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 22111111 01 11223578899999999999999999999999976
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=378.05 Aligned_cols=263 Identities=24% Similarity=0.412 Sum_probs=213.4
Q ss_pred HHHHHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCce
Q 007020 289 RELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 289 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 368 (621)
..+++..++|.+.+.||+|+||+||+|.+.++..||||+++... .....+.+|+.+++.++||||+++++++. .+..
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 44566778899999999999999999999888999999997543 34567999999999999999999999986 5678
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
++||||+++|+|.++++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLAR 332 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred EEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence 999999999999999975321 1378889999999999999999999 99999999999999999999999999998
Q ss_pred ecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 449 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
..............++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+...........
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~--------~~~~~~~i~~~~~~ 404 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--------NPEVIRALERGYRM 404 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHHHHHHTCCC
T ss_pred EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCCC
Confidence 654322112223346789999999999999999999999999999999 999995221 11222222111111
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCC
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGL 577 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 577 (621)
.. +..++..+.+++..||+.||++|||+++|++.|++...
T Consensus 405 ---~~-------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 405 ---PR-------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp ---CC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred ---CC-------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 11 12234678999999999999999999999999998643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=351.15 Aligned_cols=264 Identities=22% Similarity=0.301 Sum_probs=202.1
Q ss_pred HhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCc-hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
..++|++.+.||+|+||+||+|...+|+.||+|+++..... .....+.+|+++++.++||||+++++++.++...++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 35788999999999999999999988999999999754432 23456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++ +|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 99 e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCSE-EHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCCC-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99985 8888877643 2388999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccc--
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM-- 529 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 529 (621)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ...+ ..+...........
T Consensus 172 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~-~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 172 PVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD----DDQL-PKIFSILGTPNPREWP 245 (311)
T ss_dssp CCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST----TTHH-HHHHHHHCCCCTTTSG
T ss_pred Ccc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh----HHHH-HHHHHHHCCCChHHhh
Confidence 322 2334468999999999976 4589999999999999999999999963221 1112 11111111100000
Q ss_pred --------------ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 530 --------------LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 530 --------------~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
................++.+++..|++.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000011112357889999999999999999999976
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=357.26 Aligned_cols=264 Identities=27% Similarity=0.416 Sum_probs=214.8
Q ss_pred HHHHhcCCCcCceeeeccCceEEEEEc------CCCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeee
Q 007020 291 LQVATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCM 363 (621)
Q Consensus 291 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 363 (621)
+++..++|...+.||+|+||+||+|.+ .+++.||||+++..........+.+|+.+++++ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 455667899999999999999999974 357899999998766555667899999999999 8999999999999
Q ss_pred cCCceEEEEeccCCCchhhhhccCCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 007020 364 TPTERLLVYPYMANGSVASCLRERPPS--------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAA 429 (621)
Q Consensus 364 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 429 (621)
..+..++||||+++|+|.+++...... ...+++..+..++.|+++||+|||++ +|+||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccc
Confidence 999999999999999999999875421 23489999999999999999999999 9999999999
Q ss_pred CeeeCCCCcEEEcccccceecccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCccccccc
Q 007020 430 NILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLA 507 (621)
Q Consensus 430 Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~ 507 (621)
||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-- 252 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP-- 252 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc--
Confidence 999999999999999999876544332 2334457889999999999999999999999999999999 999996321
Q ss_pred CCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 508 NDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
........+. .. ..... .......+.+++..|++.||.+|||+.++++.|++
T Consensus 253 --~~~~~~~~~~----~~-----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 253 --VDSKFYKMIK----EG-----FRMLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp --SSHHHHHHHH----HT-----CCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --chhHHHHHhc----cC-----CCCCC----cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 1111111111 11 00100 11223678999999999999999999999999976
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=356.06 Aligned_cols=252 Identities=21% Similarity=0.305 Sum_probs=201.6
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCC-------
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------- 366 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 366 (621)
.++|+..+.||+|+||.||+|++. +|+.||||+++..........+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 357888999999999999999976 799999999986665556678999999999999999999999986543
Q ss_pred --------------------------------------------------ceEEEEeccCCCchhhhhccCCCCCCCCCH
Q 007020 367 --------------------------------------------------ERLLVYPYMANGSVASCLRERPPSQLPLDW 396 (621)
Q Consensus 367 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~ 396 (621)
..++||||+++|+|.+++..... ....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 27999999999999999987543 223566
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCC-----------eeeecccccc
Q 007020 397 PTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-----------HVTTAVRGTI 465 (621)
Q Consensus 397 ~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~gt~ 465 (621)
..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 77899999999999999999 999999999999999999999999999987654321 1223346999
Q ss_pred cccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHH
Q 007020 466 GHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVE 545 (621)
Q Consensus 466 ~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 545 (621)
.|+|||++.+..++.++||||||+++|||++|..|+.... ........ . . ..........
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~----------~~~~~~~~-~-----~----~~~~~~~~~~ 300 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV----------RIITDVRN-L-----K----FPLLFTQKYP 300 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH----------HHHHHHHT-T-----C----CCHHHHHHCH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH----------HHHHHhhc-c-----C----CCcccccCCh
Confidence 9999999999999999999999999999999988763110 11111100 0 0 1111233446
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 546 QLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 546 ~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.+.+++..||+.||++|||++|+++
T Consensus 301 ~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 301 QEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHccCCCCcCCCHHHHhh
Confidence 7789999999999999999999976
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=354.55 Aligned_cols=257 Identities=22% Similarity=0.379 Sum_probs=207.4
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
++..++|+..+.||+|+||+||+|.+.++..||+|+++.... ...++.+|++++..++||||+++++++.+....++|
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 344678888999999999999999998888999999975432 345689999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 98 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 98 TEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp ECCCTTCBHHHHHHCGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred EeccCCCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 999999999999976322 389999999999999999999999 99999999999999999999999999998654
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
...........+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.... ..+......... ..
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~--------~~~~~~~~~~~~---~~ 240 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEHIAQGL---RL 240 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHHHHHHTTC---CC
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC--------hhHHHHHHhccc---CC
Confidence 322222233446788999999999999999999999999999998 999996321 111111111110 01
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
..+. .....+.+++..||+.+|++|||++++++.|++
T Consensus 241 ~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 241 YRPH-------LASEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp CCCT-------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC-------cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 1111 112578899999999999999999999999976
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=354.71 Aligned_cols=252 Identities=25% Similarity=0.335 Sum_probs=200.3
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 371 (621)
++|+..+.||+|+||+||+|+.. +++.||+|+++.... ......+.+|..++..+ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57888999999999999999975 689999999976542 23345688999999887 899999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999997643 389999999999999999999999 99999999999999999999999999998543
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||................+.........
T Consensus 162 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 236 (345)
T 3a8x_A 162 RP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 236 (345)
T ss_dssp CT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred CC-CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence 22 2234456799999999999999999999999999999999999999964222111111111222211111111
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 565 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 565 (621)
.+ +......+.+++..|++.||++||++
T Consensus 237 --~~----p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 --RI----PRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp --CC----CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred --CC----CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11 11223678899999999999999996
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=362.36 Aligned_cols=265 Identities=25% Similarity=0.389 Sum_probs=213.7
Q ss_pred HHHHHhcCCCcCceeeeccCceEEEEEcCC------CcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeee
Q 007020 290 ELQVATDSFSNKNILGRGGFGKVYKGRLAD------GSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFC 362 (621)
Q Consensus 290 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 362 (621)
.++...++|...+.||+|+||+||+|.... ...||+|.++..........+.+|+.+++.+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 456677899999999999999999998642 3489999998766556667899999999999 899999999999
Q ss_pred ecCCceEEEEeccCCCchhhhhccCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCee
Q 007020 363 MTPTERLLVYPYMANGSVASCLRERPP----------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANIL 432 (621)
Q Consensus 363 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nil 432 (621)
...+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||++ +|+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence 999999999999999999999875321 123478999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccceecccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCC
Q 007020 433 LDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDD 510 (621)
Q Consensus 433 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~ 510 (621)
++.++.+||+|||++......... ......+|..|+|||.+.+..++.++||||||+++|||++ |..||.... .
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~----~ 272 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL----V 272 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC----S
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc----h
Confidence 999999999999999876543322 2334457889999999999999999999999999999999 999996321 1
Q ss_pred cchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 511 DVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.......+.. ... ...+ ......+.+++..||+.||.+|||+.+|++.|++
T Consensus 273 ~~~~~~~~~~----~~~--~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 273 NSKFYKLVKD----GYQ--MAQP-------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp SHHHHHHHHH----TCC--CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hHHHHHHHhc----CCC--CCCC-------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 1111111111 100 0011 1123678899999999999999999999999987
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=353.01 Aligned_cols=249 Identities=23% Similarity=0.293 Sum_probs=204.3
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
.++|+..+.||+|+||+||+|+.. +|+.||+|+++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367888999999999999999865 68999999997542 122345688999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999997643 388999999999999999999999 99999999999999999999999999998543
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ ..
T Consensus 157 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~-~~---- 222 (337)
T 1o6l_A 157 SD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILME-EI---- 222 (337)
T ss_dssp CT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC-CC----
T ss_pred cC-CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC--------HHHHHHHHHcC-CC----
Confidence 22 223345679999999999999999999999999999999999999995321 11222222211 10
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~ 570 (621)
.+ +......+.+++..|++.||++|| +++++++
T Consensus 223 --~~----p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 --RF----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CC----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CC----CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 11 112236788999999999999999 8888865
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=358.54 Aligned_cols=256 Identities=25% Similarity=0.417 Sum_probs=200.0
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCc----EEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
.++|+..+.||+|+||+||+|.+. +++ .||+|.++..........+.+|+.+++.++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 467888999999999999999864 444 368888876555555678999999999999999999999998754 78
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+|+||+.+|+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 99999999999999987432 389999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 450 MDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 450 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
....... ......+|..|+|||++.+..++.++|||||||++|||++ |+.||+... .......+.. ...
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~~~~~~~~~~---~~~- 237 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILEK---GER- 237 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHHHHT---TCC-
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC-----HHHHHHHHHc---CCC-
Confidence 6543322 2233457889999999999999999999999999999999 999996322 1112121111 100
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
..........+.+++..||+.+|++||++.++++.|+..
T Consensus 238 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 238 ---------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp ---------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 001112336788999999999999999999999999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=349.31 Aligned_cols=251 Identities=18% Similarity=0.248 Sum_probs=205.7
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.++|.+.+.||+|+||+||+|... +++.||+|.++.. ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 467889999999999999999865 6889999998643 3345568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC--CCcEEEcccccceecc
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKLMD 451 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~DfGla~~~~ 451 (621)
|+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||++....
T Consensus 82 ~~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 82 FISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred eCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 999999999997643 2489999999999999999999999 9999999999999987 7899999999998765
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.... ..+.+......... .
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~---~ 222 (321)
T 1tki_A 156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENIMNAEYT---F 222 (321)
T ss_dssp TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCC---C
T ss_pred CCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC--------HHHHHHHHHcCCCC---C
Confidence 332 3344569999999999998888999999999999999999999996321 11222222211110 0
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
+.. .....+..+.+++..|+..||++|||+.|+++
T Consensus 223 ~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 223 DEE----AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CHH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Chh----hhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 100 11122467889999999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=360.98 Aligned_cols=266 Identities=17% Similarity=0.202 Sum_probs=202.2
Q ss_pred HhcCCCcCceeeeccCceEEEEEcCC------CcEEEEEEecccCCchh----------HHHHHHHHHHHHhccCCceee
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLAD------GSLVAVKRLKEERTPGG----------ELQFQTEVEMISMAVHRNLLR 357 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~----------~~~~~~E~~~l~~l~h~niv~ 357 (621)
..++|.+.+.||+|+||+||+|.+.. ++.||||++........ ...+..|+..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998754 47899999865432110 011334555667788999999
Q ss_pred eeeeeecC----CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee
Q 007020 358 LRGFCMTP----TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL 433 (621)
Q Consensus 358 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill 433 (621)
+++++... ...++||||+ +|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99998764 4579999999 999999998742 2489999999999999999999999 99999999999999
Q ss_pred C--CCCcEEEcccccceecccCCCe------eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCccccc
Q 007020 434 D--EEFEAVVGDFGLAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLAR 505 (621)
Q Consensus 434 ~--~~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~ 505 (621)
+ .++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 8899999999999876533211 1133459999999999999999999999999999999999999997321
Q ss_pred ccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 506 LANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.......+...... ..+..+.++.+.. ...+..+.+++..||+.+|++||++++|++.|++
T Consensus 266 ----~~~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 266 ----KDPKYVRDSKIRYR-ENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp ----TCHHHHHHHHHHHH-HCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred ----cCHHHHHHHHHHhh-hhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 11122222221111 1222222222211 1123678899999999999999999999999876
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=350.16 Aligned_cols=258 Identities=17% Similarity=0.193 Sum_probs=206.2
Q ss_pred hcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceEEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 372 (621)
.++|.+.+.||+|+||+||+|.. .+|+.||||++..... ...+.+|+.+++.+ +||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 46788999999999999999985 4789999999865432 23588999999999 8999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc-----EEEcccccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE-----AVVGDFGLA 447 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~-----~kl~DfGla 447 (621)
||+ +++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 85 e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EeC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999 899999998642 2489999999999999999999999 9999999999999998887 999999999
Q ss_pred eecccCCCe------eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHH
Q 007020 448 KLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGL 521 (621)
Q Consensus 448 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 521 (621)
+........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... .....+.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~-----~~~~~~~~~~i 232 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK-----ADTLKERYQKI 232 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CSSHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc-----cccHHHHHHHH
Confidence 876543321 1235569999999999999999999999999999999999999996322 11111222211
Q ss_pred hhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 522 LKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 522 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
...... ..... .....+ .+.+++..||+.||.+||++++|++.|++
T Consensus 233 ~~~~~~---~~~~~---~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 233 GDTKRA---TPIEV---LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp HHHHHH---SCHHH---HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred Hhhhcc---CCHHH---HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 111000 00000 001122 78999999999999999999999999976
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=350.90 Aligned_cols=252 Identities=22% Similarity=0.315 Sum_probs=205.0
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc-----hhHHHHHHHHHHHHhccCCceeeeeeeeecCCce
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 368 (621)
.+.|...+.||+|+||.||+|... +|+.||+|.++..... .....+.+|+.+++.++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456888999999999999999875 6899999999754422 1356789999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC----cEEEccc
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 444 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Df 444 (621)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 99999999999999997643 389999999999999999999999 999999999999999887 8999999
Q ss_pred ccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhh
Q 007020 445 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 524 (621)
Q Consensus 445 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 524 (621)
|+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+........
T Consensus 163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~~~~~ 232 (326)
T 2y0a_A 163 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANVSAV 232 (326)
T ss_dssp TTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHT
T ss_pred CCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC--------HHHHHHHHHhc
Confidence 9998765332 2234569999999999998999999999999999999999999995221 11111111111
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 525 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 525 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. ..............+.+++..|++.||++|||+.++++
T Consensus 233 ~-------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 233 N-------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp C-------CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C-------CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 00111111122367889999999999999999999976
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=350.84 Aligned_cols=265 Identities=25% Similarity=0.412 Sum_probs=204.1
Q ss_pred HhcCCCcCceeeeccCceEEEEEc-----CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecC--C
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--T 366 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~ 366 (621)
..++|++.+.||+|+||+||+|++ .+++.||||+++... ......+.+|+.+++.++||||+++++++... .
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 356788899999999999999983 368899999987543 44456789999999999999999999998653 5
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccc
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 446 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 446 (621)
..++||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred ceEEEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 68999999999999999987532 388999999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCC--eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCccccccc-------CCCcchHHHH
Q 007020 447 AKLMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLA-------NDDDVMLLDW 517 (621)
Q Consensus 447 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~-------~~~~~~~~~~ 517 (621)
+........ .......++..|+|||.+.+..++.++||||||+++|||++|..||...... ..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 987653322 1223344778899999999999999999999999999999999998632210 0011111111
Q ss_pred HHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 518 VKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 518 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
+........ ........+..+.+++..||+.||++|||++++++.|++
T Consensus 241 ~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 241 LIELLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp HHHHHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhccC---------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 111111110 111122334679999999999999999999999999976
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=356.45 Aligned_cols=246 Identities=28% Similarity=0.369 Sum_probs=196.1
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCce
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 368 (621)
+..++|+..+.||+|+||+||+|+.. +|+.||||+++... .......+..|..++..+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34578999999999999999999865 68999999997542 122345678899999987 699999999999999999
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence 99999999999999997643 289999999999999999999999 99999999999999999999999999998
Q ss_pred ecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 449 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+....
T Consensus 173 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~--- 240 (353)
T 3txo_A 173 EGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN--------EDDLFEAILNDE--- 240 (353)
T ss_dssp CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC---
T ss_pred ecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCC---
Confidence 53322 223445679999999999999899999999999999999999999996321 112222222211
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCH
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 565 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 565 (621)
..-+ ......+.+++..|++.||++||++
T Consensus 241 -~~~p-------~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 241 -VVYP-------TWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp -CCCC-------TTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred -CCCC-------CCCCHHHHHHHHHHhhhCHHHccCC
Confidence 0111 1123568899999999999999998
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=364.89 Aligned_cols=263 Identities=19% Similarity=0.267 Sum_probs=209.5
Q ss_pred HHHHHHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeec
Q 007020 288 LRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMT 364 (621)
Q Consensus 288 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 364 (621)
+.+++...++|+..++||+|+||+||+|+.. +++.||+|++++... ......+.+|..++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4455667789999999999999999999976 578999999965321 1122248899999999999999999999999
Q ss_pred CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccc
Q 007020 365 PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 444 (621)
Q Consensus 365 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 444 (621)
.+..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999998632 2389999999999999999999999 9999999999999999999999999
Q ss_pred ccceecccCCCeeeecccccccccchhhhc-----cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHH
Q 007020 445 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 519 (621)
Q Consensus 445 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 519 (621)
|+|+..............||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+...
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~--------~~~~~~ 291 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYG 291 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC--------hhHHHH
Confidence 999876655444455567999999999997 4568999999999999999999999996321 111122
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 007020 520 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMD--RPKMSEVVR 570 (621)
Q Consensus 520 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~--RPt~~~vl~ 570 (621)
.+..... ...-+.... .....+.+++..|+..+|++ ||+++|+++
T Consensus 292 ~i~~~~~--~~~~p~~~~----~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 292 KIMNHKE--RFQFPTQVT----DVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHTHHH--HCCCCSSCC----CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hhhhccc--cccCCcccc----cCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 2221110 011111111 12357888999999988888 999999865
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=345.54 Aligned_cols=254 Identities=29% Similarity=0.451 Sum_probs=194.3
Q ss_pred hcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCc---hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP---GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
.++|+..+.||+|+||.||+|.+. ++.||||+++..... .....+.+|+++++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 467888999999999999999985 889999998754322 2245688999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC--------CCcEEEcc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE--------EFEAVVGD 443 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~--------~~~~kl~D 443 (621)
|||+++++|.+++... .+++..+..++.|+++||+|||+++..+|+||||||+||+++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 9999999999998643 3899999999999999999999992112999999999999986 67899999
Q ss_pred cccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh
Q 007020 444 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 523 (621)
Q Consensus 444 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 523 (621)
||++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... .........
T Consensus 160 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~ 228 (271)
T 3dtc_A 160 FGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG--------LAVAYGVAM 228 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH--------HHHHHHHHT
T ss_pred CCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHhhhc
Confidence 99998654322 2234699999999999999999999999999999999999999963210 111111111
Q ss_pred hcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 524 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 524 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.. ............+.+++..||+.||++|||+.|+++.|+.
T Consensus 229 ~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 229 NK---------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp SC---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CC---------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11 0011112233678999999999999999999999999975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=354.38 Aligned_cols=256 Identities=21% Similarity=0.303 Sum_probs=205.3
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC----CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER----TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
.+.|++.+.||+|+||+||+|... +|+.||||++.... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467889999999999999999864 68999999986422 1123567899999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc---EEEccccc
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGL 446 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DfGl 446 (621)
+||||+++|+|.+++.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999988876433344589999999999999999999999 9999999999999986654 99999999
Q ss_pred ceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcc
Q 007020 447 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (621)
+....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .+.........
T Consensus 180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~i~~~~- 248 (351)
T 3c0i_A 180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERLFEGIIKGK- 248 (351)
T ss_dssp CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHHHHHHHHTC-
T ss_pred eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHHHHHHHcCC-
Confidence 98765432 22344569999999999999899999999999999999999999996321 11111111111
Q ss_pred cccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 527 ~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. ..++.. .......+.+++..||+.||++|||+.++++
T Consensus 249 ~--~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 249 Y--KMNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp C--CCCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--CCCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 011110 1122367889999999999999999999985
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=373.18 Aligned_cols=261 Identities=26% Similarity=0.398 Sum_probs=206.9
Q ss_pred HHHHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 290 ELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 290 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
.+++..++|.+.+.||+|+||+||+|.+.++..||||+++.... ....+.+|+.+++.++||||+++++++.+ +..+
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 34556788999999999999999999998888899999976442 34578999999999999999999999876 6789
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+||||+++|+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 255 iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp EEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcccee
Confidence 9999999999999997532 12388999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 450 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+...........
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~--------~~~~~~~i~~~~~~- 400 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQVERGYRM- 400 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTTCCC-
T ss_pred cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCCC-
Confidence 65433223334457889999999999999999999999999999999 999995221 11222222111110
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 576 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 576 (621)
..+..++..+.+++..||+.||++|||+++|++.|++..
T Consensus 401 ---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 401 ---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 011223467899999999999999999999999998854
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=360.92 Aligned_cols=254 Identities=17% Similarity=0.243 Sum_probs=205.0
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc-hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
..++|++.+.||+|+||+||+|... +|+.||+|++...... .....+.+|+.+++.++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4577999999999999999999864 7899999999765433 3345689999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC---CCCcEEEcccccce
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAK 448 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DfGla~ 448 (621)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++.
T Consensus 89 ~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999998754 389999999999999999999999 999999999999998 56789999999998
Q ss_pred ecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 449 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
...... .......||+.|+|||++.+..++.++||||+||++|+|++|..||.... ..+........ ..
T Consensus 162 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~-~~- 230 (444)
T 3soa_A 162 EVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED--------QHRLYQQIKAG-AY- 230 (444)
T ss_dssp CCCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHT-CC-
T ss_pred EecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHhC-CC-
Confidence 765432 22344569999999999999899999999999999999999999995221 11112221111 11
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
....+ ........+.+++..|++.||++|||+.|+++
T Consensus 231 ~~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 231 DFPSP-----EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCCTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCcc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 01111 11122367889999999999999999999976
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=353.41 Aligned_cols=254 Identities=19% Similarity=0.270 Sum_probs=206.0
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
..++|.+.+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3568999999999999999999865 689999999976543 33445789999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC---CcEEEcccccce
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLAK 448 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DfGla~ 448 (621)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999999987643 389999999999999999999999 99999999999999865 459999999998
Q ss_pred ecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 449 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ........... ...
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~--------~~~~~~~i~~~-~~~ 248 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYAQIKAG-AYD 248 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHT-CCC
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhC-CCC
Confidence 765322 2334569999999999999899999999999999999999999995321 11122221111 100
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
. ...........+.+++..||+.||++||++.++++.
T Consensus 249 -~-----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 -Y-----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -C-----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -C-----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 011112233678899999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=352.70 Aligned_cols=261 Identities=28% Similarity=0.412 Sum_probs=215.6
Q ss_pred HHHHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCce
Q 007020 290 ELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 290 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 368 (621)
++++..++|+..+.||+|+||+||+|.+. ++..||+|.++... .....+.+|+.+++.++||||+++++++.+....
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 34556778999999999999999999876 48899999997543 3456789999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred EEEEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccce
Confidence 999999999999999987433 3488999999999999999999999 99999999999999999999999999998
Q ss_pred ecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 449 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
..............+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ....+.+.. .
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~-----~~~~~~~~~---~--- 228 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLEK---D--- 228 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGHHHHHHT---T---
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHhc---c---
Confidence 766554444455567889999999999999999999999999999999 9999963221 111111111 1
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
.... .....+..+.+++..|++.||++|||++++++.|+..
T Consensus 229 ---~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 229 ---YRME----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp ---CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCC----CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 0111 1112236789999999999999999999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=355.67 Aligned_cols=260 Identities=25% Similarity=0.370 Sum_probs=207.1
Q ss_pred CCcCceeeeccCceEEEEEcC-----CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecC--CceEE
Q 007020 298 FSNKNILGRGGFGKVYKGRLA-----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLL 370 (621)
Q Consensus 298 ~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 370 (621)
|+..+.||+|+||+||++.+. +++.||||+++..........+.+|+++++.++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 388899999999999988642 68899999998766556667899999999999999999999999874 67799
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
||||+++|+|.+++.... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~~-----~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhCC-----CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 999999999999997643 88999999999999999999999 9999999999999999999999999999877
Q ss_pred ccCCCe--eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCccccccc------CCCcchHHHHHHHHh
Q 007020 451 DYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLA------NDDDVMLLDWVKGLL 522 (621)
Q Consensus 451 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~------~~~~~~~~~~~~~~~ 522 (621)
...... ......++..|+|||++.+..++.++||||||+++|+|++|..||...... ..........+...
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL- 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH-
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH-
Confidence 544332 223345888899999999988999999999999999999999999633211 00000000001111
Q ss_pred hhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 523 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 523 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.............+..+.+++..||+.||++|||++++++.|+.
T Consensus 264 --------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 307 (318)
T 3lxp_A 264 --------LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307 (318)
T ss_dssp --------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --------HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 11111111122334689999999999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=353.24 Aligned_cols=263 Identities=27% Similarity=0.430 Sum_probs=212.3
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEc--------CCCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeee
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRL--------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFC 362 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 362 (621)
++..++|.+.+.||+|+||+||+|.+ .++..||||+++..........+.+|+.+++.+ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 44567899999999999999999985 246789999998766555667799999999999 899999999999
Q ss_pred ecCCceEEEEeccCCCchhhhhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 007020 363 MTPTERLLVYPYMANGSVASCLRERPPS------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAAN 430 (621)
Q Consensus 363 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 430 (621)
.+.+..++||||+++|+|.+++...... ...+++..+..++.||++||+|||+. +|+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence 9999999999999999999999875421 12388999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEcccccceecccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccC
Q 007020 431 ILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLAN 508 (621)
Q Consensus 431 ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~ 508 (621)
|+++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--- 264 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--- 264 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC---
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC---
Confidence 99999999999999999876543322 2233447889999999998889999999999999999999 999995221
Q ss_pred CCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 509 DDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
..+.......... ... .......+.+++..||+.+|++|||+.++++.|+..
T Consensus 265 -----~~~~~~~~~~~~~------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 265 -----VEELFKLLKEGHR------MDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp -----HHHHHHHHHHTCC------CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HHHHHHHHhcCCC------CCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1122222111111 111 112236788999999999999999999999999874
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=348.06 Aligned_cols=266 Identities=24% Similarity=0.348 Sum_probs=190.8
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.++|+..+.||+|+||+||+|... +|+.||+|.++..........+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457888999999999999999865 6899999999766544445678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 374 YMANGSVASCLRERP--PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|++ |+|.+++.... .....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999886532 1223488999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcc----
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK---- 526 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---- 526 (621)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+........
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-----EEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCTTTC
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCChhHh
Confidence 3322 22344689999999999764 589999999999999999999999963221 111111111110000
Q ss_pred --ccc--ccCccc------------cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 527 --LEM--LVDPDL------------QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 527 --~~~--~~d~~~------------~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
... ...+.. ...........+.+++..|++.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000 000000 00000112357889999999999999999999865
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=348.36 Aligned_cols=264 Identities=24% Similarity=0.387 Sum_probs=206.7
Q ss_pred hcCCCcCceeeeccCceEEEEEc-----CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecC--Cc
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TE 367 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 367 (621)
.+.|+..+.||+|+||.||+|.+ .+++.||+|+++..........+.+|+.+++.++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35578889999999999999983 368999999998665555567899999999999999999999999876 66
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
.++||||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence 8999999999999999965432 389999999999999999999999 9999999999999999999999999999
Q ss_pred eecccCCCe--eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccc-------cCCCcchHHHHH
Q 007020 448 KLMDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARL-------ANDDDVMLLDWV 518 (621)
Q Consensus 448 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~-------~~~~~~~~~~~~ 518 (621)
......... ......||..|+|||.+.+..++.++||||||+++|+|++|..|+..... ............
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 876544332 23345588889999999999999999999999999999999998753210 011111111111
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 519 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 519 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
....... ........+..+.+++..||+.||++|||+.++++.|+.
T Consensus 254 ~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 254 NTLKEGK----------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHHHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhccC----------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 1111111 011112234678999999999999999999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=355.63 Aligned_cols=270 Identities=26% Similarity=0.408 Sum_probs=217.1
Q ss_pred cCHHHHHHHhcCCCcCceeeeccCceEEEEEc------CCCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeee
Q 007020 286 FSLRELQVATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRL 358 (621)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 358 (621)
+....++...++|.+.+.||+|+||+||+|.+ .+++.||||+++..........+.+|+.++..+ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 45667777889999999999999999999973 357899999998766555666799999999999 79999999
Q ss_pred eeeeecCC-ceEEEEeccCCCchhhhhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 007020 359 RGFCMTPT-ERLLVYPYMANGSVASCLRERPPS------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRD 425 (621)
Q Consensus 359 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 425 (621)
++++...+ ..++||||+++|+|.+++...... ...+++..+..++.|+++||+|||+. +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99987754 489999999999999999875432 12278899999999999999999999 999999
Q ss_pred CCCCCeeeCCCCcEEEcccccceecccCCC-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCccc
Q 007020 426 VKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDL 503 (621)
Q Consensus 426 lk~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~ 503 (621)
|||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987644332 23334558899999999999999999999999999999998 9999963
Q ss_pred ccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 504 ARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
.. ... ........... .... ......+.+++..||+.||.+|||+.++++.|+..
T Consensus 254 ~~----~~~---~~~~~~~~~~~------~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 254 VK----IDE---EFCRRLKEGTR------MRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CC----CSH---HHHHHHHHTCC------CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc----hhH---HHHHHhccCcc------CCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 22 111 11111111110 0111 11235788999999999999999999999999763
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=349.09 Aligned_cols=250 Identities=25% Similarity=0.371 Sum_probs=196.1
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc-------------------------hhHHHHHHHHHHHH
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-------------------------GGELQFQTEVEMIS 348 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------------------------~~~~~~~~E~~~l~ 348 (621)
.++|.+.+.||+|+||+||+|... +++.||||++...... .....+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467889999999999999999864 6889999998654321 11245889999999
Q ss_pred hccCCceeeeeeeeec--CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 007020 349 MAVHRNLLRLRGFCMT--PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDV 426 (621)
Q Consensus 349 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 426 (621)
.++||||+++++++.+ ....++||||+++|+|.+++... ++++..+..++.||++||+|||++ +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-----PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999986 56789999999999999876532 389999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCcEEEcccccceecccCCCeeeecccccccccchhhhccCC---CCCcccchhHHHHHHHHHhCCCCccc
Q 007020 427 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGIMLLELITGQRAFDL 503 (621)
Q Consensus 427 k~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~pf~~ 503 (621)
||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. .+.++||||||+++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654332 234456999999999997765 37789999999999999999999963
Q ss_pred ccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 504 ARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.. ...+..... ..... .+. .......+.+++..||+.||++|||+.|+++
T Consensus 243 ~~--------~~~~~~~~~-~~~~~---~~~-----~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ER--------IMCLHSKIK-SQALE---FPD-----QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SS--------HHHHHHHHH-HCCCC---CCS-----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cc--------HHHHHHHHh-cccCC---CCC-----ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 21 112211111 11111 010 0112357889999999999999999999865
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=344.35 Aligned_cols=255 Identities=25% Similarity=0.430 Sum_probs=209.2
Q ss_pred HhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
..++|...+.||+|+||.||+|.+.+++.||+|.++.... ....+.+|+++++.++||||+++++++.+++..++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 3567888999999999999999988889999999976542 24578999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++++|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCTTCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCCcHHHHHhhCcc---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999999986432 388999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
.........++..|+|||++.+..++.++||||||+++|+|++ |+.||.... ..+.......... ...
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~i~~~~~---~~~ 226 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDISTGFR---LYK 226 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTCC---CCC
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC--------HHHHHHHHhcCCc---CCC
Confidence 2122223447788999999999999999999999999999999 899996321 1122222211110 011
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
+. .....+.+++..||+.||++||++.++++.|++
T Consensus 227 ~~-------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 227 PR-------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp CT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred Cc-------cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11 123678899999999999999999999999976
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=370.94 Aligned_cols=252 Identities=28% Similarity=0.411 Sum_probs=205.5
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCC-ceEE
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLL 370 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~l 370 (621)
++..++|.+.+.||+|+||+||+|.+. |+.||||+++... ....|.+|+.+++.++||||+++++++.... ..++
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 345678888999999999999999985 7899999997543 3457899999999999999999999987665 7899
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
||||+++|+|.+++..... ..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 265 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp EEECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 9999999999999986532 2368899999999999999999999 9999999999999999999999999999854
Q ss_pred ccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
... .....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ... +.........
T Consensus 340 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----~~~---~~~i~~~~~~-- 405 (450)
T 1k9a_A 340 SST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDV---VPRVEKGYKM-- 405 (450)
T ss_dssp C----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT-----TTH---HHHHHTTCCC--
T ss_pred ccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHH---HHHHHcCCCC--
Confidence 322 122357889999999999999999999999999999998 9999963221 111 1111111110
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
. .+..++..+.+++..||+.||++|||+.++++.|+.
T Consensus 406 ----~----~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 406 ----D----APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp ----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----C----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1 112234688999999999999999999999999976
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=345.59 Aligned_cols=259 Identities=28% Similarity=0.455 Sum_probs=210.6
Q ss_pred HHHHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 290 ELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 290 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
++++..++|.+.+.||+|+||+||+|...+++.||+|.++.... ....+.+|+++++.++||||+++++++. .+..+
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 83 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIY 83 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcE
Confidence 34556678999999999999999999988888999999875432 3457899999999999999999999986 45689
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+||||+++++|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++..
T Consensus 84 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp EEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 9999999999999997532 12388999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 450 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+..........
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~~~~~~~~~~~-- 228 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--------NPEVIQNLERGYR-- 228 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTTCC--
T ss_pred ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC--------HHHHHHHHhcccC--
Confidence 65443333334457889999999998889999999999999999999 999995321 1122222211110
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
... .......+.+++..|++.||++|||++++++.|++
T Consensus 229 ----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 229 ----MVR----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp ----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCC----cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 111 11223678899999999999999999999999987
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=340.30 Aligned_cols=260 Identities=15% Similarity=0.167 Sum_probs=207.5
Q ss_pred HhcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceEEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 371 (621)
..++|.+.+.||+|+||+||+|.. .+|+.||||++..... ...+.+|+.+++.+ +|+|++++++++.+....++|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 356789999999999999999985 5789999999865432 23578899999998 799999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc-----EEEccccc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE-----AVVGDFGL 446 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~-----~kl~DfGl 446 (621)
|||+ +++|.+++..... ++++..+..++.||+.||+|||++ +|+||||||+||+++.++. +||+|||+
T Consensus 85 ~e~~-~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEec-CCCHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9999 8999999986532 389999999999999999999999 9999999999999987776 99999999
Q ss_pred ceecccCCCe------eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH
Q 007020 447 AKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 520 (621)
Q Consensus 447 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 520 (621)
++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~~~~ 232 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-----NKQKYER 232 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC-----HHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccc-----cHHHHHH
Confidence 9876543321 2344569999999999999999999999999999999999999996422111 1111111
Q ss_pred HhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 521 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 521 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
........ ..+.. ....+..+.+++..||+.||++||++++|++.|++
T Consensus 233 ~~~~~~~~--~~~~~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~ 280 (298)
T 1csn_A 233 IGEKKQST--PLREL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 280 (298)
T ss_dssp HHHHHHHS--CHHHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred HHhhccCc--cHHHH----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence 11110000 00000 11223678999999999999999999999999987
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=344.05 Aligned_cols=262 Identities=23% Similarity=0.328 Sum_probs=199.1
Q ss_pred cCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCc-hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
++|+..+.||+|+||+||+|...+|+.||+|.++..... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 468889999999999999999888999999999654422 2235688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++ +|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 986 9999887643 2388999999999999999999999 99999999999999999999999999998654322
Q ss_pred CeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc-----
Q 007020 455 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE----- 528 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 528 (621)
. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+..........
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-----ADQLMRIFRILGTPNSKNWPNV 228 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCCCCTTTSTTG
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHHCCCChhhchhh
Confidence 2 22334589999999999764 589999999999999999999999963211 11111111110000000
Q ss_pred ---cccCcccc-------CcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 529 ---MLVDPDLQ-------NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 529 ---~~~d~~~~-------~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
...++... ..........+.+++..|++.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00011100 0111123467889999999999999999999976
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=350.03 Aligned_cols=254 Identities=25% Similarity=0.358 Sum_probs=194.9
Q ss_pred hcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCce---
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER--- 368 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 368 (621)
.++|++.+.||+|+||+||+|.+ .+++.||||+++.... ......+.+|+.+++.++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46788999999999999999996 4789999999976542 23345688999999999999999999998765443
Q ss_pred -EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 369 -LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 369 -~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
++||||+++|+|.+++.... ++++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 99999999999999997643 389999999999999999999999 9999999999999999999999999999
Q ss_pred eecccCCC--eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 448 KLMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 448 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
+....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ............
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--------~~~~~~~~~~~~ 235 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------PVSVAYQHVRED 235 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhcCC
Confidence 87654322 22234568999999999999999999999999999999999999996321 111111111111
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 526 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 526 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
... +. .........+.+++..||+.||++||++.+++.
T Consensus 236 ~~~----~~---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 236 PIP----PS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp CCC----HH---HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CCC----cc---cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 110 00 001112367889999999999999998777665
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=353.55 Aligned_cols=264 Identities=24% Similarity=0.410 Sum_probs=195.0
Q ss_pred HHHHHhcCCCcCceeeeccCceEEEEEcCCC----cEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeec
Q 007020 290 ELQVATDSFSNKNILGRGGFGKVYKGRLADG----SLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMT 364 (621)
Q Consensus 290 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 364 (621)
++.+..++|++.+.||+|+||+||+|.+... ..||||+++... .......+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 3445567899999999999999999987543 279999997653 33445679999999999999999999999987
Q ss_pred CCce------EEEEeccCCCchhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC
Q 007020 365 PTER------LLVYPYMANGSVASCLRERP--PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 436 (621)
Q Consensus 365 ~~~~------~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~ 436 (621)
.... ++||||+++|+|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+|||++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence 7655 99999999999999986532 2233589999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceecccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchH
Q 007020 437 FEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVML 514 (621)
Q Consensus 437 ~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~ 514 (621)
+.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||..... ...
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~~ 248 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-----AEI 248 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh-----HHH
Confidence 99999999999876433221 2223447789999999999999999999999999999999 9999963221 111
Q ss_pred HHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 515 LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 515 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
. ......... . ........+.+++..||+.||++|||+.++++.|++
T Consensus 249 ~---~~~~~~~~~------~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 295 (323)
T 3qup_A 249 Y---NYLIGGNRL------K----QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELEN 295 (323)
T ss_dssp H---HHHHTTCCC------C----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred H---HHHhcCCCC------C----CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1 111111110 0 111223678999999999999999999999999987
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=351.19 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=202.6
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
.++|.+.+.||+|+||.||+|... +++.||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467888999999999999999865 68899999986532 122345688999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+.+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999999999998643 389999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCCeeeecccccccccchhhhcc---CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+...... .
T Consensus 167 ~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-----~~~~~~~~~~~~~-~-- 236 (384)
T 4fr4_A 167 RE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-----TSSKEIVHTFETT-V-- 236 (384)
T ss_dssp TT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT-----SCHHHHHHHHHHC-C--
T ss_pred CC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC-----ccHHHHHHHHhhc-c--
Confidence 32 23345679999999999974 4578999999999999999999999963221 1111222221110 0
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-MSEVVR 570 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-~~~vl~ 570 (621)
.. ++......+.+++..||+.||++||+ +++|.+
T Consensus 237 ----~~----~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 ----VT----YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----CC----CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----cC----CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 00 11122367899999999999999998 666543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=351.31 Aligned_cols=269 Identities=24% Similarity=0.403 Sum_probs=217.2
Q ss_pred cCHHHHHHHhcCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeee
Q 007020 286 FSLRELQVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 359 (621)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 359 (621)
+..+++++..++|.+.+.||+|+||.||+|.+. +++.||+|.+...........+.+|+.+++.++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 345566777889999999999999999999754 36789999998766555666799999999999999999999
Q ss_pred eeeecCCceEEEEeccCCCchhhhhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee
Q 007020 360 GFCMTPTERLLVYPYMANGSVASCLRERP------PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL 433 (621)
Q Consensus 360 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill 433 (621)
+++.+.+..++||||+++|+|.+++.... ....++++..+..++.||+.||+|||++ +|+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence 99999999999999999999999987521 1123478899999999999999999999 99999999999999
Q ss_pred CCCCcEEEcccccceecccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCc
Q 007020 434 DEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDD 511 (621)
Q Consensus 434 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~ 511 (621)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------ 245 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------ 245 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC------
Confidence 99999999999999865433221 1223346889999999999999999999999999999999 899985321
Q ss_pred chHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 512 VMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
..+......... .. .. .......+.+++..||+.||++|||+.++++.|++.
T Consensus 246 --~~~~~~~~~~~~-~~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 246 --NEQVLRFVMEGG-LL-----DK----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp --HHHHHHHHHTTC-CC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred --HHHHHHHHHcCC-cC-----CC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 112222221111 10 01 112236788999999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=356.36 Aligned_cols=257 Identities=25% Similarity=0.394 Sum_probs=202.2
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcE----EEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSL----VAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
.++|...+.||+|+||+||+|.+. +++. ||+|.+...........+.+|+.+++.++||||+++++++. ....+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 357888899999999999999864 4443 88888765443344456788999999999999999999986 56789
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+||||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence 9999999999999997642 2378889999999999999999999 999999999999999999999999999987
Q ss_pred cccCCC-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 450 MDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 450 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
...... .......|+..|+|||++.+..++.++||||||+++|||++ |+.||.... .....+.+. ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~---~~~-- 234 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR-----LAEVPDLLE---KGE-- 234 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----TTHHHHHHH---TTC--
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC-----HHHHHHHHH---cCC--
Confidence 654332 22344558889999999999999999999999999999999 999996321 111111111 111
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 576 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 576 (621)
....+. .....+.+++..||+.||++||++.++++.|+...
T Consensus 235 -~~~~~~-------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 235 -RLAQPQ-------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp -BCCCCT-------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred -CCCCCC-------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011111 12246788999999999999999999999998753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=344.43 Aligned_cols=246 Identities=27% Similarity=0.352 Sum_probs=203.1
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++.... ......+.+|..+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357888999999999999999875 689999999975421 12345678899999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999998643 388999999999999999999999 99999999999999999999999999998654
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.........
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~------ 219 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILNAE------ 219 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHCC------
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC------
Confidence 32 234569999999999999999999999999999999999999995321 112222222211
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~ 570 (621)
.... ......+.+++..|++.||++|| +++++++
T Consensus 220 -~~~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 220 -LRFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -CCCC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCC----CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 0111 11235788999999999999999 7888764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=344.99 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=204.6
Q ss_pred HhcCCCcCceeeeccCceEEEEEcCC----CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLAD----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
..++|.+.+.||+|+||+||+|.+.+ +..||+|.++..........+.+|+.+++.++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45688889999999999999998532 346999999876656667789999999999999999999999765 4578
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 9999999999999997643 2388999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 450 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ....+.+. ....
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~-----~~~~~~~~---~~~~-- 232 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-----KDVIGVLE---KGDR-- 232 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG-----GGHHHHHH---HTCC--
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh-----HHHHHHHh---cCCC--
Confidence 65443333344557889999999999999999999999999999998 9999953211 11111111 1110
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
... .......+.+++..||+.||++||++.++++.|++.
T Consensus 233 -~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 233 -LPK-------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp -CCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCC-------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 001 111235788999999999999999999999999873
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=341.55 Aligned_cols=263 Identities=22% Similarity=0.288 Sum_probs=200.1
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc-hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
++|+..+.||+|+||+||+|... +++.||+|+++..... .....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 47888999999999999999875 6899999999755433 334678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++ ++.+.+.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9986 5655555432 2389999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCeeeecccccccccchhhhccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc----
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE---- 528 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 528 (621)
. .......||..|+|||++.+.. ++.++|||||||++|||++|..||.... ........+..........
T Consensus 155 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~----~~~~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 155 V-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN----DVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp C-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS----SHHHHHHHHHHHHCCCCTTTCTT
T ss_pred c-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC----CHHHHHHHHHHHhCCCChhhhhh
Confidence 2 2233456899999999998766 7999999999999999999988863211 1111111111111000000
Q ss_pred --cccC---------ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 529 --MLVD---------PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 529 --~~~d---------~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
...+ ..............+.+++..|++.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000 00000111123467889999999999999999999976
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=361.87 Aligned_cols=263 Identities=21% Similarity=0.260 Sum_probs=207.9
Q ss_pred CHHHHHHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeee
Q 007020 287 SLRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCM 363 (621)
Q Consensus 287 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 363 (621)
.+++.....++|+..+.||+|+||+||+|+.. +|+.||+|++++... ......+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34555667789999999999999999999975 799999999965321 122335889999999999999999999999
Q ss_pred cCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcc
Q 007020 364 TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 443 (621)
Q Consensus 364 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 443 (621)
+.+..++||||+++|+|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFGE---RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence 99999999999999999999976421 389999999999999999999999 999999999999999999999999
Q ss_pred cccceecccCCCeeeecccccccccchhhhc-------cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHH
Q 007020 444 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-------TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLD 516 (621)
Q Consensus 444 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~ 516 (621)
||+++..............||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..+
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~ 277 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS--------TAE 277 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC--------HHH
Confidence 9999876654443444567999999999997 3568999999999999999999999996321 111
Q ss_pred HHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCC---CCHHHHHH
Q 007020 517 WVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDR---PKMSEVVR 570 (621)
Q Consensus 517 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~R---Pt~~~vl~ 570 (621)
....+...... ...+.. .......+.+++..|+. +|++| |+++|+++
T Consensus 278 ~~~~i~~~~~~--~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 278 TYGKIVHYKEH--LSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHHHTHHHH--CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHHHhcccC--cCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 12222211100 001111 11223678899999999 99998 58888854
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=350.96 Aligned_cols=253 Identities=19% Similarity=0.284 Sum_probs=205.6
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.+.|.+.+.||+|+||+||+|... +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 367899999999999999999865 68999999987543 3345578999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC--CCcEEEcccccceecc
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKLMD 451 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~DfGla~~~~ 451 (621)
|+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 129 FLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 999999999987643 2489999999999999999999999 9999999999999974 5789999999998765
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
... ......||+.|+|||++.+..++.++|||||||++|||++|..||.... ..+.+........ ..
T Consensus 203 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~~~~~i~~~~~---~~ 269 (387)
T 1kob_A 203 PDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKRCDW---EF 269 (387)
T ss_dssp TTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHCCC---CC
T ss_pred CCc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCC---CC
Confidence 432 2333469999999999999999999999999999999999999996321 1112222211110 01
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
++.. .......+.+++..||+.||++|||+.++++.
T Consensus 270 ~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 DEDA----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CSST----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred Cccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1111 11223678899999999999999999999763
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=346.52 Aligned_cols=249 Identities=24% Similarity=0.301 Sum_probs=193.9
Q ss_pred hcCCCcCceeeeccCceEEEEEc----CCCcEEEEEEecccCC---chhHHHHHHHHHHHHhccCCceeeeeeeeecCCc
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL----ADGSLVAVKRLKEERT---PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 367 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 367 (621)
.++|++.+.||+|+||+||+++. .+|+.||+|+++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46788999999999999999986 4789999999976532 2234457889999999999999999999999999
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999997643 288899999999999999999999 9999999999999999999999999999
Q ss_pred eecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
+..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..+.+.......
T Consensus 169 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~-- 237 (327)
T 3a62_A 169 KESIHD-GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN--------RKKTIDKILKCK-- 237 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHTC--
T ss_pred cccccC-CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCC--
Confidence 754322 222344569999999999999899999999999999999999999996321 112222222211
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 570 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~ 570 (621)
..+ +......+.+++..||+.||++|| ++.++++
T Consensus 238 -----~~~----p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 -----LNL----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -----CCC----CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -----CCC----CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 011 111236788999999999999999 6667654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=340.61 Aligned_cols=254 Identities=22% Similarity=0.289 Sum_probs=199.8
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.++|...+.||+|+||+||+|... ++..||+|++...........+.+|+++++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 367888999999999999999864 6899999999876655556789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee---CCCCcEEEcccccceec
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfGla~~~ 450 (621)
|+++|+|.+++.........+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999999865322234489999999999999999999999 99999999999999 45678999999999865
Q ss_pred ccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
... .......||..|+|||++. ..++.++||||||+++|||++|+.||.... ..+.............
T Consensus 178 ~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~--------~~~~~~~~~~~~~~~~- 245 (285)
T 3is5_A 178 KSD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS--------LEEVQQKATYKEPNYA- 245 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCC-
T ss_pred CCc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC--------HHHHHhhhccCCcccc-
Confidence 432 2233456999999999985 568899999999999999999999996321 1111111111110000
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.. ... ....+.+++..|++.||++|||+.|+++
T Consensus 246 ~~---~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 246 VE---CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp C-----CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cc---cCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 001 1257889999999999999999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=342.48 Aligned_cols=253 Identities=30% Similarity=0.554 Sum_probs=201.4
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhH------HHHHHHHHHHHhccCCceeeeeeeeecCCc
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGE------LQFQTEVEMISMAVHRNLLRLRGFCMTPTE 367 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 367 (621)
.++|+..+.||+|+||+||+|.+. +++.||+|++......... ..+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467888999999999999999864 7899999998654432211 56899999999999999999999986654
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeeCCCCc-----EE
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK--IIHRDVKAANILLDEEFE-----AV 440 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~~~~~-----~k 440 (621)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. + |+||||||+||+++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 79999999999999887643 2489999999999999999999999 8 999999999999988776 99
Q ss_pred EcccccceecccCCCeeeecccccccccchhhhc--cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHH
Q 007020 441 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS--TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 518 (621)
Q Consensus 441 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 518 (621)
|+|||+++.... ......||+.|+|||++. ...++.++||||||+++|||++|+.||..... . ...+.
T Consensus 170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~---~~~~~ 239 (287)
T 4f0f_A 170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY---G---KIKFI 239 (287)
T ss_dssp ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC---C---HHHHH
T ss_pred eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc---c---HHHHH
Confidence 999999974332 234456999999999984 44568899999999999999999999963211 1 11111
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 519 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 519 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
....... ..+.. .......+.+++..||+.||++|||++++++.|++
T Consensus 240 ~~~~~~~-----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 240 NMIREEG-----LRPTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHSC-----CCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHhccC-----CCCCC----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1111111 11111 12233678999999999999999999999999976
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=358.40 Aligned_cols=271 Identities=18% Similarity=0.234 Sum_probs=214.2
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCC--ceEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLV 371 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 371 (621)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++..........+.+|+++++.++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467889999999999999999875 589999999976554445567889999999999999999999988765 67999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee----CCCCcEEEcccccc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLA 447 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~DfGla 447 (621)
|||+++|+|.+++..... ...+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999986432 22389999999999999999999999 99999999999999 77888999999999
Q ss_pred eecccCCCeeeecccccccccchhhhcc--------CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHH
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLST--------GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 519 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 519 (621)
+...... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||.......... +.+.
T Consensus 164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~----~~~~ 237 (396)
T 4eut_A 164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK----EVMY 237 (396)
T ss_dssp EECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH----HHHH
T ss_pred eEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH----HHHH
Confidence 8764322 2234569999999999875 456789999999999999999999997433222222 2222
Q ss_pred HHhhhcccccc------c--------CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 520 GLLKEKKLEML------V--------DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 520 ~~~~~~~~~~~------~--------d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
........... . +..............+.+++..|++.||++||+++++++.+++.
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 22222111000 0 00111233466778899999999999999999999999988774
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=342.04 Aligned_cols=263 Identities=28% Similarity=0.460 Sum_probs=197.9
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
++..++|++.+.||+|+||+||+|++. ..||+|+++.... ......+.+|+.+++.++||||+++++++ .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 445678999999999999999999874 3599999976543 33456799999999999999999999965 5567899
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 97 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence 999999999999997543 2489999999999999999999999 9999999999999999999999999999865
Q ss_pred ccC-CCeeeecccccccccchhhhc---cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcc
Q 007020 451 DYK-DTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 451 ~~~-~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (621)
... .........||+.|+|||++. +..++.++||||||+++|+|++|+.||.... ... . +........
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~---~-~~~~~~~~~ 242 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN----NRD---Q-IIEMVGRGS 242 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC----CHH---H-HHHHHHHTS
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc----hHH---H-HHHHhcccc
Confidence 432 122233456999999999986 5667889999999999999999999996321 111 1 111111111
Q ss_pred cccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007020 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 576 (621)
Q Consensus 527 ~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 576 (621)
.. +.. .......+..+.+++..||+.+|++|||+.++++.|++..
T Consensus 243 ~~----~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 243 LS----PDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CC----CCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cC----cch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 11 110 0011223467999999999999999999999999998753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=346.51 Aligned_cols=247 Identities=24% Similarity=0.293 Sum_probs=194.2
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 370 (621)
..++|+..++||+|+||+||+|... +|+.||||++..... ......+..|+..+..+ +||||+++++++.+.+..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 4468999999999999999999876 799999999865432 23334555666665555 89999999999999999999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
||||+ +++|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 135 v~e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 99999 669998887643 2489999999999999999999999 9999999999999999999999999999875
Q ss_pred ccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
... .......||+.|+|||++.+ .++.++|||||||++|||++|..||.... .| ... ....
T Consensus 208 ~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~-~~~-~~~~---- 268 (311)
T 3p1a_A 208 GTA--GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GW-QQL-RQGY---- 268 (311)
T ss_dssp C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HH-HHH-TTTC----
T ss_pred ccC--CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HH-HHH-hccC----
Confidence 432 22334569999999999876 78999999999999999999976663211 11 111 1100
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..+. ........+.+++..|++.||++|||++|+++
T Consensus 269 ~~~~----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 269 LPPE----FTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcc----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1111 11223467899999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=344.85 Aligned_cols=269 Identities=25% Similarity=0.369 Sum_probs=203.8
Q ss_pred HHHHHHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHh--ccCCceeeeeeeeecC
Q 007020 288 LRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISM--AVHRNLLRLRGFCMTP 365 (621)
Q Consensus 288 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~ 365 (621)
........++|++.+.||+|+||.||+|++. ++.||||++... ....+..|.+++.. ++||||+++++++...
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 3344556689999999999999999999985 899999998543 23344556666554 4899999999998877
Q ss_pred ----CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCeeeCCC
Q 007020 366 ----TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC-----DPKIIHRDVKAANILLDEE 436 (621)
Q Consensus 366 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlk~~Nill~~~ 436 (621)
...++||||+++|+|.+++... .+++..+..++.|++.||+|||+.+ +++|+||||||+|||++.+
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC
Confidence 6789999999999999999764 2899999999999999999999762 3489999999999999999
Q ss_pred CcEEEcccccceecccCCCee---eecccccccccchhhhccCCCCCc------ccchhHHHHHHHHHhC----------
Q 007020 437 FEAVVGDFGLAKLMDYKDTHV---TTAVRGTIGHIAPEYLSTGKSSEK------TDVFGYGIMLLELITG---------- 497 (621)
Q Consensus 437 ~~~kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlGvil~elltg---------- 497 (621)
+.+||+|||++.......... .....||+.|+|||++.+...+.+ +|||||||++|||++|
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 999999999998664332221 124469999999999988776655 9999999999999999
Q ss_pred CCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCc-ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 498 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNN-YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 498 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
..||....... ... ..+......... .+..... ...++...+.+++..||+.||++|||+.+|++.|+.
T Consensus 259 ~~p~~~~~~~~---~~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 259 QLPYHDLVPSD---PSY-EDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp CCTTTTTSCSS---CCH-HHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred cccHhhhcCCC---Cch-hhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 55553221111 111 111222211111 1111111 123567889999999999999999999999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=341.56 Aligned_cols=252 Identities=22% Similarity=0.361 Sum_probs=204.1
Q ss_pred hcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecC--CceEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLV 371 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 371 (621)
.++|...+.||+|+||+||+|++. ++.||||+++.... ......+.+|+.+++.++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 467888999999999999999985 88999999976543 34455799999999999999999999999887 788999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
|||+++|+|.+++..... ..+++..+..++.|++.||+|||+. + |+||||||+||+++.++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 999999999999987532 3489999999999999999999998 7 99999999999999999999999988764
Q ss_pred cccCCCeeeecccccccccchhhhccCCCCC---cccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcc
Q 007020 450 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE---KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (621)
... ....||+.|+|||.+.+...+. ++||||||+++|||++|+.||.... ..+.........
T Consensus 163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~- 227 (271)
T 3kmu_A 163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS--------NMEIGMKVALEG- 227 (271)
T ss_dssp TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC--------HHHHHHHHHHSC-
T ss_pred ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC--------hHHHHHHHHhcC-
Confidence 322 2235899999999998765544 7999999999999999999996221 111111111111
Q ss_pred cccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 527 ~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
..+.. .......+.+++..||+.||++|||++++++.|+..
T Consensus 228 ----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 228 ----LRPTI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp ----CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 11111 112236789999999999999999999999999863
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=352.69 Aligned_cols=246 Identities=23% Similarity=0.371 Sum_probs=200.2
Q ss_pred cCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|.+.+.||+|+||+||+|.+ .+++.||+|++..... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788899999999999999996 4789999999864321 122346889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+ +|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 89 E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred ECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 999 679999887643 389999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCeeeecccccccccchhhhccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
. .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||+....... ...+.
T Consensus 161 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-----------------~~~i~ 221 (336)
T 3h4j_B 161 G--NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-----------------FKKVN 221 (336)
T ss_dssp S--BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-----------------BCCCC
T ss_pred C--cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-----------------HHHHH
Confidence 2 22334569999999999988775 7899999999999999999999964321110 00000
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
... ...+......+.+++..|++.||.+|||++|+++
T Consensus 222 ~~~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 222 SCV--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SSC--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred cCC--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 000 0011122367889999999999999999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=349.41 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=202.4
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCc
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTE 367 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 367 (621)
....++|.+.+.||+|+||+||+|+.. +|+.||+|+++.... ......+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 455678999999999999999999975 689999999975421 22344677889988876 89999999999999999
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 999999999999999998643 289999999999999999999999 9999999999999999999999999999
Q ss_pred eecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+....
T Consensus 166 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~-- 234 (345)
T 1xjd_A 166 KENMLG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------EEELFHSIRMDN-- 234 (345)
T ss_dssp BCCCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC--
T ss_pred hhcccC-CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHhCC--
Confidence 854322 223445679999999999999999999999999999999999999996321 111222221111
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMS-EVV 569 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~-~vl 569 (621)
+... ......+.+++..|++.||++||++. +|+
T Consensus 235 -----~~~p----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 -----PFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -----CCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----CCCC----cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1111 11236788999999999999999997 553
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=343.13 Aligned_cols=255 Identities=23% Similarity=0.353 Sum_probs=206.9
Q ss_pred hcCCCcCc-eeeeccCceEEEEEcC---CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 295 TDSFSNKN-ILGRGGFGKVYKGRLA---DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 295 ~~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
.++|.+.+ .||+|+||.||+|.+. ++..||||+++..........+.+|+++++.++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35566665 8999999999999853 57889999998765556667899999999999999999999999 4567899
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
||||+++++|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 999999999999997532 2489999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCCee--eecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 451 DYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 451 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
....... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.... .. +..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~~---~~~~~i~~~~~- 231 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----GP---EVMAFIEQGKR- 231 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----TH---HHHHHHHTTCC-
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----HH---HHHHHHhcCCc-
Confidence 5433322 122346889999999998889999999999999999998 999996321 11 11111111110
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
+.. ....+..+.+++..||+.||++||++.++++.|+.
T Consensus 232 -----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 269 (287)
T 1u59_A 232 -----MEC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269 (287)
T ss_dssp -----CCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCC----CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111 12234678999999999999999999999999987
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=347.09 Aligned_cols=257 Identities=28% Similarity=0.450 Sum_probs=202.4
Q ss_pred hcCCCcCceeeeccCceEEEEEcCC-----CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLAD-----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
.++|...+.||+|+||+||+|.... +..||||.++..........+.+|+.+++.++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4567778999999999999998642 24699999987665556667999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 9999999999999998643 2389999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCCe--eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcc
Q 007020 450 MDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 450 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (621)
....... ......+|..|+|||++.+..++.++||||||+++|||++ |+.||.... ..+..........
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~~~~~~~~~~~~ 268 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--------NHEVMKAINDGFR 268 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTCC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC--------HHHHHHHHHCCCc
Confidence 6533221 1222346788999999999999999999999999999999 999995221 1122222211111
Q ss_pred cccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 527 ~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
.. ........+.+++..||+.+|++||++.++++.|+..
T Consensus 269 ~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 269 LP----------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp CC----------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 0112236788999999999999999999999999763
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=353.63 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=197.4
Q ss_pred HhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCC-chhHHHHHHHHHHHHhccC--CceeeeeeeeecCCceEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVH--RNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~l 370 (621)
..++|++.+.||+|+||+||++...+++.||||++..... ......+.+|+.++..++| +||+++++++.++...++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 3567889999999999999999988899999999975543 3344678999999999986 999999999999999999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
||| +.+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++ ++.+||+|||+++..
T Consensus 87 v~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEC-CCSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEe-CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 999 56789999998753 388999999999999999999999 999999999999997 578999999999876
Q ss_pred ccCCCe-eeecccccccccchhhhcc-----------CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHH
Q 007020 451 DYKDTH-VTTAVRGTIGHIAPEYLST-----------GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 518 (621)
Q Consensus 451 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 518 (621)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ......
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~ 230 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQISKL 230 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-------SHHHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-------hHHHHH
Confidence 543222 2334569999999999975 668899999999999999999999995211 011111
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 519 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 519 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.... ++.............+.+++..||+.||++|||+.++++.
T Consensus 231 ~~~~---------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 231 HAII---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHH---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHh---------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111 1111111111123578899999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=348.40 Aligned_cols=262 Identities=22% Similarity=0.244 Sum_probs=202.4
Q ss_pred HHHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC----CchhHHHHHHHHHHHHhccCCceeeeeeeeecC
Q 007020 291 LQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER----TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 365 (621)
Q Consensus 291 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 365 (621)
+....++|.+.+.||+|+||+||+|... +++.||+|++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4556788999999999999999999864 68899999986532 234456799999999999999999999999999
Q ss_pred CceEEEEeccCCCchhhhhccCCCC------------------------------------CCCCCHHHHHHHHHHHHHH
Q 007020 366 TERLLVYPYMANGSVASCLRERPPS------------------------------------QLPLDWPTRKRIALGSARG 409 (621)
Q Consensus 366 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~~~~~~~~~i~~~i~~~ 409 (621)
+..++||||+++|+|.+++...... ...+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999998631100 1123567788999999999
Q ss_pred HHHHHhCCCCCeEecCCCCCCeeeCCCC--cEEEcccccceecccCCC---eeeecccccccccchhhhcc--CCCCCcc
Q 007020 410 LSYLHDHCDPKIIHRDVKAANILLDEEF--EAVVGDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEYLST--GKSSEKT 482 (621)
Q Consensus 410 L~~LH~~~~~~ivH~Dlk~~Nill~~~~--~~kl~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 482 (621)
|+|||+. +|+||||||+||+++.++ .+||+|||++........ .......||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998776 899999999987644222 12344569999999999975 5788999
Q ss_pred cchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCC
Q 007020 483 DVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDR 562 (621)
Q Consensus 483 DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~R 562 (621)
||||||+++|||++|+.||.... ..+.+......... ...+ ........+.+++..|++.||++|
T Consensus 258 DiwslG~il~el~~g~~pf~~~~--------~~~~~~~~~~~~~~--~~~~-----~~~~~~~~~~~li~~~l~~~p~~R 322 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVN--------DADTISQVLNKKLC--FENP-----NYNVLSPLARDLLSNLLNRNVDER 322 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCC--TTSG-----GGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred HHHHHHHHHHHHHHCCCCCCCCC--------hHHHHHHHHhcccc--cCCc-----ccccCCHHHHHHHHHHcCCChhHC
Confidence 99999999999999999995321 11222222211110 0111 111223678899999999999999
Q ss_pred CCHHHHHH
Q 007020 563 PKMSEVVR 570 (621)
Q Consensus 563 Pt~~~vl~ 570 (621)
|++.++++
T Consensus 323 ps~~~~l~ 330 (345)
T 3hko_A 323 FDAMRALQ 330 (345)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHhc
Confidence 99999987
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=347.56 Aligned_cols=245 Identities=22% Similarity=0.293 Sum_probs=202.9
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|...+.||+|+||+||+|+.. +|+.||+|+++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999875 689999999865421 223456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999998643 289999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+.... .
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~-~----- 255 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVSGK-V----- 255 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-C-----
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC--------HHHHHHHHHcCC-C-----
Confidence 2 234569999999999999999999999999999999999999996321 112222222211 1
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-----MSEVVR 570 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-----~~~vl~ 570 (621)
.+ +......+.+++..|++.||++||+ +++|++
T Consensus 256 -~~----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 -RF----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CC----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CC----CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11 1122367889999999999999998 777754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=349.89 Aligned_cols=246 Identities=23% Similarity=0.314 Sum_probs=199.7
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCce
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 368 (621)
...++|...+.||+|+||+||+|+.. +|+.||+|+++.... ......+..|..++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 34578999999999999999999976 578999999975421 22345678899999887 799999999999999999
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 99999999999999998643 289999999999999999999999 99999999999999999999999999998
Q ss_pred ecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 449 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+.... .
T Consensus 170 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~-~- 238 (353)
T 2i0e_A 170 ENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIMEHN-V- 238 (353)
T ss_dssp CCCCT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-C-
T ss_pred ccccC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhCC-C-
Confidence 54322 223445679999999999999999999999999999999999999996321 112222222211 0
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCH
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 565 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 565 (621)
.. +......+.+++..|++.||++||++
T Consensus 239 -----~~----p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 239 -----AY----PKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp -----CC----CTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred -----CC----CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11 11223678899999999999999964
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=350.83 Aligned_cols=209 Identities=22% Similarity=0.296 Sum_probs=183.1
Q ss_pred cccccCHHHHHHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-----CCce
Q 007020 282 QLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-----HRNL 355 (621)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~ni 355 (621)
....+++++.....++|.+.+.||+|+||+||+|... +++.||||+++.. ......+..|+.+++.+. ||||
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 4456677777788899999999999999999999874 6899999998642 334456788999999886 9999
Q ss_pred eeeeeeeecCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC
Q 007020 356 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE 435 (621)
Q Consensus 356 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 435 (621)
+++++++...+..++||||+ +++|.+++...... .+++..+..++.||+.||+|||++ +|+||||||+|||++.
T Consensus 99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN--GFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDD 172 (360)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESC
T ss_pred ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcc
Confidence 99999999999999999999 88999999875432 388999999999999999999999 9999999999999975
Q ss_pred -------------------------CCcEEEcccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHH
Q 007020 436 -------------------------EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIM 490 (621)
Q Consensus 436 -------------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvi 490 (621)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 248 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence 789999999999864432 234568999999999999999999999999999
Q ss_pred HHHHHhCCCCcc
Q 007020 491 LLELITGQRAFD 502 (621)
Q Consensus 491 l~elltg~~pf~ 502 (621)
+|||++|+.||.
T Consensus 249 l~ell~g~~pf~ 260 (360)
T 3llt_A 249 LAELYTGSLLFR 260 (360)
T ss_dssp HHHHHHSSCSCC
T ss_pred HHHHHHCCCCCC
Confidence 999999999996
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=347.03 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=189.2
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
..+.|.+.+.||+|+||+||+|... +++.||||+++... ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 3567889999999999999999976 58899999997543 2346789999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---CCcEEEccccccee
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFGLAKL 449 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfGla~~ 449 (621)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.
T Consensus 128 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp CCCCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 9999999999997643 389999999999999999999999 9999999999999975 88999999999986
Q ss_pred cccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 450 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ... .......... ..
T Consensus 201 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~---~~~~~i~~~~-~~- 269 (349)
T 2w4o_A 201 VEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER----GDQ---FMFRRILNCE-YY- 269 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT----CHH---HHHHHHHTTC-CC-
T ss_pred cCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc----ccH---HHHHHHHhCC-Cc-
Confidence 5432 22334569999999999999999999999999999999999999995221 111 1111111111 00
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.. ..........+.+++..|++.||++|||+.++++
T Consensus 270 ~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 270 FI-----SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CC-----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cC-----CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 1111223467889999999999999999999976
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=350.00 Aligned_cols=257 Identities=25% Similarity=0.417 Sum_probs=200.4
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCc----EEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
.++|+..+.||+|+||+||+|.+. +++ .||+|.++..........+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467888999999999999999864 444 368888766555556778999999999999999999999998754 88
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+++||+.+|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 99999999999999987532 388999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCC-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 450 MDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 450 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
...... .......+|..|+|||.+.+..++.++||||||+++|||++ |..||.... .....+.+.. ....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-----~~~~~~~~~~---~~~~ 238 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILEK---GERL 238 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHHHHT---TCCC
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHc---CCCC
Confidence 643322 12233447889999999999999999999999999999999 999996322 1112121111 1000
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 576 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 576 (621)
.........+.+++..||+.||++||++.++++.|+...
T Consensus 239 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 239 ----------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 011122357889999999999999999999999998743
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=353.00 Aligned_cols=253 Identities=23% Similarity=0.276 Sum_probs=194.6
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.++|.+.+.||+|+||+||+++.. +++.||||++..... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 467889999999999999999975 789999999975432 23468899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc--EEEcccccceecc
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAKLMD 451 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~DfGla~~~~ 451 (621)
|+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++...
T Consensus 97 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 97 YASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred eCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 999999999997643 289999999999999999999999 9999999999999987765 9999999997433
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCc-ccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEK-TDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
.. .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...... ......+........ ..
T Consensus 170 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~~~~~~~~~~~--~~ 241 (361)
T 3uc3_A 170 LH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP----RDYRKTIQRILSVKY--SI 241 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C----CCHHHHHHHHHTTCC--CC
T ss_pred cc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH----HHHHHHHHHHhcCCC--CC
Confidence 22 22334569999999999988887655 89999999999999999999643221 112222222221110 00
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.+ .......+.+++..||+.||++|||+.|+++.
T Consensus 242 ~~-------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 242 PD-------DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CT-------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CC-------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00 00123578899999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=334.88 Aligned_cols=253 Identities=24% Similarity=0.377 Sum_probs=205.9
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.++|++.+.||+|+||.||+|... +++.||+|++...........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467888999999999999999875 6899999999765555556779999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 999999999997543 388999999999999999999999 9999999999999999999999999999876433
Q ss_pred CC-eeeecccccccccchhhhccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 454 DT-HVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 454 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
.. .......|+..|+|||.+.+..+ +.++||||||+++|||++|+.||..... .......|... .. ..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~----~~---~~ 228 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD---SCQEYSDWKEK----KT---YL 228 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT---TSHHHHHHHTT----CT---TS
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch---HHHHHHHhhhc----cc---cc
Confidence 22 12334568999999999987665 7789999999999999999999963221 11122222111 00 00
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.+ .......+.+++..|++.||++|||++++++
T Consensus 229 ~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 NP------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TT------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred Cc------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00 1122357889999999999999999999965
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=376.97 Aligned_cols=262 Identities=26% Similarity=0.396 Sum_probs=212.1
Q ss_pred HHHHHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCce
Q 007020 289 RELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 289 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 368 (621)
..+++..++|.+.+.||+|+||+||+|.+.++..||||+++.... ....|.+|+++++.++|+||+++++++.+ +..
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 345666788999999999999999999998888899999976442 34579999999999999999999999876 678
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
++||||+++|+|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 411 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred eEeeehhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence 999999999999999975321 2388999999999999999999999 99999999999999999999999999998
Q ss_pred ecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 449 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
..............++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+.+..+......
T Consensus 412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~--------~~~~~~~i~~~~~~ 483 (535)
T 2h8h_A 412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQVERGYRM 483 (535)
T ss_dssp TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC--------HHHHHHHHHTTCCC
T ss_pred ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCCC
Confidence 654221112223346789999999999999999999999999999999 999995221 11222222111111
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 576 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 576 (621)
.....+...+.+++..||+.||++|||+++|++.|+...
T Consensus 484 ----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 484 ----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 011223467899999999999999999999999998853
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=352.83 Aligned_cols=268 Identities=21% Similarity=0.294 Sum_probs=203.4
Q ss_pred hcCCCcCceeeec--cCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 295 TDSFSNKNILGRG--GFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 295 ~~~~~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
.++|++.+.||+| +||+||+|+.. +|+.||||+++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4678899999999 99999999976 799999999976543 3334568889999999999999999999999999999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
||||+++|+|.+++...... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMD--GMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999875322 389999999999999999999999 9999999999999999999999999998754
Q ss_pred ccCCC------eeeecccccccccchhhhcc--CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh
Q 007020 451 DYKDT------HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 522 (621)
Q Consensus 451 ~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 522 (621)
..... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||...... ......+.+..
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~ 254 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT----QMLLEKLNGTV 254 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST----THHHHC-----
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHhcCCC
Confidence 32211 11122368999999999987 57899999999999999999999999632111 11111110000
Q ss_pred hh---------c-------------cccccc---Cc------cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 523 KE---------K-------------KLEMLV---DP------DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 523 ~~---------~-------------~~~~~~---d~------~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.. . ...... .+ .............+.+++..||+.||++|||++|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 0 000000 00 00001122234678999999999999999999999753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=365.55 Aligned_cols=253 Identities=26% Similarity=0.335 Sum_probs=205.5
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
.++|...+.||+|+||+||+|+.. +|+.||+|+++.... ......+..|+.+++.++||||+++++++.+....++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467888899999999999999975 699999999965431 12345688999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++|+|.+++.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999987554445699999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .............. .
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~----~~~~~~~~~i~~~~-~---- 410 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK----VENKELKQRVLEQA-V---- 410 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC----CCHHHHHHHHHHCC-C----
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc----hhHHHHHHHHhhcc-c----
Confidence 3322 233457999999999999999999999999999999999999999633211 11122222222111 0
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMS 566 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ 566 (621)
.. +......+.+++..|++.||++||++.
T Consensus 411 --~~----p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 411 --TY----PDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp --CC----CTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred --CC----CcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 11 112236788999999999999999763
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=344.08 Aligned_cols=257 Identities=24% Similarity=0.352 Sum_probs=204.3
Q ss_pred HHHhcCCCcCc-eeeeccCceEEEEEc---CCCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCC
Q 007020 292 QVATDSFSNKN-ILGRGGFGKVYKGRL---ADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 366 (621)
Q Consensus 292 ~~~~~~~~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 366 (621)
.+..++|.+.+ .||+|+||+||+|.+ .+++.||||+++.... ......+.+|+.+++.++||||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 34456777777 999999999999953 2478899999976543 33356799999999999999999999998 567
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccc
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 446 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 446 (621)
..++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~ 163 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGL 163 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCc
Confidence 7899999999999999998753 388999999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCeee--ecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhh
Q 007020 447 AKLMDYKDTHVT--TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 523 (621)
Q Consensus 447 a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 523 (621)
+........... ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.... .. +.......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~---~~~~~~~~ 235 (291)
T 1xbb_A 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-----GS---EVTAMLEK 235 (291)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HH---HHHHHHHT
T ss_pred ceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC-----HH---HHHHHHHc
Confidence 987654433222 22346788999999998889999999999999999999 999996321 11 11111111
Q ss_pred hcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 524 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 524 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.. .+.. .......+.+++..||+.||++||++.++++.|++
T Consensus 236 ~~------~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 236 GE------RMGC----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp TC------CCCC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CC------CCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11 0111 11233678999999999999999999999999987
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=357.15 Aligned_cols=252 Identities=22% Similarity=0.329 Sum_probs=197.9
Q ss_pred hcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCC-chhHHHHHHHHHHHHhcc--CCceeeeeeeeecCCceEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAV--HRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv 371 (621)
.+.|.+.+.||+|+||+||+|...+++.||||++..... ......+.+|+.+++.++ ||||+++++++..++..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 456999999999999999999988899999999976543 334567899999999996 59999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|| +.+++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++ ++.+||+|||+++...
T Consensus 135 ~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred Ee-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 99 56789999998754 388889999999999999999999 999999999999996 5789999999998765
Q ss_pred cCCCe-eeecccccccccchhhhcc-----------CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHH
Q 007020 452 YKDTH-VTTAVRGTIGHIAPEYLST-----------GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 519 (621)
Q Consensus 452 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 519 (621)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .....+.
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-------~~~~~~~ 278 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQISKLH 278 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-------CHHHHHH
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-------HHHHHHH
Confidence 33222 2344569999999999875 367889999999999999999999995211 0111122
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 520 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 520 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.... +.............+.+++..||+.||++|||+.|+++.
T Consensus 279 ~~~~---------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 279 AIID---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHC---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhC---------ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 2111 111111111113578899999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=333.10 Aligned_cols=252 Identities=19% Similarity=0.294 Sum_probs=204.3
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
.++|++.+.||+|+||.||+|... +++.||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468899999999999999999865 68999999997654 3334567889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc---EEEccccccee
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGLAKL 449 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DfGla~~ 449 (621)
||+++|+|.+.+.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999887643 388999999999999999999999 9999999999999986655 99999999987
Q ss_pred cccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 450 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ........... ...
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~-~~~- 225 (284)
T 3kk8_A 158 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYAQIKAG-AYD- 225 (284)
T ss_dssp CCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHT-CCC-
T ss_pred cccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc--------hhHHHHHHHhc-ccc-
Confidence 55332 2334569999999999999999999999999999999999999995221 11111111111 110
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
...+. .......+.+++..|++.||++|||++|+++
T Consensus 226 ~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 226 YPSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CCTTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCchh-----hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 01111 1122357889999999999999999999976
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=339.24 Aligned_cols=261 Identities=21% Similarity=0.269 Sum_probs=199.9
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
.++|.+.+.||+|+||.||+|... +++.||+|++..... ......+.+|+.+++.++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467899999999999999999865 688999999975432 22346789999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++++|.+++.... ++++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999998643 389999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
...........|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ..+........ .
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~~~~~~~~~----~ 252 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---------SVMGAHINQAI----P 252 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---------HHHHHHHHSCC----C
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---------HHHHHHhccCC----C
Confidence 4433334455699999999999988899999999999999999999999963221 11111111111 0
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHhcCCCc
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-KMSEVVRMLEGDGLA 578 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-t~~~vl~~L~~~~~~ 578 (621)
.+. ......+..+.+++..||+.||++|| +++++++.|+.....
T Consensus 253 ~~~---~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 253 RPS---TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp CGG---GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred Ccc---ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 110 01112235788999999999999999 999999999875443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=350.48 Aligned_cols=253 Identities=25% Similarity=0.299 Sum_probs=196.2
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHH-HHhccCCceeeeeeeeecCCceEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEM-ISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
++|+..+.||+|+||+||+|+.. +++.||+|++++... ......+..|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 57888999999999999999975 688999999976532 2233456667766 5678999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 118 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 118 LDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999997643 388899999999999999999999 99999999999999999999999999998543
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
.. ........||+.|+|||++.+..++.++|||||||++|||++|..||.... ..+....+.... .
T Consensus 191 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~-~---- 256 (373)
T 2r5t_A 191 EH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYDNILNKP-L---- 256 (373)
T ss_dssp CC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB--------HHHHHHHHHHSC-C----
T ss_pred cC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhcc-c----
Confidence 22 223445679999999999999999999999999999999999999996321 112222222211 0
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
.+.. .....+.+++..|++.||.+||++.+.+..+...
T Consensus 257 --~~~~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 257 --QLKP----NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp --CCCS----SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred --CCCC----CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence 1111 1235788999999999999999987655555444
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=341.20 Aligned_cols=265 Identities=26% Similarity=0.348 Sum_probs=198.2
Q ss_pred HHhcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCC----chhHHHHHHHHHHHHhcc---CCceeeeeeeeec
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERT----PGGELQFQTEVEMISMAV---HRNLLRLRGFCMT 364 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 364 (621)
...++|++.+.||+|+||+||+|.+ .+++.||||+++.... ......+.+|+.+++.+. ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4567999999999999999999996 4789999999864331 112345677887777665 9999999999977
Q ss_pred CC-----ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcE
Q 007020 365 PT-----ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 439 (621)
Q Consensus 365 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 439 (621)
.. ..++||||+. |+|.+++...... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPP--GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence 55 4799999998 5999999875432 389999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHH
Q 007020 440 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 519 (621)
Q Consensus 440 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 519 (621)
||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.
T Consensus 160 kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~i~ 232 (308)
T 3g33_A 160 KLADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS-----EADQLGKIF 232 (308)
T ss_dssp EECSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS-----HHHHHHHHH
T ss_pred EEeeCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHH
Confidence 99999999865432 22344568999999999999999999999999999999999999996321 111111111
Q ss_pred HHhhhcccccc----------cCcc---ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 520 GLLKEKKLEML----------VDPD---LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 520 ~~~~~~~~~~~----------~d~~---~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
........... ..+. .......+....+.+++..|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 11100000000 0000 000001123367889999999999999999999865
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=377.11 Aligned_cols=254 Identities=23% Similarity=0.356 Sum_probs=201.4
Q ss_pred cCCCcCc-eeeeccCceEEEEEcC---CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 296 DSFSNKN-ILGRGGFGKVYKGRLA---DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 296 ~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
+++.+.+ .||+|+||+||+|.+. ++..||||+++.........++.+|+++++.++|||||++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444444 7999999999999763 4667999999876555567789999999999999999999999976 568999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 414 ~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EECCTTCBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEeCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 99999999999997542 2489999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCCee--eecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 452 YKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 452 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
...... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.... .. +.+..+......
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~-----~~---~~~~~i~~~~~~- 558 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----GP---EVMAFIEQGKRM- 558 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----SH---HHHHHHHTTCCC-
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC-----HH---HHHHHHHcCCCC-
Confidence 332221 122335689999999999999999999999999999998 999996321 11 112222111111
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
..+..++..+.+++..||+.+|++||++.+|++.|+.
T Consensus 559 ---------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 559 ---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp ---------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred ---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1112234689999999999999999999999999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=355.43 Aligned_cols=254 Identities=32% Similarity=0.485 Sum_probs=194.3
Q ss_pred CCCcCceeeeccCceEEEEEcC--C--CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeec-CCceEEE
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA--D--GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLV 371 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv 371 (621)
.|...+.||+|+||+||+|.+. + +..||||.++.........++.+|+.+++.++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4566789999999999999853 2 246899999766555667789999999999999999999998754 4678999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++|+|.+++..... .+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999976432 378899999999999999999999 99999999999999999999999999998654
Q ss_pred cCCCe---eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 452 YKDTH---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 452 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
..... ......+++.|+|||.+.+..++.++||||||+++|||++ |.+||.... .......+. ...
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~-----~~~~~~~~~---~~~-- 313 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYLL---QGR-- 313 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----SSCHHHHHH---TTC--
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC-----HHHHHHHHH---cCC--
Confidence 32211 1233457889999999999999999999999999999999 677775321 111211111 111
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
....+ ...+..+.+++..||+.||++|||+.++++.|+.
T Consensus 314 -~~~~p-------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 352 (373)
T 3c1x_A 314 -RLLQP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352 (373)
T ss_dssp -CCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11111 1223678999999999999999999999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=341.42 Aligned_cols=255 Identities=33% Similarity=0.501 Sum_probs=201.3
Q ss_pred cCCCcCceeeeccCceEEEEEcCC----CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeee-cCCceEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLAD----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM-TPTERLL 370 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~l 370 (621)
.+|...+.||+|+||+||+|.+.+ ...||+|.++..........+.+|+.++++++||||+++++++. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 467788999999999999998542 23689999987665566678999999999999999999999854 5567899
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 105 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999997643 2378999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCC---eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcc
Q 007020 451 DYKDT---HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 451 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (621)
..... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||.... ....... .....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----~~~~~~~---~~~~~- 249 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVY---LLQGR- 249 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC-----TTTHHHH---HHTTC-
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC-----HHHHHHH---HhcCC-
Confidence 43221 12233457889999999999999999999999999999999 555664211 1111111 11111
Q ss_pred cccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 527 ~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
....+ ......+.+++..||+.||++|||++++++.|++
T Consensus 250 --~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 288 (298)
T 3f66_A 250 --RLLQP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288 (298)
T ss_dssp --CCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCC-------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 01111 1123578899999999999999999999999977
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=344.01 Aligned_cols=250 Identities=21% Similarity=0.283 Sum_probs=181.2
Q ss_pred CceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-CCceeeeeeeeecCCceEEEEeccCCC
Q 007020 301 KNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYMANG 378 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 378 (621)
.+.||+|+||+||+|.+. +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 478999999999999875 6899999998643 3456789999999997 999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC---cEEEcccccceecccCCC
Q 007020 379 SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAKLMDYKDT 455 (621)
Q Consensus 379 sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~DfGla~~~~~~~~ 455 (621)
+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++......
T Consensus 92 ~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~- 163 (325)
T 3kn6_A 92 ELFERIKKKK----HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN- 163 (325)
T ss_dssp BHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-
Confidence 9999998753 389999999999999999999999 999999999999997765 89999999998654332
Q ss_pred eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccc
Q 007020 456 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 535 (621)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 535 (621)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... ....+......... ...
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~i~~~~-------~~~ 235 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-TSAVEIMKKIKKGD-------FSF 235 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C-CCHHHHHHHHTTTC-------CCC
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc-ccHHHHHHHHHcCC-------CCC
Confidence 2234456899999999999999999999999999999999999999743321111 11112222221111 011
Q ss_pred cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 536 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 536 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
...........+.+++..|++.||++|||++++++
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 11112233467899999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=347.66 Aligned_cols=267 Identities=18% Similarity=0.196 Sum_probs=199.3
Q ss_pred hcCCCcCceeeeccCceEEEEEcC----CCcEEEEEEecccCCchh----------HHHHHHHHHHHHhccCCceeeeee
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGG----------ELQFQTEVEMISMAVHRNLLRLRG 360 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~----------~~~~~~E~~~l~~l~h~niv~l~~ 360 (621)
.++|.+.+.||+|+||+||+|... ++..||+|++........ ...+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467888999999999999999875 578899999875532211 123567888899999999999999
Q ss_pred eeec----CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC
Q 007020 361 FCMT----PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 436 (621)
Q Consensus 361 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~ 436 (621)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9887 67889999999 999999998654 489999999999999999999999 99999999999999887
Q ss_pred C--cEEEcccccceecccCCCe------eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccC
Q 007020 437 F--EAVVGDFGLAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLAN 508 (621)
Q Consensus 437 ~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~ 508 (621)
+ .+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--- 264 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL--- 264 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT---
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc---
Confidence 7 9999999999876432211 1134469999999999999999999999999999999999999995221
Q ss_pred CCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCC
Q 007020 509 DDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGL 577 (621)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 577 (621)
.................... ...... ....+..+.+++..||+.||++||++++|++.|+....
T Consensus 265 -~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 265 -KDPVAVQTAKTNLLDELPQS-VLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp -TCHHHHHHHHHHHHHTTTHH-HHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred -cccHHHHHHHHhhcccccHH-HHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11111111111111110000 000000 00223579999999999999999999999999988544
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=341.22 Aligned_cols=254 Identities=28% Similarity=0.438 Sum_probs=196.6
Q ss_pred hcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
.++|++.+.||+|+||+||+|++. ++.||||.+... .....+.+|+.++++++||||+++++++. +..++||||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~ 80 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEY 80 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEEC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEc
Confidence 357888899999999999999985 788999998642 34567899999999999999999999987 358999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc-EEEcccccceecccC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE-AVVGDFGLAKLMDYK 453 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~-~kl~DfGla~~~~~~ 453 (621)
+++|+|.+++..... ...+++..+..++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 999999999986532 123788899999999999999999932228999999999999988886 799999999754322
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 533 (621)
.....||..|+|||++.+..++.++||||||+++|||++|+.||+.... ............. .+
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~------~~ 223 (307)
T 2eva_A 160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG------PAFRIMWAVHNGT------RP 223 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS------SHHHHHHHHHTTC------CC
T ss_pred ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc------cHHHHHHHHhcCC------CC
Confidence 2234589999999999999999999999999999999999999963211 1111111111111 11
Q ss_pred cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 534 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
.. .......+.+++..||+.||++|||++++++.|+..
T Consensus 224 ~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 224 PL----IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp CC----BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Cc----ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11 112235788999999999999999999999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=341.09 Aligned_cols=252 Identities=21% Similarity=0.288 Sum_probs=205.5
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCch-----hHHHHHHHHHHHHhccCCceeeeeeeeecCCce
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-----GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 368 (621)
.+.|.+.+.||+|+||.||+|... +|+.||+|.++...... ....+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467889999999999999999865 68999999997654222 356789999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC----cEEEccc
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 444 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Df 444 (621)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999997643 388999999999999999999999 999999999999999887 7999999
Q ss_pred ccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhh
Q 007020 445 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 524 (621)
Q Consensus 445 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 524 (621)
|++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.... ..+........
T Consensus 164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~ 233 (321)
T 2a2a_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANITSV 233 (321)
T ss_dssp TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTT
T ss_pred ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhc
Confidence 9998765332 2234569999999999999999999999999999999999999995321 11222221111
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 525 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 525 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. ...++.. .......+.+++..|++.||++|||+.++++
T Consensus 234 ~---~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 234 S---YDFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp C---CCCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred c---cccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 0011111 1122357889999999999999999999976
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=340.35 Aligned_cols=262 Identities=22% Similarity=0.291 Sum_probs=198.2
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc-hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
++|+..+.||+|+||+||+|... +|+.||+|++...... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888999999999999999875 5899999998665433 334568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999887543 388999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhh--------
Q 007020 454 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE-------- 524 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-------- 524 (621)
.. ......||..|+|||++.+ ..++.++||||||+++|+|++|+.||..... ......+......
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD-----VDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCHHHHHH
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhcccccccccc
Confidence 22 2334468999999999976 5679999999999999999999999963221 1111111111000
Q ss_pred ----cccc--cccCccccCc---ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 525 ----KKLE--MLVDPDLQNN---YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 525 ----~~~~--~~~d~~~~~~---~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.... ...++..... ........+.+++..||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 0011100000 00123456889999999999999999999976
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=341.41 Aligned_cols=255 Identities=28% Similarity=0.400 Sum_probs=202.2
Q ss_pred CCCcCceeeeccCceEEEEEcC-C---CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCce-EEE
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-D---GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER-LLV 371 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv 371 (621)
.|...+.||+|+||+||+|.+. + +..||+|.+...........+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3455688999999999999853 2 3379999998765555667899999999999999999999999876665 999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+.+|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 99999999999998633 2488999999999999999999999 99999999999999999999999999998653
Q ss_pred cCC---CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 452 YKD---THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 452 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
... ........++..|+|||.+.+..++.++||||||+++|+|++|..|+... .........+.. ...
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~----~~~~~~~~~~~~---~~~-- 246 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH----IDPFDLTHFLAQ---GRR-- 246 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTT----SCGGGHHHHHHT---TCC--
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCcc----CCHHHHHHHhhc---CCC--
Confidence 321 12223445889999999999999999999999999999999966554311 111112222111 110
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
... .......+.+++..||+.||++|||++++++.|++
T Consensus 247 -~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~ 284 (298)
T 3pls_A 247 -LPQ-------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ 284 (298)
T ss_dssp -CCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCC-------CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 000 11123578899999999999999999999999987
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=342.68 Aligned_cols=268 Identities=23% Similarity=0.322 Sum_probs=211.5
Q ss_pred CHHHHHHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHh--ccCCceeeeeeeeec
Q 007020 287 SLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISM--AVHRNLLRLRGFCMT 364 (621)
Q Consensus 287 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~ 364 (621)
++.......++|.+.+.||+|+||+||+|++ +|+.||||++... ....+.+|.+++.. ++||||+++++++..
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 4445566778999999999999999999998 5899999998642 34567788888887 789999999999987
Q ss_pred CC----ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCee
Q 007020 365 PT----ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH--------DHCDPKIIHRDVKAANIL 432 (621)
Q Consensus 365 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlk~~Nil 432 (621)
.. ..++||||+++|+|.+++... .+++..+..++.|++.||+||| +. +|+||||||+|||
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIl 179 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNIL 179 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEE
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEE
Confidence 76 789999999999999999764 2889999999999999999999 77 9999999999999
Q ss_pred eCCCCcEEEcccccceecccCCCe---eeecccccccccchhhhccCC------CCCcccchhHHHHHHHHHhC------
Q 007020 433 LDEEFEAVVGDFGLAKLMDYKDTH---VTTAVRGTIGHIAPEYLSTGK------SSEKTDVFGYGIMLLELITG------ 497 (621)
Q Consensus 433 l~~~~~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltg------ 497 (621)
++.++.+||+|||++......... ......||..|+|||++.+.. ++.++||||||+++|||++|
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 999999999999999876654332 223456999999999997763 23689999999999999999
Q ss_pred ----CCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCc-ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007020 498 ----QRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNN-YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 572 (621)
Q Consensus 498 ----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L 572 (621)
..||...... ......+...... . ...+..... ...+....+.+++..||+.||++|||+.+|++.|
T Consensus 260 ~~~~~~p~~~~~~~---~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 260 HEDYQLPYYDLVPS---DPSVEEMRKVVCE-Q----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp CCCCCCTTTTTSCS---SCCHHHHHHHHTT-S----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred ccccccCccccCcC---cccHHHHHHHHHH-H----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 6777532211 1122222222211 1 112222111 1235667899999999999999999999999999
Q ss_pred hcC
Q 007020 573 EGD 575 (621)
Q Consensus 573 ~~~ 575 (621)
+..
T Consensus 332 ~~i 334 (342)
T 1b6c_B 332 SQL 334 (342)
T ss_dssp HHH
T ss_pred HHH
Confidence 874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=346.91 Aligned_cols=262 Identities=23% Similarity=0.329 Sum_probs=194.2
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
++|...+.||+|+||+||+|... +++.||+|+++..........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57888999999999999999875 78999999997554333333456799999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++ +|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CSE-EHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred ccc-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 985 99998876532 388999999999999999999999 99999999999999999999999999998654322
Q ss_pred Ceeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc---cc
Q 007020 455 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE---ML 530 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 530 (621)
.......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.... .......+.......... ..
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~ 228 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST-----VEEQLHFIFRILGTPTEETWPGI 228 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCTTTSTTG
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhCCCChHhchhh
Confidence 22334458999999999976 567999999999999999999999996322 111112222111100000 00
Q ss_pred ---------cCccccC----cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 531 ---------VDPDLQN----NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 531 ---------~d~~~~~----~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..+.... .........+.+++..|++.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000000 001112356889999999999999999999976
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=339.94 Aligned_cols=261 Identities=21% Similarity=0.334 Sum_probs=198.5
Q ss_pred cCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|.+.+.||+|+||.||+|.. .+|+.||+|+++... .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5688889999999999999986 478999999997532 2344567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++.........+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999875332334488999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
.. .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.... ............. ...
T Consensus 189 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~-~~~---- 256 (310)
T 2wqm_A 189 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIEQC-DYP---- 256 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---------CCHHHHHHHHHTT-CSC----
T ss_pred CC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc------hhHHHHHHHhhcc-cCC----
Confidence 22 22234468999999999999999999999999999999999999995321 1111222222111 111
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
... .......+.+++..||+.||++|||+++|++.|+..
T Consensus 257 -~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 257 -PLP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp -CCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 110 011235788999999999999999999999999873
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=347.37 Aligned_cols=257 Identities=26% Similarity=0.423 Sum_probs=203.1
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcE--EEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSL--VAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 370 (621)
.++|.+.+.||+|+||.||+|... ++.. ||+|.++..........+.+|++++.++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 367888999999999999999865 4554 4999987655455556789999999999 89999999999999999999
Q ss_pred EEeccCCCchhhhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc
Q 007020 371 VYPYMANGSVASCLRERP------------PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE 438 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 438 (621)
||||+++|+|.+++.... .....+++..++.++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence 999999999999998653 2234589999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHH
Q 007020 439 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDW 517 (621)
Q Consensus 439 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~ 517 (621)
+||+|||+++...... ......++..|+|||++.+..++.++||||||+++|||++ |+.||.... ..+.
T Consensus 181 ~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~~~ 250 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAEL 250 (327)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHH
T ss_pred EEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc--------HHHH
Confidence 9999999997432211 1222347889999999998889999999999999999998 999995321 1122
Q ss_pred HHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 518 VKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 518 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
........ .... .......+.+++..||+.||++|||++++++.|+.
T Consensus 251 ~~~~~~~~------~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 251 YEKLPQGY------RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp HHHGGGTC------CCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhhcCC------CCCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 22211110 1111 11223678899999999999999999999999876
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=346.21 Aligned_cols=252 Identities=20% Similarity=0.288 Sum_probs=200.6
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceEEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 371 (621)
..++|++.+.||+|+||+||+|... +|+.||||++..... ...+|++++.++ +||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 3567999999999999999999875 688999999976542 235688888777 799999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC----CcEEEcccccc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE----FEAVVGDFGLA 447 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~----~~~kl~DfGla 447 (621)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+..+ +.+||+|||++
T Consensus 95 ~E~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 95 TELMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp ECCCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 99999999999997643 389999999999999999999999 99999999999998543 35999999999
Q ss_pred eecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.... .....+........ ..
T Consensus 168 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~~~~i~~~-~~ 240 (342)
T 2qr7_A 168 KQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP-----DDTPEEILARIGSG-KF 240 (342)
T ss_dssp EECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST-----TSCHHHHHHHHHHC-CC
T ss_pred ccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC-----cCCHHHHHHHHccC-Cc
Confidence 87654322 2344568999999999988888999999999999999999999996321 11122222222211 11
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. ............+.+++..|++.||++||++.++++
T Consensus 241 ~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 241 S------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp C------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred c------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 111111223467889999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=333.23 Aligned_cols=260 Identities=20% Similarity=0.233 Sum_probs=200.8
Q ss_pred HhcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeee-ecCCceEEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC-MTPTERLLV 371 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv 371 (621)
..++|+..+.||+|+||+||+|.. .+++.||||++..... ...+.+|+.+++.++|++++..++++ ...+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 457899999999999999999986 5789999998754332 23578899999999988877766655 567788999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee---CCCCcEEEcccccce
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 448 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfGla~ 448 (621)
|||+ +++|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEcc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 9999 8899999985432 389999999999999999999999 99999999999999 788999999999998
Q ss_pred ecccCCCe------eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh
Q 007020 449 LMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 522 (621)
Q Consensus 449 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 522 (621)
........ ......||..|+|||.+.+..++.++|||||||++|+|++|+.||......... ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~ 235 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEKKM 235 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-SHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh-hhhhhhhcccc
Confidence 76543321 223456999999999999999999999999999999999999999743322211 11111111111
Q ss_pred hhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 523 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 523 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
. .... ... ...+..+.+++..||+.||++|||+++|++.|++
T Consensus 236 ~-~~~~-----~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 236 S-TPIE-----VLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp H-SCHH-----HHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred c-chhh-----hhh----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 1 0000 000 1123678999999999999999999999999987
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=357.98 Aligned_cols=249 Identities=22% Similarity=0.285 Sum_probs=194.4
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
.++|++.+.||+|+||.||+|... +|+.||||+++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467889999999999999999864 68999999997542 223344678899999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 99999999999997643 38999999999999999999998 8 9999999999999999999999999999854
Q ss_pred ccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... .
T Consensus 300 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~-~--- 366 (446)
T 4ejn_A 300 IKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILMEE-I--- 366 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-C---
T ss_pred cCC-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHHhCC-C---
Confidence 322 223345679999999999999999999999999999999999999995321 112222221111 0
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 570 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~ 570 (621)
.. +......+.+++..||+.||++|| +++|+++
T Consensus 367 ---~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 ---RF----PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ---CC----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CC----CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11 111236788999999999999999 9999865
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=347.36 Aligned_cols=246 Identities=22% Similarity=0.261 Sum_probs=195.2
Q ss_pred CceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCCCc
Q 007020 301 KNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 379 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 379 (621)
.+.||+|+||.||+|... +|+.||+|+++... ......+.+|+++++.++||||+++++++.+.+..++||||+++|+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 567999999999999864 68999999997643 3445679999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee--CCCCcEEEcccccceecccCCCee
Q 007020 380 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL--DEEFEAVVGDFGLAKLMDYKDTHV 457 (621)
Q Consensus 380 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill--~~~~~~kl~DfGla~~~~~~~~~~ 457 (621)
|.+++.... ..+++..+..++.||++||+|||+. +|+||||||+|||+ +.++.+||+|||+++...... .
T Consensus 173 L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~ 244 (373)
T 2x4f_A 173 LFDRIIDES---YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--K 244 (373)
T ss_dssp EHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--B
T ss_pred HHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--c
Confidence 999887542 2388999999999999999999999 99999999999999 677899999999998765432 2
Q ss_pred eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccC
Q 007020 458 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 537 (621)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 537 (621)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+........ . .. .
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~i~~~~~--~-~~----~ 309 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN--------DAETLNNILACRW--D-LE----D 309 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCC--C-SC----S
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhccC--C-CC----h
Confidence 233469999999999998889999999999999999999999996321 1122222222110 0 00 1
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 538 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 538 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.........+.+++..|++.||++|||+.|+++
T Consensus 310 ~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 310 EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111122367889999999999999999999987
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=350.99 Aligned_cols=267 Identities=27% Similarity=0.356 Sum_probs=208.9
Q ss_pred hcCCCcCceeeeccCceEEEEEc-----CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeee--cCCc
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM--TPTE 367 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~ 367 (621)
.++|+..+.||+|+||.||+|.+ .+++.||||++.... ......+.+|+++++.++||||+++++++. +...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 46788899999999999999983 368899999997543 444567899999999999999999999886 4566
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
.++||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred EEEEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence 8999999999999999976322 389999999999999999999999 9999999999999999999999999999
Q ss_pred eecccCCCee--eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCccccccc------C-CCcchHHHHH
Q 007020 448 KLMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLA------N-DDDVMLLDWV 518 (621)
Q Consensus 448 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~------~-~~~~~~~~~~ 518 (621)
.......... .....||..|+|||++.+..++.++||||||+++|+|++|+.||...... . ..........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 8765443322 22345888899999999988999999999999999999999999632211 0 0000111111
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCCc
Q 007020 519 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLA 578 (621)
Q Consensus 519 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~ 578 (621)
.... ..............+.+++..||+.||++|||++++++.|+.....
T Consensus 255 ~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 255 ELLE----------EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHHH----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred HHhh----------cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 1111 1111111223346789999999999999999999999999886443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=352.32 Aligned_cols=252 Identities=21% Similarity=0.257 Sum_probs=190.6
Q ss_pred cCCCcC-ceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHH-HhccCCceeeeeeeeec----CCce
Q 007020 296 DSFSNK-NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMI-SMAVHRNLLRLRGFCMT----PTER 368 (621)
Q Consensus 296 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 368 (621)
++|... +.||+|+||+||+|... +|+.||||+++.. ..+.+|++++ +..+||||+++++++.. ....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 455554 68999999999999865 6899999998632 2467888886 45589999999998865 5678
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---CCcEEEcccc
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFG 445 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfG 445 (621)
++||||+++|+|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 999999999999999987532 3489999999999999999999999 9999999999999997 7899999999
Q ss_pred cceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 446 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ....+. ..
T Consensus 210 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~i~----~~ 282 (400)
T 1nxk_A 210 FAKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-MKTRIR----MG 282 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS-HHHHHH----HT
T ss_pred cccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH-HHHHHH----cC
Confidence 99865432 223345689999999999999999999999999999999999999964332211111 111111 11
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 526 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 526 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
... ...+ ........+.+++..||+.||++|||+.++++.
T Consensus 283 ~~~-~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 283 QYE-FPNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCC-CCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccc-CCCc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 110 0111 011233678899999999999999999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=349.16 Aligned_cols=201 Identities=26% Similarity=0.400 Sum_probs=162.5
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhcc-CCceeeeeeeeecCC--c
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPT--E 367 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~ 367 (621)
...++|++.+.||+|+||+||+|.+. +|+.||||++.... .......+.+|+.++..+. ||||+++++++..++ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999864 78999999986543 2334556889999999997 999999999997554 6
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
.++||||++ |+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999998 5899998763 288899999999999999999999 9999999999999999999999999999
Q ss_pred eecccC--------------------CCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcc
Q 007020 448 KLMDYK--------------------DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFD 502 (621)
Q Consensus 448 ~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~ 502 (621)
+..... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 232 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence 865321 1112334579999999999986 578999999999999999999999996
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=332.03 Aligned_cols=259 Identities=20% Similarity=0.233 Sum_probs=203.9
Q ss_pred hcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeee-ecCCceEEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC-MTPTERLLVY 372 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 372 (621)
.++|.+.+.||+|+||+||+|.. .+|+.||||++..... ..++.+|+.+++.++|++++..++++ ......++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 46889999999999999999996 5789999999865432 23588999999999988877666655 5667789999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC---CCCcEEEccccccee
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAKL 449 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DfGla~~ 449 (621)
||+ +++|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 8899999975332 389999999999999999999999 999999999999994 788999999999987
Q ss_pred cccCCCe------eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh
Q 007020 450 MDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 523 (621)
Q Consensus 450 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 523 (621)
....... ......||..|+|||.+.+..++.++||||||+++|||++|+.||........ .............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEKKMS 236 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS-SSHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh-hhhhhhhcccccC
Confidence 6544321 12345699999999999999999999999999999999999999974332211 1112121111111
Q ss_pred hcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 524 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 524 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.... ... ...+..+.+++..||+.||++|||+++|++.|++
T Consensus 237 -~~~~-----~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 237 -TPIE-----VLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp -SCHH-----HHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred -CchH-----HHH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 0000 000 1123678999999999999999999999999977
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=346.93 Aligned_cols=244 Identities=23% Similarity=0.316 Sum_probs=202.0
Q ss_pred HhcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCch-------hHHHHHHHHHHHHhccCCceeeeeeeeecC
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPG-------GELQFQTEVEMISMAVHRNLLRLRGFCMTP 365 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 365 (621)
..++|...+.||+|+||+||+|.. .+++.||||+++...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 356899999999999999999985 478999999997653211 233577899999999999999999999999
Q ss_pred CceEEEEeccCCC-chhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccc
Q 007020 366 TERLLVYPYMANG-SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 444 (621)
Q Consensus 366 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 444 (621)
+..++||||+.+| +|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999877 9999998653 389999999999999999999999 9999999999999999999999999
Q ss_pred ccceecccCCCeeeecccccccccchhhhccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh
Q 007020 445 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 523 (621)
Q Consensus 445 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 523 (621)
|++....... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........
T Consensus 175 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------------- 238 (335)
T 3dls_A 175 GSAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE-------------- 238 (335)
T ss_dssp TTCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT--------------
T ss_pred ccceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh--------------
Confidence 9998765432 2334569999999999988876 7899999999999999999999963211000
Q ss_pred hcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 524 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 524 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.....+. .....+.+++..||+.||++|||++++++.
T Consensus 239 ----~~~~~~~-------~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 ----AAIHPPY-------LVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----TCCCCSS-------CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----hccCCCc-------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000111 123578899999999999999999999774
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=333.28 Aligned_cols=249 Identities=28% Similarity=0.411 Sum_probs=200.5
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
..++|++.+.||+|+||+||+|... +++.||+|++..... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3467888999999999999999865 578999999864321 1224568899999999999999999999999999999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 999999999999997643 288999999999999999999999 9999999999999999999999999998654
Q ss_pred ccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+........
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~------ 222 (279)
T 3fdn_A 160 PSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISRV------ 222 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHT------
T ss_pred Ccc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc--------HHHHHHHHHhC------
Confidence 322 2234568999999999999999999999999999999999999996321 11111111111
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.... +......+.+++..|++.||++|||++|+++.
T Consensus 223 -~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 223 -EFTF----PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -CCCC----CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -CCCC----CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0011 11123578899999999999999999999873
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=345.18 Aligned_cols=265 Identities=26% Similarity=0.339 Sum_probs=206.1
Q ss_pred HHhcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeee----cCCc
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM----TPTE 367 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~ 367 (621)
+..++|.+.+.||+|+||.||++.. .+++.||||++... .......+.+|+.+++.++||||+++++++. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 3457899999999999999999986 57899999998653 2445567899999999999999999999986 3457
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
.++||||+++|+|.+++.........+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 7999999999999999986433344589999999999999999999999 9999999999999999999999999998
Q ss_pred eecccCCCe--------eeecccccccccchhhhccCC---CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHH
Q 007020 448 KLMDYKDTH--------VTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLD 516 (621)
Q Consensus 448 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~ 516 (621)
......... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||+........ ...
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~ 258 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS---VAL 258 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC---HHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch---hhH
Confidence 764321110 012234799999999987654 688999999999999999999999632211111 111
Q ss_pred HHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCC
Q 007020 517 WVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGL 577 (621)
Q Consensus 517 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 577 (621)
.+.. .. ..+ ........+.+++..||+.||.+|||+.++++.|+....
T Consensus 259 ~~~~-----~~---~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 259 AVQN-----QL---SIP-----QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HHHC-----C-----CC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred Hhhc-----cC---CCC-----ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 1110 00 000 011223678999999999999999999999999988543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=348.51 Aligned_cols=270 Identities=25% Similarity=0.358 Sum_probs=197.5
Q ss_pred HhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHH--HHhccCCceeeeeeeee-----cCC
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEM--ISMAVHRNLLRLRGFCM-----TPT 366 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~-----~~~ 366 (621)
..++|.+.+.||+|+||+||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 346788899999999999999987 58999999986432 2334444444 45689999999998543 233
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEecCCCCCCeeeCCCCcEE
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC------DPKIIHRDVKAANILLDEEFEAV 440 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlk~~Nill~~~~~~k 440 (621)
..++||||+++|+|.+++.... .++..+..++.||++||+|||+.+ +++|+||||||+|||++.++.+|
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred eEEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 5689999999999999997653 588899999999999999999873 33899999999999999999999
Q ss_pred EcccccceecccCC-------Ceeeecccccccccchhhhcc-------CCCCCcccchhHHHHHHHHHhCCCCcccccc
Q 007020 441 VGDFGLAKLMDYKD-------THVTTAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGIMLLELITGQRAFDLARL 506 (621)
Q Consensus 441 l~DfGla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~elltg~~pf~~~~~ 506 (621)
|+|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998765322 112234469999999999976 3456789999999999999999888753332
Q ss_pred cCCCcchHH---------HHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 507 ANDDDVMLL---------DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 507 ~~~~~~~~~---------~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
......... ..+............+..... ........+.+++..||+.||++|||++|+++.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK--ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC--CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccc--cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 221111111 111111111111111111111 1223566899999999999999999999999999873
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=356.30 Aligned_cols=248 Identities=25% Similarity=0.417 Sum_probs=203.9
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357888999999999999999875 799999999965421 12345688999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999997643 389999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCeeeecccccccccchhhhccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||+... ............ .
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~--------~~~~~~~i~~~~----~ 233 (476)
T 2y94_A 168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH--------VPTLFKKICDGI----F 233 (476)
T ss_dssp TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------SHHHHHHHHTTC----C
T ss_pred ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHhcCC----c
Confidence 322 2344569999999999988765 689999999999999999999996321 112222221111 0
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..+ ......+.+++..|++.||++|||++++++
T Consensus 234 ~~p-------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 YTP-------QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CCC-------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCC-------ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 011 112257889999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=340.56 Aligned_cols=250 Identities=28% Similarity=0.412 Sum_probs=207.2
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.+.|...+.||+|+||.||+|... +++.||+|++...........+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888899999999999999864 6899999999776655566789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 99999999998753 389999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 533 (621)
. .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.... ..+....... . ..+
T Consensus 173 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~-~-----~~~ 237 (303)
T 3a7i_A 173 Q-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH--------PMKVLFLIPK-N-----NPP 237 (303)
T ss_dssp B-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHH-S-----CCC
T ss_pred c-cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC--------HHHHHHHhhc-C-----CCC
Confidence 2 22334568999999999999999999999999999999999999996321 1111111111 1 111
Q ss_pred cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 534 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
..... ....+.+++..||+.||++|||+.++++.
T Consensus 238 ~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 238 TLEGN----YSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCCSS----CCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCccc----cCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11112 23578899999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=352.69 Aligned_cols=256 Identities=25% Similarity=0.332 Sum_probs=204.1
Q ss_pred hcCCCcCceeeeccCceEEEEEc----CCCcEEEEEEecccCC---chhHHHHHHHHHHHHhc-cCCceeeeeeeeecCC
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL----ADGSLVAVKRLKEERT---PGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPT 366 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 366 (621)
.++|.+.+.||+|+||+||+|+. .+++.||||+++.... ......+.+|+.+++.+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36788999999999999999986 3789999999865321 12234577899999999 5999999999999999
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccc
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 446 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 446 (621)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 9999999999999999998643 388999999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCeeeecccccccccchhhhccC--CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhh
Q 007020 447 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 524 (621)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 524 (621)
++..............||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .............
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~----~~~~~~~~~~~~~ 281 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK----NSQAEISRRILKS 281 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC----CCHHHHHHHHHHC
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc----chHHHHHHHHhcc
Confidence 987654333344456799999999999863 4688999999999999999999999633211 1122222222211
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHH
Q 007020 525 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVRML 572 (621)
Q Consensus 525 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~~L 572 (621)
.+.. .......+.+++..||+.||++|| +++++++..
T Consensus 282 -------~~~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 -------EPPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -------CCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -------CCCC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1111 122235788999999999999999 898887643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=342.40 Aligned_cols=261 Identities=28% Similarity=0.401 Sum_probs=206.7
Q ss_pred HHhcCCCcCceeeeccCceEEEEEc------CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCC
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 366 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 366 (621)
+..++|.+.+.||+|+||.||+|.+ .+++.||||.+..........++.+|+.+++.++||||+++++++....
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 3457899999999999999999984 2577899999976655666678999999999999999999999999999
Q ss_pred ceEEEEeccCCCchhhhhccCCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---CCcEE
Q 007020 367 ERLLVYPYMANGSVASCLRERPPS---QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---EFEAV 440 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~k 440 (621)
..++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+|||++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence 999999999999999999875422 23488999999999999999999999 9999999999999984 44699
Q ss_pred EcccccceecccCCC-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHH
Q 007020 441 VGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWV 518 (621)
Q Consensus 441 l~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~ 518 (621)
|+|||++........ .......|++.|+|||.+.+..++.++||||||+++|+|++ |..||.... ..+..
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--------~~~~~ 255 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------NQEVL 255 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC--------HHHHH
Confidence 999999976543222 22234457899999999999999999999999999999998 999995321 11122
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 519 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 519 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
........ ... .......+.+++..||+.||.+||++.++++.|+.
T Consensus 256 ~~~~~~~~------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 256 EFVTSGGR------MDP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp HHHHTTCC------CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhcCCC------CCC----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 21111111 011 11223578899999999999999999999999876
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=341.87 Aligned_cols=258 Identities=22% Similarity=0.325 Sum_probs=204.7
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeee--cCCceEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCM--TPTERLL 370 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l 370 (621)
.++|+..+.||+|+||+||+|... +++.||+|.+..... ......+.+|+.+++.++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888999999999999999875 689999999976543 344567899999999999999999999874 4567899
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEecCCCCCCeeeCCCCcEEEcccc
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK-----IIHRDVKAANILLDEEFEAVVGDFG 445 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~Dlk~~Nill~~~~~~kl~DfG 445 (621)
||||+++|+|.+++.........+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999986543444589999999999999999999998 7 9999999999999999999999999
Q ss_pred cceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 446 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
++........ ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+....... .
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~i~~-~ 231 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGKIRE-G 231 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-T
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC--------HHHHHHHHhh-c
Confidence 9976543221 1223458999999999999899999999999999999999999996321 1111111111 1
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 526 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 526 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
... .+. ......+.+++..||+.||++||++.+|++.+..
T Consensus 232 ~~~-----~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 232 KFR-----RIP----YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CCC-----CCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ccc-----cCC----cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 111 111 1223678899999999999999999999886543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=341.89 Aligned_cols=261 Identities=21% Similarity=0.248 Sum_probs=195.8
Q ss_pred hcCCCcC-ceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHh-ccCCceeeeeeeeecCCceEEE
Q 007020 295 TDSFSNK-NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 295 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv 371 (621)
.+.|.+. +.||+|+||+||+|... +++.||||++.... ......+.+|+.++.+ .+||||+++++++.+.+..++|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 3567774 78999999999999864 78999999997553 3345678899999988 4799999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc---EEEcccccce
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGLAK 448 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DfGla~ 448 (621)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 99999999999998643 388999999999999999999999 9999999999999998776 9999999987
Q ss_pred ecccCCC------eeeecccccccccchhhhcc-----CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCc---ch-
Q 007020 449 LMDYKDT------HVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDD---VM- 513 (621)
Q Consensus 449 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~---~~- 513 (621)
....... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||.........- ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 6542211 11223459999999999975 457899999999999999999999996432211000 00
Q ss_pred ---HHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 514 ---LLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 514 ---~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
......... .... .............+.+++..|++.||++|||++|+++
T Consensus 243 ~~~~~~~~~~i~-~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 243 PACQNMLFESIQ-EGKY------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHH-HCCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhHHHHHHHHHh-ccCc------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 001111111 1110 0000000112367889999999999999999999976
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=364.49 Aligned_cols=255 Identities=24% Similarity=0.304 Sum_probs=205.7
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
..++|...+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3567888999999999999999875 799999999965321 2234568899999999999999999999999999999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
||||+++|+|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 262 VmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence 9999999999999976532 2389999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........... ..
T Consensus 337 ~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~----~~~~i~~~i~~-~~---- 405 (576)
T 2acx_A 337 PEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI----KREEVERLVKE-VP---- 405 (576)
T ss_dssp CTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC----CHHHHHHHHHH-CC----
T ss_pred ccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch----hHHHHHHHhhc-cc----
Confidence 5332 2334579999999999999889999999999999999999999996432111 11111111111 10
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 570 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~ 570 (621)
..+ .......+.+++..|++.||++|| +++||++
T Consensus 406 --~~~----p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 --EEY----SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --CCC----CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --ccC----CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 111 112236788999999999999999 6777754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=343.72 Aligned_cols=265 Identities=26% Similarity=0.430 Sum_probs=199.5
Q ss_pred HHHHHHhcCCCcCceeeeccCceEEEEEcC----CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeee
Q 007020 289 RELQVATDSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCM 363 (621)
Q Consensus 289 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 363 (621)
.++.+..++|.+.+.||+|+||.||+|... ++..||+|.++.... ......+.+|+.+++.++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 344556788999999999999999999753 345899999975543 334557899999999999999999999998
Q ss_pred cCCc-----eEEEEeccCCCchhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC
Q 007020 364 TPTE-----RLLVYPYMANGSVASCLRERP--PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 436 (621)
Q Consensus 364 ~~~~-----~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~ 436 (621)
+... .++||||+++|+|.+++.... .....+++..++.++.|+++||+|||++ +|+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 7653 499999999999999985422 2234589999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceecccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchH
Q 007020 437 FEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVML 514 (621)
Q Consensus 437 ~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~ 514 (621)
+.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.... ....
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~~ 258 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ-----NHEM 258 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GGGH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC-----HHHH
Confidence 99999999999865433221 2233447889999999999999999999999999999999 889986322 1111
Q ss_pred HHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 515 LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 515 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.+ ....... +. ........+.+++..||+.||++|||+.++++.|+.
T Consensus 259 ~~---~~~~~~~------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 305 (313)
T 3brb_A 259 YD---YLLHGHR------LK----QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305 (313)
T ss_dssp HH---HHHTTCC------CC----CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HH---HHHcCCC------CC----CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11 1111111 11 112233678999999999999999999999999976
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=345.72 Aligned_cols=254 Identities=17% Similarity=0.180 Sum_probs=203.5
Q ss_pred HHHHhcCCCcCceeeeccCceEEEEE------cCCCcEEEEEEecccCCchhHHHHHHHHHHHHhcc---CCceeeeeee
Q 007020 291 LQVATDSFSNKNILGRGGFGKVYKGR------LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV---HRNLLRLRGF 361 (621)
Q Consensus 291 ~~~~~~~~~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~ 361 (621)
++...++|.+.+.||+|+||+||+|. ..+++.||||+++... ..++..|+.++..++ |+||++++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 34456789999999999999999994 3468899999986532 446778888887776 9999999999
Q ss_pred eecCCceEEEEeccCCCchhhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-----
Q 007020 362 CMTPTERLLVYPYMANGSVASCLRERPP-SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE----- 435 (621)
Q Consensus 362 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~----- 435 (621)
+...+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCc
Confidence 9999999999999999999999975221 233489999999999999999999999 9999999999999998
Q ss_pred ------CCcEEEcccccceeccc-CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccC
Q 007020 436 ------EFEAVVGDFGLAKLMDY-KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLAN 508 (621)
Q Consensus 436 ------~~~~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~ 508 (621)
++.+||+|||+|+.+.. ..........||..|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 89999999999987543 23344556679999999999999999999999999999999999999996332110
Q ss_pred CCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHhc
Q 007020 509 DDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDR-PKMSEVVRMLEG 574 (621)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~R-Pt~~~vl~~L~~ 574 (621)
...... +..... ...+.+++..|++.+|.+| |+++++.+.|++
T Consensus 293 ----------------~~~~~~----~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 293 ----------------CKPEGL----FRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp ----------------EEECSC----CTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred ----------------eeechh----ccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 001111 111111 2456778889999999998 577888777766
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=348.65 Aligned_cols=247 Identities=30% Similarity=0.433 Sum_probs=198.9
Q ss_pred cCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCc--hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
+.|...+.||+|+||+||+|.. .+|+.||||++...... .....+.+|+++++.++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4578889999999999999985 57899999999754322 23356889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+. |+|.+++.... .++++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9998 58888876432 2389999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCeeeecccccccccchhhhc---cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
. ....||+.|+|||++. ...++.++|||||||++|||++|+.||.... ....+.......
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~--------~~~~~~~~~~~~---- 269 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNE---- 269 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSC----
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhcC----
Confidence 2 2346999999999985 4678999999999999999999999995221 111222222111
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.+.... ......+.+++..||+.||++|||++++++.
T Consensus 270 --~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 270 --SPALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp --CCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --CCCCCC---CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111111 1123568899999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=333.82 Aligned_cols=249 Identities=26% Similarity=0.419 Sum_probs=182.2
Q ss_pred cCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|.+.+.||+|+||.||+|.. .+|+.||+|.+..... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5688899999999999999986 4789999999864321 122356889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++++|.+++.... .++++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999998642 2489999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .... ... +
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~~~~----~~~---~ 228 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--------LNKV----VLA---D 228 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------C----CSS---C
T ss_pred CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--------HHHH----hhc---c
Confidence 222 22335689999999999988899999999999999999999999964321110 0000 000 1
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.... ......+.+++..|++.||++|||++++++
T Consensus 229 ~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 229 YEMP----SFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cCCc----cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1111 112357889999999999999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=338.67 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=200.7
Q ss_pred hcCCCcCceeeeccCceEEEEEcCC-C-------cEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCC
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLAD-G-------SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 366 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 366 (621)
.++|...+.||+|+||+||+|.... + ..||+|++.... ......+.+|+.+++.++||||+++++++.+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 4678889999999999999998642 3 479999986543 344567999999999999999999999999999
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc--------
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE-------- 438 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~-------- 438 (621)
..++||||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCEEEEECCCCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence 99999999999999999987432 388899999999999999999999 9999999999999998887
Q ss_pred EEEcccccceecccCCCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHH
Q 007020 439 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDW 517 (621)
Q Consensus 439 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~ 517 (621)
+||+|||++..... .....||..|+|||++.+ ..++.++||||||+++|||++|..|+.... . ....
T Consensus 160 ~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~----~---~~~~ 227 (289)
T 4fvq_A 160 IKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL----D---SQRK 227 (289)
T ss_dssp EEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS----C---HHHH
T ss_pred eeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc----c---hHHH
Confidence 99999999865432 123458899999999987 678999999999999999999655442111 1 1111
Q ss_pred HHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCCc
Q 007020 518 VKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLA 578 (621)
Q Consensus 518 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~ 578 (621)
......... .... ....+.+++..||+.||++|||++++++.|++..-.
T Consensus 228 ~~~~~~~~~--------~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 228 LQFYEDRHQ--------LPAP----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HHHHHTTCC--------CCCC----SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred HHHhhccCC--------CCCC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 111111000 0011 124678999999999999999999999999986444
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=345.39 Aligned_cols=260 Identities=18% Similarity=0.224 Sum_probs=202.1
Q ss_pred hcCCCcCceeeeccCceEEEEEcCC---------CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceee--------
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLAD---------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR-------- 357 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 357 (621)
.++|.+.+.||+|+||+||+|.... ++.||+|++... ..+.+|+++++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 4678899999999999999998753 789999998754 25789999999999999998
Q ss_pred -------eeeeeec-CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 007020 358 -------LRGFCMT-PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAA 429 (621)
Q Consensus 358 -------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 429 (621)
+++++.. ....++||||+ +|+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~ 188 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAE 188 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHH
Confidence 5666655 67889999999 999999998652 12489999999999999999999999 9999999999
Q ss_pred CeeeCCCC--cEEEcccccceecccCCCe------eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCc
Q 007020 430 NILLDEEF--EAVVGDFGLAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501 (621)
Q Consensus 430 Nill~~~~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf 501 (621)
|||++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 8999999999876432211 113346999999999999989999999999999999999999999
Q ss_pred ccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 502 DLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
..... ............. .....+.+.... .......+.+++..||+.||++||++++|++.|++
T Consensus 269 ~~~~~---~~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 333 (352)
T 2jii_A 269 TNCLP---NTEDIMKQKQKFV--DKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333 (352)
T ss_dssp GGGTT---CHHHHHHHHHHHH--HSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred ccCCc---CHHHHHHHHHhcc--CChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence 74321 1111222211111 111111111100 01113678999999999999999999999999987
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=328.81 Aligned_cols=250 Identities=20% Similarity=0.237 Sum_probs=202.0
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.++|.+.+.||+|+||+||+|... ++..||+|.+..... .....+.+|+++++.++||||+++++++.+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 467889999999999999999865 577999999876543 335578999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee---CCCCcEEEcccccceec
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfGla~~~ 450 (621)
|+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 999999999987643 288999999999999999999999 99999999999999 78899999999999876
Q ss_pred ccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
.... ......||+.|+|||.+.+. ++.++||||||+++|+|++|+.||..... .+........ ...
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~-~~~-- 225 (277)
T 3f3z_A 160 KPGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD--------SEVMLKIREG-TFT-- 225 (277)
T ss_dssp CTTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC-CCC--
T ss_pred cCcc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhC-CCC--
Confidence 5332 23345699999999998654 89999999999999999999999963211 1111111111 000
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.+ ..........+.+++..|++.||++|||+.++++
T Consensus 226 -~~---~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 226 -FP---EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -CC---HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CC---chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0000122367889999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=346.79 Aligned_cols=257 Identities=24% Similarity=0.298 Sum_probs=186.3
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-CCceeeeeeeee------
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCM------ 363 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~------ 363 (621)
+....+|.+.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.++.++. ||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 344568889999999999999999964 78999999985543 344557889999999996 999999999984
Q ss_pred --cCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeeCCCCcE
Q 007020 364 --TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK--IIHRDVKAANILLDEEFEA 439 (621)
Q Consensus 364 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~ 439 (621)
.....++||||+. |+|.+++..... ..++++..++.++.||+.||+|||+. + |+||||||+|||++.++.+
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCE
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCE
Confidence 3345799999996 699998865221 22489999999999999999999999 7 9999999999999999999
Q ss_pred EEcccccceecccCCCee-----------eecccccccccchhhh---ccCCCCCcccchhHHHHHHHHHhCCCCccccc
Q 007020 440 VVGDFGLAKLMDYKDTHV-----------TTAVRGTIGHIAPEYL---STGKSSEKTDVFGYGIMLLELITGQRAFDLAR 505 (621)
Q Consensus 440 kl~DfGla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~pf~~~~ 505 (621)
||+|||+++......... .....||+.|+|||++ .+..++.++||||||+++|+|++|+.||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 999999998765332211 1134589999999998 56678899999999999999999999996322
Q ss_pred ccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 506 LANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
.. ..+.... . ... .......+.+++..||+.||++|||+.++++.|+..
T Consensus 258 ~~--------~~~~~~~-----~-~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 258 KL--------RIVNGKY-----S-IPP-------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp ----------------C-----C-CCT-------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HH--------HhhcCcc-----c-CCc-------ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 1111100 0 000 011123577899999999999999999999999774
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=353.65 Aligned_cols=260 Identities=19% Similarity=0.230 Sum_probs=193.9
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecC------C
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------T 366 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 366 (621)
.++|++.+.||+|+||+||+|... +|+.||||++.... ......++.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999864 68999999997543 233455788999999999999999999998655 3
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccc
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 446 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 446 (621)
..++||||+++ +|.+.+... +++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~~------l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTSC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 56999999987 466666432 88899999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH------
Q 007020 447 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG------ 520 (621)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~------ 520 (621)
|+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+...+..
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~----~~~~~i~~~lg~p~~ 284 (464)
T 3ttj_A 211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI----DQWNKVIEQLGTPCP 284 (464)
T ss_dssp C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHCSCCH
T ss_pred eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcCCCCH
Confidence 9865432 2234467999999999999999999999999999999999999999632210 001010000
Q ss_pred ------------Hhhhcc-cc-----cccCccc---cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 521 ------------LLKEKK-LE-----MLVDPDL---QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 521 ------------~~~~~~-~~-----~~~d~~~---~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
...... .. ....... ...........+.+++..|++.||++|||++|+++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 00 0000000 00111222567899999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=337.45 Aligned_cols=247 Identities=22% Similarity=0.348 Sum_probs=199.0
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 371 (621)
.++|+..+.||+|+||+||+|... +++.||+|+++.... .....++.+|+..+..+ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467889999999999999999875 799999999976532 33456788999999988 899999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC---------------
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE--------------- 436 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~--------------- 436 (621)
|||+++|+|.+++.........+++..+..++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999986432223489999999999999999999999 99999999999999844
Q ss_pred ----CcEEEcccccceecccCCCeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCc
Q 007020 437 ----FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDD 511 (621)
Q Consensus 437 ----~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~ 511 (621)
..+||+|||.+....... ...||..|+|||++.+. .++.++||||||+++|+|++|.+|+....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------ 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------ 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------
Confidence 479999999998765432 23489999999999876 56689999999999999999998764211
Q ss_pred chHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 512 VMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.+ .... .... +.... .....+.+++..||+.||++|||+.++++
T Consensus 236 ----~~-~~~~-~~~~-----~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 ----QW-HEIR-QGRL-----PRIPQ----VLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ----HH-HHHH-TTCC-----CCCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HH-HHHH-cCCC-----CCCCc----ccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 11 1111 1111 11111 12367889999999999999999999965
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=345.09 Aligned_cols=200 Identities=25% Similarity=0.380 Sum_probs=177.1
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.++|...+.||+|+||+||+|.+. +++.||+|+++..........+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467889999999999999999875 6899999999876655666789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999998643 2889999999999999999999832 7999999999999999999999999999755322
Q ss_pred CCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCccc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 503 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~ 503 (621)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22334699999999999999999999999999999999999999963
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=328.99 Aligned_cols=252 Identities=21% Similarity=0.304 Sum_probs=201.9
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc-----hhHHHHHHHHHHHHhccCCceeeeeeeeecCCce
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 368 (621)
.++|.+.+.||+|+||+||+|... +|+.||+|.++..... .....+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357888999999999999999876 6899999998754322 1356789999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC----cEEEccc
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 444 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Df 444 (621)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence 99999999999999997643 389999999999999999999999 999999999999998877 8999999
Q ss_pred ccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhh
Q 007020 445 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 524 (621)
Q Consensus 445 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 524 (621)
|++....... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.... ..+........
T Consensus 157 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~ 226 (283)
T 3bhy_A 157 GIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET--------KQETLTNISAV 226 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTT
T ss_pred ccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc--------hHHHHHHhHhc
Confidence 9998754322 2234458999999999999999999999999999999999999996321 11111111110
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 525 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 525 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. ...++ .........+.+++..|++.||++||++.++++
T Consensus 227 ~---~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 227 N---YDFDE----EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp C---CCCCH----HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c---cCCcc----hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 00011 111122367889999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=340.25 Aligned_cols=265 Identities=25% Similarity=0.410 Sum_probs=207.2
Q ss_pred HhcCCCcCceeeeccCceEEEEEc-----CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCC--
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-- 366 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 366 (621)
..++|.+.+.||+|+||.||+|.+ .+++.||||++.... ......+.+|+++++.++||||+++++++...+
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 346788889999999999999983 368899999997643 445567999999999999999999999987654
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccc
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 446 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 446 (621)
..++||||+++|+|.+++..... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTT---SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred ceEEEEECCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence 78999999999999999987532 388999999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCee--eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccc------cCC-CcchHHHH
Q 007020 447 AKLMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARL------AND-DDVMLLDW 517 (621)
Q Consensus 447 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~------~~~-~~~~~~~~ 517 (621)
+.......... .....++..|+|||.+.+..++.++||||||+++|||++|..||..... ... ........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 98765443322 1233477789999999988899999999999999999999999863210 000 00111111
Q ss_pred HHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 518 VKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 518 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
+........ ........+..+.+++..||+.||++|||+.+|++.|+.
T Consensus 272 ~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 272 LIELLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp HHHHHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhhcCC---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111111110 001112234678999999999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=371.01 Aligned_cols=247 Identities=25% Similarity=0.368 Sum_probs=196.7
Q ss_pred ceeeeccCceEEEEEcC---CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCC
Q 007020 302 NILGRGGFGKVYKGRLA---DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 377 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 377 (621)
+.||+|+||+||+|.+. .++.||||+++.... .....++.+|+++++.++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999642 467899999976532 3345679999999999999999999999864 568999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCe-
Q 007020 378 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH- 456 (621)
Q Consensus 378 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~- 456 (621)
|+|.+++.... .+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999997643 389999999999999999999999 9999999999999999999999999999876543221
Q ss_pred -eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 457 -VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 457 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... . .+.......... ..
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~-----~---~~~~~~i~~~~~------~~ 592 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-----G---SEVTAMLEKGER------MG 592 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----H---HHHHHHHHTTCC------CC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-----H---HHHHHHHHcCCC------CC
Confidence 2223347789999999999999999999999999999998 999995321 1 111121111111 11
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
....++..+.+++..||+.||++||++++|++.|++
T Consensus 593 ----~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 593 ----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 112234678999999999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=352.07 Aligned_cols=254 Identities=23% Similarity=0.339 Sum_probs=192.1
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-------chhHHHHHHHHHHHHhccCCceeeeeeeeec
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-------PGGELQFQTEVEMISMAVHRNLLRLRGFCMT 364 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 364 (621)
...++|.+.+.||+|+||+||+|... +++.||||++..... ......+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45678999999999999999999864 689999999865321 1112248899999999999999999999754
Q ss_pred CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC---CcEEE
Q 007020 365 PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE---FEAVV 441 (621)
Q Consensus 365 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl 441 (621)
+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 56899999999999999987643 389999999999999999999999 99999999999999754 45999
Q ss_pred cccccceecccCCCeeeecccccccccchhhhcc---CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHH
Q 007020 442 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 518 (621)
Q Consensus 442 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 518 (621)
+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ...+.+.+
T Consensus 284 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~----~~~~~~~i 357 (419)
T 3i6u_A 284 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT----QVSLKDQI 357 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS----SCCHHHHH
T ss_pred eecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc----hHHHHHHH
Confidence 999999875432 23344569999999999853 5678899999999999999999999963221 11121211
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 519 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 519 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.. .... ..+. ........+.+++..|++.||++|||++|+++
T Consensus 358 ~~----~~~~--~~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 358 TS----GKYN--FIPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HT----TCCC--CCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hc----CCCC--CCch----hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11 1100 0011 11122467889999999999999999999976
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=332.01 Aligned_cols=249 Identities=24% Similarity=0.392 Sum_probs=204.7
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
.++|...+.||+|+||+||+|... +++.||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467888999999999999999975 58899999986543 233456789999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999987643 388999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
.... ......||..|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+........ .
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~-~----- 231 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRIKKN-E----- 231 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTT-C-----
T ss_pred cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhhc-c-----
Confidence 3222 2334568999999999998889999999999999999999999996322 11111111111 0
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..... .....+.+++..|++.||++|||++++++
T Consensus 232 -~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 232 -YSIPK----HINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp -CCCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -CCCcc----ccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 01111 12257889999999999999999999976
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=331.22 Aligned_cols=247 Identities=23% Similarity=0.387 Sum_probs=203.1
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeec--------
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT-------- 364 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 364 (621)
...+|+..+.||+|+||.||+|.+. +++.||+|.++... ..+.+|+++++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 4567889999999999999999975 79999999987543 246789999999999999999998754
Q ss_pred --------CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC
Q 007020 365 --------PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 436 (621)
Q Consensus 365 --------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~ 436 (621)
....++||||+++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence 345799999999999999997642 22488999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHH
Q 007020 437 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLD 516 (621)
Q Consensus 437 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~ 516 (621)
+.+||+|||++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.... .
T Consensus 159 ~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----------~ 226 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----------K 226 (284)
T ss_dssp TEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----------H
T ss_pred CCEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----------H
Confidence 999999999998765332 2233459999999999999999999999999999999999999884211 1
Q ss_pred HHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 517 WVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 517 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
+.... ... ..... ....+.+++..||+.||++|||+.++++.|+..
T Consensus 227 ~~~~~-~~~--------~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 227 FFTDL-RDG--------IISDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp HHHHH-HTT--------CCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHh-hcc--------ccccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111 111 11111 125678999999999999999999999999764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=339.13 Aligned_cols=249 Identities=24% Similarity=0.392 Sum_probs=204.8
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
.++|.+.+.||+|+||.||++... +++.||+|++.... .......+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357888899999999999999875 58899999987543 234456789999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999987643 389999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
.... ......||..|+|||++.+..++.++||||||+++|+|++|+.||.... ..+.........
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~~~~------ 257 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRIKKNE------ 257 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTC------
T ss_pred cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC--------HHHHHHHHhcCC------
Confidence 3322 2334569999999999999889999999999999999999999996321 111111111110
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..+.. .....+.+++..||+.||++|||++++++
T Consensus 258 -~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 258 -YSIPK----HINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -CCCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -CCCCc----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111 12256889999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=342.12 Aligned_cols=263 Identities=21% Similarity=0.277 Sum_probs=192.5
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCch-hHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
..++|.+.+.||+|+||+||+|... +++.||||+++...... ....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3467899999999999999999854 78999999997554322 234578999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee-----CCCCcEEEccccc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL-----DEEFEAVVGDFGL 446 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill-----~~~~~~kl~DfGl 446 (621)
|||+++ +|.+++..... +++..+..++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 112 ~e~~~~-~L~~~~~~~~~----~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNPD----VSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCSE-EHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCCC-CHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999985 99999987543 89999999999999999999999 99999999999999 4556699999999
Q ss_pred ceecccCCCeeeecccccccccchhhhccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 447 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
++....... ......||..|+|||++.+.. ++.++|||||||++|||++|+.||..... ...+...+... ...
T Consensus 184 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~~~~~~-~~~ 257 (329)
T 3gbz_A 184 ARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE----IDQLFKIFEVL-GLP 257 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHH-CCC
T ss_pred ccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH----HHHHHHHHHHh-CCC
Confidence 987643322 233445899999999998754 79999999999999999999999963211 11111111110 000
Q ss_pred ccccc-----------cCccccCc-----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 526 KLEML-----------VDPDLQNN-----YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 526 ~~~~~-----------~d~~~~~~-----~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..... ..+..... ........+.+++..|++.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000 00000000 00112367889999999999999999999976
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=335.31 Aligned_cols=261 Identities=21% Similarity=0.262 Sum_probs=204.7
Q ss_pred HHHHHHHhcCCCcC-ceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhcc-CCceeeeeeeee
Q 007020 288 LRELQVATDSFSNK-NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAV-HRNLLRLRGFCM 363 (621)
Q Consensus 288 ~~~~~~~~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 363 (621)
++..+...+.|.+. +.||+|+||+||+|... +++.||+|+++.... ......+.+|+.++..+. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34455666778777 88999999999999865 689999999976443 334567899999999885 699999999999
Q ss_pred cCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---CCcEE
Q 007020 364 TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---EFEAV 440 (621)
Q Consensus 364 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~k 440 (621)
+....++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+|
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence 9999999999999999999986542 23489999999999999999999999 9999999999999998 78999
Q ss_pred EcccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH
Q 007020 441 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 520 (621)
Q Consensus 441 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 520 (621)
|+|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... .+....
T Consensus 175 L~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~ 244 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN--------QETYLN 244 (327)
T ss_dssp ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred EeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--------hHHHHH
Confidence 99999998764322 23345699999999999999999999999999999999999999953211 111111
Q ss_pred HhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 521 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 521 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..... . .............+.+++..|++.||++|||++++++
T Consensus 245 i~~~~-~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 245 ISQVN-V------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHTC-C------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHhcc-c------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 11110 0 0011111223367889999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=338.29 Aligned_cols=265 Identities=26% Similarity=0.373 Sum_probs=186.3
Q ss_pred HHHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 291 LQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 291 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
+.+..++|.+.+.||+|+||.||+|... +++.||||.+...........+.+|+.+++.++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 4566789999999999999999999864 689999999876544444567889999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccc
Q 007020 370 LVYPYMANGSVASCLRER----PPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 445 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 445 (621)
+||||+++|+|.+++... ......+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence 999999999999998741 11233489999999999999999999999 99999999999999999999999999
Q ss_pred cceecccCCC----eeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH
Q 007020 446 LAKLMDYKDT----HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 520 (621)
Q Consensus 446 la~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 520 (621)
++........ .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .. ...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~---~~~ 238 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM-----KV---LML 238 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG-----GH---HHH
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh-----hH---HHH
Confidence 9876543211 12234468999999999876 56899999999999999999999999632211 01 111
Q ss_pred Hhhhcc--c-ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 521 LLKEKK--L-EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 521 ~~~~~~--~-~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
...... . ....++.... .....+.+++..||+.||++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 239 TLQNDPPSLETGVQDKEMLK----KYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HHTSSCCCTTC-----CCCC----CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhccCCCccccccccchhhh----hhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111100 0 0011111111 12357889999999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=336.65 Aligned_cols=250 Identities=28% Similarity=0.404 Sum_probs=196.8
Q ss_pred HhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecC-CceEEEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-TERLLVY 372 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~ 372 (621)
..++|+..+.||+|+||+||+|... |+.||||+++... ....+.+|+.+++.++||||+++++++.+. +..++||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 4578889999999999999999884 8899999987543 345789999999999999999999987654 5789999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 99999999999976421 1267889999999999999999999 999999999999999999999999999975443
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... . +........ .
T Consensus 170 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~---~~~~~~~~~------~ 231 (278)
T 1byg_A 170 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----K---DVVPRVEKG------Y 231 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----G---GHHHHHTTT------C
T ss_pred c----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----H---HHHHHHhcC------C
Confidence 2 122347889999999999999999999999999999998 9999963211 1 111111111 0
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.... .......+.+++..||+.||++||++.++++.|++
T Consensus 232 ~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 232 KMDA----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 1111 12233678899999999999999999999999987
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.74 Aligned_cols=254 Identities=23% Similarity=0.319 Sum_probs=193.6
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCC------
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 366 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 366 (621)
.++|...+.||+|+||.||+|... +|+.||||++..... ......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467888999999999999999864 799999999865432 334557889999999999999999999987653
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccc
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 446 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 446 (621)
..++||||+ +++|.+++... .+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 78999998763 288999999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 447 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
++..... .....||..|+|||++.+ ..++.++||||+||++|||++|+.||..... .+.+..+....
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~l~~i~~~~ 242 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH--------LDQLKEIMKVT 242 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHHH
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHhc
Confidence 9875432 234568999999999987 6789999999999999999999999963221 11111111000
Q ss_pred --c-------------------cccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 526 --K-------------------LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 526 --~-------------------~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. +.......+ ..........+.+++..|++.||++|||++++++
T Consensus 243 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 243 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCHHHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0 000000000 0111122467889999999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=341.09 Aligned_cols=264 Identities=23% Similarity=0.347 Sum_probs=199.2
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc-hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
.++|+..+.||+|+||.||+|... +|+.||||++...... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357888899999999999999875 5899999998655433 33456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999999998876543 289999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH-----------
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG----------- 520 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~----------- 520 (621)
.. .......||..|+|||++.+. .++.++||||||+++|+|++|+.||...... ......+..
T Consensus 177 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 177 PG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI----DQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHHCSCCHHHHHH
T ss_pred Cc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHHHhCCCChhhhhH
Confidence 22 223345689999999999875 6899999999999999999999999632211 111111100
Q ss_pred HhhhcccccccCccccCc-----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 521 LLKEKKLEMLVDPDLQNN-----YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 521 ~~~~~~~~~~~d~~~~~~-----~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
............+..... ........+.+++..||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000011111111110 01123467899999999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=328.79 Aligned_cols=248 Identities=24% Similarity=0.371 Sum_probs=197.5
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeec----CCceE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERL 369 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 369 (621)
..|.+.+.||+|+||+||+|... ++..||+|.+.... .......+.+|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34677788999999999999864 68899999987554 33445678999999999999999999998865 35679
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeeC-CCCcEEEccccc
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK--IIHRDVKAANILLD-EEFEAVVGDFGL 446 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~-~~~~~kl~DfGl 446 (621)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||+. + |+||||||+||+++ .++.+||+|||+
T Consensus 106 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 9999999999999998643 388999999999999999999999 7 99999999999998 789999999999
Q ss_pred ceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcc
Q 007020 447 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (621)
+...... ......||+.|+|||++. +.++.++||||||+++|+|++|+.||.... ..............
T Consensus 179 ~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~ 247 (290)
T 1t4h_A 179 ATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQIYRRVTSGVK 247 (290)
T ss_dssp GGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHHHHHHHTTTCC
T ss_pred ccccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC-------cHHHHHHHHhccCC
Confidence 9754322 233456999999999886 458999999999999999999999995321 11122222211111
Q ss_pred cccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 527 ~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. ... .......+.+++..||+.||++|||++++++
T Consensus 248 ~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 P-----ASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp C-----GGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c-----ccc----CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0 011 1112256889999999999999999999976
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=339.74 Aligned_cols=265 Identities=25% Similarity=0.296 Sum_probs=196.1
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCch----hHHHHHHHHHHHHhccCCceeeeeeeeecCCce
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG----GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 368 (621)
..++|...+.||+|+||.||+|... +|+.||||.++...... ....+.+|+.+++.++||||+++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3578999999999999999999975 68999999997543221 123578999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
++||||+++ +|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999986 8888887643 2478889999999999999999999 99999999999999999999999999998
Q ss_pred ecccCCCeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 449 LMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||..... ...+....... .....
T Consensus 161 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~----~~~~~~i~~~~-~~~~~ 234 (346)
T 1ua2_A 161 SFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD----LDQLTRIFETL-GTPTE 234 (346)
T ss_dssp TTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHH-CCCCT
T ss_pred eccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHHc-CCCCh
Confidence 764332 223345689999999999764 478999999999999999999999853211 01111111110 00000
Q ss_pred cccc------C----ccccC----cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 528 EMLV------D----PDLQN----NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 528 ~~~~------d----~~~~~----~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.... + ..... .........+.+++..|++.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 0 00000 0011223678999999999999999999999764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=338.08 Aligned_cols=256 Identities=21% Similarity=0.344 Sum_probs=204.4
Q ss_pred HHHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc-------hhHHHHHHHHHHHHhc-cCCceeeeeee
Q 007020 291 LQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-------GGELQFQTEVEMISMA-VHRNLLRLRGF 361 (621)
Q Consensus 291 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l-~h~niv~l~~~ 361 (621)
.....++|...+.||+|+||.||+|... +|+.||||+++..... .....+.+|+.+++.+ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445678999999999999999999975 7999999998754321 1134578899999998 79999999999
Q ss_pred eecCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEE
Q 007020 362 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV 441 (621)
Q Consensus 362 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 441 (621)
+......++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 999999999999999999999997643 389999999999999999999999 9999999999999999999999
Q ss_pred cccccceecccCCCeeeecccccccccchhhhccC------CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHH
Q 007020 442 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG------KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 515 (621)
Q Consensus 442 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~ 515 (621)
+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.... . .
T Consensus 242 ~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-----~---~ 311 (365)
T 2y7j_A 242 SDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR-----Q---I 311 (365)
T ss_dssp CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----H---H
T ss_pred EecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC-----H---H
Confidence 9999998765332 23445699999999998643 57889999999999999999999995321 1 1
Q ss_pred HHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 516 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 516 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
......... ... ...+. .......+.+++..|++.||++|||+.++++
T Consensus 312 ~~~~~i~~~-~~~-~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 312 LMLRMIMEG-QYQ-FSSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHHHT-CCC-CCHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhC-CCC-CCCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111111 000 00000 0112356889999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=353.15 Aligned_cols=244 Identities=13% Similarity=0.125 Sum_probs=189.7
Q ss_pred hcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccC--CchhHHHHHHHHH---HHHhccCCceeeee-------ee
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEER--TPGGELQFQTEVE---MISMAVHRNLLRLR-------GF 361 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~ 361 (621)
.++|.+.+.||+|+||+||+|.+ .+|+.||||+++... .......+.+|+. .++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788889999999999999996 469999999997542 2334567899994 55566899999998 55
Q ss_pred eecCC-----------------ceEEEEeccCCCchhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 007020 362 CMTPT-----------------ERLLVYPYMANGSVASCLRERPP---SQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 421 (621)
Q Consensus 362 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i 421 (621)
+.+++ ..++||||+ +|+|.+++..... ....+++..+..|+.||+.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 55443 278999999 5799999986321 111234578889999999999999999 99
Q ss_pred EecCCCCCCeeeCCCCcEEEcccccceecccCCCeeeecccccccccchhhhccC-----------CCCCcccchhHHHH
Q 007020 422 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-----------KSSEKTDVFGYGIM 490 (621)
Q Consensus 422 vH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGvi 490 (621)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985332 3345567 999999999887 78999999999999
Q ss_pred HHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 491 LLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 491 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
+|||++|+.||........ ...+... .. .....+.+++..||+.||++|||+.++++
T Consensus 303 l~elltg~~Pf~~~~~~~~-----------------~~~~~~~--~~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG-----------------SEWIFRS--CK----NIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CC-----------------SGGGGSS--CC----CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccc-----------------hhhhhhh--cc----CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999963221110 0111110 01 12367889999999999999999999976
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=346.70 Aligned_cols=200 Identities=23% Similarity=0.317 Sum_probs=167.9
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecC-----Cc
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TE 367 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 367 (621)
.++|.+.+.||+|+||+||+|... +++.||||+++.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999865 688999999975432 33445789999999999999999999998766 57
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
.++||||+. |+|.+++.... .+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+|
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999987 49999997643 389999999999999999999999 9999999999999999999999999999
Q ss_pred eecccCCC---------------------eeeecccccccccchhhh-ccCCCCCcccchhHHHHHHHHHhCCCCcc
Q 007020 448 KLMDYKDT---------------------HVTTAVRGTIGHIAPEYL-STGKSSEKTDVFGYGIMLLELITGQRAFD 502 (621)
Q Consensus 448 ~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg~~pf~ 502 (621)
+....... .......||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 87653321 123456799999999986 55668999999999999999999766653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=341.04 Aligned_cols=262 Identities=20% Similarity=0.305 Sum_probs=201.4
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecC-----Cce
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TER 368 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 368 (621)
.++|+..+.||+|+||.||+|... +++.||||++...........+.+|++++..++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999865 68899999997655555556789999999999999999999998655 367
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
++||||+.+ +|.+++.... +++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 106 ~iv~e~~~~-~L~~~l~~~~-----~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKTQH-----LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCSE-EHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccCc-CHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 999999985 9999987642 88999999999999999999999 99999999999999999999999999998
Q ss_pred ecccCCCee--eecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 449 LMDYKDTHV--TTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 449 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
......... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+.......
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~~~ 251 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY-----LDQLNHILGILGSP 251 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG-----GGHHHHHHHHHCSC
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh-----HHHHHHHHHHhCCC
Confidence 765332211 234569999999998754 4589999999999999999999999963221 11111111111000
Q ss_pred ccc---------------cccCcccc--CcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 526 KLE---------------MLVDPDLQ--NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 526 ~~~---------------~~~d~~~~--~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
... ....+... ..........+.+++..|++.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 00000000 0001112357889999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=334.84 Aligned_cols=256 Identities=20% Similarity=0.242 Sum_probs=198.2
Q ss_pred hcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-CCceeeeeeeeec--CCceEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMT--PTERLL 370 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~l 370 (621)
.++|++.+.||+|+||+||+|.. .+++.||||+++.. ....+.+|+.+++.++ ||||+++++++.+ ....++
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 36788899999999999999985 47899999998643 2457889999999997 9999999999987 567899
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-cEEEccccccee
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKL 449 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~~ 449 (621)
||||+++++|.+++.. +++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 111 v~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp EEECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 9999999999999864 78889999999999999999999 999999999999999776 899999999987
Q ss_pred cccCCCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 450 MDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
...... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... ...+..... ........
T Consensus 181 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~---~~~l~~~~~-~~~~~~~~ 254 (330)
T 3nsz_A 181 YHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN---YDQLVRIAK-VLGTEDLY 254 (330)
T ss_dssp CCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH---HHHHHHHHH-HHCHHHHH
T ss_pred cCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch---HHHHHHHHH-hcCCchhh
Confidence 653322 334468999999999977 66899999999999999999999999522110 001111111 00000000
Q ss_pred cc-------cCc----------------cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 529 ML-------VDP----------------DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 529 ~~-------~d~----------------~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.. .++ .............+.+++..|++.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 000 0000111113467899999999999999999999976
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=341.33 Aligned_cols=270 Identities=19% Similarity=0.259 Sum_probs=198.8
Q ss_pred CHHHHHHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCch----------hHHHHHHHHHHHHhccCCcee
Q 007020 287 SLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG----------GELQFQTEVEMISMAVHRNLL 356 (621)
Q Consensus 287 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv 356 (621)
...++....++|.+.+.||+|+||.||+|...+|+.||||++....... ....+.+|+.+++.++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 3567888899999999999999999999998889999999986543221 135789999999999999999
Q ss_pred eeeeeeec-----CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 007020 357 RLRGFCMT-----PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANI 431 (621)
Q Consensus 357 ~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Ni 431 (621)
++++++.. ....++||||++ |+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 99999843 346799999998 58888887542 2489999999999999999999999 999999999999
Q ss_pred eeCCCCcEEEcccccceecccCCCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCC
Q 007020 432 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD 510 (621)
Q Consensus 432 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~ 510 (621)
+++.++.+||+|||++...... .......||..|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--- 240 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY--- 240 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---
T ss_pred EEcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH---
Confidence 9999999999999999754322 22334568999999999877 67899999999999999999999999632210
Q ss_pred cchHHHHHHHHhhhcccc-----------ccc-------CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 511 DVMLLDWVKGLLKEKKLE-----------MLV-------DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~-----------~~~-------d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.....+.......... ... ...............+.+++..|++.||++|||+.|+++
T Consensus 241 --~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 241 --NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp --HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 0111111100000000 000 000000011122356889999999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=328.13 Aligned_cols=247 Identities=24% Similarity=0.356 Sum_probs=203.0
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
.++|.+.+.||+|+||.||+|... +++.||+|++..... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367888999999999999999875 578999999864321 12245688999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999998643 388999999999999999999999 99999999999999999999999999997654
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
.. ......|+..|+|||++.+..++.++||||||+++|+|++|..||.... ...........
T Consensus 166 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~~~------- 227 (284)
T 2vgo_A 166 SL---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS--------HTETHRRIVNV------- 227 (284)
T ss_dssp SS---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTT-------
T ss_pred cc---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC--------HhHHHHHHhcc-------
Confidence 32 2234568999999999999899999999999999999999999996321 11111111111
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
+.... ......+.+++..|++.||++||+++++++
T Consensus 228 ~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 228 DLKFP----PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCCC----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 11111 112357889999999999999999999976
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=337.60 Aligned_cols=258 Identities=30% Similarity=0.400 Sum_probs=197.0
Q ss_pred hcCCCcCceeeeccCceEEEEEcC--CCc--EEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCce
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA--DGS--LVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 368 (621)
.++|++.+.||+|+||+||+|.+. +++ .||||+++... .......+.+|+.+++.++||||+++++++..+. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467888999999999999999853 333 68999987543 2344567899999999999999999999988764 8
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 99999999999999997642 2388999999999999999999999 99999999999999999999999999998
Q ss_pred ecccCCCee--eecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 449 LMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 449 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
......... .....++..|+|||++.+..++.++||||||+++|+|++ |+.||.... ..+.+.......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~ 241 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--------GSQILHKIDKEG 241 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTSC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC--------HHHHHHHHHccC
Confidence 765433322 223457889999999998888999999999999999999 999996321 112222222111
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007020 526 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 576 (621)
Q Consensus 526 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 576 (621)
... . .....+..+.+++..||+.||++|||+.++++.|++..
T Consensus 242 ~~~-----~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 242 ERL-----P----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CCC-----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCC-----C----CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 100 0 11123367899999999999999999999999998743
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=338.01 Aligned_cols=256 Identities=21% Similarity=0.307 Sum_probs=187.8
Q ss_pred HhcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHH-HHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~-~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
..++|+..+.||+|+||+||+|.. .+|+.||+|+++.........+ +..+...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 457888999999999999999986 4789999999976654444333 44445557888999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++ +|.+++.........+++..+..++.|++.||+|||+++ +|+||||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999985 888877653223345899999999999999999999853 89999999999999999999999999998654
Q ss_pred cCCCeeeecccccccccchhhh----ccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYL----STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||.... ... ..+........
T Consensus 162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~-~~~~~~~~~~~- 231 (290)
T 3fme_A 162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG------TPF-QQLKQVVEEPS- 231 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS------CHH-HHHHHHHHSCC-
T ss_pred ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC------chH-HHHHHHhccCC-
Confidence 322 22334599999999996 45678899999999999999999999996211 111 11111111111
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
+... .......+.+++..|++.||++|||+.++++
T Consensus 232 -----~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 -----PQLP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -----CCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCcc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1111 1112367889999999999999999999976
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=368.55 Aligned_cols=262 Identities=22% Similarity=0.344 Sum_probs=208.3
Q ss_pred HHHHHHhcCCCcCceeeeccCceEEEEEcC----CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeec
Q 007020 289 RELQVATDSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT 364 (621)
Q Consensus 289 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 364 (621)
.++++..++|.+.+.||+|+||+||+|.+. .+..||+|.++..........+.+|+.+++.++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 344455678899999999999999999864 256799999876655555678999999999999999999999985
Q ss_pred CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccc
Q 007020 365 PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 444 (621)
Q Consensus 365 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 444 (621)
++..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DF 535 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDF 535 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCC
T ss_pred cCceEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEec
Confidence 467899999999999999998643 2488999999999999999999999 9999999999999999999999999
Q ss_pred ccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhh
Q 007020 445 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 523 (621)
Q Consensus 445 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 523 (621)
|+++..............+|+.|+|||++.+..++.++||||||+++|||++ |..||.... ..+.+.....
T Consensus 536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~--------~~~~~~~i~~ 607 (656)
T 2j0j_A 536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--------NNDVIGRIEN 607 (656)
T ss_dssp CCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHH
T ss_pred CCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHc
Confidence 9998765443333334457889999999999999999999999999999997 999996321 1122222211
Q ss_pred hcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 524 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 524 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
.... . .+...+..+.+++..||+.||++|||+.+|++.|+..
T Consensus 608 ~~~~------~----~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 608 GERL------P----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp TCCC------C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC------C----CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111 0 1122336788999999999999999999999999873
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=350.57 Aligned_cols=195 Identities=23% Similarity=0.346 Sum_probs=154.5
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeec-----CCc
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMT-----PTE 367 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~ 367 (621)
.++|.+.+.||+|+||+||+|.+. +++.||||++..... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367999999999999999999865 789999999865432 3345578999999999999999999999843 356
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
.|+||||+. |+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccc-cchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 899999985 69999987643 389999999999999999999999 9999999999999999999999999999
Q ss_pred eecccCCC--------------------------eeeecccccccccchhhh-ccCCCCCcccchhHHHHHHHHHhC
Q 007020 448 KLMDYKDT--------------------------HVTTAVRGTIGHIAPEYL-STGKSSEKTDVFGYGIMLLELITG 497 (621)
Q Consensus 448 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg 497 (621)
+....... .......||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 87643211 123345689999999986 456689999999999999999993
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=353.26 Aligned_cols=252 Identities=24% Similarity=0.308 Sum_probs=201.8
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
.++|.+.+.||+|+||+||+|... +++.||||++.... .......+.+|+++++.++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999875 78999999986432 1233567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC---CCCcEEEccccccee
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAKL 449 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DfGla~~ 449 (621)
||+.+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 101 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999887643 389999999999999999999999 999999999999995 456799999999986
Q ss_pred cccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 450 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
.... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.... ..+.+..........
T Consensus 174 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~~- 241 (486)
T 3mwu_A 174 FQQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDILKRVETGKYAF- 241 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCCCS-
T ss_pred CCCC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCC-
Confidence 5432 22344569999999999875 58999999999999999999999995321 112222222111100
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
+ .......+..+.+++..||+.||++|||+.++++.
T Consensus 242 --~----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 --D----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp --C----SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred --C----CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 01112234678899999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=346.52 Aligned_cols=262 Identities=19% Similarity=0.243 Sum_probs=205.1
Q ss_pred hcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccC-CceeeeeeeeecCCceEEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 372 (621)
.++|.+.+.||+|+||.||+|.+ .+++.||||++..... ..++..|+++++.+.| ++|..+..++...+..++||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 46899999999999999999986 4789999998865432 2357899999999986 56666667777888899999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee---CCCCcEEEccccccee
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKL 449 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfGla~~ 449 (621)
||+ +++|.+++..... .+++..++.|+.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 83 e~~-g~sL~~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ECC-CCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999 8899999985432 389999999999999999999999 99999999999999 5889999999999987
Q ss_pred cccCCCe------eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh
Q 007020 450 MDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 523 (621)
Q Consensus 450 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 523 (621)
+...... ......||..|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-----~~~~~~~~i~~ 230 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----TKKQKYEKISE 230 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS-----SHHHHHHHHHH
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch-----hHHHHHHHHhh
Confidence 6543322 122556999999999999999999999999999999999999999632211 11111111111
Q ss_pred hcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCC
Q 007020 524 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGL 577 (621)
Q Consensus 524 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 577 (621)
.. ...... .+ ......++.+++..||+.+|++||++.+|++.|++...
T Consensus 231 ~~-~~~~~~-~l----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 231 KK-VATSIE-AL----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HH-HHSCHH-HH----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cc-ccccHH-HH----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 10 000000 00 11123678999999999999999999999999988633
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=352.99 Aligned_cols=251 Identities=25% Similarity=0.305 Sum_probs=200.0
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc------------hhHHHHHHHHHHHHhccCCceeeeeee
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP------------GGELQFQTEVEMISMAVHRNLLRLRGF 361 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 361 (621)
.++|.+.+.||+|+||+||+|... +++.||+|+++..... .....+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 578999999999999999999865 6889999999754322 234568899999999999999999999
Q ss_pred eecCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC---c
Q 007020 362 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF---E 438 (621)
Q Consensus 362 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~ 438 (621)
+.+....++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999987643 389999999999999999999999 999999999999998776 6
Q ss_pred EEEcccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHH
Q 007020 439 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 518 (621)
Q Consensus 439 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 518 (621)
+||+|||++...... .......||+.|+|||++. ..++.++||||+||++|+|++|..||.... ..+.+
T Consensus 188 ~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~ 256 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN--------DQDII 256 (504)
T ss_dssp EEECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHH
T ss_pred EEEEECCCCEEcCCC--CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHH
Confidence 999999999876533 2234456999999999986 468999999999999999999999996321 11222
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 519 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 519 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
........ . .+. ......+..+.+++..|++.||.+|||++|+++
T Consensus 257 ~~i~~~~~-~--~~~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 257 KKVEKGKY-Y--FDF----NDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHCCC-C--CCH----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHcCCC-C--CCc----cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 22221110 0 000 001122367889999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=354.23 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=204.6
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
..++|...+.||+|+||+||+|... +|+.||||++..... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467889999999999999999875 789999999965432 2345678999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee---CCCCcEEEcccccc
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLA 447 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfGla 447 (621)
||||+.+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 999999999999997643 389999999999999999999999 99999999999999 56789999999999
Q ss_pred eecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
....... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.... ..+.+....... .
T Consensus 177 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~-~ 244 (484)
T 3nyv_A 177 THFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN--------EYDILKKVEKGK-Y 244 (484)
T ss_dssp HHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-C
T ss_pred EEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcCC-C
Confidence 8654332 2334569999999999876 68999999999999999999999996321 111222221111 1
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. . ........+..+.+++..|++.||++|||+.++++
T Consensus 245 ~-~-----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 245 T-F-----ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp C-C-----CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C-C-----CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0 0 00111223467889999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=352.08 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=198.1
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
.++|...+.||+|+||+||+|... ++..||+|+++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457888999999999999999975 688999999976542 233557899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---CCcEEEccccccee
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFGLAKL 449 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfGla~~ 449 (621)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999887643 388999999999999999999999 9999999999999976 45599999999987
Q ss_pred cccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 450 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
.... .......||+.|+|||++. ..++.++||||+||++|+|++|..||.... ..+.......... .
T Consensus 189 ~~~~--~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~--~ 255 (494)
T 3lij_A 189 FENQ--KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT--------DQEILRKVEKGKY--T 255 (494)
T ss_dssp CBTT--BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCC--C
T ss_pred CCCC--ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCC--C
Confidence 6532 2234456999999999986 568999999999999999999999996321 1122222221111 0
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
...+. ....+..+.+++..||+.||.+|||+.++++
T Consensus 256 ~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 256 FDSPE-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CCSGG-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCchh-----cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 01111 1123367889999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=330.56 Aligned_cols=253 Identities=24% Similarity=0.362 Sum_probs=198.1
Q ss_pred cCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
++|....+||+|+||.||+|.. .+++.||||.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 3455566899999999999986 468899999987543 33456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-CCcEEEcccccceecccC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfGla~~~~~~ 453 (621)
+++++|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++......
T Consensus 101 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 101 VPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred CCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999999999986532 33467889999999999999999999 9999999999999987 899999999999875432
Q ss_pred CCeeeecccccccccchhhhccCC--CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
. .......|+..|+|||++.+.. ++.++||||||+++|+|++|+.||..... . .......... ..
T Consensus 177 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~-~~~~~~~~~~------~~ 243 (295)
T 2clq_A 177 N-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE-----P-QAAMFKVGMF------KV 243 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS-----H-HHHHHHHHHH------CC
T ss_pred C-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc-----h-hHHHHhhccc------cc
Confidence 2 1223456899999999997654 78999999999999999999999963211 0 0011110000 01
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.+... ......+.+++..||+.||++||++.++++
T Consensus 244 ~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 HPEIP----ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCC----TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccccc----ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111 122367889999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=364.65 Aligned_cols=247 Identities=23% Similarity=0.320 Sum_probs=201.2
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCc
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTE 367 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 367 (621)
....++|++.+.||+|+||+||+|... +++.||||+++... .......+..|..++..+ +||||+++++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 345578999999999999999999865 68899999997532 122344678899998877 79999999999999999
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
.++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred EEEEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeeccee
Confidence 999999999999999998653 289999999999999999999999 9999999999999999999999999999
Q ss_pred eecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+....
T Consensus 490 ~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~-- 558 (674)
T 3pfq_A 490 KENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIMEHN-- 558 (674)
T ss_dssp EECCCT-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHSSC--
T ss_pred eccccC-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhCC--
Confidence 864322 223455679999999999999999999999999999999999999996321 112222222211
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCH
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 565 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 565 (621)
.. ++.....++.+++..||+.||++||++
T Consensus 559 -----~~----~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 559 -----VA----YPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp -----CC----CCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred -----CC----CCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 01 111233678899999999999999997
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=348.06 Aligned_cols=255 Identities=11% Similarity=0.019 Sum_probs=181.2
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc--hhHHHHHHHHHHHHhc--cCCceeeee-------eee
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMA--VHRNLLRLR-------GFC 362 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~ 362 (621)
...|...+.||+|+||+||+|.+. +|+.||||+++..... .....+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888899999999999999965 7899999999875532 2344677886555544 699988755 333
Q ss_pred ecC-----------------CceEEEEeccCCCchhhhhccCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCC
Q 007020 363 MTP-----------------TERLLVYPYMANGSVASCLRERPPSQLPLDWPTR------KRIALGSARGLSYLHDHCDP 419 (621)
Q Consensus 363 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~------~~i~~~i~~~L~~LH~~~~~ 419 (621)
..+ ...++||||++ |+|.+++..... .+.+..+ ..++.||+.||+|||++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 322 33799999999 899999986421 1344555 68889999999999999
Q ss_pred CeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeeeecccccccccchhhhcc--CCCCCcccchhHHHHHHHHHhC
Q 007020 420 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGIMLLELITG 497 (621)
Q Consensus 420 ~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg 497 (621)
+|+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999986542 2224457799999999987 6789999999999999999999
Q ss_pred CCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 498 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 498 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
+.||........... ........................+.+++..||+.||++|||+.++++
T Consensus 290 ~~Pf~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGSW----------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTCC----------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccch----------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999974422111000 000000000111111111123467899999999999999999999965
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=330.78 Aligned_cols=253 Identities=22% Similarity=0.329 Sum_probs=197.6
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
..+.|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++..++..++||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 3567889999999999999999975 58999999986543 334567889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 96 e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp ECCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EeCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999875322 389999999999999999999999 999999999999999999999999998764321
Q ss_pred CCCeeeecccccccccchhhhc-----cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
. ........||..|+|||++. +..++.++||||||+++|+|++|+.||.... ..............
T Consensus 170 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~ 240 (302)
T 2j7t_A 170 T-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSDPP 240 (302)
T ss_dssp H-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCCC
T ss_pred c-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC--------HHHHHHHHhccCCc
Confidence 1 11122345899999999984 5678899999999999999999999996321 11112222111111
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.... .......+.+++..||+.||++|||+.++++
T Consensus 241 -~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 241 -TLLT-------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -CCSS-------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -ccCC-------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0111 1122357889999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=345.40 Aligned_cols=265 Identities=20% Similarity=0.231 Sum_probs=194.6
Q ss_pred HHHHhcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecC----
Q 007020 291 LQVATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP---- 365 (621)
Q Consensus 291 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 365 (621)
++...++|...+.||+|+||+||+|.. .+|+.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 345678899999999999999999986 4789999999865432 234799999999999999999998443
Q ss_pred ----------------------------------CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 007020 366 ----------------------------------TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 411 (621)
Q Consensus 366 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~ 411 (621)
...++||||+++ +|.+.+.........+++..+..++.||++||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 347899999985 888777643223345899999999999999999
Q ss_pred HHHhCCCCCeEecCCCCCCeeeC-CCCcEEEcccccceecccCCCeeeecccccccccchhhhccCC-CCCcccchhHHH
Q 007020 412 YLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGI 489 (621)
Q Consensus 412 ~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv 489 (621)
|||+. +|+||||||+|||++ .++.+||+|||+++...... ......||..|+|||++.+.. ++.++||||+||
T Consensus 156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 99999 999999999999997 68899999999998764332 223446899999999988754 899999999999
Q ss_pred HHHHHHhCCCCcccccccCCCcchHHHHHHHHhhh---------cccccccCccc-----cCcccHHHHHHHHHHHHhcc
Q 007020 490 MLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE---------KKLEMLVDPDL-----QNNYVEAEVEQLIQVALLCT 555 (621)
Q Consensus 490 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~d~~~-----~~~~~~~~~~~l~~l~~~c~ 555 (621)
++|||++|+.||..... ...+...++..... .......-+.. ...........+.+++..||
T Consensus 231 il~ell~g~~pf~~~~~----~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 231 VFGELILGKPLFSGETS----IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred HHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 99999999999963211 11111111100000 00000000110 00011123467899999999
Q ss_pred CCCCCCCCCHHHHHH
Q 007020 556 QGSPMDRPKMSEVVR 570 (621)
Q Consensus 556 ~~~P~~RPt~~~vl~ 570 (621)
+.||++|||+.|+++
T Consensus 307 ~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 307 RYEPDLRINPYEAMA 321 (383)
T ss_dssp CSSGGGSCCHHHHHT
T ss_pred cCChhhCCCHHHHhc
Confidence 999999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=330.52 Aligned_cols=255 Identities=21% Similarity=0.353 Sum_probs=203.2
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.++|...+.||+|+||+||+|+.. +|+.||+|.++.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 467888999999999999999865 789999999975432 234468899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee---CCCCcEEEcccccceec
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfGla~~~ 450 (621)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 999999999987643 388999999999999999999999 99999999999999 78889999999999754
Q ss_pred ccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ..+......... . .
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~~-~-~- 225 (304)
T 2jam_A 160 QNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET--------ESKLFEKIKEGY-Y-E- 225 (304)
T ss_dssp CCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHCC-C-C-
T ss_pred CCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcCC-C-C-
Confidence 322 2233458999999999999899999999999999999999999996321 111122211111 0 0
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhcC
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR--MLEGD 575 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~--~L~~~ 575 (621)
... .........+.+++..|++.||++|||++++++ .+++.
T Consensus 226 ~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 226 FES----PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp CCT----TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred CCc----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 001 111122367889999999999999999999986 34443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=329.17 Aligned_cols=252 Identities=25% Similarity=0.355 Sum_probs=198.6
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
...++|+..+.||+|+||.||+|... +|+.||+|.+.... ....+.+|+.+++.++||||+++++++...+..++|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 34578999999999999999999875 58999999997543 245688999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++|+|.+++.... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++....
T Consensus 103 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred eecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 99999999999987422 2389999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... .......... ......
T Consensus 177 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~-~~~~~~ 246 (314)
T 3com_A 177 DTM-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP--------MRAIFMIPTN-PPPTFR 246 (314)
T ss_dssp TTB-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHS-CCCCCS
T ss_pred hhc-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhcC-CCcccC
Confidence 322 223345689999999999998899999999999999999999999963211 1111111111 100111
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. .......+.+++..||+.||++|||+.++++
T Consensus 247 ~-------~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 247 K-------PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp S-------GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C-------cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1 1112367889999999999999999999976
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=333.75 Aligned_cols=253 Identities=24% Similarity=0.346 Sum_probs=196.2
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-------chhHHHHHHHHHHHHhccCCceeeeeeeeecC
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-------PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 365 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 365 (621)
..++|.+.+.||+|+||.||+|... +++.||||++..... ......+.+|+++++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4567999999999999999999865 688999999865421 12233588999999999999999999998765
Q ss_pred CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc---EEEc
Q 007020 366 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE---AVVG 442 (621)
Q Consensus 366 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~ 442 (621)
. .++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 4 899999999999999987543 389999999999999999999999 9999999999999987654 9999
Q ss_pred ccccceecccCCCeeeecccccccccchhhhc---cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHH
Q 007020 443 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 519 (621)
Q Consensus 443 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 519 (621)
|||++...... .......||..|+|||++. ...++.++||||||+++|+|++|..||..... ...+...+.
T Consensus 160 Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~ 233 (322)
T 2ycf_A 160 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT----QVSLKDQIT 233 (322)
T ss_dssp CCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC----SSCHHHHHH
T ss_pred cCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----HHHHHHHHH
Confidence 99999875432 2223456899999999974 45678999999999999999999999963221 111222211
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 520 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 520 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. .... ..+.. .......+.+++..|++.||++||++.++++
T Consensus 234 ~----~~~~--~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 S----GKYN--FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp H----TCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred h----Cccc--cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1 1100 00111 1122367889999999999999999999875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=337.16 Aligned_cols=263 Identities=23% Similarity=0.319 Sum_probs=198.7
Q ss_pred cCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecC--------
Q 007020 296 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-------- 365 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 365 (621)
++|++.+.||+|+||+||+|.. .+|+.||||++..... ......+.+|+.+++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5788999999999999999987 4789999999865443 22345678999999999999999999998763
Q ss_pred CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccc
Q 007020 366 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 445 (621)
Q Consensus 366 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 445 (621)
+..++||||+++ +|.+.+..... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999986 77777765432 389999999999999999999999 99999999999999999999999999
Q ss_pred cceecccCC---Ceeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHH
Q 007020 446 LAKLMDYKD---THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGL 521 (621)
Q Consensus 446 la~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 521 (621)
+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+...
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~ 244 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-----EQHQLALISQL 244 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHH
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHH
Confidence 998764321 222344568999999999976 457999999999999999999999996321 11111111111
Q ss_pred hhhcccc---ccc-----C----ccccCcccHHH------HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 522 LKEKKLE---MLV-----D----PDLQNNYVEAE------VEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 522 ~~~~~~~---~~~-----d----~~~~~~~~~~~------~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
....... ... + .........+. ...+.+++..|++.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 1100000 000 0 00000001111 245889999999999999999999976
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=341.90 Aligned_cols=266 Identities=21% Similarity=0.238 Sum_probs=200.7
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhcc--------CCceeeeeeeee-
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV--------HRNLLRLRGFCM- 363 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~- 363 (621)
..++|.+.+.||+|+||+||+|+.. +++.||||+++.. ......+.+|+.+++.++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 3578999999999999999999854 6889999998643 334557889999999886 788999999987
Q ss_pred ---cCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC---
Q 007020 364 ---TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF--- 437 (621)
Q Consensus 364 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~--- 437 (621)
.....++||||+. ++|.+.+..... ..+++..++.++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 113 SGVNGTHICMVFEVLG-HHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EETTEEEEEEEECCCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHH
T ss_pred cCCCCceEEEEEeccC-ccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhh
Confidence 5568899999994 566666654322 23899999999999999999999964 799999999999999775
Q ss_pred ----------------------------------------------cEEEcccccceecccCCCeeeecccccccccchh
Q 007020 438 ----------------------------------------------EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 471 (621)
Q Consensus 438 ----------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE 471 (621)
.+||+|||+++..... .....||..|+|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCCh
Confidence 7999999999876432 23346899999999
Q ss_pred hhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCC-cchHHHHHHHHhhhc--------c-cccccCc--------
Q 007020 472 YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD-DVMLLDWVKGLLKEK--------K-LEMLVDP-------- 533 (621)
Q Consensus 472 ~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~--------~-~~~~~d~-------- 533 (621)
++.+..++.++|||||||++|||++|+.||......... .......+....... . .......
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 999999999999999999999999999999643221111 011111111111000 0 0000000
Q ss_pred --cc---------cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 534 --DL---------QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 534 --~~---------~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.. ...........+.+++..||+.||++|||++|+++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 01124556778999999999999999999999976
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=325.91 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=195.2
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
..++|.+.+.||+|+||.||+|... +|+.||||++.... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3467889999999999999999975 78999999986432 12234568899999999999999999999999999999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
||||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 89 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 999999999999997643 288999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCCeeeecccccccccchhhhccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
.... ......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.... .......... ...
T Consensus 162 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~-- 228 (276)
T 2h6d_A 162 SDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--------VPTLFKKIRG-GVF-- 228 (276)
T ss_dssp CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-CCC--
T ss_pred CCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc--------HHHHHHHhhc-Ccc--
Confidence 4322 2234458999999999987765 689999999999999999999996321 1111111111 100
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..+ ......+.+++..|++.||++|||++++++
T Consensus 229 -~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 -YIP-------EYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp -CCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -cCc-------hhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 011 112357889999999999999999999987
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=337.53 Aligned_cols=256 Identities=21% Similarity=0.260 Sum_probs=191.7
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCC------
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 366 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 366 (621)
.++|...+.||+|+||+||+|... +++.||||++..... ......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367889999999999999999864 688999999975432 334456889999999999999999999987654
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccc
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 446 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 446 (621)
..++||||+++ +|.+++.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 67999999985 78888763 278899999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh---
Q 007020 447 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--- 523 (621)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--- 523 (621)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+ .....
T Consensus 174 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~-~~i~~~~~ 243 (371)
T 2xrw_A 174 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-------IDQW-NKVIEQLG 243 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHH-HHHHC-CC
T ss_pred ccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHH-HHHHHHhC
Confidence 9865432 223345699999999999999999999999999999999999999963221 0011 11100
Q ss_pred -------------------hcc------cccccCccc---cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 524 -------------------EKK------LEMLVDPDL---QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 524 -------------------~~~------~~~~~d~~~---~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
... ......... ...........+.+++..|++.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000 000000000 01112233577899999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=343.38 Aligned_cols=264 Identities=25% Similarity=0.426 Sum_probs=203.3
Q ss_pred HHHHHHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCC
Q 007020 288 LRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 366 (621)
Q Consensus 288 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 366 (621)
..++++..++|++.+.||+|+||.||+|.+.+ .||+|.++.... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 44556667889999999999999999998753 499999875432 223345788999999999999999999999999
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccc
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 446 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 446 (621)
..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++ ++.+||+|||+
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred ceEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCC
Confidence 9999999999999999997643 2488899999999999999999999 999999999999998 67999999999
Q ss_pred ceecccCC----Ceeeecccccccccchhhhcc---------CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcch
Q 007020 447 AKLMDYKD----THVTTAVRGTIGHIAPEYLST---------GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 513 (621)
Q Consensus 447 a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~ 513 (621)
+....... ........|+..|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------- 247 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-------- 247 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC--------
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------
Confidence 87653211 112233458999999999874 347889999999999999999999996321
Q ss_pred HHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCC
Q 007020 514 LLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGL 577 (621)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 577 (621)
........... ..+.... ......+.+++..||+.||++|||+.++++.|+....
T Consensus 248 ~~~~~~~~~~~------~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 248 AEAIIWQMGTG------MKPNLSQ---IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp HHHHHHHHHTT------CCCCCCC---SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred HHHHHHHhccC------CCCCCCc---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11111111111 1111110 0112468899999999999999999999999998543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=340.09 Aligned_cols=262 Identities=25% Similarity=0.370 Sum_probs=199.4
Q ss_pred HHHHHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeeec--
Q 007020 289 RELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMT-- 364 (621)
Q Consensus 289 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-- 364 (621)
.++....++|++.+.||+|+||.||+|.+. +|+.||||++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 334456788999999999999999999874 78999999986543 2345788999999998 79999999999876
Q ss_pred ----CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEE
Q 007020 365 ----PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV 440 (621)
Q Consensus 365 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 440 (621)
.+..++||||+++|+|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEE
Confidence 467899999999999999998643 22488899999999999999999999 999999999999999999999
Q ss_pred EcccccceecccCCCeeeecccccccccchhhhc-----cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHH
Q 007020 441 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 515 (621)
Q Consensus 441 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~ 515 (621)
|+|||++....... .......|+..|+|||++. +..++.++||||||+++|+|++|+.||..... .
T Consensus 170 l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~ 240 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--------M 240 (326)
T ss_dssp ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH--------H
T ss_pred EeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH--------H
Confidence 99999998654322 1223446899999999997 55688999999999999999999999952211 0
Q ss_pred HHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhcC
Q 007020 516 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR--MLEGD 575 (621)
Q Consensus 516 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~--~L~~~ 575 (621)
........ ........ . .....+.+++..||+.||++||+++++++ .+++.
T Consensus 241 ~~~~~~~~-~~~~~~~~----~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 241 RALFLIPR-NPAPRLKS----K----KWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp HHHHHHHH-SCCCCCSC----S----CSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred HHHHHhhc-CccccCCc----c----ccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 11111111 11111111 1 12357889999999999999999999987 34443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=334.92 Aligned_cols=262 Identities=22% Similarity=0.310 Sum_probs=199.3
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecC-----Cce
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TER 368 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 368 (621)
.++|.+.+.||+|+||+||+|.+. +|+.||||.++..........+.+|+.+++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467889999999999999999865 68999999997655555566788999999999999999999987654 678
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
++||||+. |+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999998 5999998763 389999999999999999999999 99999999999999999999999999998
Q ss_pred ecccCCCe---------eeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHH
Q 007020 449 LMDYKDTH---------VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 518 (621)
Q Consensus 449 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 518 (621)
........ ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~ 235 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR-----HQLLLI 235 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHH
Confidence 76532211 1223468999999998765 67899999999999999999999999632210 000111
Q ss_pred HHHhhhcc----cccccC----------cccc----CcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 519 KGLLKEKK----LEMLVD----------PDLQ----NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 519 ~~~~~~~~----~~~~~d----------~~~~----~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
........ ...... +... ..........+.+++..||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11000000 000000 0000 0001123467889999999999999999999976
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=344.70 Aligned_cols=197 Identities=21% Similarity=0.261 Sum_probs=171.0
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhc------cCCceeeeeeeeecCCc
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA------VHRNLLRLRGFCMTPTE 367 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~ 367 (621)
..+|++.+.||+|+||+||+|... +++.||||+++.. .....++.+|+.+++.+ .|+||+++++++.....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 457899999999999999999865 6899999999653 23345677888888777 46799999999999999
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc--EEEcccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFG 445 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~DfG 445 (621)
.++||||+. ++|.+++...... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQ--GFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999997 5999998875432 389999999999999999999999 9999999999999999887 9999999
Q ss_pred cceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCccc
Q 007020 446 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 503 (621)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~ 503 (621)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 99764422 2345689999999999999999999999999999999999999963
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=337.51 Aligned_cols=259 Identities=23% Similarity=0.334 Sum_probs=202.9
Q ss_pred hcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCch----------------hHHHHHHHHHHHHhccCCceeee
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG----------------GELQFQTEVEMISMAVHRNLLRL 358 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~E~~~l~~l~h~niv~l 358 (621)
.++|.+.+.||+|+||.||+|.. +|+.||||.+....... ....+.+|+.+++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46889999999999999999999 89999999986432111 11678999999999999999999
Q ss_pred eeeeecCCceEEEEeccCCCchhhh------hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCe
Q 007020 359 RGFCMTPTERLLVYPYMANGSVASC------LRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANI 431 (621)
Q Consensus 359 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Ni 431 (621)
++++.+.+..++||||+++|+|.++ +.... ...+++..+..++.|++.||+|||+ . +|+||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999999 54421 3358999999999999999999999 8 999999999999
Q ss_pred eeCCCCcEEEcccccceecccCCCeeeecccccccccchhhhccC-CCCC-cccchhHHHHHHHHHhCCCCcccccccCC
Q 007020 432 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSE-KTDVFGYGIMLLELITGQRAFDLARLAND 509 (621)
Q Consensus 432 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlGvil~elltg~~pf~~~~~~~~ 509 (621)
+++.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++||||||+++|||++|..||.....
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--- 257 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS--- 257 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC---
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc---
Confidence 9999999999999999875432 33455699999999999877 5555 99999999999999999999963221
Q ss_pred CcchHHHHHHHHhhhcccccccC------ccc---cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 510 DDVMLLDWVKGLLKEKKLEMLVD------PDL---QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~d------~~~---~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. .+........ ....-.+ +.. ...........+.+++..||+.||++|||+.++++
T Consensus 258 -~---~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 258 -L---VELFNNIRTK-NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -S---HHHHHHHTSC-CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -H---HHHHHHHhcc-CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 1112221111 1100000 000 00000223467899999999999999999999976
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=337.19 Aligned_cols=259 Identities=21% Similarity=0.278 Sum_probs=181.7
Q ss_pred hcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecC------C
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------T 366 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 366 (621)
.++|...+.||+|+||.||+|.. .+|+.||||++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46899999999999999999985 478999999986543 233455788999999999999999999998654 5
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccc
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 446 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 446 (621)
..++|+||+ +++|.+++... .+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 67999988752 389999999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 447 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
++..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+.......
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~l~~i~~~~g~p 249 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-----IDQLKLILRLVGTP 249 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSC
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCC
Confidence 9865422 234568999999999987 6789999999999999999999999963221 11111111110000
Q ss_pred c---cccccC----------ccccC----cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 526 K---LEMLVD----------PDLQN----NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 526 ~---~~~~~d----------~~~~~----~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
. ...+.. +.... .........+.+++..|++.||++|||+.++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 000000 00000 0001123568899999999999999999999763
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=322.33 Aligned_cols=252 Identities=20% Similarity=0.303 Sum_probs=198.2
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC---CchhHHHHHHHHHHHHhccCCceeeeeeeee--cCCce
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER---TPGGELQFQTEVEMISMAVHRNLLRLRGFCM--TPTER 368 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 368 (621)
.++|.+.+.||+|+||.||+|... +++.||+|+++... .......+.+|+.+++.++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 368999999999999999999974 68899999996542 1234567999999999999999999999984 45678
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
++||||+++| |.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999986 7777765432 2488999999999999999999999 99999999999999999999999999998
Q ss_pred ecccC-CCeeeecccccccccchhhhccCCC--CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 449 LMDYK-DTHVTTAVRGTIGHIAPEYLSTGKS--SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 449 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
..... .........||..|+|||++.+... +.++||||||+++|||++|+.||.... ..+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~i~~~- 228 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKLFENIGKG- 228 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHC-
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--------HHHHHHHHhcC-
Confidence 76432 2223344569999999999976543 779999999999999999999996321 11222222111
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 526 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 526 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.. .... .....+.+++..|++.||++|||++++++.
T Consensus 229 ~~------~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 229 SY------AIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CC------CCCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CC------CCCC----ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 10 1111 123578899999999999999999999863
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=322.83 Aligned_cols=253 Identities=22% Similarity=0.306 Sum_probs=202.7
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--------chhHHHHHHHHHHHHhcc-CCceeeeeeeee
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--------PGGELQFQTEVEMISMAV-HRNLLRLRGFCM 363 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 363 (621)
..++|...+.||+|+||.||+|... +|+.||||+++.... ......+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3468889999999999999999875 689999999965431 122346789999999996 999999999999
Q ss_pred cCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcc
Q 007020 364 TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 443 (621)
Q Consensus 364 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 443 (621)
.....++||||+++++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999998643 389999999999999999999999 999999999999999999999999
Q ss_pred cccceecccCCCeeeecccccccccchhhhc------cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHH
Q 007020 444 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS------TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDW 517 (621)
Q Consensus 444 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~ 517 (621)
||++....... ......|+..|+|||++. ...++.++||||||+++|+|++|..||.... ....
T Consensus 168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~ 237 (298)
T 1phk_A 168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QMLM 237 (298)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHH
T ss_pred ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc--------HHHH
Confidence 99998765332 233456899999999985 4457889999999999999999999995321 1111
Q ss_pred HHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 518 VKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 518 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
........ .. ...+ ........+.+++..|++.||++|||+.++++
T Consensus 238 ~~~~~~~~-~~-~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 238 LRMIMSGN-YQ-FGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHTC-CC-CCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHhcCC-cc-cCcc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 12111111 00 0001 11223467899999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=336.56 Aligned_cols=257 Identities=22% Similarity=0.337 Sum_probs=198.6
Q ss_pred HHHHHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCC-chhHHHHHHHHHHHHhcc--CCceeeeeeeeecC
Q 007020 289 RELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAV--HRNLLRLRGFCMTP 365 (621)
Q Consensus 289 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~ 365 (621)
+.+.+..++|.+.+.||+|+||.||++...+++.||||++..... ......+.+|+.++..++ |+||+++++++..+
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 334455678999999999999999999988899999999975443 334567899999999997 59999999999999
Q ss_pred CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccc
Q 007020 366 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 445 (621)
Q Consensus 366 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 445 (621)
+..++||| +.+++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||++++ +.+||+|||
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred CEEEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecc
Confidence 99999999 66789999998653 388999999999999999999999 9999999999999965 799999999
Q ss_pred cceecccCCCe-eeecccccccccchhhhcc-----------CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcch
Q 007020 446 LAKLMDYKDTH-VTTAVRGTIGHIAPEYLST-----------GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 513 (621)
Q Consensus 446 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~ 513 (621)
++......... ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||.... .
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~ 244 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------N 244 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC-------S
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH-------H
Confidence 99876433221 2234468999999999875 467889999999999999999999995221 0
Q ss_pred HHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 514 LLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
....+..... +.............+.+++..||+.||++||++.++++
T Consensus 245 ~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 245 QISKLHAIID---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHHHHHHHC---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHh---------cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 1111111111 11111111111357889999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=341.33 Aligned_cols=262 Identities=22% Similarity=0.282 Sum_probs=191.9
Q ss_pred hcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCC------ce
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ER 368 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~ 368 (621)
..+|...+.||+|+||+||+|+...+..||+|++..... ...+|+++++.++||||+++++++.... ..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 357888999999999999999987777799998865432 1237999999999999999999985443 27
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC-CCCcEEEcccccc
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLA 447 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DfGla 447 (621)
++||||++++.+. .+.........+++..++.++.||++||+|||++ +|+||||||+|||++ .++.+||+|||++
T Consensus 114 ~lv~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 114 NLVLEYVPETVYR-ASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEECCSEEHHH-HHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeeccCccHHH-HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 8999999885443 3332111123488999999999999999999999 999999999999998 7999999999999
Q ss_pred eecccCCCeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh----
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL---- 522 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---- 522 (621)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+...++...
T Consensus 190 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~l~~i~~~~g~p~~ 263 (394)
T 4e7w_A 190 KILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG----IDQLVEIIKVLGTPSR 263 (394)
T ss_dssp EECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCH
T ss_pred ccccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCH
Confidence 8764332 22345689999999999765 589999999999999999999999963221 111111111100
Q ss_pred ---hh--cccccccCccccC-----cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 523 ---KE--KKLEMLVDPDLQN-----NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 523 ---~~--~~~~~~~d~~~~~-----~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.. .......-+.... .+.......+.+++..||+.||++|||+.|+++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00 0000000000000 0111234678999999999999999999999863
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.55 Aligned_cols=260 Identities=25% Similarity=0.341 Sum_probs=192.1
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecC------Cce
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TER 368 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 368 (621)
.+|...+.||+|+||+||+|++. +|+.||||++..... ...+|+++++.++||||+++++++... ...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 46788899999999999999975 689999999865432 234799999999999999999988532 235
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC-CcEEEcccccc
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLA 447 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfGla 447 (621)
++||||+++ ++.+.+.........+++..+..++.||++||+|||++ +|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999986 66666553222233489999999999999999999999 99999999999999965 67899999999
Q ss_pred eecccCCCeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh----
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL---- 522 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---- 522 (621)
+....... .....||..|+|||++.+. .++.++|||||||++|||++|+.||..... ...+.+.++...
T Consensus 205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~----~~~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQLVEIIKVLGTPTR 278 (420)
T ss_dssp EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCSCCH
T ss_pred hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCH
Confidence 87643322 2345689999999999765 689999999999999999999999963211 111112211100
Q ss_pred ---h--hcccccccCccccCc-----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 523 ---K--EKKLEMLVDPDLQNN-----YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 523 ---~--~~~~~~~~d~~~~~~-----~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. .........+..... +.......+.+++..||+.||++|||+.|+++
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0 000011111111110 11122467899999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=332.80 Aligned_cols=254 Identities=20% Similarity=0.297 Sum_probs=194.6
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCce----
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER---- 368 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 368 (621)
.++|...+.||+|+||+||+|... +|+.||||++..... ......+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467888999999999999999865 689999999976443 33355788999999999999999999999877654
Q ss_pred --EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccc
Q 007020 369 --LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 446 (621)
Q Consensus 369 --~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 446 (621)
++||||+. |+|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999998 588888743 288999999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 447 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
++..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..... .+.+.......
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~ 258 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--------LDQLTQILKVT 258 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHHH
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHh
Confidence 9865432 334568999999999987 6789999999999999999999999963221 11111111100
Q ss_pred cc------ccc-----------cCccccC---cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 526 KL------EML-----------VDPDLQN---NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 526 ~~------~~~-----------~d~~~~~---~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.. ..+ ....... .........+.+++..|++.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00 000 0000000 001122467899999999999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=339.72 Aligned_cols=201 Identities=24% Similarity=0.384 Sum_probs=154.1
Q ss_pred cCCCc-CceeeeccCceEEEEEcC---CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeee--cCCceE
Q 007020 296 DSFSN-KNILGRGGFGKVYKGRLA---DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM--TPTERL 369 (621)
Q Consensus 296 ~~~~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~ 369 (621)
+.|.. .++||+|+||+||+|.+. +++.||||++..... ...+.+|+.+++.++||||+++++++. .....+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 34554 458999999999999864 578999999975432 336789999999999999999999995 467889
Q ss_pred EEEeccCCCchhhhhccC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee----CCCCcEE
Q 007020 370 LVYPYMANGSVASCLRER-----PPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL----DEEFEAV 440 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~k 440 (621)
+||||+.+ +|.+++... ......+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999975 888777532 11223489999999999999999999999 99999999999999 6778999
Q ss_pred EcccccceecccCCC--eeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCccc
Q 007020 441 VGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDL 503 (621)
Q Consensus 441 l~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~ 503 (621)
|+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 238 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence 999999987653221 223445699999999999874 489999999999999999999999964
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=329.82 Aligned_cols=264 Identities=25% Similarity=0.368 Sum_probs=199.6
Q ss_pred HhcCCCcCceeeeccCceEEEEEc--CCCcEEEEEEecccCCc-hhHHHHHHHHHHHHhc---cCCceeeeeeeee----
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRL--ADGSLVAVKRLKEERTP-GGELQFQTEVEMISMA---VHRNLLRLRGFCM---- 363 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 363 (621)
..++|++.+.||+|+||+||+|.. .+|+.||+|+++..... .....+.+|+.+++.+ .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999987 46889999998754322 1223566788777766 8999999999987
Q ss_pred -cCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEc
Q 007020 364 -TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 442 (621)
Q Consensus 364 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 442 (621)
.....++||||++ |+|.+++...... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccC--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999998 5999999875432 388999999999999999999999 99999999999999999999999
Q ss_pred ccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh
Q 007020 443 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 522 (621)
Q Consensus 443 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 522 (621)
|||++....... ......||..|+|||++.+..++.++||||||+++|+|++|+.||..... ......+....
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~ 235 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-----VDQLGKILDVI 235 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHH
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHHHc
Confidence 999998654321 22345689999999999999999999999999999999999999963221 11111111111
Q ss_pred hhcccccc----------cC---ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 523 KEKKLEML----------VD---PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 523 ~~~~~~~~----------~d---~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
........ .. ..............+.+++..||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000 00 00000111223467889999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=328.12 Aligned_cols=260 Identities=22% Similarity=0.272 Sum_probs=201.3
Q ss_pred HhcCCCcCceeeeccCceEEEEEc--CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCc------eeeeeeeeecC
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRL--ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN------LLRLRGFCMTP 365 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~ 365 (621)
..++|++.+.||+|+||+||+|.. .+++.||||+++.. ......+.+|+.+++.++|++ ++++++++...
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 356899999999999999999985 36889999998643 334556889999998887654 99999999999
Q ss_pred CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC----------
Q 007020 366 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---------- 435 (621)
Q Consensus 366 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---------- 435 (621)
+..++||||+ +++|.+++..... .++++..+..++.|++.||+|||++ +|+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence 9999999999 7899999987542 3488999999999999999999999 9999999999999987
Q ss_pred ---------CCcEEEcccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccc
Q 007020 436 ---------EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARL 506 (621)
Q Consensus 436 ---------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~ 506 (621)
++.+||+|||++...... .....||..|+|||++.+..++.++||||||+++|||++|..||.....
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred cccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 668999999999864432 2345689999999999999999999999999999999999999963221
Q ss_pred cCCCcchHHHHHHHHhhhcc--------cccc---------------------cCc-cccCcccHHHHHHHHHHHHhccC
Q 007020 507 ANDDDVMLLDWVKGLLKEKK--------LEML---------------------VDP-DLQNNYVEAEVEQLIQVALLCTQ 556 (621)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~--------~~~~---------------------~d~-~~~~~~~~~~~~~l~~l~~~c~~ 556 (621)
......+........ .... ..+ .............+.+++..||+
T Consensus 240 -----~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 240 -----KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp -----HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred -----HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence 111111111110000 0000 000 00001122345789999999999
Q ss_pred CCCCCCCCHHHHHH
Q 007020 557 GSPMDRPKMSEVVR 570 (621)
Q Consensus 557 ~~P~~RPt~~~vl~ 570 (621)
.||++|||++|+++
T Consensus 315 ~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 315 YDPAKRITLREALK 328 (339)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred cCcccccCHHHHhc
Confidence 99999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=319.29 Aligned_cols=253 Identities=24% Similarity=0.317 Sum_probs=202.2
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
...++|.+.+.||+|+||+||+|... +++.||+|++.... .......+.+|++++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999875 78999999986543 23345678999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC---CcEEEcccccc
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLA 447 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DfGla 447 (621)
||||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999999887543 388999999999999999999999 99999999999999754 47999999999
Q ss_pred eecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
....... ......|+..|+|||.+.+ .++.++||||||+++|+|++|+.||.... ..+......... .
T Consensus 172 ~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~~-~ 239 (287)
T 2wei_A 172 TCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDILKRVETGK-Y 239 (287)
T ss_dssp GTBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-C
T ss_pred eeecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCC-C
Confidence 8654322 1223458999999999875 48899999999999999999999996321 112222221111 1
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.. ..+. .......+.+++..|++.||++|||+.++++
T Consensus 240 ~~-~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 240 AF-DLPQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CC-CSGG-----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC-Cchh-----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00 0010 1122367889999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=326.03 Aligned_cols=251 Identities=25% Similarity=0.401 Sum_probs=191.6
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeec---------
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT--------- 364 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 364 (621)
.++|+..+.||+|+||.||+|... +++.||||.++.. ......+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 467888999999999999999964 7899999998642 3345678999999999999999999998754
Q ss_pred ----CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEE
Q 007020 365 ----PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV 440 (621)
Q Consensus 365 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 440 (621)
....++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence 356799999999999999998643 2377889999999999999999999 999999999999999999999
Q ss_pred EcccccceecccCC-------------CeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccc
Q 007020 441 VGDFGLAKLMDYKD-------------THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARL 506 (621)
Q Consensus 441 l~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~ 506 (621)
|+|||++....... ........|+..|+|||++.+. .++.++||||||+++|||++ ||....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~- 232 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM- 232 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-
Confidence 99999998654221 1122344589999999999865 68999999999999999998 553111
Q ss_pred cCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 507 ANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
........... . ...............+.+++..|++.||++|||++++++
T Consensus 233 ------~~~~~~~~~~~---~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 ------ERVNILKKLRS---V----SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ------HHHHHHHHHHS---T----TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------hHHHHHHhccc---c----ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 01111111111 0 111111222333467889999999999999999999976
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=332.54 Aligned_cols=259 Identities=23% Similarity=0.319 Sum_probs=180.8
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHH-HHHhccCCceeeeeeeeecCCceEEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
..++|...+.||+|+||.||+|... +|+.||||+++.........++..|+. +++.++||||+++++++..++..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 4578888999999999999999975 789999999987655555556666666 67778999999999999999999999
Q ss_pred EeccCCCchhhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 372 YPYMANGSVASCLRERP-PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
|||+++ +|.+++.... .....+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++..
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 999986 8877775311 11234889999999999999999999953 7999999999999999999999999999865
Q ss_pred ccCCCeeeecccccccccchhhh----ccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcc
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYL----STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (621)
.... ......||..|+|||++ .+..++.++||||||+++|+|++|+.||....... +.+..
T Consensus 177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~------ 241 (327)
T 3aln_A 177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-------DQLTQ------ 241 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CC------
T ss_pred cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-------HHHHH------
Confidence 4322 22233589999999998 45668999999999999999999999996321100 00000
Q ss_pred cccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 527 ~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
......+.+...........+.+++..||+.||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 242 VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00001111111111123367899999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=335.17 Aligned_cols=269 Identities=21% Similarity=0.254 Sum_probs=187.5
Q ss_pred HHHHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCc-
Q 007020 290 ELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE- 367 (621)
Q Consensus 290 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 367 (621)
......++|.+.+.||+|+||+||+|... +|+.||||++..... ....+.+|+..++.++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 34566789999999999999999999875 689999999865432 22346678888889999999999999865433
Q ss_pred ------eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCCeeeCC-CCc
Q 007020 368 ------RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH--DHCDPKIIHRDVKAANILLDE-EFE 438 (621)
Q Consensus 368 ------~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH--~~~~~~ivH~Dlk~~Nill~~-~~~ 438 (621)
.++||||+++ +|.+.+.........+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence 7899999987 554444332222334888999999999999999999 88 9999999999999996 899
Q ss_pred EEEcccccceecccCCCeeeecccccccccchhhhccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHH
Q 007020 439 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDW 517 (621)
Q Consensus 439 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~ 517 (621)
+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ...+...
T Consensus 171 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~----~~~~~~~ 244 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS----AGQLHEI 244 (360)
T ss_dssp EEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHH
T ss_pred EEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh----HHHHHHH
Confidence 9999999998765332 233456899999999987654 89999999999999999999999963221 1111111
Q ss_pred HHHHhh-----------hcccccccCc------cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 518 VKGLLK-----------EKKLEMLVDP------DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 518 ~~~~~~-----------~~~~~~~~d~------~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
++.... ........+. .............+.+++..||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 111000 0000000000 0000111123567999999999999999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=331.22 Aligned_cols=264 Identities=20% Similarity=0.270 Sum_probs=198.1
Q ss_pred hcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-----------CCceeeeeeee
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-----------HRNLLRLRGFC 362 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~ 362 (621)
.++|.+.+.||+|+||+||+|.. .+++.||||+++.. ......+.+|+.+++++. |+||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 46788999999999999999986 47899999998643 234456888999988876 89999999998
Q ss_pred ecCC----ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC----
Q 007020 363 MTPT----ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD---- 434 (621)
Q Consensus 363 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---- 434 (621)
...+ ..++||||+ +++|.+++...... .+++..+..++.||+.||+|||+++ +|+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHR--GIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhcc--CCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence 7643 789999999 88999999875332 3889999999999999999999953 799999999999994
Q ss_pred --CCCcEEEcccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCC--
Q 007020 435 --EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD-- 510 (621)
Q Consensus 435 --~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-- 510 (621)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4458999999999876432 23346899999999999999999999999999999999999999743211100
Q ss_pred cchHHHHHHHHhhhc-------------------ccccccCc---------cccCcccHHHHHHHHHHHHhccCCCCCCC
Q 007020 511 DVMLLDWVKGLLKEK-------------------KLEMLVDP---------DLQNNYVEAEVEQLIQVALLCTQGSPMDR 562 (621)
Q Consensus 511 ~~~~~~~~~~~~~~~-------------------~~~~~~d~---------~~~~~~~~~~~~~l~~l~~~c~~~~P~~R 562 (621)
...+.+.+. ..... ....+... .............+.+++..||+.||++|
T Consensus 247 ~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 247 DDHIAQIIE-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHH-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred HHHHHHHHH-hcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 001111111 00000 00000000 00112345667889999999999999999
Q ss_pred CCHHHHHH
Q 007020 563 PKMSEVVR 570 (621)
Q Consensus 563 Pt~~~vl~ 570 (621)
||++|+++
T Consensus 326 pt~~ell~ 333 (373)
T 1q8y_A 326 ADAGGLVN 333 (373)
T ss_dssp BCHHHHHT
T ss_pred CCHHHHhh
Confidence 99999976
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.60 Aligned_cols=252 Identities=22% Similarity=0.288 Sum_probs=186.2
Q ss_pred CCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceEEEEecc
Q 007020 297 SFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPYM 375 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 375 (621)
.|...+.||+|+||+||.+...+|+.||||++... ....+.+|+.++..+ +||||+++++++.+....++||||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 44556789999999998776667999999998643 234578899999876 8999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC-------------CcE
Q 007020 376 ANGSVASCLRERPPSQLP---LDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE-------------FEA 439 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~---~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-------------~~~ 439 (621)
. |+|.+++......... ..+..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 5999999875432211 13335678999999999999999 99999999999999654 489
Q ss_pred EEcccccceecccCCCe---eeecccccccccchhhhcc-------CCCCCcccchhHHHHHHHHHh-CCCCcccccccC
Q 007020 440 VVGDFGLAKLMDYKDTH---VTTAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGIMLLELIT-GQRAFDLARLAN 508 (621)
Q Consensus 440 kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~ 508 (621)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.....
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-- 245 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS-- 245 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT--
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh--
Confidence 99999999876543222 1234569999999999976 568999999999999999999 9999952210
Q ss_pred CCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 509 DDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.....+..... .+.............+.+++..|++.||++|||+.+|++
T Consensus 246 ----~~~~i~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 ----RESNIIRGIFS--------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ----HHHHHHHTCCC--------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----hHHHHhcCCCC--------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11111111110 011111123455678999999999999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=329.45 Aligned_cols=201 Identities=23% Similarity=0.308 Sum_probs=170.3
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-CC-----ceeeeeeeeec
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HR-----NLLRLRGFCMT 364 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~ 364 (621)
+...++|.+.+.||+|+||+||+|... +++.||||+++.. .....++..|+.+++.++ |+ +|+++++++..
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 344678999999999999999999865 6889999999643 233456778888888775 44 49999999999
Q ss_pred CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC--CCCcEEEc
Q 007020 365 PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD--EEFEAVVG 442 (621)
Q Consensus 365 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~ 442 (621)
.+..++||||+++ +|.+++...... .+++..+..++.|++.||.|||++ +.+|+||||||+|||++ .++.+||+
T Consensus 128 ~~~~~lv~e~~~~-~L~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 128 RNHLCLVFEMLSY-NLYDLLRNTNFR--GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp TTEEEEEEECCCC-BHHHHHHHTTTS--CCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred CCceEEEEecCCC-CHHHHHhhcCcC--CCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 9999999999975 999999875422 388999999999999999999952 12899999999999995 47789999
Q ss_pred ccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcc
Q 007020 443 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 502 (621)
Q Consensus 443 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~ 502 (621)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 204 DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~ 259 (382)
T 2vx3_A 204 DFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS 259 (382)
T ss_dssp CCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999876432 234568999999999999999999999999999999999999996
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=326.56 Aligned_cols=253 Identities=21% Similarity=0.296 Sum_probs=194.7
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCc-----
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE----- 367 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 367 (621)
.++|...+.||+|+||.||+|... +|+.||||.+..... ......+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357888999999999999999864 689999999975443 2334578899999999999999999999987654
Q ss_pred -eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccc
Q 007020 368 -RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 446 (621)
Q Consensus 368 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 446 (621)
.++||||+. |+|.+++.. .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999998 588888753 288999999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 447 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
++..... .....||..|+|||++.+ ..++.++||||||+++|+|++|+.||..... .+.+.......
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~ 240 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--------LDQLTQILKVT 240 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH--------HHHHHHHHHHH
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHh
Confidence 9764422 234468999999999977 6789999999999999999999999963221 11111111100
Q ss_pred ---------------------ccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 526 ---------------------KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 526 ---------------------~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.+.....+.+ ..........+.+++..|++.||++|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 241 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CBCCHHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCCHHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000 0111223467899999999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.70 Aligned_cols=258 Identities=23% Similarity=0.346 Sum_probs=191.0
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeee----------
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM---------- 363 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~---------- 363 (621)
.++|...+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 467889999999999999999976 58999999987543 445567899999999999999999999873
Q ss_pred ----cCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC-CCCc
Q 007020 364 ----TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD-EEFE 438 (621)
Q Consensus 364 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~ 438 (621)
+....++||||++ |+|.+++... ++++..+..++.|++.||+|||++ +|+||||||+||+++ +++.
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence 3467799999998 5999998653 388999999999999999999999 999999999999997 5679
Q ss_pred EEEcccccceecccCCC--eeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHH
Q 007020 439 AVVGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 515 (621)
Q Consensus 439 ~kl~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~ 515 (621)
+||+|||+++....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... .
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~ 231 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE--------L 231 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------H
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH--------H
Confidence 99999999987543211 12233457899999998876 6789999999999999999999999963221 1
Q ss_pred HHHHHHhhhccc-------------cc-----ccCccc-cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 516 DWVKGLLKEKKL-------------EM-----LVDPDL-QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 516 ~~~~~~~~~~~~-------------~~-----~~d~~~-~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
+.+......... .. ...+.. ...........+.+++..|++.||++|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 232 EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 111111110000 00 000000 00001123467899999999999999999999976
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=329.92 Aligned_cols=247 Identities=23% Similarity=0.391 Sum_probs=199.4
Q ss_pred HHHHHHhcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCch-----hHHHHHHHHHHHHhcc--CCceeeeee
Q 007020 289 RELQVATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPG-----GELQFQTEVEMISMAV--HRNLLRLRG 360 (621)
Q Consensus 289 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~--h~niv~l~~ 360 (621)
.+.+...++|.+.+.||+|+||.||+|.. .+++.||||.++...... ....+.+|+.+++.++ |+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 34445567899999999999999999985 478999999997543221 2235678999999996 599999999
Q ss_pred eeecCCceEEEEeccCC-CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC-CCCc
Q 007020 361 FCMTPTERLLVYPYMAN-GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD-EEFE 438 (621)
Q Consensus 361 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~ 438 (621)
++..++..++||||+.+ ++|.+++.... .+++..+..++.||++||+|||+. +|+||||||+|||++ +++.
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCC
Confidence 99999999999999986 89999998643 388999999999999999999999 999999999999999 7889
Q ss_pred EEEcccccceecccCCCeeeecccccccccchhhhccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHH
Q 007020 439 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDW 517 (621)
Q Consensus 439 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~ 517 (621)
+||+|||++...... ......||..|+|||++.+..+ +.++||||||+++|||++|+.||.... ..
T Consensus 189 ~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----------~~ 255 (320)
T 3a99_A 189 LKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EI 255 (320)
T ss_dssp EEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HH
T ss_pred EEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----------hh
Confidence 999999999876532 2234569999999999987765 688999999999999999999996321 11
Q ss_pred HHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 518 VKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 518 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. ... .... . .....+.+++..||+.||++|||++++++
T Consensus 256 ~----~~~---~~~~----~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 256 I----RGQ---VFFR----Q----RVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp H----HCC---CCCS----S----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred h----ccc---cccc----c----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000 0011 1 12257889999999999999999999976
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=328.78 Aligned_cols=244 Identities=23% Similarity=0.371 Sum_probs=190.8
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCch-----hHHHHHHHHHHHHhc----cCCceeeeeee
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-----GELQFQTEVEMISMA----VHRNLLRLRGF 361 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l----~h~niv~l~~~ 361 (621)
+...++|.+.+.||+|+||.||+|... +++.||||+++...... ....+.+|+.++.++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 445678999999999999999999864 68899999996543221 222466799999888 89999999999
Q ss_pred eecCCceEEEEec-cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC-CCCcE
Q 007020 362 CMTPTERLLVYPY-MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD-EEFEA 439 (621)
Q Consensus 362 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~ 439 (621)
+...+..++|||| +.+++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++ .++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 9999999999999 78999999998643 389999999999999999999999 999999999999999 88999
Q ss_pred EEcccccceecccCCCeeeecccccccccchhhhccCCCC-CcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHH
Q 007020 440 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 518 (621)
Q Consensus 440 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 518 (621)
||+|||++....... .....|+..|+|||++.+..+. .++||||||+++|||++|+.||.... ...
T Consensus 180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------~~~ 246 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------EIL 246 (312)
T ss_dssp EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHH
T ss_pred EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----------HHh
Confidence 999999998765332 2345589999999999877664 58999999999999999999996221 110
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 519 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 519 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. . . .... ......+.+++..||+.||++|||++++++
T Consensus 247 ~----~-~------~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 247 E----A-E------LHFP----AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp H----T-C------CCCC----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred h----h-c------cCCc----ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0 0 0011 112357889999999999999999999976
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=328.88 Aligned_cols=252 Identities=21% Similarity=0.241 Sum_probs=172.3
Q ss_pred hcCCCcC-ceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeec----CCce
Q 007020 295 TDSFSNK-NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTER 368 (621)
Q Consensus 295 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 368 (621)
.++|.+. ++||+|+||+||+|... +|+.||||++.... .........+..+.||||+++++++.. ....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 4677774 46999999999999876 68999999986421 112222334567789999999999875 4457
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---CCcEEEcccc
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFG 445 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfG 445 (621)
++||||+++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 999999999999999987542 3489999999999999999999999 9999999999999976 4559999999
Q ss_pred cceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 446 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......... ..... ....
T Consensus 177 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~~~-~~~~ 248 (336)
T 3fhr_A 177 FAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP----GMKRR-IRLG 248 (336)
T ss_dssp TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred cceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh----hHHHh-hhcc
Confidence 99865422 2234568999999999988888999999999999999999999996332111000 00000 0000
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 526 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 526 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. ..............+.+++..|++.||++|||++++++
T Consensus 249 ~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 249 Q------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp --------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred c------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 00011111223467889999999999999999999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.17 Aligned_cols=260 Identities=20% Similarity=0.245 Sum_probs=198.0
Q ss_pred HhcCCCcCceeeeccCceEEEEEcC-CC-cEEEEEEecccCCchhHHHHHHHHHHHHhccCCc------eeeeeeeeecC
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLA-DG-SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN------LLRLRGFCMTP 365 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~ 365 (621)
..++|.+.+.||+|+||+||+|... ++ +.||+|+++.. ......+.+|+.+++.++|++ ++.+++++...
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 3578999999999999999999864 34 68999998643 334557888999999988766 99999999999
Q ss_pred CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee------------
Q 007020 366 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL------------ 433 (621)
Q Consensus 366 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill------------ 433 (621)
+..++||||+ ++++.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred CeEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence 9999999999 5577777765432 2488999999999999999999999 99999999999999
Q ss_pred -------CCCCcEEEcccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccc
Q 007020 434 -------DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARL 506 (621)
Q Consensus 434 -------~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~ 506 (621)
+.++.+||+|||+++..... .....||..|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 56789999999999864432 2345699999999999999999999999999999999999999963221
Q ss_pred cCCCcchHHHHHHHHhhhc--------c-cccccCccc---------------------cCcccHHHHHHHHHHHHhccC
Q 007020 507 ANDDDVMLLDWVKGLLKEK--------K-LEMLVDPDL---------------------QNNYVEAEVEQLIQVALLCTQ 556 (621)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~--------~-~~~~~d~~~---------------------~~~~~~~~~~~l~~l~~~c~~ 556 (621)
......+....... . ......... ...........+.+++..||+
T Consensus 245 -----~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 245 -----REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp -----HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred -----HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 11111111111000 0 000000000 000112334678999999999
Q ss_pred CCCCCCCCHHHHHH
Q 007020 557 GSPMDRPKMSEVVR 570 (621)
Q Consensus 557 ~~P~~RPt~~~vl~ 570 (621)
.||++|||++|+++
T Consensus 320 ~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 320 FDPAQRITLAEALL 333 (355)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred CChhhCcCHHHHhc
Confidence 99999999999964
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=319.36 Aligned_cols=252 Identities=22% Similarity=0.338 Sum_probs=179.9
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHH-HHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~-~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
.++|+..+.||+|+||.||+|.+. +|+.||||++..........+ +..+..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888899999999999999975 789999999976654444334 444445678889999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
||+ ++.+..+..... ..+++..+..++.|+++||+|||+ . +|+||||||+||+++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 445555554321 238899999999999999999998 5 89999999999999999999999999997654
Q ss_pred cCCCeeeecccccccccchhhhc-----cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (621)
... ......|+..|+|||++. ...++.++||||||+++|||++|+.||.... . ..+.+........
T Consensus 177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~---~~~~~~~~~~~~~ 247 (318)
T 2dyl_A 177 DDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK----T---DFEVLTKVLQEEP 247 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC----S---HHHHHHHHHHSCC
T ss_pred CCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC----c---cHHHHHHHhccCC
Confidence 322 223345899999999994 4567899999999999999999999996311 1 1122222222111
Q ss_pred cccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 527 ~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. .... .......+.+++..||+.||.+||+++++++
T Consensus 248 ~------~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 P------LLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp C------CCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C------CCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 0000 0012357889999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=349.31 Aligned_cols=261 Identities=24% Similarity=0.308 Sum_probs=199.4
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeec------CCc
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT------PTE 367 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 367 (621)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++..........+.+|+.+++.++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999874 6899999999876656667789999999999999999999998765 677
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc---EEEccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDF 444 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Df 444 (621)
.++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 8999999999999999987542 23488889999999999999999999 9999999999999997664 999999
Q ss_pred ccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhh
Q 007020 445 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 524 (621)
Q Consensus 445 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 524 (621)
|++....... ......||..|+|||.+.+..++.++||||||+++|+|++|..||..... ...|.......
T Consensus 169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-------~~~~~~~i~~~ 239 (676)
T 3qa8_A 169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-------PVQWHGKVREK 239 (676)
T ss_dssp CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-------HHHSSTTCC--
T ss_pred cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-------hhhhhhhhhcc
Confidence 9998765332 23445699999999999999999999999999999999999999963210 11111100000
Q ss_pred ccc----cccc------Cc--cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 007020 525 KKL----EMLV------DP--DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 568 (621)
Q Consensus 525 ~~~----~~~~------d~--~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~v 568 (621)
... .... .. .............+.+++..|+..||++|||++++
T Consensus 240 ~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp ----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred cchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 000 0000 00 00112233456789999999999999999999763
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=334.11 Aligned_cols=250 Identities=25% Similarity=0.333 Sum_probs=185.6
Q ss_pred HhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceEEEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 372 (621)
...+|...+.||+|+||+||.....+|+.||||++...... .+.+|+.+++.+ +||||+++++++.+....++||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 34568888999999999966554557899999998654322 356899999998 7999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-----CCcEEEcccccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE-----EFEAVVGDFGLA 447 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-----~~~~kl~DfGla 447 (621)
||+. |+|.+++...... ..+..+..++.||++||+|||++ +|+||||||+|||++. ...+||+|||++
T Consensus 98 E~~~-g~L~~~l~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDFA---HLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp ECCS-EEHHHHHHSSSCC---CCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred ECCC-CCHHHHHHhcCCC---ccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9997 5999999865422 44456789999999999999999 9999999999999953 336889999999
Q ss_pred eecccCCC--eeeecccccccccchhhhc---cCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHH
Q 007020 448 KLMDYKDT--HVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGL 521 (621)
Q Consensus 448 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 521 (621)
+....... .......||+.|+|||++. ...++.++|||||||++|||++ |..||.... . ......
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~------~---~~~~~~ 241 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL------Q---RQANIL 241 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT------T---HHHHHH
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh------H---HHHHHH
Confidence 87653321 2234456999999999997 4567889999999999999999 999985211 0 111111
Q ss_pred hhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 522 LKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 522 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
....... ...+ .......+.+++..||+.||++|||+++|++
T Consensus 242 ~~~~~~~-~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 242 LGACSLD-CLHP------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTCCCCT-TSCT------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccCCcc-ccCc------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1111110 0110 1223456789999999999999999999974
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=349.85 Aligned_cols=239 Identities=21% Similarity=0.282 Sum_probs=194.3
Q ss_pred hcCCCcCceeeeccCceEEEEEcC--CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCc-----
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA--DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE----- 367 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 367 (621)
.++|.+.+.||+|+||+||+|.+. +|+.||||++...........+.+|+.+++.++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999865 5899999998765555556678999999999999999999999987665
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
.|+||||+++++|.+++.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence 6999999999999987754 389999999999999999999999 99999999999999986 8999999999
Q ss_pred eecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
+..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||........
T Consensus 229 ~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------------------ 284 (681)
T 2pzi_A 229 SRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------------------ 284 (681)
T ss_dssp EETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC------------------
T ss_pred hhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc------------------
Confidence 876432 3456999999999997765 8899999999999999999998863211100
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHHhc
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-MSEVVRMLEG 574 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-~~~vl~~L~~ 574 (621)
. ...........+.+++..||+.||++||+ ++++...|.+
T Consensus 285 ---~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 285 ---P----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ---C----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---c----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0 00011123367889999999999999995 5556555543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=308.40 Aligned_cols=231 Identities=12% Similarity=0.033 Sum_probs=183.5
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
.++|++.+.||+|+||.||+|.+. +++.||||+++.... ......+.+|+..+..++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467888999999999999999975 589999999976543 23346789999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++++|.+++... ....++..++.|++.||+|||++ +|+||||||+|||++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc------
Confidence 9999999999999642 34557889999999999999999 99999999999999999999998554
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
|++ .++.++||||||+++|||++|+.||........... .....
T Consensus 175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~--------------~~~~~ 218 (286)
T 3uqc_A 175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--------------AERDT 218 (286)
T ss_dssp ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--------------CCBCT
T ss_pred ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--------------HHHHh
Confidence 333 257899999999999999999999974332111000 00000
Q ss_pred Ccccc--CcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCC
Q 007020 532 DPDLQ--NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGL 577 (621)
Q Consensus 532 d~~~~--~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 577 (621)
..... ..........+.+++..||+.||++| |+.++++.|+....
T Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 219 AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 00000 00111234678999999999999999 99999999988443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=319.40 Aligned_cols=244 Identities=14% Similarity=0.154 Sum_probs=186.1
Q ss_pred HhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCC-------chhHHHHHHHHHHHHhcc---------CCceee
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT-------PGGELQFQTEVEMISMAV---------HRNLLR 357 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~---------h~niv~ 357 (621)
..++|++.+.||+|+||+||+|++ +|+.||||+++.... ......+.+|+.+++.++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 346788899999999999999998 689999999976532 223367889999988886 555555
Q ss_pred eee-----------------eeec-------------CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHH
Q 007020 358 LRG-----------------FCMT-------------PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSA 407 (621)
Q Consensus 358 l~~-----------------~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~ 407 (621)
+.+ ++.+ ....++||||+++|++.+.+.+. .+++..++.++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~-----~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-----LSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT-----CCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc-----CCCHHHHHHHHHHHH
Confidence 554 4433 67899999999999877777442 378999999999999
Q ss_pred HHHHHHH-hCCCCCeEecCCCCCCeeeCCCC--------------------cEEEcccccceecccCCCeeeeccccccc
Q 007020 408 RGLSYLH-DHCDPKIIHRDVKAANILLDEEF--------------------EAVVGDFGLAKLMDYKDTHVTTAVRGTIG 466 (621)
Q Consensus 408 ~~L~~LH-~~~~~~ivH~Dlk~~Nill~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~ 466 (621)
.||+||| ++ +|+||||||+|||++.++ .+||+|||+|+..... ...||+.
T Consensus 172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 88 999999999999999887 8999999999876532 2369999
Q ss_pred ccchhhhccCCCCCcccchhHHHH-HHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHH
Q 007020 467 HIAPEYLSTGKSSEKTDVFGYGIM-LLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVE 545 (621)
Q Consensus 467 y~aPE~~~~~~~~~~~DvwSlGvi-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 545 (621)
|+|||++.+.. +.++||||+|++ .+++++|..||.. ..|............................
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-----------VLWLHYLTDKMLKQMTFKTKCNTPAMKQIKR 310 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-----------HHHHHHHHHHHHHTCCCSSCCCSHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc-----------hhhhhHHHHhhhhhhccCcccchhhhhhcCH
Confidence 99999998766 889999998776 7889999999952 1222221111000001111122233456678
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHH
Q 007020 546 QLIQVALLCTQGSPMDRPKMSEVV 569 (621)
Q Consensus 546 ~l~~l~~~c~~~~P~~RPt~~~vl 569 (621)
.+.+++..|++.| |++|++
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHhccC-----CHHHHH
Confidence 8999999999966 999887
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=305.18 Aligned_cols=228 Identities=21% Similarity=0.245 Sum_probs=176.6
Q ss_pred cCCCcC-ceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHH-HhccCCceeeeeeeeec----CCce
Q 007020 296 DSFSNK-NILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMI-SMAVHRNLLRLRGFCMT----PTER 368 (621)
Q Consensus 296 ~~~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 368 (621)
++|... +.||+|+||.||+|.. .+++.||+|+++.. ..+.+|+.++ +..+||||+++++++.. ....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 456655 7899999999999986 47899999998642 3467888887 56689999999999876 6678
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---CCcEEEcccc
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFG 445 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfG 445 (621)
++||||+++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 999999999999999987542 2489999999999999999999999 9999999999999998 7899999999
Q ss_pred cceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 446 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
++.... +..++.++|||||||++|||++|+.||......... ..
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------------~~ 209 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------------PG 209 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------CC
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------------HH
Confidence 987532 134567899999999999999999999632211000 00
Q ss_pred ccccccCccc--cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 526 KLEMLVDPDL--QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 526 ~~~~~~d~~~--~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
....+..... ...........+.+++..||+.||++|||+.|+++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 210 MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000000000 00001123467899999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=325.50 Aligned_cols=244 Identities=14% Similarity=0.115 Sum_probs=179.2
Q ss_pred hcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCch--hHHHHHHHHHHHHhccC-Cceeeee-----------
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVH-RNLLRLR----------- 359 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h-~niv~l~----------- 359 (621)
...|...+.||+|+||+||+|.+ .+|+.||||+++...... ....+.+|+.+++.+.| +|...+.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34566778999999999999995 479999999987443222 24578999999998877 2211111
Q ss_pred ----------eeeec-----CCceEEEEeccCCCchhhhhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 007020 360 ----------GFCMT-----PTERLLVYPYMANGSVASCLRER---PPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 421 (621)
Q Consensus 360 ----------~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i 421 (621)
.++.. ....+++|+++ +++|.+++... ......+++..+..++.||++||+|||++ +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 11111 12356777755 57999988521 11223477889999999999999999999 99
Q ss_pred EecCCCCCCeeeCCCCcEEEcccccceecccCCCeeeecccccccccchhhh----------ccCCCCCcccchhHHHHH
Q 007020 422 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL----------STGKSSEKTDVFGYGIML 491 (621)
Q Consensus 422 vH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwSlGvil 491 (621)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999999865432 344567 999999999 444578899999999999
Q ss_pred HHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 492 LELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 492 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
|||++|+.||........ ...+.... . ..+..+.+++..||+.||++||++.++++
T Consensus 308 ~elltg~~Pf~~~~~~~~-----------------~~~~~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGG-----------------SEWIFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGSC-----------------SGGGGSSC--C----CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhhh-----------------HHHHHhhc--c----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999964322111 11111100 0 11267899999999999999999988864
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-30 Score=284.49 Aligned_cols=186 Identities=14% Similarity=0.076 Sum_probs=131.1
Q ss_pred eeeccCceEEEEE-cCCCcEEEEEEecccCC---------chhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceEEEE
Q 007020 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEERT---------PGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 304 lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 372 (621)
.+.|++|.+..++ ...|+.||+|.+..... .....+|.+|+++|+++ .|+||+++++++.++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 5566666655543 22478899999975421 22345699999999999 6999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||++|++|.++|..... ++. .+|+.||+.||+|+|++ |||||||||+|||++.+|.+||+|||+|+....
T Consensus 322 Eyv~G~~L~d~i~~~~~----l~~---~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEE----IDR---EKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHTTCC----CCH---HHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHhCCC----CCH---HHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999987542 554 35899999999999999 999999999999999999999999999987653
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf 501 (621)
.. ......+||+.|||||++.+ .+..++|+||+|++++++.++..++
T Consensus 392 ~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 DC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 32 23345679999999999975 4567899999999998887766554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-27 Score=257.06 Aligned_cols=185 Identities=15% Similarity=0.214 Sum_probs=146.1
Q ss_pred CcCceeeeccCceEEEEEcCCCcEEEEEEecccCCc-h------hHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 299 SNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP-G------GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 299 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
...+.||+|+||+||+|.. .++.+++|........ . ...++.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4457899999999999965 4788999986543221 1 123579999999999999999777777777888999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++|+|.+++.. +..++.|+++||+|||++ +|+||||||+|||++. .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999875 457999999999999999 9999999999999999 99999999999765
Q ss_pred cCCCee------eecccccccccchhhhcc--CCCCCcccchhHHHHHHHHHhCCCCc
Q 007020 452 YKDTHV------TTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGIMLLELITGQRAF 501 (621)
Q Consensus 452 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf 501 (621)
...... .....||+.|||||++.. ..|+..+|+||..+-..+-+.++.+|
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 432211 235679999999999987 56778899999999988888877665
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.93 E-value=5.1e-26 Score=231.86 Aligned_cols=175 Identities=35% Similarity=0.614 Sum_probs=161.3
Q ss_pred cccchhHHHHHHHHHhCCCCCCCCCCCCCCCCCCcc--ceeeEEcCC---CcEEEEEcCCCCccc--cCcccccCCCCCc
Q 007020 20 ASANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCT--WFHVTCNND---NSVIRVDLGNAALSG--QLVSQLGLLKNLQ 92 (621)
Q Consensus 20 ~~~~~~~~~l~~~~~~~~~~~~~l~~w~~~~~~~c~--w~gv~c~~~---~~l~~L~L~~n~l~~--~~~~~~~~l~~L~ 92 (621)
.|...|.+||++||+++.||. .+++|..+ .+||. |.||+|+.. .+|+.|+|++|+|++ .+|..|..+++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~-~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCCC-CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCC
Confidence 477789999999999999886 79999764 68998 999999864 799999999999999 8999999999999
Q ss_pred EEEeee-CCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccC
Q 007020 93 YLELYS-NNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNN 171 (621)
Q Consensus 93 ~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 171 (621)
+|+|++ |++++.+|..|.++++|++|+|++|+|++.+|..|.++++|++|+|++|++++.+|..+..+++|++|++++|
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 159 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence 999995 9999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcccCCC-CCCCC-CcccccccCCcc
Q 007020 172 RLSGVVPD-NGSFS-LFTPISFANNLD 196 (621)
Q Consensus 172 ~l~~~~~~-~~~~~-~l~~l~l~~N~~ 196 (621)
+|++..+. ...++ +|+.|++++|..
T Consensus 160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l 186 (313)
T 1ogq_A 160 RISGAIPDSYGSFSKLFTSMTISRNRL 186 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred cccCcCCHHHhhhhhcCcEEECcCCee
Confidence 99966554 46776 899999999975
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.1e-24 Score=213.82 Aligned_cols=154 Identities=14% Similarity=0.055 Sum_probs=123.5
Q ss_pred HHHHHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCc-----------------hhHHHHHHHHHHHHhcc
Q 007020 289 RELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP-----------------GGELQFQTEVEMISMAV 351 (621)
Q Consensus 289 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~ 351 (621)
..+......|.+.+.||+|+||.||+|.+.+|+.||+|.++..... .....+.+|+.+++.++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 3444455667778999999999999999977999999999643321 13456889999999998
Q ss_pred CCceeeeeeeeecCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 007020 352 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANI 431 (621)
Q Consensus 352 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Ni 431 (621)
| +++.+++.. +..++||||+++|+|.+ +.. .....++.|++.||+|||+. +|+||||||+||
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NI 224 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNV 224 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHE
Confidence 5 666665533 56799999999999998 421 13457999999999999999 999999999999
Q ss_pred eeCCCCcEEEcccccceecccCCCeeeecccccccccchhhhcc
Q 007020 432 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 475 (621)
Q Consensus 432 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 475 (621)
|++ ++.+||+|||+|+ .+..|+|||++..
T Consensus 225 Ll~-~~~vkl~DFG~a~--------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSV--------------EVGEEGWREILER 253 (282)
T ss_dssp EEE-TTEEEECCCTTCE--------------ETTSTTHHHHHHH
T ss_pred EEE-CCcEEEEECCCCe--------------ECCCCCHHHHHHH
Confidence 999 9999999999997 3445789998853
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.4e-23 Score=235.80 Aligned_cols=155 Identities=32% Similarity=0.422 Sum_probs=104.1
Q ss_pred hhhcccchhHHHHHHHHHhCCCCCCCCCCCCCCCCCCccceeeEEcCCCcEEEEEcCCCCcccc---Ccc----------
Q 007020 17 SWLASANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAALSGQ---LVS---------- 83 (621)
Q Consensus 17 ~~~~~~~~~~~~l~~~~~~~~~~~~~l~~w~~~~~~~c~w~gv~c~~~~~l~~L~L~~n~l~~~---~~~---------- 83 (621)
+.+++...|++||++||+++.||. .+++|.. ..+||+|.||+|+ .++|+.|+|+++.++|. +++
T Consensus 5 ~~~~~~~~~~~all~~k~~~~~~~-~l~~W~~-~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~ 81 (768)
T 3rgz_A 5 SPSQSLYREIHQLISFKDVLPDKN-LLPDWSS-NKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLES 81 (768)
T ss_dssp ---CCHHHHHHHHHHHHTTCSCTT-SSTTCCT-TSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCE
T ss_pred ccccCCHHHHHHHHHHHhhCCCcc-cccCCCC-CCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCcccc
Confidence 333456678899999999999998 8999974 4789999999999 78999999999999886 554
Q ss_pred -------------cccCCCCCcEEEeeeCCCCCCCcc--cccCCCccceeeeccccCCCCCCccc-cccccccccccccc
Q 007020 84 -------------QLGLLKNLQYLELYSNNITGPIPS--DLGNLTSLVSLDLYLNSFTGPIPDTL-GKLSKLRFLRLNNN 147 (621)
Q Consensus 84 -------------~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~l~~N 147 (621)
.|+.+++|++|+|++|.+++.+|. .|+++++|++|+|++|.+++.+|..+ .++++|++|+|++|
T Consensus 82 l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n 161 (768)
T 3rgz_A 82 LFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSAN 161 (768)
T ss_dssp EECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSS
T ss_pred cCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCC
Confidence 555666666666666666666665 66666666666666666665555543 45555555555555
Q ss_pred ccCCCCCCC---ccCCccccEEeeccCcCc
Q 007020 148 SLSGPIPMS---LTNISSLQVLDLSNNRLS 174 (621)
Q Consensus 148 ~l~~~~p~~---~~~l~~L~~L~l~~N~l~ 174 (621)
++++..|.. +.++++|++|++++|.++
T Consensus 162 ~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~ 191 (768)
T 3rgz_A 162 SISGANVVGWVLSDGCGELKHLAISGNKIS 191 (768)
T ss_dssp CCEEETHHHHHHTTCCTTCCEEECCSSEEE
T ss_pred ccCCcCChhhhhhccCCCCCEEECCCCccc
Confidence 555444333 333333333333333333
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.86 E-value=9.7e-22 Score=190.64 Aligned_cols=149 Identities=23% Similarity=0.240 Sum_probs=137.3
Q ss_pred CCCccceeeEEcCC----------CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeee
Q 007020 51 VNPCTWFHVTCNND----------NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDL 120 (621)
Q Consensus 51 ~~~c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 120 (621)
.+.|+|.+|.|... .+|+.|+|++|+|++..+..|..+++|++|+|++|+|+...+..|.++++|+.|+|
T Consensus 16 ~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 95 (229)
T 3e6j_A 16 QCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDL 95 (229)
T ss_dssp TCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEEC
Confidence 57899999999752 47999999999999988999999999999999999999777778999999999999
Q ss_pred ccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcccCC
Q 007020 121 YLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDLCG 199 (621)
Q Consensus 121 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~~~ 199 (621)
++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+++++.. ..+++|+.|++++|++.|.
T Consensus 96 s~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 96 GTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred CCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 999999777778999999999999999999 78999999999999999999999998764 7789999999999999886
Q ss_pred C
Q 007020 200 P 200 (621)
Q Consensus 200 ~ 200 (621)
+
T Consensus 175 c 175 (229)
T 3e6j_A 175 C 175 (229)
T ss_dssp B
T ss_pred c
Confidence 4
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-22 Score=231.60 Aligned_cols=172 Identities=20% Similarity=0.218 Sum_probs=148.9
Q ss_pred ccchhHHHHHHHHHhCCCCCCCCCCCCCCC----CCC--ccc------------eeeEEcCCCcEEEEEcCCCCccccCc
Q 007020 21 SANMEGDALHSLRSNLIDPNNVLQSWDPTL----VNP--CTW------------FHVTCNNDNSVIRVDLGNAALSGQLV 82 (621)
Q Consensus 21 ~~~~~~~~l~~~~~~~~~~~~~l~~w~~~~----~~~--c~w------------~gv~c~~~~~l~~L~L~~n~l~~~~~ 82 (621)
+...|..||++||.++.+| +|+.+. .+| |+| .||+|+..++|+.|+|++|+|+|.+|
T Consensus 266 ~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip 340 (876)
T 4ecn_A 266 EYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVP 340 (876)
T ss_dssp HHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEEC
T ss_pred cchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCc
Confidence 3457888999999999877 786553 355 999 99999988899999999999999999
Q ss_pred ccccCCCCCcEEEe-eeCCCCCC---------------------------------------------------------
Q 007020 83 SQLGLLKNLQYLEL-YSNNITGP--------------------------------------------------------- 104 (621)
Q Consensus 83 ~~~~~l~~L~~L~L-~~N~l~~~--------------------------------------------------------- 104 (621)
+.|++|++|++|+| ++|.++|.
T Consensus 341 ~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~ 420 (876)
T 4ecn_A 341 DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD 420 (876)
T ss_dssp GGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCC
T ss_pred hHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccc
Confidence 99999999999999 77754333
Q ss_pred -------------------CcccccCCCccceeeeccccCCC-----------------CCCcccc--cccccccccccc
Q 007020 105 -------------------IPSDLGNLTSLVSLDLYLNSFTG-----------------PIPDTLG--KLSKLRFLRLNN 146 (621)
Q Consensus 105 -------------------~p~~~~~l~~L~~L~L~~N~l~~-----------------~~p~~~~--~l~~L~~L~l~~ 146 (621)
+|..|++|++|+.|+|++|+|++ .+|..++ ++++|+.|+|++
T Consensus 421 ~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~ 500 (876)
T 4ecn_A 421 SRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYN 500 (876)
T ss_dssp CCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEES
T ss_pred cccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcC
Confidence 78889999999999999999997 3888877 999999999999
Q ss_pred cccCCCCCCCccCCccccEEeeccCc-Ccc--cCCCC-------CCCCCcccccccCCccc
Q 007020 147 NSLSGPIPMSLTNISSLQVLDLSNNR-LSG--VVPDN-------GSFSLFTPISFANNLDL 197 (621)
Q Consensus 147 N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~--~~~~~-------~~~~~l~~l~l~~N~~~ 197 (621)
|++.+.+|..|.++++|+.|+|++|+ |++ +|... ..+++|+.|++++|...
T Consensus 501 N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 501 CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp CTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred CCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 99999999999999999999999998 887 33322 34558999999998754
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.85 E-value=2.2e-21 Score=186.83 Aligned_cols=149 Identities=22% Similarity=0.324 Sum_probs=136.6
Q ss_pred CCccceeeEEcCC----------CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeec
Q 007020 52 NPCTWFHVTCNND----------NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLY 121 (621)
Q Consensus 52 ~~c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 121 (621)
..|.|..|.|... .+|+.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 9 C~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls 88 (220)
T 2v9t_B 9 CTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLY 88 (220)
T ss_dssp SEEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECC
T ss_pred CEECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECC
Confidence 4578888998642 379999999999998888899999999999999999998889999999999999999
Q ss_pred cccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcccCCC
Q 007020 122 LNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDLCGP 200 (621)
Q Consensus 122 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~~~~ 200 (621)
+|+|+...+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+++++.. ..+++|+.|++++|++.|.+
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 168 (220)
T 2v9t_B 89 GNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDC 168 (220)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence 99999766677899999999999999999988999999999999999999999998874 77899999999999999864
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.85 E-value=3.8e-22 Score=204.43 Aligned_cols=175 Identities=17% Similarity=0.236 Sum_probs=152.9
Q ss_pred cccchhHHHHHHHHHhC-CCCCCCCCCCC---CCCCCCccceeeEEc---------CCCcEEEEEcCCCCccccCccccc
Q 007020 20 ASANMEGDALHSLRSNL-IDPNNVLQSWD---PTLVNPCTWFHVTCN---------NDNSVIRVDLGNAALSGQLVSQLG 86 (621)
Q Consensus 20 ~~~~~~~~~l~~~~~~~-~~~~~~l~~w~---~~~~~~c~w~gv~c~---------~~~~l~~L~L~~n~l~~~~~~~~~ 86 (621)
++...+.+||++||.++ .|+.+.+.+|. ....++|.|.|+.|. ...+|+.|+|++|+|+ .+|+.+.
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~ 101 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAF 101 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGG
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhh
Confidence 34567889999999988 57878888994 445789999999995 2478999999999999 7788899
Q ss_pred CCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccccccccCCCCCCCccC-------
Q 007020 87 LLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTN------- 159 (621)
Q Consensus 87 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~------- 159 (621)
.+++|++|+|++|.|+ .+|..|+++++|++|+|++|+|+ .+|..|.++++|+.|+|++|++.+.+|..+..
T Consensus 102 ~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~ 179 (328)
T 4fcg_A 102 RLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179 (328)
T ss_dssp GGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCE
T ss_pred hCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhh
Confidence 9999999999999999 88989999999999999999999 78989999999999999999988888887765
Q ss_pred --CccccEEeeccCcCcccCCCCCCCCCcccccccCCccc
Q 007020 160 --ISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDL 197 (621)
Q Consensus 160 --l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~ 197 (621)
+++|+.|+|++|+|+.++.....+++|+.|++++|...
T Consensus 180 ~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~ 219 (328)
T 4fcg_A 180 QGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS 219 (328)
T ss_dssp EESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCC
T ss_pred ccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCC
Confidence 89999999999999977766678889999999998753
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.85 E-value=4.7e-22 Score=222.29 Aligned_cols=174 Identities=22% Similarity=0.247 Sum_probs=151.5
Q ss_pred cchhHHHHHHHHHhCCCCC--------CCCCCCCCCCCCCccc---eeeEEcCCCcEEEEEcCCCCccccCcccccCCCC
Q 007020 22 ANMEGDALHSLRSNLIDPN--------NVLQSWDPTLVNPCTW---FHVTCNNDNSVIRVDLGNAALSGQLVSQLGLLKN 90 (621)
Q Consensus 22 ~~~~~~~l~~~~~~~~~~~--------~~l~~w~~~~~~~c~w---~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~ 90 (621)
...|..||.+++.++.++. ....+|+.. .+||.| .||+|+..++|+.|+|++|+++|.+|+.|+.|++
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~-~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~ 106 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTE 106 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCS-SCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTT
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC-CCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCcc
Confidence 4468889999999886553 124479865 789999 9999988899999999999999999999999999
Q ss_pred CcEEEeeeCC----------------------------------------------------------------------
Q 007020 91 LQYLELYSNN---------------------------------------------------------------------- 100 (621)
Q Consensus 91 L~~L~L~~N~---------------------------------------------------------------------- 100 (621)
|++|+|++|.
T Consensus 107 L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l 186 (636)
T 4eco_A 107 LEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186 (636)
T ss_dssp CCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTT
T ss_pred ceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhh
Confidence 9999999984
Q ss_pred --------CCCCCcccccCCCccceeeeccccCCCC-----------------CCcccc--cccccccccccccccCCCC
Q 007020 101 --------ITGPIPSDLGNLTSLVSLDLYLNSFTGP-----------------IPDTLG--KLSKLRFLRLNNNSLSGPI 153 (621)
Q Consensus 101 --------l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----------------~p~~~~--~l~~L~~L~l~~N~l~~~~ 153 (621)
|++ +|..|+++++|++|+|++|+|++. +|..++ ++++|++|+|++|++.+.+
T Consensus 187 ~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~ 265 (636)
T 4eco_A 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKL 265 (636)
T ss_dssp TTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSC
T ss_pred hhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccC
Confidence 344 788899999999999999999985 899998 9999999999999999999
Q ss_pred CCCccCCccccEEeeccCc-Ccc--cCCCCCCC------CCcccccccCCccc
Q 007020 154 PMSLTNISSLQVLDLSNNR-LSG--VVPDNGSF------SLFTPISFANNLDL 197 (621)
Q Consensus 154 p~~~~~l~~L~~L~l~~N~-l~~--~~~~~~~~------~~l~~l~l~~N~~~ 197 (621)
|..|.++++|+.|++++|+ +++ +|.....+ ++|+.|++++|...
T Consensus 266 p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~ 318 (636)
T 4eco_A 266 PTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318 (636)
T ss_dssp CTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS
T ss_pred hHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC
Confidence 9999999999999999998 987 44434444 88999999999754
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.5e-20 Score=179.34 Aligned_cols=150 Identities=23% Similarity=0.241 Sum_probs=135.0
Q ss_pred CCCccceeeEEcCC----------CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeee
Q 007020 51 VNPCTWFHVTCNND----------NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDL 120 (621)
Q Consensus 51 ~~~c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 120 (621)
...|.|.+|.|... .+|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 4 ~C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 83 (208)
T 2o6s_A 4 RCSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNL 83 (208)
T ss_dssp TCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEEC
Confidence 34689999999642 36999999999999877778999999999999999999877778899999999999
Q ss_pred ccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcccCC
Q 007020 121 YLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDLCG 199 (621)
Q Consensus 121 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~~~ 199 (621)
++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|+|+++++.. ..+++|+.|++++|++.|.
T Consensus 84 s~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 163 (208)
T 2o6s_A 84 STNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 163 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC
T ss_pred CCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC
Confidence 999999777777899999999999999999877777899999999999999999998874 7789999999999998775
Q ss_pred C
Q 007020 200 P 200 (621)
Q Consensus 200 ~ 200 (621)
.
T Consensus 164 ~ 164 (208)
T 2o6s_A 164 C 164 (208)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=7.8e-21 Score=182.99 Aligned_cols=150 Identities=19% Similarity=0.247 Sum_probs=134.9
Q ss_pred CCccceeeEEcCC----------CcEEEEEcCCCCccccCc-ccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeee
Q 007020 52 NPCTWFHVTCNND----------NSVIRVDLGNAALSGQLV-SQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDL 120 (621)
Q Consensus 52 ~~c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 120 (621)
.-|.|..+.|++. ..++.|+|++|+|++..+ ..|..+++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 9 C~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~L 88 (220)
T 2v70_A 9 CRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILL 88 (220)
T ss_dssp CEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CEECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEEC
Confidence 3467888888642 367899999999998755 46899999999999999999888889999999999999
Q ss_pred ccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcccCC
Q 007020 121 YLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDLCG 199 (621)
Q Consensus 121 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~~~ 199 (621)
++|+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+++++.. ..+++|+.|++++|++.|.
T Consensus 89 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 89 TSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp CSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 999999888888999999999999999999888999999999999999999999997655 7899999999999999886
Q ss_pred CC
Q 007020 200 PV 201 (621)
Q Consensus 200 ~~ 201 (621)
+.
T Consensus 169 c~ 170 (220)
T 2v70_A 169 CY 170 (220)
T ss_dssp GG
T ss_pred Cc
Confidence 53
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=179.11 Aligned_cols=138 Identities=17% Similarity=0.189 Sum_probs=106.9
Q ss_pred CCCcCceeeeccCceEEEEEc-CCCcE--EEEEEecccCCc-----------------------hhHHHHHHHHHHHHhc
Q 007020 297 SFSNKNILGRGGFGKVYKGRL-ADGSL--VAVKRLKEERTP-----------------------GGELQFQTEVEMISMA 350 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~-----------------------~~~~~~~~E~~~l~~l 350 (621)
-|.+.+.||+|+||.||+|.. .+|+. ||||+++..... .....+.+|+..+..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356778999999999999998 67888 999987543211 0113578899999999
Q ss_pred cCCce--eeeeeeeecCCceEEEEeccCC-C----chhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeE
Q 007020 351 VHRNL--LRLRGFCMTPTERLLVYPYMAN-G----SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH-DHCDPKII 422 (621)
Q Consensus 351 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH-~~~~~~iv 422 (621)
.|+++ ..++++ ...++||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---giv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEE
Confidence 88764 333332 367899999943 4 56655432 224467889999999999999 88 999
Q ss_pred ecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 423 HRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 423 H~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
||||||+|||++. .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 8999999999754
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.8e-21 Score=207.75 Aligned_cols=143 Identities=20% Similarity=0.198 Sum_probs=103.5
Q ss_pred ccceeeEEcCCCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCccccc-CCCccceeeeccccCCCCCCcc
Q 007020 54 CTWFHVTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLG-NLTSLVSLDLYLNSFTGPIPDT 132 (621)
Q Consensus 54 c~w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~ 132 (621)
|.+.++.|....+|+.|+|++|.|++..|..|+.+++|++|+|++|.|++..|..|. ++++|+.|+|++|.|++. |.
T Consensus 109 N~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~- 186 (487)
T 3oja_A 109 NNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG- 186 (487)
T ss_dssp SCCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-
T ss_pred CcCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-
Confidence 455566666666777777777777777777777777777777777777776776665 677777777777777754 22
Q ss_pred cccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcccCC
Q 007020 133 LGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCG 199 (621)
Q Consensus 133 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~ 199 (621)
+..+++|+.|+|++|.|++ +|..+..+++|+.|+|++|.|+++++....+++|+.|++++|++.|+
T Consensus 187 ~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 187 QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHH
T ss_pred cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCc
Confidence 3357777778888887775 44447777778888888888777766666677777777877777664
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.2e-19 Score=176.61 Aligned_cols=131 Identities=21% Similarity=0.242 Sum_probs=107.5
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 145 (621)
+++.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus 36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 115 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG 115 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence 57788888888888777788888888888888888888777778888888888888888887667778888888888888
Q ss_pred ccccCCCCCCCccCCccccEEeeccCcCcccCCC-CCCCCCcccccccCCcc
Q 007020 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD-NGSFSLFTPISFANNLD 196 (621)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~ 196 (621)
+|+|++..+..|..+++|+.|+|++|+|+++++. ...+++|+.|++++|..
T Consensus 116 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 167 (251)
T 3m19_A 116 GNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQL 167 (251)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcC
Confidence 8888866666678888888888888888888775 36778888888888864
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.78 E-value=6.8e-19 Score=173.13 Aligned_cols=136 Identities=24% Similarity=0.256 Sum_probs=126.7
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+|+.|+|++|.|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 58 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 137 (251)
T 3m19_A 58 LTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELR 137 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEE
Confidence 46899999999999998888999999999999999999988888899999999999999999977777789999999999
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcccCC
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDLCG 199 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~~~ 199 (621)
|++|+|++..+..|..+++|+.|+|++|+|+++++.. ..+++|+.|++++|++.|.
T Consensus 138 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 138 LNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 9999999877778999999999999999999998854 7889999999999999875
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2.1e-19 Score=205.37 Aligned_cols=123 Identities=37% Similarity=0.667 Sum_probs=116.2
Q ss_pred cCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccE
Q 007020 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQV 165 (621)
Q Consensus 86 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 165 (621)
..+++|++|+|++|+++|.+|..|+++++|+.|+|++|+|+|.+|..|+++++|+.|||++|+++|.+|..+..+++|++
T Consensus 629 ~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~ 708 (768)
T 3rgz_A 629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTE 708 (768)
T ss_dssp SSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSE
T ss_pred hccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCE
Confidence 34578999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EeeccCcCcccCCCCCCCCCcccccccCCcccCCCCCCCCCCCC
Q 007020 166 LDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGS 209 (621)
Q Consensus 166 L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~~~~~~c~~~ 209 (621)
|+|++|+++|.+|....+.++....+.+|+.+||.+.. .|...
T Consensus 709 L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~~ 751 (768)
T 3rgz_A 709 IDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDPS 751 (768)
T ss_dssp EECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCSC
T ss_pred EECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCCC
Confidence 99999999999999888999999999999999999876 77543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.3e-18 Score=172.96 Aligned_cols=131 Identities=21% Similarity=0.231 Sum_probs=90.6
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 145 (621)
+++.|+|++|+|++..+..|..+++|++|+|++|+|+...+..|.++++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 46667777777776555667777777777777777775555556777777777777777775555566777777777777
Q ss_pred ccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcc
Q 007020 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLD 196 (621)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~ 196 (621)
+|++++..+..|..+++|+.|+|++|+|+++++.. ..+++|+.|++++|..
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 169 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQL 169 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcC
Confidence 77777666666677777777777777777666653 5667777777777653
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2.8e-18 Score=170.86 Aligned_cols=137 Identities=22% Similarity=0.187 Sum_probs=108.5
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+|+.|+|++|.|++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 84 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 163 (272)
T 3rfs_A 84 LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD 163 (272)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence 45788888888888877777778888888888888888877777778888888888888888866666678888888888
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcccCCC
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDLCGP 200 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~~~~ 200 (621)
|++|++++..+..|..+++|+.|++++|+|++.++.. ..+++|+.|++++|++.|..
T Consensus 164 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 221 (272)
T 3rfs_A 164 LSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC 221 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccC
Confidence 8888888776767778888888888888888877764 67788888888888876653
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2.7e-18 Score=172.54 Aligned_cols=136 Identities=25% Similarity=0.161 Sum_probs=111.1
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 76 l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 154 (290)
T 1p9a_G 76 LPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLS 154 (290)
T ss_dssp CTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEE
Confidence 356778888888887 5677788888888888888888877777888888888888888888877677788888888888
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcccCCC
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGP 200 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~ 200 (621)
|++|+|++..+..|..+++|+.|+|++|+|+.++.....+.+|+.+++++||+.|.+
T Consensus 155 L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 155 LANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcC
Confidence 888888866666677888888888888888888777777778888888888888764
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=2.9e-19 Score=168.15 Aligned_cols=129 Identities=25% Similarity=0.347 Sum_probs=87.5
Q ss_pred EEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcc-cccCCCccceeeeccccCCCCCCccccccccccccccccc
Q 007020 69 RVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPS-DLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147 (621)
Q Consensus 69 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 147 (621)
.|++++|+|+ .+|..+.. +|++|+|++|+|++..+. .|.++++|++|+|++|+|++..|..|.++++|+.|+|++|
T Consensus 12 ~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 12 TVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 4666666665 45554432 677777777777755543 3677777777777777777666777777777777777777
Q ss_pred ccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcccCCC
Q 007020 148 SLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDLCGP 200 (621)
Q Consensus 148 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~~~~ 200 (621)
+|++..+..|..+++|+.|+|++|+|++.++.. ..+++|+.|++++|++.|..
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 777666666777777777777777777765544 56677777777777776654
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.75 E-value=4.6e-19 Score=180.33 Aligned_cols=136 Identities=26% Similarity=0.423 Sum_probs=109.9
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 145 (621)
+|+.|+|++|.+++.+|..+..++ |++|+|++|++++..|..|.++++|+.|+|++|++++.+|. +..+++|++|+|+
T Consensus 175 ~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls 252 (313)
T 1ogq_A 175 LFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLR 252 (313)
T ss_dssp TCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECC
T ss_pred cCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECc
Confidence 566666666666666666666665 66666666766666777777888888888888888765554 7788899999999
Q ss_pred ccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcccCCCCCC
Q 007020 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTG 203 (621)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~~~~ 203 (621)
+|+|++.+|..+..+++|+.|+|++|+|++.+|....+++|+.+++++|+++||.+..
T Consensus 253 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~ 310 (313)
T 1ogq_A 253 NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp SSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred CCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC
Confidence 9999988999999999999999999999988888888999999999999999997543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=4.8e-18 Score=159.77 Aligned_cols=129 Identities=24% Similarity=0.312 Sum_probs=117.0
Q ss_pred EEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccccccc
Q 007020 69 RVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNS 148 (621)
Q Consensus 69 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 148 (621)
.+++++|+|+ .+|..+. ++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 5888899998 5666553 68999999999999 778899999999999999999998888889999999999999999
Q ss_pred cCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcccCCCC
Q 007020 149 LSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDLCGPV 201 (621)
Q Consensus 149 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~~~~~ 201 (621)
|++..|..|..+++|+.|+|++|+|+++++.. ..+++|+.|++++|++.|.+.
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 99888889999999999999999999998864 778999999999999998653
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.74 E-value=7e-18 Score=167.77 Aligned_cols=131 Identities=24% Similarity=0.271 Sum_probs=71.4
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+|+.|+|++|.|+...+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 61 ~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 140 (270)
T 2o6q_A 61 TKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSL 140 (270)
T ss_dssp TTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEEC
Confidence 45666666666665444444555666666666666665544445555555555555555555544445555555555555
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCc
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNL 195 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~ 195 (621)
++|+|++..+..|..+++|+.|+|++|+|+++++.. ..+++|+.|++++|.
T Consensus 141 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 192 (270)
T 2o6q_A 141 GYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQ 192 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCc
Confidence 555555444444555555555555555555554432 344555555555553
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=4e-18 Score=160.32 Aligned_cols=150 Identities=23% Similarity=0.261 Sum_probs=125.2
Q ss_pred CCccceeeEEcCC----------CcEEEEEcCCCCccccCcc-cccCCCCCcEEEeeeCCCCCCCcccccCCCccceeee
Q 007020 52 NPCTWFHVTCNND----------NSVIRVDLGNAALSGQLVS-QLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDL 120 (621)
Q Consensus 52 ~~c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 120 (621)
..|.|+.+.|+.. .+++.|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 6 C~C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 85 (192)
T 1w8a_A 6 CHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL 85 (192)
T ss_dssp SEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CEECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEEC
Confidence 4578888888642 3799999999999977665 5999999999999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcccCCC
Q 007020 121 YLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGP 200 (621)
Q Consensus 121 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~ 200 (621)
++|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..+...-...++...+.++...|+.
T Consensus 86 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~ 165 (192)
T 1w8a_A 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp CSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCS
T ss_pred CCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCC
Confidence 99999988888899999999999999999999999999999999999999999976542211112333345555555654
Q ss_pred C
Q 007020 201 V 201 (621)
Q Consensus 201 ~ 201 (621)
+
T Consensus 166 P 166 (192)
T 1w8a_A 166 P 166 (192)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.3e-17 Score=154.62 Aligned_cols=135 Identities=24% Similarity=0.293 Sum_probs=96.4
Q ss_pred CCccceeeEEcCCCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCc
Q 007020 52 NPCTWFHVTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPD 131 (621)
Q Consensus 52 ~~c~w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 131 (621)
..|+|.++.|. +|+++. +|..+ .++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+.
T Consensus 5 C~C~~~~l~~~-----------~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 70 (177)
T 2o6r_A 5 CSCSGTEIRCN-----------SKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDG 70 (177)
T ss_dssp CEEETTEEECC-----------SSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT
T ss_pred CEeCCCEEEec-----------CCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChh
Confidence 34677766554 455653 34333 26778888888888766666677788888888888888766566
Q ss_pred ccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcccCCC
Q 007020 132 TLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDLCGP 200 (621)
Q Consensus 132 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~~~~ 200 (621)
.|..+++|+.|+|++|+|++..+..|..+++|+.|++++|+|+++++.. ..+++|+.|++++|++.|..
T Consensus 71 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 71 VFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred HccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 6777888888888888887666666777788888888888888777765 56777888888888776654
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=8.4e-18 Score=187.90 Aligned_cols=133 Identities=17% Similarity=0.140 Sum_probs=121.6
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+++.|||++|+|+++.+..|.++++|++|+|++|+|+++.|..|.+|++|++|+|++|+|++..++.|.++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 37999999999999888889999999999999999999888889999999999999999999777788999999999999
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCC-C-CCCCCCcccccccCCccc
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP-D-NGSFSLFTPISFANNLDL 197 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~-~~~~~~l~~l~l~~N~~~ 197 (621)
++|+|++..+..|.++++|++|+|++|.|++... . ...+++|+.|++++|...
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 186 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 186 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccc
Confidence 9999998777789999999999999999987643 3 367899999999999753
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.71 E-value=6.4e-18 Score=175.48 Aligned_cols=145 Identities=21% Similarity=0.181 Sum_probs=126.8
Q ss_pred CCccceeeEEcCC----------CcEEEEEcCCCCccccCccccc-CCCCCcEEEeeeCCCCCCCcccccCCCccceeee
Q 007020 52 NPCTWFHVTCNND----------NSVIRVDLGNAALSGQLVSQLG-LLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDL 120 (621)
Q Consensus 52 ~~c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 120 (621)
.-|.+..+.|... ..++.|+|++|+|++..+..|. .+++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 16 C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~L 95 (361)
T 2xot_A 16 CLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDL 95 (361)
T ss_dssp CEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEEC
Confidence 3466777777542 3588999999999988888887 9999999999999999888888999999999999
Q ss_pred ccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCC----CCCCCcccccccCCcc
Q 007020 121 YLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN----GSFSLFTPISFANNLD 196 (621)
Q Consensus 121 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~----~~~~~l~~l~l~~N~~ 196 (621)
++|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++++... ..+++|+.|+|++|..
T Consensus 96 s~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l 175 (361)
T 2xot_A 96 SSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKL 175 (361)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCC
T ss_pred CCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCC
Confidence 999999777778999999999999999999888899999999999999999999988765 4688999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=7.1e-18 Score=172.91 Aligned_cols=140 Identities=16% Similarity=0.144 Sum_probs=100.2
Q ss_pred cCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCC-------------chhHHHH--------HHHHHHHHhccCCc
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT-------------PGGELQF--------QTEVEMISMAVHRN 354 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------~~~~~~~--------~~E~~~l~~l~h~n 354 (621)
.-|++.+.||+|+||.||+|...+|+.||||+++.... ....... .+|...+.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34888999999999999999998999999999764211 0011112 23455555554433
Q ss_pred eeeeeeeeecCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC
Q 007020 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD 434 (621)
Q Consensus 355 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~ 434 (621)
+.-..-+.. ...++||||++|++|..+... .....++.|++.+|.|||+. |||||||||.|||++
T Consensus 175 v~vp~p~~~--~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEE--ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred CCCCeeeec--cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEe
Confidence 321111111 234799999999988765431 13457889999999999999 999999999999998
Q ss_pred CCC----------cEEEcccccceec
Q 007020 435 EEF----------EAVVGDFGLAKLM 450 (621)
Q Consensus 435 ~~~----------~~kl~DfGla~~~ 450 (621)
+++ .+.|+||+-+...
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 876 3899999987653
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=8.8e-18 Score=168.44 Aligned_cols=131 Identities=24% Similarity=0.230 Sum_probs=69.7
Q ss_pred CcEEEEEcCCCC-ccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 65 NSVIRVDLGNAA-LSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 65 ~~l~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
.+|+.|+|++|. ++...+..|..+++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 80 ~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 159 (285)
T 1ozn_A 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLF 159 (285)
T ss_dssp TTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEE
Confidence 345555565554 5544455555555555555555555555555555555555555555555544444455555555555
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCc
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNL 195 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~ 195 (621)
|++|++++..+..|..+++|+.|++++|+|++..+.. ..+++|+.|++++|.
T Consensus 160 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 212 (285)
T 1ozn_A 160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212 (285)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCc
Confidence 5555555443344555555555555555555553322 444555555555553
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1.3e-17 Score=153.25 Aligned_cols=130 Identities=24% Similarity=0.258 Sum_probs=118.5
Q ss_pred CcEEEEEcCCCCcc-ccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 65 NSVIRVDLGNAALS-GQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 65 ~~l~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
.+|+.|+|++|+|+ +.+|..+..+++|++|+|++|.|++. ..|..+++|++|+|++|+|++.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 57999999999998 78888899999999999999999966 7899999999999999999987888888899999999
Q ss_pred ccccccCCCC-CCCccCCccccEEeeccCcCcccCC----CCCCCCCcccccccCCcc
Q 007020 144 LNNNSLSGPI-PMSLTNISSLQVLDLSNNRLSGVVP----DNGSFSLFTPISFANNLD 196 (621)
Q Consensus 144 l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~~----~~~~~~~l~~l~l~~N~~ 196 (621)
|++|+|++.. +..+..+++|+.|++++|+|++.++ ....+++|+.|++++|..
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~ 159 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRED 159 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCCh
Confidence 9999999643 2789999999999999999999887 458899999999999974
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.9e-17 Score=177.51 Aligned_cols=137 Identities=23% Similarity=0.234 Sum_probs=129.5
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+|+.|+|++|.+++..|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|+.|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 47999999999999999999999999999999999999988999999999999999999999888899999999999999
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcccCCCC
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDLCGPV 201 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~~~~~ 201 (621)
++|++++..|..|..+++|++|++++|+|+++++.. ..+++|+.|++++|++.|..+
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 999999888999999999999999999999988876 789999999999999988654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.1e-16 Score=148.32 Aligned_cols=114 Identities=25% Similarity=0.252 Sum_probs=104.9
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 107 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL 107 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence 58999999999999877788999999999999999999877778999999999999999999877778899999999999
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCC
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 178 (621)
++|+|++..+..+..+++|+.|++++|++.+..+
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 9999997777678899999999999999997665
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=6.7e-17 Score=151.94 Aligned_cols=124 Identities=26% Similarity=0.338 Sum_probs=111.6
Q ss_pred CCccceeeEEcCC----------CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeec
Q 007020 52 NPCTWFHVTCNND----------NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLY 121 (621)
Q Consensus 52 ~~c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 121 (621)
..|.|..+.|++. .+|+.|+|++|+|+ .+|..|..+++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 8 C~C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls 86 (193)
T 2wfh_A 8 CTCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILS 86 (193)
T ss_dssp CEEETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CEeCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECC
Confidence 3466777777542 37999999999999 677999999999999999999998888899999999999999
Q ss_pred cccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccCcCccc
Q 007020 122 LNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGV 176 (621)
Q Consensus 122 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 176 (621)
+|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++...
T Consensus 87 ~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 87 YNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 9999988888999999999999999999977777899999999999999999754
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.3e-17 Score=173.23 Aligned_cols=138 Identities=22% Similarity=0.208 Sum_probs=121.2
Q ss_pred CCCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccc
Q 007020 63 NDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFL 142 (621)
Q Consensus 63 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 142 (621)
...+|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|
T Consensus 62 ~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 141 (361)
T 2xot_A 62 RLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKL 141 (361)
T ss_dssp CCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred cccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEE
Confidence 45689999999999998888899999999999999999998888889999999999999999998888999999999999
Q ss_pred cccccccCCCCCCCc---cCCccccEEeeccCcCcccCCCC-CCCCC--cccccccCCcccCCC
Q 007020 143 RLNNNSLSGPIPMSL---TNISSLQVLDLSNNRLSGVVPDN-GSFSL--FTPISFANNLDLCGP 200 (621)
Q Consensus 143 ~l~~N~l~~~~p~~~---~~l~~L~~L~l~~N~l~~~~~~~-~~~~~--l~~l~l~~N~~~~~~ 200 (621)
+|++|+|++..+..| ..+++|+.|+|++|+|+++++.. ..++. ++.|+|++|++.|.+
T Consensus 142 ~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C 205 (361)
T 2xot_A 142 YLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDC 205 (361)
T ss_dssp ECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred ECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCc
Confidence 999999996544445 57999999999999999887543 44555 478999999999975
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=8.6e-17 Score=161.18 Aligned_cols=132 Identities=24% Similarity=0.232 Sum_probs=116.8
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeecccc-CCCCCCccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNS-FTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~ 143 (621)
.+|+.|+|++|.|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|. ++...|..|..+++|+.|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 478999999999998777889999999999999999998888899999999999999997 8866688899999999999
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcc
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLD 196 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~ 196 (621)
|++|++++..|..|..+++|+.|++++|+++++++.. ..+++|+.|++++|..
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 165 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI 165 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcc
Confidence 9999999887888999999999999999999888764 6788999999999864
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=6.2e-17 Score=161.44 Aligned_cols=132 Identities=17% Similarity=0.135 Sum_probs=119.2
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|+.|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 36999999999999888889999999999999999999888888999999999999999999887888999999999999
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCccc--CCCCCCCCCcccccccCCcc
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGV--VPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~~~l~~l~l~~N~~ 196 (621)
++|++.+..+..+..+++|+.|++++|++++. +.....+++|+.|++++|..
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l 161 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCC
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCC
Confidence 99999987777899999999999999999984 34457889999999999964
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=3.7e-17 Score=169.23 Aligned_cols=145 Identities=23% Similarity=0.274 Sum_probs=123.9
Q ss_pred CCCccceeeEEcC------------CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCcccee
Q 007020 51 VNPCTWFHVTCNN------------DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSL 118 (621)
Q Consensus 51 ~~~c~w~gv~c~~------------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 118 (621)
..+|.|.|+ |+. ..+|+.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|
T Consensus 27 ~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 27 SLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 346777766 532 2479999999999998777799999999999999999998888899999999999
Q ss_pred eeccccCCCCCCcccccccccccccccccccCCCCC-CCccCCccccEEeeccC-cCcccCCCC-CCCCCcccccccCCc
Q 007020 119 DLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIP-MSLTNISSLQVLDLSNN-RLSGVVPDN-GSFSLFTPISFANNL 195 (621)
Q Consensus 119 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N-~l~~~~~~~-~~~~~l~~l~l~~N~ 195 (621)
+|++|+|++..+..|.++++|++|+|++|++++..+ ..+..+++|+.|++++| .+.++++.. ..+++|+.|++++|.
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~ 185 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCC
Confidence 999999996555569999999999999999995444 47899999999999999 577776654 788999999999996
Q ss_pred c
Q 007020 196 D 196 (621)
Q Consensus 196 ~ 196 (621)
.
T Consensus 186 l 186 (353)
T 2z80_A 186 L 186 (353)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.3e-17 Score=150.01 Aligned_cols=127 Identities=21% Similarity=0.247 Sum_probs=114.8
Q ss_pred CcEEEEEcCCCCcc-ccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 65 NSVIRVDLGNAALS-GQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 65 ~~l~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
.+|+.|+|++|.++ +.+|..+..+++|++|+|++|+|++. ..|.++++|++|+|++|+|++.+|..+..+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 47899999999999 78899999999999999999999966 7899999999999999999987888888999999999
Q ss_pred ccccccCCC-CCCCccCCccccEEeeccCcCcccCC----CCCCCCCcccccccC
Q 007020 144 LNNNSLSGP-IPMSLTNISSLQVLDLSNNRLSGVVP----DNGSFSLFTPISFAN 193 (621)
Q Consensus 144 l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~~----~~~~~~~l~~l~l~~ 193 (621)
|++|++++. .+..+..+++|+.|++++|++++.++ ....+++|+.|++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999963 34789999999999999999999887 347788999998863
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2.7e-16 Score=156.43 Aligned_cols=132 Identities=26% Similarity=0.281 Sum_probs=120.6
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+|+.|+|++|.+++. +.+..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 62 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 62 LPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp CTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 46899999999999963 4899999999999999999988888899999999999999999988788899999999999
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCccc
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDL 197 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~ 197 (621)
|++|++++..+..|..+++|+.|++++|+|+++++.. ..+++|+.|++++|...
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 194 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK 194 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCC
Confidence 9999999887878899999999999999999988876 77899999999999753
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.67 E-value=5.2e-17 Score=164.57 Aligned_cols=133 Identities=25% Similarity=0.316 Sum_probs=94.1
Q ss_pred CCcEEEEEcCCCCccccCc-ccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCC-CCCccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLV-SQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTG-PIPDTLGKLSKLRF 141 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~ 141 (621)
..+|+.|+|++|.+++..+ ..+..+++|++|+|++|.+++..+..|.++++|++|+|++|.+++ .+|..|..+++|+.
T Consensus 100 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 179 (306)
T 2z66_A 100 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 179 (306)
T ss_dssp CTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred CCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCE
Confidence 4567777777777775544 467777777777777777776666677777777777777777765 45666777777777
Q ss_pred ccccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcc
Q 007020 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLD 196 (621)
Q Consensus 142 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~ 196 (621)
|+|++|++++..|..|..+++|+.|++++|+|++.++.. ..+++|+.|++++|..
T Consensus 180 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 235 (306)
T 2z66_A 180 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 235 (306)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCC
T ss_pred EECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCC
Confidence 777777777666677777777777777777777665533 5566777777777754
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.1e-16 Score=156.01 Aligned_cols=130 Identities=20% Similarity=0.232 Sum_probs=118.0
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCC-CCCCCcccccCCCccceeeecc-ccCCCCCCcccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNN-ITGPIPSDLGNLTSLVSLDLYL-NSFTGPIPDTLGKLSKLRFL 142 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L 142 (621)
.+|+.|+|++|+|++..+..|..+++|++|+|++|+ +++..+..|.++++|++|+|++ |+|++..+..|.++++|+.|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 479999999999998888899999999999999997 9977777999999999999999 99997777889999999999
Q ss_pred cccccccCCCCCCCccCCcccc---EEeeccC-cCcccCCCC-CCCCCcc-cccccCCcc
Q 007020 143 RLNNNSLSGPIPMSLTNISSLQ---VLDLSNN-RLSGVVPDN-GSFSLFT-PISFANNLD 196 (621)
Q Consensus 143 ~l~~N~l~~~~p~~~~~l~~L~---~L~l~~N-~l~~~~~~~-~~~~~l~-~l~l~~N~~ 196 (621)
+|++|++++ +|. |..+++|+ .|++++| +++++++.. ..+++|+ .|++++|..
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l 168 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF 168 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCC
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCC
Confidence 999999996 666 88888888 9999999 999998874 7789999 999999964
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.66 E-value=1e-16 Score=164.05 Aligned_cols=131 Identities=21% Similarity=0.356 Sum_probs=120.3
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccc--------
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGK-------- 135 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-------- 135 (621)
..+|++|+|++|.|+ .+|..++.+++|++|+|++|+|+ .+|..|.++++|++|+|++|++.+.+|..+..
T Consensus 103 l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~ 180 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180 (328)
T ss_dssp GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEE
T ss_pred CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhc
Confidence 357999999999999 88999999999999999999999 78989999999999999999988899987765
Q ss_pred -ccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCccc
Q 007020 136 -LSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDL 197 (621)
Q Consensus 136 -l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~ 197 (621)
+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++++++....+++|+.|++++|+..
T Consensus 181 ~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~ 242 (328)
T 4fcg_A 181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTAL 242 (328)
T ss_dssp ESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTC
T ss_pred cCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcch
Confidence 999999999999999 7888999999999999999999998887788999999999998754
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.6e-16 Score=176.72 Aligned_cols=133 Identities=17% Similarity=0.174 Sum_probs=122.1
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 57999999999999888889999999999999999999888999999999999999999999888999999999999999
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcc--cCCCCCCCCCcccccccCCccc
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSG--VVPDNGSFSLFTPISFANNLDL 197 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~~~l~~l~l~~N~~~ 197 (621)
++|++++..+..+.++++|++|++++|.+++ ++.....+++|+.|++++|...
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~ 166 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ 166 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCC
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcce
Confidence 9999998777889999999999999999986 3444588999999999999653
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.65 E-value=5.2e-16 Score=155.77 Aligned_cols=127 Identities=25% Similarity=0.221 Sum_probs=62.1
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 145 (621)
+++.|+|++|.|++..+..|..+++|++|+|++|+|++..+ ...+++|++|+|++|+|+ .+|..+..+++|+.|+|+
T Consensus 32 ~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~ 108 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (290)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECC
Confidence 45556666666655555555555555555555555553211 144444455555554444 344444444444444444
Q ss_pred ccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCc
Q 007020 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNL 195 (621)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~ 195 (621)
+|+|++..+..|..+++|+.|+|++|+|+++++.. ..+++|+.|++++|.
T Consensus 109 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred CCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 44444443444444444444444444444444433 334444444444443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=2.2e-16 Score=151.79 Aligned_cols=115 Identities=21% Similarity=0.204 Sum_probs=108.7
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+
T Consensus 56 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 135 (220)
T 2v70_A 56 LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLS 135 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEE
T ss_pred CCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEE
Confidence 46899999999999988888999999999999999999988888899999999999999999988899999999999999
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCC
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 178 (621)
|++|+|++..|..|..+++|+.|+|++|++.+..+
T Consensus 136 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 136 LYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99999998889999999999999999999986543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1e-16 Score=176.12 Aligned_cols=143 Identities=24% Similarity=0.263 Sum_probs=125.3
Q ss_pred CccceeeEEcCC------------CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeee
Q 007020 53 PCTWFHVTCNND------------NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDL 120 (621)
Q Consensus 53 ~c~w~gv~c~~~------------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 120 (621)
.|.|.|+ |+.. .+|+.|+|++|+|++..|..|..+++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 4888887 7532 37999999999999888899999999999999999999888899999999999999
Q ss_pred ccccCCCCCCcccccccccccccccccccCC-CCCCCccCCccccEEeeccCc-CcccCC-CCCCCCCcccccccCCcc
Q 007020 121 YLNSFTGPIPDTLGKLSKLRFLRLNNNSLSG-PIPMSLTNISSLQVLDLSNNR-LSGVVP-DNGSFSLFTPISFANNLD 196 (621)
Q Consensus 121 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~-l~~~~~-~~~~~~~l~~l~l~~N~~ 196 (621)
++|+|++..|..|+++++|++|+|++|++++ ..|..+.++++|++|++++|+ +..+++ ....+++|+.|++++|..
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l 160 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence 9999998777779999999999999999986 357789999999999999998 555554 347889999999999864
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.4e-16 Score=176.82 Aligned_cols=155 Identities=17% Similarity=0.163 Sum_probs=126.8
Q ss_pred CCCCCCCCCCCCCcc----ceeeEEcC-----------------CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeC
Q 007020 41 NVLQSWDPTLVNPCT----WFHVTCNN-----------------DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSN 99 (621)
Q Consensus 41 ~~l~~w~~~~~~~c~----w~gv~c~~-----------------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 99 (621)
..+++|.+. .+||. |.++.|.. ..+++.|++++|.++...+..|..+++|++|+|++|
T Consensus 7 ~~l~~~~~~-~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n 85 (597)
T 3oja_B 7 YNVKPRQPE-YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDL 85 (597)
T ss_dssp ----CCCSE-ECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTS
T ss_pred ccccCCCCC-CcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCC
Confidence 357788765 44552 66655531 146788999999999777777889999999999999
Q ss_pred CCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCC
Q 007020 100 NITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179 (621)
Q Consensus 100 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 179 (621)
.|++..|..|.++++|++|+|++|.|++..|..|+++++|++|+|++|.|++..+..|.++++|+.|+|++|.|+++++.
T Consensus 86 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 165 (597)
T 3oja_B 86 QIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDD 165 (597)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTT
T ss_pred CCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChh
Confidence 99988888999999999999999999988888889999999999999999966666678999999999999999998886
Q ss_pred C-CCCCCcccccccCCcc
Q 007020 180 N-GSFSLFTPISFANNLD 196 (621)
Q Consensus 180 ~-~~~~~l~~l~l~~N~~ 196 (621)
. ..+++|+.|++++|..
T Consensus 166 ~~~~l~~L~~L~L~~N~l 183 (597)
T 3oja_B 166 TFQATTSLQNLQLSSNRL 183 (597)
T ss_dssp TTTTCTTCCEEECTTSCC
T ss_pred hhhcCCcCcEEECcCCCC
Confidence 4 7889999999999864
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.65 E-value=3.4e-16 Score=150.43 Aligned_cols=126 Identities=22% Similarity=0.249 Sum_probs=114.6
Q ss_pred EEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccccccc
Q 007020 68 IRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147 (621)
Q Consensus 68 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 147 (621)
..+++++|+++ .+|..+. ++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 36999999999 5666554 79999999999999888889999999999999999999888999999999999999999
Q ss_pred ccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcc
Q 007020 148 SLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLD 196 (621)
Q Consensus 148 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~ 196 (621)
+|++..+..|..+++|+.|+|++|+|+++++.. ..+++|+.|+|++|..
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 140 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcC
Confidence 999776777899999999999999999998765 7889999999999975
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.65 E-value=4.7e-16 Score=150.45 Aligned_cols=134 Identities=21% Similarity=0.204 Sum_probs=118.8
Q ss_pred ceeeEEcCCCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccc
Q 007020 56 WFHVTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGK 135 (621)
Q Consensus 56 w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 135 (621)
|..-.|+ .+.+++++++++ .+|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|+...+..|..
T Consensus 14 ~~~~~Cs----~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~ 86 (229)
T 3e6j_A 14 PSQCSCS----GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDS 86 (229)
T ss_dssp CTTCEEE----TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred CCCCEEe----CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhccc
Confidence 4445675 346999999998 5666554 89999999999999998999999999999999999999766677899
Q ss_pred ccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 136 LSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 136 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+.++.....+++|+.|++++|..
T Consensus 87 l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l 147 (229)
T 3e6j_A 87 LTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQL 147 (229)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCC
T ss_pred CCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcC
Confidence 9999999999999998777788999999999999999998887778899999999999975
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.5e-16 Score=166.90 Aligned_cols=132 Identities=19% Similarity=0.198 Sum_probs=118.5
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+++.|++++|.++...+..|..+++|++|+|++|.|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 57889999999999766667899999999999999999888889999999999999999999888888999999999999
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcc
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLD 196 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~ 196 (621)
++|+++...+..|..+++|++|++++|+++++++.. ..+++|+.|++++|..
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 177 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL 177 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCC
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcC
Confidence 999999655556789999999999999999988764 7889999999999974
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=1.1e-16 Score=171.67 Aligned_cols=145 Identities=23% Similarity=0.323 Sum_probs=127.8
Q ss_pred CCcccee--eEEcCC---------CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCC-cccccCCCccceee
Q 007020 52 NPCTWFH--VTCNND---------NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPI-PSDLGNLTSLVSLD 119 (621)
Q Consensus 52 ~~c~w~g--v~c~~~---------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ 119 (621)
..|.|.+ |.|... .+|++|+|++|.|++..|..|.++++|++|+|++|.+.+.+ +..|.++++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 3566666 777643 47999999999999988999999999999999999998554 67799999999999
Q ss_pred eccccCCCCCCcccccccccccccccccccCCCCCCC--ccCCccccEEeeccCcCcccCCC--CCCCCCcccccccCCc
Q 007020 120 LYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMS--LTNISSLQVLDLSNNRLSGVVPD--NGSFSLFTPISFANNL 195 (621)
Q Consensus 120 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~~~--~~~~~~l~~l~l~~N~ 195 (621)
|++|++++..|..|.++++|++|+|++|++++.+|.. |..+++|++|+|++|+|++..+. ...+++|+.|++++|.
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 9999999888999999999999999999999755544 89999999999999999999776 4788999999999997
Q ss_pred c
Q 007020 196 D 196 (621)
Q Consensus 196 ~ 196 (621)
.
T Consensus 166 l 166 (455)
T 3v47_A 166 V 166 (455)
T ss_dssp B
T ss_pred c
Confidence 5
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=3.5e-16 Score=166.95 Aligned_cols=135 Identities=24% Similarity=0.256 Sum_probs=102.7
Q ss_pred CcEEEEEcCCCCccccCcccc-------------------------cCCCCCcEEEeeeCCCCCCCcccccCCCccceee
Q 007020 65 NSVIRVDLGNAALSGQLVSQL-------------------------GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLD 119 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~-------------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 119 (621)
.+|+.|+|++|.|+...+..| ..+++|++|+|++|+|+ .+| .+..+++|+.|+
T Consensus 136 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~ 213 (440)
T 3zyj_A 136 SKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELD 213 (440)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEE
T ss_pred ccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEE
Confidence 578888888887775554444 44555555556666665 333 366677777777
Q ss_pred eccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcccC
Q 007020 120 LYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDLC 198 (621)
Q Consensus 120 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~~ 198 (621)
|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+++++.. ..+++|+.|+|++||+.|
T Consensus 214 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 214 LSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred CCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence 7777777766778888888888888888888777888888899999999999999888776 678899999999999988
Q ss_pred CCC
Q 007020 199 GPV 201 (621)
Q Consensus 199 ~~~ 201 (621)
.+.
T Consensus 294 dC~ 296 (440)
T 3zyj_A 294 NCD 296 (440)
T ss_dssp SST
T ss_pred CCC
Confidence 763
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=3e-16 Score=169.32 Aligned_cols=132 Identities=18% Similarity=0.225 Sum_probs=119.6
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+++.|+|++|+|++..+..|..+++|++|+|++|.|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|
T Consensus 32 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 111 (477)
T 2id5_A 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDI 111 (477)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEEC
T ss_pred CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEEC
Confidence 47889999999999888889999999999999999999888999999999999999999999766677899999999999
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcc
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLD 196 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~ 196 (621)
++|++.+..|..|..+++|+.|++++|.++++.+.. ..+++|+.|++++|..
T Consensus 112 s~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 164 (477)
T 2id5_A 112 SENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNL 164 (477)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCC
T ss_pred CCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcC
Confidence 999999888889999999999999999999887754 7788999999999864
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1.1e-16 Score=177.98 Aligned_cols=137 Identities=20% Similarity=0.178 Sum_probs=105.4
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCC-CCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITG-PIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
.+|+.|+|++|.+++..|..+..+++|++|+|++|++++ .+|..|.++++|+.|+|++|+|++..|..|.++++|+.|+
T Consensus 424 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 503 (606)
T 3vq2_A 424 EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLN 503 (606)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred ccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEE
Confidence 467777777777777777777777777777777777776 3677777888888888888888777777788888888888
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCC-CcccccccCCcccCCCC
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFS-LFTPISFANNLDLCGPV 201 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-~l~~l~l~~N~~~~~~~ 201 (621)
|++|++++..|..|..+++|+.|++++|+|+.+++....++ +|+.|++++|++.|.+.
T Consensus 504 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 504 MSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp CCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred CCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 88888887777778888888888888888887777666665 58888888888877654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.63 E-value=3.8e-16 Score=167.29 Aligned_cols=141 Identities=22% Similarity=0.238 Sum_probs=124.0
Q ss_pred ceeeEEcCC----------CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccC
Q 007020 56 WFHVTCNND----------NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSF 125 (621)
Q Consensus 56 w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 125 (621)
|..|.|... .+++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 456777532 4799999999999999999999999999999999999988889999999999999999999
Q ss_pred CCCCCcccccccccccccccccccCCCCCCCccCCccccEEeecc-CcCcccCCCC-CCCCCcccccccCCcc
Q 007020 126 TGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSN-NRLSGVVPDN-GSFSLFTPISFANNLD 196 (621)
Q Consensus 126 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~~~~-~~~~~l~~l~l~~N~~ 196 (621)
++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|++++ |.+..+++.. ..+++|+.|++++|..
T Consensus 136 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l 208 (452)
T 3zyi_A 136 TVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI 208 (452)
T ss_dssp SBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred CccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcc
Confidence 977777899999999999999999977777899999999999998 5666665543 7788999999999864
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.2e-16 Score=178.33 Aligned_cols=174 Identities=18% Similarity=0.143 Sum_probs=112.5
Q ss_pred ccchhHHHHHHHHHhCCCC-CCCCCCCCCCCCCCccceeeEEcCC-----------------CcEEEEEcCCCCccc---
Q 007020 21 SANMEGDALHSLRSNLIDP-NNVLQSWDPTLVNPCTWFHVTCNND-----------------NSVIRVDLGNAALSG--- 79 (621)
Q Consensus 21 ~~~~~~~~l~~~~~~~~~~-~~~l~~w~~~~~~~c~w~gv~c~~~-----------------~~l~~L~L~~n~l~~--- 79 (621)
....+++++.++...+... ...-..|.......++|.+++++.. ..+..++|++|.|.+
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~~ 208 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVSTPLTPKIELFANGKDEANQALLQHKKLSQYSIDEDDD 208 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecCCccceEEeeCCCCCcchhhHhhcCccCcccccCccc
Confidence 3456677888887665321 2233457555556778887766542 123444555555443
Q ss_pred ------cCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccccccccCCCC
Q 007020 80 ------QLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPI 153 (621)
Q Consensus 80 ------~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 153 (621)
..+..|..+++|+.|+|++|.|+ .+|..+.++++|++|+|++|.|+ .+|..|.+|++|+.|+|++|+|+ .+
T Consensus 209 ~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~l 285 (727)
T 4b8c_D 209 IENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SL 285 (727)
T ss_dssp -------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SC
T ss_pred cccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-cc
Confidence 34677889999999999999999 77778889999999999999999 88999999999999999999999 78
Q ss_pred CCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCccc
Q 007020 154 PMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDL 197 (621)
Q Consensus 154 p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~ 197 (621)
|..|..|++|++|+|++|.|+.++..+..+++|+.|+|++|+..
T Consensus 286 p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~ 329 (727)
T 4b8c_D 286 PAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLE 329 (727)
T ss_dssp CSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCC
T ss_pred ChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccC
Confidence 99999999999999999999988888889999999999999864
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.9e-16 Score=181.30 Aligned_cols=133 Identities=24% Similarity=0.219 Sum_probs=89.3
Q ss_pred CcEEEEEcCCCCccccCcc-cccCCCCCcEEEeeeCCCC-----CCCcccccCCCccceeeeccccCCCCCCcccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVS-QLGLLKNLQYLELYSNNIT-----GPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSK 138 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 138 (621)
.+|+.|+|++|++++..+. .+..+++|++|+|++|.++ +..+..|.++++|+.|+|++|+|++..|..|.++++
T Consensus 426 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 505 (844)
T 3j0a_A 426 PHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTA 505 (844)
T ss_dssp TTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCS
T ss_pred CccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhh
Confidence 3555666666666543332 3444566666666666665 333445667777777777777777666666777777
Q ss_pred cccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcccCCCC
Q 007020 139 LRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPV 201 (621)
Q Consensus 139 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~~ 201 (621)
|+.|+|++|+|++..+..+. ++|+.|+|++|+|++.++.. +.+|+.+++++||+.|.+.
T Consensus 506 L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 506 LRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICECE 564 (844)
T ss_dssp CSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSS
T ss_pred hheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCcccccc
Confidence 77777777777765555554 67777777777777776643 5688999999999999654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.9e-16 Score=160.43 Aligned_cols=144 Identities=22% Similarity=0.244 Sum_probs=123.3
Q ss_pred CCccceeeEEcCC----------CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCC--CcccccCCCccceee
Q 007020 52 NPCTWFHVTCNND----------NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGP--IPSDLGNLTSLVSLD 119 (621)
Q Consensus 52 ~~c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~ 119 (621)
..|.|.+|.|+.. .+|+.|+|++|+|+...+..|..+++|++|+|++|+|+.. .+..+..+++|++|+
T Consensus 5 C~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~ 84 (306)
T 2z66_A 5 CSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84 (306)
T ss_dssp CEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEE
T ss_pred CeeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEE
Confidence 4589999999752 3799999999999966666789999999999999999833 367788899999999
Q ss_pred eccccCCCCCCcccccccccccccccccccCCCCC-CCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcc
Q 007020 120 LYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIP-MSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLD 196 (621)
Q Consensus 120 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~ 196 (621)
|++|.++ .+|..+..+++|+.|+|++|++++..+ ..+..+++|+.|++++|.+.+..+.. ..+++|+.|++++|..
T Consensus 85 Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 162 (306)
T 2z66_A 85 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 162 (306)
T ss_dssp CCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEE
T ss_pred CCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcc
Confidence 9999998 577778999999999999999986554 57889999999999999999887765 6788999999999875
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=2.4e-16 Score=175.98 Aligned_cols=138 Identities=22% Similarity=0.265 Sum_probs=126.5
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCC-CCCcccccCCCccceeeeccccCCCCCCcccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNIT-GPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFL 142 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 142 (621)
..+++.++++.|.+++..+..+..+++|+.|+|++|++. +..|..|..+++|+.|+|++|+|++..|..|.++++|+.|
T Consensus 444 l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L 523 (635)
T 4g8a_A 444 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 523 (635)
T ss_dssp CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEE
Confidence 357889999999999999999999999999999999754 4678899999999999999999999889999999999999
Q ss_pred cccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCC-CCcccccccCCcccCCCC
Q 007020 143 RLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSF-SLFTPISFANNLDLCGPV 201 (621)
Q Consensus 143 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~-~~l~~l~l~~N~~~~~~~ 201 (621)
+|++|+|++..|..|..+++|+.|+|++|+|+++++.. ..+ ++|+.|++++||+.|.+.
T Consensus 524 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 524 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp ECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred ECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 99999999888889999999999999999999998876 555 689999999999999763
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.5e-16 Score=160.42 Aligned_cols=141 Identities=21% Similarity=0.204 Sum_probs=107.7
Q ss_pred ceeeEEcCCCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccc-cCCCccceeeeccccCCCCCCcccc
Q 007020 56 WFHVTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDL-GNLTSLVSLDLYLNSFTGPIPDTLG 134 (621)
Q Consensus 56 w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~~ 134 (621)
..++.+....+|+.|+|++|+|++..+..+..+++|++|+|++|+|++..+..+ ..+++|++|+|++|+|++. +. ..
T Consensus 111 l~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~ 188 (317)
T 3o53_A 111 ISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QV 188 (317)
T ss_dssp CSEEEECCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CC
T ss_pred cCCcCccccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-cc
Confidence 334444445667888888888887777788888888888888888887666666 4688888888888888844 33 33
Q ss_pred cccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcccCC
Q 007020 135 KLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCG 199 (621)
Q Consensus 135 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~ 199 (621)
.+++|+.|+|++|+|++ +|..+..+++|+.|++++|+|++++.....+++|+.|++++|++.|+
T Consensus 189 ~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 189 VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp CCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCCBHH
T ss_pred ccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCcccchhhHhhcCCCCCEEEccCCCccCc
Confidence 58888888888888884 45558888888888888888888777677788888888888887764
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=7.8e-16 Score=153.40 Aligned_cols=136 Identities=20% Similarity=0.239 Sum_probs=94.3
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCC-CCccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGP-IPDTLGKLSKLRFLR 143 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~ 143 (621)
.+|+.|+|++|.|++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|+|++. +|..|..+++|+.|+
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~ 155 (276)
T 2z62_A 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD 155 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEE
T ss_pred cCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEE
Confidence 5677778877777776667777777777777777777766665677777777777777777753 467777777777777
Q ss_pred ccccccCCCCCCCccCC---------------------------ccccEEeeccCcCcccCCCC-CCCCCcccccccCCc
Q 007020 144 LNNNSLSGPIPMSLTNI---------------------------SSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNL 195 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l---------------------------~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~ 195 (621)
|++|++++..+..+..+ .+|+.|++++|+|+++++.. ..+++|+.|++++|+
T Consensus 156 Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 235 (276)
T 2z62_A 156 LSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 235 (276)
T ss_dssp CCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSC
T ss_pred CCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCc
Confidence 77777765444333332 35667777777777666654 556777777777777
Q ss_pred ccCCC
Q 007020 196 DLCGP 200 (621)
Q Consensus 196 ~~~~~ 200 (621)
+.|.+
T Consensus 236 ~~c~c 240 (276)
T 2z62_A 236 WDCSC 240 (276)
T ss_dssp BCCCT
T ss_pred ccccC
Confidence 76654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.62 E-value=7.2e-16 Score=146.78 Aligned_cols=127 Identities=24% Similarity=0.225 Sum_probs=114.6
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 130 (208)
T 2o6s_A 51 LTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLR 130 (208)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEE
Confidence 46899999999999987777889999999999999999987777899999999999999999977777799999999999
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
|++|++++..+..|..+++|+.|++++|.+.+. +++|+.|+++.|..
T Consensus 131 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~------~~~l~~L~~~~n~~ 177 (208)
T 2o6s_A 131 LYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT------CPGIRYLSEWINKH 177 (208)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC------TTTTHHHHHHHHHC
T ss_pred CCCCccceeCHHHhccCCCccEEEecCCCeecC------CCCHHHHHHHHHhC
Confidence 999999987777799999999999999988754 45788999988864
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.62 E-value=6.7e-16 Score=165.38 Aligned_cols=136 Identities=25% Similarity=0.263 Sum_probs=109.6
Q ss_pred CCcEEEEEcCCCCccccCccc-------------------------ccCCCCCcEEEeeeCCCCCCCcccccCCCcccee
Q 007020 64 DNSVIRVDLGNAALSGQLVSQ-------------------------LGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSL 118 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~-------------------------~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 118 (621)
..+|+.|+|++|.|+...+.. |..+++|++|+|++|+|++ +| .+..+++|+.|
T Consensus 146 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L 223 (452)
T 3zyi_A 146 LSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEEL 223 (452)
T ss_dssp CTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEE
T ss_pred cCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEE
Confidence 357888999888887655444 4455666666666666663 33 46777788888
Q ss_pred eeccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCccc
Q 007020 119 DLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDL 197 (621)
Q Consensus 119 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~ 197 (621)
+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+++++.. ..+++|+.|+|++|++.
T Consensus 224 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp ECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred ECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 88888888777888999999999999999999888888999999999999999999888876 67899999999999999
Q ss_pred CCCC
Q 007020 198 CGPV 201 (621)
Q Consensus 198 ~~~~ 201 (621)
|.+.
T Consensus 304 CdC~ 307 (452)
T 3zyi_A 304 CDCD 307 (452)
T ss_dssp CSTT
T ss_pred CCCC
Confidence 8764
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.61 E-value=3.2e-16 Score=145.01 Aligned_cols=128 Identities=19% Similarity=0.109 Sum_probs=111.0
Q ss_pred CCcEEEEEcCCCCccccCcccccCCC-CCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLK-NLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFL 142 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 142 (621)
..+|+.|+|++|+|+. ++. +..+. +|++|+|++|+|++. ..|..+++|++|+|++|+|++..+..|..+++|+.|
T Consensus 18 ~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 18 AVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 93 (176)
T ss_dssp TTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred cCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEE
Confidence 4579999999999995 454 55554 999999999999965 689999999999999999996655666999999999
Q ss_pred cccccccCCCCCC--CccCCccccEEeeccCcCcccCCC----CCCCCCcccccccCCcc
Q 007020 143 RLNNNSLSGPIPM--SLTNISSLQVLDLSNNRLSGVVPD----NGSFSLFTPISFANNLD 196 (621)
Q Consensus 143 ~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~~~----~~~~~~l~~l~l~~N~~ 196 (621)
+|++|+|. .+|. .+..+++|+.|++++|+++..+.. ...+++|+.|++++|..
T Consensus 94 ~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 94 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred ECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCH
Confidence 99999997 5666 788999999999999999987764 57789999999999864
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=7.2e-16 Score=171.50 Aligned_cols=133 Identities=21% Similarity=0.174 Sum_probs=123.2
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+++.|+|++|.|++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 47999999999999988999999999999999999999989999999999999999999999888999999999999999
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccC-CCCCCCCCcccccccCCccc
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVV-PDNGSFSLFTPISFANNLDL 197 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~~~l~~l~l~~N~~~ 197 (621)
++|++++..|..+.++++|++|++++|+++++. +....+++|+.|++++|...
T Consensus 113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 166 (606)
T 3t6q_A 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH 166 (606)
T ss_dssp TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCC
T ss_pred cccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCccc
Confidence 999999777888999999999999999999864 44556899999999999753
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.3e-15 Score=162.62 Aligned_cols=141 Identities=25% Similarity=0.278 Sum_probs=119.2
Q ss_pred ceeeEEcC----------CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccC
Q 007020 56 WFHVTCNN----------DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSF 125 (621)
Q Consensus 56 w~gv~c~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 125 (621)
|..|.|.. ..+++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 45677753 24688999999999988889999999999999999999988888999999999999999999
Q ss_pred CCCCCcccccccccccccccccccCCCCCCCccCCccccEEeecc-CcCcccCCCC-CCCCCcccccccCCcc
Q 007020 126 TGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSN-NRLSGVVPDN-GSFSLFTPISFANNLD 196 (621)
Q Consensus 126 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~~~~-~~~~~l~~l~l~~N~~ 196 (621)
++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|++++ |.+..+++.. ..+++|+.|++++|..
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l 197 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL 197 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCC
T ss_pred CeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcC
Confidence 976677899999999999999999977777888889999999988 4555555543 6788888888888864
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.60 E-value=5.2e-16 Score=146.44 Aligned_cols=126 Identities=18% Similarity=0.286 Sum_probs=80.4
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+|+.|+|++|.++. ++.+..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..|..+..+++|+.|+|
T Consensus 66 ~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L 143 (197)
T 4ezg_A 66 HNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143 (197)
T ss_dssp TTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEEC
T ss_pred CCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEc
Confidence 456666666665542 235666667777777777766555666666677777777777766555666666677777777
Q ss_pred cccc-cCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCc
Q 007020 145 NNNS-LSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNL 195 (621)
Q Consensus 145 ~~N~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~ 195 (621)
++|. +. .+| .+..+++|+.|++++|+|++++ ....+++|+.|++++|+
T Consensus 144 ~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 144 SYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYR-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp CSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCT-TGGGCSSCCEEEECBC-
T ss_pred cCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChH-HhccCCCCCEEEeeCcc
Confidence 7776 44 344 4666666777777777766644 44556666777776665
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.60 E-value=2.9e-15 Score=137.71 Aligned_cols=109 Identities=31% Similarity=0.332 Sum_probs=97.3
Q ss_pred EEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccccccc
Q 007020 68 IRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147 (621)
Q Consensus 68 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 147 (621)
+.|++++|+|+. +|..+ .++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 12 ~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 468899999994 66655 389999999999999888999999999999999999999777778899999999999999
Q ss_pred ccCCCCCCCccCCccccEEeeccCcCcccCCC
Q 007020 148 SLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179 (621)
Q Consensus 148 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 179 (621)
+|++..+..|..+++|+.|+|++|++....+.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~ 120 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD 120 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence 99987777899999999999999999876653
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=9.4e-16 Score=177.01 Aligned_cols=142 Identities=28% Similarity=0.278 Sum_probs=123.6
Q ss_pred ccceeeEEcCCCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCC-cccccCCCccceeeeccccCCCCCCcc
Q 007020 54 CTWFHVTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPI-PSDLGNLTSLVSLDLYLNSFTGPIPDT 132 (621)
Q Consensus 54 c~w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~ 132 (621)
|.|..|.+ -..+|+.|||++|.|++..+..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|+|++..|+.
T Consensus 14 ~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~ 92 (844)
T 3j0a_A 14 CNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA 92 (844)
T ss_dssp CCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS
T ss_pred CCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH
Confidence 45666766 5578999999999999888999999999999999999666555 788999999999999999999888999
Q ss_pred cccccccccccccccccCCCCCCC--ccCCccccEEeeccCcCcccCCC--CCCCCCcccccccCCcc
Q 007020 133 LGKLSKLRFLRLNNNSLSGPIPMS--LTNISSLQVLDLSNNRLSGVVPD--NGSFSLFTPISFANNLD 196 (621)
Q Consensus 133 ~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~~~--~~~~~~l~~l~l~~N~~ 196 (621)
|.++++|++|+|++|.+++.+|.. |.++++|+.|+|++|.+++..+. ...+++|+.|++++|..
T Consensus 93 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i 160 (844)
T 3j0a_A 93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI 160 (844)
T ss_dssp SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCC
T ss_pred ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcC
Confidence 999999999999999999866665 88999999999999999987653 47889999999999865
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=2.3e-15 Score=169.84 Aligned_cols=132 Identities=21% Similarity=0.183 Sum_probs=116.6
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+|+.|+|++|.|++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 47899999999999888888999999999999999999888989999999999999999999655567999999999999
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcc
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLD 196 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~ 196 (621)
++|++++..|..|.++++|++|++++|.+++.++.. ..+++|+.|++++|..
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 157 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKI 157 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCC
T ss_pred CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcc
Confidence 999999777788999999999999999999887764 6788999999998864
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.59 E-value=3.1e-15 Score=153.32 Aligned_cols=141 Identities=20% Similarity=0.258 Sum_probs=122.7
Q ss_pred CCccceeeEEcCC----------CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeec
Q 007020 52 NPCTWFHVTCNND----------NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLY 121 (621)
Q Consensus 52 ~~c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 121 (621)
..|.|..+.|... .+|+.|+|++|.|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 31 c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 31 CHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp CEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred CcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 3478999999642 379999999999998888899999999999999999998889999999999999999
Q ss_pred cccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcc--cCCCC-CCCCCcccccccCCcc
Q 007020 122 LNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSG--VVPDN-GSFSLFTPISFANNLD 196 (621)
Q Consensus 122 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~~~~-~~~~~l~~l~l~~N~~ 196 (621)
+|+|+ .+|..+. ++|++|+|++|++++..+..|..+++|+.|++++|.++. ..+.. ..+ +|+.|++++|..
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l 184 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKL 184 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBC
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCC
Confidence 99999 6666654 899999999999997777779999999999999999974 44443 444 899999999974
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.3e-15 Score=168.09 Aligned_cols=136 Identities=26% Similarity=0.349 Sum_probs=92.7
Q ss_pred CcEEEEEcCCCCccccCc-ccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCC-CCCCcccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLV-SQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFT-GPIPDTLGKLSKLRFL 142 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L 142 (621)
.+|+.|+|++|.+++..+ ..+..+++|++|+|++|.+++..|..|.++++|+.|+|++|.++ +.+|..|..+++|+.|
T Consensus 396 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L 475 (570)
T 2z63_A 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475 (570)
T ss_dssp TTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEE
Confidence 355556666666655444 35666667777777777776666666777777777777777766 4566677777777777
Q ss_pred cccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcccCCC
Q 007020 143 RLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDLCGP 200 (621)
Q Consensus 143 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~~~~ 200 (621)
+|++|++++..|..|..+++|+.|++++|+|++.++.. ..+++|+.|++++|++.|..
T Consensus 476 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 534 (570)
T 2z63_A 476 DLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 534 (570)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred ECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCC
Confidence 77777777666777777777777777777777776654 56677777777777766643
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.58 E-value=4.4e-15 Score=136.96 Aligned_cols=109 Identities=28% Similarity=0.266 Sum_probs=96.7
Q ss_pred EEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccccccc
Q 007020 68 IRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147 (621)
Q Consensus 68 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 147 (621)
+.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 56999999998 5676664 89999999999999888999999999999999999999766667899999999999999
Q ss_pred ccCCCCCCCccCCccccEEeeccCcCcccCCC
Q 007020 148 SLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179 (621)
Q Consensus 148 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 179 (621)
+|++..+..|..+++|+.|+|++|+|...+..
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~ 123 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECRD 123 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBGG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccccccc
Confidence 99976666799999999999999999876653
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.1e-15 Score=144.31 Aligned_cols=128 Identities=16% Similarity=0.256 Sum_probs=114.7
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+|+.|+|++|.|+ .+| .+..+++|++|+|++|.++ .+ ..+..+++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 43 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 118 (197)
T 4ezg_A 43 MNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118 (197)
T ss_dssp HHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-CC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred cCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-cc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence 357999999999999 455 6999999999999999887 33 4899999999999999999987888999999999999
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCc-CcccCCCCCCCCCcccccccCCcc
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNR-LSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
|++|++++..|..+..+++|+.|++++|+ ++.++ ....+++|+.|++++|..
T Consensus 119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i 171 (197)
T 4ezg_A 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGV 171 (197)
T ss_dssp CCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCC
T ss_pred ecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCC
Confidence 99999998788889999999999999998 77664 567889999999999964
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.58 E-value=4e-15 Score=163.93 Aligned_cols=137 Identities=26% Similarity=0.319 Sum_probs=89.7
Q ss_pred CCCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCC--CcccccCCCccceeeeccccCCCCCCc-cccccccc
Q 007020 63 NDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGP--IPSDLGNLTSLVSLDLYLNSFTGPIPD-TLGKLSKL 139 (621)
Q Consensus 63 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L 139 (621)
...+|+.|+|++|.+++.+|..+..+++|++|+|++|+|++. +|..|.++++|+.|+|++|++++.+|. .+..+++|
T Consensus 351 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L 430 (562)
T 3a79_B 351 SPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI 430 (562)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTC
T ss_pred CCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccC
Confidence 446788888888888887888888888888888888888853 245678888888888888888864544 35555555
Q ss_pred ccccccccccCC---------------------CCCCCccCCccccEEeeccCcCcccCCC-CCCCCCcccccccCCccc
Q 007020 140 RFLRLNNNSLSG---------------------PIPMSLTNISSLQVLDLSNNRLSGVVPD-NGSFSLFTPISFANNLDL 197 (621)
Q Consensus 140 ~~L~l~~N~l~~---------------------~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~ 197 (621)
+.|+|++|++++ .+|..+..+++|+.|+|++|+|+++++. ...+++|+.|++++|++.
T Consensus 431 ~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~ 510 (562)
T 3a79_B 431 LVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWD 510 (562)
T ss_dssp CEEECCSSCCCGGGGSSCCTTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBC
T ss_pred CEEECCCCCCCcchhhhhcCcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcC
Confidence 555555555443 3444444555556666666665555554 345555556666666555
Q ss_pred CC
Q 007020 198 CG 199 (621)
Q Consensus 198 ~~ 199 (621)
|.
T Consensus 511 c~ 512 (562)
T 3a79_B 511 CT 512 (562)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.57 E-value=4.4e-15 Score=136.43 Aligned_cols=108 Identities=23% Similarity=0.307 Sum_probs=98.1
Q ss_pred CCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeec
Q 007020 90 NLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLS 169 (621)
Q Consensus 90 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 169 (621)
..+.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|+
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 3578999999999 5776663 899999999999998889999999999999999999998777788999999999999
Q ss_pred cCcCcccCCCC-CCCCCcccccccCCcccCCC
Q 007020 170 NNRLSGVVPDN-GSFSLFTPISFANNLDLCGP 200 (621)
Q Consensus 170 ~N~l~~~~~~~-~~~~~l~~l~l~~N~~~~~~ 200 (621)
+|+|+++++.. ..+++|+.|+|++|++.|.+
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 99999999874 78999999999999998865
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=1.9e-15 Score=170.56 Aligned_cols=137 Identities=25% Similarity=0.261 Sum_probs=104.9
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCc--------ccccCCCccceeeeccccCCCCCCcccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIP--------SDLGNLTSLVSLDLYLNSFTGPIPDTLGKL 136 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p--------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 136 (621)
.+|+.|+|++|+|++..+..|..+++|++|+|++|++++..+ ..|.++++|+.|+|++|+|+...+..|.++
T Consensus 480 ~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l 559 (680)
T 1ziw_A 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL 559 (680)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred CCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccc
Confidence 467788888888887667777888888888888888774321 236778888888888888884444568888
Q ss_pred cccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-C-CCCCcccccccCCcccCCCC
Q 007020 137 SKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-G-SFSLFTPISFANNLDLCGPV 201 (621)
Q Consensus 137 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~-~~~~l~~l~l~~N~~~~~~~ 201 (621)
++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+++++.. . .+++|+.+++++||+.|.+.
T Consensus 560 ~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred cCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 88888888888888666666788888888888888888877654 2 57788899999999988754
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.57 E-value=2.3e-15 Score=146.64 Aligned_cols=130 Identities=18% Similarity=0.182 Sum_probs=116.5
Q ss_pred CCcEEEEEcCCCC-ccccCcccccCCCCCcEEEeee-CCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccc-
Q 007020 64 DNSVIRVDLGNAA-LSGQLVSQLGLLKNLQYLELYS-NNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLR- 140 (621)
Q Consensus 64 ~~~l~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~- 140 (621)
..+|+.|+|++|. ++...+..|..+++|++|+|++ |+|++..+..|.++++|++|+|++|+|++ +|. |..+++|+
T Consensus 54 l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~ 131 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDI 131 (239)
T ss_dssp CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCS
T ss_pred CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccc
Confidence 4689999999997 9877777999999999999999 99997777889999999999999999995 676 88888888
Q ss_pred --ccccccc-ccCCCCCCCccCCcccc-EEeeccCcCcccCCCCCCCCCcccccccCCc
Q 007020 141 --FLRLNNN-SLSGPIPMSLTNISSLQ-VLDLSNNRLSGVVPDNGSFSLFTPISFANNL 195 (621)
Q Consensus 141 --~L~l~~N-~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~ 195 (621)
.|+|++| ++++..+..|..+++|+ .|++++|+|+.+++.....++|+.|++++|+
T Consensus 132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~ 190 (239)
T 2xwt_C 132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNK 190 (239)
T ss_dssp EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCT
T ss_pred ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCC
Confidence 9999999 99977777899999999 9999999999887776555889999999995
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.8e-15 Score=163.25 Aligned_cols=133 Identities=18% Similarity=0.158 Sum_probs=122.2
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+|+.|+|++|.|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+
T Consensus 55 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 134 (477)
T 2id5_A 55 FPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE 134 (477)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEE
Confidence 46899999999999998899999999999999999999977777899999999999999999988889999999999999
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcc
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLD 196 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~ 196 (621)
|++|.+.+..+..|..+++|+.|++++|+++++++.. ..+++|+.|++++|..
T Consensus 135 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i 188 (477)
T 2id5_A 135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNI 188 (477)
T ss_dssp ECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCC
T ss_pred CCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcC
Confidence 9999999888889999999999999999999887653 7788999999999864
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=3e-15 Score=163.28 Aligned_cols=137 Identities=23% Similarity=0.282 Sum_probs=89.8
Q ss_pred CCCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCC--CCcccccCCCccceeeeccccCCCCCCcc-ccccccc
Q 007020 63 NDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITG--PIPSDLGNLTSLVSLDLYLNSFTGPIPDT-LGKLSKL 139 (621)
Q Consensus 63 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L 139 (621)
...+|+.|+|++|.+++.+|..+..+++|++|+|++|+|++ .+|..|.++++|++|+|++|++++.+|.. +..+++|
T Consensus 322 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L 401 (520)
T 2z7x_B 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401 (520)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTC
T ss_pred hCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccC
Confidence 34578888888888887777788888888888888888875 44566778888888888888887645543 5555555
Q ss_pred ccccccccccCC---------------------CCCCCccCCccccEEeeccCcCcccCCC-CCCCCCcccccccCCccc
Q 007020 140 RFLRLNNNSLSG---------------------PIPMSLTNISSLQVLDLSNNRLSGVVPD-NGSFSLFTPISFANNLDL 197 (621)
Q Consensus 140 ~~L~l~~N~l~~---------------------~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~ 197 (621)
+.|+|++|++++ .+|..+..+++|+.|++++|+|+++++. ...+++|+.|++++|++.
T Consensus 402 ~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~ 481 (520)
T 2z7x_B 402 LSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481 (520)
T ss_dssp CEEECCSSCCCGGGGGSCCTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CEEECcCCCCCcchhhhhcccCCEEECCCCcccccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCc
Confidence 555555554443 4444445566666666666666655554 345556666666666655
Q ss_pred CC
Q 007020 198 CG 199 (621)
Q Consensus 198 ~~ 199 (621)
|.
T Consensus 482 c~ 483 (520)
T 2z7x_B 482 CS 483 (520)
T ss_dssp CC
T ss_pred cc
Confidence 53
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=2.8e-15 Score=164.18 Aligned_cols=121 Identities=24% Similarity=0.261 Sum_probs=108.7
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 145 (621)
.|+.|+|++|+|++ +|. |+.+++|++|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .|+.+++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 47889999999996 565 999999999999999999 889999999999999999999996 67 89999999999999
Q ss_pred ccccCCCC-CCCccCCccccEEeeccCcCcccCCCCC----CCCCcccccc
Q 007020 146 NNSLSGPI-PMSLTNISSLQVLDLSNNRLSGVVPDNG----SFSLFTPISF 191 (621)
Q Consensus 146 ~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~~~~~----~~~~l~~l~l 191 (621)
+|+|++.. |..|..+++|+.|+|++|+|++.++... .+++|+.|++
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 99999876 9999999999999999999999988653 2677777753
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=2.7e-15 Score=155.13 Aligned_cols=133 Identities=18% Similarity=0.205 Sum_probs=118.7
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCC-cccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP-DTLGKLSKLRFL 142 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L 142 (621)
..+|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+ ..|..+++|+.|
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L 154 (353)
T 2z80_A 75 CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQIL 154 (353)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred CCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEE
Confidence 4689999999999998888999999999999999999997666669999999999999999995433 479999999999
Q ss_pred ccccc-ccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcc
Q 007020 143 RLNNN-SLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLD 196 (621)
Q Consensus 143 ~l~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~ 196 (621)
+|++| .+.+..+..|..+++|+.|++++|++++..+.. ..+++|+.|++++|..
T Consensus 155 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l 210 (353)
T 2z80_A 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210 (353)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCS
T ss_pred ECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcc
Confidence 99999 577666788999999999999999999986654 7889999999999863
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=3.2e-15 Score=153.02 Aligned_cols=142 Identities=22% Similarity=0.296 Sum_probs=123.5
Q ss_pred CCccceeeEEcCC----------CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeec
Q 007020 52 NPCTWFHVTCNND----------NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLY 121 (621)
Q Consensus 52 ~~c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 121 (621)
..|.|+.+.|... .+++.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 29 c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 29 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp CEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 4578999999642 478999999999998888899999999999999999998889999999999999999
Q ss_pred cccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcc--cCCC-CCCCCCcccccccCCcc
Q 007020 122 LNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSG--VVPD-NGSFSLFTPISFANNLD 196 (621)
Q Consensus 122 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~~~-~~~~~~l~~l~l~~N~~ 196 (621)
+|+|+ .+|..+. ++|+.|++++|++++..+..|..+++|+.|++++|.++. ..+. ...+++|+.|++++|..
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l 183 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcc
Confidence 99999 5666554 799999999999997777778999999999999999974 3333 36788999999999864
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.56 E-value=7.5e-15 Score=135.39 Aligned_cols=107 Identities=22% Similarity=0.252 Sum_probs=97.1
Q ss_pred CcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeecc
Q 007020 91 LQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSN 170 (621)
Q Consensus 91 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 170 (621)
-+.+++++|+|+ .+|..+. ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 378999999998 6777664 8999999999999988899999999999999999999977677789999999999999
Q ss_pred CcCcccCCC-CCCCCCcccccccCCcccCCC
Q 007020 171 NRLSGVVPD-NGSFSLFTPISFANNLDLCGP 200 (621)
Q Consensus 171 N~l~~~~~~-~~~~~~l~~l~l~~N~~~~~~ 200 (621)
|+|+++++. ...+++|+.|+|++|++.|.+
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred CccceeCHHHhccccCCCEEEeCCCCccccc
Confidence 999999987 478999999999999998764
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=1.1e-15 Score=170.04 Aligned_cols=135 Identities=20% Similarity=0.218 Sum_probs=76.9
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCC---CcccccCCCccceeeeccccCCCCCCccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGP---IPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 141 (621)
.+|+.|+|++|.+++..|..+..+++|++|+|++|++++. .+..|..+++|+.|+|++|++++..|..|..+++|+.
T Consensus 425 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 504 (606)
T 3t6q_A 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNH 504 (606)
T ss_dssp TTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred ccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCE
Confidence 3455555555555555555555555555555555555531 2234555555555555555555555555556666666
Q ss_pred ccccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcccCCC
Q 007020 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDLCGP 200 (621)
Q Consensus 142 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~~~~ 200 (621)
|+|++|++++..|..+..+++| .|++++|++++.++.. ..+++|+.|++++|++.|.+
T Consensus 505 L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 505 VDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC 563 (606)
T ss_dssp EECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred EECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence 6666666655555556666666 6666666666555543 44566667777777766643
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=3e-15 Score=165.16 Aligned_cols=132 Identities=17% Similarity=0.135 Sum_probs=115.5
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+++.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 46889999999999888888999999999999999999888888999999999999999999777788999999999999
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCccc--CCCCCCCCCcccccccCCcc
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGV--VPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~~~l~~l~l~~N~~ 196 (621)
++|++++..+..+.++++|++|++++|.++++ +.....+++|+.|++++|..
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l 161 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCcc
Confidence 99999976666789999999999999999874 44457788999999999864
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.56 E-value=7.1e-15 Score=154.19 Aligned_cols=130 Identities=23% Similarity=0.172 Sum_probs=118.5
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+|+.|+|++|.|++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|+|+...+..|.++++|++|+|
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEEC
Confidence 58999999999999888889999999999999999999888889999999999999999999555555799999999999
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
++|++++..|..|..+++|+.|++++|++++.+ ...+++|+.|++++|..
T Consensus 149 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~l~~L~~L~l~~n~l 198 (390)
T 3o6n_A 149 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNLL 198 (390)
T ss_dssp CSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC--GGGCTTCSEEECCSSCC
T ss_pred CCCccCccChhhccCCCCCCEEECCCCcCCccc--cccccccceeecccccc
Confidence 999999888888999999999999999999874 45678899999998853
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.56 E-value=6.5e-15 Score=163.33 Aligned_cols=131 Identities=23% Similarity=0.160 Sum_probs=120.0
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+|+.|+|++|.|++..+..|..+++|++|+|++|.|++..|..|+++++|++|+|++|.|++..+..|.++++|++|+
T Consensus 74 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 153 (597)
T 3oja_B 74 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 153 (597)
T ss_dssp CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE
Confidence 35899999999999998888999999999999999999998888999999999999999999976666689999999999
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
|++|.|++..|..|..+++|+.|+|++|.|++.+ ...+++|+.|++++|..
T Consensus 154 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~l~~L~~L~l~~n~l 204 (597)
T 3oja_B 154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNLL 204 (597)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC--GGGCTTCSEEECCSSCC
T ss_pred eeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC--hhhhhhhhhhhcccCcc
Confidence 9999999988989999999999999999999874 35678888899888854
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.55 E-value=5.6e-16 Score=157.41 Aligned_cols=129 Identities=19% Similarity=0.178 Sum_probs=61.7
Q ss_pred cEEEEEcCCCCccccCcccc--cCCCCCcEEEeeeCCCCCCCcccccCC-----CccceeeeccccCCCCCCcccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQL--GLLKNLQYLELYSNNITGPIPSDLGNL-----TSLVSLDLYLNSFTGPIPDTLGKLSK 138 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~ 138 (621)
+|+.|+|++|+|++.+|..+ ..+++|++|+|++|+|++. |..+..+ ++|++|+|++|+|++..|..|..+++
T Consensus 96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 45555555555555444443 4555555555555555543 4444444 55555555555555444455555555
Q ss_pred cccccccccccCCC--CCCCc--cCCccccEEeeccCcCcccCC---CC-CCCCCcccccccCCc
Q 007020 139 LRFLRLNNNSLSGP--IPMSL--TNISSLQVLDLSNNRLSGVVP---DN-GSFSLFTPISFANNL 195 (621)
Q Consensus 139 L~~L~l~~N~l~~~--~p~~~--~~l~~L~~L~l~~N~l~~~~~---~~-~~~~~l~~l~l~~N~ 195 (621)
|+.|+|++|++.+. .|..+ ..+++|+.|++++|+|++.+. .. ..+++|+.|++++|.
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~ 239 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNS 239 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSC
T ss_pred CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCc
Confidence 55555555554432 11112 444555555555555542211 11 233455555555554
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.4e-14 Score=148.36 Aligned_cols=130 Identities=24% Similarity=0.271 Sum_probs=63.5
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCC--CCCcccccCC--------------------Cccceeeeccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNIT--GPIPSDLGNL--------------------TSLVSLDLYLN 123 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l--------------------~~L~~L~L~~N 123 (621)
+|+.|+|++|.|++..+..|..+++|++|+|++|.++ +..+..|..+ ++|+.|+|++|
T Consensus 124 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n 203 (332)
T 2ft3_A 124 SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHN 203 (332)
T ss_dssp TCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCSS
T ss_pred cCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCCC
Confidence 3444444444444433444555555555555555553 2334444333 23333444444
Q ss_pred cCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCc
Q 007020 124 SFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNL 195 (621)
Q Consensus 124 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~ 195 (621)
+|++..+..|..+++|+.|+|++|++++..+..+..+++|+.|++++|+|+.++.....+++|+.|++++|+
T Consensus 204 ~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~ 275 (332)
T 2ft3_A 204 KIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNN 275 (332)
T ss_dssp CCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGCTTCCEEECCSSC
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChhhhcCccCCEEECCCCC
Confidence 444333344555555555555555555444444555555555555555555444444445555555555554
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=3.7e-15 Score=151.15 Aligned_cols=129 Identities=18% Similarity=0.128 Sum_probs=76.6
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCC--C--cccccCCCccceeeeccccCCCCCCc----ccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGP--I--PSDLGNLTSLVSLDLYLNSFTGPIPD----TLGKL 136 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l 136 (621)
.+|+.|+|++|+|++..+..|..+++|++|+|++|++.+. + +..+.++++|++|+|++|+|+ .++. .+..+
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcC
Confidence 3566666666666665556666666666666666665531 1 122355666666666666665 2333 23556
Q ss_pred cccccccccccccCCCCCCCccCC---ccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 137 SKLRFLRLNNNSLSGPIPMSLTNI---SSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 137 ~~L~~L~l~~N~l~~~~p~~~~~l---~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
++|++|+|++|+|++..|..+..+ ++|+.|+|++|+|+.++.... ++|+.|++++|..
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~--~~L~~L~Ls~N~l 284 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPKGLP--AKLRVLDLSSNRL 284 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCSCCC--SCCSCEECCSCCC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhhhhc--CCCCEEECCCCcC
Confidence 666666666666666556555555 466666676666665544332 5666666666653
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.54 E-value=2.4e-15 Score=152.79 Aligned_cols=132 Identities=21% Similarity=0.182 Sum_probs=90.2
Q ss_pred CCcEEEEEcCCCCccccCcccccCC-----CCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCC--CCccc--c
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLL-----KNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGP--IPDTL--G 134 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~--~ 134 (621)
..+|+.|+|++|+|++. |..+..+ ++|++|+|++|+|++..|..|.++++|++|+|++|++.+. ++..+ .
T Consensus 120 l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp SCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 45677888888888766 6666666 7788888888888777777778888888888888876643 22333 6
Q ss_pred cccccccccccccccCCC--CC-CCccCCccccEEeeccCcCcccCC--CCCCCCCcccccccCCcc
Q 007020 135 KLSKLRFLRLNNNSLSGP--IP-MSLTNISSLQVLDLSNNRLSGVVP--DNGSFSLFTPISFANNLD 196 (621)
Q Consensus 135 ~l~~L~~L~l~~N~l~~~--~p-~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~~l~~l~l~~N~~ 196 (621)
.+++|+.|+|++|+|++. ++ ..+..+++|+.|++++|+|++.++ ....+++|+.|++++|..
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l 265 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL 265 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCC
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCcc
Confidence 777777777777777621 11 223456777777777777777653 224466777777777764
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.5e-15 Score=169.47 Aligned_cols=143 Identities=22% Similarity=0.321 Sum_probs=125.0
Q ss_pred ccceeeEE--cCCCcEEEEEcCCCCcccc-----------------Cccccc--CCCCCcEEEeeeCCCCCCCcccccCC
Q 007020 54 CTWFHVTC--NNDNSVIRVDLGNAALSGQ-----------------LVSQLG--LLKNLQYLELYSNNITGPIPSDLGNL 112 (621)
Q Consensus 54 c~w~gv~c--~~~~~l~~L~L~~n~l~~~-----------------~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l 112 (621)
+...|+.- .+..+|+.|+|++|.|++. +|..++ ++++|++|+|++|++.+.+|..|.++
T Consensus 193 n~l~~ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 272 (636)
T 4eco_A 193 NNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL 272 (636)
T ss_dssp CEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTC
T ss_pred CCCccCCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcC
Confidence 45556431 2357899999999999986 999999 99999999999999999999999999
Q ss_pred Cccceeeecccc-CCC-CCCcccccc------cccccccccccccCCCCCC--CccCCccccEEeeccCcCcccCCCCCC
Q 007020 113 TSLVSLDLYLNS-FTG-PIPDTLGKL------SKLRFLRLNNNSLSGPIPM--SLTNISSLQVLDLSNNRLSGVVPDNGS 182 (621)
Q Consensus 113 ~~L~~L~L~~N~-l~~-~~p~~~~~l------~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~~~~~~ 182 (621)
++|++|+|++|+ +++ .+|..++.+ ++|+.|+|++|+++ .+|. .+.++++|+.|++++|+++|..|....
T Consensus 273 ~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~ 351 (636)
T 4eco_A 273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGS 351 (636)
T ss_dssp SSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEE
T ss_pred CCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhCC
Confidence 999999999998 998 789888887 99999999999999 7888 899999999999999999966666677
Q ss_pred CCCcccccccCCccc
Q 007020 183 FSLFTPISFANNLDL 197 (621)
Q Consensus 183 ~~~l~~l~l~~N~~~ 197 (621)
+++|+.|++++|...
T Consensus 352 l~~L~~L~L~~N~l~ 366 (636)
T 4eco_A 352 EIKLASLNLAYNQIT 366 (636)
T ss_dssp EEEESEEECCSSEEE
T ss_pred CCCCCEEECCCCccc
Confidence 888999999988754
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.53 E-value=6.8e-15 Score=162.07 Aligned_cols=127 Identities=20% Similarity=0.172 Sum_probs=113.4
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+|+.|+|++|.|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|+ .+|.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 57999999999999888899999999999999999999888999999999999999999999 67766 8999999999
Q ss_pred cccccCCC-CCCCccCCccccEEeeccCcCcccCCCCCCCCCc--ccccccCCcc
Q 007020 145 NNNSLSGP-IPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLF--TPISFANNLD 196 (621)
Q Consensus 145 ~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l--~~l~l~~N~~ 196 (621)
++|++++. +|..|.++++|++|++++|+|++. ....+++| +.|++++|..
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~--~~~~l~~L~L~~L~L~~n~l 181 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL--DLLPVAHLHLSCILLDLVSY 181 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT--TTGGGTTSCEEEEEEEESSC
T ss_pred CCCCccccCchHhhcccCcccEEecCCCccccC--chhhhhhceeeEEEeecccc
Confidence 99999963 468999999999999999999863 33455566 9999999864
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.53 E-value=1.6e-14 Score=144.95 Aligned_cols=124 Identities=27% Similarity=0.366 Sum_probs=98.0
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+|+.|+|++|+|++..+ +..+++|++|+|++|+|++ ++ .+..+++|+.|+|++|+|++. +.+..+++|+.|+
T Consensus 67 l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~ 140 (291)
T 1h6t_A 67 LPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLY 140 (291)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEE
T ss_pred CCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEE
Confidence 3578888888888886544 8888888888888888885 33 488888888888888888853 4577888888888
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
|++|++++. ..+..+++|+.|++++|+|++.++ ...+++|+.|++++|..
T Consensus 141 l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 141 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred ccCCcCCcc--hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcC
Confidence 888888854 567788888888888888888766 66778888888888854
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.4e-14 Score=143.14 Aligned_cols=126 Identities=21% Similarity=0.228 Sum_probs=98.2
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+|+.|+|++|+|++..+ +..+++|++|+|++|+|++ +|. +.. ++|+.|+|++|+|++ ++ .+..+++|+.|+
T Consensus 62 l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~ 134 (263)
T 1xeu_A 62 FTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILS 134 (263)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEE
Confidence 3578888888888886544 8888888888888888885 333 333 888888888888885 33 588888888999
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcccCC
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCG 199 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~ 199 (621)
|++|+|++. + .+..+++|+.|++++|+|++. .....+++|+.|++++|+..+.
T Consensus 135 Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 135 IRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred CCCCcCCCC-h-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence 999988854 3 678888899999999988887 5557788888889988886554
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1.7e-14 Score=144.73 Aligned_cols=127 Identities=30% Similarity=0.315 Sum_probs=113.0
Q ss_pred CCCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccc
Q 007020 63 NDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFL 142 (621)
Q Consensus 63 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 142 (621)
...+|+.|+|++|.|++ + +.+..+++|++|+|++|+|++. ..+..+++|+.|+|++|+|++. ..+..+++|+.|
T Consensus 88 ~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 161 (291)
T 1h6t_A 88 NLKNLGWLFLDENKVKD-L-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTL 161 (291)
T ss_dssp TCTTCCEEECCSSCCCC-G-GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred cCCCCCEEECCCCcCCC-C-hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEE
Confidence 45689999999999996 3 4499999999999999999964 4799999999999999999965 679999999999
Q ss_pred cccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcccC
Q 007020 143 RLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLC 198 (621)
Q Consensus 143 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~ 198 (621)
+|++|++++..+ +..+++|+.|++++|+|++++. ...+++|+.|++++|+..+
T Consensus 162 ~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l~~-l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 162 SLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRA-LAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBCGG-GTTCTTCSEEEEEEEEEEC
T ss_pred EccCCccccchh--hcCCCccCEEECCCCcCCCChh-hccCCCCCEEECcCCcccC
Confidence 999999997655 8999999999999999998754 6788999999999998654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=1.9e-14 Score=147.22 Aligned_cols=128 Identities=20% Similarity=0.234 Sum_probs=75.6
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCC--CCcccccCCCccceeeeccccCCCCCCcccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITG--PIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFL 142 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 142 (621)
.+|+.|+|++|.+++..+..|..+++|++|+|++|.++. ..+..|.++++|+.|+|++|+++ .+|..+. ++|+.|
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L 197 (330)
T 1xku_A 121 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTEL 197 (330)
T ss_dssp TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEE
T ss_pred ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEE
Confidence 467788888888877666677777777777777777753 55666777766666666666665 3333322 455555
Q ss_pred cccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCc
Q 007020 143 RLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNL 195 (621)
Q Consensus 143 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~ 195 (621)
+|++|++++..|..|..+++|+.|++++|+|++.++.. ..+++|+.|++++|.
T Consensus 198 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~ 251 (330)
T 1xku_A 198 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 251 (330)
T ss_dssp ECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSC
T ss_pred ECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCc
Confidence 55555555444444555555555555555555444422 344455555555554
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.52 E-value=3.9e-15 Score=169.87 Aligned_cols=142 Identities=20% Similarity=0.257 Sum_probs=123.9
Q ss_pred ccceeeEE--cCCCcEEEEEcCCCCccc-----------------cCccccc--CCCCCcEEEeeeCCCCCCCcccccCC
Q 007020 54 CTWFHVTC--NNDNSVIRVDLGNAALSG-----------------QLVSQLG--LLKNLQYLELYSNNITGPIPSDLGNL 112 (621)
Q Consensus 54 c~w~gv~c--~~~~~l~~L~L~~n~l~~-----------------~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l 112 (621)
+...|+.- .+..+|+.|+|++|.|++ .+|+.++ ++++|++|+|++|++.+.+|..|.+|
T Consensus 435 N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L 514 (876)
T 4ecn_A 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDL 514 (876)
T ss_dssp CEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGC
T ss_pred CcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCC
Confidence 45555432 235789999999999998 3889887 99999999999999999999999999
Q ss_pred Cccceeeecccc-CCC-CCCccccccc-------ccccccccccccCCCCCC--CccCCccccEEeeccCcCcccCCCCC
Q 007020 113 TSLVSLDLYLNS-FTG-PIPDTLGKLS-------KLRFLRLNNNSLSGPIPM--SLTNISSLQVLDLSNNRLSGVVPDNG 181 (621)
Q Consensus 113 ~~L~~L~L~~N~-l~~-~~p~~~~~l~-------~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~~~~~ 181 (621)
++|+.|+|++|+ |++ .+|..+..++ +|+.|+|++|+|+ .+|. .|.++++|+.|+|++|+|+.++ ...
T Consensus 515 ~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~~lp-~~~ 592 (876)
T 4ecn_A 515 PELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRHLE-AFG 592 (876)
T ss_dssp SSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCCBCC-CCC
T ss_pred CCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcccch-hhc
Confidence 999999999998 987 7888777776 9999999999999 8888 8999999999999999999555 678
Q ss_pred CCCCcccccccCCccc
Q 007020 182 SFSLFTPISFANNLDL 197 (621)
Q Consensus 182 ~~~~l~~l~l~~N~~~ 197 (621)
.+++|+.|++++|...
T Consensus 593 ~L~~L~~L~Ls~N~l~ 608 (876)
T 4ecn_A 593 TNVKLTDLKLDYNQIE 608 (876)
T ss_dssp TTSEESEEECCSSCCS
T ss_pred CCCcceEEECcCCccc
Confidence 8899999999999754
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.52 E-value=1.6e-14 Score=146.22 Aligned_cols=125 Identities=28% Similarity=0.405 Sum_probs=92.7
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+|+.|+|++|.|++. +.+..+++|++|+|++|+|++. + .+..+++|+.|+|++|+|++. +. +..+++|+.|+
T Consensus 84 l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~ 157 (308)
T 1h6u_A 84 LTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNI-SP-LAGLTNLQYLS 157 (308)
T ss_dssp CCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEE
T ss_pred CCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcC-cc-ccCCCCccEEE
Confidence 46788888888888853 3678888888888888888853 3 378888888888888888754 33 77788888888
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCccc
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDL 197 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~ 197 (621)
|++|++++..+ +..+++|+.|++++|+|+++++ ...+++|+.|++++|...
T Consensus 158 l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~ 208 (308)
T 1h6u_A 158 IGNAQVSDLTP--LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQIS 208 (308)
T ss_dssp CCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCC
T ss_pred ccCCcCCCChh--hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccC
Confidence 88888875433 7777788888888887777655 556677777777777643
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=9.1e-15 Score=148.31 Aligned_cols=128 Identities=23% Similarity=0.240 Sum_probs=109.2
Q ss_pred CCcEEEEEcCCCCcccc--C--cccccCCCCCcEEEeeeCCCCCCCcc----cccCCCccceeeeccccCCCCCCccccc
Q 007020 64 DNSVIRVDLGNAALSGQ--L--VSQLGLLKNLQYLELYSNNITGPIPS----DLGNLTSLVSLDLYLNSFTGPIPDTLGK 135 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~--~--~~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 135 (621)
..+|+.|+|++|++.+. + +..+..+++|++|+|++|+|+ .++. .+.++++|++|+|++|+|++..|..+..
T Consensus 168 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 246 (310)
T 4glp_A 168 FPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPR 246 (310)
T ss_dssp CTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSS
T ss_pred CCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHh
Confidence 46899999999998753 2 233578999999999999998 4443 3578999999999999999887888777
Q ss_pred c---cccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 136 L---SKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 136 l---~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
+ ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++++. ...+++|+.|++++|+.
T Consensus 247 ~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~~~-~~~l~~L~~L~L~~N~l 306 (310)
T 4glp_A 247 CMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRAPQ-PDELPEVDNLTLDGNPF 306 (310)
T ss_dssp CCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSCCC-TTSCCCCSCEECSSTTT
T ss_pred ccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCCch-hhhCCCccEEECcCCCC
Confidence 7 69999999999999 6787774 899999999999998744 57789999999999986
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.50 E-value=1.3e-14 Score=132.94 Aligned_cols=114 Identities=25% Similarity=0.169 Sum_probs=101.8
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCC-Ccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPI-PDTLGKLSKLRFL 142 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L 142 (621)
..+|+.|+|++|.|++. ..+..+++|++|+|++|+|++.+|..+.++++|++|+|++|+|++.. +..+..+++|+.|
T Consensus 48 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L 125 (168)
T 2ell_A 48 FVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSL 125 (168)
T ss_dssp GGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEE
T ss_pred CCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEE
Confidence 46899999999999976 88999999999999999999878888889999999999999999542 2789999999999
Q ss_pred cccccccCCCCC---CCccCCccccEEeeccCcCcccCCC
Q 007020 143 RLNNNSLSGPIP---MSLTNISSLQVLDLSNNRLSGVVPD 179 (621)
Q Consensus 143 ~l~~N~l~~~~p---~~~~~l~~L~~L~l~~N~l~~~~~~ 179 (621)
+|++|.+++..+ ..+..+++|+.|++++|.+...+..
T Consensus 126 ~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 165 (168)
T 2ell_A 126 DLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAPDS 165 (168)
T ss_dssp ECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCCSS
T ss_pred EeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhcccc
Confidence 999999996544 4789999999999999999887654
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=1.8e-14 Score=158.19 Aligned_cols=132 Identities=19% Similarity=0.215 Sum_probs=114.3
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCC-CCcccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGP-IPDTLGKLSKLRFL 142 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L 142 (621)
..+|++|+|++|+|++..|..|..+++|++|+|++|++++..|..|+++++|++|+|++|++++. .|..|.++++|+.|
T Consensus 49 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L 128 (549)
T 2z81_A 49 CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128 (549)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred CCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEE
Confidence 46899999999999998889999999999999999999988888899999999999999999963 57789999999999
Q ss_pred cccccccCCCCC-CCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCc
Q 007020 143 RLNNNSLSGPIP-MSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNL 195 (621)
Q Consensus 143 ~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~ 195 (621)
+|++|++.+.+| ..|..+++|+.|++++|++++..+.. ..+++|+.|++++|.
T Consensus 129 ~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~ 183 (549)
T 2z81_A 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE 183 (549)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSB
T ss_pred ECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCc
Confidence 999999544554 68999999999999999999876654 556666666666554
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.50 E-value=4.3e-14 Score=143.15 Aligned_cols=124 Identities=27% Similarity=0.385 Sum_probs=102.0
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+|+.|+|++|.|++..+ +..+++|++|+|++|+|++. + .+..+++|+.|+|++|+|++ ++. +..+++|+.|+
T Consensus 62 l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~ 135 (308)
T 1h6u_A 62 LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLY 135 (308)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEE
T ss_pred cCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEE
Confidence 4578899999998886444 88899999999999998853 4 68889999999999999885 443 88889999999
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
|++|++++..+ +..+++|+.|++++|++++.++ ...+++|+.|++++|..
T Consensus 136 l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l 185 (308)
T 1h6u_A 136 LDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKI 185 (308)
T ss_dssp CCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred CCCCccCcCcc--ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCcc
Confidence 99999886543 8888899999999999988766 67788899999988864
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=1e-14 Score=159.07 Aligned_cols=127 Identities=21% Similarity=0.187 Sum_probs=114.8
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+|+.|+|++|.|++..|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|+ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 58999999999999888899999999999999999999888999999999999999999999 57766 8999999999
Q ss_pred cccccCC-CCCCCccCCccccEEeeccCcCcccCCCCCCCCCc--ccccccCCcc
Q 007020 145 NNNSLSG-PIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLF--TPISFANNLD 196 (621)
Q Consensus 145 ~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l--~~l~l~~N~~ 196 (621)
++|++++ .+|..|..+++|++|++++|+|++. ....+++| +.|++++|..
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~--~~~~l~~L~L~~L~l~~n~l 150 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS--SVLPIAHLNISKVLLVLGET 150 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG--GGGGGTTSCEEEEEEEECTT
T ss_pred cCCccccccchhhhccCCcceEEEecCcccchh--hccccccceeeEEEeecccc
Confidence 9999997 4788999999999999999999873 34556777 9999999875
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.49 E-value=3.6e-14 Score=140.21 Aligned_cols=124 Identities=27% Similarity=0.346 Sum_probs=107.9
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+|+.|+|++|+|+. ++ .+..+++|++|+|++|+|++..+ |.++++|+.|+|++|+|++ +|... . ++|+.|+
T Consensus 40 l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~-~-~~L~~L~ 112 (263)
T 1xeu_A 40 LSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGIP-S-ACLSRLF 112 (263)
T ss_dssp HTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTCC-C-SSCCEEE
T ss_pred cCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCccc-c-CcccEEE
Confidence 3579999999999995 44 78999999999999999996554 9999999999999999995 55433 3 9999999
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCccc
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDL 197 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~ 197 (621)
|++|+|++. + .+..+++|+.|++++|+|++++ ....+++|+.|++++|...
T Consensus 113 L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 113 LDNNELRDT-D-SLIHLKNLEILSIRNNKLKSIV-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp CCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBCG-GGGGCTTCCEEECTTSCCC
T ss_pred ccCCccCCC-h-hhcCcccccEEECCCCcCCCCh-HHccCCCCCEEECCCCcCc
Confidence 999999963 3 5899999999999999999885 4678899999999999754
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.6e-14 Score=155.91 Aligned_cols=125 Identities=26% Similarity=0.170 Sum_probs=87.5
Q ss_pred EEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccc-ccccccccccc
Q 007020 67 VIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLG-KLSKLRFLRLN 145 (621)
Q Consensus 67 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~ 145 (621)
|+.|+|++|.|++..+. .+++|++|+|++|.|++..|..|+++++|+.|+|++|.|++.+|..+. .+++|+.|+|+
T Consensus 101 L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls 177 (487)
T 3oja_A 101 IETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177 (487)
T ss_dssp CCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECT
T ss_pred cCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecC
Confidence 34444444444433322 356777788888888777777777788888888888888776676665 67888888888
Q ss_pred ccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
+|.|++..+ +..+++|+.|+|++|+|+++++....+++|+.|++++|..
T Consensus 178 ~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l 226 (487)
T 3oja_A 178 YNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226 (487)
T ss_dssp TSCCCEEEC--CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCC
T ss_pred CCccccccc--cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcC
Confidence 888775422 3357788888888888888777767777888888888764
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.49 E-value=2e-14 Score=148.29 Aligned_cols=110 Identities=25% Similarity=0.208 Sum_probs=96.1
Q ss_pred ccceeeEEcCCCcEEEEEcCCC-CccccCcccccCCCCCcEEEeee-CCCCCCCcccccCCCccceeeeccccCCCCCCc
Q 007020 54 CTWFHVTCNNDNSVIRVDLGNA-ALSGQLVSQLGLLKNLQYLELYS-NNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPD 131 (621)
Q Consensus 54 c~w~gv~c~~~~~l~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 131 (621)
|.|..|.| +++ +|+. +|. |..+++|++|+|++ |+|++..+..|.+|++|+.|+|++|+|++..|.
T Consensus 8 C~~~~v~~-----------~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 8 HGSSGLRC-----------TRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp SSSSCEEC-----------CSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred ccCCEEEc-----------CCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 77765555 455 7884 677 99999999999996 999988889999999999999999999998899
Q ss_pred ccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccC
Q 007020 132 TLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVV 177 (621)
Q Consensus 132 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 177 (621)
.|.+|++|+.|+|++|+|++..+..|..++ |+.|+|++|+|....
T Consensus 75 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c 119 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCSC 119 (347)
T ss_dssp GGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCCG
T ss_pred HhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCCC
Confidence 999999999999999999976666676666 999999999998653
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.3e-14 Score=158.12 Aligned_cols=134 Identities=25% Similarity=0.334 Sum_probs=106.0
Q ss_pred CCCCCCCCCCCc-----cceee-EEcCCCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccc
Q 007020 43 LQSWDPTLVNPC-----TWFHV-TCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLV 116 (621)
Q Consensus 43 l~~w~~~~~~~c-----~w~gv-~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 116 (621)
+.+|... .++| .|.|+ .|.. ++|+.|+|++|+|++ +|..+ +++|++|+|++|+|+ .+| ..+++|+
T Consensus 33 l~~W~~~-~~~~~~~~~~~~~l~~C~~-~~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~ 103 (571)
T 3cvr_A 33 WDKWEKQ-ALPGENRNEAVSLLKECLI-NQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLE 103 (571)
T ss_dssp HHHHHTT-CCTTCCHHHHHHHHHHHHH-TTCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCC
T ss_pred HHHHhcc-CCccccccchhhhcccccc-CCccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCC
Confidence 4456443 5677 79999 6763 579999999999996 66655 378999999999999 566 4578999
Q ss_pred eeeeccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 117 SLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 117 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
.|+|++|+|++ +|. |.+ +|+.|+|++|+|++ +|. .+++|+.|+|++|+|++++. .+++|+.|++++|..
T Consensus 104 ~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~L 172 (571)
T 3cvr_A 104 YLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTMLPE---LPTSLEVLSVRNNQL 172 (571)
T ss_dssp EEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCC
T ss_pred EEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCcCCC---cCCCcCEEECCCCCC
Confidence 99999999996 676 655 89999999999986 565 57888889999998888665 567888888888864
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.47 E-value=3.2e-16 Score=148.01 Aligned_cols=128 Identities=23% Similarity=0.293 Sum_probs=102.0
Q ss_pred cEEEEEcCCCCccccCcc------cccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVS------QLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKL 139 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 139 (621)
+++.++|+.+.+++..|. .|..+++|++|+|++|+|++ +| .+.++++|++|+|++|+|+ .+|..+..+++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 455566666666665555 88888999999999999885 56 8888899999999999988 678778888899
Q ss_pred ccccccccccCCCCCCCccCCccccEEeeccCcCcccCC--CCCCCCCcccccccCCcccC
Q 007020 140 RFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP--DNGSFSLFTPISFANNLDLC 198 (621)
Q Consensus 140 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~~l~~l~l~~N~~~~ 198 (621)
+.|+|++|+|++ +| .+..+++|+.|++++|+|++.+. ....+++|+.|++++|+..+
T Consensus 96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~ 154 (198)
T 1ds9_A 96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHH
T ss_pred CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccc
Confidence 999999999885 45 57788889999999999887654 34678888999999887644
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.46 E-value=9.8e-14 Score=152.90 Aligned_cols=123 Identities=29% Similarity=0.395 Sum_probs=76.0
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+|+.|+|++|.|++..+ +..+++|+.|+|++|+|++ +| .|..|++|+.|+|++|+|++ + +.+..|++|+.|+
T Consensus 64 l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~ 137 (605)
T 1m9s_A 64 LPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLY 137 (605)
T ss_dssp CTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEE
T ss_pred CCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEE
Confidence 3466777777777765443 6666667777777766663 23 56666666666666666663 2 3356666666666
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCc
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNL 195 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~ 195 (621)
|++|+|++. ..+..+++|+.|+|++|+|++.++ ...+++|+.|+|++|.
T Consensus 138 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~ 186 (605)
T 1m9s_A 138 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNH 186 (605)
T ss_dssp CCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred CCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCC
Confidence 666666643 455566666666666666666555 5555666666666664
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.46 E-value=4.7e-14 Score=145.33 Aligned_cols=122 Identities=25% Similarity=0.325 Sum_probs=56.1
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 145 (621)
+|+.|++++|.+++..+ +..+++|++|+|++|++++..+ +..+++|+.|+|++|.+++. +.+..+++|+.|+|+
T Consensus 200 ~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~ 273 (347)
T 4fmz_A 200 SLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVG 273 (347)
T ss_dssp TCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECC
T ss_pred ccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEcc
Confidence 44555555555543322 4444555555555555543222 44455555555555554432 234444555555555
Q ss_pred ccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCc
Q 007020 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNL 195 (621)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~ 195 (621)
+|++++. ..+..+++|+.|++++|++++..+.. ..+++|+.|++++|+
T Consensus 274 ~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 322 (347)
T 4fmz_A 274 SNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322 (347)
T ss_dssp SSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSS
T ss_pred CCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCc
Confidence 5544432 23444444555555555444443332 334444445554444
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.46 E-value=1e-13 Score=152.82 Aligned_cols=127 Identities=29% Similarity=0.305 Sum_probs=113.4
Q ss_pred CCCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccc
Q 007020 63 NDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFL 142 (621)
Q Consensus 63 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 142 (621)
...+|+.|+|++|.|++. +.+..+++|++|+|++|+|++. ..|..|++|+.|+|++|+|++. ..|..+++|+.|
T Consensus 85 ~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L 158 (605)
T 1m9s_A 85 NLKNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTL 158 (605)
T ss_dssp GCTTCCEEECCSSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEE
T ss_pred cCCCCCEEECcCCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEE
Confidence 356899999999999963 3799999999999999999963 4699999999999999999965 679999999999
Q ss_pred cccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcccC
Q 007020 143 RLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLC 198 (621)
Q Consensus 143 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~ 198 (621)
+|++|+|++..| +..+++|+.|+|++|+|+++ +....+++|+.|+|++|+...
T Consensus 159 ~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 159 SLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEEC
T ss_pred ECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCcC
Confidence 999999997766 99999999999999999987 456789999999999998654
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.45 E-value=2.4e-14 Score=128.35 Aligned_cols=108 Identities=20% Similarity=0.227 Sum_probs=98.4
Q ss_pred CCCCCcEEEeeeCCCC-CCCcccccCCCccceeeeccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccE
Q 007020 87 LLKNLQYLELYSNNIT-GPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQV 165 (621)
Q Consensus 87 ~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 165 (621)
..++|+.|+|++|.++ +.+|..+..+++|+.|+|++|.|++. ..+..+++|+.|+|++|++++.+|..+..+++|+.
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 3478999999999999 78898999999999999999999965 77999999999999999999878888888999999
Q ss_pred EeeccCcCcccC--CCCCCCCCcccccccCCcc
Q 007020 166 LDLSNNRLSGVV--PDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 166 L~l~~N~l~~~~--~~~~~~~~l~~l~l~~N~~ 196 (621)
|++++|+|++.+ .....+++|+.|++++|+.
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l 125 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGG
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcc
Confidence 999999999865 5568899999999999975
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.44 E-value=4.3e-14 Score=143.82 Aligned_cols=126 Identities=27% Similarity=0.173 Sum_probs=88.0
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccc-ccccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTL-GKLSKLRFLRL 144 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~l 144 (621)
+|+.|+|++|.|++..+. .+++|++|+|++|+|++..+..|..+++|++|+|++|.|++..+..+ ..+++|+.|+|
T Consensus 100 ~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L 176 (317)
T 3o53_A 100 SIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176 (317)
T ss_dssp TCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEEC
T ss_pred CcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEEC
Confidence 344444444444433222 35677888888888887767777788888888888888886666655 36788888888
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
++|+|++. +. ...+++|+.|+|++|+|+++++....+++|+.|++++|..
T Consensus 177 ~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l 226 (317)
T 3o53_A 177 QYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226 (317)
T ss_dssp TTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCC
T ss_pred CCCcCccc-cc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCcc
Confidence 88888744 32 3347788888888888888777767778888888888864
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.44 E-value=1.3e-13 Score=142.21 Aligned_cols=144 Identities=14% Similarity=0.141 Sum_probs=116.7
Q ss_pred CccceeeEEcCC----------CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCc-ccccCCCccce-eee
Q 007020 53 PCTWFHVTCNND----------NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIP-SDLGNLTSLVS-LDL 120 (621)
Q Consensus 53 ~c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~L 120 (621)
-|+|..|.|+.. .+++.|+|++|+|+.+.+..|.++++|++|+|++|++.+.+| ..|.++++|.. +++
T Consensus 8 ~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 8 HCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp EEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred EeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 478888999642 478999999999997767789999999999999999876555 56899998775 677
Q ss_pred ccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeecc-CcCcccCCCC-CCC-CCcccccccCCcc
Q 007020 121 YLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSN-NRLSGVVPDN-GSF-SLFTPISFANNLD 196 (621)
Q Consensus 121 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~~~~-~~~-~~l~~l~l~~N~~ 196 (621)
++|+|+...|+.|..+++|++|++++|+|++..+..+....++..|++.+ |++..+++.. ..+ ..++.|++++|..
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i 166 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 166 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCC
T ss_pred cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccc
Confidence 78999977788999999999999999999977777777777888888865 6777776654 333 4577888888864
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.44 E-value=5.6e-14 Score=158.63 Aligned_cols=129 Identities=24% Similarity=0.316 Sum_probs=112.6
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+|+.|+|++|.|. .+|..+..+++|++|+|++|.|+ .+|..|.+|++|+.|+|++|+|+ .+|..|.+|++|++|+
T Consensus 223 l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 299 (727)
T 4b8c_D 223 DQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFY 299 (727)
T ss_dssp CCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEE
T ss_pred CCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEE
Confidence 468999999999999 67777889999999999999999 88999999999999999999999 7899999999999999
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCCC-CC-CCcccccccCCcc
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNG-SF-SLFTPISFANNLD 196 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~-~~l~~l~l~~N~~ 196 (621)
|++|.|+ .+|..|..|++|+.|+|++|+|++.++... .+ ..+..++|++|..
T Consensus 300 L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l 353 (727)
T 4b8c_D 300 FFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRP 353 (727)
T ss_dssp CCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCC
T ss_pred CCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcc
Confidence 9999998 788889999999999999999998877542 11 1122356777754
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.41 E-value=3.2e-13 Score=145.06 Aligned_cols=123 Identities=29% Similarity=0.382 Sum_probs=75.0
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+|+.|+|++|.+++..+ +..+++|++|+|++|++++..+ +..+++|+.|+|++|++++..+ +..+++|+.|+|
T Consensus 243 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L 316 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTL 316 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEEC
T ss_pred CCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEEC
Confidence 466777777777765443 6666677777777776664433 6666666666666666664322 566666666666
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
++|++++..| +..+++|+.|++++|++++. +....+++|+.|++++|+.
T Consensus 317 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l 365 (466)
T 1o6v_A 317 YFNNISDISP--VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQI 365 (466)
T ss_dssp CSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCC
T ss_pred cCCcCCCchh--hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCCcc
Confidence 6666665444 55566666666666666654 2334555666666665543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.40 E-value=2.2e-13 Score=140.35 Aligned_cols=108 Identities=18% Similarity=0.114 Sum_probs=97.0
Q ss_pred cEEEeeeC-CCCCCCcccccCCCccceeeecc-ccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeec
Q 007020 92 QYLELYSN-NITGPIPSDLGNLTSLVSLDLYL-NSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLS 169 (621)
Q Consensus 92 ~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 169 (621)
..++++++ +|+ .+|. |..+++|+.|+|++ |+|++..+..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35688998 899 5777 99999999999996 99998877899999999999999999999889999999999999999
Q ss_pred cCcCcccCCCCCCCCCcccccccCCcccCCCC
Q 007020 170 NNRLSGVVPDNGSFSLFTPISFANNLDLCGPV 201 (621)
Q Consensus 170 ~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~~ 201 (621)
+|+|+++++.......|+.|+|.+|++.|.+.
T Consensus 89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 89 FNALESLSWKTVQGLSLQELVLSGNPLHCSCA 120 (347)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred CCccceeCHHHcccCCceEEEeeCCCccCCCc
Confidence 99999999877444449999999999998754
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.40 E-value=7.6e-14 Score=128.95 Aligned_cols=108 Identities=21% Similarity=0.263 Sum_probs=96.6
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCc--ccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPD--TLGKLSKLRFL 142 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L 142 (621)
.+|+.|+|++|.|++. +.|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|. .+..+++|+.|
T Consensus 42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L 118 (176)
T 1a9n_A 42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 118 (176)
T ss_dssp TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence 3799999999999975 78999999999999999999766666799999999999999997 6676 79999999999
Q ss_pred cccccccCCCCCCC----ccCCccccEEeeccCcCccc
Q 007020 143 RLNNNSLSGPIPMS----LTNISSLQVLDLSNNRLSGV 176 (621)
Q Consensus 143 ~l~~N~l~~~~p~~----~~~l~~L~~L~l~~N~l~~~ 176 (621)
+|++|.++ .+|.. +..+++|+.|++++|.+...
T Consensus 119 ~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~~ 155 (176)
T 1a9n_A 119 CILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKER 155 (176)
T ss_dssp ECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHHH
T ss_pred EecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHHH
Confidence 99999998 56664 88999999999999988654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.39 E-value=3.6e-13 Score=146.82 Aligned_cols=99 Identities=29% Similarity=0.355 Sum_probs=62.1
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+|+.|+|++|+|++ +|. +.. +|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+
T Consensus 99 l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~ 166 (571)
T 3cvr_A 99 PASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLS 166 (571)
T ss_dssp CTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEE
T ss_pred cCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEE
Confidence 4577888888888876 555 554 77777777777775 444 46666677777776664 444 355666666
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCC
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 178 (621)
|++|+|++ +|. |. ++|+.|+|++|+|+.++.
T Consensus 167 Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp~ 197 (571)
T 3cvr_A 167 VRNNQLTF-LPE-LP--ESLEALDVSTNLLESLPA 197 (571)
T ss_dssp CCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCCC
T ss_pred CCCCCCCC-cch-hh--CCCCEEECcCCCCCchhh
Confidence 66666664 444 43 555556666555554444
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.37 E-value=6.7e-13 Score=142.53 Aligned_cols=125 Identities=31% Similarity=0.397 Sum_probs=98.5
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+|+.|+|++|.+++. +.+..+++|++|+|++|.+++..+ +..+++|+.|+|++|++++..+ +..+++|+.|+
T Consensus 220 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 293 (466)
T 1o6v_A 220 LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLE 293 (466)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred cCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEE
Confidence 35788888888888853 467788888888888888886544 8888888888888888885433 77888888888
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCccc
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDL 197 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~ 197 (621)
|++|++++..+ +..+++|+.|++++|++++.++ ...+++|+.|++++|+..
T Consensus 294 L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~ 344 (466)
T 1o6v_A 294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVS 344 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCC
T ss_pred cCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccC
Confidence 88888886544 7788888888888888888766 567788888888888653
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=5.3e-14 Score=154.08 Aligned_cols=103 Identities=26% Similarity=0.341 Sum_probs=94.9
Q ss_pred CCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeec
Q 007020 90 NLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLS 169 (621)
Q Consensus 90 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 169 (621)
.|+.|+|++|+|++ +|. |+++++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .+..+++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 58999999999995 676 999999999999999999 889999999999999999999996 67 89999999999999
Q ss_pred cCcCccc--CCCCCCCCCcccccccCCccc
Q 007020 170 NNRLSGV--VPDNGSFSLFTPISFANNLDL 197 (621)
Q Consensus 170 ~N~l~~~--~~~~~~~~~l~~l~l~~N~~~ 197 (621)
+|+|++. +.....+++|+.|+|++|+..
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~ 546 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCC
Confidence 9999999 455588999999999999853
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.37 E-value=4.1e-15 Score=140.41 Aligned_cols=125 Identities=20% Similarity=0.192 Sum_probs=108.1
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+|+.|+|++|.|++ +| .+..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++ +| .+..+++|+.|+
T Consensus 47 l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~ 121 (198)
T 1ds9_A 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEE
T ss_pred CCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEE
Confidence 4689999999999997 56 8999999999999999999 678888889999999999999995 55 689999999999
Q ss_pred ccccccCCCCC-CCccCCccccEEeeccCcCcccCCC-----------CCCCCCcccccccCCc
Q 007020 144 LNNNSLSGPIP-MSLTNISSLQVLDLSNNRLSGVVPD-----------NGSFSLFTPISFANNL 195 (621)
Q Consensus 144 l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~-----------~~~~~~l~~l~l~~N~ 195 (621)
|++|+|++..+ ..+..+++|+.|++++|++++.++. ...+++|+.|+ +|+
T Consensus 122 l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~ 183 (198)
T 1ds9_A 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMP 183 (198)
T ss_dssp ESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGG
T ss_pred CCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--Ccc
Confidence 99999995332 4788999999999999999888665 35677888775 554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.35 E-value=2.1e-12 Score=137.95 Aligned_cols=120 Identities=23% Similarity=0.245 Sum_probs=91.1
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+|+.|+|++|.|++. | .+..+++|++|+|++|+|++. | ++.+++|++|+|++|+|++. + ++++++|++|+
T Consensus 41 l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~ 112 (457)
T 3bz5_A 41 LATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLN 112 (457)
T ss_dssp HTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEE
T ss_pred cCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEE
Confidence 35678888888888864 3 678888888888888888854 3 77888888888888888854 3 77888888888
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
|++|++++ +| +..+++|+.|++++|+|++++ ...+++|+.|++++|..
T Consensus 113 L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l~--l~~l~~L~~L~l~~n~~ 160 (457)
T 3bz5_A 113 CDTNKLTK-LD--VSQNPLLTYLNCARNTLTEID--VSHNTQLTELDCHLNKK 160 (457)
T ss_dssp CCSSCCSC-CC--CTTCTTCCEEECTTSCCSCCC--CTTCTTCCEEECTTCSC
T ss_pred CCCCcCCe-ec--CCCCCcCCEEECCCCccceec--cccCCcCCEEECCCCCc
Confidence 88888885 34 777888888888888888752 55677777777777753
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.34 E-value=9.6e-13 Score=135.49 Aligned_cols=123 Identities=25% Similarity=0.394 Sum_probs=80.6
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+|+.|+|++|.+++..+ +..+++|++|++++|.+++..+ +..+++|+.|+|++|++++. +. +..+++|+.|+|
T Consensus 177 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l 250 (347)
T 4fmz_A 177 TDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL-SP-LANLSQLTWLEI 250 (347)
T ss_dssp TTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEEC
T ss_pred CCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCC-cc-hhcCCCCCEEEC
Confidence 467777777777764332 6667777777777777774433 66677777777777777643 33 667777777777
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
++|.+++. ..+..+++|+.|++++|+++++ +....+++|+.|++++|+.
T Consensus 251 ~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l 299 (347)
T 4fmz_A 251 GTNQISDI--NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQL 299 (347)
T ss_dssp CSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCC
T ss_pred CCCccCCC--hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcC
Confidence 77777643 3466677777777777777665 2345566777777777654
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.31 E-value=6e-13 Score=146.81 Aligned_cols=135 Identities=21% Similarity=0.217 Sum_probs=89.5
Q ss_pred CCCCCCCCCCCccceeeEE------cC-CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCcc
Q 007020 43 LQSWDPTLVNPCTWFHVTC------NN-DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSL 115 (621)
Q Consensus 43 l~~w~~~~~~~c~w~gv~c------~~-~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 115 (621)
.++|... .+||.|.|..| .+ .++++.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|. .+++|
T Consensus 12 w~~W~~~-~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L 83 (622)
T 3g06_A 12 WSAWRRA-APAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPEL 83 (622)
T ss_dssp HHHHHHT-CCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTC
T ss_pred HHHHHhc-CCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCC
Confidence 3445432 46777766332 11 134777888888887 5566554 67888888888887 4554 46778
Q ss_pred ceeeeccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCc
Q 007020 116 VSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNL 195 (621)
Q Consensus 116 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~ 195 (621)
++|+|++|+|+ .+|. .+++|++|+|++|+|++ +|. .+++|+.|++++|+|++++.. +++|+.|++++|.
T Consensus 84 ~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~lp~~---l~~L~~L~Ls~N~ 152 (622)
T 3g06_A 84 RTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTSLPVL---PPGLQELSVSDNQ 152 (622)
T ss_dssp CEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSC
T ss_pred CEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCcCCCC---CCCCCEEECcCCc
Confidence 88888888877 4554 56777788888887774 444 456777777777777776553 3667777777775
Q ss_pred c
Q 007020 196 D 196 (621)
Q Consensus 196 ~ 196 (621)
.
T Consensus 153 l 153 (622)
T 3g06_A 153 L 153 (622)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.30 E-value=6.3e-12 Score=134.26 Aligned_cols=128 Identities=16% Similarity=0.147 Sum_probs=85.9
Q ss_pred ceeeEEcCCCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccc
Q 007020 56 WFHVTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGK 135 (621)
Q Consensus 56 w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 135 (621)
..++......+|+.|+|++|.|++. + +..+++|++|+|++|+|++. + ++++++|++|+|++|+..+.+ .+..
T Consensus 97 l~~~~~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~ 168 (457)
T 3bz5_A 97 LTNLDVTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTP 168 (457)
T ss_dssp CSCCCCTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTT
T ss_pred CceeecCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--cccc
Confidence 3444434456889999999999864 3 88888999999999988864 3 667777777777777544444 3566
Q ss_pred ccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 136 LSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 136 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
+++|+.|+|++|++++ +| +..+++|+.|++++|+|+++ ....+++|+.|++++|..
T Consensus 169 l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l 224 (457)
T 3bz5_A 169 QTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKL 224 (457)
T ss_dssp CTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCC
T ss_pred CCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcc
Confidence 6777777777777664 33 55666666666666666655 244556666666666653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=1.5e-11 Score=121.28 Aligned_cols=144 Identities=13% Similarity=0.048 Sum_probs=112.5
Q ss_pred hcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-CCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 373 (621)
-+.|.....++.|+.+.||++... ++.+++|+...... .....+.+|+.+++.+. +..+.++++++...+..++|||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 356877788888999999999864 68899999864321 12235889999998885 6678889999888888999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC------------------------------------ 417 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~------------------------------------ 417 (621)
|++|.+|.+.+.. ......++.+++++|+.||+..
T Consensus 91 ~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 91 EADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp CCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred ecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999876321 1134578889999999999810
Q ss_pred --------------------CCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 418 --------------------DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 418 --------------------~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
.+.++|+|+++.||+++++..+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13689999999999998766667999998754
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.25 E-value=9.2e-12 Score=137.39 Aligned_cols=52 Identities=31% Similarity=0.288 Sum_probs=23.8
Q ss_pred cccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCc
Q 007020 137 SKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNL 195 (621)
Q Consensus 137 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~ 195 (621)
++|+.|+|++|+|++ +| ..+++|+.|+|++|+|++++. .+++|+.|++++|.
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~lp~---~~~~L~~L~Ls~N~ 272 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSLPM---LPSGLLSLSVYRNQ 272 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSC
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcCCc---ccccCcEEeCCCCC
Confidence 445555555555553 33 223444555555555444333 23344444444443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.25 E-value=1.5e-13 Score=143.82 Aligned_cols=131 Identities=22% Similarity=0.237 Sum_probs=71.5
Q ss_pred CcEEEEEcCCCCcc-ccCc---ccccCCCCCcEEEeeeCCCC--C---CCcccccCCCccceeeeccccCC----CCCCc
Q 007020 65 NSVIRVDLGNAALS-GQLV---SQLGLLKNLQYLELYSNNIT--G---PIPSDLGNLTSLVSLDLYLNSFT----GPIPD 131 (621)
Q Consensus 65 ~~l~~L~L~~n~l~-~~~~---~~~~~l~~L~~L~L~~N~l~--~---~~p~~~~~l~~L~~L~L~~N~l~----~~~p~ 131 (621)
.+|+.|+|++|+|+ +.++ ..+..+++|++|+|++|+|+ + ..+..+.++++|+.|+|++|.|+ +.+|.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 35555666666554 2222 34455566666666666665 1 23335556666666666666663 34555
Q ss_pred ccccccccccccccccccCCC----CCCCcc--CCccccEEeeccCcCcc-----cCCCC-CCCCCcccccccCCc
Q 007020 132 TLGKLSKLRFLRLNNNSLSGP----IPMSLT--NISSLQVLDLSNNRLSG-----VVPDN-GSFSLFTPISFANNL 195 (621)
Q Consensus 132 ~~~~l~~L~~L~l~~N~l~~~----~p~~~~--~l~~L~~L~l~~N~l~~-----~~~~~-~~~~~l~~l~l~~N~ 195 (621)
.+..+++|+.|+|++|.|++. ++..+. .+++|+.|+|++|.|++ ++... ..+++|+.|++++|+
T Consensus 239 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~ 314 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 314 (386)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSB
T ss_pred HHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCc
Confidence 556666666666666666543 333442 25666666666666665 33322 335566666666664
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.24 E-value=1.7e-11 Score=130.78 Aligned_cols=117 Identities=26% Similarity=0.344 Sum_probs=70.8
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+|+.|+|++|++++. +.. .++|++|+|++|++++ +| .|.++++|++|+|++|+|++ +|..+ ++|+.|+|
T Consensus 111 ~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L 180 (454)
T 1jl5_A 111 QSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAA 180 (454)
T ss_dssp TTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEEC
T ss_pred CCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEEC
Confidence 3556666666665532 111 1567777777777774 55 47777777777777777774 45432 46677777
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
++|++++ +| .+..+++|+.|++++|++++++... ++|+.|++++|..
T Consensus 181 ~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~~~---~~L~~L~l~~n~l 227 (454)
T 1jl5_A 181 GNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPDLP---LSLESIVAGNNIL 227 (454)
T ss_dssp CSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCCCC---TTCCEEECCSSCC
T ss_pred cCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCCCc---CcccEEECcCCcC
Confidence 7777764 44 4666677777777777666644321 3566666666643
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.24 E-value=9.1e-12 Score=128.37 Aligned_cols=125 Identities=17% Similarity=0.144 Sum_probs=104.9
Q ss_pred EEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCC-ccccccccccc-ccccc
Q 007020 69 RVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP-DTLGKLSKLRF-LRLNN 146 (621)
Q Consensus 69 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~l~~ 146 (621)
.++.++++|+ .+|..+ .++|++|+|++|+|+.+.+..|.+|++|++|+|++|+|.+.+| ..|.++++|.. +++++
T Consensus 13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 5889999999 567666 3789999999999996666789999999999999999976665 56889998875 67778
Q ss_pred cccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcc
Q 007020 147 NSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLD 196 (621)
Q Consensus 147 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~ 196 (621)
|+|+...|..|..+++|+.|++++|+|++.++.. ....++..+++.+|..
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~ 140 (350)
T 4ay9_X 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 140 (350)
T ss_dssp TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTT
T ss_pred CcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccc
Confidence 9999888899999999999999999999887755 4555677788876543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.24 E-value=1.6e-13 Score=140.56 Aligned_cols=130 Identities=22% Similarity=0.166 Sum_probs=86.9
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCC-CcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGP-IPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
.+++.|+|++|.+++..+. +..+++|++|+|++|.+++. ++..+.++++|++|+|++|++++..+..+..+++|+.|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 4567777777777755444 44677777777777777654 666677777777777777777766666677777777777
Q ss_pred cccc-ccCCC-CCCCccCCccccEEeeccC-cCccc--CCCCCCCC-CcccccccCCc
Q 007020 144 LNNN-SLSGP-IPMSLTNISSLQVLDLSNN-RLSGV--VPDNGSFS-LFTPISFANNL 195 (621)
Q Consensus 144 l~~N-~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~~--~~~~~~~~-~l~~l~l~~N~ 195 (621)
|++| .+++. ++..+..+++|+.|++++| .+++. +.....++ +|+.|++++|.
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~ 206 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR 206 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCc
Confidence 7777 56532 4555666777777777777 76642 22234566 77777777764
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.23 E-value=4.8e-13 Score=138.68 Aligned_cols=132 Identities=20% Similarity=0.193 Sum_probs=90.2
Q ss_pred CcEEEEEcCCCCccccCc----ccccCCC-CCcEEEeeeCCCCCCCcccccCC-----CccceeeeccccCCCCCCcccc
Q 007020 65 NSVIRVDLGNAALSGQLV----SQLGLLK-NLQYLELYSNNITGPIPSDLGNL-----TSLVSLDLYLNSFTGPIPDTLG 134 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~ 134 (621)
.+|+.|||++|.|++..+ ..|..++ +|++|+|++|+|++..+..|..+ ++|++|+|++|+|++..+..+.
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 357888888888876666 6677777 78888888888887666666664 7888888888888766555444
Q ss_pred cc-----cccccccccccccCCCCCCCcc----C-CccccEEeeccCcCcccCCCC-----CCCC-CcccccccCCcc
Q 007020 135 KL-----SKLRFLRLNNNSLSGPIPMSLT----N-ISSLQVLDLSNNRLSGVVPDN-----GSFS-LFTPISFANNLD 196 (621)
Q Consensus 135 ~l-----~~L~~L~l~~N~l~~~~p~~~~----~-l~~L~~L~l~~N~l~~~~~~~-----~~~~-~l~~l~l~~N~~ 196 (621)
.. ++|+.|+|++|+|++..+..+. . .++|++|+|++|+|++..... ..++ +|+.|++++|..
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l 179 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL 179 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCG
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCC
Confidence 43 7788888888888755444332 2 257888888888877432211 2233 777888887753
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.22 E-value=3e-13 Score=138.63 Aligned_cols=133 Identities=22% Similarity=0.279 Sum_probs=96.9
Q ss_pred CCcEEEEEcCCCCcccc-CcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccc-cCCCC-CCcccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQ-LVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLN-SFTGP-IPDTLGKLSKLR 140 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~ 140 (621)
..+|+.|+|++|.+++. ++..+..+++|++|+|++|++++..+..|.++++|++|+|++| .+++. ++..+.++++|+
T Consensus 92 ~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~ 171 (336)
T 2ast_B 92 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 171 (336)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCC
Confidence 35788888888888765 7777888888888888888888777778888888888888888 56642 556677788888
Q ss_pred ccccccc-ccCCC-CCCCccCCc-cccEEeeccCc--Cc--ccCCCCCCCCCcccccccCCcc
Q 007020 141 FLRLNNN-SLSGP-IPMSLTNIS-SLQVLDLSNNR--LS--GVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 141 ~L~l~~N-~l~~~-~p~~~~~l~-~L~~L~l~~N~--l~--~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
.|+|++| .+++. ++..+..++ +|+.|++++|. ++ +++.....+++|+.|++++|..
T Consensus 172 ~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~ 234 (336)
T 2ast_B 172 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVM 234 (336)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTT
T ss_pred EEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCc
Confidence 8888888 77743 455566777 78888888773 43 2222234567777777777763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.22 E-value=3.2e-11 Score=118.60 Aligned_cols=129 Identities=14% Similarity=0.047 Sum_probs=98.2
Q ss_pred eeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCc--eeeeeeeeecCCceEEEEeccCCCchhh
Q 007020 305 GRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN--LLRLRGFCMTPTERLLVYPYMANGSVAS 382 (621)
Q Consensus 305 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~ 382 (621)
+.|..+.||++...+|+.+++|+.... ....+..|+.+++.+.+.+ +.+++++...++..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence 455669999998777888999997543 1235788999998886545 456888888777889999999998884
Q ss_pred hhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 007020 383 CLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC--------------------------------------------- 417 (621)
Q Consensus 383 ~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------------- 417 (621)
... . ....++.++++.|..||+..
T Consensus 104 -~~~-------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 -SSH-------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp -TSC-------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred -cCc-------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 221 1 12367788888888888752
Q ss_pred ----------CCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 418 ----------DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 418 ----------~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
.+.++|+|++|.||++++++.+.|+|||.+..
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998876677999998764
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.21 E-value=3.4e-13 Score=141.10 Aligned_cols=131 Identities=21% Similarity=0.271 Sum_probs=64.1
Q ss_pred CcEEEEEcCCCCccc----cCcccccCCCCCcEEEeeeCCCCCCCccccc----CC---------CccceeeeccccCC-
Q 007020 65 NSVIRVDLGNAALSG----QLVSQLGLLKNLQYLELYSNNITGPIPSDLG----NL---------TSLVSLDLYLNSFT- 126 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~l---------~~L~~L~L~~N~l~- 126 (621)
.+|+.|+|++|.|++ .++..+..+++|++|+|++|.|++..+..+. .+ ++|++|+|++|+|+
T Consensus 94 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~ 173 (386)
T 2ca6_A 94 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 173 (386)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCc
Confidence 455555555555554 2444555555555555555555432222222 22 55555555555554
Q ss_pred CCCC---cccccccccccccccccccC--C---CCCCCccCCccccEEeeccCcCc-----ccCCCCCCCCCcccccccC
Q 007020 127 GPIP---DTLGKLSKLRFLRLNNNSLS--G---PIPMSLTNISSLQVLDLSNNRLS-----GVVPDNGSFSLFTPISFAN 193 (621)
Q Consensus 127 ~~~p---~~~~~l~~L~~L~l~~N~l~--~---~~p~~~~~l~~L~~L~l~~N~l~-----~~~~~~~~~~~l~~l~l~~ 193 (621)
+.++ ..+..+++|+.|+|++|+|+ | ..|..+..+++|+.|+|++|.|+ .++.....+++|+.|+|++
T Consensus 174 ~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~ 253 (386)
T 2ca6_A 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 253 (386)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred HHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCC
Confidence 2222 23445555555555555554 1 22334555555555555555553 1222224445555555555
Q ss_pred Cc
Q 007020 194 NL 195 (621)
Q Consensus 194 N~ 195 (621)
|.
T Consensus 254 n~ 255 (386)
T 2ca6_A 254 CL 255 (386)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.17 E-value=5.7e-11 Score=126.75 Aligned_cols=117 Identities=23% Similarity=0.261 Sum_probs=96.8
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+|+.|+|++|.+++ +|.. +++|++|+|++|++++ +|.. .++|++|+|++|+|++ +| .|.++++|++|++
T Consensus 91 ~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l 160 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDV 160 (454)
T ss_dssp TTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEEC
Confidence 578999999999997 5543 4889999999999985 3321 2689999999999995 77 5999999999999
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
++|++++ +|..+ ++|++|++++|++++++ ....+++|+.|++++|..
T Consensus 161 ~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l~-~~~~l~~L~~L~l~~N~l 207 (454)
T 1jl5_A 161 DNNSLKK-LPDLP---PSLEFIAAGNNQLEELP-ELQNLPFLTAIYADNNSL 207 (454)
T ss_dssp CSSCCSC-CCCCC---TTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCC
T ss_pred CCCcCcc-cCCCc---ccccEEECcCCcCCcCc-cccCCCCCCEEECCCCcC
Confidence 9999995 66543 58999999999999865 678899999999999864
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.16 E-value=2e-12 Score=134.07 Aligned_cols=128 Identities=23% Similarity=0.183 Sum_probs=109.6
Q ss_pred EEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCc----ccccCCC-ccceeeeccccCCCCCCcccccc-----cc
Q 007020 69 RVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIP----SDLGNLT-SLVSLDLYLNSFTGPIPDTLGKL-----SK 138 (621)
Q Consensus 69 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~ 138 (621)
.++|++|++++.+|..+...++|++|+|++|.|++..+ ..|.+++ +|++|+|++|+|++..+..|..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 47899999999999888888889999999999997777 7888999 99999999999998878888876 99
Q ss_pred cccccccccccCCCCCCCcc----CC-ccccEEeeccCcCcccCCCC-----CC-CCCcccccccCCcc
Q 007020 139 LRFLRLNNNSLSGPIPMSLT----NI-SSLQVLDLSNNRLSGVVPDN-----GS-FSLFTPISFANNLD 196 (621)
Q Consensus 139 L~~L~l~~N~l~~~~p~~~~----~l-~~L~~L~l~~N~l~~~~~~~-----~~-~~~l~~l~l~~N~~ 196 (621)
|+.|+|++|++++..+..+. .+ ++|+.|+|++|+|++..... .. .++|+.|++++|..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l 150 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDL 150 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCG
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcC
Confidence 99999999999976665443 44 89999999999998876532 22 25899999999964
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.13 E-value=2.6e-10 Score=117.86 Aligned_cols=142 Identities=12% Similarity=0.146 Sum_probs=106.0
Q ss_pred CceeeeccCceEEEEEcCCCcEEEEEEec--ccCCchhHHHHHHHHHHHHhcc--CCceeeeeeeeecC---CceEEEEe
Q 007020 301 KNILGRGGFGKVYKGRLADGSLVAVKRLK--EERTPGGELQFQTEVEMISMAV--HRNLLRLRGFCMTP---TERLLVYP 373 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e 373 (621)
.+.|+.|.++.||+.... +..+++|+.. ..........+.+|..+++.+. +..+.++++++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 456899999999999875 4678888875 3322223346888999999887 45578888888766 45799999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC------------------------------------ 417 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~------------------------------------ 417 (621)
|++|..+.+... ..++...+..++.++++.|+.||+..
T Consensus 122 ~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 122 FVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred ecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999988754221 12667788899999999999999731
Q ss_pred -------------------CCCeEecCCCCCCeeeCCCCc--EEEccccccee
Q 007020 418 -------------------DPKIIHRDVKAANILLDEEFE--AVVGDFGLAKL 449 (621)
Q Consensus 418 -------------------~~~ivH~Dlk~~Nill~~~~~--~kl~DfGla~~ 449 (621)
.+.++|+|+++.||+++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.02 E-value=3e-10 Score=114.52 Aligned_cols=186 Identities=19% Similarity=0.193 Sum_probs=121.7
Q ss_pred CceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-CCc--eeeeeeeeecCC---ceEEEEec
Q 007020 301 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRN--LLRLRGFCMTPT---ERLLVYPY 374 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~ 374 (621)
.+.++.|....||+.. ..+++|+.... .....+.+|..+++.+. +.. +.+++......+ ..|+|||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 3568999999999874 45889986432 33457889999998874 322 334444433332 34889999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH-------------------------------------- 416 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-------------------------------------- 416 (621)
++|.++.+.... .++..++..++.++++.++.||+.
T Consensus 98 i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 999888754322 156677788888888888888861
Q ss_pred -----------------CCCCeEecCCCCCCeeeCC--CCcEEEcccccceecccCCCeee--e-----------ccccc
Q 007020 417 -----------------CDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKLMDYKDTHVT--T-----------AVRGT 464 (621)
Q Consensus 417 -----------------~~~~ivH~Dlk~~Nill~~--~~~~kl~DfGla~~~~~~~~~~~--~-----------~~~gt 464 (621)
..+.++|+|+++.||+++. +..+.|+||+.+...+....... . .....
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 1246899999999999998 55688999999876432100000 0 00000
Q ss_pred ccccc-hhhhccCCCCCcccchhHHHHHHHHHhCCCCc
Q 007020 465 IGHIA-PEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501 (621)
Q Consensus 465 ~~y~a-PE~~~~~~~~~~~DvwSlGvil~elltg~~pf 501 (621)
.++.. |+..... ..-.+.|++|.++|++.+|..+|
T Consensus 252 Y~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 11112 2222111 11258999999999999999876
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.01 E-value=2.8e-12 Score=137.41 Aligned_cols=111 Identities=24% Similarity=0.204 Sum_probs=57.2
Q ss_pred CcEEEEEcCCCCccccC-----cccccCCCCCcEEEeeeCCCCCC----CcccccCCCccceeeeccccCCCCCCccccc
Q 007020 65 NSVIRVDLGNAALSGQL-----VSQLGLLKNLQYLELYSNNITGP----IPSDLGNLTSLVSLDLYLNSFTGPIPDTLGK 135 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 135 (621)
.+|+.|+|++|.|++.. +..+..+++|++|+|++|+|++. ++..+.++++|+.|+|++|.|++..+..+..
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 45666666666665432 22223456666666666666632 4455555666666666666655332222222
Q ss_pred c-----cccccccccccccCCC----CCCCccCCccccEEeeccCcCcc
Q 007020 136 L-----SKLRFLRLNNNSLSGP----IPMSLTNISSLQVLDLSNNRLSG 175 (621)
Q Consensus 136 l-----~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~ 175 (621)
. ++|+.|+|++|.+++. ++..+..+++|+.|++++|+|++
T Consensus 307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~ 355 (461)
T 1z7x_W 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLED 355 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHH
T ss_pred HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcccc
Confidence 1 4555555555555532 23334444555555555555544
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.92 E-value=2.5e-11 Score=129.89 Aligned_cols=132 Identities=17% Similarity=0.135 Sum_probs=71.9
Q ss_pred CCcEEEEEcCCCCccccCccccc-----CCCCCcEEEeeeCCCCCC----CcccccCCCccceeeeccccCCCCCCcccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLG-----LLKNLQYLELYSNNITGP----IPSDLGNLTSLVSLDLYLNSFTGPIPDTLG 134 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 134 (621)
..+|+.|+|++|.|++..+..+. ..++|++|+|++|++++. ++..+..+++|+.|+|++|.+++..+..+.
T Consensus 112 ~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~ 191 (461)
T 1z7x_W 112 LPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLC 191 (461)
T ss_dssp CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHH
T ss_pred CCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHH
Confidence 34677777777776644333222 245677777777766643 244455566666666666666533222222
Q ss_pred c-----ccccccccccccccCCC----CCCCccCCccccEEeeccCcCcccC-----CC-CCCCCCcccccccCCc
Q 007020 135 K-----LSKLRFLRLNNNSLSGP----IPMSLTNISSLQVLDLSNNRLSGVV-----PD-NGSFSLFTPISFANNL 195 (621)
Q Consensus 135 ~-----l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~-----~~-~~~~~~l~~l~l~~N~ 195 (621)
. +++|+.|+|++|.+++. ++..+..+++|+.|++++|++++.. +. ...+++|+.|++++|.
T Consensus 192 ~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~ 267 (461)
T 1z7x_W 192 QGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECG 267 (461)
T ss_dssp HHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred HHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCC
Confidence 1 34666666666666642 3444555566666666666655431 11 1234555666666553
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.91 E-value=8.8e-10 Score=112.38 Aligned_cols=57 Identities=11% Similarity=0.169 Sum_probs=26.3
Q ss_pred ccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcc-cccccC
Q 007020 136 LSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFT-PISFAN 193 (621)
Q Consensus 136 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~-~l~l~~ 193 (621)
+++|+.|+|++|+++.+.+..|.+|++|+.|++.+| ++.+.... ..+.+|+ .+.+.+
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~ 283 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA 283 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc
Confidence 344455555555444333344445555555555444 44444333 3444444 444444
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.90 E-value=1.9e-11 Score=126.69 Aligned_cols=132 Identities=17% Similarity=0.171 Sum_probs=99.5
Q ss_pred CcEEEEEcCCCCccccCcccc-cCCCCCcEEEeeeCCCCCCCcccc-----cCCCccceeeeccccCCCC----CCcccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQL-GLLKNLQYLELYSNNITGPIPSDL-----GNLTSLVSLDLYLNSFTGP----IPDTLG 134 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~----~p~~~~ 134 (621)
.+|+.|+|++|.|+......+ ..+++|++|+|++|+|+......+ ...++|+.|+|++|.|+.. ++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 589999999999975433333 346789999999999985444444 3568899999999998742 344557
Q ss_pred cccccccccccccccCCC----CCCCccCCccccEEeeccCcCcccCCC-----CCCCCCcccccccCCcc
Q 007020 135 KLSKLRFLRLNNNSLSGP----IPMSLTNISSLQVLDLSNNRLSGVVPD-----NGSFSLFTPISFANNLD 196 (621)
Q Consensus 135 ~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~~-----~~~~~~l~~l~l~~N~~ 196 (621)
.+++|++|+|++|.|.+. ++..+...++|+.|+|++|.|+..... ....++|+.|+|++|+.
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i 251 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL 251 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSC
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCC
Confidence 789999999999998742 245567778999999999999864321 13457899999999963
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.87 E-value=1.9e-09 Score=109.97 Aligned_cols=130 Identities=16% Similarity=0.135 Sum_probs=105.5
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCccccc---------------------------------
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLG--------------------------------- 110 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~--------------------------------- 110 (621)
..+|+.|+|.+ +++.+.+.+|.++++|+.|+|++|.++.+.+..|.
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 45788999998 88877778899999999999999986422222111
Q ss_pred ---------------------------------------------CCCccceeeeccccCCCCCCccccccccccccccc
Q 007020 111 ---------------------------------------------NLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145 (621)
Q Consensus 111 ---------------------------------------------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 145 (621)
.+++|+.|+|++|+++.+.+..|.++++|+.|+|+
T Consensus 179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~ 258 (329)
T 3sb4_A 179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLP 258 (329)
T ss_dssp EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECC
T ss_pred ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECC
Confidence 26789999999999996666789999999999999
Q ss_pred ccccCCCCCCCccCCcccc-EEeeccCcCcccCCCC-CCCCCcccccccCCcc
Q 007020 146 NNSLSGPIPMSLTNISSLQ-VLDLSNNRLSGVVPDN-GSFSLFTPISFANNLD 196 (621)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~ 196 (621)
+| ++.+.+..|.+|++|+ .|++.+ .++.+.+.. ..+++|+.+++++|..
T Consensus 259 ~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i 309 (329)
T 3sb4_A 259 HN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKI 309 (329)
T ss_dssp TT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCC
T ss_pred cc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCcc
Confidence 98 7767778899999999 999998 788887665 7789999999987754
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.77 E-value=9.3e-11 Score=114.44 Aligned_cols=67 Identities=28% Similarity=0.377 Sum_probs=46.0
Q ss_pred cCCCccceeeeccccCCC--CCCcccccccccccccccccccCCCCCCCccCCc--cccEEeeccCcCcccCC
Q 007020 110 GNLTSLVSLDLYLNSFTG--PIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNIS--SLQVLDLSNNRLSGVVP 178 (621)
Q Consensus 110 ~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~~ 178 (621)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|.+++..+
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 457778888888888876 3345666778888888888888754 2334444 77788888888776443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.71 E-value=6.2e-10 Score=115.24 Aligned_cols=112 Identities=21% Similarity=0.219 Sum_probs=89.6
Q ss_pred CcEEEEEcCCCCccccCcccc-----cCCCCCcEEEeeeCCCCCC----CcccccCCCccceeeeccccCCCC----CCc
Q 007020 65 NSVIRVDLGNAALSGQLVSQL-----GLLKNLQYLELYSNNITGP----IPSDLGNLTSLVSLDLYLNSFTGP----IPD 131 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~ 131 (621)
.+|+.|+|++|.|+......+ ...++|++|+|++|.|+.. ++..+..+++|++|+|++|.|++. ++.
T Consensus 126 ~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~ 205 (372)
T 3un9_A 126 LRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAA 205 (372)
T ss_dssp HTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHH
T ss_pred HhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHH
Confidence 379999999999986544444 3568999999999999842 445567899999999999999843 245
Q ss_pred ccccccccccccccccccCCC----CCCCccCCccccEEeeccCcCccc
Q 007020 132 TLGKLSKLRFLRLNNNSLSGP----IPMSLTNISSLQVLDLSNNRLSGV 176 (621)
Q Consensus 132 ~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~ 176 (621)
.+...++|+.|+|++|.|++. ++..+...++|++|+|++|.|+..
T Consensus 206 ~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 206 QLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp HGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred HHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 677889999999999999843 333455678999999999999764
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.63 E-value=3e-09 Score=103.80 Aligned_cols=80 Identities=26% Similarity=0.255 Sum_probs=65.9
Q ss_pred cCCCCCcEEEeeeCCCCC--CCcccccCCCccceeeeccccCCCCCCccccccc--ccccccccccccCCCCCC------
Q 007020 86 GLLKNLQYLELYSNNITG--PIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLS--KLRFLRLNNNSLSGPIPM------ 155 (621)
Q Consensus 86 ~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~p~------ 155 (621)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|.+++.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 568999999999999997 3456778999999999999999965 4455565 999999999999976663
Q ss_pred -CccCCccccEEe
Q 007020 156 -SLTNISSLQVLD 167 (621)
Q Consensus 156 -~~~~l~~L~~L~ 167 (621)
.+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 356778888776
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.57 E-value=8.7e-09 Score=113.79 Aligned_cols=84 Identities=15% Similarity=-0.047 Sum_probs=37.9
Q ss_pred CCCccceeeeccccCCCCCCcccccccccccccccccccC---CCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcc
Q 007020 111 NLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLS---GPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFT 187 (621)
Q Consensus 111 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~---~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~ 187 (621)
++++|+.|+|++|.+.+ +|..+..+++|+.|+++++... +..+..+..+++|+.|+++++.....+.....+++|+
T Consensus 218 ~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~ 296 (592)
T 3ogk_B 218 NCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIR 296 (592)
T ss_dssp HCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGGGGGCC
T ss_pred hCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchhHHHHHHhhcCCCc
Confidence 34444444444444442 3333444444444444432111 1222334444555555555543333333334556677
Q ss_pred cccccCCc
Q 007020 188 PISFANNL 195 (621)
Q Consensus 188 ~l~l~~N~ 195 (621)
.|++++|.
T Consensus 297 ~L~Ls~~~ 304 (592)
T 3ogk_B 297 KLDLLYAL 304 (592)
T ss_dssp EEEETTCC
T ss_pred EEecCCCc
Confidence 77777665
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.56 E-value=1.2e-09 Score=120.78 Aligned_cols=131 Identities=17% Similarity=0.139 Sum_probs=76.1
Q ss_pred CcEEEEEcCCCCccccCcccccC-CCCCcEEEee----eCCCCCC-----CcccccCCCccceeeeccc--cCCCCCCcc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGL-LKNLQYLELY----SNNITGP-----IPSDLGNLTSLVSLDLYLN--SFTGPIPDT 132 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~-----~p~~~~~l~~L~~L~L~~N--~l~~~~p~~ 132 (621)
.+|+.|+|+.|++++..+..+.. +++|+.|+|+ .|.+++. ++..+.++++|+.|+|+++ .+++..+..
T Consensus 378 ~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~ 457 (592)
T 3ogk_B 378 QELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSY 457 (592)
T ss_dssp TTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHH
T ss_pred ccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHH
Confidence 34556666556665544444444 6666666664 4555542 2223455666666666532 244333333
Q ss_pred cc-cccccccccccccccCC-CCCCCccCCccccEEeeccCcCcccCC-C-CCCCCCcccccccCCc
Q 007020 133 LG-KLSKLRFLRLNNNSLSG-PIPMSLTNISSLQVLDLSNNRLSGVVP-D-NGSFSLFTPISFANNL 195 (621)
Q Consensus 133 ~~-~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~~-~-~~~~~~l~~l~l~~N~ 195 (621)
+. .+++|+.|+|++|++++ .++..+..+++|+.|++++|.|++... . ...+++|+.|++++|+
T Consensus 458 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 458 IGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp HHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred HHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence 33 36777777777777764 233445667788888888887754311 1 2456778888888876
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.49 E-value=5.4e-09 Score=96.91 Aligned_cols=111 Identities=18% Similarity=0.214 Sum_probs=68.3
Q ss_pred CCcEEEEEcCCC-Ccccc----CcccccCCCCCcEEEeeeCCCCCC----CcccccCCCccceeeeccccCCCC----CC
Q 007020 64 DNSVIRVDLGNA-ALSGQ----LVSQLGLLKNLQYLELYSNNITGP----IPSDLGNLTSLVSLDLYLNSFTGP----IP 130 (621)
Q Consensus 64 ~~~l~~L~L~~n-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p 130 (621)
..+|+.|+|++| .|... +...+...++|++|+|++|+|+.. +...+...++|++|+|++|.|+.. +.
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 346777777777 77632 344556667777777777777632 333455556777777777777632 23
Q ss_pred cccccccccccccc--cccccCCC----CCCCccCCccccEEeeccCcCc
Q 007020 131 DTLGKLSKLRFLRL--NNNSLSGP----IPMSLTNISSLQVLDLSNNRLS 174 (621)
Q Consensus 131 ~~~~~l~~L~~L~l--~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 174 (621)
..+...++|+.|+| ++|.|... +...+...++|+.|+|++|.|.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 44556667777777 66776632 2223344466777777666654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=1.3e-06 Score=85.95 Aligned_cols=135 Identities=20% Similarity=0.183 Sum_probs=98.0
Q ss_pred eeeeccCc-eEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-CCceeeeeeeeecCCceEEEEeccCCCc
Q 007020 303 ILGRGGFG-KVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYMANGS 379 (621)
Q Consensus 303 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 379 (621)
.+..|..| .||+.... ++..+++|+-.. .....+.+|...++.+. +--+-++++++.+.+..++|||+++|.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 45666666 69988765 466799998643 23446788999888774 3336678888888889999999999988
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 007020 380 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH------------------------------------------- 416 (621)
Q Consensus 380 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~------------------------------------------- 416 (621)
+.+...... .....+..+++..|..||+.
T Consensus 107 ~~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 107 AFQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 877654321 23345666777777777742
Q ss_pred ------------CCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 417 ------------CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 417 ------------~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
..+.++|+|+.+.||+++.++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112488999999999999887778999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=1.9e-06 Score=86.55 Aligned_cols=136 Identities=18% Similarity=0.174 Sum_probs=94.3
Q ss_pred CceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCC---ceeeeeeeee-cCCceEEEEeccC
Q 007020 301 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR---NLLRLRGFCM-TPTERLLVYPYMA 376 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~ 376 (621)
.+.++.|....||+. |..+++|+.. .......+..|..+++.+.+. .+.+++.+.. ..+..++||||++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 356888888999988 4668888853 223455789999999988753 2455666653 4456789999999
Q ss_pred CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 007020 377 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH---------------------------------------- 416 (621)
Q Consensus 377 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~---------------------------------------- 416 (621)
|.++.+..-.. ++......++.++++.|+.||+.
T Consensus 97 G~~l~~~~~~~------l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 97 GQILGEDGMAV------LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp SEECHHHHHTT------SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CeECchhhhhh------CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 98887632111 33445555555565555555542
Q ss_pred -----------------CCCCeEecCCCCCCeeeCC---CCc-EEEccccccee
Q 007020 417 -----------------CDPKIIHRDVKAANILLDE---EFE-AVVGDFGLAKL 449 (621)
Q Consensus 417 -----------------~~~~ivH~Dlk~~Nill~~---~~~-~kl~DfGla~~ 449 (621)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2336799999999999987 455 58999998875
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.34 E-value=1.1e-08 Score=112.94 Aligned_cols=129 Identities=12% Similarity=0.066 Sum_probs=67.3
Q ss_pred cEEEEEcCCCCccccCccccc-CCCCCcEEEee--e----CCCCCCC-----cccccCCCccceeeeccccCCCCCCccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLG-LLKNLQYLELY--S----NNITGPI-----PSDLGNLTSLVSLDLYLNSFTGPIPDTL 133 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~--~----N~l~~~~-----p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 133 (621)
+|+.|+++.|++++.....+. .+++|+.|+|+ + |++++.. +..+.++++|+.|+|++ .+++..+..+
T Consensus 373 ~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l 451 (594)
T 2p1m_B 373 KLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYI 451 (594)
T ss_dssp TCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHH
T ss_pred hHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHH
Confidence 444455555555543333333 35566666665 2 3444211 11144555666666654 4443323333
Q ss_pred cc-ccccccccccccccCCCCCCCc-cCCccccEEeeccCcCcccCCC--CCCCCCcccccccCCc
Q 007020 134 GK-LSKLRFLRLNNNSLSGPIPMSL-TNISSLQVLDLSNNRLSGVVPD--NGSFSLFTPISFANNL 195 (621)
Q Consensus 134 ~~-l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~~~--~~~~~~l~~l~l~~N~ 195 (621)
.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++.... ...+++|+.|++++|+
T Consensus 452 ~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~ 517 (594)
T 2p1m_B 452 GTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCS 517 (594)
T ss_dssp HHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSC
T ss_pred HHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCC
Confidence 33 6667777777777654333333 4567777777777777433221 2346677777777764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.33 E-value=1e-08 Score=95.04 Aligned_cols=118 Identities=18% Similarity=0.165 Sum_probs=91.2
Q ss_pred cccCcccccCCCCCcEEEeeeC-CCCCC----CcccccCCCccceeeeccccCCCC----CCcccccccccccccccccc
Q 007020 78 SGQLVSQLGLLKNLQYLELYSN-NITGP----IPSDLGNLTSLVSLDLYLNSFTGP----IPDTLGKLSKLRFLRLNNNS 148 (621)
Q Consensus 78 ~~~~~~~~~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~ 148 (621)
...+...+...++|++|+|++| .|... +...+...++|++|+|++|.|... +...+...++|+.|+|++|.
T Consensus 25 ~~~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~ 104 (185)
T 1io0_A 25 EETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNF 104 (185)
T ss_dssp HHHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSC
T ss_pred HHHHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCc
Confidence 3345567788999999999999 98842 445677789999999999999742 23445666899999999999
Q ss_pred cCCC----CCCCccCCccccEEee--ccCcCcccCC-----CCCCCCCcccccccCCc
Q 007020 149 LSGP----IPMSLTNISSLQVLDL--SNNRLSGVVP-----DNGSFSLFTPISFANNL 195 (621)
Q Consensus 149 l~~~----~p~~~~~l~~L~~L~l--~~N~l~~~~~-----~~~~~~~l~~l~l~~N~ 195 (621)
|... +...+...++|+.|+| ++|.|..... .....++|+.|+|++|.
T Consensus 105 i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~ 162 (185)
T 1io0_A 105 ISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 162 (185)
T ss_dssp CCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred CCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCC
Confidence 9843 3556777889999999 8899976421 12345789999999985
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.25 E-value=2.3e-06 Score=89.26 Aligned_cols=125 Identities=14% Similarity=0.090 Sum_probs=78.4
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 145 (621)
+|+.++|.+ .++.+...+|.++++|+.++|++|+++.+....|. ..+|+.+.|.+| ++.+-...|.++++|+.++|.
T Consensus 158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~ 234 (401)
T 4fdw_A 158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIP 234 (401)
T ss_dssp CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECC
T ss_pred CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecC
Confidence 477777775 56656667788888888888887777755555555 477777777744 554555667777777777776
Q ss_pred ccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcc
Q 007020 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLD 196 (621)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~ 196 (621)
+| ++.+....|.+ .+|+.+.+ .|.++.+.... ..+++|+.+.+.+|..
T Consensus 235 ~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~ 283 (401)
T 4fdw_A 235 EN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTF 283 (401)
T ss_dssp TT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCC
T ss_pred CC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccc
Confidence 54 34344445555 56666666 34455554443 4555666666655543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.22 E-value=1.5e-06 Score=90.58 Aligned_cols=126 Identities=12% Similarity=0.088 Sum_probs=103.1
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCC-----CCCCccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFT-----GPIPDTLGKLSKL 139 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L 139 (621)
.+|+.|+|.+| ++.+...+|.+ .+|+.+.| .|.++.+....|.++++|+.++|.+|.+. ...+..|.++++|
T Consensus 226 ~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L 302 (401)
T 4fdw_A 226 SQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKL 302 (401)
T ss_dssp TTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTC
T ss_pred CCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccC
Confidence 47889999875 66666778888 89999999 56677677889999999999999998875 3456789999999
Q ss_pred ccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcc
Q 007020 140 RFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLD 196 (621)
Q Consensus 140 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~ 196 (621)
+.++|. |.++.+....|.+|.+|+.|.|..| ++.+.... ..+ +|+.+.+.+|..
T Consensus 303 ~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~ 357 (401)
T 4fdw_A 303 ARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTP 357 (401)
T ss_dssp CEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSC
T ss_pred CeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCC
Confidence 999999 4577677788999999999999655 77776665 556 899999998853
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.22 E-value=3e-08 Score=109.43 Aligned_cols=86 Identities=16% Similarity=0.118 Sum_probs=39.7
Q ss_pred CCCCCcEEEeeeCCCCCCCccccc-CCCccceeeeccc-cCCCC-CCcccccccccccccccccccCCCCCCCc----cC
Q 007020 87 LLKNLQYLELYSNNITGPIPSDLG-NLTSLVSLDLYLN-SFTGP-IPDTLGKLSKLRFLRLNNNSLSGPIPMSL----TN 159 (621)
Q Consensus 87 ~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~~----~~ 159 (621)
.+++|++|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++..+.++++|+.|+|++|.+++..+..+ ..
T Consensus 103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~ 182 (594)
T 2p1m_B 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT 182 (594)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence 345555555555555544343443 3555555555555 33311 22223345555555555555443322222 23
Q ss_pred CccccEEeeccCc
Q 007020 160 ISSLQVLDLSNNR 172 (621)
Q Consensus 160 l~~L~~L~l~~N~ 172 (621)
+++|+.|++++|.
T Consensus 183 ~~~L~~L~l~~~~ 195 (594)
T 2p1m_B 183 YTSLVSLNISCLA 195 (594)
T ss_dssp CCCCCEEECTTCC
T ss_pred CCcCcEEEecccC
Confidence 4455555555554
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=2.4e-06 Score=87.71 Aligned_cols=81 Identities=9% Similarity=0.008 Sum_probs=54.5
Q ss_pred cee-eeccCceEEEEEcC-------CCcEEEEEEecccCC--chhHHHHHHHHHHHHhccC---CceeeeeeeeecC---
Q 007020 302 NIL-GRGGFGKVYKGRLA-------DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVH---RNLLRLRGFCMTP--- 365 (621)
Q Consensus 302 ~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~--- 365 (621)
+.| +.|....+|+.... +++.+++|+...... ......+..|..+++.+.. -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78888999988754 267789998653220 0011356788888887752 3466777776554
Q ss_pred CceEEEEeccCCCchhh
Q 007020 366 TERLLVYPYMANGSVAS 382 (621)
Q Consensus 366 ~~~~lv~e~~~~gsL~~ 382 (621)
...++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.18 E-value=1.8e-07 Score=95.96 Aligned_cols=128 Identities=16% Similarity=0.241 Sum_probs=74.3
Q ss_pred CCcEEEEEcCCCC-ccccCcccccCCCCCcEEEeeeCCCCCCCccccc--CCCccceeeecc--ccCCCC-----CCccc
Q 007020 64 DNSVIRVDLGNAA-LSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLG--NLTSLVSLDLYL--NSFTGP-----IPDTL 133 (621)
Q Consensus 64 ~~~l~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~--N~l~~~-----~p~~~ 133 (621)
..+|+.|+|++|. ++ ++. +. +++|+.|+|..|.++......+. .+++|+.|+|+. |...+. +...+
T Consensus 171 ~P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l 246 (362)
T 2ra8_A 171 MPLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLF 246 (362)
T ss_dssp CTTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGS
T ss_pred CCCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHH
Confidence 3567777777662 32 222 32 67788888877776633323333 677888887753 221111 11122
Q ss_pred --ccccccccccccccccCCCCCCCcc---CCccccEEeeccCcCccc-----CCCCCCCCCcccccccCCc
Q 007020 134 --GKLSKLRFLRLNNNSLSGPIPMSLT---NISSLQVLDLSNNRLSGV-----VPDNGSFSLFTPISFANNL 195 (621)
Q Consensus 134 --~~l~~L~~L~l~~N~l~~~~p~~~~---~l~~L~~L~l~~N~l~~~-----~~~~~~~~~l~~l~l~~N~ 195 (621)
..+++|+.|+|++|.+.+..+..+. .+++|+.|+|+.|.|.+. ......+++|+.|++++|.
T Consensus 247 ~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~ 318 (362)
T 2ra8_A 247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNY 318 (362)
T ss_dssp CTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBB
T ss_pred hcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCc
Confidence 2467888888887777632222222 467788888888887763 2221346778888887774
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.03 E-value=4.1e-07 Score=93.28 Aligned_cols=113 Identities=16% Similarity=0.195 Sum_probs=82.3
Q ss_pred CCcEEEEEcCCCCccccCccccc--CCCCCcEEEeee--CCCCCC-----Ccccc--cCCCccceeeeccccCCCCCCcc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLG--LLKNLQYLELYS--NNITGP-----IPSDL--GNLTSLVSLDLYLNSFTGPIPDT 132 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~--N~l~~~-----~p~~~--~~l~~L~~L~L~~N~l~~~~p~~ 132 (621)
..+|+.|+|..+.+.......+. .+++|++|+|+. |...+. +...+ ..+++|+.|+|++|.+.+..+..
T Consensus 192 ~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~ 271 (362)
T 2ra8_A 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEM 271 (362)
T ss_dssp CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHH
T ss_pred CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHH
Confidence 35799999999988754444454 789999999974 222111 11223 35899999999999987533333
Q ss_pred cc---cccccccccccccccCCC----CCCCccCCccccEEeeccCcCccc
Q 007020 133 LG---KLSKLRFLRLNNNSLSGP----IPMSLTNISSLQVLDLSNNRLSGV 176 (621)
Q Consensus 133 ~~---~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~ 176 (621)
+. .+++|+.|+|+.|.|.+. ++..+.++++|+.|+|++|.|+..
T Consensus 272 la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~ 322 (362)
T 2ra8_A 272 FLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322 (362)
T ss_dssp HHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred HHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHH
Confidence 32 589999999999999853 445556789999999999988743
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.02 E-value=3.3e-05 Score=78.55 Aligned_cols=142 Identities=18% Similarity=0.258 Sum_probs=79.6
Q ss_pred ceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-----CCceeeee-e--eeecCCceEEEEe
Q 007020 302 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-----HRNLLRLR-G--FCMTPTERLLVYP 373 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e 373 (621)
+.|+.|..+.||+....+| .+++|+.... ...+..|..++..+. .|.++... | +....+..+++||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 3466677899999987554 5899988642 123344555555443 23333311 1 1224566789999
Q ss_pred ccCCCchh--------------hhhccCC-----CCC-----CCCCHHHH------------------------------
Q 007020 374 YMANGSVA--------------SCLRERP-----PSQ-----LPLDWPTR------------------------------ 399 (621)
Q Consensus 374 ~~~~gsL~--------------~~l~~~~-----~~~-----~~~~~~~~------------------------------ 399 (621)
|++|.++. ..+|... ... ....|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 1122110 000 00122211
Q ss_pred -HHHHHHHHHHHHHHHh----------CCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 400 -KRIALGSARGLSYLHD----------HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 400 -~~i~~~i~~~L~~LH~----------~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
..+...+..++++|+. ...+.++|+|+++.||+++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223446667763 0234899999999999998888899999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=3.1e-05 Score=80.63 Aligned_cols=76 Identities=11% Similarity=0.003 Sum_probs=48.9
Q ss_pred CceeeeccCceEEEEEcC-CCcEEEEEEecccCC------chhHHHHHHHHHHHHhccC--Cc-eeeeeeeeecCCceEE
Q 007020 301 KNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT------PGGELQFQTEVEMISMAVH--RN-LLRLRGFCMTPTERLL 370 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 370 (621)
.+.||.|.++.||++... +++.|+||....... ......+..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 357999999999999764 468899998653211 1122346778888877642 33 3345543 3456789
Q ss_pred EEeccCCC
Q 007020 371 VYPYMANG 378 (621)
Q Consensus 371 v~e~~~~g 378 (621)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.82 E-value=0.00014 Score=72.67 Aligned_cols=139 Identities=15% Similarity=0.145 Sum_probs=92.2
Q ss_pred CceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhcc---CCceeeeeeeeecCCceEEEEeccCC
Q 007020 301 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV---HRNLLRLRGFCMTPTERLLVYPYMAN 377 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~ 377 (621)
.+.|+.|....+|+... ++..+++|+.... ....+..|...++.+. ...+.+++++....+..++||||+++
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 45689999999999987 4678899986532 2456888988888774 35677888888777889999999998
Q ss_pred Cchhh-----------hhccCCC-CCC-----------------CCCHHHHH---HHH----------------HHHHHH
Q 007020 378 GSVAS-----------CLRERPP-SQL-----------------PLDWPTRK---RIA----------------LGSARG 409 (621)
Q Consensus 378 gsL~~-----------~l~~~~~-~~~-----------------~~~~~~~~---~i~----------------~~i~~~ 409 (621)
..+.. .++.... ... .-+|.... ++. ..+...
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 76521 2333221 000 12444321 111 111111
Q ss_pred -HHHHHh-CCCCCeEecCCCCCCeeeCCCCcEEEcccc
Q 007020 410 -LSYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFG 445 (621)
Q Consensus 410 -L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 445 (621)
...|.. ...|.++|+|+.+.|++++.++ +.|.||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223321 2356899999999999999887 8899984
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.75 E-value=3.9e-06 Score=75.86 Aligned_cols=58 Identities=12% Similarity=0.205 Sum_probs=27.6
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCC-CCCCCcccccCC----Cccceeeeccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNN-ITGPIPSDLGNL----TSLVSLDLYLN 123 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~L~~N 123 (621)
+|+.|||+++.|+..--..+..+++|+.|+|+++. |+..--..+..+ ++|++|+|+++
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C 124 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISC 124 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCC
Confidence 45555655555554433444555555555555542 443222223332 24555555554
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.75 E-value=9.9e-05 Score=73.12 Aligned_cols=80 Identities=19% Similarity=0.266 Sum_probs=56.1
Q ss_pred cCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccC---CceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH---RNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~ 372 (621)
......+.+|.|..+.||+.+..+|+.|.+|+..... ......|..|...|+.+.- --+.+++++ +..++||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~ 89 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAM 89 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEE
Confidence 3444567799999999999999999999999865433 2223357889998887742 123444444 2347899
Q ss_pred eccCCCch
Q 007020 373 PYMANGSV 380 (621)
Q Consensus 373 e~~~~gsL 380 (621)
||++++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987643
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.72 E-value=6.4e-06 Score=74.45 Aligned_cols=93 Identities=12% Similarity=0.054 Sum_probs=69.5
Q ss_pred cccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeecccc-CCCCCCcccccc----cccccccccccc-cCCCCCC
Q 007020 82 VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNS-FTGPIPDTLGKL----SKLRFLRLNNNS-LSGPIPM 155 (621)
Q Consensus 82 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~~~~p~ 155 (621)
|.....-.+|+.|||+++.|+..--..+.++++|+.|+|+++. |+..--..+..+ ++|+.|+|+++. |+..--.
T Consensus 54 P~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~ 133 (176)
T 3e4g_A 54 PTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGII 133 (176)
T ss_dssp CCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHH
T ss_pred CcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHH
Confidence 4433333579999999999996655678999999999999995 664222234443 479999999985 8754344
Q ss_pred CccCCccccEEeeccCc-Cc
Q 007020 156 SLTNISSLQVLDLSNNR-LS 174 (621)
Q Consensus 156 ~~~~l~~L~~L~l~~N~-l~ 174 (621)
.+..+++|+.|+|+++. ++
T Consensus 134 ~L~~~~~L~~L~L~~c~~It 153 (176)
T 3e4g_A 134 ALHHFRNLKYLFLSDLPGVK 153 (176)
T ss_dssp HGGGCTTCCEEEEESCTTCC
T ss_pred HHhcCCCCCEEECCCCCCCC
Confidence 57789999999999985 44
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00022 Score=74.84 Aligned_cols=79 Identities=11% Similarity=0.015 Sum_probs=48.0
Q ss_pred CCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCeeeecccccccccchhhhccCC---CCCcccchhHHHHHHHHH
Q 007020 419 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGIMLLELI 495 (621)
Q Consensus 419 ~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~ell 495 (621)
+.++|+|+++.|||++.++ ++++||+.+..-.....-...-..-...|++|+...... .....++.+....+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 4899999999999999876 999999998753311100000000113466666543111 112345567788888887
Q ss_pred hCC
Q 007020 496 TGQ 498 (621)
Q Consensus 496 tg~ 498 (621)
++.
T Consensus 311 ~~~ 313 (420)
T 2pyw_A 311 NKR 313 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00055 Score=68.17 Aligned_cols=71 Identities=10% Similarity=0.073 Sum_probs=44.8
Q ss_pred CceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCcee-eeeeeeecCCceEEEEecc-CCC
Q 007020 301 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL-RLRGFCMTPTERLLVYPYM-ANG 378 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~-~~g 378 (621)
.+.|+.|....+|+. +.+++|+...... .......|..+++.+....+. +++++ +.+.-++++||+ ++.
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE--EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCcc--ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 567999999999999 4588888754311 111245677777766533333 44444 344567899999 654
Q ss_pred ch
Q 007020 379 SV 380 (621)
Q Consensus 379 sL 380 (621)
++
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00044 Score=71.29 Aligned_cols=137 Identities=15% Similarity=0.129 Sum_probs=92.9
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 145 (621)
.++.+.+..+ +..+....|..+.+|+.+.+..+ ++.+-...|.++.+|+.+.+..+ ++..-...|.++++|+.+.+.
T Consensus 218 ~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~ 294 (379)
T 4h09_A 218 NLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMD 294 (379)
T ss_dssp SCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEEC
T ss_pred ccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccccccccc
Confidence 3445555433 44345566777888888888765 66566677888888888888655 553445678888888888888
Q ss_pred ccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcccCCCCCCCCC
Q 007020 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDLCGPVTGRPC 206 (621)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~~~~~~~~~c 206 (621)
+|.++.+....|.+|.+|+.+.|..+ ++.+.... ..+.+|+.+.+..|-..-|......|
T Consensus 295 ~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~v~~I~~~aF~~c 355 (379)
T 4h09_A 295 NSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKSITLIESGAFEGS 355 (379)
T ss_dssp CTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTTTTS
T ss_pred ccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCccCEEchhHhhCC
Confidence 88887666778888888888888654 66665554 56677888887665433333333334
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00016 Score=75.17 Aligned_cols=116 Identities=6% Similarity=0.122 Sum_probs=77.8
Q ss_pred ccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccccccccCCCCCCC
Q 007020 77 LSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMS 156 (621)
Q Consensus 77 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 156 (621)
++.+-..+|.++.+|+.+.+.++..+ +....|.++++|+.+.+. +.++..-...|.++.+|+.++|..| ++.+....
T Consensus 253 v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~a 329 (394)
T 4gt6_A 253 VARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDA 329 (394)
T ss_dssp EEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTT
T ss_pred ceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhH
Confidence 44344556777788888887665544 556677778888888875 4455344566777888888887654 55455567
Q ss_pred ccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcc
Q 007020 157 LTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLD 196 (621)
Q Consensus 157 ~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~ 196 (621)
|.+|.+|+.+.+..+ ++.+.... ..+.+|+.+.+.+|..
T Consensus 330 F~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 330 FAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp TTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred hhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence 778888888887544 55555444 5667778887777654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00091 Score=67.57 Aligned_cols=142 Identities=18% Similarity=0.126 Sum_probs=72.4
Q ss_pred ceeeeccCce-EEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccC--CceeeeeeeeecCCceEEEEeccCCC
Q 007020 302 NILGRGGFGK-VYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH--RNLLRLRGFCMTPTERLLVYPYMANG 378 (621)
Q Consensus 302 ~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 378 (621)
+.|+.|.... +|+....+|+.+++|....... ..+..|+.++..+.. -.+.+++.+..+. -+++||++.+.
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~ 97 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDA 97 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCc
Confidence 3465555444 6677654467787876543210 234556666666542 2344566653322 37899999876
Q ss_pred chhhhhccC---------------------CCCCCC-CCHHHHH-------H-------------HHHHHHHHHHHHHh-
Q 007020 379 SVASCLRER---------------------PPSQLP-LDWPTRK-------R-------------IALGSARGLSYLHD- 415 (621)
Q Consensus 379 sL~~~l~~~---------------------~~~~~~-~~~~~~~-------~-------------i~~~i~~~L~~LH~- 415 (621)
++.+.+... .....+ ++..... . ....+...++.+..
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 665433211 110111 2211100 0 00111122233311
Q ss_pred --CCCCCeEecCCCCCCeeeCCC----CcEEEccccccee
Q 007020 416 --HCDPKIIHRDVKAANILLDEE----FEAVVGDFGLAKL 449 (621)
Q Consensus 416 --~~~~~ivH~Dlk~~Nill~~~----~~~kl~DfGla~~ 449 (621)
...+.++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123489999999999999874 6799999998875
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.26 E-value=1.6e-05 Score=73.15 Aligned_cols=62 Identities=19% Similarity=0.222 Sum_probs=29.2
Q ss_pred CcEEEEEcCCC-Cccc----cCcccccCCCCCcEEEeeeCCCCCC----CcccccCCCccceeeeccccCC
Q 007020 65 NSVIRVDLGNA-ALSG----QLVSQLGLLKNLQYLELYSNNITGP----IPSDLGNLTSLVSLDLYLNSFT 126 (621)
Q Consensus 65 ~~l~~L~L~~n-~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 126 (621)
..|+.|+|++| +|.. .+...+..-+.|+.|+|++|+|... +...+..-+.|+.|+|++|.|.
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 34555666553 4442 1233444445555555555555521 2223333445555555555554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00036 Score=72.42 Aligned_cols=124 Identities=17% Similarity=0.137 Sum_probs=84.5
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
..|+.+.+.++-.+ +....|.++++|+.+.+. +.++.+....|.++.+|+.++|..| ++..-..+|.++++|+.+.|
T Consensus 265 ~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~i 341 (394)
T 4gt6_A 265 AYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAI 341 (394)
T ss_dssp SSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEE
T ss_pred ccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEE
Confidence 35666777655333 556678888999999986 5566566778999999999999865 66455677889999999999
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCC
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANN 194 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N 194 (621)
..+ ++.+....|.+|.+|+.+++.+|.... .......+|+.+.+..|
T Consensus 342 p~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~--~~~~~~~~L~~i~i~~~ 388 (394)
T 4gt6_A 342 PSS-VTKIPESAFSNCTALNNIEYSGSRSQW--NAISTDSGLQNLPVAPG 388 (394)
T ss_dssp CTT-CCBCCGGGGTTCTTCCEEEESSCHHHH--HTCBCCCCC--------
T ss_pred Ccc-cCEEhHhHhhCCCCCCEEEECCceeeh--hhhhccCCCCEEEeCCC
Confidence 755 664666788899999999998876542 12234456666666544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0033 Score=63.19 Aligned_cols=143 Identities=16% Similarity=0.143 Sum_probs=81.3
Q ss_pred ceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCc--eeeeeee-----eecCCceEEEEec
Q 007020 302 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN--LLRLRGF-----CMTPTERLLVYPY 374 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~e~ 374 (621)
..++ |....||+....+|+.+++|..+.... ....+..|..++..+.... +.+++.. ....+..+++|+|
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 3566 888899998877777899999864322 2345667887777664222 3444433 1123456789999
Q ss_pred cCCCchhh--------------hhcc----CCC-CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhC
Q 007020 375 MANGSVAS--------------CLRE----RPP-SQLPLDWPTR----KRI---------------ALGSARGLSYLHDH 416 (621)
Q Consensus 375 ~~~gsL~~--------------~l~~----~~~-~~~~~~~~~~----~~i---------------~~~i~~~L~~LH~~ 416 (621)
++|..+.. .+|. ... ....+++... ..+ ...+...++.+...
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 99854321 0111 000 0011222111 000 11111223333221
Q ss_pred ----CCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 417 ----CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 417 ----~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
..+.++|+|+++.||+++ + .+.|+||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234688999999999999 4 899999998764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00052 Score=70.77 Aligned_cols=111 Identities=11% Similarity=0.088 Sum_probs=90.1
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
..|+.+.+..+ ++.+-...|.++.+|+.+.+..+ ++.+....|.++++|+.+.|.+|.++..-...|.++.+|+.+.|
T Consensus 240 ~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~l 317 (379)
T 4h09_A 240 KALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTL 317 (379)
T ss_dssp SSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEEC
T ss_pred ccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEc
Confidence 46888888765 66566778999999999999765 66566678999999999999999998666778999999999999
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCCC
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 179 (621)
..+ ++.+....|.+|.+|+.+.+..+ ++.+...
T Consensus 318 p~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~ 350 (379)
T 4h09_A 318 PTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESG 350 (379)
T ss_dssp CTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred Ccc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchh
Confidence 765 66566778999999999998755 5555443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0029 Score=63.42 Aligned_cols=159 Identities=9% Similarity=0.043 Sum_probs=85.9
Q ss_pred CHHHHHHHhcCCCcC-----ceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCc--eeeee
Q 007020 287 SLRELQVATDSFSNK-----NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN--LLRLR 359 (621)
Q Consensus 287 ~~~~~~~~~~~~~~~-----~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~ 359 (621)
+.+++.....+|... +.|+.|....+|+....+| .+++|+...... ...+..|..++..+.... +.+++
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCccc
Confidence 344455444456542 3466788889999987655 688998765211 224556777776664222 22333
Q ss_pred ee------eecCCceEEEEeccCCCchhh--------------hhccC----CCCC-CCC---CHHHHHH----------
Q 007020 360 GF------CMTPTERLLVYPYMANGSVAS--------------CLRER----PPSQ-LPL---DWPTRKR---------- 401 (621)
Q Consensus 360 ~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~----~~~~-~~~---~~~~~~~---------- 401 (621)
.. ....+..+++|+|++|..+.. .++.. .... ... .|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 112355689999999865421 12211 0000 001 1221100
Q ss_pred --HHHHHHHHHHHHHhC----CCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 402 --IALGSARGLSYLHDH----CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 402 --i~~~i~~~L~~LH~~----~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+...+.+.+++++.. ..++++|+|+++.|||++.+..+.|+||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011234455555532 234799999999999999876668999998763
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.15 E-value=0.00047 Score=59.15 Aligned_cols=56 Identities=29% Similarity=0.317 Sum_probs=39.8
Q ss_pred EEEcCCCCcc-ccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCC
Q 007020 69 RVDLGNAALS-GQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFT 126 (621)
Q Consensus 69 ~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 126 (621)
.++.++++|+ ..+|..+. ++|++|+|++|+|+.+.+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5788888887 24454332 46788888888888666667777888888888887765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.14 E-value=0.001 Score=69.81 Aligned_cols=72 Identities=17% Similarity=0.223 Sum_probs=48.5
Q ss_pred ceeeeccCceEEEEEcCC--------CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCce-eeeeeeeecCCceEEEE
Q 007020 302 NILGRGGFGKVYKGRLAD--------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVY 372 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 372 (621)
+.|+.|....||+....+ ++.|++|+...... ...+..|..+++.+...++ .++++.+.+ .+|+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 468888889999998653 57899998743211 1345578888887754444 456665432 3899
Q ss_pred eccCCCch
Q 007020 373 PYMANGSV 380 (621)
Q Consensus 373 e~~~~gsL 380 (621)
||++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987444
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.00045 Score=59.32 Aligned_cols=56 Identities=23% Similarity=0.288 Sum_probs=32.5
Q ss_pred EEEeeeCCCC-CCCcccccCCCccceeeeccccCCCCCCcccccccccccccccccccC
Q 007020 93 YLELYSNNIT-GPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLS 150 (621)
Q Consensus 93 ~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 150 (621)
.++.++++|+ ..+|..+. ++|+.|+|++|+|+.+.++.|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5666666665 23443322 24666666666666544555666666666666666553
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00099 Score=69.09 Aligned_cols=137 Identities=9% Similarity=0.035 Sum_probs=73.0
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+|+.+.|.. .++.+-..+|.++++|+.++|.+| ++.+-...|.++.+|+.+.+..+ ++..-...|.++..+.....
T Consensus 71 ~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~~~~~~ 147 (394)
T 4fs7_A 71 RKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFKEITIP 147 (394)
T ss_dssp TTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCSEEECC
T ss_pred CCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccccccccC
Confidence 4577777764 365555566777777777777644 55445556777777776666544 22133333444433322222
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcccCCCCCCCCCC
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDLCGPVTGRPCP 207 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~~~~~~~~~c~ 207 (621)
..... .....|.++++|+.+.+.++. ..+.... ..+.+|+.+.+..|-..-+......|.
T Consensus 148 ~~~~~--i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~~~~I~~~~F~~~~ 208 (394)
T 4fs7_A 148 EGVTV--IGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRNLKIIRDYCFAECI 208 (394)
T ss_dssp TTCCE--ECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTTCCEECTTTTTTCT
T ss_pred ccccc--cchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCCceEeCchhhcccc
Confidence 22211 223456677777777776543 3343333 455667777776664433333333443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.00076 Score=69.97 Aligned_cols=84 Identities=11% Similarity=0.055 Sum_probs=52.4
Q ss_pred cccCCCccceeeeccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCc
Q 007020 108 DLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLF 186 (621)
Q Consensus 108 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l 186 (621)
.|..+.+|+.+.+.+| ++..-...|.++++|+.++|.++ ++.+....|.+|.+|+.+++..| ++.+.... ..+.+|
T Consensus 292 ~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L 368 (394)
T 4fs7_A 292 TFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINL 368 (394)
T ss_dssp TTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTC
T ss_pred cccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCC
Confidence 4566666666666554 44334456777777777777544 55444566777777777777665 65555544 556667
Q ss_pred ccccccCC
Q 007020 187 TPISFANN 194 (621)
Q Consensus 187 ~~l~l~~N 194 (621)
+.+.+..|
T Consensus 369 ~~i~lp~~ 376 (394)
T 4fs7_A 369 KKVELPKR 376 (394)
T ss_dssp CEEEEEGG
T ss_pred CEEEECCC
Confidence 77766554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.003 Score=64.78 Aligned_cols=142 Identities=16% Similarity=0.144 Sum_probs=82.4
Q ss_pred ceeeeccCceEEEEEcC--------CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCce-eeeeeeeecCCceEEEE
Q 007020 302 NILGRGGFGKVYKGRLA--------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVY 372 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 372 (621)
+.|..|-...+|+.... +++.|++|+.... ......+.+|..+++.+.-.++ .++++++.+ .+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 45777888899999864 2478999986321 1223456789998887753222 456666543 3999
Q ss_pred eccCCCchhhh-----------------hccCCC-CCCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 007020 373 PYMANGSVASC-----------------LRERPP-SQLPLD--WPTRKRIALGSAR-------------------GLSYL 413 (621)
Q Consensus 373 e~~~~gsL~~~-----------------l~~~~~-~~~~~~--~~~~~~i~~~i~~-------------------~L~~L 413 (621)
||++|.+|..- +|.... ...... +.++.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998655311 122111 011122 3444444443321 23333
Q ss_pred H----hC-CCCCeEecCCCCCCeeeCCC----CcEEEccccccee
Q 007020 414 H----DH-CDPKIIHRDVKAANILLDEE----FEAVVGDFGLAKL 449 (621)
Q Consensus 414 H----~~-~~~~ivH~Dlk~~Nill~~~----~~~kl~DfGla~~ 449 (621)
. .. ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 21 23378899999999999876 7899999998864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0026 Score=65.24 Aligned_cols=73 Identities=8% Similarity=0.050 Sum_probs=43.6
Q ss_pred ceeeeccCceEEEEEcCC---------CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCce-eeeeeeeecCCceEEE
Q 007020 302 NILGRGGFGKVYKGRLAD---------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLV 371 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv 371 (621)
+.|+.|....+|+....+ ++.+++|+..... ........|..+++.+...++ .++++.. .-++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cceecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence 457788889999998653 2688888864321 111134678888877753343 3565543 23789
Q ss_pred EeccCCCch
Q 007020 372 YPYMANGSV 380 (621)
Q Consensus 372 ~e~~~~gsL 380 (621)
|||++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999998544
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0037 Score=65.90 Aligned_cols=73 Identities=10% Similarity=0.101 Sum_probs=47.1
Q ss_pred ceeeeccCceEEEEEcCC-CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCce-eeeeeeeecCCceEEEEeccCCCc
Q 007020 302 NILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVYPYMANGS 379 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs 379 (621)
+.|+.|-...+|+....+ +..|++|+..... . .......|..++..+...++ .++++.+. + .+||||++|.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-D-EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C-C-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-h-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 568888889999998764 4788898874322 1 11123588888888865444 45666652 2 35999999855
Q ss_pred h
Q 007020 380 V 380 (621)
Q Consensus 380 L 380 (621)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0061 Score=61.63 Aligned_cols=31 Identities=26% Similarity=0.354 Sum_probs=27.8
Q ss_pred CCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 419 PKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 419 ~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999988764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.59 E-value=0.00012 Score=67.44 Aligned_cols=114 Identities=12% Similarity=0.103 Sum_probs=78.7
Q ss_pred CcccccCCCCCcEEEeeeC-CCCC----CCcccccCCCccceeeeccccCCCC----CCcccccccccccccccccccCC
Q 007020 81 LVSQLGLLKNLQYLELYSN-NITG----PIPSDLGNLTSLVSLDLYLNSFTGP----IPDTLGKLSKLRFLRLNNNSLSG 151 (621)
Q Consensus 81 ~~~~~~~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~ 151 (621)
+...+.+-+.|++|+|++| +|.. .+...+..-+.|+.|+|++|+|... +.+.+..-+.|+.|+|++|.|..
T Consensus 33 l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~ 112 (197)
T 1pgv_A 33 INRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 112 (197)
T ss_dssp HHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred HHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence 3445556689999999985 8873 2455677788999999999999832 33445567899999999999984
Q ss_pred C----CCCCccCCccccEEeeccCc---CcccC-----CCCCCCCCcccccccCC
Q 007020 152 P----IPMSLTNISSLQVLDLSNNR---LSGVV-----PDNGSFSLFTPISFANN 194 (621)
Q Consensus 152 ~----~p~~~~~l~~L~~L~l~~N~---l~~~~-----~~~~~~~~l~~l~l~~N 194 (621)
. +-..+..-+.|+.|+|++|. |.... .....-+.|+.|+++.|
T Consensus 113 ~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~ 167 (197)
T 1pgv_A 113 ELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 167 (197)
T ss_dssp HHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCC
Confidence 2 22244555679999998763 33211 11123456777887655
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.20 E-value=0.061 Score=49.71 Aligned_cols=101 Identities=16% Similarity=0.110 Sum_probs=64.4
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee
Q 007020 378 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457 (621)
Q Consensus 378 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 457 (621)
-||.+.|...+ .++++.+++.++.|.+.+|.-+-....+ ..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc---------
Confidence 37888888754 3599999999999999998876321111 1233456888899998887763 1110
Q ss_pred eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCC
Q 007020 458 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQ 498 (621)
Q Consensus 458 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~ 498 (621)
.....+.|||... ...+.+.=|||+|+++|.-+-=.
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 1233466888763 34467788999999999988633
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.85 E-value=0.0057 Score=40.49 Aligned_cols=34 Identities=24% Similarity=0.217 Sum_probs=24.2
Q ss_pred CcceeeeeehhhhHHHhhhhHHHHHhhhcCCCCc
Q 007020 232 ATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQE 265 (621)
Q Consensus 232 ~~~~i~~~v~~~~~~~~~~~~~~~~~~~r~~~~~ 265 (621)
.+.+|++++++|++.++++.+..++++|||+.++
T Consensus 9 ~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~~ 42 (44)
T 2ks1_B 9 KIPSIATGMVGALLLLLVVALGIGLFMRRRHIVR 42 (44)
T ss_dssp CSSSSTHHHHHHHHHHHHHHHHHHHHHHTTTCCS
T ss_pred CcceEEeehhHHHHHHHHHHHHHHHHhhhhHhhc
Confidence 3456888888888777777777777777766543
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.32 E-value=0.0087 Score=39.49 Aligned_cols=35 Identities=26% Similarity=0.306 Sum_probs=25.1
Q ss_pred CCcceeeeeehhhhHHHhhhhHHHHHhhhcCCCCc
Q 007020 231 SATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQE 265 (621)
Q Consensus 231 ~~~~~i~~~v~~~~~~~~~~~~~~~~~~~r~~~~~ 265 (621)
+....|++++++|++.++++.+..|+++|||+.++
T Consensus 7 s~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 7 ARTPLIAAGVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp CSSHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred CCcceEEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 34456888888888887777777777777776554
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.10 E-value=0.044 Score=56.93 Aligned_cols=73 Identities=5% Similarity=0.063 Sum_probs=47.1
Q ss_pred ceeeeccCceEEEEEcCC--------CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCce-eeeeeeeecCCceEEEE
Q 007020 302 NILGRGGFGKVYKGRLAD--------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVY 372 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 372 (621)
+.+..|-...+|+....+ ++.|++|+..... .......+|..+++.+...++ .++++.+ .-++||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ 149 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE 149 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence 457778888999998653 5789999864321 111234678888877753333 3455433 237899
Q ss_pred eccCCCch
Q 007020 373 PYMANGSV 380 (621)
Q Consensus 373 e~~~~gsL 380 (621)
||++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.58 E-value=0.12 Score=53.40 Aligned_cols=30 Identities=30% Similarity=0.453 Sum_probs=25.4
Q ss_pred CeEecCCCCCCeee------CCCCcEEEccccccee
Q 007020 420 KIIHRDVKAANILL------DEEFEAVVGDFGLAKL 449 (621)
Q Consensus 420 ~ivH~Dlk~~Nill------~~~~~~kl~DfGla~~ 449 (621)
.++|+|+.+.|||+ +++..+.++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567799999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.87 E-value=0.54 Score=43.30 Aligned_cols=116 Identities=11% Similarity=0.108 Sum_probs=78.8
Q ss_pred cCCceeeeeeeeecCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 007020 351 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAAN 430 (621)
Q Consensus 351 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 430 (621)
.||+++.. .+-.+++...+.++.-+.+.=...++. .+...+++++.+|+....++++. +|--++|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~-------~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS-------FTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG-------SCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh-------cCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 57888865 455566666666665543322233443 67789999999999888777665 788999999
Q ss_pred eeeCCCCcEEEcccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcc
Q 007020 431 ILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 502 (621)
Q Consensus 431 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~ 502 (621)
++++.++.+++.-.|+...+. |. ..+...=.-.+=+++..+++++..|+
T Consensus 110 L~f~~~~~p~i~~RGik~~l~------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVVD------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTBS------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCCC------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999998777643221 11 00111112345678889999999886
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=88.41 E-value=0.13 Score=33.80 Aligned_cols=28 Identities=21% Similarity=0.272 Sum_probs=14.8
Q ss_pred eeeeehhhhHHHhhhhHHHHHhhhcCCCC
Q 007020 236 IAGGVAAGAALLFAAPAIAFAWWRRRKPQ 264 (621)
Q Consensus 236 i~~~v~~~~~~~~~~~~~~~~~~~r~~~~ 264 (621)
++++++ |+++++++.+..++|.|||+.+
T Consensus 14 Ia~~vV-Gvll~vi~~l~~~~~~RRR~~~ 41 (44)
T 2jwa_A 14 IISAVV-GILLVVVLGVVFGILIKRRQQK 41 (44)
T ss_dssp HHHHHH-HHHHHHHHHHHHHHHHHHHCSC
T ss_pred hHHHHH-HHHHHHHHHHHHHhheehhhhh
Confidence 444433 3555555555556666666544
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=86.40 E-value=0.26 Score=31.47 Aligned_cols=28 Identities=18% Similarity=-0.059 Sum_probs=12.1
Q ss_pred ceeeeeehhhhHHHhhhhHHHHHhhhcC
Q 007020 234 GAIAGGVAAGAALLFAAPAIAFAWWRRR 261 (621)
Q Consensus 234 ~~i~~~v~~~~~~~~~~~~~~~~~~~r~ 261 (621)
.+++..++..++.+.++.++.|+++|||
T Consensus 11 GaIAGiVvG~v~gv~li~~l~~~~~rrr 38 (38)
T 2k1k_A 11 GEIVAVIFGLLLGAALLLGILVFRSRRA 38 (38)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHCCC
T ss_pred CceeeeehHHHHHHHHHHHHHHHHeecC
Confidence 3444433333333333444445555543
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.46 E-value=1.6 Score=40.25 Aligned_cols=115 Identities=16% Similarity=0.181 Sum_probs=77.5
Q ss_pred cCCceeeeeeeeecCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEecCCCCC
Q 007020 351 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS-YLHDHCDPKIIHRDVKAA 429 (621)
Q Consensus 351 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~-~LH~~~~~~ivH~Dlk~~ 429 (621)
.||++ -..+-.+++...+.++.-+++.=...++. ++...+++++.+|+.... +++.. +|--++|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-------~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-------TTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-------SCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-------cCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCc
Confidence 47777 44445667777777776545433444443 677899999999888777 66554 78889999
Q ss_pred CeeeCCCCcEEEcccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcc
Q 007020 430 NILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 502 (621)
Q Consensus 430 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~ 502 (621)
|++++.++.++|.-.|+-..+ +|.-+ +..-=.-.+=+++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~l------------------pP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESL------------------PPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTTB------------------SSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcccC------------------CCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999877764322 22111 111112345677888888888885
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.19 E-value=0.21 Score=52.59 Aligned_cols=61 Identities=5% Similarity=0.008 Sum_probs=17.9
Q ss_pred cCceeeeccCceEEEEEcCC-CcEEEE------EEecccCCc-hhHHHHHHHHHHHHhccCCceeeeeeeee
Q 007020 300 NKNILGRGGFGKVYKGRLAD-GSLVAV------KRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCM 363 (621)
Q Consensus 300 ~~~~lG~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 363 (621)
+.+.|| ||.||+|.+.. ...||| |..+..... .....+.+|..++...+|+|+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 445676 99999999853 357888 766543322 22345778888888899999999988754
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.13 E-value=0.44 Score=31.06 Aligned_cols=29 Identities=41% Similarity=0.646 Sum_probs=14.2
Q ss_pred cceeeeeehhhhHHHhhhhHHHHHhhhcC
Q 007020 233 TGAIAGGVAAGAALLFAAPAIAFAWWRRR 261 (621)
Q Consensus 233 ~~~i~~~v~~~~~~~~~~~~~~~~~~~r~ 261 (621)
...+++++++|++++++++.+.++++||+
T Consensus 12 ~~~I~~~vv~Gv~ll~~iv~~~~~~~rRr 40 (41)
T 2k9y_A 12 NLAVIGGVAVGVVLLLVLAGVGFFIHRRR 40 (41)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHSSSSSC
T ss_pred eEEEEeehhHHHHHHHHHHHHheeEeeec
Confidence 34455666666555442344444444443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 621 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-65 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-63 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-04 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-10 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.004 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.003 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 9e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 4e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 6e-66
Identities = 75/283 (26%), Positives = 125/283 (44%), Gaps = 27/283 (9%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRN 354
+ +G G FG VYKG+ VAVK L +LQ F+ EV ++ H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
+L G+ T + +V + S+ L + IA +A+G+ YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLH 121
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYL 473
IIHRD+K+ NI L E+ +GDFGLA + + +H + G+I +APE +
Sbjct: 122 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 474 STGKS---SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530
S ++DV+ +GI+L EL+TGQ + ++ D + ++ L
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPY--------SNINNRDQIIFMVGRGYL--- 227
Query: 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
PDL + + ++ C + +RP +++ +E
Sbjct: 228 -SPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 4e-65
Identities = 72/278 (25%), Positives = 124/278 (44%), Gaps = 25/278 (8%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 355
++ LG G FG+V+ G + VAVK LK+ F E ++ H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRL 70
Query: 356 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 415
+RL T ++ YM NGS+ L+ + L +A A G++++ +
Sbjct: 71 VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE 127
Query: 416 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 475
IHRD++AANIL+ + + DFGLA+L++ + + I APE ++
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 476 GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 535
G + K+DV+ +GI+L E++T R + ++ + E+ M+ +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPY----PGMTNPEVIQNL-----ERGYRMVRPDNC 235
Query: 536 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
E+L Q+ LC + P DRP + +LE
Sbjct: 236 --------PEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 6e-64
Identities = 71/290 (24%), Positives = 127/290 (43%), Gaps = 30/290 (10%)
Query: 292 QVATDSFSNKNILGRGGFGKVYKGRLADGS-----LVAVKRLKEERTPGGELQFQTEVEM 346
++ + + ++G G FG+VYKG L S VA+K LK T + F E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 347 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGS 406
+ H N++RL G +++ YM NG++ LRE+ + G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGI 119
Query: 407 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGT 464
A G+ YL + +HRD+ A NIL++ V DFGL++++ D + T+ T+ +
Sbjct: 120 AAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 465 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 524
I APE +S K + +DV+ +GI++ E++T L
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-----------------LSN 219
Query: 525 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574
++ ++ + + Q+ + C Q RPK +++V +L+
Sbjct: 220 HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 210 bits (534), Expect = 1e-63
Identities = 73/314 (23%), Positives = 128/314 (40%), Gaps = 47/314 (14%)
Query: 287 SLRELQVATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQF 340
L L+ ++ +G G FG+V++ R ++VAVK LKEE + + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 341 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQL-------- 392
Q E +++ + N+++L G C L++ YMA G + LR P +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 393 ------------PLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV 440
PL + IA A G++YL + K +HRD+ N L+ E
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 441 VGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQR 499
+ DFGL++ + D I + PE + + + ++DV+ YG++L E+ +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 500 AFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSP 559
G+ E+ + + D ++ E +L + LC P
Sbjct: 241 ----------------QPYYGMAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLP 283
Query: 560 MDRPKMSEVVRMLE 573
DRP + R+L+
Sbjct: 284 ADRPSFCSIHRILQ 297
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 1e-63
Identities = 66/278 (23%), Positives = 118/278 (42%), Gaps = 25/278 (8%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 355
+ +G G FG V+ G + VA+K ++E E F E E++ H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKL 62
Query: 356 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 415
++L G C+ LV+ +M +G ++ LR + T + L G++YL +
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF---AAETLLGMCLDVCEGMAYLEE 119
Query: 416 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 475
C +IHRD+ A N L+ E V DFG+ + + +T + + +PE S
Sbjct: 120 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 476 GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 535
+ S K+DV+ +G+++ E+ + + N + +++ + L P L
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPY----ENRSNSEVVEDI------STGFRLYKPRL 226
Query: 536 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ Q+ C + P DRP S ++R L
Sbjct: 227 -------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 209 bits (532), Expect = 2e-63
Identities = 73/306 (23%), Positives = 125/306 (40%), Gaps = 42/306 (13%)
Query: 286 FSLRELQVATDSFSNK---------NILGRGGFGKVYKGRLA----DGSLVAVKRLKEER 332
F+ + A F+ + ++G G FG+V G L VA+K LK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 333 TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQL 392
T F +E ++ H N++ L G T +++ +M NGS+ S LR+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--- 123
Query: 393 PLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452
+ G A G+ YL D +HRD+ A NIL++ V DFGL++ ++
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 453 KDTHVTT----AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLA 507
+ T + I APE + K + +DV+ YGI++ E+++ G+R +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW----- 235
Query: 508 NDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSE 567
+ + + ++ D + L Q+ L C Q RPK +
Sbjct: 236 -------------DMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282
Query: 568 VVRMLE 573
+V L+
Sbjct: 283 IVNTLD 288
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 9e-63
Identities = 83/281 (29%), Positives = 122/281 (43%), Gaps = 31/281 (11%)
Query: 301 KNILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 356
++GRG FG VY G L D AVK L G QF TE ++ H N+L
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 357 RLRGFCM-TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 415
L G C+ + L+V PYM +G + + +R L A+G+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGM---KF 145
Query: 416 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAPEY 472
K +HRD+ A N +LDE+F V DFGLA+ M ++ H T + + +A E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 473 LSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532
L T K + K+DV+ +G++L EL+T DV D LL+ ++L
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPP-------YPDVNTFDITVYLLQGRRLL---Q 255
Query: 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
P+ + L +V L C RP SE+V +
Sbjct: 256 PEY-------CPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 3e-62
Identities = 64/294 (21%), Positives = 115/294 (39%), Gaps = 29/294 (9%)
Query: 301 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG 360
+ +G+G FG+V++G+ G VAVK + E+ M H N+L
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIA 64
Query: 361 FCM----TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 416
T T+ LV Y +GS+ L + ++AL +A GL++LH
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHME 119
Query: 417 C-----DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV---TTAVRGTIGHI 468
P I HRD+K+ NIL+ + + D GLA D + GT ++
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 469 APEYLST------GKSSEKTDVFGYGIMLLELITGQRAFDLARLAND--DDVMLLDWVKG 520
APE L +S ++ D++ G++ E+ + D++ D
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 521 LLKEKKLEMLVDPDLQNNYVEAEV-EQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
+++ E + P++ N + E + ++ C + R + + L
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 1e-61
Identities = 63/292 (21%), Positives = 119/292 (40%), Gaps = 32/292 (10%)
Query: 289 RELQVATDSFSNKNI-LGRGGFGKVYKGRLA---DGSLVAVKRLKEERTPGGELQFQTEV 344
++L + D+ +I LG G FG V +G VA+K LK+ + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 345 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIAL 404
+++ + ++RL G C +LV G + L + + +
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLH 116
Query: 405 GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVR 462
+ G+ YL + +HRD+ A N+LL A + DFGL+K + D++ T +A +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 463 GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGL 521
+ APE ++ K S ++DV+ YG+ + E ++ GQ+ + ++ +++
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK-----KMKGPEVMAFIE-- 226
Query: 522 LKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ M P+ +L + C DRP V + +
Sbjct: 227 ---QGKRMECPPEC--------PPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 8e-61
Identities = 62/332 (18%), Positives = 129/332 (38%), Gaps = 54/332 (16%)
Query: 291 LQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISM 349
+++ D F + LG G G V+K G ++A K + E P Q E++++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 350 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARG 409
++ G + E + +M GS+ L++ + ++++ +G
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKG 116
Query: 410 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 469
L+YL + KI+HRDVK +NIL++ E + DFG++ + + + GT +++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMS 171
Query: 470 PEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529
PE L S ++D++ G+ L+E+ G+ A + ++M V+G E
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP-PPDAKELELMFGCQVEGDAAETPPRP 230
Query: 530 LVD-----------------------------PDLQNNYVEAEVEQLIQVALLCTQGSPM 560
P L + E + + C +P
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN---KCLIKNPA 287
Query: 561 DRPKMSEVVRMLEGDGLAERW---DEWQKVEV 589
+R + ++ + + + ++V+
Sbjct: 288 ERADLKQL--------MVHAFIKRSDAEEVDF 311
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-60
Identities = 69/302 (22%), Positives = 118/302 (39%), Gaps = 41/302 (13%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMIS- 348
+ S LG G FGKV + VAVK LK +E++++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 349 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPS--------------QLPL 394
+ H N++ L G C L++ Y G + + LR + S +L L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 395 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454
D + A+G+++L IHRD+ A NILL + DFGLA+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 455 TH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 513
+ V R + +APE + + ++DV+ YGI L EL + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246
Query: 514 LLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
G+ + K ++ + E ++ + C P+ RP ++V+++E
Sbjct: 247 ---PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
Query: 574 GD 575
Sbjct: 304 KQ 305
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 200 bits (510), Expect = 3e-60
Identities = 73/291 (25%), Positives = 123/291 (42%), Gaps = 25/291 (8%)
Query: 284 KRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQT 342
+ + ++ + K+ LG G +G+VY+G VAVK LKE+ E F
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLK 62
Query: 343 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRI 402
E ++ H NL++L G C ++ +M G++ LRE + +
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ--EVSAVVLLYM 120
Query: 403 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 462
A + + YL IHRD+ A N L+ E V DFGL++LM +
Sbjct: 121 ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
Query: 463 GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 522
I APE L+ K S K+DV+ +G++L E+ T + +
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-----------------PGI 220
Query: 523 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
++ L++ D + E E++ ++ C Q +P DRP +E+ + E
Sbjct: 221 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 5e-60
Identities = 75/278 (26%), Positives = 119/278 (42%), Gaps = 25/278 (8%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 355
+S + LG+G FG+V+ G + VA+K LK F E +++ H L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKL 74
Query: 356 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 415
++L + +V YM+ GS+ L+ L P +A A G++Y+
Sbjct: 75 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVER 131
Query: 416 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 475
+HRD++AANIL+ E V DFGLA+L++ + + I APE
Sbjct: 132 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 476 GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 535
G+ + K+DV+ +GI+L EL T R + +LD V E+ M P+
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPY----PGMVNREVLDQV-----ERGYRMPCPPEC 239
Query: 536 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
E L + C + P +RP + LE
Sbjct: 240 --------PESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 6e-60
Identities = 58/279 (20%), Positives = 111/279 (39%), Gaps = 27/279 (9%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 355
+ LG G FG V G+ VA+K +KE E +F E +++ H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKL 61
Query: 356 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 415
++L G C ++ YMANG + + LRE + + YL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLES 118
Query: 416 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 475
+HRD+ A N L++++ V DFGL++ + + + + + PE L
Sbjct: 119 KQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 476 GKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534
K S K+D++ +G+++ E+ + G+ ++ + + + + L P
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYE-----RFTNSETAEHI------AQGLRLYRPH 224
Query: 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
L + E++ + C +RP ++ +
Sbjct: 225 LAS-------EKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 3e-59
Identities = 66/306 (21%), Positives = 112/306 (36%), Gaps = 48/306 (15%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGS------LVAVKRLKEERTPGGELQFQTEVEMISM 349
++ +LG G FGKV S VAVK LKE+ +E++M++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 350 AV-HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER-------------------PP 389
H N++ L G C L++ Y G + + LR +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 390 SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449
L + A A+G+ +L +HRD+ A N+L+ + DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 450 MDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLA 507
+ +V R + +APE L G + K+DV+ YGI+L E+ + G +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP----- 268
Query: 508 NDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSE 567
G+ + L+ + + E++ + C RP
Sbjct: 269 ------------GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316
Query: 568 VVRMLE 573
+ L
Sbjct: 317 LTSFLG 322
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 2e-58
Identities = 67/294 (22%), Positives = 125/294 (42%), Gaps = 38/294 (12%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSL---VAVKRLKEERTPGGELQFQTEVEMIS-MAV 351
+ ++++G G FG+V K R+ L A+KR+KE + F E+E++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 352 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQL------------PLDWPTR 399
H N++ L G C L Y +G++ LR+ + L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 400 KRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 459
A ARG+ YL + IHRD+ A NIL+ E + A + DFGL++ + T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 460 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 519
R + +A E L+ + +DV+ YG++L E+++ + + +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-------YCGMTCAELYE 237
Query: 520 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
L + +LE ++ D +++ + C + P +RP ++++ L
Sbjct: 238 KLPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 3e-58
Identities = 74/279 (26%), Positives = 113/279 (40%), Gaps = 31/279 (11%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 355
+G+G FG V G G+ VAVK +K + T F E +++ H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNL 62
Query: 356 LRLRGFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
++L G + L +V YMA GS+ LR R S L + +L + YL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLE 120
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 474
+ +HRD+ A N+L+ E+ A V DFGL K + + APE L
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEALR 173
Query: 475 TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534
K S K+DV+ +GI+L E+ + R + L D V + K K++
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVP-------YPRIPLKDVVPRVEKGYKMDA----- 221
Query: 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ + +V C RP ++ LE
Sbjct: 222 -----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 1e-57
Identities = 64/281 (22%), Positives = 111/281 (39%), Gaps = 25/281 (8%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHR 353
+ + +G G +G+ K R +DG ++ K L E Q +EV ++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 354 NLLRLRGFCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 411
N++R + T L V Y G +AS + + + LD R+ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 412 YLHDH--CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 469
H ++HRD+K AN+ LD + +GDFGLA++++ DT A GT +++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKAFVGTPYYMS 182
Query: 470 PEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529
PE ++ +EK+D++ G +L EL F A + +G
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT----AFSQKELAGKIREG--------- 229
Query: 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
E+ ++I RP + E++
Sbjct: 230 --KFRRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 3e-57
Identities = 64/277 (23%), Positives = 112/277 (40%), Gaps = 32/277 (11%)
Query: 301 KNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNLLRL 358
+GRG F VYKG + VA L++ + E Q F+ E EM+ H N++R
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 359 RGFCMTPTER----LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
+ + +LV M +G++ + L+ + + +GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLH 129
Query: 415 DHCDPKIIHRDVKAANILL-DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 473
P IIHRD+K NI + +GD GLA L AV GT +APE
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMY 185
Query: 474 STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533
K E DV+ +G+ +LE+ T + + + + V +K + + P
Sbjct: 186 E-EKYDESVDVYAFGMCMLEMATSEYPYS----ECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
+++ + C + + +R + +++
Sbjct: 241 EVKE------------IIEGCIRQNKDERYSIKDLLN 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 8e-57
Identities = 61/279 (21%), Positives = 111/279 (39%), Gaps = 33/279 (11%)
Query: 302 NILGRGGFGKVYKGRLAD---GSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLR 357
LG G FG V KG VAVK LK E P + + E ++ + ++R
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 358 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 417
+ G C + +LV G + L++ + + + G+ YL +
Sbjct: 73 MIGICEAES-WMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEES- 126
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAPEYLST 475
+HRD+ A N+LL + A + DFGL+K + D T + + APE ++
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 476 GKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534
K S K+DV+ +G+++ E + GQ+ + +K ++ +++
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYR------------------GMKGSEVTAMLEKG 226
Query: 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ ++ + LC +RP + V L
Sbjct: 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 2e-56
Identities = 60/278 (21%), Positives = 110/278 (39%), Gaps = 26/278 (9%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 354
+ + LG G +G+V VAVK + +R + E+ + M H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
+++ G + L Y + G + + + + P +R G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLH 120
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYL 473
I HRD+K N+LLDE + DFGLA + Y + + + GT+ ++APE L
Sbjct: 121 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 474 STGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532
+ +E DV+ GI+L ++ G+ +D +D DW + +
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKEKKTYLNPWK---- 230
Query: 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
+++ L+ +P R + ++ +
Sbjct: 231 ------KIDSAPLALLH---KILVENPSARITIPDIKK 259
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 188 bits (479), Expect = 1e-55
Identities = 73/282 (25%), Positives = 110/282 (39%), Gaps = 35/282 (12%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGEL--QFQTEVEMISMAV 351
FS+ +G G FG VY R + + +VA+K++ E EV +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 352 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 411
H N ++ RG + LV Y + + P L + G+ +GL+
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLA 129
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 471
YLH H +IHRDVKA NILL E +GDFG A +M ++ V GT +APE
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPE 181
Query: 472 YLST---GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528
+ G+ K DV+ GI +EL + + L +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLF----NMNAMSALYHIAQN-------- 229
Query: 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
P LQ+ + + C Q P DRP +++
Sbjct: 230 --ESPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 2e-54
Identities = 71/290 (24%), Positives = 117/290 (40%), Gaps = 39/290 (13%)
Query: 284 KRFSLRELQVATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEER--TPGGELQF 340
++++L + ++ LG+G FG VY R ++A+K L + + G E Q
Sbjct: 1 RQWALEDFEI-------GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53
Query: 341 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK 400
+ EVE+ S H N+LRL G+ T L+ Y G+V L++ D
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTA 109
Query: 401 RIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 460
A LSY H ++IHRD+K N+LL E + DFG +
Sbjct: 110 TYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT--- 163
Query: 461 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 520
+ GT+ ++ PE + EK D++ G++ E + G+ F+ + +
Sbjct: 164 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE------------ANTYQE 211
Query: 521 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
K PD +V LI + +P RP + EV+
Sbjct: 212 TYKRISRVEFTFPD----FVTEGARDLIS---RLLKHNPSQRPMLREVLE 254
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 3e-54
Identities = 68/299 (22%), Positives = 129/299 (43%), Gaps = 33/299 (11%)
Query: 290 ELQVATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTE 343
E +VA + + LG+G FG VY+G + VA+K + E + ++F E
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 344 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR------ERPPSQLPLDWP 397
++ +++RL G L++ M G + S LR P P
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 398 TRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-TH 456
++A A G++YL+ + K +HRD+ A N ++ E+F +GDFG+ + + D
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 457 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLD 516
+ ++PE L G + +DV+ +G++L E+ T
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-------------- 236
Query: 517 WVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575
+GL E+ L +++ L + + + L ++ +C Q +P RP E++ ++ +
Sbjct: 237 --QGLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-53
Identities = 64/291 (21%), Positives = 124/291 (42%), Gaps = 33/291 (11%)
Query: 291 LQVATDS-FSNKNILGRGGFGKVYKGRLAD-----GSLVAVKRLKEERTPGGELQFQTEV 344
L++ ++ F +LG G FG VYKG VA+K L+E +P + E
Sbjct: 3 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 345 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIAL 404
+++ + ++ RL G C+T T +L+ M G + +RE + +
Sbjct: 63 YVMASVDNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNI---GSQYLLNWCV 118
Query: 405 GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRG 463
A+G++YL D +++HRD+ A N+L+ + DFGLAKL+ ++ + +
Sbjct: 119 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175
Query: 464 TIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 522
I +A E + + ++DV+ YG+ + EL+T G + +D +
Sbjct: 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD------------------GI 217
Query: 523 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
++ +++ + + + + C RPK E++
Sbjct: 218 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 1e-52
Identities = 77/279 (27%), Positives = 108/279 (38%), Gaps = 33/279 (11%)
Query: 304 LGRGGFGKVYKGRL----ADGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLR 357
LG G FG V +G VAVK LK + P F EV + HRNL+R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 358 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 417
L G +TP ++ V GS+ LR+ T R A+ A G+ YL
Sbjct: 76 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESKR 131
Query: 418 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTIGHIAPEYLST 475
IHRD+ A N+LL +GDFGL + + D H + + APE L T
Sbjct: 132 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 476 GKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534
S +D + +G+ L E+ T GQ + GL + L +
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWI-----------------GLNGSQILHKIDKEG 231
Query: 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ E + + V + C P DRP + L
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 6e-52
Identities = 58/282 (20%), Positives = 110/282 (39%), Gaps = 28/282 (9%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLAD----GSLVAVKRLKEERTPGGELQFQTEVEMISMAV 351
+ +G G FG V++G VA+K K + +F E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 352 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 411
H ++++L G T ++ G + S L+ R LD + A + L+
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALA 122
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 471
YL + +HRD+ A N+L+ +GDFGL++ M+ + + + I +APE
Sbjct: 123 YLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 472 YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531
++ + + +DV+ +G+ + E++ V D + + ++L M
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKP-------FQGVKNNDVIGRIENGERLPM-- 230
Query: 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
P+ L + C P RP+ +E+ L
Sbjct: 231 PPNCP--------PTLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 7e-52
Identities = 75/299 (25%), Positives = 121/299 (40%), Gaps = 40/299 (13%)
Query: 296 DSFSNKNILGRGGFGKVYKGR------LADGSLVAVKRLKEERTPGGELQFQTEVEMISM 349
D LGRG FG+V + A VAVK LKE T +E++++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 350 AVHR-NLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPPSQLP------------LD 395
H N++ L G C P L ++ + G++++ LR + +P L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 396 WPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455
+ A+G+ +L K IHRD+ A NILL E+ + DFGLA+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 456 HV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 514
+V R + +APE + + ++DV+ +G++L E+ + + V +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-------YPGVKI 242
Query: 515 LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ LKE D ++ Q L C G P RP SE+V L
Sbjct: 243 DEEFCRRLKEGTRMRAPDYT---------TPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 3e-51
Identities = 62/282 (21%), Positives = 114/282 (40%), Gaps = 30/282 (10%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 353
D + LG G FGKVYK + L A K + + E + E+++++ H
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHP 69
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
N+++L ++ + A G+V + + E + PL + + + L+YL
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYL 126
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 473
HD+ KIIHRD+KA NIL + + + DFG++ + + GT +APE +
Sbjct: 127 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVV 182
Query: 474 STGKS-----SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528
S K DV+ GI L+E+ + + +LL K
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH----ELNPMRVLLKIAKSEPPTLAQP 238
Query: 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
+ ++ ++ C + + R S++++
Sbjct: 239 SRWSSNFKD---------FLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 6e-51
Identities = 76/300 (25%), Positives = 122/300 (40%), Gaps = 42/300 (14%)
Query: 296 DSFSNKNILGRGGFGKVYKGRL--------ADGSLVAVKRLKEERTPGGELQFQTEVEMI 347
D LG G FG+V + VAVK LK + T +E+EM+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 348 SMAV-HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQL------------PL 394
M H+N++ L G C ++ Y + G++ L+ R P L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 395 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454
A ARG+ YL K IHRD+ A N+L+ E+ + DFGLA+ + + D
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 455 THVTTAV-RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 513
+ T R + +APE L + ++DV+ +G++L E+ T + +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--------YPGV 241
Query: 514 LLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
++ + LLKE D +N +L + C P RP ++V L+
Sbjct: 242 PVEELFKLLKEGHR-----MDKPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 1e-50
Identities = 61/278 (21%), Positives = 116/278 (41%), Gaps = 29/278 (10%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 353
++ +G+G G VY +A G VA++++ ++ P E E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNP 77
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
N++ + E +V Y+A GS+ + E D + + L +L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-----DEGQIAAVCRECLQALEFL 132
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 473
H + ++IHRD+K+ NILL + + DFG + + + +T V GT +APE +
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 188
Query: 474 STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533
+ K D++ GIM +E+I G+ + N++ + L + P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYL-----NENPLRAL---------YLIATNGTP 234
Query: 534 DLQN-NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
+LQN + A + C R E+++
Sbjct: 235 ELQNPEKLSAIFRDFLN---RCLDMDVEKRGSAKELLQ 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 164 bits (416), Expect = 3e-46
Identities = 55/276 (19%), Positives = 101/276 (36%), Gaps = 27/276 (9%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 354
D + LG G FG V++ A G+ A K + E + E++ +S+ H
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPT 84
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
L+ L E +++Y +M+ G + + + + +GL ++H
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMH 141
Query: 415 DHCDPKIIHRDVKAANILL--DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 472
++ +H D+K NI+ E + DFGL +D K + T GT APE
Sbjct: 142 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEV 196
Query: 473 LSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532
TD++ G++ L++G F +DD L +
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFG----GENDDETLRNVKSCDWNM-------- 244
Query: 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 568
D + + + + I+ P R + +
Sbjct: 245 DDSAFSGISEDGKDFIR---KLLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 1e-45
Identities = 57/282 (20%), Positives = 102/282 (36%), Gaps = 30/282 (10%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVH 352
+ F ILG G F V R LA A+K L++ E +++S H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 353 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 412
++L + Y NG L + D + A +S
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYT---AEIVSA 120
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPE 471
L IIHRD+K NILL+E+ + DFG AK++ + + GT +++PE
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 472 YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531
L+ + + +D++ G ++ +L+ G F A ++ ++ +K
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLIFQKIIKL----------- 225
Query: 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ D + + L++ R E+
Sbjct: 226 EYDFPEKFFP-KARDLVE---KLLVLDATKRLGCEEMEGYGP 263
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (406), Expect = 3e-45
Identities = 58/286 (20%), Positives = 115/286 (40%), Gaps = 28/286 (9%)
Query: 289 RELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMI 347
++ + D + +++LG G F +V LVA+K + ++ G E + E+ ++
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 348 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSA 407
H N++ L + L+ ++ G + + E+ R+
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVL 117
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 464
+ YLHD I+HRD+K N+L DE+ + ++ DFGL+K+ D V + GT
Sbjct: 118 DAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGT 172
Query: 465 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 524
G++APE L+ S+ D + G++ L+ G F +D + +K +
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY----DENDAKLFEQILKAEYE- 227
Query: 525 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
+ + + I+ + P R + ++
Sbjct: 228 -------FDSPYWDDISDSAKDFIR---HLMEKDPEKRFTCEQALQ 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 161 bits (409), Expect = 3e-45
Identities = 56/278 (20%), Positives = 105/278 (37%), Gaps = 27/278 (9%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 354
D + LG G FG V++ A G + K + P + + E+ +++ H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPK 87
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
L+ L E +L+ +++ G + + + + GL ++H
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMH 144
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 472
+H I+H D+K NI+ + + + V DFGLA ++ + T APE
Sbjct: 145 EH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEI 199
Query: 473 LSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532
+ TD++ G++ L++G F +DD+ L V K E
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFA-----GEDDLETLQNV----KRCDWEF--- 247
Query: 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
+ + V E + I+ Q P R + + +
Sbjct: 248 DEDAFSSVSPEAKDFIK---NLLQKEPRKRLTVHDALE 282
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 158 bits (401), Expect = 8e-45
Identities = 59/289 (20%), Positives = 106/289 (36%), Gaps = 40/289 (13%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK--------EERTPGGELQFQTEVE- 345
+++ K ILGRG V + AVK + E EV+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 346 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALG 405
+ ++ H N+++L+ T T LV+ M G + L E+ L ++I
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRA 118
Query: 406 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 465
+ LH I+HRD+K NILLD++ + DFG + +D V GT
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTP 173
Query: 466 GHIAPEYLSTG------KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 519
++APE + ++ D++ G+++ L+ G F + +++L +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-----HRKQMLMLRMI- 227
Query: 520 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 568
+ + + V+ L+ P R E
Sbjct: 228 ---MSGNYQF---GSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEA 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 3e-44
Identities = 47/270 (17%), Positives = 98/270 (36%), Gaps = 28/270 (10%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 362
LGRG FG V++ + K +K + T ++ + E+ ++++A HRN+L L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESF 70
Query: 363 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 422
+ E ++++ +++ + + L+ L +LH H I
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIG 124
Query: 423 HRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 480
H D++ NI+ + + +FG A+ + D + APE S
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVST 182
Query: 481 KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 540
TD++ G ++ L++G F A + ++ + + + +
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFL----AETNQQIIENIMNAEYT--------FDEEAFKEI 230
Query: 541 EAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
E + R SE ++
Sbjct: 231 SIEAMDFVD---RLLVKERKSRMTASEALQ 257
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 156 bits (394), Expect = 7e-44
Identities = 65/289 (22%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEE--RTPGGELQFQTEVEMISMAV 351
+D + ILG GG +V+ R L VAVK L+ + R P L+F+ E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 352 HRNLLRLRGFCMTPTERL----LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSA 407
H ++ + T +V Y+ ++ + P + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 121
Query: 408 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV--TTAVRGTI 465
+ L++ H + IIHRDVK ANI++ V DFG+A+ + V T AV GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 466 GHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525
+++PE ++DV+ G +L E++TG+ F D + + +
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPV------SVAYQH 226
Query: 526 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-MSEVVRMLE 573
E + P ++ + A+++ ++ +P +R + +E+ L
Sbjct: 227 VREDPIPPSARHEGLSADLDAVVL---KALAKNPENRYQTAAEMRADLV 272
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-43
Identities = 67/291 (23%), Positives = 114/291 (39%), Gaps = 21/291 (7%)
Query: 294 ATDSFSNKNILGRGGFGKVYKGR--LADGSLVAVKRLK-EERTPGGELQFQTEVEMISMA 350
A + +G G +GKV+K R G VA+KR++ + G L EV ++
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 351 V---HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE--RPPSQLPLDWPTRKRIALG 405
H N++RL C + V L + + T K +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 406 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 465
RGL +LH H +++HRD+K NIL+ + + DFGLA++ ++ + V T+
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTL 179
Query: 466 GHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF----DLARLANDDDVMLL----DW 517
+ APE L + D++ G + E+ + F D+ +L DV+ L DW
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 518 VKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 568
+ + ++ +V E + L C +P R
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 157 bits (398), Expect = 2e-43
Identities = 65/214 (30%), Positives = 96/214 (44%), Gaps = 17/214 (7%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEER--TPGGELQFQTEVEMISMAV- 351
+ FS I+GRGGFG+VY R AD G + A+K L ++R GE E M+S+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 352 --HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARG 409
++ + TP + + M G + L + + A G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EADMRFYAAEIILG 119
Query: 410 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 469
L ++H+ +++RD+K ANILLDE + D GLA K H + GT G++A
Sbjct: 120 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 173
Query: 470 PEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFD 502
PE L G + D F G ML +L+ G F
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (386), Expect = 2e-42
Identities = 52/294 (17%), Positives = 96/294 (32%), Gaps = 31/294 (10%)
Query: 290 ELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMIS 348
EL+V + + +G G FG +Y G +A G VA+K + Q E ++
Sbjct: 2 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYK 57
Query: 349 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR 408
M + +C + ++ + S+ T +A
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMIS 114
Query: 409 GLSYLHDHCDPKIIHRDVKAANIL---LDEEFEAVVGDFGLAKLMDYKDTHV------TT 459
+ Y+H IHRDVK N L + + DFGLAK TH
Sbjct: 115 RIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 460 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 519
+ GT + + + S + D+ G +L+ G + + +
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW--------QGLKAATKRQ 223
Query: 520 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
+ + +M ++ +E + C D+P S + ++
Sbjct: 224 KYERISEKKMSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 152 bits (384), Expect = 2e-42
Identities = 56/286 (19%), Positives = 109/286 (38%), Gaps = 18/286 (6%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRN 354
+ + +G G +G VYK + G A+K+++ E+ G E+ ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
+++L T +LV+ ++ L+ T K L G++Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCH 117
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 474
D +++HRD+K N+L++ E E + DFGLA+ T + +
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 475 TGKSSEKTDVFGYGIMLLELITGQRAFD----------LARLANDDDVMLLDWVKGLLKE 524
+ K S D++ G + E++ G F + R+ + V L K
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 525 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
+ +P ++++ E I + + P R + +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 4e-42
Identities = 59/277 (21%), Positives = 109/277 (39%), Gaps = 33/277 (11%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRG 360
+LG G GKV + A+K L++ + + EVE+ A +++R+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVD 72
Query: 361 FCMTPTER----LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 416
L+V + G + S +++R I + YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ--AFTEREASEIMKSIGEAIQYLHSI 130
Query: 417 CDPKIIHRDVKAANILLDEEFE---AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 473
I HRDVK N+L + + DFG AK ++ T T ++APE L
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVL 185
Query: 474 STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533
K + D++ G+++ L+ G F ++ + + +K ++ + E P
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFY-----SNHGLAISPGMKTRIRMGQYEF---P 237
Query: 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
+ + + V EV+ LI+ + P R ++E +
Sbjct: 238 NPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 1e-41
Identities = 66/279 (23%), Positives = 106/279 (37%), Gaps = 31/279 (11%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEER--TPGGELQFQTEVEMISMAV- 351
+ F +LG+G FGKV+ A+K LK++ E ++S+A
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 352 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 411
H L + T V Y+ G + ++ D A GL
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQ 117
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 471
+LH I++RD+K NILLD++ + DFG+ K D T GT +IAPE
Sbjct: 118 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE 173
Query: 472 YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531
L K + D + +G++L E++ GQ F D+ L ++
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH-----GQDEEELFHSIRM----------- 217
Query: 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
D ++E E + L+ P R + +R
Sbjct: 218 DNPFYPRWLEKEAKDLLV---KLFVREPEKRLGVRGDIR 253
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 3e-41
Identities = 53/292 (18%), Positives = 112/292 (38%), Gaps = 20/292 (6%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 353
++N + +G G +G V + VA+K++ + E++++ H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
N++ + PT + Y+ + + L + +Q L RGL Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 125
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPE 471
H ++HRD+K +N+LL+ + + DFGLA++ D H T T + APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 472 YLSTG-KSSEKTDVFGYGIMLLELITGQRAFD-----------LARLANDDDVMLLDWVK 519
+ ++ D++ G +L E+++ + F L L + L +
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 520 GLLKEKKLEMLVDPDLQNNYVEAEV-EQLIQVALLCTQGSPMDRPKMSEVVR 570
+ L + + N + + + + +P R ++ + +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 146 bits (369), Expect = 3e-40
Identities = 35/282 (12%), Positives = 79/282 (28%), Gaps = 32/282 (11%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 362
+G G FG +++G L + VA+K Q + E + + +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 363 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 422
++ + S+ L T A + +H+ ++
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLV 123
Query: 423 HRDVKAANILLDEEFEAVVG-----DFGLAKLMDYKDTHV------TTAVRGTIGHIAPE 471
+RD+K N L+ DFG+ K T + GT +++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 472 YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531
+ S + D+ G + + + G + + A + + + +
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY--------ERIGEKKQST 235
Query: 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573
E + + + P + +
Sbjct: 236 PLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFS 274
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 5e-40
Identities = 55/286 (19%), Positives = 98/286 (34%), Gaps = 20/286 (6%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK-EERTPGGELQFQTEVEMISMAVHR 353
++F +G G +G VYK R G +VA+K+++ + T G E+ ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
N+++L T + LV+ ++ + P K +GL++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT---GIPLPLIKSYLFQLLQGLAFC 118
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 473
H H ++HRD+K N+L++ E + DFGLA+ T V L
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 474 STGKSSEKTDVFGYGIMLLELITGQRAFD-----------LARLANDDDVMLLDWVKGLL 522
S D++ G + E++T + F L D+V+
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 523 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 568
+ D + E + P R
Sbjct: 236 YKPSFPKWARQDFSKVVPPLD-EDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 146 bits (369), Expect = 6e-40
Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 21/220 (9%)
Query: 286 FSLRELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERT--PGGELQFQT 342
+SL++ Q+ LG G FG+V+ R +G A+K LK+E
Sbjct: 1 YSLQDFQI-------LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 53
Query: 343 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRI 402
E M+S+ H ++R+ G + ++ Y+ L P K
Sbjct: 54 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFY 109
Query: 403 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 462
A L YLH II+RD+K NILLD+ + DFG AK + +
Sbjct: 110 AAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC---- 162
Query: 463 GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 502
GT +IAPE +ST ++ D + +GI++ E++ G F
Sbjct: 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY 202
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 9e-40
Identities = 62/291 (21%), Positives = 112/291 (38%), Gaps = 28/291 (9%)
Query: 296 DSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 354
S+++ ++G G FG VY+ +L D G LVA+K++ +++ E++++ H N
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCN 74
Query: 355 LLRLRGFCMTPTER------LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR 408
++RLR F + E+ LV Y+ R ++ L K R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 409 GLSYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 467
L+Y+H I HRD+K N+LLD + + DFG AK + + +V+ +
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYR 189
Query: 468 IAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD----------LARLANDDDVMLLDW 517
+ DV+ G +L EL+ GQ F + ++ +
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 518 VKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 568
+ E K + + + I + + +P R E
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-39
Identities = 61/285 (21%), Positives = 103/285 (36%), Gaps = 34/285 (11%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGEL-----QFQTEVEMISM 349
D + LG G F V K R + G A K +K+ RT + EV ++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 350 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARG 409
H N++ L T+ +L+ +A G L + + L G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 410 LSYLHDHCDPKIIHRDVKAANILLDEE----FEAVVGDFGLAKLMDYKDTHVTTAVRGTI 465
+ YLH I H D+K NI+L + + DFGLA +D+ + + GT
Sbjct: 126 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTP 180
Query: 466 GHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525
+APE ++ + D++ G++ L++G F D L V + E
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL-----GDTKQETLANVSAVNYE- 234
Query: 526 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
D + A + I+ P R + + ++
Sbjct: 235 ------FEDEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-38
Identities = 74/320 (23%), Positives = 116/320 (36%), Gaps = 44/320 (13%)
Query: 302 NILGRGGFGKVYKGR-LADGSLVAVKRLK----EERTPGGELQFQTEVEMISMAVHRNLL 356
+ LG G F VYK R +VA+K++K E G E++++ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 357 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 416
L + LV+ +M + L L K L + +GL YLH H
Sbjct: 64 GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 417 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 476
I+HRD+K N+LLDE + DFGLAK + T V T + APE L
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 477 KS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 535
+ D++ G +L EL+ D D+ L + L E D
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLP-----GDSDLDQLTRIFETLGTPTEEQWPDMCS 230
Query: 536 QNNYVEAEV--------------EQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERW 581
+YV + + L+ + +P R ++ ++M
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM---------- 280
Query: 582 DEWQKVEVLRQEVELAPHPN 601
++ P PN
Sbjct: 281 -KYFSNRPGPTPGCQLPRPN 299
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 2e-37
Identities = 59/278 (21%), Positives = 101/278 (36%), Gaps = 44/278 (15%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGE-----LQFQTEVEMISM--AVHRN 354
+LG GGFG VY G ++D VA+K ++++R + EV ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 355 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
++RL + P +L+ L + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH 127
Query: 415 DHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 473
+ ++HRD+K NIL+D E + DFG L+ V T GT + PE++
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 181
Query: 474 STGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532
+ V+ GI+L +++ G F E E++
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPF----------------------EHDEEIIRG 219
Query: 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570
V +E + LI+ C P DRP E+
Sbjct: 220 QVFFRQRVSSECQHLIR---WCLALRPSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 6e-36
Identities = 60/267 (22%), Positives = 103/267 (38%), Gaps = 18/267 (6%)
Query: 293 VATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEER--TPGGELQFQTEVEMISM 349
V + F +LG+G FGKV R A G A+K L++E TE ++
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 350 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARG 409
H L L+ T V Y G + L T +R A
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-------FTEERARFYGAEI 114
Query: 410 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 469
+S L +++RD+K N++LD++ + DFGL K GT ++A
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLA 173
Query: 470 PEYLSTGKSSEKTDVFGYGIMLLELITGQRAF------DLARLANDDDVMLLDWVKGLLK 523
PE L D +G G+++ E++ G+ F L L +++ + K
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK 233
Query: 524 EKKLEMLV-DPDLQNNYVEAEVEQLIQ 549
+L DP + ++ +++++
Sbjct: 234 SLLAGLLKKDPKQRLGGGPSDAKEVME 260
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 4e-35
Identities = 53/288 (18%), Positives = 103/288 (35%), Gaps = 20/288 (6%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK-EERTPGGELQFQTEVEMISMAVHR 353
+ +G G +G V+K + +VA+KR++ ++ G E+ ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 354 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 413
N++RL + + LV+ + + LD K +GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 414 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 473
H ++HRD+K N+L++ E + +FGLA+ + V
Sbjct: 118 HSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 474 STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533
S D++ G + EL R +D + + +E+ M P
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 534 DLQNNYVEAEVEQLIQVA---------LL--CTQGSPMDRPKMSEVVR 570
D + + L+ V LL + +P+ R E ++
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (336), Expect = 4e-35
Identities = 51/226 (22%), Positives = 92/226 (40%), Gaps = 19/226 (8%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGEL--QFQTEVEMISMAVH 352
D F LG G FG+V + G+ A+K L +++ + E ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 412
L++L + +V Y+A G + S LR P + A Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEY 156
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 472
LH +I+RD+K N+L+D++ V DFG AK + + + GT +APE
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPEALAPEI 209
Query: 473 LSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 518
+ + ++ D + G+++ E+ G F D + + + +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFF-----ADQPIQIYEKI 250
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-34
Identities = 59/295 (20%), Positives = 114/295 (38%), Gaps = 27/295 (9%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRL-KEERTPGGELQFQTEVEMISMAVHR 353
+ +G+G FG+V+K R G VA+K++ E G + E++++ + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 354 NLLRLRGFCMTPTER--------LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALG 405
N++ L C T LV+ + + KR+
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVM-- 123
Query: 406 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT---HVTTAVR 462
L+ L+ KI+HRD+KAAN+L+ + + DFGLA+ + T
Sbjct: 124 -QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 463 GTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGL 521
T+ + PE L + D++G G ++ E+ T + + L + L
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ-----GNTEQHQLALISQL 237
Query: 522 LKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV-RMLEGD 575
E+ + D Y + E+ + + + + + P +++ ++L D
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 292
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 3e-33
Identities = 45/222 (20%), Positives = 86/222 (38%), Gaps = 12/222 (5%)
Query: 286 FSLRELQVATDSFSNK----NILGRGGFGKVYKGR-LADGSLVAVKRL-KEERTPGGELQ 339
F +E+ +G G +G V G+ VA+K+L + ++ +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 340 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTR 399
E+ ++ H N++ L + + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 400 KRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 459
+ + +GL Y+H IIHRD+K N+ ++E+ E + DFGLA+ D+ +T
Sbjct: 124 QFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTG 177
Query: 460 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
V L+ + ++ D++ G ++ E+ITG+ F
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 219
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 2e-31
Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 17/221 (7%)
Query: 292 QVATDSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEER---TPGGELQFQTEV 344
+V ++F +LG G +GKV+ R G L A+K LK+ +TE
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 345 EMISMAVHR-NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIA 403
+++ L+ L T T+ L+ Y+ G + + L +R I
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI- 138
Query: 404 LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 463
+ L II+RD+K NILLD V+ DFGL+K +T G
Sbjct: 139 ------VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 192
Query: 464 TIGHIAPEYLSTGKS--SEKTDVFGYGIMLLELITGQRAFD 502
TI ++AP+ + G S + D + G+++ EL+TG F
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 119 bits (298), Expect = 4e-30
Identities = 44/212 (20%), Positives = 83/212 (39%), Gaps = 22/212 (10%)
Query: 296 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVE-MISMAVHR 353
D + LGRG + +V++ + + V VK LK + + + + E++ + ++
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGP 90
Query: 354 NLLRLRGFCMTPTERL--LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 411
N++ L P R LV+ ++ N + L + + L
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALD 143
Query: 412 YLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 470
Y H I+HRDVK N+++D E + + D+GLA+ + + P
Sbjct: 144 YCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGP 198
Query: 471 E-YLSTGKSSEKTDVFGYGIMLLELITGQRAF 501
E + D++ G ML +I + F
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 8e-29
Identities = 44/207 (21%), Positives = 80/207 (38%), Gaps = 20/207 (9%)
Query: 303 ILGRGGFGKVYKGR-LADGSLVAVKRL-KEERTPGGELQFQTEVEMISMAVHRNLLRLRG 360
+G G G V VA+K+L + + + E+ ++ H+N++ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 361 FCMTP------TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 414
+ LV M + Q+ LD + G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDAN----LCQVI---QMELDHERMSYLLYQMLCGIKHLH 136
Query: 415 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 474
IIHRD+K +NI++ + + DFGLA+ + + T T + APE +
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVIL 191
Query: 475 TGKSSEKTDVFGYGIMLLELITGQRAF 501
E D++ G ++ E++ + F
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILF 218
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 2e-28
Identities = 46/210 (21%), Positives = 83/210 (39%), Gaps = 8/210 (3%)
Query: 295 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRL-KEERTPGGELQFQTEVEMISMAVH 352
+ + N + +G G +G V G VAVK+L + ++ + E+ ++ H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 353 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 412
N++ L + L + + RGL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 472
+H IIHRD+K +N+ ++E+ E + DFGLA+ D +T V
Sbjct: 137 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIM 190
Query: 473 LSTGKSSEKTDVFGYGIMLLELITGQRAFD 502
L+ ++ D++ G ++ EL+TG+ F
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (266), Expect = 9e-26
Identities = 38/214 (17%), Positives = 76/214 (35%), Gaps = 19/214 (8%)
Query: 304 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 362
LG G F V+ + + + + VA+K ++ ++ + E++++ + +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 363 MTPTERLLVYPY------------MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGL 410
+LL + + + K+I+ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 411 SYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHI 468
Y+H C IIH D+K N+L++ + +A L + T +
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 469 APEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 502
+PE L D++ ++ ELITG F+
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 95.2 bits (236), Expect = 3e-23
Identities = 24/162 (14%), Positives = 46/162 (28%), Gaps = 20/162 (12%)
Query: 302 NILGRGGFGKVYKGRLADGSLVAVKRLKEERT---------PGGELQFQTEVEMISMAVH 352
++G G V+ VK K T G+L F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 353 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 412
R L +L+G + Y G+ + + ++
Sbjct: 66 RALQKLQGLAV-------PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 413 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454
+ I+H D+ N+L+ E + DF + + +
Sbjct: 119 FYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG 156
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 81.2 bits (199), Expect = 4e-17
Identities = 27/84 (32%), Positives = 42/84 (50%), Gaps = 6/84 (7%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
LKNL YL LY NNI+ P + +LT L L N + +L L+ + +L +N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHN 361
Query: 148 SLSGPIPMSLTNISSLQVLDLSNN 171
+S P L N++ + L L++
Sbjct: 362 QISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 71.2 bits (173), Expect = 8e-14
Identities = 35/160 (21%), Positives = 56/160 (35%), Gaps = 48/160 (30%)
Query: 61 CNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIP-SDLGNLTSL---- 115
++ + L L + L L NL L+L +N I+ P S L LT L
Sbjct: 215 LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGA 272
Query: 116 -------------------------------------VSLDLYLNSFTGPIPDTLGKLSK 138
L LY N+ + P + L+K
Sbjct: 273 NQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTK 330
Query: 139 LRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
L+ L NN +S SL N++++ L +N++S + P
Sbjct: 331 LQRLFFANNKVSDVS--SLANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 54.6 bits (130), Expect = 2e-08
Identities = 22/85 (25%), Positives = 39/85 (45%), Gaps = 8/85 (9%)
Query: 88 LKNLQYLELYSNNITGPIP-SDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L L N+T + +DL +T+L + L + S G + L+ L + +N
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 75
Query: 147 NSLSGPIPMSLTNISSLQVLDLSNN 171
N L+ P L N++ L + ++NN
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNN 98
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 52.3 bits (124), Expect = 1e-07
Identities = 17/90 (18%), Positives = 36/90 (40%), Gaps = 14/90 (15%)
Query: 96 LYSNNITGPIPSD----LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSG 151
L S IT P + L + L + T + + L ++ L+ + +
Sbjct: 1 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK- 57
Query: 152 PIPMSLTNI---SSLQVLDLSNNRLSGVVP 178
S+ + ++L ++ SNN+L+ + P
Sbjct: 58 ----SIDGVEYLNNLTQINFSNNQLTDITP 83
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 3e-05
Identities = 24/76 (31%), Positives = 38/76 (50%), Gaps = 4/76 (5%)
Query: 110 GNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLS 169
LT+L SL N + P + + L L LN N L +L ++++L LDL+
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKDIG--TLASLTNLTDLDLA 249
Query: 170 NNRLSGVVPDNGSFSL 185
NN++S + P +G L
Sbjct: 250 NNQISNLAPLSGLTKL 265
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 7e-04
Identities = 14/60 (23%), Positives = 25/60 (41%), Gaps = 4/60 (6%)
Query: 59 VTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSL 118
V+ + + V + + + + L NL + +N +T P L NLT LV +
Sbjct: 38 VSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI 93
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 77.5 bits (189), Expect = 4e-16
Identities = 54/164 (32%), Positives = 83/164 (50%), Gaps = 10/164 (6%)
Query: 25 EGDALHSLRSNLIDPNNVLQSWDPTLVNPC--TWFHVTCNNDNSVIRV---DLGNAALSG 79
+ AL ++ +L +P L SW PT + C TW V C+ D RV DL L
Sbjct: 7 DKQALLQIKKDLGNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 80 --QLVSQLGLLKNLQYLELYSN-NITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKL 136
+ S L L L +L + N+ GPIP + LT L L + + +G IPD L ++
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 137 SKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN 180
L L + N+LSG +P S++++ +L + NR+SG +PD+
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS 168
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 75.2 bits (183), Expect = 2e-15
Identities = 22/57 (38%), Positives = 31/57 (54%)
Query: 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGP 200
L NN + G +P LT + L L++S N L G +P G+ F ++ANN LCG
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 67.9 bits (164), Expect = 6e-13
Identities = 26/68 (38%), Positives = 34/68 (50%), Gaps = 3/68 (4%)
Query: 89 KNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL-NNN 147
KNL L+L +N I G +P L L L SL++ N+ G IP G L + NN
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302
Query: 148 SLSG-PIP 154
L G P+P
Sbjct: 303 CLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 57.5 bits (137), Expect = 1e-09
Identities = 22/81 (27%), Positives = 30/81 (37%), Gaps = 3/81 (3%)
Query: 52 NPCTWFHVTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGN 111
N + ++ +DL N + G L L LK L L + NN+ G IP GN
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGN 289
Query: 112 LTSLVSLDLYLNSFT--GPIP 130
L N P+P
Sbjct: 290 LQRFDVSAYANNKCLCGSPLP 310
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 67.4 bits (163), Expect = 9e-13
Identities = 23/88 (26%), Positives = 35/88 (39%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145
L + L+L +N IT D NL +L +L L N + P L KL L L+
Sbjct: 28 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRL 173
N L + L+V + ++
Sbjct: 88 KNQLKELPEKMPKTLQELRVHENEITKV 115
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 58.5 bits (140), Expect = 6e-10
Identities = 22/75 (29%), Positives = 29/75 (38%), Gaps = 2/75 (2%)
Query: 105 IPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQ 164
+P DL LDL N T L L L L NN +S P + + L+
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 165 VLDLSNNRLSGVVPD 179
L LS N+L +
Sbjct: 83 RLYLSKNQLKELPEK 97
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 56.6 bits (135), Expect = 3e-09
Identities = 34/115 (29%), Positives = 50/115 (43%), Gaps = 2/115 (1%)
Query: 86 GLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145
GL +L L L N IT + L L +L L L NS + +L LR L LN
Sbjct: 168 GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 227
Query: 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDLCG 199
NN L +P L + +QV+ L NN +S + ++ T + + + L
Sbjct: 228 NNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS 281
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 49.7 bits (117), Expect = 5e-07
Identities = 23/132 (17%), Positives = 40/132 (30%), Gaps = 26/132 (19%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNS------ 124
L N +S L L+ L L N + L L + +
Sbjct: 61 ILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVF 120
Query: 125 -----------------FTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLD 167
+G + KL ++R+ + +++ IP L SL L
Sbjct: 121 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELH 177
Query: 168 LSNNRLSGVVPD 179
L N+++ V
Sbjct: 178 LDGNKITKVDAA 189
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 57.0 bits (137), Expect = 1e-10
Identities = 26/107 (24%), Positives = 40/107 (37%), Gaps = 6/107 (5%)
Query: 71 DLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP 130
L + L+ + L L + +L+L N + P+ L L L L N+
Sbjct: 4 HLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDG 60
Query: 131 DTLGKLSKLRFLRLNNNSL-SGPIPMSLTNISSLQVLDLSNNRLSGV 176
L +L+ L L NN L L + L +L+L N L
Sbjct: 61 VA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.1 bits (106), Expect = 2e-06
Identities = 26/115 (22%), Positives = 38/115 (33%), Gaps = 10/115 (8%)
Query: 92 QYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSG 151
+ L L ++T + L L + LDL N P L L L L + +
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLE--VLQASDNAL 55
Query: 152 PIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCG-PVTGRP 205
+ N+ LQ L L NNRL + L+L G +
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQ-SAAIQPLVSCPRLVL---LNLQGNSLCQEE 106
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.7 bits (137), Expect = 2e-09
Identities = 21/91 (23%), Positives = 35/91 (38%), Gaps = 5/91 (5%)
Query: 114 SLVSLDLYLNSFT-GPIPDTLGKLSKLRFLRLNNNSLSG----PIPMSLTNISSLQVLDL 168
+ SLD+ + + L L + + +RL++ L+ I +L +L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 169 SNNRLSGVVPDNGSFSLFTPISFANNLDLCG 199
+N L V L TP L L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.1 bits (133), Expect = 6e-09
Identities = 18/92 (19%), Positives = 28/92 (30%), Gaps = 10/92 (10%)
Query: 90 NLQYLELYSNNIT-GPIPSDLGNLTSLVSLDLYLNSFTG----PIPDTLGKLSKLRFLRL 144
++Q L++ ++ L L + L T I L L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 145 NNNSLSGPIPMSL-----TNISSLQVLDLSNN 171
+N L + T +Q L L N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (128), Expect = 2e-08
Identities = 19/91 (20%), Positives = 31/91 (34%), Gaps = 13/91 (14%)
Query: 89 KNLQYLELYSNNITG----PIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGK-----LSKL 139
L+ L L +++ + + L SL LDL N L + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 140 RFLRLNNNSLSGPIPMSLTNIS----SLQVL 166
L L + S + L + SL+V+
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.8 bits (127), Expect = 4e-08
Identities = 18/90 (20%), Positives = 31/90 (34%), Gaps = 5/90 (5%)
Query: 71 DLGNAALSGQLVSQL-GLLKNLQYLELYSNNITG----PIPSDLGNLTSLVSLDLYLNSF 125
D+ LS ++L LL+ Q + L +T I S L +L L+L N
Sbjct: 8 DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNEL 67
Query: 126 TGPIPDTLGKLSKLRFLRLNNNSLSGPIPM 155
+ + + ++ SL
Sbjct: 68 GDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 1e-07
Identities = 18/83 (21%), Positives = 26/83 (31%), Gaps = 9/83 (10%)
Query: 106 PSDLGNLTSLVSLDLYLNSFTG----PIPDTLGKLSKLRFLRLNNNSLSGPIPMSL---- 157
+ L L L + + TL LR L L+NN L + L
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 158 -TNISSLQVLDLSNNRLSGVVPD 179
L+ L L + S + D
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMED 444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 1e-06
Identities = 19/107 (17%), Positives = 34/107 (31%), Gaps = 15/107 (14%)
Query: 53 PCTWFHVTCNNDNSVIRVDLGNAALSGQ----LVSQLGLLKNLQYLELYSNNITGPIPSD 108
+ + + L + +S L + L +L+ L+L +N +
Sbjct: 357 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ 416
Query: 109 LG-----NLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLS 150
L L L LY ++ + D L L K + SL
Sbjct: 417 LVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK------DKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 9e-05
Identities = 20/67 (29%), Positives = 26/67 (38%), Gaps = 4/67 (5%)
Query: 137 SKLRFLRLNNNSLSG----PIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFA 192
S LR L L + +S + +L SL+ LDLSNN L S+ P
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 193 NNLDLCG 199
L L
Sbjct: 429 EQLVLYD 435
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.8 bits (130), Expect = 1e-08
Identities = 18/114 (15%), Positives = 38/114 (33%), Gaps = 9/114 (7%)
Query: 52 NPCTWFHVTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGN 111
+ + + A S ++ S L +L+ L + +N + +P+
Sbjct: 247 TFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR 305
Query: 112 LTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQV 165
L L N +P+ L+ L + N L P ++ L++
Sbjct: 306 LE---RLIASFNHLAE-VPELPQ---NLKQLHVEYNPLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 2e-07
Identities = 19/81 (23%), Positives = 30/81 (37%), Gaps = 8/81 (9%)
Query: 96 LYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPM 155
Y N + I S SL L++ N +P +L +L + N L+ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI---ASFNHLAE-VPE 321
Query: 156 SLTNISSLQVLDLSNNRLSGV 176
N L+ L + N L
Sbjct: 322 LPQN---LKQLHVEYNPLREF 339
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 6e-06
Identities = 18/93 (19%), Positives = 33/93 (35%), Gaps = 12/93 (12%)
Query: 54 CTWFHVTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLT 113
C+ S+ +++ N +L+ L L+ L N++ +P NL
Sbjct: 273 SNEIRSLCDLPPSLEELNVSN----NKLIELPALPPRLERLIASFNHLAE-VPELPQNLK 327
Query: 114 SLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L + N PD + LR+N+
Sbjct: 328 QL---HVEYNPLRE-FPDIPESVED---LRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 0.001
Identities = 16/63 (25%), Positives = 25/63 (39%), Gaps = 5/63 (7%)
Query: 87 LLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L + LEL + ++ +P +L SL NS T +P+ L L N
Sbjct: 36 LDRQAHELELNNLGLSS-LPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNL 90
Query: 147 NSL 149
+L
Sbjct: 91 KAL 93
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.7 bits (127), Expect = 2e-08
Identities = 33/147 (22%), Positives = 50/147 (34%)
Query: 29 LHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAALSGQLVSQLGLL 88
L S+ L + ++ + L + AL L
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152
Query: 89 KNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNS 148
NL +L L+ N I+ L SL L L+ N P L +L L L N+
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 149 LSGPIPMSLTNISSLQVLDLSNNRLSG 175
LS +L + +LQ L L++N
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVC 239
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.1 bits (123), Expect = 7e-08
Identities = 31/158 (19%), Positives = 50/158 (31%), Gaps = 1/158 (0%)
Query: 23 NMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAALSGQLV 82
+ G+ + + + L + ++DL + A +
Sbjct: 38 FLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVD 97
Query: 83 S-QLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRF 141
L L L L + P L +L L L N+ DT L L
Sbjct: 98 PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTH 157
Query: 142 LRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPD 179
L L+ N +S + + SL L L NR++ V P
Sbjct: 158 LFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (108), Expect = 4e-06
Identities = 28/182 (15%), Positives = 52/182 (28%), Gaps = 28/182 (15%)
Query: 18 WLASANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAAL 77
L + +++ L L L LQ T + ++ + L +
Sbjct: 106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI 165
Query: 78 SGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLT------------------------ 113
S L +L L L+ N + P +L
Sbjct: 166 SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225
Query: 114 SLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRL 173
+L L L N + + L+ R +++ + +P L + L+ N L
Sbjct: 226 ALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDL 281
Query: 174 SG 175
G
Sbjct: 282 QG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (99), Expect = 6e-05
Identities = 28/144 (19%), Positives = 45/144 (31%), Gaps = 7/144 (4%)
Query: 60 TCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLD 119
C N+ V L V G+ Q + L+ N I+ + +L L
Sbjct: 7 VCYNEPKV-TTSCPQQGLQA--VPV-GIPAASQRIFLHGNRISHVPAASFRACRNLTILW 62
Query: 120 LYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPI-PMSLTNISSLQVLDLSNNRLSGVVP 178
L+ N L+ L L L++N+ + P + + L L L L + P
Sbjct: 63 LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP 122
Query: 179 DNGS--FSLFTPISFANNLDLCGP 200
+L N L
Sbjct: 123 GLFRGLAALQYLYLQDNALQALPD 146
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (84), Expect = 0.004
Identities = 18/135 (13%), Positives = 31/135 (22%), Gaps = 17/135 (12%)
Query: 6 WALCLILVVHSSWLASANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTW--------- 56
L + + + + LHSL L+ N V +
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 57 ----FHVTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNL 112
++ + L + L LQ S+ + +P L
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRLAGR 271
Query: 113 TSLVSLDLYLNSFTG 127
L N G
Sbjct: 272 D---LKRLAANDLQG 283
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 52.7 bits (125), Expect = 2e-08
Identities = 21/65 (32%), Positives = 31/65 (47%), Gaps = 4/65 (6%)
Query: 106 PSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQV 165
+ L NL+ L +L N + P L L L + L NN +S P L N S+L +
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
Query: 166 LDLSN 170
+ L+N
Sbjct: 222 VTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 6e-05
Identities = 16/69 (23%), Positives = 25/69 (36%), Gaps = 5/69 (7%)
Query: 52 NPCTWFHVTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGN 111
+ N N +S +S L L NL + L +N I+ P L N
Sbjct: 161 AQVSDLTPLANLSKLTTLKADDNK-ISD--ISPLASLPNLIEVHLKNNQISDVSP--LAN 215
Query: 112 LTSLVSLDL 120
++L + L
Sbjct: 216 TSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 17/49 (34%), Positives = 27/49 (55%), Gaps = 2/49 (4%)
Query: 130 PDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVP 178
L LSKL L+ ++N +S P L ++ +L + L NN++S V P
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 2e-04
Identities = 15/70 (21%), Positives = 31/70 (44%), Gaps = 6/70 (8%)
Query: 88 LKNLQYLELYSNNITGPIP-SDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNN 146
L N + +N+T + +DL +T+L + + + G + L+ L L L +
Sbjct: 18 LANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-----VQYLNNLIGLELKD 72
Query: 147 NSLSGPIPMS 156
N ++ P+
Sbjct: 73 NQITDLAPLK 82
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.002
Identities = 10/60 (16%), Positives = 23/60 (38%), Gaps = 4/60 (6%)
Query: 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSF 125
+ I++ G + ++ L + L + +T + L +L+ L+L N
Sbjct: 20 NAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQI 75
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.5 bits (112), Expect = 6e-07
Identities = 21/101 (20%), Positives = 36/101 (35%), Gaps = 3/101 (2%)
Query: 85 LGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTG--PIPDTLGKLSKLRFL 142
L L +++ + N+ L+SL+L N + + K L+ L
Sbjct: 38 LVAQNIDVVLNR-RSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96
Query: 143 RLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSF 183
L+ N L + L+ L L N LS D ++
Sbjct: 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (84), Expect = 0.003
Identities = 24/104 (23%), Positives = 38/104 (36%), Gaps = 7/104 (6%)
Query: 57 FHVTCNNDNSVIRVDLGNAALSGQ--LVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTS 114
+ N ++ ++L N L + S + NL+ L L N + D
Sbjct: 57 LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116
Query: 115 LVSLDLYLNSFTGPIPDTLGKLSKLRFL-----RLNNNSLSGPI 153
L L L NS + D +S +R RL+ + L PI
Sbjct: 117 LEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHELPPPI 160
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.8 bits (112), Expect = 2e-06
Identities = 18/79 (22%), Positives = 32/79 (40%), Gaps = 2/79 (2%)
Query: 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITG-PIPSDLGNLTSLVSLDLYLN 123
VI + + L + +Q+++L ++ I + L + L +L L
Sbjct: 23 QGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81
Query: 124 SFTGPIPDTLGKLSKLRFL 142
+ PI +TL K S L L
Sbjct: 82 RLSDPIVNTLAKNSNLVRL 100
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.5 bits (106), Expect = 8e-06
Identities = 17/88 (19%), Positives = 37/88 (42%), Gaps = 3/88 (3%)
Query: 92 QYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSG 151
Q L+L N+ + L + +++ + P+ + +++ + L+N+ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEV 60
Query: 152 -PIPMSLTNISSLQVLDLSNNRLSGVVP 178
+ L+ S LQ L L RLS +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIV 88
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.002
Identities = 18/115 (15%), Positives = 39/115 (33%), Gaps = 4/115 (3%)
Query: 52 NPCTWFHVTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLEL-YSNNITGPIPSDLG 110
+ N V + L + L LQ+L L +I +LG
Sbjct: 163 QKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELG 222
Query: 111 NLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQV 165
+ +L +L ++ G + L L++N + + ++ N + ++
Sbjct: 223 EIPTLKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIARPTIGNKKNQEI 274
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 3e-06
Identities = 14/61 (22%), Positives = 22/61 (36%), Gaps = 3/61 (4%)
Query: 60 TCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLD 119
+ S + V+ L+ L L K+ L L N + + L T L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 120 L 120
L
Sbjct: 62 L 62
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.9 bits (102), Expect = 2e-05
Identities = 16/51 (31%), Positives = 20/51 (39%), Gaps = 1/51 (1%)
Query: 99 NNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSL 149
NN+T L L +L +L L NS IP L F L+ N
Sbjct: 158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.9 bits (102), Expect = 2e-05
Identities = 13/65 (20%), Positives = 25/65 (38%), Gaps = 3/65 (4%)
Query: 108 DLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLD 167
++ + S + ++ + T +P L K L L+ N L +L + L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 168 LSNNR 172
L
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 3e-05
Identities = 21/77 (27%), Positives = 23/77 (29%), Gaps = 1/77 (1%)
Query: 97 YSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMS 156
N + P L L L L N+ T L L L L L NSL IP
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190
Query: 157 LTNISSLQVLDLSNNRL 173
L L N
Sbjct: 191 FFGSHLLPFAFLHGNPW 207
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.3 bits (105), Expect = 8e-06
Identities = 7/44 (15%), Positives = 13/44 (29%)
Query: 129 IPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNR 172
D S L ++ + L N+ L+ N +
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.9 bits (104), Expect = 1e-05
Identities = 13/53 (24%), Positives = 17/53 (32%), Gaps = 1/53 (1%)
Query: 97 YSNNITGPIPSD-LGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNS 148
NN +P+D + V LD+ L L KLR N
Sbjct: 184 SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 8e-05
Identities = 7/37 (18%), Positives = 10/37 (27%)
Query: 85 LGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLY 121
L++ I L NL L + Y
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.002
Identities = 9/76 (11%), Positives = 17/76 (22%), Gaps = 14/76 (18%)
Query: 54 CTWFHVTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLT 113
C+ C + V + L +N L +
Sbjct: 8 CSNRVFLCQE-SKVTEIPSD-------------LPRNAIELRFVLTKLRVIQKGAFSGFG 53
Query: 114 SLVSLDLYLNSFTGPI 129
L +++ N I
Sbjct: 54 DLEKIEISQNDVLEVI 69
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 2e-05
Identities = 11/69 (15%), Positives = 23/69 (33%), Gaps = 4/69 (5%)
Query: 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147
L ++T + + L S+ + + + L + L LN N
Sbjct: 23 FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 148 SLSGPIPMS 156
L+ P++
Sbjct: 79 KLTDIKPLA 87
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 6e-04
Identities = 13/38 (34%), Positives = 23/38 (60%), Gaps = 2/38 (5%)
Query: 133 LGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSN 170
L L+KL+ L L+ N +S + +L + +L VL+L +
Sbjct: 174 LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 13/37 (35%), Positives = 18/37 (48%), Gaps = 2/37 (5%)
Query: 85 LGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLY 121
L L LQ L L N+I+ L L +L L+L+
Sbjct: 174 LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.3 bits (100), Expect = 5e-05
Identities = 10/89 (11%), Positives = 27/89 (30%), Gaps = 5/89 (5%)
Query: 89 KNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGP----IPDTLGKLSKLRFLRL 144
K+L+ + + + + + L S+ + L N+ + + + L
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRL 173
++ + L L +L
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.3 bits (100), Expect = 5e-05
Identities = 11/93 (11%), Positives = 32/93 (34%), Gaps = 8/93 (8%)
Query: 114 SLVSLDLYLNSFTG----PIPDTLGKLSKLRFLRLNNNSLSGP----IPMSLTNISSLQV 165
S+ L L++ T + L + ++ + L+ N++ + ++ + L++
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 166 LDLSNNRLSGVVPDNGSFSLFTPISFANNLDLC 198
+ S+ V + + L
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLH 96
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.6 bits (98), Expect = 9e-05
Identities = 23/138 (16%), Positives = 37/138 (26%), Gaps = 10/138 (7%)
Query: 15 HSSWLASANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGN 74
L L L ++ S + ND + G
Sbjct: 203 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS--ARGA 260
Query: 75 AALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDL-----GNLTSLVSLDLYLNSFTGPI 129
AA+ LQ L L N I L + L+ L+L N F+
Sbjct: 261 AAVVDAF--SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE-E 317
Query: 130 PDTLGKLSKLRFLRLNNN 147
D + ++ ++ R
Sbjct: 318 DDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 2e-04
Identities = 12/48 (25%), Positives = 20/48 (41%), Gaps = 5/48 (10%)
Query: 132 TLGKLSKLRFLRLNNNSLSGPIPMSL-----TNISSLQVLDLSNNRLS 174
+ + L+ LRL N + +L + L L+L+ NR S
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 7e-04
Identities = 15/78 (19%), Positives = 25/78 (32%), Gaps = 13/78 (16%)
Query: 96 LYSNNITGPIPSDLGN------LTSLVSLDLYLNSFTGPIPDTL-----GKLSKLRFLRL 144
L ++ + + + L +L L N TL K+ L FL L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 145 NNNSLS--GPIPMSLTNI 160
N N S + + +
Sbjct: 310 NGNRFSEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.6 bits (85), Expect = 0.003
Identities = 9/74 (12%), Positives = 21/74 (28%), Gaps = 4/74 (5%)
Query: 80 QLVSQLGLLKNLQYLELYSNNITGP----IPSDLGNLTSLVSLDLYLNSFTGPIPDTLGK 135
+ + L +++ + L N I + ++ + L + +
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 136 LSKLRFLRLNNNSL 149
L L L L
Sbjct: 82 LRLLLQALLKCPKL 95
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (94), Expect = 1e-04
Identities = 12/72 (16%), Positives = 22/72 (30%), Gaps = 1/72 (1%)
Query: 136 LSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNL 195
+ R L L + I + +D S+N + + L T + N +
Sbjct: 17 AVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRI 75
Query: 196 DLCGPVTGRPCP 207
G + P
Sbjct: 76 CRIGEGLDQALP 87
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (93), Expect = 2e-04
Identities = 24/103 (23%), Positives = 39/103 (37%), Gaps = 6/103 (5%)
Query: 77 LSGQLVSQLGLLKN---LQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTL 133
L+ +L+ Q N + L+L I I + L ++D N D
Sbjct: 3 LTAELIEQAAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI--RKLDGF 59
Query: 134 GKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGV 176
L +L+ L +NNN + + L L L+NN L +
Sbjct: 60 PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVEL 102
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (90), Expect = 4e-04
Identities = 19/110 (17%), Positives = 31/110 (28%), Gaps = 2/110 (1%)
Query: 90 NLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP-DTLGKLSKLRFLRLNNNS 148
L + L +L L + + L L +LR L + +
Sbjct: 9 GSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 149 LSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLC 198
L P + L L+LS N L + + + N C
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 621 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.7 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.64 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.62 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.58 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.57 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.55 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.51 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.49 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.46 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.46 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.43 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.41 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.41 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.33 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.33 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.31 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.31 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.29 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.28 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.27 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.27 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.23 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.21 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.15 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.94 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.81 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.6 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.53 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.49 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.43 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.43 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.38 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.35 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.29 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.15 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.13 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.98 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.77 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.65 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.17 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.1 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.99 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.52 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.51 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.43 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-53 Score=423.29 Aligned_cols=265 Identities=28% Similarity=0.383 Sum_probs=217.8
Q ss_pred HHHHHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCce
Q 007020 290 ELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 290 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 368 (621)
+|++..++|++.+.||+|+||+||+|.+. +|+.||||+++.... ..++|.+|+.++++++|||||+++|++.+++..
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 45566778999999999999999999875 588999999875432 355799999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
++||||+++|+|.+++..... ..+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred EEEeecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccccee
Confidence 999999999999999976432 3489999999999999999999999 99999999999999999999999999998
Q ss_pred ecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 449 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
..............|++.|+|||++.+..++.++|||||||++|||++|..||.... . ..+... .....
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~----~---~~~~~~-~i~~~--- 232 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----D---LSQVYE-LLEKD--- 232 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC----C---HHHHHH-HHHTT---
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc----h---HHHHHH-HHhcC---
Confidence 776555555555668999999999999999999999999999999999777763211 1 111111 11111
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCCc
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLA 578 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~ 578 (621)
.....+...+..+.+++..||+.||++|||+++|++.|+.....
T Consensus 233 ------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 233 ------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred ------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11111222346789999999999999999999999999876443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=412.62 Aligned_cols=253 Identities=25% Similarity=0.431 Sum_probs=199.3
Q ss_pred cCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEecc
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 375 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 375 (621)
++|+..+.||+|+||+||+|.+.+++.||||+++.... ...+|.+|++++++++|||||+++|++.+++..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC--cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 56788899999999999999998889999999976432 3457999999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCC
Q 007020 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 455 (621)
++|+|.+++.... ..+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 9999999987643 2488999999999999999999999 999999999999999999999999999987655444
Q ss_pred eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhC-CCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 456 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG-QRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
.......||+.|+|||++.+..++.++|||||||++|||+|+ .+||.. .. ..+.+........ ...|.
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~-----~~---~~~~~~~i~~~~~---~~~p~ 225 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-----RS---NSEVVEDISTGFR---LYKPR 225 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-----CC---HHHHHHHHHHTCC---CCCCT
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC-----CC---HHHHHHHHHhcCC---CCCcc
Confidence 444456699999999999999999999999999999999995 544431 11 1222222222111 11121
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.+..++.+++..||+.||++|||++||++.|++
T Consensus 226 -------~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 226 -------LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp -------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 223678899999999999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-52 Score=414.03 Aligned_cols=262 Identities=28% Similarity=0.450 Sum_probs=204.5
Q ss_pred HHHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 291 LQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 291 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
|++..++|++.+.||+|+||+||+|++. ..||||+++... .......|.+|+.++++++|||||++++++.+ +..+
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~ 79 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA 79 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence 4455678999999999999999999875 359999997554 34455679999999999999999999998754 5689
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+||||+++|+|.+++..... .+++..+..++.||++||+|||++ +||||||||+|||++.++.+||+|||+|+.
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred EEEecCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceee
Confidence 99999999999999976432 389999999999999999999999 999999999999999999999999999987
Q ss_pred cccCC-CeeeecccccccccchhhhccC---CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 450 MDYKD-THVTTAVRGTIGHIAPEYLSTG---KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 450 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
..... ........||+.|||||++.+. .++.++|||||||++|||+||+.||.... .. ..+.......
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~----~~----~~~~~~~~~~ 225 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN----NR----DQIIFMVGRG 225 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC----CH----HHHHHHHHHT
T ss_pred ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC----hH----HHHHHHHhcC
Confidence 65432 2334456799999999999643 47899999999999999999999996221 11 1111111111
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 526 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 526 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
. ..+.. .......+..+.+++.+||+.||++|||++||++.|+.
T Consensus 226 ~----~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 226 Y----LSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp S----CCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----CCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1 11111 01122334678999999999999999999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=414.05 Aligned_cols=252 Identities=24% Similarity=0.377 Sum_probs=202.8
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
++|++.+.||+|+||+||+|++. +|+.||||+++..........+.+|++++++++|||||++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 56888999999999999999875 68999999997665444556789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++|+|.+++.... .+++..++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 85 ~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999997643 389999999999999999999999 99999999999999999999999999999765443
Q ss_pred C-eeeecccccccccchhhhccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 455 T-HVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 455 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
. ......+||+.|||||++.+..+ +.++||||+||++|||++|+.||.... +.......+ ..... . .
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~---~~~~~~~~~----~~~~~-~--~- 226 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS---DSCQEYSDW----KEKKT-Y--L- 226 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS---TTSHHHHHH----HTTCT-T--S-
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC---hHHHHHHHH----hcCCC-C--C-
Confidence 2 23345679999999999988775 678999999999999999999996322 111111111 11000 0 0
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
........++.+++..||+.||++|||++|+++
T Consensus 227 -----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 -----NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001122357788999999999999999999854
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=416.04 Aligned_cols=259 Identities=27% Similarity=0.424 Sum_probs=210.8
Q ss_pred HHHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 291 LQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 291 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
|++..++|++.+.||+|+||+||+|.+++++.||||+++... ....+|.+|++++++++|||||+++|++.+ +..++
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 445567888999999999999999999888899999997543 234579999999999999999999998754 56799
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
||||+++|+|.+++.... ..++++..+..|+.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+..
T Consensus 85 v~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp EEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEc
Confidence 999999999999876532 22389999999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
............||+.|+|||++.+..++.++|||||||++|||+||..|+... .. ..+.+.......
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~----~~---~~~~~~~i~~~~----- 227 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG----MT---NPEVIQNLERGY----- 227 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT----CC---HHHHHHHHHTTC-----
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC----CC---HHHHHHHHHhcC-----
Confidence 655444455567999999999999999999999999999999999966555311 11 112222221111
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.+.. +...+..+.+++..||+.||++||||++|++.|++
T Consensus 228 -~~~~----p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 228 -RMVR----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp -CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCC----cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 1111 11233678899999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-51 Score=412.89 Aligned_cols=256 Identities=28% Similarity=0.446 Sum_probs=200.1
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CC---cEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DG---SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
.++|++.++||+|+||+||+|.+. ++ ..||||.+...........|.+|++++++++|||||+++|++.+++..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 356777889999999999999875 23 36899998776666667789999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
||||+++|+|.+++..... .+++.++..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 105 v~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEecCCCcceeeeccccC---CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999999998876432 389999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCCe----eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 451 DYKDTH----VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 451 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
...... ......||+.|||||.+.++.++.++|||||||++|||+| |+.||.... ..+.+.......
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~--------~~~~~~~i~~~~ 250 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT--------NQDVINAIEQDY 250 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCC
Confidence 543221 1122457899999999999999999999999999999998 899995221 112222222111
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 526 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 526 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.. ..+.+.+..+.+++..||+.||++|||++||++.|+.
T Consensus 251 ~~----------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 251 RL----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp CC----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CC----------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11 1122334678999999999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-51 Score=401.30 Aligned_cols=255 Identities=22% Similarity=0.372 Sum_probs=213.7
Q ss_pred hcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
.++|+..+.||+|+||+||+|++++++.||||+++.... ...+|.+|+.++++++||||++++|++.+++..++||||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 367889999999999999999998888999999986543 345799999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++|+|.+++..... .+++..+.+++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 81 ~~~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 81 MANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CTTEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred cCCCcHHHhhhcccc---CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 999999999765432 388999999999999999999999 99999999999999999999999999998765544
Q ss_pred CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccCc
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 533 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 533 (621)
........||..|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+......... ....|
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--------~~~~~~~i~~~~---~~~~p 223 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEHIAQGL---RLYRP 223 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--------HHHHHHHHHTTC---CCCCC
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC--------HHHHHHHHHhCC---CCCCc
Confidence 444445669999999999999999999999999999999998 899996221 112222222111 11122
Q ss_pred cccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 534 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 534 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
. ..+..+.+++..||+.||++|||+++|++.|.++
T Consensus 224 ~-------~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 H-------LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp T-------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred c-------cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 2 2236789999999999999999999999998763
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=405.16 Aligned_cols=249 Identities=21% Similarity=0.318 Sum_probs=206.6
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
++|+..+.||+|+||+||+|... +|+.||||+++.... .....+.+|+.+++.++|||||++++++.+++..++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 47999999999999999999864 799999999875442 2345789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 99 ~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 9999999988764 289999999999999999999999 99999999999999999999999999998765433
Q ss_pred CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+.......... ..
T Consensus 171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~~~~~~~~~-~~--- 237 (293)
T d1yhwa1 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------PLRALYLIATNGTPE-LQ--- 237 (293)
T ss_dssp -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHHCSCC-CS---
T ss_pred -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC--------HHHHHHHHHhCCCCC-CC---
Confidence 23345579999999999999999999999999999999999999995221 111222222211111 11
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.+......+.+++..||+.||++|||++|+++
T Consensus 238 ----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 238 ----NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ----SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11223367889999999999999999999865
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=408.31 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=195.0
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeec--CCceEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLV 371 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 371 (621)
++|++.+.||+|+||+||+|+.. +|+.||||.++... .+.....+.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57889999999999999999864 78999999997654 33445678999999999999999999999865 4567999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC--DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
|||+++|+|.+++.........+++..++.++.||+.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998754333345899999999999999999999862 11499999999999999999999999999987
Q ss_pred cccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 450 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+....... ....
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~--------~~~~~~~i~~-~~~~- 232 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGKIRE-GKFR- 232 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHH-TCCC-
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC--------HHHHHHHHHc-CCCC-
Confidence 65332 23345679999999999999999999999999999999999999996321 1122222211 1111
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.... ..+.++.+++..||+.||++|||++|+++
T Consensus 233 ----~~~~----~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 ----RIPY----RYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ----CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCc----ccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1111 22357889999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=399.82 Aligned_cols=246 Identities=28% Similarity=0.417 Sum_probs=205.2
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|++.+.||+|+||+||+|++. +++.||+|++.... .......+.+|+++++.++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 56888999999999999999975 68999999986432 1223557899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++.... .+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999998643 389999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......+..
T Consensus 159 ~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~~------- 220 (263)
T d2j4za1 159 S---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISRVE------- 220 (263)
T ss_dssp C---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTTC-------
T ss_pred C---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCC-------
Confidence 2 2344679999999999999999999999999999999999999996321 112222222111
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
... +...+.++.+++..||+.||++|||++|+++
T Consensus 221 ~~~----p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 FTF----PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC----CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 111 1122367889999999999999999999976
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-51 Score=405.33 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=207.6
Q ss_pred hcCCCcCce-eeeccCceEEEEEcC---CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 295 TDSFSNKNI-LGRGGFGKVYKGRLA---DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 295 ~~~~~~~~~-lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
.++|...+. ||+|+||+||+|.+. ++..||||+++.........+|.+|++++++++|||||+++|++.+ +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 345666664 999999999999764 3557999999876666667789999999999999999999999865 56899
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
||||+++|+|.+++..... .+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 86 vmE~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHhhcccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence 9999999999999865432 389999999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCCee--eecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 451 DYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 451 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
....... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.... .. +....+.....
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~-----~~---~~~~~i~~~~~- 230 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----GP---EVMAFIEQGKR- 230 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----TH---HHHHHHHTTCC-
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC-----HH---HHHHHHHcCCC-
Confidence 6543322 223458999999999999999999999999999999998 999996221 11 22222211111
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
+.. +...+.++.+++..||+.||++||||.+|++.|+.
T Consensus 231 -----~~~----p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 231 -----MEC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp -----CCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCC----CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 111 12234678999999999999999999999999876
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=409.69 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=202.5
Q ss_pred hcCCCcCceeeeccCceEEEEEcCCC-----cEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLADG-----SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
.+.|+..++||+|+||+||+|.+.++ ..||||+++.........+|.+|+.++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35677889999999999999986532 4799999987666666678999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+||||+.+|++.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhhcccc---cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999998876432 389999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCC--eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccc
Q 007020 450 MDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 527 (621)
Q Consensus 450 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (621)
...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.... . ..+.........
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~----~---~~~~~~~i~~~~-- 230 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----S---NHEVMKAINDGF-- 230 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----C---HHHHHHHHHTTC--
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC----C---HHHHHHHHhccC--
Confidence 654322 22334468999999999999999999999999999999999766653211 1 112222221111
Q ss_pred ccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 528 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 528 ~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
....+...+..+.+++.+||+.||++||||.||++.|+.
T Consensus 231 --------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 231 --------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp --------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 111122234678999999999999999999999999876
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=418.85 Aligned_cols=263 Identities=25% Similarity=0.383 Sum_probs=209.7
Q ss_pred HHHHhcCCCcCceeeeccCceEEEEEcCC------CcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeee
Q 007020 291 LQVATDSFSNKNILGRGGFGKVYKGRLAD------GSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCM 363 (621)
Q Consensus 291 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 363 (621)
|++..++|++.+.||+|+||+||+|++.. ...||||.+...........+.+|+.++.++ +|||||++++++.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 45566789999999999999999998642 2369999997665555566799999999988 8999999999999
Q ss_pred cCCceEEEEeccCCCchhhhhccCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 007020 364 TPTERLLVYPYMANGSVASCLRERPPS-------------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHR 424 (621)
Q Consensus 364 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 424 (621)
+.+..++||||+++|+|.++++..... ...+++..++.++.||++||+|||++ +||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence 999999999999999999999765321 23489999999999999999999999 99999
Q ss_pred CCCCCCeeeCCCCcEEEcccccceecccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcc
Q 007020 425 DVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFD 502 (621)
Q Consensus 425 Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~ 502 (621)
||||+|||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876544332 3345568999999999999999999999999999999998 899996
Q ss_pred cccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007020 503 LARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 573 (621)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 573 (621)
... ....+.+.+. .. ..+. .+...+..+.+++..||+.||++|||++||+++|.
T Consensus 269 ~~~----~~~~~~~~~~----~~-----~~~~----~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIP----VDANFYKLIQ----NG-----FKMD----QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCC----CSHHHHHHHH----TT-----CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCC----HHHHHHHHHh----cC-----CCCC----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 221 1112222221 11 0111 12223467899999999999999999999999984
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=418.44 Aligned_cols=201 Identities=25% Similarity=0.384 Sum_probs=180.1
Q ss_pred HHhcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 293 VATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 293 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
+..++|++.+.||+|+||+||+|++. +|+.||+|+++....+....++.+|+.+++.++|||||++++++.++++.++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34678999999999999999999964 78999999998766566667899999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
|||+++|+|.+++.+.. .+++..+..++.|+++||+|||+ + +|+||||||+|||++.++.+||+|||+|+..
T Consensus 83 mEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 99999999999998643 28999999999999999999997 5 8999999999999999999999999999876
Q ss_pred ccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCccc
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 503 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~ 503 (621)
.... ....+||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 156 ~~~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 156 IDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp HHHT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred CCCc---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 4322 2345799999999999999999999999999999999999999963
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=404.12 Aligned_cols=260 Identities=27% Similarity=0.381 Sum_probs=204.5
Q ss_pred HHHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 291 LQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 291 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
|++..++|++.+.||+|+||+||+|++.+++.||||+++.... ....|.+|+.++++++|||||+++|++.+ +..++
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~l 88 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 88 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC--CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEE
Confidence 3445678999999999999999999998888999999975433 34679999999999999999999999854 56899
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
||||+++|+|..++..... ..++|..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+..
T Consensus 89 v~Ey~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp EECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EEEecCCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhc
Confidence 9999999999998876322 2389999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
............||+.|+|||++.++.++.++|||||||++|||++|..||.... . ..+.+..+.+...
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~----~---~~~~~~~i~~~~~---- 232 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM----V---NREVLDQVERGYR---- 232 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC----C---HHHHHHHHHTTCC----
T ss_pred cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC----C---HHHHHHHHHhcCC----
Confidence 5444444455669999999999999999999999999999999999766653211 1 1122222221111
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
+. .....+.++.+++.+||+.||++||++++|+++|+..
T Consensus 233 --~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 233 --MP----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp --CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred --CC----CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 11 1222346789999999999999999999999998873
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=401.63 Aligned_cols=251 Identities=24% Similarity=0.310 Sum_probs=203.1
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
+.|++.+.||+|+||+||+|++. +|+.||||+++... ......+.+|+++++.++|||||++++++.+++..++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 56888899999999999999865 68999999997543 34456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+++|+|.+++.+.. .++++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 91 ~~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 91 CAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp CTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 99999999986532 2389999999999999999999999 99999999999999999999999999998654321
Q ss_pred Ceeeecccccccccchhhhc-----cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 455 THVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
.......||+.|+|||++. +..++.++|||||||++|||+||+.||..... .. .+........ ..
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~----~~----~~~~i~~~~~-~~ 234 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP----MR----VLLKIAKSEP-PT 234 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG----GG----HHHHHHHSCC-CC
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH----HH----HHHHHHcCCC-CC
Confidence 1223456999999999984 44578999999999999999999999963211 11 1111111111 11
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
+.. ....+..+.+++..||+.||++|||++|+++
T Consensus 235 ~~~-------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 LAQ-------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CSS-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCc-------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 1223467889999999999999999999865
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=401.10 Aligned_cols=247 Identities=25% Similarity=0.361 Sum_probs=198.3
Q ss_pred ceeeeccCceEEEEEcC---CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEeccCC
Q 007020 302 NILGRGGFGKVYKGRLA---DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 377 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 377 (621)
+.||+|+||+||+|.+. .++.||||+++.... +....+|.+|++++++++|||||+++|++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999754 356899999975433 3345679999999999999999999999865 467899999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCCee
Q 007020 378 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 457 (621)
Q Consensus 378 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 457 (621)
|+|.++++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.........
T Consensus 92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999998654 389999999999999999999999 99999999999999999999999999998765443332
Q ss_pred --eecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccccccCcc
Q 007020 458 --TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 534 (621)
Q Consensus 458 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 534 (621)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+......+... +.
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~--------~~~~~~~i~~~~~------~~ 230 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------GSEVTAMLEKGER------MG 230 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTTCC------CC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC--------HHHHHHHHHcCCC------CC
Confidence 233568999999999999999999999999999999998 899996221 1121222211111 11
Q ss_pred ccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 535 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 535 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.+...+..+.+++..||+.||++|||+++|++.|+.
T Consensus 231 ----~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 231 ----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ----CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 112234678899999999999999999999998876
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-49 Score=401.36 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=191.2
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.+.|++.+.||+|+||+||+|++. +|+.||||++...........+.+|+.+++.++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467899999999999999999875 6899999999766554455678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC---CCCcEEEcccccceec
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAKLM 450 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DfGla~~~ 450 (621)
|++||+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+. +++.+||+|||+|+..
T Consensus 88 ~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999997643 389999999999999999999999 999999999999995 5789999999999865
Q ss_pred ccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccc
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 530 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (621)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+..........
T Consensus 161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~~~---- 226 (307)
T d1a06a_ 161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN--------DAKLFEQILKAEY---- 226 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHTTCC----
T ss_pred cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHhccCC----
Confidence 4322 2344569999999999999999999999999999999999999996221 1111122221111
Q ss_pred cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 531 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 531 ~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
..........+..+.+++..||+.||++|||++|+++.
T Consensus 227 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 227 ---EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ---CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01111112234678899999999999999999999873
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=392.05 Aligned_cols=245 Identities=24% Similarity=0.380 Sum_probs=195.6
Q ss_pred CcCceeeeccCceEEEEEcC-CCcEEEEEEecccC-CchhHHHHHHHHHHHHhccCCceeeeeeeeec----CCceEEEE
Q 007020 299 SNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERLLVY 372 (621)
Q Consensus 299 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 372 (621)
...+.||+|+||+||+|.+. +++.||+|.+.... .......+.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45567999999999999865 68899999987654 34445679999999999999999999999864 34579999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeeC-CCCcEEEccccccee
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK--IIHRDVKAANILLD-EEFEAVVGDFGLAKL 449 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~-~~~~~kl~DfGla~~ 449 (621)
||+++|+|.+++.... .+++..+..++.||++||+|||++ + |+||||||+|||++ +++.+||+|||+|+.
T Consensus 92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 9999999999998643 389999999999999999999998 6 99999999999996 578999999999985
Q ss_pred cccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 450 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
... .......||+.|||||++.+ .++.++|||||||++|||++|+.||.... ......+.......
T Consensus 165 ~~~---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-------~~~~~~~~i~~~~~--- 230 (270)
T d1t4ha_ 165 KRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQIYRRVTSGVK--- 230 (270)
T ss_dssp CCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHHHHHHHTTTCC---
T ss_pred ccC---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc-------cHHHHHHHHHcCCC---
Confidence 432 22345679999999999865 58999999999999999999999995211 11111122211111
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.+.. ......++.+++..||+.||++|||++|+++
T Consensus 231 --~~~~----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 --PASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --CGGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --Cccc----CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1111 1112356889999999999999999999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=401.44 Aligned_cols=249 Identities=22% Similarity=0.306 Sum_probs=203.1
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|++.+.||+|+||+||+|+.. +|+.||||+++... .......+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56889999999999999999874 78999999986432 1233456899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999988654 389999999999999999999999 999999999999999999999999999997654
Q ss_pred CC-CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 453 KD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 453 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
.. ........||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+......+..
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~~------ 226 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EYLIFQKIIKLE------ 226 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHTTC------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC--------HHHHHHHHHcCC------
Confidence 32 223445679999999999999999999999999999999999999996321 111122222111
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..+. .....++.+++..||+.||++|||++|++.
T Consensus 227 -~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 227 -YDFP----EKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -CCCC----TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -CCCC----ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1111 122357889999999999999999998754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=400.94 Aligned_cols=258 Identities=21% Similarity=0.347 Sum_probs=199.9
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcCC----CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCc
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLAD----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 367 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 367 (621)
++..++|++.+.||+|+||+||+|.+.. +..||||.++..........+.+|+.++++++|||||+++|++. ++.
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 81 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence 3456789999999999999999998642 45699999876666666678999999999999999999999985 467
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
.++||||+++|+|.+++.... .++++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||+|
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred EEEEEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhh
Confidence 899999999999999877643 2489999999999999999999999 9999999999999999999999999999
Q ss_pred eecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcc
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (621)
+..............||+.|+|||++.+..++.++|||||||++|||++ |.+||.... .......+ .....
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~-----~~~~~~~i---~~~~~ 227 (273)
T d1mp8a_ 156 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-----NNDVIGRI---ENGER 227 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHHH---HTTCC
T ss_pred eeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC-----HHHHHHHH---HcCCC
Confidence 8766544444555668999999999999999999999999999999998 899986322 11122211 11111
Q ss_pred cccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 527 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 527 ~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
. . .+...+..+.+++..||+.||++|||++||++.|+.
T Consensus 228 ~------~----~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 228 L------P----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp C------C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C------C----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1 1 122234678999999999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.9e-50 Score=402.54 Aligned_cols=267 Identities=26% Similarity=0.423 Sum_probs=216.4
Q ss_pred HHHHHHHhcCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeee
Q 007020 288 LRELQVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 361 (621)
Q Consensus 288 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 361 (621)
+.+++.+.++|++.+.||+|+||+||+|++. +++.||||+++.........+|.+|+++++.++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 4556777889999999999999999999853 4578999999876666667789999999999999999999999
Q ss_pred eecCCceEEEEeccCCCchhhhhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 007020 362 CMTPTERLLVYPYMANGSVASCLRERPP--------------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 421 (621)
Q Consensus 362 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i 421 (621)
+.+.+..+++|||+++|+|.+++..... ....+++..+..|+.|++.||+|||++ +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 9999999999999999999999975321 123488999999999999999999999 99
Q ss_pred EecCCCCCCeeeCCCCcEEEcccccceecccCC-CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCC-C
Q 007020 422 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQ-R 499 (621)
Q Consensus 422 vH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~ 499 (621)
|||||||+|||++.++.+||+|||+|+...... ........|++.|+|||.+.+..++.++|||||||++|||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999998664432 22334566899999999999999999999999999999999986 5
Q ss_pred CcccccccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 500 AFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 500 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
||... . ..+.+...... .. +.. +...+.++.+++..||+.+|++||||.||+++|+++
T Consensus 242 p~~~~-----~---~~e~~~~v~~~-~~-----~~~----p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 242 PYYGM-----A---HEEVIYYVRDG-NI-----LAC----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTTS-----C---HHHHHHHHHTT-CC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCC-----C---HHHHHHHHHcC-CC-----CCC----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 66421 1 11222222211 11 111 122336789999999999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-50 Score=403.45 Aligned_cols=246 Identities=29% Similarity=0.420 Sum_probs=200.8
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc--hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
+.|+..+.||+|+||+||+|+.. +|+.||||+++..... .....+.+|+++++.++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45888899999999999999864 7889999999765432 23356899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
|||++|+|..++.... ++++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999987766543 389999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCeeeecccccccccchhhhcc---CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 529 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (621)
.....||+.|||||++.+ ..++.++|||||||++|||++|+.||.... ..+.+........
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~--------~~~~~~~i~~~~~--- 231 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNES--- 231 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCC---
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCCC---
Confidence 234569999999999864 457899999999999999999999995221 1121222221111
Q ss_pred ccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 530 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 530 ~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
+.... ...+..+.+++..||+.||++|||++|+++
T Consensus 232 ---~~~~~---~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 ---PALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ---CCCSC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCCCC---CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11111 112357889999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=392.83 Aligned_cols=252 Identities=22% Similarity=0.315 Sum_probs=206.2
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc-----hhHHHHHHHHHHHHhccCCceeeeeeeeecCCce
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 368 (621)
.++|++.+.||+|+||+||+|++. +|+.||||+++..... .....+.+|+.++++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999974 7899999999754322 2356799999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC----cEEEccc
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 444 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Df 444 (621)
++|||||++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+|++||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999997653 389999999999999999999999 999999999999998776 4999999
Q ss_pred ccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhh
Q 007020 445 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 524 (621)
Q Consensus 445 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 524 (621)
|+|....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........
T Consensus 162 G~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~ 231 (293)
T d1jksa_ 162 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANVSAV 231 (293)
T ss_dssp TTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHTT
T ss_pred hhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC--------HHHHHHHHHhc
Confidence 9998765332 2344569999999999999999999999999999999999999996221 11222222111
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 525 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 525 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. ...........+..+.+++..||+.||++|||++|+++
T Consensus 232 ~-------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 232 N-------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C-------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C-------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 01111111223467889999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.9e-48 Score=397.93 Aligned_cols=252 Identities=19% Similarity=0.268 Sum_probs=206.9
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ......+.+|+.++++++|||||++++++.+++..++||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 57999999999999999999864 78999999997543 34456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC--CCCcEEEcccccceeccc
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD--EEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~DfGla~~~~~ 452 (621)
|++|+|.+++.... ..+++..+..++.||+.||+|||++ +||||||||+|||++ .++.+||+|||+|+....
T Consensus 105 ~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 99999999986542 2389999999999999999999999 999999999999996 457899999999987654
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
.. ......||+.|||||++.+..++.++||||+||++|||++|+.||.... ..+.+..+..... ..+
T Consensus 179 ~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~~~---~~~ 245 (350)
T d1koaa2 179 KQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNVKSCDW---NMD 245 (350)
T ss_dssp TS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCC---CSC
T ss_pred cc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCC---CCC
Confidence 33 3344569999999999999999999999999999999999999995221 1122222221111 011
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
.......+..+.+++..||+.||++|||++|+++.
T Consensus 246 ----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 ----DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ----CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ----cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112223678899999999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.7e-48 Score=398.46 Aligned_cols=252 Identities=18% Similarity=0.290 Sum_probs=206.9
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
+.|++.+.||+|+||+||+|... +|+.||||+++... ......+.+|+.++++++|||||++++++.+++..++||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 57999999999999999999864 79999999987543 33455788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC--CCCcEEEcccccceeccc
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD--EEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~DfGla~~~~~ 452 (621)
|++|+|.+++.... .++++..++.|+.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|.....
T Consensus 108 ~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence 99999998876543 2489999999999999999999999 999999999999998 678999999999998654
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
.. ......||+.|+|||++.+..++.++||||+||++|||+||+.||.... ..+....+.+..
T Consensus 182 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~------- 244 (352)
T d1koba_ 182 DE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKRCD------- 244 (352)
T ss_dssp TS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHCC-------
T ss_pred CC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-------
Confidence 32 3344569999999999999999999999999999999999999995221 112222221111
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
...........+..+.+++..||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 245 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011111112233678899999999999999999999763
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=399.93 Aligned_cols=268 Identities=26% Similarity=0.365 Sum_probs=203.8
Q ss_pred CHHHHHHHhcCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeee
Q 007020 287 SLRELQVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLR 359 (621)
Q Consensus 287 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 359 (621)
..++|++..++|++.+.||+|+||+||+|.+. +++.||||+++..........+.+|...+.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 45667777889999999999999999999842 35689999998766666666788888887776 689999999
Q ss_pred eeeecC-CceEEEEeccCCCchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 007020 360 GFCMTP-TERLLVYPYMANGSVASCLRERPP------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDV 426 (621)
Q Consensus 360 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 426 (621)
+++.++ ...++|||||++|+|.++++.... ....+++..+..++.||++||+|||++ +||||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcC
Confidence 998765 468999999999999999975432 123488999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCcEEEcccccceecccCCC-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCC-CCcccc
Q 007020 427 KAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQ-RAFDLA 504 (621)
Q Consensus 427 k~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~pf~~~ 504 (621)
||+|||+++++.+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||+||. +||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987544332 2334456999999999999999999999999999999999974 567422
Q ss_pred cccCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 505 RLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
. ... .+......... +.. +...+.++.+++..||+.||++|||++||+++|++
T Consensus 241 ~----~~~----~~~~~~~~~~~-----~~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 241 K----IDE----EFCRRLKEGTR-----MRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp C----CSH----HHHHHHHHTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----HHH----HHHHHHhcCCC-----CCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1 111 11122211111 111 11223578999999999999999999999999976
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=390.95 Aligned_cols=250 Identities=28% Similarity=0.393 Sum_probs=197.1
Q ss_pred HhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeec-CCceEEEE
Q 007020 294 ATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLVY 372 (621)
Q Consensus 294 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 372 (621)
..++|+..+.||+|+||.||+|.++ |+.||||+++... ..+++.+|++++++++||||++++|++.+ .+..++||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 3467788899999999999999984 7899999997543 34578999999999999999999999865 46689999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+++|+|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+|++|||+++....
T Consensus 81 ey~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC
Confidence 99999999999976421 2378999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
. .....++..|+|||++.+..++.++||||||+++|||+| |+.||... .......++. .. .
T Consensus 156 ~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-----~~~~~~~~i~---~~------~ 217 (262)
T d1byga_ 156 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRVE---KG------Y 217 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-----CGGGHHHHHT---TT------C
T ss_pred C----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC-----CHHHHHHHHH---cC------C
Confidence 2 223458899999999999999999999999999999998 68777522 1112222221 11 1
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.+.. +.....++.+++.+||+.||++|||+.+|+++|++
T Consensus 218 ~~~~----~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 218 KMDA----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC----CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 1111 22233678899999999999999999999999976
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=397.61 Aligned_cols=254 Identities=25% Similarity=0.426 Sum_probs=200.7
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCc----EEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 370 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 370 (621)
++|+..++||+|+||+||+|.+. +|+ .||+|.++........++|.+|++++++++|||||+++|++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46888999999999999999864 444 68999987666556677899999999999999999999999865 5678
Q ss_pred EEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceec
Q 007020 371 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 450 (621)
Q Consensus 371 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 450 (621)
++||+.+|+|.+++.... ..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 88 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 899999999999887643 2489999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCCe-eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 451 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 451 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
...... ......||+.|+|||++.++.++.++|||||||++|||+| |..||+... ...+...+.. ....
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~-----~~~~~~~i~~---~~~~- 232 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILEK---GERL- 232 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----GGGHHHHHHH---TCCC-
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHc---CCCC-
Confidence 543332 2334568999999999999999999999999999999999 788886321 1112222211 1111
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
..+...+..+.+++.+||+.||++|||+.||++.|+.
T Consensus 233 ---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 233 ---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp ---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 1112233678999999999999999999999998865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-49 Score=397.32 Aligned_cols=265 Identities=26% Similarity=0.405 Sum_probs=215.4
Q ss_pred HHHHHhcCCCcCceeeeccCceEEEEEc------CCCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeee
Q 007020 290 ELQVATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFC 362 (621)
Q Consensus 290 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 362 (621)
.|++..++|++.+.||+|+||.||+|++ .+++.||||+++..........+.+|+.+++.+ +|||||+++|++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 3455668899999999999999999974 356789999998776666677899999999998 699999999999
Q ss_pred ecCCceEEEEeccCCCchhhhhccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 007020 363 MTPTERLLVYPYMANGSVASCLRERPP--------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKA 428 (621)
Q Consensus 363 ~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~ 428 (621)
.+.+..++||||+++|+|.++++.... ....+++..+..++.||++||+|||++ +||||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence 999999999999999999999976432 223589999999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEcccccceecccCCC-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccc
Q 007020 429 ANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARL 506 (621)
Q Consensus 429 ~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~ 506 (621)
+||+++.++.+|++|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+| |.+||...
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~-- 251 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-- 251 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC--
Confidence 999999999999999999997654433 33445679999999999999999999999999999999999 55555321
Q ss_pred cCCCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 507 ANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.....+.+.+.. .. .+. .....+..+.+++..||+.||++||||++|+++|++
T Consensus 252 --~~~~~~~~~i~~----~~-----~~~----~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 252 --PVDSKFYKMIKE----GF-----RML----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp --CSSHHHHHHHHH----TC-----CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CHHHHHHHHHhc----CC-----CCC----CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111112222221 11 111 111223678999999999999999999999999976
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=392.96 Aligned_cols=265 Identities=24% Similarity=0.399 Sum_probs=216.0
Q ss_pred HHHHHhcCCCcCceeeeccCceEEEEEcC------CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeee
Q 007020 290 ELQVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM 363 (621)
Q Consensus 290 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 363 (621)
+|++..++|++.+.||+|+||+||+|.+. +++.||||+++..........|.+|+.++++++|||||+++|++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 45666788999999999999999999863 357899999987665666667999999999999999999999999
Q ss_pred cCCceEEEEeccCCCchhhhhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC
Q 007020 364 TPTERLLVYPYMANGSVASCLRERP------PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF 437 (621)
Q Consensus 364 ~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 437 (621)
.++..++||||+++|+|.+++.... .....+++..+..++.|+++||.|||++ +|+||||||+|||+++++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence 9999999999999999999986421 1223478899999999999999999999 999999999999999999
Q ss_pred cEEEcccccceecccCCCee-eecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCC-CCcccccccCCCcchHH
Q 007020 438 EAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQ-RAFDLARLANDDDVMLL 515 (621)
Q Consensus 438 ~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~pf~~~~~~~~~~~~~~ 515 (621)
++||+|||+|+......... .....||+.|+|||.+.+..++.++||||||+++|||+||. .||.. ....
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~--------~~~~ 242 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG--------LSNE 242 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT--------SCHH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC--------CCHH
Confidence 99999999998765433322 23345899999999999999999999999999999999985 66642 1222
Q ss_pred HHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 516 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 516 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
++...+....... . +...+..+.+++..||+.+|++|||+++|+++|++.
T Consensus 243 ~~~~~i~~~~~~~------~----p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 243 QVLRFVMEGGLLD------K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHHHHHTTCCCC------C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHHHhCCCCC------C----cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 3333332221111 1 112336799999999999999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=391.00 Aligned_cols=249 Identities=23% Similarity=0.285 Sum_probs=205.5
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 371 (621)
-++|++.+.||+|+||+||+|+.. +|+.||||++++.. ......++.+|+.+++.++||||+++++++.+++..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 357889999999999999999964 79999999997542 123356788999999999999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++|+|.+++..... +++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~~~~----~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhcccC----CcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999999987543 88999999999999999999999 99999999999999999999999999998654
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
... ......+||+.|+|||++.+..++.++||||+||++|||++|++||.... ..+..+..... .
T Consensus 157 ~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~--------~~~~~~~i~~~-~----- 221 (337)
T d1o6la_ 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILME-E----- 221 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC-C-----
T ss_pred cCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC--------HHHHHHHHhcC-C-----
Confidence 322 23445679999999999999999999999999999999999999996322 11222222111 1
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-----MSEVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-----~~~vl~ 570 (621)
..+ +...+.++.+++..||+.||++||+ ++|+++
T Consensus 222 -~~~----p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 222 -IRF----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CCC----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCC----CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 111 1122356889999999999999995 777754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=388.10 Aligned_cols=256 Identities=30% Similarity=0.395 Sum_probs=196.1
Q ss_pred hcCCCcCceeeeccCceEEEEEcC--CC--cEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCCce
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA--DG--SLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 368 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 368 (621)
.++|++.+.||+|+||+||+|++. ++ ..||||+++.... .....+|.+|+.++++++|||||+++|++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 356888899999999999999853 22 3789999875432 3344579999999999999999999999976 467
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccce
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 448 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 448 (621)
++||||+++|++.+++..... ++++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred heeeeeecCcchhhhhhcccC---CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence 899999999999998876432 389999999999999999999999 99999999999999999999999999999
Q ss_pred ecccCCCee--eecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 449 LMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 449 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
......... .....|+..|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+.+..+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~--------~~~~~~~i~~~~ 231 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--------GSQILHKIDKEG 231 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTSC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC--------HHHHHHHHHhCC
Confidence 875443322 233458889999999999999999999999999999998 899995221 112222222221
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 526 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 526 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.. + ......+..+.+++..||+.||++||||.+|++.|++
T Consensus 232 ~~-----~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 232 ER-----L----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC-----C----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 10 1 1112233678899999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=392.47 Aligned_cols=263 Identities=29% Similarity=0.417 Sum_probs=208.9
Q ss_pred HHHhcCCCcCceeeeccCceEEEEEcC--------CCcEEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeee
Q 007020 292 QVATDSFSNKNILGRGGFGKVYKGRLA--------DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFC 362 (621)
Q Consensus 292 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 362 (621)
++..++|++.+.||+|+||.||+|+.. ++..||||+++.........++.+|...+.++ +|||||++++++
T Consensus 9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 345678999999999999999999752 23479999998777666667889999998888 799999999999
Q ss_pred ecCCceEEEEeccCCCchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 007020 363 MTPTERLLVYPYMANGSVASCLRERPP------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAAN 430 (621)
Q Consensus 363 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 430 (621)
.+++..++||||+++|+|.+++..... ....+++.+++.++.||+.||+|||+. +||||||||+|
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~N 165 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 165 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccc
Confidence 999999999999999999999976532 123589999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEcccccceecccCCC-eeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHh-CCCCcccccccC
Q 007020 431 ILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLAN 508 (621)
Q Consensus 431 ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~ 508 (621)
||++.++.+||+|||+++....... .......|++.|+|||.+.++.++.++|||||||++|||++ |.+||....
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~--- 242 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--- 242 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC---
Confidence 9999999999999999987654332 23344568999999999999999999999999999999998 688885221
Q ss_pred CCcchHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 509 DDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
.. + +...+... ..+... ...+..+.+++.+||+.||++|||+.||++.|+++
T Consensus 243 --~~---~-~~~~i~~~-----~~~~~p----~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 243 --VE---E-LFKLLKEG-----HRMDKP----SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp --HH---H-HHHHHHTT-----CCCCCC----SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HH---H-HHHHHHcC-----CCCCCC----ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11 1 11111111 111111 12236789999999999999999999999999763
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=387.44 Aligned_cols=252 Identities=33% Similarity=0.474 Sum_probs=202.6
Q ss_pred CceeeeccCceEEEEEcCCC----cEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeec-CCceEEEEecc
Q 007020 301 KNILGRGGFGKVYKGRLADG----SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLVYPYM 375 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 375 (621)
.++||+|+||+||+|.+.++ ..||||+++.........+|.+|++++++++||||++++|++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999986432 36999999866666666789999999999999999999999865 46789999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCC
Q 007020 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 455 (621)
++|+|.+++..... ..++..+..++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccccc---cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999886533 377889999999999999999999 999999999999999999999999999987654322
Q ss_pred e---eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 456 H---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 456 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
. ......||..|+|||.+.+..++.++||||||+++|||+||..||..... .. ++......... ...
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~----~~---~~~~~i~~g~~---~~~ 255 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----TF---DITVYLLQGRR---LLQ 255 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCC---CCC
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC----HH---HHHHHHHcCCC---CCC
Confidence 2 22234689999999999999999999999999999999998888753221 11 11222222111 111
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
|. .....+.+++.+||+.||++||+|.||++.|+++
T Consensus 256 p~-------~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 256 PE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp CT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc-------cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 2235788999999999999999999999999774
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.1e-47 Score=385.22 Aligned_cols=245 Identities=27% Similarity=0.353 Sum_probs=203.7
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|++.+.||+|+||+||+|++. +|+.||||+++... .......+.+|+.+++.++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56888999999999999999964 69999999997532 1223457899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||++||+|..++..... +++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~~----~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR----FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHTSS----CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccccccc----ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999999887543 78889999999999999999999 999999999999999999999999999987643
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+..........
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~i~~~~~------ 218 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILNAEL------ 218 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHCCC------
T ss_pred c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC--------HHHHHHHHHcCCC------
Confidence 2 234679999999999999999999999999999999999999996321 1122222222110
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 570 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~ 570 (621)
.. +...+..+.+++..|+..||.+|+ |++++++
T Consensus 219 -~~----p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 -RF----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -CC----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CC----CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11 111235688999999999999996 8888865
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3e-47 Score=379.51 Aligned_cols=258 Identities=25% Similarity=0.330 Sum_probs=201.0
Q ss_pred hcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCC--chhHHHHHHHHHHHHhccCCceeeeeeeeecCC----c
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----E 367 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 367 (621)
.++|++.+.||+|+||+||+|++ .+|+.||||+++.... ......+.+|+++++.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999986 4799999999976543 334457999999999999999999999987654 3
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
.|+||||+++|+|.+++.... ++++.+++.++.||+.||+|||++ +|+||||||+|||++.++..+++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 789999999999999987654 389999999999999999999999 9999999999999999999999999998
Q ss_pred eecccCC--CeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 448 KLMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 448 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+.........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~~~~~~ 230 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------PVSVAYQHVRED 230 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC--------HHHHHHHHHhcC
Confidence 7654322 223445679999999999999999999999999999999999999996321 112222222221
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHhc
Q 007020 526 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-KMSEVVRMLEG 574 (621)
Q Consensus 526 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-t~~~vl~~L~~ 574 (621)
... +.. .....+..+.+++.+|++.||++|| |+++++..|..
T Consensus 231 ~~~----~~~---~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 231 PIP----PSA---RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCC----GGG---TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCC----Cch---hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 111 100 1112236788999999999999999 89999887754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-48 Score=389.06 Aligned_cols=256 Identities=25% Similarity=0.413 Sum_probs=202.6
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCc--EEEEEEecccCCchhHHHHHHHHHHHHhc-cCCceeeeeeeeecCCceEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGS--LVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 371 (621)
++|++.+.||+|+||+||+|++. +|. .||||.++..........+.+|++++.++ +|||||+++|++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67888899999999999999875 343 47888886655555566799999999998 799999999999999999999
Q ss_pred EeccCCCchhhhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcE
Q 007020 372 YPYMANGSVASCLRERP------------PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 439 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 439 (621)
|||+++|+|.++++... .....+++..+..++.||++||.|||++ +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997642 2234589999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCC-CcccccccCCCcchHHHHH
Q 007020 440 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQR-AFDLARLANDDDVMLLDWV 518 (621)
Q Consensus 440 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~-pf~~~~~~~~~~~~~~~~~ 518 (621)
||+|||+|+....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||... ...+..
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~--------~~~~~~ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--------TCAELY 236 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHH
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC--------CHHHHH
Confidence 9999999986443221 223458999999999999999999999999999999999765 56421 122222
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 519 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 519 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
..+.... .+.. +...+.++.+++.+||+.||++||||++|++.|+.
T Consensus 237 ~~i~~~~------~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 282 (309)
T d1fvra_ 237 EKLPQGY------RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282 (309)
T ss_dssp HHGGGTC------CCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhcC------CCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 2222211 1111 12233678999999999999999999999999876
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=384.27 Aligned_cols=268 Identities=22% Similarity=0.307 Sum_probs=201.1
Q ss_pred cCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCC----ceEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERLLV 371 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv 371 (621)
++|.+.+.||+|+||+||+|++ +|+.||||+++... .....++.|+..+..++|||||++++++.+++ ..++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 4677788999999999999997 58999999986432 11222334555556789999999999997654 57999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCCeeeCCCCcEEEccccc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH-----CDPKIIHRDVKAANILLDEEFEAVVGDFGL 446 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 446 (621)
|||+++|+|.+++++.. ++|..+..++.|++.||+|||+. ..++||||||||+|||++.++.+||+|||+
T Consensus 80 ~Ey~~~g~L~~~l~~~~-----l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecccCCCHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 99999999999998642 89999999999999999999973 123999999999999999999999999999
Q ss_pred ceecccCCCe---eeecccccccccchhhhccCC------CCCcccchhHHHHHHHHHhCCCCcccccccCC------Cc
Q 007020 447 AKLMDYKDTH---VTTAVRGTIGHIAPEYLSTGK------SSEKTDVFGYGIMLLELITGQRAFDLARLAND------DD 511 (621)
Q Consensus 447 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltg~~pf~~~~~~~~------~~ 511 (621)
++........ ......||+.|+|||++.+.. ++.++|||||||++|||+||..||........ ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9987554332 233467999999999987653 46789999999999999999988853221111 01
Q ss_pred chHHHHHHHHhhhcccccccCccccCcc-cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007020 512 VMLLDWVKGLLKEKKLEMLVDPDLQNNY-VEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 575 (621)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~-~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 575 (621)
....+.+....... ..+|.+.... ..+....+.+++..||+.||++|||+.||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp SCCHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 11112222222211 2223222211 234567799999999999999999999999999763
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.9e-47 Score=374.52 Aligned_cols=251 Identities=22% Similarity=0.304 Sum_probs=203.4
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCc--------hhHHHHHHHHHHHHhcc-CCceeeeeeeeecC
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--------GGELQFQTEVEMISMAV-HRNLLRLRGFCMTP 365 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 365 (621)
++|++.+.||+|+||+||+|+.. +|+.||||+++..... .....+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 67899999999999999999864 7899999999754321 12235889999999997 99999999999999
Q ss_pred CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccc
Q 007020 366 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 445 (621)
Q Consensus 366 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 445 (621)
+..|+||||+++|+|.+++.... ++++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999997643 389999999999999999999999 99999999999999999999999999
Q ss_pred cceecccCCCeeeecccccccccchhhhcc------CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHH
Q 007020 446 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST------GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 519 (621)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 519 (621)
+++...... ......||..|+|||++.+ ..++.++||||+||++|||++|+.||.... ......
T Consensus 156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~--------~~~~~~ 225 (277)
T d1phka_ 156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QMLMLR 225 (277)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH
T ss_pred heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC--------HHHHHH
Confidence 998765432 2344669999999999864 346889999999999999999999996321 111111
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 520 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 520 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
...... .. .........+.++.+++.+||+.||++|||++||++
T Consensus 226 ~i~~~~-~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 226 MIMSGN-YQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHTC-CC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhCC-CC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 222111 11 111112223467889999999999999999999865
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-47 Score=383.33 Aligned_cols=251 Identities=18% Similarity=0.241 Sum_probs=205.4
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
.++|++.+.||+|+||+||+|.+. +|+.||||.++... .....+.+|+++++.++|||||++++++.+++..|+|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 467899999999999999999875 68899999997543 334568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC--CcEEEcccccceecc
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE--FEAVVGDFGLAKLMD 451 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~DfGla~~~~ 451 (621)
||+||+|.+++.... ..+++.++..++.||++||+|||++ +|+||||||+|||++.+ ..+||+|||+++...
T Consensus 82 ~~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 82 FISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 999999999997643 2489999999999999999999999 99999999999999854 589999999998764
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
.. .......||+.|+|||.+.+..++.++||||+||++|+|++|+.||.... ..+.+....+.... .
T Consensus 156 ~~--~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~--------~~~~~~~i~~~~~~---~ 222 (321)
T d1tkia_ 156 PG--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENIMNAEYT---F 222 (321)
T ss_dssp TT--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCC---C
T ss_pred cC--CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCC---C
Confidence 33 23344568999999999999999999999999999999999999996321 11222222221110 0
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
+. ......+.++.+++..|+..||++|||++|+++
T Consensus 223 ~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 223 DE----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CH----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Ch----hhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10 011122357889999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-46 Score=385.51 Aligned_cols=245 Identities=22% Similarity=0.293 Sum_probs=203.6
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 372 (621)
++|++.+.||+|+||+||+|++. +|+.||||++.... .......+.+|+.+++.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57889999999999999999874 79999999986432 1223456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceeccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 452 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 452 (621)
||+.+|+|.+++.... .+++..++.++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999997654 389999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC
Q 007020 453 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 532 (621)
Q Consensus 453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 532 (621)
. .....||+.|||||++.+..++.++|||||||++|||+||+.||.... .......+.... .
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~i~~~~-~----- 255 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVSGK-V----- 255 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-C-----
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--------HHHHHHHHhcCC-C-----
Confidence 2 234569999999999999999999999999999999999999996221 112222222111 0
Q ss_pred ccccCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007020 533 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 570 (621)
Q Consensus 533 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~ 570 (621)
.. +......+.+++..||+.||.+|+ |++++++
T Consensus 256 -~~----p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 -RF----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CC----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CC----CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11 112236788999999999999994 8888865
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.1e-46 Score=385.17 Aligned_cols=249 Identities=27% Similarity=0.334 Sum_probs=196.8
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC--chhHHHHHH---HHHHHHhccCCceeeeeeeeecCCceE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQT---EVEMISMAVHRNLLRLRGFCMTPTERL 369 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~ 369 (621)
++|++.+.||+|+||+||+|+.. +|+.||||++..... ......+.+ |+.+++.++|||||++++++.+++..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57889999999999999999865 699999999864321 111223444 466677778999999999999999999
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999998643 378899999999999999999999 999999999999999999999999999987
Q ss_pred cccCCCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc
Q 007020 450 MDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 528 (621)
Q Consensus 450 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (621)
.... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... ......+....
T Consensus 157 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~~~~~~~~~~----- 223 (364)
T d1omwa3 157 FSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDRMTLT----- 223 (364)
T ss_dssp CSSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS-----CHHHHHHHSSS-----
T ss_pred cCCC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhccc-----
Confidence 6533 2334569999999999975 56899999999999999999999999632211 11111111100
Q ss_pred cccCccccCcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007020 529 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-----MSEVVR 570 (621)
Q Consensus 529 ~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-----~~~vl~ 570 (621)
....... ..+.++.+++..||+.||++||| ++|+++
T Consensus 224 --~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 224 --MAVELPD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --CCCCCCS----SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --CCCCCCC----CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0111111 22357889999999999999999 677764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=379.23 Aligned_cols=257 Identities=25% Similarity=0.276 Sum_probs=193.3
Q ss_pred CceeeeccCceEEEEEcC-CCcEEEEEEecccCCch----hHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEecc
Q 007020 301 KNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG----GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 375 (621)
Q Consensus 301 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 375 (621)
.++||+|+||+||+|++. +|+.||||+++...... ....+.+|+.+++.++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 478999999999999975 68999999997543222 1235889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCCC
Q 007020 376 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 455 (621)
Q Consensus 376 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 455 (621)
.++++..+..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNSL----VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTCCS----SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhccc----CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9988777665432 388889999999999999999999 999999999999999999999999999987654322
Q ss_pred eeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccccccC--
Q 007020 456 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD-- 532 (621)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-- 532 (621)
......||+.|+|||++.+. .++.++|||||||++|||++|..||.... .......+.............+
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~-----~~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-----DLDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC-----HHHHHHHHHHhcCCCChhhccchh
Confidence 23345699999999998754 57999999999999999999999995321 1111111111110000000000
Q ss_pred --------ccccC----cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 533 --------PDLQN----NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 533 --------~~~~~----~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..... .........+.+++..|++.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000 001122367889999999999999999999976
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-47 Score=384.81 Aligned_cols=251 Identities=22% Similarity=0.244 Sum_probs=197.3
Q ss_pred cCCCcC-ceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHh-ccCCceeeeeeeeec----CCce
Q 007020 296 DSFSNK-NILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISM-AVHRNLLRLRGFCMT----PTER 368 (621)
Q Consensus 296 ~~~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~ 368 (621)
++|.+. +.||+|+||+||+|++ .+++.||||+++.. ..+.+|+.++.+ .+|||||++++++.+ ....
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 578766 4699999999999986 47899999998642 356789988655 589999999999865 4568
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---CCcEEEcccc
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFG 445 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfG 445 (621)
|+|||||+||+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence 999999999999999986532 3489999999999999999999999 9999999999999985 5679999999
Q ss_pred cceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 446 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
+|+...... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||........ ...+.....
T Consensus 160 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-----~~~~~~~i~-- 230 (335)
T d2ozaa1 160 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----SPGMKTRIR-- 230 (335)
T ss_dssp TCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------CCC--
T ss_pred eeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-----HHHHHHHHh--
Confidence 998765432 23445699999999999999999999999999999999999999963321110 011110000
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 526 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 526 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
. ....+........+.++.+++..|++.||++|||+.|+++
T Consensus 231 -~---~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 231 -M---GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -S---CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -c---CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 0011111222344577999999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-47 Score=383.34 Aligned_cols=248 Identities=24% Similarity=0.331 Sum_probs=200.8
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccC--CchhHHHHHHHHHHHH-hccCCceeeeeeeeecCCceEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMIS-MAVHRNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 371 (621)
++|.+.+.||+|+||+||+|++. +|+.||||++++.. .......+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57888999999999999999875 68999999996532 1223345666776655 68999999999999999999999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecc
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 451 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 451 (621)
|||+++|+|.+++..... +++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+...
T Consensus 82 mEy~~~g~L~~~i~~~~~----~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999986543 88999999999999999999999 99999999999999999999999999998654
Q ss_pred cCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhccccccc
Q 007020 452 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 531 (621)
Q Consensus 452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (621)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+....... .
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~-~------ 218 (320)
T d1xjda_ 155 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------EEELFHSIRM-D------ 218 (320)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-C------
T ss_pred ccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHHc-C------
Confidence 332 23344569999999999999999999999999999999999999996321 1111122111 1
Q ss_pred CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 007020 532 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMS-EVVR 570 (621)
Q Consensus 532 d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~-~vl~ 570 (621)
.+... ...+..+.+++..||+.||++||++. ++++
T Consensus 219 ~~~~p----~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 NPFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCCC----ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11111 12236788999999999999999995 6643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-46 Score=374.56 Aligned_cols=264 Identities=22% Similarity=0.327 Sum_probs=197.1
Q ss_pred cCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCc-hhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 296 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
++|++.+.||+|+||+||+|++ .+|+.||||+++..... ....++.+|++++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788999999999999999986 47999999999654322 235678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
|+.++ +.+++..... ..+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~-~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEE-HHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCc-hhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 99875 4444433222 2389999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCeeeecccccccccchhhhccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcc-----c
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK-----L 527 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~ 527 (621)
. .......||+.|+|||.+.... ++.++||||+||++|+|++|+.||..... ...+............ .
T Consensus 156 ~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 156 V-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE----IDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp S-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCTTTSTTG
T ss_pred c-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH----HHHHHHHHHhcCCCchhhcccc
Confidence 2 2333456999999999987765 57899999999999999999999963211 0011111111000000 0
Q ss_pred ccccC-----ccccCc----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 528 EMLVD-----PDLQNN----YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 528 ~~~~d-----~~~~~~----~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
....+ +..... ........+.+++..|++.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00000 000000 01122367889999999999999999999976
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=371.24 Aligned_cols=241 Identities=23% Similarity=0.397 Sum_probs=196.3
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCch-----hHHHHHHHHHHHHhcc--CCceeeeeeeeecCC
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-----GELQFQTEVEMISMAV--HRNLLRLRGFCMTPT 366 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 366 (621)
.++|++.+.||+|+||+||+|+.. +|+.||||+++...... ...++.+|+.++++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357899999999999999999864 78999999997543211 1234678999999986 899999999999999
Q ss_pred ceEEEEeccCC-CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-CCcEEEccc
Q 007020 367 ERLLVYPYMAN-GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDF 444 (621)
Q Consensus 367 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Df 444 (621)
..++||||+.+ +++.+++.... .+++..++.++.||++||+|||++ +|+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence 99999999986 67888877643 389999999999999999999999 9999999999999985 479999999
Q ss_pred ccceecccCCCeeeecccccccccchhhhccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh
Q 007020 445 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 523 (621)
Q Consensus 445 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 523 (621)
|+|+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... + ..+
T Consensus 156 G~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------~----i~~ 218 (273)
T d1xwsa_ 156 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------E----IIR 218 (273)
T ss_dssp TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------H----HHH
T ss_pred ccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------H----Hhh
Confidence 999865432 2345679999999999987765 577999999999999999999996321 1 111
Q ss_pred hcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 524 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 524 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.. ....+ . .+.++.+++.+||+.||++|||++|+++
T Consensus 219 ~~---~~~~~----~----~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 219 GQ---VFFRQ----R----VSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CC---CCCSS----C----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cc---cCCCC----C----CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 10 01111 1 2257889999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.7e-46 Score=370.94 Aligned_cols=262 Identities=23% Similarity=0.314 Sum_probs=199.9
Q ss_pred cCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEec
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 374 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 374 (621)
++|++.+.||+|+||+||+|++++|+.||||+++.... .....++.+|+.++++++||||+++++++..++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57889999999999999999998999999999976542 23356789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccCC
Q 007020 375 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454 (621)
Q Consensus 375 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 454 (621)
+.++.+..+..... .+++..+..++.||+.||+|||+. +||||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhcC----CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 99877777765443 389999999999999999999999 99999999999999999999999999998765332
Q ss_pred CeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcccc-----
Q 007020 455 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE----- 528 (621)
Q Consensus 455 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 528 (621)
.......|++.|+|||.+.+. .++.++||||+||++|||++|+.||..... ...+.+... ........
T Consensus 155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~----~~~~~~i~~-~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE----ADQLMRIFR-ILGTPNSKNWPNV 228 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHH-HHCCCCTTTSTTG
T ss_pred -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH----HHHHHHHHH-hhCCCChhhccch
Confidence 223344589999999999765 568999999999999999999999963211 001111111 00000000
Q ss_pred -cc---------cCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 529 -ML---------VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 529 -~~---------~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.. ..+.............+.+++..|++.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000001111222367889999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-45 Score=367.43 Aligned_cols=263 Identities=24% Similarity=0.339 Sum_probs=195.1
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-C-CcEEEEEEecccCCc-hhHHHHHHHHHHHHhc---cCCceeeeeeeeec----
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-D-GSLVAVKRLKEERTP-GGELQFQTEVEMISMA---VHRNLLRLRGFCMT---- 364 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 364 (621)
.++|++.+.||+|+||+||+|++. + ++.||||+++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999863 4 667999998754322 2233466788777665 79999999999853
Q ss_pred -CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcc
Q 007020 365 -PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 443 (621)
Q Consensus 365 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 443 (621)
....+++|||+.+|++........ ..+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 346799999999987765544322 2388999999999999999999999 999999999999999999999999
Q ss_pred cccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh
Q 007020 444 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 523 (621)
Q Consensus 444 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 523 (621)
||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .....-+.....
T Consensus 160 fg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~ 232 (305)
T d1blxa_ 160 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-----VDQLGKILDVIG 232 (305)
T ss_dssp CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHC
T ss_pred hhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHhhC
Confidence 9998864332 233455699999999999999999999999999999999999999963221 111111111100
Q ss_pred hccccc----------cc---CccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 524 EKKLEM----------LV---DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 524 ~~~~~~----------~~---d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
...... .. ...............+.+++..|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 00 000001111222356788999999999999999999976
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-44 Score=366.07 Aligned_cols=264 Identities=20% Similarity=0.295 Sum_probs=197.4
Q ss_pred hcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecCC----ceE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERL 369 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 369 (621)
+++|++.+.||+|+||+||+|.. .+|+.||||+++.........++.+|+.+++.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45789999999999999999985 4799999999976655556668899999999999999999999987653 335
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
++++|+.+|+|.+++... .+++..++.++.|+++||+|||++ +||||||||+|||+++++.+||+|||+|+.
T Consensus 87 ~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 666777899999999764 289999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCCe--eeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcc
Q 007020 450 MDYKDTH--VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 450 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (621)
....... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||...... ..............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~-----~~~~~~~~~~~~~~ 233 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-----DQLNHILGILGSPS 233 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCSCC
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH-----HHHHHHhhhccCCC
Confidence 6443221 2344569999999999854 56789999999999999999999999632211 00010000000000
Q ss_pred ccc-------------ccCccccC----cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 527 LEM-------------LVDPDLQN----NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 527 ~~~-------------~~d~~~~~----~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
... ...+.... ........++.+++..|++.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 00000000 0001112468899999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=358.81 Aligned_cols=263 Identities=22% Similarity=0.289 Sum_probs=194.1
Q ss_pred cCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeec--------C
Q 007020 296 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMT--------P 365 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 365 (621)
++|++.+.||+|+||+||+|++ .+|+.||||++..... .....++.+|+++++.++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6888999999999999999996 4799999999865432 3345678899999999999999999998855 3
Q ss_pred CceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccc
Q 007020 366 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 445 (621)
Q Consensus 366 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 445 (621)
+..++||||+.++.+........ .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~----~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLV----KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhhccc----ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 46799999999877765554332 388899999999999999999999 99999999999999999999999999
Q ss_pred cceecccCCC---eeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHH
Q 007020 446 LAKLMDYKDT---HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGL 521 (621)
Q Consensus 446 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 521 (621)
+++....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.... .......+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~-----~~~~~~~i~~~ 237 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-----EQHQLALISQL 237 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHH
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC-----HHHHHHHHHHh
Confidence 9987653221 122334699999999999765 58999999999999999999999996221 11111111111
Q ss_pred hhhccc---ccc---------cCccccCcccH------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 522 LKEKKL---EML---------VDPDLQNNYVE------AEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 522 ~~~~~~---~~~---------~d~~~~~~~~~------~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
...... ... ........... .....+.+++..|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 110000 000 00000000011 11245678999999999999999999975
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.8e-43 Score=349.92 Aligned_cols=259 Identities=15% Similarity=0.166 Sum_probs=203.3
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccC-CceeeeeeeeecCCceEEEE
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTERLLVY 372 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 372 (621)
.++|++.+.||+|+||+||+|++. +|+.||||++..... ...+.+|++.++.+.| +|++.+++++......++||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 468999999999999999999965 689999999865432 2357788999998875 89999999999999999999
Q ss_pred eccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-----CCcEEEcccccc
Q 007020 373 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE-----EFEAVVGDFGLA 447 (621)
Q Consensus 373 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-----~~~~kl~DfGla 447 (621)
||+ +|+|.+++..... .+++.++..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+|
T Consensus 81 e~~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHhhcc---chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccccee
Confidence 999 6799999876432 389999999999999999999999 9999999999999974 578999999999
Q ss_pred eecccCCCe------eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHH
Q 007020 448 KLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGL 521 (621)
Q Consensus 448 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 521 (621)
+.+...... ......||+.|||||++.+..++.++|||||||++|||+||+.||....... ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~-----~~~~~~~i 228 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-----NKQKYERI 228 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC-----HHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchh-----HHHHHHHH
Confidence 986543221 2334569999999999999999999999999999999999999996322111 11111111
Q ss_pred hhhcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 522 LKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 522 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
....... ..+.+.. ..+.++.+++..|++.+|++||+++.+.+.|++
T Consensus 229 ~~~~~~~--~~~~l~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 229 GEKKQST--PLRELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp HHHHHHS--CHHHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred HhccCCC--ChHHhcC----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 1110000 0011111 123578899999999999999999999887765
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-44 Score=363.02 Aligned_cols=253 Identities=26% Similarity=0.351 Sum_probs=202.5
Q ss_pred cCCCcCceeeeccCceEEEEEc----CCCcEEEEEEecccCC---chhHHHHHHHHHHHHhccC-CceeeeeeeeecCCc
Q 007020 296 DSFSNKNILGRGGFGKVYKGRL----ADGSLVAVKRLKEERT---PGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTE 367 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 367 (621)
++|++.+.||+|+||+||+|+. .+|+.||||.++.... ......+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999974 2588999999865431 2234467899999999977 899999999999999
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
.+++|||+.+|+|.+++..... +.+..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~----~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhccc----ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999987543 67889999999999999999999 9999999999999999999999999999
Q ss_pred eecccCCCeeeecccccccccchhhhccC--CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhc
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 525 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 525 (621)
+.+............|++.|+|||.+.+. .++.++||||+||++|||++|+.||....... ......+.....
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~----~~~~i~~~~~~~- 251 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----SQAEISRRILKS- 251 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC----CHHHHHHHHHHC-
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcccC-
Confidence 87765544445556799999999999765 36789999999999999999999996433221 122222221111
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007020 526 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-----MSEVVR 570 (621)
Q Consensus 526 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-----~~~vl~ 570 (621)
.+. .+.....++.+++..||+.||++||| ++|+++
T Consensus 252 ------~~~----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 ------EPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ------CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ------CCC----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 011 11223468899999999999999994 777754
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.7e-43 Score=351.68 Aligned_cols=258 Identities=19% Similarity=0.207 Sum_probs=195.5
Q ss_pred cCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCcee-eeeeeeecCCceEEEEe
Q 007020 296 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL-RLRGFCMTPTERLLVYP 373 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e 373 (621)
++|++.+.||+|+||+||+|++ .+|+.||||++..... ..++..|+++++.++|+|++ .+.+++.+.+..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 5799999999999999999986 4689999999875432 23578899999999877655 45566677788899999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---CCcEEEcccccceec
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFGLAKLM 450 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfGla~~~ 450 (621)
|+.+ ++.+.+.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++. +..+||+|||+|+.+
T Consensus 84 ~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LLGP-SLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CCCC-BHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EcCC-chhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 9954 6666655432 2389999999999999999999999 9999999999998763 557999999999987
Q ss_pred ccCCCe------eeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhh
Q 007020 451 DYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 524 (621)
Q Consensus 451 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 524 (621)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ....+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~-~~~~~~~~~~~- 234 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYERISEKKMS- 234 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHH-
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH-HHHHhhcccCC-
Confidence 543321 2334569999999999999999999999999999999999999996432211111 11111111000
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007020 525 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574 (621)
Q Consensus 525 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 574 (621)
.. .+... ...+.++.+++..||+.+|++||+++++.+.|++
T Consensus 235 ~~-----~~~~~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 235 TP-----IEVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp SC-----HHHHT----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred CC-----hhHhc----cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 00 00111 1223678999999999999999999999888876
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=361.70 Aligned_cols=259 Identities=22% Similarity=0.278 Sum_probs=192.5
Q ss_pred hcCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCC------
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 366 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 366 (621)
.++|++.+.||+|+||+||+|.+. +|+.||||+++.... ......+.+|+++++.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999864 699999999975433 334557889999999999999999999997654
Q ss_pred ceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEccccc
Q 007020 367 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 446 (621)
Q Consensus 367 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 446 (621)
+.++||||+ +++|..+++.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 569999999 55788777653 289999999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCeeeecccccccccchhhhccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh--
Q 007020 447 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK-- 523 (621)
Q Consensus 447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-- 523 (621)
|+..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ...+.........
T Consensus 168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~----~~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH----LDQLKEIMKVTGTPP 239 (346)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCC
T ss_pred eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh----HHHHHHHHhccCCCc
Confidence 9875432 2345699999999998765 568999999999999999999999963211 0011111000000
Q ss_pred ---------------hcccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007020 524 ---------------EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 571 (621)
Q Consensus 524 ---------------~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 571 (621)
...........+ ..........+.+++..|+..||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000000 00111223567899999999999999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=363.91 Aligned_cols=259 Identities=24% Similarity=0.316 Sum_probs=190.2
Q ss_pred CCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCceeeeeeeeecC------CceE
Q 007020 297 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TERL 369 (621)
Q Consensus 297 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 369 (621)
+|+..++||+|+||+||+|++. +|+.||||+++.... ...+|++++++++||||+++++++... ...+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 5777889999999999999975 699999999975432 234799999999999999999998543 3468
Q ss_pred EEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-cEEEcccccce
Q 007020 370 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAK 448 (621)
Q Consensus 370 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~ 448 (621)
+||||+++|.+..+... ......+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++
T Consensus 96 lv~Ey~~~~~~~~l~~~-~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEECCSEEHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEeccCCccHHHHHhh-hhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence 99999987644443321 11233489999999999999999999999 999999999999999775 89999999998
Q ss_pred ecccCCCeeeecccccccccchhhhcc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHH---------
Q 007020 449 LMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV--------- 518 (621)
Q Consensus 449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~--------- 518 (621)
...... ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+...+
T Consensus 172 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~----~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 172 QLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTPTRE 245 (350)
T ss_dssp ECCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH----HHHHHHHHHHCCCCHH
T ss_pred hccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH----HHHHHHHHHhCCChHH
Confidence 765332 2334569999999998875 46899999999999999999999999632210 1111111
Q ss_pred --HHHhhhc---ccccccCccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 519 --KGLLKEK---KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 519 --~~~~~~~---~~~~~~d~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
....... .....................+.+++.+|++.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1000000 000000000000011122357889999999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-43 Score=351.48 Aligned_cols=260 Identities=21% Similarity=0.281 Sum_probs=203.3
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecCCceEEEEe
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 373 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 373 (621)
++|++.+.||+|+||+||+|++. +|+.||||+++.... .....++.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57889999999999999999964 789999999975543 3345679999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccceecccC
Q 007020 374 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 453 (621)
Q Consensus 374 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 453 (621)
++.++++..++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.|+.....
T Consensus 82 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999988877543 378999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCeeeecccccccccchhhhccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcc---c--
Q 007020 454 DTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK---L-- 527 (621)
Q Consensus 454 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~-- 527 (621)
.. ......++..|+|||.+.+.. ++.++||||+||++|||++|+.||.... . ..+....+..... .
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~----~---~~~~~~~~~~~~~~~~~~~ 226 (292)
T d1unla_ 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN----D---VDDQLKRIFRLLGTPTEEQ 226 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS----S---HHHHHHHHHHHHCCCCTTT
T ss_pred Cc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC----C---HHHHHHHHHhhcCCCChhh
Confidence 32 233345788999999987665 6899999999999999999999974221 1 1111111111000 0
Q ss_pred ----ccccC---------ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 528 ----EMLVD---------PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 528 ----~~~~d---------~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
....+ ..............+.+++..|++.||.+|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 00001111222356888999999999999999999965
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.8e-43 Score=357.99 Aligned_cols=259 Identities=20% Similarity=0.253 Sum_probs=194.8
Q ss_pred cCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-CCceeeeeeeeecC--CceEEE
Q 007020 296 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTP--TERLLV 371 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv 371 (621)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ..++.+|+++++.+. ||||+++++++... ...++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 5799999999999999999987 478999999986432 456889999999995 99999999998744 568999
Q ss_pred EeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-cEEEcccccceec
Q 007020 372 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLM 450 (621)
Q Consensus 372 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~~~ 450 (621)
|||+.+|+|..+.+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+..
T Consensus 111 ~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 111 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence 99999999987643 288999999999999999999999 999999999999998654 6999999999876
Q ss_pred ccCCCeeeecccccccccchhhhccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcch---------HHHHHHH
Q 007020 451 DYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM---------LLDWVKG 520 (621)
Q Consensus 451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~---------~~~~~~~ 520 (621)
.... ......||+.|+|||.+.+.. ++.++||||+||++|||++|+.||.......+.... ...|...
T Consensus 181 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 181 HPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp CTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred cCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 5332 234456899999999987754 799999999999999999999999632211000000 0000000
Q ss_pred Hhhhc--ccccccC--------ccccCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 521 LLKEK--KLEMLVD--------PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 521 ~~~~~--~~~~~~d--------~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
..... ....... .............++.+++..|++.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0000000 00001111122357889999999999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-42 Score=353.54 Aligned_cols=265 Identities=19% Similarity=0.207 Sum_probs=192.2
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeec------CCc
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMT------PTE 367 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 367 (621)
++|++.++||+|+||+||+|.+. +|+.||||+++.... .....++.+|+.+++.++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57899999999999999999975 699999999976543 3344568899999999999999999999864 367
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
.|+||||+.++.+. .+.. .+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~~------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEEHHH-HHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchHHHH-hhhc------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 89999999875554 4432 288999999999999999999999 9999999999999999999999999998
Q ss_pred eecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHH---------
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV--------- 518 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~--------- 518 (621)
+..... .......||+.|+|||++.+..+++++||||+||++|||++|+.||..... .......+
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~----~~~~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY----IDQWNKVIEQLGTPCPE 240 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCHH
T ss_pred hccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH----HHHHHHHHHhccCCCHH
Confidence 865432 233445699999999999999999999999999999999999999953211 00000000
Q ss_pred ---------HHHhhhcc-c-----ccccCccc---cCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCCcc
Q 007020 519 ---------KGLLKEKK-L-----EMLVDPDL---QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAE 579 (621)
Q Consensus 519 ---------~~~~~~~~-~-----~~~~d~~~---~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~ 579 (621)
........ . ........ ...........+.+++..|+..||++|||++|++ +...+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL---~Hpw~~~ 316 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL---QHPYINV 316 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH---TSTTTGG
T ss_pred HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh---cCcccCC
Confidence 00000000 0 00000000 1112334567889999999999999999999995 4455544
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=350.85 Aligned_cols=259 Identities=20% Similarity=0.258 Sum_probs=193.5
Q ss_pred hcCCCcCceeeeccCceEEEEEc-CCCcEEEEEEecccCC-chhHHHHHHHHHHHHhccCCceeeeeeeeecC-----Cc
Q 007020 295 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TE 367 (621)
Q Consensus 295 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 367 (621)
.++|++.+.||+|+||+||+|++ .+|+.||||+++.... .....++.+|+++++.++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999986 4799999999976543 33445788999999999999999999998643 34
Q ss_pred eEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEEcccccc
Q 007020 368 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 447 (621)
Q Consensus 368 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 447 (621)
.+++++|+.+|+|.+++... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 57778888999999999653 289999999999999999999999 9999999999999999999999999999
Q ss_pred eecccCCCeeeecccccccccchhhhccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhhcc
Q 007020 448 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 526 (621)
Q Consensus 448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (621)
..... ......|+..|+|||.+.+.. ++.++||||+||++|+|++|+.||.... .......+........
T Consensus 169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~-----~~~~~~~i~~~~~~~~ 239 (348)
T d2gfsa1 169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-----HIDQLKLILRLVGTPG 239 (348)
T ss_dssp -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCC
T ss_pred cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhcCCCC
Confidence 75432 233456899999999877654 6899999999999999999999995321 1111111110000000
Q ss_pred cc-----------cccC--ccccCc----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007020 527 LE-----------MLVD--PDLQNN----YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 570 (621)
Q Consensus 527 ~~-----------~~~d--~~~~~~----~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 570 (621)
.. .... +..... ........+.+++..|++.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00 0000 000000 00112356789999999999999999999976
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-37 Score=319.92 Aligned_cols=265 Identities=19% Similarity=0.222 Sum_probs=188.4
Q ss_pred cCCCcCceeeeccCceEEEEEcC-CCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-----------CCceeeeeeeee
Q 007020 296 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-----------HRNLLRLRGFCM 363 (621)
Q Consensus 296 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 363 (621)
.+|++.++||+|+||+||+|+.. +|+.||||+++.. ......+.+|+.+++.++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 45899999999999999999864 7999999999753 233456788888887775 578999998875
Q ss_pred c--CCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeeCCCC---
Q 007020 364 T--PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILLDEEF--- 437 (621)
Q Consensus 364 ~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~--- 437 (621)
. ....+++++++..+.......... ....+++..++.++.||+.||+|||+ . +|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred eccccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence 4 355667777766554333322211 22348889999999999999999998 6 899999999999998665
Q ss_pred ---cEEEcccccceecccCCCeeeecccccccccchhhhccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCc--c
Q 007020 438 ---EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDD--V 512 (621)
Q Consensus 438 ---~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~--~ 512 (621)
.++++|||.+...... .....||+.|+|||++.+..++.++||||+||++++|++|+.||.......... .
T Consensus 167 ~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 3999999999865432 234569999999999999999999999999999999999999996432211110 0
Q ss_pred hHHHHHHHHh-------hh-cccccccC---------c----------cccCcccHHHHHHHHHHHHhccCCCCCCCCCH
Q 007020 513 MLLDWVKGLL-------KE-KKLEMLVD---------P----------DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 565 (621)
Q Consensus 513 ~~~~~~~~~~-------~~-~~~~~~~d---------~----------~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 565 (621)
.+...+...- .. .......+ . .............+.+++..|+..||++|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 1111111000 00 00000000 0 00112345567889999999999999999999
Q ss_pred HHHHH
Q 007020 566 SEVVR 570 (621)
Q Consensus 566 ~~vl~ 570 (621)
+|+++
T Consensus 323 ~e~L~ 327 (362)
T d1q8ya_ 323 GGLVN 327 (362)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99975
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.95 E-value=3.2e-28 Score=245.90 Aligned_cols=180 Identities=33% Similarity=0.554 Sum_probs=157.2
Q ss_pred ccchhHHHHHHHHHhCCCCCCCCCCCCCCCCCCc--cceeeEEcCCC---cEEEEEcCCCCccc--cCcccccCCCCCcE
Q 007020 21 SANMEGDALHSLRSNLIDPNNVLQSWDPTLVNPC--TWFHVTCNNDN---SVIRVDLGNAALSG--QLVSQLGLLKNLQY 93 (621)
Q Consensus 21 ~~~~~~~~l~~~~~~~~~~~~~l~~w~~~~~~~c--~w~gv~c~~~~---~l~~L~L~~n~l~~--~~~~~~~~l~~L~~ 93 (621)
|...|++||++||+++.||. .+++|... .||| +|+||+|+..+ +|+.|||++|+++| .+|+.+++|++|++
T Consensus 3 c~~~e~~aLl~~k~~~~~~~-~l~sW~~~-~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCHHHHHHHHHHHHHCCCCC-cCCCCCCC-CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccc
Confidence 67789999999999999985 69999764 7999 59999998653 79999999999998 47899999999999
Q ss_pred EEeee-CCCCCCCcccccCCCccceeeeccccCCC---------------------------------------------
Q 007020 94 LELYS-NNITGPIPSDLGNLTSLVSLDLYLNSFTG--------------------------------------------- 127 (621)
Q Consensus 94 L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--------------------------------------------- 127 (621)
|+|++ |+++|.+|..|++|++|++|+|++|+|.+
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence 99997 89999999999999999999999988751
Q ss_pred --------------------------------------------------------------------------CCCccc
Q 007020 128 --------------------------------------------------------------------------PIPDTL 133 (621)
Q Consensus 128 --------------------------------------------------------------------------~~p~~~ 133 (621)
..+..+
T Consensus 161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~ 240 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV 240 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 011223
Q ss_pred ccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcccCCCCC
Q 007020 134 GKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVT 202 (621)
Q Consensus 134 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~~~ 202 (621)
..+++|+.|+|++|+|+|.+|..|.++++|++|+|++|+|+|.+|....+++|+.+++++|+++||.|.
T Consensus 241 ~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~pl 309 (313)
T d1ogqa_ 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp CCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred ccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCC
Confidence 446677889999999999999999999999999999999999888888899999999999999999764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=3.3e-24 Score=199.65 Aligned_cols=163 Identities=12% Similarity=0.058 Sum_probs=120.5
Q ss_pred CcCceeeeccCceEEEEEcCCCcEEEEEEecccCCc-----------------hhHHHHHHHHHHHHhccCCceeeeeee
Q 007020 299 SNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP-----------------GGELQFQTEVEMISMAVHRNLLRLRGF 361 (621)
Q Consensus 299 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 361 (621)
.+.+.||+|+||+||+|...+|+.||||+++..... ........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 456889999999999999888999999987632110 011234568888999999999988766
Q ss_pred eecCCceEEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCcEEE
Q 007020 362 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV 441 (621)
Q Consensus 362 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 441 (621)
. ..+++|||++++.+.+ ++......++.|++++++|||++ +|+||||||+|||++++ .++|
T Consensus 83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 3 2479999999876543 23335678999999999999999 99999999999999976 5899
Q ss_pred cccccceecccCCCeeeecccccccccc------hhhhccCCCCCcccchhHHHH
Q 007020 442 GDFGLAKLMDYKDTHVTTAVRGTIGHIA------PEYLSTGKSSEKTDVFGYGIM 490 (621)
Q Consensus 442 ~DfGla~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~DvwSlGvi 490 (621)
+|||+|......... .|.. .+. ..+.++.++|+||..--
T Consensus 144 iDFG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 144 IDFPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCCTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHH
T ss_pred EECCCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHH
Confidence 999999865432211 1111 122 23567788999997543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=1.1e-18 Score=161.85 Aligned_cols=124 Identities=25% Similarity=0.310 Sum_probs=75.3
Q ss_pred CccceeeEEcCC----------CcEEEEEcCCCCccccC-cccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeec
Q 007020 53 PCTWFHVTCNND----------NSVIRVDLGNAALSGQL-VSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLY 121 (621)
Q Consensus 53 ~c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 121 (621)
-|.|..|.|++. .++++|+|++|.|++.+ +..|..+++|+.|+|++|+++...+..|..+++|++|+|+
T Consensus 7 ~C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 7 HCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp EEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred EEcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 355666666431 24566666666665433 4455666666666666666666666666666666666666
Q ss_pred cccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccCcCccc
Q 007020 122 LNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGV 176 (621)
Q Consensus 122 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 176 (621)
+|+|++..|+.|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+...
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence 6666655555566666666666666666655555666666666666666665543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=3.2e-18 Score=158.68 Aligned_cols=136 Identities=24% Similarity=0.337 Sum_probs=120.9
Q ss_pred eeEEcCCCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCC-CcccccCCCccceeeeccccCCCCCCcccccc
Q 007020 58 HVTCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGP-IPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKL 136 (621)
Q Consensus 58 gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 136 (621)
|-+|.. +.++.++++|+ .+|..+. +++++|+|++|+|++. .+..|.++++|+.|+|++|++.+..++.|..+
T Consensus 5 ~C~C~~----~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~ 77 (192)
T d1w8aa_ 5 MCHCEG----TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGA 77 (192)
T ss_dssp TSEEET----TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTC
T ss_pred CCEEcC----CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccc
Confidence 445643 36999999999 5676653 7899999999999864 46678999999999999999998889999999
Q ss_pred cccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcccCCC
Q 007020 137 SKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDLCGP 200 (621)
Q Consensus 137 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~~~~ 200 (621)
++|++|+|++|+|++..|..|.++++|++|+|++|+|+++++.. ..+++|+.|+|++|++.|..
T Consensus 78 ~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 78 SHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp TTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred cccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc
Confidence 99999999999999888889999999999999999999999886 78899999999999997754
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=2.6e-17 Score=160.84 Aligned_cols=134 Identities=25% Similarity=0.175 Sum_probs=97.9
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 145 (621)
+|+.|+|++|+|+ ..+..+..+++|++|+|++|.+.+..+..+..+.+|+.|++++|.++...+..+..+++|+.|+++
T Consensus 78 ~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~ 156 (266)
T d1p9ag_ 78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA 156 (266)
T ss_dssp TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred ccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccc
Confidence 3444444444444 233344455555555555555554445555555666666666666665556667788999999999
Q ss_pred ccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcccCCC
Q 007020 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGP 200 (621)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~ 200 (621)
+|+|++..+..|..+++|++|+|++|+|+.+++....+++|+.|+|++|||.|.+
T Consensus 157 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 157 NNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp TSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred cccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCc
Confidence 9999988888899999999999999999988888888999999999999999875
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=8.2e-17 Score=158.89 Aligned_cols=137 Identities=20% Similarity=0.213 Sum_probs=127.1
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+|+.|+|++|.+....+..+..+.+|+.+++++|+|+++.+..|..+++|+.|+|++|+|++..+..|.++++|+.|+
T Consensus 104 l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~ 183 (284)
T d1ozna_ 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (284)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred cccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhh
Confidence 35899999999999988888899999999999999999988788899999999999999999988888999999999999
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcccCCC
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDLCGP 200 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~~~~ 200 (621)
+++|++++..|..|..+++|+.|++++|++.++++.. ..+++|+.|++++|++.|.+
T Consensus 184 l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C 241 (284)
T d1ozna_ 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241 (284)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred hhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCc
Confidence 9999999888999999999999999999999988765 78899999999999998864
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.62 E-value=2.8e-16 Score=133.82 Aligned_cols=105 Identities=26% Similarity=0.317 Sum_probs=91.0
Q ss_pred EEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccccccc
Q 007020 69 RVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNS 148 (621)
Q Consensus 69 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 148 (621)
.|+|++|+|+ .++ .+..+++|++|+|++|+|+ .+|..|+.+++|+.|++++|+|++ +| .+..+++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 6999999999 444 4899999999999999999 667789999999999999999994 55 48999999999999999
Q ss_pred cCCCC-CCCccCCccccEEeeccCcCcccCC
Q 007020 149 LSGPI-PMSLTNISSLQVLDLSNNRLSGVVP 178 (621)
Q Consensus 149 l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~~ 178 (621)
|+... ...+..+++|+.|++++|+++....
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~ 107 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 107 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCcCcc
Confidence 98543 2468889999999999999987643
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.58 E-value=1.8e-15 Score=150.75 Aligned_cols=75 Identities=27% Similarity=0.309 Sum_probs=66.4
Q ss_pred CCccceeeEEcCC----------CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeec
Q 007020 52 NPCTWFHVTCNND----------NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLY 121 (621)
Q Consensus 52 ~~c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 121 (621)
.-|.|.+|.|+.. .++++|+|++|+|+...+..|.++++|++|++++|.++...|..|.++++|+.|+|+
T Consensus 8 c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 8 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp CEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 4478999999642 579999999999997666789999999999999999998888899999999999999
Q ss_pred cccCC
Q 007020 122 LNSFT 126 (621)
Q Consensus 122 ~N~l~ 126 (621)
+|+|+
T Consensus 88 ~n~l~ 92 (305)
T d1xkua_ 88 KNQLK 92 (305)
T ss_dssp SSCCS
T ss_pred CCccC
Confidence 99876
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=6.1e-16 Score=138.46 Aligned_cols=126 Identities=19% Similarity=0.106 Sum_probs=104.0
Q ss_pred CCCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccc
Q 007020 63 NDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFL 142 (621)
Q Consensus 63 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 142 (621)
+..+++.|||++|+|+. ++..+..+++|+.|+|++|+|+. ++ .|..+++|++|+|++|+|+...+..+..+++|+.|
T Consensus 16 n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp CTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccccc
Confidence 34578999999999995 57777889999999999999994 43 58999999999999999996556667889999999
Q ss_pred cccccccCCCCC-CCccCCccccEEeeccCcCcccCCC----CCCCCCcccccc
Q 007020 143 RLNNNSLSGPIP-MSLTNISSLQVLDLSNNRLSGVVPD----NGSFSLFTPISF 191 (621)
Q Consensus 143 ~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~~~l~~l~l 191 (621)
+|++|+|+.... ..+..+++|+.|++++|+++..+.. ...+++|+.|+.
T Consensus 93 ~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 93 ILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp ECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred eeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCC
Confidence 999999984321 4678899999999999999876541 256778887763
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=3.9e-15 Score=145.11 Aligned_cols=129 Identities=25% Similarity=0.226 Sum_probs=98.8
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+++.|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .++.+++|+.|+|++|+|+ ..+..+..+++|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccc
Confidence 46889999999999777778999999999999999998 444 4678889999999999988 45667888888888888
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCcc
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLD 196 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~ 196 (621)
++|.+.+..+..+..+.+|+.|++++|.++.+++.. ..+++++.+++++|..
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l 160 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccc
Confidence 888877666666666667777777777666666554 4456666666666653
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.51 E-value=9.1e-15 Score=124.32 Aligned_cols=101 Identities=27% Similarity=0.324 Sum_probs=89.6
Q ss_pred cEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccC
Q 007020 92 QYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNN 171 (621)
Q Consensus 92 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 171 (621)
++|+|++|+|+ .++ .+.++++|++|+|++|+|+ .+|+.|..+++|+.|++++|+|++ +| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 57999999999 555 5899999999999999999 678889999999999999999995 44 5899999999999999
Q ss_pred cCcccCCC--CCCCCCcccccccCCccc
Q 007020 172 RLSGVVPD--NGSFSLFTPISFANNLDL 197 (621)
Q Consensus 172 ~l~~~~~~--~~~~~~l~~l~l~~N~~~ 197 (621)
+|+..+.. ...+++|+.|++++|+..
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 99987652 377899999999999853
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=2.8e-14 Score=140.37 Aligned_cols=131 Identities=24% Similarity=0.233 Sum_probs=79.0
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeec-cccCCCCCCccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLY-LNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+++|+|++|+|+...+..|.++++|++|++++|+|..+.+..+.+++.+..|++. .|.++...+..|.++++|+.|+
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~ 111 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence 357899999999997777789999999999999998876555555555555554432 3344433344455555555555
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCC-CCCCCcccccccCCc
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNL 195 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~ 195 (621)
|++|.+....+..+..+.+|+.+++++|+|+++++.. ..+++|+.|++++|.
T Consensus 112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~ 164 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR 164 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCc
Confidence 5555554444444444555555555555555544433 334445555555543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=1.1e-14 Score=130.03 Aligned_cols=111 Identities=21% Similarity=0.130 Sum_probs=95.9
Q ss_pred ccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccccccccCCCCCCCccCCcc
Q 007020 83 SQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISS 162 (621)
Q Consensus 83 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 162 (621)
+.|.+..+|++|+|++|+|+ .++..+..+++|+.|+|++|+|+ .++ .|..+++|+.|+|++|+|+...+..+..+++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred HhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccc
Confidence 34678889999999999999 55777788999999999999999 454 5899999999999999999655555678999
Q ss_pred ccEEeeccCcCcccCC--CCCCCCCcccccccCCcc
Q 007020 163 LQVLDLSNNRLSGVVP--DNGSFSLFTPISFANNLD 196 (621)
Q Consensus 163 L~~L~l~~N~l~~~~~--~~~~~~~l~~l~l~~N~~ 196 (621)
|+.|++++|+|+.... ....+++|+.|++++|+.
T Consensus 89 L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i 124 (162)
T d1a9na_ 89 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 124 (162)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGG
T ss_pred cccceeccccccccccccccccccccchhhcCCCcc
Confidence 9999999999997754 346789999999999985
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=4.3e-14 Score=125.31 Aligned_cols=103 Identities=23% Similarity=0.159 Sum_probs=82.0
Q ss_pred EEcCCCCccccCcccccCCCCCcEEEeeeC-CCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccccccc
Q 007020 70 VDLGNAALSGQLVSQLGLLKNLQYLELYSN-NITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNS 148 (621)
Q Consensus 70 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 148 (621)
++++++++. ..|..+..+++|++|+|++| .|+.+.+..|.++++|+.|+|++|+|+.+.+..|..+++|++|+|++|+
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 455566666 46777888999999999766 5887777889999999999999999997778889999999999999999
Q ss_pred cCCCCCCCccCCccccEEeeccCcCc
Q 007020 149 LSGPIPMSLTNISSLQVLDLSNNRLS 174 (621)
Q Consensus 149 l~~~~p~~~~~l~~L~~L~l~~N~l~ 174 (621)
|+...+..| ...+|+.|+|++|++.
T Consensus 92 l~~l~~~~~-~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 92 LESLSWKTV-QGLSLQELVLSGNPLH 116 (156)
T ss_dssp CSCCCSTTT-CSCCCCEEECCSSCCC
T ss_pred CcccChhhh-ccccccccccCCCccc
Confidence 984444444 4446888888888875
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.43 E-value=1.3e-13 Score=137.01 Aligned_cols=131 Identities=25% Similarity=0.313 Sum_probs=113.8
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRL 144 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 144 (621)
.+|+.+++++|+++. +|..+ +++|+.|+|++|.+++..+..|.+++.++.|++++|.|++..+..|.++++|+.|+|
T Consensus 150 ~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L 226 (305)
T d1xkua_ 150 KKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 226 (305)
T ss_dssp TTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred cccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeec
Confidence 578999999999984 45443 689999999999999899999999999999999999999888889999999999999
Q ss_pred cccccCCCCCCCccCCccccEEeeccCcCcccCCCC-------CCCCCcccccccCCcccCC
Q 007020 145 NNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN-------GSFSLFTPISFANNLDLCG 199 (621)
Q Consensus 145 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-------~~~~~l~~l~l~~N~~~~~ 199 (621)
++|+|+ .+|..|..+++|++|+|++|+|+.+.... ..+.+|+.|+|++|++.+.
T Consensus 227 ~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 227 NNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp CSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred cccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence 999999 67889999999999999999999875432 3457789999999997543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.41 E-value=2.6e-13 Score=125.79 Aligned_cols=124 Identities=29% Similarity=0.439 Sum_probs=101.4
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+|++|+|++|+|++..+ +.++++|++|++++|.+. .++ .+.++++|+.|++++|.+... +.+..+++|+.|+
T Consensus 61 l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~ 134 (199)
T d2omxa2 61 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLE 134 (199)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEE
T ss_pred CCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-ccccccccccccccccccccc--cccchhhhhHHhh
Confidence 4678999999999986433 888999999999999888 444 488899999999999988743 3478899999999
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
+++|++.. ++ .+..+++|+.|++++|+++++++ ...+++|+.|++++|+.
T Consensus 135 l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~~-l~~l~~L~~L~ls~N~i 184 (199)
T d2omxa2 135 LSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDLKP-LANLTTLERLDISSNKV 184 (199)
T ss_dssp CCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred hhhhhhcc-cc-cccccccccccccccccccCCcc-ccCCCCCCEEECCCCCC
Confidence 99999873 33 57888999999999999988754 57788999999999863
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=2.5e-13 Score=120.27 Aligned_cols=112 Identities=17% Similarity=0.068 Sum_probs=93.8
Q ss_pred CCCCcEEEeeeCCCCCCCcccccCCCccceeeeccc-cCCCCCCcccccccccccccccccccCCCCCCCccCCccccEE
Q 007020 88 LKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLN-SFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVL 166 (621)
Q Consensus 88 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 166 (621)
....+.++.++++++ ..|..+..+++|+.|+|++| .|+...++.|.++++|+.|+|++|+|+.+.+..|..+++|++|
T Consensus 7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (156)
T ss_dssp CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence 345567888888888 66778888999999999766 4886666779999999999999999997778889999999999
Q ss_pred eeccCcCcccCCCCCCCCCcccccccCCcccCCC
Q 007020 167 DLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGP 200 (621)
Q Consensus 167 ~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~ 200 (621)
+|++|+|+.+++......+|+.|+|++|++.|..
T Consensus 86 ~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 86 NLSFNALESLSWKTVQGLSLQELVLSGNPLHCSC 119 (156)
T ss_dssp ECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred eccCCCCcccChhhhccccccccccCCCcccCCc
Confidence 9999999988887765567899999999998754
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.33 E-value=1.5e-12 Score=121.60 Aligned_cols=124 Identities=28% Similarity=0.388 Sum_probs=99.5
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+|+.|+|++|+|++.. .+..+++|++|+|++|+|++ +| .+.++++|+.|++++|.+.. + ..+..+++|+.++
T Consensus 67 l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~ 140 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLY 140 (210)
T ss_dssp CTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEE
T ss_pred CCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-cccccccccccccccccccc-c-ccccccccccccc
Confidence 457889999999888643 36788999999999999884 44 58888999999999998873 3 3578888889999
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
+++|.+++ +..+..+++|+.+++++|+++++++ ...+++|+.|++++|..
T Consensus 141 ~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~-l~~l~~L~~L~Ls~N~i 190 (210)
T d1h6ta2 141 LGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHI 190 (210)
T ss_dssp CCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred cccccccc--ccccccccccccccccccccccccc-ccCCCCCCEEECCCCCC
Confidence 99888874 3356788899999999999987654 56788899999998864
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.33 E-value=1.4e-12 Score=120.66 Aligned_cols=124 Identities=26% Similarity=0.368 Sum_probs=106.4
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+++.|++++|+|+.. +.+..+++|++|+|++|+|++..| |.++++|++|++++|.+. .++ .+.++++|+.|+
T Consensus 39 l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~ 112 (199)
T d2omxa2 39 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLT 112 (199)
T ss_dssp HTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEE
T ss_pred hcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-cccccccccccc
Confidence 35789999999999853 358899999999999999996543 999999999999999998 454 488999999999
Q ss_pred ccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 144 LNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 144 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
+++|.+... ..+..+++|+.|++++|++..++ ....+++|+.|++.+|..
T Consensus 113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~-~l~~~~~L~~L~l~~n~l 162 (199)
T d2omxa2 113 LFNNQITDI--DPLKNLTNLNRLELSSNTISDIS-ALSGLTSLQQLNFSSNQV 162 (199)
T ss_dssp CCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCC
T ss_pred ccccccccc--cccchhhhhHHhhhhhhhhcccc-cccccccccccccccccc
Confidence 999999853 35788999999999999998654 457788999999999864
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.31 E-value=1.2e-12 Score=133.91 Aligned_cols=124 Identities=26% Similarity=0.307 Sum_probs=68.5
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCC----------------
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPI---------------- 129 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~---------------- 129 (621)
+++.|++++|.++.. +.+..+++|+.|++++|.+++.. .+..+++|+.|++++|++++..
T Consensus 220 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n 295 (384)
T d2omza2 220 NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNEN 295 (384)
T ss_dssp TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSS
T ss_pred CCCEEECCCCCCCCc--chhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCCcccccccccccccccc
Confidence 455566666655531 24455555555555555555332 2455555555555555544221
Q ss_pred ----CcccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 130 ----PDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 130 ----p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
...+..+++|+.|+|++|++++.. .+..+++|+.|++++|+|++++ ....+++|+.|++++|..
T Consensus 296 ~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l~-~l~~l~~L~~L~l~~N~l 363 (384)
T d2omza2 296 QLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDVS-SLANLTNINWLSAGHNQI 363 (384)
T ss_dssp CCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECCSSCC
T ss_pred ccccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCCCh-hHcCCCCCCEEECCCCcC
Confidence 122445566666666666666432 2566666667777666666543 345566666666666653
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.31 E-value=1.2e-14 Score=134.48 Aligned_cols=122 Identities=23% Similarity=0.295 Sum_probs=95.1
Q ss_pred EEcCCC--CccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccccccc
Q 007020 70 VDLGNA--ALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNN 147 (621)
Q Consensus 70 L~L~~n--~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 147 (621)
++|.++ .+. .++..+..|++|++|+|++|+|+. ++ .|.+|++|+.|+|++|+|+ .+|..+..+++|+.|++++|
T Consensus 28 ~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N 103 (198)
T d1m9la_ 28 VELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYN 103 (198)
T ss_dssp EECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEE
T ss_pred eeeecccCchh-hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccc
Confidence 444443 343 456778889999999999999984 44 5888999999999999988 56766667788999999999
Q ss_pred ccCCCCCCCccCCccccEEeeccCcCcccCC--CCCCCCCcccccccCCccc
Q 007020 148 SLSGPIPMSLTNISSLQVLDLSNNRLSGVVP--DNGSFSLFTPISFANNLDL 197 (621)
Q Consensus 148 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~~l~~l~l~~N~~~ 197 (621)
+|+. ++ .+..+++|+.|++++|+|+.... ....+++|+.|++++|+..
T Consensus 104 ~i~~-l~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 104 QIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp ECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred cccc-cc-cccccccccccccccchhccccccccccCCCccceeecCCCccc
Confidence 9884 33 47788899999999999987653 3477888999999999753
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.29 E-value=2.8e-12 Score=119.71 Aligned_cols=122 Identities=30% Similarity=0.311 Sum_probs=105.1
Q ss_pred CCCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccc
Q 007020 63 NDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFL 142 (621)
Q Consensus 63 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 142 (621)
...+|+.|+|++|+|++ ++ .+..+++|+.|++++|.++. + ..+.++++|+.+++++|.+++ +..+..+++|+.+
T Consensus 88 ~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l 161 (210)
T d1h6ta2 88 NLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTL 161 (210)
T ss_dssp TCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEE
T ss_pred cCccccccccccccccc-cc-cccccccccccccccccccc-c-ccccccccccccccccccccc--ccccccccccccc
Confidence 35689999999999995 44 58999999999999999984 3 368999999999999999984 3457889999999
Q ss_pred cccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccC
Q 007020 143 RLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFAN 193 (621)
Q Consensus 143 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~ 193 (621)
++++|++++. + .+.++++|+.|+|++|+|+.++ ....+++|+.|++++
T Consensus 162 ~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 162 SLEDNQISDI-V-PLAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp ECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCBCG-GGTTCTTCSEEEEEE
T ss_pred cccccccccc-c-cccCCCCCCEEECCCCCCCCCh-hhcCCCCCCEEEccC
Confidence 9999999964 3 3889999999999999999764 467889999999874
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.28 E-value=2.9e-14 Score=131.87 Aligned_cols=122 Identities=21% Similarity=0.225 Sum_probs=101.1
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccc
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLR 143 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 143 (621)
..+|+.|+|++|+|+. ++ .|..+++|++|+|++|+|+ .+|..+..+++|+.|++++|+|+. + +.+..+++|+.|+
T Consensus 47 L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L~~L~ 121 (198)
T d1m9la_ 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNLRVLY 121 (198)
T ss_dssp TTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHSSEEE
T ss_pred ccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccccccccccc
Confidence 4689999999999995 44 5899999999999999999 567666777899999999999994 4 3588999999999
Q ss_pred ccccccCCCCC-CCccCCccccEEeeccCcCcccCCCC-----------CCCCCccccc
Q 007020 144 LNNNSLSGPIP-MSLTNISSLQVLDLSNNRLSGVVPDN-----------GSFSLFTPIS 190 (621)
Q Consensus 144 l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~-----------~~~~~l~~l~ 190 (621)
|++|+|+.... ..+..+++|+.|++++|++....+.. ..+++|+.||
T Consensus 122 L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp ESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 99999984322 46889999999999999998776653 2356676665
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.27 E-value=1e-12 Score=130.89 Aligned_cols=108 Identities=37% Similarity=0.564 Sum_probs=100.0
Q ss_pred CCCcEEEeeeCCCCC--CCcccccCCCccceeeecc-ccCCCCCCcccccccccccccccccccCCCCCCCccCCccccE
Q 007020 89 KNLQYLELYSNNITG--PIPSDLGNLTSLVSLDLYL-NSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQV 165 (621)
Q Consensus 89 ~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 165 (621)
.+++.|+|++|.+++ .+|..+++|++|++|+|++ |+++|.+|..|++|++|++|+|++|+|.+..+..+..+.+|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 479999999999998 4889999999999999997 8999999999999999999999999999989999999999999
Q ss_pred EeeccCcCcccCCCC-CCCCCcccccccCCcc
Q 007020 166 LDLSNNRLSGVVPDN-GSFSLFTPISFANNLD 196 (621)
Q Consensus 166 L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~ 196 (621)
+++++|.+.+..|.. ..++.++.+++++|..
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l 161 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred cccccccccccCchhhccCcccceeecccccc
Confidence 999999999887654 7889999999999965
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=5.4e-12 Score=120.47 Aligned_cols=97 Identities=18% Similarity=0.294 Sum_probs=71.4
Q ss_pred ccceeeEEcCC----------CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCC-cccccCCCccceeeecc
Q 007020 54 CTWFHVTCNND----------NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPI-PSDLGNLTSLVSLDLYL 122 (621)
Q Consensus 54 c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~ 122 (621)
|....|.|... .++++|||++|.|+...+..|.++++|++|+|++|.+...+ +..|.+++++++|++..
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 45666777531 36889999999999766778999999999999999887543 44677777777777653
Q ss_pred -ccCCCCCCcccccccccccccccccccC
Q 007020 123 -NSFTGPIPDTLGKLSKLRFLRLNNNSLS 150 (621)
Q Consensus 123 -N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 150 (621)
|++....+..|.++++|+.|++++|.+.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~ 116 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIK 116 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred cccccccccccccccccccccccchhhhc
Confidence 5666556666777777777777777665
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.23 E-value=1.1e-11 Score=117.22 Aligned_cols=126 Identities=26% Similarity=0.409 Sum_probs=94.9
Q ss_pred CCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCC-------------
Q 007020 64 DNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIP------------- 130 (621)
Q Consensus 64 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p------------- 130 (621)
..+|+.|+|++|.|++..+ +..+++|++|++++|.++. ++ .+.++++|+.|++++|.+.+..+
T Consensus 62 l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~ 137 (227)
T d1h6ua2 62 LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLD 137 (227)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECC
T ss_pred CCCCcEeecCCceeecccc--ccccccccccccccccccc-cc-cccccccccccccccccccccchhccccchhhhhch
Confidence 5688888888888885443 7888888888888888873 43 57788888888888887663211
Q ss_pred -------cccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCCcc
Q 007020 131 -------DTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 131 -------~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 196 (621)
..+.++++|+.|++++|.+.+.. .+.++++|+.|+|++|+++++++ ...+++|+.|++++|+.
T Consensus 138 ~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~~-l~~l~~L~~L~Ls~N~l 207 (227)
T d1h6ua2 138 LNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQI 207 (227)
T ss_dssp SSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCC
T ss_pred hhhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCCChh-hcCCCCCCEEECcCCcC
Confidence 23456777888888888887432 37788888899998888887643 56778888888888863
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.21 E-value=1.2e-11 Score=116.73 Aligned_cols=122 Identities=28% Similarity=0.395 Sum_probs=96.2
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCc--------------------ccccCCCccceeeecccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIP--------------------SDLGNLTSLVSLDLYLNS 124 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p--------------------~~~~~l~~L~~L~L~~N~ 124 (621)
.+++.|++++|.++. + +.+..+++|++|++++|.+.+..+ ..+.++++|+.|++++|.
T Consensus 85 ~~l~~l~~~~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~ 162 (227)
T d1h6ua2 85 TKITELELSGNPLKN-V-SAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQ 162 (227)
T ss_dssp CSCCEEECCSCCCSC-C-GGGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSC
T ss_pred ccccccccccccccc-c-ccccccccccccccccccccccchhccccchhhhhchhhhhchhhhhccccccccccccccc
Confidence 577888888888773 3 346777778777777776553211 235778889999999999
Q ss_pred CCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccC
Q 007020 125 FTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFAN 193 (621)
Q Consensus 125 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~ 193 (621)
+++. ..+.++++|+.|+|++|++++. + .+.++++|++|+|++|+|+++++ ...+++|+.|++++
T Consensus 163 ~~~~--~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~-l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 163 VSDL--TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTN 226 (227)
T ss_dssp CCCC--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEE
T ss_pred cccc--hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc-cccCCCCCEEEeeC
Confidence 9843 3488999999999999999954 3 38899999999999999998765 67889999999874
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.15 E-value=3.2e-11 Score=123.08 Aligned_cols=123 Identities=28% Similarity=0.454 Sum_probs=86.0
Q ss_pred CcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCc--------------------ccccCCCccceeeecccc
Q 007020 65 NSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIP--------------------SDLGNLTSLVSLDLYLNS 124 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p--------------------~~~~~l~~L~~L~L~~N~ 124 (621)
.+++.|++++|.+++.. .+..+++|++|++++|++++..+ ..+..+++|+.|+|++|+
T Consensus 241 ~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~ 318 (384)
T d2omza2 241 TNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNN 318 (384)
T ss_dssp TTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSC
T ss_pred cccchhccccCccCCCC--cccccccCCEeeccCcccCCCCccccccccccccccccccccccccchhcccCeEECCCCC
Confidence 46777888888777543 26677777888777777764321 235556677777777777
Q ss_pred CCCCCCcccccccccccccccccccCCCCCCCccCCccccEEeeccCcCcccCCCCCCCCCcccccccCC
Q 007020 125 FTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANN 194 (621)
Q Consensus 125 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N 194 (621)
|++. + .+..+++|+.|+|++|+|++ ++ .+.++++|++|++++|+|+++++ ...+++|+.|++++|
T Consensus 319 l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 319 ISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp CSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred CCCC-c-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence 7754 2 36777788888888887774 33 57777788888888888777665 566777777777776
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.94 E-value=8.5e-10 Score=104.74 Aligned_cols=130 Identities=19% Similarity=0.200 Sum_probs=100.6
Q ss_pred EEcCCCcEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCC-Ccccccccc
Q 007020 60 TCNNDNSVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPI-PDTLGKLSK 138 (621)
Q Consensus 60 ~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~ 138 (621)
.|++.+ +.++.++++++ .+|+.+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+ +..|.++++
T Consensus 5 ~C~C~~--~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~ 79 (242)
T d1xwdc1 5 ICHCSN--RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79 (242)
T ss_dssp SEEECS--SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTT
T ss_pred cCCCcC--CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccc
Confidence 355444 35888899999 6666553 68999999999999666678999999999999999998654 456899999
Q ss_pred cccccccc-cccCCCCCCCccCCccccEEeeccCcCcccCCCC--CCCCCcccccccCC
Q 007020 139 LRFLRLNN-NSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN--GSFSLFTPISFANN 194 (621)
Q Consensus 139 L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~~l~~l~l~~N 194 (621)
++.|++.. |++....+..|.++++|+.|++++|.+...++.. ..+..+..+...++
T Consensus 80 l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~ 138 (242)
T d1xwdc1 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI 138 (242)
T ss_dssp CCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCT
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccccccccccccccc
Confidence 99998864 7788778888999999999999999998765432 23344444344433
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.81 E-value=5.6e-09 Score=104.41 Aligned_cols=101 Identities=30% Similarity=0.360 Sum_probs=81.5
Q ss_pred cEEEEEcCCCCccccCcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCccccccccccccccc
Q 007020 66 SVIRVDLGNAALSGQLVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLN 145 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 145 (621)
+++.|||++|+|+ .+|+. +++|++|+|++|+|+ .+|.. +.+|+.|++++|+++ .+++. .+.|++|+|+
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 5788999999998 46653 578999999999999 67755 457899999999998 45432 2469999999
Q ss_pred ccccCCCCCCCccCCccccEEeeccCcCcccCCCC
Q 007020 146 NNSLSGPIPMSLTNISSLQVLDLSNNRLSGVVPDN 180 (621)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~ 180 (621)
+|.+. .+|. +..+++|+.|++++|.+...+...
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~~ 139 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDLP 139 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCCC
T ss_pred ccccc-cccc-hhhhccceeecccccccccccccc
Confidence 99998 5564 578999999999999998776543
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.60 E-value=4.5e-10 Score=99.61 Aligned_cols=105 Identities=22% Similarity=0.164 Sum_probs=56.8
Q ss_pred ccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCC--CcccccccccccccccccccCCCCCCCccCCcc
Q 007020 85 LGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPI--PDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISS 162 (621)
Q Consensus 85 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 162 (621)
+..+..+..|++.+|.++ .++..+..+++|++|+|++|+|+..- +..+..+++|+.|+|++|.|+...+-.+....+
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~ 116 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence 333444444444444433 33444456667777777777776432 234556677777777777776332212223345
Q ss_pred ccEEeeccCcCcccCCC--------CCCCCCccccc
Q 007020 163 LQVLDLSNNRLSGVVPD--------NGSFSLFTPIS 190 (621)
Q Consensus 163 L~~L~l~~N~l~~~~~~--------~~~~~~l~~l~ 190 (621)
|+.|++++|+++..... ...+++|+.||
T Consensus 117 L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 117 LEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 67777777777654332 13456666553
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.53 E-value=1.3e-07 Score=94.26 Aligned_cols=96 Identities=27% Similarity=0.283 Sum_probs=78.7
Q ss_pred CCCcEEEeeeCCCCCCCcccccCCCccceeeeccccCCCCCCcccccccccccccccccccCCCCCCCccCCccccEEee
Q 007020 89 KNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMSLTNISSLQVLDL 168 (621)
Q Consensus 89 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 168 (621)
.+|+.|+|++|.|+ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++.. .++|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 47899999999999 67753 578999999999999 778754 57889999999998 44432 246999999
Q ss_pred ccCcCcccCCCCCCCCCcccccccCCccc
Q 007020 169 SNNRLSGVVPDNGSFSLFTPISFANNLDL 197 (621)
Q Consensus 169 ~~N~l~~~~~~~~~~~~l~~l~l~~N~~~ 197 (621)
++|.|+.++. ...+++|+.|++++|...
T Consensus 106 ~~n~l~~lp~-~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 106 SNNQLEKLPE-LQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp CSSCCSSCCC-CTTCTTCCEEECCSSCCS
T ss_pred cccccccccc-hhhhccceeecccccccc
Confidence 9999998764 567899999999988753
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.49 E-value=5.5e-09 Score=101.62 Aligned_cols=37 Identities=19% Similarity=0.180 Sum_probs=20.4
Q ss_pred CCccccEEeeccCc-CcccCC-CCCCCCCcccccccCCc
Q 007020 159 NISSLQVLDLSNNR-LSGVVP-DNGSFSLFTPISFANNL 195 (621)
Q Consensus 159 ~l~~L~~L~l~~N~-l~~~~~-~~~~~~~l~~l~l~~N~ 195 (621)
++++|+.|++++|. +++... ....+++|+.|+++++.
T Consensus 173 ~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~ 211 (284)
T d2astb2 173 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 211 (284)
T ss_dssp HCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred ccccccccccccccCCCchhhhhhcccCcCCEEECCCCC
Confidence 35667777776643 443222 22455666666666643
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.43 E-value=6e-09 Score=92.11 Aligned_cols=92 Identities=25% Similarity=0.118 Sum_probs=70.4
Q ss_pred cCcccccCCCCCcEEEeeeCCCCCCC--cccccCCCccceeeeccccCCCCCCcccccccccccccccccccCCCCCCC-
Q 007020 80 QLVSQLGLLKNLQYLELYSNNITGPI--PSDLGNLTSLVSLDLYLNSFTGPIPDTLGKLSKLRFLRLNNNSLSGPIPMS- 156 (621)
Q Consensus 80 ~~~~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~- 156 (621)
.++..+..+++|++|+|++|+|+... +..+..+++|+.|+|++|+|+...+-.+....+|+.|+|++|.++......
T Consensus 56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~ 135 (162)
T d1koha1 56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQS 135 (162)
T ss_dssp HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHH
T ss_pred hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccch
Confidence 44555667999999999999999653 456788999999999999999543324445568999999999998654432
Q ss_pred ------ccCCccccEEeeccCcC
Q 007020 157 ------LTNISSLQVLDLSNNRL 173 (621)
Q Consensus 157 ------~~~l~~L~~L~l~~N~l 173 (621)
+..+|+|+.|| ++.+
T Consensus 136 ~y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 136 TYISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp HHHHHHHTTSTTCCEET--TEEC
T ss_pred hHHHHHHHHCCCCCEEC--cCCC
Confidence 56789999886 5444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.43 E-value=7.8e-07 Score=84.74 Aligned_cols=149 Identities=14% Similarity=0.077 Sum_probs=99.3
Q ss_pred HHHHHhcCCCcCceeeeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhcc-CCceeeeeeeeecCCce
Q 007020 290 ELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTER 368 (621)
Q Consensus 290 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 368 (621)
++...-+.|+..+..+.++.+.||+... +++.+.+|+...... .....+.+|...+..+. +--+-+++.+...++..
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 4444456666655544444578999875 466678888754321 12234677888877664 33355677777778889
Q ss_pred EEEEeccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 007020 369 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC------------------------------- 417 (621)
Q Consensus 369 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~------------------------------- 417 (621)
++||++++|.++.+..... .....++.++++.++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEeccccccccccccc---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 9999999998876554321 122335556666666666420
Q ss_pred -------------------------CCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 418 -------------------------DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 418 -------------------------~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
.+.++|+|+.|.||++++++.+-|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12488999999999999876667999998864
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.38 E-value=7.8e-09 Score=107.20 Aligned_cols=111 Identities=28% Similarity=0.341 Sum_probs=85.9
Q ss_pred cEEEEEcCCCCccccC-cccccCCCCCcEEEeeeCCCCC----CCcccccCCCccceeeeccccCCCC----CCcccc-c
Q 007020 66 SVIRVDLGNAALSGQL-VSQLGLLKNLQYLELYSNNITG----PIPSDLGNLTSLVSLDLYLNSFTGP----IPDTLG-K 135 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~-~ 135 (621)
+|+.||++.|+|++.. ...+..+++|+.|+|++|+|+. .++..+..+++|++|||++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 6899999999998643 4456778999999999999983 3455678899999999999998621 112222 2
Q ss_pred ccccccccccccccCCC----CCCCccCCccccEEeeccCcCccc
Q 007020 136 LSKLRFLRLNNNSLSGP----IPMSLTNISSLQVLDLSNNRLSGV 176 (621)
Q Consensus 136 l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~ 176 (621)
..+|+.|+|++|++++. ++..+..+++|+.|+|++|.|+..
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~ 127 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDA 127 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhh
Confidence 35799999999999743 345677889999999999998753
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.35 E-value=7.5e-09 Score=100.63 Aligned_cols=134 Identities=21% Similarity=0.235 Sum_probs=90.9
Q ss_pred CcEEEEEcCCCCcccc-CcccccCCCCCcEEEeeeCCCCCCCcccccCCCccceeeeccc-cCCCC-CCccccccccccc
Q 007020 65 NSVIRVDLGNAALSGQ-LVSQLGLLKNLQYLELYSNNITGPIPSDLGNLTSLVSLDLYLN-SFTGP-IPDTLGKLSKLRF 141 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~ 141 (621)
.+|+.|||+++.++.. +...+.++++|++|+|+++.+++..+..+..+++|++|+|+++ .++.. +...+.++++|+.
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 4688899998888743 3456788899999999999888777778888899999999884 56521 1222456788999
Q ss_pred cccccc-ccCCC-CCCCcc-CCccccEEeeccC--cCccc--CCCCCCCCCcccccccCCcccC
Q 007020 142 LRLNNN-SLSGP-IPMSLT-NISSLQVLDLSNN--RLSGV--VPDNGSFSLFTPISFANNLDLC 198 (621)
Q Consensus 142 L~l~~N-~l~~~-~p~~~~-~l~~L~~L~l~~N--~l~~~--~~~~~~~~~l~~l~l~~N~~~~ 198 (621)
|+|+++ .++.. +...+. ..++|+.|+++++ .++.. ..-...+++|+.|++++|..+.
T Consensus 126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~it 189 (284)
T d2astb2 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLK 189 (284)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCC
T ss_pred cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCC
Confidence 999885 44421 111222 2467889988864 34321 1111456788899998876554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.29 E-value=1e-08 Score=102.59 Aligned_cols=131 Identities=21% Similarity=0.157 Sum_probs=81.4
Q ss_pred cEEEEEcCCCCcccc----CcccccCCCCCcEEEeeeCCCCCC-----CcccccCCCccceeeeccccCCCC----CCcc
Q 007020 66 SVIRVDLGNAALSGQ----LVSQLGLLKNLQYLELYSNNITGP-----IPSDLGNLTSLVSLDLYLNSFTGP----IPDT 132 (621)
Q Consensus 66 ~l~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~ 132 (621)
.++.|++++|.++.. +...+...+.|++|+|++|+|+.. +...+..+++|+.|+|++|.|+.. +...
T Consensus 159 ~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 238 (344)
T d2ca6a1 159 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 238 (344)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred ccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccc
Confidence 455666666665522 233455667788888888887631 234466777888888888877532 2344
Q ss_pred cccccccccccccccccCCCCCCC----cc--CCccccEEeeccCcCcccCC-----CC-CCCCCcccccccCCcc
Q 007020 133 LGKLSKLRFLRLNNNSLSGPIPMS----LT--NISSLQVLDLSNNRLSGVVP-----DN-GSFSLFTPISFANNLD 196 (621)
Q Consensus 133 ~~~l~~L~~L~l~~N~l~~~~p~~----~~--~l~~L~~L~l~~N~l~~~~~-----~~-~~~~~l~~l~l~~N~~ 196 (621)
+..+++|+.|+|++|.|.+..... +. ..++|+.|++++|+|+.... .. ..++.|+.|++++|..
T Consensus 239 l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~ 314 (344)
T d2ca6a1 239 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 314 (344)
T ss_dssp GGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred ccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcC
Confidence 667788888888888876431111 22 23568888888888764211 11 1356678888888764
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.15 E-value=4.3e-08 Score=97.96 Aligned_cols=131 Identities=19% Similarity=0.201 Sum_probs=82.5
Q ss_pred CcEEEEEcCCCCcccc----CcccccCCCCCcEEEeeeCCCCCCCcc-------------cccCCCccceeeeccccCCC
Q 007020 65 NSVIRVDLGNAALSGQ----LVSQLGLLKNLQYLELYSNNITGPIPS-------------DLGNLTSLVSLDLYLNSFTG 127 (621)
Q Consensus 65 ~~l~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~-------------~~~~l~~L~~L~L~~N~l~~ 127 (621)
++|+.|+|++|.++.. +...+...++|+.|+|++|.++..-.. .....+.|+.|++++|+++.
T Consensus 93 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~ 172 (344)
T d2ca6a1 93 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 172 (344)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccc
Confidence 4677788888877653 333455667788888887776521100 11345677777777777662
Q ss_pred C----CCcccccccccccccccccccCCC-----CCCCccCCccccEEeeccCcCccc-----CCCCCCCCCcccccccC
Q 007020 128 P----IPDTLGKLSKLRFLRLNNNSLSGP-----IPMSLTNISSLQVLDLSNNRLSGV-----VPDNGSFSLFTPISFAN 193 (621)
Q Consensus 128 ~----~p~~~~~l~~L~~L~l~~N~l~~~-----~p~~~~~l~~L~~L~l~~N~l~~~-----~~~~~~~~~l~~l~l~~ 193 (621)
. +...+...+.|+.|+|++|+|... +...+..+++|+.|+|++|.|+.. ......+++|+.|+|++
T Consensus 173 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~ 252 (344)
T d2ca6a1 173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 252 (344)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred cccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhc
Confidence 2 222345567788888888887631 334566777888888888887542 11224566788888877
Q ss_pred Cc
Q 007020 194 NL 195 (621)
Q Consensus 194 N~ 195 (621)
|.
T Consensus 253 n~ 254 (344)
T d2ca6a1 253 CL 254 (344)
T ss_dssp CC
T ss_pred Cc
Confidence 74
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.13 E-value=5.6e-06 Score=78.13 Aligned_cols=131 Identities=15% Similarity=0.062 Sum_probs=86.7
Q ss_pred eeeeccC-ceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccC--CceeeeeeeeecCCceEEEEeccCCCc
Q 007020 303 ILGRGGF-GKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH--RNLLRLRGFCMTPTERLLVYPYMANGS 379 (621)
Q Consensus 303 ~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gs 379 (621)
.+..|.. +.||+....++..+++|.-.... ...+..|...++.+.. -.+.+++++..+++..++||+|++|.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 3455554 67999998888889999865433 2246778887776653 235567888788888999999999866
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 007020 380 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD-------------------------------------------- 415 (621)
Q Consensus 380 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-------------------------------------------- 415 (621)
+.+.. .. ...++.++++.|+-||+
T Consensus 93 ~~~~~---------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
T d1nd4a_ 93 LLSSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 160 (255)
T ss_dssp TTTSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred ccccc---------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence 54321 00 11122233333333332
Q ss_pred -------C----CCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 416 -------H----CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 416 -------~----~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
. ..+.++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1 122489999999999999876678999998764
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.98 E-value=8.3e-08 Score=99.21 Aligned_cols=108 Identities=20% Similarity=0.208 Sum_probs=81.9
Q ss_pred CCCcEEEeeeCCCCCCC-cccccCCCccceeeeccccCCC----CCCcccccccccccccccccccCCC----CCCCcc-
Q 007020 89 KNLQYLELYSNNITGPI-PSDLGNLTSLVSLDLYLNSFTG----PIPDTLGKLSKLRFLRLNNNSLSGP----IPMSLT- 158 (621)
Q Consensus 89 ~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~- 158 (621)
.+|+.|||++|+|++.. ...+..+++|+.|+|++|.|+. .+...+..+++|+.|||++|+|+.. +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 36899999999999532 3446778999999999999873 2345567899999999999998621 222232
Q ss_pred CCccccEEeeccCcCcccC-----CCCCCCCCcccccccCCcc
Q 007020 159 NISSLQVLDLSNNRLSGVV-----PDNGSFSLFTPISFANNLD 196 (621)
Q Consensus 159 ~l~~L~~L~l~~N~l~~~~-----~~~~~~~~l~~l~l~~N~~ 196 (621)
...+|+.|+|++|+|+... .....+++|+.|++++|..
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i 124 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLL 124 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBC
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccc
Confidence 2357999999999997642 2235678999999999963
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.77 E-value=1.1e-06 Score=77.36 Aligned_cols=86 Identities=16% Similarity=0.154 Sum_probs=48.8
Q ss_pred CcEEEEEcCCC-Ccccc----CcccccCCCCCcEEEeeeCCCCC----CCcccccCCCccceeeeccccCCCC----CCc
Q 007020 65 NSVIRVDLGNA-ALSGQ----LVSQLGLLKNLQYLELYSNNITG----PIPSDLGNLTSLVSLDLYLNSFTGP----IPD 131 (621)
Q Consensus 65 ~~l~~L~L~~n-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~ 131 (621)
.+|+.|+|+++ .++.. +-..+...++|++|+|++|.++. .+...+...+.|+.|+|++|.|+.. +-.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 45777777763 45432 23345566677777777777662 2223444556677777777766632 112
Q ss_pred ccccccccccccccccccC
Q 007020 132 TLGKLSKLRFLRLNNNSLS 150 (621)
Q Consensus 132 ~~~~l~~L~~L~l~~N~l~ 150 (621)
.+...++|+.|+|++|.+.
T Consensus 95 aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HTTTTCCCSEEECCCCSSC
T ss_pred HHHhCCcCCEEECCCCcCC
Confidence 2344455666666666544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.65 E-value=6.7e-05 Score=75.42 Aligned_cols=77 Identities=12% Similarity=0.037 Sum_probs=47.9
Q ss_pred ceeeeccCceEEEEEcCC-CcEEEEEEeccc------CCchhHHHHHHHHHHHHhcc-C--CceeeeeeeeecCCceEEE
Q 007020 302 NILGRGGFGKVYKGRLAD-GSLVAVKRLKEE------RTPGGELQFQTEVEMISMAV-H--RNLLRLRGFCMTPTERLLV 371 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~------~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv 371 (621)
+.||.|....||+....+ ++.|+||.-... ..+....+...|.+.++.+. + ..+.+++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998754 678999964321 11112223456777776553 2 334455544 45667899
Q ss_pred EeccCCCch
Q 007020 372 YPYMANGSV 380 (621)
Q Consensus 372 ~e~~~~gsL 380 (621)
||++.+..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999987543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.17 E-value=2.8e-05 Score=68.09 Aligned_cols=109 Identities=12% Similarity=0.099 Sum_probs=75.0
Q ss_pred cCCCCCcEEEeee-CCCCCC----CcccccCCCccceeeeccccCCCC----CCcccccccccccccccccccCCC----
Q 007020 86 GLLKNLQYLELYS-NNITGP----IPSDLGNLTSLVSLDLYLNSFTGP----IPDTLGKLSKLRFLRLNNNSLSGP---- 152 (621)
Q Consensus 86 ~~l~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~---- 152 (621)
.+.++|++|+|++ |.++.. +-..+...+.|+.|+|++|.|... +...+...+.|+.|+|++|.|...
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 4568999999997 457632 334577888999999999998732 234456678999999999998842
Q ss_pred CCCCccCCccccEEeeccCcCcccCCC--------CCCCCCcccccccCC
Q 007020 153 IPMSLTNISSLQVLDLSNNRLSGVVPD--------NGSFSLFTPISFANN 194 (621)
Q Consensus 153 ~p~~~~~l~~L~~L~l~~N~l~~~~~~--------~~~~~~l~~l~l~~N 194 (621)
+-..+...++|+.|++++|.+..+... ....++|+.|+++.+
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 222456668899999999876643211 122455666666544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.10 E-value=1.4e-05 Score=69.97 Aligned_cols=108 Identities=16% Similarity=0.174 Sum_probs=60.4
Q ss_pred CcEEEEEcCC-CCcccc----CcccccCCCCCcEEEeeeCCCCCC----CcccccCCCccceeeeccccCCCC----CCc
Q 007020 65 NSVIRVDLGN-AALSGQ----LVSQLGLLKNLQYLELYSNNITGP----IPSDLGNLTSLVSLDLYLNSFTGP----IPD 131 (621)
Q Consensus 65 ~~l~~L~L~~-n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~ 131 (621)
..|+.|+|++ +.|+.. +...+...++|++|+|++|.++.. +...+...++|+.|++++|.++.. +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 4677777776 445432 334455677777777777777632 223445567777777777776522 123
Q ss_pred cccccccccc--ccccccccCC----CCCCCccCCccccEEeeccCc
Q 007020 132 TLGKLSKLRF--LRLNNNSLSG----PIPMSLTNISSLQVLDLSNNR 172 (621)
Q Consensus 132 ~~~~l~~L~~--L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~ 172 (621)
.+...++|+. |++++|.+.. .+...+...++|+.|+++.|.
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 4455566664 3344555542 122233445566666665543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.99 E-value=0.0014 Score=63.59 Aligned_cols=136 Identities=15% Similarity=0.112 Sum_probs=76.9
Q ss_pred ceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCce--eeeee-----eeecCCceEEEEeccCCCchhh
Q 007020 310 GKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL--LRLRG-----FCMTPTERLLVYPYMANGSVAS 382 (621)
Q Consensus 310 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL~~ 382 (621)
-.||++..++|+.|++|+.+.... ...++..|...+..+....+ +..+. .+......+.++++++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 589999999999999999875543 24567788888777653222 11111 1233456788999998743210
Q ss_pred --------------hhcc----CC-CCCCCCCHH----------------------HHHHHHHHHHHHHHHH-HhCCCCC
Q 007020 383 --------------CLRE----RP-PSQLPLDWP----------------------TRKRIALGSARGLSYL-HDHCDPK 420 (621)
Q Consensus 383 --------------~l~~----~~-~~~~~~~~~----------------------~~~~i~~~i~~~L~~L-H~~~~~~ 420 (621)
.++. .. ......++. .....+..+...+.-. .+....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0111 10 001111111 1112222222222222 1222447
Q ss_pred eEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 421 IIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 421 ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
+||+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 45899998764
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.52 E-value=2e-05 Score=68.93 Aligned_cols=115 Identities=18% Similarity=0.171 Sum_probs=80.3
Q ss_pred CcccccCCCCCcEEEeee-CCCCCC----CcccccCCCccceeeeccccCCCC----CCcccccccccccccccccccCC
Q 007020 81 LVSQLGLLKNLQYLELYS-NNITGP----IPSDLGNLTSLVSLDLYLNSFTGP----IPDTLGKLSKLRFLRLNNNSLSG 151 (621)
Q Consensus 81 ~~~~~~~l~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~ 151 (621)
+.....+.++|++|+|++ |.|+.. +-..+...++|+.|+|++|.|+.. +-..+...++|+.|++++|.+..
T Consensus 9 l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~ 88 (166)
T d1io0a_ 9 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 88 (166)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccc
Confidence 344456679999999998 567632 334567889999999999998743 22345677999999999999873
Q ss_pred C----CCCCccCCccccEEee--ccCcCcccC-----CCCCCCCCcccccccCCc
Q 007020 152 P----IPMSLTNISSLQVLDL--SNNRLSGVV-----PDNGSFSLFTPISFANNL 195 (621)
Q Consensus 152 ~----~p~~~~~l~~L~~L~l--~~N~l~~~~-----~~~~~~~~l~~l~l~~N~ 195 (621)
. +...+...++|+.++| ++|.+.... ......++|+.|+++.|.
T Consensus 89 ~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 89 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred hhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 2 2345667788987555 567775421 112356778888887664
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.51 E-value=0.0045 Score=61.60 Aligned_cols=72 Identities=15% Similarity=0.190 Sum_probs=47.9
Q ss_pred ceeeeccCceEEEEEcCC--------CcEEEEEEecccCCchhHHHHHHHHHHHHhccCCcee-eeeeeeecCCceEEEE
Q 007020 302 NILGRGGFGKVYKGRLAD--------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL-RLRGFCMTPTERLLVY 372 (621)
Q Consensus 302 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~ 372 (621)
+.|+.|-.-.+|+....+ .+.|.+++.- .. . ......+|..+++.+.-.+++ ++++++.+ .+|+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-E-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-C-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-c-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 468878888999997643 3456666654 22 2 233567888888877644444 67777642 6899
Q ss_pred eccCCCch
Q 007020 373 PYMANGSV 380 (621)
Q Consensus 373 e~~~~gsL 380 (621)
||++|.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.43 E-value=0.016 Score=55.34 Aligned_cols=160 Identities=9% Similarity=0.027 Sum_probs=82.6
Q ss_pred cCHHHHHHHhcCCCcCcee-----eeccCceEEEEEcCCCcEEEEEEecccCCchhHHHHHHHHHHHHhccCCc-----e
Q 007020 286 FSLRELQVATDSFSNKNIL-----GRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN-----L 355 (621)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~l-----G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-----i 355 (621)
++.++++...++|.+.+.. ..|---+.|+.+..+|+ |++|++..... ..++..|++++..+...+ .
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~---~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC---HHHHHHHHHHHHhhhhcccccccc
Confidence 4566777777888776543 35556788999876554 89998864322 223455666666654322 2
Q ss_pred eeee-e--eeecCCceEEEEeccCCCchhh--------------hhcc----CC-CCCCCCCH-----------------
Q 007020 356 LRLR-G--FCMTPTERLLVYPYMANGSVAS--------------CLRE----RP-PSQLPLDW----------------- 396 (621)
Q Consensus 356 v~l~-~--~~~~~~~~~lv~e~~~~gsL~~--------------~l~~----~~-~~~~~~~~----------------- 396 (621)
+... | +.........++.++.+..... .++. .. ........
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 2111 1 1122345566777766642211 0110 00 00000000
Q ss_pred -HHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeeCCCCcEEEccccccee
Q 007020 397 -PTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 449 (621)
Q Consensus 397 -~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 449 (621)
......+..+...+...+. ....++||+|+.+.||+++++...-|+||+.+..
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 0111112222222222221 1233899999999999999987778999998863
|